PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kluth, LA; Rieken, M; Xylinas, E; Kent, M; Rink, M; Roupret, M; Sharifi, N; Jamzadeh, A; Kassouf, W; Kaushik, D; Boorjian, SA; Roghmann, F; Noldus, J; Masson-Lecomte, A; Vordos, D; Ikeda, M; Matsumoto, K; Hagiwara, M; Kikuchi, E; Fradet, Y; Izawa, J; Rendon, R; Fairey, A; Lotan, Y; Bachmann, A; Zerbib, M; Fisch, M; Scherr, DS; Vickers, A; Shariat, SF				Kluth, Luis A.; Rieken, Malte; Xylinas, Evanguelos; Kent, Matthew; Rink, Michael; Roupret, Morgan; Sharifi, Nasim; Jamzadeh, Asha; Kassouf, Wassim; Kaushik, Dharam; Boorjian, Stephen A.; Roghmann, Florian; Noldus, Joachim; Masson-Lecomte, Alexandra; Vordos, Dimitri; Ikeda, Masaomi; Matsumoto, Kazumasa; Hagiwara, Masayuki; Kikuchi, Eiji; Fradet, Yves; Izawa, Jonathan; Rendon, Ricardo; Fairey, Adrian; Lotan, Yair; Bachmann, Alexander; Zerbib, Marc; Fisch, Margit; Scherr, Douglas S.; Vickers, Andrew; Shariat, Shahrokh F.			Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 Patients	EUROPEAN UROLOGY			English	Article						Bladder cancer; Radical cystectomy; Gender; Prognosis; Disease recurrence; Survival	CANCER-SPECIFIC SURVIVAL; HUMAN URINARY-BLADDER; UROTHELIAL CARCINOMA; TUMOR STAGE; RECEPTOR; RISK; EXPRESSION; MORTALITY; TISSUE; WOMEN	Background: The impact of gender on the staging and prognosis of urothelial carcinoma of the bladder (UCB) is insufficiently understood. Objective: To assess gender-specific differences in pathologic factors and survival of UCB patients treated with radical cystectomy (RC). Design, setting, and participants: Data from 8102 patients treated with RC (6497 men [80%] and 1605 women [20%]) for UCB between 1971 and 2012 were analyzed. Outcome measurements and statistical analysis: Multivariable competing-risk regression analyses were performed to evaluate the relationship of gender on disease recurrence (DR) and cancer-specific mortality (CSM). We also tested the interaction of gender and tumor stage, nodal status, and lymphovascular invasion (LVI). Results and limitations: Female patients were older at the time of RC (p = 0.033) and had higher rates of pathologic stage T3/T4 disease (p < 0.001). In univariable, but not in multivariable analysis, female gender was associated with a higher risk of DR (p = 0.022 and p = 0.11, respectively). Female gender was an independent predictor for CSM(p = 0.004). We did not find a significant interaction between gender and stage, nodal metastasis, or LVI (all p values > 0.05). Conclusions: We found female gender to be associated with a higher risk of CSM following RC. However, these findings do not appear to be explainedby gender differences in pathologic stage, nodal status, or LVI. This gender disparity may be due to differences in care and/or the biology of UCB. (C) 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.	[Kluth, Luis A.; Rieken, Malte; Xylinas, Evanguelos; Jamzadeh, Asha; Scherr, Douglas S.; Shariat, Shahrokh F.] New York Presbyterian Hosp, Dept Urol, Weill Cornell Med Coll, New York, NY USA; [Shariat, Shahrokh F.] New York Presbyterian Hosp, Div Med Oncol, Weill Cornell Med Coll, New York, NY USA; [Kluth, Luis A.; Rink, Michael; Sharifi, Nasim; Fisch, Margit] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany; [Rieken, Malte; Bachmann, Alexander] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland; [Xylinas, Evanguelos; Zerbib, Marc] Paris Descartes Univ, Cochin Hosp, Dept Urol, AP HP, Paris, France; [Kent, Matthew; Vickers, Andrew] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Roupret, Morgan] Univ Paris 06, Fac Med Pierre & Marie Curie, Acad Dept Urol Pitie Salpetrie, AP HP, Paris, France; [Kassouf, Wassim] McGill Univ, Dept Urol, Montreal, PQ, Canada; [Kaushik, Dharam; Boorjian, Stephen A.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA; [Kaushik, Dharam; Boorjian, Stephen A.] Mayo Clin, Rochester, MN USA; [Roghmann, Florian; Noldus, Joachim] Ruhr Univ Bochum, Dept Urol, Marien Hosp, Herne, Germany; [Masson-Lecomte, Alexandra; Vordos, Dimitri] Hop Henri Mondor, Dept Urol, F-94010 Creteil, France; [Ikeda, Masaomi; Matsumoto, Kazumasa] Kitasato Univ, Sch Med, Dept Urol, Minami Ku, Sagamihara, Kanagawa 228, Japan; [Hagiwara, Masayuki; Kikuchi, Eiji] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Tokyo, Japan; [Fradet, Yves] Univ Laval, Dept Urol Surg, Quebec City, PQ, Canada; [Izawa, Jonathan] Univ Western Ontario, Dept Urol Surg, London, ON, Canada; [Rendon, Ricardo] Dalhousie Univ, Dept Urol, Halifax, NS, Canada; [Fairey, Adrian] Univ Alberta, Dept Urol Surg, Edmonton, AB, Canada; [Lotan, Yair] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Shariat, Shahrokh F.] Med Univ Vienna, Dept Urol, Vienna, Austria	Shariat, SF (reprint author), Med Univ Vienna, Dept Urol, Vienna Gen Hosp, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	sfshariat@gmail.com	Izawa, Jonathan/C-1111-2015; 	Jamzadeh, Asha/0000-0003-4431-5605			KIEMENEY LALM, 1994, EUR J CANCER, V30A, P1134, DOI 10.1016/0959-8049(94)90472-3; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fleshner NE, 1996, CANCER, V78, P1505, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Boorjian S, 2004, UROLOGY, V64, P383, DOI 10.1016/j.urology.2004.03.025; Liberman D, 2011, UROLOGY, V77, P660, DOI 10.1016/j.urology.2010.07.537; May M, 2013, UROL ONCOL-SEMIN ORI, V31, P1141, DOI 10.1016/j.urolonc.2011.09.011; Noon AP, 2013, BRIT J CANCER, V108, P1534, DOI 10.1038/bjc.2013.106; Otto W, 2012, GENDER MED, V9, P481, DOI 10.1016/j.genm.2012.11.001; Xylinas E, 2013, ANN SURG ONCOL, V20, P1027, DOI 10.1245/s10434-012-2708-5; Rink M, 2012, EUR UROL, V61, P854, DOI 10.1016/j.eururo.2011.12.055; Kluth LA, 2013, WORLD J UROL, V31, P1029, DOI 10.1007/s00345-012-0996-9; Zhuang YH, 1997, HISTOPATHOLOGY, V30, P556, DOI 10.1046/j.1365-2559.1997.5610801.x; Shariat SF, 2010, BJU INT, V105, P1402, DOI 10.1111/j.1464-410X.2010.09217.x; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; McGrath M, 2006, AM J EPIDEMIOL, V163, P236, DOI 10.1093/aje/kwj028; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Boorjian SA, 2010, BJU INT, V106, P357, DOI 10.1111/j.1464-410X.2009.09137.x; Mungan NA, 2000, UROLOGY, V55, P876, DOI 10.1016/S0090-4295(00)00523-9; Mungan NA, 2000, UROLOGY, V55, P368, DOI 10.1016/S0090-4295(99)00481-1; Siegrist T, 2010, UROL ONCOL-SEMIN ORI, V28, P112, DOI 10.1016/j.urolonc.2009.04.012; Shen SS, 2006, CANCER, V106, P2610, DOI 10.1002/cncr.21945; Fajkovic H, 2011, WORLD J UROL, V29, P457, DOI 10.1007/s00345-011-0709-9; Scosyrev E, 2012, BJU INT, V109, P57, DOI 10.1111/j.1464-410X.2011.10318.x; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Shariat SF, 2006, CLIN CANCER RES, V12, P6663, DOI 10.1158/1078-0432.CCR-06-0372; Donsky H, 2014, UROL ONCOL, V32; Lyratzopoulos G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002861; SAEZ S, 1981, J STEROID BIOCHEM, V15, P317, DOI 10.1016/0022-4731(81)90291-0; Taub DA, 2006, UROLOGY, V67, P288, DOI 10.1016/j.urology.2005.09.003	30	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0302-2838	1873-7560		EUR UROL	Eur. Urol.	NOV	2014	66	5					913	919		10.1016/j.eururo.2013.11.040		7	Urology & Nephrology	Urology & Nephrology	AT1KY	WOS:000344693500031		
J	Ito, T; Tokura, Y				Ito, Taisuke; Tokura, Yoshiki			The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata	EXPERIMENTAL DERMATOLOGY			English	Article						alopecia areata; chemokine; cytokine; immune privilege; swarm of bees	HUMAN HAIR FOLLICLE; CORTICOTROPIN-RELEASING HORMONE; IMMUNE PRIVILEGE; CLASS-I; CYTOMEGALOVIRUS DNA; INTERFERON-GAMMA; VIRUS-INFECTION; MESSENGER-RNA; C3H/HEJ MICE; MOUSE MODEL	The aetiology of alopecia areata (AA) is still not fully understood. However, recent clinical and experimental studies have provided insights into the pathomechanisms of AA and revealed that it is an organ-specific and cell-mediated autoimmune disease. Some triggers, such as viral infections, trauma, hormones and emotional/physical stressors, may cause activation of autoreactive T cells that target hair follicle (HF) autoantigens. In these immunological responses, cytokines and chemokines are regarded as key players that mediate the autoimmune inflammation. This results in the collapse of HF immune privilege, which is central to the pathogenesis of AA. This essay will focus on how cytokines and chemokines contribute to the immunological aspects of AA. The management of AA often remains difficult in a number of cases. Our review suggests that novel therapies for AA may involve targeting cytokines and chemokines.	[Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Ito, T (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	itoutai@hama-med.ac.jp			Japan Society for the Promotion of Science [23591642]	TI and YT are responsible for all content and were supported by research grant (No. 23591642) from the Japan Society for the Promotion of Science.	Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; McPhee CG, 2012, J INVEST DERMATOL, V132, P1736, DOI 10.1038/jid.2012.17; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Stenn KS, 2001, PHYSIOL REV, V81, P449; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Bowes J, 2011, ANN RHEUM DIS, V70, P1016, DOI 10.1136/ard.2010.143123; Lew BL, 2012, ANN DERMATOL, V24, P61, DOI 10.5021/ad.2012.24.1.61; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Slominski A, 2000, PHYSIOL REV, V80, P979; Alli R, 2012, J IMMUNOL, V188, P477, DOI 10.4049/jimmunol.1100657; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Nakamura M, 2008, AM J PATHOL, V172, P650, DOI 10.2353/ajpath.2008.061249; Jagielska D, 2012, J INVEST DERMATOL, V132, P2192, DOI 10.1038/jid.2012.129; Ito T, 2013, J DERMATOL SCI, V69, P140, DOI 10.1016/j.jdermsci.2012.12.003; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; HOFFMANN R, 1994, J INVEST DERMATOL, V103, P530, DOI 10.1111/1523-1747.ep12395722; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Chu SY, 2011, J AM ACAD DERMATOL, V65, P949, DOI 10.1016/j.jaad.2010.08.032; Harris JE, 2013, EXP DERMATOL, V22, P785, DOI 10.1111/exd.12264; Paus R, 1999, J INVEST DERM SYMP P, V4, P226, DOI 10.1038/sj.jidsp.5640217; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Glassman SJ, 2011, CLIN SCI, V120, P99, DOI 10.1042/CS20090603; Rodriguez TA, 2008, J AM ACAD DERMATOL, V59, P137, DOI 10.1016/j.jaad.2008.02.005; Gregoriou S, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/928030; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Tanemura A, 2013, DERMATOLOGY, V226, P333, DOI 10.1159/000350933; Beghe B, 2010, ALLERGY, V65, P474, DOI 10.1111/j.1398-9995.2009.02167.x; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Ghoreishi M, 2010, BRIT J DERMATOL, V163, P57, DOI 10.1111/j.1365-2133.2010.09775.x; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Barahmani N, 2010, CLIN EXP DERMATOL, V35, P409, DOI 10.1111/j.1365-2230.2009.03523.x; Teraki Y, 1996, ACTA DERM-VENEREOL, V76, P421; Tembhre MK, 2013, BRIT J DERMATOL, V169, P543, DOI 10.1111/bjd.12396; Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x; Wise RP, 1997, JAMA-J AM MED ASSOC, V278, P1176, DOI 10.1001/jama.278.14.1176; Katagiri K, 2007, ARCH DERMATOL RES, V298, P397, DOI 10.1007/s00403-006-0700-2; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Subramanya RD, 2010, GENOMICS, V96, P146, DOI 10.1016/j.ygeno.2010.05.002; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Sladkova T, 2006, ACTA VIROL, V50, P151; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; Tojo G, 2013, DERMATOLOGY, V227, P78, DOI 10.1159/000353159; Benoit S, 2003, J INVEST DERMATOL, V121, P933, DOI 10.1046/j.1523-1747.2003.12524.x; Botchkarev VA, 1999, ANN NY ACAD SCI, V885, P433; BROCKER EB, 1987, J INVEST DERMATOL, V88, P564, DOI 10.1111/1523-1747.ep12470166; Freyschmidt-Paul P, 2005, J Investig Dermatol Symp Proc, V10, P282, DOI 10.1111/j.0022-202X.2005.10130_5.x; Garcia-Hernandez MJ, 1998, J INVEST DERMATOL, V110, P185; Gilhar A, 2003, CLIN IMMUNOL, V106, P181, DOI 10.1016/S1521-6616(02)00042-6; Gilhar A, 2005, J INVEST DERMATOL, V124, P288, DOI 10.1111/j.0022-202X.2004.23580.x; Gulzar N, 2011, HUM IMMUNOL, V72, P995, DOI 10.1016/j.humimm.2011.08.012; Happle R, 1995, J Invest Dermatol, V104, p14S; Inui S, 2013, J DERMATOL, V40, P881, DOI 10.1111/1346-8138.12273; Ito T, 2004, AM J PATHOL, V164, P623, DOI 10.1016/S0002-9440(10)63151-3; Ito T, 2013, J DERMATOL SCI, V72, P68, DOI 10.1016/j.jdermsci.2013.04.029; Ito T, 2012, J DERMATOL, V39, P863, DOI 10.1111/j.1346-8138.2011.01437.x; Kartal ED, 2007, EUR J GASTROEN HEPAT, V19, P817, DOI 10.1097/MEG.0b013e32818b27e5; Kinori M, 2012, EXP DERMATOL, V21, P223, DOI 10.1111/j.1600-0625.2011.01432.x; Li HM, 1996, J IMMUNOL, V156, P4833; MCDONAGH AJG, 1993, BRIT J DERMATOL, V129, P250, DOI 10.1111/j.1365-2133.1993.tb11842.x; McElwee KJ, 2013, EXP DERMATOL, V22, P609, DOI 10.1111/exd.12209; Moseley RP, 1997, J PATHOL, V181, P419, DOI 10.1002/(SICI)1096-9896(199704)181:4<419::AID-PATH796>3.0.CO;2-W; Offidani  A, 2000, J Cutan Med Surg, V4, P63; Ono S, 2014, J DERMATOL SCI, V73, P74, DOI 10.1016/j.jdermsci.2013.08.009; Sato-Kawamura M, 2003, ARCH DERMATOL RES, V294, P536, DOI 10.1007/s00403-002-0354-7; SKINNER RB, 1995, JAMA-J AM MED ASSOC, V273, P1419, DOI 10.1001/jama.273.18.1419; Slominski A, 1998, BBA-MOL CELL RES, V1448, P147, DOI 10.1016/S0167-4889(98)00124-4; Sundberg John P., 2007, Journal of Experimental Animal Science, V43, P265, DOI 10.1016/j.jeas.2006.10.005; Tang LR, 2003, J INVEST DERMATOL, V120, P400, DOI 10.1046/j.1523-1747.2003.12059.x; van densWijngaard R M, 2003, LAB INVEST, V83, P683; vansKooyk Y, 2003, NAT REV IMMUNOL, V3, P697; Weedon D, 2002, WEEDONS SKIN PATHOLO, P397; Welker P, 1997, ARCH DERMATOL RES, V289, P554, DOI 10.1007/s004030050239	75	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	NOV	2014	23	11					787	791		10.1111/exd.12489		5	Dermatology	Dermatology	AS8WB	WOS:000344524800001		
J	Koganezawa, T; Paton, JFR				Koganezawa, Tadachika; Paton, Julian F. R.			Intrinsic chemosensitivity of rostral ventrolateral medullary sympathetic premotor neurons in the in situ arterially perfused preparation of rats	EXPERIMENTAL PHYSIOLOGY			English	Article							SUBRETROFACIAL BULBOSPINAL NEURONS; RESPIRATORY RHYTHM GENERATION; PRESYMPATHETIC NEURONS; BLOOD-PRESSURE; BRAIN-STEM; REGIONAL DIFFERENTIATION; PACEMAKER NEURONS; NEURAL MECHANISMS; NEONATAL-RAT; HYPOXIA	Brainstem hypoperfusion is a major excitant of sympathetic activity triggering hypertension, but the exact mechanisms involved remain incompletely understood. A major source of excitatory drive to preganglionic sympathetic neurons originates from the ongoing activity of premotor neurons in the rostral ventrolateral medulla (RVLM sympathetic premotor neurons). The chemosensitivity profile of physiologically characterized RVLM sympathetic premotor neurons during hypoxia and hypercapnia remains unclear. We examined whether physiologically characterized RVLM sympathetic premotor neurons can sense brainstem ischaemia intrinsically. We addressed this issue in a unique in situ arterially perfused preparation before and after a complete blockade of fast excitatory and inhibitory synaptic transmission. During hypercapnic hypoxia, respiratory modulation of RVLM sympathetic premotor neurons was lost, but tonic firing of most RVLM sympathetic premotor neurons was elevated. After blockade of fast excitatory and inhibitory synaptic transmission, RVLM sympathetic premotor neurons continued to fire and exhibited an excitatory firing response to hypoxia but not hypercapnia. This study suggests that RVLM sympathetic premotor neurons can sustain high levels of neuronal discharge when oxygen is scarce. The intrinsic ability of RVLM sympathetic premotor neurons to maintain responsivity to brainstem hypoxia is an important mechanism ensuring adequate arterial pressure, essential for maintaining cerebral perfusion in the face of depressed ventilation and/or high cerebral vascular resistance.	[Koganezawa, Tadachika] Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Physiol, Tsukuba, Ibaraki 3058575, Japan; [Paton, Julian F. R.] Univ Bristol, Bristol Heart Inst, Sch Physiol & Pharmacol, Sch Med Sci, Bristol BS8 1TD, Avon, England	Koganezawa, T (reprint author), Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Physiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	t-kogane@md.tsukuba.ac.jp		Paton, Julian/0000-0001-7410-2913	British Heart Foundation [RG/12/6/29670]; Japan Society for the Promotion of Science [24790206]; National Institutes of Health [R01 NS069220]; Royal Society; Daiwa Anglo-Japanese Foundation; Takeda Science Foundation; Ichiro Kanehara Foundation	The research was funded by the British Heart Foundation (RG/12/6/29670), the Japan Society for the Promotion of Science (24790206), the National Institutes of Health (R01 NS069220) and the Royal Society, the Daiwa Anglo-Japanese Foundation, the Takeda Science Foundation and the Ichiro Kanehara Foundation.	D'Agostino D, 2009, AM J PHYSIOL-REG I, V296, pR102, DOI 10.1152/ajpregu.90325.2008; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323; KUMADA M, 1990, PROG NEUROBIOL, V35, P331, DOI 10.1016/0301-0082(90)90036-G; HASELTON JR, 1990, AM J PHYSIOL, V258, pR1051; Cates MJ, 2011, J APPL PHYSIOL, V111, P149, DOI 10.1152/japplphysiol.00220.2011; Chizh BA, 1998, J PHYSIOL-LONDON, V508, P907, DOI 10.1111/j.1469-7793.1998.907bp.x; Pickering AE, 2003, J PHYSIOL-LONDON, V551, P589, DOI 10.1113/jphysiol.2003.046615; St-John WM, 2009, J PHYSIOL-LONDON, V587, P3175, DOI 10.1113/jphysiol.2009.170308; Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; KANGRGA IM, 1995, BRAIN RES, V670, P215, DOI 10.1016/0006-8993(94)01282-M; GUYENET PG, 1989, PROG BRAIN RES, V81, P105; SCHMIDT C, 1995, J PHYSIOL-LONDON, V483, P769; Cao WH, 2004, NEUROSCIENCE, V126, P229, DOI 10.1016/j.neuroscience.2004.03.013; Paton JFR, 2009, EXP PHYSIOL, V94, P11, DOI 10.1113/expphysiol.2008.043455; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Dampney RAL, 2000, CLIN EXP PHARMACOL P, V27, P1049, DOI 10.1046/j.1440-1681.2000.03375.x; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Verberne AJM, 1999, J PHYSIOL-LONDON, V517, P477, DOI 10.1111/j.1469-7793.1999.0477t.x; Moraes DJA, 2014, HYPERTENSION, V63, P1309, DOI 10.1161/HYPERTENSIONAHA.113.02283; Smith JC, 2013, TRENDS NEUROSCI, V36, P152, DOI 10.1016/j.tins.2012.11.004; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Archer Stephen L, 2006, Novartis Found Symp, V272, P157; Cushing H, 1901, ANN SURG, V33, P544, DOI 10.1097/00000658-190101000-00050; DAMPNEY RAL, 1979, CIRC RES, V45, P48; DICKINSON CJ, 1990, CLIN SCI, V79, P543; DICKINSON CJ, 1960, CLIN SCI, V19, P513; Golanov EV, 1999, BRAIN RES, V827, P210, DOI 10.1016/S0006-8993(99)01256-1; GREGOR M, 1977, PFLUG ARCH EUR J PHY, V368, P71, DOI 10.1007/BF01063457; IRIKI M, 1971, PFLUG ARCH EUR J PHY, V328, P320, DOI 10.1007/BF00586834; IRIKI M, 1975, BRAIN RES, V87, P281, DOI 10.1016/0006-8993(75)90425-4; Kemp Paul J, 2006, Novartis Found Symp, V272, P141; Koganezawa T, 2005, BRAIN RES, V1061, P13, DOI 10.1016/j.brainres.2005.08.040; Koganezawa T, 2007, AM J PHYSIOL-HEART C, V292, pH408, DOI 10.1152/ajpheart.00881.2006; KOSHIYA N, 1993, BRAIN RES, V609, P174, DOI 10.1016/0006-8993(93)90871-J; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Lipski J, 1996, J PHYSIOL-LONDON, V490, P729; Lipski J, 2002, AUTON NEUROSCI-BASIC, V98, P85, DOI 10.1016/S1566-0702(02)00038-3; Mazza E, 2000, J APPL PHYSIOL, V88, P2319; MCALLEN RM, 1987, J PHYSIOL-LONDON, V388, P533; MCALLEN RM, 1992, J AUTONOM NERV SYST, V40, P181, DOI 10.1016/0165-1838(92)90199-Q; McAllen RM, 2001, J NEUROPHYSIOL, V85, P1697; Ootsuka Y, 2002, AUTON NEUROSCI-BASIC, V101, P48, DOI 10.1016/S1566-0702(02)00181-9; Paton JFR, 2005, J NEUROSCI METH, V147, P138, DOI 10.1016/j.jneumeth.2005.04.003; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Paton JFR, 1997, J PHYSIOL-LONDON, V502, P623, DOI 10.1111/j.1469-7793.1997.623bj.x; Richter DW, 2014, PHYSIOLOGY, V29, P58, DOI 10.1152/physiol.00035.2013; RODBARD S, 1955, CIRCULATION, V12, P883; St-John WM, 2003, RESP PHYSIOL NEUROBI, V139, P97, DOI 10.1016/S1569-9048(03)00193-9; Sun MK, 1992, AM J PHYSIOL-REG I, V262, pR182; SUN MK, 1994, J PHYSIOL-LONDON, V476, P101; SUN MK, 1988, BRAIN RES, V442, P229, DOI 10.1016/0006-8993(88)91508-9; SUN MK, 1988, BRAIN RES, V451, P345, DOI 10.1016/0006-8993(88)90781-0; Sun MK, 1994, AM J PHYSIOL-REG I, V266, pR245; Wang G, 2001, NEUROSCI LETT, V309, P125, DOI 10.1016/S0304-3940(01)02032-8	55	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	NOV 1	2014	99	11					1453	1466		10.1113/expphysiol.2014.080069		14	Physiology	Physiology	AT0UM	WOS:000344650200003		
J	Nohuddin, PNE; Sunayama, W; Christley, R; Coenen, F; Setzkorn, C				Nohuddin, Puteri N. E.; Sunayama, Wataru; Christley, Rob; Coenen, Frans; Setzkorn, Christian			Trend mining in social networks: from trend identification to visualization	EXPERT SYSTEMS			English	Article						trend mining; social network data; visualization	LARGE DOCUMENT COLLECTIONS; SELF-ORGANIZING MAPS; EMERGING TRENDS; ANIMATION; PATTERNS	A four-stage social network trend mining framework, the Identification, Grouping, Clustering and Visualization framework, is described. The framework extracts trends from social network data and then applies a sequence of techniques (tools') to this data to facilitate interpretation of the identified trends. Of particular note is the visualization of trend migrations (changes) that feature within time-stamped network data. The framework is illustrated using a sequence of four social networks extracted from the Cattle Tracing System in operation in Great Britain, although it could equally well be applied to other forms of temporal data. The presented analysis of the Identification, Grouping, Clustering and Visualization framework indicates advantages, with respect to network trend mining, that can be gained, especially when the framework is applied to real data.	[Nohuddin, Puteri N. E.] Natl Def Univ Malaysia, Fac Sci & Technol Def, Kuala Lumpur, Malaysia; [Sunayama, Wataru] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima, Japan; [Christley, Rob] Univ LiverpoolW, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Leahurst, Neston, England; [Christley, Rob] Natl Ctr Zoonosis Res, Leahurst, Neston, England; [Coenen, Frans] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England; [Setzkorn, Christian] Capenhurst Technol Pk, EA Technol, Capenhurst, England	Nohuddin, PNE (reprint author), Natl Def Univ Malaysia, Fac Sci & Technol Def, Kuala Lumpur, Malaysia.	puteri@upnm.edu.my		Christley, Robert/0000-0001-9250-3032			Agarwal P., 2008, SELF ORGANISING MAPS; AGRAWAL R, 1995, PROC INT CONF DATA, P3, DOI 10.1109/ICDE.1995.380415; Agrawal R., 1994, P 20 INT C VER LARG, V1215, P487; Agrawal R., 1993, P ACM SIGMOD C MAN D, V22, P207, DOI DOI 10.1145/170035.170072; Havre S, 2002, IEEE T VIS COMPUT GR, V8, P9, DOI 10.1109/2945.981848; Khan MS, 2010, KNOWL-BASED SYST, V23, P316, DOI 10.1016/j.knosys.2009.11.005; Mannila H, 1997, DATA MIN KNOWL DISC, V1, P259, DOI 10.1023/A:1009748302351; Somaraki V, 2010, LECT NOTES ARTIF INT, V6171, P418, DOI 10.1007/978-3-642-14400-4_32; Coenen F, 2004, IEEE T KNOWL DATA EN, V16, P774, DOI 10.1109/TKDE.2004.8; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Schreck T, 2009, INFORM VISUAL, V8, P14, DOI 10.1057/ivs.2008.29; SUGIYAMA K, 1995, J VISUAL LANG COMPUT, V6, P217, DOI 10.1006/jvlc.1995.1013; Kohavi R, 2002, COMMUN ACM, V45, P45; Robertson G, 2008, IEEE T VIS COMPUT GR, V14, P1325, DOI 10.1109/TVCG.2008.125; Choudhury M. D., 2008, P 19 ACM C HYP HYP, P55; Coenen F. P., 2001, LECT NOTES ARTIF INT, V2168, P54; Dong G., 1999, P 5 ACM SIGKDD INT C, P43, DOI DOI 10.1145/312129.312191; Gloor P. A., 2008, WEB SCI 2 0 IDENT TR; Harms SK, 2004, J INTELL INF SYST, V22, P7, DOI 10.1023/A:1025824629047; Kandogan E., 2001, P 7 ACM SIGKDD INT C, P107, DOI DOI 10.1145/502512.502530; Kohonen T, 1995, SER INFORMAT SCI, V30; Kohonen T, 1997, FR ART INT, V40, P5; Lauw H. W., 2005, Computational & Mathematical Organization Theory, V11, DOI 10.1007/s10588-005-3939-9; Lent B., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113; Nishikido T, 2009, LECT NOTES COMPUT SC, V5549, P233, DOI 10.1007/978-3-642-01818-3_31; Nohuddin PNE, 2010, IFIP ADV INF COMM TE, V340, P163, DOI 10.1007/978-3-642-16327-2_22; Nohuddin PNE, 2010, LECT NOTES ARTIF INT, V6171, P464, DOI 10.1007/978-3-642-14400-4_36; Nohuddin PNE, 2012, KNOWL-BASED SYST, V29, P104, DOI 10.1016/j.knosys.2011.07.003; Raza J., 2008, J PROCESS MECH ENG E, V223, P251; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61; Safaei M., 2009, 33 ANN IEEE INT COMP, V2, P31; Streibel O., 2008, P CAISE DC, V358; Wasserman S., 2006, SOCIAL NETWORK ANAL; Xu Z, 2010, LECT NOTES COMPUT SC, V5498, P77	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-4720	1468-0394		EXPERT SYST	Expert Syst.	NOV	2014	31	5			SI		457	468		10.1111/exsy.12024		12	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Computer Science	AT3PW	WOS:000344847300008		
J	Akita, M; Nakajima, M; Uematsu, Y; Tokaji, K; Kojima, T				Akita, M.; Nakajima, M.; Uematsu, Y.; Tokaji, K.; Kojima, T.			High-cycle fatigue properties of beta Ti alloy 55Ti-30Nb-10Ta-5Zr, gum metal	FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES			English	Article						beta titanium alloy; corrosion fatigue; crack growth; crack initiation; fatigue; slip deformation; S-N diagram	TITANIUM-ALLOYS; PLASTIC-DEFORMATION; MECHANISM; BEHAVIOR; EVOLUTION	This paper describes the fatigue properties of the beta titanium alloy 55Ti-30Nb-10Ta-5Zr, generally referred to as 'Gum Metal'. Rotating bending fatigue tests have been performed in laboratory air and in a 3% NaCl aqueous solution. The results obtained were compared with those of a conventional beta titanium alloy, Ti-22V-4Al. In tensile tests, 55Ti-30Nb-10Ta-5Zr indicated elasticity and microplasticity in the elastic region. Thus, the elastic modulus slightly decreased with an increasing strain, and the work hardening was minimal during plastic deformation. The mechanical properties of both of the alloys were comparable. The fatigue strength of 55Ti-30Nb-10Ta-5Zr in laboratory air was higher than that of Ti-22V-4Al, which could be attributed to the higher fatigue crack initiation resistance of 55Ti-30Nb-10Ta-5Zr than Ti-22V-4Al, while the resistance to small fatigue crack growth was similar. The fatigue strength of 55Ti-30Nb-10Ta-5Zr in laboratory air and in the 3% NaCl aqueous solution was analogous. In addition, corrosion pits were not observed in the run-out specimen in the 3% NaCl aqueous solution, indicating a high resistance of 55Ti-30Nb-10Ta-5Zr against corrosion fatigue.	[Akita, M.] Gifu Univ, Fac Engn, Gifu 5011193, Japan; [Nakajima, M.] Toyota Natl Coll Technol, Dept Mech Engn, Toyota 4718525, Japan; [Uematsu, Y.; Tokaji, K.] Gifu Univ, Dept Mech Engn, Gifu 5011193, Japan; [Kojima, T.] Okuma Corp LTD, Oguchi, Aichi 4800193, Japan	Akita, M (reprint author), Gifu Univ, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	akita@gifu-u.ac.jp					Tokaji K, 2004, INT J FATIGUE, V26, P543, DOI 10.1016/j.ijfatigue.2003.08.024; Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8; Furuta T, 2005, MATER TRANS, V46, P3001, DOI 10.2320/matertrans.46.3001; Gutkin MY, 2008, INT J PLASTICITY, V24, P1333, DOI 10.1016/j.ijplas.2007.09.009; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Gutkin MY, 2006, ACTA MATER, V54, P2489, DOI 10.1016/j.actamat.2006.01.027; MORINAGA M, 1986, TETSU TO HAGANE, V72, P555; Boyer RR, 1996, MAT SCI ENG A-STRUCT, V213, P103, DOI 10.1016/0921-5093(96)10233-1; Talling RJ, 2009, SCRIPTA MATER, V60, P1000, DOI 10.1016/j.scriptamat.2009.02.044; Plancher E, 2013, SCRIPTA MATER, V68, P805, DOI 10.1016/j.scriptamat.2013.01.034; Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957; Furuta T, 2013, SCRIPTA MATER, V68, P767, DOI 10.1016/j.scriptamat.2013.01.027; Yang Y, 2010, ACTA MATER, V58, P2778, DOI 10.1016/j.actamat.2010.01.015; Kuramoto S, 2006, MAT SCI ENG A-STRUCT, V442, P454, DOI 10.1016/j.msea.2005.12.089; Kuramoto S, 2006, METALL MATER TRANS A, V37A, P657, DOI 10.1007/s11661-006-0037-7; Bobylev SV, 2011, SCRIPTA MATER, V65, P668, DOI 10.1016/j.scriptamat.2011.07.004; MORISHITA M, 1990, TETSU TO HAGANE, V76, P2175; Niinomi M., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.09.002; Nishino K., 2003, R D REV TOYOTA CRDL, V38, P50; Premkumar M, 2012, MAT SCI ENG A-STRUCT, V552, P15, DOI 10.1016/j.msea.2012.04.077; SHIRATORI M, 1987, T JPN SOC MECH ENG, V53, P779; *SOC MAT SCI JAP, 2007, STAND EV METH FAT RE; Talling RJ, 2009, ACTA MATER, V57, P1188, DOI 10.1016/j.actamat.2008.11.013; Tokaji K, 2000, FATIGUE FRACT ENG M, V23, P759, DOI 10.1046/j.1460-2695.2000.00325.x; Tokaji K, 2003, J MATER SCI, V38, P1153, DOI 10.1023/A:1022880914473; WAKITA M, 2004, T JPN SOC MECH ENG, V49, P27; Xing H, 2007, T NONFERR METAL SOC, V17, P1456, DOI 10.1016/S1003-6326(07)60294-5; Yamada M, 1996, MAT SCI ENG A-STRUCT, V213, P8, DOI 10.1016/0921-5093(96)10241-0	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8756-758X	1460-2695		FATIGUE FRACT ENG M	Fatigue Fract. Eng. Mater. Struct.	NOV	2014	37	11					1223	1231		10.1111/ffe.12201		9	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	AT0WG	WOS:000344652300005		
J	Hayashi, T; Harada, N				Hayashi, Takanori; Harada, Nobuhiro			Post-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation	FEBS JOURNAL			English	Article						aromatase; calcineurin; calcium/calmodulin kinase II; phosphorylation; post-translational regulation	HUMAN PLACENTAL AROMATASE; BRAIN AROMATASE; GENE-EXPRESSION; RAPID CONTROL; QUAIL BRAIN; PHOSPHORYLATION; ESTRADIOL; ENZYME; TISSUE; OVARY	The post-translational regulation of aromatase has not been well characterized as compared with transcriptional regulation. Several studies of post-translational regulation have focused on decreases in catalytic activity following phosphorylation. We report here dual post-translational regulation of aromatase, at the catalytic activity and protein levels. Microsomal aromatase prepared from JEG-3 cells was rapidly inactivated and subsequently degraded in the presence of a cytosolic fraction with calcium, magnesium, and ATP. In a reconstituted system consisting of microsomal and cytosolic fractions, aromatase was protected from protein degradation by treatment with alkaline phosphatase, whereas degradation was enhanced by treatment with calcineurin inhibitors (FK506 and cyclosporin A). Furthermore, aromatase was protected from degradation by treatment with kinase inhibitors, especially the calcium/calmodulin kinase inhibitors KN62 and KN93. Similarly to the reconstituted system, aromatase in cultured JEG-3 cells was protected from degradation by KN93, whereas FK503 increased degradation in the presence of cycloheximide, although cellular aromatase mRNA levels were unchanged by these reagents. Knockdown of calcineurin and calcium/calmodulin kinase II (CaMKII) with small interfering RNAs resulted in a dose-dependent increase in aromatase degradation and protection from degradation, respectively. The cytosol fraction-dependent phosphorylation of microsomal aromatase was inhibited by calcineurin, KN62, and KN93, and promoted by CaMKII and FK506. These results indicate that aromatase is regulated acutely at the catalytic activity level and subsequently at the enzyme content level by CaMKII/calcineurin-dependent phosphorylation/dephosphorylation.	[Hayashi, Takanori; Harada, Nobuhiro] Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 4701192, Japan	Harada, N (reprint author), Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 4701192, Japan.	nharada@fujita-hu.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [25461398]; Fujita Health University	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (25461398 to N. Harada), and Grants-in-Aid for Research from Fujita Health University.	HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Karpuzoglu-Sahin E, 2001, CYTOKINE, V14, P208, DOI 10.1006/cyto.2001.0876; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; Cornil CA, 2006, BEHAV BRAIN RES, V166, P110, DOI 10.1016/j.bbr.2005.07.017; Balthazart J, 2005, J NEUROENDOCRINOL, V17, P553, DOI 10.1111/j.1365-2826.2005.01344.x; BEDNARSKI PJ, 1985, J MED CHEM, V28, P775, DOI 10.1021/jm00383a014; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Miller TW, 2008, J STEROID BIOCHEM, V112, P95, DOI 10.1016/j.jsbmb.2008.09.001; Catalano S, 2009, MOL ENDOCRINOL, V23, P1634, DOI 10.1210/me.2009-0039; Balthazart J, 2001, J STEROID BIOCHEM, V79, P261, DOI 10.1016/S0960-0760(01)00143-1; ZHAO Y, 1995, J BIOL CHEM, V270, P16449; Charlier TD, 2011, ENDOCRINOLOGY, V152, P4199, DOI 10.1210/en.2011-0119; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; Xu SY, 2011, ENDOCRINOLOGY, V152, P3941, DOI 10.1210/en.2011-1147; SETHUMADHAVAN K, 1991, MOL CELL ENDOCRINOL, V78, P25, DOI 10.1016/0303-7207(91)90182-R; Harada N, 1998, BRIT J CANCER, V77, P567, DOI 10.1038/bjc.1998.92; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Cornil CA, 2010, J NEUROENDOCRINOL, V22, P664, DOI 10.1111/j.1365-2826.2010.02023.x; Zhang B, 2010, ENDOCRINOLOGY, V151, P4949, DOI 10.1210/en.2010-0294; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Cross E, 1999, AM J PHYSIOL-REG I, V276, pR1346; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106; HARADA N, 1992, MOL BRAIN RES, V15, P19, DOI 10.1016/0169-328X(92)90146-3; Harada N, 2003, J STEROID BIOCHEM, V86, P327, DOI 10.1016/S0960-0760(03)00375-3; HONDA S, 1994, BIOCHEM BIOPH RES CO, V198, P1153, DOI 10.1006/bbrc.1994.1163; Kagawa N, 2011, METHODS MOL BIOL, V705, P109, DOI 10.1007/978-1-61737-967-3_7; LEPHART ED, 1992, MOL CELL ENDOCRINOL, V85, P205, DOI 10.1016/0303-7207(92)90259-9; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; Pandey AV, 2003, J BIOL CHEM, V278, P2837, DOI 10.1074/jbc.M209527200; REED KC, 1976, J BIOL CHEM, V251, P1625; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860; Su B, 2011, J STEROID BIOCHEM, V123, P101, DOI 10.1016/j.jsbmb.2010.11.012; Tan J, 1986, EUR J BIOCHEM, V156, P243; YAMADA K, 1995, J BIOL CHEM, V270, P25064	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	NOV	2014	281	21					4830	4840		10.1111/febs.13021		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AS9YF	WOS:000344593600007		
J	Suenaga, H; Mizuta, S; Miyazaki, K; Yaoi, K				Suenaga, Hikaru; Mizuta, Shiori; Miyazaki, Kentaro; Yaoi, Katsuro			Diversity of extradiol dioxygenases in aromatic-degrading microbial community explored using both culture-dependent and culture-independent approaches	FEMS MICROBIOLOGY ECOLOGY			English	Article						functional diversity; microbial community; metagenomics; extradiol dioxygenase; catechol 2; 3-dioxygenase	RING-CLEAVING DIOXYGENASES; CATECHOL 2,3-DIOXYGENASE; METAGENOMIC LIBRARY; GENES; DEGRADATION; PROTOCATECHUATE; BACTERIA; PATHWAY; CLONING; SOIL	Culture-dependent and culture-independent approaches were used for extensive retrieval of the extradiol dioxygenase (EDO) gene from the environment to investigate the relationship between the EDO genes from isolated bacteria and the metagenomic EDO genes from which they were isolated. In our previous study, we identified 91 fosmid clones showing EDO enzyme activity using a metagenomic approach. In the present study, we classified all these metagenome-derived EDOs and newly isolated 88 phenol-utilizing bacteria from the same sample and identified four EDO genes from them. Of these, two EDOs had amino acid sequences similar to those reported previously in aromatic-utilizing strains, and one EDO had a sequence almost identical to that of metagenomic EDOs identified in our previous study. Unexpectedly, one EDO showed no similarity to any class I EDOs and was categorized as class II, which has not been found in past metagenomic approaches. Quantitative polymerase chain reaction (PCR) assay indicated that the low-abundance class II EDO gene can be enriched by culturing approaches. We conclude that the combined use of the two approaches can explore the gene community more extensively than their individual use.	[Suenaga, Hikaru; Mizuta, Shiori; Yaoi, Katsuro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Miyazaki, Kentaro] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Sapporo, Hokkaido, Japan	Suenaga, H (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	suenaga-hikaru@aist.go.jp			JSPS KAKENHI [26440255]	This study was supported partially by JSPS KAKENHI Grant Number 26440255.	Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Mampel J, 2005, ARCH MICROBIOL, V183, P130, DOI 10.1007/s00203-004-0755-4; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Eaton RW, 2001, J BACTERIOL, V183, P3689, DOI 10.1128/JB.183.12.3689-3703.2001; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; Sipila TP, 2008, ISME J, V2, P968, DOI 10.1038/ismej.2008.50; Lee HS, 2010, CURR OPIN BIOTECH, V21, P353, DOI 10.1016/j.copbio.2010.01.015; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; AMANN RI, 1995, MICROBIOL REV, V59, P143; Vilchez-Vargas R, 2010, ENVIRON MICROBIOL, V12, P3089, DOI 10.1111/j.1462-2920.2010.02340.x; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3378, DOI 10.1128/AEM.02715-09; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Eltis LD, 1996, J BACTERIOL, V178, P5930; Masai E, 2000, J BACTERIOL, V182, P6651, DOI 10.1128/JB.182.23.6651-6658.2000; Abraham WR, 2002, CURR OPIN MICROBIOL, V5, P246, DOI 10.1016/S1369-5274(02)00323-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Kasai D, 2009, J BACTERIOL, V191, P6758, DOI 10.1128/JB.00840-09; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Dai SD, 2002, NAT STRUCT BIOL, V9, P934, DOI 10.1038/nsb866; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; CRAWFORD RL, 1979, APPL ENVIRON MICROB, V37, P614; Dennis JJ, 2004, J MOL BIOL, V341, P753, DOI 10.1016/j.jmb.2004.06.034; FRAZEE RW, 1993, J BACTERIOL, V175, P6194; HIROSE J, 1994, FEMS MICROBIOL LETT, V118, P273; Hjort K, 2010, FEMS MICROBIOL ECOL, V71, P197, DOI 10.1111/j.1574-6941.2009.00801.x; Kasuga I, 2007, FEMS MICROBIOL ECOL, V61, P449, DOI 10.1111/j.1574-6941.2007.00347.x; Kasuga K, 1997, J FERMENT BIOENG, V84, P387, DOI 10.1016/S0922-338X(97)81997-6; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Marchesi JR, 2003, APPL ENVIRON MICROB, V69, P4375, DOI 10.1128/AEM.69.8.4375-4382.2003; Maruyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P1434, DOI 10.1271/bbb.68.1434; Osman S, 2008, ISME J, V2, P482, DOI 10.1038/ismej.2008.11; Suenaga H, 2010, APPL MICROBIOL BIOT, V88, P915, DOI 10.1007/s00253-010-2840-8; Taguchi K, 2004, BIOSCI BIOTECH BIOCH, V68, P787, DOI 10.1271/bbb.68.787; Viggiani A, 2004, J BIOL CHEM, V279, P48630, DOI 10.1074/jbc.M406243200; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	NOV	2014	90	2					367	379		10.1111/1574-6941.12390		13	Microbiology	Microbiology	AS9ZC	WOS:000344595800003		
J	Komeda, H; Yamasaki-Yashiki, S; Hoshino, K; Asano, Y				Komeda, Hidenobu; Yamasaki-Yashiki, Shino; Hoshino, Kazuhiro; Asano, Yasuhisa			Identification and characterization of D-xylulokinase from the D-xylose-fermenting fungus, Mucor circinelloides	FEMS MICROBIOLOGY LETTERS			English	Article						pentose catabolism; pentose fermentation; Zygomycetes	RECOMBINANT SACCHAROMYCES-CEREVISIAE; L-ARABINITOL 4-DEHYDROGENASE; YEAST PICHIA-STIPITIS; D-XYLULOSE KINASE; ETHANOL-PRODUCTION; ASPERGILLUS-NIGER; XYLITOL-DEHYDROGENASE; NEUROSPORA-CRASSA; L-ARABINOSE; MOLECULAR-CLONING	d-Xylulokinase catalyzes the phosphorylation of d-xylulose in the final step of the pentose catabolic pathway to form d-xylulose-5-phosphate. The d-xylulokinase activity was found to be induced by both d-xylose and l-arabinose, as well as some of the other enzymes involved in the pentose catabolism, in the d-xylose-fermenting zygomycetous fungus, Mucor circinelloides NBRC 4572. The putative gene, xyl3, which may encode d-xylulokinase, was detected in the genome sequence of this strain. The amino acid sequence deduced from the gene was more similar to d-xylulokinases from an animal origin than from other fungi. The recombinant enzyme was purified from the E.coli transformant expressing xyl3 and then characterized. The ATP-dependent phosphorylative activity of the enzyme was the highest toward d-xylulose. Its kinetic parameters were determined as K-m (d-xylulose)=0.29 mM and K-m (ATP)=0.51mM, indicating that the xyl3 gene encoded d-xylulokinase (McXK). Western blot analysis revealed that McXK was induced by l-arabinose as well as d-xylose and the induction was repressed in the presence of d-glucose, suggesting that the enzyme may be involved in the catabolism of d-xylose and l-arabinose and is subject to carbon catabolite repression in this fungus. This is the first study on d-xylulokinase from zygomycetous fungi.	[Komeda, Hidenobu; Yamasaki-Yashiki, Shino; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Komeda, Hidenobu; Yamasaki-Yashiki, Shino; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Hoshino, Kazuhiro] Toyama Univ, Grad Sch Sci & Engn, Gofu Ku, Toyama 930, Japan	Komeda, H (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	hkomeda@pu-toyama.ac.jp			NEDO (New Energy and Industrial Technology Development Organization)	We gratefully acknowledge support for this study by a grant from NEDO (New Energy and Industrial Technology Development Organization).	Woodyer R, 2005, APPL ENVIRON MICROB, V71, P1642, DOI 10.1128/AEM.71.3.1642-1647.2005; Matsushika A, 2008, APPL MICROBIOL BIOT, V81, P243, DOI 10.1007/s00253-008-1649-1; RIZZI M, 1989, J FERMENT BIOENG, V67, P20, DOI 10.1016/0922-338X(89)90080-9; BRUINENBERG PM, 1984, APPL MICROBIOL BIOT, V19, P256; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; Karimi K, 2006, ENZYME MICROB TECH, V40, P138, DOI 10.1016/j.enzmictec.2005.10.046; Richard P, 2000, FEMS MICROBIOL LETT, V190, P39, DOI 10.1016/S0378-1097(00)00312-8; Millati R, 2005, ENZYME MICROB TECH, V36, P294, DOI 10.1016/j.enzmictec.2004.09.007; Guo C, 2006, J APPL MICROBIOL, V101, P139, DOI 10.1111/j.1365-2672.2006.02915.x; Bunker RD, 2013, J BIOL CHEM, V288, P1643, DOI 10.1074/jbc.M112.427997; Watanabe S, 2007, MICROBIOL-SGM, V153, P3044, DOI 10.1099/mic.0.2007/007856-0; KOTTER P, 1990, CURR GENET, V18, P493, DOI 10.1007/BF00327019; UENG PP, 1982, ENZYME MICROB TECH, V4, P169, DOI 10.1016/0141-0229(82)90111-9; FLANAGAN T, 1992, ENZYME MICROB TECH, V14, P975, DOI 10.1016/0141-0229(92)90080-8; Kato Y, 2013, APPL MICROBIOL BIOT, V97, P10045, DOI 10.1007/s00253-013-5210-5; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Bengtsson O, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-9; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776; Mojzita D, 2010, J BIOL CHEM, V285, P23622, DOI 10.1074/jbc.M110.113399; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Richard P, 2003, FEMS YEAST RES, V3, P185, DOI 10.1016/S1567-1356(02)00184-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Karimi K, 2006, PROCESS BIOCHEM, V41, P653, DOI 10.1016/j.procbio.2005.08.014; vanKuyk PA, 2001, EUR J BIOCHEM, V268, P5414, DOI 10.1046/j.0014-2956.2001.02482.x; DENG X X, 1990, Applied Biochemistry and Biotechnology, V24-25, P193, DOI 10.1007/BF02920245; DILLS WL, 1994, PROTEIN EXPRES PURIF, V5, P259, DOI 10.1006/prep.1994.1039; Fonseca C, 2007, FEBS J, V274, P3589, DOI 10.1111/j.1742-4658.2007.05892.x; Jin YS, 2002, APPL ENVIRON MICROB, V68, P1232, DOI 10.1128/AEM.68.3.1232-1239.2002; Karhumaa K, 2007, APPL MICROBIOL BIOT, V73, P1039, DOI 10.1007/s00253-006-0575-3; Karhumaa K., 2007, MICROB CELL FACT, V6, P1; Klaubauf S, 2013, FEBS LETT, V587, P1346, DOI 10.1016/j.febslet.2013.03.003; Komeda H, 2015, J BIOSCI BIOENG, V119, P57, DOI 10.1016/j.jbiosc.2014.06.012; Lee J, 1997, J BIOTECHNOL, V56, P1, DOI 10.1016/S0168-1656(97)00073-4; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Matsushika A, 2011, ENZYME MICROB TECH, V48, P466, DOI 10.1016/j.enzmictec.2011.02.002; Pival SL, 2011, PROTEIN EXPRES PURIF, V79, P223, DOI 10.1016/j.pep.2011.05.018; RAWAT U, 1993, BIOTECHNOL LETT, V15, P1173, DOI 10.1007/BF00131211; RIZZI M, 1988, APPL MICROBIOL BIOT, V29, P148; Rodriguez-Pena MJ, 1998, FEMS MICROBIOL LETT, V162, P155; Sambrook J., 1989, MOL CLONING LAB MANU; Sues A, 2005, FEMS YEAST RES, V5, P669, DOI 10.1016/j.femsyr.2004.10.013; Sullivan R, 2007, APPL MICROBIOL BIOT, V77, P845, DOI 10.1007/s00253-007-1225-0; Suzuki T, 2005, J BIOSCI BIOENG, V100, P472, DOI 10.1263/jbb.100.472; Takano Maki, 2012, Frontiers of Chemical Science and Engineering, V6, DOI 10.1007/s11705-012-1281-6; Van Heeswijck R, 1988, MOD METHOD PLANT, VIII; Wang V. W., 1990, APPL BIOCHEM BIOTECH, V26, P197; Yamasaki-Yashiki S, 2014, BIOSCI BIOTECH BIOCH, V78, P1943, DOI 10.1080/09168451.2014.943646	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	NOV	2014	360	1					51	61		10.1111/1574-6968.12589		11	Microbiology	Microbiology	AT4OJ	WOS:000344919000008		
J	Fukuda, M; Fukuda, K; Shimizu, T; Nobunaga, M; Mamsen, LS; Andersen, CY				Fukuda, Misao; Fukuda, Kiyomi; Shimizu, Takashi; Nobunaga, Miho; Mamsen, Linn Salto; Andersen, Claus Yding			Climate change is associated with male: female ratios of fetal deaths and newborn infants in Japan	FERTILITY AND STERILITY			English	Article						Climate change; climate extreme; sex ratio of fetal deaths; sex ratio of newborn infants; temperature difference	BIRTH SEX-RATIO; MALEFEMALE RATIO; AIR-POLLUTION; EARTHQUAKE; TRENDS; COUNTRIES; LATITUDE; DECLINE; TIME	Objective: To evaluate whether climate change is associated with male: female ratios (sex ratios) of fetal deaths and births in Japan. Design: A population-based cohort study. Setting: Not applicable. Patient(s): Newborn infants and fetuses spontaneously aborted after 12 weeks of gestation. Intervention(s): None. Main Outcome Measure(s): Yearly sex ratios of fetal deaths and newborn infants and monthly fetal death rates and sex ratios of newborn infants. Result(s): A statistically significant positive association was found between yearly temperature differences and sex ratios of fetal deaths; a statistically significant negative association was found between temperature differences and sex ratios of newborn infants from 1968 to 2012, and between sex ratios of births and of fetal deaths. The sex ratios of fetal deaths have been increasing steadily along with temperature differences, whereas the sex ratios of newborn infants have been decreasing since the 1970s. Two climate extremes, a very hot summer in 2010 and a very cold winter in January 2011, showed not only statistically significant declines in sex ratios of newborn infants 9 months later in June 2011 and October 2011 but also statistically significant increases of fetal death rates immediately, in September 2010 and January 2011. Conclusion(s): The recent temperature fluctuations in Japan seem to be linked to a lower male: female sex ratio of newborn infants, partly via increased male fetal deaths. Male concepti seem to be especially vulnerable to external stress factors, including climate changes. (C) 2014 by American Society for Reproductive Medicine.	[Fukuda, Misao; Fukuda, Kiyomi] M&K Hlth Inst, Ako, Hyogo 6780239, Japan; [Shimizu, Takashi; Nobunaga, Miho] Shimizu Womens Clin, Takarazuka, Hyogo, Japan; [Mamsen, Linn Salto; Andersen, Claus Yding] Univ Copenhagen Hosp, Rigshosp, Juliane Marie Ctr Children Women & Reprod, Reprod Biol Lab, DK-2100 Copenhagen, Denmark	Fukuda, M (reprint author), M&K Hlth Inst, 30-9 Kariya, Ako, Hyogo 6780239, Japan.	web@fukuda8767.com		Andersen, Claus Yding/0000-0001-7681-253X			Parazzini F, 1998, HUM REPROD, V13, P1394, DOI 10.1093/humrep/13.5.1394; Allan BB, 1997, CAN MED ASSOC J, V156, P37; Grech V, 2013, PEDIATR INT, V55, P219, DOI 10.1111/ped.12063; Helle S, 2009, J ANIM ECOL, V78, P1226, DOI 10.1111/j.1365-2656.2009.01598.x; Saadat M, 2008, J BIOSOC SCI, V40, P935, DOI 10.1017/S0021932008002745; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Moller H, 1998, APMIS, V106, P232; Bromen K, 1997, LANCET, V349, P804, DOI 10.1016/S0140-6736(05)60233-4; Davis DL, 2007, ENVIRON HEALTH PERSP, V115, P941, DOI 10.1289/ehp.9540; Catalano R, 2013, AM J HUM BIOL, V25, P555, DOI 10.1002/ajhb.22414; Cagnacci A, 2003, HUM REPROD, V18, P885, DOI 10.1093/humrep.deg185; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Lerchl A, 1998, HUM REPROD, V13, P1401, DOI 10.1093/humrep/13.5.1401; Sakamoto M, 2001, ENVIRON RES, V87, P92, DOI 10.1006/enrs.2001.4293; Lerchl A, 1999, NATURWISSENSCHAFTEN, V86, P340, DOI 10.1007/s001140050630; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Moller H, 1996, LANCET, V348, P828, DOI 10.1016/S0140-6736(05)65253-1; D'Alfonso A, 2012, SCI WORLD J, DOI 10.1100/2012/162017; Dickinson HO, 1996, J EPIDEMIOL COMMUN H, V50, P227, DOI 10.1136/jech.50.2.227-a; Dixson BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025064; Fukuda M, 2002, LANCET, V359, P1407, DOI 10.1016/S0140-6736(02)08362-9; Grech V, 2000, J EPIDEMIOL COMMUN H, V54, P244, DOI 10.1136/jech.54.4.244; Hamamatsu Y, 2014, J BIOSOC SCI, V6, P1; Lichtenfels AJFC, 2007, FERTIL STERIL, V87, P230, DOI 10.1016/j.fernstert.2006.06.023; Ministry of Health Labour and Welfare, 1968, VIT STAT JAP; Mizuno R, 2000, LANCET, V356, P738, DOI 10.1016/S0140-6736(00)02637-4; Sagiv SK, 2005, ENVIRON HEALTH PERSP, V113, P602, DOI 10.1289/ehp.7646; vanderPaldeBruin KM, 1997, LANCET, V349, P62, DOI 10.1016/S0140-6736(05)62204-0	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	NOV	2014	102	5								10.1016/j.fertnstert.2014.07.1213		9	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	AT1JE	WOS:000344688400025		
J	Konishi, S; Nishihama, Y; Iida, A; Yoshinaga, J; Imai, H				Konishi, Shoko; Nishihama, Yukiko; Iida, Ayaka; Yoshinaga, Jun; Imai, Hideki			Association of antimullerian hormone levels with menstrual-cycle type and dysmenorrhea in young asymptomatic women	FERTILITY AND STERILITY			English	Article						Antimullerian hormone; menstrual-cycle regularity; menstrual pain; young women	ANTI-MULLERIAN HORMONE; OVARIAN RESERVE; ENDOMETRIOSIS; HEALTHY; FECUNDABILITY; PATHOGENESIS; COHORT	Objective: To examine the association between antimullerian hormone (AMH) levels and menstrual-cycle and lifestyle characteristics among young Japanese women. Design: Cross-sectional study. Setting: University. Patient(s): Female students aged 20-22 years (n = 65) who had never used oral contraceptives. Intervention(s): Participants completed a questionnaire on reproductive and lifestyle characteristics, and kept a menstrual-cycle diary for 5 consecutive months. Serum AMH was measured once during the study period. Main Outcome Measure(s): Serum AMH concentration. Result(s): Compared with women with very mild menstrual pain, serum AMH concentration was 49.6% (95% CI 6.5%-72.8%) lower among women with severe menstrual pain. Higher AMH concentration was associated with irregular menstrual cycles. Even after adjusting for menstrual-cycle regularity and its interaction, more-severe menstrual pain was associated with significantly lower AMH concentration. Conclusion(s): Circulating AMH concentration was significantly lower among young Japanese women who had more-severe menstrual pain. Underlying physiological mechanisms need to be addressed in future studies. ((C)2014 by American Society for Reproductive Medicine.)	[Konishi, Shoko] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo 1130033, Japan; [Konishi, Shoko] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Nishihama, Yukiko; Iida, Ayaka; Yoshinaga, Jun] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Tokyo 1130033, Japan; [Iida, Ayaka] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 228, Japan; [Imai, Hideki] Tokyo Healthcare Univ, Fac Nursing, Tokyo, Japan	Konishi, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moe@humeco.m.u-tokyo.ac.jp			KAKENHI [70451771]	The authors greatly appreciate the kind cooperation of the participants and Dr. Kouda, who helped with the sampling. Thanks are also due to Dr. Kathleen A. O'Connor who gave useful comments. This study was supported by KAKENHI 70451771.	Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; Steiner AZ, 2011, OBSTET GYNECOL, V117, P798, DOI 10.1097/AOG.0b013e3182116bc8; Shaw CM, 2011, FERTIL STERIL, V95, P2718, DOI 10.1016/j.fertnstert.2011.05.051; Su HI, 2008, MENOPAUSE, V15, P857, DOI [10.1097/gme.0b013e318165981e, 10.1097/gme.0b01e318165981e]; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Porpora MG, 1999, J AM ASSOC GYN LAP, V6, P429, DOI 10.1016/S1074-3804(99)80006-1; Broer SL, 2013, HUM REPROD UPDATE, V19, P26, DOI 10.1093/humupd/dms041; Seifer DB, 2009, FERTIL STERIL, V92, P1674, DOI 10.1016/j.fertnstert.2008.08.110; Lemos NA, 2008, FERTIL STERIL, V89, P1064, DOI 10.1016/j.fertnstert.2007.04.048; Sowers MR, 2010, ANN NY ACAD SCI, V1204, P95, DOI 10.1111/j.1749-6632.2010.05523.x; Hagen CP, 2012, FERTIL STERIL, V98, P1602, DOI 10.1016/j.fertnstert.2012.08.008; van Hooff MHA, 2004, HUM REPROD, V19, P383, DOI 10.1093/humrep/deh079; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Kristensen SL, 2012, FERTIL STERIL, V97, P779, DOI 10.1016/j.fertnstert.2011.12.017; Butts SF, 2010, FERTIL STERIL, V93, P681, DOI 10.1016/j.fertnstert.2009.10.047; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Cramer DW, 1904, JAMA-J AM MED ASSOC, V1986, P255; Dólleman M, 2013, J Clin Endocrinol Metab, V98, P2106, DOI 10.1210/jc.2012-3995; Sjaarda LA, 2014, J CLIN ENDOCR METAB, V99, P2208, DOI 10.1210/jc.2013-3781; Terakawa N., 2006, STANDARD TXB OBSTET, P174	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	NOV	2014	102	5								10.1016/j.fertnstert.2014.07.1255		5	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	AT1JE	WOS:000344688400036		
J	Matthes, R; Mizuno, Y				Matthes, Roland; Mizuno, Yoshinori			Spectral theory on 3-dimensional hyperbolic space and Hermitian modular forms	FORUM MATHEMATICUM			English	Article						3-dimensional hyperbolic space; Hermitian modular forms	HALF-INTEGRAL WEIGHT; EISENSTEIN SERIES; FOURIER COEFFICIENTS; EXPLICIT FORMULA; POINCARE-SERIES	We study some arithmetics of Hermitian modular forms of degree two by applying the spectral theory on 3-dimensional hyperbolic space. This paper presents three main results: (1) a 3-dimensional analogue of Katok-Sarnak's correspondence, (2) an analytic proof of a Hermitian analogue of the Saito-Kurokawa lift by means of a converse theorem, (3) an explicit formula for the Fourier coefficients of a certain Hermitian Eisenstein series.	[Matthes, Roland] Univ Kassel, Kassel, Germany; [Mizuno, Yoshinori] Univ Tokushima, Fac & Sch Engn, Tokushima 7708506, Japan	Matthes, R (reprint author), Univ Kassel, Fachbereich 17, Kassel, Germany.	R.Matthes@t-online.de; mizuno@pm.tokushima-u.ac.jp			21st Century COE Program at Keio University; Max-Planck-Institut fur Mathematik; JSPS [23740021]	During the preparation of this paper, the second author was supported by the 21st Century COE Program at Keio University and by Max-Planck-Institut fur Mathematik. During revising this paper, the second author is supported by JSPS Grant-in-Aid for Young Scientists (B) 23740021.	Andrianov A., 1987, GRUNDLEHREN MATH WIS, V286; BRAUN H, 1949, ANN MATH, V50, P827, DOI 10.2307/1969581; SZMIDT J, 1983, ACTA ARITH, V42, P391; SHIMURA G, 1973, ANN MATH, V97, P440, DOI 10.2307/1970831; Arakawa T., 2001, COMMENT MATH U ST PA, V50, P197; ARAKAWA T, 1990, TOHOKU MATH J, V42, P261, DOI 10.2748/tmj/1178227657; Bauer H, 2006, MATH Z, V254, P219, DOI 10.1007/s00209-006-0943-9; BRAUN H, 1951, ANN MATH, V53, P143, DOI 10.2307/1969345; Breulmann S., 1999, NAGOYA MATH J, V155, P153; Duke W., 1996, INT MATH RES NOT IMR, V1996, P347, DOI 10.1155/S1073792896000220; ELSTRODT J, 1987, MATH ANN, V277, P655, DOI 10.1007/BF01457865; Elstrodt J., 1998, SPRINGER MONOGRAPHS, p[xvi, 524]; Gradshteyn I. S., 2000, TABLE INTEGRALS SERI; Greefrath G., 1999, SCHRIFTENREIHE MA 24, V3; Haverkamp K., 1995, SCHRIFTENREIHE MA 15, V3; Ibukiyama T., 1997, 5 SUMM SCH NUMB THEO, P134; Ibukiyama T., 1999, P 1 AUT WORKSH NUMB, P1; IMAI K, 1980, AM J MATH, V102, P903, DOI 10.2307/2374197; Iwaniec H., 2002, GRADUATE STUDIES MAT, V53; Katok S., 1993, ISR J MATH, V84, P193; Kikuta T, 2012, J NUMBER THEORY, V132, P1949, DOI 10.1016/j.jnt.2012.03.003; KOJIMA H, 1982, INVENT MATH, V69, P217, DOI 10.1007/BF01399502; Koyama SY, 2000, COMMUN MATH PHYS, V215, P477, DOI 10.1007/s002200000317; Krieg A., 1985, LECT NOTES MATH, V1143; KRIEG A, 1991, MATH ANN, V289, P663, DOI 10.1007/BF01446595; Maass H., 1950, MATH ANN, V122, P90, DOI 10.1007/BF01342953; Magnus W., 1966, GRUNDLEHREN MATH WIS, V52; Matthes R, 2012, FORUM MATH, V24, P1239, DOI 10.1515/FORM.2011.103; Matthes R., PREPRINT; Matthes R, 1999, FORUM MATH, V11, P483, DOI 10.1515/form.1999.010; Miyake T., 1989, MODULAR FORMS; Mizuno Y, 2009, MATH Z, V263, P837, DOI 10.1007/s00209-008-0442-2; Mizuno Y, 2006, MANUSCRIPTA MATH, V119, P159, DOI 10.1007/s00229-005-0613-y; Mizuno Y, 2008, J NUMBER THEORY, V128, P898, DOI 10.1016/j.jnt.2007.10.012; Mizuno Y, 2005, ABH MATH SEM HAMBURG, V75, P1, DOI 10.1007/BF02942033; NAGAOKA S, 1992, ABH MATH SEM HAMBURG, V62, P117, DOI 10.1007/BF02941621; NAGAOKA S, 1989, ABH MATH SEM HAMBURG, V59, P235, DOI 10.1007/BF02942331; S Bocherer, 1986, MATH GOTTINGENSIS SC, V68; Sasaki Ryuji, 2007, TSUKUBA J MATH, V31, P301; SHIMURA G, 1983, DUKE MATH J, V50, P417, DOI 10.1215/S0012-7094-83-05019-6; Zagier D., 1981, J FS U TOKYO IAM, V28, P415	41	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0933-7741	1435-5337		FORUM MATH	Forum Math.	NOV	2014	26	6					1763	1806		10.1515/forum-2011-0113		44	Mathematics, Applied; Mathematics	Mathematics	AT0EM	WOS:000344610000007		
J	Graham, WM; Gelcich, S; Robinson, KL; Duarte, CM; Brotz, L; Purcell, JE; Madin, LP; Mianzan, H; Sutherland, KR; Uye, S; Pitt, KA; Lucas, CH; Bogeberg, M; Brodeur, RD; Condon, RH				Graham, William M.; Gelcich, Stefan; Robinson, Kelly L.; Duarte, Carlos M.; Brotz, Lucas; Purcell, Jennifer E.; Madin, Laurence P.; Mianzan, Hermes; Sutherland, Kelly R.; Uye, Shin-ichi; Pitt, Kylie A.; Lucas, Cathy H.; Bogeberg, Molly; Brodeur, Richard D.; Condon, Rolert H.			Linking human well-being and jellyfish: ecosystem services, impacts, and societal responses	FRONTIERS IN ECOLOGY AND THE ENVIRONMENT			English	Review							GELATINOUS ZOOPLANKTON; BIODIVERSITY; COASTAL; BLOOMS; OCEAN; GULF; SEA; ASSOCIATIONS; CALIFORNIA; WATERS	Jellyfish are usually perceived as harmful to humans and are seen as "pests". This negative perception has hindered knowledge regarding their value in terms of ecosystem services. As humans increasingly modify and interact with coastal ecosystems, it is important to evaluate the benefits and costs of jellyfish, given that jellyfish bloom size, frequency, duration, and extent are apparently increasing in some regions of the world. Here we explore those benefits and costs as categorized by regulating, supporting, cultural, and provisioning ecosystem services. A geographical perspective of human vulnerability to jellyfish over four categories of human well-being (health care, food, energy, and freshwater production) is also discussed in the context of thresholds and trade-offs to enable social adaptation. Whereas beneficial services provided by jellyfish likely scale linearly with biomass (perhaps peaking at a saturation point), non-linear thresholds exist for negative impacts to ecosystem services. We suggest that costly adaptive strategies will outpace the beneficial services if jellyfish populations continue to increase in the future.	[Graham, William M.; Robinson, Kelly L.] Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS 39529 USA; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Lab Int Cambio Global, Fac Ciencias Biol, Santiago, Chile; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil, Fac Ciencias Biol, Santiago, Chile; [Duarte, Carlos M.] Inst Mediterraneo Estudios Avanzaaos IMEDEA, Dept Global Change Res, Esporles, Spain; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [Duarte, Carlos M.] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Brotz, Lucas] Univ British Columbia, Sea Us Project, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Brotz, Lucas] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Purcell, Jennifer E.] Shannon Point Marine Ctr, Anacortes, WA USA; [Madin, Laurence P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Mianzan, Hermes] Inst Nacl Invest & Desarrollo Pesquero, Mar Del Plata, Buenos Aires, Argentina; [Sutherland, Kelly R.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Uye, Shin-ichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [Pitt, Kylie A.] Griffith Univ, Australian Rivers Inst, Gold Coast, Australia; [Pitt, Kylie A.] Griffith Univ, Griffith Sch Environm, Gold Coast, Australia; [Lucas, Cathy H.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Bogeberg, Molly] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Brodeur, Richard D.] NOAA, Natl Marine Fisheries Serv, Newport, OR USA; [Condon, Rolert H.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	Graham, WM (reprint author), Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS 39529 USA.	monty.graham@usm.edu	Duarte, Carlos M/A-7670-2013; Pitt, Kylie/N-7421-2014	Duarte, Carlos M/0000-0002-1213-1361; Pitt, Kylie/0000-0002-2292-2052	National Center for Ecological Analysis and Synthesis comes from National Science Foundation [DEB-94-21535]; University of California at Santa Barbara; State of California	Funding for the National Center for Ecological Analysis and Synthesis comes from National Science Foundation Grant DEB-94-21535, the University of California at Santa Barbara, and the State of California. We thank S Piraino for suggested references.	Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Gasca R, 2004, HYDROBIOLOGIA, V530, P529, DOI 10.1007/s10750-004-2657-5; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Sutherland KR, 2010, P NATL ACAD SCI USA, V107, P15129, DOI 10.1073/pnas.1003599107; HARBISON GR, 1976, LIMNOL OCEANOGR, V21, P517; Daryanabard R, 2008, J MAR BIOL ASSOC UK, V88, P477, DOI 10.1017/S0025315408000945; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Henschke N, 2013, MAR ECOL PROG SER, V491, P165, DOI 10.3354/meps10450; Ohtsuka Susumu, 2009, Plankton & Benthos Research, V4, P1; Gershwin LA, 2010, COAST MANAGE, V38, P22, DOI 10.1080/08920750903345031; Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Robinson KL, 2013, LIMNOL OCEANOGR, V58, P235, DOI 10.4319/lo.2013.58.1.0235; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Uye S, 2011, HYDROBIOLOGIA, V666, P71, DOI 10.1007/s10750-010-0208-9; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Kim DH, 2012, FISHERIES SCI, V78, P1147, DOI 10.1007/s12562-012-0533-1; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Yu HH, 2006, FOOD CHEM, V95, P123, DOI 10.1016/j.foodchem.2004.12.025; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; [Anonymous], 2005, EC HUM WELL BEING FR; Quinones J, 2013, FISH RES, V139, P47, DOI 10.1016/j.fishres.2012.04.014; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; [Anonymous], 1999, ECONOMIST       1216; Lebrato M, 2012, HYDROBIOLOGIA, V690, P227, DOI 10.1007/s10750-012-1046-8; Tacon AGJ, 2009, AMBIO, V38, P294; Balamurugan E, 2010, MOL CELL BIOCHEM, V338, P69, DOI 10.1007/s11010-009-0339-3; Bastian T, 2011, ICES J MAR SCI, V68, P436, DOI 10.1093/icesjms/fsq178; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Currie BJ, 2005, MED J AUSTRALIA, V183, P631; Doyle TK, 2014, JELLYFISH BLOOMS; FAO (Food and Agriculture Organization of the United Nations Fisheries and Aquaculture Department), 2011, FISHSTAT J UN SOFTW; FEIGENBAUM D, 1984, MAR ECOL PROG SER, V19, P39, DOI 10.3354/meps019039; Fenner PJ, 1999, MED J AUSTRALIA, V170, P512; Gasca R, 2007, MAR BIOL, V151, P233, DOI 10.1007/s00227-006-0478-y; Graham William M., 2003, Biological Invasions, V5, P53, DOI 10.1023/A:1024046707234; Hay SJ, 2006, CURR BIOL, V16, P679, DOI DOI 10.1016/J.CUB.2006.08.010; Hinder SL, 2014, GLOBAL CHANGE BIOL, V20, P140, DOI 10.1111/gcb.12387; Kideys Ahmet Erkan, 2005, Oceanography, V18, P76; Leone A, 2013, MAR DRUGS, V11, P1728, DOI 10.3390/md11051728; Madin LP, 2006, DEEP-SEA RES PT I, V53, P804, DOI 10.1016/j.dsr.2005.12.018; Mancuso R, 2006, NEWS AU; Masuda R, 2009, HYDROBIOLOGIA, V616, P269, DOI 10.1007/s10750-008-9598-3; Okino A, 2009, NIPPON SUISAN GAKK, V75, P6; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Phillips B, 2009, MAR BIOL, V156, P455, DOI 10.1007/s00227-008-1099-4; Prusaczyk WK, 1995, 9524 NAV HLTH RES CT; Vaidya S., 2003, JELLYFISH CHOKE OMAN; Walker B, 2004, ECOL SOC, V9	57	2	2	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	1540-9295	1540-9309		FRONT ECOL ENVIRON	Front. Ecol. Environ.	NOV	2014	12	9					515	523		10.1890/130298		9	Ecology; Environmental Sciences	Environmental Sciences & Ecology	AT3PK	WOS:000344846200016		
J	Fujimoto, Y				Fujimoto, Yukari			Bacterial glycoconjugates; chemical synthesis and functional analysis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			PEPTIDOGLYCAN		[Fujimoto, Yukari] Keio Univ, Tokyo 108, Japan							Wang N, 2013, CHEMBIOCHEM, V14, P482, DOI 10.1002/cbic.201200655; Fujimoto Y, 2012, NAT PROD REP, V29, P568, DOI 10.1039/c2np00091a; Fujimoto Y, 2007, J ENDOTOXIN RES, V13, P189, DOI 10.1177/0968051907080739; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				2	1086	1086				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300010		
J	Suda, Y; Saksono, B; Dewi, BE; Nainggolan, L				Suda, Yasuo; Saksono, Budi; Dewi, Beti Ernawati; Nainggolan, Leonardo			Development of highly sensitive diagnostic system for dengue viruses using the interaction between sulfated sugar-chain and viral particle	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Suda, Yasuo; Saksono, Budi] Kagoshima Univ, Kagoshima 890, Japan; [Suda, Yasuo] SUDx Biotec Corp, Shiroyama, Japan; [Saksono, Budi] Indonesian Inst Sci, Jakarta, Indonesia; [Dewi, Beti Ernawati; Nainggolan, Leonardo] Univ Indonesia, Depok, Indonesia; [Nainggolan, Leonardo] Cipto Mangun Kusumo Hosp, Jakarta, Indonesia								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				10	1088	1088				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300018		
J	Matsubara, N; Takematsu, H; Ishida, H; Tsubata, T				Matsubara, Naoko; Takematsu, Hiromu; Ishida, Hideharu; Tsubata, Takeshi			Role of CD22/Siglec-2 and its ligand in B lymphocyte activation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Matsubara, Naoko; Tsubata, Takeshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan; [Takematsu, Hiromu] Kyoto Univ, Dept Biol Chem, Grad Sch Med, Kyoto 6068501, Japan; [Ishida, Hideharu] Gifu Univ, Fac Appl Biol Sci, Dept Appl Bioorgan Chem, Gifu, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				16	1090	1090				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300024		
J	Takematsu, H; Naito-Matsui, Y; Tsubata, T; Oka, S				Takematsu, Hiromu; Naito-Matsui, Yuko; Tsubata, Takeshi; Oka, Shogo			Functional evaluation of sialoglycans expressed in activated T cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Naito-Matsui, Yuko] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Tsubata, Takeshi] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				19	1091	1092				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300027		
J	Kitagawa, H; Miyata, S; Mikami, T; Nadanaka, S				Kitagawa, Hiroshi; Miyata, Shinji; Mikami, Tadahisa; Nadanaka, Satomi			Regulation of neuronal development by glycosaminoglycans	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kitagawa, Hiroshi; Miyata, Shinji; Mikami, Tadahisa; Nadanaka, Satomi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan							Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				20	1092	1092				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300028		
J	Kohda, D				Kohda, Daisuke			Crystal structures of an archaeal oligosaccharyltransferase provide insights into the catalytic cycle of N-linked protein glycosylation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kohda, Daisuke] Kyushu Univ, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				22	1092	1093				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300030		
J	Takeda, N; Tamura, J				Takeda, Naoko; Tamura, Jun-ichi			Synthesis of biotinylated keratan sulfate oligosaccharides	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takeda, Naoko] Tottori Univ, Tottori 6808551, Japan; [Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Tottori 6808551, Japan							Takeda N, 2013, BIOSCI BIOTECH BIOCH, V78, P29	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				32	1096	1096				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300040		
J	Ninagawa, S; Okada, T; Sumitomo, Y; Kamiya, Y; Horimoto, S; Ishikawa, T; Takeda, S; Sakuma, T; Yamamoto, T; Kato, K; Mori, K				Ninagawa, Satoshi; Okada, Tetsuya; Sumitomo, Yoshiki; Kamiya, Yukiko; Horimoto, Satoshi; Ishikawa, Tokiro; Takeda, Shunichi; Sakuma, Tetsushi; Yamamoto, Takashi; Kato, Koichi; Mori, Kazutoshi			EDEM1/2/3 are alpha 1,2-mannosidases essential for endoplasmic reticulum-associated degradation of glycoproteins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ninagawa, Satoshi; Okada, Tetsuya; Sumitomo, Yoshiki; Horimoto, Satoshi; Ishikawa, Tokiro; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068501, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Tokyo, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Yamamoto, Takashi; Kato, Koichi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 730, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				34	1097	1097				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300042		
J	Nishihara, S				Nishihara, Shoko			Glycan structures regulate the states of pluripotent stem cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nishihara, Shoko] Soka Univ, Dept Bioinformat, Fac Engn, Hachioji, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				36	1098	1098				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300044		
J	Fujita, M; Lee, GH; Murakami, Y; Kanzawa, N; Maeda, Y; Kinoshita, T				Fujita, Morihisa; Lee, Gun-Hee; Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh			Shedding of GPI-anchored proteins by a novel GPI cleaving enzyme	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Lee, Gun-Hee; Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan; [Lee, Gun-Hee; Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				48	1102	1103				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300056		
J	Narimatsu, H; Takasaki, N				Narimatsu, Hisashi; Takasaki, Nobuyoshi			A heterozygous mutation of glycosyltransferase-like gene causes asthenozoospermia	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Narimatsu, Hisashi; Takasaki, Nobuyoshi] Natl Inst Adv Ind Sci & Technol, Glycomed Technol Res Ctr GTRC, Tsukuba, Ibaraki 3058568, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				50	1103	1103				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300058		
J	Suzuki-Anekoji, M; Yeh, JC; Kawakubo, M; Nonaka, M; Shibata, TK; Sugihara, K; Nakayama, J; Fukuda, M; Fukuda, MN				Suzuki-Anekoji, Misa; Yeh, Jiunn-Chern; Kawakubo, Masatomo; Nonaka, Motohiro; Shibata, Toshiaki K.; Sugihara, Kazuhiro; Nakayama, Jun; Fukuda, Minoru; Fukuda, Michiko N.			Targeted drug delivery to brain tumor vasculature by carbohydrate mimetic peptide in mouse glioma model	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Suzuki-Anekoji, Misa; Yeh, Jiunn-Chern; Nonaka, Motohiro; Fukuda, Minoru; Fukuda, Michiko N.] Sanford Burnham Med Res Inst, Ctr Canc, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Kawakubo, Masatomo; Nakayama, Jun] Shinshu Univ, Dept Pathol, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Shibata, Toshiaki K.; Sugihara, Kazuhiro] Hamamatsu Univ Sch Med, Dept Gynecol & Obstet, Hamamatsu, Shizuoka 4313192, Japan							[Anonymous], 2008, CLIN CANC RES, V4, P2145; [Anonymous], 2011, JBC, V286, P32824; [Anonymous], 2011, PNAS, V108, P19587	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				53	1104	1105				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300061		
J	Aoki-Kinoshita, K; Agravat, S; Aoki, NP; Arpinar, S; Cummings, RD; Fujita, A; Fujita, N; Hart, GM; Haslam, S; Kawasaki, T; Matsubara, M; Moreman, KW; Narimatsu, H; Okuda, S; Pierce, JM; Ranzinger, R; Shikanai, T; Shinmachi, D; Solovieva, E; Suzuki, Y; Tsuchiya, S; Yamada, I; York, WS; Zaia, J				Aoki-Kinoshita, Kiyoko; Agravat, Sanjay; Aoki, Nobuyuki P.; Arpinar, Sena; Cummings, Richard D.; Fujita, Akihiro; Fujita, Noriaki; Hart, Gerald M.; Haslam, Stuart; Kawasaki, Toshisuke; Matsubara, Masaaki; Moreman, Kelley W.; Narimatsu, Hisashi; Okuda, Shujiro; Pierce, J. Michael; Ranzinger, Rene; Shikanai, Toshihide; Shinmachi, Daisuke; Solovieva, Elena; Suzuki, Yoshinori; Tsuchiya, Shinichiro; Yamada, Issaku; York, William S.; Zaia, Joseph			Development of an International Glycan Structure Repository	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Aoki-Kinoshita, Kiyoko; Aoki, Nobuyuki P.; Fujita, Akihiro; Shinmachi, Daisuke; Tsuchiya, Shinichiro] Soka Univ, Dept Bioinformat, Fac Engn, Tokyo, Japan; [Aoki-Kinoshita, Kiyoko; Fujita, Noriaki; Narimatsu, Hisashi; Shikanai, Toshihide; Solovieva, Elena; Suzuki, Yoshinori] AIST, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan; [Agravat, Sanjay] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Arpinar, Sena; Moreman, Kelley W.; Pierce, J. Michael; Ranzinger, Rene; York, William S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Hart, Gerald M.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Haslam, Stuart] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Natl Sci, London, England; [Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga, Japan; [Matsubara, Masaaki; Yamada, Issaku] Noguchi Inst, Tokyo, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Zaia, Joseph] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA			Shikanai, Toshihide/H-4242-2015					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				56	1106	1106				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300064		
J	Ishiwata, A; Kaeothip, S; Takeda, Y; Ito, Y				Ishiwata, Akihiro; Kaeothip, Sophon; Takeda, Yoichi; Ito, Yukishige			Synthetic study and structural analysis of highly glycosylated hydrophilic motif of plant extensins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			BETA-L-ARABINOFURANOSIDASE		[Ishiwata, Akihiro] RIKEN, Wako, Saitama, Japan; [Kaeothip, Sophon; Takeda, Yoichi; Ito, Yukishige] Japan Sci & Technol Agcy, ERATO Glycotril Project, Tokyo, Japan			Ishiwata, Akihiro/B-4710-2015				Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Ishiwata A, 2011, J AM CHEM SOC, V133, P2275, DOI 10.1021/ja109932t; Ishiwata A, 2006, ORG LETT, V8, P5525, DOI 10.1021/ol062198j; Fujita K, 2014, J BIOL CHEM, V289, P5240, DOI 10.1074/jbc.M113.528711; Ishiwata A, 2008, EUR J ORG CHEM, P4250, DOI 10.1002/ejoc.200800249; Ishiwata A, 2014, ANGEW CHEM IN PRESS; Ito T., 2014, BIOCHEM BIOPH RES CO, P447; Kaeothip S, 2013, CARBOHYD RES, V382, P95, DOI 10.1016/j.carres.2013.10.005; Kaeothip S, 2013, ORG BIOMOL CHEM, P4250	10	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				59	1107	1107				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300067		
J	Haga, Y; Ishii, K; Hibino, K; Sako, Y; Ito, Y; Taniguchi, N; Suzuki, T				Haga, Yoshimi; Ishii, Kumiko; Hibino, Kayo; Sako, Yasushi; Ito, Yukishige; Taniguchi, Naoyuki; Suzuki, Tadashi			Glycoform imaging: use of transmembrane FRET to investigate the internalization of glycosylated proteins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Haga, Yoshimi; Ishii, Kumiko; Suzuki, Tadashi] RIKEN Global Res Cluster, Glycometabolome Team, Wako, Saitama, Japan; [Sako, Yasushi] RIKEN, Cellular Informat Lab, Wako, Saitama, Japan; [Hibino, Kayo; Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama, Japan; [Taniguchi, Naoyuki] RIKEN, Dis Glyc Team, Wako, Saitama, Japan			Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455			Haga Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1906	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				63	1108	1109				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300071		
J	Tamura, J; Tanaka, H; Nakamura, A; Toita, R; Hosaka, YZ; Nagamine, K; Himono, A; Takeda, N				Tamura, Jun-ichi; Tanaka, Haruna; Nakamura, Ayumi; Toita, Ryosuke; Hosaka, Yoshinao Z.; Nagamine, Ken-ichi; Himono, Ayaka; Takeda, Naoko			Fucosyl chondroitin sulfate from sea cucumber - chemical synthesis and structural analysis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Tamura, Jun-ichi; Tanaka, Haruna; Nakamura, Ayumi; Toita, Ryosuke] Tottori Univ, Dept Reg Environm, Tottori 6808551, Japan; [Hosaka, Yoshinao Z.] Tottori Univ, Joint Dept Vet Med, Tottori 6808553, Japan; [Nagamine, Ken-ichi; Himono, Ayaka] Tottori Univ, Res & Dev Ctr, Nichirei Biosci, Tottori 6808551, Japan; [Takeda, Naoko] Tottori Univ, Tottori 6808551, Japan							Arima K, 2013, CARBOHYD RES, V366, P25, DOI 10.1016/j.carres.2012.11.010; Tamura J, 2013, TETRAHEDRON LETT, V54, P3940, DOI 10.1016/j.tetlet.2013.05.064	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				62	1108	1108				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300070		
J	Tanaka, K; Ogura, A				Tanaka, Katsunori; Ogura, Akihiro			Noninvasive Molecular Imaging and Targeting Studies of Neo-N-glycoproteins: Significant Effects of N-Glycan Clusterization on Albumin	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Tanaka, Katsunori; Ogura, Akihiro] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama, Japan							Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Tanaka K, 2008, ANGEW CHEM INT EDIT, V47, P102, DOI 10.1002/anie.200702989	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				61	1108	1108				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300069		
J	Hisada, A; Koizumi, K; Sato, T				Hisada, Akari; Koizumi, Keisuke; Sato, Toshinori			Cell interaction and physicochemical characterization of hyaluronic acid nanoparticles	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hisada, Akari; Koizumi, Keisuke; Sato, Toshinori] Keio Univ, Tokyo 108, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				65	1109	1109				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300073		
J	Shibata, R; Matsubara, T; Sato, T				Shibata, Rabi; Matsubara, Teruhiko; Sato, Toshinori			Analysis of the interaction between peptide aptamers and hemagglutinin	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shibata, Rabi; Matsubara, Teruhiko; Sato, Toshinori] Keio Univ, Tokyo 108, Japan							Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				66	1109	1110				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300074		
J	Takeda, Y; Seko, A; Ohara, K; Hachisu, M; Fujikawa, K; Wang, N; Ito, Y				Takeda, Yoichi; Seko, Akira; Ohara, Keiichiro; Hachisu, Masakazu; Fujikawa, Kohki; Wang, Ning; Ito, Yukishige			Catalytic Domain of UDP-Glc: Glycoprotein Glucosyltransferase; Functional Analysis using Synthetic Substrates	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takeda, Yoichi; Seko, Akira; Ohara, Keiichiro; Hachisu, Masakazu; Fujikawa, Kohki; Wang, Ning; Ito, Yukishige] Japan Sci & Technol Agcy JST, ERATO, Ito Glycotril Project, Tokyo, Japan; [Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama, Japan							Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				64	1109	1109				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300072		
J	Kitajima, K; Wu, D; Tajima, K; Maruyama, E; Yasukawa, Y; Chang, LY; Taniguchi, Y; Kamei, Y; Adachi, T; Hashimoto, H; Hibi, M; Fujita, A; Sato, C				Kitajima, Ken; Wu, Di; Tajima, Katsue; Maruyama, Emi; Yasukawa, Yuko; Chang, Lan-Yi; Taniguchi, Yoshihito; Kamei, Yasuhiro; Adachi, Tomoko; Hashimoto, Hisashi; Hibi, Masahiko; Fujita, Akiko; Sato, Chihiro			Critical importance of the surface expression of alpha 2,6-sialosides during early development of medaka fish	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kitajima, Ken; Wu, Di; Tajima, Katsue; Maruyama, Emi; Yasukawa, Yuko; Chang, Lan-Yi; Adachi, Tomoko; Hashimoto, Hisashi; Hibi, Masahiko; Fujita, Akiko; Sato, Chihiro] Nagoya Univ, Biosci Biotech Ctr, Nagoya, Aichi 4648601, Japan; [Kitajima, Ken; Wu, Di; Tajima, Katsue; Maruyama, Emi; Yasukawa, Yuko; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Taniguchi, Yoshihito] Keio Univ, Sch Med, Tokyo 108, Japan; [Kamei, Yasuhiro] Natl Inst Basic Biol, Dept Appl Life Sci, Okazaki, Aichi, Japan			SATO, Chihiro/B-7396-2014					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				67	1110	1110				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300075		
J	Watanabe, H; Okahara, K; Kozutsumi, Y; Oka, S; Takematsu, H				Watanabe, Hiroshi; Okahara, Kyohei; Kozutsumi, Yasunori; Oka, Shogo; Takematsu, Hiromu			Polyploidization triggered by psychosine is modulated by cellular glycosphingolipids and sphingomyelin	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Watanabe, Hiroshi; Oka, Shogo; Takematsu, Hiromu] Kyoto Univ, Grad Sch Med, Lab Biol Chem, Kyoto 6068501, Japan; [Okahara, Kyohei; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				68	1110	1111				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300076		
J	Tanaka, T; Ishitani, H; Miura, Y; Oishi, K; Takahashi, T; Suzuki, T				Tanaka, Tomonari; Ishitani, Hideki; Miura, Yoshiko; Oishi, Kenta; Takahashi, Tadanobu; Suzuki, Takashi			Protecting-group-free Synthesis and Binding with Influenza Virus of Glycopolymers Bearing Sialyloligosaccharides	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Tanaka, Tomonari; Ishitani, Hideki] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto, Japan; [Miura, Yoshiko] Kyushu Univ, Grad Sch Engn, Fukuoka 812, Japan; [Oishi, Kenta; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				69	1111	1111				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300077		
J	Aoyagi, T; Ohira, S; Tanaka, H				Aoyagi, Taku; Ohira, Shuichi; Tanaka, Hiroshi			alpha-Selective glycosidation of using N-acetyl sialyl donors possessing a free hydroxyl group at the C4 position	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Aoyagi, Taku; Ohira, Shuichi; Tanaka, Hiroshi] Tokyo Inst Technol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				74	1112	1112				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300082		
J	Miyazawa, S; Ishii, N; Utsui, T; Hamada, M; Matsuo, I				Miyazawa, Shinpei; Ishii, Nozomi; Utsui, Takashi; Hamada, Masaki; Matsuo, Ichiro			Convergent synthesis of biantennary complex type nonasaccharide containing LacdiNAc structure based on the regioselective glycosylation and inversion reactions	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Miyazawa, Shinpei; Ishii, Nozomi; Utsui, Takashi; Hamada, Masaki; Matsuo, Ichiro] Gunma Univ, Div Mol Sci, Maebashi, Gumma, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				75	1112	1113				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300083		
J	Arai, K; Kimura, H; Kabayama, K; Kanie, O				Arai, Kenta; Kimura, Hiroshi; Kabayama, Kazuya; Kanie, Osamu			A study toward understanding cellular dynamics of glycosphingolipid based on chemical engineering approach	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Arai, Kenta] Tokai Univ, Grad Sch Engn, Hiratsuka, Kanagawa 25912, Japan; [Kimura, Hiroshi] Tokai Univ, Fac Engn, Hiratsuka, Kanagawa 25912, Japan; [Kabayama, Kazuya] Osaka Univ, Grad Sch Sci, Suita, Osaka 565, Japan; [Kanie, Osamu] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan			Kanie, Osamu/D-1741-2010	Kanie, Osamu/0000-0003-4147-6868				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				76	1113	1113				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300084		
J	Izumi, M; Kuruma, R; Okamoto, R; Seko, A; Ito, Y; Kajihara, Y				Izumi, Masayuki; Kuruma, Rie; Okamoto, Ryo; Seko, Akira; Ito, Yukishige; Kajihara, Yasuhiro			Chemical synthesis of misfolded glycoproteins as substrates of folding sensor enzyme UGGT	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Izumi, Masayuki; Kuruma, Rie; Okamoto, Ryo; Kajihara, Yasuhiro] Osaka Univ, Suita, Osaka 565, Japan; [Seko, Akira; Ito, Yukishige; Kajihara, Yasuhiro] JST ERATO, Tokyo, Japan; [Ito, Yukishige] RIKEN, Wako, Saitama, Japan			Izumi, Masayuki/C-6230-2008	Izumi, Masayuki/0000-0001-6486-9678			Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				78	1113	1114				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300086		
J	Totani, K; Hirano, M; Adachi, Y				Totani, Kiichiro; Hirano, Makoto; Adachi, Yuka			Glycoprotein folding influences on its association with lectin-like molecular chaperone calreticulin	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Totani, Kiichiro; Hirano, Makoto; Adachi, Yuka] Seikei Univ, Tokyo, Japan							Rodan AR, 1996, EMBO J, V15, P6921; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				77	1113	1113				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300085		
J	Hirano, M; Watanabe, C; Kubo, K; Ito, Y; Williams, SJ; Totani, K				Hirano, Makoto; Watanabe, Chie; Kubo, Karen; Ito, Yukishige; Williams, Spencer J.; Totani, Kiichiro			Biological function of endomannosidase activity found in the endoplasmic reticulum	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hirano, Makoto; Watanabe, Chie; Kubo, Karen; Totani, Kiichiro] Seikei Univ, Tokyo, Japan; [Ito, Yukishige] JST, RIKEN, ERATO, Tokyo, Japan; [Williams, Spencer J.] Univ Melbourne, Melbourne, Vic 3010, Australia			Williams, Spencer/C-3545-2009	Williams, Spencer/0000-0001-6341-4364			Iwamoto S, 2013, GLYCOBIOLOGY, V23, P121, DOI 10.1093/glycob/cws130	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				81	1114	1115				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300089		
J	Kitsunezuka, T; Iwayama, Y; Haneda, K; Inazu, T				Kitsunezuka, Tetsuya; Iwayama, Yuki; Haneda, Katsuji; Inazu, Toshiyuki			Synthesis of 3-deoxy-GlcNAc and its application to transglycosylation using Endo-M	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kitsunezuka, Tetsuya; Inazu, Toshiyuki] Tokai Univ, Inst Glycosci, Sch Engn, Hiratsuka, Kanagawa 25912, Japan; [Iwayama, Yuki] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Haneda, Katsuji] Tokai Univ, Sch Engn, Hiratsuka, Kanagawa 25912, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				79	1114	1114				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300087		
J	Ishida, H; Nishikawa, Y; Ishihara, M; Ota, T; Iino, K; Saburoumaru, M; Matsuzaki, Y				Ishida, Hideki; Nishikawa, Yoshihide; Ishihara, Mikio; Ota, Takashi; Iino, Kenta; Saburoumaru, Miyuki; Matsuzaki, Yuji			The chemical synthesis of various N-linked oligosaccharides as the substrates for endo-beta-N-acetylglucosaminidase Endo-M or its mutated enzyme (Endo-M-N-175Q) toward production of glycoproteins having homogenous N-glycans	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ishida, Hideki; Nishikawa, Yoshihide; Ishihara, Mikio; Ota, Takashi; Iino, Kenta; Saburoumaru, Miyuki; Matsuzaki, Yuji] Tokyo Chem Ind Co Ltd, Tokyo, Japan							Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Yamamoto K., BIOCH BIOPHYS RES CO, P203	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				86	1116	1117				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300094		
J	Kumada, J; Habu, M; Tanji, T; Yuasa, N; Iwaki, J; Katoh, T; Yamamoto, K; Matsuzaki, Y				Kumada, Junichi; Habu, Masato; Tanji, Takahiro; Yuasa, Noriyuki; Iwaki, Jun; Katoh, Toshihiko; Yamamoto, Kenji; Matsuzaki, Yuji			N-Glycan Replacement of a Therapeutic Antibody with Structure-defined Glycan by Chemoenzymatic Glycoengineering using Endo-M and Glycosynthase	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kumada, Junichi; Habu, Masato; Tanji, Takahiro; Yuasa, Noriyuki; Iwaki, Jun; Matsuzaki, Yuji] Tokyo Chem Ind Co LTD, Tokyo, Japan; [Katoh, Toshihiko; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Kahoku, Ishikawa, Japan							Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				88	1117	1117				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300096		
J	Yi, RQ; Ichiyanagi, T				Yi, Ruiqin; Ichiyanagi, Tsuyoshi			Synthetic study of branched inner-core oligosaccharides of LPS/LOS	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yi, Ruiqin; Ichiyanagi, Tsuyoshi] Tottori Univ, Tottori, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				89	1117	1118				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300097		
J	Ishii, N; Iwamoto, S; Kumada, J; Matsuzaki, Y; Matsuo, I				Ishii, Nozomi; Iwamoto, Shogo; Kumada, Jyunichi; Matsuzaki, Yuji; Matsuo, Ichiro			Analysis of substrate specificity for endo-M and its mutants using synthetic glycans	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ishii, Nozomi; Iwamoto, Shogo; Matsuo, Ichiro] Gunma Univ, Fac Sci & Technol, Maebashi, Gumma, Japan; [Kumada, Jyunichi; Matsuzaki, Yuji] Tokyo Chem Ind Co Ltd, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				90	1118	1118				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300098		
J	Okamoto, R; Mandal, K; Ling, M; Luster, A; Sawaya, M; Yeates, T; Kajihara, Y; Kent, S				Okamoto, Ryo; Mandal, Kalyanswer; Ling, Morris; Luster, Andrew; Sawaya, Michael; Yeates, Todd; Kajihara, Yasuhiro; Kent, Stephen			Biological activities of the homogeneous glycosylated chemokines CCL1 and Ser-CCL1 prepared by total chemical synthesis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			NONGLYCOSYLATED FORMS		[Okamoto, Ryo; Kajihara, Yasuhiro; Kent, Stephen] Osaka Univ, Suita, Osaka 565, Japan; [Mandal, Kalyanswer] Univ Chicago, Chicago, IL 60637 USA; [Ling, Morris; Luster, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cambridge, MA 02138 USA							Okamoto R, 2014, ANGEW CHEM INT EDIT, V53, P5194, DOI 10.1002/anie.201400679; Okamoto R, 2014, ANGEW CHEM INT EDIT, V53, P5188, DOI 10.1002/anie.201310574	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				91	1118	1119				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300099		
J	Kiuchi, T; Okamoto, R; Izumi, M; Seko, A; Ito, Y; Kajihara, Y				Kiuchi, Tatsuto; Okamoto, Ryo; Izumi, Masayuki; Seko, Akira; Ito, Yukishige; Kajihara, Yasuhiro			Synthetic Study of Erythropoietin Having High Mannose-type Oligosaccharide by Chemical Methodology	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kiuchi, Tatsuto; Okamoto, Ryo; Izumi, Masayuki; Kajihara, Yasuhiro] Osaka Univ, Suita, Osaka 565, Japan; [Seko, Akira] JST ERATO, Tokyo, Japan; [Ito, Yukishige] RIKEN, Wako, Saitama, Japan			Izumi, Masayuki/C-6230-2008	Izumi, Masayuki/0000-0001-6486-9678				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				93	1119	1119				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300101		
J	Murakami, M; Okamoto, R; Izumi, M; Kajihara, Y				Murakami, Masumi; Okamoto, Ryo; Izumi, Masayuki; Kajihara, Yasuhiro			A synthetic study of a homogeneous hematopoietic glycoprotein bearing three biantennary sialyloligosaccharides	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			CHEMICAL-SYNTHESIS		[Murakami, Masumi; Okamoto, Ryo; Izumi, Masayuki; Kajihara, Yasuhiro] Osaka Univ, Grad Sch Sci, Suita, Osaka 565, Japan			Izumi, Masayuki/C-6230-2008	Izumi, Masayuki/0000-0001-6486-9678			Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Murakami M, 2012, ANGEW CHEM INT EDIT, V51, P3567, DOI 10.1002/anie.201109034; [Anonymous], 2012, CHEM SOC REV, V41, P7001; Fang GM, 2011, ANGEW CHEM INT EDIT, V50, P7645, DOI 10.1002/anie.201100996; Richard J, 2010, CHEM COMMUN, V46, P21	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				92	1119	1119				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300100		
J	Ohira, S; Yasuda, Y; Sato, C; KItajima, K; Tomita, I; Takahashi, T; Tanaka, H				Ohira, Shuichi; Yasuda, Yu; Sato, Chihiro; KItajima, Ken; Tomita, Ikuyoshi; Takahashi, Takashi; Tanaka, Hiroshi			The Synthesis of Sialo-containing Glycopolymers by pi-Allyl Nickel Catalyzed Coordination Polymerization	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ohira, Shuichi; Tanaka, Hiroshi] Tokyo Inst Technol, Dept Appl Chem, Tokyo, Japan; [Yasuda, Yu; Sato, Chihiro; KItajima, Ken] Nagoya Univ, Grad Sch Bioagr Sci & Biosci, Nagoya, Aichi 4648601, Japan; [Yasuda, Yu; Sato, Chihiro; KItajima, Ken] Nagoya Univ, Ctr Biotechnol, Nagoya, Aichi 4648601, Japan; [Tomita, Ikuyoshi] Tokyo Inst, Dept Elect Chem, Tokyo, Japan			SATO, Chihiro/B-7396-2014					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				94	1119	1120				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300102		
J	Kuribara, T; Hirano, M; Totani, K				Kuribara, Taiki; Hirano, Makoto; Totani, Kiichiro			Analysis of glycan processing in the endoplasmic reticulum based on selective inhibition of mannosidases	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kuribara, Taiki; Hirano, Makoto; Totani, Kiichiro] Seikei Univ, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				95	1120	1120				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300103		
J	Shiba, M; Iwata, K; Shinoda, Y; Hirano, M; Totani, K				Shiba, Masaaki; Iwata, Kodai; Shinoda, Yuki; Hirano, Makoto; Totani, Kiichiro			Synergistic improvement in chemical synthesis of high-mannose glycans	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shiba, Masaaki; Iwata, Kodai; Shinoda, Yuki; Hirano, Makoto; Totani, Kiichiro] Seikei Univ, Tokyo, Japan							Matsuo I, 2003, J AM CHEM SOC, V125, P3402, DOI 10.1021/ja021288q; Matsuo I, 2006, TETRAHEDRON, V62, P8262, DOI 10.1016/j.tet.2006.06.045	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				96	1120	1120				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300104		
J	Iwamoto, S; Takeda, Y; Seko, A; Ito, Y; Matsuo, I				Iwamoto, Shogo; Takeda, Yoichi; Seko, Akira; Ito, Yukishige; Matsuo, Ichiro			Synthesis of glucosylated N-glycans using transglycosylation activity of Golgi endo-alpha-mannosidase	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Iwamoto, Shogo; Matsuo, Ichiro] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Maebashi, Gumma, Japan; [Takeda, Yoichi; Seko, Akira] ERATO JST, Tokyo, Japan; [Ito, Yukishige] RIKEN, ERATO JST, Synthet Cellular Chem Lab, Wako, Saitama, Japan							Iwamoto S, 2014, BIOSCI BIOTECH BIOCH, V78, P927, DOI 10.1080/09168451.2014.910101	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				98	1121	1121				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300106		
J	Yamaguchi, M; Yamaguchi, Y; Nakata, M; Henningham, A; Olson, J; Dahesh, S; Cole, J; Kawabata, S; Varki, A; Victor				Yamaguchi, Masaya; Yamaguchi, Yuka; Nakata, Masanobu; Henningham, Anna; Olson, Joshua; Dahesh, Samira; Cole, Jason; Kawabata, Shigetada; Varki, Ajit; Victor			Enzymatically active extracellular hyaluronidase (HylA) of group A Streptococcus promotes intracellular survival and virulence	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yamaguchi, Masaya; Nakata, Masanobu; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Suita, Osaka 565, Japan; [Yamaguchi, Masaya; Yamaguchi, Yuka; Henningham, Anna; Olson, Joshua; Dahesh, Samira; Cole, Jason; Victor] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Henningham, Anna; Cole, Jason] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Henningham, Anna; Cole, Jason] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Varki, Ajit] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				102	1122	1123				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300110		
J	Okamura, T; Sakai, Y; Hoshino, H; Iwaya, Y; Tanaka, E; Kobayashi, M				Okamura, Takuma; Sakai, Yasuhiro; Hoshino, Hitomi; Iwaya, Yugo; Tanaka, Eiji; Kobayashi, Motohiro			Superficially-Located Enlarged Lymphoid Follicles Characterize Nodular Gastritis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Okamura, Takuma] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 390, Japan; [Sakai, Yasuhiro; Hoshino, Hitomi; Kobayashi, Motohiro] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Eiheiji, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				104	1123	1124				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300112		
J	Zheng, X; Ohsaki, E; Ueda, K				Zheng, Xin; Ohsaki, Eriko; Ueda, Keiji			Mechanism of up-regulation of a glycoprotein: Angpt-1 in Kaposi's sarcoma-associated herpesvirus infected primary effusion lymphoma cell lines	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Zheng, Xin; Ohsaki, Eriko; Ueda, Keiji] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Div Virol, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				106	1124	1124				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300114		
J	Ishitsubo, E; Hosozawa, T; Igarashi, M; Kirshner, KN; Sriwilaijaroen, N; Yokoe, H; Tubuki, M; Suzuki, Y; Tokiwa, H				Ishitsubo, Erika; Hosozawa, Takumi; Igarashi, Manabu; Kirshner, Karl N.; Sriwilaijaroen, Nongluk; Yokoe, Hiromasa; Tubuki, Masayoshi; Suzuki, Yasuo; Tokiwa, Hiroaki			Rational Design and Development of Novel Multi-target Inhibitors for Influenza Virus	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ishitsubo, Erika; Hosozawa, Takumi; Tokiwa, Hiroaki] Rikkyo Univ, Dept Chem, Tokyo 171, Japan; [Igarashi, Manabu] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Kirshner, Karl N.] Fraunhofer Inst SCAI, St Augustin, Germany; [Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Pathum Thani, Thailand; [Sriwilaijaroen, Nongluk; Suzuki, Yasuo] Chubu Univ, Kasugai, Aichi 487, Japan; [Yokoe, Hiromasa; Tubuki, Masayoshi] Hoshi Univ, Inst Med Chem, Tokyo 142, Japan; [Tokiwa, Hiroaki] Rikkyo Univ, Res Ctr Smart Mol, Tokyo 171, Japan							Amaro R.E., 2011, NATURE COMM, V2, DOI 10.1038; Sriwilaijaroen N, 2011, FOOD CHEM, V127, P1, DOI 10.1016/j.foodchem.2010.12.031	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				115	1128	1128				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300123		
J	Nio-Kobayashi, J; Iwanaga, T; Duncan, C				Nio-Kobayashi, Junko; Iwanaga, Toshihiko; Duncan, Colin			Implication of a galectin switch in the regulation of luteal function in women	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nio-Kobayashi, Junko; Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido 060, Japan; [Duncan, Colin] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH8 9YL, Midlothian, Scotland								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				116	1128	1129				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300124		
J	Hasan, I; Fujii, Y; Ogawa, Y; Sugawara, S; Hosono, M; Koide, Y; Rajia, S; Kawsar, SMA; Kanaly, R; Fujiwara, T; Fujita, H; Ozeki, Y				Hasan, Imtiaj; Fujii, Yuki; Ogawa, Yukiko; Sugawara, Shigeki; Hosono, Masahiro; Koide, Yasuhiro; Rajia, Sultana; Kawsar, Sarkar M. A.; Kanaly, Robert; Fujiwara, Toshiyuki; Fujita, Hideaki; Ozeki, Yasuhiro			Intracellular trafficking of MytiLec, a Gb3-specific R-type mussel lectin with cytotoxic activity	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hasan, Imtiaj; Koide, Yasuhiro; Kanaly, Robert; Ozeki, Yasuhiro] Yokohama City Univ, Grad Sch, Yokohama, Kanagawa 232, Japan; [Fujii, Yuki; Ogawa, Yukiko; Fujiwara, Toshiyuki; Fujita, Hideaki] Nagasaki Int Univ, Grad Sch, Sasebo, Nagasaki, Japan; [Sugawara, Shigeki; Hosono, Masahiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Rajia, Sultana] Varendra Univ, Rajshahi, Bangladesh; [Kawsar, Sarkar M. A.] Univ Chittagong, Chittagong, Bangladesh							Fujii, 2012, J BIOL CHEM, V287, P44772	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				125	1131	1132				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300133		
J	Nagae, M; Morita-Matsumoto, K; Kato, M; Kaneko, M; Kato, Y; Yamaguchi, Y				Nagae, Masamichi; Morita-Matsumoto, Kana; Kato, Masaki; Kaneko, Mika; Kato, Yukinari; Yamaguchi, Yoshiki			Atomic details of the glycosylation-dependent and independent ligand interactions of C- type lectin-like receptor-2 (CLEC-2)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nagae, Masamichi; Morita-Matsumoto, Kana; Kato, Masaki; Yamaguchi, Yoshiki] RIKEN, Struct Glycobiol Team, Wako, Saitama, Japan; [Kaneko, Mika; Kato, Yukinari] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				123	1131	1131				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300131		
J	Angata, T; Ishii, T; Motegi, T; Gao, CX; Ohtsubo, K; Kitazume, S; Gemma, A; Kida, K; Taniguchi, N				Angata, Takashi; Ishii, Takeo; Motegi, Takashi; Gao, Congxiao; Ohtsubo, Kazuaki; Kitazume, Shinobu; Gemma, Akihiko; Kida, Kozui; Taniguchi, Naoyuki			Influence of SIGLEC9 polymorphisms on the phenotypes of chronic obstructive pulmonary disease (COPD)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Angata, Takashi; Gao, Congxiao; Ohtsubo, Kazuaki; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Global Res Cluster, Syst Glycobiol Res Grp, Saitama, Japan; [Ishii, Takeo; Motegi, Takashi; Kida, Kozui] Nippon Med Sch, Resp Care Clin, Tokyo 113, Japan; [Ishii, Takeo; Motegi, Takashi; Gemma, Akihiko; Kida, Kozui] Nippon Med Sch, Dept Internal Med, Div Pulm Med Infect Dis & Oncol, Tokyo 113, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				126	1132	1132				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300134		
J	Miyagawa, A; Oda, M; Yamamura, H				Miyagawa, Atsushi; Oda, Masayuki; Yamamura, Hatsuo			Synthetic beta-1,3-Oligoglucans as Probes to Study for Hydrolysis and Recognition of Endo-beta-1,3-Glucanase	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Miyagawa, Atsushi; Yamamura, Hatsuo] Nagoya Inst Technol, Nagoya, Aichi, Japan; [Oda, Masayuki] Kyoto Prefectural Univ, Kyoto, Japan							Yamaguchi T, 2000, PLANT CELL, V12, P817, DOI 10.1105/tpc.12.5.817; Tanabe Y., 2008, J BIOL MACROMOL, V8, P60	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				127	1132	1132				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300135		
J	Hanashima, S; Kanagawa, M; Gotze, S; Liu, Y; Ikeda, A; Silva, DV; Feizi, T; Seeberger, P; Yamaguchi, Y				Hanashima, Shinya; Kanagawa, Mayumi; Goetze, Sebastian; Liu, Yan; Ikeda, Akemi; Silva, Daniel Varon; Feizi, Ten; Seeberger, Peter; Yamaguchi, Yoshiki			NMR interaction analysis of intestinal soluble lectin ZG16p with mycobacterium phosphatidylinositol mannosides	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hanashima, Shinya; Kanagawa, Mayumi; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN, Struct Glycobiol Team, Wako, Saitama, Japan; [Goetze, Sebastian; Silva, Daniel Varon; Seeberger, Peter] MPI, Dept Biomol Syst, Saarbrucken, Germany; [Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				130	1133	1134				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300138		
J	Nakagawa, A; Konta, K; Inoue, K; Komiya, S; Kanie, O				Nakagawa, Atsushi; Konta, Kazuki; Inoue, Kento; Komiya, Shinobu; Kanie, Osamu			Investigation of organic framework based on carbohydrate-protein interaction	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nakagawa, Atsushi; Kanie, Osamu] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Konta, Kazuki; Inoue, Kento] Tokai Univ, Fac Engn, Hiratsuka, Kanagawa 25912, Japan; [Komiya, Shinobu] Tokai Univ, Grad Sch Engn, Hiratsuka, Kanagawa 25912, Japan			Kanie, Osamu/D-1741-2010	Kanie, Osamu/0000-0003-4147-6868				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				139	1137	1137				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300147		
J	Kaneko, S; Ochiai, I; Sato, S; Kimura, K; Oda, T; Miyanishi, N				Kaneko, Satoki; Ochiai, Ikumi; Sato, Shun; Kimura, Koki; Oda, Tatsuya; Miyanishi, Nobumitsu			Purification and characterization of the novel lectin from Ceroplastes ceriferusi	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kaneko, Satoki; Miyanishi, Nobumitsu] Toyo Univ, Grad Sch Life Sci, Tokyo, Japan; [Ochiai, Ikumi; Sato, Shun; Kimura, Koki] Toyo Univ, Fac Life Sci, Tokyo, Japan; [Oda, Tatsuya] Nagasaki Univ, Fac Fisheries, Nagasaka, Yamanashi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				143	1138	1139				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300151		
J	Kurimoto, K; Yamamura, H; Miyagawa, A				Kurimoto, Kenta; Yamamura, Hatsuo; Miyagawa, Atsushi			Comprehensive syntheses of sialyl galactoside regioisomers	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kurimoto, Kenta; Yamamura, Hatsuo; Miyagawa, Atsushi] Nagoya Inst Technol, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				147	1140	1140				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300155		
J	Moriuchi, H; Unno, H; Goda, S; Hatakeyama, T				Moriuchi, Hiromi; Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu			Alteration of the carbohydrate-binding specificity of the C-type lectin CEL-I by site-directed mutagenesis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Moriuchi, Hiromi; Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu] Nagasaki Univ, Grad Sch Engn, Nagasaki, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				149	1140	1141				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300157		
J	Ichise, A; Unno, H; Goda, S; Nakagawa, H; Hatakeyama, T				Ichise, Ayaka; Unno, Hideaki; Goda, Shuichiro; Nakagawa, Hideyuki; Hatakeyama, Tomomitsu			Expression and characterization of the recombinant lectin SUL-1 derived from the venom of the sea urchin Toxopneustes pileolus	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ichise, Ayaka; Unno, Hideaki; Goda, Shuichiro; Hatakeyama, Tomomitsu] Nagasaki Univ, Grad Sch Engn, Nagasaki, Japan; [Nakagawa, Hideyuki] Univ Tokushima, Grad Sch Integrated Arts & Sci, Tokushima, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				151	1141	1141				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300159		
J	Fukasawa, A; Sakagami, H; Nakamura, K; Nagasawa, N; Ohta, Y; Kawasaki, N; Ogawa, H				Fukasawa, Ayano; Sakagami, Hiromi; Nakamura, Kosuke; Nagasawa, Nao; Ohta, Yuki; Kawasaki, Nana; Ogawa, Haruko			Characterization and interaction analyses of multispecific Pleurocybella porrigens lectins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fukasawa, Ayano; Sakagami, Hiromi; Nakamura, Kosuke; Nagasawa, Nao; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo, Japan; [Ohta, Yuki; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Limerick, Ireland; [Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Tokyo, Japan							Nakamura K, 2013, CARBOHYD RES, V382, P77, DOI 10.1016/j.carres.2013.10.003; Suzuki T, 2009, BIOSCI BIOTECH BIOCH, V73, P702, DOI 10.1271/bbb.80774	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				160	1144	1144				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300168		
J	Suzuki, K; Yuzaki, M				Suzuki, Kunimichi; Yuzaki, Michisuke			Investigation into molecular mechanism of synapse elimination mediated by complement C1q and C3	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Suzuki, Kunimichi; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Neurophysiol, Tokyo 108, Japan			Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				159	1144	1144				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300167		
J	Furukawa, K; Sabit, I; Hashimoto, N; Matsumoto, Y; Yamaji, T; Furukawa, K				Furukawa, Koichi; Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Yamaji, Toshiyuki; Furukawa, Keiko			Modulation of malignant properties of cancer cells by binding of a sialic acid-recognizing lectin Siglec-9 via calpain-mediated degradation of focal adhesion kinase and related proteins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Furukawa, Koichi; Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Furukawa, Keiko] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; Natl Inst Infect Dis, Dept Biochem, Tokyo 1628640, Japan; [Yamaji, Toshiyuki] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biochem, Kasugai, Aichi 4878501, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				163	1145	1146				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300171		
J	Yoneyama, T; Hatakeyama, S; Tobisawa, Y; Nonaka, M; Ohyama, C; Fukuda, M				Yoneyama, Tohru; Hatakeyama, Shingo; Tobisawa, Yuki; Nonaka, Motohiro; Ohyama, Chikara; Fukuda, Minoru			Laminin binding glycan depletion on alpha-dystroglycan in prostate cancer cells promotes epithelial-mesenchymal transition and enhances tumor formation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yoneyama, Tohru; Hatakeyama, Shingo; Tobisawa, Yuki; Ohyama, Chikara] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori, Japan; [Nonaka, Motohiro; Fukuda, Minoru] Burnham Med Res Inst, Canc Ctr Sanford, Tumor Microenvironment Program, Glycobiol Unit, La Jolla, CA USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				165	1146	1146				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300173		
J	Manya, H; Yamada, T; Takahashi, T; Akasaka-Manya, K; Endo, T				Manya, Hiroshi; Yamada, Takeyuki; Takahashi, Tetsuo; Akasaka-Manya, Keiko; Endo, Tamao			Functional interaction of POMT and DPM synthase in protein O-mannosylation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Manya, Hiroshi; Yamada, Takeyuki; Akasaka-Manya, Keiko; Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Takahashi, Tetsuo] Tokai Univ, Sch Engn, Dept Appl Biochem, Hiratsuka, Kanagawa 25912, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				168	1147	1148				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300176		
J	Morise, J; Takeuchi, Y; Takematsu, H; Oka, S				Morise, Jyoji; Takeuchi, Yusuke; Takematsu, Hiromu; Oka, Shogo			HNK-1 carbohydrate regulates the cell surface expression level of AMPA-type glutamate receptors	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Morise, Jyoji; Takeuchi, Yusuke; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				166	1147	1147				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300174		
J	Ihara, Y; Ikezaki, M; Inai, Y; Matsui, ISL; Manabe, S; Ito, Y				Ihara, Yoshito; Ikezaki, Midori; Inai, Yoko; Matsui, In-Sook Lee; Manabe, Shino; Ito, Yukishige			C-Mannosylated TSR-derived peptides modulate TGF-beta signaling in cultured lung epithelial-derived cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ihara, Yoshito; Ikezaki, Midori; Inai, Yoko; Matsui, In-Sook Lee] Wakayama Med Univ, Dept Biochem, Wakayama, Japan; [Manabe, Shino] RIKEN, Adv Sci Inst, Wako, Saitama, Japan; [Ito, Yukishige] RIKEN, Wako, Saitama, Japan; [Ito, Yukishige] ERATO Glycotril Project JST, Wako, Saitama, Japan			Manabe, Shino/F-2334-2014	Manabe, Shino/0000-0002-2763-1414				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				169	1148	1148				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300177		
J	Yabuno, K; Izumikawa, T; Takematsu, H; Kitagawa, H; Oka, S				Yabuno, Keiko; Izumikawa, Tomomi; Takematsu, Hiromu; Kitagawa, Hiroshi; Oka, Shogo			A novel HNK-1 epitope in perineuronal nets	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yabuno, Keiko; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068501, Japan; [Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				171	1148	1149				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300179		
J	Takahashi, M; Hasegawa, Y; Ikeda, Y; Wada, Y; Tajiri, M; Ariki, S; Takamiya, R; Yamaguchi, Y; Taniguchi, N; Kuroki, Y				Takahashi, Motoko; Hasegawa, Yoshihiro; Ikeda, Yoshitaka; Wada, Yoshinao; Tajiri, Michiko; Ariki, Shigeru; Takamiya, Rina; Yamaguchi, Yoshiki; Taniguchi, Naoyuki; Kuroki, Yoshio			Signaling-inhibitory effects of sErbB3 is enhanced by single N-glycan deletion	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takahashi, Motoko; Hasegawa, Yoshihiro; Ariki, Shigeru; Takamiya, Rina; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido, Japan; [Ikeda, Yoshitaka] Saga Univ, Fac Med, Dept Biomol Sci, Saga, Japan; [Wada, Yoshinao; Tajiri, Michiko] Osaka Med Ctr, Dept Mol Med, Osaka, Japan; [Wada, Yoshinao; Tajiri, Michiko] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan; [Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKE, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				172	1149	1149				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300180		
J	Kamimura, K; Hamada, R; Maeda, N				Kamimura, Keisuke; Hamada, Rie; Maeda, Nobuaki			Glypican and the heparan sulfate fine structure at the Drosophila neuromuscular junction	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kamimura, Keisuke; Hamada, Rie; Maeda, Nobuaki] Tokyo Metropolitan Inst Med Sci, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				183	1153	1153				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300191		
J	Mikami, T; Shida, M; Kitagawa, H				Mikami, Tadahisa; Shida, Miharu; Kitagawa, Hiroshi			Highly sulfated chondroitin sulfate chains regulate neuronal polarity formation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Mikami, Tadahisa; Shida, Miharu; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo, Japan							Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				185	1153	1154				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300193		
J	Miyata, S; Komatsu, Y; Yoshimura, Y; Taya, C; Kitagawa, H				Miyata, Shinji; Komatsu, Yukio; Yoshimura, Yumiko; Taya, Choji; Kitagawa, Hiroshi			Sulfation patterns of chondroitin sulfate regulate neural development and plasticity	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Miyata, Shinji] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Komatsu, Yukio] Nagoya Univ, Dept Neurosci, Nagoya, Aichi 4648601, Japan; [Yoshimura, Yumiko] Natl Inst Physiol Sci, Div Dev Neurophysiol, Okazaki, Aichi, Japan; [Taya, Choji] Tokyo Metro Inst Med Sci, Lab Transgen Technol, Tokyo, Japan; [Kitagawa, Hiroshi] Kobe Pharma Univ, Dept Biochem, Kobe, Hyogo, Japan							Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				184	1153	1153				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300192		
J	Yuasa, T; Hamano, K; Seki, R; Oka, S; Takematsu, H				Yuasa, Taishi; Hamano, Kumiko; Seki, Ryosuke; Oka, Shogo; Takematsu, Hiromu			Glycosphinglipid CD77 specifically attenuates the CD19-PI3K-Akt pathway of the B cell receptor signaling in model germinal center B cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yuasa, Taishi; Hamano, Kumiko] Kyoto Univ, Grad Sch Biostudies, Grad Sch Med, Kyoto 6068501, Japan; [Seki, Ryosuke] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Oka, Shogo; Takematsu, Hiromu] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				187	1154	1154				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300195		
J	Naito-Matsui, Y; Davies, L; Takematsu, H; Chou, HHHH; Tangvoranuntakul, P; Heyser, C; Carlin, A; Verhagen, A; Gagneux, P; Varki, A				Naito-Matsui, Yuko; Davies, Leela; Takematsu, Hiromu; Chou, Hsun-Hua Hsun-Hua; Tangvoranuntakul, Pam; Heyser, Charles; Carlin, Aaron; Verhagen, Andrea; Gagneux, Pascal; Varki, Ajit			Exploring consequences of N-glycolylneuraminic acid overexpression in the brain	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Naito-Matsui, Yuko; Davies, Leela; Chou, Hsun-Hua Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron; Verhagen, Andrea; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Naito-Matsui, Yuko; Davies, Leela; Takematsu, Hiromu; Chou, Hsun-Hua Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron; Verhagen, Andrea; Gagneux, Pascal; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Takematsu, Hiromu] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Heyser, Charles] Univ Calif San Diego, Neurosci Behav Testing Core, La Jolla, CA 92093 USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				193	1156	1157				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300201		
J	Nakamura, M; Tamura, J; Kitagawa, H; Tojima, T; Kamiguchi, H				Nakamura, Masao; Tamura, Jun-ichi; Kitagawa, Hiroshi; Tojima, Takuro; Kamiguchi, Hiroyuki			Regulatory mechanism of chondroitin sulfate-mediated axon guidance	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nakamura, Masao; Kamiguchi, Hiroyuki] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Tamura, Jun-ichi] Tottori Univ, Tottori, Japan; [Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Kobe, Hyogo, Japan; [Tojima, Takuro] Japan Sci & Technol Agcy, PRESTO, RIKEN, Brain Sci Inst, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				198	1158	1158				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300206		
J	Nakayama, H; Iwabuchi, K				Nakayama, H.; Iwabuchi, K.			Lactosylceramide mediates innate immune responses depending on PAMPs in human neutrophils	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					Juntendo Univ, Fac Hlth Care & Nursing, Urayasu, Chiba 2790023, Japan; Juntendo Univ, Inst Environm & Gender Specif Med, Fac Med, Urayasu, Chiba 2790021, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				197	1158	1158				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300205		
J	Sakuda, K; Sobukawa, N; Sano, K; Sato, C; Kitajima, K; Ogawa, H				Sakuda, Kanoko; Sobukawa, Naomi; Sano, Kotone; Sato, Chihiro; Kitajima, Ken; Ogawa, Haruko			Consecutive detection of sialylation changes of plasma vitronectin by isoelectric points during liver regeneration	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Sakuda, Kanoko; Sobukawa, Naomi; Sano, Kotone; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo, Japan; [Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Tokyo, Japan			SATO, Chihiro/B-7396-2014				[Anonymous], 2010, J BIOL CHEM, V285, P17301; [Anonymous], 1988, CELL STRUCT FUNCT, V13, P281	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				199	1159	1159				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300207		
J	Urashima, T; Inamori, H; Fukuda, K; Saito, T; Messer, M				Urashima, Tadasu; Inamori, Hiroaki; Fukuda, Kenji; Saito, Tadao; Messer, Michael			Chemical characterization of acidic milk oligosaccharides of the platypus (Ornithorhynchus anatinus)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Urashima, Tadasu; Inamori, Hiroaki; Fukuda, Kenji] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido, Japan; [Saito, Tadao] Tohoku Univ, Sendai, Miyagi 980, Japan; [Messer, Michael] Univ Sydney, Sydney, NSW 2006, Australia								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				201	1159	1160				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300209		
J	Akune, Y; Campbell, M; Zhang, JQ; Aoki-Kinoshita, K; Packer, N				Akune, Yukie; Campbell, Matthew; Zhang, Junqi; Aoki-Kinoshita, Kiyoko; Packer, Nicolle			Comprehensive analysis of the N-glycan biosynthetic pathway using bioinformatics	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Akune, Yukie] Soka Univ, Grad Sch Engn, Div Bioinfor, Tokyo, Japan; [Aoki-Kinoshita, Kiyoko] Soka Univ, Div Bioinfor, Tokyo, Japan; [Campbell, Matthew; Zhang, Junqi; Packer, Nicolle] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia							Akune Y, 2010, OMICS, V14, P475, DOI 10.1089/omi.2009.0129; Krambeck FJ, 2009, GLYCOBIOLOGY, V19, P1163, DOI 10.1093/glycob/cwp081; Campbell M.P, 2013, NUCLEIC ACIDS RES, P1	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				212	1163	1163				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300219		
J	Horiuchi, R; Ensaka, T; Hirotsu, N; Miyanishi, N				Horiuchi, Risa; Ensaka, Tsubasa; Hirotsu, Naoki; Miyanishi, Nobumitsu			Variability analysis of N-linked glycans in each growth stage of rice	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Horiuchi, Risa; Ensaka, Tsubasa; Hirotsu, Naoki; Miyanishi, Nobumitsu] Toyo Univ, Grad Sch Life Sci, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				213	1163	1164				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300220		
J	Yamada, I; Aoki-Kinoshita, KF; Matsubara, M; Tsuchiya, S; Kotera, M; Tanaka, K; Fujita, N; Shikanai, T; Kat, M				Yamada, Issaku; Aoki-Kinoshita, Kiyoko F.; Matsubara, Masaaki; Tsuchiya, Shinichiro; Kotera, Masaaki; Tanaka, Kenichi; Fujita, Noriaki; Shikanai, Toshihide; Kat, Masaki			WURCS: Web3 Unique Representation of Carbohydrate Structures for Semantic Web	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yamada, Issaku; Matsubara, Masaaki] Noguchi Inst, Tokyo, Japan; [Aoki-Kinoshita, Kiyoko F.; Tsuchiya, Shinichiro] Soka Univ, Tokyo, Japan; [Kotera, Masaaki] Tokyo Inst Technol, Tokyo 152, Japan; [Tanaka, Kenichi; Fujita, Noriaki; Shikanai, Toshihide] Natl Inst Adv Ind Sci & Technol, Ibaraki, Japan; RIKEN, Global Res Cluster, Saitama, Japan; Res Org Informat & Syst, Database Ctr Life Sci, Chiba, Japan			Shikanai, Toshihide/H-4242-2015					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				211	1163	1163				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300218		
J	Hosoda, M; Akune, Y; Kinoshita, KF				Hosoda, Masae; Akune, Yukie; Kinoshita, Kiyoko F.			Lectin recognition pattern analysis using MCAW	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			ALIGNMENT		[Hosoda, Masae; Akune, Yukie; Kinoshita, Kiyoko F.] Soka Univ, Grad Sch Engneering, Div Bioinformat, Hachioji, Tokyo, Japan							Akune Y, 2010, OMICS, V14, P475, DOI 10.1089/omi.2009.0129; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Hosoda M, 2012, LECT NOTES COMPUT SC, V7632, P49, DOI 10.1007/978-3-642-34123-6_5; Yagi F, 2002, EUR J BIOCHEM, V269, P4335, DOI 10.1046/j.1432-1033.2002.03127.x	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				214	1164	1164				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300221		
J	Shikanai, T; Fujita, N; Suzuki, Y; Solovieva, E; Aoki-Kinoshita, K; Soyama, M; Kuno, A; Kaji, H; Shinmachi, D; Yamada, I; Okuda, S; Kawasaki, T; Narimatsu, H				Shikanai, Toshihide; Fujita, Noriaki; Suzuki, Yoshinori; Solovieva, Elena; Aoki-Kinoshita, Kiyoko; Soyama, Madoka; Kuno, Atsushi; Kaji, Hiroyuki; Shinmachi, Daisuke; Yamada, Issaku; Okuda, Shujiro; Kawasaki, Toshisuke; Narimatsu, Hisashi			Next JCGGDB Plan for Semantic Web	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shikanai, Toshihide; Fujita, Noriaki; Suzuki, Yoshinori; Solovieva, Elena; Soyama, Madoka; Kuno, Atsushi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Glycomed Technol Res Ctr, Tsukuba, Ibaraki 3058567, Japan; [Aoki-Kinoshita, Kiyoko; Shinmachi, Daisuke] Soka Univ, Aliso Viejo, CA USA; [Yamada, Issaku] Noguchi Inst, Legon, Ghana; [Okuda, Shujiro] Niigata Univ, Niigata 95021, Japan; [Kawasaki, Toshisuke] Ritsumeikan Univ, Kyoto, Japan			Shikanai, Toshihide/H-4242-2015					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				221	1166	1167				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300228		
J	Campbell, M; Peterson, R; Aoki-Kinoshita, K; Abrahams, J; Mariethoz, J; Lisacek, F; Packer, N				Campbell, Matthew; Peterson, Robyn; Aoki-Kinoshita, Kiyoko; Abrahams, Jodie; Mariethoz, Julien; Lisacek, Frederique; Packer, Nicolle			UniCarbKB: a glycobioinformatics infrastructure for data discovery using semantics	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Campbell, Matthew; Peterson, Robyn; Abrahams, Jodie; Packer, Nicolle] Macquarie Univ, Biomol Frontiers Res Ctr, Sydney, NSW 2109, Australia; [Aoki-Kinoshita, Kiyoko] Soka Univ, Dept Bioinformat, Fac Engn, Tokyo, Japan; [Mariethoz, Julien; Lisacek, Frederique] Swiss Inst Bioinformat, Proteome Informat Grp, Geneva, Switzerland								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				225	1168	1168				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300231		
J	Suzuki, A; Sano, K; Fujiwaki, H; Umemura, Y				Suzuki, Akemi; Sano, Kunihiro; Fujiwaki, Hideshi; Umemura, Yoshikatsu			Analysis of glycosphingolipids using LC-MS and a GSL MS library	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Suzuki, Akemi; Sano, Kunihiro] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan; [Fujiwaki, Hideshi; Umemura, Yoshikatsu] Shimadzu Co, Kyoto 6048511, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				226	1168	1168				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300232		
J	Kawarabayasi, Y				Kawarabayasi, Yutaka			Characterization of the UDP-GlcNAc biosynthetic pathway in Archaea by experimental confirmation of each enzymatic activity	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kawarabayasi, Yutaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				234	1171	1172				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300240		
J	Kawasaki, T; Nakao, H; Matsumoto, S; Toyoda, H; Kawabata, K; Taki, T; Kawasaki, N				Kawasaki, Toshisuke; Nakao, Hiromi; Matsumoto, Shogo; Toyoda, Hidenao; Kawabata, Kenji; Taki, Takao; Kawasaki, Nobuko			Novel Carbohydrate-Recognizing Antibodies for Human iPS/ES Cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kawasaki, Toshisuke; Nakao, Hiromi; Matsumoto, Shogo; Kawasaki, Nobuko] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan; [Toyoda, Hidenao] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Kusatsu, Shiga 5258577, Japan; [Kawabata, Kenji] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka 5670085, Japan; [Taki, Takao] Niigata Univ Pharm & Appl Life Sci, Niigata 9560841, Japan							Kawabe K, 2013, GLYCOBIOLOGY, V23, P322, DOI 10.1093/glycob/cws159	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				243	1174	1175				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300249		
J	Diederichs, U; Krocher, T; Rockle, I; Yanagawa, Y; Weinhold, B; Hildebrandt, H				Diederichs, Ute; Kroecher, Tim; Roeckle, Iris; Yanagawa, Yuchio; Weinhold, Birgit; Hildebrandt, Herbert			A crucial role of polysialic acid in developmental migration of cortical interneurons	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Diederichs, Ute; Roeckle, Iris; Weinhold, Birgit; Hildebrandt, Herbert] Hannover Med Sch, Inst Cellular Chem, Hannover, Germany; [Kroecher, Tim] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Maebashi, Gumma, Japan			Hildebrandt, Herbert/A-7873-2010	Hildebrandt, Herbert/0000-0002-1044-0881				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				246	1176	1176				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300252		
J	Gu, JG; Lu, JS; Im, S; Fukuda, T; Hashii, N; Takakura, D; Kawasaki, N; Isaji, T				Gu, Jianguo; Lu, Jishun; Im, Sanghun; Fukuda, Tomohiko; Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana; Isaji, Tomoya			Functional analysis of the expression of N-glycans in epithelial-mesenchymal transition: Importance of alpha 2,6 sialylation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Gu, Jianguo; Lu, Jishun; Im, Sanghun; Fukuda, Tomohiko; Isaji, Tomoya] Tohoku Pharmaceut Univ, Sendai, Miyagi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				249	1177	1177				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300255		
J	Oiwa, Y; Mizumoto, S; Kojima, R; Nagamatsu, T; Yamada, S				Oiwa, Yuka; Mizumoto, Shuji; Kojima, Ryoji; Nagamatsu, Tadashi; Yamada, Shuhei			Expression Analysis of Hyaluronidases in the Mouse Brain during Development	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Oiwa, Yuka; Mizumoto, Shuji; Kojima, Ryoji; Nagamatsu, Tadashi; Yamada, Shuhei] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				253	1178	1179				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300259		
J	Harada, Y; Nakajima, K; Masahara-Negishi, Y; Freeze, H; Angata, T; Taniguchi, N; Suzuki, T				Harada, Yoichiro; Nakajima, Kazuki; Masahara-Negishi, Yuki; Freeze, Hudson; Angata, Takashi; Taniguchi, Naoyuki; Suzuki, Tadashi			Metabolically programmed quality control system for dolichol-linked oligosaccharides	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Harada, Yoichiro; Masahara-Negishi, Yuki; Suzuki, Tadashi] RIKEN, Glycometabolome Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr,Global Res Cluster, Wako, Saitama, Japan; [Nakajima, Kazuki] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Freeze, Hudson] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA; [Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Taniguchi, Naoyuki] RIKEN, Dis Glyc Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr,Global Res Cluster, Wako, Saitama, Japan							Harada, 2013, P NATL ACAD SCI USA, V110, P19366	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				254	1179	1179				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300260		
J	Honke, K; Yamashita, T; Nio, K; Miyahara, K; Kosugi, T; Kadomatsu, K				Honke, Koichi; Yamashita, Tatsuyuki; Nio, Keiko; Miyahara, Kaoru; Kosugi, Tomoki; Kadomatsu, Kenji			Seminolipid is required for transfer of MCT4 from Sertoli cells to the spermatocyte plasma membrane where MCT4 forms a functional lactate transporter assembly with basigin	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Honke, Koichi; Yamashita, Tatsuyuki; Nio, Keiko; Miyahara, Kaoru] Kochi Univ, Sch Med, Nankoku, Kochi, Japan; [Kosugi, Tomoki; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				255	1179	1179				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300261		
J	Inamori, K; Willer, T; Hara, Y; Venzke, D; Anderson, ME; Clarke, NF; Guicheney, P; Bonnemann, CG; Moore, SA; Campbell, KP				Inamori, Kei-ichiro; Willer, Tobias; Hara, Yuji; Venzke, David; Anderson, Mary E.; Clarke, Nigel F.; Guicheney, Pascale; Boennemann, Carsten G.; Moore, Steven A.; Campbell, Kevin P.			Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of alpha-dystroglycan in cells and tissues	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Inamori, Kei-ichiro; Willer, Tobias; Hara, Yuji; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Inamori, Kei-ichiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Clarke, Nigel F.] Univ Sydney, Inst Neurosci & Muscle Res, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Guicheney, Pascale] INSERM, Inst Cardiometab & Nutr, U1166, Paris, France; [Guicheney, Pascale] Univ Paris 04, Paris, France; [Boennemann, Carsten G.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				262	1181	1182				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300268		
J	Kizuka, Y; Kitazume, S; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki			Epigenetic regulation of glycosyltransferase	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr, Dis Glyc Team, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				264	1182	1182				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300270		
J	Murakami, S; Komatsuzaki, A; Kitajima, T; Chiba, Y				Murakami, Satoshi; Komatsuzaki, Akiko; Kitajima, Toshihiko; Chiba, Yasunori			Mutational studies of an endo-beta-N-acetylglucosaminidase from Ogataea minuta (Endo-Om)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Murakami, Satoshi; Komatsuzaki, Akiko; Chiba, Yasunori] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Kitajima, Toshihiko] Jiangnan Univ, Wuxi, Jiangsu, Peoples R China								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				263	1182	1182				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300269		
J	Aikawa, J; Takeda, Y; Seko, A; Matsuo, I; Ito, Y				Aikawa, Jun-ichi; Takeda, Yoichi; Seko, Akira; Matsuo, Ichiro; Ito, Yukishige			Enzymatic properties of Golgi alpha-1,2 mannosidases toward denatured glycoproteins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Aikawa, Jun-ichi; Ito, Yukishige] RIKEN, Wako, Saitama, Japan; [Takeda, Yoichi; Seko, Akira; Ito, Yukishige] JST ERATO, Tokyo, Japan; [Matsuo, Ichiro] Gunma Univ, Grad Sch Engn, Maebashi, Gumma, Japan							Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Aikawa J, 2014, J BIOCHEM, V155, P375, DOI 10.1093/jb/mvu008; Matsushima H, 2013, CHEMBIOCHEM, V14, P753, DOI 10.1002/cbic.201300028; Aikawa J, 2012, GLYCOCONJUGATE J, V29, P35, DOI 10.1007/s10719-011-9362-1	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				270	1184	1185				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300276		
J	Kataoka, Y; Okazaki, H; Nomura, T; Suganuma, M; Higa, Y; Hunaguma, S; Suzuki, T; Usami, A; Fujiyama, K; Sezutsu, H; Tatematsu, K; Tamura, T				Kataoka, Yukiko; Okazaki, Hironobu; Nomura, Tsuyoshi; Suganuma, Masatoshi; Higa, Yukiko; Hunaguma, Shyunsuke; Suzuki, Takeo; Usami, Akihiro; Fujiyama, Kazuhito; Sezutsu, Hideki; Tatematsu, Ken-ichiro; Tamura, Toshiki			N-glycan sialylation in silkworm protein expression system and application	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kataoka, Yukiko; Okazaki, Hironobu; Nomura, Tsuyoshi; Suganuma, Masatoshi; Higa, Yukiko; Hunaguma, Shyunsuke; Suzuki, Takeo; Usami, Akihiro] Sysmex Corp, Kobe, Hyogo, Japan; [Fujiyama, Kazuhito] Osaka Univ, ICBiotech, Suita, Osaka 565, Japan; [Sezutsu, Hideki; Tatematsu, Ken-ichiro; Tamura, Toshiki] Natl Inst Agrobiol Sci, Gen Mod Org Res Cent, Tsukuba, Ibaraki, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				269	1184	1184				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300275		
J	Date, K; Satoh, A; Ogawa, H				Date, Kimie; Satoh, Ayano; Ogawa, Haruko			Pancreatic alpha-amylase controls glucose assimilation in duodenum through N-glycan-specific binding, followed by endocytosis and degradation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			GLYCOPROTEINS		[Date, Kimie; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Human Sci, Tokyo, Japan; [Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Tech, Okayama 7008530, Japan; [Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Tokyo, Japan							Matsushita H, 2002, J BIOL CHEM, V277, P4680, DOI 10.1074/jbc.M105877200; Asanuma-Date K, 2012, J BIOL CHEM, V287, P23104, DOI 10.1074/jbc.M111.314658	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				271	1185	1185				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300277		
J	Hirata, T; Fujita, M; Nakamura, S; Gotoh, K; Motooka, D; Murakami, Y; Maeda, Y; Kinoshita, T				Hirata, Tetsuya; Fujita, Morihisa; Nakamura, Shota; Gotoh, Kazuyoshi; Motooka, Daisuke; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh			Endosomes-to-TGN retrograde transport mediated by GARP is required for post-Golgi anterograde transport and glycosylation	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hirata, Tetsuya; Murakami, Yoshiko; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Hirata, Tetsuya] JSPS, Tokyo, Japan; [Fujita, Morihisa] Jiangnan Univ, Sch Biotech, Wuxi, Peoples R China; [Nakamura, Shota; Gotoh, Kazuyoshi; Motooka, Daisuke] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				282	1188	1189				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300288		
J	Huang, CC; Harada, Y; Hosomi, A; Masahara-Negishi, Y; Seino, J; Fujihira, H; Funakoshi, Y; Suzuki, T; Dohmae, N; Suzuki, T				Huang, Chengcheng; Harada, Yoichiro; Hosomi, Akira; Masahara-Negishi, Yuki; Seino, Junichi; Fujihira, Haruhiko; Funakoshi, Yoko; Suzuki, Takehiro; Dohmae, Naoshi; Suzuki, Tadashi			Functional studies of cytosolic deglycosylating enzymes in mammalian cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Huang, Chengcheng; Harada, Yoichiro; Hosomi, Akira; Masahara-Negishi, Yuki; Seino, Junichi; Fujihira, Haruhiko; Funakoshi, Yoko; Suzuki, Tadashi] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama, Japan; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN Global Res Cluster, Collaborat Promot Unit, Wako, Saitama, Japan							Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Enns G.M., 2014, GENET MED	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				281	1188	1188				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300287		
J	Satoh, T; Toshimori, T; Yamaguchi, T; Tong, Z; Kato, K				Satoh, Tadashi; Toshimori, Takayasu; Yamaguchi, Takumi; Tong, Zhu; Kato, Koichi			Structural basis for glycoprotein quality control mediated by glucose tagging in the endoplasmic reticulum	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Satoh, Tadashi] Nagoya City Univ, Grad Sch Pharm Sci, Nagoya, Aichi, Japan; [Toshimori, Takayasu] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Yamaguchi, Takumi; Tong, Zhu; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integra Biosci, Okazaki, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				280	1188	1188				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300286		
J	Gong, YH; Sakamoto, K; Takeda, N; Ozaki, T; Tsutsumishita-Nakai, N; Kawano, M; Tamura, J; Kadomatsu, K				Gong, Yuanhao; Sakamoto, Kazuma; Takeda, Naoko; Ozaki, Tomoya; Tsutsumishita-Nakai, Nao; Kawano, Manami; Tamura, Jun-ichi; Kadomatsu, Kenji			Identification of Minimum Essential Structure in Chondroitin Sulfate Which Is Responsible for Their Interaction with Their Receptor, PTP sigma and LAR	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Gong, Yuanhao; Sakamoto, Kazuma; Ozaki, Tomoya; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Gong, Yuanhao] Nagoya Univ, PhD Profess Program, Nagoya, Aichi 4648601, Japan; [Takeda, Naoko; Tsutsumishita-Nakai, Nao; Kawano, Manami; Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Tottori, Japan; [Takeda, Naoko] Tottori Univ, Tottori, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				284	1189	1189				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300290		
J	Ozaki, T; Sakamoto, K; Gong, YH; Uchimura, K; Kadomatsu, K				Ozaki, Tomoya; Sakamoto, Kazuma; Gong, Yuanhao; Uchimura, Kenji; Kadomatsu, Kenji			Perturbation of autophagic flux is involved in the dystrophic endball formation induced by a proteoglycan gradient	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ozaki, Tomoya; Sakamoto, Kazuma; Gong, Yuanhao; Uchimura, Kenji; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				283	1189	1189				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300289		
J	Sakamoto, K; Gong, YH; Ozaki, T; Kadomatsu, K				Sakamoto, Kazuma; Gong, Yuanhao; Ozaki, Tomoya; Kadomatsu, Kenji			Keratan sulfate is another ligand for PTPs & LAR, which are involved in axonal regeneration failure after injury	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Sakamoto, Kazuma; Gong, Yuanhao; Ozaki, Tomoya; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				285	1189	1190				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300291		
J	Gao, CX; Yoshida, T; Ota, F; Fujinawa, R; Yoshida, K; Betsuyaku, T; Taniguchi, N				Gao, Congxiao; Yoshida, Takayuki; Ota, Fumi; Fujinawa, Reiko; Yoshida, Keiichi; Betsuyaku, Tomoko; Taniguchi, Naoyuki			Suppression of inflammatory response by Keratan sulfate disaccharide in the development of COPD model mice	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Gao, Congxiao; Ota, Fumi; Fujinawa, Reiko; Yoshida, Keiichi; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr, Global Res Cluster, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yoshida, Takayuki] Hokkaido Univ, Sch Med, Dept Med 1, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Betsuyaku, Tomoko] Keio Univ, Dept Internal Med, Shinjyuku Ku, Tokyo 1608582, Japan							Shirato K, 2013, BIOCHEM BIOPH RES CO, V435, P460, DOI 10.1016/j.bbrc.2013.05.009	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				290	1191	1192				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300296		
J	Miyoshi, E; Akita, M; Mizutani, K; Fujii, H; Takamatsu, S; Kamada, Y				Miyoshi, Eiji; Akita, Maaya; Mizutani, Kayo; Fujii, Hironobu; Takamatsu, Shinji; Kamada, Yoshihiro			Combination of two glyco-biomarkers could make a noninvasive diagnosis for nonalcoholic steatohepatitis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Miyoshi, Eiji; Akita, Maaya; Mizutani, Kayo; Fujii, Hironobu; Takamatsu, Shinji; Kamada, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				291	1192	1192				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300297		
J	Mizumoto, S; Nakajima, M; Muller, T; Miyake, N; Kogawa, R; Komatsu, Y; Matsumoto, N; Janecke, AR; Ikegawa, S; Sugahara, K				Mizumoto, Shuji; Nakajima, Masahiro; Muller, Thomas; Miyake, Noriko; Kogawa, Ryo; Komatsu, Yoshie; Matsumoto, Naomichi; Janecke, Andreas R.; Ikegawa, Shiro; Sugahara, Kazuyuki			Spondyloepimetaphyseal dysplasia and Ehlers-Danlos syndrome caused by mutations of glycosaminoglycan biosynthetic enzymes, GalT-II and DS-epimerase	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Mizumoto, Shuji] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 060, Japan; [Nakajima, Masahiro; Ikegawa, Shiro] RIKEN, Lab Bone & Joint Dis, Wako, Saitama, Japan; [Muller, Thomas; Janecke, Andreas R.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa, Japan; [Kogawa, Ryo; Komatsu, Yoshie; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 060, Japan							Nakajima M, 2013, AM J HUM GENET, V92, P927, DOI 10.1016/j.ajhg.2013.04.003; Mizumoto, 2013, J BIOL CHEM, V288, P10953; Muller, 2013, HUM MOL GENET, V22, P3761	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				292	1192	1193				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300298		
J	Furukawa, K; Tagawa, M; Kuji, R; Sato, T; Shirane, K				Furukawa, Kiyoshi; Tagawa, Masatoshi; Kuji, Ryo; Sato, Takeshi; Shirane, Katsunori			Reverted expression of the beta 4-galactosyltransferase 2 or 5 gene in cancer cells impairs tumor growth	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Furukawa, Kiyoshi; Kuji, Ryo; Sato, Takeshi; Shirane, Katsunori] Nagaoka Univ Technol, Grad Sch Engn, Lab Glycobiol, Nagaoka, Niigata 9402188, Japan; [Tagawa, Masatoshi] Chiba Canc Res Inst, Div Pathol & Cell Therapy, Chiba 2608717, Japan							Shirane K, 2014, GLYCOBIOLOGY, V24, P532, DOI 10.1093/glycob/cwu021; Shirane K, 1999, BIOCHEM BIOPH RES CO, V265, P434, DOI 10.1006/bbrc.1999.1684; Tagawa M, 2014, CANCER GENE THER, V21, P219, DOI 10.1038/cgt.2014.21	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				294	1193	1193				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300300		
J	Nishimura, S; Hane, M; Niimi, Y; Kitajima, K; Sato, C				Nishimura, Saki; Hane, Masaya; Niimi, Yuki; Kitajima, Ken; Sato, Chihiro			An anti-schizophrenic drug affects the surface expression of polySia-NCAM in IMR-32 human neuroblastoma cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res			MUTATED POLYSIALYLTRANSFERASE; FUNCTIONAL IMPAIRMENTS; ACID		[Nishimura, Saki; Hane, Masaya; Niimi, Yuki; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan			SATO, Chihiro/B-7396-2014				Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				293	1193	1193				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300299		
J	Fujii, S; Takamiya, R; Takamatsu, S; Korekane, H; Taniguchi, N; Ohtsubo, K				Fujii, Shusaku; Takamiya, Rina; Takamatsu, Shinji; Korekane, Hiroaki; Taniguchi, Naoyuki; Ohtsubo, Kazuaki			Sialyl-Tn antigen is a potential target for the development of metastasis specific anti-tumor drugs	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fujii, Shusaku; Ohtsubo, Kazuaki] Kumamoto Univ, Fac Life Sci, Dept Analyt Biochem, Kumamoto 860, Japan; [Takamiya, Rina] Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido, Japan; [Takamatsu, Shinji] Osaka Univ, Dept Funct Diagnost Sci, Div Hlth Sci, Suita, Osaka 565, Japan; [Korekane, Hiroaki; Taniguchi, Naoyuki] RIKEN Max Plank Joint Res Ctr, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				298	1194	1195				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300304		
J	Gao, C; Imamura, A; Liu, Y; Zhang, HT; Zhang, YB; Chai, WG; Kiso, M; Greene, M; Ten, FZ				Gao, Chao; Imamura, Akihiro; Liu, Yan; Zhang, Hongtao; Zhang, Yibing; Chai, Wengang; Kiso, Makoto; Greene, Mark; Ten Feizi			Clinching the elusive prostate cancer antigen F77	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Gao, Chao; Liu, Yan; Zhang, Yibing; Chai, Wengang; Ten Feizi] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London SW7 2AZ, England; [Imamura, Akihiro; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu, Japan; [Zhang, Hongtao; Greene, Mark] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA							Gao C, 2014, J BIOL CHEM, V289, P16462, DOI 10.1074/jbc.M114.558932; Nonaka M, 2014, J BIOL CHEM, V289, P16478, DOI 10.1074/jbc.M114.559047	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				300	1195	1196				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300306		
J	Yagi, H; Nakagawa, N; Oka, S; Kato, K				Yagi, Hirokazu; Nakagawa, Naoki; Oka, Shogo; Kato, Koichi			Molecular mechanisms underlying the formation of laminin-binding glycans displayed on alpha-dystroglycan	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yagi, Hirokazu] Nagoya City Univ, Grad Sch Pharm Sci, Nagoya, Aichi, Japan; [Nakagawa, Naoki; Oka, Shogo] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integra Biosci, Okazaki, Aichi, Japan							Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				303	1196	1197				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300309		
J	Fujii, Y; Fujiwara, T; Ogawa, Y; Sugawara, S; Hosono, M; Hasan, I; Koide, Y; Kawsar, SMA; Ozeki, Y; Fujita, H				Fujii, Yuki; Fujiwara, Toshiyuki; Ogawa, Yukiko; Sugawara, Shigeki; Hosono, Masahiro; Hasan, Imtiaji; Koide, Yasuhiro; Kawsar, S. M. A.; Ozeki, Yasuhiro; Fujita, Hideaki			The molecular morphology of the cytotoxic retrotranslocation by an N-acetylhexosamine-binding lectin isolated from slipper lobster in breast and ovarian cancer cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fujii, Yuki; Fujiwara, Toshiyuki; Ogawa, Yukiko; Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Nagasaki, Japan; [Sugawara, Shigeki; Hosono, Masahiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Sendai, Miyagi, Japan; [Hasan, Imtiaji; Koide, Yasuhiro; Ozeki, Yasuhiro] Yokohama City Univ, Grad Sch NanoBio Sci, Lab Glycobiol & Marine Biochem, Yokohama, Kanagawa, Japan; [Hasan, Imtiaji] Univ Rajishahi, Grad Sch Sci, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Kawsar, S. M. A.] Univ Chittagong, Grad Sch Sci, Dept Chem, Chittagong, Bangladesh								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				306	1197	1198				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300312		
J	Fujihira, H; Masahara-Negishi, Y; Tamura, M; Wakana, S; Huang, CC; Kondoh, G; Yamashita, T; Funakoshi, Y; Suzuki, T				Fujihira, Haruhiko; Masahara-Negishi, Yuki; Tamura, Masaru; Wakana, Shigeharu; Huang, Chengcheng; Kondoh, Gen; Yamashita, Tadashi; Funakoshi, Yoko; Suzuki, Tadashi			Physiological function of deglycosylating enzymes in mice	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fujihira, Haruhiko; Masahara-Negishi, Yuki; Huang, Chengcheng; Funakoshi, Yoko; Suzuki, Tadashi] RIKEN, RIKEN Max Planck Joint Res Ctr, Glycometabolome Team, Global Res Cluster,Syst Glycobiol Res Grp, Wako, Saitama, Japan; [Tamura, Masaru; Wakana, Shigeharu] RIKEN, BioResourse Ctr, Japan Mouse Clin, Technol & Dev Team Mouse Phenotyp Anal, Wako, Saitama, Japan; [Kondoh, Gen] Kyoto Univ, Inst Frontier Med Sci, Lab Anim Expt Regenerat, Kyoto 6068501, Japan; [Yamashita, Tadashi] Azabu Univ, Sch Vet Med, Biochem Lab, Sagamihara, Kanagawa, Japan							Enns M.G, 2014, GENET MED IN PRESS; Need C.A., 2012, J MED GENET, V49, P353; Wiertz E.J, 1996, CELL, V84, P764	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				308	1198	1198				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300314		
J	Minehira, T; Uozumi, N; Asazawa, H; Sawanobori, A; Takamatsu, S; Kamada, Y; Tanaka, K; Fukase, K; Miyoshi, E				Minehira, Tomomi; Uozumi, Naofumi; Asazawa, Hitomi; Sawanobori, Atsuko; Takamatsu, Shinji; Kamada, Yoshihiro; Tanaka, Katsunori; Fukase, Koichi; Miyoshi, Eiji			Functional analyses of a novel type of CA19-9 carrier molecules in micro lipid membrane	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Minehira, Tomomi; Uozumi, Naofumi; Asazawa, Hitomi; Sawanobori, Atsuko; Takamatsu, Shinji; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 565, Japan; [Tanaka, Katsunori; Fukase, Koichi] Osaka Univ, Dept Chem, Grad Sch Sci, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				310	1199	1199				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300316		
J	Takamatsu, S; Azuma, K; Serada, S; Terao, N; Takeishi, S; Kamada, Y; Naka, T; Miyoshi, E				Takamatsu, Shinji; Azuma, Kanako; Serada, Satoshi; Terao, Naoko; Takeishi, Shunsaku; Kamada, Yoshihiro; Naka, Tetsuji; Miyoshi, Eiji			Identification of sialylated glycoproteins in doxorubicin-treated hepatoma cells with glycoproteomic analyses	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takamatsu, Shinji; Azuma, Kanako; Terao, Naoko; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 565, Japan; [Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Ibaraki, Japan; [Takeishi, Shunsaku] GP BioSci Ltd, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				312	1200	1200				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300318		
J	Takamiya, R; Takahashi, M; Hasegawa, Y; Uehara, Y; Hashimoto, J; Ariki, S; Kuroki, Y				Takamiya, Rina; Takahashi, Motoko; Hasegawa, Yoshihiro; Uehara, Yasuaki; Hashimoto, Jiro; Ariki, Shigeru; Kuroki, Yoshio			N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin-induced tumor progression by blockade of HIF-1 pathway	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Takamiya, Rina; Takahashi, Motoko; Hasegawa, Yoshihiro; Uehara, Yasuaki; Hashimoto, Jiro; Ariki, Shigeru; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				313	1200	1200				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300319		
J	Endo, J; Takeo, Y; Matsuda, S; Yuzaki, M				Endo, Junnosuke; Takeo, Yukari; Matsuda, Shinji; Yuzaki, Michisuke			Optogenetic control of the function of the Golgi apparatus in neurons	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Endo, Junnosuke; Takeo, Yukari; Matsuda, Shinji; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Neurophysiol, Tokyo 108, Japan			Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544				0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				316	1201	1201				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300322		
J	Kanagawa, M; Yu, CC; Fukada, S; Ohtsuka, Y; Ito, C; Chiyo, T; Okada, T; Takeda, S; Toda, T				Kanagawa, Motoi; Yu, Chih-Chieh; Fukada, So-ichiro; Ohtsuka, Yoshihisa; Ito, Chiyomi; Chiyo, Tomoko; Okada, Takashi; Takeda, Shin'ichi; Toda, Tatsushi			Pathophysiological roles for dystroglycan glycosylation in skeletal muscle and gene therapy challenge using glycosylation-deficient muscular dystrophy models	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kanagawa, Motoi; Yu, Chih-Chieh; Ohtsuka, Yoshihisa; Ito, Chiyomi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan; [Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 565, Japan; [Chiyo, Tomoko; Okada, Takashi; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				317	1201	1202				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300323		
J	Ji, ST; Ohmi, Y; Ohkawa, Y; Furukawa, K; Furukawa, K				Ji, Shuting; Ohmi, Yuhsuke; Ohkawa, Yuki; Furukawa, Keiko; Furukawa, Koichi			Regulatory function of b-series gangliosides in adipose tissues leptin secretion and in central nervous system which controls the lipid metabolism	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ji, Shuting; Ohmi, Yuhsuke; Ohkawa, Yuki; Furukawa, Koichi] Nagoya Univ, Dept Biochem 2, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				318	1202	1202				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300324		
J	Ogawa, Y; Fujii, Y; Sugawara, S; Hosono, M; Tatsuta, T; Nitta, K; Koide, Y; Hasan, I; Kawsar, SMA; Kobayashi, H; Ozeki, Y				Ogawa, Yukiko; Fujii, Yuki; Sugawara, Shigeki; Hosono, Masahiro; Tatsuta, Takeo; Nitta, Kazuo; Koide, Yasuhiro; Hasan, Imtiaji; Kawsar, S. M. A.; Kobayashi, Hidemitsu; Ozeki, Yasuhiro			A sialic acid-binding lectin(SBL)dependent apoptosis is triggered by sialylated-glycoconjugates in GEM of P388 cells	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ogawa, Yukiko; Fujii, Yuki; Kobayashi, Hidemitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Nagasaki, Japan; [Sugawara, Shigeki; Hosono, Masahiro; Tatsuta, Takeo; Nitta, Kazuo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Sendai, Miyagi, Japan; [Koide, Yasuhiro; Hasan, Imtiaji; Ozeki, Yasuhiro] Yokohama City Univ, Lab Glycobiol & Marine Biochem, Grad Sch NanoBio Sci, Yokohama, Kanagawa, Japan; [Hasan, Imtiaji] Rajshahi Univ, Grad Sch Sci, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Kawsar, S. M. A.] Univ Chittagong, Grad Sch Sci, Dept Chem, Chittagong, Bangladesh								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				319	1202	1202				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300325		
J	Stewart, T; Takahashi, K; Bian, Q; Huang, ZQ; Raska, M; Renfrow, M; Novak, J				Stewart, Tyler; Takahashi, Kazuo; Bian, Qi; Huang, Zhiqiang; Raska, Milan; Renfrow, Matthew; Novak, Jan			Initiation of Clustered O-glycosylation of IgA1 by GalNAc-transferases in IgA Nephropathy: New Methods for Complex Product Analysis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Stewart, Tyler; Bian, Qi; Huang, Zhiqiang; Renfrow, Matthew; Novak, Jan] Univ Alabama Birmingham, Birmingham, AL USA; [Takahashi, Kazuo] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan; [Raska, Milan] Palacky Univ, Olomouc, Czech Republic								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				321	1203	1203				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300327		
J	Ogawa, M; Kawai, T; Nadano, D; Matsuda, T; Yagi, H; Kato, K; Furukawa, K; Tetsuya, T				Ogawa, Mitsutaka; Kawai, Takami; Nadano, Daita; Matsuda, Tsukasa; Yagi, Hirokazu; Kato, Koichi; Furukawa, Koichi; Tetsuya, Tetsuya			Impaired O-GlcNAc Modification in the Endoplasmic Reticulum by Mutated EOGT Associated with Adams-Oliver Syndrome	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ogawa, Mitsutaka; Kawai, Takami; Furukawa, Koichi; Tetsuya, Tetsuya] Nagoya Univ, Dept Biochem 2, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Nadano, Daita; Matsuda, Tsukasa] Nagoya Univ, Dept Appt Mol Bio, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharm Sci, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				325	1204	1205				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300331		
J	Yasumori, H; Nishihara, M; Matsubara, T; Sato, T				Yasumori, Hanaki; Nishihara, Masaya; Matsubara, Teruhiko; Sato, Toshinori			AFM Observation of Beta-Amyloid Aggregates Induced by Ganglioside GM1-containing Lipid Membrane	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Yasumori, Hanaki; Nishihara, Masaya; Matsubara, Teruhiko; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				324	1204	1204				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300330		
J	Arai, T; Sato, T				Arai, Takahiro; Sato, Toshinori			Development of Reverse Transfection Method Using pDNA/polysaccharide Complexes	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Arai, Takahiro; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				326	1205	1205				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300332		
J	Ohtake-Niimi, S; Takeda-Uchimura, Y; Foyez, T; Michikawa, M; Kadomatsu, K; Uchimura, K				Ohtake-Niimi, Shiori; Takeda-Uchimura, Yoshiko; Foyez, Tahmina; Michikawa, Makoto; Kadomatsu, Kenji; Uchimura, Kenji			Deficiency in C-6 sulfation of GlcNAc within keratan sulfate mitigates Alzheimer's pathology and memory impairment in mice	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ohtake-Niimi, Shiori; Takeda-Uchimura, Yoshiko; Foyez, Tahmina; Kadomatsu, Kenji; Uchimura, Kenji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Michikawa, Makoto] Nagoya City Univ, Sch Med, Nagoya, Aichi, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				327	1205	1205				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300333		
J	Terao, N; Takamatsu, S; Minehira, T; Kamada, Y; Miyoshi, E				Terao, Naoko; Takamatsu, Shinji; Minehira, Tomomi; Kamada, Yoshihiro; Miyoshi, Eiji			Fucosylation is a common type of glycosylation in the cancer stem cell-like phenotype of pancreatic cancer under various conditions	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Terao, Naoko; Takamatsu, Shinji; Minehira, Tomomi; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				328	1205	1206				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300334		
J	Hane, M; Nishimura, S; Hayakawa, T; Kitajima, K; Sato, C				Hane, Masaya; Nishimura, Saki; Hayakawa, Toshiyuki; Kitajima, Ken; Sato, Chihiro			Insight into single nucleotide polymorphisms (SNPs) of the polysialyltransferase ST8SIA2/STX in psychiatric disorders	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nishimura, Saki] Nagoya Univ, Biosci Biotech Ctr, Nagoya, Aichi 4648601, Japan; [Hayakawa, Toshiyuki] Nagoya Univ, Program Leading Grad Sch IGER, Nagoya, Aichi 4648601, Japan			SATO, Chihiro/B-7396-2014					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				330	1206	1206				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300336		
J	Nadanaka, S; Purunomo, E; Takeda, N; Tamura, J; Kitagawa, H				Nadanaka, Satomi; Purunomo, Eko; Takeda, Naoko; Tamura, Jun-ichi; Kitagawa, Hiroshi			Heparan Sulfate Containing Unsubstituted Glucosamine Residues: Biosynthesis and Heparanase Inhibitory Activity	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nadanaka, Satomi; Purunomo, Eko; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo, Japan; [Takeda, Naoko] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori, Japan; [Takeda, Naoko] Tottori Univ, Dept Reg Environm, Fac Reg Sci, Tottori, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				329	1206	1206				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300335		
J	Shibano, Y; Konno, Y; Furuichi, Y; Sato, T				Shibano, Yuki; Konno, Yusuke; Furuichi, Yu; Sato, Toshinori			Analysis of Glycans Related to Metastasis of Human Cancer Cells by Saccharide Primer Method	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shibano, Yuki; Konno, Yusuke; Furuichi, Yu; Sato, Toshinori] Keio Univ, Dept Biosci & informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				332	1207	1207				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300338		
J	Shimada, Y; Wakabayashi, T; Akiyama, K; Higuchi, T; Kobayashi, H; Eto, Y; Ida, H; Ohashi, T				Shimada, Yohta; Wakabayashi, Taichi; Akiyama, Kazumasa; Higuchi, Takashi; Kobayashi, Hiroshi; Eto, Yoshikatsu; Ida, Hiroyuki; Ohashi, Toya			Development of novel method for analysis of disease-specific glycosaminoglycans in mucopolysaccharidosis type II	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shimada, Yohta; Wakabayashi, Taichi; Higuchi, Takashi; Kobayashi, Hiroshi; Ohashi, Toya] Jikei Univ, Sch Med, Div Gene Therapy, Res Ctr Med Sci, Tokyo, Japan; [Akiyama, Kazumasa] Kitasato Univ, Dept Pediat, Sch Med, Minato, Kanagawa, Japan; [Eto, Yoshikatsu] Inst Neurol Disorders, Adv Clin Res Ctr, Yokohama, Kanagawa, Japan; [Ida, Hiroyuki] Jikei Univ, Dept Pediat, Sch Med, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				340	1210	1210				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300346		
J	Kizuka, Y; Kitazume, S; Sato, K; Ohnuki, T; Kukimoto-Niino, M; Mishima-Tsumagari, C; Shirouzu, M; Yoshida, M; Engel, L; Zegzouti, H; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Sato, Keiko; Ohnuki, Tetsuo; Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Shirouzu, Mikako; Yoshida, Minoru; Engel, Laurie; Zegzouti, Hicham; Taniguchi, Naoyuki			High-throughput screening of GnT-III inhibitors using UDP-Glo system to develop a novel drug candidate for Alzheimer's disease	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kizuka, Yasuhiko; Kitazume, Shinobu; Sato, Keiko; Taniguchi, Naoyuki] RIKEN, RIKEN Max Planck Joint Res Ctr, Dis Glyc Team, Wako, Saitama, Japan; [Ohnuki, Tetsuo; Yoshida, Minoru] RIKEN, Seed Cpds Exploratory Unit Drug Discovery Platfor, Wako, Saitama, Japan; [Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Shirouzu, Mikako] RIKEN, Drug Discovery Struct Biol Platform Unit, Wako, Saitama, Japan; [Engel, Laurie; Zegzouti, Hicham] Promega Corp, Madison, WI USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				348	1213	1213				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300354		
J	Sugahara, K; Pothacharoen, P; Najarus, S; Settakorn, J; Mizumoto, S; Kongtawelert, P				Sugahara, Kazuyuki; Pothacharoen, Peraphan; Najarus, Sumet; Settakorn, Jongkolnee; Mizumoto, Shuji; Kongtawelert, Prachya			Effects of Sesamin on the Biosynthesis of Chondroitin Sulfate Proteoglycans In Human Articular Chondrocytes in Primary Culture	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Sugahara, Kazuyuki; Mizumoto, Shuji] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Sapporo, Hokkaido 0010021, Japan; [Pothacharoen, Peraphan; Najarus, Sumet; Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Chiang Mai 50200, Thailand; [Settakorn, Jongkolnee] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50200, Thailand							Pothacharoen P, 2014, GLYCOCONJUGATE J, V31, P221, DOI 10.1007/s10719-013-9514-6	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				349	1213	1213				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300355		
J	Ehara, M; Nakao, J; Nagayama, M; Shiota, M; Aoki-Kinoshita, KF; Tanuma, J				Ehara, Michiko; Nakao, Juna; Nagayama, Motohiko; Shiota, Masaaki; Aoki-Kinoshita, Kiyoko F.; Tanuma, Jun-ichi			Potential for using lectin sugar chains as diagnostic markers in oral precancerous lesions	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ehara, Michiko; Nakao, Juna; Nagayama, Motohiko; Tanuma, Jun-ichi] Asahi Univ, Sch Dent, Dept Oral Pathol, Mizuho, Gifu, Japan; [Shiota, Masaaki; Aoki-Kinoshita, Kiyoko F.] Soka Univ, Grad Sch Engn, Aliso Viejo, CA USA								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				353	1214	1215				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300359		
J	Wakabayashi, T; Shimada, Y; Higuchi, T; Kobayashi, H; Ida, H; Ohashi, T				Wakabayashi, Taichi; Shimada, Yohta; Higuchi, Takashi; Kobayashi, Hiroshi; Ida, Hiroyuki; Ohashi, Toya			Ex vivo gene therapy improves the accumulation of glycosaminoglycans in brain from murine model of mucopolysaccharidosis type II	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Wakabayashi, Taichi; Ida, Hiroyuki] Jikei Univ, Sch Med, Dept Pediat, Minato, Tokyo, Japan; [Shimada, Yohta; Higuchi, Takashi; Kobayashi, Hiroshi; Ohashi, Toya] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Gene Therapy, Minato, Tokushima, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				352	1214	1214				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300358		
J	Shirai, K; Fujinawa, R; Kobayashi, S; Ota, F; Kitazume, S; Taniguchi, N; Nakano, M				Shirai, Katsunori; Fujinawa, Reiko; Kobayashi, Satoshi; Ota, Fumi; Kitazume, Shinobu; Taniguchi, Naoyuki; Nakano, Miyako			Structural analyses of plasma glycoproteins in exacerbation and emphysema model mice as biomarker candidates for chronic obstructive lung disease (COPD)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Shirai, Katsunori; Nakano, Miyako] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan; [Fujinawa, Reiko; Kobayashi, Satoshi; Ota, Fumi; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN Global Res Cluster, Dis Glyc Team, Saitama, Japan; [Fujinawa, Reiko; Kobayashi, Satoshi; Ota, Fumi; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				357	1216	1216				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300363		
J	Nakano, M; Shirai, R; Ito, J; Kavallaris, M; Packer, N				Nakano, Miyako; Shirai, Ryohei; Ito, Jun; Kavallaris, Maria; Packer, Nicolle			Acquired drug resistance by decrease of sialylated glycans on acute lymphoblastic leukemia cell-membrane glycoproteins	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Nakano, Miyako; Shirai, Ryohei; Ito, Jun] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan; [Kavallaris, Maria] Lowy Canc Res Ctr, Childrens Canc Inst Australia, Sydney, NSW, Australia; [Packer, Nicolle] Macquarie Univ, Biomol Frontiers Res Ctr, N Ryde, NSW 2109, Australia								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				359	1217	1217				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300365		
J	Fujinawa, R; Ota, F; Gao, CX; Hirayama, T; Kabata, H; Korekane, H; Kitazume, S; Ohtsubo, K; Yoshida, K; Yamguchi, Y; Lepenies, R; Rademacher, C; Betsuyaku, T; Kida, K; Taniguchi, N				Fujinawa, Reiko; Ota, Fumi; Gao, Congxiao; Hirayama, Tetsuya; Kabata, Hiroki; Korekane, Hiroaki; Kitazume, Shinobu; Ohtsubo, Kazuaki; Yoshida, Keiichi; Yamguchi, Yoshiki; Lepenies, RBernd; Rademacher, Christoph; Betsuyaku, Tomoko; Kida, Kozui; Taniguchi, Naoyuki			Binding of langerin/CD207 to keratan sulfate disaccharide, Gal (6SO3) beta 1, 4-GlcNAc (6SO3) and its triangle derivative in vitro and in vivo: possible drug targets for COPD (chronic obstructive pulmonary disease)	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Fujinawa, Reiko; Ota, Fumi; Gao, Congxiao; Korekane, Hiroaki; Kitazume, Shinobu; Ohtsubo, Kazuaki; Yoshida, Keiichi; Yamguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Wako, Saitama, Japan; [Hirayama, Tetsuya] Seikagaku Corp, Cent Res Inst, Tokyo, Japan; [Kabata, Hiroki; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Tokyo 160, Japan; [Lepenies, RBernd; Rademacher, Christoph] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Kida, Kozui] Nippon Med Sch, Resp Care Clin, Tokyo 113, Japan			Rademacher, Christoph/H-3101-2012					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				363	1218	1218				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300369		
J	Kitazume, S; Imamaki, R; Kurimoto, A; Ogawa, K; Kato, M; Yamaguchi, Y; Tanaka, K; Ishida, H; Ando, H; Kiso, M; Hashii, N; Kawasaki, N; Taniguchi, N				Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Kato, Masaki; Yamaguchi, Yoshiki; Tanaka, Katsunori; Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto; Hashii, Noritaka; Kawasaki, Nana; Taniguchi, Naoyuki			Sweet Role of Platelet Endothelial Cell Adhesion Molecule (PECAM) in Understanding Angiogenesis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr, Dis Glyc Team, Global Res Cluster, Wako, Saitama, Japan; [Kato, Masaki; Yamaguchi, Yoshiki] RIKEN, Max Planck Joint Res Ctr, Glycobiol Team 2Struct, Wako, Saitama, Japan; [Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Ando, Hiromune; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Kato, Masaki; Yamaguchi, Yoshiki] Global Res Cluster, Tokyo, Japan							Kitazume, 2010, J BIOL CHEM, V285, P6515	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				362	1218	1218				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300368		
J	Ota, F; Fujinawa, R; Korekane, H; Yoshida, K; Taniguchi, N				Ota, Fumi; Fujinawa, Reiko; Korekane, Hiroaki; Yoshida, Keiichi; Taniguchi, Naoyuki			Development of a sensitive assay method of keratan sulfate disaccharide levels in mice plasma and bronchoalveolar lavage fluid	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Ota, Fumi; Fujinawa, Reiko; Korekane, Hiroaki; Yoshida, Keiichi; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				364	1218	1219				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300370		
J	Hashimoto, Y; Hoshi, K; Saito, T; Ito, H; Kariya, Y; Honda, T; Yamaguchi, Y				Hashimoto, Yasuhiro; Hoshi, Kyoka; Saito, Toshie; Ito, Hiromi; Kariya, Yoshinobu; Honda, Takashi; Yamaguchi, Yoshiki			High throughput detection of an alpha2,6-sialylated glycoform of transferrin in cerebrospinal fluid: Application for dementia diagnosis	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hashimoto, Yasuhiro; Hoshi, Kyoka; Saito, Toshie; Ito, Hiromi; Kariya, Yoshinobu] Fukushima Med Univ, Dept Biochem, Fukushima, Japan; [Hashimoto, Yasuhiro] Fukushima Med Univ, Fukushima Ind Univ, Govt Res Ctr, Fukushima, Japan; [Honda, Takashi] Fukushima Med Univ, Fukushima, Japan; [Yamaguchi, Yoshiki] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp,Struct Glycobiol Team, Wako, Saitama, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				366	1219	1220				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300372		
J	Hashimoto, N; Hamamura, K; Kotani, N; Furukawa, K; Kaneko, K; Honke, K; Furukawa, K				Hashimoto, Noboru; Hamamura, Kazunori; Kotani, Norihiro; Furukawa, Keiko; Kaneko, Kei; Honke, Koichi; Furukawa, Koichi			Proteomic analysis of ganglioside-associated microdomain in malignant melanomas	GLYCOBIOLOGY			English	Meeting Abstract	Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR)	NOV 16-19, 2014	Honolulu, HI	Society For Glycobiology, Japanese Soc Carbohydrate Res					[Hashimoto, Noboru; Hamamura, Kazunori; Kaneko, Kei; Honke, Koichi; Furukawa, Koichi] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Kotani, Norihiro] Kochi Univ, Kochi, Japan; [Furukawa, Keiko] Chubu Univ, Kasugai, Aichi 487, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	NOV	2014	24	11				367	1220	1220				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT1CI	WOS:000344670300373		
J	Kawada, T				Kawada, Tomoyuki			Factors affecting macular pigment optical density	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter							RESONANCE RAMAN-SPECTROSCOPY; AGE		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Demirel S, 2014, GRAEF ARCH CLIN EXP, V252, P213, DOI 10.1007/s00417-013-2424-2; Obana A, 2014, GRAEF ARCH CLIN EXP, V252, P1221, DOI 10.1007/s00417-014-2574-x; Hogg RE, 2007, BRIT J OPHTHALMOL, V91, P485, DOI 10.1136/bjo.2006.090936	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	NOV	2014	252	11					1865	1866		10.1007/s00417-014-2801-5		2	Ophthalmology	Ophthalmology	AT0NE	WOS:000344631900025		
J	Obana, A; Gohto, Y; Tanito, M; Okazaki, S; Gellermann, W; Bernstein, PS; Ohira, A				Obana, Akira; Gohto, Yuko; Tanito, Masaki; Okazaki, Shigetoshi; Gellermann, Werner; Bernstein, Paul S.; Ohira, Akihiro			Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Letter									[Obana, Akira; Gohto, Yuko] Seirei Hamamatsu Gen Hosp, Dept Ophthalmol, Naka Ku, Hamamatus City, Sizuoka 4308558, Japan; [Obana, Akira; Okazaki, Shigetoshi] Hamamatsu Univ Sch Med, Dept Med Spect, Appl Med Photon Lab, Med Photon Res Ctr,Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Tanito, Masaki; Ohira, Akihiro] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane 6938501, Japan; [Gellermann, Werner] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Bernstein, Paul S.] Univ Utah, Sch Med, Moran Eye Ctr, Salt Lake City, UT 84132 USA	Obana, A (reprint author), Seirei Hamamatsu Gen Hosp, Dept Ophthalmol, Naka Ku, Sumiyoshi 2-12-12, Hamamatus City, Sizuoka 4308558, Japan.	obana@sis.seirei.or.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	NOV	2014	252	11					1867	1867		10.1007/s00417-014-2802-4		1	Ophthalmology	Ophthalmology	AT0NE	WOS:000344631900026		
J	Iioka, F; Shimomura, D; Nakamura, F; Ohno, H; Yada, K; Nogami, K; Shima, M				Iioka, F.; Shimomura, D.; Nakamura, F.; Ohno, H.; Yada, K.; Nogami, K.; Shima, M.			Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor	HAEMOPHILIA			English	Letter							CONGENITAL HEMOPHILIA; RITUXIMAB		[Iioka, F.; Ohno, H.] Tenri Hosp, Dept Hematol, Tenri, Nara 6328552, Japan; [Shimomura, D.; Nakamura, F.] Tenri Hosp, Dept Lab Med, Tenri, Nara 6328552, Japan; [Yada, K.; Nogami, K.; Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan	Iioka, F (reprint author), Tenri Hosp, Dept Hematol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	Iioka@tenriyorozu.jp					Scanavini D, 2005, THROMB HAEMOSTASIS, V93, P453, DOI 10.1160/TH04-09-0629; Carcao M, 2006, HAEMOPHILIA, V12, P7, DOI 10.1111/j.1365-2516.2005.01170.x; Franchini M, 2008, HAEMOPHILIA, V14, P903, DOI 10.1111/j.1365-2516.2008.01839.x; Bogdanova N, 2007, HUM MUTAT, V28, P54, DOI 10.1002/humu.20403; Viel KR, 2009, NEW ENGL J MED, V360, P1618, DOI 10.1056/NEJMoa075760; Collins PW, 2013, BRIT J HAEMATOL, V160, P153, DOI 10.1111/bjh.12091; Dolnicar MB, 2014, BLOOD TRANSFUS-ITALY, V12, pS345, DOI 10.2450/2013.0229-12; Dunkley S, 2006, HAEMOPHILIA, V12, P663, DOI 10.1111/j.1365-2516.2006.01351.x; Franchini M, 2010, J THROMB HAEMOST, V8, P421, DOI 10.1111/j.1538-7836.2009.03717.x; Kemball-Cook G., HAEMOPHILIA MUTATION	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-8216	1365-2516		HAEMOPHILIA	Haemophilia	NOV	2014	20	6					E402	E404		10.1111/hae.12491		3	Hematology	Hematology	AS8WL	WOS:000344525800005		
J	Sasaki, T; Matsumoto, T; Wada, H; Ohishi, K; Kanda, H; Yamada, Y; Arima, K; Katayama, N; Sugimura, Y				Sasaki, T.; Matsumoto, T.; Wada, H.; Ohishi, K.; Kanda, H.; Yamada, Y.; Arima, K.; Katayama, N.; Sugimura, Y.			Successful treatment of non-invasive bladder tumour in a haemophilia A patient with high-responding inhibitors: a case report	HAEMOPHILIA			English	Letter									[Sasaki, T.; Kanda, H.; Yamada, Y.; Arima, K.; Sugimura, Y.] Mie Univ, Grad Sch Med, Dept Nephrourol Surg & Androl, Tsu, Mie 514, Japan; [Matsumoto, T.; Ohishi, K.] Mie Univ Hosp, Div Blood Transfus, Tsu, Mie 5148507, Japan; [Matsumoto, T.; Ohishi, K.; Katayama, N.] Mie Univ, Grad Sch Med, Dept Haematol, Tsu, Mie 514, Japan; [Wada, H.] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 514, Japan	Matsumoto, T (reprint author), Mie Univ Hosp, Div Blood Transfus, Dept Haematol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	matsutak@clin.medic.mie-u.ac.jp					Dunn AL, 2012, HAEMOPHILIA, V18, P532, DOI 10.1111/j.1365-2516.2011.02731.x; Tjonnfjord GE, 2004, HAEMOPHILIA, V10, P174, DOI 10.1046/j.1365-2516.2003.00857.x; Astermark J, 2012, HAEMOPHILIA, V18, P664, DOI 10.1111/j.1365-2516.2012.02846.x; Dunn AL, 2010, HAEMOPHILIA, V16, P427, DOI 10.1111/j.1365-2516.2009.02128.x; Jones AE, 2009, HAEMOPHILIA, V15, P1327; Sakuragi Tohru, 2009, Interact Cardiovasc Thorac Surg, V9, P767, DOI 10.1510/icvts.2009.212696; Shu Tung, 2004, Urology, V63, P175, DOI 10.1016/j.urology.2003.08.032; Tanaka I, 2008, JPN J THROMB HEMOST, V19, P520	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-8216	1365-2516		HAEMOPHILIA	Haemophilia	NOV	2014	20	6					E399	E401		10.1111/hae.12486		3	Hematology	Hematology	AS8WL	WOS:000344525800004		
J	Yada, K; Nogami, K; Kawamura, T; Minami, H; Shima, M				Yada, K.; Nogami, K.; Kawamura, T.; Minami, H.; Shima, M.			The first case of int1h-related inversion in Japanese haemophilia A patients	HAEMOPHILIA			English	Letter							FACTOR-VIII GENE		[Yada, K.; Nogami, K.; Kawamura, T.; Minami, H.; Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan	Nogami, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp					Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Fukuda K, 2004, INT J HEMATOL, V79, P303, DOI 10.1532/IJH97.03138; Polakova H, 2003, GEN PHYSIOL BIOPHYS, V22, P243	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-8216	1365-2516		HAEMOPHILIA	Haemophilia	NOV	2014	20	6					E408	E410		10.1111/hae.12509		3	Hematology	Hematology	AS8WL	WOS:000344525800008		
J	Suzuki, T; Nakamura, Y; Yoshida, S; Yoshida, Y; Nakamura, K; Sasaki, T; Fujino, M; Kawasaki, Y; Ehara, E; Murakami, Y; Shintaku, H				Suzuki, Tsugutoshi; Nakamura, Yoshihide; Yoshida, Shuichiro; Yoshida, Yoko; Nakamura, Kae; Sasaki, Takeshi; Fujino, Mitsuhiro; Kawasaki, Yuki; Ehara, Eiji; Murakami, Yosuke; Shintaku, Haruo			Radiofrequency catheter ablation of idiopathic left anterior fascicular ventricular tachycardia in children	HEART RHYTHM			English	Article						Idiopathic left ventricular tachycardia; Left anterior fascicular ventricular tachycardia; Pediatric; Radiofrequency catheter ablation	MACROREENTRY; BLOCK	BACKGROUND Idiopathic ventricular tachycardia of left anterior fascicular origin (IVT-LAF) is a rare condition, and radio-frequency catheter ablation (RFCA) therapy has not been reported in children. OBJECTIVE This study aimed to evaluate the procedures and outcomes of RFCA for pediatric IVT-LAF. METHODS Pediatric IVT-LAF cases for which RFCA was performed between June 2006 and May 2012 at our hospital were reviewed. RESULTS Of 537 pediatric cases of RFCA, 6 had IVT-LAF; 4 had anterior fascicular involvement only, while 2 had both anterior and posterior fascicular involvement. All 6 of them underwent RFCA at the median age of 8.8 years (range 4.3-14.3 years). RFCA was successful in all patients, but 4 had recurrence and underwent 1-3 additional sessions of RFCA. In a total of 10 RFCA sessions, the overall recurrence rate was 500/. The site of RFCA was determined on the basis of detection of diastolic potential during ventricular tachycardia (7 sessions) or isolated delayed potential during sinus rhythm (1) or by pace mapping (2). During the median follow-up period of 33 months, no further recurrence was reported except for 1 patient, who had a recurrence and was scheduled for additional session at the time of this report. Major complications included 1 case of complete atrioventricular block and 1 case of complete left bundle branch block. CONCLUSION Despite a high recurrence rate and a few complications, RFCA of the site of isolated delayed potential or diastolic potential, if applied cautiously, is a possible treatment of choice for pediatric IVT-LAF.	[Suzuki, Tsugutoshi; Nakamura, Yoshihide; Yoshida, Shuichiro; Yoshida, Yoko] Osaka City Gen Hosp, Pediat Med Care Ctr, Dept Pediat & Electrophysiol, Osaka 5340021, Japan; [Nakamura, Kae; Sasaki, Takeshi; Fujino, Mitsuhiro; Kawasaki, Yuki; Ehara, Eiji; Murakami, Yosuke] Osaka City Gen Hosp, Pediat Med Care Ctr, Dept Pediat Cardiol, Osaka 5340021, Japan; [Shintaku, Haruo] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan	Suzuki, T (reprint author), Osaka City Gen Hosp, Pediat Med Care Ctr, Dept Pediat & Electrophysiol, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	tsugutoshi@me.com					SAUL JP, 1994, CIRCULATION, V90, P492; ZIPES DP, 1979, AM J CARDIOL, V44, P1, DOI 10.1016/0002-9149(79)90242-X; Nogami A, 1998, J CARDIOVASC ELECTR, V9, P1269, DOI 10.1111/j.1540-8167.1998.tb00102.x; Lin D, 2005, HEART RHYTHM, V2, P934, DOI 10.1016/j.hrthm.2005.06.009; Ouyang F, 2002, CIRCULATION, V105, P462, DOI 10.1161/hc0402.102663; Nogami A, 2000, J AM COLL CARDIOL, V36, P811, DOI 10.1016/S0735-1097(00)00780-4; Collins KK, 2013, J CARDIOVASC ELECTR, V24, P640, DOI 10.1111/jce.12105; Kataria V, 2013, HEART RHYTHM, V10, P638, DOI 10.1016/j.hrthm.2013.01.001; Friedman RA, 2002, PACE, V25, P1000, DOI 10.1046/j.1460-9592.2002.01000.x; Morishima I, 2008, J INTERV CARD ELECTR, V22, P233, DOI 10.1007/s10840-008-9268-4; Nagai T, 2006, PACE, V29, P549, DOI 10.1111/j.1540-8159.2006.00393.x; Nogami A, 2009, PURKINJE ARRHYTHMIA, P26; Nogami A, 2008, CATHETER ABLATION CA, P298	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	NOV	2014	11	11					1948	1956		10.1016/j.hrthm.2014.06.024		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AS8DI	WOS:000344480000017		
J	Okazaki, R				Okazaki, Renji			Kinetic Stabilization of Highly Reactive Species Bearing Heteroatoms	HETEROATOM CHEMISTRY			English	Review							STABLE SELENENIC ACID; AROMATIC S-NITROSOTHIOL; DOUBLE-BOND COMPOUNDS; MAIN-GROUP ELEMENTS; C-H INSERTION; CRYSTAL-STRUCTURE; N-THIOSULFINYLANILINES; SULFENIC ACID; SPECTROSCOPIC DETECTION; THERMAL-DISSOCIATION	Bulky substituents, i.e., 2,4,6-tri-t-butylphenyl, 1,1,3,3-tetramethylindane-2,2-diyl, and 2,4,6-tris[bis(trimethylsilyl)methyl]phenyl, the last of which was developed in our laboratory, were successfully utilized to provide kinetic stabilization to novel types of highly reactive chemical species such as N-thiosulfinylaniline, thioaldehyde, selenoaldehyde, telluroketone, heavy ketone (a heavier element congener of a ketone), distibene, dibismuthene, disilene, digermene, and silaaromatic compounds (silabenzene and 2-silanaphthalene). Bowl- and capsule-shaped molecules having a functional group in their cavities were synthesized and applied to the stabilization of highly reactive species such as sulfenic acid, selenenic acid, sulfenyl iodide, nitrosothiol, and a simple enol. (C) 2014 Wiley Periodicals, Inc.	Univ Tokyo, Setagaya Ku, Tokyo 1580093, Japan	Okazaki, R (reprint author), Univ Tokyo, Setagaya Ku, Tokyo 1580093, Japan.	rokazaki@qb4.so-net.ne.jp					Jutzi P, 1996, ORGANOMETALLICS, V15, P741, DOI 10.1021/om950558t; Okazaki R, 2000, ACCOUNTS CHEM RES, V33, P625, DOI 10.1021/ar980073b; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Saito M, 2004, J AM CHEM SOC, V126, P15572, DOI 10.1021/ja048453h; Matsumoto T, 1999, J AM CHEM SOC, V121, P8811, DOI 10.1021/ja991147x; TOKITOH N, 1993, J AM CHEM SOC, V115, P10428, DOI 10.1021/ja00075a096; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; LANGE L, 1987, J ORGANOMET CHEM, V329, pC17, DOI 10.1016/S0022-328X(00)99800-0; Goto K, 2001, ORG LETT, V3, P3569, DOI 10.1021/ol016682s; TOKITOH N, 1993, J AM CHEM SOC, V115, P8855, DOI 10.1021/ja00072a055; Wakita K, 1999, J AM CHEM SOC, V121, P11336, DOI 10.1021/ja992024f; Goto K, 1997, J AM CHEM SOC, V119, P1460, DOI 10.1021/ja962994s; YOSHIFUJI M, 1981, J AM CHEM SOC, V103, P4587, DOI 10.1021/ja00405a054; Tokitoh N, 1999, B CHEM SOC JPN, V72, P1665, DOI 10.1246/bcsj.72.1665; Tajima T, 2006, ORGANOMETALLICS, V25, P3552, DOI 10.1021/om0604627; SUZUKI H, 1995, B CHEM SOC JPN, V68, P2471, DOI 10.1246/bcsj.68.2471; Saito M, 1997, J AM CHEM SOC, V119, P11124, DOI 10.1021/ja972221j; Tokitoh N, 1997, SCIENCE, V277, P78, DOI 10.1126/science.277.5322.78; Tokitoh N, 2001, ADV ORGANOMET CHEM, V47, P121, DOI 10.1016/S0065-3055(01)47011-0; COWLEY AH, 1983, J AM CHEM SOC, V105, P5506, DOI 10.1021/ja00354a069; Wakita K, 2000, ANGEW CHEM INT EDIT, V39, P634, DOI 10.1002/(SICI)1521-3773(20000204)39:3<634::AID-ANIE634>3.0.CO;2-#; Tokitoh N, 1997, J AM CHEM SOC, V119, P6951, DOI 10.1021/ja9710924; SUZUKI H, 1994, J AM CHEM SOC, V116, P11578, DOI 10.1021/ja00104a052; de Marcillac P, 2003, NATURE, V422, P876, DOI 10.1038/nature01541; Nagase S, 2014, B CHEM SOC JPN, V87, P167, DOI 10.1246/bcsj.20130266; Tokitoh N, 2002, POLYHEDRON, V21, P563, DOI 10.1016/S0277-5387(01)01035-X; Wakita K, 2000, J AM CHEM SOC, V122, P5648, DOI 10.1021/ja000309i; Sasamori T, 2013, B CHEM SOC JPN, V86, P1005, DOI 10.1246/bcsj.20130134; Li LC, 2012, NAT CHEM, V4, P361, DOI [10.1038/nchem.1305, 10.1038/NCHEM.1305]; Goto K, 2001, TETRAHEDRON LETT, V42, P4875, DOI 10.1016/S0040-4039(01)00871-1; GOTO K, 1995, ANGEW CHEM INT EDIT, V34, P1124, DOI 10.1002/anie.199511241; ATES M, 1989, CHEM BER, V122, P473, DOI 10.1002/cber.19891220313; ATES M, 1992, ORGANOMETALLICS, V11, P145, DOI 10.1021/om00037a030; Back T. G., 1976, J CHEM SOC PERK T, V1, P2079; BARRETT AGM, 1979, J CHEM SOC CHEM COMM, P645, DOI 10.1039/c39790000645; Barrett A. G., 1980, J CHEM SOC PERK T, V1, P2191; BARTON DHR, 1974, J CHEM SOC PERK T 1, P1245, DOI 10.1039/p19740001245; BROOK AG, 1981, J CHEM SOC CHEM COMM, P191, DOI 10.1039/c39810000191; COWLEY AH, 1985, J AM CHEM SOC, V107, P8211, DOI 10.1021/ja00312a066; GILES HG, 1976, CAN J CHEM, V54, P537, DOI 10.1139/v76-075; Goto K, 2005, J SYN ORG CHEM JPN, V63, P1157; Goto K, 2001, HETEROATOM CHEM, V12, P195, DOI 10.1002/hc.1031; Goto K, 2001, CHEM LETT, P1204; Goto K, 1997, LIEBIGS ANN-RECL, P2393; Goto K, 1998, CHEM COMMUN, P1915, DOI 10.1039/a805449e; INAGAKI Y, 1979, B CHEM SOC JPN, V52, P2008, DOI 10.1246/bcsj.52.2008; INAGAKI Y, 1979, B CHEM SOC JPN, V52, P2002, DOI 10.1246/bcsj.52.2002; Inagaki Y., 1982, SULFUR REPORTS, V2, P137; INAGAKI Y, 1975, TETRAHEDRON LETT, P4575; INAGAKI Y, 1979, B CHEM SOC JPN, V52, P1998, DOI 10.1246/bcsj.52.1998; ISHII A, 1986, B CHEM SOC JPN, V59, P2529, DOI 10.1246/bcsj.59.2529; Ishii A, 1996, B CHEM SOC JPN, V69, P709, DOI 10.1246/bcsj.69.709; Itoh M, 2001, CHEM LETT, P1206; Kano N, 1997, ORGANOMETALLICS, V16, P4237, DOI 10.1021/om9705564; Kano N, 1999, ORGANOMETALLICS, V18, P2999, DOI 10.1021/om990188z; Kishikawa K, 1998, CHEM LETT, P239; Kuhn N, 2007, HANDBOOK OF CHALCOGEN CHEMISTRY: NEW PERSPECTIVES IN SULFUR, SELENIUM AND TELLURIUM, P107; Lee V. Y., 2010, ORGANOMETALLIC COMPO; MARKOVSKY LN, 1993, REV HETEROATOM CHEM, V9, P21; MATSUMOTO T, 1994, ANGEW CHEM INT EDIT, V33, P2316, DOI 10.1002/anie.199423161; MIDDLETO.WJ, 1966, J AM CHEM SOC, V88, P3842, DOI 10.1021/ja00968a030; Minoura M, 1997, TETRAHEDRON LETT, V38, P2501, DOI 10.1016/S0040-4039(97)00377-8; Minoura M, 1997, TETRAHEDRON, V53, P8137, DOI 10.1016/S0040-4020(97)00498-5; MINOURA M, 1993, J AM CHEM SOC, V115, P7019, DOI 10.1021/ja00068a088; Minoura M., 1996, J CHEM SOC CHEM COMM, P123; MINOURA M, 1994, CHEM LETT, P1691, DOI 10.1246/cl.1994.1691; Mizuhata Y, 2011, J SYN ORG CHEM JPN, V69, P691; Okazaki R., 1991, TETRAHEDRON LETT, V45, P6601; Okazaki R., 1995, CHEM THIOALDEHYDES O, P225; OKAZAKI R, 1987, CHEM LETT, P2293, DOI 10.1246/cl.1987.2293; OKAZAKI R, 1969, B CHEM SOC JPN, V42, P3611, DOI 10.1246/bcsj.42.3611; OKAZAKI R, 1993, CHEM LETT, P1047, DOI 10.1246/cl.1993.1047; Okazaki R., 1996, ADV ORGANOMET CHEM, V39, P231, DOI DOI 10.1016/S0065-3055(08)60469-4; OKAZAKI R, 1989, CHEM LETT, P2083, DOI 10.1246/cl.1989.2083; Okazaki R., 1982, CHEM COMMUN, P1187; Okazaki R., 1996, SYNTHETIC METHODS OR, V2, P260; OKAZAKI R, 1989, J AM CHEM SOC, V111, P5949, DOI 10.1021/ja00197a070; Saiki T, 2000, J ORGANOMET CHEM, V611, P146, DOI 10.1016/S0022-328X(00)00322-3; Saiki T, 1996, J ORG CHEM, V61, P2924, DOI 10.1021/jo960068q; Saiki T, 1997, ANGEW CHEM INT EDIT, V36, P2223, DOI 10.1002/anie.199722231; Sasamori T, 2000, CHEM COMMUN, P1353, DOI 10.1039/b001900n; Sasamori T, 2002, ANGEW CHEM INT EDIT, V41, P139, DOI 10.1002/1521-3773(20020104)41:1<139::AID-ANIE139>3.0.CO;2-3; Sasamori T, 2002, B CHEM SOC JPN, V75, P661, DOI 10.1246/bcsj.75.661; SEVERENGIZ T, 1987, J CHEM SOC CHEM COMM, P820, DOI 10.1039/c39870000820; Shimada K, 2004, J AM CHEM SOC, V126, P13238, DOI 10.1021/ja0457009; SUZUKI H, 1995, ORGANOMETALLICS, V14, P1016, DOI 10.1021/om00002a056; Suzuki H., 1994, J AM CHEM SOC, V116; Suzuki H., 1998, J AM CHEM SOC, V120, P11086; TAKAHASHI M, 1992, J AM CHEM SOC, V114, P1830, DOI 10.1021/ja00031a043; Takahashi M., 1993, SULFUR REP, V13, P293; Takeda N, 1996, ANGEW CHEM INT EDIT, V35, P660, DOI 10.1002/anie.199606601; Takeda N., 2007, HDB CHALCOGEN CHEM; Takeda N, 2003, CHEM-EUR J, V9, P3530, DOI 10.1002/chem.200204643; Takeda N, 1997, J AM CHEM SOC, V119, P1456, DOI 10.1021/ja963092u; Tokitoh N, 1998, POL J CHEM, V72, P971; Tokitoh N, 2004, ACCOUNTS CHEM RES, V37, P86, DOI 10.1021/ar020093k; Tokitoh N., 2002, SILICON CHEM, V1, P313, DOI 10.1023/B:SILC.0000025574.54359.7a; Tokitoh N, 1998, J AM CHEM SOC, V120, P433, DOI 10.1021/ja973295y; Tokitoh N., 2002, CHEM ORGANIC GERMANI, V2; TOKITOH N, 1991, TETRAHEDRON LETT, V32, P2049, DOI 10.1016/S0040-4039(00)78905-2; Tokitoh N, 2004, B CHEM SOC JPN, V77, P429, DOI 10.1246/bcsj.77.429; Tokitoh N, 2002, CHEM LETT, P34, DOI 10.1246/cl.2002.34; Tokitoh N, 1997, J AM CHEM SOC, V119, P2337, DOI 10.1021/ja963517c; Wakita K, 2000, B CHEM SOC JPN, V73, P2157, DOI 10.1246/bcsj.73.2157; WATANABE S, 1995, TETRAHEDRON LETT, V36, P7677, DOI 10.1016/0040-4039(95)01610-T; Watanabe S, 1997, J AM CHEM SOC, V119, P3195, DOI 10.1021/ja963093m	106	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		293	305		10.1002/hc.21195		13	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100002		
J	Sasamori, T; Sakagami, M; Tokitoh, N				Sasamori, Takahiro; Sakagami, Michiyasu; Tokitoh, Norihiro			Bromination of a Stable 1,2-Bis(ferrocenyl) dibismuthene: Synthesis of a 1,2-Dibromodibismuthane Derivative	HETEROATOM CHEMISTRY			English	Article							DOUBLY BONDED SYSTEMS; ORGANOMETALLIC COMPOUNDS; ELEMENTS; BI; DIPNICTENES; REACTIVITY; COMPOUND; CRYSTAL; SB	The bromination reaction of the stable bis(ferrocenyl)dibismuthene, Fc*Bi=BiFc* (1, Fc* = 2,5-bis(3,5-di-t-butylphenyl)ferrocenyl), with 0.5 equiv of BiBr3 resulted in the formation of the first stable 1,2-dibromodibismuthane derivative, Fc*(Br)Bi-Bi(Br)Fc* (3). The structure of 3 was revealed by X-ray crystallographic analysis, showing its unique structure with the bromine atom intramolecularly coordinating to the bismuth atom.	[Sasamori, Takahiro; Sakagami, Michiyasu; Tokitoh, Norihiro] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Sasamori, T (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	sasamori@boc.kuicr.kyoto-u.ac.jp	Sasamori, Takahiro/C-4963-2009	Sasamori, Takahiro/0000-0001-5410-8488	JSPS KAKENHI [22350017, 23685010, 25102519, 2401, 24109013, 2408]; MEXT Project of Integrated Research on Chemical Synthesis from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Contract grant sponsor: JSPS KAKENHI.; Contract grant number: 22350017 (Scientific Research (B)), 23685010 (Young Scientist (A)), 25102519 (Scientific Research on Innovative Areas, "New Polymeric Materials Based on Element-Blocks" [#2401]), 24109013 (Scientific Research on Innovative Areas, "Stimuli-responsive Chemical Species for the Creation of Functional Molecules" [#2408]).; Contract grant sponsor: MEXT Project of Integrated Research on Chemical Synthesis from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Sakagami M, 2013, B CHEM SOC JPN, V86, P1132, DOI 10.1246/bcsj.20130174; Sakagami M, 2013, CHEM-ASIAN J, V8, P690, DOI 10.1002/asia.201201227; CALDERAZZO F, 1984, J CHEM SOC DALTON, P2365, DOI 10.1039/dt9840002365; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; ASHE AJ, 1983, ORGANOMETALLICS, V2, P1859, DOI 10.1021/om50006a027; Sasamori T, 2006, J AM CHEM SOC, V128, P12582, DOI 10.1021/ja064062m; Balazs L, 2004, COORDIN CHEM REV, V248, P603, DOI 10.1016/j.ccr.2003.12.001; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Tokitoh N, 1997, SCIENCE, V277, P78, DOI 10.1126/science.277.5322.78; Twamley B, 1999, J AM CHEM SOC, V121, P3357, DOI 10.1021/ja983999n; Breunig HJ, 2004, ORGANOMETALLICS, V23, P304, DOI 10.1021/om030601+; Breunig HJ, 2005, Z ANORG ALLG CHEM, V631, P621, DOI 10.1002/zaac.200400476; Breunig HJ, 1998, ANGEW CHEM INT EDIT, V37, P3175, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3175::AID-ANIE3175>3.3.CO;2-D; ASHE AJ, 1982, ORGANOMETALLICS, V1, P1408, DOI 10.1021/om00070a029; Balazs L, 2006, INORG CHEM, V45, P2341, DOI 10.1021/ic052160n; Breunig HJ, 2009, ORGANOMETALLICS, V28, P1202, DOI 10.1021/om800934c; CALDERAZZO F, 1988, INORG CHEM, V27, P3730, DOI 10.1021/ic00294a012; Li XW, 1998, J ORGANOMET CHEM, V560, P211, DOI 10.1016/S0022-328X(98)00482-3; Sasamori T, 2008, DALTON T, P1395, DOI 10.1039/b715033d; Sasamori T, 2002, B CHEM SOC JPN, V75, P661, DOI 10.1246/bcsj.75.661; Sheldrick G. M., 1997, SHELX 97 PROGRAM CRY; Suzuki H., 2001, ORGANOBISMUTH CHEM	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		306	312		10.1002/hc.21154		7	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100003		
J	Lee, VY; McNiece, K; Ito, Y; Sekiguchi, A; Geinik, N; Becker, JY				Lee, Vladimir Ya; McNiece, Kiera; Ito, Yuki; Sekiguchi, Akira; Geinik, Natalie; Becker, James Y.			Tetrakis(di-tert-butylmethylsilyl) digermene: Synthesis, Structure, Electrochemical Properties, and Reactivity	HETEROATOM CHEMISTRY			English	Article							COMPLEXES; BOND	The tetrasilyl-substituted digermene ((Bu2MeSi)-Bu-t)(2)GeGe((SiMeBu2)-Bu-t)(2) 1 was prepared by the reduction of the readily available 1,1-dichlorogermane ((Bu2MeSi)-Bu-t)(2)GeCl2 with potassium graphite. Compound 1 is a rather unusual example of a digermene featuring planar geometry at the doubly bonded germanium atoms, on the one hand, and an extraordinarily twisted GeGe bond, on the other hand, caused by the electronic and steric factors of the bulky sigma-donating silyl substituents. Although it maintains the structural integrity of its double bond in solution, 1 revealed reactivity that is not characteristic of the >GeGe< bond but is typical for germylenes >Ge: upon reaction with nucleophilic reagents (isocyanide, orthoquinone). Unlike common alkenes, 1 affords stable cation and anion radicals generated by cyclic voltammetry.	[Lee, Vladimir Ya; McNiece, Kiera; Ito, Yuki; Sekiguchi, Akira] Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Chem, Tsukuba, Ibaraki 3058571, Japan; [Geinik, Natalie; Becker, James Y.] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel	Lee, VY (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Chem, Tsukuba, Ibaraki 3058571, Japan.	leevya@chem.tsukuba.ac.jp; sekiguch@chem.tsukuba.ac.jp		McNeice, Kiera/0000-0003-2839-4067	Scientific Research Program from the Ministry of Education, Science, Sports, and Culture of Japan [24109006, 24245007, 24550038]	Contract grant sponsor: Scientific Research Program from the Ministry of Education, Science, Sports, and Culture of Japan, Grants-in-Aid.; Contract grant number: 24109006, 24245007, and 24550038.	ANDO W, 1988, ORGANOMETALLICS, V7, P1880, DOI 10.1021/om00098a035; ANDO W, 1989, ORGANOMETALLICS, V8, P2759, DOI 10.1021/om00114a004; LeSuer RJ, 2004, ANAL CHEM, V76, P6395, DOI 10.1021/ac040087x; NEUMANN WP, 1991, CHEM REV, V91, P311, DOI 10.1021/cr00003a002; Pyykko P, 2009, CHEM-EUR J, V15, P186, DOI 10.1002/chem.200800987; Tokitoh N, 2002, POLYHEDRON, V21, P563, DOI 10.1016/S0277-5387(01)01035-X; BARRAU J, 1990, CHEM REV, V90, P283, DOI 10.1021/cr00099a010; DAVIDSON PJ, 1976, J CHEM SOC DALTON, P2268, DOI 10.1039/dt9760002268; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Goldberg D. E., 1976, CHEM COMMUN, P261; Kira M, 1996, ORGANOMETALLICS, V15, P3767, DOI 10.1021/om960370p; Klinkhammer K. W., 2002, CHEM ORGANIC GERMANI, V2, P283, DOI 10.1002/0470857188.ch4; Lee V. Y., 2010, ORGANOMETALLIC COMPO; Lee V. Ya., 2013, COMPREHENSIVE INORGA, V1, P289; Lee V. Ya, 2011, CHEM COMMUN, P3272; Lee VY, 2003, J ORGANOMET CHEM, V685, P168, DOI 10.1016/S0022-328X(03)00651-X; Pyykko P, 2009, CHEM-EUR J, V15, P2770; Reichardt C, 1990, SOLVENTS SOLVENT EFF, P408; Rupar PA, 2007, CAN J CHEM, V85, P141, DOI 10.1139/V07-002; Schafer A, 2009, CHEM-EUR J, V15, P8424, DOI 10.1002/chem.200901001; Takeda N, 2003, CHEM-EUR J, V9, P3530, DOI 10.1002/chem.200204643; Tokitoh N., 2002, CHEM ORGANIC GERMA 1, V2, P843, DOI 10.1002/0470857188.ch13	22	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		313	319		10.1002/hc.21165		7	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100004		
J	Uchiyama, Y; Kawaguchi, T; Kuroda, K				Uchiyama, Yosuke; Kawaguchi, Toshifumi; Kuroda, Koichi			Synthesis, Crystal Structures, and Skeletal Inversion of Dithienodiphosphorines	HETEROATOM CHEMISTRY			English	Article							LIGAND ELECTRONEGATIVITY; CONVENIENT SYNTHESIS; ASYMMETRIC-SYNTHESIS; MAGNETIC-RESONANCE; PERIODIC TRENDS; EDGE INVERSION; 9,10-DIHYDROANTHRACENE; STEREOCHEMISTRY; ISOMERIZATION; CONFORMATION	trans- and cis_endo-Diphenyl[c]dithienodiphosphorines 1a and 1b were successfully synthesized as phosphorus atoms are trivalent. Two stereoisomers, trans form 1a and cis_endo form 1b, were isolated by preparative gel permeation chromatography (GPC) and their butterfly structures were shown by X-ray crystallographic analyses of the single crystals from hexane/CHCl3 and CH3CN/CHCl3, respectively. The VT-P-31{H-1} NMR spectra in CD2Cl2 showed that the signal due to cis_endo form 1b appeared at (P) -45.0 with 9.5Hz of half-width at -90 degrees C, which is almost same as that at room temperature, while broadening of the signal due to trans form 1a was observed and finally the signal appeared at (P) -33.7 with 55.5Hz of half-width at -90 degrees C. The results indicated that the skeletal inversion of a tricyclic system in solution is a fast process on the NMR timescale. On the other hand, X-ray crystallographic analysis showed that trans-dimesityl[c]dithienodiphosphorine 2a has a planar structure, which is considered as the corresponding transition state of the skeletal inversion of trans form 1a. The P-31 signal due to 2a in CD2Cl2 did not change at all even at -90 degrees C, which was in a different manner from 1a at the same temperature, showing that its planar structure is also kept in solution because of the release of the steric repulsion between bulky mesityl groups and fused thiophene rings in the butterfly structure. The density functional theory calculations suggested the low-energy barriers of the skeletal inversion of trans-trans and cis_endo-cis_exo forms, which were estimated to be 3.79 and 3.31 kcal/mol by searching for transition state using the synchronous transit-guided quasi-Newton (STQN) methods.	[Uchiyama, Yosuke; Kawaguchi, Toshifumi; Kuroda, Koichi] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Uchiyama, Y (reprint author), Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	yosuke@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [16750041, 18750037]; Kitasato University	Contract grant sponsor: Grant-in-Aid for Encouragement of Young Scientists (B) (to YU) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Contract grant numbers: 16750041 and 18750037.; Contract grant sponsor: Kitasato University Research Grant for Young Researchers.	AKUTSU H, 1995, SYNTHETIC MET, V70, P1109, DOI 10.1016/0379-6779(94)02776-U; DIXON DA, 1987, J AM CHEM SOC, V109, P338, DOI 10.1021/ja00236a007; DIXON DA, 1986, J AM CHEM SOC, V108, P2461, DOI 10.1021/ja00269a063; Kolodiazhnyi OI, 1998, TETRAHEDRON-ASYMMETR, V9, P1279, DOI 10.1016/S0957-4166(98)00089-5; Copolovici D, 2010, DALTON T, V39, P6410, DOI 10.1039/c003318a; BAECHLER RD, 1972, J AM CHEM SOC, V94, P2859, DOI 10.1021/ja00763a054; BECKETT AH, 1955, J CHEM SOC, P4159, DOI 10.1039/jr9550004159; Chatt X., 1940, J CHEM SOC, P1184; CURTIN DY, 1964, CAN J CHEM, V42, P565, DOI 10.1139/v64-083; Dai WM, 2002, TETRAHEDRON-ASYMMETR, V13, P2187, DOI 10.1016/S0957-4166(02)00588-8; DALLING DK, 1981, J AM CHEM SOC, V103, P4817, DOI 10.1021/ja00406a025; Davies WC, 1935, J CHEM SOC, P462, DOI 10.1039/jr9350000462; DAVIS M, 1964, J CHEM SOC, P3770, DOI 10.1039/jr9640003770; Doyle R. J., 2000, J CHEM SOC DA, V691, P3603; Eliel E.L., 1994, STEREOCHEMISTRY ORGA; Frisch M. J., 2004, GAUSSIAN 03 REVISION; GOLDWHITE H, 1986, J ORGANOMET CHEM, V310, P21, DOI 10.1016/S0022-328X(00)99656-6; HERBSTEIN FH, 1986, ACTA CRYSTALLOGR B, V42, P181, DOI 10.1107/S0108768186098385; HOLUBEC ZM, 1968, J AM CHEM SOC, V90, P5986, DOI 10.1021/ja01024a007; JANDA M, 1972, SYNTH-INT J METHODS, P545; Kolodiazhnyi OI, 2003, TETRAHEDRON-ASYMMETR, V14, P181, DOI 10.1016/S0957-4166(02)00750-4; LAMPIN JP, 1974, J ORGANOMET CHEM, V71, P239, DOI 10.1016/S0022-328X(00)93116-4; Magiera D, 2003, ORGANOMETALLICS, V22, P2464, DOI 10.1021/om0209529; BAECHLER RD, 1971, J AM CHEM SOC, V93, P773; MOC J, 1994, INORG CHEM, V33, P551, DOI 10.1021/ic00081a025; MURAFUJI T, 1995, ORGANOMETALLICS, V14, P1542, DOI 10.1021/om00003a071; OSHIKAWA T, 1985, CHEM IND-LONDON, P126; RABIDEAU PW, 1978, ACCOUNTS CHEM RES, V11, P141, DOI 10.1021/ar50124a003; Ren Y, 2010, CHEM-ASIAN J, V5, P1918, DOI 10.1002/asia.201000196; Ren Y, 2009, CAN J CHEM, V87, P1222, DOI 10.1139/V09-108; Suzuki H., 1993, J CHEM SOC P1, V23, P2969; Uchiyama Y, 2011, HETEROATOM CHEM, V22, P377, DOI 10.1002/hc.20693; Uchiyama Y, 2011, PHOSPHORUS SULFUR, V186, P822, DOI 10.1080/10426507.2010.515957; YAMAMOTO Y, 1995, J AM CHEM SOC, V117, P3922, DOI 10.1021/ja00119a005; Yasuike S., 2006, J ORGANOMET CHEM, P2213; ZIEGER HE, 1969, TETRAHEDRON LETT, P5027	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		326	336		10.1002/hc.21163		11	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100006		
J	Murai, T; Miwa, T				Murai, Toshiaki; Miwa, Tomoaki			Kinetic Resolution of Secondary 2-Aryl-1-cycloalkanols with Phosphoroselenoyl Chloride with a Binaphthyl Group	HETEROATOM CHEMISTRY			English	Article							CHIRAL MOLECULAR TOOL; GRIGNARD-REAGENTS; ABSOLUTE-CONFIGURATION; ENZYMATIC RESOLUTION; ASYMMETRIC-SYNTHESIS; ALCOHOLS; DERIVATIVES; CATALYSTS; ACID; LIPASE	Phosphoroselenoic acid esters with a binaphthyl group were prepared by reacting phosphoroselenoyl chloride with excess racemic secondary cyclic alcohols. While the reactions of trans-2-aryl-1-cyclohexanols, 2-pheny-1-cycloheptanols, and 2-phenyl-1-cyclooctanols proceeded with high diastereoselectivity, those of 2-alkyl-1-cylcohexanols and 2-aryl-1-cyclopentanols did not show any diastereoselectivity. The resulting diastereomeric mixtures of the esters were purified by column chromatography on silica gel to give fractions that contained only one of the diastereomers. Reduction of the separated esters gave optically active cyclic alcohols with high enantiomeric excess. Extrusion of the selenium atom of the esters with PBu3 gave optically active phosphites in high yields.	[Murai, Toshiaki; Miwa, Tomoaki] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan; [Murai, Toshiaki] JST, Kawaguchi, Saitama 3320012, Japan	Murai, T (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan.	mtoshi@gifu-u.ac.jp			MEXT	This research was supported by MEXT, Grants-in-Aid for Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species for the Creation of Functional Molecules."	Shibahara F, 2014, CHEM-ASIAN J, V9, P237, DOI 10.1002/asia.201300882; Tomizawa M, 2009, ORG LETT, V11, P1829, DOI 10.1021/ol900441f; Cravotto G, 2001, J ORG CHEM, V66, P8447, DOI 10.1021/jo015854w; Murai T, 2013, CHEM LETT, V42, P828, DOI 10.1246/cl.130274; Murai T, 2013, CHEM-EUR J, V19, P13112, DOI 10.1002/chem.201301573; Li XM, 2012, J ORG CHEM, V77, P1722, DOI 10.1021/jo202220x; Wagner AJ, 2011, ORG LETT, V13, P4470, DOI 10.1021/ol201902y; Mizuno M, 1997, TETRAHEDRON, V53, P10699, DOI 10.1016/S0040-4020(97)00701-1; Birman VB, 2008, ORG LETT, V10, P1115, DOI 10.1021/ol703119n; Giampietro NC, 2009, J AM CHEM SOC, V131, P12556, DOI 10.1021/ja905930s; Sheppard CI, 2011, ORG LETT, V13, P3794, DOI 10.1021/ol2012617; Mandai H, 2013, HETEROCYCLES, V87, P329, DOI 10.3987/COM-12-12624; Pellissier H, 2011, ADV SYNTH CATAL, V353, P1613, DOI 10.1002/adsc.201100111; Ebner DC, 2008, ANGEW CHEM INT EDIT, V47, P6367, DOI 10.1002/anie.200801865; Lyubimov SE, 2011, TETRAHEDRON LETT, V52, P1395, DOI 10.1016/j.tetlet.2011.01.104; NISHIYAMA H, 1992, TETRAHEDRON-ASYMMETR, V3, P1029, DOI 10.1016/S0957-4166(00)86036-X; Oguni N, 1998, TETRAHEDRON LETT, V39, P9023, DOI 10.1016/S0040-4039(98)02024-3; Crouch IT, 2013, J AM CHEM SOC, V135, P4970, DOI 10.1021/ja401606e; Shibahara F, 2013, CHEM-EUR J, V19, P304, DOI 10.1002/chem.201203470; Geng XL, 2008, J ORG CHEM, V73, P8558, DOI 10.1021/jo801859m; Yang X, 2009, ORG LETT, V11, P1499, DOI 10.1021/ol900098q; Murai T, 2012, CHEM LETT, V41, P2, DOI 10.1246/cl.2012.2; Barreto RD, 2007, TETRAHEDRON-ASYMMETR, V18, P435, DOI 10.1016/j.tetasy.2007.01.030; BASAVAIAH D, 1991, TETRAHEDRON LETT, V32, P3417, DOI 10.1016/S0040-4039(00)92724-2; BASAVAIAH D, 1994, TETRAHEDRON-ASYMMETR, V5, P223, DOI 10.1016/S0957-4166(00)86177-7; BROWN HC, 1987, J ORG CHEM, V52, P310, DOI 10.1021/jo00378a037; Carpenter BE, 1996, TETRAHEDRON-ASYMMETR, V7, P3107, DOI 10.1016/0957-4166(96)00409-0; Celia EC, 1999, J MOL CATAL B-ENZYM, V6, P495, DOI 10.1016/S1381-1177(99)00014-4; Clapham B, 2001, J ORG CHEM, V66, P868, DOI 10.1021/jo0013610; Copeland GT, 2001, J AM CHEM SOC, V123, P6496, DOI 10.1021/ja0108584; Del R., 1998, BIOTECHNOL LETT, V20, P1021; Denmark SE, 1999, J AM CHEM SOC, V121, P3046, DOI 10.1021/ja9829970; Denmark SE, 2001, J ORG CHEM, V66, P4276, DOI 10.1021/jo0101510; Geng X.-L., 2008, J AM CHEM SOC, V130, P13836; Gleeson O, 2013, SYNLETT, V24, P1728, DOI 10.1055/s-0033-1339286; HUYNH C, 1979, TETRAHEDRON LETT, P1503; Iwata T, 2002, J CHEM SOC PERK T 1, P1548, DOI 10.1039/b203465d; Jeong KS, 2002, CHEM LETT, P1114, DOI 10.1246/cl.2002.1114; Jiane JL, 2009, J MED CHEM, V52, P3039, DOI 10.1021/jm8016514; Jumde VR, 2011, TETRAHEDRON-ASYMMETR, V22, P2151, DOI 10.1016/j.tetasy.2011.12.006; Kassick AJ, 2013, J MED CHEM, V56, P5940, DOI 10.1021/jm400751p; Koter I, 2003, J MOL CATAL B-ENZYM, V24-5, P17, DOI 10.1016/S1381-1177(03)00068-7; Kumazawa K, 2004, ORG LETT, V6, P2551, DOI 10.1021/ol049126h; Lin P, 2007, BIOORG MED CHEM LETT, V17, P5191, DOI 10.1016/j.bmcl.2007.06.085; Mandai H, 2012, ORG LETT, V14, P3486, DOI 10.1021/ol301373x; Matsugi M, 2002, CHEM-EUR J, V8, P5551, DOI 10.1002/1521-3765(20021216)8:24<5551::AID-CHEM5551>3.0.CO;2-V; Mueller C. E., 2011, ANGEW CHEM INT EDIT, V50, P6012; Murai T, 2010, CHEM LETT, V39, P524, DOI 10.1246/cl.2010.524; Murai T, 2007, CHEM LETT, V36, P852, DOI 10.1246/cl.2007.852; Murai T, 2008, PHOSPHORUS SULFUR, V183, P889, DOI 10.1080/10426500801898218; Murai T., 2013, CHEM COMMUN, P9675; Murai T, 2006, J AM CHEM SOC, V128, P4584, DOI 10.1021/ja060308b; Murai T, 2006, CHEM LETT, V35, P1424, DOI 10.1246/cl.2006.1424; Murai T, 2010, PHOSPHORUS SULFUR, V185, P964, DOI 10.1080/10426501003771575; Oriyama T, 1996, TETRAHEDRON LETT, V37, P8543, DOI 10.1016/0040-4039(96)01987-9; Sano T, 1999, CHEM LETT, P265; Schwartz A., 1990, ORG SYNTH, V69, P1; Sekar G, 2001, J AM CHEM SOC, V123, P3603, DOI 10.1021/ja010029i; Shamoto K, 2013, SYNTHETIC COMMUN, V43, P1425, DOI 10.1080/00397911.2011.636498; She YH, 2005, SYNTHESIS-STUTTGART, P749, DOI 10.1055/s-2005-861819; Sukhorukov AY, 2011, J ORG CHEM, V76, P7893, DOI 10.1021/jo201331h; Taglialatela-Scafati O, 2010, EUR J ORG CHEM, P2067, DOI 10.1002/ejoc.200901464; TAKAHASHI M, 1995, TETRAHEDRON-ASYMMETR, V6, P1617, DOI 10.1016/0957-4166(95)00206-5; Tanikaga R, 2003, TETRAHEDRON LETT, V44, P6781, DOI 10.1016/S0040-4039(03)01514-4; Vrancken E, 2005, EUR J ORG CHEM, P1354, DOI 10.1002/ejoc.200400745; Wagner AJ, 2013, ORG LETT, V15, P5504, DOI 10.1021/ol402643n; WHITESELL JK, 1986, CHIMIA, V40, P318; WHITESELL JK, 1985, J ORG CHEM, V50, P4663, DOI 10.1021/jo00223a055; Zhang YH, 2009, ADV SYNTH CATAL, V351, P2525, DOI 10.1002/adsc.200900383	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		337	347		10.1002/hc.21168		11	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100007		
J	Ishida, S; Uchida, K; Iwamoto, T				Ishida, Shintaro; Uchida, Kenya; Iwamoto, Takeaki			Unexpected Formation of Highly Strained 2,5-Dioxa-3-Silabicyclo[2.1.0] Pentane by the Reaction of Isolable Dialkylsilylene with Benzil	HETEROATOM CHEMISTRY			English	Article							POTENTIAL-ENERGY SURFACES; HYPERSPHERE SEARCH METHOD; QUATERNARY CARBON STEREOCENTERS; SILYLENE TRANSFER; STABLE DIALKYLSILYLENE; SILACARBONYL YLIDES; ORGANIC-COMPOUNDS; LOW COORDINATION; DOUBLE-BONDS; CHEMISTRY	The reaction of isolable dialkylsilylene 1 with benzil gave [1+4] cycloadduct 1,3-dioxa-2-sila-cyclopent-4-ene 2 and unexpected 2,5-dioxa-3-silabicyclo[2.1.0]pentane derivative 3. Compound 3 slowly isomerized to 2. The global reaction route mapping method of the model compounds suggests that three reaction paths from an initial silylene-ketone complex (carbonyl silaylide) to 2. A large ring strain energy of model compound for 3 (3) (218.9 kJmol(-1)) was estimated by density functional theory calculations.	[Ishida, Shintaro; Uchida, Kenya; Iwamoto, Takeaki] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Ishida, S (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	sishida@m.tohoku.ac.jp	Ishida, Shintaro/M-3342-2015	Ishida, Shintaro/0000-0001-7832-912X	JSPS KAKENHI [25708004, 25620020, 25248010]; MEXT KAKENHI [24109004]	Contract grant sponsor: JSPS KAKENHI.; Contract grant numbers: 25708004 and 25620020 (to SI) and 25248010 (to TI).; Contract grant sponsor: MEXT KAKENHI (Grant-in-aid from Scientific Research on Innovative Areas "Stimuli-Responsive Chemical Species").; Contract grant number: 24109004 (to TI).	ALLEN FH, 1987, J CHEM SOC PERK T 2, pS1, DOI 10.1039/p298700000s1; ANDO W, 1979, CHEM COMMUN, P655; Belzner J, 1996, J ORG CHEM, V61, P3315, DOI 10.1021/jo951583b; GEORGE P, 1976, TETRAHEDRON, V32, P317, DOI 10.1016/0040-4020(76)80043-9; Kira M, 1999, J AM CHEM SOC, V121, P9722, DOI 10.1021/ja9925305; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; ISHIDA K, 1977, J CHEM PHYS, V66, P2153, DOI 10.1063/1.434152; Maeda S, 2005, J PHYS CHEM A, V109, P5742, DOI 10.1021/jp0513162; Kira M, 2010, CHEM COMMUN, V46, P2893, DOI 10.1039/c002806a; Calad SA, 2005, J AM CHEM SOC, V127, P2046, DOI 10.1021/ja042893r; PAGE M, 1988, J CHEM PHYS, V88, P922, DOI 10.1063/1.454172; ANDO W, 1977, J AM CHEM SOC, V99, P6447, DOI 10.1021/ja00461a050; Jutzi P, 1999, CHEM REV, V99, P969, DOI 10.1021/cr941099t; Ohno K, 2004, CHEM PHYS LETT, V384, P277, DOI 10.1016/j.cplett.2003.12.030; Mizuhata Y, 2009, CHEM REV, V109, P3479, DOI 10.1021/cr900093s; Ishida S, 2011, HETEROATOM CHEM, V22, P432, DOI 10.1002/hc.20705; Kira M, 2004, J ORGANOMET CHEM, V689, P4475, DOI 10.1016/j.jorganchem.2004.05.054; Ohno K, 2006, J PHYS CHEM A, V110, P8933, DOI 10.1021/jp0611491; Weidenbruch M, 2003, ORGANOMETALLICS, V22, P4348, DOI 10.1021/om034085z; Kira M, 2007, B CHEM SOC JPN, V80, P258, DOI 10.1246/bcsj.80.258; Tokitoh N, 2000, COORDIN CHEM REV, V210, P251, DOI 10.1016/S0010-8545(00)00313-1; Maeda S, 2007, J PHYS CHEM A, V111, P4527, DOI 10.1021/jp070606a; Kira M, 2004, CHEM REC, V4, P243, DOI 10.1002/tcr.20019; Gaspar PP, 1998, CHEM FUNCT, V2, P2463, DOI 10.1002/0470857250.ch43; Asay M, 2011, ANGEW CHEM INT EDIT, V50, P9589, DOI 10.1002/anie.201104805; Weidenbruch M, 2002, J ORGANOMET CHEM, V646, P39, DOI 10.1016/S0022-328X(01)01262-1; Azhakar R, 2011, INORG CHEM, V50, P3028, DOI 10.1021/ic102566c; Azhakar R, 2011, ORGANOMETALLICS, V30, P3853, DOI 10.1021/om200388a; AZHAKAR R, 2013, EUR J INORG CHEM, V15, P2777; Azhakar R, 2013, Z ANORG ALLG CHEM, V639, P934, DOI 10.1002/zaac.201300138; BALDWIN JE, 1973, J ORG CHEM, V38, P1063, DOI 10.1021/jo00945a050; BELZNER J, 1992, J ORGANOMET CHEM, V430, pC51, DOI 10.1016/0022-328X(92)83274-L; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Borst MLG, 2005, J ORG CHEM, V70, P8110, DOI 10.1021/jo0513010; Bourque LE, 2008, ORG LETT, V10, P5257, DOI 10.1021/ol8018538; Calad SA, 2007, ORG LETT, V9, P1037, DOI 10.1021/ol063072p; CRIEGEE R, 1957, CHEM BER-RECL, V90, P414, DOI 10.1002/cber.19570900319; Driess M., 1996, ANGEW CHEM INT EDIT, V35, P828, DOI DOI 10.1002/ANIE.199608281; EIGENMAN.HK, 1973, J PHYS CHEM-US, V77, P1687, DOI 10.1021/j100632a019; Frisch M.J., 2009, GAUSSIAN 09; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; Gau D, 2010, CHEM-EUR J, V16, P8255, DOI 10.1002/chem.201001054; Gehrhus B, 1997, ORGANOMETALLICS, V16, P4861, DOI 10.1021/om9705362; Ghadwal RS, 2010, ANGEW CHEM INT EDIT, V49, P3952, DOI 10.1002/anie.201000835; HALBERSTADT ML, 1962, J AM CHEM SOC, V84, P2688, DOI 10.1021/ja00873a008; Heinicke J, 1998, J ORGANOMET CHEM, V561, P121, DOI 10.1016/S0022-328X(98)00533-6; HEINICKE J, 1992, J ORGANOMET CHEM, V423, P13, DOI 10.1016/0022-328X(92)83019-E; Hill NJ, 2004, J ORGANOMET CHEM, V689, P4165, DOI 10.1016/j.jorganchem.2004.09.012; Howard BE, 2007, ORG LETT, V9, P4651, DOI 10.1021/ol702148x; Ishida S, 2010, ORGANOMETALLICS, V29, P5526, DOI 10.1021/om1004644; Ishida S, 2012, ORGANOMETALLICS, V31, P5983, DOI 10.1021/om3005178; Jutzi P, 1996, ORGANOMETALLICS, V15, P1930, DOI 10.1021/om950897m; Kira M, 2004, ANGEW CHEM INT EDIT, V43, P4510, DOI 10.1002/anie.200460317; Maeda S., 2011, GRRM 11 VERSION 11 0; Minakata S, 2007, SYNTHESIS-STUTTGART, P2481, DOI 10.1055/s-2007-983807; REDDY NP, 1992, J AM CHEM SOC, V114, P6596, DOI 10.1021/ja00042a071; Rodriguez R, 2012, ANGEW CHEM INT EDIT, V51, P7158, DOI 10.1002/anie.201201581; Sakai N, 2003, J ORGANOMET CHEM, V686, P368, DOI 10.1016/j.jordanchem.2003.08.009; Sakai N, 1999, CHEM COMMUN, P1857, DOI 10.1039/a906139h; STEEL C, 1964, J AM CHEM SOC, V86, P679, DOI 10.1021/ja01058a027; Tavcar G, 2010, ORGANOMETALLICS, V29, P3930, DOI 10.1021/om100581u	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		348	353		10.1002/hc.21162		6	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100008		
J	Saito, M; Matsumoto, K; Fujita, M; Minoura, M				Saito, Masaichi; Matsumoto, Kaori; Fujita, Masahiro; Minoura, Mao			Unexpected Dehalogenation Reactions of Dichloroborane Bearing a NCN-Pincer Ligand: Formation of a Borenium Salt	HETEROATOM CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STANNOLE DIANION; SUPPORTED BORON; CATIONS; REACTIVITY; CHEMISTRY; DICATION; IONS; BORYLLITHIUM; BORYLATION	2,6-Bis[(diisopropylamino)methyl]phenyllithium 1 reacted with trichloroborane etherate to afford dichloroarylborane 4. The treatment of 4 with Ag triflate provided bistriflate 5. The reaction of 4 with AgBF4, however, afforded an unexpected product, borenium salt 6.	[Saito, Masaichi; Matsumoto, Kaori; Fujita, Masahiro] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Minoura, Mao] Rikkyo Univ, Dept Chem, Coll Sci, Toshima Ku, Tokyo 1718501, Japan	Saito, M (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3388570, Japan.	masaichi@chem.saitama-u.ac.jp	Saito, Masaichi/N-9607-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan [2408, 22350015, 25109510, 25109541]; Mitsubishi Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311027]	Contract grant sponsor: Grant-in-Aid for Scientific Research (B) and Priority Areas "Stimuli-responsive Chemical Species for the Creation of Functional Molecules" [#2408] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Contract grant numbers: (22350015, 25109510, and 25109541).; Contract grant sponsor: Mitsubishi Foundation.; Contract grant sponsor: MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017.; Contract grant numbers: S1311027.	Dostal L, 2006, J ORGANOMET CHEM, V691, P35, DOI 10.1016/j.jorganchem.2005.08.043; Del Grosso A, 2010, ORGANOMETALLICS, V29, P241, DOI 10.1021/om900893g; Saito M, 2010, SCIENCE, V328, P339, DOI 10.1126/science.1183648; Segawa Y, 2006, SCIENCE, V314, P113, DOI 10.1126/science.1131914; Kim Y, 2009, J AM CHEM SOC, V131, P3363, DOI 10.1021/ja8091467; Prokofjevs A, 2011, J AM CHEM SOC, V133, P20056, DOI 10.1021/ja208093c; De Vries TS, 2009, J AM CHEM SOC, V131, P14679, DOI 10.1021/ja905369n; Marwitz AJV, 2010, ANGEW CHEM INT EDIT, V49, P7444, DOI 10.1002/anie.201004084; Del Grosso A, 2011, CHEM COMMUN, V47, P12459, DOI 10.1039/c1cc14226g; Saito M, 2005, ANGEW CHEM INT EDIT, V44, P6553, DOI 10.1002/anie.200501632; Wang YZ, 2011, INORG CHEM, V50, P12326, DOI 10.1021/ic200675u; Piers WE, 2005, ANGEW CHEM INT EDIT, V44, P5016, DOI 10.1002/anie.200500402; Matsumoto T, 2009, ORGANOMETALLICS, V28, P4252, DOI 10.1021/om900476g; McArthur D, 2011, CHEM COMMUN, V47, P6650, DOI 10.1039/c1cc10767d; KOLLE P, 1985, CHEM REV, V85, P399; CONTRERAS L, 1995, J ORGANOMET CHEM, V489, pC1, DOI 10.1016/0022-328X(94)05132-U; Saito M, 2010, CHEM LETT, V39, P700, DOI 10.1246/cl.2010.700; Ines B, 2011, ANGEW CHEM INT EDIT, V50, P8400, DOI 10.1002/anie.201103197; Chiu CW, 2008, ORGANOMETALLICS, V27, P1657, DOI 10.1021/om701249n; Tsurumaki E, 2011, J AM CHEM SOC, V133, P11956, DOI 10.1021/ja2056566; Segawa Y, 2008, J AM CHEM SOC, V130, P16069, DOI 10.1021/ja8057919; Bekaert A, 2002, Z KRIST-NEW CRYST ST, V217, P507; Bekaert A, 2003, Z KRIST-NEW CRYST ST, V218, P123; Bibal C, 2002, POLYHEDRON, V21, P2827, DOI 10.1016/S0277-5387(02)01279-2; Bonnier C, 2008, CHEM COMMUN, P4593, DOI 10.1039/b808739c; Braunschweig H, 2008, INORG CHEM, V47, P7456, DOI 10.1021/ic800876p; Chase PA, 2008, DALTON T, P5783, DOI 10.1039/b805092a; Corey EJ, 2009, ANGEW CHEM INT EDIT, V48, P2100, DOI 10.1002/anie.200805374; Del Grosso A, 2011, ANGEW CHEM INT EDIT, V50, P2102, DOI 10.1002/anie.201006196; Dinda R, 2007, ANGEW CHEM INT EDIT, V46, P9110, DOI 10.1002/anie.200703616; Dureen MA, 2008, CHEM COMMUN, P4303, DOI 10.1039/b808348g; Gates DP, 1998, CHEM-EUR J, V4, P1489, DOI 10.1002/(SICI)1521-3765(19980807)4:8<1489::AID-CHEM1489>3.0.CO;2-Q; Grant DJ, 2009, J PHYS CHEM A, V113, P777, DOI 10.1021/jp806627r; Haga R, 2008, CHEM-EUR J, V14, P4068, DOI 10.1002/chem.200800010; Haga R, 2006, J AM CHEM SOC, V128, P4934, DOI 10.1021/ja057228c; Hayashi Y, 2011, CHEM COMMUN, V47, P5888, DOI 10.1039/c1cc11334h; JASTRZEBSKI JTBH, 1982, J AM CHEM SOC, V104, P5490, DOI 10.1021/ja00384a041; Marwitz AJV, 2011, ORGANOMETALLICS, V30, P52, DOI 10.1021/om101083p; McGovern GP, 2013, INORG CHEM, V52, P13865, DOI 10.1021/ic401486y; Saito M, 2002, CHEM COMMUN, P1002, DOI 10.1039/b200238h; Saito M, 2006, CHEM LETT, V35, P940, DOI 10.1246/cl.2006.940; Saito M, 2006, ORGANOMETALLICS, V25, P2967, DOI 10.1021/om050879x; Schlengermann R, 1997, MAIN GROUP CHEM, V2, P141, DOI 10.1080/10241229712331341274; Schlengermann R, 1997, CHEM COMMUN, P197, DOI 10.1039/a606670d; Slovyev A., 2012, ORGANOMETALLICS, V31, P54; Someya CI, 2011, CHEM COMMUN, V47, P6599, DOI 10.1039/c1cc11789k; Toyota S, 2004, CHEM LETT, V33, P206, DOI 10.1246/cl.2004.206; Vargas-Baca I, 2008, DALTON T, P6421, DOI 10.1039/b810575h; Vidovic D, 2007, J AM CHEM SOC, V129, P8436, DOI 10.1021/ja072865j	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		354	360		10.1002/hc.21211		7	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100009		
J	Uno, H; Yoshino, M; Seike, A; Mori, S; Nakae, T; Okujima, T				Uno, Hidemitsu; Yoshino, Masaki; Seike, Aya; Mori, Shigeki; Nakae, Takahiro; Okujima, Tetsuo			Face-and Regioselectivity in Electrophilic Phenylsulfenylation of 7-tert-Butoxybicyclo[2.2.1] hepta-2,5-dienes	HETEROATOM CHEMISTRY			English	Article							PHOTOCHEMICAL-SYNTHESIS; CRYSTAL-STRUCTURE; PENTACENE; PHOTOGENERATION; DERIVATIVES; PRECURSOR	Electrophilic phenylsulfenylation of syn-7-tert-butoxy-2-phenylsulfonyl- bicyclo[2.2.1] hepta-2,5-diene with phenylsulfenyl chloride yielded a mixture of three simple adducts, two of which were derived by the endo face attack of the phenylsulfenyl cation. In the analogous reaction with the anti derivative, only one adduct with the exo phenylsulfanyl group at the nearer carbon was obtained. This product was derived by the attack of the phenylsulfenyl cation from the exo face followed by the endo attack of a chloride anion at the carbon opposite to the phenylsulfonyl group. The similar reaction of 7-tert-butoxybicyclo[2.2.1]hepta-2,5-diene itself underwent no Wager-Meerwein-type rearrangement or transannular reaction, and simple adducts were formed in good combined yield. The combined yield of the products reacted at the syn double bond was ca. 80%.	[Uno, Hidemitsu; Yoshino, Masaki; Seike, Aya; Mori, Shigeki; Nakae, Takahiro; Okujima, Tetsuo] Ehime Univ, Grad Sch Sci & Engn, Dept Biol & Chem, Matsuyama, Ehime 7908577, Japan; [Mori, Shigeki] Ehime Univ, Integrated Ctr Sci, Matsuyama, Ehime 7908577, Japan	Uno, H (reprint author), Ehime Univ, Grad Sch Sci & Engn, Dept Biol & Chem, Matsuyama, Ehime 7908577, Japan.	uno@ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23350020, 25110003]	Contract grant sponsor: Grant-in-Aids for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.; Contract grant numbers: 23350020 and 25110003.	Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Jurchescu OD, 2004, APPL PHYS LETT, V84, P3061, DOI 10.1063/1.1704874; Katsuta S, 2011, ORG LETT, V13, P1454, DOI 10.1021/ol200145r; Mondal R, 2006, J AM CHEM SOC, V128, P9612, DOI 10.1021/ja063823i; Uno H, 2005, TETRAHEDRON LETT, V46, P1981, DOI 10.1016/j.tetlet.2005.01.157; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Yamada H, 2005, CHEM-EUR J, V11, P6212, DOI 10.1002/chem.200500564; Watanabe M, 2012, NAT CHEM, V4, P574, DOI [10.1038/nchem.1381, 10.1038/NCHEM.1381]; Aotake T, 2013, TETRAHEDRON LETT, V54, P1790, DOI 10.1016/j.tetlet.2013.01.014; Bettinger HF, 2013, J ORG CHEM, V78, P1851, DOI 10.1021/jo301622f; Bo L. D., 1989, TETRAHEDRON LETT, V30, P807; Chen KY, 2007, CHEM COMMUN, P1065, DOI 10.1039/b616511g; Chen Y, 2001, J ORG CHEM, V66, P6932, DOI 10.1021/jo010268o; Chuang TH, 2008, ORG LETT, V10, P2869, DOI 10.1021/ol8010419; Jackson W, 2008, AUST J CHEM, V61, P956, DOI 10.1071/CH08402; Katsuta S, 2010, TETRAHEDRON LETT, V51, P1397, DOI 10.1016/j.tetlet.2010.01.009; Ma B, 2002, ORG LETT, V4, P2731, DOI 10.1021/ol026250x; Marchand A. P., 1982, STEREOCHEMICAL APPL; Mondal R., 2007, ORG LETT, V9, P505; Nakamura M, 2014, ORG BIOMOL CHEM, V12, P1309, DOI 10.1039/c3ob41996g; Okujima T, 2013, CHEM-EUR J, V19, P13970, DOI 10.1002/chem.201301294; Rodriguez-Otero J, 2003, J ORG CHEM, V68, P8823, DOI 10.1021/jo034526o; Seike A, 2013, RSC ADV, V3, P3006, DOI 10.1039/c2ra22870j; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Toenshoff C., 2010, ANGEW CHEM INT EDIT, V49, P4125; TRAYLOR TG, 1969, ACCOUNTS CHEM RES, V2, P152, DOI 10.1021/ar50017a004; Umano K., 1981, TETRAHEDRON LETT, P73; UNO H, 1994, B CHEM SOC JPN, V67, P1441, DOI 10.1246/bcsj.67.1441; Uno H, 2000, J CHEM SOC PERK T 1, P4347, DOI 10.1039/b006584f; Uno H., 2014, METHODS APPL CYCLOAD	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		367	378		10.1002/hc.21172		12	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100011		
J	Shibata, T; Takayasu, S				Shibata, Takanori; Takayasu, Satoshi			Synthesis of Multicyclic Heterocycles Initiated by C-H Bond Activation Along with "Rollover" Using a Rh(III) Catalyst	HETEROATOM CHEMISTRY			English	Article							DEHYDROGENATIVE CYCLIZATION; FLUORENE DERIVATIVES; RHODIUM; RH; CYCLOMETALATION; ALKENYLATION; MONODENTATE; ALKYNES; ACIDS; COMPLEXES	Various multicyclic heterocycles were synthesized via rollover as the key pathway using a Rh(III) catalyst with a catalytic amount of sodium pivalate or copper(II) acetate. 3-Alkynyl-2-heteroarylpyridines were transformed into tri- or tetracyclic heterocycles containing two heteroatoms via an intramolecular alkyne insertion. 3-Aryloyl-2-arylpyridines were derived into 4-azafluoren-9-ols via the intramolecular carbonyl insertion.	[Shibata, Takanori; Takayasu, Satoshi] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan; [Shibata, Takanori] ACT C, JST, Kawaguchi, Saitama 3320012, Japan	Shibata, T (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan.	tshibata@waseda.jp			MEXT; JST; ACT-C; grants for Excellent Graduate School (Practical Chemical Wisdom), Waseda University, MEXT, Japan	This work was supported by Grand-in-aid for Scientific Research on Innovative Area, "Molecular Activation Directed toward Straightforward Synthesis," MEXT, JST, ACT-C, and grants for Excellent Graduate School (Practical Chemical Wisdom), Waseda University, MEXT, Japan. We thank for Dr. Natsuhiko Sugimura (Materials Characterization Central Laboratory, Waseda University) for his assistant of Gaussian calculation.	Zhou BW, 2013, J AM CHEM SOC, V135, P1264, DOI 10.1021/ja311689k; Gao K, 2010, J AM CHEM SOC, V132, P12249, DOI 10.1021/ja106814p; Li Y, 2012, ORG LETT, V14, P636, DOI 10.1021/ol2032784; Shibata T, 2012, ORG LETT, V14, P5106, DOI 10.1021/ol302375c; Ackermann L, 2011, ORG LETT, V13, P3332, DOI 10.1021/ol2010648; Mizuno H, 2011, J AM CHEM SOC, V133, P1251, DOI 10.1021/ja109097z; Morimoto K, 2012, ANGEW CHEM INT EDIT, V51, P5359, DOI 10.1002/anie.201201526; Itoh M, 2013, J ORG CHEM, V78, P1365, DOI 10.1021/jo4000465; Butschke B, 2012, CHEM SCI, V3, P308, DOI 10.1039/c1sc00651g; Iitsuka T, 2013, J ORG CHEM, V78, P7216, DOI 10.1021/jo4011969; Li Y, 2012, ORG LETT, V14, P4498, DOI 10.1021/ol301989n; Tyo EC, 2009, J AM CHEM SOC, V131, P13009, DOI 10.1021/ja902773b; Tsai AS, 2011, J AM CHEM SOC, V133, P1248, DOI 10.1021/ja109562x; Umeda N, 2011, J ORG CHEM, V76, P13, DOI 10.1021/jo1021184; Li L, 2009, ORGANOMETALLICS, V28, P3492, DOI 10.1021/om9000742; Ueyama T, 2011, ORG LETT, V13, P706, DOI 10.1021/ol102942w; Vogler T, 2008, ORG LETT, V10, P129, DOI 10.1021/ol702659a; Zhang XS, 2013, EUR J ORG CHEM, V2013, P6530, DOI 10.1002/ejoc.201301115; Kuninobu Y, 2009, ORG LETT, V11, P2711, DOI 10.1021/ol900962v; Katagiri T, 2009, CHEM LETT, V38, P118, DOI 10.1246/cl.2009.118; Petretto GL, 2010, J ORGANOMET CHEM, V695, P256, DOI 10.1016/j.jorganchem.2009.10.002; Takeda D, 2011, CHEM LETT, V40, P1015, DOI 10.1246/cl.2011.1015; Boutadla Y, 2009, DALTON T, P5887, DOI 10.1039/b905469c; BRATERMAN PS, 1984, INORG CHEM, V23, P3425, DOI 10.1021/ic00189a032; Butschke B, 2010, ORGANOMETALLICS, V29, P6002, DOI 10.1021/om100757e; Davies D. L., 2006, J AM CHEM SOC, V128; Davies DL, 2003, DALTON T, P4132, DOI 10.1039/b303737a; Kwak J, 2012, J AM CHEM SOC, V134, P17778, DOI 10.1021/ja308205d; Minghetti G., 1999, CHEM HETEROCYCL COMP, V35, P992, DOI 10.1007/BF02252169; NORD G, 1983, INORG CHEM, V22, P3429, DOI 10.1021/ic00165a013; Shibata T, 2011, SYNLETT, P2075, DOI 10.1055/s-0030-1260981; SKAPSKI AC, 1985, J CHEM SOC CHEM COMM, P609, DOI 10.1039/c39850000609; SPELLANE PJ, 1983, INORG CHEM, V22, P4060, DOI 10.1021/ic00168a047; SPELLANE PJ, 1981, INORG CHEM, V20, P3561, DOI 10.1021/ic50224a079; WATTS RJ, 1977, J AM CHEM SOC, V99, P2179, DOI 10.1021/ja00449a026; WICKRAMASINGHE WA, 1981, J CHEM SOC CHEM COMM, P1284, DOI 10.1039/c39810001284	36	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		379	388		10.1002/hc.21158		10	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100012		
J	Nakagawa, H; Tsukada, S; Abe, N; Gunji, T				Nakagawa, Hajime; Tsukada, Satoru; Abe, Noritaka; Gunji, Takahiro			Unexpected Formation of 2-Amino-(1-(2-nitrophenylsulfinyl) azulene by the Reaction of 2-Aminoazulene with 2-Nitrobenzenesulfonyl Chloride	HETEROATOM CHEMISTRY			English	Article							DERIVATIVES; CELLS	2-Amino-(1-(2-nitrophenylsulfinyl)azulene derivatives were synthesized by the reaction of 2-aminoazulene with 2-nitrobenzenesulfonyl chloride. Crystal structures of these compounds were determined by X-ray diffraction analysis. The sulfur atom derived nosyl group shows unique geometry. Furthermore, a reaction using 4-nitrobenzenesulfonyl chloride is also demonstrated.	[Nakagawa, Hajime; Tsukada, Satoru; Abe, Noritaka; Gunji, Takahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan	Gunji, T (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan.	gunji@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2401, 24102008A02]	Contract grant sponsor: Grant-in-Aid for Scientific Research on Innovative Areas "New polymeric Materials Based on Element-Blocks (no. 2401)" of The Ministry of Education, Culture, Sports, Science and Technology, Japan.; Contract grant number: 24102008A02.	Abe N., 1997, J CHEM RES M, P2434; Abe N, 1997, J CHEM RES-S, P434, DOI 10.1039/a703817h; FUKUYAMA T, 1995, TETRAHEDRON LETT, V36, P6373, DOI 10.1016/0040-4039(95)01316-A; DuBose DL, 2006, LANGMUIR, V22, P4599, DOI 10.1021/la0532050; Hashiba K, 2004, ANTICANCER RES, V24, P3939; Herrmann R, 1998, J ORGANOMET CHEM, V571, P261, DOI 10.1016/S0022-328X(98)00872-9; Hyoudou M, 2012, HETEROCYCLES, V86, P233, DOI 10.3987/COM-12-S(N)4; Ito S, 2003, TETRAHEDRON, V59, P4651, DOI 10.1016/S0040-4020(03)00637-9; NOZOE T, 1962, B CHEM SOC JPN, V35, P1179, DOI 10.1246/bcsj.35.1179; Okujima T., 2000, HETEROCYCLES, V54, P667; Robinson RE, 2005, ORGANOMETALLICS, V24, P2386, DOI 10.1021/om0502180; TAKAKI Y, 1959, J PHYS SOC JPN, V14, P771, DOI 10.1143/JPSJ.14.771; WHELAND GW, 1949, J CHEM PHYS, V17, P264, DOI 10.1063/1.1747237	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		389	395		10.1002/hc.21173		7	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100013		
J	Kamimura, A; Takechi, Y; Watanabe, R				Kamimura, Akio; Takechi, Yasuko; Watanabe, Ryusuke			Preparation of Hydrophobic 2-Phenylthiohydroquinone Dimers and Evaluation of Their Photophysical Properties	HETEROATOM CHEMISTRY			English	Article							SOLUBLE FLUORESCENT DYE; FACILE SYNTHESIS; DERIVATIVES	Tetra-O-alkylated hydrophobic 2-phenylthiohydroquinone dimers were prepared by the Fe(III)-mediated oxidative dimerization. The prepared dimers were soluble in hexane and served as fluorescent dyes in the hydrophobic solvent. Their physical properties were also examined.	[Kamimura, Akio; Takechi, Yasuko; Watanabe, Ryusuke] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan	Kamimura, A (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan.	ak10@yamaguchi-u.ac.jp					Anderson JC, 2005, ORG LETT, V7, P123, DOI 10.1021/ol047825a; Wadumethrige SH, 2008, ORG LETT, V10, P5139, DOI 10.1021/ol8020429; Zhu XH, 2011, CHEM SOC REV, V40, P3509, DOI 10.1039/c1cs15016b; Boens N, 2012, CHEM SOC REV, V41, P1130, DOI 10.1039/c1cs15132k; Kim E, 2009, CHEM-ASIAN J, V4, P1646, DOI 10.1002/asia.200900102; Hayashi N, 2007, ORG LETT, V9, P5417, DOI 10.1021/ol702289u; Bovicelli P, 2006, TETRAHEDRON, V62, P635, DOI 10.1016/j.tet.2005.10.009; Kamimura A, 2012, CHEM LETT, V41, P950, DOI 10.1246/cl.2012.950; Kamimura A, 2014, J ORG CHEM, V79, P1068, DOI 10.1021/jo402522y; Kamimura A., 2011, Jpn. Patent, Patent No. 2011116749; Love BE, 2009, TETRAHEDRON LETT, V50, P5050, DOI 10.1016/j.tetlet.2009.06.103; Nokubi T, 2013, CHEM LETT, V42, P876, DOI 10.1246/cl.130348; Yersin H., 2008, HIGHLY EFFICIENT OLE	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		402	409		10.1002/hc.21169		8	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100015		
J	Akine, S; Nabeshima, T				Akine, Shigehisa; Nabeshima, Tatsuya			Increased Nuclearity of Salen-Type Transition Metal Complexes by Incorporation of O-Alkyloxime Functionality	HETEROATOM CHEMISTRY			English	Article							SITE-SELECTIVE TRANSMETALATION; SUPPORTING CONFORMATIONAL CHANGE; OLIGOMETALLIC TEMPLATE STRATEGY; NONLINEAR-OPTICAL PROPERTIES; DYNAMIC HELICITY CONTROL; SCHIFF-BASE LIGANDS; CRYSTAL-STRUCTURE; ZINC(II) COMPLEX; COMPARTMENTAL LIGANDS; COPPER(II) COMPLEXES	The effect of incorporation of O-alkyloxime functionality in the salen-type tetradentate ligand was investigated from a viewpoint of complexation behavior with cobalt(II), nickel(II), and zinc(II). The complexation of salamo ligands (H(2)salamo = 1,2-bis(salicylideneaminooxy)ethane) with zinc(II) and cobalt(II) afforded trinuclear complexes [M3L2(OAc)(2)] (M = Zn-II, Co-II; L = salamo, 3-MeOsalamo). The phenoxo groups of the two [ML] units coordinate to the third M-II, which results in the trinuclear structure. Upon complexation with nickel(II) acetate, the parent H(2)salamo gave a trinuclear complex [Ni-3(salamo)(2)(OAc)(2)(EtOH)(2)], whereas H-2(3-MeOsalamo) produced a mononuclear complex [Ni(3-MeOsalamo)(H2O)(2)]. The salamo complexes described here are similar to the corresponding complexes with N,N-disalicylidene-1,4-diaminobutane (H(2)salbn), indicating that the difference between the -OCH2CH2O- and -(CH2)(4)- groups has a small influence on the structural features of the complexes. However, this difference affects the complexation process with zinc(II) acetate. The trinuclear complex [Zn-3(3-MeOsalamo)(2)(OAc)(2)] was formed cooperatively, whereas the imine analog [Zn-3(3-MeOsalbn)(2)(OAc)(2)] was not.	[Akine, Shigehisa] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Nabeshima, Tatsuya] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Akine, S (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	akine@se.kanazawa-u.ac.jp; nabesima@chem.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	Contract grant sponsor: Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Akine S, 2005, INORG CHEM, V44, P1205, DOI 10.1021/ic048347g; Akine S, 2010, EUR J INORG CHEM, P3143, DOI 10.1002/ejic.200901243; Akine S, 2006, CHEM LETT, V35, P604, DOI 10.1246/cl.2006.604; Akine S, 2008, INORG CHEM, V47, P875, DOI 10.1021/ic701525c; Akine S, 2010, INORG CHEM, V49, P2141, DOI 10.1021/ic9019926; Akine S, 2007, INORG CHEM, V46, P2959, DOI 10.1021/ic062327s; Akine S, 2007, INORG CHEM, V46, P9525, DOI 10.1021/ic701585x; Akine S, 2006, TETRAHEDRON LETT, V47, P8419, DOI 10.1016/j.tetlet.2006.09.125; Akine S, 2008, INORG CHEM, V47, P3255, DOI 10.1021/ic702255s; Akine S, 2008, IOP CONF SER-MAT SCI, V1, DOI 10.1088/1757-8981/1/1/012009; Akine S, 2012, INORG CHEM, V51, P11478, DOI 10.1021/ic3012525; Akine S, 2006, CHEM COMMUN, P4961, DOI 10.1039/b610641b; Akine S, 2011, SUPRAMOL CHEM, V23, P106, DOI 10.1080/10610278.2010.514906; Akine S, 2008, CHEM COMMUN, P4604, DOI 10.1039/b810426c; Akine S, 2001, CHEM LETT, P682; Akine S, 2009, INORG CHEM, V48, P10670, DOI 10.1021/ic901372k; Akine S, 2009, DALTON T, P10395, DOI 10.1039/b910989g; Akine S, 2004, INORG CHEM, V43, P6142, DOI 10.1021/ic049282k; Akine S, 2012, J INCL PHENOM MACRO, V72, P25, DOI 10.1007/s10847-011-0026-3; Akine S, 2010, PHOSPHORUS SULFUR, V185, P1000, DOI 10.1080/10426501003772110; Akine S, 2011, CHEM COMMUN, V47, P2925, DOI 10.1039/c0cc04998k; Akine S, 2011, J AM CHEM SOC, V133, P13868, DOI 10.1021/ja205570z; Akine S, 2005, J ORG CHEM, V70, P1704, DOI 10.1021/jo048030y; Zolezzi S, 2002, POLYHEDRON, V21, P55, DOI 10.1016/S0277-5387(01)00960-3; Pfeiffer P, 1933, LIEBIGS ANN CHEM, V503, P84; Akine S, 2011, CHEM-EUR J, V17, P6853, DOI 10.1002/chem.201100122; Akine S, 2002, ANGEW CHEM INT EDIT, V41, P4670, DOI 10.1002/anie.200290011; Reglinski J, 2002, POLYHEDRON, V21, P2175, DOI 10.1016/S0277-5387(02)01172-5; Akine S, 2006, J AM CHEM SOC, V128, P15765, DOI 10.1021/ja0646702; Vigato PA, 2008, COORDIN CHEM REV, V252, P1871, DOI 10.1016/j.ccr.2007.10.030; Rigamonti L, 2006, INORG CHEM, V45, P10976, DOI 10.1021/ic0613513; Vigato PA, 2012, COORDIN CHEM REV, V256, P953, DOI 10.1016/j.ccr.2012.01.009; Elmali A, 2004, Z NATURFORSCH B, V59, P228; Baleizao C, 2006, CHEM REV, V106, P3987, DOI 10.1021/cr050973n; Akine S, 2006, INORG CHEM, V45, P4677, DOI 10.1021/ic060055n; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Akine S, 2005, J AM CHEM SOC, V127, P540, DOI 10.1021/ja046790k; Sairenji S, 2014, TETRAHEDRON LETT, V55, P1987, DOI 10.1016/j.tetlet.2014.02.009; Vigato PA, 2004, COORDIN CHEM REV, V248, P1717, DOI 10.1016/j.cct.2003.09.003; Akine S, 2005, INORG CHEM, V44, P3270, DOI 10.1021/ic0481677; Akine S, 2013, J AM CHEM SOC, V135, P12948, DOI 10.1021/ja405979v; Ardakani M Mazloum, 2005, Talanta, V66, P837, DOI 10.1016/j.talanta.2004.12.039; BATLEY GE, 1967, AUST J CHEM, V20, P885, DOI 10.1071/CH9670885; Beurskens P.T., 1999, DIRDIF 99 PROGRAM SY; BRUCKNER S, 1969, ACTA CRYSTALL B-STRU, VB 25, P1671, DOI 10.1107/S0567740869004523; Cox EG, 1935, J CHEM SOC, P459, DOI 10.1039/jr9350000459; Cupertino D, 2001, POLYHEDRON, V20, P3239, DOI 10.1016/S0277-5387(01)00947-0; DREW MGB, 1985, ACTA CRYSTALLOGR C, V41, P1755, DOI 10.1107/S0108270185009337; Durmus S, 2005, Z KRISTALLOGR, V220, P973, DOI 10.1524/zkri.2005.220.11_2005.973; Di Bella S, 2000, SYNTHETIC MET, V115, P191, DOI 10.1016/S0379-6779(00)00354-4; GERLI A, 1991, INORG CHEM, V30, P4673, DOI 10.1021/ic00024a043; GUERRIERO P, 1995, COORDIN CHEM REV, V139, P17, DOI 10.1016/0010-8545(93)01105-7; HALL D, 1966, J CHEM SOC A, P1822, DOI 10.1039/j19660001822; Hoshino N, 1998, COORDIN CHEM REV, V174, P77, DOI 10.1016/S0010-8545(98)00129-5; Jacobsen E. N., 1993, CATALYTIC ASYMMETRIC; JARSKI MA, 1964, ACTA CRYSTALLOGR, V17, P1109, DOI 10.1107/S0365110X64002900; Kaplan SF, 2001, EUR J INORG CHEM, P1031; KATSUKI T, 1995, COORDIN CHEM REV, V140, P189, DOI 10.1016/0010-8545(94)01124-T; Lacroix PG, 2001, EUR J INORG CHEM, P339; MANFREDOTTI AG, 1983, ACTA CRYSTALLOGR C, V39, P863; MERRITT LL, 1956, ACTA CRYSTALLOGR, V9, P253, DOI 10.1107/S0365110X5600070X; Mizukami S, 2003, CHEM COMMUN, P1148, DOI 10.1039/b301099f; MOCKLER GM, 1972, INORG CHEM, V11, P1308, DOI 10.1021/ic50112a030; NARANG KK, 1977, CURR SCI INDIA, V46, P401; ORIOLI PL, 1964, ACTA CRYSTALLOGR, V17, P1113, DOI 10.1107/S0365110X64002912; Palanchuk S. V., 1995, RUSS J COORD CHEM, V21, P884; Pfeiffer P, 1937, J PRAKTISCHE CHEMIE, V149, P217, DOI 10.1002/prac.19371490801; PFLUGER CE, 1970, ACTA CRYSTALL B-STRU, VB 26, P1631, DOI 10.1107/S0567740870004600; Potocnak I, 1997, ACTA CRYSTALLOGR C, V53, P54, DOI 10.1107/S0108270196011353; Reglinski J, 2002, POLYHEDRON, V21, P2167, DOI 10.1016/S0277-5387(02)01171-3; Sairenji S, 2014, CHEM LETT, V43, P1107, DOI 10.1246/cl.140263; SCHAEFER WP, 1969, ACTA CRYSTALL B-STRU, VB 25, P1675, DOI 10.1107/S0567740869004547; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SRIVASTA.RC, 1967, ACTA CRYSTALLOGR, V22, P922, DOI 10.1107/S0365110X6700180X; Ulku D, 2001, ACTA CRYSTALLOGR C, V57, P273, DOI 10.1107/S0108270100019983; Ulku D, 1997, ACTA CRYSTALLOGR C, V53, P1056, DOI 10.1107/S0108270197004733; vansVeggel F. C. J. M., 1989, J ORG CHEM, V54, P2351; Viswanathamurthi P, 1998, TRANSIT METAL CHEM, V23, P337, DOI 10.1023/A:1006953224166; VORONKOVA VK, 1995, INORG CHIM ACTA, V238, P139, DOI 10.1016/0020-1693(95)04694-5; Yampol'skaya M. A., 1983, RUSS J INORG CHEM, V28, P984; You ZL, 2004, ACTA CRYSTALLOGR E, V60, pM1900, DOI 10.1107/S1600536804029605	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		410	421		10.1002/hc.21205		12	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100016		
J	Ito, S; Nanko, M; Mikami, K				Ito, Shigekazu; Nanko, Masaki; Mikami, Koichi			Preparation via Sterically Promoted SN2 ' Substitution and Structural Characteristics of a Mes*-Substituted Tertiary Ethynylphosphine	HETEROATOM CHEMISTRY			English	Article							BULKY END CAPS; ELEMENTS; LIGANDS	The reaction of a sterically encumbered 2-bromo-3-silyloxyphosphapropene [(Z)-Mes*-P = C(Br)CH(OSiMe3)Mes; Mes* = 2,4,6-tBu(3)C(6)H(2), Mes = 2,4,6-Me3C6H2] and butyllithium afforded a bulky ethynylphosphine [Mes*P(nBu)CCMes] via S(N)2 reaction of the alkyllithium and subsequent beta-elimination of HBr. The orbital-controlled reaction and prohibition of the halogen-metal exchange would be induced by the steric encumbrance of the mesityl group. Structural characteristics of the novel ethynylphosphine were also discussed in views of steric encumbrance as well as stereochemistry. The remarkable distortion of Mes* aromatic ring was further discussed according to DFT calculations.	[Ito, Shigekazu; Nanko, Masaki; Mikami, Koichi] Tokyo Inst Technol, Dept Appl Chem, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan	Ito, S (reprint author), Tokyo Inst Technol, Dept Appl Chem, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan.	ito.s.ao@m.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Institute of Chemical Research, Kyoto University, Japan; Nissan Chemicals Co. Ltd. [22350058, 23655173, 25109518, 2013-10]	Contract grant sponsor: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Institute of Chemical Research, Kyoto University, Japan, and Nissan Chemicals Co. Ltd.; Contract grant numbers: 22350058, 23655173, 25109518 and 2013-10.	Markl G, 2000, CHEM-EUR J, V6, P3806, DOI 10.1002/1521-3765(20001016)6:20<3806::AID-CHEM3806>3.0.CO;2-J; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Sugiyama H, 2004, CHEM-EUR J, V10, P2700, DOI 10.1002/chem.200306069; Ochida A, 2006, J AM CHEM SOC, V128, P16486, DOI 10.1021/ja066800c; SCOTT LT, 1990, J AM CHEM SOC, V112, P7823, DOI 10.1021/ja00177a069; CABELLI DE, 1981, J AM CHEM SOC, V103, P3290, DOI 10.1021/ja00402a010; Frisch M J, 2010, GAUSSIAN 09 REVISION; Ito S, 2005, B CHEM SOC JPN, V78, P1142, DOI 10.1246/bcsj.78.1142; Ito S, 2006, DALTON T, P710, DOI 10.1039/b510432g; Ito S, 2000, ANGEW CHEM INT EDIT, V39, P2781, DOI 10.1002/1521-3773(20000804)39:15<2781::AID-ANIE2781>3.0.CO;2-5; Ito S, 2012, ARKIVOC, P6; Ito S, 2000, HETEROATOM CHEM, V11, P171, DOI 10.1002/(SICI)1098-1071(2000)11:3<171::AID-HC1>3.0.CO;2-6; Iwai T, 2013, ANGEW CHEM INT EDIT, V52, P4239, DOI 10.1002/anie.201300265; Kabuto C., 2009, J CRYST SOC JPN, V51, P218; Ochida A, 2007, CHEM-ASIAN J, V2, P609, DOI 10.1002/asia.200700006; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; vansAssema S. G. A., 2007, J ORGANOMET CHEM, V692, P2314; vansAssema S. G. A., 2006, EUR J ORG CHEM, P2405; vansAssema S. G. A., 2008, ORGANOMETALLICS, V27, P3210; YOSHIFUJI M, 1981, TETRAHEDRON LETT, V22, P3057, DOI 10.1016/S0040-4039(01)81826-8	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		422	427		10.1002/hc.21182		6	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100017		
J	Kimura, T; Murakami, N				Kimura, Takeshi; Murakami, Naoko			Preparation of 1,3-Diphenylselenopheno-tetraazaporphyrinato Ruthenium(II) Bis(4-methylpyridine) by the Reaction of 3,4-Dicyano-2,5-diphenylselenophene and Phthalonitrile: Its Optical and Electrochemical Properties	HETEROATOM CHEMISTRY			English	Article							NONCLASSICAL THIOPHENE; PHTHALOCYANINE ANALOGS; SELENOPHENES; MACROCYCLES; DYES	2,5-Diphenylselenophene (2a) was treated with bromine and then copper(I) cyanide to produce 3,4-dicyano-2,5-diphenylselenophene (4). Compound 4 was mixed with phthalonitrile, and the mixture was reacted with ruthenium(III) trichloride and 4-methylpyridine in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in refluxed 2-ethoxyethanol to give 1,3-diphenylselenophenotetraazaporphyrinato ruthenium(II) bis(4-methylpyridine) (6). The structure of 6 was determined by H-1 NMR and fast atom bombardment mass spectrometry (FABMS). In the H-1 NMR spectrum, the signals of 4-methylpyridine coordinating to the central ruthenium atom were observed at a higher magnetic field than those of free 4-methylpyridine itself but at a lower magnetic field than those of phthaocyaninato ruthenium(II) bis(4-methylpyridine) (7). The Se-77 NMR spectrum of 6 showed one singlet peak at = 759.5 ppm, which is a lower magnetic field than those of 2a and 4. The Q band absorption of 6 ((max) = 660 nm) lies at a longer wavelength than does that of 7. Oxidation and reduction potentials of 6 were measured with cyclic voltammetry using Ag/AgNO3 as a reference electrode.	[Kimura, Takeshi; Murakami, Naoko] Iwate Univ, Ctr Instrumental Anal, Morioka, Iwate 0208551, Japan	Kimura, T (reprint author), Iwate Univ, Ctr Instrumental Anal, Morioka, Iwate 0208551, Japan.	kimura@iwate-u.ac.jp					Amaresh RR, 2002, J ORG CHEM, V67, P2453, DOI 10.1021/jo010858m; Cook MJ, 2000, TETRAHEDRON, V56, P4085, DOI 10.1016/S0040-4020(00)00323-9; Knawby DM, 1997, CHEM MATER, V9, P535, DOI 10.1021/cm960368o; Mack J, 2011, CHEM REV, V111, P281, DOI 10.1021/cr9003049; Rawling T, 2007, COORDIN CHEM REV, V251, P1128, DOI 10.1016/j.ccr.2006.09.011; Cook MJ, 1997, J MATER CHEM, V7, P5, DOI 10.1039/a607004c; Gai BM, 2012, ORG BIOMOL CHEM, V10, P798, DOI 10.1039/c1ob06548c; de la Torre G, 2004, CHEM REV, V104, P3723, DOI 10.1021/cr030206t; Donzello MP, 2006, COORDIN CHEM REV, V250, P1530, DOI 10.1016/j.ccr.2006.02.009; Miyazaki E, 2009, J MATER CHEM, V19, P5913, DOI 10.1039/b910824f; Wohrle D, 2004, J PORPHYR PHTHALOCYA, V8, P1020; Shahid M, 2013, J MATER CHEM C, V1, P6198, DOI 10.1039/c3tc31584c; Barros OSD, 2006, TETRAHEDRON LETT, V47, P2179, DOI 10.1016/j.tetlet.2006.01.118; Bilton JA, 1937, J CHEM SOC, P922, DOI 10.1039/jr9370000922; CAVA MP, 1969, J AM CHEM SOC, V91, P3952, DOI 10.1021/ja01042a051; de la Torre G, 2007, CHEM COMMUN, P2000, DOI 10.1039/b614234f; GLICK MD, 1972, ACTA CRYSTALL B-STRU, VB 28, P1336, DOI 10.1107/S056774087200425X; Gronowitz S., 1977, CHEM COMMUN, P163; GRONOWITZ S, 1977, CHEM SCRIPTA, V12, P11; Hains A. W., 2012, CHEM REV, V110, P6689; ISHII A, 1991, J ORG CHEM, V56, P78, DOI 10.1021/jo00001a018; Kadish K. M., 2003, PORPHYRIN HDB, V16-20; Kimura T., 2011, EUR J INORG CHEM, V888-894; Kimura T, 2013, HETEROCYCLES, V87, P245, DOI 10.3987/REV-12-753; Leznoff C., 1989, PHTHALOCYANINES PROP, V1-4; Nemykin VN, 2000, CHEM LETT, P1236, DOI 10.1246/cl.2000.1236; Prediger P, 2006, J ORG CHEM, V71, P3786, DOI 10.1021/jo0601056; Stuzhin PA., 2003, PORPHYRIN HDB, V15, P263; Vegh D, 1995, KHIM GETEROTSIKL+, P1409; YONEDA S, 1985, J AM CHEM SOC, V107, P5801, DOI 10.1021/ja00306a037	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		428	433		10.1002/hc.21178		6	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100018		
J	Sasaki, S; Sutoh, K; Yoshifuji, M				Sasaki, Shigeru; Sutoh, Katsuhide; Yoshifuji, Masaaki			Synthesis, Structure, and Reactivity of 2,6-Diaryl-4-hydroxybenzenethiol	HETEROATOM CHEMISTRY			English	Article							MAIN-GROUP ELEMENTS; REDOX PROPERTIES; THIOQUINONE METHIDES; PHOSPHORUS CENTERS; MULTIPLE BONDS; RADICAL-ANION; EPR; DIPHOSPHENES; 2-COORDINATE; COMPLEXES	Novel 2,6-diaryl-4-hydroxybenzenethiol, 2,6-bis(2,4,6-triisopropylphenyl)-4-hydroxybenzenethiol, was synthesized from the corresponding 2,6-diaryl-4-bromoiodobenzene as a potential precursor of the corresponding thiobenzoquinone. The X-ray crystallography showed that the two aryl groups are nearly orthogonal to the central benzene ring and shield the mercapto group, but there still remains open space and the oxidation of the 4-hydroxybenzenethiol by MnO2 led to the formation of the corresponding disulfide. The oxidation of the 4-hydroxybenzenethiol as well as the corresponding disulfide was studied, and the spectroscopic studies suggested the formation of the labile thiobenzoquinone.	[Sasaki, Shigeru; Sutoh, Katsuhide; Yoshifuji, Masaaki] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Yoshifuji, Masaaki] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA	Sasaki, S (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	ssasaki@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [12740335]	Contract grant sponsor: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Contract grant number: 12740335.	Hachiya M, 2011, ORG LETT, V13, P2666, DOI 10.1021/ol200768b; Power PP, 2003, CHEM REV, V103, P789, DOI 10.1021/cr020406p; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; RAASCH MS, 1979, J ORG CHEM, V44, P632, DOI 10.1021/jo01318a034; Smith RC, 2004, J AM CHEM SOC, V126, P2268, DOI 10.1021/ja0394683; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; CASERIO MC, 1985, J ORG CHEM, V50, P4390, DOI 10.1021/jo00222a041; Twamley B, 1999, J AM CHEM SOC, V121, P3357, DOI 10.1021/ja983999n; Power PP, 2012, CHEM REV, V112, P3482, DOI 10.1021/cr2004647; Goto K, 2001, TETRAHEDRON LETT, V42, P4875, DOI 10.1016/S0040-4039(01)00871-1; Beuskens P. T., 1994, DIRDIF 94 PROGRAM SY; BOCK H, 1983, CHEM BER-RECL, V116, P273, DOI 10.1002/cber.19831160131; Dutan C, 2003, INORG CHEM, V42, P6241, DOI 10.1021/ic030079j; Fujisawa T., 1975, Jpn Kokai Tokkyo Koho, Patent No. [JP50117767, 50117767]; Goto K, 2001, CHEM LETT, P1204; GRIESBAU.K, 1970, ANGEW CHEM INT EDIT, V9, P273, DOI 10.1002/anie.197002731; Gudimetla VB, 2006, INORG CHEM, V45, P4895, DOI 10.1021/ic0520521; Ionkin AS, 2003, HETEROATOM CHEM, V14, P360, DOI 10.1002/hc.10162; Itoh T, 1996, J ORG CHEM, V61, P8329, DOI 10.1021/jo9609541; Lakshmikantham M. V., 1996, J ORG CHEM, V51, P411; Molecular Structure Corporation, 1998, SINGL CRYST STRUCT; Molina M.T., 1997, CHEM DOUBLE BONDED 2, P1355, DOI 10.1002/0470857234.ch23; Murakami F, 2002, ANGEW CHEM INT EDIT, V41, P2574, DOI 10.1002/1521-3773(20020715)41:14<2574::AID-ANIE2574>3.0.CO;2-K; Murakami F, 2005, J AM CHEM SOC, V127, P8926, DOI 10.1021/ja052271l; OSWALD AA, 1962, J AM CHEM SOC, V84, P3897, DOI 10.1021/ja00879a020; ELLISON JJ, 1994, ANGEW CHEM INT EDIT, V33, P1178, DOI 10.1002/anie.199411781; Sasaki S, 1999, ANGEW CHEM INT EDIT, V38, P340, DOI 10.1002/(SICI)1521-3773(19990201)38:3<340::AID-ANIE340>3.0.CO;2-8; Sasaki S, 2002, HELV CHIM ACTA, V85, P3842, DOI 10.1002/1522-2675(200211)85:11<3842::AID-HLCA3842>3.0.CO;2-U; Shah S, 1997, ORGANOMETALLICS, V16, P3395, DOI 10.1021/om970025f; Shah S, 2000, INORG CHEM, V39, P3860, DOI 10.1021/ic0001558; Suzuki R, 2000, CHEM COMMUN, P1357, DOI 10.1039/b003330h; Suzuki R, 1999, CHEM LETT, P571; Tsuji K, 1997, CHEM LETT, P855, DOI 10.1246/cl.1997.855; Tsuji K, 1999, TETRAHEDRON LETT, V40, P3203, DOI 10.1016/S0040-4039(99)00466-9; Urnezius E, 1996, MAIN GROUP CHEM, V1, P369, DOI 10.1080/13583149612331338697	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		442	448		10.1002/hc.21213		7	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100020		
J	Hayashi, S; Matsuiwa, K; Miza, H; Nakanishi, W				Hayashi, Satoko; Matsuiwa, Kohei; Miza, Hiroaki; Nakanishi, Waro			Dynamic and Static Behavior of E-E ' Bonds in Neutral and Charged Forms of HEE'H, MeEE'Me, and Cyclo-1,2-EE'(CH2)(3) (E, E ' = O, S, Se, and Te) Elucidated by AIM Dual Functional Analysis	HETEROATOM CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; HYDROGEN-BONDS; MOLECULAR-STRUCTURE; GA-KR; INTERNAL VIBRATIONS; ELECTRON-DENSITIES; 3RD-ROW ATOMS; WEAK; CRYSTAL; SULFUR	The nature of the E-*-E' bonds in neutral, monoanionic, monocationic, and dicationic forms of HEE'H (1), MeEE'Me (2), and cyclo-1,2-EE'(CH2)(3) (3) (E, E' = O, S, Se, Te) is investigated by applying AIM (atoms-in-molecules method) dual functional analysis. H-b(r(c)) are plotted versus H-b(r(c)) - V-b(r(c))/2 for the data of E-*-E' at bond critical points (BCPs) of fully optimized structures and perturbed structures around the fully optimized ones. Plots for the fully optimized structures are analyzed by the polar coordinate (R, ) representation. The ((p), (p)) parameters are derived from those of the perturbed structures: (p) corresponds to the tangent line of each plot, and (p) is the curvature. While (R, ) correspond to the static nature, ((p), (p)) represent the dynamic nature of interactions. The nature of E-*-E' in the neutral and charged species is classified by comparing their and (p) values with those of the standard interactions as a reference. Data for E-*-E' in the neutral forms of 1-3 appear in the shared-shell (SS) region (180 degrees < ), except for MeS-*-TeMe (2c), which does in the regular closed-shell (CS) region (90 degrees < < 180 degrees). The E-E' bonds in the monoanionic forms of 1-3 become much longer and weakened. Therefore, data of the monoanionic forms appear in the regular CS. On the other hand, the strengths of E-*-E' in the mono- and dicationic forms are almost equal to those in the neutral forms of 1-3 in the plots, irrespective of the shorter E-*-E' lengths in the cationic forms, relative to the neutral forms.	[Hayashi, Satoko; Matsuiwa, Kohei; Miza, Hiroaki; Nakanishi, Waro] Wakayama Univ, Fac Syst Engn, Dept Mat Sci & Chem, Wakayama 6408510, Japan	Nakanishi, W (reprint author), Wakayama Univ, Fac Syst Engn, Dept Mat Sci & Chem, 930 Sakaedani, Wakayama 6408510, Japan.	nakanisi@sys.wakayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [20550042, 21550046, 23350019]; Wakayama University Original Research Support Project Grant [2010001]; Wakayama University Graduate School Project Research Grant [2009002]	Contract grant sponsor: Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.; Contract grant numbers: 20550042, 21550046, and 23350019.; Contract grant sponsor: Wakayama University Original Research Support Project Grant.; Contract grant number: 2010001.; Contract grant sponsor: Wakayama University Graduate School Project Research Grant.; Contract grant number: 2009002.	Akiba K.-y., 1999, CHEMISTRY OF HYPERVA; Parthasarathi R, 2006, J PHYS CHEM A, V110, P3349, DOI 10.1021/jp060571z; Beleaga A, 2009, J ORGANOMET CHEM, V694, P1308, DOI 10.1016/j.jorganchem.2008.12.011; FUJIHARA H, 1991, TETRAHEDRON LETT, V32, P4345, DOI 10.1016/S0040-4039(00)92166-X; Bader RFW, 1998, J PHYS CHEM A, V102, P7314, DOI 10.1021/jp981794v; Biegler-Konig F, 2000, J COMPUT CHEM, V21, P1040, DOI 10.1002/1096-987X(200009)21:12<1040::AID-JCC2>3.0.CO;2-8; Nakanishi W, 2010, J PHYS CHEM A, V114, P7423, DOI 10.1021/jp104278j; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P269, DOI 10.1016/0022-1902(58)80004-4; TANG TH, 1985, INORG CHEM, V24, P2047, DOI 10.1021/ic00207a018; Grabowski SJ, 2005, J PHYS CHEM A, V109, P4331, DOI 10.1021/jp0444215; Nakanishi W, 2010, CURR ORG CHEM, V14, P181; MCGRATH MP, 1991, J CHEM PHYS, V94, P511, DOI 10.1063/1.460367; Koga T, 2002, THEOR CHEM ACC, V108, P41, DOI 10.1007/s00214-002-0354-x; Dobado JA, 2000, J AM CHEM SOC, V122, P1144, DOI 10.1021/ja992672z; Ignatov SK, 2004, CHEM-EUR J, V10, P4991, DOI 10.1002/chem.200400230; Wakamiya A, 2002, J AM CHEM SOC, V124, P15038, DOI 10.1021/ja028297j; Domagala M, 2005, J PHYS CHEM A, V109, P5683, DOI 10.1021/jp0511496; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; GAUSS J, 1993, J CHEM PHYS, V99, P3629, DOI 10.1063/1.466161; Nakanishi W, 2007, CHEM-EUR J, V13, P255, DOI 10.1002/chem.200600471; Grabowski SJ, 2001, J PHYS CHEM A, V105, P10739, DOI 10.1021/jp011819h; GLASS RS, 1989, J AM CHEM SOC, V111, P4036, DOI 10.1021/ja00193a041; Mundt O, 2006, Z ANORG ALLG CHEM, V632, P1687, DOI 10.1002/zaac.200600014; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P264, DOI 10.1016/0022-1902(58)80003-2; Sekiya M, 2001, THEOR CHEM ACC, V106, P297, DOI 10.1007/s002140100278; Panda A, 1999, ORGANOMETALLICS, V18, P1986, DOI 10.1021/om9808312; Hayashi S, 2013, J PHYS CHEM A, V117, P1804, DOI 10.1021/jp3098928; Nakanishi W, 2008, J PHYS CHEM A, V112, P13593, DOI 10.1021/jp8054763; Biegler-Konig F, 2002, J COMPUT CHEM, V23, P1489, DOI 10.1002/jcc.10085; Mukherjee AJ, 2010, CHEM REV, V110, P4357, DOI 10.1021/cr900352j; BIEGLERKONIG FW, 1982, J COMPUT CHEM, V3, P317, DOI 10.1002/jcc.540030306; Espinosa E, 2002, J CHEM PHYS, V117, P5529, DOI 10.1063/1.1501133; Rozas I, 2000, J AM CHEM SOC, V122, P11154, DOI 10.1021/ja0017864; Domagala M, 2003, J PHYS CHEM A, V107, P2730, DOI 10.1021/jp021520e; Molina JM, 2001, THEOR CHEM ACC, V105, P328, DOI 10.1007/s002140000231; CURTISS LA, 1995, J CHEM PHYS, V103, P6104, DOI 10.1063/1.470438; GLASS RS, 1991, J AM CHEM SOC, V113, P1065, DOI 10.1021/ja00004a001; Tripathi SK, 2005, J ORG CHEM, V70, P9237, DOI 10.1016/jo051309+; BINNING RC, 1990, J COMPUT CHEM, V11, P1206, DOI 10.1002/jcc.540111013; Morihashi K., 1997, THEOCHEM, V418, DOI 10.1016/S0166-1280(97)00171-1; BADER RFW, 1983, J AM CHEM SOC, V105, P5061, DOI 10.1021/ja00353a035; Biegler-Konig F, 2001, J COMPUT CHEM, V22, P545; BADER RFW, 1991, CHEM REV, V91, P893, DOI 10.1021/cr00005a013; Nakanishi W, 2012, B CHEM SOC JPN, V85, P1293, DOI 10.1246/bcsj.20110377; Nakanishi W, 2009, J PHYS CHEM A, V113, P10050, DOI 10.1021/jp903622a; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Nakanishi W, 2008, NEW J CHEM, V32, P1881, DOI 10.1039/b805678a; Back T. G., 1999, ORGANOSELENIUM CHEMI; Bader R. F. W., 1990, ATOMS IN MOLECULES A; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; BOYD RJ, 1986, CHEM PHYS LETT, V129, P62, DOI 10.1016/0009-2614(86)80169-5; CARROLL MT, 1988, MOL PHYS, V65, P695, DOI 10.1080/00268978800101351; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Fujihara H, 1996, CHEM COMMUN, P311, DOI 10.1039/cc9960000311; FUJIHARA H, 1992, CHEM LETT, P1437, DOI 10.1246/cl.1992.1437; FUJIHARA H, 1995, CHEM LETT, P571, DOI 10.1246/cl.1995.571; FURUKAWA N, 1994, CHEM LETT, P1007, DOI 10.1246/cl.1994.1007; GAUSS J, 1995, BER BUNSEN PHYS CHEM, V99, P1001; Hayashi S., 2011, INVITED PAPER ON THE; Klayman D. L., 1973, THEIR CHEMISTRY AND; Kulcsar M, 2007, DALTON T, P2187, DOI 10.1039/b702629c; Liotta D., 1987, ORGANIC SELENIUM CHE; MARTIN JC, 1974, J AM CHEM SOC, V96, P3319, DOI 10.1021/ja00817a053; Matta C. F., 2007, THE QUANTUM THEORY O; Mueller B, 2008, DALTON T, P4424, DOI 10.1039/b802259n; Mueller B, 2011, EUR J INORG CHEM, P4970, DOI 10.1002/ejic.201100620; Nakanishi W., 2006, HDB CHALCOGEN CHEM N, P644, DOI DOI 10.1039/9781847557575-00644; Nakanishi W., 2013, HANDBOOK OF CHALCOGE, V2, P335; Patai S., 1986, THE CHEMISTRY OF ORG, V1; Patai S., 1986, THE CHEMISTRY OF ORG, V1; Patai S., 1986, THE CHEMISTRY OF ORG, V2; POTTS KT, 1974, J ORG CHEM, V39, P3783, DOI 10.1021/jo00939a041; Wirth T., 2000, TOPICS IN CURRENT CH, V208	74	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		449	472		10.1002/hc.21194		24	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100021		
J	Muraoka, H; Watanabe, Y; Takahashi, A; Kamoto, H; Ogawa, S				Muraoka, Hiroki; Watanabe, Yudai; Takahashi, Aki; Kamoto, Hironobu; Ogawa, Satoshi			Synthesis of New Types of Ferrocene Dimers Bridged by a Fused Oligothiophene Spacer and Study of Their Electrochemical Oxidation Process via a Mixed-Valence State	HETEROATOM CHEMISTRY			English	Article							CUMULENE MOLECULAR WIRES; CHARGE-TRANSFER; ELECTRON-TRANSFER; OXIDIZED STATES; REDOX; SYSTEMS; BENZOCHALCOGENOPHENES; DELOCALIZATION; COMMUNICATION; THIOPHENES	We describe the synthesis and electrochemical oxidation properties of ferrocene dimers bridged by a fused oligothiophene spacer (thienothiophene, benzodithiophene, and dithienothiophene), which are designed as new types of ferrocene dimers for the study of the oxidation process via a mixed-valence state. The electrochemical properties of all ferrocene dimers were examined by a cyclic voltammetry technique. The voltammograms showed a reversible two-electron oxidation wave derived from the two ferrocene fragments with a potential difference between the first and second oxidation waves (E-1/2 = E-1/2(+1/+2) - E-1/2(0/+1)), which ranges from 0 to +127 mV. This result indicates that the chemical structure of the fused oligothiophene spacer can be attuned to the two-electron oxidation process of two ferrocene terminals via a mixed-valence state.	[Muraoka, Hiroki; Watanabe, Yudai; Takahashi, Aki; Kamoto, Hironobu; Ogawa, Satoshi] Iwate Univ, Fac Engn, Dept Chem & Bioengn, Morioka, Iwate 020, Japan	Ogawa, S (reprint author), Iwate Univ, Fac Engn, Dept Chem & Bioengn, 4-3-5 Ueda, Morioka, Iwate 020, Japan.	ogawa@iwate-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23550038]	Contract grant sponsor: Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.; Contract grant number: 23550038.	Jin BK, 2008, J ELECTROANAL CHEM, V624, P179, DOI 10.1016/j.jelechem.2008.09.006; Chawdhury N, 2004, J ORGANOMET CHEM, V689, P840, DOI 10.1016/j.jorganchem.2003.11.035; Hildebrandt A, 2011, INORG CHEM, V50, P10623, DOI 10.1021/ic200926z; Sundararaman A, 2006, J AM CHEM SOC, V128, P16554, DOI 10.1021/ja064396b; Li Y, 2010, J AM CHEM SOC, V132, P10374, DOI 10.1021/ja101585z; Adams RD, 2002, ORGANOMETALLICS, V21, P3867, DOI 10.1021/om020270l; Xu GL, 2006, ORGANOMETALLICS, V25, P5213, DOI 10.1021/om0607550; Ogawa S, 2007, J ORGANOMET CHEM, V692, P60, DOI 10.1016/j.jorganchem.2006.08.049; Zhu YB, 2000, J AM CHEM SOC, V122, P10121, DOI 10.1021/ja0008564; Barlow S, 1997, CHEM REV, V97, P637, DOI 10.1021/cr960083v; Lin YC, 2009, INORG CHEM, V48, P1857, DOI 10.1021/ic801271q; Mishra A, 2009, CHEM REV, V109, P1141, DOI 10.1021/cr8004229; Anthony JE, 2006, CHEM REV, V106, P5028, DOI 10.1021/cr050966z; Bildstein B, 2004, ORGANOMETALLICS, V23, P1825, DOI 10.1021/om034234d; Casado J, 2009, CHEM-EUR J, V15, P2548, DOI 10.1002/chem.200801589; Fichou D., 1999, HDB OLIGO POLYTHIOPH; Frisch M J, 2010, GAUSSIAN 09 REVISION; Iyoda M, 1997, CHEM LETT, P35, DOI 10.1246/cl.1997.35; LEVANDA C, 1976, J ORG CHEM, V41, P2700, DOI 10.1021/jo00878a008; Muraoka H, 2013, PURE APPL CHEM, V85, P777, DOI 10.1351/PAC-CON-12-06-14; Nishihara H, 2001, B CHEM SOC JPN, V74, P19, DOI 10.1246/bcsj.74.19; Nishihara H, 2002, ADV INORG CHEM, V53, P41, DOI 10.1016/S0898-8838(02)53003-8; Ogawa S, 2006, TETRAHEDRON LETT, V47, P2887, DOI 10.1016/j.tetlet.2006.02.122; Ribou AC, 1996, INORG CHEM, V35, P3735, DOI 10.1021/ic951376u; RICHARDSON DE, 1981, INORG CHEM, V20, P1278, DOI 10.1021/ic50218a062; Sato M, 2001, THIN SOLID FILMS, V393, P210, DOI 10.1016/S0040-6090(01)01071-9; Sato M, 2001, B CHEM SOC JPN, V74, P1737, DOI 10.1246/bcsj.74.1737; Sato M, 2009, CHEM LETT, V38, P924, DOI 10.1246/cl.2009.924; Sato MA, 2006, CHEM LETT, V35, P804, DOI 10.1246/cl.2006.804; Sato MA, 2007, SYNTHETIC MET, V157, P619, DOI 10.1016/j.synthmet.2007.06.011; Skibar W, 2004, ORGANOMETALLICS, V23, P1024, DOI 10.1021/om034233l; Thomas KRJ, 2000, ORGANOMETALLICS, V19, P1008	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		473	481		10.1002/hc.21156		9	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100022		
J	Sakae, M; Oshitani, S; Ibara, C; Natsuyama, M; Nokami, T; Itoh, T				Sakae, Mikei; Oshitani, Shun-suke; Ibara, Chie; Natsuyama, Machiko; Nokami, Toshiki; Itoh, Toshiyuki			Iron-Catalyzed Nazarov Reaction of Indole, Benzofuran, and Benzo[b] thiophene Derivatives	HETEROATOM CHEMISTRY			English	Article							SUBSTITUTED DIVINYL KETONES; LIQUID SOLVENT SYSTEM; IONIC LIQUIDS; ORGANIC-SYNTHESIS; CYCLIZATION; DESIGN; CYCLOISOMERIZATION; INTERMEDIATE; YUEHCHUKENE; ANALOGS	Nazarov cyclization of indole, benzofuran, and benzo[b]thiophene was accomplished in the presence of catalytic amounts of iron salts. The corresponding cyclization product was obtained for indole derivative in the presence of 5 mol% of Fe(ClO4)(3)Al2O3 using the CH2Cl2 solvent system. On the other hand, FeCl3 worked as the common catalyst for realizing cyclization of benzofuran and benzo[b]thiophene derivatives. Very strict combination of the catalyst with solvent was required: 1,2-dichloroethane was essential for the reaction of benzofuran, while this solvent gave a poor result for benzo[b]thiophene derivatives and CH2Cl2 solvent was the best solvent.	[Sakae, Mikei; Oshitani, Shun-suke; Ibara, Chie; Natsuyama, Machiko; Nokami, Toshiki; Itoh, Toshiyuki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Itoh, Toshiyuki] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan	Itoh, T (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan.	titoh@chem.tottori-u.ac.jp					Pellissier H, 2005, TETRAHEDRON, V61, P6479, DOI 10.1016/j.tet.2005.04.014; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Abe Y, 2012, IND ENG CHEM RES, V51, P9952, DOI 10.1021/ie202740u; Abe Y, 2010, GREEN CHEM, V12, P1976, DOI 10.1039/c0gc00151a; JONES TK, 1983, HELV CHIM ACTA, V66, P2377, DOI 10.1002/hlca.19830660802; Ranke J, 2007, CHEM REV, V107, P2183, DOI 10.1021/cr050942s; Vaidya T, 2011, CHEMCATCHEM, V3, P1531, DOI 10.1002/cctc.201100137; Ishikura M, 2000, HETEROCYCLES, V53, P2201; Frontier AJ, 2005, TETRAHEDRON, V61, P7577, DOI 10.1016/j.tet.2005.05.019; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Rueping M, 2007, ANGEW CHEM INT EDIT, V46, P2097, DOI 10.1002/anie.200604809; Correa A, 2008, CHEM SOC REV, V37, P1108, DOI 10.1039/b801794h; [Anonymous], 1994, ORG REACTIONS; JONES TK, 1983, HELV CHIM ACTA, V66, P2397, DOI 10.1002/hlca.19830660803; Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h; Bender JA, 1999, J AM CHEM SOC, V121, P7443, DOI 10.1021/ja991215f; KANG KT, 1992, TETRAHEDRON LETT, V33, P3495, DOI 10.1016/S0040-4039(00)92672-8; Malona JA, 2006, ORG LETT, V8, P5661, DOI 10.1021/ol062403v; Fujiwara M, 2009, ADV SYNTH CATAL, V351, P123, DOI 10.1002/adsc.200800702; Bender JA, 1998, J ORG CHEM, V63, P2430, DOI 10.1021/jo9803030; He W, 2003, J AM CHEM SOC, V125, P14278, DOI 10.1021/ja037910b; BERGMAN J, 1990, TETRAHEDRON, V46, P6067, DOI 10.1016/S0040-4020(01)87931-X; Blanchard P, 1997, J ORG CHEM, V62, P2401, DOI 10.1021/jo9623447; CHENG KF, 1991, J CHEM SOC PERK T 1, P2461, DOI 10.1039/p19910002461; Giese S, 2000, ANGEW CHEM INT EDIT, V39, P1970, DOI 10.1002/1521-3773(20000602)39:11<1970::AID-ANIE1970>3.0.CO;2-B; GRANT HG, 1978, J HETEROCYCLIC CHEM, V15, P1235; Hu HP, 1999, J AM CHEM SOC, V121, P9895, DOI 10.1021/ja992669f; Ibara C, 2012, SCI CHINA CHEM, V55, P1627, DOI 10.1007/s11426-012-4629-3; DENMARK SE, 1982, J AM CHEM SOC, V104, P2642, DOI 10.1021/ja00373a055; Kawatsura M, 2010, SYNLETT, P1243, DOI 10.1055/s-0029-1219782; Li ET, 2014, TETRAHEDRON, V70, P874, DOI 10.1016/j.tet.2013.12.025; MAFFRAND JP, 1981, J HETEROCYCLIC CHEM, V18, P727; Ohara H, 2001, CHEM LETT, P624; Sahan A. A., 2009, CHEM SOC REV, V38, P2730; SONG C, 2005, ORG LETT, V8, P163; Takagi Y, 2012, AUST J CHEM, V65, P1557, DOI 10.1071/CH12331; Tius MA, 2005, EUR J ORG CHEM, P2193, DOI 10.1002/ejoc.200500005; Uehara H, 2006, ELECTROCHEMISTRY, V74, P635; Wang Y, 1999, J AM CHEM SOC, V121, P876, DOI 10.1021/ja9837001; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE	40	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		482	491		10.1002/hc.21179		10	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100023		
J	Daicho, Y; Kano, N; Yukimoto, M; Minoura, M; Kawashima, T				Daicho, Yuya; Kano, Naokazu; Yukimoto, Mariko; Minoura, Mao; Kawashima, Takayuki			Synthesis, Structure, and Thermolysis of Tetracoordinated 1 lambda(4),2-Selenazetidines Bearing Two Chiral Centers at the 3-and 4-Positions	HETEROATOM CHEMISTRY			English	Article							4-MEMBERED HETEROCYCLIC-COMPOUNDS; COREY-CHAYKOVSKY REACTION; MAIN-GROUP ELEMENTS; ASYMMETRIC AZIRIDINATION; ORGANIC-SYNTHESIS; CRYSTAL-STRUCTURE; SULFUR YLIDES; PENTACOORDINATE; PETERSON; WITTIG	The title trans and cis isomers (trans-3 and cis-3) were successfully synthesized as stable compounds by taking advantage of the Martin ligand. The X-ray crystallographic analysis of trans-3 showed that it has a distorted pseudotrigonal bipyramidal structure, and that the two phenyl groups at the 3- and 4-positions are cis to each other. The thermolysis of trans-3 in the presence of excess dimethyl acetylenedicarboxylate (DMAD) gave a mixture of the corresponding aziridines (trans-7 and cis-7) and cycloadducts (11a and 11b) of the azomethine ylides formed by ring opening of the aziridines with DMAD. Heating of cis-7 and excess DMAD under the same conditions gave diastereomeric mixtures of both the aziridines and the cycloadducts, which means that the stereochemistry of the aziridine formation from the 1,2-selenazetidine cannot be determined in this system.	[Daicho, Yuya; Kano, Naokazu; Kawashima, Takayuki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Yukimoto, Mariko; Minoura, Mao] Rikkyo Univ, Dept Chem, Coll Sci, Toshima Ku, Tokyo 1718501, Japan	Kawashima, T (reprint author), Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma 3768515, Japan.	kawashima.t@gunma-u.ac.jp	Kano, Naokazu/E-7403-2010	Kano, Naokazu/0000-0002-7019-0378	Ministry of Education, Culture, Sports, Science and Technology of Japan [25109512, 25109541]; 21 Century and Global COE Programs	Contract grant sponsor: Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Contract grant numbers: 25109512 and 25109541.; Contract grant sponsor: The 21 Century and Global COE Programs.	Abid M, 2007, J FLUORINE CHEM, V128, P587, DOI 10.1016/j.jfluchem.2007.01.011; Ager D. J., 1990, ORG REACTIONS, V38, P1; AGER DJ, 1984, SYNTHESIS-STUTTGART, P384; DAVIS FA, 1982, J ORG CHEM, V47, P1774, DOI 10.1021/jo00348a039; PEROZZI EF, 1981, J ORG CHEM, V46, P1049, DOI 10.1021/jo00319a001; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; DAVIS FA, 1995, TETRAHEDRON-ASYMMETR, V6, P1511, DOI 10.1016/0957-4166(95)00185-R; Blazejewski JC, 1999, TETRAHEDRON LETT, V40, P5475, DOI 10.1016/S0040-4039(99)01004-7; Colvin E. W, 1981, SILICON ORGANIC SYNT, P141; Gosney I., 1979, ORGANOPHOSPHORUS REA, P17; GRANOTH I, 1979, J AM CHEM SOC, V101, P4618, DOI 10.1021/ja00510a029; GRANOTH I, 1981, J AM CHEM SOC, V103, P2711, DOI 10.1021/ja00400a037; HORTMANN AG, 1967, J AM CHEM SOC, V89, P5974, DOI 10.1021/ja00999a057; Huisgen T., 1969, ANGEW CHEM INT EDIT, V8, P604; Kano N, 2006, ORG LETT, V8, P4625, DOI 10.1021/ol0618499; Kano N., 2004, MODERN CARBONYL OLEF, P18; Kano N, 2001, ORG LETT, V3, P691, DOI 10.1021/ol007015m; KAUFFMANN T, 1980, TOP CURR CHEM, V92, P109; KAUFFMANN T, 1982, ANGEW CHEM INT EDIT, V21, P410, DOI 10.1002/anie.198204101; Kawashima T, 1996, J SYN ORG CHEM JPN, V54, P696; Kawashima T, 1996, ANGEW CHEM INT EDIT, V35, P1096, DOI 10.1002/anie.199610961; Kawashima T, 1996, SYNLETT, P600; Kawashima T, 2003, B CHEM SOC JPN, V76, P471; Kawashima T, 1996, J AM CHEM SOC, V118, P12455, DOI 10.1021/ja9629975; Kawashima T., 1999, ADV STRAINED INTERES, P1; Kawashima T, 1999, CHEMISTRY OF HYPERVALENT COMPOUNDS, P171; Kawashima T, 2003, COORDIN CHEM REV, V244, P137, DOI 10.1016/S0010-8545(03)00103-6; Kawashima T, 2000, J ORGANOMET CHEM, V611, P256, DOI 10.1016/S0022-328X(00)00491-5; KAWASHIMA T, 1993, J AM CHEM SOC, V115, P10434, DOI 10.1021/ja00075a099; Kusaka S, 2010, HETEROATOM CHEM, V21, P412, DOI 10.1002/hc.20630; Lown J. W., 1990, 1 3 DIPOLAR CYCLOADD, P269; MARTIN JC, 1983, SCIENCE, V221, P509, DOI 10.1126/science.221.4610.509; MARTIN JC, 1976, SCIENCE, V191, P154, DOI 10.1126/science.191.4223.154; Ohno F, 1996, J AM CHEM SOC, V118, P697, DOI 10.1021/ja953533u; Ohno F., 1997, J CHEM SOC CHEM COMM, P1671; Ohno F, 2001, CHEM COMMUN, P463, DOI 10.1039/b009789f; Pereyre M., 1987, TIN ORGANIC SYNTHESI, P176; Ruano JLG, 1996, TETRAHEDRON-ASYMMETR, V7, P3407; RUANO JLG, 1995, TETRAHEDRON LETT, V36, P295; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith D. J. H., 1979, COMPREHENSIVE ORGANI, V2, P1316; Uchiyama Y, 2006, J ORG CHEM, V71, P659, DOI 10.1021/jo0520700; Uchiyama Y, 2003, J AM CHEM SOC, V125, P13346, DOI 10.1021/ja037586k; Vedejs E., 1994, TOP STEREOCHEM, V20, P1; Yokoyama Y, 1997, TETRAHEDRON LETT, V38, P3443, DOI 10.1016/S0040-4039(97)00641-2	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	5			SI		492	499		10.1002/hc.21177		8	Chemistry, Multidisciplinary	Chemistry	AS9AE	WOS:000344535100024		
J	Kyushin, S; Saito, Y; Yoshimura, K; Horiuchi, H; Hiratsuka, H				Kyushin, Soichiro; Saito, Yuta; Yoshimura, Kimio; Horiuchi, Hiroaki; Hiratsuka, Hiroshi			Synthesis and Properties of 5,10,15,20-Tetrakis(4 '-trimethylsilylphenyl)chlorin	HETEROATOM CHEMISTRY			English	Article							PHOTODYNAMIC ACTIVITY; ELECTRONIC-PROPERTIES; TETRAPHENYLPORPHYRIN; FLUORESCENCE; SILYLATION; TRIMETHYLSILYL; CONFORMATION; ENHANCEMENT; DERIVATIVES; PORPHYRIN	5,10,15,20-Tetrakis(4 '-trimethylsilylphenyl) chlorin (2) was synthesized by the reduction of 5,10,15,20-tetrakis(4 '-trimethylsilylphenyl) porphyrin (1) with p-toluenesulfonyl hydrazide. The structure of 2 was analyzed by spectroscopic data and X-ray crystallography. In the UV-vis spectrum, the Soret and Q bands of 2 show slight bathochromic shifts compared with those of 5,10,15,20-tetraphenylchlorin (TPC) and have slightly larger molecular extinction coefficients than those of TPC. (C) 2014 Wiley Periodicals, Inc.	[Kyushin, Soichiro; Saito, Yuta; Yoshimura, Kimio; Horiuchi, Hiroaki; Hiratsuka, Hiroshi] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan	Kyushin, S (reprint author), Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan.	kyushin@gunma-u.ac.jp			Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C) of the Japan Science and Technology Agency	This work was supported in part by the Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C) of the Japan Science and Technology Agency.	SILVERS SJ, 1967, J AM CHEM SOC, V89, P3331, DOI 10.1021/ja00989a036; SAKURAI H, 1990, J PHYS CHEM-US, V94, P1837, DOI 10.1021/j100368a022; SHIZUKA H, 1984, J CHEM SOC FARAD T 1, V80, P383, DOI 10.1039/f19848000383; Di Stasio B, 2005, EUR J MED CHEM, V40, P1111, DOI 10.1016/j.ejmech.2005.04.007; Kyushin S, 1996, ORGANOMETALLICS, V15, P1067, DOI 10.1021/om950776m; Banfi S, 2004, BIOORGAN MED CHEM, V12, P4853, DOI 10.1016/j.bmc.2004.07.011; Fan KFM, 1997, INT J CANCER, V73, P25; Bonnett R., 1999, J CHEM SOC P2, V2, P325; Horiuchi H, 2006, CHEM LETT, V35, P662, DOI 10.1246/cl.2006.662; Horiuchi H, 2014, CHEM-EUR J, V20, P6054, DOI 10.1002/chem.201303120; Horiuchi H, 2011, J PHOTOCH PHOTOBIO A, V221, P98, DOI 10.1016/j.jphotochem.2011.04.032; Kakiage K, 2010, CHEM LETT, V39, P1063, DOI 10.1246/cl.2010.1063; Karatsu T, 2008, J PHOTOCH PHOTOBIO C, V9, P111, DOI 10.1016/j.jphotochemrev.2008.06.001; Karatsu T, 2003, J PHYS CHEM B, V107, P12184, DOI 10.1021/jp0355760; Kyushin S, 1998, CHEM LETT, P471, DOI 10.1246/cl.1998.471; Kyushin S, 2009, CHEM LETT, V38, P324, DOI 10.1246/cl.2009.324; Kyushin S, 2003, CHEM LETT, V32, P1048, DOI 10.1246/cl.2003.1048; Kyushin S, 2006, CHEM LETT, V35, P64, DOI 10.1246/cl.2006.64; Maeda H, 2001, CHEM LETT, P1224; Otsuka K, 2012, CHEM LETT, V41, P307, DOI 10.1246/cl.2012.307; Sheldrick G.M., 1986, SHELXS86 PROGRAM CRY; Shimizu M, 2006, CHEM LETT, V35, P1022, DOI 10.1246/cl.2006.1022; teXsan, 1985, TEXSAN CRYST STRUCT; Toma Y, 2013, CHEM LETT, V42, P250, DOI 10.1246/cl.2013.250; Vollhardt K. P. C., 1999, ORGANIC CHEM STRUCTU; Ye BH, 2003, TETRAHEDRON, V59, P3593, DOI 10.1016/S0040-4020(03)00541-6	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		514	517		10.1002/hc.21232		4	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000002		
J	Shiro, D; Nagai, H; Fujiwara, S; Tsuda, S; Iwasaki, T; Kuniyasu, H; Kambe, N				Shiro, Daisuke; Nagai, Hiroyuki; Fujiwara, Shin-ichi; Tsuda, Susumu; Iwasaki, Takanori; Kuniyasu, Hitoshi; Kambe, Nobuaki			Palladium-Catalyzed Decarbonylative Rearrangement of N-Allenyl Seleno- and Tellurocarbamates	HETEROATOM CHEMISTRY			English	Article							ALKYNES; CYCLOADDITION; PHTHALIMIDES; BONDS; ANHYDRIDES; 1,3-DIENES; COMPLEXES; ADDITIONS	Decarbonylative rearrangement of seleno- and tellurocarbamates carrying an allenyl group on the nitrogen was found to proceed in the presence of a palladium catalyst to afford 3-chalcogeno1- azadienes. This transformation may involve oxidative addition of Pd to a carbon-chalcogen bond, decarbonylation from a carbamoylpalladium unit (R2N-C(O)-PdChPh: Ch = Se or Te), Pd shift, and reductive elimination. (C) 2014 Wiley Periodicals, Inc.	[Shiro, Daisuke; Nagai, Hiroyuki; Iwasaki, Takanori; Kuniyasu, Hitoshi; Kambe, Nobuaki] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Fujiwara, Shin-ichi; Tsuda, Susumu] Osaka Dent Univ, Dept Chem, Osaka 5731121, Japan	Kambe, N (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kambe@chem.eng.osaka-u.ac.jp			JSPS Japanese-German Graduate Externship Program on "Environmentally Benign Bio- and Chemical Processes"	Daisuke Shiro expresses his special thanks to the JSPS Japanese-German Graduate Externship Program on "Environmentally Benign Bio- and Chemical Processes" for financial support of the stay in RWTH, Aachen, Germany.	Kondo T, 2000, CHEM REV, V100, P3205, DOI 10.1021/cr9902749; Sugoh K, 2001, J AM CHEM SOC, V123, P5108, DOI 10.1021/ja010261o; Birkholz MN, 2009, CHEM SOC REV, V38, P1099, DOI 10.1039/b806211k; Alonso F, 2004, CHEM REV, V104, P3079, DOI 10.1021/cr0201068; Pattison G, 2010, J AM CHEM SOC, V132, P14373, DOI 10.1021/ja106809p; Ogawa A, 2000, J ORGANOMET CHEM, V611, P463, DOI 10.1016/S0022-328X(00)00469-1; Dermenci A, 2013, SCI CHINA CHEM, V56, P685, DOI 10.1007/s11426-012-4791-7; Kajita Y, 2008, J AM CHEM SOC, V130, P17226, DOI 10.1021/ja806569h; Toyofuku M, 2008, ORG LETT, V10, P3957, DOI 10.1021/ol801329q; Beletskaya I, 2006, CHEM REV, V106, P2320, DOI 10.1021/cr050530j; Fujiwara K, 2010, ORG LETT, V12, P4548, DOI 10.1021/ol101842y; Suginome M, 2000, CHEM REV, V100, P3221, DOI 10.1021/cr9902805; ODONNELL MJ, 1990, TETRAHEDRON LETT, V31, P5135, DOI 10.1016/S0040-4039(00)97824-9; Toyofuku M, 2005, J AM CHEM SOC, V127, P9706, DOI 10.1021/ja052175k; Havlik SE, 2011, J ORG CHEM, V76, P3588, DOI 10.1021/jo200347j; Fujiwara K, 2011, CHEM LETT, V40, P322, DOI 10.1246/cl.2011.322; Ochi Y, 2011, ORG LETT, V13, P1374, DOI 10.1021/ol200044y; Fujiwara S, 2010, PURE APPL CHEM, V82, P565, DOI 10.1351/PAC-CON-09-11-13; Maizuru N, 2011, ORG LETT, V13, P1206, DOI 10.1021/ol200090g; Hua R, 2001, J AM CHEM SOC, V123, P2899, DOI 10.1021/ja004063t; Kajita Y, 2008, J AM CHEM SOC, V130, P6058, DOI 10.1021/ja7114426; Yamashita F, 2008, ORG LETT, V10, P101, DOI 10.1021/ol7025069; CHOI N, 1991, TETRAHEDRON LETT, V32, P4573, DOI 10.1016/0040-4039(91)80042-5; Colquhoun H. M., 1991, CARBONYLATION; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Haynes W. M., 2012, CRC HDB CHEM PHYS, P9; Hirai T, 2005, SYNLETT, P1161, DOI 10.1055/s-2005-865232; Hirai T, 2004, CHEM LETT, V33, P1148, DOI 10.1246/cl.2004.1148; Hirai T, 2003, ORG LETT, V5, P3871, DOI 10.1021/ol03545223; Inami T, 2011, CHEM COMMUN, V47, P9711, DOI 10.1039/c1cc13540f; Inami T, 2011, ORG LETT, V13, P1912, DOI 10.1021/ol200336c; Kuniyasu H., 2002, CHEM-EUR J, V8, P2660, DOI 10.1002/1521-3765(20020617)8:12<2660::AID-CHEM2660>3.0.CO;2-Q; Murai M, 2009, CHEM COMMUN, P3466, DOI 10.1039/b904127c; Nakao Y, 2006, ANGEW CHEM INT EDIT, V45, P2271, DOI 10.1002/anie.200504283; Toyofuku M, 2008, J AM CHEM SOC, V130, P10504, DOI 10.1021/ja804121j	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		518	524		10.1002/hc.21217		7	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000003		
J	Unno, M; Endo, H; Takeda, N				Unno, Masafumi; Endo, Hisayuki; Takeda, Nobuhiro			Synthesis and Structures of Extended Cyclic Siloxanes	HETEROATOM CHEMISTRY			English	Article							ANION RECOGNITION; ORGANIC-SOLVENTS; ALUMINA MEMBRANE; DI(1-NAPHTHYL)SILANEDIOL; ALKOXYSILYLAZOBENZENES; LADDERSILOXANES; SILANOL; LADDER; DYES	The facile synthesis of all-cis-tetrasiloxycyclotetrasiloxanes (extended cyclic siloxanes) [i-BuSi(OSiHMe2)O](4) 1, [PhSi(OSiHMe2)O](4) 2, and [CH2 = CHSi(OSiHMe2)O](4) 3 was accomplished via sodium or potassium silanolates from respective trialkoxysilanes. The treatment of 1 or 2 with m-chloroperoxybenzoic acid afforded respective extended cyclic silanols [i-BuSi(OSiMe2OH)O](4) 4 and [PhSi(OSiMe2OH)O](4) 5. The structures of 4 and 5 were unequivocally established by X-ray crystallography. Among these new compounds, compound 3 possesses both vinyl and hydrosilyl groups in the molecule, thus this could serve as a potential monomer of well-defined cage silsesquioxanes. Extended cyclic silanols 4 and 5 contain four silanol moieties in the same direction, and application of host molecules or building units of cage silsesquioxanes is expected. (C) 2014 Wiley Periodicals, Inc.	[Unno, Masafumi] Gunma Univ, Dept Chem & Chem Biol, Fac Sci & Technol, Kiryu, Gunma 3768515, Japan; Gunma Univ, Int Educ & Res Ctr Silicon Sci, Fac Sci & Technol, Kiryu, Gunma 3768515, Japan	Unno, M (reprint author), Gunma Univ, Dept Chem & Chem Biol, Fac Sci & Technol, Kiryu, Gunma 3768515, Japan.	unno@gunma-u.ac.jp					Tran NT, 2012, ORG LETT, V14, P186, DOI 10.1021/ol202971m; Shchegolikhina OI, 2002, INORG CHEM, V41, P6892, DOI 10.1021/ic020546h; Unno M, 2002, J AM CHEM SOC, V124, P1574, DOI 10.1021/ja0173876; Unno M, 2000, B CHEM SOC JPN, V73, P215, DOI 10.1246/bcsj.73.215; Shchegolikhina O, 2000, ORGANOMETALLICS, V19, P1077, DOI 10.1021/om9909284; Kondo S, 2009, TETRAHEDRON LETT, V50, P2754, DOI 10.1016/j.tetlet.2009.03.134; Kakiage K, 2010, CHEM LETT, V39, P260, DOI 10.1246/cl.2010.260; Kondo SI, 2007, TETRAHEDRON LETT, V48, P7946, DOI 10.1016/j.tetlet.2007.09.067; Unno M, 2007, J ORGANOMET CHEM, V692, P307, DOI 10.1016/j.jorganchem.2006.08.068; Unno M, 2005, J AM CHEM SOC, V127, P2256, DOI 10.1021/ja043894m; Kondo S, 2006, ORG LETT, V8, P4621, DOI 10.1021/ol061855p; Chang S, 2010, APPL ORGANOMET CHEM, V24, P241, DOI 10.1002/aoc.1607; Ito R, 2009, CHEM LETT, V38, P364, DOI 10.1246/cl.2009.364; Hirotsu M, 2005, CHEM LETT, V34, P1542, DOI 10.1246/cl.2005.1542; HOSSAIN MA, 1988, ACTA CRYSTALLOGR C, V44, P1318, DOI 10.1107/S0108270188002276; Kakiage K, 2011, APPL ORGANOMET CHEM, V25, P98, DOI 10.1002/aoc.1722; Kakiage K., 2008, SILICON CHEM, V3, P303; Kakiage K, 2009, SILICON-NETH, V1, P191, DOI 10.1007/s12633-009-9027-x; Kakiage K, 2010, APPL ORGANOMET CHEM, V24, P198, DOI 10.1002/aoc.1586; Lickiss P. D., 1995, ADV INORG CHEM, V42, P147; Lickiss P. D., 2001, CHEM ORGANIC SILICON, V3; Shchegolikhina OI, 2007, RUSS CHEM B+, V56, P83, DOI 10.1007/s11172-007-0014-3; Sheldrick G. M., 1997, SHELXS 97; Unno M, 2010, APPL ORGANOMET CHEM, V24, P247, DOI 10.1002/aoc.1612; Unno M, 2012, INT J POLYM SCI, DOI 10.1155/2012/723892; Unno M, 2000, CHEM LETT, P242; Unno M, 1998, CHEM LETT, P489, DOI 10.1246/cl.1998.489	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		525	532		10.1002/hc.21198		8	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000004		
J	Matano, Y; Hayashi, Y; Nakano, H; Imahori, H				Matano, Yoshihiro; Hayashi, Yukiko; Nakano, Haruyuki; Imahori, Hiroshi			N,S,P-Hybrid Donor-pi-Acceptor Organic Dyes for Dye-Sensitized Solar Cell: Synthesis, Optical Properties, and Photovoltaic Performances	HETEROATOM CHEMISTRY			English	Article							MOLECULAR-ORBITAL METHODS; CROSS-COUPLING REACTIONS; GAUSSIAN-TYPE BASIS; ELECTROCHEMICAL PROPERTIES; CONJUGATED SYSTEMS; CONVENIENT METHOD; ENERGY-LEVELS; TIO2 FILMS; BASIS-SETS; PHOSPHOLE	New donor-pi-acceptor organic (D-pi-A) dyes composed of triarylamine, oligothiophene, and phosphole subunits were prepared, and their optical and photovoltaic properties were investigated. The regioselective alpha-lithiation of the thiophene ring of 2-(thiophen-2-yl) phospholes bearing an ester group, followed by treatment with tributyltin chloride afforded 2-(5-(tributylstannyl) thiophen-2-yl) phosphole derivatives, which underwent Stille coupling with 5'-( p-(diarylamino) phenyl)-5-bromo-2,2'-bithiophene to give triarylamine-terthiophene-phosphole hybrid pi systems bearing the terminal ester group. The alkaline hydrolysis of the ester group yielded the target dyes, bearing the carboxylic acid anchoring group. The UV-vis absorption spectra of the new N, S, P-hybrid dyes displayed broad and intense pi-pi* transitions with two absorptionmaxima in the visible region. Density functional theory (DFT) calculations of two dye models revealed that each highest occupied molecular orbital (HOMO) resides on the triarylamine-oligothiophene p network, whereas each lowest unoccupied molecular orbital (LUMO) is basically located on the phosphole subunit. In addition, the time-dependent DFT calculations of the models showed that the lowest energy bands of these hybrid dyes are mainly consisted of the HOMO-to-LUMO+ 1 and HOMO-to-LUMO transitions with the large intramolecular charge-transfer character. The N, S, P-hybrid-dye-sensitized TiO2 cells exhibitedmoderate power conversion efficiencies of up to 5.6%. The present findings corroborate the potential utility of the phosphole skeletons as the acceptor components in the D-pi-A sensitizers. (C) 2014 Wiley Periodicals, Inc.	[Matano, Yoshihiro] Niigata Univ, Dept Chem, Fac Sci, Niigata 9502181, Japan; [Hayashi, Yukiko; Imahori, Hiroshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Nakano, Haruyuki] Kyushu Univ, Grad Sch Sci, Dept Chem, Fukuoka 8128581, Japan; [Imahori, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6158510, Japan	Matano, Y (reprint author), Niigata Univ, Dept Chem, Fac Sci, Niigata 9502181, Japan.	matano@chem.sc.niigata-u.ac.jp	Imahori, Hiroshi/B-5574-2013	Imahori, Hiroshi/0000-0003-3506-5608	Ministry of Education, Culture, Sports, Science and Technology, Japan [25288020]; Ogasawara Foundation	Contract grant sponsor: Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Contract grant number: 25288020. Contract grant sponsor: Ogasawara Foundation.	Kim S, 2006, J AM CHEM SOC, V128, P16701, DOI 10.1021/ja066376f; Hissler M, 2003, COORDIN CHEM REV, V244, P1, DOI 10.1016/S0010-8545(03)00098-5; Wang P, 2003, NAT MATER, V2, P402, DOI 10.1038/nmat904; Kurotobi K, 2013, CHEM-EUR J, V19, P17075, DOI 10.1002/chem.201303460; Hissler M, 2005, TOP CURR CHEM, V250, P127, DOI 10.1007/b100984; Ren XM, 2012, CHEM MATER, V24, P3493, DOI 10.1021/cm302250y; Robson KCD, 2012, DALTON T, V41, P7814, DOI 10.1039/c2dt30825h; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Clifford JN, 2012, J MATER CHEM, V22, P24195, DOI [10.1039/c2jm34289, 10.1039/c2jm34289h]; Li LL, 2013, CHEM SOC REV, V42, P291, DOI 10.1039/c2cs35257e; Ye S, 2013, J PHYS CHEM C, V117, P6066, DOI 10.1021/jp400336r; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Hagberg DP, 2007, J ORG CHEM, V72, P9550, DOI 10.1021/jo701592x; Matano Y, 2014, EUR J INORG CHEM, V2014, P1620, DOI 10.1002/ejic.201301132; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Tawada Y, 2004, J CHEM PHYS, V120, P8425, DOI 10.1063/1.1688752; Imahori H, 2011, J PHYS CHEM A, V115, P3679, DOI 10.1021/jp103747t; Matano Y, 2009, ORG BIOMOL CHEM, V7, P1258, DOI 10.1039/b819255n; Mishra A, 2009, ANGEW CHEM INT EDIT, V48, P2474, DOI 10.1002/anie.200804709; Wu YZ, 2013, CHEM SOC REV, V42, P2039, DOI 10.1039/c2cs35346f; Liang M, 2013, CHEM SOC REV, V42, P3453, DOI 10.1039/c3cs35372a; Wang ZS, 2008, CHEM MATER, V20, P3993, DOI 10.1021/cm8003276; Matano Y, 2010, CR CHIM, V13, P1035, DOI 10.1016/j.crci.2010.03.017; Imahori H, 2012, CHEM COMMUN, V48, P4032, DOI 10.1039/c2cc30621b; Yum JH, 2009, ANGEW CHEM INT EDIT, V48, P1576, DOI 10.1002/anie.200804719; Ren Y, 2012, DALTON T, V41, P7792, DOI 10.1039/c2dt00024e; Ning ZJ, 2010, ENERG ENVIRON SCI, V3, P1170, DOI 10.1039/c003841e; Bozic-Weber B, 2013, COORDIN CHEM REV, V257, P3089, DOI 10.1016/j.ccr.2013.05.019; Haid S, 2012, ADV FUNCT MATER, V22, P1291, DOI 10.1002/adfm.201102519; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Clifford JN, 2004, J AM CHEM SOC, V126, P5225, DOI 10.1021/ja039924n; Matano Y, 2011, ANGEW CHEM INT EDIT, V50, P8016, DOI 10.1002/anie.201102782; Zeng WD, 2010, CHEM MATER, V22, P1915, DOI 10.1021/cm9036988; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Matano Y, 2013, ORG LETT, V15, P932, DOI 10.1021/ol4000982; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; Yin JF, 2012, COORDIN CHEM REV, V256, P3008, DOI 10.1016/j.ccr.2012.06.022; Saito A, 2010, ORG LETT, V12, P2675, DOI 10.1021/ol100926q; Koumura N, 2009, J MATER CHEM, V19, P4829, DOI 10.1039/b905831a; Matano Y, 2013, ORG LETT, V15, P4458, DOI 10.1021/ol401994e; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; Hayashi Y, 2012, CHEM-EUR J, V18, P15972, DOI 10.1002/chem.201203047; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; Hara K, 2003, J PHYS CHEM B, V107, P597, DOI 10.1021/jp026963x; Listorti A, 2011, CHEM MATER, V23, P3381, DOI 10.1021/cm200651e; Imahori H, 2010, J PHYS CHEM C, V114, P10656, DOI 10.1021/jp102486b; Tsuji H, 2009, J MATER CHEM, V19, P3364, DOI 10.1039/b906197e; Islam A, 2003, J PHOTOCH PHOTOBIO A, V158, P131, DOI 10.1016/S1010-6030(03)00027-3; Hardin BE, 2012, NAT PHOTONICS, V6, P162, DOI [10.1038/nphoton.2012.22, 10.1038/NPHOTON.2012.22]; Koumura N, 2006, J AM CHEM SOC, V128, P14256, DOI 10.1021/ja0645640; Ahmad S, 2013, ENERG ENVIRON SCI, V6, P3439, DOI 10.1039/c3ee41888j; Ooyama Y, 2009, EUR J ORG CHEM, P2903, DOI 10.1002/ejoc.200900236; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Ooyama Y, 2012, CHEMPHYSCHEM, V13, P4032, DOI 10.1002/cphc.201200218; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Hobbs MG, 2007, EUR J INORG CHEM, P3611, DOI 10.1002/ejic.200700236; Baumgartner T, 2007, CHEM REV, V107, P303, DOI 10.1021/cr068047b; Cances M. T., 1997, J CHEM PHYS, V107, P3032, DOI DOI 10.1063/1.474659; Chen F, 2011, CHEM LETT, V40, P978, DOI 10.1246/cl.2011.978; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Frisch M J, 2010, GAUSSIAN 09 REVISION; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hissler M, 2008, CR CHIM, V11, P628, DOI 10.1016/j.crci.2008.01.010; Joly D., 2013, SCI REP, V4, P4033; Kira A, 2010, CHEM LETT, V39, P448, DOI 10.1246/cl.2010.448; Matano Y, 2011, HETEROATOM CHEM, V22, P457, DOI 10.1002/hc.20708; Matano Y, 2007, J ORG CHEM, V72, P6200, DOI 10.1021/jo070822f; Matano Y, 2011, CHEM LETT, V40, P919, DOI 10.1246/cl.2011.919; Matano Y., 2011, J SYNTH ORG CHEM JPN, V70, P629; Matano Y, 2006, J ORG CHEM, V71, P5792, DOI 10.1021/jo0605748; Matano Y, 2009, ANGEW CHEM INT EDIT, V48, P4002, DOI 10.1002/anie.200900542; Matano Y, 2009, ORG LETT, V11, P3338, DOI 10.1021/ol901194m; Mathey F, 2003, ANGEW CHEM INT EDIT, V42, P1578, DOI 10.1002/anie.200200557; Nazeeruddin M. K, 2004, COORDIN CHEM REV, P248; Nyulaszi L, 2009, TOP HETEROCYCL CHEM, V19, P27, DOI 10.1007/7081_2008_6; Reau R., 2008, COMPREHENSIVE HETERO, P1029; Reynal A, 2011, EUR J INORG CHEM, P4509, DOI 10.1002/ejic.201100516; Sato F, 2000, CHEM REV, V100, P2835, DOI 10.1021/cr9902771; Sato F, 1999, PURE APPL CHEM, V71, P1511, DOI 10.1351/pac199971081511; Yin Q. S., 2012, SCI CHINA CHEM, V55, P677; Zhang GL, 2009, CHEM COMMUN, P2198, DOI 10.1039/b822325d	85	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		533	547		10.1002/hc.21188		15	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000005		
J	Saito, M; Osaka, I; Koganezawa, T; Takimiya, K				Saito, Masahiko; Osaka, Itaru; Koganezawa, Tomoyuki; Takimiya, Kazuo			Effect of Oxygen-Containing Functional Side Chains on the Electronic Properties and Photovoltaic Performances in a Thiophene-Thiazolothiazole Copolymer System	HETEROATOM CHEMISTRY			English	Article							POLYMER SOLAR-CELLS; POWER CONVERSION EFFICIENCY; THIAZOLE; SEMICONDUCTORS; ORIENTATION; NETWORK	We report the synthesis and characterization of new thiazolothiazole-based semiconducting polymers with alkoxy and/or ester groups as the side chain. An introduction of the alkoxy groups raised the HOMO energy level of the polymers, whereas the introduction of the ester groups lowered the LUMO energy level. It is found that, interestingly, in the monomers the electronic effect of the ester group was more significant than that of the alkoxy groups, whereas in the polymers the effect of the alkoxy group was more significant. PTzBT-oBOeHD with both the alkoxy and ester groups gave the most redshifted absorption spectrum compared to the polymers with the alkyl and alkoxy groups (PTzBT-oBOHD) and with the alkyl and ester groups (PTzBT-BOeHD). Solar cells using PTzBT-oBOeHD gave the highest power conversion efficiencies of up to 4.5% with the highest short-circuit current density (J(SC)) of 10.9 mA/cm(2) among those with the newly synthesized polymers. (C) 2014 Wiley Pe-riodicals, Inc.	[Saito, Masahiko; Osaka, Itaru; Takimiya, Kazuo] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Hiroshima 7398527, Japan; [Osaka, Itaru; Takimiya, Kazuo] RIKEN Ctr Emergent Matter Sci, Emergent Mol Funct Res Grp, Wako, Saitama 3510198, Japan; [Koganezawa, Tomoyuki] Japan Synchrotron Radiat Res Inst, Tatsunocho, Hyogo 6795198, Japan	Osaka, I (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Hiroshima 7398527, Japan.	itaru.osaka@riken.jp	Takimiya, Kazuo/A-5841-2010; Osaka, Itaru/B-3153-2010	Takimiya, Kazuo/0000-0002-6001-1129; 			Hou JH, 2008, J AM CHEM SOC, V130, P16144, DOI 10.1021/ja806687u; Huo LJ, 2011, ANGEW CHEM INT EDIT, V50, P9697, DOI 10.1002/anie.201103313; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Jung IH, 2010, CHEM-EUR J, V16, P3743, DOI 10.1002/chem.200903064; Price SC, 2011, J AM CHEM SOC, V133, P4625, DOI 10.1021/ja1112595; Osaka I, 2009, J AM CHEM SOC, V131, P2521, DOI 10.1021/ja801475h; Zhang MJ, 2011, ADV ENERGY MATER, V1, P557, DOI 10.1002/aenm.201100193; Osaka I, 2014, ADV MATER, V26, P331, DOI 10.1002/adma.201303059; Huo LJ, 2011, MACROMOLECULES, V44, P4035, DOI 10.1021/ma200743b; Subramaniyan S, 2012, MACROMOLECULES, V45, P9029, DOI 10.1021/ma301660j; Helgesen M, 2011, POLYM CHEM-UK, V2, P2536, DOI 10.1039/c1py00323b; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Chu TY, 2011, J AM CHEM SOC, V133, P4250, DOI 10.1021/ja200314m; Lee SK, 2011, CHEM COMMUN, V47, P1791, DOI 10.1039/c0cc03036h; Chen HC, 2012, CHEM MATER, V24, P4766, DOI 10.1021/cm302861s; Shi QQ, 2010, J PHYS CHEM C, V114, P16843, DOI 10.1021/jp106319x; Chen HY, 2009, NAT PHOTONICS, V3, P649, DOI 10.1038/NPHOTON.2009.192; Muhlbacher D, 2006, ADV MATER, V18, P2884, DOI 10.1002/adma.200600160; Zhang MJ, 2011, CHEM MATER, V23, P4264, DOI 10.1021/cm2019586; Subramaniyan S, 2011, ADV ENERGY MATER, V1, P854, DOI 10.1002/aenm.201100215; Osaka I, 2010, CHEM MATER, V22, P4191, DOI 10.1021/cm101052b; Lin YZ, 2012, ADV MATER, V24, P3087, DOI 10.1002/adma.201200721; Osaka I, 2013, J AM CHEM SOC, V135, P8834, DOI 10.1021/ja404064m; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Osaka I, 2012, ADV MATER, V24, P425, DOI 10.1002/adma.201103065; Yang MA, 2010, J PHYS CHEM C, V114, P17989, DOI 10.1021/jp1063885; Hai JF, 2013, POLYMER, V54, P4930, DOI 10.1016/j.polymer.2013.07.001; Osaka I., 2007, ADV MATER, V19, P41560; Peet J., 2011, APPL PHYS LETT, V98; Li YF, 2012, ACCOUNTS CHEM RES, V45, P723, DOI 10.1021/ar2002446; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		556	564		10.1002/hc.21196		9	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000007		
J	Honda, M; Nakamura, T; Sumigawa, T; Kunimoto, KK; Segi, M				Honda, Mitsunori; Nakamura, Takayoshi; Sumigawa, Takumi; Kunimoto, Ko-Ki; Segi, Masahito			Stereoselective Synthesis of 1,2,3-Triol Derivatives from alpha,beta-Unsaturated Acylsilanes	HETEROATOM CHEMISTRY			English	Article							SILYL ENOL ETHERS; ALLYLIC ALCOHOLS; STEREOSPECIFIC SYNTHESIS; REGIOSELECTIVE SYNTHESIS; BETA-ALKOXYACYLSILANES; BROOK REARRANGEMENT; CHIRAL ACYLSILANES; ORGANIC-SYNTHESIS; EPOXIDATION; CONSTRUCTION	The stereoselective synthesis of 1,2,3-triol derivatives having contiguous stereogenic centers from alpha,beta-unsaturated acylsilanes 1 was described. The oxidation of an olefin moiety of 1 with osmium tetroxide proceeded smoothly to give the corresponding 2,3-syn-dihydroxyacylsilanes 2. The protection of two hydroxy groups of 2 followed by a nucleophilic reaction to the silyl carbonyl group gave the corresponding silylated triol derivatives (7 and 8) with high stereoselectivity, depending on the kind of nucleophilic reagents. The deprotection for 7 and 8 and the following protodesilylation gave two isomers of possible four 1,2,3-triol derivatives. The stereoselective triol synthesis by asymmetric diolization of alpha-silylated allyl alcohols 11 derived by nucleophilic addition to 1 was also investigated. (C) 2014 Wiley Periodicals, Inc.	[Honda, Mitsunori; Nakamura, Takayoshi; Sumigawa, Takumi; Kunimoto, Ko-Ki; Segi, Masahito] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan	Honda, M (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan.	honda@se.kanazawa-u.ac.jp; segi@se.kanazawa-u.ac.jp	Kunimoto, Ko-Ki/J-8390-2015				Alp C, 2009, SYNLETT, P2765, DOI 10.1055/s-0029-1217965; Francais A, 2008, TETRAHEDRON, V64, P2495, DOI 10.1016/j.tet.2007.11.068; Honda M, 2005, TETRAHEDRON LETT, V46, P7345, DOI 10.1016/j.tetlet.2005.08.117; Page PCB, 1998, CHEM FUNCT, V2, P1599, DOI 10.1002/0470857250.ch27; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; IMAMOTO T, 1984, TETRAHEDRON LETT, V25, P4233, DOI 10.1016/S0040-4039(01)81404-0; Bonini BF, 2000, SYNLETT, P1688; Bonini BF, 1998, J ORGANOMET CHEM, V567, P181, DOI 10.1016/S0022-328X(98)00694-9; Brook M. A., 2000, SILICON ORGANIC ORGA; Cirillo P. F., 1992, ORG PREP P INT, V24, P553; Daignault R. A., 1973, ORG SYNTH, VV, P303; Donohoe T. J., 2000, OXIDATION REDUCTION; Dunlap N. K., 2007, J ORG CHEM, V73, P2928; ENDA J, 1985, J AM CHEM SOC, V107, P5495, DOI 10.1021/ja00305a028; Fassler J, 1999, HELV CHIM ACTA, V82, P561, DOI 10.1002/(SICI)1522-2675(19990407)82:4<561::AID-HLCA561>3.0.CO;2-U; Fujino A, 2007, TETRAHEDRON LETT, V48, P979, DOI 10.1016/j.tetlet.2006.12.011; FUJISAWA T, 1990, B CHEM SOC JPN, V63, P1894, DOI 10.1246/bcsj.63.1894; Honda M, 2005, CHEM LETT, V34, P1432, DOI 10.1246/cl.2005.1432; Honda M., 2005, CHEM LETT, P466; Honda M, 2003, TETRAHEDRON, V59, P8203, DOI 10.1016/j.tet.2003.08.050; Honda M, 2005, TETRAHEDRON LETT, V46, P6465, DOI 10.1016/j.tetlet.2005.07.092; Honda M, 2002, TETRAHEDRON, V58, P6815, DOI 10.1016/S0040-4020(02)00787-1; Honda M, 2011, TETRAHEDRON LETT, V52, P3740, DOI 10.1016/j.tetlet.2011.05.041; Honda M, 2010, J SYN ORG CHEM JPN, V68, P601; Honda M, 2006, TETRAHEDRON LETT, V47, P5751, DOI 10.1016/j.tetlet.2006.06.002; Huber P, 1996, TETRAHEDRON-ASYMMETR, V7, P69, DOI 10.1016/0957-4166(95)00422-X; Johnson R. A., 1993, CATALYTIC ASYMMETRIC, P103; Johnson R. A., 1991, COMPREHENSIVE ORGANI, V7, P389; Hashimoto N, 2002, ORG PROCESS RES DEV, V6, P405, DOI 10.1021/op025511f; KATO M, 1984, J AM CHEM SOC, V106, P1773, DOI 10.1021/ja00318a036; Katsuki T., 1996, ORG REACTIONS, V48, P1; Mash E. A., 1993, ORG SYNTH, VVIII, P155; Mukerjee P, 2010, ORG LETT, V12, P3986, DOI 10.1021/ol1015306; NAKADA M, 1994, TETRAHEDRON LETT, V35, P741, DOI 10.1016/S0040-4039(00)75805-9; NAKADA M, 1988, J AM CHEM SOC, V110, P4826, DOI 10.1021/ja00222a050; OGATA Y, 1964, TETRAHEDRON, V20, P2065, DOI 10.1016/S0040-4020(01)98478-9; Page P. C. B., 2001, SCI SYNTHESIS HOUBEN, V4, P513; Qi H., 1995, COMPREHENSIVE ORGANI, V5, P409; Sasaki M, 2010, J ORG CHEM, V75, P3941, DOI [10.1021/jo100708n, 10.1021/jo.100708n]; SATO T, 1977, J AM CHEM SOC, V99, P5827, DOI 10.1021/ja00459a064; TAKEDA K, 1993, SYNLETT, P841; Takeda K, 2007, YAKUGAKU ZASSHI, V127, P1399, DOI 10.1248/yakushi.127.1399; TAKEDA K, 1993, J AM CHEM SOC, V115, P9351, DOI 10.1021/ja00073a086; Tsubouchi A, 2013, TETRAHEDRON LETT, V54, P1264, DOI 10.1016/j.tetlet.2012.12.089; VALENTE VR, 1966, J ORG CHEM, V31, P2509, DOI 10.1021/jo01346a019; Yamashita M, 2003, TETRAHEDRON LETT, V44, P2339, DOI 10.1016/S0040-4039(03)00255-7	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		565	577		10.1002/hc.21176		13	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000008		
J	Okuma, K; Matsui, H; Mori, Y				Okuma, Kentaro; Matsui, Hiroyuki; Mori, Yuichi			Reaction of Seleno- or Thiofenchone with Propiolic Acid: Wagner-Meerwein Rearrangement	HETEROATOM CHEMISTRY			English	Article							INTERMEDIATE; LIGANDS; KETONES	A reaction of selenofenchone with propiolic acid in refluxing chloroform produced 1,3-oxaselenin-6-one, which further reacted with acid to afford the ring-opened product. A reaction of 1,3-oxathiin-6-one prepared from thiofenchone with trifluoroacetic acid gave a Wagner-Meerwein rearranged product. In the presence of AlCl3, thiofenchone reacted with methyl propiolate to afford the corresponding rearranged ester. (C) 2014 Wiley Periodicals, Inc.	[Okuma, Kentaro; Matsui, Hiroyuki; Mori, Yuichi] Fukuoka Univ, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan	Okuma, K (reprint author), Fukuoka Univ, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan.	kokuma@fukuoka-u.ac.jp					Aggarwal VK, 1998, J AM CHEM SOC, V120, P8328, DOI 10.1021/ja9812150; LIBMAN J, 1969, TETRAHEDRON, V25, P1679, DOI 10.1016/S0040-4020(01)82741-1; Okuma K, 2001, J AM CHEM SOC, V123, P7166, DOI 10.1021/ja010640h; Bradshaw D, 2004, J AM CHEM SOC, V126, P6106, DOI 10.1021/ja0316420; GUZIEC FS, 1984, J ORG CHEM, V49, P189, DOI 10.1021/jo00175a046; Hanyu N, 2000, TETRAHEDRON-ASYMMETR, V11, P4127, DOI 10.1016/S0957-4166(00)00393-1; Hiroi K, 2001, TETRAHEDRON-ASYMMETR, V12, P3067, DOI 10.1016/S0957-4166(01)00546-8; HUISGEN R, 1985, TETRAHEDRON LETT, V26, P4431, DOI 10.1016/S0040-4039(00)88922-4; Huisgen R, 2001, HETEROATOM CHEM, V12, P136, DOI 10.1002/hc.1022; Majchrzak A, 2004, HELV CHIM ACTA, V87, P790, DOI 10.1002/hlca.200490077; Martinez AG, 2005, TETRAHEDRON, V61, P599, DOI 10.1016/j.tet.2004.11.006; Martinez AG, 2001, TETRAHEDRON LETT, V42, P6539; Martinez AG, 1998, TETRAHEDRON, V54, P4607, DOI 10.1016/S0040-4020(98)00176-8; Nakano H, 2001, J ORG CHEM, V66, P620, DOI 10.1021/jo001245x; Node M, 2000, J AM CHEM SOC, V122, P1927, DOI 10.1021/ja993546y; Okuma K, 2003, EUR J ORG CHEM, P3727, DOI 10.1002/ejoc.200300300; Okuma K, 2006, ORG BIOMOL CHEM, V4, P2745, DOI 10.1039/b605068a; Okuma K, 2007, TETRAHEDRON LETT, V48, P8311, DOI 10.1016/j.tetlet.2007.09.120; Paquette LA, 1998, PURE APPL CHEM, V70, P1449, DOI 10.1351/pac199870081449; Takahashi T, 1997, TETRAHEDRON-ASYMMETR, V8, P3293, DOI 10.1016/S0957-4166(97)00423-0	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		578	583		10.1002/hc.21181		6	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000009		
J	Kako, M; Inaba, D; Minami, K; Iida, R; Nakahodo, T; Akasaka, T				Kako, Masahiro; Inaba, Daiki; Minami, Kazuya; Iida, Ryosuke; Nakahodo, Tsukasa; Akasaka, Takeshi			Thermal Reactions of Fullerenes with Cyclic Organosilicon and Organogermanium Compounds: Silylation and Germylation of C-60 and C-70	HETEROATOM CHEMISTRY			English	Article							SILYLENE; LA-2-AT-C-80; SILIRANE; DENSITY; ATOMS; ORGANOFULLERENES; LU3N-AT-I-H-C-80; CARBOSILYLATION; DERIVATIZATION; CYCLOADDITION	Thermal reactions of empty fullerenes with disilirane (1) and digermirane (2) afforded the corresponding bis-silylated and bis-germylated derivatives. When a bicyclic fused silirane (3a) was heated in the presence of C-70, two silylene adducts were obtained through thermal extrusion of silylenes. These results provide a complementary method to the photochemical addition of reactive silicon and germanium compounds, which have been long employed for derivatization of fullerenes. Electrochemical analyses revealed the redox properties of the silylated and germylated C-70, indicating the electronic perturbation caused by silyl and germyl groups introduced on the fullerene cages. Theoretical calculations were also conducted for understanding of the electronic property of the fullerene derivatives. C (C) 2014 Wiley Periodicals, Inc.	[Kako, Masahiro; Inaba, Daiki; Minami, Kazuya; Iida, Ryosuke] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Nakahodo, Tsukasa] Kinki Univ, Dept Appl Chem, Fac Sci & Engn, Osaka 5778502, Japan; [Nakahodo, Tsukasa; Akasaka, Takeshi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Akasaka, Takeshi] Fdn Adv Int Sci, Ibaraki 3050821, Japan; [Akasaka, Takeshi] Tokyo Gakugei Univ, Dept Chem, Tokyo 1848501, Japan	Kako, M (reprint author), Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan.	kako@e-one.uec.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20245006, 24350019]; Strategic Japanese Spanish Cooperative Program - JST; Strategic Japanese Spanish Cooperative Program - MICINN;  [20108001]	Contract grant sponsor: Grant-in-Aid for Scientific Research on Innovative Areas.; Contract grant number: 20108001, "pi-Space".; Contract grant sponsor: Grant-in-Aid for Scientific Research (A) and (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Contract grant numbers: 20245006 and 24350019.; Contract grant sponsor: The Strategic Japanese Spanish Cooperative Program funded by JST and MICINN.	AKASAKA T, 1994, J AM CHEM SOC, V116, P2627, DOI 10.1021/ja00085a056; Akasaka T., 2010, CHEM NANOCARBONS; Akasaka T., 2002, ENDOFULLERENES NEW F; AKASAKA T, 1995, J CHEM SOC CHEM COMM, P1529, DOI 10.1039/c39950001529; AKASAKA T, 1995, ANGEW CHEM INT EDIT, V34, P2139, DOI 10.1002/anie.199521391; AKASAKA T, 1995, J CHEM SOC CHEM COMM, P1343, DOI 10.1039/c39950001343; Yamada M, 2013, CHEM REV, V113, P7209, DOI 10.1021/cr3004955; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Akasaka T, 1999, J ORG CHEM, V64, P566, DOI 10.1021/jo981689h; Akasaka T, 1996, TETRAHEDRON, V52, P5015, DOI 10.1016/0040-4020(96)00109-3; Kusukawa T, 1996, ANGEW CHEM INT EDIT, V35, P1315, DOI 10.1002/anie.199613151; Sato K, 2012, ORG LETT, V14, P5908, DOI 10.1021/ol302832k; Chaur MN, 2009, ANGEW CHEM INT EDIT, V48, P7514, DOI 10.1002/anie.200901746; AKASAKA T, 1993, J AM CHEM SOC, V115, P10366, DOI 10.1021/ja00075a065; Yamada M, 2010, ACCOUNTS CHEM RES, V43, P92, DOI 10.1021/ar900140n; Martin N, 1998, CHEM REV, V98, P2527, DOI 10.1021/cr9701039; Yamada M, 2010, J AM CHEM SOC, V132, P17953, DOI 10.1021/ja108671b; AKASAKA T, 1995, NATURE, V374, P600, DOI 10.1038/374600a0; Sato K, 2012, J AM CHEM SOC, V134, P16033, DOI 10.1021/ja3073929; Nagatsuka J, 2010, J AM CHEM SOC, V132, P12106, DOI 10.1021/ja1049719; SUZUKI T, 1994, J AM CHEM SOC, V116, P1359, DOI 10.1021/ja00083a022; Akasaka T, 2000, ORG LETT, V2, P2671, DOI 10.1021/ol000157w; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; AKASAKA T, 1993, J AM CHEM SOC, V115, P1605, DOI 10.1021/ja00057a072; Wakahara T, 2006, J AM CHEM SOC, V128, P9919, DOI 10.1021/ja062233h; Yamada M, 2005, J AM CHEM SOC, V127, P14570, DOI 10.1021/ja054346r; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Iiduka Y, 2005, J AM CHEM SOC, V127, P9956, DOI 10.1021/ja052534b; Averdung J, 1996, FULLERENE SCI TECHN, V4, P633, DOI 10.1080/10641229608003008; Frisch M. J., 2004, GAUSSIAN 03 REVISION; HIRSCH A, 1995, SYNTHESIS-STUTTGART, P895; Kako M, 2014, FULLER NANOTUB CAR N, V22, P155, DOI 10.1080/1536383X.2013.798722; Maeda Y, 2005, J AM CHEM SOC, V127, P2143, DOI 10.1021/ja043986b; Martin N, 2006, CHEM COMMUN, P2093, DOI 10.1039/b601582b; Morvillo P, 2008, PHYS STATUS SOLIDI-R, V2, P260, DOI 10.1002/pssr.200802136; Wakahara T, 2007, CHEM COMMUN, P2680, DOI 10.1039/b703473c; Yamada M, 2008, CHEM COMMUN, P558, DOI 10.1039/b712568b	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		584	591		10.1002/hc.21230		8	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000010		
J	Fukumoto, K; Sakai, A; Murai, T; Nakazawa, H				Fukumoto, Kozo; Sakai, Akane; Murai, Toshiaki; Nakazawa, Hiroshi			Transformation of RN=CHPh to R( R ' Si-3)NCH2Ph in the Catalytic Desulfurization of Secondary Thioamide with R ' 3SiH Promoted by an Iron Complex	HETEROATOM CHEMISTRY			English	Article							C BOND-CLEAVAGE; TRANSITION-METAL COMPLEX; ASYMMETRIC HYDROSILYLATION; ENANTIOSELECTIVE HYDROSILYLATION; TITANIUM COMPLEXES; RHODIUM COMPLEX; IMINES; AMINES; REDUCTION; SILYLATION	The reaction of imine (RN=CHPh) with hydrosilane (R'3SiH) in the presence of CpFe(CO)(2)Me (1) revealed the formation of a hydrosilylation product (R(R'Si-3)NCH2Ph). The findings helped us to understand the reaction mechanism of desulfurization of secondary thioamide catalyzed by 1 to give the corresponding imine and amine as a major and minor product, respectively. (C) 2014 Wiley Periodicals, Inc.	[Fukumoto, Kozo] Univ Ryukyus, Dept Chem, Fac Educ, Nishihara, Okinawa 9030213, Japan; [Sakai, Akane; Nakazawa, Hiroshi] Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan; [Murai, Toshiaki] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan	Nakazawa, H (reprint author), Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan.	nakazawa@sci.osaka-cu.ac.jp					Andersson P. G., 2008, J MOD REDUCT METHOD, P321; Park BM, 2006, ADV SYNTH CATAL, V348, P1029, DOI 10.1002/adsc.200606149; Castro LCM, 2012, CHEM COMMUN, V48, P151, DOI 10.1039/c1cc14403k; Fukumoto K, 2012, ORGANOMETALLICS, V31, P787, DOI 10.1021/om201257h; Kamitani M, 2012, ORGANOMETALLICS, V31, P2957, DOI 10.1021/om3001845; Park BM, 2011, B KOREAN CHEM SOC, V32, P2960, DOI 10.5012/bkcs.2011.32.8.2960; Chen DJ, 2012, CHEM-EUR J, V18, P5184, DOI 10.1002/chem.201200244; Gajewy J, 2011, ORG BIOMOL CHEM, V9, P3863, DOI 10.1039/c1ob05074e; Nakazawa H, 2004, ORGANOMETALLICS, V23, P117, DOI 10.1021/om0208319; Lipshutz BH, 2004, ANGEW CHEM INT EDIT, V43, P2228, DOI 10.1002/anie.200353294; Bheeter LP, 2013, CATAL SCI TECHNOL, V3, P3111, DOI 10.1039/c3cy00514c; Murai T, 2009, J SULFUR CHEM, V30, P225, DOI 10.1080/17415990902774202; Nakazawa H, 2007, CHEM-ASIAN J, V2, P882, DOI 10.1002/asia.200700076; Wu PC, 2008, TETRAHEDRON, V64, P11304, DOI 10.1016/j.tet.2008.09.034; Heutling A, 2005, ANGEW CHEM INT EDIT, V44, P2951, DOI 10.1002/anie.200462250; Verdaguer X, 1996, J AM CHEM SOC, V118, P6784, DOI 10.1021/ja960808c; Fukumoto K, 2013, ORGANOMETALLICS, V32, P2889, DOI 10.1021/om400304v; Fukumoto K, 2012, CHEM COMMUN, V48, P3809, DOI 10.1039/c2cc17163e; Fukurnoto K, 2009, J AM CHEM SOC, V131, P38, DOI 10.1021/ja807896b; Gruber-Woelfler H, 2009, ORGANOMETALLICS, V28, P2546, DOI 10.1021/om800643q; Gruber-Woelfler H, 2012, DALTON T, V41, P12711, DOI 10.1039/c2dt31207g; Hansen MC, 1999, TETRAHEDRON LETT, V40, P2033, DOI 10.1016/S0040-4039(99)00085-4; KAGAN HB, 1975, J ORGANOMET CHEM, V90, P353, DOI 10.1016/S0022-328X(00)88129-2; Klahn M, 2008, ORGANOMETALLICS, V27, P5846, DOI 10.1021/om800605x; LANGLOIS N, 1973, TETRAHEDRON LETT, P4865; Li B, 2012, CHEMSUSCHEM, V5, P396, DOI 10.1002/cssc.201100585; Lin B., 2011, ACS CATAL, V1, P1221; Mewald M, 2012, CHEM-EUR J, V18, P14079, DOI 10.1002/chem.201202693; Murai T, 2003, J ORG CHEM, V68, P8514, DOI 10.1021/jo034934s; Murai T, 2004, CHEM LETT, V33, P508, DOI 10.1246/cl.2004.508; Nakazawa H, 2005, CHEM COMMUN, P4004, DOI 10.1039/b504131g; Nishibayashi Y, 1996, ORGANOMETALLICS, V15, P370, DOI 10.1021/om950533u; Renzetti A., 2014, B CHEM SOC JPN, V1, P59; Sharma HK, 2009, ANGEW CHEM INT EDIT, V48, P7052, DOI 10.1002/anie.200903021; Takaki K, 1999, J ORG CHEM, V64, P3891, DOI 10.1021/jo982154r; Takei I, 1999, ORGANOMETALLICS, V18, P2271, DOI 10.1021/om981005w; Verdaguer X, 1998, ANGEW CHEM INT EDIT, V37, P1103, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1103::AID-ANIE1103>3.0.CO;2-M; VETTER AH, 1995, SYNTHESIS-STUTTGART, P419; Yun JS, 2000, J ORG CHEM, V65, P767, DOI 10.1021/jo991328h	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		607	611		10.1002/hc.21175		5	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000012		
J	Li, BL; Tsujimoto, S; Li, YM; Tsuji, H; Tamao, K; Hashizume, D; Matsuo, T				Li, Baolin; Tsujimoto, Shota; Li, Yongming; Tsuji, Hayato; Tamao, Kohei; Hashizume, Daisuke; Matsuo, Tsukasa			Synthesis and Characterization of Diphosphenes Bearing Fused-Ring Bulky Rind Groups	HETEROATOM CHEMISTRY			English	Article							DOUBLE-BOND; CONJUGATED MATERIALS; CHEMISTRY; ELEMENTS; PHOSPHORUS; REACTIVITY; DISILENES; COMPOUND	Diphosphenes stabilized by the fused-ring bulky 1,1,3,3,5,5,7,7-octa-R-substituted s-hydrindacen-4-yl (Rind) groups have been obtained as orange crystals by the reduction of the corresponding dichlorophosphines, (Rind)PCl2, with lithium naphthalenide (LiNaph). The molecular structures of (Eind) PCl2 and the diphosphenes, (Eind) P=P(Eind) and (EMind) P=P(EMind), having the bulky Eind and the less bulky EMind groups, have been confirmed by X-ray crystallography. The formation of the P=P bond has been fully characterized by spectroscopic methods. (C) 2014 Wiley Periodicals, Inc.	[Li, Baolin; Tamao, Kohei; Matsuo, Tsukasa] RIKEN Adv Sci Inst, Funct Elementoorgan Chem Unit, Wako, Saitama 3510198, Japan; [Tsujimoto, Shota; Matsuo, Tsukasa] Kinki Univ, Dept Appl Chem, Fac Sci & Engn, Osaka 5778502, Japan; [Li, Yongming; Tsuji, Hayato; Tamao, Kohei] Kyoto Univ, Inst Chem Res, Int Res Ctr Element Sci, Kyoto 6110011, Japan; [Tsuji, Hayato; Matsuo, Tsukasa] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hashizume, Daisuke] RIKEN Ctr Emergent Matter Sci CEMS, Mat Characterizat Support Unit, Wako, Saitama 3510198, Japan	Matsuo, T (reprint author), RIKEN Adv Sci Inst, Funct Elementoorgan Chem Unit, Wako, Saitama 3510198, Japan.	t-matsuo@apch.kindai.ac.jp	Tsuji, Hayato/F-1802-2014; Hashizume, Daisuke/D-3187-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan [19002008]; Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species"	Contract grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan for the Grant-in-Aid for Specially Promoted Research.; Contract grant number: 19002008.; Contract grant sponsor: Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species".	Kobayashi M, 2010, J AM CHEM SOC, V132, P15162, DOI 10.1021/ja108094m; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Suzuki K, 2011, SCIENCE, V331, P1306, DOI 10.1126/science.1199906; Scheschkewitz D, 2011, CHEM LETT, V40, P2, DOI 10.1246/cl.2011.2; Matsuo T, 2010, CR CHIM, V13, P1104, DOI 10.1016/j.crci.2010.07.005; Fukazawa A, 2007, J AM CHEM SOC, V129, P14164, DOI 10.1021/ja0764207; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Matsuo T, 2010, DALTON T, V39, P9203, DOI 10.1039/c0dt00287a; Bates JI, 2010, DALTON T, V39, P3151, DOI 10.1039/b918938f; Kobayashi M, 2014, CHEM LETT, V43, P432, DOI 10.1246/cl.131043; Gates DP, 2005, TOP CURR CHEM, V250, P107, DOI 10.1007/b100983; YOSHIFUJI M, 1981, J AM CHEM SOC, V103, P4587, DOI 10.1021/ja00405a054; Sasamori T, 2006, J AM CHEM SOC, V128, P12582, DOI 10.1021/ja064062m; Suzuki K, 2011, J AM CHEM SOC, V133, P19710, DOI 10.1021/ja209736d; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Matsuo T, 2011, B CHEM SOC JPN, V84, P1178, DOI 10.1246/bcsj.20110090; Scheschkewitz D, 2009, CHEM-EUR J, V15, P2476, DOI 10.1002/chem.200801968; Tamao K, 2012, CHEM COMMUN, V48, P1030, DOI 10.1039/c1cc16067b; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Kira M, 2006, ADV ORGANOMET CHEM, V54, P73, DOI 10.1016/S0065-3055(05)54003-6; Li BL, 2011, ORGANOMETALLICS, V30, P3453, DOI 10.1021/om2003442; Baumgartner T, 2006, CHEM REV, V106, P4681, DOI 10.1021/cr040179m; Li BL, 2009, J AM CHEM SOC, V131, P13222, DOI 10.1021/ja9051153; Asay M, 2012, B CHEM SOC JPN, V85, P1245, DOI 10.1246/bcsj.20120212; Simpson MC, 2013, PURE APPL CHEM, V85, P801, DOI 10.1351/PAC-CON-12-09-13; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Wang YZ, 2009, CHEM COMMUN, P5201, DOI 10.1039/b908048a; Sasamori T, 2013, B CHEM SOC JPN, V86, P1005, DOI 10.1246/bcsj.20130134; BROOK AG, 1981, J CHEM SOC CHEM COMM, P191, DOI 10.1039/c39810000191; Fryzuk M. D., 1998, J INORG CHEM, V67, P6928; Ito S, 2009, PHOSPHORUS SULFUR, V184, P917, DOI 10.1080/10426500902718240; Karsh H. H., 1996, SYNTHETIC METHODS OR, V3, P122; Lee Y. Va., 2010, ORGANOMETALLIC COMPO; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Protasiewicz JD, 2010, INORG CHIM ACTA, V364, P39, DOI 10.1016/j.ica.2010.07.018; Rigaku, 2005, CRYSTALCLEAR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tokitoh N, 2000, J ORGANOMET CHEM, V611, P217, DOI 10.1016/S0022-328X(00)00437-X; Toyota K., 2003, SCI REP TOHOKU U, V80, P27; WEBER L, 1992, CHEM REV, V92, P1839, DOI 10.1021/cr00016a008	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		612	618		10.1002/hc.21197		7	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000013		
J	Takeda, N; Tagawa, T; Unno, M				Takeda, Nobuhiro; Tagawa, Tomonori; Unno, Masafumi			Synthesis, Reactivities, and Coordination Chemistry of Tris(2-isopropoxyphenyl)phosphine	HETEROATOM CHEMISTRY			English	Article							TRANSITION-METAL-COMPLEXES; PLATINUM(II) COMPLEXES; CRYSTAL-STRUCTURES; LIGAND; BOND; TRIS(2,4,6-TRIMETHOXYPHENYL)PHOSPHINE; ACTIVATION; PHOSPHINES; BEARING; RADII	A phosphine bearing three 2-isopropoxyphenyl groups, P{C6H4[2-O(i-Pr)]}(3) (1), was synthesized. Phosphine 1 readily reacted with CH2Cl2 and ClCH2CH2Cl at 25 degrees C to give the corresponding phosphonium salts [RCH2P{C6H4[2-O(i-Pr)]}(3)] X (2: R=X=Cl, 3: R=CH2Cl, X=BF4). Platinum, palladium, and rhodium complexes with ligand 1, [PtCl2(1)(2)] (4), [PdCl2(1)(2)] (5), [{PdCl(1)} 2(mu-Cl) 2] (6), and [RhCl(cod)(1)] (7) were synthesized and their structures were determined by X-ray crystallography, which revealed that ligand 1 works as a monodentate ligand in these complexes. (C) 2014 Wiley Periodicals, Inc.	[Takeda, Nobuhiro] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; Gunma Univ, Fac Sci & Technol, Int Educ & Res Ctr Silicon Sci, Kiryu, Gunma 3768515, Japan	Takeda, N (reprint author), Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan.	ntakeda@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	Contract grant sponsor: Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS).	ABBASSIOUN MS, 1990, ACTA CRYSTALLOGR C, V46, P902, DOI 10.1107/S0108270190000695; Romeo R, 2006, ANGEW CHEM INT EDIT, V45, P4494, DOI 10.1002/anie.200600827; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; Hierso JC, 2003, COORDIN CHEM REV, V236, P143, DOI 10.1016/S0010-8545(02)00221-7; Awada M, 2011, DALTON T, V40, P10063, DOI 10.1039/c1dt10375j; BEDFORD RB, 1994, ACTA CRYSTALLOGR C, V50, P356, DOI 10.1107/S0108270193009424; Bell NA, 2002, POLYHEDRON, V21, P1845, DOI 10.1016/S0277-5387(02)01042-2; BinShawkataly O, 1996, ACTA CRYSTALLOGR C, V52, P1352, DOI 10.1107/S0108270196001527; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Borovik AS, 2005, ACCOUNTS CHEM RES, V38, P54, DOI 10.1021/ar030160q; Bowmaker GA, 2005, INORG CHIM ACTA, V358, P4307, DOI 10.1016/j.ica.2005.04.007; BRANDSMA L, 1990, SYNTHETIC COMMUN, V20, P2273, DOI 10.1080/00397919008053168; Chiu G, 2007, BIOORG MED CHEM LETT, V17, P3930, DOI 10.1016/j.bmcl.2007.04.098; Hirsivaara L, 2000, INORG CHIM ACTA, V307, P47; Hu XL, 2005, J ORGANOMET CHEM, V690, P5474, DOI 10.1016/j.jorganchem.2005.07.119; Huttner G., 2004, COMPREHENSIVE COORDI, V1; Kuang SM, 2002, INORG CHEM, V41, P1036, DOI 10.1021/ic0112084; KUROSAWA H, 1987, B CHEM SOC JPN, V60, P3563, DOI 10.1246/bcsj.60.3563; Ma JF, 2000, J ORGANOMET CHEM, V616, P149, DOI 10.1016/S0022-328X(00)00586-6; ORPEN AG, 1989, J CHEM SOC DALTON, pS1, DOI 10.1039/dt98900000s1; Pettinari C., 2004, COMPREHENSIVE COOR 2, V1, P211; Ramaprabhu S, 1998, Z NATURFORSCH A, V53, P625; Schrock RR, 1997, ACCOUNTS CHEM RES, V30, P9, DOI 10.1021/ar950195t; Sheldrick G. M., 1997, SHELXS 97 SHELXL 97; Smith DC, 2003, DALTON T, P2950; STEYN MMD, 1981, J CHEM RES-S, P267; Sun JS, 1998, POLYHEDRON, V17, P2049, DOI 10.1016/S0277-5387(97)00483-X; Takeda N, 2010, B CHEM SOC JPN, V83, P157, DOI 10.1246/bcsj.20090187; WADA M, 1984, J CHEM SOC CHEM COMM, P482, DOI 10.1039/c39840000482	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		628	635		10.1002/hc.21174		8	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000015		
J	Sato, O; Nitta, A; Yamamoto, A				Sato, Ohki; Nitta, Ai; Yamamoto, Ami			Regioselective Nucleophilic Substitution of 5-Bromo-2-methoxytropone	HETEROATOM CHEMISTRY			English	Article							DERIVATIVES; CLEAVAGE; ETHER	The reaction of 5-bromo-2methoxytropone with O- and N-nucleophiles, such as ethanol/potassium carbonate, sodium hydroxide, diethylamine, propylamine, p-chloroaniline/triethylamine, and p-phenylenediamine/triethylamine, gave corresponding 2-O- and 2-N-substituted troponoids. Alkyl diamines reacted with the substrate to produce bis(2-aminotropone)s. In the case of S-nucleophiles as 1-propanethiol, thiophenol, and 4-aminothiophenol with a base, the regioselective substitution at the 5-position occurred. Halogenation reagents, triphenyldibromophosphorane and its dichloro analogue, furnished 2,5-dibromo- and 2,5-dichlorotropones, respectively. (C) 2014 Wiley Periodicals, Inc.	[Sato, Ohki; Nitta, Ai; Yamamoto, Ami] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Saitama 3388570, Japan	Sato, O (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Saitama 3388570, Japan.	ohkisato@chem.saitama-u.ac.jp					ANDERSON AG, 1972, J ORG CHEM, V37, P626, DOI 10.1021/jo00969a023; ANDERSON AG, 1973, TETRAHEDRON LETT, P5121; Hicks FA, 2003, ORGANOMETALLICS, V22, P3533, DOI 10.1021/om030142c; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Seganish WM, 2005, J ORG CHEM, V70, P8948, DOI 10.1021/jo051636h; Alfarra A, 2004, APPL SURF SCI, V228, P84, DOI 10.1016/j.apsusc.2003.12.033; BANWELL MG, 1988, ORG PREP PROCED INT, V20, P393; BRYANT BE, 1953, J AM CHEM SOC, V75, P3784, DOI 10.1021/ja01111a053; COOK JW, 1951, J CHEM SOC, P503, DOI 10.1039/jr9510000503; DOERING WV, 1951, J AM CHEM SOC, V73, P828, DOI 10.1021/ja01146a101; IMAFUKU K, 1979, B CHEM SOC JPN, V52, P2447, DOI 10.1246/bcsj.52.2447; IYODA M, 1987, TETRAHEDRON LETT, V28, P625, DOI 10.1016/S0040-4039(00)95797-6; Kubo K, 2002, B CHEM SOC JPN, V75, P1353, DOI 10.1246/bcsj.75.1353; Mori A, 2005, J MATER CHEM, V15, P3005, DOI 10.1039/b501974e; NAIR V, 1987, SYNTHETIC COMMUN, V17, P1897, DOI 10.1080/00397918708057801; Nozoe T., 1951, P JAPAN ACAD, V27, P556; Nozoe T., 1951, P JAPAN ACAD, V27, P224; NOZOE T, 1951, J AM CHEM SOC, V73, P1895, DOI 10.1021/ja01148a560; Nozoe T., 1961, TOHOKU DAIGAKU HISUI, V10, P251; Nozoe T, 1936, B CHEM SOC JPN, V3, P295, DOI 10.1246/bcsj.11.295; Nozoe T., 1954, P JAPAN ACAD, V30, P204; Sato O, 2014, HETEROCYCLES, V88, P1573, DOI 10.3987/COM-13-S(S)96; Takagi K, 2009, B CHEM SOC JPN, V82, P236, DOI 10.1246/bcsj.82.236; WAKABAYASHI H, 1985, B CHEM SOC JPN, V58, P2840, DOI 10.1246/bcsj.58.2840	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		644	650		10.1002/hc.21201		7	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000017		
J	Ishii, A; Kobayashi, S; Aoki, Y; Annaka, T; Nakata, N				Ishii, Akihiko; Kobayashi, Shota; Aoki, Yutaro; Annaka, Tatsuro; Nakata, Norio			Thiophene-Fused 3-Methylene-2,3-dihydrochalcogenophenes: Fluorescent Dyes Incorporated in a Rigid Dibenzobarrelene Skeleton	HETEROATOM CHEMISTRY			English	Article							CORE OLIGOTHIOPHENE-S,S-DIOXIDES; SOLID-STATE; ATOM; ABSORPTION; PHOSPHORESCENCE; DERIVATIVES; POLYMERS; STILBENE; BEHAVIOR; SYSTEMS	3-Methylene-2,3-dihydrothienothiophene and -selenophenothiophene derivatives incorporated in a rigid dibenzobarrelene skeleton were synthesized by intramolecular Diels-Alder reaction, and their structures, fluorescent properties, and electrochemistry were elucidated. In 3-methylene-2,3-dihydrothieno[ 3,2-b] thiophene derivatives, silyl and phenyl substituents at the terminal position were effective for strong blue fluorescence (lambda(em) = 412-455 nm) with high quantum yields (Phi(F) = 0.65-0.99), whereas the unsubstituted parent compound was weakly fluorescent (lambda(em) = 338 nm, Phi(F) = 0.03). The phenylsubstituted [3,2-b]-derivative showed strong emission also in the solid state (Phi(F) = 0.70). The corresponding [2,3-b]-isomer showed blueshifted absorption (.abs = 342 nm) and emission (lambda(em) = 436 nm) maxima with low-to-moderate quantum yields in solution (Phi(F) = 0.24) and in the solid state (Phi(F) = 0.41). In the case of the selenium congeners (3-methylene2,3-dihydroselenopheno[3,2-b] thiophene derivatives), the heavy atom effect due to the selenium was decisive to decrease the quantum yields (Phi(F) = 0.01-0.06). The oxidation of phenyl-substituted [3,2-b]-derivative yielded the corresponding sulfoxide and sulfone, which showed strong emission at around 440 nm with high quantum yields in dichloromethane (Phi(F) = 0.91 and 0.98, respectively). A dimer of the phenyl-substituted [3,2-b]-derivative was prepared by oxidative coupling of the lithio derivative. The dimer had weak redshifted emission (lambda(em) = 547 nm, Phi(F) = 0.10) and showed a reversible cyclic voltammogram with E-1/2 = 0.35 V versus Fc/Fc(+) redox couple. (C) 2014 Wiley Periodicals, Inc.	[Ishii, Akihiko; Kobayashi, Shota; Aoki, Yutaro; Annaka, Tatsuro; Nakata, Norio] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Saitama 3388570, Japan	Ishii, A (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Saitama 3388570, Japan.	ishiiaki@chem.saitama-u.ac.jp	Nakata, Norio/B-4017-2012				Wakamiya A, 2003, J ORG CHEM, V68, P8305, DOI 10.1021/jo034754i; Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b; Solovyov KN, 2005, PHYS-USP+, V48, P231, DOI 10.1070/PU2005v048n03ABEH001761; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Ishii A, 2012, CHEM-EUR J, V18, P6428, DOI 10.1002/chem.201200761; Kyushin S, 1996, ORGANOMETALLICS, V15, P1067, DOI 10.1021/om950776m; Casado J, 2006, J AM CHEM SOC, V128, P10134, DOI 10.1021/ja061372w; Holliday S, 2014, CHEM MATER, V26, P647, DOI 10.1021/cm402421p; Bartocci G, 2004, PHOTOCH PHOTOBIO SCI, V3, P870, DOI 10.1039/b408241a; Wang SL, 2000, J PHOTOCH PHOTOBIO A, V135, P119, DOI 10.1016/S1010-6030(00)00289-6; Li C, 2010, CHEM REV, V110, P6817, DOI 10.1021/cr100052z; Beaujuge PM, 2010, CHEM REV, V110, P268, DOI 10.1021/cr900129a; Kobayashi J, 2009, CHEM-ASIAN J, V4, P42, DOI 10.1002/asia.200800302; Kwong FY, 2002, ORG LETT, V4, P3517, DOI 10.1021/ol0266673; Maeda H, 2012, MOLECULES, V17, P5108, DOI 10.3390/molecules17055108; Apperloo JJ, 2002, CHEM-EUR J, V8, P2384, DOI 10.1002/1521-3765(20020517)8:10<2384::AID-CHEM2384>3.0.CO;2-L; Ishii A, 2011, ORG LETT, V13, P3702, DOI 10.1021/ol2013523; Barbarella G, 2005, ADV MATER, V17, P1581, DOI 10.1002/adma.200402020; Barbarella G, 2001, CHEM MATER, V13, P4112, DOI 10.1021/cm010436t; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Gajdek P, 1996, J PHOTOCH PHOTOBIO A, V100, P57, DOI 10.1016/S1010-6030(96)04449-8; Ginocchietti G, 2008, CHEM PHYS, V352, P28, DOI 10.1016/j.chemphys.2008.05.005; Grimsdale A. C., 2006, ORGANIC LIGHT EMITTI, P215; GRONOWITZ S, 1958, ARK KEMI, V13, P239; Maeda H, 2001, CHEM LETT, P1224; Pappenfus TM, 2007, ORG LETT, V9, P3721, DOI 10.1021/ol071369x; Scrowston R. M, 1986, THIOPHENE ITS DERI 3, P344; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467; Sugimoto Y., 1959, B U OSAKA PREFECT, V8, P71; Tedesco E, 2003, J AM CHEM SOC, V125, P12277, DOI 10.1021/ja035570o; Turro N.J., 2010, MODERN MOL PHOTOCHEM, P306; ZANDER M, 1989, Z NATURFORSCH A, V44, P205; ZANDER M, 1989, Z NATURFORSCH A, V44, P1116	35	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		658	673		10.1002/hc.21185		16	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000019		
J	Yoshimura, A; Tomisaka, Y; Li, ZF; Nomoto, A; Ogawa, A				Yoshimura, Aya; Tomisaka, Yuri; Li, Zhifang; Nomoto, Akihiro; Ogawa, Akiya			Photoinduced Reductive Coupling of Organochlorosilanes with SmI2/Sm	HETEROATOM CHEMISTRY			English	Article							ELECTRON-TRANSFER REACTIONS; POLYSILANE HIGH POLYMERS; SAMARIUM(II) IODIDE; ELECTROLUMINESCENT DEVICES; ELECTROCHEMICAL SYNTHESIS; 9-MEMBERED CARBOCYCLES; SEQUENCED REACTIONS; ORGANIC-CHEMISTRY; DIIODIDE; BONDS	We report efficient reductive dimerization of chlorosilanes with SmI2/Sm in 1,2-dimethoxyethane upon visible light irradiation. This procedure can be applied to the synthesis of polysilanes from dichlorosilanes. The molecular weight of the obtained polysilanes was higher and their molecular weight distribution was narrower than the polysilanes produced by reactions with SmI2/Sm in dark. (C) 2014 Wiley Periodicals, Inc.	[Yoshimura, Aya; Tomisaka, Yuri; Nomoto, Akihiro; Ogawa, Akiya] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Sakai, Osaka 5998531, Japan; [Li, Zhifang] Hangzhou Normal Univ, Key Lab Organosilicon Chem, Hangzhou 310012, Zhejiang, Peoples R China	Ogawa, A (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Sakai, Osaka 5998531, Japan.	ogawa@chem.osakafu-u.ac.jp	Ogawa, Akiya/B-2039-2010		Industry-University Cooperation Program of Sakai City	This research was supported by the Industry-University Cooperation Program of Sakai City.	AITKEN C, 1985, J ORGANOMET CHEM, V279, pC11, DOI 10.1016/0022-328X(85)87029-7; AKANE N, 1992, CHEM LETT, P2431, DOI 10.1246/cl.1992.2431; Amil-Levy M., 2010, CHEM-EUR J, V16, P805; AITKEN CT, 1986, J AM CHEM SOC, V108, P4059, DOI 10.1021/ja00274a034; Fujiki M, 2001, MACROMOL RAPID COMM, V22, P539, DOI 10.1002/1521-3927(20010501)22:8<539::AID-MARC539>3.0.CO;2-K; Kagan HB, 2003, TETRAHEDRON, V59, P10351, DOI 10.1016/j.tet.2003.09.101; KIDO J, 1993, J ALLOY COMPD, V192, P30, DOI 10.1016/0925-8388(93)90176-N; MOLANDER GA, 1992, CHEM REV, V92, P29, DOI 10.1021/cr00009a002; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006; AITKEN C, 1986, CAN J CHEM, V64, P1677, DOI 10.1139/v86-276; Molander GA, 1996, CHEM REV, V96, P307, DOI 10.1021/cr950019y; Edmonds DJ, 2004, CHEM REV, V104, P3371, DOI 10.1021/cr030017a; WEST R, 1986, J ORGANOMET CHEM, V300, P327, DOI 10.1016/0022-328X(86)84068-2; SAKAMOTO K, 1989, J AM CHEM SOC, V111, P7641, DOI 10.1021/ja00201a070; Hasegawa E, 1997, J ORG CHEM, V62, P2396, DOI 10.1021/jo9622439; FUJINO M, 1992, MACROMOLECULES, V25, P1079, DOI 10.1021/ma00029a011; Nicolaou KC, 2009, ANGEW CHEM INT EDIT, V48, P7140, DOI 10.1002/anie.200902151; Tamiya H, 2004, ORG LETT, V6, P545, DOI 10.1021/036329h; Gopalaiah K, 2013, CHEM REC, V13, P187, DOI 10.1002/tcr.201200028; Hoshino S, 1996, APPL PHYS LETT, V69, P224, DOI 10.1063/1.117379; Gopalaiah K, 2008, NEW J CHEM, V32, P607, DOI 10.1039/b718330p; Concellon JM, 2005, ORG LETT, V7, P5833, DOI 10.1021/ol0523392; Concellon JM, 2008, ORG LETT, V10, P4549, DOI 10.1021/ol801752m; CURRAN DP, 1992, SYNLETT, P943; Elangovan M, 2005, EUR POLYM J, V41, P2450, DOI 10.1016/j.eurpolymj.2005.04.014; FUKUZAWA S, 1991, TETRAHEDRON LETT, V32, P7691, DOI 10.1016/0040-4039(91)80567-P; Fukuzawa S, 2005, ORG LETT, V7, P5809, DOI 10.1021/ol0523291; Grignard P., 1980, J AM CHEM SOC, V102, P2693; Grogger C, 2006, J ORGANOMET CHEM, V691, P105, DOI 10.1016/j.jorganchem.2005.08.016; HARRAH LA, 1987, MACROMOLECULES, V20, P601, DOI 10.1021/ma00169a023; Hasegawa E, 2002, CHEM COMMUN, P1966, DOI 10.1039/b205781f; HASEGAWA Y, 1986, J MATER SCI, V21, P321, DOI 10.1007/BF01144739; HENGGE E, 1981, J ORGANOMET CHEM, V212, P155, DOI 10.1016/S0022-328X(00)81911-7; HENGGE E, 1978, MONATSH CHEM, V109, P1217, DOI 10.1007/BF00913023; HENGGE E, 1976, ANGEW CHEM INT EDIT, V15, P370, DOI 10.1002/anie.197603701; Horguchi R., 1988, MACROMOLECULES, V21, P304; IMAMOTO T, 1984, J SYN ORG CHEM JPN, V42, P143; INANAGA J, 1991, TETRAHEDRON LETT, V32, P1737, DOI 10.1016/S0040-4039(00)74317-6; Inanaga J, 1990, REV HETEROATOM CHEM, V3, P87; INANAGA J, 1987, CHEM LETT, P1485, DOI 10.1246/cl.1987.1485; Itazaki M., 2009, ANGEW CHEM, V121, P3363; Kagan H. B., 1999, T ORGANOMET CHEM, V2, P155; Kamata N, 2002, APPL PHYS LETT, V81, P4350, DOI 10.1063/1.1527231; Kamiya I, 2006, J ALLOY COMPD, V408, P437, DOI 10.1016/j.jallcom.2004.12.085; KAN T, 1994, J ORG CHEM, V59, P5111, DOI 10.1021/jo00097a001; Karatsu T, 2008, J PHOTOCH PHOTOBIO C, V9, P111, DOI 10.1016/j.jphotochemrev.2008.06.001; Kashimura S, 1997, TETRAHEDRON LETT, V38, P4607, DOI 10.1016/S0040-4039(97)00987-8; Kasimura S., 1999, J ORG CHEM, V64, P6615; KIDO J, 1991, APPL PHYS LETT, V59, P2760, DOI 10.1063/1.105880; KIM HK, 1988, J AM CHEM SOC, V110, P3321, DOI 10.1021/ja00218a064; Li ZF, 2007, ORGANOMETALLICS, V26, P1212, DOI 10.1021/om060745z; Marschner C, 2006, DALTON T, P5667, DOI 10.1039/b613642g; MATYJASZEWSKI K, 1995, MACROMOLECULES, V28, P59, DOI 10.1021/ma00105a007; MILLER RD, 1988, MACROMOLECULES, V21, P3120, DOI 10.1021/ma00188a038; Molander GA, 1998, J ORG CHEM, V63, P4366, DOI 10.1021/jo980119e; Molander GA, 1998, J ORG CHEM, V63, P9031, DOI 10.1021/jo981537m; Molander GA, 1999, J ORG CHEM, V64, P4119, DOI 10.1021/jo990216n; Nomura R, 1998, CHEM-EUR J, V4, P1605, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1605::AID-CHEM1605>3.0.CO;2-I; OGAWA A, 1992, J AM CHEM SOC, V114, P8729, DOI 10.1021/ja00048a072; Ogawa A, 1997, J AM CHEM SOC, V119, P2745, DOI 10.1021/ja963117p; Ogawa A., 1996, RARE EARTHS, V28, P298; Ogawa A, 1997, CHEM LETT, P275, DOI 10.1246/cl.1997.275; Ogawa A, 1998, TETRAHEDRON LETT, V39, P6341, DOI 10.1016/S0040-4039(98)01347-1; Ogawa A., 1995, RARE EARTHS, V26, P338; Ogawa A, 1999, TETRAHEDRON LETT, V40, P7113, DOI 10.1016/S0040-4039(99)01504-X; Okumoto H, 2003, ADV MATER, V15, P716, DOI 10.1002/adma.200304809; PANNELL KH, 1988, MACROMOLECULES, V21, P276, DOI 10.1021/ma00179a058; Prasad E, 2005, CHEM-EUR J, V11, P3105, DOI 10.1002/chem.2004101163; SAKURAI H, 1989, J SYN ORG CHEM JPN, V47, P1051; Shankar R, 2002, J ORGANOMET CHEM, V650, P223, DOI 10.1016/S0022-328X(02)01254-8; SHONO T, 1990, J CHEM SOC CHEM COMM, P1160, DOI 10.1039/c39900001160; Skene WG, 1996, J ORG CHEM, V61, P7918, DOI 10.1021/jo960473h; Soderquist A., 1991, J ALDRICH ACTA, V24, P15; Sumino Y, 2003, TETRAHEDRON, V59, P10499, DOI 10.1016/j.tet.2003.08.070; Sumino Y, 2003, J SYN ORG CHEM JPN, V61, P201; SUZUKI H, 1993, ADV MATER, V5, P743, DOI 10.1002/adma.19930051013; TILLEY TD, 1993, ACCOUNTS CHEM RES, V26, P22, DOI 10.1021/ar00025a004; Tomisaka Y, 2013, RES CHEM INTERMEDIAT, V39, P43, DOI 10.1007/s11164-012-0630-x; Tomisaka Y, 2009, TETRAHEDRON LETT, V50, P584, DOI 10.1016/j.tetlet.2008.11.077; WEST R, 1982, COMPREHENSIVE ORGANO, V2, P365; Yajima A., 1975, CHEM LETT, P931; Yoshida M, 1996, CHEM COMMUN, P1381, DOI 10.1039/cc9960001381	83	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		684	689		10.1002/hc.21186		6	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000022		
J	Umeda, R; Kouno, H; Kitagawa, T; Okamoto, T; Kawashima, K; Mashino, T; Nishiyama, Y				Umeda, Rui; Kouno, Hiroshi; Kitagawa, Takayuki; Okamoto, Tomohiro; Kawashima, Keisuke; Mashino, Tsukasa; Nishiyama, Yutaka			Selective Synthesis of Quinolines and Indoles: Sulfur-Assisted or Selenium-Catalyzed Reaction of beta-(2-Nitrophenyl)-alpha, beta-unsaturated Ketones with Carbon Monoxide	HETEROATOM CHEMISTRY			English	Article							REDUCTIVE N-HETEROCYCLIZATION; RH(I)-CATALYZED DIRECT ARYLATION; AROMATIC NITRO-COMPOUNDS; SYMMETRICAL 1,3-DIARYLUREAS; ATMOSPHERIC-PRESSURE; ACRIDONE ALKALOIDS; SOLVENT-FREE; CARBONYLATION; NITROARENES; DERIVATIVES	A simple and selective synthetic method of quinolines and indoles by the reaction of beta-(2-nitrophenyl)-alpha, beta-unsaturated ketones with carbon monoxide was developed. When beta-(2-nitrophenyl)a, beta-unsaturated ketones were allowed to react with carbon monoxide and water in the presence of a stoichiometric amount of sulfur or a catalytic amount of selenium, the corresponding quinolines were produced in moderate-to-good yields. On the other hand, in the absence of water, the indoles were produced by the selenium-catalyzed reaction of the beta-(2-nitrophenyl)-alpha,beta-unsaturated ketones with carbon monoxide. (C) 2014 Wiley Periodicals, Inc.	[Umeda, Rui; Kouno, Hiroshi; Kitagawa, Takayuki; Okamoto, Tomohiro; Kawashima, Keisuke; Mashino, Tsukasa; Nishiyama, Yutaka] Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan	Nishiyama, Y (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan.	nishiya@kansai-u.ac.jp			MEXT; Kansai University	Contract grant sponsor: MEXT-Supported Program for the Strategic Research Foundation at Private Universities.; Contract grant sponsor: Grant-in-Aid for Scientific Research.; Contract grant sponsor: Kansai University Research Grants: Grant-in-Aid for Encouragement of Scientists.	AKAZOME M, 1992, CHEM LETT, P769, DOI 10.1246/cl.1992.769; Wang Y, 2013, ANGEW CHEM INT EDIT, V52, P5323, DOI 10.1002/anie.201300586; Yan RL, 2013, ORG LETT, V15, P4876, DOI 10.1021/ol402312h; Nishiyama Y, 1999, TETRAHEDRON LETT, V40, P5717, DOI 10.1016/S0040-4039(99)01080-1; Berman AM, 2010, J ORG CHEM, V75, P7863, DOI 10.1021/jo101793r; Scott TL, 2006, TETRAHEDRON, V62, P10835, DOI 10.1016/j.tet.2006.08.100; Abbiati G, 2006, ORG LETT, V8, P4839, DOI 10.1021/ol061872u; Yu DG, 2009, ORG LETT, V11, P3374, DOI 10.1021/ol901217m; Ji XC, 2012, ANGEW CHEM INT EDIT, V51, P7292, DOI 10.1002/anie.201202412; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; AKAZOME M, 1994, J ORG CHEM, V59, P3375, DOI 10.1021/jo00091a026; Kouznetsov VV, 2005, CURR ORG CHEM, V9, P141, DOI 10.2174/1385272053369196; Zhang XS, 2013, EUR J ORG CHEM, V2013, P6530, DOI 10.1002/ejoc.201301115; Umeda R, 2011, HETEROATOM CHEM, V22, P571, DOI 10.1002/hc.20685; Okuro K, 2011, J ORG CHEM, V76, P4715, DOI 10.1021/jo200320k; Berman AM, 2008, J AM CHEM SOC, V130, P14926, DOI 10.1021/ja8059396; Arthuis M, 2009, ORG LETT, V11, P4608, DOI 10.1021/ol901875z; Cenini S, 1996, J MOL CATAL A-CHEM, V111, P37, DOI 10.1016/1381-1169(96)00123-9; Chen JZ, 2003, TETRAHEDRON, V59, P8251, DOI 10.1016/j.tet.2003.08.035; Chen JZ, 2004, ADV SYNTH CATAL, V346, P1267, DOI 10.1002/adsc.200404077; Cummings MM, 2011, TETRAHEDRON, V67, P4753, DOI 10.1016/j.tet.2011.04.107; Funayama S, 2001, HETEROCYCLES, V54, P1139; Jeganmohan M, 2010, ANGEW CHEM INT EDIT, V49, P8520, DOI 10.1002/anie.201003558; Jones G., 1996, COMPREHENSIVE HETE 2, V5, P167; Jones G., 1984, COMPREHENSIVE HETERO, V2, P395; KONDO K, 1979, ANGEW CHEM INT EDIT, V18, P691, DOI 10.1002/anie.197906911; Liu XZ, 2005, CHINESE J CATAL, V26, P74; Liu XZ, 2004, CHINESE J CATAL, V25, P597; Liu XZ, 2003, CHINESE J CATAL+, V24, P731; Liu XZ, 2004, J MOL CATAL A-CHEM, V212, P127, DOI 10.1016/j.molcata.2003.12.004; Liu XZ, 2009, J MOL CATAL A-CHEM, V300, P36, DOI 10.1016/j.molcata.2008.10.014; Mei JT, 2003, CHINESE J CATAL+, V24, P321; Mei J., 2002, HUAXUE JINZHAN, V14, P433; Michael JP, 2001, NAT PROD REP, V18, P543, DOI 10.1039/b005387m; MIYATA T, 1987, NIPPON KAGAKU KAISHI, P1332; Miyata T., 1991, HETEROATOM CHEM, V4, P473, DOI 10.1002/hc.520020409; Nishiyama Y, 2006, SYNLETT, P109, DOI 10.1055/s-2005-922771; Nishiyama Y, 2002, TETRAHEDRON LETT, V43, P1855, DOI 10.1016/S0040-4039(02)00035-7; Nishiyama Y, 2004, SYNLETT, P886, DOI 10.1055/s-2004-820018; SONODA N, 1980, ANGEW CHEM INT EDIT, V19, P308, DOI 10.1002/anie.198003082; Umeda R., 2013, HETEROCYCLES, V57, P1249; Wagman A. S., 2006, COMPREHENSIVE MED CH, V7, P567; Wang XB, 2005, TRIQUARTERLY, P26; Wang XF, 2004, ADV SYNTH CATAL, V346, P929, DOI 10.1002/adsc.200303244; Wang XF, 2006, J MOL CATAL A-CHEM, V253, P261, DOI 10.1016/j.molcata.2006.03.048; Xue Y, 2001, CHINESE J CATAL+, V22, P387; Yang Y., 1999, CHINESE J CATAL, V20, P224; Yang Y, 1999, TETRAHEDRON LETT, V40, P4845, DOI 10.1016/S0040-4039(99)00890-4; Zhang X., 2012, HUAXUE TONGBAO, V75, P368; Zhang XP, 2005, SYNLETT, P1535, DOI 10.1055/s-2005-869839; Zhang XP, 2008, PROG CHEM, V20, P1102; Zhang XP, 2008, J CHEM RES, P589, DOI 10.3184/030823408X360346; Zhang XP, 2009, J MOL CATAL A-CHEM, V302, P137, DOI 10.1016/j.molcata.2008.12.012; Zhang YC, 2012, ORG LETT, V14, P2206, DOI 10.1021/ol300391t; Zhang ZH, 2008, ORG LETT, V10, P173, DOI 10.1021/ol702153x	55	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7163	1098-1071		HETEROATOM CHEM	Heteroatom Chem.	NOV	2014	25	6			SI		698	703		10.1002/hc.21189		6	Chemistry, Multidisciplinary	Chemistry	AT0WL	WOS:000344653000024		
J	Mizuki, Y; Takaki, M; Okahisa, Y; Sakamoto, S; Kodama, M; Ujike, H; Uchitomi, Y				Mizuki, Yutaka; Takaki, Manabu; Okahisa, Yuko; Sakamoto, Shinji; Kodama, Masafumi; Ujike, Hiroshi; Uchitomi, Yosuke			Human Rho guanine nucleotide exchange factor 11 gene is associated with schizophrenia in a Japanese population	HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL			English	Article						ARHGEF11; case-control study; schizophrenia; type 2 diabetes mellitus	DRUG-NAIVE PATIENTS; SUSCEPTIBILITY LOCUS; GLUCOSE-TOLERANCE; THALAMUS; 1ST-EPISODE; DISC1	ObjectiveThe human Rho guanine nucleotide exchange factor 11 (ARHGEF11) gene is one of the candidate genes for type 2 diabetes mellitus (T2DM). ARHGEF11 is mapped to chromosome 1q21, which has susceptible risk loci for T2DM and schizophrenia. We hypothesized that ARHGEF11 contributes to the pathogenesis of schizophrenia. MethodWe selected eight single nucleotide polymorphisms of ARHGEF11 that had significant associations with T2DM for a case-control association study of 490 patients with schizophrenia and 500 age-matched and sex-matched controls. ResultsWe did not find any differences in allelic, genotypic associations, or minor allele frequencies with schizophrenia. Analysis of the rs6427340-rs6427339 haplotype and the rs822585-rs6427340-rs6427339 haplotype combination provided significant evidence of an association with schizophrenia (global permutations p=0.00047 and 0.0032, respectively). C-C of the rs6427340-rs6427339 haplotype and A-C-C of the rs822585-rs6427340-rs6427339 haplotype carried higher risk factors for schizophrenia (permutation p=0.0010 and 0.0018, respectively). A-C-T of the rs822585-rs6427340-rs6427339 haplotype had a possible protective effect (permutation p=0.031). ConclusionThese results provide new evidence that ARHGEF11 may constitute a risk factor for schizophrenia. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Mizuki, Yutaka; Takaki, Manabu; Okahisa, Yuko; Sakamoto, Shinji; Kodama, Masafumi; Ujike, Hiroshi; Uchitomi, Yosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama 7008558, Japan	Takaki, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	manabuta@cc.okayama-u.ac.jp			Kobayashi Magobe Memorial Medical Foundation; Okayama Medical Foundation; Research Group for Schizophrenia	This work was supported in part by grants from the Kobayashi Magobe Memorial Medical Foundation (Yutaka Mizuki), the Okayama Medical Foundation (Manabu Takaki), and the Research Group for Schizophrenia (Manabu Takaki). The authors would like to thank the Zikei Institute of Psychiatry (Okayama, Japan). We thank all the subjects who participated in this study. All authors declare that they have no conflict of interest.	Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Scheen AJ, 2007, DIABETES METAB, V33, P169, DOI 10.1016/j.diabet.2007.01.003; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Guest PC, 2010, MOL PSYCHIATR, V15, P118, DOI 10.1038/mp.2009.81; Byne W, 2009, ACTA NEUROPATHOL, V117, P347, DOI 10.1007/s00401-008-0404-0; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Böttcher Yvonne, 2008, J Hum Genet, V53, P365, DOI 10.1007/s10038-008-0252-8; Bushe Chris, 2004, Br J Psychiatry Suppl, V47, pS67; Dass SK, 2007, CURR DIABETES REP, V7, P154; Davidkova G, 2003, ANN NY ACAD SCI, V1003, P375, DOI 10.1196/annals.1300.030; Fus M, 2007, DIABETES, V56, P1363; Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Huerta Ibone, 2006, Synapse, V59, P394, DOI 10.1002/syn.20250; Jins QS, 2010, KOREAN DIABETES J, V34, P368; Lins PI, 2010, SCHIZOPHR RES, V123, P234; Lius J, 2011, MOL BIOL REP, V38, P2499; Luos L., 2000, NAT REV NEUROSCI, V1, P173; Martinez-Granados B, 2008, SCHIZOPHR RES, V104, P13, DOI 10.1016/j.schres.2008.05.025; Mas L, 2007, DIABETES, V56, P1454; Mirnics K, 2001, TRENDS MOL MED, V7, P281, DOI 10.1016/S1471-4914(01)02067-6; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Suvisaari J, 2008, EUR ARCH PSY CLIN N, V258, P129, DOI 10.1007/s00406-007-0762-y	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6222	1099-1077		HUM PSYCHOPHARM CLIN	Hum. Psychopharmacol.-Clin. Exp.	NOV	2014	29	6					552	558		10.1002/hup.2435		7	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry; Psychology	AT2QZ	WOS:000344780400006		
J	Utsuno, H; Miyamoto, T; Oka, K; Shiozawa, T				Utsuno, H.; Miyamoto, T.; Oka, K.; Shiozawa, T.			Morphological alterations in protamine-deficient spermatozoa	HUMAN REPRODUCTION			English	Article						spermatozoa; morphology; protamines; TUNEL; vacuoles	HUMAN SPERM MORPHOLOGY; CHROMATIN CONDENSATION; HIGH MAGNIFICATION; HEAD VACUOLES; DNA-DAMAGE; CHROMOMYCIN A(3); PREDICTIVE VALUE; STRICT CRITERIA; MALE-FERTILITY; ANILINE BLUE	How are protamine deficiencies associated with sperm head morphology in subfertile men? The prevalence of morphological variations and large nuclear vacuoles was slightly higher in protamine-deficient spermatozoa than in non-deficient spermatozoa. A protamine deficiency was previously reported to be associated with an abnormal sperm morphology; however, how they are related to each other remains unclear. This is further confounded by a number of protamine-deficient spermatozoa having a normal head morphology. This is a cross-sectional study, including 36 men diagnosed with male factor infertility or participating in an assisted reproduction program. To assess sperm head morphology, this study analyzed 2400 spermatozoa with a protamine deficiency and 2400 spermatozoa with a normal protamine status. An additional 21 men were analyzed to examine DNA fragmentation and its relationship with protamine deficiencies and sperm head morphologies. The morphology of the sperm head was evaluated based on its shape, size and nuclear vacuoles at a magnification of > 6000x. Using elliptic Fourier analysis, the shape was summarized into four numeric variables. The protamine status was evaluated with chromomycin A(3) (CMA(3)). Sperm head size, vacuoles and shape were compared between protamine-deficient and non-deficient spermatozoa. DNA fragmentation was evaluated with the terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) assay. The percentages of protamine-deficient spermatozoa and DNA fragmentation were compared between spermatozoa with morphologically normal heads and those with abnormal heads. Variations in head size (P < 0.0001) and shape (P < 0.0001) were significantly higher, with narrower (P < 0.001), more fan-shaped (P < 0.01) and more square-shaped forms (P < 0.001) in protamine-deficient spermatozoa than in non-deficient spermatozoa; however, the distribution of morphological variations markedly overlapped. Protamine deficiencies were more frequently observed in spermatozoa with large nuclear vacuoles than in those without them (32.0 +/- 3.1 versus 39.4 +/- 2.9%, P < 0.001). The percentage of protamine-deficient spermatozoa was significantly lower in spermatozoa with a normal head morphology than in those with an abnormal head morphology (25.4 +/- 2.6 versus 38.0 +/- 2.5%, P < 0.001). The percentage of DNA fragmentation was significantly higher in protamine-deficient spermatozoa than in non-deficient spermatozoa (11.3 +/- 2.1 versus 1.6 +/- 0.6%, P < 0.001), and was lower in spermatozoa with a normal head morphology than in those with an abnormal head morphology (2.6 +/- 0.7 versus 6.4 +/- 0.2%, P < 0.001). We were unable to discriminate the kind of protamines or quantify the extent of the protamine deficiency in spermatozoa using the CMA(3) staining method. This study provided a novel insight into how abnormal protamination affects sperm head morphology as well as the relationship between sperm head morphology and its own molecular integrity. Our results will contribute to a deeper understanding of the benefits and limitations of the morphological selection of spermatozoa for ICSI. This study was supported by a JSPS Grant-in-Aid for the Encouragement of Scientists (25931009, 26931010). All authors have no conflicts of interest to disclose. N/A.	[Utsuno, H.; Miyamoto, T.; Oka, K.; Shiozawa, T.] Shinshu Univ, Dept Obstet & Gynecol, Matsumoto, Nagano 390, Japan	Miyamoto, T (reprint author), Shinshu Univ, Dept Obstet & Gynecol, Matsumoto, Nagano 390, Japan.	tmiya@shinshu-u.ac.jp			JSPS [25931009, 26931010]	This study was supported by a JSPS Grant-in-Aid for the Encouragement of Scientists (25931009, 26931010).	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727; Angelopoulos T, 1998, FERTIL STERIL, V69, P740, DOI 10.1016/S0015-0282(98)00016-8; Zini A, 2009, FERTIL STERIL, V91, P2495, DOI 10.1016/j.fertnstert.2008.03.032; Maree L, 2010, HUM REPROD, V25, P1369, DOI 10.1093/humrep/deq075; Avendano C, 2009, FERTIL STERIL, V91, P1077, DOI 10.1016/j.fertnstert.2008.01.015; Aitken RJ, 2010, MOL HUM REPROD, V16, P3, DOI 10.1093/molehr/gap059; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Franco JG, 2012, INT J ANDROL, V35, P46, DOI 10.1111/j.1365-2605.2011.01154.x; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; ZAMBONI L, 1987, FERTIL STERIL, V48, P711; Aoki VW, 2005, J ANDROL, V26, P741, DOI 10.2164/jandrol.05063; Van Waart J, 2001, HUM REPROD UPDATE, V7, P495, DOI 10.1093/humupd/7.5.495; Perdrix A, 2011, HUM REPROD, V26, P47, DOI 10.1093/humrep/deq297; Carrell DT, 2008, INT J ANDROL, V31, P537, DOI 10.1111/j.1365-2605.2008.00872.x; Corzett M, 2002, MOL REPROD DEV, V61, P519, DOI 10.1002/mrd.10105; HOFMANN N, 1991, HUM REPROD, V6, P979; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Cassuto NG, 2012, REPROD BIOMED ONLINE, V24, P211, DOI 10.1016/j.rbmo.2011.10.006; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; Perdrix A, 2013, HUM REPROD UPDATE, V19, P527, DOI 10.1093/humupd/dmt021; De Iuliis GN, 2009, BIOL REPROD, V81, P517, DOI 10.1095/biolreprod.109.076836; Boitrelle F, 2011, HUM REPROD, V26, P1650, DOI 10.1093/humrep/der129; KRUGER TF, 1988, FERTIL STERIL, V49, P112; Auger J, 2010, ASIAN J ANDROL, V12, P36, DOI 10.1038/aja.2009.8; BIANCHI PG, 1993, BIOL REPROD, V49, P1083, DOI 10.1095/biolreprod49.5.1083; Bianchi P G, 1996, Mol Hum Reprod, V2, P139, DOI 10.1093/molehr/2.3.139; Bianchi PG, 1996, J ASSIST REPROD GEN, V13, P246, DOI 10.1007/BF02065944; Bizzaro D, 1998, MOL HUM REPROD, V4, P127, DOI 10.1093/molehr/4.2.127; Boitrelle F, 2013, REPROD BIOMED ONLINE, V27, P201, DOI 10.1016/j.rbmo.2013.05.004; EggertKruse W, 1996, HUM REPROD, V11, P139; Franken DR, 1999, ANDROLOGIA, V31, P361, DOI 10.1046/j.1439-0272.1999.00290.x; Hotaling JM, 2011, FERTIL STERIL, V95, P1141, DOI 10.1016/j.fertnstert.2010.09.029; Komiya A, 2013, REPROD MED BIOL, V13, P21; Iranpour FG, 2000, J ASSIST REPROD GEN, V17, P60, DOI 10.1023/A:1009406231811; MESCHEDE D, 1993, INT J ANDROL, V16, P362, DOI 10.1111/j.1365-2605.1993.tb01363.x; Oral E, 2002, ARCH ANDROLOGY, V48, P307, DOI 10.1080/01485010290031628; Tanaka A, 2012, FERTIL STERIL, V98, P315, DOI 10.1016/j.fertnstert.2012.04.034; Tarozzi N, 2009, REPROD BIOMED ONLINE, V18, P486; Utsuno H, 2013, FERTIL STERIL, V99, P1573, DOI 10.1016/j.fertnstert.2013.01.100; van der Merwe FH, 2005, GYNECOL OBSTET INVES, V59, P86, DOI 10.1159/000082368; World Health Organization, 2010, WHO LAB MAN EX PROC; Zhang SC, 2012, ULTRASTRUCT PATHOL, V36, P185, DOI 10.3109/01913123.2012.658988	42	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1161	1460-2350		HUM REPROD	Hum. Reprod.	NOV	2014	29	11					2374	2381		10.1093/humrep/deu225		8	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	AT1EJ	WOS:000344675700005		
J	Khan, KN; Fujishita, A; Kitajima, M; Hiraki, K; Nakashima, M; Masuzaki, H				Khan, Khaleque Newaz; Fujishita, Akira; Kitajima, Michio; Hiraki, Koichi; Nakashima, Masahiro; Masuzaki, Hideaki			Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis(aEuro)	HUMAN REPRODUCTION			English	Article						endometriosis; bacterial vaginosis; intra-uterine bacterial colonization; endometritis; GnRHa	HEPATOCYTE GROWTH-FACTOR; BACTERIAL VAGINOSIS; STROMAL CELLS; UTERINE MYOMA; GNRH AGONIST; PROLIFERATION; ADENOMYOSIS; INFECTION; RECEPTOR; PEPTIDE	Is there any risk of intra-uterine bacterial colonization and concurrent occurrence of endometritis in women with endometriosis? An increase in intra-uterine microbial colonization and concurrent endometritis occurred in women with endometriosis that was further increased after GnRH agonist (GnRHa) treatment. Higher bacterial contamination of menstrual blood and increased endotoxin level in menstrual and peritoneal fluids have been found in women with endometriosis than in control women. However, information on intra-uterine microbial colonization across the phases of the menstrual cycle and possible occurrence of endometritis in women with endometriosis is still lacking. This is a case-controlled study with prospective collection of vaginal smears/endometrial samples from women with and without endometriosis and retrospective evaluation. Vaginal smears and endometrial smears were collected from 73 women with endometriosis and 55 control women. Twenty of the women with endometriosis and 19 controls had received GnRHa therapy for a period of 4-6 months. Vaginal pH was measured by intra-vaginal insertion of a pH paper strip. The bacterial vaginosis (BV) score was analyzed by Gram-staining of vaginal smears and based on a modified Nugent-BV scoring system. A panel of bacteria was analyzed by culture of endometrial samples from women treated with GnRHa or not treated. Immunohistochemcial analysis was performed using antibody against Syndecan-1 (CD138) and myeloperoxidase in endometrial biopsy specimens from women with and without endometriosis. A significant shifting of intra-vaginal pH to a parts per thousand yen4.5 was observed in women with endometriosis compared with control women (79.3 versus 58.4%, P < 0.03). Compared with untreated women, use of GnRHa therapy also shifted vaginal pH to a parts per thousand yen4.5 in both control women (P = 0.004) and in women with endometriosis (P = 0.03). A higher risk of increasing intermediate flora (total score, 4-6) (P = 0.05) was observed in women with endometriosis who had GnRHa treatment versus untreated women. The number of colony forming units (CFU/ml) of Gardnerella, alpha-Streptococcus, Enterococci and Escherichia coli was significantly higher in endometrial samples from women with endometriosis than control women (P < 0.05 for each bacteria). GnRHa-treated women also showed significantly higher colony formation for some of these bacteria in endometrial samples than in untreated women (Gardnerella and E. coli for controls; Gardnerella, Enterococci and E. coli for women with endometriosis, P < 0.05 for all). Although there was no significant difference in the occurrence of acute endometritis between women with and without endometriosis, both GnRHa-treated controls and women with endometriosis had a significantly higher occurrence of acute endometritis (P = 0.003 for controls, P = 0.001 for endometriosis versus untreated women). Multiple analysis of covariance analysis revealed that an intra-vaginal pH of a parts per thousand yen4.5 (P = 0.03) and use of GnRHa (P = 0.04) were potential factors that were significantly and independently associated with intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis. These findings indicated the occurrence of sub-clinical uterine infection and endometritis in women with endometriosis after GnRHa treatment. We cannot exclude the introduction of bias from unknown previous treatment with immunosuppressing or anti-microbial agents. We have studied a limited range of bacterial species and used only culture-based methods. More sensitive molecular approaches would further delineate the similarities/differences between the vaginal cavity and uterine environment. Our current findings may have epidemiological and biological implications and help in understanding the pathogenesis of endometriosis and related disease burden. The worsening of intra-uterine microbial colonization and higher occurrence of endometritis in women with endometriosis who were treated with GnRHa identifies some future therapeutic avenues for the management, as well as prevention of recurrence, of endometriosis. Further studies are needed to examine intra-uterine colonization of a broad range of common bacteria as well as different viruses and their role in the occurrence of endometritis. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Sports, Culture, Science and Technology of Japan. There is no conflict of interest related to this study. Not applicable.	[Khan, Khaleque Newaz; Kitajima, Michio; Hiraki, Koichi; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan; [Fujishita, Akira] Saiseikai Nagasaki Hosp, Nagasaki, Japan; [Nakashima, Masahiro] Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan	Khan, KN (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nemokhan@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [21592101, 24592474]	This work was supported in part by Grants-in-aid for Scientific Research (Grant Nos 21592101 and 24592474) from the Japan Society for the Promotion of Science (to K.N.K.).	Canis M, 1997, FERTIL STERIL, V67, P817; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Khan KN, 2010, HUM REPROD, V25, P2878, DOI 10.1093/humrep/deq240; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Wilson JD, 2007, INT J STD AIDS, V18, P308, DOI 10.1258/095646207780749583; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Khan KN, 2004, FERTIL STERIL, V81, P652, DOI 10.1016/j.fertnstert.2003.07.037; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; Khan KN, 2008, AM J REPROD IMMUNOL, V60, P383, DOI 10.1111/j.1600-0897.2008.00643.x; HELLBERG D, 1995, GENITOURIN MED, V71, P88; Khan KN, 2005, HUM REPROD, V20, P2715, DOI 10.1093/humrep/dei156; Khan KN, 2012, HUM REPROD, V27, P3417, DOI 10.1093/humrep/des331; Khan KN, 2003, FERTIL STERIL, V79, P173, DOI 10.1016/S0015-0282(02)04535-1; Khan KN, 2009, GYNECOL OBSTET INVES, V68, P40, DOI 10.1159/000212061; Khan KN, 2010, FERTIL STERIL, V94, P2860, DOI 10.1016/j.fertnstert.2010.04.053; KIVIAT NB, 1990, AM J SURG PATHOL, V14, P167, DOI 10.1097/00000478-199002000-00008; Miyamoto A, 2009, AM J REPROD IMMUNOL, V61, P277, DOI 10.1111/j.1600-0897.2009.00691.x; Noda Y, 2007, KANTO J OBSTET GYNEC, V44, P3; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055	25	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1161	1460-2350		HUM REPROD	Hum. Reprod.	NOV	2014	29	11					2446	2456		10.1093/humrep/deu222		11	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	AT1EJ	WOS:000344675700013		
J	Oshima, N; Onimaru, H; Yamamoto, K; Takechi, H; Nishida, Y; Oda, T; Kumagai, H				Oshima, Naoki; Onimaru, Hiroshi; Yamamoto, Kojiro; Takechi, Hanako; Nishida, Yasuhiro; Oda, Takashi; Kumagai, Hiroo			Expression and functions of beta(1)- and beta(2)-adrenergic receptors on the bulbospinal neurons in the rostral ventrolateral medulla	HYPERTENSION RESEARCH			English	Article						beta-adrenergic receptor; immunofluorescence; metoprolol; RVLM neurons; whole-cell patch-clamp	SPONTANEOUSLY HYPERTENSIVE-RATS; ADRENERGIC-RECEPTORS; BRAIN-STEM; C1 NEURONS; IN-VITRO; ADRENOCEPTOR ANTAGONISTS; NERVE ACTIVITY; NEONATAL-RAT; NEWBORN RATS; MECHANISM	The expression and effects of beta-adrenergic receptors (beta-ARs) on the neurons of the bulbospinal rostral ventrolateral medulla (RVLM) have been limitedly examined to date. The objective of this study was to examine the expression of beta(1)-and beta(2)-ARs on the bulbospinal RVLM neurons electrophysiologically and histologically. To directly investigate whether RVLM neurons display sensitivity to metoprolol (a beta(1)-AR antagonist), dobutamine (a beta(1)-AR agonist), butoxamine (a beta(2)-AR antagonist), and salbutamol (a beta(2)-AR agonist), we examined changes in the membrane potentials of the bulbospinal RVLM neurons using the whole-cell patch-clamp technique during superfusion of these drugs. During metoprolol superfusion, 16 of the 20 RVLM neurons were hyperpolarized, and 5 of the 6 RVLM neurons were depolarized during dobutamine superfusion. During butoxamine superfusion, 11 of the 16 RVLM neurons were depolarized, and all of the 8 RVLM neurons were hyperpolarized during salbutamol superfusion. These results suggest the expression of beta(1)-and beta(2)-ARs on the RVLM neurons. To determine the presence of beta(1)- and beta(2)-ARs histologically, immunofluorescence examination was performed. Five metoprolol-hyperpolarized neurons were examined for beta(1)-AR and tyrosine hydroxylase (TH) immunoreactivity. All of the neurons displayed beta(1)-AR immunoreactivity, whereas three of the neurons displayed TH immunoreactivity. All of the five RVLM neurons that became depolarized during metoprolol superfusion and hyperpolarized during butoxamine superfusion displayed beta(1)-and beta(2)-AR immunoreactivity. Our findings suggest that beta(1)-AR antagonists or beta(2)-AR agonists may decrease blood pressure through decreasing the activity of the bulbospinal RVLM neurons.	[Oshima, Naoki; Yamamoto, Kojiro; Takechi, Hanako; Oda, Takashi; Kumagai, Hiroo] Natl Def Med Coll, Dept Nephrol & Endocrinol, Tokorozawa, Saitama 3598513, Japan; [Onimaru, Hiroshi] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan; [Nishida, Yasuhiro] Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3598513, Japan	Oshima, N (reprint author), Natl Def Med Coll, Dept Nephrol & Endocrinol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	oshima@ndmc.ac.jp					ABRAHAMSSON T, 1989, DRUG METAB DISPOS, V17, P82; Amadi A, 1995, J Cardiovasc Risk, V2, P222, DOI 10.1097/00043798-199506000-00007; Qu LL, 2008, HIPPOCAMPUS, V18, P1131, DOI 10.1002/hipo.20478; Guo NN, 2007, NEUROSCIENCE, V146, P298, DOI 10.1016/j.neuroscience.2007.01.013; Oshima N, 2013, HYPERTENS RES, V36, P504, DOI 10.1038/hr.2012.224; KOEPKE JP, 1985, HYPERTENSION, V7, P350; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Abbott SBG, 2014, EUR J NEUROSCI, V39, P98, DOI 10.1111/ejn.12421; Matsuura T, 2002, HYPERTENSION, V40, P560, DOI 10.1161/01.HYP.0000032043.64223.87; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Madden CJ, 2003, CELL MOL NEUROBIOL, V23, P739, DOI 10.1023/A:1025000919468; Paschalis A, 2009, NEUROSCI LETT, V458, P84, DOI 10.1016/j.neulet.2009.04.023; Qian L, 2011, J IMMUNOL, V186, P4443, DOI 10.4049/jimmunol.1002449; Kasparov S, 2008, EXP PHYSIOL, V93, P725, DOI 10.1113/expphysiol.2007.041814; Berg T, 2010, HYPERTENSION, V55, P1224, DOI 10.1161/HYPERTENSIONAHA.109.149286; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; CHAMBA G, 1983, BRAIN RES, V259, P95, DOI 10.1016/0006-8993(83)91069-7; Chan CKS, 2007, J HYPERTENS, V25, P147, DOI 10.1097/HJH.0b013e3280105ef0; CHAN HC, 1994, BIOL REPROD, V51, P1040, DOI 10.1095/biolreprod51.5.1040; Chen SY, 2001, PROG NEURO-PSYCHOPH, V25, P1063, DOI 10.1016/S0278-5846(01)00170-1; CLAUSEN T, 1993, J PHYSIOL-LONDON, V472, P521; Cruickshank JM, 1980, CLIN SCI, V59, p453s; Gaiddon C, 1999, J NEUROCHEM, V73, P1467, DOI 10.1046/j.1471-4159.1999.0731467.x; Goyagi T, 2010, BRAIN RES, V1343, P213, DOI 10.1016/j.brainres.2010.04.079; Goyagi T, 2012, BRAIN RES, V1461, P96, DOI 10.1016/j.brainres.2012.04.040; Gu QH, 2007, J APPL PHYSIOL, V102, P1545, DOI 10.1152/japplphysiol.01010.2006; Hayar A, 1999, AM J PHYSIOL-HEART C, V277, pH1069; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Iigaya K, 2007, AM J PHYSIOL-REG I, V292, pR927, DOI 10.1152/ajpregu.00254.2006; Jacobus AP, 2005, HORM METAB RES, V37, P198, DOI 10.1055/s-2005-861414; Kawai A, 2006, J PHYSIOL-LONDON, V572, P525, DOI 10.1113/jphysiol.2005.102533; KOEPKE JP, 1986, CIRC RES, V58, P241; Lin HH, 1998, NEUROSCIENCE, V82, P429; Menegaz RG, 2001, AM J PHYSIOL-REG I, V281, pR98; Milner TA, 2008, NEUROSCI LETT, V431, P167, DOI 10.1016/j.neulet.2007.11.036; Morrison SF, 2003, CELL MOL NEUROBIOL, V23, P761, DOI 10.1023/A:1025005020376; Murchison CF, 2011, NEUROSCIENCE, V181, P109, DOI 10.1016/j.neuroscience.2011.02.049; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; Oshima N, 2000, AUTON NEUROSCI-BASIC, V84, P40, DOI 10.1016/S1566-0702(00)00179-X; Oshima N, 2012, HYPERTENS RES, V35, P500, DOI 10.1038/hr.2011.211; Oshima N, 2008, HYPERTENS RES, V31, P1445, DOI 10.1291/hypres.31.1445; PRIVITERA PJ, 1988, J PHARMACOL EXP THER, V246, P529; Schreihofer AM, 2000, AM J PHYSIOL-REG I, V279, pR1753; SUN MK, 1990, BRAIN RES, V511, P30, DOI 10.1016/0006-8993(90)90222-W; TSUSHIMA H, 1994, JPN J PHARMACOL, V64, P201, DOI 10.1254/jjp.64.201; Wang DW, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00144; White R, 2012, FILM QUART, V65, P4, DOI 10.1525/FQ.2012.65.3.04; Zlotnik A, 2012, J NEUROSURG ANESTH, V24, P30, DOI 10.1097/ANA.0b013e318232deaa	49	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2014	37	11					976	983		10.1038/hr.2014.112		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4XT	WOS:000344946500003		
J	Tomimatsu, T; Fujime, M; Kanayama, T; Mimura, K; Koyama, S; Kanagawa, T; Endo, M; Shimoya, K; Kimura, T				Tomimatsu, Takuji; Fujime, Mika; Kanayama, Tomoko; Mimura, Kazuya; Koyama, Shinsuke; Kanagawa, Takeshi; Endo, Masayuki; Shimoya, Koichiro; Kimura, Tadashi			Abnormal pressure-wave reflection in pregnant women with chronic hypertension: association with maternal and fetal outcomes	HYPERTENSION RESEARCH			English	Article						arterial stiffness; abnormal pressure-wave reflection; chronic hypertension; pregnancy; pulse-wave analysis	INTRAUTERINE GROWTH RESTRICTION; CENTRAL AORTIC PRESSURE; ARTERIAL PULSE-WAVE; AUGMENTATION INDEX; SOLUBLE ENDOGLIN; ANTIHYPERTENSIVE THERAPY; BLOOD-PRESSURE; PREECLAMPSIA; RISK; DISORDERS	The current study tested the hypothesis that abnormal pressure-wave reflection may have an important role in identifying pregnant women with chronic hypertension who might develop pre-eclampsia (PE) and/or fetal growth restriction. Pulse-wave analyses were performed to assess maternal arterial stiffness during 26-32 weeks of gestation in 41 women with chronic hypertension. We measured the central systolic pressure (CSP) and augmentation index (AIx) noninvasively using pulse waveforms of the radial artery with an automated applanation tonometric system. In a multiple regression analysis that included AIx-75 (AIx at a heart rate of 75 beats per minute), brachial systolic pressure, maternal height, smoking status, gestational age at testing and the presence of antihypertensive treatment at testing as independent determinants, AIx-75 was the only significant determinant of birth weight, whereas the brachial systolic pressure was not. In pregnant women with chronic hypertension who subsequently developed both superimposed PE and fetal growth restriction, CSP, AIx, AIx-75, and the brachial systolic and pulse pressures were all significantly higher than those who did not develop superimposed PE nor small for gestational age. In contrast, AIx-75 was the only significantly elevated hemodynamic parameter in patients who developed fetal growth restriction but not superimposed PE. In addition, CSP was the only significantly elevated hemodynamic parameter in patients who developed superimposed PE but not fetal growth restriction. Abnormal pressure-wave reflection during 26-32 weeks of gestation showed a stronger correlation with birth weight than conventional brachial blood pressure. Our findings might provide new insight into the pathophysiology of fetal growth restriction as well as superimposed PE in pregnancies complicated with chronic hypertension.	[Tomimatsu, Takuji; Shimoya, Koichiro] Kawasaki Med Univ, Dept Obstet & Gynecol, Kurashiki, Okayama 7010192, Japan; [Fujime, Mika; Kanayama, Tomoko; Mimura, Kazuya; Koyama, Shinsuke; Kanagawa, Takeshi; Endo, Masayuki; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan	Tomimatsu, T (reprint author), Kawasaki Med Univ, Dept Obstet & Gynecol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	tomimatsu@med.kawasaki-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [T23592402, T25462555, T25462556, T24592493 T25462556, A00249080]	This study was supported in part by Grant-in-Aid for General Scientific Research (T23592402, T25462555, T25462556, T24592493 T25462556 and A00249080) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	American College of Obstetricians and Gynaecologist, 2001, OBSTET GYNECOL, V98, P177; Chirinos JA, 2005, HYPERTENSION, V45, P980, DOI 10.1161/01.HYP.0000165025.16381.44; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; London GM, 2001, HYPERTENSION, V38, P434; Lydakis C, 1999, AM J HYPERTENS, V12, P541, DOI 10.1016/S0895-7061(99)00031-X; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Domanski MJ, 1999, HYPERTENSION, V34, P375; Fujime M, 2012, HYPERTENS RES, V35, P633, DOI 10.1038/hr.2012.1; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1016/01.CIR.0000131515.03336.f8; Khalil A, 2012, ULTRASOUND OBST GYN, V40, P28, DOI 10.1002/uog.11183; Soga J, 2008, HYPERTENS RES, V31, P1293, DOI 10.1291/hypres.31.1293; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Melchiorre K, 2012, HYPERTENSION, V60, P437, DOI 10.1161/HYPERTENSIONAHA.112.194159; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; August P, 1999, CHESLEYS HYPERTENSIV, P605; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Cunningham FG, 2010, WILLIAMS OBSTET, P983; Funada J, 2010, ATHEROSCLEROSIS, V210, P268, DOI 10.1016/j.atherosclerosis.2009.11.003; Jia RZ, 2010, INT J GYNECOL OBSTET, V110, P61, DOI 10.1016/j.ijgo.2010.02.007; Kelly R., 1989, J VASC MED BIOL, V1, P142; Khalil A, 2010, ULTRASOUND OBST GYN, V35, P688, DOI 10.1002/uog.7611; Khalil A, 2009, OBSTET GYNECOL, V113, P646, DOI 10.1097/AOG.0b013e318197c392; Khalil AA, 2009, BJOG-INT J OBSTET GY, V116, P268, DOI 10.1111/j.1471-0528.2008.01906.x; Kohara K, 2005, AM J HYPERTENS, V18, p11S, DOI 10.1016/j.amjhyper.2004.10.010; Koopmans CM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.022; Nichols WW, 2005, AM J HYPERTENS, V18, P3, DOI 10.1016/j.amjhyper.2004.10.009; Nishida H, 1984, NIPPON SHINSEIJI GAK, V20, P90; Richardson CJ, 2009, ARTERY RES, V3, P24; Sibai BM, 2009, AM J OBSTET GYNECOL, V200, pe1; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Spasojevic M, 2005, BJOG-INT J OBSTET GY, V112, P1475, DOI 10.1111/j.1471-0528.2005.00701.x; Stepan H, 2007, J CLIN ENDOCR METAB, V92, P2831, DOI 10.1210/jc.2006-2774; Sugawara J, 2007, J HYPERTENS, V25, P375, DOI 10.1097/HJH.0b013e32801092ae; Tomimatsu T, 2013, EUR J OBSTET GYN R B, V169, P24, DOI 10.1016/j.ejogrb.2013.01.016	40	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2014	37	11					989	992		10.1038/hr.2014.109		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4XT	WOS:000344946500005		
J	Fujisaki, K; Tsuruya, K; Nakano, T; Taniguchi, M; Higashi, H; Katafuchi, R; Kanai, H; Nakayama, M; Hirakata, H; Kitazono, T				Fujisaki, Kiichiro; Tsuruya, Kazuhiko; Nakano, Toshiaki; Taniguchi, Masatomo; Higashi, Harumichi; Katafuchi, Ritsuko; Kanai, Hidetoshi; Nakayama, Masaru; Hirakata, Hideki; Kitazono, Takanari		Impact Combined Losartan Hydrochlo	Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension	HYPERTENSION RESEARCH			English	Article						angiotensin II type 1 receptor blocker; chronic kidney disease; hydrochlorothiazide	TIMED URINE COLLECTIONS; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; PROGNOSTIC-SIGNIFICANCE; ARTERIAL-HYPERTENSION; CLINICAL-PRACTICE; CIRCADIAN-RHYTHM; NEPHROPATHY; INHIBITION; GUIDELINES	It is unknown whether the use of diuretics is optimal over other antihypertensive agents in patients with chronic kidney disease (CKD) whose blood pressure remains uncontrolled despite treatment with renin-angiotensin system (RAS) inhibitors. In this study, we assessed the additive effects of hydrochlorothiazide (HCTZ) on reducing proteinuria in CKD patients under treatment with losartan (LS). We conducted a multicenter, open-labeled, randomized trial. One hundred and two CKD patients with hypertension and overt proteinuria were recruited from nine centers and randomly assigned to receive either LS (50 mg, n = 51) or a combination of LS (50mg per day) and HCTZ (12.5 mg per day) (LS/HCTZ, n = 51). The primary outcome was a decrease in the urinary protein-to-creatinine ratio (UPCR). The target blood pressure was <130/80 mmHg, and antihypertensive agents (other than RAS inhibitors and diuretics) were added if the target was not attained. Baseline characteristics of the two groups were similar. After 12 months of treatment, decreases in the UPCR were significantly greater in the LS/HCTZ group than in the LS group. There were no significant differences in blood pressure or the estimated glomerular filtration rate between the two groups. LS/HCTZ led to a greater reduction in proteinuria than treatment with LS, even though blood pressure in the LS group was similar to that in the LS/HCTZ group following the administration of additive antihypertensive agents throughout the observation period. This finding suggests that LS/HCTZ exerts renoprotective effects through a mechanism independent of blood pressure reduction.	[Fujisaki, Kiichiro; Tsuruya, Kazuhiko; Nakano, Toshiaki; Taniguchi, Masatomo; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 8128582, Japan; [Higashi, Harumichi] St Marys Hosp, Dept Nephrol, Kurume, Fukuoka, Japan; [Katafuchi, Ritsuko] Natl Fukuoka Higashi Med Ctr, Kidney Unit, Koga, Japan; [Kanai, Hidetoshi] Kokura Mem Hosp, Div Nephrol, Kitakyushu, Fukuoka, Japan; [Nakayama, Masaru] Natl Kyushu Med Ctr Hosp, Dept Internal Med, Div Nephrol, Fukuoka, Japan; [Nakayama, Masaru] Natl Kyushu Med Ctr Hosp, Clin Res Inst, Dept Internal Med, Fukuoka, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Uzu T, 1997, CIRCULATION, V96, P1859; Bakris GL, 2008, KIDNEY INT, V73, P1303, DOI 10.1038/ki.2008.102; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; [Anonymous], 2004, KIDNEY INT S; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Uzu T, 1999, CIRCULATION, V100, P1635; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Uzu T, 2005, J HYPERTENS, V23, P861, DOI 10.1097/01.hjh.0000163156.37363.47; KANNEL WB, 1984, AM HEART J, V108, P1347, DOI 10.1016/0002-8703(84)90763-4; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Buter H, 1997, NEPHROL DIAL TRANSPL, V12, P53; De Leeuw PW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027871.86296.92; Gai M, 2006, SCAND J CLIN LAB INV, V66, P299, DOI 10.1080/00365510600608563; Gaspari F, 2006, AM J KIDNEY DIS, V47, P1, DOI 10.1053/ajkd.2005.10.014; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS93; Shidham G, 2006, AM J KIDNEY DIS, V47, P8, DOI 10.1053/j.ajkd.2005.10.013; Skalska A, 2005, AM J HYPERTENS, V18, P1130, DOI 10.1016/j.amjhyper.2005.03.731; TAGUMA Y, 1985, NEW ENGL J MED, V313, P1617, DOI 10.1056/NEJM198512263132601; Wassertheil-Smoller S, 2004, JAMA-J AM MED ASSOC, V292, P2849, DOI 10.1001/jama.292.23.2849	28	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2014	37	11					993	998		10.1038/hr.2014.110		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4XT	WOS:000344946500006		
J	Takiwaki, M; Tomoda, F; Koike, T; Taki, T; Inoue, H; Kigawa, M; Kitajima, I; Uji, Y				Takiwaki, Masaki; Tomoda, Fumihiro; Koike, Tsutomu; Taki, Tomohiko; Inoue, Hiroshi; Kigawa, Mika; Kitajima, Isaso; Uji, Yoshinori			Increased levels of small dense low-density lipoprotein cholesterol associated with hemorheological abnormalities in untreated, early-stage essential hypertensives	HYPERTENSION RESEARCH			English	Article						atherosclerosis; blood viscosity; dyslipidemia; essential hypertension; small dense low-density lipoprotein cholesterol	WHOLE-BLOOD VISCOSITY; ISCHEMIC-HEART-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ARTERIAL-HYPERTENSION; CARDIAC-HYPERTROPHY; INSULIN-RESISTANCE; LDL CHOLESTEROL; RISK-FACTOR; RHEOLOGY	Among subfractions of low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (SdLDL-C) has been highlighted as the most atherogenic lipoprotein cholesterol. The present study aimed to compare the relationship of SdLDL-C with blood viscosity, a surrogate marker for cardiovascular disease, with that of other lipid fractions with blood viscosity in essential hypertensives (EHTs). In 128 untreated, early-stage EHTs, blood viscosity was measured with a falling-ball microviscometer, and serum levels of lipid fractions were determined. Blood and plasma viscosity was significantly higher in 49 patients with dyslipidemia (fasting serum level of LDL-C > 140 mgdl(-1), triglyceride 4150 mgdl(-1) or high-density lipoprotein cholesterol (HDL-C) < 40 mgdl(-1)) compared with 79 patients without dyslipidemia, although hematocrit and RBC rigidity index 'k' did not differ between the two groups. Together, SdLDL-C, LDL-C, triglyceride and large LDL-C were positively correlated with blood viscosity, but for HDL-C, the correlation was negative. After adjusting for non-lipid variables that correlated with blood viscosity (that is, the age, body mass index, resting diastolic blood pressure, sex, hematocrit, plasma viscosity and homeostasis model of assessment of insulin resistance), SdLDL-C was most strongly associated with blood viscosity among the lipid fractions. These data suggest that SdLDL-C could strongly increase blood viscosity in EHTs.	[Takiwaki, Masaki; Kitajima, Isaso] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Lab & Mol Pathol, Toyama 9300194, Japan; [Tomoda, Fumihiro; Koike, Tsutomu; Taki, Tomohiko; Inoue, Hiroshi] Toyama Univ, Dept Internal Med 2, Toyama 9300194, Japan; [Kigawa, Mika] Toyama Univ, Dept Publ Hlth, Toyama 9300194, Japan; [Uji, Yoshinori] Fukuoka Int Univ Hlth & Welf, Sch Hlth Sci, Dept Med Technol & Sci, Fukuoka, Japan	Tomoda, F (reprint author), Toyama Univ, Dept Internal Med 2, Toyama 9300194, Japan.	tomoda@med.u-toyama.ac.jp					Aloulou I, 2006, CLIN HEMORHEOL MICRO, V35, P207; Arai H, 2013, J ATHEROSCLER THROMB, V20, P195; Ai M, 2010, CLIN CHEM, V56, P967, DOI 10.1373/clinchem.2009.137489; Hoieggen A, 1998, J HYPERTENS, V16, P203, DOI 10.1097/00004872-199816020-00011; Moriarty PM, 2005, CURR OPIN CARDIOL, V20, P318, DOI 10.1097/01.hco.0000167722.22453.47; Stamos TD, 1999, ATHEROSCLEROSIS, V146, P161, DOI 10.1016/S0021-9150(99)00114-8; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Hirayama S, 2012, CLIN CHIM ACTA, V414, P215, DOI 10.1016/j.cca.2012.09.010; LENG GC, 1994, PROSTAG LEUKOTR ESS, V51, P101, DOI 10.1016/0952-3278(94)90085-X; Banyai S, 2001, ATHEROSCLEROSIS, V159, P513, DOI 10.1016/S0021-9150(01)00532-9; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P45; DEVEREUX RB, 1984, AM J CARDIOL, V54, P592, DOI 10.1016/0002-9149(84)90255-8; Rizzo M, 2009, TRANSL RES, V153, P217, DOI 10.1016/j.trsl.2009.01.008; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; DESIMONE G, 1990, CIRCULATION, V81, P107; Wannamethee SG, 2005, ATHEROSCLEROSIS, V181, P101, DOI 10.1016/j.atherosclerosis.2004.12.031; Sloop GD, 1997, CLIN SCI, V92, P473; QUEMADA D, 1978, RHEOL ACTA, V17, P632, DOI 10.1007/BF01522036; Zicha J, 1999, AM J HYPERTENS, V12, P315, DOI 10.1016/S0895-7061(98)00178-2; Brook RD, 2000, AM J HYPERTENS, V13, p112S; Brun JF, 2002, CLIN HEMORHEOL MICRO, V26, P63; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Chabanel Anne, 1995, P365; Contreras T, 2004, CLIN HEMORHEOL MICRO, V30, P423; Cowan AQ, 2012, CARDIOVASC DRUG THER, V26, P339, DOI 10.1007/s10557-012-6402-4; FONS C, 1993, CLIN HEMORHEOL, V13, P651; Irace C, 2013, CLIN HEMORHEOL MICRO; Ito Y, 2011, CLIN CHEM, V57, P57, DOI 10.1373/clinchem.2010.149559; Jaeger BR, 2001, THER APHER, V5, P207, DOI 10.1046/j.1526-0968.2001.00289.x; KOENIG W, 1992, CIRCULATION, V85, P2197; Kondo T, 2011, EUR J CARDIOV PREV R, V18, P574, DOI 10.1177/1741826710389529; Lewington S, 2007, LANCET, V370, P1829; RICHTER WO, 1993, METABOLISM, V42, P888, DOI 10.1016/0026-0495(93)90065-V; Sharma SB, 2012, INDIAN J BIOCHEM BIO, V49, P77; Slyper A, 2005, METABOLISM, V54, P764, DOI 10.1016/j.metabol.2005.01.018; FOWKES FGR, 1993, EUR HEART J, V14, P597; SMITH WCS, 1992, J HYPERTENS, V10, P467, DOI 10.1097/00004872-199205000-00010; St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4; Sugimori H, 2013, HYPERTENS RES, V36, P247, DOI 10.1038/hr.2012.172; Sugimori H., 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/109830; Tan KCB, 1999, J CLIN ENDOCR METAB, V84, P3212, DOI 10.1210/jc.84.9.3212; TERANO T, 1983, ATHEROSCLEROSIS, V46, P321, DOI 10.1016/0021-9150(83)90181-8; ZANNAD F, 1988, J HYPERTENS, V6, P293	45	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2014	37	11					1008	1013		10.1038/hr.2014.111		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4XT	WOS:000344946500008		
J	Otsuka, K; Fukuda, S; Shimada, K; Suzuki, K; Nakanishi, K; Yoshiyama, M; Yoshikawa, J				Otsuka, Kenichiro; Fukuda, Shota; Shimada, Kenei; Suzuki, Kenji; Nakanishi, Koki; Yoshiyama, Minoru; Yoshikawa, Junichi			Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease	HYPERTENSION RESEARCH			English	Article						arterial stiffness; cardiovascular disease; prognosis	TYPE-2 DIABETIC-PATIENTS; INTIMA-MEDIA THICKNESS; BLOOD-PRESSURE; PITAVASTATIN; HEART; ATHEROSCLEROSIS; HYPERTENSION; ASSOCIATION; INDICATOR; PARAMETER	Arterial stiffness is a significant predictor of cardiovascular disease (CVD), the risk of which is modified by medications for atherosclerotic risk factors and life-style changes. Cardio-ankle vascular index (CAVI) provides noninvasive, objective information on arterial stiffness, independent of blood pressure. This study aimed to investigate changes in CAVI after management of atherosclerotic risk factors, and the impact of these changes on future CVD outcomes in patients with coronary artery disease (CAD). The study consisted of 211 CAD patients (65+/-10 years, 118 men) with impaired CAVI. CAVI examination was repeated 6 months later. Impaired CAVI was defined as greater than the mean plus 1 s.d. of the age-and gender-specific normal CAVI values, according to results obtained in 5188 healthy subjects. All patients were followed for >1 year or until the occurrence of a CVD event. Of the 211 patients, CAVI improved in 106 (50%) patients after 6 months, but remained high in 105 (50%) patients. During follow-up (2.9+/-1.0 years), CVD events occurred in 28 (13%) patients. Persistently impaired CAVI was an independent predictor of future CVD events (P = 0.01), independent of baseline CAVI. CVD outcomes were worse in patients with persistently impaired CAVI than in those with improved CAVI (P<0.001). Among patients with a normalized CAVI after treatment (n = 22) only one suffered a CVD event. This study was the first to demonstrate that persistent impairment of arterial stiffness was an independent risk factor of future CVD events. Serial measurements of CAVI provide important prognostic information regarding patients with CAD in clinical practice.	[Otsuka, Kenichiro; Shimada, Kenei; Nakanishi, Koki; Yoshiyama, Minoru] Osaka City Univ, Grad Sch Med, Dept Internal Med & Cardiol, Osaka 558, Japan; [Fukuda, Shota] Osaka Ekisaikai Hosp, Dept Med, Osaka 5500022, Japan; [Suzuki, Kenji] Japan Hlth Promot Fdn, Tokyo, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Cardiovasc Ctr, Nishinomiya, Hyogo, Japan	Fukuda, S (reprint author), Osaka Ekisaikai Hosp, Dept Med, Nishi Ku, 2-1-10 Honden, Osaka 5500022, Japan.	h-syouta@mve.biglobe.ne.jp					Wilson PWF, 1998, CIRCULATION, V97, P1837; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; van Bussel BC, 2011, HYPERTENSION, V58, P588, DOI 10.1161/HYPERTENSIONAHA.111.174557; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P49; Noike H, 2010, J ATHEROSCLER THROMB, V17, P517; Otsuka K, 2013, JACC-CARDIOVASC IMAG, V6, P448, DOI [10.1016/j.jcmg.2012.09.016, 10.1016/j.jcmg.2012.12.016]; Costanzo P, 2010, J AM COLL CARDIOL, V56, P2006, DOI 10.1016/j.jacc.2010.05.059; Takaki A, 2008, HYPERTENS RES, V31, P1347, DOI 10.1291/hypres.31.1347; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; SHEAR CL, 1992, CIRCULATION, V85, P1293; Miyashita Y, 2009, J ATHEROSCLER THROMB, V16, P539; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Nakamura K, 2008, CIRC J, V72, P598; Bots ML, 1997, CIRCULATION, V96, P1432; Satoh N, 2009, HYPERTENS RES, V32, P1004, DOI 10.1038/hr.2009.145; Takaki A, 2007, CIRC J, V71, P1710, DOI 10.1253/circj.71.1710; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Gibbons Raymond J., 2003, Journal of the American College of Cardiology, V41, P159, DOI 10.1016/S0735-1097(02)02848-6; Kono Y, 2013, DRUG DES DEV THER, V7, P369, DOI 10.2147/DDDT.S44099; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Nakanishi K, 2012, J CARDIOL, V59, P167, DOI 10.1016/j.jjcc.2011.11.010; Namekata T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-51; Ohira M, 2010, METABOLISM, V60, P78; Park HE, 2012, J CARDIOL, V60, P372, DOI 10.1016/j.jjcc.2012.07.005; Sakabe K, 2008, INT J CARDIOL, V125, P136, DOI 10.1016/j.ijcard.2007.01.040; Sasaki H, 2009, J ATHEROSCLER THROMB, V16, P568	29	3	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2014	37	11					1014	1020		10.1038/hr.2014.116		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4XT	WOS:000344946500009		
J	Kano, Y; Iida, M; Tetsuka, K; Saitoh, T; Kato, F; Sato, T; Nishida, S				Kano, Yuichi; Iida, Midori; Tetsuka, Kenshi; Saitoh, Toshihiro; Kato, Fumihiro; Sato, Tatsuro; Nishida, Shin			Effect of waterfalls on fluvial fish distribution and landlocked Rhinogobius brunneus populations on Yakushima Island, Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Biogeographic barrier; Fish migration; Mitochondrial DNA; Otolith Sr:Ca ratios; Rhinogobius sp DA	LAKE BIWA; RIVER; SPP.; GOBY	The distribution of fluvial fish was surveyed at 55 sites on Yakushima Island, Japan, which has precipitous mountains and waterfalls (below- or no-waterfall sites: 31; above-waterfall sites: 24). Eleven diadromous and one river resident (introduced Oncorhynchus masou masou) species were found, but absolutely no fish were detected at the 18 above-waterfall sites. Statistical analyses revealed that the presence of waterfalls (> 5 m in height) below the sites had a significant negative effect on fish distribution, suggesting that waterfalls prevent migration of diadromous fishes. We found Rhinogobius brunneus populations above high waterfalls such as Nunobiki Falls (50 m) and Ohko Falls (88 m). Otolith Sr:Ca ratios and mitochondrial DNA (cyt-b region) were examined to determine the migratory history and genetic properties of these populations; the Sr:Ca ratios indicated that the populations had a landlocked life cycle, whereas the genetic endemism/isolation of landlocked populations was unexpectedly absent. There is no clear explanation for this phenomenon, but fairly infrequent individuals of nonlandlocked type might have migrated beyond the waterfalls with their sucker-like organ and mated with landlocked populations, disrupting the genetic isolation of landlocked populations.	[Kano, Yuichi] Kyushu Univ, Ctr Asian Conservat Ecol, Nishi Ku, Fukuoka 8190395, Japan; [Iida, Midori] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan; [Tetsuka, Kenshi; Saitoh, Toshihiro] Yakushima Biodivers Conserving Conf, Kagoshima 8914203, Japan; [Kato, Fumihiro] Kyushu Univ, Amakusa Marine Biol Lab, Kumamoto 8632507, Japan; [Sato, Tatsuro] Kyushu Univ, Grad Sch, Dept Urban & Environm Engn, Nishi Ku, Fukuoka 8190395, Japan; [Nishida, Shin] Miyazaki Univ, Fac Educ & Culture, Miyazaki 8892192, Japan	Kano, Y (reprint author), Kyushu Univ, Ctr Asian Conservat Ecol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kano@species.jp	IIDA, Midori/C-4062-2011	IIDA, Midori/0000-0002-0294-1985	Global COE Program (Center of Excellence for Asian Conservation Ecology), MEXT, Japan; Cooperative Program of Atmosphere and Ocean Research Institute, the University of Tokyo; Japan Society for the Promotion of Science (JSPS)	We are grateful for the assistance provided by M. Oya, and K. Tsukamoto. The authors would like to thank Enago (www.enago.jp) for the English language review. This study was supported by the Global COE Program (Center of Excellence for Asian Conservation Ecology), MEXT, Japan. This study was partly supported by the Cooperative Program of Atmosphere and Ocean Research Institute, the University of Tokyo. M. Iida was partly supported by Research Fellowships of the Japan Society for the Promotion of Science (JSPS).	Abe S, 2007, HYDROBIOLOGIA, V575, P415, DOI 10.1007/s10750-006-0389-4; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akihito A., 2000, GENE, V259, P5; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; [Anonymous], 2014, WATCH; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Thorstad EB, 2008, REV FISH BIOL FISHER, V18, P345, DOI 10.1007/s11160-007-9076-4; Covich AP, 2009, FRESHWATER BIOL, V54, P450, DOI 10.1111/j.1365-2427.2008.02121.x; Sato T, 2011, ECOLOGY, V92, P201, DOI 10.1890/09-1565.1; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Burnham K. P., 2002, MODEL SELECTION MULT; EXCOFFIER L, 1992, GENETICS, V131, P479; Kano Y, 2012, ECOL EVOL, V2, P1805, DOI 10.1002/ece3.295; Kano Y, 2011, ENVIRON BIOL FISH, V92, P447, DOI 10.1007/s10641-011-9861-8; Kano Y, 2013, ICHTHYOL RES, V60, P293, DOI 10.1007/s10228-013-0349-8; Koblmuller S, 2012, AFR ZOOL, V47, P182; Kosmidis I., 2013, BRGLM BIAS REDUCTION; Kruse CG, 1997, T AM FISH SOC, V126, P418, DOI 10.1577/1548-8659(1997)126<0418:GIOTDO>2.3.CO;2; Markert JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-149; Maruyama A, 2004, ICHTHYOL RES, V51, P172, DOI 10.1007/s10228-003-0198-y; Mizuno N, 2005, FRESHWATER FISHES JA, P588; Musilova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065047; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakabo T., 2000, FISHES JAPAN PICTORI, V2nd; Oota I, 2006, YAKUSHIMA NO SANGAKU; Powers PD, 1985, ANAL BARRIERS UPSTRE; Pringle CM, 1997, ECOLOGY, V78, P2432; Sakai H, 2004, JPN J ICHTHYOL, V51, P175; Suzuki H, 2000, P BIOL SOC WASH, V113, P30; Takagi Motohiro, 2011, Ecology and Civil Engineering, V14, P35; Takahara H, 2002, J GEOGR, V111, P726; Takahashi S, 2002, ICHTHYOL RES, V49, P333, DOI 10.1007/s102280200049; Torrente-Vilara G, 2011, ECOL FRESHW FISH, V20, P588, DOI 10.1111/j.1600-0633.2011.00508.x; Tsunagawa T, 2008, J FISH BIOL, V73, P2421, DOI 10.1111/j.1095-8649.2008.02089.x; Willis SC, 2012, MOL PHYLOGENET EVOL, V63, P798, DOI 10.1016/j.ympev.2012.02.018; Yonezawa Toshihiko, 2010, P249	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					305	316		10.1007/s10228-014-0400-4		12	Zoology	Zoology	AT2DF	WOS:000344740800001		
J	Hibino, Y; Shibata, J; Kimura, S				Hibino, Yusuke; Shibata, Jun-ya; Kimura, Seishi			Description of a new snake eel, Apterichtus hatookai sp nov (Anguilliformes: Ophichthidae), from the Pacific coast of Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Ophichthidae; Apterichtus; New species; Japan; Pacific Ocean		A new species of snake eel (family Ophichthidae, subfamily Ophichthinae), Apterichtus hatookai, is described based on the 478.5 mm holotype and three paratypes, 265.0-519.4 mm in total length (TL), collected from the Pacific Ocean, off the coasts of Shikoku Island and central Honshu Island, Japan. The new species can be distinguished from its congeners, except for Apterichtus monodi and Apterichtus orientalis, by having seven supratemporal pores. The new species is distinguishable from A. monodi by having a longer tail (60.4-62.0 % TL vs. 57.4-60.2 %), four preopercular pores (vs. three), fewer lateral-line pores before the anus (54-58 vs. 63-68), and fewer total vertebrae (137-141 vs. 142-151). Apterichtus hatookai differs from A. orientalis in having a shorter head (5.1-6.1 % TL vs. 7.1-8.1 %; 13.3-16.0 % of preanal length vs. 16.2-18.0 %), a longer tail (60.4-62.0 % TL vs. 54.8-56.0 %), lower body depth at gill opening (0.9-1.5 % TL vs. 1.8-1.9; 2.3-3.8 % of preanal length vs. 4.1-4.2 %), more numerous total vertebrae (137-141 vs. 131-133), and by the anterior tip of the lower jaw below the center of the eye (vs. anterior to a vertical through anterior margin of eye).	[Hibino, Yusuke; Kimura, Seishi] Mie Univ, Fisheries Res Lab, Shima, Mie 5170703, Japan; [Shibata, Jun-ya] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan	Hibino, Y (reprint author), Mie Univ, Fisheries Res Lab, 4190-172 Wagu,Shima Cho, Shima, Mie 5170703, Japan.	513d303@m.mie-u.ac.jp					BLACHE J, 1972, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V34, P692; Bohlke J. E., 1968, Notulae Naturae, VNo. 415, P1; Castle P. H. J., 1999, Records of the Australian Museum, V51, P113; Dumeril A., 1806, ZOOLOGIE ANAL METHOD; Fricke R., 2013, GUIDE FISH COLLECTIO; Gilbert C.H, 1891, B US FISH COM, V9, P310; Jordan D.S., 1901, P US NATN MUS, V23, P837, DOI DOI 10.5479/SI.00963801.23-1239.837; Kaup J.J., 1856, ARCH NATURGESCH, V22, P41; Linnaeus C, 1758, SYSTEMA NATURAE ED X, VI; MACHIDA Y, 1994, JPN J ICHTHYOL, V41, P1; McCosker J.E., 1986, P176; McCosker JE, 2005, ZOOTAXA, P1; Myers G. S., 1941, Allan Hancock Pacific Expeditions 1932-40 Los Angeles, V9; Peters WCH, 1877, AKAD WISS BERLIN, V1876, P831; Roux C., 1966, Bull Mus natn Hist nat Paris (2), V37, P593; Smith DG, 1999, FAO SPECIES IDENTIFI, P1662; Snyder J.O., 1904, B US FISH COMM, V22, P513; Takagi M., 2010, FISHES AINAN EHIME; Weber M, 1913, FISCHE SIBOGA EXPEDI	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					317	321		10.1007/s10228-014-0398-7		5	Zoology	Zoology	AT2DF	WOS:000344740800002		
J	Shimose, T; Nanami, A				Shimose, Tamaki; Nanami, Atsushi			Age, growth, and reproductive biology of blacktail snapper, Lutjanus fulvus, around the Yaeyama Islands, Okinawa, Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Age; Blacktail snapper; Growth; Lunar spawning; Reproduction	GREAT-BARRIER-REEF; FISH SPAWNING AGGREGATIONS; SOUTHERN ARABIAN GULF; BLACKSPOT SNAPPER; PERCIFORMES LUTJANIDAE; ISHIGAKI ISLAND; RYUKYU ISLANDS; RED SNAPPER; AUSTRALIA; MORTALITY	Age, growth, and reproductive characteristics of blacktail snapper, Lutjanus fulvus, which is a commercial fish species, were investigated using 322 specimens (40-332 mm in fork length) caught around the Yaeyama Islands, Okinawa, Japan. Spawning season was estimated to be from April to October, and spawning was confirmed around the full moon and the last quarter moon. Age determination using sectioned otoliths revealed that ages ranged from 0 to 34 years and the majority was a parts per thousand yen 3 years. Parameters of the von Bertalanffy growth function were estimated to be L (a) = 270 mm, k = 0.40, and t (0) = -0.48 years for females, and 257 mm, 0.44, and -0.42 years for males. Initial growth was rapid during the first 3 years, attaining over 200 mm for both sexes, and then females grew larger than males. Sizes (ages) at the first sexual maturity were 225 mm (4 years) for females and 207 mm (3 years) for males. The wide range of age composition in catch with majority of a parts per thousand yen3 years old implied that the current fishing effort to harvest was not sufficiently large enough to collapse the stock immediately.	[Shimose, Tamaki; Nanami, Atsushi] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Ishigaki, Okinawa 9070451, Japan	Shimose, T (reprint author), Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, 148-446 Fukai Ohta, Ishigaki, Okinawa 9070451, Japan.	shimose@affrc.go.jp					Akita Y, 2011, ANN REP PREF FISH OC, V72, P17; Allen GR, 1985, FAO FISHERIES SYNOPS, V6; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Domeier ML, 1997, B MAR SCI, V60, P698; Shimose T, 2009, FISHERIES SCI, V75, P109, DOI 10.1007/s12562-008-0006-8; Heyman WD, 2008, B MAR SCI, V83, P531; Newman SJ, 2000, FISH RES, V48, P263, DOI 10.1016/S0165-7836(00)00184-3; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Wilson CA, 2001, FISH B-NOAA, V99, P653; Cappo M, 2000, FISH B-NOAA, V98, P474; DAVIS TLO, 1993, FISH B-NOAA, V91, P224; Ebisawa A, 1999, ICHTHYOL RES, V46, P341, DOI 10.1007/BF02673977; Fernandes CAF, 2012, NEOTROP ICHTHYOL, V10, P587; Fry G, 2009, FISHERIES SCI, V75, P145, DOI 10.1007/s12562-008-0034-4; Fry GC, 2009, FISHERIES SCI, V75, P1219, DOI 10.1007/s12562-009-0157-2; Grandcourt E, 2011, J APPL ICHTHYOL, V27, P1203, DOI 10.1111/j.1439-0426.2011.01776.x; Grandcourt EM, 2006, FISH RES, V78, P203, DOI 10.1016/j.fishres.2005.11.021; Grimes CB, 1987, TROPICAL SNAPPERS GR, P238; HAMAMOTO S, 1992, JPN J ICHTHYOL, V39, P219; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Luckhurst BE, 2000, MAR ECOL PROG SER, V203, P255, DOI 10.3354/meps203255; Marriott RJ, 2006, FISH RES, V80, P322, DOI 10.1016/j.fishres.2006.04.017; McPherson G.R., 1992, Asian Fisheries Science, V5, P15; Nakamura Y, 2008, MAR ECOL PROG SER, V355, P257, DOI 10.3354/meps07234; Nanami A, 2010, ICHTHYOL RES, V57, P314, DOI 10.1007/s10228-010-0155-5; Nanami A, 2010, ICHTHYOL RES, V57, P240, DOI 10.1007/s10228-010-0160-8; Newman SJ, 1996, MAR FRESHWATER RES, V47, P575, DOI 10.1071/MF9960575; Newman SJ, 2010, J APPL ICHTHYOL, V26, P120, DOI 10.1111/j.1439-0426.2009.01362.x; Polovina J., 1987, TROPICAL SNAPPERS GR; RANDALL JOHN E., 1960, TRANS AMER FISH SOC, V89, P9, DOI 10.1577/1548-8659(1960)89[9:OOTEOE]2.0.CO;2; Sadovy de Mitcheson Y, 2012, REEF FISH SPAWNING A, P458; Shimose T, 2005, FISHERIES SCI, V71, P48, DOI 10.1111/j.1444-2906.2005.00929.x; Shimose T, 2009, FISH RES, V100, P134, DOI 10.1016/j.fishres.2009.06.016; Shimose T, 2006, NIPPON SUISAN GAKK, V72, P6, DOI 10.2331/suisan.72.6; Shimose T, 2013, PAC SCI, V67, P15, DOI 10.2984/67.1.2	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					322	331		10.1007/s10228-014-0401-3		10	Zoology	Zoology	AT2DF	WOS:000344740800003		
J	Higuchi, M; Sakai, H; Goto, A				Higuchi, Masahito; Sakai, Harumi; Goto, Akira			A new threespine stickleback, Gasterosteus nipponicus sp nov (Teleostei: Gasterosteidae), from the Japan Sea region	ICHTHYOLOGICAL RESEARCH			English	Article						New species; Taxonomy; Morphology; Lateral plate; Anadromy	2 MIGRATORY FORMS; 3-SPINED STICKLEBACK; SYMPATRIC FORMS; REPRODUCTIVE ISOLATION; EASTERN HOKKAIDO; GENETIC-EVIDENCE; PACIFIC-OCEAN; FRESH-WATER; ACULEATUS; DIVERGENCE	Gasterosteus nipponicus sp. nov. is described from the holotype, 35 paratypes, and 60 additional specimens. The species differs from congeners in the following combination of characters: lateral plates complete, abruptly reducing in size above the anus, depth of lateral plate above the anus < 60 % that of the deepest plate; caudal keels thin, membranous. The new species is distributed in coastal Japan facing the Sea of Japan from Kyushu to Hokkaido Islands, along the Pacific coast of northern Japan from the Chiba Prefecture to Hokkaido, along the Sea of Okhotsk of Hokkaido, west to the southern and eastern coasts of Korean Peninsula, the Maritime Territory and north to Sakhalin Island, Russia.	[Higuchi, Masahito] Niigata Prefectural Govt, Sado Maritime Dist Fishery Coordinat Commiss, Niigata 9520006, Japan; [Sakai, Harumi] Natl Fisheries Univ, Dept Appl Aquabiol, Yamaguchi 7596595, Japan; [Goto, Akira] Hokkaido Univ, Dept Sci Environm Educ, Hakodate, Hokkaido 0408567, Japan	Sakai, H (reprint author), Natl Fisheries Univ, Dept Appl Aquabiol, 2-7-1 Nagata Honmachi, Yamaguchi 7596595, Japan.	higuchi.masahito@pref.niigata.lg.jp; sakaih@fish-u.ac.jp; akir@fish.hokudai.ac.jp					AMAOKA K, 1972, Japanese Journal of Ichthyology, V19, P129; Kitano J, 2012, ICHTHYOL RES, V59, P293, DOI 10.1007/s10228-012-0289-8; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; BELL MA, 1976, SYST ZOOL, V25, P211, DOI 10.2307/2412489; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Kottelat M, 1997, BIOLOGIA, V52, P1; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; MORI S, 1987, JPN J ICHTHYOL, V34, P165; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Kume M, 2011, ZOOL STUD, V50, P309; AOYAMA N, 2002, OUR LAKE SHINJI, P118; Arai T, 2003, J MAR BIOL ASSOC UK, V83, P223; Arai T, 2003, ICHTHYOL RES, V50, P90, DOI 10.1007/s102280300014; Bell MA, 1994, EVOLUTIONARY BIOL TH; Berg L. S., 1949, FRESHWATER FISHES US; BLOUW DM, 1990, BIOL J LINN SOC, V39, P195, DOI 10.1111/j.1095-8312.1990.tb00512.x; CHOI KC, 1983, ATLAS KOREAN FRESH W; Choi KC, 2002, COLOURED ILLUSTRATIO; Cuvier G, 1829, HIST NATURELLE POISO, V4; Cuvier G., 1829, REGNE ANIMAL DISTRIB, V2; Eschmeyer W. N., 1998, CATALOG FISHES, VI; Girard C., 1854, US ARMY P ACAD NAT S, V7, P129; GOTO A, 2003, NATURAL HIST THRESPI; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1673; HAGLUND TR, 1992, COPEIA, P432; HATAMA T, 2009, BULL YAMAGUCHI PREF, P19; HIRAI K, 1989, FRESHWATER FISHES OF, P433; HONMA Y, 1956, J FAC SCI NIIGATA UN, V2, P79; HOSOYA K, 2013, FISHES JAPAN PICTORI, P606; Hubbs C. L., 1958, B CRANBROOK I SCI, V26, P1; IKEDA H, 1937, SUISAN KENKYU SHI, V32, P1; IKEDA H, 1936, MAG NAT HIST, V34, P12; Ikeda K, 1933, ZOOL MAG TOKYO, V45, P141; Ikeda K., 1935, Bulletin of the Biogeographical Society Tokyo, V5, P213; INOUE N, 1983, ILLUSTR BOOK INL WAT, P48; ISHIKAWA K, 2000, BEHAVIOUR, V137, P1065; Ishikawa M, 2006, J FISH BIOL, V69, P938, DOI 10.1111/j.1095-8649.2006.01135.x; KATAYAMA M, 1971, B FAC ED YAMAGUCHI U, V21, P72; Katayama Satoshi, 2000, Bulletin of the Japanese Society of Fisheries Oceanography, V64, P209; Kim I. S., 1997, ILLUSTRATED ENCY FAU; Kitano J, 2008, BEHAVIOUR, V145, P443, DOI 10.1163/156853908792451430; Kume M, 2010, J EVOLUTION BIOL, V23, P1436, DOI 10.1111/j.1420-9101.2010.02009.x; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; Kume M, 2009, J FISH BIOL, V75, P2845, DOI 10.1111/j.1095-8649.2009.02472.x; KUME M, 2008, BIOL INLAND WATER, V23, P21; Lindberg G. U., 1972, LARGE SCALE FLUCTUAT; *LINN SOC LOND, 2007, LIB ARCH ONL COLL LI; Linnaeus C., 1758, SYSTEMA NATURAE REGN; McPhail J.D., 1994, P399; MCPHAIL JD, 1969, J FISH RES BOARD CAN, V26, P3183; MOODIE GEE, 1982, EVOLUTION, V36, P1096, DOI 10.2307/2408085; MORI F, 1997, FRESHWATER FISHES; MORI T, 1930, J CHOSEN NAT HIST SO, P1; Mori T., 1956, Mem Hyogo Univ Agric, V2, P1; NAKAJIMA J, 2009, B HOSHIZAKI GREEN FD, P285; NAKAMURA M, 1976, RES REPORTS ICTHYO F; NISHIMURA S, 1974, FORMATION SEA JAPAN; OKABE N, 2000, REPORTS FRESHWATER F; PALLAS PS, 1814, ACAD SCI IMP PEROPOL; PUTNAM FW, 1867, P ESSEX I, V5, P4; Regan C. T., 1909, Annals & Magazine of Natural History, V4; SAKAI H, 2013, B BIOGEOGR SOC JAPAN, V68, P57; SAKAI H, 2003, NATURAL HIST STICKLE, P23; Scott WB, 1973, FRESHWATER FISHES CA; SUGIYAMA H, 1985, FRESHWATER FISHES AK; TAJIMA M, 1995, FRESHWATER FISHES SA; TAKEUCHI M, 1994, FRESHWATER FISHES KU; TANIGUCHI N, 1990, JPN J ICHTHYOL, V37, P230; Tinbergen N., 1951, STUDY INSTINCT; van den Assem J., 1967, BEHAVIOUR S, V16, P1; Wootton R. J., 1976, BIOL STICKLEBACKS; Yamada M, 2001, ENVIRON BIOL FISH, V61, P269, DOI 10.1023/A:1010874117127; ZIUGANOV VV, 1987, ENVIRON BIOL FISH, V18, P241, DOI 10.1007/BF00004877	75	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					341	351		10.1007/s10228-014-0403-1		11	Zoology	Zoology	AT2DF	WOS:000344740800005		
J	Watanabe, K; Mori, S; Tanaka, T; Kanagawa, N; Itai, T; Kitamura, J; Suzuki, N; Tominaga, K; Kakioka, R; Tabata, R; Abe, T; Tashiro, Y; Hashimoto, Y; Nakajima, J; Onikura, N				Watanabe, Katsutoshi; Mori, Seiichi; Tanaka, Tetsuo; Kanagawa, Naoyuki; Itai, Takahiko; Kitamura, Jyun-ichi; Suzuki, Noriyasu; Tominaga, Koji; Kakioka, Ryo; Tabata, Ryoichi; Abe, Tsukasa; Tashiro, Yushu; Hashimoto, Yoshiki; Nakajima, Jun; Onikura, Norio			Genetic population structure of Hemigrammocypris rasborella (Cyprinidae) inferred from mtDNA sequences	ICHTHYOLOGICAL RESEARCH			English	Article						Cytochrome b (cytb); Molecular dating; Phylogeography; Secondary contact; Western Japan	FRESH-WATER FISHES; CYPRINIFORMES; DIVERSITY; JAPAN	The genetic population structure of the small cyprinid Hemigrammocypris rasborella, distributed widely in lowlands of western Japan, was examined using partial sequence data of mitochondrial DNA (mtDNA). Molecular phylogenetic analysis revealed that the populations of the western Kyushu region were markedly differentiated from all eastern populations, such that the groups would be comparable to different species; their divergence was inferred to have occurred in the Late Miocene-Pliocene. Also, a largely divergent mtDNA group (with divergence in the early Pleistocene) was found in the Sanyo and northeastern Shikoku regions, forming a secondary contact zone in the western Kinki with the eastern mtDNA group. To date, these aspects of the population structure of H. rasborella appear to be unique among lowland fishes in western Japan. Deeper understanding of the formation processes of freshwater faunas in western Japan will require further comparisons of the phylogeographic patterns and ecological traits of constituent species.	[Watanabe, Katsutoshi; Tominaga, Koji; Kakioka, Ryo; Tabata, Ryoichi] Kyoto Univ, Grad Sch Sci, Div Biol Sci, Dept Zool,Sakyo Ku, Kyoto 6068502, Japan; [Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Ogaki, Gifu 5038550, Japan; [Tanaka, Tetsuo] Museum Nat & Human Act, Sanda, Hyogo 6691546, Japan; [Itai, Takahiko] Museum Nat Hist, NPO Network Shizuoka Prefecture, Aoi Ku, Shizuoka 4200803, Japan; [Kitamura, Jyun-ichi] Mie Prefectural Museum, Tsu, Mie 5140061, Japan; [Suzuki, Noriyasu] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Suzuki, Noriyasu] Chiba Prefectural Govt, Environm & Community Affairs Dept, Nat Conservat Div, Chiba Biodivers Ctr,Chuo Ku, Chiba 2608682, Japan; [Abe, Tsukasa] Lago Co Ltd, Biodivers Res Div, Okayama Freshwater Fish Soc, Omihachiman, Shiga 5230821, Japan; [Tashiro, Yushu] Sanagochi Nat Ctr, Tokushima 7714102, Japan; [Hashimoto, Yoshiki] Conservat Fresh Water Fish Kagawa, Takamatsu, Kagawa 7610113, Japan; [Nakajima, Jun] Fukuoka Inst Hlth & Environm Sci, Fukuoka 8180135, Japan; [Onikura, Norio] Kyushu Univ, Fishery Res Lab, Fukuoka 8113304, Japan	Watanabe, K (reprint author), Kyoto Univ, Grad Sch Sci, Div Biol Sci, Dept Zool,Sakyo Ku, Kyoto 6068502, Japan.	watanak@terra.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21370035]; Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of Kyoto University	We thank T. Asaka, H. Egi, Z. Shimizu, M. Tsujio, N. Oshima, O. Masuda, S. Fujita, T. Tanimoto, Y. Yasui, and T. Nishioka for their help with obtaining the specimens. This study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (nos. 21370035), and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of Kyoto University).	Abe T, 2013, JPN J ICHTHYOL, V60, P49; Akada Jinsuke, 2006, Japanese Journal of Ichthyology, V53, P175; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Miyake T, 2011, CONSERV GENET, V12, P383, DOI 10.1007/s10592-010-0146-0; Aoyama J, 2000, ICHTHYOL RES, V47, P157, DOI 10.1007/BF02684236; Takeuchi H, 2011, ICHTHYOL RES, V58, P175, DOI 10.1007/s10228-010-0203-1; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Watanabe K, 2009, ICHTHYOL RES, V56, P411, DOI 10.1007/s10228-009-0107-0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Avise JC., 2000, PHYLOGEOGRAPHY HIST; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fowler H. W., 1910, Proceedings of the Academy of Natural Sciences of Philadelphia, V62; Japan Ministry of the Environment, 2003, THREAT WILDL JAP RED; Kanagawa N, 1998, SAKANA KARA MITA MIZ, P61; Kawabe T, 1994, BIWAKO NO SHIZENSHI, P24; Komiya T, 2014, ENVIRON BIOL FISH, V97, P741, DOI 10.1007/s10641-013-0176-9; Kuwashiro I, 1959, GEOGRAPHICAL REV JAP, V32, P24; Nakajima Jun, 2006, Bulletin of the Biogeographical Society of Japan, V61, P109; Nakamura M., 1969, CYPRINID FISHES JAPA; Nishimura S., 1974, NIHON KAI NO SEIRITS; Palumbi S.R., 1991, SIMPLE FOOLS GUIDE P; Rambaut A., 2009, FIGTREE VERSION 1 3; Rambaut A, 2009, TRACER VERSION 1 5; Rambaut A, 2009, REGIONAL GEOMORPHOLO; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Stieler Paul, 1907, Blaetter fuer Aquarienkunde Magdeburg, V18; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; UEDA K, 1989, Acta Phytotaxonomica et Geobotanica, V40, P190; Watanabe K, 2010, TANSUIGYORUI CHIRI N; Watanabe K, 2012, ENVIRON BIOL FISH, V94, P533, DOI 10.1007/s10641-010-9601-5; Watanabe K, 2010, ICHTHYOL RES, V57, P107, DOI 10.1007/s10228-009-0129-7; Watanabe K, 1998, ICHTHYOL RES, V45, P259, DOI 10.1007/BF02673924; Watanabe K, 2008, ICHTHYOL RES, V55, P309, DOI 10.1007/s10228-008-0038-1; Watanabe K, 2010, ZOOL SCI, V27, P647, DOI 10.2108/zsj.27.647; Yokoyama T, 1988, SEINAN NIHON NO SHIZ; Zarske A, 2013, VERTEBR ZOOL, V63, P253	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					352	360		10.1007/s10228-014-0406-y		9	Zoology	Zoology	AT2DF	WOS:000344740800006		
J	Kuriiwa, K; Chiba, SN; Motomura, H; Matsuura, K				Kuriiwa, Kaoru; Chiba, Satoru N.; Motomura, Hiroyuki; Matsuura, Keiichi			Phylogeography of Blacktip Grouper, Epinephelus fasciatus (Perciformes: Serranidae), and influence of the Kuroshio Current on cryptic lineages and genetic population structure	ICHTHYOLOGICAL RESEARCH			English	Article						Marine biogeography; Dispersal; Migration; Pelagic larval duration	CORAL-REEF FISH; HUMAN MITOCHONDRIAL-DNA; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; STATISTICAL TESTS; COMPUTER-PROGRAM; PACIFIC-OCEAN; MARINE FISH; DISPERSAL; LARVAL	To investigate the influence of the Kuroshio Current on the high diversity of marine fishes in Japanese waters, the intraspecific phylogeographic structure of Blacktip Grouper, Epinephelus fasciatus, was determined. The genetic analysis of E. fasciatus indicated three intraspecific mtDNA lineages representing different evolutionary histories: the first lineage differentiated in Japanese waters during a long period of fluctuations of the ancient Kuroshio Current, the second lineage, widely distributed in the tropical western Pacific, was transported to Japanese waters by the Kuroshio Current and the third lineage was distributed primarily around the Ogasawara (Bonin) Islands. Present-day sympatric distributions of the three lineages, characterized by different ratios of such individuals at each geographic site, indicated a complex genetic pattern that was classified into three demographic groups, the dispersal and gene flows of which were strongly influenced by the Kuroshio Current and factors such as countercurrent and island arc. Genetic breaks in E. fasciatus populations were congruent with other fish faunal boundaries in Japanese waters.	[Kuriiwa, Kaoru; Chiba, Satoru N.; Matsuura, Keiichi] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan; [Motomura, Hiroyuki] Kagoshima Univ Museum, Kagoshima 8900065, Japan	Kuriiwa, K (reprint author), Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	kaorukuriiwa@07.alumni.u-tokyo.ac.jp; chiba_s@kahaku.go.jp; motomura@kaum.kagoshima-u.ac.jp; matsuura@kahaku.go.jp			Japan Society for the Promotion of Science [19208019, 24370041]; Ministry of Education, Science, Sports and Culture, Japan [22770089]; Kuroshio Project of the National Museum of Nature and Science	We express our sincere gratitude to the following persons and organizations for helping in the collection of fishes: Y. Iwatsuki (MUFS); K. T. Shao (Research Center of Biodiversity, Academia Sinica, Taiwan); H. C. Ho (National Museum of Marine Biology and Aquarium, Taiwan); W. C. Jiang and colleagues (Eastern Marine Biology Research Center, Fisheries Research Institute, Taiwan); S. Kimura (FRLM); G. Ogihara and M. Matsunuma (KAUM); G. Shinohara, Y. Takata and M. Nakae (NSMT); Y. Sakurai (Okinawa Environmental Research Co. Ltd.); A. Murase and H. Arihara (Tokyo University of Marine Science and Technology); M. Mizukami (Fukuyama University); N. Akama, Y. Matsue, E. Nagao and Y. Minagawa (professional fishermen on Hachijo-jima, Kozu, Fukue, and Ishigaki-jima Island, respectively); Ogasawara Diving Service KAIZIN; Ogasawara Flippers Inn; and the Fisheries Cooperative Associations on Chichi-jima Island, Minami-Izu-machi, Goto Islands, Tanegashima Island and Yaku-shima Island. We also thank K. Kawabe (Tokyo Metropolitan Ogasawara Fisheries Research Center) for useful information about ecology of E. fasciatus and T. Yonezawa (Fudan University, China) for helping phylogenetic and demographic analyses. We are grateful to G. S. Hardy (Ngunguru, New Zealand) and E. Murdy (George Washington University) for their help with English. This study was supported by a Grant-in-Aid for Scientific Researches (A) and (B) from the Japan Society for the Promotion of Science (A: 19208019, B: 24370041), a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Science, Sports and Culture, Japan (22770089) and the Kuroshio Project of the National Museum of Nature and Science.	Akaike H., 1973, 2 INT S INF THEOR, P267; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Hickey AJR, 2009, MOL ECOL, V18, P680, DOI 10.1111/j.1365-294X.2008.04052.x; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.2307/2410314; KIMURA M, 1964, GENETICS, V49, P561; Vos RA, 2003, SYST BIOL, V52, P368, DOI 10.1080/10635150390196993; Fu YX, 1997, GENETICS, V147, P915; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; TEMPLETON AR, 1992, GENETICS, V132, P619; TAJIMA F, 1989, GENETICS, V123, P585; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Bernardi G, 2003, EVOLUTION, V57, P1599; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Schneider S, 1999, GENETICS, V152, P1079; Kuriiwa K, 2007, MOL PHYLOGENET EVOL, V45, P69, DOI 10.1016/j.ympev.2007.04.018; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Bowen BW, 2006, J HERED, V97, P1, DOI 10.1093/jhered/esj006; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ujiie Y, 2003, MAR MICROPALEONTOL, V49, P335, DOI 10.1016/S0377-8398(03)00062-8; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Shirai SM, 2006, ICHTHYOL RES, V53, P357, DOI 10.1007/s10228-006-0356-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Ujiie H, 1999, MAR MICROPALEONTOL, V37, P23, DOI 10.1016/S0377-8398(99)00010-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Avise J., 2000, PHYLOGEOGRAPHY HIST, P3; Briggs JC, 1974, MARINE ZOOGEOGRAPHY, p[196, 247]; Drummond A. J., 2009, TRACER V1 5; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Herpending HC, 1994, HUM BIOL, V66, P591; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jordan DS, 1901, SCIENCE, V14, P545, DOI 10.1126/science.14.354.545; Kawabe K, 1997, AQUAC SCI, V45, P207; Kawabe K, 2009, FISHERIES SCI, V75, P1239, DOI 10.1007/s12562-009-0128-7; Kawabe K, 2005, AQUAC SCI, V53, P333; Kawabe K, 2000, AQUAC SCI, V48, P467; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Matsuura K, 2012, FISHES KUROSHIO CURR, P3; Nakabo T, 2002, FISHES JAPAN PICTORI, pxliii; Nishimura S, 1992, GUIDE SEASHORE ANIMA, pxi; Randall JE, 1991, REVISION INDO PACIFI; Randall JE, 1997, NATN SCI MUS MONOGRA, V11; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Senou H., 2002, FISHES JAPAN PICTORI, P690; Senou H, 2003, I O P DIVING NEWS, V14, P2; Senou Hiroshi, 2002, Memoirs of the National Science Museum (Tokyo), V38, P195; Senou Hiroshi, 2006, Memoirs of the National Science Museum (Tokyo), P389; Shimada K, 2002, FISHES JAPAN PICTORI, P884; Springer VG, 1982, SMITHSON CONTRIB ZOO, V367; Tanabe AS, 2008, PHYLOGEARS VERSION 1; TANAKA SHIGEHO, 1931, JOUR FAC SCI IMP UNIV TOKYO SECT 4 ZOOL, V3, P1; Tavare S., 1986, LECTURES MATH LIFE S, V17, P57; Yoshigou Hidenori, 2004, Miscellaneous Reports of the Hiwa Museum for Natural History, V43, P1	72	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					361	374		10.1007/s10228-014-0408-9		14	Zoology	Zoology	AT2DF	WOS:000344740800007		
J	Yokogawa, K; Ogihara, G; Watanabe, K				Yokogawa, Koji; Ogihara, Gota; Watanabe, Ken-ichi			Identity of the lectotype of the East Asian flatfish Pleuronichthys cornutus (Temminck and Schlegel 1846) and reinstatement of Pleuronichthys lighti Wu 1929	ICHTHYOLOGICAL RESEARCH			English	Article						Pleuronichthys cornutus; Pleuronichthys japonicus; Lectotype; Scale; Reidentification	KIISUIDO CHANNEL WATERS; GENUS PLEURONICHTHYS; PACIFIC COAST; CENTRAL JAPAN; 2 FORMS	The taxonomy of two species of Pleuronichthys from East Asia was re-examined on the basis of scale characteristics. The lectotype of Pleuronichthys cornutus (Temminck and Schlegel 1846) was shown to be conspecific with Pleuronichthys japonicus Suzuki, Kawashima and Nakabo 2009, being characterized by oval scales, a greater exposed scale area and lower scale counts than a second species, formerly recognized as P. cornutus, but to which Pleuronichthys lighti Wu 1929, formerly considered a junior synonym of P. cornutus, should now be applied. Accordingly, P. japonicus is now considered a junior synonym of P. cornutus.	[Ogihara, Gota] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima Univ Museum, Kagoshima 8900065, Japan	Yokogawa, K (reprint author), 13-5 Higashihama, Tadotsu, Kagawa 7640016, Japan.	gargariscus@ybb.ne.jp; go.synanceiidae@gmail.com; w-tnb7584@me.pikara.ne.jp					Yokogawa K, 2011, ICHTHYOL RES, V58, P24, DOI 10.1007/s10228-010-0186-y; Suzuki S, 2009, ICHTHYOL RES, V56, P276, DOI 10.1007/s10228-009-0100-7; Watanabe K, 1996, NIPPON SUISAN GAKK, V62, P23; BOESEMAN M., 1947, ZOOL MEDEDEEL LEYDEN, V28, P1; Cheng B, 1955, SURVEY REPORT FISHES, P274; Chu Y, 1931, BIOL B ST JOHNS U; Eschmeyer WN, 2013, CATALOG FISHES ELECT; Evseenko SA, 2003, J ICHTHYOL S1, V43, pS57; Evseenko SA, 2004, ANNOTATED CHECKLISTS, V37, P1; Fitch JE, 1963, LOS ANGELES COUNTY M, V76, P3; Fowler H. W., 1933, Hong Kong Naturalist, V4, P156; Fujio Y, 1979, FISH GENET BLEED SCI, V4, P10; Masaki Y., 1984, Bulletin of Nansei National Fisheries Research Institute, P11; NOZAWA M, 1981, Bulletin of the Japan Sea National Fisheries Research Institute, P1; Li S, 1995, FAUNA SINICA OSTICHT; Matsuoka M., 1989, Bulletin of the Seikai National Fisheries Research Institute, P23; Nakabo T, 2000, FISHES JAPAN PICTORI, p[1371, 1637]; Ohashi Y, 2011, NATURE KAGOSHIMA, V37, P71; REEVES CORA D., 1927, JOUR PAN PACIFIC RES INST, V2, P3; Temminck C.J., 1846, FAUNA JAPONICA SI 10, P173; WANG KING F., 1933, CONTR BIOL LAB SCI SOC CHINA ZOOL SER, V9, P1; Watanabe K, 1994, B TOKUSHIMA PREF FIS, P1; WATANABE K, 1994, NIPPON SUISAN GAKK, V60, P515; WATANABE K, 1988, NIPPON SUISAN GAKK, V54, P765; Wu H, 1929, CONT BIOL LAB SCI SO, V5; Wu H, 1932, THESIS U PARIS PARIS; Yagura W, 1922, SHUMI KENKYU KAIRUI; Yamada U, 2007, FISHES FISHERIES E C; Yamada U, 1986, FISHES E CHINA SEA Y, P378; Yokogawa Koji, 2007, Venus (Tokyo), V65, P375; Zhang H, 2011, PERIOD OCEAN U CHINA, V41, P51	31	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					385	392		10.1007/s10228-014-0405-z		8	Zoology	Zoology	AT2DF	WOS:000344740800009		
J	Kurita, Y; Onikura, N; Inui, R				Kurita, Yoshihisa; Onikura, Norio; Inui, Ryutei			Factors affecting the establishment success of the invasive piscivorous chub in small irrigation ditches in northern Kyushu, Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Invasion; Predator; Cyprinidae; Occurrence pattern	OPSARIICHTHYS-UNCIROSTRIS-UNCIROSTRIS; FRESH-WATER FISHES; NONNATIVE FISHES; ISLAND	Habitat matching is an important factor for the establishment of alien fishes in recipient environments. The piscivorous chub, Opsariichthys uncirostris uncirostris, originally exclusively inhabited large water areas; however, the species has been introduced and established in small irrigation ditches on Kyushu Island. The evaluation of the habitat use of the piscivorous chub suggested that this alien fish uses the lentic-type irrigation ditches as a nursery ground and the lotic-type ditches as a spawning ground. This finding implies that the establishment of the piscivorous chub may require connectivity between lentic and lotic habitats.	[Kurita, Yoshihisa; Onikura, Norio] Kyushu Univ, Fishery Res Lab, Fukuoka 8113304, Japan; [Inui, Ryutei] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Kurita, Y (reprint author), Kyushu Univ, Fishery Res Lab, 4-46-24 Tsuyazaki, Fukuoka 8113304, Japan.	katachiya@gmail.com			JSPS	We thank Dr. Takahiro Morosawa for advice on the statistical analysis. YK and RI were supported by JSPS as postdoctoral research fellows.	Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kurita Y, 2008, J FAC AGR KYUSHU U, V53, P429; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; Onikura N, 2011, ICHTHYOL RES, V58, P382, DOI 10.1007/s10228-011-0235-1; Ma BS, 2011, ENVIRON BIOL FISH, V90, P159, DOI 10.1007/s10641-010-9727-5; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Ribeiro F, 2008, BIOL INVASIONS, V10, P89, DOI 10.1007/s10530-007-9112-2; Katano O, 2003, ENVIRON BIOL FISH, V66, P107, DOI 10.1023/A:1023678401886; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Bates D. M., 2014, LME4 LINEAR MIXED EF; Bomford N, 2010, BIOL INVASIONS, V12, P2559; ELTON C.S., 1958, ECOLOGY INVASION ANI; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; ICHIMURA SHUN-EI, 1954, JAPANESE JOUR BOT, V14, P269; Ihara T, 2011, B BIOGEOGR SOC JPN, V66, P44; Japanese Ministry of Land Infrastructure Transport and Tourism, 2011, DAT RIV ENV; Matsuzawa Y, 2008, ALIEN FISHES JAPAN, P121; Nakajima Jun, 2008, Bulletin of the Biogeographical Society of Japan, V63, P177; Nakamura M., 1969, CYPRINID FISHES JAPA; Onikura N, 2008, J JPN SOC WATER ENV, V31, P395, DOI DOI 10.2965/JSWE.31.395; Onikura N, 2013, B BIOGEOGR SOC JPN, V68, P11; R Development Core Team, 2011, R LANG ENV STAT COMP; Sato M, 2010, BIOL INVASIONS, V12, P3677, DOI 10.1007/s10530-010-9762-3; SUNAGA T, 1970, Japanese Journal of Ecology, V20, P129; Sunaga T., 1980, FRESHWATER ORGANISMS, P30; TANAKA S, 1970, Japanese Journal of Ecology, V20, P13; Tanaka S, 2005, FRESHWATER FISHES JA, P250	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2014	61	4					393	398		10.1007/s10228-014-0407-x		6	Zoology	Zoology	AT2DF	WOS:000344740800010		
J	Umezawa, H; Matsumoto, T; Shikata, SI				Umezawa, Hitoshi; Matsumoto, Takeshi; Shikata, Shin-Ichi			Diamond Metal-Semiconductor Field-Effect Transistor With Breakdown Voltage Over 1.5 kV	IEEE ELECTRON DEVICE LETTERS			English	Article						Diamond; metal-semiconductor field-effect transistor; breakdown voltage	OPERATION; DIODE	A diamond metal-semiconductor field-effect transistor (MESFET) with a Pt Schottky gate was fabricated. The MESFET exhibited clear saturation and pinchoff characteristics. The drain current of the MESFET operated at 300 degrees C was 20 times higher than that at room temperature due to the activation of acceptors. The breakdown voltage was highly dependent on the gate-drain length and reached 1.5 kV at a gate-drain length of 30 mu m, which is the highest reported for a diamond FET.	[Umezawa, Hitoshi; Matsumoto, Takeshi; Shikata, Shin-Ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Diamond Res Grp, Osaka 5638577, Japan	Umezawa, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Diamond Res Grp, Osaka 5638577, Japan.	hitoshi.umezawa@aist.go.jp	Umezawa, Hitoshi/C-9629-2011	Umezawa, Hitoshi/0000-0002-0838-4497	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT through the Nano-Processing Facility; National Institute of Advanced Industrial Science and Technology, Osaka, Japan; Nano Technology Hub, Kyoto University, Kyoto, Japan	This work was supported in part by the Grants-in-Aid for Scientific Research, in part by a Grant-in-Aid for Scientific Research (B), Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science, and Technology (MEXT), in part by MEXT through the Nano-Processing Facility, National Institute of Advanced Industrial Science and Technology, Osaka, Japan, and the Nano Technology Hub, Kyoto University, Kyoto, Japan. The review of this letter was arranged by Editor S.-H. Ryu.	Saito W, 2004, SOLID STATE ELECTRON, V48, P1555, DOI 10.1016/j.sse.2003.10.003; Kawarada H, 1996, SURF SCI REP, V26, P205, DOI 10.1016/S0167-5729(97)80002-7; Funaki T, 2012, IEICE ELECTRON EXPR, V9, P1835, DOI 10.1587/elex.9.1835; CHOU SY, 1987, IEEE T ELECTRON DEV, V34, P448, DOI 10.1109/T-ED.1987.22942; Iwasaki T, 2013, IEEE ELECTR DEVICE L, V34, P1175, DOI 10.1109/LED.2013.2271377; Kawarada H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4884828; Iwasaki T, 2014, IEEE ELECTR DEVICE L, V35, P241, DOI 10.1109/LED.2013.2294969; Umezawa H, 2012, DIAM RELAT MATER, V24, P201, DOI 10.1016/j.diamond.2012.01.011; Umezawa H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.011302; Ikeda K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.011202; Aleksov A, 2003, DIAM RELAT MATER, V12, P391, DOI 10.1016/S0925-9635(02)00401-6; Choi YC, 2006, J VAC SCI TECHNOL B, V24, P2601, DOI 10.1116/1.2366542; EBERT W, 1994, IEEE ELECTR DEVICE L, V15, P289, DOI 10.1109/55.296219; Hirama K, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.044001; Makino T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3159837; Umezawa H, 2009, IEEE ELECTR DEVICE L, V30, P960, DOI 10.1109/LED.2009.2026439; Volpe P. -N., 2010, APPL PHYS LETT, V97	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	NOV	2014	35	11					1112	1114		10.1109/LED.2014.2356191		3	Engineering, Electrical & Electronic	Engineering	AS9WA	WOS:000344588100014		
J	Abderrahmane, A; Ko, PJ; Okada, H; Sato, SI; Ohshima, T; Sandhu, A				Abderrahmane, Abdelkader; Ko, Pil Ju; Okada, Hiroshi; Sato, Shin-Ichiro; Ohshima, Takeshi; Sandhu, Adarsh			Proton Irradiation Enhancement of Low-Field Negative Magnetoresistance Sensitivity of AlGaN/GaN-Based Magnetic Sensor at Cryogenic Temperature	IEEE ELECTRON DEVICE LETTERS			English	Article						AlGaN/GaN heterostructures; two-dimensional electron gas; micro-Hall sensors; proton irradiation; weak localization; magnetoresistance		The longitudinal and transverse magnetoresistances of AlGaN/GaN heterostructure-based micro-Hall sensors were compared with samples irradiated with protons with an energy of 380 keV and fluence of 10(14) (protons/cm(2)). Increases in the elastic and inelastic scattering were deduced from weak localization behavior in both samples. The AlGaN/GaN micro-Hall sensors showed stable magnetic sensitivity in non and irradiated samples and increased resistivity after proton irradiation yielded an enhanced magnetoresistance sensitivity in nonirradiated sensors from 160 to 417 VA(-1)T(-1). The minimum detectable magnetic field of irradiated micro-Hall sensors determined from magneto-voltage measurements at similar to 4 K was similar to the minimum detectable magnetic field in the nonirradiated sensors.	[Abderrahmane, Abdelkader] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Ko, Pil Ju; Okada, Hiroshi; Sandhu, Adarsh] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi 4418580, Japan; [Sato, Shin-Ichiro; Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gumma 3701292, Japan	Abderrahmane, A (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	sandhu@eiiris.tut.ac.jp	Okada, Hiroshi/G-9612-2011; Sandhu, Adarsh/A-1818-2011	Okada, Hiroshi/0000-0003-0921-880X; 			Abderrahmane A, 2014, AIP CONF PROC, V1585, P123, DOI 10.1063/1.4866629; Abderrahmane A., 2013, J PHYS C SER, V433; Abderrahmane A., 2013, APPL PHYS LETT, V102; Abderrahmane A., 2014, APPL PHYS LETT, V104; Kravchenko SV, 2004, REP PROG PHYS, V67, P1, DOI 10.1088/0034-4885/67/1/R01; Bouguen L., 2008, APPL PHYS LETT, V92; Kim H, 2010, J KOREAN PHYS SOC, V56, P1523, DOI 10.3938/jkps.56.1523; Henriksen A. D., 2010, APPL PHYS LETT, V97; Koide S., 2012, J PHYS C SER, V352; Kurdak C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.113308; Lo ST, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245201; Minkov GM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245423; Scholl E., 1998, THEORY TRANSPORT PRO, P1; Sun X, 2013, MICROELECTRON ENG, V111, P77, DOI 10.1016/j.mee.2013.01.063	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	NOV	2014	35	11					1130	1132		10.1109/LED.2014.2358613		3	Engineering, Electrical & Electronic	Engineering	AS9WA	WOS:000344588100020		
J	Zhang, X; Chen, PH; Okuma, Y; Ishida, K; Ryu, Y; Watanabe, K; Sakurai, T; Takamiya, M				Zhang, Xin; Chen, Po-Hung; Okuma, Yasuyuki; Ishida, Koichi; Ryu, Yoshikatsu; Watanabe, Kazunori; Sakurai, Takayasu; Takamiya, Makoto			A 0.6 V Input CCM/DCM Operating Digital Buck Converter in 40 nm CMOS	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Buck converter; DC-DC converter; forward body bias; low voltage; voltage detector		This paper presents a 0.6 V input, 0.3-0.55 V output buck converter in 40 nm CMOS, for low-voltage low-power wireless sensor network systems. A low power CCM/DCM controller of the buck converter enables automatic selection of DCM or CCM operation depending on load situation, therefore improving the power efficiency. A dual-mode-body-biased (DMBB) zero-crossing detector with both forward body bias mode and zero body bias mode is designed to enable DCM operation with both low supply voltage and normal supply voltage. An ultra-low-power hysteresis voltage detector is proposed for body bias modes selection. The proposed buck converter achieves a peak efficiency of 94% with an output current range of 50 mu A to 10 mA. Thanks to the DCM operation, the efficiency at an output current of 10 mu A is improved by 20% and 9%, with an output voltage of 0.35 V and 0.5 V, respectively.	[Zhang, Xin; Ishida, Koichi; Sakurai, Takayasu; Takamiya, Makoto] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Chen, Po-Hung] Univ Tokyo, Tokyo 1538505, Japan; [Okuma, Yasuyuki; Ryu, Yoshikatsu; Watanabe, Kazunori] STARC, Yokohama, Kanagawa, Japan	Zhang, X (reprint author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.				Ministry of Economy, Trade and Industry (METI); New Energy and Industrial Technology Development Organization (NEDO)	This paper was approved by Guest Editor Zhihua Wang. This work was carried out as a part of the Extremely Low Power (ELP) project supported by the Ministry of Economy, Trade and Industry (METI) and the New Energy and Industrial Technology Development Organization (NEDO).	Bandyopadhyay S, 2011, IEEE J SOLID-ST CIRC, V46, P2807, DOI 10.1109/JSSC.2011.2162914; Lee CF, 2004, IEEE J SOLID-ST CIRC, V39, P3, DOI 10.1109/JSSC.2003.820870; Chiang CY, 2009, IEEE T POWER ELECTR, V24, P2120, DOI 10.1109/TPEL.2009.2021186; Tan YK, 2011, IEEE T IND ELECTRON, V58, P4424, DOI 10.1109/TIE.2010.2102321; Alippi C, 2008, IEEE T CIRCUITS-I, V55, P1742, DOI 10.1109/TCSI.2008.922023; Sridhara SR, 2010, SYMP VLSI CIRCUITS, P15, DOI 10.1109/VLSIC.2010.5560251; Chen PH, 2012, IEEE J SOLID-ST CIRC, V47, P1252, DOI 10.1109/JSSC.2012.2185589; Canales F., 2000, P IEEE APEC, P314; Dallago E, 2000, IEEE T IND ELECTRON, V47, P1249, DOI 10.1109/41.887952; Harb S., 2013, IEEE T POWER ELECTR, V28, P319; Hauke B., 2011, BASIC CALCULATION BU; Hirairi K., 2012, IEEE INT SOL STAT CI, P486; Nomura M., 2013, IEEE S VLSI CIRC JUN, P36; Okuma Y., 2010, P IEEE CICC SAN JOS, P323; Ramadass Y., 2007, IEEE ISSCC, P64; Tang Ning, 2009, EFFICIENCY SYNCHRONO; Zhang X, 2013, IEEE ASIAN SOLID STA, P45; Zhang X., 2012, IEEE S VLSI CIRC JUN, P194	18	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2014	49	11					2377	2386		10.1109/JSSC.2014.2339325		10	Engineering, Electrical & Electronic	Engineering	AS6YD	WOS:000344404200002		
J	Nakane, H; Ujiie, R; Oshima, T; Yamamoto, T; Kimura, K; Okuda, Y; Tsuiji, K; Matsuura, T				Nakane, Hideo; Ujiie, Ryuichi; Oshima, Takashi; Yamamoto, Takaya; Kimura, Keisuke; Okuda, Yuichi; Tsuiji, Kosuke; Matsuura, Tatsuji			A Fully Integrated SAR ADC Using Digital Correction Technique for Triple-Mode Mobile Transceiver	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Asynchronous; calibration; digital correction; passive amplifier; perturbation; reconfigurable; SAR ADC; transceiver		This paper presents a fully integrated SAR ADC for GSM/WCDMA/LTE triple-mode transceiver (RFIC) with non-binary DAC structure and digital correction techniques. All blocks including input buffer, ADC core, bias, references and ADC logics are implemented in a single chip with a small die area of 0.044mm(2)/0.066 mm(2) for ADC core and ADC logic. The proposed ADC does not require off-chip decoupling capacitor for reference voltage by employing charge-sharing topology. Reconfigurable structure is used for multi-mode operation by adjusting ADC speed and noise, where SNDR of 67.0 dB in GSM and 58.2 dB in WCDMA/LTE are achieved at the sampling frequencies of 52 MS/s and 80 MS/s, respectively.	[Nakane, Hideo; Ujiie, Ryuichi; Yamamoto, Takaya; Kimura, Keisuke; Okuda, Yuichi; Tsuiji, Kosuke] Renesas Elect Corp, Kawasaki, Kanagawa, Japan; [Oshima, Takashi] Hitachi Cent Res Lab, Kokubunji, Tokyo, Japan; [Matsuura, Tatsuji] Tokyo Univ Sci, Dept Elect Engn, Fac Sci & Technol, Noda, Chiba 278, Japan	Nakane, H (reprint author), Renesas Elect Corp, Kawasaki, Kanagawa, Japan.	hideo.nakane.zj@renesas.com					Ahmed I., 2009, IEEE ISSCC FEB, P164; Andersson M, 2014, IEEE J SOLID-ST CIRC, V49, P1535, DOI 10.1109/JSSC.2014.2319254; Lee SK, 2011, IEEE J SOLID-ST CIRC, V46, P651, DOI 10.1109/JSSC.2010.2102590; Craninckx J., 2007, IEEE INT SOL STAT CI, P246; Fredenburg J., 2012, INT SOL STAT CIRC C, P468; Giannini V., 2008, IEEE ISSCC, P238; Hershberg B., 2013, P IEEE S VLSI CIRC, pC94; Kauffman J., 2011, IEEE INT SOL STAT CI, P472; Lee H.-Y., 2012, IEEE ISSCC, P474; Liu C. C., 2010, IEEE ISSCC, P386; Liu W., 2010, IEEE ISSCC, P380; Matsukawa K., 2012, P 2012 S VLSI CIRC H, P160; Morie T., 2013, IEEE ISSCC, P272; Nakane H., 2013, P IEEE A SSCC, P83; Shu Y.-S., 2013, IEEE ISSCC, P268; Verbruggen B., 2013, P S VLSI CIRC, pC268; Verbruggen B., 2012, IEEE ISSCC, P466; Yoshioka M., 2010, IEEE ISSCC, P384	18	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2014	49	11					2503	2514		10.1109/JSSC.2014.2357436		12	Engineering, Electrical & Electronic	Engineering	AS6YD	WOS:000344404200012		
J	Kawai, N; Takayama, S; Masumi, J; Kikuchi, N; Itoh, Y; Ogawa, K; Ugawa, A; Suzuki, H; Tanaka, Y				Kawai, Natsumi; Takayama, Shinichi; Masumi, Junya; Kikuchi, Naoto; Itoh, Yasuo; Ogawa, Kyosuke; Ugawa, Akimitsu; Suzuki, Hiroaki; Tanaka, Yasunori			A Fully Static Topologically-Compressed 21-Transistor Flip-Flop With 75% Power Saving	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Flip-flops; low-power; VLSI	SWING CLOCKING SCHEME; REDUCTION	An extremely low-power flip-flop (FF) named topologically-compressed flip-flop (TCFF) is proposed. As compared with conventional FFs, the FF reduces power dissipation by 75% at 0% data activity. This power reduction ratio is the highest among FFs that have been reported so far. The reduction is achieved by applying topological compression method, merger of logically equivalent transistors to an unconventional latch structure. The very small number of transistors, only three, connected to clock signal reduces the power drastically, and the smaller total transistor count assures the same cell area as conventional FFs. In addition, fully static full-swing operation makes the cell tolerant of supply voltage and input slew variation. An experimental chip design with 40 nm CMOS technology shows that almost all conventional FFs are replaceable with proposed FF while preserving the same system performance and layout area.	[Kawai, Natsumi; Takayama, Shinichi; Masumi, Junya; Kikuchi, Naoto; Ogawa, Kyosuke; Ugawa, Akimitsu; Tanaka, Yasunori] Toshiba Microelect Corp, Log & Analog IP Dev Dept, Kawasaki, Kanagawa 2108538, Japan; [Itoh, Yasuo] Toshiba Microelect Corp, Kawasaki, Kanagawa 2108538, Japan; [Suzuki, Hiroaki] Toshiba Microelect Corp, Design Solut Div, Kawasaki, Kanagawa 2108538, Japan	Kawai, N (reprint author), Toshiba Microelect Corp, Log & Analog IP Dev Dept, Kawasaki, Kanagawa 2108538, Japan.	natsumi.hirakawa@toshiba.co.jp					Absel K, 2013, IEEE T VLSI SYST, V21, P1693, DOI 10.1109/TVLSI.2012.2213280; Kawaguchi H, 1998, IEEE J SOLID-ST CIRC, V33, P807, DOI 10.1109/4.668997; Kong BS, 2001, IEEE J SOLID-ST CIRC, V36, P1263; Hamada M, 2005, IEEE CUST INTEGR CIR, P527; Hirata A., 2005, S VLSI CIRC, P306; Kim JC, 1999, IEICE T ELECTRON, VE82C, P1777; Klass F., 1998, S VLSI CIRC JUN, P108; KOJIMA H, 1995, IEEE J SOLID-ST CIRC, V30, P432, DOI 10.1109/4.375963; MATSUI M, 1994, IEEE J SOLID-ST CIRC, V29, P1482, DOI 10.1109/4.340421; Nedovic N., 2000, Proceedings 13th Symposium on Integrated Circuits and Systems Design (Cat. No.PR00843), DOI 10.1109/SBCCI.2000.876032; Nomura S., IEEE ISSCC; Partovi H, 1996, ISSCC DIG TECH PAP I, V39, P138, DOI 10.1109/ISSCC.1996.488543; Stojanovic V, 1999, IEEE J SOLID-ST CIRC, V34, P536, DOI 10.1109/4.753687; Teh C., 2011, IEEE INT SOL STAT CI, P338; Ueda Y., 2006, IEEE INT SOL STAT CI, P1636; YUAN J, 1989, IEEE J SOLID-ST CIRC, V24, P62, DOI 10.1109/4.16303	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2014	49	11					2526	2533		10.1109/JSSC.2014.2332532		8	Engineering, Electrical & Electronic	Engineering	AS6YD	WOS:000344404200014		
J	Tajima, T; Song, HJ; Ajito, K; Yaita, M; Kukutsu, N				Tajima, Takuro; Song, Ho-Jin; Ajito, Katsuhiro; Yaita, Makoto; Kukutsu, Naoya			300-GHz Step-Profiled Corrugated Horn Antennas Integrated in LTCC	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Dielectric substrates; horn antennas; low-temperature co-fired ceramics (LTCC); terahertz (THz)	RECTANGULAR-WAVE-GUIDE; TERAHERTZ COMMUNICATIONS; BAND; FUTURE; DESIGN	This paper presents 300-GHz step-profiled corrugated horn antennas, aiming at their integration in low-temperature co-fired ceramic (LTCC) packages. Using substrate integrated waveguide technology, the cavity inside the multi-layer LTCC substrate and a surrounding via fence are used to form a feeding hollow waveguide and horn structure. Owing to the vertical configuration, we were able to design the corrugations and stepped profile of horn antennas to approximate smooth metallic surface. To verify the design experimentally, the LTCC waveguides and horn antennas were fabricated with an LTCC multi-layer process. The LTCC waveguide exhibits insertion loss of 0.6 dB/mm, and the LTCC horn antenna exhibits 18-dBi peak gain and 100-GHz bandwidth with more than 10-dB return loss. The size of the horn antenna is only, 5 x 5 x 2.8 mm(3) which makes it easy to integrate it in LTCC transceiver modules.	[Tajima, Takuro; Song, Ho-Jin; Ajito, Katsuhiro; Yaita, Makoto; Kukutsu, Naoya] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Tajima, T (reprint author), NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan.	tajima.takurou@lab.ntt.co.jp			Ministry of Internal Affairs and Communications, Japan	Received December 02, 2013; revised July 23, 2014; accepted August 07, 2014. Date of publication August 20, 2014; date of current version October 28, 2014. This work was supported in part by the research and development program "Multi-ten Gigabit Wireless Communications Technology at Sub-terahertz Frequencies" of the Ministry of Internal Affairs and Communications, Japan.	Tajima T, 2013, EUR MICROW CONF, P231; Song HJ, 2011, IEEE T THZ SCI TECHN, V1, P256, DOI 10.1109/TTHZ.2011.2159552; Song HJ, 2012, ELECTRON LETT, V48, P953, DOI 10.1049/el.2012.1708; ELEFTHERIADES GV, 1992, IEEE T MICROW THEORY, V40, P801, DOI 10.1109/22.137381; Esquius-Morote M, 2013, IEEE T ANTENN PROPAG, V61, P2911, DOI 10.1109/TAP.2013.2254449; Xu JF, 2012, IEEE T ANTENN PROPAG, V60, P3025, DOI 10.1109/TAP.2012.2194673; Xu JF, 2013, IEEE T ANTENN PROPAG, V61, P1794, DOI 10.1109/TAP.2012.2237007; Zhang YP, 2009, IEEE T ANTENN PROPAG, V57, P2842, DOI 10.1109/TAP.2009.2029290; Wang H, 2010, IEEE T ANTENN PROPAG, V58, P640, DOI 10.1109/TAP.2009.2039298; Balanis C. A., 2005, ANTENNA THEORY, P785; BALDWIN R, 1975, P I ELECTR ENG, V122, P465; BRYANT GH, 1969, P I ELECTR ENG, V116, P203; Eshrah IA, 2005, IEEE T MICROW THEORY, V53, P3298, DOI 10.1109/TMTT.2005.855748; ESTEBAN J, 1991, IEEE T MICROW THEORY, V39, P937, DOI 10.1109/22.81662; MENTZER CA, 1974, IEEE T ANTENN PROPAG, VAP22, P191, DOI 10.1109/TAP.1974.1140757; Schneider T, 2012, IEEE T THZ SCI TECHN, V2, P250, DOI 10.1109/TTHZ.2011.2182118; She YF, 2012, IEICE T ELECTRON, VE95C, P1635, DOI 10.1587/transele.E95.C.1635; WITEBSKY C, 1987, IEEE T ANTENN PROPAG, V35, P1310, DOI 10.1109/TAP.1987.1144021; Xu JF, 2013, IEEE T ANTENN PROPAG, V61, P1784, DOI 10.1109/TAP.2012.2220317; Xu JF, 2013, IEEE T ANTENN PROPAG, V61, P1679, DOI 10.1109/TAP.2012.2232261; Yeap S. B., 2012, P IEEE AS PAC C ANT, P279	21	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	NOV	2014	62	11					5437	5444		10.1109/TAP.2014.2350520		8	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AS9WI	WOS:000344588900002		
J	Maruyama, S; Fukusako, T				Maruyama, Sotaro; Fukusako, Takeshi			An Interpretative Study on Circularly Polarized Patch Antenna Using Artificial Ground Structure	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Artificial ground structure (AGS); artificial magnetic conductor (AMC); axial ratio; broadband antenna; circular polarization; matching; microstrip patch antenna; polarizer	L-PROBE; BAND	This communication presents some interpretative studies on a circularly polarized broadband patch antenna using an artificial ground structure (AGS). This patch antenna has a broadband characteristics in both impedance and axial ratio, which are more than 20% and 40%, respectively. The principle to expand the 3-dB axial ratio characteristics is discussed using a combination of circularly polarized patch antenna and an AGS polarizer. Furthermore, a broadband matching method using an extended outer conductor of coaxial cable is discussed. The mechanism of the matching structure is also discussed.	[Maruyama, Sotaro; Fukusako, Takeshi] Kumamoto Univ, Dept Comp Sci & Elect Engn, Kumamoto 8608555, Japan	Maruyama, S (reprint author), Kumamoto Univ, Dept Comp Sci & Elect Engn, Kumamoto 8608555, Japan.	fukusako@ieee.org			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan through a Grant-in-Aid for Scientific Research (C).	Yang F, 2005, IEEE T ANTENN PROPAG, V53, P3083, DOI 10.1109/TAP.2005.854536; Luk KM, 1998, ELECTRON LETT, V34, P1442, DOI 10.1049/el:19981009; Herscovici N, 1998, IEEE T ANTENN PROPAG, V46, P471, DOI 10.1109/8.664109; Sievenpiper D, 1999, IEEE T MICROW THEORY, V47, P2059, DOI 10.1109/22.798001; Zhang Y, 2003, IEEE T ANTENN PROPAG, V51, P2704, DOI 10.1109/TAP.2003.817550; Mosallaei H, 2004, IEEE T ANTENN PROPAG, V52, P2403, DOI 10.1109/TAP.2004.834135; Foroozesh A, 2011, IEEE T ANTENN PROPAG, V59, P4, DOI 10.1109/TAP.2010.2090458; Chen Z. N., 2007, P 37 EUR MICR C MUN, P1019; Chung KL, 2003, IEEE T ANTENN PROPAG, V51, P3239, DOI 10.1109/TAP.2003.820949; Kim SM, 2007, ELECTRON LETT, V43, P703, DOI 10.1049/el:20070677; Lau KL, 2005, IEEE T ANTENN PROPAG, V53, P2636, DOI 10.1109/TAP.2005.851818; Lau KL, 2005, IEEE T ANTENN PROPAG, V53, P577, DOI 10.1109/TAP.2004.838796; Nakamura T., 2011, IEEE T ANTENN PROPAG, V59, P2013; Noro T., 2007, P IEEE ANT PROP INT, P733; Targonski S. D., 1998, IEEE T ANTENNAS PROP, V46; Tugonski S. D., 1996, P ANT PROP SOC INT S, V1, P18; Yan D., 2005, P IEEE AS PAC MICR C, V3; Yang F, 2004, MICROW OPT TECHN LET, V41, P439, DOI 10.1002/mop.20164	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	NOV	2014	62	11					5919	5924		10.1109/TAP.2014.2357431		7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AS9WI	WOS:000344588900061		
J	Ohtsuka, T				Ohtsuka, Toshiyuki			A Recursive Elimination Method for Finite-Horizon Optimal Control Problems of Discrete-Time Rational Systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Discrete-time systems; Euler-Lagrange equations (ELE); nonlinear systems; optimal control	ALGEBRAIC-GEOMETRY	In this technical note, a method of solving finite-horizon optimal control problems involving discrete-time rational systems is proposed. Sequences of algebraic equations for the control input and costate at each time are constructed backward, starting from the terminal condition, by the recursive elimination of variables in the optimality conditions. This recursive elimination can be viewed as a generalization of the classical backward sweep method to obtain the discrete-time Riccati equation for finite-horizon linear quadratic control. Sufficient conditions are given for the existence and uniqueness of locally optimal state feedback laws in the form of algebraic functions of the state.	Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan	Ohtsuka, T (reprint author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan.	ohtsuka@i.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24656263]	This work was supported in part by a Grant-in-Aid for Exploratory Research (24656263) from the Japan Society for the Promotion of Science. Recommended by Associate Editor D. Bauso.	Anderson B., 1989, OPTIMAL CONTROL; Rostalski P, 2011, SIAM J OPTIMIZ, V21, P417, DOI 10.1137/090768308; Becker T., 1993, GROBNER BASES; Bryson Jr AE, 1975, APPL OPTIMAL CONTROL; Cox D., 2007, IDEALS VARIETIES ALG; Cox D., 2005, USING ALGEBRAIC GEOM; Fiacco A. V., 1983, INTRO SENSITIVITY ST; Fotiou IA, 2006, INT J CONTROL, V79, P1340, DOI 10.1080/00207170600726592; Fukushima M., 2001, FUNDAMENTALS NONLINE; HUYNH DT, 1986, INFORM COMPUT, V68, P196, DOI 10.1016/S0019-9958(86)80035-3; Ichihara H, 2009, IEEE T AUTOMAT CONTR, V54, P1048, DOI 10.1109/TAC.2009.2017159; Iwane H, 2011, LECT NOTES COMPUT SC, V6885, P239, DOI 10.1007/978-3-642-23568-9_19; Kawano Yu, 2013, SICE Journal of Control, Measurement, and System Integration, V6; Kreuzer M., 2000, COMPUTATIONAL COMMUT, V1; Nesic D., 2002, P 15 IFAC WORLD C BA, P1052; Ohtsuka T, 2011, IEEE T AUTOMAT CONTR, V56, P1874, DOI 10.1109/TAC.2010.2097130; Ohtsuka T., 2012, 4 IFAC NONL MOD PRED, P916; Vasconcelos W., 2004, ALGORITHMS COMPUTATI, V2; Walther U, 2001, IEEE T AUTOMAT CONTR, V46, P534, DOI 10.1109/9.917655	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	NOV	2014	59	11			SI		3081	3086		10.1109/TAC.2014.2321231		6	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AS8EI	WOS:000344482500027		
J	Zhang, YM; Zhang, QL; Tanaka, T; Yan, XG				Zhang, Youmei; Zhang, Qingling; Tanaka, Tamaki; Yan, Xing-Gang			Positivity of Continuous-Time Descriptor Systems With Time Delays	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Continuous-time systems; descriptor systems; positive systems; time-delay systems	INCOMMENSURATE POINT DELAYS; LINEAR-SYSTEMS; STABILITY; REACHABILITY	This technical note is concerned with positivity characteristic of continuous-time descriptor systems with time delays. First, a set of necessary and sufficient conditions is presented to check the property. Then, considering a descriptor time-delay system with two assumptions, a new time-delay system is established whose positivity is equivalent to that of the original system. Furthermore, a set of necessary and sufficient conditions is provided to check the positivity of the new system. Finally, a numerical example is given to illustrate the validity of the results obtained.	[Zhang, Youmei; Zhang, Qingling] Northeastern Univ, State Key Lab Synthet Automat Proc Ind, Inst Syst Sci, Liaoning, Peoples R China; [Tanaka, Tamaki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Yan, Xing-Gang] Univ Kent, Sch Engn & Digital Arts, Canterbury CT2 7NT, Kent, England	Zhang, QL (reprint author), Northeastern Univ, State Key Lab Synthet Automat Proc Ind, Inst Syst Sci, Liaoning, Peoples R China.	youmeizhang0808@163.com; qlzhang@mail.neu.edu.cn; tamaki@math.sc.niigata-u.ac.jp; x.yan@kent.ac.uk			National Natural Science Foundation of China [61273008]; Royal Academy of Engineering of the United Kingdom [12/13RECI027]	This work was supported in part by the National Natural Science Foundation of China under Grants 61273008 and in part by the Royal Academy of Engineering of the United Kingdom with the Award 12/13RECI027. Recommended by Associate Editor C. Altafini. (Corresponding author: Qingling Zhang.)	Rami MA, 2007, IEEE T CIRCUITS-II, V54, P151, DOI 10.1109/TCSII.2006.886888; Commault C, 2007, SYST CONTROL LETT, V56, P272, DOI 10.1016/j.sysconle.2006.10.021; Virnik E, 2008, LINEAR ALGEBRA APPL, V429, P2640, DOI 10.1016/j.laa.2008.03.002; Feng JE, 2011, INT J ROBUST NONLIN, V21, P44, DOI 10.1002/rnc.1575; Kaczorek T, 2009, B POL ACAD SCI-TECH, V57, P395, DOI 10.2478/v10175-010-0143-y; Shorten R, 2006, IEEE ACM T NETWORK, V14, P616, DOI 10.1109/TNET.2006.876178; Back J, 2006, IEEE DECIS CONTR P, P4734, DOI 10.1109/CDC.2006.377824; Canto B, 2008, INT J SYST SCI, V39, P81, DOI 10.1080/00207720701683033; De La Sen M, 2010, ROCKY MT J MATH, V40, P177, DOI 10.1216/RMJ-2010-40-1-177; De la Sen M, 2007, APPL MATH COMPUT, V190, P382, DOI 10.1016/j.amc.2007.01.053; Farina L., 2000, POSITIVE LINEAR SYST; Fridman E, 2002, IEEE T AUTOMAT CONTR, V47, P253, DOI 10.1109/9.983353; Kaczorek T., 2001, POSITIVE 1D 2D SYSTE; Kaczorek T, 2012, B POL ACAD SCI-TECH, V60, P9, DOI 10.2478/v10175-012-0002-0; Kaczorek Tadeusz, 2011, Control and Cybernetics, V40; Kaczorek T., 2005, International Journal of Applied Mathematics and Computer Science, V15; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; Leenheer P. D., 2001, SYST CONTROL LETT, V44, P259; Liu XW, 2010, IEEE T AUTOMAT CONTR, V55, P1024, DOI 10.1109/TAC.2010.2041982; Pepe P, 2008, AUTOMATICA, V44, P2266, DOI 10.1016/j.automatica.2008.01.010; Twardy M, 2007, BULL POL ACAD SCI-TE, V55, P379; Valcher M.E., 2008, P 16 MED C CONTR AUT, P990; Zhang YM, 2013, INT J SYST SCI, V44, P2158, DOI 10.1080/00207721.2012.685200	23	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	NOV	2014	59	11			SI		3093	3097		10.1109/TAC.2014.2321233		5	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AS8EI	WOS:000344482500029		
J	Liu, LC; Pokharel, R				Liu, Lechang; Pokharel, Ramesh			Post-Layout Simulation Time Reduction for Phase-Locked Loop Frequency Synthesizer Using System Identification Techniques	IEEE TRANSACTIONS ON COMPUTER-AIDED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS			English	Article						Autoregressive exogenous model (ARX); compact model; neural network; phase-locked loop; system identification		Compact model extraction of phase-locked loop (PLL) frequency synthesizer using system identification techniques is proposed to reduce post-layout simulation time. This is the first published compact model for PLL using system identification techniques. It features an autoregressive exogenous model for the charge pump and the loop filter with a lookup table for nonlinearity compensation and a radial basis function neural network for the voltage-controlled oscillator with nonlinear frequency-voltage relationship, thereby reducing the post-layout simulation time to 26% of the original circuits with the accuracy of 93%.	[Liu, Lechang; Pokharel, Ramesh] Kyushu Univ, Fukuoka 8190395, Japan	Liu, LC (reprint author), Kyushu Univ, Fukuoka 8190395, Japan.	liu@ejust.kyushu-u.ac.jp					Zhang Z, 2013, IEEE T COMPUT AID D, V32, P1533, DOI 10.1109/TCAD.2013.2263039; Bond BN, 2010, IEEE T COMPUT AID D, V29, P1149, DOI 10.1109/TCAD.2010.2049155; Liu HZ, 2002, DES AUT CON, P437; Liu LC, 2011, IEEE J SOLID-ST CIRC, V46, P1349, DOI 10.1109/JSSC.2011.2128210; Ljung L, 1999, SYSTEM IDENTIFICATIO; Razavi B., 1996, MONOLITHIC PHASE LOC; Wang F., 2013, P IEEE MTT S INT MIC, P1, DOI 10.1109/ISIE.2013.6563713	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0070	1937-4151		IEEE T COMPUT AID D	IEEE Trans. Comput-Aided Des. Integr. Circuits Syst.	NOV	2014	33	11					1751	1755		10.1109/TCAD.2014.2354291		5	Computer Science, Hardware & Architecture; Computer Science, Interdisciplinary Applications; Engineering, Electrical & Electronic	Computer Science; Engineering	AS8YH	WOS:000344530400014		
J	Alam, K; Takagi, S; Takenaka, M				Alam, Khairul; Takagi, Shinichi; Takenaka, Mitsuru			A Ge Ultrathin-Body n-Channel Tunnel FET: Effects of Surface Orientation	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Band-to-band (BTB) tunneling; crystal orientation; performance metrics; ultrathin-body (UTB) tunneling field-effect transistor (TFET)	FIELD-EFFECT-TRANSISTORS; SILICON; GERMANIUM; TRANSPORT; TFETS; GAAS	We theoretically investigated the surface orientation effects on the complex band structures and performance of a 5-nm ultrathin-body Ge n-channel double gate tunnel field-effect transistor. The Ge is an indirect bandgap material, and the direct band-to-band (BTB) tunneling rate in Ge is not appreciated. We use (001) and (011) Ge thin-body to project the X[001] and X[100] valley to the 2-D Brillouin zone center, and (111) Ge thin-body to project the L[111] valley pair to the zone center. The trajectory of imaginary k is the key factor for direct BTB tunneling, and we find that the imaginary k-axis of the projected L[111] valley of (111) Ge thin-body provides the best BTB tunneling rate among the three orientations. The direct bandgap of (111) orientation is lowest among the three orientations, which results in the thinnest tunnel barrier in (111) device. The drive current of (111) device is 4x higher than (011) device and 15x higher than (001) device. The (001), (011), and (111) devices have subthreshold slope substantially lower than thermal limit, however, only (111) device has an I-60 (current at 60 mV/decade slope) value close to the desired limit. We use lower Gaussian doping in drain region to suppress ambipolar current. A 5x lower doping results in a 2x longer tunnel barrier at the drain-channel interface and more than two orders of magnitude suppression of ambipolar current.	[Alam, Khairul; Takagi, Shinichi; Takenaka, Mitsuru] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Alam, Khairul; Takagi, Shinichi; Takenaka, Mitsuru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1138656, Japan	Alam, K (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan.	kalam@ewubd.edu; takagi@ee.t.u-tokyo.ac.jp; takenaka@ee.t.u-tokyo.ac.jp			Japan Society for Promotion of Sciences Fellowship	This work was supported by the Japan Society for Promotion of Sciences Fellowship. The review of this paper was arranged by Editor H. S. Momose.	Alam K, 2013, IEEE T ELECTRON DEV, V60, P4213, DOI 10.1109/TED.2013.2285394; Lee MH, 2013, IEEE T ELECTRON DEV, V60, P2423, DOI 10.1109/TED.2013.2264101; Baravelli E, 2014, IEEE T ELECTRON DEV, V61, P178, DOI 10.1109/TED.2013.2289739; Villalon A, 2013, IEEE T ELECTRON DEV, V60, P4079, DOI 10.1109/TED.2013.2287610; Nayfeh OM, 2008, IEEE ELECTR DEVICE L, V29, P1074, DOI 10.1109/LED.2008.2000970; Koswatta SO, 2010, IEEE T ELECTRON DEV, V57, P3222, DOI 10.1109/TED.2010.2079250; Lake R, 1997, J APPL PHYS, V81, P7845, DOI 10.1063/1.365394; SLATER JC, 1954, PHYS REV, V94, P1498, DOI 10.1103/PhysRev.94.1498; Kao KH, 2012, IEEE T ELECTRON DEV, V59, P292, DOI 10.1109/TED.2011.2175228; Choi WY, 2007, IEEE ELECTR DEVICE L, V28, P743, DOI 10.1109/LED.2007.901273; KANE EO, 1961, J APPL PHYS, V32, P83, DOI 10.1063/1.1735965; Patel N, 2008, MICROELECTRON J, V39, P1671, DOI 10.1016/j.mejo.2008.02.020; Boykin TB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115201; Eyert V, 1996, J COMPUT PHYS, V124, P271, DOI 10.1006/jcph.1996.0059; Boykin TB, 1996, PHYS REV B, V54, P8107, DOI 10.1103/PhysRevB.54.8107; Brocard S, 2014, IEEE ELECTR DEVICE L, V35, P184, DOI 10.1109/LED.2013.2295884; CHANG YC, 1982, PHYS REV B, V25, P605, DOI 10.1103/PhysRevB.25.605; Dayeh S A, 2010, Proceedings 2010 10th IEEE International Conference on Nanotechnology and Joint Symposium with Nano Korea 2010 KINTEX (IEEE-NANO 2010), DOI 10.1109/NANO.2010.5697747; Goyal N., 2011, P INT SEM DEV RES S, P1; Krishnamohan T., 2008, P IEEE IEDM DEC, P1; Le ST, 2012, NANO LETT, V12, P5850, DOI 10.1021/nl3032058; Lee S., 2008, PHYS REV B, V69; Low T., 2005, J APPL PHYS, V98; Luisier M, 2009, P IEEE INT EL DEV M, P1; Rahman A., 2005, THESIS PURDUE U W LA; Rivas C, 2003, J APPL PHYS, V94, P5005, DOI 10.1063/1.1606114; Shih CH, 2011, IEEE ELECTR DEVICE L, V32, P1498, DOI 10.1109/LED.2011.2164512; Vandenberghe W., 2011, J APPL PHYS, V109; Vandenberghe W. G., 2013, APPL PHYS LETT, V102; Verhulst A. S., 2007, APPL PHYS LETT, V91; Verhulst AS, 2008, IEEE ELECTR DEVICE L, V29, P1398, DOI 10.1109/LED.2008.2007599; Zhang Q, 2009, SOLID STATE ELECTRON, V53, P30, DOI 10.1016/j.sse.2008.09.010; Zhou G. L., 2012, P IEEE IEDM DEC, P777	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2014	61	11					3594	3600		10.1109/TED.2014.2353513		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AS9DU	WOS:000344544200003		
J	Zhang, R; Yu, X; Takenaka, M; Takagi, S				Zhang, Rui; Yu, Xiao; Takenaka, Mitsuru; Takagi, Shinichi			Impact of Channel Orientation on Electrical Properties of Ge p- and n-MOSFETs With 1-nm EOT Al2O3/GeOx/Ge Gate-Stacks Fabricated by Plasma Postoxidation	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Germanium; mobility; MOSFET; substrate orientation	DRIVE-CURRENT ENHANCEMENT; HIGH-MOBILITY; OXIDATION; FETS	The impact of surface orientations on electrical characteristics of Ge p-and n-channel MOSFETs with ultrathin equivalent oxide thickness Al2O3/GeOx/Ge gate-stacks is systematically investigated. It is found that (100), (110), and (111) GeOx/p-Ge metal-oxide-semiconductor (MOS) interfaces have a similar interface trap density (D-it) level, but (100) GeOx/n-Ge MOS interfaces exhibit the lowest D-it. As a result, the highest peak mobility is obtained in (110) Ge pMOSFETs for holes and in (100) Ge nMOSFETs for electrons. The higher interface state density is observed inside valence band of Ge for (110) GeOx/Ge MOS interface and inside conduction band of Ge for (110) and (111) GeOx/Ge MOS interfaces, leading to the significant effective mobility reduction in high normal field for (110) Ge pMOSFETs, and (110) and (111) Ge nMOSFETs. It is also confirmed that decrease of plasma oxidation temperature is also effective in reduction of the interface roughness at (100) to (111) GeOx/Ge interfaces, resulting in clear enhancement of both hole and electron mobility in high normal field region.	[Zhang, Rui; Yu, Xiao; Takenaka, Mitsuru; Takagi, Shinichi] Univ Tokyo, Sch Engn, Tokyo 1138654, Japan; [Zhang, Rui] Zhejiang Univ, Dept Informat Syst & Elect Engn, Hangzhou 310027, Peoples R China	Zhang, R (reprint author), Univ Tokyo, Sch Engn, Tokyo 1138654, Japan.	zhang@mosfet.t.u-tokyo.ac.jp; yuxiao@mosfet.t.u-tokyo.ac.jp; takenaka@ee.t.u-tokyo.ac.jp; takagi@ee.t.u-tokyo.ac.jp			National Program on Key Basic Research Project of China (973 Program) [2011CBA00607]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23246058, 26249038]	This work was supported in part by the National Program on Key Basic Research Project of China (973 Program) under Grant 2011CBA00607, and in part by the Grant-in-Aid for Scientific Research through the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant 23246058 and Grant 26249038. The review of this paper was arranged by Editor W. Tsai.	Saraswat KC, 2005, MICROELECTRON ENG, V80, P15, DOI 10.1016/j.mee.2005.04.038; Martens K, 2006, IEEE ELECTR DEVICE L, V27, P405, DOI 10.1109/LED.2006.873767; Zhang R, 2013, IEEE T ELECTRON DEV, V60, P927, DOI 10.1109/TED.2013.2238942; Kuzum D, 2007, INT EL DEVICES MEET, P723, DOI 10.1109/IEDM.2007.4419048; Zhang R, 2012, IEEE T ELECTRON DEV, V59, P335, DOI 10.1109/TED.2011.2176495; BREWS JR, 1983, SOLID STATE ELECTRON, V26, P711, DOI 10.1016/0038-1101(83)90030-8; Kuzum D, 2009, IEEE T ELECTRON DEV, V56, P648, DOI 10.1109/TED.2009.2014198; Shang H, 2006, IBM J RES DEV, V50, P377; Zhang R, 2014, IEEE T ELECTRON DEV, V61, P2316, DOI 10.1109/TED.2014.2325604; Zhang R, 2014, IEEE T ELECTRON DEV, V61, P416, DOI 10.1109/TED.2013.2295822; Zhang R, 2011, MICROELECTRON ENG, V88, P1533, DOI 10.1016/j.mee.2011.03.130; Lee CH, 2011, IEEE T ELECTRON DEV, V58, P1295, DOI 10.1109/TED.2011.2111373; Chang ST, 2008, JPN J APPL PHYS, V47, P5345, DOI 10.1143/JJAP.47.5345; Dissanayake S., 2011, J APPL PHYS, V109; Dissanayake S., 2010, APPL PHYS EXP, V3; Kamata Y, 2010, S VLSI TECH, P211, DOI 10.1109/VLSIT.2010.5556231; Krishnamohan T., 2008, P IEEE IEDM DEC, P1; Lee C H, 2009, P IEDM, P457; Lee C. H., 2010, P IEEE IEDM; Low T., 2004, APPL PHYS LETT, V85, P2042; Matsubara H., 2007, P SCI LAT2007, P18; MITARD J, 2009, P S VLSI TECHN, P82; Nicholas G, 2007, IEEE T ELECTRON DEV, V54, P1425, DOI [10.1109/TED.2007.896352, 10.1169/TED.2007.896352]; Sasada T., 2009, J APPL PHYS, V106; Takagi S., 2003, IEDM, P331; Takagi S., 2003, S VLSI, P115; Taoka N., 2011, P IEEE INT EL DEV M; Taoka N., 2006, P SSDM, P396; Toriumi A., 2006, P IEDM, P1; Zhang QC, 2006, IEEE ELECTR DEVICE L, V27, P728, DOI 10.1109/LED.2006.880655; Zhang R., 2011, P IEEE IEDM DEC; Zhang R., 2012, P IEEE IEDM DEC, p16 1 1; Zhang R., 2013, APPL PHYS LETT, V102; Zhang R., 2011, APPL PHYS LETT, V98	34	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2014	61	11					3668	3675		10.1109/TED.2014.2359678		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AS9DU	WOS:000344544200014		
J	Takenaka, I; Takahashi, S; Takahashi, H; Ando, Y; Kakuta, Y; Sasaoka, C				Takenaka, Isao; Takahashi, Shinnosuke; Takahashi, Hidemasa; Ando, Yuji; Kakuta, Yuji; Sasaoka, Chiaki			Broadband Distortion Cancellation Technique in GaAs HJFET and GaN FET Cascode Amplifier	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						AlGaN/GaN heterostructure field-effect transistor (HFET); cable television (CATV); capacitance nonlinearity; cascode; composite triple beat (CTB); distortion cancellation; GaAs heterojunction FET (HJFET); gate-orientation; gm-profile; load-line; low distortion; power amplifiers	DERIVATIVE SUPERPOSITION METHOD; MODEL; HEMT	This paper describes broadband distortion cancellation technique in the cascode configuration composed of GaAs heterojunction field-effect transistor (HJFET) for the first stage and AlGaN/GaN heterojunction FET (HJFET), for the final stage to realize broadband low-distortion cable television (CATV) power amplifier. The device structures of GaAs HJFET and GaN FET were optimized using the Volterra distortion analysis on a load-line. The transconductance gm-profile on a load-line of the first-stage GaAs HJFET was designed to obtain the gain expansion at near Class-A operation to cancel the gain compression of the final-stage GaN FET. The gate-orientation of GaAs HJFET was optimized to achieve low distortion at lower current condition. The field-plate electrode structure of the final-stage GaN FET was optimized to improve the high-frequency distortion characteristics by reducing the capacitance nonlinearity on a load-line. The developed CATV power amplifier demonstrated low composite triple beat characteristics less than -72 dBc at low drain current condition of 380 mA 53.7 dBmV at 865 MHz, 11.7-dB tilt, and 132 channels.	[Takenaka, Isao; Takahashi, Hidemasa; Ando, Yuji; Sasaoka, Chiaki] Renesas Syst Design Co Ltd, Otsu, Shiga 5200833, Japan; [Takahashi, Shinnosuke] Renesas SP Drivers Inc, Tokyo 1878588, Japan; [Kakuta, Yuji] Renesas Syst Design Co Ltd, Yokohama, Kanagawa 2118666, Japan	Takenaka, I (reprint author), Renesas Syst Design Co Ltd, Otsu, Shiga 5200833, Japan.	isao.takenaka.jc@renesas.com; shinnosuke.takahashi.xw@rsp.renesas.com; hidemasa.takahashi.ym@renesas.com; yuji.ando.ry@renesas.com; yuji.kakuta.rh@renesas.com; chiaki.sasaoka.xe@renesas.com					[Anonymous], 2013, GAAS HIGH OUTP POW D; [Anonymous], 2013, GAAS GAN POW DOUBL H; Aparin V, 2005, IEEE T MICROW THEORY, V53, P571, DOI 10.1109/TMTT.2004.840635; ANGELOV I, 1992, IEEE T MICROW THEORY, V40, P2258, DOI 10.1109/22.179888; ASBECK PM, 1984, IEEE T ELECTRON DEV, V31, P1377, DOI 10.1109/T-ED.1984.21719; Brech H, 2000, IEEE T ELECTRON DEV, V47, P1957, DOI 10.1109/16.870581; Geddada HM, 2009, ELECTRON LETT, V45, P435, DOI 10.1049/el.2009.3168; Kobayashi KW, 2012, IEEE J SOLID-ST CIRC, V47, P2316, DOI 10.1109/JSSC.2012.2204929; Leong YC, 2000, IEEE MTT-S, P1385, DOI 10.1109/MWSYM.2000.862232; Liu LS, 2009, IEEE T MICROW THEORY, V57, P3106, DOI 10.1109/TMTT.2009.2034049; ONODERA T, 1985, IEEE T ELECTRON DEV, V32, P2314, DOI 10.1109/T-ED.1985.22276; Pedro JC, 1997, 27TH EUROPEAN MICROWAVE 97, CONFERENCE + EXHIBITION - BRIDGING THE GAP BETWEEN INDUSTRY AND ACADEMIA, VOLS I AND II, P739, DOI 10.1109/EUMA.1997.337882; Qu G., 2005, P AS PAC MICR C APMC, V5, P1; RAMIREZ JC, 1988, IEEE T ELECTRON DEV, V35, P1232, DOI 10.1109/16.2542; Shealy JB, 2009, BCTM PROC, P146; Takenaka I., 2013, P IEEE COMP SEM INT, P1	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2014	61	11					3684	3690		10.1109/TED.2014.2353049		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AS9DU	WOS:000344544200016		
J	Toda, T; Wang, DP; Jiang, JX; Hung, MP; Furuta, M				Toda, Tatsuya; Wang, Deapeng; Jiang, Jingxin; Hung, Mai Phi; Furuta, Mamoru			Quantitative Analysis of the Effect of Hydrogen Diffusion from Silicon Oxide Etch-Stopper Layer into Amorphous In-Ga-Zn-O on Thin-Film Transistor	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Amorphous In-Ga-Zn-O (a-IGZO); etchstopper (ES); hydrogen diffusion; silane (SiH4) partial pressure; silicon oxide (SiOx); thin-film transistor (TFT)	ELECTRICAL-PROPERTIES; NEGATIVE-BIAS; CHANNEL	To investigate the effect of hydrogen diffusion from the silicon oxide etch-stopper (SiOx ES) layer into the amorphous In-Ga-Zn-O (a-IGZO) on thin-film transistor (TFT) properties and stabilities, we fabricated a-IGZO TFTs with a SiOx ES layer deposited by plasma-enhanced chemical vapor deposition at various silane (SiH4) partial pressures (P[SiH4]). Then, quantitative analysis was performed to investigate the relationship between the hydrogen content of the a-IGZO and electrical properties and stability of the TFTs. We found that a low resistance region was formed at the backchannel of the TFT, when the SiOx ES layer was deposited at higher P[SiH4], leading to a drastic negative threshold voltage (V-th) shift. In addition, it was also found that at the frontchannel, the increase in the carrier concentration of a-IGZO was proportional to the increase in the amount of hydrogen in a-IGZO. On the other hand, when P[SiH4] was increased, the subthreshold swing, hysteresis, and gate-bias stability of the TFT improved. The results indicate that hydrogen diffused from the SiOx ES layer passivates the electron traps at the a-IGZO and/or gate insulator/a-IGZO interface, and almost all of the hydrogen also acts as shallow-donor in a-IGZO.	[Toda, Tatsuya; Jiang, Jingxin; Hung, Mai Phi] Kochi Univ Technol, Grad Sch Engn, Kochi 7828502, Japan; [Wang, Deapeng; Furuta, Mamoru] Kochi Univ Technol, Dept Environm Sci & Engn, Kochi 7828502, Japan	Toda, T (reprint author), Kochi Univ Technol, Grad Sch Engn, Kochi 7828502, Japan.	176004n@gs.kochi-tech.ac.jp; wang.dapeng@kochi-tech.ac.jp; 166004j@gs.kochi-tech.ac.jp; maiphihung@gmail.com; furuta.mamoru@kochi-tech.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [23560408, 2611657]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Tokyo, Japan, under Grant 23560408 and Grant 2611657, and in part by the the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Nanotechnology Platform Program (Molecule and Material Synthesis). The review of this paper was arranged by Editor J. Huang.	Wu CH, 2009, J DISP TECHNOL, V5, P515, DOI 10.1109/JDT.2009.2026189; Nomura K, 2013, ECS J SOLID STATE SC, V2, pP5, DOI 10.1149/2.011301jss; Fung TC, 2009, J DISP TECHNOL, V5, P452, DOI 10.1109/JDT.2009.2020611; LIBSCH FR, 1993, APPL PHYS LETT, V62, P1286, DOI 10.1063/1.108709; Dong JJ, 2010, ACS APPL MATER INTER, V2, P1780, DOI 10.1021/am100298p; Furuta M, 2012, IEEE ELECTR DEVICE L, V33, P851, DOI 10.1109/LED.2012.2192902; Oh SI, 2013, IEEE T ELECTRON DEV, V60, P2537, DOI 10.1109/TED.2013.2265326; Wang DP, 2014, ACS APPL MATER INTER, V6, P5713, DOI 10.1021/am500300g; Furuhashi M., 2013, J DISP TECHNOL, P1; Furuta M, 2010, IEEE ELECTR DEVICE L, V31, P1257, DOI 10.1109/LED.2010.2068276; Furuta M, 2013, ECS TRANSACTIONS, V54, P127, DOI 10.1149/05401.0127ecst; Furuta M, 2009, ELECTROCHEM SOLID ST, V12, pK74, DOI 10.1149/1.3238481; HANYU Y, 2013, APPL PHYS LETT, V103; Hung MP, 2014, ECS SOLID STATE LETT, V3, pQ13, DOI 10.1149/2.010403ssl; Kamada Y., 2011, APPL PHYS LETT, V98; Kamada Y, 2011, IEEE ELECTR DEVICE L, V32, P509, DOI 10.1109/LED.2011.2105459; Kim MW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713859; Kimura M, 2011, IEEE T ELECTRON DEV, V58, P3018, DOI 10.1109/TED.2011.2158546; Lee J.-M., 2009, APPL PHYS LETT, V94; Li M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.076501; Noh H. K., 2013, J APPL PHYS, V113; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Ohara H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CD02; SATO A, 2009, APPL PHYS LETT, V94; Wang DP, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03CC01	25	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2014	61	11					3762	3767		10.1109/TED.2014.2359739		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AS9DU	WOS:000344544200027		
J	Banno, N; Tada, M; Sakamoto, T; Okamoto, K; Miyamura, M; Iguchi, N; Hada, H				Banno, Naoki; Tada, Munehiro; Sakamoto, Toshitsugu; Okamoto, Koichiro; Miyamura, Makoto; Iguchi, Noriyuki; Hada, Hiromitsu			Improved Switching Voltage Variation of Cu Atom Switch for Nonvolatile Programmable Logic	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Atom switch (AS); field-programmable gate array (FPGA); nonvolatile memory; polymer; programmable logic device (PLD); reconfigurable logic; solid electrolyte	SOLID-ELECTROLYTE; GATE ARRAYS	Switching voltage variation of a Cu atom switch (AS) is improved to sigma = 9.5% by adjusting the buffer oxidation state and electrode surface roughness. The complementary AS (CAS) connects two Cu lines at each edge and is composed of a dual-layered electrolyte of oxidized Ti buffer metal/polymer solid electrolyte. A sufficiently oxidized Ti buffer layer prevents both Cu oxidation and Ti diffusion during the fabrication processes, reducing the OFF-state leakage current and making the ON/OFF current ratio high. A dry cleaning process reduces the Cu electrode surface roughness, tightening the set voltage distribution and enabling the use of a low programming voltage, 1.8 V. A large-scale crossbar switch block consisting of CASs has been operated by the improved switches.	[Banno, Naoki; Tada, Munehiro; Sakamoto, Toshitsugu; Okamoto, Koichiro; Miyamura, Makoto; Iguchi, Noriyuki; Hada, Hiromitsu] Low Power Elect Assoc & Project, Tsukuba, Ibaraki 3058569, Japan	Banno, N (reprint author), Low Power Elect Assoc & Project, Tsukuba, Ibaraki 3058569, Japan.	banno@leap.or.jp; tada@leap.or.jp; sakamoto@leap.or.jp; okamoto@leap.or.jp; miyamura@leap.or.jp; iguchi@leap.or.jp; hada@leap.or.jp			Ministry of Economy, Trade and Industry; New Energy and Industrial Technology Development Organization through the Ultralow Voltage Device Project	This work was supported in part by the Ministry of Economy, Trade and Industry and in part by the New Energy and Industrial Technology Development Organization through the Ultralow Voltage Device Project. The review of this paper was arranged by Editor R. M. Todi.	Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Tada M, 2011, IEEE T ELECTRON DEV, V58, P4398, DOI 10.1109/TED.2011.2169070; Tada M, 2010, IEEE T ELECTRON DEV, V57, P1987, DOI 10.1109/TED.2010.2051191; Kaeriyama S, 2005, IEEE J SOLID-ST CIRC, V40, P168, DOI 10.1109/JSSC.2004.837244; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Burr GW, 2010, J VAC SCI TECHNOL B, V28, P223, DOI 10.1116/1.3301579; Tada M, 2012, IEEE T ELECTRON DEV, V59, P2357, DOI 10.1109/TED.2012.2204263; Banno N., 2012, P S VLSI TECHN, P39; Banno N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.074201; Cheng H. Y., 2012, P IEEE IEDM DEC; Degraeve R., 2013, P S VER LARG SCAL IN, pT98; Gouttebaron R, 2000, SURF INTERFACE ANAL, V30, P527, DOI 10.1002/1096-9918(200008)30:1<527::AID-SIA834>3.0.CO;2-Z; GREENE J, 1993, P IEEE, V81, P1042, DOI 10.1109/5.231343; Hirose Y., 1976, J APPL PHYS, V47, P2267; Kim B., 2012, INT C SOL STAT DEV M, P616; Kozicki M. N., 2002, SIL NAN WORKSH, P51; Miyamura M., 2012, P IEEE IEDM DEC, P247; Miyamura M., 2011, IEEE ISSCC, P228; Patel R, 2014, MICROELECTRON J, V45, P133, DOI 10.1016/j.mejo.2013.11.015; ROSE J, 1993, P IEEE, V81, P1013, DOI 10.1109/5.231340; Tada M., 2012, P IEEE IEDM DEC, P2981; Tamamoto Y., 1976, J APPL PHYS, V47, P3603; Wang W. Q., 2006, P 10 IEEE SING INT C, P1, DOI 10.3115/1220835.1220836; Watanabe H, 2006, JPN J APPL PHYS 1, V45, P2933, DOI 10.1143/JJAP.45.2933	24	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2014	61	11					3827	3832		10.1109/TED.2014.2355830		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AS9DU	WOS:000344544200037		
J	Han, TS; Endo, H; Sasaki, M				Han, Te Sun; Endo, Hiroyuki; Sasaki, Masahide			Reliability and Secrecy Functions of the Wiretap Channel Under Cost Constraint	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Reliability function; secrecy function; secrecy measures; Poisson wiretap channel; cost constraint; Gaussian wiretap channel; binary symmetric wiretap channel; tradeoff between reliability and secrecy; concatenation; rate shifting; rate exchange; change of cost constraint	BROADCAST CHANNELS; RESOLVABILITY; INFORMATION; CAPACITY	The wiretap channel has been devised and studied first by Wyner, and subsequently extended to the case with nondegraded general wiretap channels by Csiszar and Korner. Focusing mainly on the stationary memoryless channel with cost constraint, we newly introduce the notion of reliability and secrecy functions as a fundamental tool to analyze and/or design the performance of an efficient wiretap channel system, including binary symmetric wiretap channels, Poisson wiretap channels, and Gaussian wiretap channels. Compact formulas for those functions are explicitly given for stationary memoryless wiretap channels. It is also demonstrated that, based on such a pair of reliability and secrecy functions, we can control the tradeoff between reliability and secrecy (usually conflicting), both with exponentially decreasing rates as block length n becomes large. Four ways to do so are given on the basis of rate shifting, rate exchange, concatenation, and change of cost constraint. In addition, the notion of the delta secrecy capacity is defined and shown to attain the strongest secrecy standard among others. The maximized versus averaged secrecy measures is also discussed.	[Han, Te Sun; Endo, Hiroyuki; Sasaki, Masahide] Natl Inst Informat & Commun Technol, Quantum ICT Lab, Koganei, Tokyo 1848795, Japan; [Endo, Hiroyuki] Waseda Univ, Dept Appl Phys, Tokyo 1698050, Japan	Han, TS (reprint author), Natl Inst Informat & Commun Technol, Quantum ICT Lab, 4-2-1 Nukuikitamachi, Koganei, Tokyo 1848795, Japan.	han@is.uec.ac.jp; h-endo-1212@ruri.waseda.jp; psasaki@nict.go.jp					Laourine A, 2012, IEEE T INFORM THEORY, V58, P7073, DOI 10.1109/TIT.2012.2217191; Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Liu T, 2007, IEEE T INFORM THEORY, V53, P1839, DOI 10.1109/TIT.2007.894680; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Bloch MR, 2013, IEEE T INFORM THEORY, V59, P8077, DOI 10.1109/TIT.2013.2283722; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; WYNER AD, 1975, AT&T TECH J, V54, P1355; Cover T. M., 2006, ELEMENTS INFORM THEO; Csiszar I., 2011, INFORM THEORY CODING, V2nd; Csiszar I., 1996, Problems of Information Transmission, V32; Gallager R.G., 1968, INFORM THEORY RELIAB; Han T.S., 2003, INFORM SPECTRUM METH; Hou J., 2014, EFFECTIVE SECRECY RE; Lapidoth A, 2003, IEEE T INFORM THEORY, V49, P3250, DOI 10.1109/TIT.2003.820036; Lueng-Yan-Cheong S., 1978, IEEE T INFORM THEORY, V24, P451; Pinsker M., 1964, INFORM INFORM STABIL; Wyner A. D., 1988, IEEE T INFORM THEORY, V36, P1449	18	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	NOV	2014	60	11					6819	6843		10.1109/TIT.2014.2355811		25	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AS8UT	WOS:000344524100008		
J	Ren, DN; Chan, SHG; Cheung, G; Frossard, P				Ren, Dongni; Chan, S. -H. Gary; Cheung, Gene; Frossard, Pascal			Coding Structure and Replication Optimization for Interactive Multiview Video Streaming	IEEE TRANSACTIONS ON MULTIMEDIA			English	Article						Multimedia computing; digital video broadcasting	NETWORKS; FRAME	Multiview video refers to videos of the same dynamic 3-D scene captured simultaneously by multiple closely spaced cameras from different viewpoints. We study interactive streaming of pre-encoded multiview videos, where, at any time, a client can request any one of many captured views for playback. Moreover, the client can periodically freeze the video in time and switch to neighboring views for a compelling look-around visual effect. We consider distributed content servers to support large-scale interactive multiview video service. These servers collaboratively replicate and access video contents. We study two challenges in this setting: what is an efficient coding structure that supports interactive view switching and, given that, what to replicate in each server in order to minimize the cost incurred by interactive temporal and view switches? We first propose a redundant coding structure that facilitates interactive view-switching, trading off storage with transmission rate. Using the coding structure, we next propose a content replication strategy that takes advantage of indirect hit to lower view-switching cost: in the event that the exact requested view is not available locally, the local server can fetch a different but correlated view from the other servers, so that the remote repository only needs to supply the pre-encoded view differential. We formulate the video content replication problem to minimize the switching cost as an integer linear programming (ILP) problem and show that it is NP-hard. We first propose an LP relaxation and rounding algorithm (termed Minimum Eviction) with bounded approximation error. We then study a more scalable solution based on dynamic programming and Lagrangian optimization (DPLO) with little sacrifice in performance. Simulation results show that our replication algorithms achieve substantially lower switching cost compared to other content replication schemes.	[Ren, Dongni] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, S. -H. Gary] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Cheung, Gene] Natl Inst Informat, Tokyo 1018430, Japan; [Frossard, Pascal] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Ren, DN (reprint author), Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China.	tonyren@cse.ust.hk; gchan@cse.ust.hk; cheung@nii.ac.jp; pascal.frossard@epfl.ch			Hong Kong Research Grant Council (RGC) General Research Fund [610713]; HKUST [FSGRF13EG15]; Hong Kong Innovation and Technology Fund [UIM/246]	This work was supported in part by Hong Kong Research Grant Council (RGC) General Research Fund under Grant 610713, HKUST under Grant FSGRF13EG15, and the Hong Kong Innovation and Technology Fund under Grant UIM/246. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Ebroul Izquierdo.	Xiu XY, 2012, IEEE T MULTIMEDIA, V14, P1109, DOI 10.1109/TMM.2012.2191267; Cheung G, 2011, IEEE T IMAGE PROCESS, V20, P744, DOI 10.1109/TIP.2010.2070074; Merkle P, 2007, IEEE T CIRC SYST VID, V17, P1461, DOI 10.1109/TCSVT.2007.903665; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Ataee S, 2013, EUROMICRO WORKSHOP P, P68, DOI 10.1109/PDP.2013.19; Borst S., 2009, ACM SIGMETRICS PERFO, V37, P71; Borst S., 2010, P IEEE INFOCOM, P1; Chan SHG, 2001, IEEE COMMUN LETT, V5, P384, DOI 10.1109/4234.951385; Chen Z., 2010, P 2 INT C E BUS INF, P1; Cheung G., 2010, P SPIE VIS COMM IM P; Cheung N.-M., 2009, P PICT COD S MAY, P1; Dai W., 2013, P IEEE INT C IM PROC, P1787; Maugey T, 2013, IEEE T IMAGE PROCESS, V22, P3459, DOI 10.1109/TIP.2013.2270183; Ding Y, 2011, IEEE INT CONF PEER, P182; Fujii T, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO - ICME 2006, VOLS 1-5, PROCEEDINGS, P437, DOI 10.1109/ICME.2006.262566; Ghandeharizadeh S., 2011, ACM T MULTIM COMPUT, V7; Huang H., 2011, P MIN IEEE INFOCOM O, P3073; Huang H., 2012, P INT PACK VID WKSP, P95; Jaho E, 2012, COMPUT COMMUN, V35, P637, DOI 10.1016/j.comcom.2011.12.006; Karczewicz M, 2003, IEEE T CIRC SYST VID, V13, P637, DOI 10.1109/TCSVT.2003.814969; Lou J.-G., 2005, P 13 ANN ACM INT C M, P161, DOI 10.1145/1101149.1101173; Mao SW, 2007, IEEE T WIREL COMMUN, V6, P338, DOI 10.1109/TWC.2007.05236; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI; Savas SS, 2012, SIGNAL PROCESS-IMAGE, V27, P522, DOI 10.1016/j.image.2012.02.013; Shimizu S, 2007, IEEE T CIRC SYST VID, V17, P1485, DOI 10.1109/TCSVT.2007.903773; Tanimoto M, 2011, IEEE SIGNAL PROC MAG, V28, P67, DOI 10.1109/MSP.2010.939077; Wang M, 2011, COMPUT NETW, V55, P4069, DOI 10.1016/j.comnet.2011.07.014; Zhang X., 2010, P IEEE INT C CLUST C, P88	28	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1520-9210	1941-0077		IEEE T MULTIMEDIA	IEEE Trans. Multimedia	NOV	2014	16	7					1874	1887		10.1109/TMM.2014.2332139		14	Computer Science, Information Systems; Computer Science, Software Engineering; Telecommunications	Computer Science; Telecommunications	AT1UX	WOS:000344720300007		
J	Ishii, Y; Inamura, N; Kayatani, F; Iwai, S; Kawata, H; Arakawa, H; Kishimoto, H				Ishii, Yoichiro; Inamura, Noboru; Kayatani, Futoshi; Iwai, Shigemitsu; Kawata, Hiroaki; Arakawa, Hirokazu; Kishimoto, Hidefumi			Evaluation of bilateral pulmonary artery banding for initial palliation in single-ventricle neonates and infants: risk factors for mortality before the bidirectional Glenn procedure	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Congenital heart disease; Hypoplastic left heart syndrome; Risk factor; Bilateral pulmonary artery banding; Bidirectional Glenn procedure	HYPOPLASTIC LEFT-HEART; NORWOOD STAGE-I; RECONSTRUCTION; EXPERIENCE; MANAGEMENT; STRATEGY; REPAIR	Bilateral pulmonary artery banding is considered as 'first-stage' palliation for neonates who have hypoplastic left heart syndrome. This study aimed to identify risk factors that influence outcome before the bidirectional Glenn operation. This retrospective evaluation involved 30 consecutive patients with hypoplastic left heart syndrome, or a variant, who underwent bilateral pulmonary artery banding between August 2005 and December 2011 at our institution. Clinical echocardiographic, operative and catheter examination data were reviewed. This study included 9 patients with hypoplastic left heart syndrome and 21 patients with variants. Bilateral pulmonary artery banding was performed at a median age of 7 days. Finally, 19 patients had the bidirectional Glenn operation performed (Group A), and the remaining 11 patients died before the bidirectional Glenn procedure (Group NA). Catheter evaluations before the bidirectional Glenn procedure were carried out at 97 +/- 34 days. The mean pulmonary venous wedge pressure was significantly lower (Group A: 13.1 +/- 3.1 mmHg vs Group NA: 22.9 +/- 3.7 mmHg, P < 0.01), systemic ventricular ejection fraction was higher (54.4 +/- 10.7 vs 41.7 +/- 9.9%, P < 0.05), systemic ventricular end-diastolic pressure was lower (6.1 +/- 2.4 vs 10.5 +/- 3.6 mmHg, P < 0.05) and the rate of patients with more than mild systemic atrioventricular valve regurgitation was lower in Group A than in Group NA (15.7 vs 62.5%, P < 0.05). Multivariate logistic regression analysis showed that mean pulmonary venous wedge pressure was the most significant predictor of attaining the bidirectional Glenn anastomosis (odds ratio: 2.35, P < 0.01). Postoperative atrioventricular valve regurgitation, cardiac function and mean pulmonary venous wedge pressure are closely correlated with mortality after bilateral pulmonary artery banding. Additional treatments, including operations, are considered to maintain cardiac function and not to raise pulmonary venous wedge pressure before the bidirectional Glenn procedure.	[Ishii, Yoichiro; Inamura, Noboru; Kayatani, Futoshi] Osaka Med Ctr, Dept Pediat Cardiol, Osaka, Japan; [Ishii, Yoichiro; Inamura, Noboru; Kayatani, Futoshi; Iwai, Shigemitsu; Kawata, Hiroaki; Kishimoto, Hidefumi] Res Inst Maternal & Child Hlth, Osaka, Japan; [Ishii, Yoichiro] Gunma Childrens Med Ctr, Dept Cardiol, Gunma 3778577, Japan; [Ishii, Yoichiro] Gunma Univ, Dept Pediat, Grad Sch Med, Gunma, Japan; [Iwai, Shigemitsu; Kawata, Hiroaki; Kishimoto, Hidefumi] Osaka Med Ctr, Dept Cardiovasc Surg, Osaka, Japan	Ishii, Y (reprint author), Gunma Childrens Med Ctr, Dept Cardiol, 779 Shimohakoda, Gunma 3778577, Japan.	yishii@pj8.so-net.ne.jp					Galantowicz M, 2005, PEDIATR CARDIOL, V26, P190, DOI 10.1007/s00246-004-0962-4; Bacha EA, 2006, J THORAC CARDIOV SUR, V131, P163, DOI 10.1016/j.jtcvs.2005.07.053; McGuirk SP, 2006, HEART, V92, P364, DOI 10.1136/hrt.2005.068684; Stasik CN, 2006, J THORAC CARDIOV SUR, V131, P412, DOI 10.1016/j.jtcvs.2005.09.030; Weinstein S, 1999, CIRCULATION, V100, P167; Daebritz SH, 2000, J THORAC CARDIOV SUR, V119, P358, DOI 10.1016/S0022-5223(00)70192-9; Akintuerk H, 2002, CIRCULATION, V105, P1099, DOI 10.1161/hc0902.104709; Gaynor JW, 2002, EUR J CARDIO-THORAC, V22, P82, DOI 10.1016/S1010-7940(02)00198-7; Ghanayem NS, 2012, J THORAC CARDIOV SUR, V144, P896, DOI 10.1016/j.jtcvs.2012.05.020; BARBER G, 1988, AM HEART J, V116, P1563, DOI 10.1016/0002-8703(88)90744-2; Bove EL, 1996, ANN SURG, V224, P387, DOI 10.1097/00000658-199609000-00015; Caldarone CA, 2007, ANN THORAC SURG, V84, P1294, DOI 10.1016/j.athoracsur.2007.04.127; DiBardino DJ, 2008, PEDIATR CARDIOL, V29, P251, DOI 10.1007/s00246-007-0012-0; Galantowicz M, 2008, ANN THORAC SURG, V85, P2063, DOI 10.1016/j.athoracsur.2008.02.009; Galantowicz M., 2008, ANN THORAC SURG, V85, P2070; Helton JG, 1986, CIRCULATION 2, V74, P170; Ishino K, 1999, J THORAC CARDIOV SUR, V117, P920, DOI 10.1016/S0022-5223(99)70373-9; NORWOOD WI, 1980, AM J CARDIOL, V45, P87, DOI 10.1016/0002-9149(80)90224-6; Pearl JM, 2002, ANN THORAC SURG, V73, P339; Pearl JM, 2002, ANN THORAC SURG, V73, P331, DOI 10.1016/S0003-4975(01)02720-5; Pigula Frank A, 2007, Semin Thorac Cardiovasc Surg, V19, P238, DOI 10.1053/j.semtcvs.2007.07.002; Pizarro C, 2008, EUR J CARDIO-THORAC, V33, P613, DOI 10.1016/j.ejcts.2007.12.042; Sakurai T, 2009, EUR J CARDIO-THORAC, V36, P973, DOI 10.1016/j.ejcts.2009.05.009; Sano S, 2009, ANN THORAC SURG, V87, P178, DOI 10.1016/j.athoracsur.2008.08.027	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	NOV	2014	19	5					807	811		10.1093/icvts/ivu240		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT0BM	WOS:000344602000019		
J	Ozeki, N; Iwano, S; Taniguchi, T; Kawaguchi, K; Fukui, T; Ishiguro, F; Fukumoto, K; Nakamura, S; Hirakawa, A; Yokoi, K				Ozeki, Naoki; Iwano, Shingo; Taniguchi, Tetsuo; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Fukumoto, Koichi; Nakamura, Shota; Hirakawa, Akihiro; Yokoi, Kohei			Therapeutic surgery without a definitive diagnosis can be an option in selected patients with suspected lung cancer	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung cancer; Diagnosis; Surgery; Frozen section	SOLITARY PULMONARY NODULES; NEEDLE-BIOPSY; CT; ACCURACY; RISK; COMPLICATION; PROBABILITY; MULTICENTER; MALIGNANCY; RESECTION	With the recent improvements in the diagnostic accuracy of radiographic modalities, it might be an option to perform therapeutic surgery without a definitive diagnosis for selected patients with suspected lung cancer based on the findings of diagnostic imaging. Between April 2008 and December 2012, all nodules without a definitive diagnosis were classified into five categories according to the probability of lung cancer based on the diagnostic imaging: Category 1 (Benign), Category 2 (Probably benign), Category 3 (Intermediate), Category 4 (Suspected malignancy) and Category 5 (Highly suggestive of malignancy). In this study, the 232 surgical candidates for suspected clinical stage I lung cancer without a preoperative definitive diagnosis were considered to be Category 3 (n = 29), Category 4 (n = 46) and Category 5 (n = 157). Eighty-two patients (72% of Category 3, 46% of Category 4 and 25% of Category 5) had an intraoperative diagnosis during surgery, whereas the remaining 150 patients did not. The final pathological diagnosis and surgical outcomes were analysed. The final pathological diagnosis of the 232 suspicious nodules revealed 214 lung cancers (52% of Category 3, 93% of Category 4 and 99% of Category 5). Wedge resection was performed for all seven benign tumours. In the multiple regression analysis, intraoperative diagnosis was a significant factor for the length of the operation. In the multivariate logistic regression analysis, the length of the operation was a significant factor predicting both the postoperative morbidity and a prolonged hospital stay. Based on a careful clinical decision made using the current diagnostic imaging strategies, patients with a high probability of lung cancer are good candidates for therapeutic surgery, even without a preoperative or intraoperative definitive diagnosis.	[Ozeki, Naoki; Taniguchi, Tetsuo; Kawaguchi, Koji; Fukui, Takayuki; Ishiguro, Futoshi; Fukumoto, Koichi; Nakamura, Shota; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4668550, Japan; [Iwano, Shingo] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4668550, Japan; [Hirakawa, Akihiro] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Biostat Sect, Nagoya, Aichi 4668550, Japan	Yokoi, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Thorac Surg, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	k-yokoi@med.nagoya-u.ac.jp	Kawaguchi, Koji/I-7418-2014; IWANO, Shingo/I-7355-2014	Kawaguchi, Koji/0000-0002-5986-9419; 	Takeda Science Foundation	This study was supported in part by a grant from the Takeda Science Foundation.	Donahue JM, 2012, ANN THORAC SURG, V93, P381, DOI 10.1016/j.athoracsur.2011.10.079; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645; Marchevsky AM, 2004, ANN THORAC SURG, V78, P1755, DOI 10.1016/j.athoracsur.2004.05.003; Swensen SJ, 2000, RADIOLOGY, V214, P73; Deppen S, 2011, ANN THORAC SURG, V92, P428, DOI 10.1016/j.athoracsur.2011.02.052; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Donington J, 2012, CHEST, V142, P1620, DOI 10.1378/chest.12-0790; Lee SM, 2013, RADIOLOGY, V268, P265, DOI 10.1148/radiol.13120949; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI [10.7326/0003-4819-155-3-201108020-00003, 10.1059/0003-4819-155-3-201108020-00003]; Matsuguma H, 2005, ANN THORAC SURG, V80, P2026, DOI 10.1016/j.athoracsur.2005.06.074; Eapen GA, 2013, CHEST, V143, P1044, DOI 10.1378/chest.12-0350; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Balekian Alex A, 2013, Ann Am Thorac Soc, V10, P629, DOI 10.1513/AnnalsATS.201305-107OC; Goldstraw P., 2009, IASLC STAGING MANUAL; Gould MK, 2013, CHEST S, V143, pe93S; Harders SW, 2011, ACTA RADIOL, V52, P401, DOI 10.1258/ar.2011.100377; Howington JA, 2013, CHEST S, V143, pe278S; Ishikawa Y, 2009, ANN THORAC SURG, V87, P1622, DOI 10.1016/j.athoracsur.2008.08.035; KEAGY BA, 1984, ANN THORAC SURG, V38, P314; Martini N, 1996, COMPREHENSIVE TXB TH, P338; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Sihoe ADL, 2013, EUR J CARDIO-THORAC, V44, P231, DOI 10.1093/ejcts/ezs671; Society of Thoracic Surgeons, 2012, STS NAT DAT; Travis WD, 2004, PATHOLOGY GENETICS	25	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	NOV	2014	19	5					830	837		10.1093/icvts/ivu233		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT0BM	WOS:000344602000023		
J	Yokoyama, Y; Chen, FS; Aoyama, A; Sato, T; Date, H				Yokoyama, Yuhei; Chen, Fengshi; Aoyama, Akihiro; Sato, Toshihiko; Date, Hiroshi			Combined operative technique with anterior surgical approach and video-assisted thoracoscopic surgical lobectomy for anterior superior sulcus tumours	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung cancer; Superior sulcus tumour; Transmanubrial approach; Video-assisted thoracoscopic surgical lobectomy; Video-assisted thoracoscopic surgery		Video-assisted thoracoscopic surgery (VATS) has been widely used, but surgical resections of superior sulcus tumours remain challenging because of their anatomical location. For such cases, less-invasive procedures, such as the anterior transcervical-thoracic and transmanubrial approaches, have been widely performed because of their excellent visualization of the subclavian vessels. Recently, a combined operative technique with an anterior surgical approach and VATS for anterior superior sulcus tumours has been introduced. Herein, we report three cases of anterior superior sulcus tumours successfully resected by surgical approaches combined with a VATS-based lobectomy. In all cases, operability was confirmed by VATS, and upper lobectomies with hilar and mediastinal lymph node dissections were performed. Subsequently, dissections of the anterior inlet of the tumours were performed using the transmanubrial approach in two patients and the anterior trans-cervical-thoracic approach in one patient. Both approaches provided excellent access to the anterior inlet of the tumour and exposure of the subclavian vessels, resulting in radical resection of the tumour with concomitant resection of the surrounding anatomical structures, including the chest wall and vessels. In conclusion, VATS lobectomy combined with the anterior surgical approach might be an excellent procedure for the resection of anterior superior sulcus tumours.	[Yokoyama, Yuhei; Chen, Fengshi; Aoyama, Akihiro; Sato, Toshihiko; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Kyoto, Japan	Date, H (reprint author), Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp					Grunenwald D, 1997, ANN THORAC SURG, V63, P563; DARTEVELLE PG, 1993, J THORAC CARDIOV SUR, V105, P1025; Shikuma K, 2012, ANN THORAC SURG, V94, pE29, DOI 10.1016/j.athoracsur.2012.04.053; Truin W, 2010, INTERACT CARDIOV TH, V11, P512, DOI 10.1510/icvts.2010.237941	4	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	NOV	2014	19	5					864	866		10.1093/icvts/ivu231		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT0BM	WOS:000344602000028		
J	Ito, H; Abe, T; Oshima, H; Usui, A				Ito, Hideki; Abe, Tomonobu; Oshima, Hideki; Usui, Akihiko			Cervical aortic arch with multiple aortic aneurysms that required two aortic replacements with a 34-year interval	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Editorial Material						Cervical aortic arch; Aneurysm formation; Surgical repair		A 57-year old female was referred to our hospital after symptoms of hoarseness and dysphagia for a few years. She was diagnosed with a cervical vessel anomaly during childhood and had undergone surgery for a right-sided thoracic descending aortic aneurysm through a right thoracotomy at the age of 23 years. Now, enhanced computed tomography revealed newly developed multiple aneurysms in the aorta between the left carotid artery and the proximal descending aorta in the left hemithorax. A successful aortic surgical repair was accomplished via a left posterolateral thoracotomy. To our knowledge, this is the first case of a cervical aortic arch with formation of multiple aneurysms that required multiple surgeries via bilateral thoracotomies. This case suggests the inherent fragility and possibility of later aneurysmal formation in malformed vessels, thereby emphasizing the importance of periodical imaging tests in this rare congenital anomaly.	[Ito, Hideki; Abe, Tomonobu; Oshima, Hideki; Usui, Akihiko] Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Nagoya, Aichi 4668560, Japan	Ito, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Syowa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	sinngehide@yahoo.co.jp	Usui, Akihiko/I-7251-2014				Charrot F, 2009, INTERACT CARDIOV TH, V10, P346; Kaul P, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-108; Mitsumori Y, 2008, ANN VASC SURG, V22, P140, DOI 10.1016/j.avsg.2007.07.028; Takahashi Y, 2011, J CARDIAC SURG, V26, P400, DOI 10.1111/j.1540-8191.2011.01260.x; Turkvatan A, 2010, VASA, V38, P259	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	NOV	2014	19	5					878	880		10.1093/icvts/ivu260		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT0BM	WOS:000344602000033		
J	Behrens, K; Mion, G; Murata, Y; Sudekum, J				Behrens, Kristian; Mion, Giordano; Murata, Yasusada; Suedekum, Jens			TRADE, WAGES, AND PRODUCTIVITY	INTERNATIONAL ECONOMIC REVIEW			English	Article							MONOPOLISTIC COMPETITION; INTERNATIONAL-TRADE; BORDER PUZZLE; GAINS; MARKET; FIRMS; MODELS; COSTS; US; DIFFERENTIATION	We develop a general equilibrium monopolistic competition model in which wages, productivity, consumption diversity, and markups respond to trade integration. We structurally estimate the model and simulate the impacts of removing all trade barriers generated by the Canada-U.S. border. Firm selection gets tougher by 8.09% in Canada and by 0.80% in the United States. Markups that consumers face, which are central to welfare, fall by up to 12.11% in Canadian provinces and by up to 2.82% in U.S. states. However, changes in markups measured at the firm level are ambiguous, thus providing a different piece of information.	Univ Quebec Montreal, Montreal, PQ, Canada; CIRPEE, Montreal, PQ, Canada; CEPR, Montreal, PQ, Canada; Univ Surrey, Guildford GU2 7XH, Surrey, England; CEP, Bonn, Germany; Nihon Univ, Tokyo 102, Japan; DICE, Berlin, Germany; Univ Dusseldorf, Dusseldorf, Germany; CE Sifo, Munich, Germany; IZA, Bonn, Germany	Mion, G (reprint author), Univ Surrey, Fac Business Econ & Law, Surrey Business Sch, Guildford GU2 7XH, Surrey, England.	g.mion@surrey.ac.uk					Aw BY, 2000, WORLD BANK ECON REV, V14, P65; Behrens K, 2007, J ECON THEORY, V136, P776, DOI 10.1016/j.jet.2006.10.001; Demidova S, 2008, INT ECON REV, V49, P1437; Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Bernard AB, 2003, AM ECON REV, V93, P1268, DOI 10.1257/000282803769206296; Bernard AB, 2007, J ECON PERSPECT, V21, P105, DOI 10.1257/jep.21.3.105; KRUGMAN PR, 1979, J INT ECON, V9, P469, DOI 10.1016/0022-1996(79)90017-5; Atkeson A, 2008, AM ECON REV, V98, P1998, DOI 10.1257/aer.98.5.1998; De Loecker J, 2011, ECONOMETRICA, V79, P1407, DOI 10.3982/ECTA7617; Syverson C, 2004, J POLIT ECON, V112, P1181, DOI 10.1086/424743; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Trefler D, 2004, AM ECON REV, V94, P870, DOI 10.1257/0002828042002633; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Feenstra RC, 2003, ECON LETT, V78, P79, DOI 10.1016/S0165-1765(02)00181-7; KRUGMAN P, 1980, AM ECON REV, V70, P950; Behrens K, 2012, J MONETARY ECON, V59, P703, DOI 10.1016/j.jmoneco.2012.10.010; Redding S, 2004, J INT ECON, V62, P53, DOI 10.1016/j.jinteco.2003.07.001; Bernard AB, 2007, REV ECON STUD, V74, P31, DOI 10.1111/j.1467-937X.2007.00413.x; Arkolakis C, 2012, AM ECON REV, V102, P94, DOI 10.1257/aer.102.1.94; Melitz MJ, 2008, REV ECON STUD, V75, P295, DOI 10.1111/j.1467-937X.2007.00463.x; Chaney T, 2008, AM ECON REV, V98, P1707, DOI 10.1257/aer.98.4.1707; Disdier AC, 2008, REV ECON STAT, V90, P37, DOI 10.1162/rest.90.1.37; Foster L, 2008, AM ECON REV, V98, P394, DOI 10.1257/aer.98.1.394; Balistreri EJ, 2007, J INT ECON, V72, P451, DOI 10.1016/j.jinteco.2007.01.001; Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; Pavcnik N, 2002, REV ECON STUD, V69, P245, DOI 10.1111/1467-937X.00205; Zhelobodko E, 2012, ECONOMETRICA, V80, P2765, DOI 10.3982/ECTA9986; Behrens K, 2012, J INT ECON, V87, P1, DOI 10.1016/j.jinteco.2011.11.005; Balistreri EJ, 2011, J INT ECON, V83, P95, DOI 10.1016/j.jinteco.2011.01.001; Arkolakis C, 2008, AM ECON REV, V98, P444, DOI 10.1257/aer.98.2.444; Behrens K., 2013, 7175 IZA; Broda C, 2006, Q J ECON, V121, P541, DOI 10.1162/qjec.2006.121.2.541; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; De Loecker J., 2012, 17925 NBER; FEENSTRA R., 2010, PRODUCT VARIETY GAIN; Feenstra R., 2010, 15749 NBER; Feenstra RC, 2004, ADVANCED INTERNATIONAL TRADE: THEORY AND EVIDENCE, P1; Feenstra RC, 2010, CAN J ECON, V43, P1; Helpman E, 2008, Q J ECON, V123, P441, DOI 10.1162/qjec.2008.123.2.441; Holmes T. J., 2012, ALLOCATIVE EFF UNPUB; MCCALLUM J, 1995, AM ECON REV, V85, P615; Reza F, 1994, INTRO INFORM THEORY; Bernard AB, 2009, STUD INCOME, V68, P513; Simonovska I., 2011, INCOME DIFFERE UNPUB; Syverson C, 2007, J IND ECON, V55, P197, DOI 10.1111/j.1467-6451.2007.00308.x; Tybout J., 2003, HDB INT TRADE, P388, DOI DOI 10.1002/9780470756461.CH13	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-6598	1468-2354		INT ECON REV	Int. Econ. Rev.	NOV	2014	55	4					1305	1348		10.1111/iere.12091		44	Economics	Business & Economics	AS7XE	WOS:000344464300013		
J	Umehara, H; Nakajima, A; Nakamura, T; Kawanami, T; Tanaka, M; Dong, LL; Kawano, M				Umehara, Hisanori; Nakajima, Akio; Nakamura, Takuji; Kawanami, Takafumi; Tanaka, Masao; Dong, Lingli; Kawano, Mitsuhiro			IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity	INTERNATIONAL IMMUNOLOGY			English	Review						IgG4; regulatory T cell; T(h)2; toll-like receptor	TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS; AUTOIMMUNE PANCREATITIS; MIKULICZS-DISEASE; SYSTEMIC-DISEASE; IGG4 ANTIBODIES; TUBULOINTERSTITIAL NEPHRITIS; RETROPERITONEAL FIBROSIS; COMPLEMENT ACTIVATION	IgG4-RD, a novel disease involving many immune-system components.IgG4-related disease (IgG4-RD) is a novel clinical entity proposed in Japan in the 21th century and is attracting strong attention over the world. The characteristic manifestations of IgG4-RD are increased serum IgG4 concentration and tumefaction by IgG4(+) plasma cells. Although the clinical manifestations in various organs have been established, the pathogenesis of IgG4-RD is still unknown. Recently, many reports of aberrant acquired immunity such as T(h)2-diminated immune responses have been published. However, many questions still remain, including questions about the pathogenesis of IgG4-RD and the roles of IgG4. In this review, we discuss the pathogenesis of IgG4-RD by focusing on the cross-talk between innate and acquired immunity.	[Umehara, Hisanori; Nakajima, Akio; Nakamura, Takuji; Kawanami, Takafumi; Tanaka, Masao] Kanazawa Med Univ, Dept Internal Med, Div Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Umehara, Hisanori] Kyoto Univ, Grad Sch Med, Dept Clin Immunol, Kyoto 6068501, Japan; [Umehara, Hisanori] Kyoto Univ, Fac Med, Kyoto 6068501, Japan; [Dong, Lingli] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol & Immunol, Wuhan 430030, Hubei, Peoples R China; [Kawano, Mitsuhiro] Kanazawa Univ, Grad Sch Med Sci, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 9208641, Japan	Umehara, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Clin Immunol, Kyoto 6068501, Japan.	umehara606@gmail.com			Ministry of Health, Labor and Welfare of Japan [H21 nannchi-ippan-112]	Intractable Diseases and Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H21 nannchi-ippan-112 to H.U.).	Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Kasashima S, 2011, CURR OPIN RHEUMATOL, V23, P18, DOI 10.1097/BOR.0b013e32833ee95f; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Miyake K, 2008, MOD RHEUMATOL, V18, P86, DOI 10.1007/s10165-007-0010-3; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Zen Y, 2009, AM J SURG PATHOL, V33, P1833; Guarneri F, 2005, J CELL MOL MED, V9, P741, DOI 10.1111/j.1582-4934.2005.tb00506.x; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Okazaki K, 2008, J GASTROENTEROL, V43, P409, DOI 10.1007/s00535-008-2190-9; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Okazaki K, 2011, CLIN REV ALLERG IMMU, V41, P126, DOI 10.1007/s12016-010-8214-2; Li YQ, 2009, PATHOL INT, V59, P636, DOI 10.1111/j.1440-1827.2009.02419.x; He B, 2004, J IMMUNOL, V173, P4479; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Akitake R, 2010, GUT, V59, P542, DOI 10.1136/gut.2009.200972; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Kawano M, 2009, MOD RHEUMATOL, V19, P87, DOI 10.1007/s10165-008-0127-z; Hussain A, 2009, IMMUNOLOGY, V128, P236, DOI 10.1111/j.1365-2567.2009.03108.x; Kamisawa T, 2006, PANCREATOLOGY, V6, P132, DOI 10.1159/000090033; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Sato Y, 2009, MODERN PATHOL, V22, P589, DOI 10.1038/modpathol.2009.17; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Siddiquee Z, 2012, CARDIOVASC PATHOL, V21, P470, DOI 10.1016/j.carpath.2012.02.001; Jeannin P, 1998, J IMMUNOL, V160, P3555; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; TERNESS P, 1995, J IMMUNOL, V154, P6446; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1039/ni829; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Yamamoto M, 2006, SCAND J RHEUMATOL, V35, P410; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; AALBERSE RC, 1983, J IMMUNOL, V130, P722; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Okazaki K, 2011, J GASTROENTEROL, V46, P277, DOI 10.1007/s00535-011-0386-x; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Kakudo K, 2011, PATHOL INT, V61, P175, DOI 10.1111/j.1440-1827.2011.02661.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Dahlgren M, 2010, ARTHRIT CARE RES, V62, P1312, DOI 10.1002/acr.20215; Nanda A, 2004, J ALLERGY CLIN IMMUN, V114, P1339, DOI 10.1016/j.jaci.2004.08.049; Zen Y, 2009, AM J SURG PATHOL, V33, P1886, DOI 10.1097/PAS.0b013e3181bd535b; van de Stadt LA, 2014, ARTHRITIS RHEUMATOL, V66, P1133, DOI 10.1002/art.38335; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Banchereau J, 2013, NAT IMMUNOL, V13, P925; Fukui R, 2010, EXP CELL RES, V318, P1461; Gniadecki R, 2006, AUTOIMMUNITY, V39, P541, DOI 10.1080/08916930600971505; Kamisawa T, 2004, AM J SURG PATHOL, V28, P1114, DOI 10.1097/01.pas.0000126634.43301.45; Kawano M., 2012, INT J RHEUMATOL, V2012; Kiyama K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3810; Kojima M, 2010, PATHOBIOLOGY, V77, P267, DOI 10.1159/000319873; Kulkarni R, 2011, CELL TISSUE RES, V343, P141, DOI 10.1007/s00441-010-1017-1; Maehara T., 2013, ANN RHEUM DIS, V71, P2011; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Nagamachi Seiji, 2011, Case Rep Nephrol Urol, V1, P7, DOI 10.1159/000330664; Nakashima H, 2010, CLIN NEPHROL, V73, P385; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Plomp JJ, 2012, ANN NY ACAD SCI, V1275, P114, DOI 10.1111/j.1749-6632.2012.06808.x; Saeki T, 2009, CLIN NEPHROL, V71, P173; Saeki Takako, 2007, Clin Exp Nephrol, V11, P168, DOI 10.1007/s10157-007-0464-9; Sakuma H, 2010, SCAND J IMMUNOL, V72, P44, DOI 10.1111/j.1365-3083.2010.02405.x; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Stone JH, 2009, ARTHRITIS RHEUM, V60, P3139, DOI 10.1002/art.24798; Suzuki K, 2010, RHEUMATOLOGY, V49, P1789, DOI 10.1093/rheumatology/keq113; Takato K., 2008, INTERNAL MED, V47, P291; Tsuboi H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3924; Uchiyama-Tanaka Yoko, 2004, Am J Kidney Dis, V43, pe18, DOI 10.1053/j.ajkd.2003.12.006; Umehara H., 2010, REPORTS GRANT INTRAC; Umehara H, 2011, MOD RHEUMATOL, V22, P21, DOI DOI 10.1007/S10165-011-0571-Z; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; Yamamoto M, 2009, RHEUMATOLOGY, V48, P860, DOI 10.1093/rheumatology/kep098; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439	94	5	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	NOV	2014	26	11					585	595		10.1093/intimm/dxu074		11	Immunology	Immunology	AT0CG	WOS:000344604000001		
J	Watanabe, M; Kudo, Y; Kawano, M; Nakayama, M; Nakamura, K; Kameda, M; Ebara, M; Sato, T; Nakamura, M; Omine, K; Kametani, Y; Suzuki, R; Ogasawara, K				Watanabe, Masamichi; Kudo, Yohei; Kawano, Mitsuko; Nakayama, Masafumi; Nakamura, Kyohei; Kameda, Mai; Ebara, Masamune; Sato, Takeki; Nakamura, Marina; Omine, Kaito; Kametani, Yoshie; Suzuki, Ryuji; Ogasawara, Kouetsu			NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus)	INTERNATIONAL IMMUNOLOGY			English	Article						cytotoxicity; marmosets; NK cells; NKG2D	DENGUE VIRUS-INFECTION; NK CELLS; IMMUNE-RESPONSES; VIRAL-INFECTIONS; B INFECTION; CYTOTOXICITY; EXPRESSION; DISEASE; RETROVIRUS; TRIGGERS	NKG2D is a functional NK cell-activating receptor in marmosets.The natural killer group 2 membrane D (NKG2D) receptor is an NK-activating receptor that plays an important role in host defense against tumors and viral infections. Although the marmoset is an important and reliable animal model, especially for the study of human-specific viral infections, functional characterization of NKG2D on marmoset NK cells has not previously been conducted. In the present study, we investigated a subpopulation of marmoset NK cells that express NKG2D and exhibit cytolytic potential. On the basis of their CD16 and CD56 expression patterns, marmoset NK cells can be classified into three subpopulations: CD16(+) CD56(-), CD16(-) CD56(+) and CD16(-) CD56(-) cells. NKG2D expression on marmoset CD16(+) CD56(-) and CD16(-) CD56(+) splenocytes was confirmed using an NKG2D ligand composed of an MHC class I chain-related molecule A (MICA)-Fc fusion protein. When marmoset splenocytes were cultured with IL-2 for 4 days, NKG2D expression was retained on CD16(+) CD56(-) and CD16(-) CD56(+). In addition, CD16(+) CD56(+) cells within the marmoset NK population appeared which expressed NKG2D after IL-2 stimulation. IL-2-activated marmoset NK cells showed strong cytolytic activity against K562 target cells and target cells stably expressing MICA. Further, the cytolytic activity of marmoset splenocytes was significantly reduced after addition of MICA-Fc fusion protein. Thus, NKG2D functions as an activating receptor on marmoset NK cells that possesses cytotoxic potential, and phenotypic profiles of marmoset NK cell subpopulations are similar to those seen in humans.	[Watanabe, Masamichi; Kudo, Yohei; Kawano, Mitsuko; Nakayama, Masafumi; Nakamura, Kyohei; Kameda, Mai; Ebara, Masamune; Sato, Takeki; Nakamura, Marina; Omine, Kaito; Ogasawara, Kouetsu] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi 9808575, Japan; [Kametani, Yoshie] Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 2591193, Japan; [Suzuki, Ryuji] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Dept Rheumatol & Clin Immunol, Sagamihara, Kanagawa 2520315, Japan	Ogasawara, K (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi 9808575, Japan.	ogasawara@idac.tohoku.ac.jp	Ogasawara, Kouetsu/G-9892-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan [H22-meneki-ippan-004]	This work was supported by Grants-in-Aid for Scientific Research from Grants-in Aid for Scientific Research from Japanese Ministry of Education, Culture, Sports, Science and Technology (to Y.K., R.S. and K.O.) and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan (H22-meneki-ippan-004 to K.O.).	Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Onishi M, 1996, EXP HEMATOL, V24, P324; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Yoshida T, 2013, ARCH VIROL, V158, P1209, DOI 10.1007/s00705-013-1618-6; Miletic A, 2013, EUR J IMMUNOL, V43, P867, DOI 10.1002/eji.201243101; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Li PW, 2001, NAT IMMUNOL, V2, P443; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Averdam A, 2007, J IMMUNOL, V178, P7151; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Brok HPM, 2001, CYTOMETRY, V45, P294, DOI 10.1002/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C; Carville A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078793; Hayashi S., 2007, CYTOMETRY RES, V17, P21; Iwasaki Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00240; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KURANE I, 1986, IMMUNOLOGY, V58, P429; Leibovitch E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003138; Neubert Reinhard, 1996, Life Sciences, V58, P317; Pinto MA, 2000, EXP TOXICOL PATHOL, V52, P3; Rutjens E, 2007, J IMMUNOL, V178, P1702; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; TEFFERI A, 1994, BLOOD, V84, P2721; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Woollard DJ, 2008, J VIROL, V82, P3054, DOI 10.1128/JVI.01153-07; Yoshida T, 2012, ARCH VIROL, V157, P363, DOI 10.1007/s00705-011-1178-6; Yoshida T, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00128	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	NOV	2014	26	11					597	606		10.1093/intimm/dxu053		10	Immunology	Immunology	AT0CG	WOS:000344604000002		
J	Mise-Omata, S; Alles, N; Fukazawa, T; Aoki, K; Ohya, K; Jimi, E; Obata, Y; Doi, T				Mise-Omata, Setsuko; Alles, Neil; Fukazawa, Taro; Aoki, Kazuhiro; Ohya, Keiichi; Jimi, Eijiro; Obata, Yuichi; Doi, Takahiro			NF-kappa B RELA-deficient bone marrow macrophages fail to support bone formation and to maintain the hematopoietic niche after lethal irradiation and stem cell transplantation	INTERNATIONAL IMMUNOLOGY			English	Article						bone remodeling; hematopoietic niche; macrophage; NF-kappa B; osteoimmunology	OSTEOCLAST DIFFERENTIATION; IKK-BETA; IN-VITRO; T-CELLS; C-REL; MICE; PROSTAGLANDIN-E2; ACTIVATION; EXPRESSION; SURVIVAL	Bone marrow macrophages are required for bone homeostasis and the hematopoietic niche.Bone remodeling and hematopoiesis are interrelated and bone marrow (BM) macrophages are considered to be important for both bone remodeling and maintenance of the hematopoietic niche. We found that NF-kappa B Rela-deficient chimeric mice, generated by transplanting Rela (-/-) fetal liver cells into lethally irradiated hosts, developed severe osteopenia, reduced lymphopoiesis and enhanced mobilization of hematopoietic stem and progenitor cells when BM cells were completely substituted by Rela-deficient cells. Rela (-/-) hematopoietic stem cells from fetal liver had normal hematopoietic ability, but those harvested from the BM of osteopenic Rela (-/-) chimeric mice had reduced repopulation ability, indicating impairment of the microenvironment for the hematopoietic niche. Osteopenia in Rela (-/-) chimeric mice was due to reduced bone formation, even though osteoblasts differentiated from host cells. This finding indicates impaired functional coupling between osteoblasts and hematopoietic stem cell-derived cells. Rela-deficient BM macrophages exhibited an aberrant inflammatory phenotype, and transplantation with wild-type F4/80(+) BM macrophages recovered bone formation and ameliorated lymphopoiesis in Rela (-/-) chimeric mice. Therefore, RELA in F4/80(+) macrophages is important both for bone homeostasis and for maintaining the hematopoietic niche after lethal irradiation and hematopoietic stem cell transplantation.	[Mise-Omata, Setsuko; Fukazawa, Taro; Obata, Yuichi; Doi, Takahiro] Riken Inst Phys & Chem Res, RIKEN BioResource Ctr, BioSignal Program, Technol & Dev Team, Tsukuba, Ibaraki 305074, Japan; [Alles, Neil] Univ Peradeniya, Fac Med, Dept Biochem, Peradeniya 20400, Sri Lanka; [Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Pharmacol Sect, Tokyo 1138549, Japan; [Jimi, Eijiro] Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Kitakyushu, Fukuoka 8038580, Japan	Mise-Omata, S (reprint author), Riken Inst Phys & Chem Res, RIKEN BioResource Ctr, BioSignal Program, Technol & Dev Team, Tsukuba, Ibaraki 305074, Japan.	smise@brc.riken.jp			Japan Society for the Promotion of Science (JSPS) [22591073, 25462392]	Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (22591073, 25462392).	Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Chang MK, 2008, J IMMUNOL, V181, P1232; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Lord AM, 2007, CELL CYCLE, V6, P3054; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Ellis SL, 2011, BLOOD, V118, P1516, DOI 10.1182/blood-2010-08-303800; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mills CD, 2000, J IMMUNOL, V164, P6166; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Dominici M, 2008, BLOOD, V111, P4386, DOI 10.1182/blood-2007-10-115725; Dominici M, 2004, P NATL ACAD SCI USA, V101, P11761, DOI 10.1073/pnas.0404626101; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Gao Q, 2009, PROSTAG OTH LIPID M, V89, P20, DOI 10.1016/j.prostaglandins.2009.03.003; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Iwasaki K, 2008, J DENT RES, V87, P937; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Keila S, 2001, J ENDOCRINOL, V168, P131, DOI 10.1677/joe.0.1680131; Kuroda E, 2003, J IMMUNOL, V170, P757; Li M, 2007, INT ORTHOP, V31, P767, DOI 10.1007/s00264-007-0406-x; Mise-Omata S, 2007, J IMMUNOL, V179, P6596; Mise-Omata S, 2009, J IMMUNOL, V182, P4910, DOI 10.4049/jimmunol.0800967; NEFUSSI JR, 1985, ANAT REC, V211, P9, DOI 10.1002/ar.1092110103; Prendes M, 2003, J IMMUNOL, V171, P3963; RUFF MR, 1980, J IMMUNOL, V125, P1671; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Weinreb M, 1999, AM J PHYSIOL-ENDOC M, V276, pE376	54	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	NOV	2014	26	11					607	618		10.1093/intimm/dxu062		12	Immunology	Immunology	AT0CG	WOS:000344604000003		
J	Shima, H; Watanabe, T; Fukuda, S; Fukuoka, SI; Ohara, O; Ohno, H				Shima, Hideaki; Watanabe, Takashi; Fukuda, Shinji; Fukuoka, Shin-Ichi; Ohara, Osamu; Ohno, Hiroshi			A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses	INTERNATIONAL IMMUNOLOGY			English	Article						IgA; M cell; mucosal vaccine; vaccine delivery	SINGLE-CHAIN FV; ORAL IMMUNIZATION; COMPLEXES; ADJUVANTS; FRAGMENT; ANTIBODY	Mucosal vaccines can induce mucosal immunity, including antigen-specific secretory IgA production, to protect from invasion by pathogens and to neutralize toxins at mucosal surfaces. We established an effective antigen-delivering fusion protein, anti-GP2-SA, as a mucosal vaccine. The anti-GP2-SA consists of streptavidin (SA) fused to the antigen-binding fragment region from a mAb against glycoprotein 2 (GP2), an antigen-uptake receptor specifically expressed on M cells. Anti-GP2-SA targets antigen-sampling M cells in the follicle-associated epithelium covering Peyer's patches. Immunofluorescence showed that anti-GP2-SA specifically bound to M cells. Orally administered biotinylated ovalbumin peptide (bOVA) conjugated with anti-GP2-SA more efficiently induced OVA-specific fecal IgA secretion compared with bOVA alone or bOVA conjugated with SA. Furthermore, mice immunized by oral administration of the biotinylated Salmonella enterica serovar Typhimurium (S. Typhimurium) lysate conjugated with anti-GP2-SA were significantly better protected from subsequent infection by virulent S. Typhimurium than mice treated with the bacterial lysate alone or conjugated with SA. These results suggest that anti-GP2-SA-based M-cell-targeting vaccines are a novel strategy for inducing efficient mucosal immunity.	[Shima, Hideaki; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Supramol Biol, Div Immunobiol, Yokohama, Kanagawa 2300045, Japan; [Shima, Hideaki; Fukuda, Shinji; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Watanabe, Takashi; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci, Immunogenet Lab, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan; [Fukuoka, Shin-Ichi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa 2298558, Japan	Ohno, H (reprint author), Yokohama City Univ, Grad Sch Supramol Biol, Div Immunobiol, Yokohama, Kanagawa 2300045, Japan.	ohno@rcai.riken.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661	Japan Society for Promotion of Science [10266]; Takeda Science Foundation; Mitsubishi Foundation;  [24249029];  [21390155]	Grants-in-aid for Scientific Research (A) (24249029 to H.O.) and (B) (21390155 to H.O.); Grant-in-aid for Research Fellow of the Japan Society for Promotion of Science (10266 to H. S.); Takeda Science Foundation (to H.O.); The Mitsubishi Foundation (to H.O.)	Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866; Mercier GT, 2007, VACCINE, V25, P8687, DOI 10.1016/j.vaccine.2007.10.030; Gulig PA, 1998, INFECT IMMUN, V66, P2471; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; HOLMGREN J, 1993, VACCINE, V11, P1179, DOI 10.1016/0264-410X(93)90039-Z; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Diamanti E, 1998, VACCINE, V16, P940, DOI 10.1016/S0264-410X(98)80025-X; Kipriyanov SM, 1996, PROTEIN ENG, V9, P203, DOI 10.1093/protein/9.2.203; LEVINE MM, 1983, MICROBIOL REV, V47, P510; MOWAT AM, 1993, IMMUNOLOGY, V80, P527; Perez O, 2012, BRAZ J MED BIOL RES, V45, P681, DOI 10.1590/S0100-879X2012007500067; Reiter Y, 1996, CLIN CANCER RES, V2, P245; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175	20	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	NOV	2014	26	11					619	625		10.1093/intimm/dxu061		7	Immunology	Immunology	AT0CG	WOS:000344604000004		
J	Foruzan, AH; Chen, YW; Hori, M; Sato, Y; Tomiyama, N				Foruzan, Amir H.; Chen, Yen-Wei; Hori, Masatoshi; Sato, Yoshinobu; Tomiyama, Noriyuki			Capturing large shape variations of liver using population-based statistical shape models	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Statistical shape model; Population-based shape model; Shape representation; Medical image analysis	RECONSTRUCTION	Statistical shape models (SSMs) represent morphological variations of a specific object. When there are large shape variations, the shape parameters constitute a large space that may include incorrect parameters. The human liver is a non-rigid organ subject to large deformations due to external forces or body position changes during scanning procedures. We developed and tested a population-based model to represent the shape of liver. Upper abdominal CT-scan input images are represented by a conventional shape model. The shape parameters of individual livers extracted from the CT scans are employed to classify them into different populations. Corresponding to each population, an SSM model is built. The liver surface parameter space is divided into several subspaces which are more compact than the original space. The proposed model was tested using 29 CT-scan liver image data sets. The method was evaluated by model compactness, reconstruction error, generality and specificity measures. The proposed model is implemented and tested using CT scans that included liver shapes with large shape variations. The method was compared with conventional and recently developed shape modeling methods. The accuracy of the proposed model was nearly twice that achieved with the conventional model. The proposed population-based model was more general compared with the conventional model. The mean reconstruction error of the proposed model was 0.029 mm while that of the conventional model was 0.052 mm. A population-based model to represent the shape of liver was developed and tested with favorable results. Using this approach, the liver shapes from CT scans were modeled by a more compact, more general, and more accurate model.	[Foruzan, Amir H.] Shahed Univ, Fac Engn, Dept Biomed Engn, Tehran, Iran; [Foruzan, Amir H.; Chen, Yen-Wei] Ritsumeikan Univ, Coll Informat Sci & Engn, Intelligent Image Proc Lab, Shiga, Japan; [Hori, Masatoshi; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Osaka, Japan; [Sato, Yoshinobu] Osaka Univ, Grad Sch Med, Div Image Anal, Osaka, Japan	Foruzan, AH (reprint author), Shahed Univ, Fac Engn, Dept Biomed Engn, Tehran, Iran.	a.foruzan@ece.ut.ac.ir; chen@is.ritsumei.ac.jp; mhori@radiol.med.osaka_u.ac.jp; yoshi@image.med.osaka-u.ac.jp					Zhang ST, 2012, MED IMAGE ANAL, V16, P265, DOI 10.1016/j.media.2011.08.004; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Zhang WX, 2011, I S BIOMED IMAGING, P1451; Davies RH, 2002, IEEE T MED IMAGING, V21, P525, DOI 10.1109/TMI.2002.1009388; Davatzikos C, 2003, IEEE T MED IMAGING, V22, P414, DOI 10.1109/TMI.2003.809688; Feng J, 2009, PATTERN RECOGN, V42, P1543, DOI 10.1016/j.patcog.2008.11.019; Zhu Y, 2010, IEEE T MED IMAGING, V29, P669, DOI 10.1109/TMI.2009.2031063; Styner MA, 2003, LECT NOTES COMPUT SC, V2732, P63; Pepe A, 2013, MAGN RESON IMAGING, V31, P676, DOI 10.1016/j.mri.2012.10.021; Wang GT, 2013, MED PHYS, V40, DOI 10.1118/1.4802215; Buchaillard SI, 2007, COMPUT BIOL MED, V37, P1461, DOI 10.1016/j.compbiomed.2007.01.003; Chen YW, 2013, COMPUT MATH METHOD M, DOI 10.1155/2013/264809; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; COOTES TF, 1995, IMAGE VISION COMPUT, V13, P403, DOI 10.1016/0262-8856(95)99727-I; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285; Heimann T, 2006, OP SCI WORKSH MICCAI; Heitz G, 2005, P SOC PHOTO-OPT INS, V5747, P1411, DOI [10.1117/12.594802, 10.1117/12.59802]; Lamecker H, 2002, MED IM COMP COMP ASS, V2489, P421, DOI 10.1007/3-540-45787-9_53; Lorensen W. E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI DOI 10.1145/37402.37422; Okada T., 2012, ABDOMINAL IMAGING CO, V7029, P173; Su Z, 2006, P IEEE 5 INT SPEC TO; van de Giessen M, 2010, J BIOMECH, V43, P1463	22	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	NOV	2014	9	6					967	977		10.1007/s11548-014-1000-5		11	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AS8ZX	WOS:000344534400005		
J	Mori, M; Chiba, T; Nakamizo, A; Kumashiro, R; Murata, M; Akahoshi, T; Tomikawa, M; Kikkawa, Y; Yoshimoto, K; Mizoguchi, M; Sasaki, T; Hashizume, M				Mori, Megumu; Chiba, Toru; Nakamizo, Akira; Kumashiro, Ryuichi; Murata, Masaharu; Akahoshi, Tomohiko; Tomikawa, Morimasa; Kikkawa, Yuichiro; Yoshimoto, Koji; Mizoguchi, Masahiro; Sasaki, Tomio; Hashizume, Makoto			Intraoperative visualization of cerebral oxygenation using hyperspectral image data: a two-dimensional mapping method	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Optical intrinsic signal image; Visible light spectroscopy; Oxygen saturation; Misery perfusion; Hyperspectral camera; Continuous spectral data	CORTICAL SPREADING DEPRESSION; INDOCYANINE GREEN ANGIOGRAPHY; BLOOD-FLOW; LASER SPECKLE; OPTICAL SPECTROSCOPY; SCATTERING CHANGES; NEURONAL-ACTIVITY; MOYAMOYA-DISEASE; ISCHEMIC-STROKE; BRAIN-TUMOR	Superficial temporal artery (STA)-middle cerebral artery (MCA) bypass is an important technique for cerebrovascular reconstruction. Intraoperative hemodynamic imaging is needed to perform cerebrovascular reconstruction safely and effectively. Optical intrinsic signal (OIS) imaging is commonly used for assessing cerebral hemodynamics in experimental studies, because it can provide high-resolution mapping images. However, OIS is not used clinically due to algorithm, instrumentation and spectral resolution limitations. We tested the feasibility of a hyperspectral camera (HSC) for assessment of cortical hemodynamics with spectral imaging of the cerebral cortex in rats and in vivo humans. A hyperspectral camera (HSC) was tested in a rat model of cerebral ischemia (middle cerebral artery occlusion) and during human revascularization surgery (STA-MCA anastomosis). Changes in cortical oxygen saturation were derived from spectral imaging data (400-800 nm) collected by exposing the cortex to Xenon light. Reflected light was sampled using the HSC. The system was then tested intraoperatively during superficial temporal artery to middle cerebral artery anastomosis procedures. Comparison with single-photon emission computed tomography (SPECT) imaging data was done. During middle cerebral artery occlusion in rats, the HSC technique showed a significant decrease in cortical oxygen saturation in the ischemic hemisphere. In clinical cases, the cortical oxygen saturation was increased after STA-MCA anastomosis, which agreed with the SPECT imaging data. Continuous collection of imaging spectroscopic data is feasible and may provide reliable quantification of the hemodynamic responses in the brain. The HSC system may be useful for monitoring intraoperative changes in cortical surface hemodynamics during revascularization procedures in humans.	[Mori, Megumu; Nakamizo, Akira; Kikkawa, Yuichiro; Yoshimoto, Koji; Mizoguchi, Masahiro; Sasaki, Tomio] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, Fukuoka 8128582, Japan; [Chiba, Toru] HOYA Corp, PENTAX Lifecare Div Med Instrument SBU, Akishima, Tokyo 1960012, Japan; [Kumashiro, Ryuichi; Tomikawa, Morimasa] Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Higashi Ku, Fukuoka 8128582, Japan; [Murata, Masaharu] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan; [Akahoshi, Tomohiko; Hashizume, Makoto] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka 8128582, Japan	Hashizume, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	mhashi@dem.med.kyushu-u.ac.jp					Akbari H, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076005; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Li L, 2010, ULTRASOUND MED BIOL, V36, P595, DOI 10.1016/j.ultrasmedbio.2010.01.005; HONGO K, 1995, NEUROL RES, V17, P89; Maslov K, 2007, INVERSE PROBL, V23, pS113, DOI 10.1088/0266-5611/23/6/S09; Paul JS, 2006, NEUROIMAGE, V29, P38, DOI 10.1016/j.neuroimage.2005.07.019; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Bannon D, 2009, NAT PHOTONICS, V3, P627; Valdes PA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646916; POWERS WJ, 1987, ANN INTERN MED, V106, P27; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; BARON JC, 1981, STROKE, V12, P454; Awano T, 2010, WORLD NEUROSURG, V73, P668, DOI 10.1016/j.wneu.2010.03.027; Casasent D, 2004, APPL OPTICS, V43, P227, DOI 10.1364/AO.43.000227; EGGERT HR, 1987, NEUROSURGERY, V21, P459; Ellingsen PG, 2013, J BIOMED OPT, V18, DOI [10.1117/1.JBO.18.2.020501, 10.1117/JBO.18.2.020501]; Ellingsen PG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101313; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Graf BW, 2009, OPT EXPRESS, V17, P13447, DOI 10.1364/OE.17.013447; HAGLUND MM, 1992, NATURE, V358, P668, DOI 10.1038/358668a0; Hochman DW, 2000, BRAIN COGNITION, V42, P56, DOI 10.1006/brcg.1999.1161; Hoshino T, 2006, SURG NEUROL, V65, P569, DOI 10.1016/j.surneu.2005.09.028; Ishikawa T, 1997, STROKE, V28, P1170; JOBSIS FF, 1977, J APPL PHYSIOL, V43, P858; Kashani AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024482; KAYAMA T, 1991, J NEUROSURG, V74, P55, DOI 10.3171/jns.1991.74.1.0055; KIYOTA Y, 1993, EXP BRAIN RES, V95, P388; Lin WC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3080144; Mendelowitsch A, 1997, NEUROL RES, V19, P66; Mirkovic J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3194142; Nakagawa A, 2009, J NEUROSURG, V111, P1158, DOI 10.3171/2009.4.JNS08585; Prakash N, 2009, NEUROIMAGE, V47, pT116, DOI 10.1016/j.neuroimage.2008.07.066; Rajamani K, 2007, CURR DRUG TARGETS, V8, P860; Ramella-Roman JC, 2008, OPT EXPRESS, V16, P6170, DOI 10.1364/OE.16.006170; Sheth SA, 2009, NEUROIMAGE, V47, pT36, DOI 10.1016/j.neuroimage.2008.09.060; Subramanian NR, 2006, MED IMAGING 2006; Sun XL, 2011, NEUROIMAGE, V57, P873, DOI 10.1016/j.neuroimage.2011.05.040; SYLVIA AL, 1979, BRAIN RES, V165, P235, DOI 10.1016/0006-8993(79)90556-0; Toms SA, 2007, NEUROSURGERY, V61, P327, DOI [10.1227/01.neu.0000279226.68751.21, 10.1227/01.NEU.000176855.39826.2D]; Toms SA, 2007, NEUROSURGERY, V61, P335, DOI 10.1227/01.neu.0000279226.68751.21; Towle EL, 2012, NEUROSURGERY, V71, P1023, DOI 10.1227/NEU.0b013e31826adf88; Valdes PA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00798; Wolf T, 1996, J CEREBR BLOOD F MET, V16, P1100; Yin C, 2013, NEUROIMAGE, V76, P70, DOI 10.1016/j.neuroimage.2013.02.079; Zhang H. F., 2007, APPL PHYS LETT, V90	48	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	NOV	2014	9	6					1059	1072		10.1007/s11548-014-0989-9		14	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AS8ZX	WOS:000344534400013		
J	Maruyama, K; Kin, T; Saito, T; Suematsu, S; Gomyo, M; Noguchi, A; Nagane, M; Shiokawa, Y				Maruyama, Keisuke; Kin, Taichi; Saito, Toki; Suematsu, Shinya; Gomyo, Miho; Noguchi, Akio; Nagane, Motoo; Shiokawa, Yoshiaki			Neurosurgical simulation by interactive computer graphics on iPad	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Interactive computer graphics; iPad; Neurosurgery; Simulation	MALFORMATIONS	Presurgical simulation before complicated neurosurgery is a state-of-the-art technique, and its usefulness has recently become well known. However, simulation requires complex image processing, which hinders its widespread application. We explored handling the results of interactive computer graphics on the iPad tablet, which can easily be controlled anywhere. Data from preneurosurgical simulations from 12 patients (4 men, 8 women) who underwent complex brain surgery were loaded onto an iPad. First, DICOM data were loaded using Amira visualization software to create interactive computer graphics, and ParaView, another free visualization software package, was used to convert the results of the simulation to be loaded using the free iPad software KiwiViewer. The interactive computer graphics created prior to neurosurgery were successfully displayed and smoothly controlled on the iPad in all patients. The number of elements ranged from 3 to 13 (mean 7). The mean original data size was 233 MB, which was reduced to 10.4 MB (4.4 % of original size) after image processing by ParaView. This was increased to 46.6 MB (19.9 %) after decompression in KiwiViewer. Controlling the magnification, transfer, rotation, and selection of translucence in 10 levels of each element were smoothly and easily performed using one or two fingers. The requisite skill to smoothly control the iPad software was acquired within 1.8 trials on average in 12 medical students and 6 neurosurgical residents. Using an iPad to handle the result of preneurosurgical simulation was extremely useful because it could easily be handled anywhere.	[Maruyama, Keisuke; Suematsu, Shinya; Noguchi, Akio; Nagane, Motoo; Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Kin, Taichi] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan; [Saito, Toki] Univ Tokyo, Grad Sch Engn, Dept Clin Informat Engn, Tokyo, Japan; [Gomyo, Miho] Kyorin Univ, Sch Med, Dept Radiol, Tokyo, Japan	Maruyama, K (reprint author), Kyorin Univ, Sch Med, Dept Neurosurg, Tokyo, Japan.	kskmaru-tky@umin.ac.jp			Takeda Science Foundation; Ministry of Education, Science, and Culture of Japan [24592145]	This work was supported in part by Takeda Science Foundation and grants-in-aid for scientific research awarded to Dr. Maruyama from the Ministry of Education, Science, and Culture of Japan (Grant No. 24592145).	Ruparel RK, 2014, UROLOGY, V83, P116, DOI 10.1016/j.urology.2013.09.030; Kin T, 2009, NEUROSURGERY, V65, P121, DOI 10.1227/01.NEU.0000347890.19718.0A; Takai K, 2011, J NEUROSURG-SPINE, V15, P654, DOI 10.3171/2011.8.SPINE11155; George P, 2013, PATIENT EDUC COUNS, V93, P522, DOI 10.1016/j.pec.2013.04.018; De Oliveira GS, 2013, ANAESTHESIA, V68, P1053, DOI 10.1111/anae.12379; Kin T, 2012, J NEUROSURG, V117, P78, DOI 10.3171/2012.3.JNS111541; Biddiscombe J, 2007, IEEE T VIS COMPUT GR, V13, P1376, DOI 10.1109/TVCG.2007.70600; Biddiscombe J, 2012, IEEE T VIS COMPUT GR, V18, P852, DOI 10.1109/TVCG.2012.63; Kamada Kyousuke, 2005, Neurosurgery, V56, P98; Kamada K, 2005, NEUROSURGERY, V57, P121, DOI 10.1227/01.NEU.0000163526.60240.B6; Kin T, 2011, NEUROSURGERY, V69, P40, DOI 10.1227/NEU.0b013e318211019a; Luo N, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2524	12	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	NOV	2014	9	6					1073	1078		10.1007/s11548-014-0993-0		6	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AS8ZX	WOS:000344534400014		
J	Sato, N; Takagi, K; Suzuki, T; Miki, Y; Tanaka, S; Nagase, S; Warita, H; Fukudo, S; Sato, F; Sasano, H; Ito, K				Sato, Naoko; Takagi, Kiyoshi; Suzuki, Takashi; Miki, Yasuhiro; Tanaka, Sota; Nagase, Satoru; Warita, Hitoshi; Fukudo, Shin; Sato, Fumiko; Sasano, Hironobu; Ito, Kiyoshi			Immunolocalization of Corticotropin-Releasing Hormone (CRH) and Its Receptors (CRHR1 and CRHR2) in Human Endometrial Carcinoma CRHR1 as a Potent Prognostic Factor	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Corticotropin-releasing hormone; Corticotropin-releasing hormone receptor 1; Endometrial cancer; Immunohistochemistry; Prognosis	INTESTINAL INFLAMMATION; BREAST-CARCINOMA; CANCER CELLS; TUMOR-GROWTH; STRESS; EXPRESSION; INVASIVENESS; INHIBITION; STATISTICS; ACTIVATION	Objective: Corticotropin-releasing hormone (CRH), a major regulator of the stress response, regulates various biological functions through its interaction with CRH receptors 1 (CRHR1) and 2 (CRHR2). CRH, CRHR1, and CRHR2 have recently been reported in several types of carcinoma, but the significance of these proteins has remained largely unknown in human endometrial carcinoma. Materials and Methods: A total of 87 endometrial carcinoma specimens were obtained from Japanese female patients who underwent surgical treatment, fixed in 10% formalin, and embedded in paraffin wax. Immunohistochemistry for CRH, CRHR1, and CRHR2 was performed, and clinical data were obtained from the medical records. Results: Immunopositivity of CRH, CRHR1, and CRHR2 in the specimens was 26%, 15%, and 10%, respectively. Univariate analysis revealed that immunohistochemical CRH status was positively associated with CRHR1 and CRHR2 status and that CRHR1 status was significantly associated with the risk of recurrence and poorer clinical outcome, whereas CRHR2 status was marginally associated with better prognosis for overall survival. Multivariate analysis demonstrated CRHR1 status as an independent prognostic factor for both disease-free and overall survival. Conclusions: These results suggest that intratumoral CRH-CRHR1 signaling plays an important role in the progression of endometrial carcinoma and that CRHR1 is a potent prognostic factor in patients with this disease.	[Sato, Naoko; Takagi, Kiyoshi; Suzuki, Takashi; Miki, Yasuhiro; Tanaka, Sota; Nagase, Satoru; Warita, Hitoshi; Fukudo, Shin; Sato, Fumiko; Sasano, Hironobu; Ito, Kiyoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808557, Japan	Ito, K (reprint author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808557, Japan.	kito@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare, Japan	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare, Japan.	Androulidaki A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-30; AlHilli MM, 2013, GYNECOL ONCOL, V131, P103, DOI 10.1016/j.ygyno.2013.06.037; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Bale TL, 2002, P NATL ACAD SCI USA, V99, P7734, DOI 10.1073/pnas.102187099; Anton PM, 2004, P NATL ACAD SCI USA, V101, P8503, DOI 10.1073/pnas.0402693101; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Takagi K, 2013, HORM CANCER-US, V4, P1, DOI 10.1007/s12672-012-0126-6; Hasegawa H, 2002, JPN J CANCER RES, V93, P729; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Jemal A, 2004, CA-CANCER J CLIN, V54, P8; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Arranz A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-261; Carlson KW, 2001, ANTICANCER RES, V21, P1173; Florio P, 2006, J ENDOCRINOL, V190, P99, DOI 10.1677/joe.1.06726; Fukuda T, 2005, J CLIN ENDOCR METAB, V90, P4671, DOI 10.1210/jc2005-0090; Fukudo S, 2006, GUT, V55, P146, DOI 10.1136/gut.2005.070888; Fukudo S, 2012, PHYSL GASTROINTESTIN, P795; Graziani G, 2007, MOL CELL ENDOCRINOL, V264, P44, DOI 10.1016/j.mce.2006.10.006; Huvila J, 2013, GYNECOL ONCOL, V130, P463, DOI 10.1016/j.ygyno.2013.06.015; Jo YH, 2011, J INT MED RES, V39, P2067; Kaprara A, 2010, CELL MOL LIFE SCI, V67, P1293, DOI 10.1007/s00018-010-0265-2; Kaprara A, 2010, NEUROPEPTIDES, V44, P355, DOI 10.1016/j.npep.2010.06.005; Miceli F, 2009, MOL CELL ENDOCRINOL, V305, P6, DOI 10.1016/j.mce.2009.02.013; Minas V, 2007, BRIT J CANCER, V97, P637, DOI 10.1038/sj.bjc.6603918; Ota K, 2006, CLIN CANCER RES, V12, P4200, DOI 10.1158/1078-0432.CCR-05-1833; Pecorelli S, 2010, INT J GYNECOL OBSTET, V108, P176, DOI 10.1016/j.ijgo.2009.08.009; Reubi JC, 2003, J CLIN ENDOCR METAB, V88, P3312, DOI 10.1210/jc.2002-021853; Saez MD, 2007, MOL CELL BIOCHEM, V294, P19, DOI 10.1007/s11010-005-9067-5; Saito S, 2006, CANCER SCI, V97, P1308, DOI 10.1111/j.1349-7006.2006.00332.x; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Tavassoli FADP, 2003, WHO CLASSIFICATION T, P113; Tsatsanis C, 2007, CELL MOL LIFE SCI, V64, P1638, DOI 10.1007/s00018-007-6555-7	37	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9					1549	1557		10.1097/IGC.0000000000000269		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FE	WOS:000344611800007		
J	Fujiwara, H; Yokota, H; Monk, B; Treilleux, I; Devouassoux-Shisheboran, M; Davis, A; Kim, JW; Mahner, S; Stany, M; Pignata, S; Ray-Coquard, I; Fujiwara, K				Fujiwara, Hiroyuki; Yokota, Harushige; Monk, Bradley; Treilleux, Isabelle; Devouassoux-Shisheboran, Mojgan; Davis, Alison; Kim, Jae-Weon; Mahner, Sven; Stany, Michael; Pignata, Sandro; Ray-Coquard, Isabelle; Fujiwara, Keiichi			Gynecologic Cancer InterGroup (GCIG) Consensus Review for Cervical Adenocarcinoma	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Review						Cervical Cancer; Adenocarcinoma; Pathology; Staging; Clinical management	SQUAMOUS-CELL CARCINOMA; UTERINE CERVIX; ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; RADICAL SURGERY; PHASE-III; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; UNITED-STATES; EARLY-STAGE	Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.	[Fujiwara, Hiroyuki] Jichi Med Univ, Shimono City, Japan; [Yokota, Harushige] Saitama Canc Ctr, Saitama, Japan; [Monk, Bradley] Univ Arizona, Phoenix, AZ USA; [Treilleux, Isabelle; Ray-Coquard, Isabelle] Ctr Leon Berard, F-69373 Lyon, France; [Devouassoux-Shisheboran, Mojgan] Hosp Civils Lyon, Lyon, France; [Davis, Alison] Canberra Hosp, Canberra, ACT, Australia; [Davis, Alison] ANZGOG, Camperdown, NSW, Australia; [Kim, Jae-Weon] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Mahner, Sven] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Stany, Michael] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Pignata, Sandro] Ist Nazl Tumori Fdn G Pascale IRCCS, Milan, Italy; [Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Hidaka City, Japan	Fujiwara, K (reprint author), Saitama Med Univ, Int Med Ctr, Hidaka City, Japan.	fujiwara@saitama-med.ac.jp			Roche Pharmaceuticals; Amgen; Novartis; Genentech; Eli Lilly and Company; Janssen Pharmaceuticals/Johnson Johnson; Array BioPharma; Tesaro; Roche/Genentech; Johnson Johnson; Taiho Pharmaceutical; Janssen Pharmaceuticals	Isabelle Ray Coquard, MD has served on the board of, and received grant funding from, Roche Pharmaceuticals. She has also received payment for lectures from Amgen. Bradley J. Monk, MD has served as a consultant for Qiagen, GlaxoSmithKline, Merck, Arno Therapeutics, Insys Therapeutics, Tesaro, Celgene, Boehringer Ingelheim, and Roche/Genentech. He has also received grant funding from Novartis, Amgen, Genentech, Eli Lilly and Company, Janssen Pharmaceuticals/Johnson & Johnson, Array BioPharma, and Tesaro, and has received payment for lectures from Roche/Genentech and Johnson & Johnson. Keiichi Fujiwara, MD, PhD has served as a consultant for Zeria Pharmaceutical, GlaxoSmithKline, and Eisai, and has received payment for lectures from Taiho Pharmaceutical and Janssen Pharmaceuticals. The remaining authors declare no conflicts of interest.	Ramirez PT, 2011, CANCER-AM CANCER SOC, V117, P1928, DOI 10.1002/cncr.25739; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Monk BJ, 2007, GYNECOL ONCOL, V105, P427, DOI 10.1016/j.ygyno.2006.12.027; Kenny SL, 2012, AM J SURG PATHOL, V36, P799, DOI 10.1097/PAS.0b013e31824a72c6; Castellsague X, 2006, J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Shimada M, 2006, GYNECOL ONCOL, V101, P234, DOI 10.1016/j.ygyno.2005.10.004; Peters WA, 2000, J CLIN ONCOL, V18, P1606; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; Curtin JP, 2001, J CLIN ONCOL, V19, P1275; Farley JH, 2003, CANCER, V97, P2196, DOI 10.1002/cncr.11371; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Sherman ME, 2005, CANCER, V103, P1258, DOI 10.1002/cncr.20877; Wang SS, 2004, CANCER, V100, P1035, DOI 10.1002/cncr.20064; Kim HS, 2013, EJSO-EUR J SURG ONC, V39, P115, DOI 10.1016/j.ejso.2012.09.003; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Kuragaki C, 2003, LAB INVEST, V83, P35, DOI 10.1097/01.LAB.0000049821.16698.D0; Look KY, 1996, GYNECOL ONCOL, V63, P304, DOI 10.1006/gyno.1996.0327; Mabuchi S, 2012, GYNECOL ONCOL, V127, P114, DOI 10.1016/j.ygyno.2012.06.021; Katsumata N, 2013, BRIT J CANCER, V108, P1957, DOI 10.1038/bjc.2013.179; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; EIFEL PJ, 1995, GYNECOL ONCOL, V59, P38, DOI 10.1006/gyno.1995.1265; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Baalbergen A, 2004, GYNECOL ONCOL, V92, P262, DOI 10.1016/j.ygyno.2003.09.001; Kojima A, 2007, AM J SURG PATHOL, V31, P664, DOI 10.1097/01.pas.0000213434.91868.b0; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Huang YT, 2012, INT J RADIAT ONCOL, V84, P420, DOI 10.1016/j.ijrobp.2011.12.013; Takekida S, 2010, INT J GYNECOL CANCER, V20, P1563, DOI 10.1111/IGC.0b013e3181a81221; Rajkumar T, 2006, INT J CANCER, V118, P1481; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Davy MLJ, 2003, OBSTET GYNECOL, V101, P38, DOI 10.1016/S0029-7844(02)02275-5; EIFEL PJ, 1990, CANCER, V65, P2507, DOI 10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9; HOPKINS MP, 1991, OBSTET GYNECOL, V77, P912; HOPKINS MP, 1988, OBSTET GYNECOL, V72, P915; Huang YT, 2011, INT J RADIAT ONCOL, V80, P429, DOI 10.1016/j.ijrobp.2010.02.009; Irie T, 2000, EUR J SURG ONCOL, V26, P464, DOI 10.1053/ejso.1999.0923; Kasamatsu T, 2002, GYNECOL ONCOL, V85, P327, DOI 10.1006/gyno.2002.6624; Kastritis E, 2005, GYNECOL ONCOL, V99, P376, DOI 10.1016/j.ygyno.2005.06.024; Kuji S, 2014, J GYNECOL ONCOL, V25, P90, DOI 10.3802/jgo.2014.25.2.90; Kurman RJ, 2014, WHO CLASSIFICATION T; Nagai Y, 2012, ANTICANCER RES, V32, P1475; Nagao S, 2005, GYNECOL ONCOL, V96, P805, DOI 10.1016/j.ygyno.2004.11.044; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Ramirez Pedro T, 2007, Gynecol Oncol, V104, P9, DOI 10.1016/j.ygyno.2006.10.032; Seamon LG, 2014, 15 MIENN M GYN CANC; Tang J, 2012, GYNECOL ONCOL, V125, P297, DOI 10.1016/j.ygyno.2012.01.033; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288	48	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		3			S96	S101		10.1097/IGC.0000000000000263		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FS	WOS:000344613200019		
J	Hasegawa, K; Nagao, S; Yasuda, M; Millan, D; Viswanathan, AN; Glasspool, RM; Devouassoux-Shisheboran, M; Covens, A; Lorusso, D; Kurzeder, C; Kim, JW; Gladieff, L; Bryce, J; Friedlander, M; Fujiwara, K				Hasegawa, Kosei; Nagao, Shoji; Yasuda, Masanori; Millan, David; Viswanathan, Akila N.; Glasspool, Rosalind M.; Devouassoux-Shisheboran, Mojgan; Covens, Alan; Lorusso, Domenica; Kurzeder, Christian; Kim, Jae-Weon; Gladieff, Laurence; Bryce, Jane; Friedlander, Michael; Fujiwara, Keiichi			Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Review						Clear cell carcinoma; Uterine corpus; Uterine cervix; Histological feature; Immunohistochemical; Treatment	RECURRENT ENDOMETRIAL CARCINOMA; PHASE-III TRIAL; ONCOLOGY-GROUP; PROGESTERONE-RECEPTOR; ADENOCARCINOMA; CHEMOTHERAPY; EXPRESSION; PAPILLARY; MANAGEMENT; THERAPY	Clear cell carcinomas of the uterine corpus and cervix are rare gynecological cancers with limited information regarding the pathogenesis and biology. At present, the approach to management is the same as for patients with the more common histological subtypes of endometrioid endometrial cancer and adenocarcinoma of the cervix. Surgical resection is the standard treatment for patients with early-stage disease, but there is no evidence-based approach to direct the management of patients with more advanced-stage disease at presentation or with recurrent disease. We review the epidemiology, pathology, and what is known about both uterine corpus and cervical clear cell cancers and make management recommendations.	[Hasegawa, Kosei; Yasuda, Masanori; Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Hidaka City, Saitama, Japan; [Nagao, Shoji] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Viswanathan, Akila N.] Harvard Univ, Sch Med, Boston, MA USA; [Millan, David] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; [Glasspool, Rosalind M.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Devouassoux-Shisheboran, Mojgan] Hosp Civils Lyon, Lyon, France; [Covens, Alan] Sunnybrook Reg Canc Ctr, Toronto, ON, Canada; [Lorusso, Domenica] Fdn IRCCS Natl Canc Inst Milan, Milan, Italy; [Kurzeder, Christian] Kliniken Essen Mitte, Essen, Germany; [Kim, Jae-Weon] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Gladieff, Laurence] Inst Claudius Regaud, Toulouse, France; [Bryce, Jane] Inst Nazl Tumori, Naples, Italy; [Friedlander, Michael] Prince Wales Hosp, Sydney, NSW, Australia	Fujiwara, K (reprint author), Saitama Med Univ, Int Med Ctr, 1397-1 Yamane, Hidaka City, Saitama, Japan.	fujiwara@saitama-med.ac.jp	GLADIEFF, Laurence/O-5129-2014	GLADIEFF, Laurence/0000-0002-6980-9719			Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; Craighead PS, 2000, GYNECOL ONCOL, V77, P248, DOI 10.1006/gyno.2000.5746; Lax SF, 1998, HUM PATHOL, V29, P924, DOI 10.1016/S0046-8177(98)90197-6; Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y; Coosemans A, 2008, GYNECOL ONCOL, V111, P502, DOI 10.1016/j.ygyno.2008.08.032; Chiang S, 2014, SEMIN DIAGN PATHOL, V31, P205, DOI 10.1053/j.semdp.2014.03.002; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05.0508; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Fadare O, 2014, AM J SURG PATHOL, V38, P189, DOI 10.1097/PAS.0000000000000085; McMeekin DS, 2007, GYNECOL ONCOL, V106, P16, DOI 10.1016/j.ygyno.2007.04.032; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Olawaiye AB, 2009, GYNECOL ONCOL, V113, P277, DOI 10.1016/j.ygyno.2009.02.003; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Murphy KT, 2003, INT J RADIAT ONCOL, V55, P1272, DOI 10.1016/S0360-3016(02)04404-8; Thomas M, 2008, GYNECOL ONCOL, V108, P293, DOI 10.1016/j.ygyno.2007.11.008; Arai T, 2006, INT J GYNECOL CANCER, V16, P391, DOI 10.1111/j.1525-1438.2006.00494.x; Lax SF, 1998, HUM PATHOL, V29, P551, DOI 10.1016/S0046-8177(98)80002-6; Hanselaar A, 1997, CANCER, V79, P2229, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2229::AID-CNCR22>3.0.CO;2-X; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Cirisano FD, 2000, GYNECOL ONCOL, V77, P55, DOI 10.1006/gyno.2000.5737; Miller D, 2012, GYNECOL ONCOL, V125, P771, DOI 10.1016/j.ygyno.2012.03.034; Slomovitz BM, 2010, CANCER-AM CANCER SOC, V116, P5415, DOI 10.1002/cncr.25515; Mendivil A, 2009, CANCER CONTROL, V16, P46; Yamamoto S, 2007, HUM PATHOL, V38, P1074, DOI 10.1016/j.humpath.2006.12.018; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Cirisano FD, 1999, GYNECOL ONCOL, V74, P385, DOI 10.1006/gyno.1999.5505; Verloop J, 2010, CANCER CAUSE CONTROL, V21, P999, DOI 10.1007/s10552-010-9526-5; KHALIFA MA, 1994, GYNECOL ONCOL, V53, P84, DOI 10.1006/gyno.1994.1092; Hogberg T, 2010, EUR J CANCER, V46, P2422, DOI 10.1016/j.ejca.2010.06.002; SCULLY RE, 1967, CANCER, V20, P1405, DOI 10.1002/1097-0142(196709)20:9<1405::AID-CNCR2820200907>3.0.CO;2-B; Ansari DO, 2012, J PEDIAT HEMATOL ONC, V34, pE174, DOI 10.1097/MPH.0b013e318257dc91; Boyd J, 1996, CANCER, V77, P507, DOI 10.1002/(SICI)1097-0142(19960201)77:3<507::AID-CNCR12>3.0.CO;2-8; Chan KKL, 2008, INT J GYNECOL CANCER, V18, P559, DOI 10.1111/j.1525-1438.2007.01037.x; Christopherson WM, CANCER; Fadare O, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-6; Hiromura T, 2009, Br J Radiol, V82, pe20, DOI 10.1259/bjr/75304693; Ito H, 1997, DIAGN CYTOPATHOL, V16, P500, DOI 10.1002/(SICI)1097-0339(199706)16:6<500::AID-DC6>3.0.CO;2-D; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Lee L, 2009, J REPROD MED, V54, P133; Neoplasms NU, 2014, NCCN CLIN PRACTICE G; Pirog EC, 2014, MOD PATHOL; Rauh-Hain JA, GYNECOL ONCOL; Rolitsky CD, 1999, INT J GYNECOL PATHOL, V18, P138, DOI 10.1097/00004347-199904000-00007; Savvari P, 2009, ONKOLOGIE, V32, P517, DOI 10.1159/000226209; Seki Hiroyuki, 2003, Int J Clin Oncol, V8, P399, DOI 10.1007/s10147-003-0358-0; Thomas MB, 2008, GYNECOL ONCOL, V109, P335, DOI 10.1016/j.ygyno.2008.02.007; Tredan O, 2012, TARGET ONCOL, DOI 10.1007/s11523-012-0242-9; Wibur DC, 2014, WHO CLASSIFICATION T, P183	48	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		3			S90	S95		10.1097/IGC.0000000000000297		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FS	WOS:000344613200018		
J	Okamoto, A; Glasspool, RM; Mabuchi, S; Matsumura, N; Nomura, H; Itamochi, H; Takano, M; Takano, T; Susumu, N; Aoki, D; Konishi, I; Covens, A; Ledermann, J; Mezzazanica, D; Steer, C; Millan, D; McNeish, IA; Pfisterer, J; Kang, S; Gladieff, L; Bryce, J; Oza, A				Okamoto, Aikou; Glasspool, Rosalind M.; Mabuchi, Seiji; Matsumura, Noriomi; Nomura, Hiroyuki; Itamochi, Hiroaki; Takano, Masashi; Takano, Tadao; Susumu, Nobuyuki; Aoki, Daisuke; Konishi, Ikuo; Covens, Alan; Ledermann, Jonathan; Mezzazanica, Delia; Steer, Christopher; Millan, David; McNeish, Iain A.; Pfisterer, Jacobus; Kang, Sokbom; Gladieff, Laurence; Bryce, Jane; Oza, Amit			Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Review						Clear cell carcinoma of the ovary (CCC); Deep venous thrombosis; Glycogen; Hepatocyte nuclear factor-1 beta; WT1; Pulmonary embolism; Ethnics; ARID1A; PIK3CA; PPM1D; PPP2R1A; KRAS; Cytoreductive surgery; Paclitaxel; Platinum; Irinotecan hydrochloride; Cisplatin; PI3K/AKT/mTOR	THROMBOEMBOLIC COMPLICATIONS; SURVIVAL BENEFIT; PHASE-II; CHEMOTHERAPY; ADENOCARCINOMA; MUTATIONS; RECURRENT; PLATINUM; TRIAL; IDENTIFICATION	Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer with a distinct clinical behavior. There are marked geographic differences in the prevalence of CCC. The CCC is more likely to be detected at an early stage than high-grade serous cancers, and when confined within the ovary, the prognosis is good. However, advanced disease is associated with a very poor prognosis and resistance to standard treatment. Cytoreductive surgery should be performed for patients with stage II, III, or IV disease. An international phase III study to compare irinotecan/cisplatin and paclitaxel/carboplatin as adjuvant chemotherapy for stage IIV CCC has completed enrollment (GCIG/JGOG3017). Considering the frequent PIK3CA mutation in CCC, dual inhibitors targeting PI3K, AKT in the mTOR pathway, are promising. Performing these trials and generating the evidence will require considerable international collaboration.	[Okamoto, Aikou] Jikei Univ, Sch Med, Tokyo 1058461, Japan; [Glasspool, Rosalind M.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Mabuchi, Seiji] Osaka Univ, Grad Sch Med, Osaka, Japan; [Matsumura, Noriomi; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Nomura, Hiroyuki; Susumu, Nobuyuki; Aoki, Daisuke] Keio Univ, Tokyo, Japan; [Itamochi, Hiroaki] Tottori Univ, Sch Med, Tottori 680, Japan; [Takano, Masashi] Natl Def Med Coll, Saitama, Japan; [Takano, Tadao] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi, Japan; [Covens, Alan] Sunnybrook Med Ctr, Toronto, ON, Canada; [Ledermann, Jonathan] UCL Canc Inst, London, England; [Mezzazanica, Delia] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Steer, Christopher] Border Med Oncol, Wodonga, Vic, Australia; [Millan, David] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland; [McNeish, Iain A.] Univ Glasgow, Inst Canc Sci, Beatson Inst Canc Res, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland; [Pfisterer, Jacobus] Gynecol Oncol Ctr, Kiel, Germany; [Kang, Sokbom] Natl Canc Ctr, Goyang, South Korea; [Gladieff, Laurence] Inst Claudius Regaud, Toulouse, France; [Bryce, Jane] Natl Canc Inst, Naples, Italy; [Oza, Amit] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada	Okamoto, A (reprint author), Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	aikou7000@gmail.com	GLADIEFF, Laurence/O-5129-2014; 	GLADIEFF, Laurence/0000-0002-6980-9719; McNeish, Iain/0000-0002-9387-7586			Kajiyama H, 2011, HUM REPROD, V26, P3297, DOI 10.1093/humrep/der342; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Hoskins PJ, 2012, J CLIN ONCOL, V30, P1656, DOI 10.1200/JCO.2011.40.1646; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; McCluggage WG, 2005, SEMIN DIAGN PATHOL, V22, P3, DOI 10.1053/j.semdp.2005.11.002; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Swenerton KD, 2011, ANN ONCOL, V22, P341, DOI 10.1093/annonc/mdq383; Mabuchi S, 2011, CLIN CANCER RES, V17, P4462, DOI 10.1158/1078-0432.CCR-10-2987; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; HOSKINS WJ, 1992, GYNECOL ONCOL, V47, P159, DOI 10.1016/0090-8258(92)90100-W; JENISON EL, 1989, GYNECOL ONCOL, V32, P65, DOI 10.1016/0090-8258(89)90852-4; Ferrandina G, 2008, J CLIN ONCOL, V26, P890, DOI 10.1200/JCO.2007.13.6606; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Takano M, 2010, INT J GYNECOL CANCER, V20, P1506, DOI 10.1111/IGC.0b013e3181fcd089; Utsunomiya H, 2006, INT J GYNECOL CANCER, V16, P52, DOI 10.1111/j.1525-1438.2006.00289.x; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Takakura S, 2010, INT J GYNECOL CANCER, V20, P240, DOI 10.1111/IGC.0b013e3181cafb47; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Magazzino F, 2011, INT J GYNECOL CANCER, V21, P1063, DOI 10.1097/IGC.0b013e318218f270; BLACKLEDGE G, 1989, BRIT J CANCER, V59, P650, DOI 10.1038/bjc.1989.132; Japanese Gynecologic Cancer Committee, 2012, ACTA OBSTET GYNECOL, V64, P1029; Kajiyama H, 2012, INT J GYNECOL CANCER, V22, P801, DOI 10.1097/IGC.0b013e3182540145; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Mabuchi S, 2011, CURR MED CHEM, V18, P2960; Recio F, 1996, CANCER, V78, P2157, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2157::AID-CNCR17>3.0.CO;2-Y; Satoh T, J CLIN ONCOL; Suzuki S, 2008, ANN ONCOL, V19, P1284, DOI 10.1093/annonc/mdn059; Takano M, BR J CANC; Takano M, 2008, INT J GYNECOL CANCER, V18, P937, DOI 10.1111/j.1525-1438.2007.01158.x; Takano M, 2009, INT J GYNECOL CANCER, V19, P1353, DOI 10.1111/IGC.0b013e3181a83f4f	36	7	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		3			S20	S25		10.1097/IGC.0000000000000289		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FS	WOS:000344613200006		
J	Sagae, S; Susumu, N; Viswanathan, AN; Aoki, D; Backes, FJ; Provencher, DM; Vaughan, M; Creutzberg, CL; Kurzeder, C; Kristensen, G; Lee, C; Kurtz, JE; Glasspool, RM; Small, W				Sagae, Satoru; Susumu, Nobuyuki; Viswanathan, Akila N.; Aoki, Daisuke; Backes, Floor J.; Provencher, Diane M.; Vaughan, Michelle; Creutzberg, Carien L.; Kurzeder, Christian; Kristensen, Gunnar; Lee, Chulmin; Kurtz, Jean-Emmanuel; Glasspool, Rosalind M.; Small, William, Jr.			Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Review						Uterine serous carcinoma; GCIG; Review	ADVANCED ENDOMETRIAL CARCINOMA; WHOLE-ABDOMINAL IRRADIATION; PHASE-III TRIAL; STAGE-I; ONCOLOGY-GROUP; CLEAR-CELL; SURVIVAL OUTCOMES; PAPILLARY; CHEMOTHERAPY; DOXORUBICIN	Objectives: Uterine serous carcinoma (USC) represents a rare and aggressive histologic subtype of endometrial cancer, associated with a poor prognosis. This article critically reviews the literature pertinent to the epidemiology, pathology, molecular biology, diagnosis, management, and perspectives of patients with USC. Methods: As one of a series of The Gynecologic Cancer InterGroup (GCIG) Rare Tumor Working Group in London, November 2013, we discussed about USC many times with various experts among international GCIG groups. Results: Both USC and approximately 25% of high-grade endometrioid tumors represent extensive copy number alterations, few DNA methylation changes, low estrogen and progesterone levels, and frequent P53mutations. Uterine serous carcinoma shares molecular characteristics with ovarian serous and basal-like breast carcinomas. In addition to optimal surgery, platinum-and taxane-based chemotherapy should be considered in the treatment of both early-and advanced-stage disease. The combination of radiation and chemotherapy appears to be associated with the highest survival rates. The role of radiation therapy in the management of this disease, with a high propensity for distant failures, remains elusive. Conclusions: Uterine serous carcinoma is a unique and biologically aggressive subtype of endometrial cancer and should be studied as a distinct entity. Futures studies should identify the optimized chemotherapy and radiation regimens, sequence of therapy and schedule, and the role of targeted biologic therapy.	[Sagae, Satoru] JR Sapporo Hosp, Dept Obstet & Gynecol, Sapporo, Hokkaido 0600033, Japan; [Susumu, Nobuyuki; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Viswanathan, Akila N.] Harvard Univ, Sch Med, Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA; [Backes, Floor J.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Provencher, Diane M.] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Vaughan, Michelle] Christchurch Hosp, Dept Oncol, Canterbury, New Zealand; [Creutzberg, Carien L.] Leiden Univ, Dept Clin Oncol, Med Ctr, Leiden, Netherlands; [Kurzeder, Christian] Kliniken Essen Mitte KEM AGO, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Kristensen, Gunnar] Norwegian Radium Hosp, Oslo, Norway; [Lee, Chulmin] Inje Univ, Sanggye Paik Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Kurtz, Jean-Emmanuel] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France; [Glasspool, Rosalind M.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Small, William, Jr.] Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA	Sagae, S (reprint author), JR Sapporo Hosp, Dept Obstet & Gynecol, Chuou Ku, North 3 East 1, Sapporo, Hokkaido 0600033, Japan.	s-sagae@jrhokkaido.co.jp					AMBROS RA, 1995, HUM PATHOL, V26, P1260, DOI 10.1016/0046-8177(95)90203-1; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Growdon WB, 2012, INT J GYNECOL CANCER, V22, P417, DOI 10.1097/IGC.0b013e31823c6e36; Lavie O, 2004, GYNECOL ONCOL, V92, P521, DOI 10.1016/j.ygyno.2003.11.009; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Huang GS, 2007, AM J OBSTET GYNECOL, V196, P243, DOI 10.1016/j.ajog.2006.09.035; Boruta DM, 2009, GYNECOL ONCOL, V115, P142, DOI 10.1016/j.ygyno.2009.06.011; Fader AN, 2009, CANCER, V115, P2119, DOI 10.1002/cncr.24247; Miller D, 2012, GYNECOL ONCOL, V125, P771, DOI 10.1016/j.ygyno.2012.03.034; Fader AN, 2009, GYNECOL ONCOL, V112, P558, DOI 10.1016/j.ygyno.2008.11.016; Slomovitz BM, 2004, J CLIN ONCOL, V22, P3126, DOI 10.1200/JCO.2004.11.154; Hogberg T, 2010, EUR J CANCER, V46, P2422, DOI 10.1016/j.ejca.2010.06.002; Boruta DM, 2004, CANCER, V101, P2214, DOI 10.1002/cncr.20645; Viswanathan AN, 2011, GYNECOL ONCOL, V123, P542, DOI 10.1016/j.ygyno.2011.09.005; Rauh-Hain JA, 2010, GYNECOL ONCOL, V119, P299, DOI 10.1016/j.ygyno.2010.07.010; Barney BM, 2013, INT J RADIAT ONCOL, V85, P109, DOI 10.1016/j.ijrobp.2012.03.011; Benedetti Pancini P, 2008, J NATL CANCER I, V100, P1707; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Fader AN, 2009, GYNECOL ONCOL, V112, pS72; Homesley HD, 2008, GYNECOL ONCOL, V22, P131; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Kelly MG, 2005, GYNECOL ONCOL, V98, P353, DOI 10.1016/j.ygyno.2005.06.012; Naumann RW, 2008, CURR ONCOL REP, V10, P505, DOI 10.1007/s11912-008-0076-x; Sutton G, 2006, GYNECOL ONCOL, V100, P349, DOI 10.1016/j.ygyno.2005.08.037; Yi XF, 2008, CURR OPIN OBSTET GYN, V20, P20, DOI 10.1097/GCO.0b013e3282f2fd50	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		3			S83	S89		10.1097/IGC.0000000000000264		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FS	WOS:000344613200017		
J	Satoh, T; Takei, Y; Treilleux, I; Devouassoux-Shisheboran, M; Ledermann, J; Viswanathan, AN; Mahner, S; Provencher, DM; Mileshkin, L; Avall-Lundqvist, E; Pautier, P; Reed, NS; Fujiwara, K				Satoh, Toyomi; Takei, Yuji; Treilleux, Isabelle; Devouassoux-Shisheboran, Mojgan; Ledermann, Jonathan; Viswanathan, Akila N.; Mahner, Sven; Provencher, Diane M.; Mileshkin, Linda; Avall-Lundqvist, Elizabeth; Pautier, Patricia; Reed, Nicholas Simon; Fujiwara, Keiichi			Gynecologic Cancer InterGroup (GCIG) Consensus Review for Small Cell Carcinoma of the Cervix	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Review						Small cell carcinoma of the uterine cervix; Cervical cancer; Surgery; Chemotherapy	PHASE-III TRIAL; UTERINE CERVIX; NEUROENDOCRINE CARCINOMA; PROGNOSTIC-FACTORS; LUNG-CANCER; CRANIAL IRRADIATION; ENDOCRINE TUMORS; SINGLE-CENTER; ETOPOSIDE; SURVIVAL	Small cell carcinoma of the cervix (SCCC) is a rare histological entity of uterine cervical cancer. Compared with other common histological types, squamous cell carcinoma or adenocarcinoma, the outcome of SCCC is poor because of the high incidence of nodal or distant metastasis even with early stage. In this review, current consensus of epidemiology, pathology, and initial treatment for SCCC will be discussed.	[Satoh, Toyomi] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Takei, Yuji] Jichi Med Univ, Shimono City, Japan; [Treilleux, Isabelle] Ctr Leon Berard, F-69373 Lyon, France; [Treilleux, Isabelle; Devouassoux-Shisheboran, Mojgan; Pautier, Patricia] GINECO, Madrid, Spain; [Devouassoux-Shisheboran, Mojgan] Hosp Civils Lyon, Lyon, France; [Ledermann, Jonathan] UCL, London, England; [Ledermann, Jonathan] NCRI MRC, London, England; [Viswanathan, Akila N.] Harvard Univ, Sch Med, Boston, MA USA; [Viswanathan, Akila N.] RTOG, Philadelphia, PA USA; [Mahner, Sven] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Provencher, Diane M.] Univ Montreal, Montreal, PQ, Canada; [Mileshkin, Linda] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Mileshkin, Linda] ANZGOG, Camperdown, NSW, Australia; [Avall-Lundqvist, Elizabeth] Karolinska Inst, Stockholm, Sweden; [Avall-Lundqvist, Elizabeth] NSGO, Copenhagen, Denmark; [Pautier, Patricia] Inst Gustave Roussy, Villejuif, France; [Reed, Nicholas Simon] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; [Reed, Nicholas Simon] EORTC, Brussels, Belgium; [Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Hidaka City, Saitama, Japan	Fujiwara, K (reprint author), Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Saitama, Japan.	fujiwara@saitama-med.ac.jp					Naidoo J, 2013, J THORAC ONCOL, V8, P1215, DOI 10.1097/JTO.0b013e31829f6b03; Wang TY, 2001, HUM PATHOL, V32, P479, DOI 10.1053/hupa.2001.24324; Gardner GJ, 2011, GYNECOL ONCOL, V122, P190, DOI 10.1016/j.ygyno.2011.04.011; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; Haider K, 2006, CANCER, V107, P2262, DOI 10.1002/cncr.22235; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; McCusker ME, 2003, GYNECOL ONCOL, V88, P333, DOI 10.1016/S0090-8258(02)00150-6; Chung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x; Chen J, 2008, OBSTET GYNECOL, V111, P1394, DOI 10.1097/AOG.0b013e318173570b; Kuji S, 2013, GYNECOL ONCOL, V129, P522, DOI 10.1016/j.ygyno.2013.02.025; Hainsworth JD, 2006, J CLIN ONCOL, V24, P3548, DOI 10.1200/JCO.2005.05.0575; McCluggage WG, 2010, AM J SURG PATHOL, V34, P525, DOI 10.1097/PAS.0b013e3181d1d457; Lee SS, 2007, ACTA ONCOL, V46, P846, DOI 10.1080/02841860601071893; ROTH BJ, 1992, J CLIN ONCOL, V10, P282; Lee JM, 2008, ANN ONCOL, V19, P321, DOI 10.1093/annonc/mdm465; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Viswanathan AN, 2004, GYNECOL ONCOL, V93, P27, DOI 10.1016/j.ygyno.2003.12.027; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Wang KL, 2012, EUR J CANCER, V48, P1484, DOI 10.1016/j.ejca.2011.12.014; Cohen JG, 2010, AM J OBSTET GYNECOL, V203; Crowder S, 2007, SEMIN ONCOL, V34, P57, DOI 10.1053/j.seminoncol.2006.10.028; DiSaia PJ, 2007, CLIN GYNECOLOGIC ONC; Hirai Y, 2004, AM J OBSTET GYNECOL, V191, P1173, DOI 10.1016/j.ajog.2004.04.015; Kim YM, 2009, EUR J GYNAECOL ONCOL, V30, P539; Liao LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033674; Muller AC, 2012, STRAHLENTHER ONKOL, V188, P269, DOI 10.1007/s00066-011-0045-4; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; Tian WJ, 2012, ONCOL LETT, V3, P125, DOI 10.3892/ol.2011.439; Tokunaga H, 2013, TOHOKU J EXP MED, V229, P75, DOI 10.1620/tjem.229.75; Wistuba II, 1999, GYNECOL ONCOL, V72, P3, DOI 10.1006/gyno.1998.5248; Wong YNS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-209; Zivanovic O, GYNECOL ONCOL	33	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	NOV	2014	24	9		3			S102	S108		10.1097/IGC.0000000000000262		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AT0FS	WOS:000344613200020		
J	Efremenko, VG; Shimizu, K; Cheiliakh, AP; Kozarevskaya, TV; Kusumoto, K; Yamamoto, K				Efremenko, V. G.; Shimizu, K.; Cheiliakh, A. P.; Kozarevskaya, T. V.; Kusumoto, K.; Yamamoto, K.			Effect of vanadium and chromium on the microstructural features of V-Cr-Mn-Ni spheroidal carbide cast irons	INTERNATIONAL JOURNAL OF MINERALS METALLURGY AND MATERIALS			English	Article						cast irons; carbides; microstructure; vanadium; chromium; austenite; pearlite	WEAR-RESISTANCE; WHITE IRON; HEAT-TREATMENT; TRANSFORMATION; PRECIPITATION; CORROSION	The objective of this investigation is to study the influence of vanadium (5.0wt%-10.0wt%) and chromium (0-9.0wt%) on the microstructure and hardness of Cr-V-Mn-Ni white cast irons with spheroidal vanadium carbides. The alloys' microstructural features are presented and discussed with regard to the distribution of phase elements. The structural constituents of the alloys are spheroidal VC, proeutectoid cementite, ledeburite eutectic, rosette-shaped carbide eutectic (based on M7C3), pearlite, martensite, and austenite. Their combinations and area fraction (AF) ratios are reported to be influenced by the alloys' chemical composition. Spheroidized VC particles are found to be sites for the nucleation of carbide eutectics. Cr and V are shown to substitute each other in the VC and M7C3 carbides, respectively. Chromium alloying leads to the formation of a eutectic (gamma-Fe + M7C3), preventing the appearance of proeutectoid cementite in the structure. Vanadium and chromium are revealed to increase the total carbide fraction and the amount of austenite in the matrix. Cr is observed to play a key role in controlling the metallic matrix microstructure.	[Efremenko, V. G.; Cheiliakh, A. P.] Pryazovskyi State Tech Univ, Dept Met Sci & Heat Treatment Met, UA-87500 Mariupol, Ukraine; [Shimizu, K.; Kozarevskaya, T. V.; Kusumoto, K.; Yamamoto, K.] Muroran Inst Technol, Mfg & Engn Design Ctr, Muroran, Hokkaido 0508585, Japan	Efremenko, VG (reprint author), Pryazovskyi State Tech Univ, Dept Met Sci & Heat Treatment Met, UA-87500 Mariupol, Ukraine.	vgefremenko@rambler.ru			Muroran Institute of Technology	The authors are grateful to the Muroran Institute of Technology for funding this project and for use of its research facilities.	Zhou YF, 2012, MATER CHARACT, V72, P77, DOI 10.1016/j.matchar.2012.07.004; Correa R, 2009, WEAR, V267, P495, DOI 10.1016/j.wear.2008.11.009; Albertin E, 2001, WEAR, V250, P492, DOI 10.1016/S0043-1648(01)00664-0; Mohammadnezhad M, 2013, MATER DESIGN, V49, P888, DOI 10.1016/j.matdes.2013.02.043; Albertin E, 2011, WEAR, V271, P1813, DOI 10.1016/j.wear.2011.01.079; Tokaji K, 2006, INT J FATIGUE, V28, P281, DOI 10.1016/j.ijfatigue.2005.05.009; Qi XW, 2011, SURF COAT TECH, V205, P5510, DOI 10.1016/j.surfcoat.2011.06.027; Shimizu K, 2009, WEAR, V267, P104, DOI 10.1016/j.wear.2008.12.086; Tang XH, 2011, WEAR, V271, P1426, DOI 10.1016/j.wear.2010.11.047; Ribeiro L, 2011, WEAR, V270, P535, DOI 10.1016/j.wear.2011.01.008; Zhi XH, 2008, MATER CHARACT, V59, P1221, DOI 10.1016/j.matchar.2007.10.010; Bedolla-Jacuinde A, 2003, J MATER ENG PERFORM, V12, P371, DOI 10.1361/105994903770342881; Efremenko VG, 2013, WEAR, V305, P155, DOI 10.1016/j.wear.2013.06.006; Karantzalis AE, 2009, J MATER ENG PERFORM, V18, P1078, DOI 10.1007/s11665-009-9353-6; Karantzalis AE, 2009, J MATER ENG PERFORM, V18, P174, DOI 10.1007/s11665-008-9285-6; Kawalec M., 2012, ARCH FOUNDRY ENG, V12, P221; Liu K.M., 2005, IRON STEEL S, V40, P207; Liu YX, 2004, 14TH CONGRESS OF INTERNATIONAL FEDERATION FOR HEAT TREATMENT AND SURFACE ENGINEERING, VOLS 1 and 2, PROCEEDINGS, P631; Shigenori N., 2002, J JPN FOUNDRY ENG SO, V74, P279; Shigenori N., 2007, J JPN FOUNDRY ENG SO, V79, P133; Shimizu K, 2011, KEY ENG MATER, V457, P255, DOI 10.4028/www.scientific.net/KEM.457.255; Silman GI, 2007, MET SCI HEAT TREAT+, V49, P405, DOI 10.1007/s11041-007-0076-8; Spanos G, 2009, INT MATER REV, V54, P19, DOI 10.1179/174328009X392949; Tian HH, 2009, WEAR, V267, P2039, DOI 10.1016/j.wear.2009.08.007; WANG CC, 1990, MATER SCI TECH SER, V6, P905; Wang J, 2006, J MATER ENG PERFORM, V15, P316, DOI 10.1361/105994906X108602; Wang YP, 2011, WEAR, V271, P1623, DOI 10.1016/j.wear.2010.12.029; Xinba Y., 2008, WEAR, V264, P947; Yoneta N, 2011, KEY ENG MATER, V457, P249, DOI 10.4028/www.scientific.net/KEM.457.249	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1674-4799	1869-103X		INT J MIN MET MATER	Int. J. Miner. Metall. Mater.	NOV	2014	21	11					1096	1108		10.1007/s12613-014-1014-6		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	AT2EK	WOS:000344744500007		
J	Tajima, T; Chosa, E; Kawahara, K; Nakamura, Y; Yoshikawa, D; Yamaguchi, N; Kashiwagi, T				Tajima, T.; Chosa, E.; Kawahara, K.; Nakamura, Y.; Yoshikawa, D.; Yamaguchi, N.; Kashiwagi, T.			Comprehensive Safety Management and Assessment at Rugby Football Competitions	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						medical-care system; environment; medical staff; rugby-football	SPINAL-INJURIES; CERVICAL-SPINE; CONCUSSION; CORD	The present study aims to improve medical systems by designing objective safety assessment criteria for rugby competitions. We evaluated 195 competitions between 2002 and 2011 using an original safety scale comprising the following sections: 1) competence of staff such as referees, medical attendants and match day doctor; 2) environment such as weather, wet bulb globe temperature and field conditions; and 3) emergency medical care systems at the competitions. Each section was subdivided into groups A, B and C according to good, normal or fair degrees of safety determined by combinations of the results. Overall safety was assessed as A, B and C for 110, 78 and 7 competitions, respectively. The assessments of individual major factors were mostly favorable for staff, but the environment and medical care systems were assessed as C in 25 and 70, respectively, of the 195 competitions. Medical management involves not having a match day doctor, but also comprehensive management including preventive factors and responses from the staff, environment and medical-care systems. 6 cases of severe injuries and accidents occurred between 2002 and 2011, which were observed in Grade A competition. These cases revealed better prognosis without obvious impairment, thus confirming the value of the present assessment scale.	[Tajima, T.; Chosa, E.; Kawahara, K.; Nakamura, Y.; Yoshikawa, D.; Yamaguchi, N.] Miyazaki Univ, Fac Med, Dept Med Sensory & Motor Organs, Div Orthopaed Surg, Miyazaki 8891692, Japan; [Kashiwagi, T.] Tachibana Hosp, Dept Orthopaed Surg, Miyazaki, Japan	Tajima, T (reprint author), Miyazaki Univ, Fac Med, Dept Med Sensory & Motor Organs, Div Orthopaed Surg, 5200 Kihara, Miyazaki 8891692, Japan.	kingt2@hotmail.com			University of Miyazaki, Miyazaki Rugby Football Union; Japanese Orthopedics Society for Sports Medicine; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Orthopaedic Society for Sports Medicine Foundation	This study was supported by the University of Miyazaki, Miyazaki Rugby Football Union, the Japanese Orthopedics Society for Sports Medicine and Japanese Ministry of Education, Culture, Sports, Science and Technology. Financial support: Grant of the Japanese Orthopaedic Society for Sports Medicine Foundation, 2010.	Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119; Boden BP, 2008, NEUROL CLIN, V26, P63, DOI 10.1016/j.ncl.2007.12.005; Fuller CW, 2007, CLIN J SPORT MED, V17, P10, DOI 10.1097/JSM.0b013e31802e9c28; Gianotti SM, 2008, J SCI MED SPORT, V12, P371; Isayama K, 2008, JPN J CLIN SPORTS ME, V25, P361; Kawahara T, 1996, GUIDELINES PREVENT H, P12; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Maruyama K, 2005, JPN J ORTHOP SPORTS, V24, P18; Musya H, 2004, JPN J CLIN SPORTS ME, V12, P138; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; SCHER AT, 1991, AM J SPORT MED, V19, P485, DOI 10.1177/036354659101900511; Scher AT, 1998, CLIN SPORT MED, V17, P195, DOI 10.1016/S0278-5919(05)70073-9; Shelly MJ, 2006, J BONE JOINT SURG BR, V88B, P771, DOI 10.1302/0301-620X.88B6; Silver JR, 2002, SPINAL CORD, V40, P552, DOI 10.1038/sj.sc.3101349; Simon G, 2007, NEUROREHABILITATION, V22, P181; The American Heart Association in collaboration with the International Liaison Committee on Resuscitation, 2000, CIRCULATION S1, V102, pl86; Wetzler MJ, 1998, AM J SPORT MED, V26, P177	20	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	NOV	2014	35	12					1012	1016		10.1055/s-0034-1372634		5	Sport Sciences	Sport Sciences	AS9JZ	WOS:000344560400007		
J	Ebihara, T; Kubota, K; Takehara, H; Yokota, E				Ebihara, Takashi; Kubota, Keiichi; Takehara, Hitoshi; Yokota, Eri			Market liquidity, private information, and the cost of capital: Market microstructure studies on family firms in Japan	JAPAN AND THE WORLD ECONOMY			English	Article						Family businesses; Cost of equity; Cost of debt; Information asymmetry; Liquidity	CORPORATE GOVERNANCE; OWNERSHIP STRUCTURE; PERFORMANCE; RETURNS; WORLD; DEBT	We investigate cost of capital, information asymmetry, and market liquidity of listed family firms vs. non-family firms in Japan. First, we find that the cost of debt is lower and the cost of equity is higher for family firms than non-family firms, but the differences are not significant. The WACC of family firms becomes higher than that for non-family firms and the difference is significant probably because family firms in Japan use less leverage. Next, we find that the stocks of family firms are traded with higher information asymmetry than non-family firms. As for information asymmetry and illiquidity measures, we utilize the variables Adjusted PIN and Probability of Symmetric Order Flow Shocks (PSOS). Concomitantly we also estimate alternate conventional measures of market liquidity as a robustness check. Overall, the evidence on liquidity is somewhat mixed, while we find family firms show higher information asymmetry, which may affect cost of equity. As a final policy implication, we recommend family firms in Japan conduct more voluntary and timely disclosure, in particular, for the benefit of general stock investors, and may want to increase leverage to reduce the WACC. (C) 2014 Elsevier B.V. All rights reserved.	[Ebihara, Takashi] Musashi Univ, Fac Econ, Nerima, Tokyo 1768534, Japan; [Kubota, Keiichi] Chuo Univ, Grad Sch Strateg Management, Bunkyo Ku, Kasuga, Tokyo 1128511, Japan; [Takehara, Hitoshi] Waseda Univ, Grad Sch Finance Accounting & Law, Chuo Ku, Tokyo 1030027, Japan; [Yokota, Eri] Keio Univ, Fac Business & Commerce, Minato Ku, Tokyo 1088345, Japan	Kubota, K (reprint author), Chuo Univ, Grad Sch Strateg Management, Bunkyo Ku, 1-13-27, Kasuga, Tokyo 1128511, Japan.	ebihara@cc.musashi.ac.jp; kekubota@tamacc.chuo-u.ac.jp; takehara@waseda.jp; yokota@fbc.keio-u.ac.jp					Allouche J, 2008, FAM BUS REV, V21, P315, DOI 10.1111/j.1741-6248.2008.00132.x; Almeida H., 2010, WORKING PAPER; Anderson RC, 2003, J FINANC ECON, V68, P263, DOI 10.1016/S0304-405X(03)00067-9; HOLDEN CW, 1992, J FINANC, V47, P247, DOI 10.2307/2329097; Mehrotra V, 2013, J FINANC ECON, V108, P840, DOI 10.1016/j.jfineco.2013.01.011; Avramov D, 2006, REV FINANC STUD, V19, P1001, DOI 10.1093/rfs/hhj025; O'Hara M, 2003, J FINANC, V58, P1335, DOI 10.1111/1540-6261.00569; Ali A, 2007, J ACCOUNT ECON, V44, P238, DOI 10.1016/j.jacceco.2007.01.006; Wang DC, 2006, J ACCOUNTING RES, V44, P619, DOI 10.1111/j.1475-679X.2006.00213.x; Anderson RC, 2003, J FINANC, V58, P1301, DOI 10.1111/1540-6261.00567; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; Aghion P, 1997, J POLIT ECON, V105, P1, DOI 10.1086/262063; Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Lambert RA, 2012, REV FINANC, V16, P1, DOI 10.1093/rof/rfr014; Saito T, 2008, J JPN INT ECON, V22, P620, DOI 10.1016/j.jjie.2008.06.001; Anderson RC, 2012, J FINANC, V67, P351, DOI 10.1111/j.1540-6261.2011.01714.x; Liu WM, 2006, J FINANC ECON, V82, P631, DOI 10.1016/j.jfineco.2005.10.005; Lesmond DA, 1999, REV FINANC STUD, V12, P1113, DOI 10.1093/rfs/12.5.1113; Oh WY, 2011, J BUS ETHICS, V104, P283, DOI 10.1007/s10551-011-0912-z; Easley D, 2002, J FINANC, V57, P2185, DOI 10.1111/1540-6261.00493; La Porta R, 1999, J FINANC, V54, P471, DOI 10.1111/0022-1082.00115; Claessens S, 2000, J FINANC ECON, V58, P81, DOI 10.1016/S0304-405X(00)00067-2; Villalonga B, 2006, J FINANC ECON, V80, P385, DOI 10.1016/j.jfineco.2004.12.005; Morck R, 2005, J ECON LIT, V43, P655, DOI 10.1257/002205105774431252; Anderson RC, 2009, J FINANC ECON, V92, P205, DOI 10.1016/j.jfineco.2008.04.006; Gomez-Mejia LR, 2001, ACAD MANAGE J, V44, P81, DOI 10.2307/3069338; Graham JR, 2000, J FINANC, V55, P1901, DOI 10.1111/0022-1082.00277; Easley D, 2004, J FINANC, V59, P1553, DOI 10.1111/j.1540-6261.2004.00672.x; Masulis RW, 2011, REV FINANC STUD, V24, P3556, DOI 10.1093/rfs/hhr052; Aoi M., 2012, INT FAM ENT AC ANN C; Asaba S., 2012, ASIA PACIFIC J  0826; Bolton P.A., 2005, CONTRACT THEORY; Cipriani M, 2012, INFORM CHANNEL UNPUB; Dennis Jr J. E., 1983, NUMERICAL METHODS UN; Ebihara T., 2012, QUALITY ACCOUNTING D; Eoyang C., 1998, LIQUEFACTION JAPANES; Fama E. F., 1993, J FINANC, V48, P427; Jensen M. C., 2004, WORKING PAPER; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Easley D, 1996, J FINANC, V51, P1405, DOI 10.2307/2329399; Kubota K., 2010, MANAG FINANC, V368, P655; Kubota K., 2009, PACIFIC BASIN FINANC, V17, P295; Kubota K., 2012, 2012 EC SOC EUR M MA; Kubota K, 2007, FINANZARCHIV, V63, P163, DOI 10.1625/001522107X220062; Mazzi C., 2011, J FAMILY BUSINESS ST, V2, P166; McConaughy D. L., 1999, FAMILY BUSINESS REV, V12, P353, DOI 10.1111/j.1741-6248.1999.00353.x; Myers S., 1977, J FINANC ECON, V5, P146; Reinking J. F., 2011, 2011 AM ACC ASS ANN; Ross S. A., 1976, BELL J ECON, V7, P23; Yafeh Y, 2000, OXFORD REV ECON POL, V16, P74, DOI 10.1093/oxrep/16.2.74; Duarte J, 2009, J FINANC ECON, V91, P119, DOI 10.1016/j.jfineco.2007.10.008	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0922-1425	1879-2006		JPN WORLD ECON	Jpn. World Econ.	NOV	2014	32						1	13		10.1016/j.japwor.2014.07.001		13	Economics	Business & Economics	AT5IG	WOS:000344976500001		
J	Montgomery, H; Takahashi, Y				Montgomery, Heather; Takahashi, Yuki			The economic consequences of the TARP: The effectiveness of bank recapitalization policies in the US	JAPAN AND THE WORLD ECONOMY			English	Article						Bank; Crisis; Recapitalization; Capital; TARP	CAPITAL CRUNCH; PANEL-DATA; JAPAN; CREDIT; RISK; INVESTMENT; MANAGEMENT; MODELS; SYSTEM; CRISES	This study empirically analyzes the impact of the United States' bank recapitalization program, the centerpiece of the United States' $700 billion Troubled Asset Relief Program (TARP), on bank portfolios. Through superior empirical analysis and correct model specification, our findings overturn much of the existing literature on the effectiveness of capital injections into the banking sector in Japan and the United States. We show that the TARP program did not achieve the stated policy objective of stimulating bank lending. On the contrary, we find evidence that recipient banks grew assets significantly slower, particularly heavily risk-weighted assets such as loans. These findings are robust to various empirical specifications, including two-stage least squares estimation using instrumental variables, difference-indifference techniques and generalized method of moments. These techniques control for pre-existing trends in loan growth while addressing potential endogeneity bias. (C) 2014 Elsevier B.V. All rights reserved.	[Montgomery, Heather] Int Christian Univ, Tokyo 1810015, Japan; [Takahashi, Yuki] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA	Montgomery, H (reprint author), Int Christian Univ, 3-10-4 Osawa, Tokyo 1810015, Japan.	montgomery@icu.ac.jp; yuki.takahashi.1@stonybrook.edu					Allen L, 2011, J INT BUS STUD, V42, P875, DOI 10.1057/jibs.2011.17; Roodman D, 2009, STATA J, V9, P86; Montgomery H, 2005, J JPN INT ECON, V19, P24, DOI 10.1016/j.jjie.2004.02.002; Woo D, 2003, J MONEY CREDIT BANK, V35, P1019, DOI 10.1353/mcb.2003.0050; Black LK, 2013, J FINANC STABIL, V9, P790, DOI 10.1016/j.jfs.2012.04.001; PEEK J, 1995, J MONEY CREDIT BANK, V27, P625, DOI 10.2307/2077739; [Anonymous], 2008, NY TIMES; Ivashina V, 2010, J FINANC ECON, V97, P319, DOI 10.1016/j.jfineco.2009.12.001; BERGER AN, 1993, J BANK FINANC, V17, P317, DOI 10.1016/0378-4266(93)90035-C; Duchin R, 2014, J FINANC ECON, V113, P1, DOI 10.1016/j.jfineco.2014.03.005; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Li L, 2013, J BANK FINANC, V37, P4777, DOI 10.1016/j.jbankfin.2013.08.009; Veronesi P, 2010, J FINANC ECON, V97, P339, DOI 10.1016/j.jfineco.2010.03.011; Cornett MM, 2011, J FINANC ECON, V101, P297, DOI 10.1016/j.jfineco.2011.03.001; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Hoshi T, 2010, J FINANC ECON, V97, P398, DOI 10.1016/j.jfineco.2010.02.005; Duchin R, 2012, J FINANC ECON, V106, P24, DOI 10.1016/j.jfineco.2012.04.009; Diamond DW, 2000, J FINANC, V55, P2431, DOI 10.1111/0022-1082.00296; Montgomery H, 2009, JPN WORLD ECON, V21, P1, DOI 10.1016/j.japwor.2007.07.004; HECKMAN JJ, 1978, ECONOMETRICA, V46, P931, DOI 10.2307/1909757; Windmeijer F, 2005, J ECONOMETRICS, V126, P25, DOI 10.1016/j.jeconom.2004.02.005; Peek J, 2005, AM ECON REV, V95, P1144, DOI 10.1257/0002828054825691; Furfine C, 2001, J FINANC SERV RES, V20, P33, DOI 10.1023/A:1011147609099; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Bayazitova D, 2012, REV FINANC STUD, V25, P377, DOI 10.1093/rfs/hhr121; Berger A. N., 2013, DID TARP BANKS GET C; Board of Governors of the Federal Reserve System, 2009, SUP CAP ASS PROGR DE; Congressional Oversight Panel, 2009, 2 C OV PAN; DIAMOND DW, 1984, REV ECON STUD, V51, P393, DOI 10.2307/2297430; Eubanks W. W., 2006, RL33278 CRS; Giannetti M, 2013, AM ECON J-MACROECON, V5, P135, DOI 10.1257/mac.5.1.135; Hoshi T., 2008, NIHON KEIZAI SH 1023, P27; Hoshi T., 2001, MONETARY EC STUDIES, V19, P1; Hyun JS, 2011, J BANK FINANC, V35, P323, DOI 10.1016/j.jbankfin.2010.08.018; Ito T, 2005, INT J FINANC ECON, V10, P195, DOI 10.1002/ijfe.259; Iwatsubo K, 2007, JPN WORLD ECON, V19, P166, DOI 10.1016/j.japwor.2005.09.001; Jickling M., 2010, R40249 CRS; Kasahara H., 2011, NBER JAP PROJ UNPUB; Maddala G.S., 1983, LTD DEPENDENT QUALIT; Office of Financial Stability, 2013, TROUBL ASS REL PROGR; Onji K, 2012, J JPN INT ECON, V26, P495, DOI 10.1016/j.jjie.2012.08.002; SHARPE SA, 1990, J FINANC, V45, P1069, DOI 10.2307/2328715; Shimizutani S., 2008, NIHON KEIZAI SH 1127, P31; Takenaka H., 2008, NIHON KEIZAI SH 1016, P27; U. S. Department of the Treasury, 2008, ACT SECR DOM FIN ANT; U. S. Department of the Treasury, 2008, STAT SECR HM PAULS C; U. S. Department of the Treasury, 2011, CAP PURCH PROGR; Ueda Kazuo, 2000, CRISIS CHANGE JAPANE, P59; Watanabe W, 2007, J MONEY CREDIT BANK, V39, P639, DOI 10.1111/j.0022-2879.2007.00039.x; Watanabe W, 2010, J JPN INT ECON, V24, P116, DOI 10.1016/j.jjie.2010.01.001; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0922-1425	1879-2006		JPN WORLD ECON	Jpn. World Econ.	NOV	2014	32						49	64		10.1016/j.japwor.2014.07.004		16	Economics	Business & Economics	AT5IG	WOS:000344976500004		
J	Kuba, S; Ishida, M; Nakamura, Y; Yamanouchi, K; Minami, S; Taguchi, K; Eguchi, S; Ohno, S				Kuba, Sayaka; Ishida, Mayumi; Nakamura, Yoshiaki; Yamanouchi, Kosho; Minami, Shigeki; Taguchi, Kenichi; Eguchi, Susumu; Ohno, Shinji			Treatment and Prognosis of Breast Cancer Patients with Brain Metastases According to Intrinsic Subtype	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						brain metastasis; breast cancer; subtype; prognosis; whole-brain radiation therapy; stereotactic radiosurgery	RANDOMIZED-TRIAL; SURVIVAL; RADIOTHERAPY; RADIOSURGERY; OUTCOMES; THERAPY	Objective: How breast cancer subtypes should affect treatment decisions for breast cancer patients with brain metastases is unclear. We analyzed local brain metastases treatments and their outcomes according to subtype in patients with breast cancer and brain metastases. Methods: We reviewed records and database information for women treated at the National Kyushu Cancer Center between 2001 and 2010. Patients were divided into three breast cancer subtype groups: Luminal (estrogen receptor positive and/or progesterone receptor positive, but human epidermal growth factor receptor 2 negative); human epidermal growth factor receptor 2 positive and triple negative (estrogen receptor negative, progesterone receptor negative and human epidermal growth factor receptor 2 negative). Results: Of 524 advanced breast cancer patients, we reviewed 65 (12%) with brain metastases and records showing estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status, as well as outcome data; there were 26 (40%) Luminal, 26 (40%) had human epidermal growth factor receptor 2 and 13 (20%) had triple negative subtypes. There was no statistical difference in the number of brain metastases among subtypes; however, rates of stereotactic radiosurgery or surgery for brain metastases differed significantly by subtype (human epidermal growth factor receptor 2: 81%, Luminal: 42% and triple negative: 47%; P = 0.03). Patients having the human epidermal growth factor receptor 2 subtype, a performance status of <= 1 and <= 4 brain metastases, who underwent systemic therapy after brain metastases and underwent stereotactic radiosurgery or surgery, were predicted to have longer overall survival after brain metastases. Multivariate analysis demonstrated that not having systemic therapy and not having the human epidermal growth factor receptor 2 subtype were independent factors associated with an increased risk of death (hazard ratio 2.4, 95% confidence interval 1.01-5.6; P = 0.05 and hazard ratio 2.9, 95% confidence interval 1.5-5.8; P = 0.003, respectively). Conclusion: Our study showed that local brain treatments and prognosis differed by subtype in breast cancer patients with brain metastases.	[Kuba, Sayaka; Ishida, Mayumi; Nakamura, Yoshiaki; Ohno, Shinji] Natl Hosp Org, Dept Breast Oncol, Kyushu Canc Ctr, Fukuoka, Japan; [Kuba, Sayaka; Yamanouchi, Kosho; Minami, Shigeki; Eguchi, Susumu] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Taguchi, Kenichi] Natl Hosp Org, Dept Pathol, Kyushu Canc Ctr, Fukuoka, Japan	Kuba, S (reprint author), Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto Machi, Nagasaki 8528501, Japan.	skuba@nagasaki-u.ac.jp					Lin NU, 2008, CANCER, V113, P2638, DOI 10.1002/cncr.23930; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Tarhan MO, 2013, CLIN EXP METASTAS, V30, P201, DOI 10.1007/s10585-012-9528-7; Aoyama HI, 2003, INT J RADIAT ONCOL, V56, P793, DOI 10.1016/S0360-3016(03)00014-2; Arvold ND, 2012, BREAST CANCER RES TR, V136, P153, DOI 10.1007/s10549-012-2243-x; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Park YH, 2009, BRIT J CANCER, V100, P894, DOI 10.1038/sj.bjc.6604941; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; NOORDIJK EM, 1994, INT J RADIAT ONCOL, V29, P711; VECHT CJ, 1993, ANN NEUROL, V33, P583, DOI 10.1002/ana.410330605; TSUKADA Y, 1983, CANCER, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109; Bartsch R, 2007, J NEURO-ONCOL, V85, P311, DOI 10.1007/s11060-007-9420-5; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Berghoff A, 2012, BRIT J CANCER, V106, P440, DOI 10.1038/bjc.2011.597; Grasselin O, 2010, J CLIN ONCOL, V28, P2032; Hasegawa T, 2003, NEUROSURGERY, V52, P1318, DOI 10.1227/01.NEU.0000064569.18914.DE; Niwinska A, 2010, INT J RADIAT ONCOL, V77, P1134, DOI 10.1016/j.ijrobp.2009.06.030	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1025	1031		10.1093/jjco/hyu126		7	Oncology	Oncology	AT0FY	WOS:000344613700002		
J	Satoh, T; Gemma, A; Kudoh, S; Sakai, F; Yamaguchi, K; Watanabe, T; Ishiguro, M; Inoshiri, S; Izawa, M; Sugihara, K; Sakata, Y				Satoh, Taroh; Gemma, Akihiko; Kudoh, Shoji; Sakai, Fumikazu; Yamaguchi, Kensei; Watanabe, Toshiaki; Ishiguro, Megumi; Inoshiri, Shogo; Izawa, Makiko; Sugihara, Kenichi; Sakata, Yuh			Incidence and Clinical Features of Drug-induced Lung Injury in Patients with Advanced Colorectal Cancer Receiving Cetuximab: Results of a Prospective Multicenter Registry	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						biological therapy; cetuximab; chemotherapy; colorectal cancer; drug-induced lung injury	INDUCED PULMONARY-DISEASE; JAPANESE PATIENTS; RISK-FACTORS; PREDICTIVE FACTORS; PLUS IRINOTECAN; GEFITINIB; FIBROSIS; CHEMOTHERAPY; ARTHRITIS	Objective: We investigated the incidence and clinical features of drug-induced lung injury during cetuximab therapy in Japanese patients with colorectal cancer in a prospective multicenter registry based on a central registration system. Methods: We investigated and followed up patients with or suspected of having drug-induced lung injury among 2006 patients with cetuximab-treated colorectal cancer. A subcommittee of medical oncologists, pulmonologists and a radiologist evaluated and discussed each case of drug-induced lung injury that occurred during cetuximab therapy. Results: Sixty-six patients were identified and further examinations of drug-induced lung injury were conducted during the registration period. We analyzed time to onset, patient characteristics and factors associated with mortality. Cetuximab-related drug-induced lung injury occurred in 24 (1.2%) patients, and was rated as Grade 3 or worse in 15 (0.7%) patients. Fourteen patients received steroid pulse therapy. Ten patients with drug-induced lung injury died, of whom eight received steroid pulse therapy. The incidence of drug-induced lung injury was significantly higher in elderly patients, and in patients with prior interstitial lung disease. There was no particular trend in the time to onset. Patients with early onset of drug-induced lung injury (within 90 days) after starting cetuximab therapy had higher mortality than patients with later onset (over 90 days). Conclusions: The incidence of drug-induced lung injury in cetuximab-treated patients was 1.2%. Because drug-induced lung injury is potentially serious, it is important to promptly initiate appropriate treatments. Considering that early onset drug-induced lung injury during cetuximab therapy is associated with a poor prognosis, close monitoring is mandatory for these patients.	[Satoh, Taroh] Kinki Univ, Dept Med Oncol, Osaka, Japan; [Satoh, Taroh] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Gemma, Akihiko] Nippon Med Sch, Pulm Med Infect Dis & Oncol Dept Internal Med, Bunkyo Ku, Tokyo 113, Japan; [Kudoh, Shoji] Fukujuji Hosp, Tokyo, Japan; [Sakai, Fumikazu] Saitama Med Univ, Int Med Ctr, Dept Diagnost Imaging, Hidaka, Saitama, Japan; [Yamaguchi, Kensei] Saitama Canc Ctr, Dept Gastroenterol, Ina, Saitama, Japan; [Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan; [Ishiguro, Megumi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Bunkyo Ku, Tokyo, Japan; [Inoshiri, Shogo] Merck Serono Co Ltd, Meguro Ku, Tokyo, Japan; [Izawa, Makiko] Bristol Myers KK, Shinjuku Ku, Tokyo, Japan; [Sakata, Yuh] Misawa City Hosp, Misawa, Aomori, Japan	Satoh, T (reprint author), Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	taroh@cfs.med.osaka-u.ac.jp			Merck Serono Co. Ltd, Japan; Bristol-Myers K.K., Japan; Merck Serono Co., Ltd., Japan	This work was supported by Merck Serono Co. Ltd, Japan and Bristol-Myers K.K., Japan. The sponsors were involved in protocol development and data analysis through the contributions of S. I. and M. I., who are employees of the sponsors. Funding to pay the Open Access publication charges for this article was provided by Merck Serono Co., Ltd., Japan and Bristol-Myers K.K., Japan.	Swigris JJ, 2012, RESP MED, V106, P588, DOI 10.1016/j.rmed.2012.01.002; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ishiguro M, 2012, JPN J CLIN ONCOL, V42, P287, DOI 10.1093/jjco/hys005; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Sawada T, 2009, RHEUMATOLOGY, V48, P1069, DOI 10.1093/rheumatology/kep052; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P321; Tsuboi M, 2006, MED ONCOL, V23, P161, DOI 10.1385/MO:23:2:161; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Shimura T, 2010, ANN ONCOL, V21, P2005, DOI 10.1093/annonc/mdq061; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Azuma A., 2007, JMAJ - Japan Medical Association Journal, V50, P405; Chou Chun-Liang, 2010, Chang Gung Med J, V33, P100; COOPER JAD, 1986, AM REV RESPIR DIS, V133, P488; Hotta K, 2005, CANCER J, V11, P417, DOI 10.1097/00130404-200509000-00010; Lin WC, 2006, LUNG CANCER, V54, P193, DOI 10.1016/j.lungcan.2006.07.013; McCurry J, 2004, LANCET, V363, P461, DOI 10.1016/S0140-6736(04)15527-X; Shih Yu-Ning, 2005, J Chin Med Assoc, V68, P183; Takano T, 2004, LUNG CANCER-J IASLC, V45, P93, DOI 10.1016/j.lungcan.2004.01.010	24	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1032	1039		10.1093/jjco/hyu128		8	Oncology	Oncology	AT0FY	WOS:000344613700003		
J	Nagao, S; Nishikawa, T; Hanaoka, T; Kurosaki, A; Iwasa, N; Hasegawa, K; Fujiwara, K				Nagao, Shoji; Nishikawa, Tadaaki; Hanaoka, Tatsuya; Kurosaki, Akira; Iwasa, Norihiro; Hasegawa, Kosei; Fujiwara, Keiichi			Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colony-stimulating Factor Injection for Intermediate-to-high Risk or Recurrent Endometrial Cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						endometrial cancer; chemotherapy; paclitaxel; doxorubicin; cisplatin	GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; CARCINOMA; HYPONATREMIA; DIAGNOSIS; MANAGEMENT; UPDATE	Objective: We evaluated the feasibility of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high-risk or recurrent endometrial cancer. Methods: Women with histologically confirmed FIGO Stages I-II with >1/2 myometrial invasion, Stage III/IV or recurrent endometrial cancer were enrolled. Patients received intravenous doxorubicin (45 mg/m(2)), followed by cisplatin (50 mg/m(2)) on Day 1 and intravenous paclitaxel (160 mg/m(2)) on Day 2. Granisetron (75 mu g) was administered depending on neutrophil counts on Days 3 and 8. Treatment was repeated every 21 days for six cycles or until disease progression or unacceptable toxicity. The primary endpoint was the completion rate of the scheduled chemotherapy; secondary endpoints were Grade 3/4 toxicity and response rate in patients with measurable lesions. Results: From September 2010 to December 2012, 35 women, including 7 with FIGO Stage I, 4 with Stage II, 13 with Stage III, 10 with Stage IV and 1 with recurrent endometrial cancer, were enrolled. There were 26 endometrial carcinomas (Grade 1, 16; Grade 2, 6; Grade 3, 4), 4 carcinosarcomas, 2 serous adenocarcinomas, 1 neuroendocrine carcinoma, 1 poorly differentiated carcinoma and 1 mixed carcinoma. Twenty-five patients (71%) completed six chemotherapy cycles. Grade 3/4 hematological toxicities included neutrocytopenia (97%), thrombocytopenia (6%) and anemia (34%). Three patients (9%) experienced neutropenic fever. Grade 3/4 non-hematological toxicities were observed in 13 patients. In 15 patients with evaluable lesions, the response rate was 80%. Conclusions: Combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection is feasible.	[Nagao, Shoji] Hyogo Canc Ctr, Dept Gynecol Oncol, Akashi, Hyogo 6738558, Japan; [Nishikawa, Tadaaki; Kurosaki, Akira; Iwasa, Norihiro; Hasegawa, Kosei; Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Saitama, Japan; [Hanaoka, Tatsuya] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Kawagoe, Saitama, Japan	Nagao, S (reprint author), Hyogo Canc Ctr, Dept Gynecol Oncol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	nagao@hp.pref.hyogo.jp					Fleming GF, 2007, J CLIN ONCOL, V25, P2983, DOI 10.1200/JCO.2007.10.8431; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Berghmans T, 2000, SUPPORT CARE CANCER, V8, P192, DOI 10.1007/s005200050284; Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Castillo JJ, 2012, ONCOLOGIST, V17, P756, DOI 10.1634/theoncologist.2011-0400; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Miller D, 2012, GYNECOL ONCOL, V125, P771, DOI 10.1016/j.ygyno.2012.03.034; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Fleming GF, 2004, ANN ONCOL, V15, P1173, DOI 10.1093/annonc/mdh316; Homesley HD, 2009, GYNECOL ONCOL, V112, P543, DOI 10.1016/j.ygyno.2008.11.014; Fleming GF, 2001, J CLIN ONCOL, V19, P1021; Fleming GF, 2004, J CLIN ONCOL, V22, P2259; Hamdi T, 2010, SOUTH MED J, V103, P793, DOI 10.1097/SMJ.0b013e3181e63682; Onitilo Adedayo A, 2007, Clin Med Res, V5, P228, DOI 10.3121/cmr.2007.762; Raftopoulos H, 2007, SUPPORT CARE CANCER, V15, P1341, DOI 10.1007/s00520-007-0309-9; Small EJ, 1996, J CLIN ONCOL, V14, P1617	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1040	1044		10.1093/jjco/hyu124		5	Oncology	Oncology	AT0FY	WOS:000344613700004		
J	Shinozaki, T; Hayashi, R; Miyazaki, M; Tomioka, T; Zenda, S; Tahara, M; Akimoto, T				Shinozaki, Takeshi; Hayashi, Ryuichi; Miyazaki, Masakazu; Tomioka, Toshifumi; Zenda, Sadamoto; Tahara, Makoto; Akimoto, Tetsuo			Gastrostomy Dependence in Head and Neck Carcinoma Patient Receiving Post-operative Therapy	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						post-operative therapy; prophylactic PEG; nutritional management; enteral feeding; H and N-RadOncol; deglutition training	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; SQUAMOUS-CELL CARCINOMA; WEIGHT-LOSS; CANCER-PATIENTS; FLUOROSCOPIC GASTROSTOMY; TUBE PLACEMENT; DIETARY-INTAKE; PHASE-II; RADIOTHERAPY; CHEMORADIOTHERAPY	Objective: Post-operative concurrent chemoradiotherapy significantly improves the rates of locoregional control and disease-free survival in high-risk patients but has significant adverse effects. Percutaneous endoscopic gastrostomy and opioid-based pain control increase treatment completion rates but can result in dysphagia. Methods: The rate and duration of use of prophylactically placed percutaneous endoscopic gastrostomies were evaluated in 43 patients who underwent post-operative radiotherapy or chemoradiotherapy from April 2007 through March 2010. All patients completed treatment and received 60 Gy or more of radiotherapy. Results: Thirty four of 43 patients (79.1%) used percutaneous endoscopic gastrostomies, which could later be removed in 25 of 34 patients. The median period of use was 108 days. Only one disease-free patient was permanently dependent on percutaneous endoscopic gastrostomy feeding. The frequency of percutaneous endoscopic gastrostomy use among patients with oral, oropharyngeal and hypopharyngeal cancer was 91.7, 100 and 54.5%, respectively. Conclusions: Prolonged percutaneous endoscopic gastrostomy use is not required in patients receiving post-operative chemoradiotherapy and will not lead to dysphagia.	[Shinozaki, Takeshi; Hayashi, Ryuichi; Miyazaki, Masakazu; Tomioka, Toshifumi] Natl Canc Ctr Hosp East, Dept Head & Neck Surg, Kashiwa, Chiba 2778577, Japan; [Zenda, Sadamoto; Akimoto, Tetsuo] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba 2778577, Japan; [Tahara, Makoto] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba 2778577, Japan	Shinozaki, T (reprint author), Natl Canc Ctr Hosp East, Dept Head & Neck Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tashinoz@east.ncc.go.jp					Al-Othman MOF, 2003, HEAD NECK-J SCI SPEC, V25, P741, DOI 10.1002/hed.10279; Marcy PY, 2000, SUPPORT CARE CANCER, V8, P410, DOI 10.1007/s005200050010; Ames JA, 2011, HEAD NECK-J SCI SPEC, V33, P638, DOI 10.1002/hed.21506; Lango MN, 2010, HEAD NECK-J SCI SPEC, V32, P341, DOI 10.1002/hed.21188; Unsal D, 2006, AM J CLIN ONCOL-CANC, V29, P183, DOI 10.1097/01.coc.0000198745.94757.ee; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; BACKSTROM I, 1995, ORAL ONCOL, V31B, P253; Mekhail TM, 2001, CANCER, V91, P1785, DOI 10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>3.0.CO;2-1; Kubrak C, 2010, HEAD NECK-J SCI SPEC, V32, P290, DOI 10.1002/hed.21174; Wiggenraad RGJ, 2007, CLIN OTOLARYNGOL, V32, P384; Corry J, 2008, J MED IMAG RADIAT ON, V52, P503, DOI 10.1111/j.1440-1673.2008.02003.x; Hammerlid E, 1998, HEAD NECK-J SCI SPEC, V20, P540, DOI 10.1002/(SICI)1097-0347(199809)20:6<540::AID-HED9>3.0.CO;2-J; Beer KT, 2005, NUTR CANCER, V52, P29, DOI 10.1207/s15327914nc5201_4; Larsson M, 2005, CANCER NURS, V28, P425, DOI 10.1097/00002820-200511000-00004; Munshi A, 2003, NUTR CANCER, V47, P136, DOI 10.1207/s15327914nc4702_5; Beaver ME, 2001, OTOLARYNG HEAD NECK, V125, P645, DOI 10.1067/mhn.2001.120428; Baredes Soly, 2004, Ear Nose Throat J, V83, P417; Beaver ME, 1998, ARCH OTOLARYNGOL, V124, P1141; Chaudu A, 2003, J ORAL MAXILLOFACIAL, V61, P1279; Harrison Jody S, 2003, Gen Dent, V51, P552; Kiyota N, 2012, JPN J CLIN ONCOL, V42, P927, DOI 10.1093/jjco/hys128; Lee H, 2008, SUPPORT CARE CANCER, V16, P285, DOI 10.1007/s00520-007-0313-0; National Collaborating Centre for Acute Care, 2006, NUTR SUPP AD OR NUTR; Newman LA, 1998, ARCH OTOLARYNGOL, V124, P589; Paccagnella A, 2009, SUPPORT CARE CANCER, V18, P837; Thomas B, 2007, MANUAL DIETETIC PRAC; Zenda S, 2011, RADIOTHER ONCOL, V101, P410, DOI 10.1016/j.radonc.2011.09.016	28	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1058	1062		10.1093/jjco/hyu118		5	Oncology	Oncology	AT0FY	WOS:000344613700007		
J	Ijichi, K; Hanai, N; Kawakita, D; Ozawa, T; Suzuki, H; Hirakawa, H; Kodaira, T; Murakami, S; Hasegawa, Y				Ijichi, Kei; Hanai, Nobuhiro; Kawakita, Daisuke; Ozawa, Taijiro; Suzuki, Hidenori; Hirakawa, Hitoshi; Kodaira, Takeshi; Murakami, Shingo; Hasegawa, Yasuhisa			Selection of Therapeutic Treatment with Alternating Chemoradiotherapy for Larynx Preservation in Laryngeal Carcinoma Patients	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						laryngeal carcinoma; head and neck carcinoma; chemoradiotherapy; laryngeal preservation	SQUAMOUS-CELL CARCINOMA; NECK-CANCER; INDUCTION CHEMOTHERAPY; CONCURRENT CHEMOTHERAPY; ORGAN PRESERVATION; RESECTABLE HEAD; RADIATION; FLUOROURACIL; CISPLATIN; RADIOTHERAPY	Objective: We analyzed the efficacy of treatments that included alternating chemoradiotherapy in laryngeal cancer patients. Methods: Alternating chemoradiotherapy consisted of chemotherapy with 5-fluorouracil (600 mg/m(2)/day) on Days 1-6 and cisplatin (80 mg/m(2)) on Day 7 followed by radiotherapy with 30 Gy. Additional chemoradiotherapy was administered to responders, and laryngectomy was performed in non-responders. The contribution of alternating chemoradiotherapy to laryngeal preservation was compared with that of radiotherapy in patients with T2 disease and with that of laryngectomy in patients with T3/T4 disease. Results: Analysis of 87 patients was conducted. The 5-year overall survival rate of T2 patients (n = 46) was 88.9% for definitive radiotherapy and 82.5% for alternating chemoradiotherapy. The laryngectomy-free rate in T2 patients was 90.5% for definitive radiotherapy and 80.0% for alternating chemoradiotherapy. In patients with T3/T4 disease (n = 41), the 5-year overall survival rate was 86.9% for alternating chemoradiotherapy and 67.4% for laryngectomy. The laryngectomy-free rate in T3/T4 patients was 91.7% for alternating chemoradiotherapy and 0.0% for laryngectomy. Conclusions: In advanced carcinoma of the larynx, alternating chemoradiotherapy treatment might enable larynx preservation.	[Ijichi, Kei; Kawakita, Daisuke; Murakami, Shingo] Nagoya City Univ, Grad Sch Med Sci, Dept Otolaryngol Head & Neck Surg, Nagoya, Aichi 4678601, Japan; [Hanai, Nobuhiro; Ozawa, Taijiro; Suzuki, Hidenori; Hirakawa, Hitoshi; Hasegawa, Yasuhisa] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi 464, Japan	Ijichi, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Otolaryngol Head & Neck Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ijichi@med.nagoya-cu.ac.jp			Ministry of Health, Labor and Welfare, Japan [H24-Gannrinshou-Ippan-006]	This study was supported by a Health and Labor Sciences Research Grant for Clinical Cancer Research (H24-Gannrinshou-Ippan-006) from the Ministry of Health, Labor and Welfare, Japan.	Lee NY, 2007, INT J RADIAT ONCOL, V69, P459, DOI 10.1016/j.ijrobp.2007.03.013; URBA SG, 1994, J CLIN ONCOL, V12, P946; PFISTER DG, 1991, J CLIN ONCOL, V9, P850; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Urba S, 2006, J CLIN ONCOL, V24, P593, DOI 10.1200/JCO.2005.01.2047; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Yao M, 2005, INT J RADIAT ONCOL, V63, P410, DOI 10.1016/j.ijrobp.2005.02.025; Forastiere AA, 2013, J CLIN ONCOL, V31, P845, DOI 10.1200/JCO.2012.43.6097; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eisbruch A, 2004, INT J RADIAT ONCOL, V59, P28, DOI 10.1016/j.ijrobp.2003.10.032; Richard JM, 1998, ORAL ONCOL, V34, P224, DOI 10.1016/S1368-8375(97)00090-0; Calais G, 2006, J CLIN ONCOL, V24, P5506; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Laccourreye O, 1996, J CLIN ONCOL, V14, P2331; The Department of Veterans Affairs Laryngeal Cancer Study Group, 1991, N ENGL J MED, V324, P1685; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1063	1069		10.1093/jjco/hyu131		7	Oncology	Oncology	AT0FY	WOS:000344613700008		
J	Miura, T; Matsumoto, Y; Motonaga, S; Hasuo, H; Abe, K; Kinoshita, H				Miura, Tomofumi; Matsumoto, Yoshihisa; Motonaga, Shinya; Hasuo, Hideaki; Abe, Keiko; Kinoshita, Hiroya			Dyspnea, Relative Youth and Low Daily Doses of Opioids Predict Increased Opioid Dosage in the Last Week of a Terminal Cancer Patient's Life	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						palliative care; opioid; pain; dyspnea	PAIN; MORPHINE; ANXIETY; SURVIVAL; HOSPICE; POPULATION; SEDATIVES; SYMPTOMS; THERAPY; END	Objective: Most cancer patients become increasingly anxious toward the end of their life. The objective of this study was to identify predictors of increased opioid dosage in the last week of a terminal cancer patient's life. Methods: We retrospectively reviewed charts of patients who died in our palliative care unit. We assigned the patients to increased group or decreased group according to changes in oral morphine equivalent dosage in their last 7 days. Logistic regression analysis was used to identify predictors of increased oral morphine equivalent dosage. Results: We analyzed data of 158 patients (female: 43.7%, median age: 64 years). The median oral morphine equivalent dosages on Days 7 and 1 before death were 50 mg (interquartile range: 24-122) and 61 mg (28-129), respectively. Independent predictors of increased oral morphine equivalent dosage included dyspnea (odds ratio: 11.5, 95% confidence interval: 4.98-28.83, P < 0.01), age <65 years (odds ratio: 2.3, 95% confidence interval: 1.04-5.26, P = 0.04) and oral morphine equivalent dosage < 50 mg on Day 7 before death (odds ratio: 3.7, 95% confidence interval: 1.68-8.89, P < 0.01). The median oral morphine equivalent dosages on Days 7 and 1 before death were 48 mg (interquartile range: 20-126) and 75 mg (36-170) in patients with dyspnea, and 50 mg (25-120) and 57 mg (25-124) in patients with pain, respectively. Conclusions: Dyspnea, relative youth and oral morphine equivalent dosage < 50 mg on Day 7 before death were predictive of increased oral morphine equivalent dosage in the last 7 days. Our findings may help oncologists to more accurately inform patients about expected opioid requirements and thus relieve their end-of-life anxiety.	[Miura, Tomofumi; Matsumoto, Yoshihisa; Hasuo, Hideaki; Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan; [Motonaga, Shinya] Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Chiba 2778577, Japan; [Abe, Keiko] Shimane Univ Hosp, Palliat Care Ctr, Matsue, Shimane, Japan	Miura, T (reprint author), Natl Canc Ctr Hosp East, Dept Palliat Med, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tomiura@east.ncc.go.jp					Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; GLOVER J, 1995, J PAIN SYMPTOM MANAG, V10, P120, DOI 10.1016/0885-3924(94)00073-T; Navigante AH, 2006, J PAIN SYMPTOM MANAG, V31, P38, DOI 10.1016/j.jpainsymmnan.2005.06.009; Tanaka K, 2002, J PAIN SYMPTOM MANAG, V23, P484, DOI 10.1016/S0885-3924(02)00394-9; Seow H, 2011, J CLIN ONCOL, V29, P1151, DOI 10.1200/JCO.2010.30.7173; Bercovitch M, 1999, CANCER-AM CANCER SOC, V86, P871, DOI 10.1002/(SICI)1097-0142(19990901)86:5<871::AID-CNCR25>3.0.CO;2-L; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Dudgeon DJ, 1998, J PAIN SYMPTOM MANAG, V16, P212, DOI 10.1016/S0885-3924(98)00065-7; Lin CS, 2013, BRAIN RES, V1493, P40, DOI 10.1016/j.brainres.2012.11.035; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Zaza C, 2002, J PAIN SYMPTOM MANAG, V24, P526, DOI 10.1016/S0885-3924(02)00497-9; REUBEN DB, 1986, CHEST, V89, P234, DOI 10.1378/chest.89.2.234; Morita T, 1999, J PAIN SYMPTOM MANAG, V18, P338, DOI 10.1016/S0885-3924(99)00096-2; Branford R, 2012, CLIN GENET, V82, P301, DOI 10.1111/j.1399-0004.2012.01923.x; WEISENBERG M, 1984, PAIN, V20, P371, DOI 10.1016/0304-3959(84)90114-3; Good PD, 2005, INTERN MED J, V35, P512, DOI 10.1111/j.1445-5994.2005.00888.x; Ben-Aharon I, 2008, J CLIN ONCOL, V26, P2396, DOI 10.1200/JCO.2007.15.5796; Portenoy RK, 2006, J PAIN SYMPTOM MANAG, V32, P532, DOI 10.1016/j.jpainsymman.2006.08.003; Ploghaus A, 2001, J NEUROSCI, V21, P9896; Brown W, 2008, EUR J CANCER CARE, V17, P65, DOI 10.1111/j.1365-2354.2007.00810.x; BRUERA E, 1993, ANN INTERN MED, V119, P906; Pinna MAC, 2008, J CLIN ONCOL, V26, P4225, DOI 10.1200/JCO.2008.18.3566; Cuervo Pinna MA, 2008, J CLIN ONCOL, V26, P6; Fainsinger RL, 2000, J PALLIATIVE CARE, V16, P5; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; Gatchel RJ, 2008, SPINE J, V8, P40, DOI 10.1016/j.spinee.2007.10.007; Gondo M, 2012, NEUROIMAGE, V63, P1011, DOI 10.1016/j.neuroimage.2012.07.025; Hanks GCW, 1998, OXFORD TXB PALLIATIV, P331; Imai S, 2013, BRAIN, V136, P828, DOI 10.1093/brain/aws330; Mazzocato C, 1999, ANN ONCOL, V10, P1511, DOI 10.1023/A:1008337624200; Mercadante S, 2000, SUPPORT CARE CANCER, V8, P123, DOI 10.1007/s005200050026; Oiwa T., 2009, JPN J LUNG CANC, V49, P339; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Thielking Paul D, 2003, Curr Pain Headache Rep, V7, P249, DOI 10.1007/s11916-003-0045-x; Turk DC, 2002, PSYCHOL APPROACHES P; Wilcock A, 2007, J PAIN SYMPTOM MANAG, V34, P1, DOI 10.1016/j.jpainsymman.2007.03.001; World Health Organization, 1996, CANC PAIN REL GUID O; Zerzan J, 2010, J PALLIAT MED, V13, P501, DOI 10.1089/jpm.2009.0406	38	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1082	1087		10.1093/jjco/hyu137		6	Oncology	Oncology	AT0FY	WOS:000344613700010		
J	Hattori, A; Suzuki, K; Aokage, K; Mimae, T; Nagai, K; Tsuboi, M; Okada, M				Hattori, Aritoshi; Suzuki, Kenji; Aokage, Keiju; Mimae, Takahiro; Nagai, Kanji; Tsuboi, Masahiro; Okada, Morihito			Prognosis of Lung Cancer Patients with a Past History of Colorectal Cancer	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						lung cancer; colorectal cancer; multiple primary cancers; prognosis	MULTIPLE PRIMARY MALIGNANCIES; COMPUTED-TOMOGRAPHY; ADENOCARCINOMA; CLASSIFICATION; METASTASIS; MORTALITY; CARCINOMA; RESECTION; JAPAN	Objectives: The prognosis in lung cancer patients with a prior history of extrapulmonary cancer is controversial. In the current multicenter joint research in Japan, we focused on the relationship between a history of colorectal cancer and its prognostic impact in patients with subsequent lung cancer. Methods: Between 2000 and 2013, we designed a retrospective multicenter study at three institutes in Japan to evaluate the prognostic factors in lung cancer patients with a previous surgery for colorectal cancer. Results: The cohorts consisted of 123/4431 lung cancer patients with/without a previous history of surgery for colorectal cancer. The median follow-up period was 6.1 years after lung cancer surgery. The 5-year overall survival in lung cancer patients with/without colorectal cancer was not significantly different, regardless of the stage of lung cancer (overall: 71.3 versus 74.7%, P = 0.1426; Stage I lung cancer: 83.3 versus 84.8%, P = 0.3779; Stage II or more lung cancer: 47.7 versus 54.4%, P = 0.1445). Based on multivariate Cox regression analysis in 4554 lung cancer patients, a past history of colorectal cancer was not a significant prognostic factor (P = 0.5335). Among the 123 lung cancer patients with colorectal cancer, age and absence of adjuvant chemotherapy for colorectal cancer were significant prognostic factors based on multivariate analysis (P = 0.0001 and 0.0236). Furthermore, there was no difference in the overall survival of lung cancer patients according to the stage of colorectal cancer (Stage I: 74.7%; Stage II/III: 66.5%, P = 0.7239). Conclusions: A history of antecedent colorectal cancer did not contribute to the prognosis in patients with subsequent lung cancers.	[Hattori, Aritoshi; Suzuki, Kenji] Juntendo Univ, Dept Gen Thorac Surg, Sch Med, Tokyo 1138431, Japan; [Aokage, Keiju; Nagai, Kanji; Tsuboi, Masahiro] Natl Canc Ctr Hosp East, Div Thorac Surg, Kashiwa, Chiba, Japan; [Mimae, Takahiro; Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Hiroshima, Japan	Suzuki, K (reprint author), Juntendo Univ, Dept Gen Thorac Surg, Sch Med, Bunkyo Ku, 1-3,Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labour and Welfare, Japan; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan and Smoking Research Foundation.	Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Park CM, 2008, CHEST, V133, P1402, DOI 10.1378/chest.07-2568; Liu YY, 2002, LUNG CANCER-J IASLC, V35, P189, DOI 10.1016/S0169-5002(01)00408-1; CAHAN WG, 1974, CANCER, V33, P414, DOI 10.1002/1097-0142(197402)33:2<414::AID-CNCR2820330216>3.0.CO;2-O; CAHAN WG, 1969, SURG CLIN N AM, V49, P323; Ferlay J, 2010, IARC CANCERBASE; Gaeta M, 1996, J COMPUT ASSIST TOMO, V20, P300, DOI 10.1097/00004728-199603000-00025; Hashiguchi Y, 2012, COLORECTAL DIS, V14, P1065, DOI 10.1111/j.1463-1318.2011.02917.x; Kim C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-394; Lee GD, 2013, ANN SURG ONCOL, V20, P4260, DOI 10.1245/s10434-013-3183-3; Mery CM, 2004, CHEST, V125, P2175, DOI 10.1378/chest.125.6.2175; Nakahara R, 2001, THORAX, V56, P302, DOI 10.1136/thorax.56.4.302; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Pages PB, 2013, ANN THORAC SURG, V95, P1000, DOI 10.1016/j.athoracsur.2012.11.072; Sobin LH, 2009, TNM CLASSIFICATION M; Warren S, 1932, AM J CANCER, V16, P1358; Yamamoto S, 2006, DIS COLON RECTUM, V49, pS30, DOI 10.1007/s10350-006-0600-8	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1088	1095		10.1093/jjco/hyu122		8	Oncology	Oncology	AT0FY	WOS:000344613700011		
J	Ikezawa, E; Kondo, T; Hashimoto, Y; Kobayashi, H; Iizuka, J; Takagi, T; Omae, K; Tanabe, K				Ikezawa, Eri; Kondo, Tsunenori; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Takagi, Toshio; Omae, Kenji; Tanabe, Kazunari			Clinical Symptoms Predict Poor Overall Survival in Chronic-dialysis Patients with Renal Cell Carcinoma Associated with End-stage Renal Disease	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						renal cancer; symptoms; diagnosis; end-stage renal disease; hemodialysis	INCIDENTAL DETECTION; PROGNOSIS; KIDNEY; CANCER; IMPACT	Objective: To evaluate which clinical symptoms predict the survival of patients with renal cell carcinoma associated with end-stage renal disease under chronic dialysis. Methods: We retrospectively evaluated 401 patients with renal cell carcinoma associated with end-stage renal disease who underwent radical nephrectomy at our institute up through December 2012. Patients were divided into two groups: the symptomatic group and the incidental group, by diagnosis. We compared the clinicopathologic features and patient survival of the two groups and investigated prognostic factors using Cox multivariate analysis. Results: Of the 401 patients, 124 (30.9%) were in the symptomatic group and 277 (69.0%) in the incidental group. The symptomatic group included more advanced tumors in terms of larger tumor size, higher stage and higher grade compared with the incidental group. The 5-year cancer-specific survival and overall survival of the symptomatic and incidental groups were 76.9 vs. 95.3% (P < 0.001) and 64.2 vs. 84.9% (P < 0.001), respectively. On multivariate analysis, the presence of symptoms, higher age, higher stage, diabetic nephropathy and longer hemodialysis duration were independent prognostic factors. Conclusions: Symptomatic detection was significantly associated with worse overall survival in patients with renal cell carcinoma associated with end-stage renal disease as well as sporadic renal cell carcinoma. The high incidence of renal cell carcinoma as well as the poor oncologic outcome in patients with longer dialysis therapy may suggest an important role for routine screening in these patients.	[Ikezawa, Eri; Kondo, Tsunenori; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Takagi, Toshio; Omae, Kenji; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo 1628666, Japan	Ikezawa, E (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	bon10fian@yahoo.co.jp					SARASIN FP, 1995, KIDNEY INT, V48, P207, DOI 10.1038/ki.1995.286; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Ishikawa I, 2004, THER APHER DIAL, V8, P468, DOI 10.1111/j.1774-9987.2004.00192.x; Takagi T, 2011, INT J UROL, V18, P806, DOI 10.1111/j.1442-2042.2011.02852.x; Denton MD, 2002, KIDNEY INT, V61, P2201, DOI 10.1046/j.1523-1755.2002.00374.x; Palsdottir HB, 2012, J UROLOGY, V187, P48, DOI 10.1016/j.juro.2011.09.025; Lee CT, 2002, UROL ONCOL, V7, P135, DOI 10.1016/S1078-1439(01)00185-5; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Neuzillet Y, 2011, EUR UROL, V60, P366, DOI 10.1016/j.eururo.2011.02.035; Ishikawa I, 2004, NEPHRON CLIN PRACT, V97, pC11, DOI 10.1159/000077590; Luciani LG, 2000, UROLOGY, V56, P58, DOI 10.1016/S0090-4295(00)00534-3; Collins AJ, 2012, AM J KIDNEY S1, V59, pe129; Haliloglu AH, 2011, INT UROL NEPHROL, V43, P687, DOI 10.1007/s11255-010-9843-3; Lightfoot N, 2000, EUR UROL, V37, P521, DOI 10.1159/000020188; Nakai S, 2010, THER APHER DIAL, V14, P505; Ornstein DK, 2004, J UROL 1, V172, P2511, DOI 10.1097/01.ju.0000145260.89322.2d; Schips L, 2003, UROLOGY, V62, P1024, DOI 10.1016/S0090-4295(03)00763-5; Sobin L, 2010, TNM CLASSIFICATION M, P255; Terasawa Y, 1993, JPN J UROL, V84, P2137	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1096	1100		10.1093/jjco/hyu117		5	Oncology	Oncology	AT0FY	WOS:000344613700012		
J	Nishiyama, N; Kitamura, H; Hotta, H; Takahashi, A; Yanase, M; Itoh, N; Tachiki, H; Miyao, N; Matsukawa, M; Kunishima, Y; Taguchi, K; Masumori, N				Nishiyama, Naotaka; Kitamura, Hiroshi; Hotta, Hiroshi; Takahashi, Atsushi; Yanase, Masahiro; Itoh, Naoki; Tachiki, Hitoshi; Miyao, Noriomi; Matsukawa, Masanori; Kunishima, Yasuharu; Taguchi, Keisuke; Masumori, Naoya			Construction of Predictive Models for Cancer-specific Survival of Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Results from a Multicenter Retrospective Study	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						non-muscle-invasive bladder cancer; bacillus Calmette-Guerin; BCG failure classification	UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; THERAPY; TUMORS; RISK; PROGRESSION; MANAGEMENT; FAILURE; INSTILLATIONS; RECURRENCE	Objective: The aims of this study were to clarify the prognostic factors and to validate the bacillus Calmette-Guerin failure classification advocated by Nieder et al. in patients with non-muscle-invasive bladder cancer who had intravesical recurrence after bacillus Calmette-Guerin therapy. Methods: Data from 402 patients who received intravesical bacillus Calmette-Guerin therapy between January 1990 and November 2011 were collected from 10 institutes. Among these patients, 187 with bacillus Calmette-Guerin failure were analyzed for this study. Results: Twenty-nine patients (15.5%) were diagnosed with progression at the first recurrence after bacillus Calmette-Guerin therapy. Eighteen (62.1%) of them died of bladder cancer. A total of 158 patients were diagnosed with non-muscle-invasive bladder cancer at the first recurrence after bacillus Calmette-Guerin therapy. Of them, 23 (14.6%) underwent radical cystectomy. No patients who underwent radical cystectomy died of bladder cancer during the follow-up. On multivariate analysis of the 135 patients with bladder preservation, the independent prognostic factors for cancer-specific survival were age (>= 70 [P = 0.002]), tumor size (>= 3 cm [P = 0.015]) and the Nieder classification (bacillus Calmette-Guerin refractory [P < 0.001]). In a subgroup analysis, the estimated 5-year cancer-specific survival rates in the groups with no positive, one positive and two to three positive factors were 100, 93.4 and 56.8%, respectively (P < 0.001). Conclusions: Patients with stage progression at the first recurrence after bacillus Calmette-Guerin therapy had poor prognoses. Three prognostic factors for predicting survival were identified and used to categorize patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin into three risk groups based on the number of prognostic factors in each one.	[Nishiyama, Naotaka; Kitamura, Hiroshi; Masumori, Naoya] Sapporo Med Univ, Dept Urol, Sch Med, Sapporo, Hokkaido 0608543, Japan; [Hotta, Hiroshi] Asahikawa Red Cross Hosp, Dept Urol, Asahikawa, Hokkaido, Japan; [Takahashi, Atsushi] Hakodate Goryoukaku Hosp, Dept Urol, Hakodate, Hokkaido, Japan; [Yanase, Masahiro] Sunagawa City Med Ctr, Dept Urol, Sunagawa, Japan; [Itoh, Naoki] NTT East Japan Sapporo Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Tachiki, Hitoshi] Steel Mem Muroran Hosp, Dept Urol, Muroran, Hokkaido, Japan; [Miyao, Noriomi] Muroran City Gen Hosp, Dept Urol, Muroran, Hokkaido, Japan; [Matsukawa, Masanori] Takikawa Municipal Hosp, Dept Urol, Takikawa, Hokkaido, Japan; [Kunishima, Yasuharu] Hokkaido Social Work Assoc Obihiro Hosp, Dept Urol, Obihiro, Hokkaido, Japan; [Taguchi, Keisuke] Oji Gen Hosp, Dept Urol, Tomakomai, Japan	Nishiyama, N (reprint author), Sapporo Med Univ, Dept Urol, Sch Med, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	nishiyan@sapmed.ac.jp			Ministry of Health, Labor and Welfare of Japan [H22-Clinical Cancer-026, 1010387]	This work was supported in part by a grant-in-aid for Clinical Cancer Research (H22-Clinical Cancer-026, Project ID: 1010387) from the Ministry of Health, Labor and Welfare of Japan.	Andius P, 2004, BJU INT, V93, P980, DOI 10.1111/j.1464-410X.2004.04764.x; Nieder AM, 2005, UROLOGY, V66, P108, DOI 10.1016/j.urolog.2005.08.066; Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Herr HW, 2001, J UROLOGY, V166, P1296, DOI 10.1016/S0022-5347(05)65756-4; Kulkarni GS, 2010, EUR UROL, V57, P60, DOI 10.1016/j.eururo.2009.08.024; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; de Reijke TM, 1999, J UROLOGY, V161, P67, DOI 10.1016/S0022-5347(01)62065-2; Sylvester RJ, 2010, EUR UROL, V57, P766, DOI 10.1016/j.eururo.2009.12.024; Lopez-Beltran A, 2008, SCAND J UROL NEPHROL, V42, P95, DOI 10.1080/03008880802325226; Lerner SP, 2009, UROL ONCOL-SEMIN ORI, V27, P155, DOI 10.1016/j.urolonc.2007.11.033; Schrier BP, 2004, EUR UROL, V45, P292, DOI 10.1016/j.eururo.2003.10.006; Gontero P, 2010, EUR UROL, V57, P410, DOI 10.1016/j.eururo.2009.11.023; Thomas F, 2012, CANCER-AM CANCER SOC, V118, P5525, DOI 10.1002/cncr.27587; Parekh DJ, 2006, J CLIN ONCOL, V24, P5519, DOI 10.1200/JCO.2006.08.5431; Herr HW, 1997, BRIT J UROL, V80, P762, DOI 10.1046/j.1464-410X.1997.00431.x; Sylvester RJ, 2011, INT J UROL, V18, P113, DOI 10.1111/j.1442-2042.2010.02678.x; Soloway MS, 2002, J UROLOGY, V167, P1573, DOI 10.1016/S0022-5347(05)65157-9; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Ehdaie B, 2013, EUR UROL, V64, P579, DOI 10.1016/j.eururo.2013.05.027; Fritsche HM, 2010, EUR UROL, V57, P300, DOI 10.1016/j.eururo.2009.09.024; Guzzo TJ, 2009, UROLOGY, V74, P1276, DOI 10.1016/j.urology.2009.05.092; Herr HW, 2007, UROLOGY, V70, P65, DOI 10.1016/j.urology.2007.03.024; Joudi FN, 2006, J UROLOGY, V175, P9; Joudi FN, 2006, J UROLOGY, V175, P1634, DOI 10.1016/S0022-5347(05)00973-0; Kitamura Hiroshi, 2006, Int J Clin Oncol, V11, P28, DOI 10.1007/s10147-006-0552-y; Matsumoto K, 2012, BJU INT, V110, pE508, DOI 10.1111/j.1464-410X.2012.11194.x; Shirakawa H, 2012, BJU INT, V110, pE216, DOI [10.1111/j.1464-410X.2011.10894.x, 10.1111/j.1464-410X.2011.10894]; Soloway MS, 2011, BJU INT, V108, P182, DOI 10.1111/j.1464-410X.2010.09830.x; Yates DR, 2012, EUR UROL, V62, P1088, DOI 10.1016/j.eururo.2012.08.055	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1101	1108		10.1093/jjco/hyu119		8	Oncology	Oncology	AT0FY	WOS:000344613700013		
J	Maebayashi, T; Ishikawa, H; Yorozu, A; Yoshida, D; Katoh, H; Nemoto, K; Ishihara, S; Takemoto, S; Ishibashi, N; Tokumaru, S; Akimoto, T				Maebayashi, Toshiya; Ishikawa, Hitoshi; Yorozu, Atsunori; Yoshida, Daisaku; Katoh, Hiroyuki; Nemoto, Kenji; Ishihara, Shunichi; Takemoto, Shinya; Ishibashi, Naoya; Tokumaru, Sunao; Akimoto, Tetsuo		Japanese Radiation Oncology Study	Patterns of Practice in the Radiation Therapy for Bladder Cancer: Survey of the Japanese Radiation Oncology Study Group (JROSG)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						bladder cancer; radiation therapy; systemic chemotherapy; intra-arterial chemotherapy	SELECTIVE ORGAN PRESERVATION; TRANSITIONAL-CELL-CARCINOMA; COMBINED-MODALITY PROGRAM; INTRAARTERIAL CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; RADICAL CYSTECTOMY; II TRIAL; CISPLATIN; RADIOTHERAPY; METHOTREXATE	Objective: To retrospectively analyze the clinical outcomes of radiation therapy with or without chemotherapy for bladder cancer in Japan. Methods: A questionnaire-based survey of patients with pathologically proven bladder cancer treated by definitive radiation therapy between 2002 and 2006 was conducted by the Japanese Radiation Oncology Study Group, and the clinical records of 159 patients were collected from 17 institutions. Concurrent intra-arterial chemoradiotherapy and concurrent systemic chemoradiotherapy were administered in 51 and 33 patients, respectively. Results: The 5-year overall survival and bladder preservation rates were 48 and 39%, respectively. Eighty-nine (56%) patients developed recurrence (bladder, 48; regional lymph nodes, 4; distant sites, 41). The results of multivariate analysis revealed that adoption of chemotherapy was the only significant prognostic factor for overall survival (relative risk = 0.615 [95% confidence interval: 0.439-0.862], P = 0.005). The type of chemotherapy administered did not significantly affect the local control or overall survival rates. The actuarial 5-year overall survival rates and bladder preservation in the radiation therapy combined with intra-arterial chemotherapy group were 64 and 58%, respectively, and the corresponding rates in the radiation therapy combined with systemic chemotherapy group were 67 and 42%, respectively. Conclusions: The results of this survey revealed the current status of practice of radiation therapy for bladder cancer in Japan. A multi-institutional prospective study is needed based on the results of this study to determine the optimal radiotherapeutic approach, including the need for concurrent chemotherapy and the appropriate chemotherapy regimen for invasive bladder cancer.	[Maebayashi, Toshiya; Ishibashi, Naoya] Nihon Univ, Dept Radiol, Sch Med, Tokyo 1738610, Japan; [Ishikawa, Hitoshi] Univ Tsukuba, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan; [Yorozu, Atsunori] Natl Hosp Org Tokyo Med Ctr, Dept Radiol, Tokyo, Japan; [Yoshida, Daisaku] Gunma Prefectural Canc Ctr, Dept Radiat Oncol, Ota, Japan; [Katoh, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gumma 371, Japan; [Nemoto, Kenji] Yamagata Univ, Fac Med, Dept Radiat Oncol, Yamagata 990, Japan; [Ishihara, Shunichi] Toyohashi Municipal Hosp, Dept Radiol, Toyohashi, Aichi, Japan; [Takemoto, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Tokumaru, Sunao] Saga Univ, Dept Heavy Particle Therapy & Radiat Oncol, Saga 840, Japan; [Akimoto, Tetsuo] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan	Maebayashi, T (reprint author), Nihon Univ, Dept Radiol, Sch Med, Itabashi Ku, 30-1 Oyaguchikami Cho, Tokyo 1738610, Japan.	maebayashi.toshiya@nihon-u.ac.jp			Ministry of Education, Science and Culture of Japan; Ministry of Health and Welfare; National Cancer Center Research and Development Fund [25-A-10]	This study was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan, and by Health Science Research Grants from the Ministry of Health and Welfare. In addition, this study was supported in part by the National Cancer Center Research and Development Fund (25-A-10).	Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; Munro NP, 2010, INT J RADIAT ONCOL, V77, P119, DOI 10.1016/j.ijrobp.2009.04.050; James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106; Hagan MP, 2003, INT J RADIAT ONCOL, V57, P665, DOI 10.1016/S0360-3016(03)00718-1; Hautmann RE, 2012, EUR UROL, V61, P1039, DOI 10.1016/j.eururo.2012.02.028; Kachnic LA, 1997, J CLIN ONCOL, V15, P1022; Choudhury A, 2011, J CLIN ONCOL, V29, P733, DOI 10.1200/JCO.2010.31.5721; Ennis RD, 2000, J UROLOGY, V163, P1413, DOI 10.1016/S0022-5347(05)67632-X; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; TESTER W, 1993, INT J RADIAT ONCOL, V25, P783; Efstathiou JA, 2009, J CLIN ONCOL, V27, P4055, DOI 10.1200/JCO.2008.19.5776; Tester W, 1996, J CLIN ONCOL, V14, P119; Chen WC, 2003, INT J RADIAT ONCOL, V56, P726, DOI 10.1016/S0360-3016(03)00124-X; Danesi DT, 2004, CANCER, V101, P2540, DOI 10.1002/cncr.20654; DUNCAN W, 1986, RADIOTHER ONCOL, V7, P299, DOI 10.1016/S0167-8140(86)80059-7; Higano CS, 2008, CANCER, V112, P2181, DOI 10.1002/cncr.23420; Jahnson S, 2009, SCAND J UROL NEPHROL, V43, P271, DOI 10.1080/00365590902909778; Kaufman DS, 2008, UROLOGY, V73, P833; Lagrange JL, 2010, INT J RADIAT ONCOL, V79, P172; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Miyanaga N, 1999, Nihon Hinyokika Gakkai Zasshi, V90, P445; Mokarim A, 1997, CANCER, V80, P1776, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1776::AID-CNCR12>3.0.CO;2-2; Mori KI, 2007, INT J UROL, V14, P591, DOI 10.1111/j.1442-2042.2007.01780.x; National Cancer Institute. Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Peyromaure M, 2004, UROLOGY, V63, P73, DOI 10.1016/j.urology.2003.09.018; Poortmans PM, 2008, ACTA ONCOL, V47, P937, DOI 10.1080/02841860801888799; Stein JP, 2001, J CLIN ONCOL, V19, P666; Tunio MA, 2012, INT J RADIAT ONCOL, V82, P457; Zapatero A, 2012, UROLOGY, V80, P1056, DOI 10.1016/j.urology.2012.07.045	29	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1109	1115		10.1093/jjco/hyu129		7	Oncology	Oncology	AT0FY	WOS:000344613700014		
J	Yanazume, S; Douzono, H; Kubo, H; Nagata, T; Douchi, T; Kobayashi, H				Yanazume, Shintaro; Douzono, Haruhiko; Kubo, Hidemichi; Nagata, Tomomi; Douchi, Tsutomu; Kobayashi, Hiroaki			Cryotherapy for Massive Vulvar Lymphatic Leakage Complicated with Lymphangiomas Following Gynecological Cancer Treatment	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						cryotherapy; vulva; lymphangioma; lymphatic leakage	OF-THE-LITERATURE; MIMICKING GENITAL WARTS; SURGICAL-MANAGEMENT; CIRCUMSCRIPTUM	Vulvar lymphatic leakage is a severe complication associated with gynecological cancer treatments. However, standard treatment strategies have not yet been determined. We encountered a rare case of a 76-year-old multiparous woman suffering from massive lymphatic fluid leakage from the entire vulva, and papules developed and were identified as lymphangiomas. A large amount of straw-colored discharge continued from all vulvar papules, which extended over the mons pubis. Nine years ago, the patient had undergone a radical hysterectomy with concurrent chemoradiation for uterine cervical cancer treatment. Her serum albumin level was 1.9 mg/dl, which was attributed to the loss of a large amount of lymph fluid due to leakage from the vulva. Her quality of life gradually decreased because of general fatigue and the need for frequent diaper exchanges every 2 h. The patient received a less-invasive treatment with cryotherapy using liquid nitrogen. She also received a multimodality treatment consisting of the intravenous administration of albumin, massage of the lower limbs and intensive rehabilitation. Cryotherapy was administered once a week for 3 months. Her discharge almost stopped and vulvar lymphangiomas decreased without any major complications. To the best of our knowledge, this is the first case report of massive lymphatic leakage complicated with vulvar lymphangiomas. Additionally, this case may represent the first successful treatment of vulva lymph leakage by cryotherapy without recurrence. Cryotherapy may have the potential to improve the quality of life as a less-invasive treatment for gynecological cancer survivors without serious complications.	[Yanazume, Shintaro; Nagata, Tomomi; Douchi, Tsutomu; Kobayashi, Hiroaki] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 890, Japan; [Douzono, Haruhiko] Dozono Med House, Kagoshima, Japan; [Kubo, Hidemichi] Kagoshima Univ, Fac Med, Dept Dermatol, Kagoshima 890, Japan	Yanazume, S (reprint author), Natl Hosp Org Kagoshima Med Ctr, Dept Obstet & Gynecol, 8-1 Shiroyama, Kagoshima 8920853, Japan.	s-yana@kagomc2.hosp.go.jp					Vlastos AT, 2003, OBSTET GYNECOL, V101, P946, DOI 10.1016/S0029-7844(03)00048-6; ELIEZRI YD, 1988, J DERMATOL SURG ONC, V14, P357; Ghaemmaghami F, 2008, ARCH GYNECOL OBSTET, V278, P57, DOI 10.1007/s00404-007-0440-3; Ghaemmaghami F, 2008, J MINIM INVAS GYN, V15, P205, DOI [10.1016/j.jmig.2007.09.005, 10.1016/j.mig.2007.09.005]; HANDFIELDJONES SE, 1989, GENITOURIN MED, V65, P335; HARWOOD CA, 1993, BRIT J DERMATOL, V129, P334, DOI 10.1111/j.1365-2133.1993.tb11858.x; MALLETT RB, 1992, BRIT J DERMATOL, V126, P380, DOI 10.1111/j.1365-2133.1992.tb00684.x; Mu XC, 1999, J CUTAN PATHOL, V26, P150, DOI 10.1111/j.1600-0560.1999.tb01820.x; Nadler Scott F, 2004, Pain Physician, V7, P395; Sasaki Ryosuke, 2014, Case Rep Dermatol, V6, P1, DOI 10.1159/000358006; WHIMSTER IW, 1976, BRIT J DERMATOL, V94, P473, DOI 10.1111/j.1365-2133.1976.tb05134.x	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1116	1119		10.1093/jjco/hyu125		4	Oncology	Oncology	AT0FY	WOS:000344613700015		
J	Fukushima, T; Gomi, D; Kobayashi, T; Sekiguchi, N; Sakamoto, A; Sasaki, S; Koizumi, T				Fukushima, Toshirou; Gomi, Daisuke; Kobayashi, Takashi; Sekiguchi, Nodoka; Sakamoto, Akiyuki; Sasaki, Shigeru; Koizumi, Tomonobu			Successful Salvage Chemotherapy with Amrubicin for Invasive Thymoma Associated with Myasthenia Gravis	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						relapsed thymoma; chemotherapy; anthracycline; topoisomerase II inhibitor	CARCINOMA	Anthracycline-based regimens with cisplatin have been commonly used for inoperable and relapsed thymoma. However, little information is available regarding the usefulness of salvage chemotherapy. Here, we describe a case of invasive thymoma associated with myasthenia gravis that showed a marked response to third-line chemotherapy, with single-agent amrubicin, a synthetic anthracycline analog and potent deoxyribonucleic acid topoisomerase II inhibitor. Amrubicin appears to have significant activity against invasive thymoma.	[Fukushima, Toshirou; Gomi, Daisuke; Kobayashi, Takashi; Sekiguchi, Nodoka; Sakamoto, Akiyuki; Sasaki, Shigeru; Koizumi, Tomonobu] Shinshu Univ, Dept Comprehens Canc Therapy, Sch Med, Matsumoto, Nagano 3908621, Japan	Koizumi, T (reprint author), Shinshu Univ, Dept Comprehens Canc Therapy, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tomonobu@shinshu-u.ac.jp					Grassin F, 2010, J THORAC ONCOL, V5, P893, DOI 10.1097/JTO.0b013e3181db3dee; Murakami H, 2014, LUNG CANCER, V84, P67, DOI 10.1016/j.lungcan.2014.01.012; Mikhail M, 2012, CURR ONCOL REP, V14, P350, DOI 10.1007/s11912-012-0246-8; Hejna M, 1999, CANCER, V85, P1871, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1871::AID-CNCR1>3.0.CO;2-Y; Hirai F, 2013, JPN J CLIN ONCOL, V43, P1018, DOI 10.1093/jjco/hyt106; Igawa S, 2009, J THORAC ONCOL, V4, P778, DOI 10.1097/JTO.0b013e3181a52e74; Kawashima Y, 2013, J CLIN ONCOL S, V31; Koizumi T, 2010, MED ONCOL, V27, P392, DOI 10.1007/s12032-009-9223-y; Yoh K, 2012, J CLIN ONCOL SE17513, V30	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1120	1122		10.1093/jjco/hyu136		3	Oncology	Oncology	AT0FY	WOS:000344613700016		
J	Inomata, M; Akagi, T; Katayama, H; Kimura, A; Mizusawa, J; Etoh, T; Yamaguchi, S; Ito, M; Kinugasa, Y; Saida, Y; Hasegawa, H; Ota, M; Kanemitsu, Y; Shimada, Y; Kitano, S				Inomata, Masafumi; Akagi, Tomonori; Katayama, Hiroshi; Kimura, Aya; Mizusawa, Junki; Etoh, Tsuyoshi; Yamaguchi, Shigeki; Ito, Masaaki; Kinugasa, Yusuke; Saida, Yoshihisa; Hasegawa, Hirotoshi; Ota, Mitsuyoshi; Kanemitsu, Yukihide; Shimada, Yasuhiro; Kitano, Seigo		Japan Clinical Oncology Grp	A Randomized Controlled Trial Comparing Laparoscopic Surgery with Open Surgery in Palliative Resection of Primary Tumor in Incurable Stage IV Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE Trial)	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						colorectal cancer; palliative resection; laparoscopic surgery; randomized controlled trial	MULTICENTER	A randomized controlled trial was started in Japan to evaluate the non-inferiority of overall survival of laparoscopic surgery to open surgery for palliative resection of primary tumor in incurable Stage IV colorectal cancer. Symptomatic, Stage IV colorectal cancer patients with non-curable metastasis are pre-operatively randomized to either open or laparoscopic colorectal resection. Surgeons in 56 specialized institutions will recruit 450 patients. The primary endpoint is overall survival. Secondary endpoints are progression-free survival, the proportion of conversion from laparoscopic surgery to open surgery, the proportion of patients who fulfill the criteria of starting chemotherapy by 6 weeks after operation, intraoperative and post-operative complications, adverse events during chemotherapy and serious adverse events.	[Inomata, Masafumi; Akagi, Tomonori; Etoh, Tsuyoshi; Kitano, Seigo] Oita Univ, Dept Gastroenterol & Pediat Surg, Fac Med, Oita 8795593, Japan; [Katayama, Hiroshi; Kimura, Aya; Mizusawa, Junki] Natl Canc Ctr, Ctr Res Adm & Support, JCOG Data Ctr, Operat Off, Tokyo 104, Japan; [Yamaguchi, Shigeki] Saitama Med Univ, Saitama Int Med Ctr, Ctr Comprehens Canc, Dept Surg Gastroenterol, Saitama, Japan; [Ito, Masaaki] Natl Canc Ctr Hosp East, Chiba, Japan; [Kinugasa, Yusuke] Shizuoka Canc Ctr, Shizuoka, Japan; [Saida, Yoshihisa] Toho Univ, Ohashi Hosp, Sch Med, Tokyo, Japan; [Hasegawa, Hirotoshi] Keio Univ Hosp, Tokyo, Japan; [Ota, Mitsuyoshi] Yokohama City Univ, Gastroenterol Ctr, Dept Surg, Yokohama, Kanagawa, Japan; [Kanemitsu, Yukihide] Natl Canc Ctr, Dept Colorectal Surg Div, Tokyo, Japan; [Shimada, Yasuhiro] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan	Inomata, M (reprint author), Oita Univ, Dept Gastroenterol & Pediat Surg, Fac Med, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	inomata@oita-u.ac.jp					Hida K, 2012, ANN SURG, V255, P929, DOI 10.1097/SLA.0b013e31824a99e4; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Akagi T, 2013, J GASTROINTEST SURG, V17, P776, DOI 10.1007/s11605-013-2173-x; Kitano S, 2005, JPN J CLIN ONCOL, V35, P475, DOI 10.1093/jjco/hyi124; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nishizawa Y, 2012, J CLIN ONCOL S, V30	8	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1123	1126		10.1093/jjco/hyu115		4	Oncology	Oncology	AT0FY	WOS:000344613700017		
J	Saika, K; Matsuda, T; Sobue, T				Saika, Kumiko; Matsuda, Tomohiro; Sobue, Tomotaka			Incidence Rate of Thyroid Cancer by Histological Type in Japan	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Saika, Kumiko; Matsuda, Tomohiro] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Singapore, Singapore; [Sobue, Tomotaka] Osaka Univ, Fac Med, Grad Sch Med, Dept Social Med, Suita, Osaka 565, Japan	Saika, K (reprint author), Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Singapore, Singapore.						Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	NOV	2014	44	11					1131	1132		10.1093/jjco/hyu179		2	Oncology	Oncology	AT0FY	WOS:000344613700020		
J	Yoshizawa, K; Taguchi, T				Yoshizawa, Keiko; Taguchi, Tetsushi			Bonding behavior of hydrophobically modified gelatin films on the intestinal surface	JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS			English	Article						Hydrophobic groups; gelatin film; adhesive; intestine; agglutination prevention; porcine intestine adhesion; bonding to intestinal surfaces	CROSS-LINKED GELATIN; CELL-ADHESION; DISUCCINIMIDYL TARTARATE; POSTOPERATIVE ADHESION; PERITONEAL ADHESIONS; TISSUE ADHESIVE; FATTY-ACIDS; MEMBRANE; ENHANCEMENT; PREVENTION	The bonding behavior was determined for hydrophobically modified alkaline-treated gelatin on wet porcine intestinal surfaces. The modified gelatin films were obtained by reacting the amino groups of alkaline-treated gelatin with fatty acid chlorides of different alkyl chain lengths, namely, hexanoyl (Hx: C-6) chloride, decanoyl (Dec: C-10) chloride, and stearoyl (Ste: C-18) chloride. Three kinds of the films were prepared, 32HxAlGltn, 24DecAlGltn, and 26SteAlGltn that had substitution ratios of hydrophobic groups to the amino groups of 32HxAlGltn, 24DecAlGltn, and 26SteAlGltn of 32%, 24%, and 26%, respectively. The 32HxAlGltn film had the strongest bonding to porcine intestinal surfaces. A thick 32HxAlGltn film remained on the intestinal surface even after the bonded film was scraped off for the measurement of bonding strength. In addition, the burst strength increased with an increase in the substitution ratio of the Hx group. Thus, the HxAlGltn film with the higher Hx modification ratio has a potential as a sealant material to prevent agglutination of intestinal surfaces.	[Yoshizawa, Keiko; Taguchi, Tetsushi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Taguchi, Tetsushi] Natl Inst Mat Sci, Biomat Unit, Int Ctr Mat Nanoarchitecton MANA, Nanolife Field, Tsukuba, Ibaraki 3050044, Japan	Taguchi, T (reprint author), Natl Inst Mat Sci, Biomat Unit, Int Ctr Mat Nanoarchitecton MANA, Nanolife Field, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	TAGUCHI.Tetsushi@nims.go.jp			JSPS KAKENHI [26630356, 25289254]; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics (MANA), MEXT, Japan	This work was supported partially by JSPS KAKENHI Grant Numbers 26630356 and 25289254, and the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics (MANA), MEXT, Japan.	Aewsiri T, 2011, FOOD BIOPROCESS TECH, V6, P671; Aewsiri T, 2011, INT J BIOL MACROMOL, V48, P650, DOI 10.1016/j.ijbiomac.2011.02.006; Lang G, 2004, EUR J CARDIO-THORAC, V25, P160, DOI 10.1016/j.ejcts.2003.11.018; Matsuda M, 2012, COLLOID SURFACE B, V91, P48, DOI 10.1016/j.colsurfb.2011.10.030; Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006; Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149; [Anonymous], F2392042004; Matsuda M, 2012, J BIOACT COMPAT POL, V27, P481, DOI 10.1177/0883911512455116; Okuyama N, 1999, ANN THORAC SURG, V68, P913, DOI 10.1016/S0003-4975(99)00556-1; Pabla D, 2010, EUR J PHARM SCI, V40, P466, DOI 10.1016/j.ejps.2010.05.002; Morales DLS, 2008, ANN THORAC SURG, V86, P897, DOI 10.1016/j.athoracsur.2008.04.044; Tsujimoto H, 2013, J BIOMED MATER RES B, V101B, P99, DOI 10.1002/jbm.b.32821; YODOYA E, 1994, J PHARMACOL EXP THER, V271, P1509; Wu SC, 2011, J BIOACT COMPAT POL, V26, P565, DOI 10.1177/0883911511423563; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Brochhausen C, 2012, J GASTROINTEST SURG, V16, P1256, DOI 10.1007/s11605-011-1819-9; Chang SJ, 2013, J BIOACT COMPAT POL, V28, P178, DOI 10.1177/0883911513475942; Delio M, 2013, AM J MED GENET A, V161A, P527, DOI 10.1002/ajmg.a.35784; Ellis Harold, 2005, J Am Coll Surg, V200, P641; FRANKLIN RR, 1995, OBSTET GYNECOL, V86, P335, DOI 10.1016/0029-7844(95)00175-Q; GOLDBERG JM, 1987, OBSTET GYNECOL, V70, P846; Inoue M, 2012, ADV HEALTHC MATER, V1, P573, DOI 10.1002/adhm.201200001; Inoue M, 2005, J PEDIATR SURG, V40, P1301, DOI 10.1016/j.jpedsurg.2005.05.015; Karacam V, 2011, INT J MED SCI, V8, P380; Kolodgie FD, 2000, CIRC RES, V87, P264; Lin LH, 2006, COLLOID SURFACE A, V272, P8, DOI 10.1016/j.colsurfa.2005.07.006; Liu RH, 2012, BIOMACROMOLECULES, V13, P1100, DOI 10.1021/bm201847n; Liu WT, 2013, J BIOACT COMPAT POL, V28, P453, DOI 10.1177/0883911513494623; Matsuda M, 2012, J BIOACT COMPAT POL, V27, P31, DOI 10.1177/0883911511434426; Morcol T, 1997, J IMMUNOL METHODS, V203, P45, DOI 10.1016/S0022-1759(97)00013-6; Ofer T, 1997, J COLLOID INTERF SCI, V193, P172; Peng HH, 2011, J BIOACT COMPAT POL, V26, P552, DOI 10.1177/0883911511423562; Saito H, 2007, BIOMACROMOLECULES, V8, P1992, DOI 10.1021/bm070122k; Sasaki T, 2004, SURG ENDOSC, V18, P246, DOI 10.1007/s00464-003-8128-7; Taguchi T, 2009, J BIOACT COMPAT POL, V24, P546, DOI 10.1177/0883911509349688; Yoshizawa K, 2014, INT J MOL SCI, V15, P2142, DOI 10.3390/ijms15022142; Yuan SJ, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0030-1; Zeng QQ, 2007, WORLD J SURG, V31, P2125, DOI 10.1007/s00268-007-9242-9; Zhu AP, 2009, ACTA BIOMATER, V5, P2033, DOI 10.1016/j.actbio.2009.02.016	39	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0883-9115	1530-8030		J BIOACT COMPAT POL	J. Bioact. Compat. Polym.	NOV	2014	29	6					560	571		10.1177/0883911514553731		12	Biotechnology & Applied Microbiology; Materials Science, Biomaterials; Polymer Science	Biotechnology & Applied Microbiology; Materials Science; Polymer Science	AT0WZ	WOS:000344654800003		
J	Yamashiro, S; Watanabe, N				Yamashiro, Sawako; Watanabe, Naoki			A new link between the retrograde actin flow and focal adhesions	JOURNAL OF BIOCHEMISTRY			English	Review						actin; cell migration; focal adhesion; retrograde flow; single-molecule speckle microscopy	FLUORESCENT SPECKLE MICROSCOPY; NEURONAL GROWTH CONES; MIGRATING CELLS; LEADING-EDGE; DYNAMICS; FILAMENTS; FIBROBLASTS; MOLECULE; TURNOVER; MOTILITY	The retrograde actin flow, continuous centripetal movement of the cell peripheral actin networks, is widely observed in adherent cells. The retrograde flow is believed to facilitate cell migration when linked to cell adhesion molecules. In this review, we summarize our current knowledge regarding the functional relationship between the retrograde actin flow and focal adhesions (FAs). We also introduce our recent study in which single-molecule speckle (SiMS) microscopy dissected the complex interactions between FAs and the local actin flow. FAs do not simply impede the actin flow, but actively attract and remodel the local actin network. Our findings provide a new insight into the mechanisms for protrusion and traction force generation at the cell leading edge. Furthermore, we discuss possible roles of the actin flow-FA interaction based on the accumulated knowledge and our SiMS study.	[Yamashiro, Sawako; Watanabe, Naoki] Kyoto Univ Fac Med, Dept Pharmacol, Kyoto 6068501, Japan	Yamashiro, S (reprint author), Kyoto Univ Fac Med, Dept Pharmacol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	yamashiro.sawako.5c@kyoto-u.ac.jp			Cabinet Office, Government of Japan [LS013]; Takeda Science Foundation; Ministry of Education, Science, Sports and Culture of Japan [00624347]	This work was supported by NEXT program grant LS013 from the Cabinet Office, Government of Japan (N.W.), a grant from Takeda Science Foundation (N.W.) and a Grant-in-Aid for Scientific Research on Innovative Areas Grant Number 00624347 from the Ministry of Education, Science, Sports and Culture of Japan (S.Y.).	ABERCROM.M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Vallotton P, 2009, J CELL SCI, V122, P1955, DOI 10.1242/jcs.042036; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Sabass B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194112; Hanein D, 2012, CURR OPIN CELL BIOL, V24, P134, DOI 10.1016/j.ceb.2011.12.001; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Wolgemuth CW, 2005, BIOPHYS J, V89, P1643, DOI 10.1529/biophysj.105.066720; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Shimada T, 2008, J CELL BIOL, V181, P817, DOI 10.1083/jcb.200712138; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Decourt B, 2009, J NEUROSCI RES, V87, P1057, DOI 10.1002/jnr.21937; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; Henson JH, 1999, MOL BIOL CELL, V10, P4075; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Danuser G, 2009, J CELL SCI, V122, P1959, DOI 10.1242/jcs.054379; Dunn G, 1998, TRENDS CELL BIOL, V8, P124, DOI 10.1016/S0962-8924(97)01213-0; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Higashida C, 2013, NAT CELL BIOL, V15, P395, DOI 10.1038/ncb2693; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Lu P, 2011, COLD SPRING HARB PER, V3, P12, DOI DOI 10.1101/CSHPERSPECT.A005058; Narita A, 2012, J MOL BIOL, V419, P359, DOI 10.1016/j.jmb.2012.03.015; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Oldenbourg R, 2000, BIOPHYS J, V78, P1176; Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Yamashiro S, 2014, MOL BIOL CELL, V25, P1010, DOI 10.1091/mbc.E13-03-0162; Yumura S, 2013, BIOL OPEN, V2, P200, DOI 10.1242/bio.20122899	56	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2014	156	5					239	248		10.1093/jb/mvu053		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT0DF	WOS:000344606500001		
J	Kondo, Y				Kondo, Yutaka			Targeting histone methyltransferase EZH2 as cancer treatment	JOURNAL OF BIOCHEMISTRY			English	Review						cancer; epigenetics; EZH2; polycomb; treatment	EMBRYONIC STEM-CELLS; GROUP PROTEIN EZH2; GENE-EXPRESSION; NONCODING RNAS; DEVELOPMENTAL REGULATORS; SELECTIVE-INHIBITION; SOMATIC MUTATIONS; INITIATING CELLS; DNA METHYLATION; PROSTATE-CANCER	It is widely accepted that epigenetic alterations are associated with different stages of tumour formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers are emerging as important biomarkers and may have therapeutic potential. The polycomb repressive complex 2 (PRC2) is a key epigenetic regulator that catalyses trimethylation of lysine 27 on histone H3 (H3K27me3) via the histone methyltransferase, EZH2, which confers stemness and regulates differentiation during embryonic development. Given these roles of EZH2 and H3K27me3, plastic and dynamic features of cancer cells, especially cancer stem cells (CSCs), may be closely associated with this epigenetic mechanism. In addition, recent sequencing technology revealed that there are many recurrent mutations in polycomb-related genes, including EZH2, in different types of cancers. Therefore, researchers focused on targeting EZH2 as a novel cancer treatment and identified small compounds that inhibit EZH2 activity. Some of them are now under clinical trial in B-cell lymphoma. However, the underlying mechanisms by which PRC2 precisely regulate epigenetic alterations at certain genomic loci under different cellular conditions remain unclear. In this review, I focus on the recent advancements in EZH2 research, especially its dynamic regulation of epigenetic alterations in tumour cells, including the CSC population, and discuss perspectives and challenges for cancer treatment in the near future.	[Kondo, Yutaka] Nagoya City Univ Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi 4678601, Japan	Kondo, Y (reprint author), Nagoya City Univ Grad Sch Med Sci, Dept Epigen, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ykondo@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	This work was supported by the P-Direct from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Goff LA, 2013, NAT STRUCT MOL BIOL, V20, P1344, DOI 10.1038/nsmb.2728; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrcd1991; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Trost M, 2012, BLOOD, V120, pE17, DOI 10.1182/blood-2011-12-397844; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Gupta PB, 2009, NAT MED, V15, P1010, DOI [10.1038/nm0909-1010, 10.1038/nm.2032]; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/nchembio.1331, 10.1038/NCHEMBIO.1331]; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/nchembio.1084, 10.1038/NCHEMBIO.1084]; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Yap DB, 2010, BLOOD, V117, P2451	59	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2014	156	5					249	257		10.1093/jb/mvu054		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT0DF	WOS:000344606500002		
J	Ichiyama, S; Nemoto, R; Tanabe, H; Haga, T				Ichiyama, Susumu; Nemoto, Reiko; Tanabe, Hiroaki; Haga, Tatsuya			Interaction of the muscarinic acetylcholine receptor M-2 subtype with G protein G alpha(i/o) isotypes and G beta gamma subunits as studied with the maltose-binding protein-M-2-G alpha(i/o) fusion proteins expressed in Escherichia coli	JOURNAL OF BIOCHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); muscarinic acetylcholine receptor M-2 subtype	GUANINE-NUCLEOTIDE BINDING; RAT NEUROTENSIN RECEPTOR; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; OPIOID RECEPTORS; ALPHA-SUBUNIT; RECONSTITUTION; PURIFICATION; MU; CONFORMATION	We expressed the fusion proteins of the muscarinic acetylcholine receptor M-2 subtype (M-2 receptor) with a maltose-binding protein (MBP) and various G protein alpha subunits (G alpha(i1-i3/o)) at its N- and C-terminals, respectively (MBP-M-2-G alpha(i/o)), in Escherichia coli, and examined the effect of G protein beta gamma subunits (G beta gamma) on the receptor-G alpha interaction as assessed by agonist- and GDP-dependent [S-35]GTP gamma S binding of the fusion proteins. We found that (i) G beta gamma promoted both the agonist-dependent and -independent [S-35]GTP gamma S binding with little effect on the guanine nucleotide-sensitive high-affinity agonist binding, (ii) the specific [S-35]GTP gamma S binding activity was much greater for MBP-M-2-G alpha(oA) than for MBP-M-2-G alpha(i1-i3) in the absence of G beta gamma, whereas G beta gamma preferentially promoted the agonist-dependent decrease in the affinity for GDP of MBP-M-2-G alpha(i1-i3) rather than of MBP-M-2-G alpha(oA), and (iii) the proportion of agonist-dependent [S-35]GTP gamma S binding was roughly 50% irrespective of species of G alpha and the presence or absence of G beta gamma. These results demonstrate that receptor-G alpha fusion proteins expressed in E. coli could be useful for studies of receptor-G interaction.	[Ichiyama, Susumu; Nemoto, Reiko; Tanabe, Hiroaki; Haga, Tatsuya] Gakushuin Univ, Inst Biomol Sci, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	Ichiyama, S (reprint author), Gakushuin Univ, Inst Biomol Sci, Fac Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	susumuG4ichiyama@gmail.com			Abe Yoshishige Memorial Education Fund	This work was supported by the Abe Yoshishige Memorial Education Fund 2007 [S.I.].	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Zhang QL, 2004, J BIOCHEM, V135, P589, DOI 10.1093/jb/mvh072; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Furukawa H, 2002, MOL PHARMACOL, V62, P778, DOI 10.1124/mol.62.4.778; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; KAMEYAMA K, 1994, EUR J BIOCHEM, V226, P267, DOI 10.1111/j.1432-1033.1994.tb20050.x; Furukawa H, 2000, J BIOCHEM-TOKYO, V127, P151; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Tucker J, 1996, BIOCHEM J, V317, P891; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Hayashi MK, 1996, J BIOCHEM-TOKYO, V120, P1232; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; Gomperts B.D., 2002, SIGNAL TRANSDUCTION, P71, DOI 10.1016/B978-012289631-6/50024-7; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571; Guo ZD, 2001, LIFE SCI, V68, P2319, DOI 10.1016/S0024-3205(01)01021-9; HAGA K, 1986, J BIOL CHEM, V261, P133; Haga T, 2002, METHOD ENZYMOL, V343, P559; Hayashi MK, 1997, ARCH BIOCHEM BIOPHYS, V340, P376, DOI 10.1006/abbi.1997.9906; Ichiyama Susumu, 2006, FEBS Lett, V580, P23, DOI 10.1016/j.febslet.2005.11.042; Ichiyama S., 2009, HDB NEUROCHEMISTRY M, P417; IKEGAYA T, 1990, J MOL CELL CARDIOL, V22, P343, DOI 10.1016/0022-2828(90)91467-L; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Minaba M, 2006, FEBS J, V273, P5508, DOI 10.1111/j.1742-4658.2006.05542.x; Molinari P, 2003, J BIOL CHEM, V278, P15778, DOI 10.1074/jbc.M300731200; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Snook LA, 2008, J NEUROCHEM, V105, P865, DOI 10.1111/j.1471-4159.2008.05215.x; Stanasila L, 1999, EUR J BIOCHEM, V260, P430, DOI 10.1046/j.1432-1327.1999.00187.x; Stanasila L, 2000, J NEUROCHEM, V75, P1190, DOI 10.1046/j.1471-4159.2000.0751190.x; Suga H, 2004, J BIOCHEM, V135, P605, DOI 10.1093/jb/mvh058; Suga H, 2007, NEUROCHEM INT, V51, P140, DOI 10.1016/j.neuint.2007.06.006; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; Vanhauwe JFM, 2000, J PHARMACOL EXP THER, V295, P274; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.biochem.60.1.101	39	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2014	156	5					259	272		10.1093/jb/mvu036		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT0DF	WOS:000344606500003		
J	Harada, G; Neng, Q; Fujiki, T; Katakura, Y				Harada, Gakuro; Neng, Qian; Fujiki, Tsukasa; Katakura, Yoshinori			Molecular mechanisms for the p38-induced cellular senescence in normal human fibroblast	JOURNAL OF BIOCHEMISTRY			English	Article						cellular senescence; hTERT; human fibroblast; TAK1; p38	ACTIVATED PROTEIN-KINASE; BETA SIGNAL-TRANSDUCTION; HUMAN-CELLS; P38 MAPK; CATALYTIC SUBUNIT; TELOMERASE HTERT; GENE-EXPRESSION; PATHWAY; TAK1; TRANSCRIPTION	We previously reported that TAK1, one of the mitogen-activated protein kinase kinase kinases (MAP3Ks), represses the transcription of the human telomerase reverse transcriptase (hTERT) gene in human cancer cells and induces cellular senescence in normal diploid human cells. On the basis of these results, we presumed a link between hTERT repression and the induction of cellular senescence. In this study, we identified the MAPK p38 as a downstream mediator of TAK1, which represses hTERT transcription. Further, we observed that hTERT expression was repressed in senescent normal human fibroblast, and was attenuated on treatment with SB203580, a p38-specific inhibitor, which suggests that p38 represses hTERT expression during cellular senescence. Next, we demonstrated that repression of hTERT, irrespective of the activation status of p38, is important for the induction of cellular senescence, by using hTERT-overexpressing cells and hTERT-knockdown cells. Our results suggested that p38 is activated during the serial passagings of normal human fibroblast, which results in the repression of hTERT transcription and induction of cellular senescence.	[Harada, Gakuro; Neng, Qian; Katakura, Yoshinori] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Fujiki, Tsukasa; Katakura, Yoshinori] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Katakura, Y (reprint author), Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan.	katakura@grt.kyushu-u.ac.jp			JSPS KAKENHI [24580190]	This work was supported by JSPS KAKENHI (grant number 24580190 to Y.K.).	Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Hou M, 2002, EXP CELL RES, V274, P25, DOI 10.1006/excr.2001.5462; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Fujishiro M, 2001, J BIOL CHEM, V276, P19800, DOI 10.1074/jbc.M101087200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Udono M, 2012, METHODS, V56, P383, DOI 10.1016/j.ymeth.2012.02.012; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Katakura Y, 2009, J BIOCHEM, V146, P87, DOI 10.1093/jb/mvp046; Nony PA, 2005, J BIOL CHEM, V280, P31413, DOI 10.1074/jbc.M500418200; Philip B, 2005, CELL SIGNAL, V17, P365, DOI 10.1016/j.cellsig.2004.08.003; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247	27	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2014	156	5					283	290		10.1093/jb/mvu040		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT0DF	WOS:000344606500005		
J	Okabe, T; Miyajima, T; Nakagawa, K; Tsukamoto, S; Fujiwara, K; Ikeguchi, M				Okabe, Takahiro; Miyajima, Toshiaki; Nakagawa, Kanako; Tsukamoto, Seiichi; Fujiwara, Kazuo; Ikeguchi, Masamichi			Effect of non-native helix destabilization on the folding of equine beta-lactoglobulin	JOURNAL OF BIOCHEMISTRY			English	Article						circular dichroism; folding intermediate; fluorescence; helical propensity; stopped flow	MOLTEN GLOBULE STATE; PROTEIN; INTERMEDIATE; EQUILIBRIUM; MECHANISM	beta-lactoglobulin forms a non-native alpha-helix during an early stage of folding. To address the role of the non-native structure in the folding process, we designed several mutants of equine beta-lactoglobulin with reduced helical propensity in the non-native helix region. One of them, A123T, showed a similar structure to that of the wild-type protein; its folding kinetics was investigated by stopped-flow circular dichroism (CD) and fluorescence. Although A123T showed a reduced burst-phase CD intensity, its folding rate was similar to that of the wild-type protein, which indicated that the formation of the non-native helix does not accelerate or decelerate the folding reaction.	[Okabe, Takahiro; Miyajima, Toshiaki; Nakagawa, Kanako; Tsukamoto, Seiichi; Fujiwara, Kazuo; Ikeguchi, Masamichi] Soka Univ, Dept Bioinformat, Hachioji, Tokyo 1928577, Japan	Ikeguchi, M (reprint author), Soka Univ, Dept Bioinformat, 1-236 Tangi Machi, Hachioji, Tokyo 1928577, Japan.	ikeguchi@soka.ac.jp					Nakagawa K, 2014, BIOPOLYMERS, V101, P651, DOI 10.1002/bip.22433; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Nishimura C, 2006, J MOL BIOL, V355, P139, DOI 10.1016/j.jmb.2005.10.047; Sakurai K, 2011, BIOCHEMISTRY-US, V50, P6498, DOI 10.1021/bi200241a; Kuwata K, 2001, NAT STRUCT BIOL, V8, P151, DOI 10.1038/84145; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Prigozhin MB, 2013, P NATL ACAD SCI USA, V110, P8087, DOI 10.1073/pnas.1219163110; Nakagawa K, 2006, BIOCHEMISTRY-US, V45, P15468, DOI 10.1021/bi061420p; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; Fujiwara K, 1999, BIOCHEMISTRY-US, V38, P4455, DOI 10.1021/bi982683p; Hamada D, 1997, J MOL BIOL, V269, P479, DOI 10.1006/jmbi.1997.1055; Ikeguchi M, 1997, PROTEINS, V27, P567, DOI 10.1002/(SICI)1097-0134(199704)27:4<567::AID-PROT9>3.0.CO;2-7; Kobayashi T, 2000, J MOL BIOL, V299, P757, DOI 10.1006/jmbi.2000.3761; Krishna MMG, 2004, J MOL BIOL, V343, P1095, DOI 10.1016/j.jmb.2004.08.098; Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; Tsukamoto S, 2009, PROTEINS, V76, P226, DOI 10.1002/prot.22340; Yamamoto M, 2011, BIOCHEMISTRY-US, V50, P10590, DOI 10.1021/bi2013239	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	NOV	2014	156	5					291	297		10.1093/jb/mvu043		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT0DF	WOS:000344606500006		
J	Yamada, T; Hirashiki, A; Okumura, T; Adachi, S; Shimazu, S; Shimizu, S; Morimoto, R; Takeshita, K; Naganawa, S; Kondo, T; Murohara, T				Yamada, Takashi; Hirashiki, Akihiro; Okumura, Takahiro; Adachi, Shiro; Shimazu, Shuzo; Shimizu, Shinya; Morimoto, Ryota; Takeshita, Kyosuke; Naganawa, Shinji; Kondo, Takahisa; Murohara, Toyoaki			Prognostic Impact of Combined Late Gadolinium Enhancement on Cardiovascular Magnetic Resonance and Peak Oxygen Consumption in Ambulatory Patients With Nonischemic Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Article						Exercise tolerance; magnetic resonance imaging; prognosis	CHRONIC HEART-FAILURE; MYOCARDIAL FIBROSIS; CARDIAC TRANSPLANTATION; VENTRICULAR-TACHYCARDIA; MITOCHONDRIAL-FUNCTION; TASK-FORCE; EXERCISE; DYSFUNCTION; CLASSIFICATION; ASSOCIATION	Background: Peak oxygen consumption (peak VO2) and late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) are prognostic in heart failure. We investigated whether LGE-CMR and peak VO2 combined had additive value in risk stratifying patients with nonischemic dilated cardiomyopathy (DCM). Methods and Results: Fifty-seven DCM patients underwent CMR and cardiopulmonary exercise testing. Cardiac events were cardiac death, hospitalization for decompensated heart failure, or lethal arrhythmia. Twenty-five (44%) were LGE-positive. The median peak VO2 was 18.5 mL.kg(-1).min(-1). On multivariate analysis, positive LGE (P = .048) and peak VO2 (P =.003) were independent cardiac event predictors. Cardiac event risk was significantly higher with positive LGE and peak VO2 < 18.5 mL.kg(-1).min(-1) than with negative LGE and peak VO2 >= 18.5 mL.kg(-1).min(-1) (hazard ratio 12.5; 95% CI 1.57-100; P = .017). In 3 patient groups (group A: no LGE, peak VO2 >= 18.5 mL.kg(-1).min(-1), n = 18; group B: positive LGE or peak VO2 < 18.5 mL.kg(-1).min(-1), n = 24; group C: positive LGE and peak VO2 < 18.5 mL.kg(-1).min(-1), n = 15) during follow-up (71 +/- 32 months), group C had higher cardiac event rates than the others. Conclusions: Combined assessment of LGE-CMR and peak VO2 provides additive prognostic information in ambulatory DCM.	[Yamada, Takashi; Okumura, Takahiro; Adachi, Shiro; Shimazu, Shuzo; Shimizu, Shinya; Morimoto, Ryota; Takeshita, Kyosuke; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Hirashiki, Akihiro; Kondo, Takahisa] Nagoya Univ, Dept Adv Med Cardiopulm Dis, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Naganawa, Shinji] Nagoya Univ, Dept Radiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Hirashiki, A (reprint author), Nagoya Univ, Dept Adv Med Cardiopulm Dis, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	hirasiki@med.nagoya-u.ac.jp	Takeshita, Kyosuke/B-7008-2012; Murohara, Toyoaki/M-4958-2014	Takeshita, Kyosuke/0000-0002-8283-3799; 			American Thoracic Society American College of Chest Physicians, 2003, AM J RESP CRIT CARE, V167, P211, DOI DOI 10.1164/RCCM.167.2.211; Ponikowski P, 2001, CIRCULATION, V103, P967; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; UNVERFERTH DV, 1986, AM J CARDIOL, V57, P816, DOI 10.1016/0002-9149(86)90620-X; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; MANCINI DM, 1991, CIRCULATION, V83, P778; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Bello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057; Clerico A, 2002, CLIN CHEM LAB MED, V40, P371, DOI 10.1515/CCLM.2002.060; Waller TA, 1998, AM J CARDIOL, V81, P884, DOI 10.1016/S0002-9149(98)00020-4; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; RIHAL CS, 1994, CIRCULATION, V90, P2772; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Shimizu I, 2010, INT J CARDIOL, V142, P224, DOI 10.1016/j.ijcard.2008.12.189; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Yamada T, 2013, J CARD FAIL, V19, P557, DOI 10.1016/j.cardfail.2013.05.018; Leong DP, 2012, EUR HEART J, V33, P640, DOI 10.1093/eurheartj/ehr391; Adams KF, 1996, J AM COLL CARDIOL, V28, P1781; Myers J, 1998, ANN INTERN MED, V129, P286; White JA, 2007, CARDIOL CLIN, V25, P71, DOI 10.1016/j.ccl.2007.02.003; de Groote P, 2004, J AM COLL CARDIOL, V43, P1584, DOI 10.1016/j.jacc.2003.11.059; Richardson P, 1996, CIRCULATION, V93, P841; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Nazarian S, 2005, CIRCULATION, V112, P2821, DOI 10.1161/CIRCULATIONAHA.105.549659; Bard RL, 2006, J HEART LUNG TRANSPL, V25, P589, DOI 10.1016/j.healun.2005.11.448; Hayashi D, 2013, J AM COLL CARDIOL, V61, P2007, DOI 10.1016/j.jacc.2013.01.074; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; McCrohon J. A., 2003, Circulation, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; Opasich C, 1998, J AM COLL CARDIOL, V31, P766, DOI 10.1016/S0735-1097(98)00002-3	33	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	NOV	2014	20	11					825	832		10.1016/j.cardfail.2014.08.005		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT3LW	WOS:000344837300005		
J	Watabe, T; Abe, H; Kohno, R; Oginosawa, Y; Hayashi, K; Ohe, H; Tamura, M; Takeuchi, M; Otsuji, Y				Watabe, Taichi; Abe, Haruhiko; Kohno, Ritsuko; Oginosawa, Yasushi; Hayashi, Katsuhide; Ohe, Hisaharu; Tamura, Masahito; Takeuchi, Masaaki; Otsuji, Yutaka			Atrial Pacing Site and Atrioventricular Conduction in Patients Paced for Sinus Node Disease	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						atrial pacing; atrioventricular conduction; atrioventricular pacing; low atrial septum; right atrial appendage; sinus node disease	DUAL-CHAMBER PACEMAKERS; INTERATRIAL SEPTUM; HEART-FAILURE; FIBRILLATION; EFFICACY; DYSFUNCTION; TRIAL; PREVENTION; REDUCTION; THERAPY	Atrial Pacing Site and AV Conduction BackgroundUnnecessary ventricular pacing in sinus node disease (SND) must be avoided. To test the hypothesis that in SND, with or without 1st degree atrioventricular (AV) block, cumulative percent ventricular pacing (cum%VP) can be limited by low right atrial septal (LRAS) instead of right atrial appendage (RAA) pacing. MethodsWe studied 102 dual-chamber pacemaker recipients with SND. The PQ interval on 12-lead electrocardiogram and the atrial paced to ventricular sensed interval (Ap-Vs) during LRAS and RAA pacing were measured and compared at implantation, 3 months and 1 year of follow-up. Group 1 included 62 patients with baseline PQ interval <200milliseconds during LRAS (n = 28) versus RAA (n = 34) pacing. Group 2 included 40 patients with baseline PQ 200 milliseconds during LRAS (n = 20) versus RAA (n = 20) pacing. cum%VP were measured at 3 months and 1 year. ResultsThe characteristics and AV conduction properties were similar and the Ap-Vs interval was significantly shorter in the LRAS than in the RAA pacing group up to 1 year (193 32 milliseconds vs. 220 +/- 27 milliseconds in Group 1; P = 0.003, 222 +/- 41 milliseconds vs. 281 +/- 30 milliseconds in Group 2; P < 0.001). While cumulative percent atrial pacing was consistently similar, cum%VP was significantly smaller during LRAS than RAA pacing (1 +/- 1% vs. 8 +/- 18% in Group 1; P = 0.03, 7 +/- 10% vs. 48 +/- 38% in Group 2; P < 0.001). Similar observations were made with or without left atrial (LA) enlargement. ConclusionCompared with RAA, LRAS pacing showed shorter AV interval in SND patients with or without 1st degree AV block and LA enlargement. This beneficial effect persisted through 1-year follow-up, and decreased cum%VP significantly.	[Watabe, Taichi; Oginosawa, Yasushi; Hayashi, Katsuhide; Ohe, Hisaharu; Tamura, Masahito; Takeuchi, Masaaki; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Dept Internal Med 2, Kitakyushu, Fukuoka 8078555, Japan; [Abe, Haruhiko; Kohno, Ritsuko] Univ Occupat & Environm Hlth, Dept Heart Rhythm Management, Kitakyushu, Fukuoka 8078555, Japan	Abe, H (reprint author), Univ Occupat & Environm Hlth, Dept Heart Rhythm Management, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	haru-abe@med.uoeh-u.ac.jp					Abe H, 2012, J ARRHYTHMIA, V28, P19; Acosta H, 2012, EUROPACE, V14, P1311, DOI 10.1093/europace/eus043; Barold SS, 2006, J INTERV CARD ELECTR, V17, P139, DOI 10.1007/s10840-006-9065-x; Sharma AD, 2005, HEART RHYTHM, V2, P830, DOI 10.1016/j.hrthm.2005.05.015; Zhang XH, 2008, J CARDIOVASC ELECTR, V19, P136, DOI 10.1111/j.1540-8167.2007.01014.x; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Barold SS, 1997, PACE, V20, P989, DOI 10.1111/j.1540-8159.1997.tb05506.x; Bode F, 1999, PACE, V22, P1425, DOI 10.1111/j.1540-8159.1999.tb00345.x; de Groot JR, 2008, PACE, V31, P1554, DOI 10.1111/j.1540-8159.2008.01226.x; de Voogt W, 2007, EUROPACE, V9, P798, DOI 10.1093/europace/eum149; De Voogt WG, 2005, PACE, V28, P639, DOI 10.1111/j.1540-8159.2005.00157.x; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Hermida JS, 2003, PACE, V26, P26, DOI 10.1046/j.1460-9592.2003.00146.x; Hermida JS, 2004, AM HEART J, V148, P312, DOI 10.1016/j.ahj.2004.03.012; Hohnloser SH, 2012, HEART RHYTHM, V9, P1667, DOI 10.1016/j.hrthm.2012.06.012; Kohno R, 2011, PACE, V34, P1301, DOI 10.1111/j.1540-8159.2011.03077.x; Kohno R, 2011, CIRC J, V75, P1090, DOI 10.1253/circj.CJ-10-0896; Lau CP, 2013, CIRCULATION, V128, P687, DOI 10.1161/CIRCULATIONAHA.113.001644; Minamiguchi H, 2012, CIRC J, V76, P598, DOI 10.1253/circj.CJ-11-0745; Padeletti L, 2001, AM HEART J, V142, P1047, DOI 10.1067/mhj.2001.119373; Stabile G, 1999, J CARDIOVASC ELECTR, V10, P2, DOI 10.1111/j.1540-8167.1999.tb00635.x; Steinberg JS, 2005, J CARDIOVASC ELECTR, V16, P359, DOI 10.1046/j.1540-8167.2005.50038.x; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880; Sweeney MO, 2010, HEART RHYTHM, V7, P1552, DOI 10.1016/j.hrthm.2010.05.038; Verlato R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P844, DOI 10.1161/CIRCEP.110.957126; Wang M, 2011, EUROPACE, V13, P1268, DOI 10.1093/europace/eur110	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	NOV	2014	25	11					1224	1231		10.1111/jce.12476		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AS7ZL	WOS:000344470300013		
J	Miyazaki, S; Kinjo, T; Iesaka, Y				Miyazaki, Shinsuke; Kinjo, Tsunemichi; Iesaka, Yoshito			Wide QRS Tachycardia: What is the Mechanism?	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						AV reentry; catheter ablation; entrainment; nodoventricular pathway; WPW syndrome			[Miyazaki, Shinsuke; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Tsuchiura, Ibaraki 3000053, Japan; [Kinjo, Tsunemichi] Hokushin Gen Hosp, Nagano, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Div Cardiol, Cardiovasc Ctr, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Bennett MT, 2011, CIRC-ARRHYTHMIA ELEC, V4, P506, DOI 10.1161/CIRCEP.111.961987	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	NOV	2014	25	11					1266	1268		10.1111/jce.12484		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AS7ZL	WOS:000344470300021		
J	Mazzucco, S; Wang, Y; Tanase, M; Picher, M; Li, K; Wu, ZJ; Irle, S; Sharma, R				Mazzucco, Stefano; Wang, Ying; Tanase, Mihaela; Picher, Matthieu; Li, Kai; Wu, Zhijian; Irle, Stephan; Sharma, Renu			Direct evidence of active and inactive phases of Fe catalyst nanoparticles for carbon nanotube formation	JOURNAL OF CATALYSIS			English	Article						Active and inactive catalyst; Carbon nanotubes; Fischer-Tropsch; In situ Environmental transmission electron microscopy; ETEM; Iron carbides	INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; IRON CATALYST; HAGG-CARBIDE; BASIS-SET; ADSORPTION; EFFICIENT; SURFACES; POINTS	Iron-carbon interactions play an important role in various industrial activities such as liquid fuel production by the Fischer-Tropsch process and carbon nanotube synthesis by chemical vapor deposition. In both cases, catalytic activity is confined to a subset of catalyst nanoparticles. Despite the large number of experimental and theoretical studies on the activity of Fe nanoparticles, very little is known about the difference between the active and inactive particles. We use in situ environmental transmission electron microscopy to elucidate the differences between active and inactive nanoparticles with respect to carbon nanotube formation. We present direct evidence that nanoparticles with the cementite (Fe3C) structure are active for nanotube growth (C-C bond formation), while carbon-rich particles with Hagg (Fe5C2) structure are inactive. Density functional theory calculations suggest that reduced activity may be due to lower carbon mobility and higher C-C bond formation energies on the surface of nanoparticles with Fe5C2 structure. Published by Elsevier Inc.	[Mazzucco, Stefano; Tanase, Mihaela; Picher, Matthieu; Sharma, Renu] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Wang, Ying; Li, Kai; Wu, Zhijian] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China; [Tanase, Mihaela; Picher, Matthieu] Univ Maryland, IREAP, College Pk, MD 20742 USA; [Irle, Stephan] Nagoya Univ, WPI Inst Transformat Biomol, Nagoya, Aichi 4648602, Japan; [Irle, Stephan] Nagoya Univ, Dept Chem, Nagoya, Aichi 4648602, Japan	Sharma, R (reprint author), NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA.	renu.sharma@nist.gov	Irle, Stephan/E-8984-2011	Irle, Stephan/0000-0003-4995-4991	National Natural Science Foundation of China [21203174]; Natural Science Foundation of Jilin Province [20130522141JH]	Ying Wang thanks the National Natural Science Foundation of China for financial support (Grant No.: 21203174) and Natural Science Foundation of Jilin Province (20130522141JH).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Sharma R, 2009, NANO LETT, V9, P689, DOI 10.1021/nl803180e; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Dry ME, 2002, CATAL TODAY, V71, P227, DOI 10.1016/S0920-5861(01)00453-9; Kukovecz A, 2000, PHYS CHEM CHEM PHYS, V2, P3071, DOI 10.1039/b002331k; Wirth CT, 2012, CHEM MATER, V24, P4633, DOI 10.1021/cm301402g; Chiou WC, 2003, SURF SCI, V530, P87, DOI 10.1016/S0039-6028(03)00352-2; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Casey CP, 2007, J AM CHEM SOC, V129, P5816, DOI 10.1021/ja071159f; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Herranz T, 2006, J CATAL, V243, P199, DOI 10.1016/j.jcat.2006.07.012; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Sorescu DC, 2009, J PHYS CHEM C, V113, P9256, DOI 10.1021/jp811381d; Cao DB, 2008, J PHYS CHEM C, V112, P14883, DOI 10.1021/jp803326k; Chee S.-W., 2011, MICRON, V43, P1181; Gamalski A., 2009, APPL PHYS LETT, V95; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Retief JJ, 1999, POWDER DIFFR, V14, P130; Schneider A, 2007, CALPHAD, V31, P141, DOI 10.1016/j.calphad.2006.07.008; Steynberg P.J., 2008, J PHYS CONDENS MATT, V20, P11; Tsui F, 2004, J NANOSCI NANOTECHNO, V4, P408, DOI 10.1166/jnn.2004.062; Wei Q, 1999, MATER CORROS, V50, P628, DOI 10.1002/(SICI)1521-4176(199911)50:11<628::AID-MACO628>3.0.CO;2-3; Yoshida H., 2008, NANO LETT, V9, P3810	26	6	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	NOV	2014	319						54	60		10.1016/j.jcat.2014.07.023		7	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	AS7LK	WOS:000344437400006		
J	Jin, F; Chen, SY; Jang, LY; Lee, JF; Cheng, SF				Jin, Fang; Chen, Shih-Yuan; Jang, Ling-Yun; Lee, Jyh-Fu; Cheng, Soofin			New Ti-incorporated MCM-36 as an efficient epoxidation catalyst prepared by pillaring MCM-22 layers with titanosilicate	JOURNAL OF CATALYSIS			English	Article						MCM-36 analogue; Titanosilicate; Pillar; Epoxidation	MOLECULAR-SIEVE; TITANIA-SILICA; LAMELLAR PRECURSOR; HYDROGEN-PEROXIDE; MWW; ZEOLITE; ALKANES; SYSTEMS; XANES	A new Ti-incorporated MCM-36 material (shortly termed Si/Ti-MCM-36) with bimodal pore structures was prepared through sequential steps. The hexadecyltrimethylammonium swollen MCM-22 precursor was pillared with titanosilicate formed via hydrolysis of an interlayer mixture of tetraethylorthosilicate (TEOS) and tetrabutylorthotitanate (TBOT). Hydrolyzation of TEOS and TBOT was a key step for intercalation efficiency. The X-ray diffraction (XRD) patterns and N-2 sorption isotherm data confirmed the intercalation efficiency and the retention of basal layer MWW structure. A slightly ordered stacking of MWW sheets along c-direction was observed, generating mesopores of ca. 2 nm in diameter. Ti(IV) was well dispersed in the matrix of titanosilicate pillars, which expand the MWW layers apart. The Ti coordination environment examined by DR UV-Vis and Ti K-edge X-ray absorption spectroscopies was mainly in tetrahedral coordination. Post-treatment of the Si/Ti-MCM-36 materials with acid resulted in a new Ti-incorporated MCM-36 with good catalytic activities in cyclohexene epoxidation. (C) 2014 Elsevier Inc. All rights reserved.	[Jin, Fang; Cheng, Soofin] Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan; [Jin, Fang] Wuhan Inst Technol, Sch Chem & Pharmaceut Engn, Minist Educ, Key Lab Green Chem Proc, Wuhan 430073, Peoples R China; [Chen, Shih-Yuan] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Resource Convers Catalyst Grp, Tsukuba, Ibaraki 3058565, Japan; [Jang, Ling-Yun; Lee, Jyh-Fu] Natl Synchrotron Radiat Res Ctr, Div Res, Hsinchu 300, Taiwan	Cheng, SF (reprint author), Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan.	chem1031@ntu.edu.tw			Ministry of Science 82 Technology, Taiwan [NSC 101-2113-M-002-012-MY3, NSC 102-2811-M-002-136]; Natural Science Foundation, China (NSFC) [21306143]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Education Ministry (SEM), China; C.-Y. Chien of Instrumentation Center, National Taiwan University for the assistances in SEM and TEM experiments	The financial supports from Ministry of Science 82 Technology, Taiwan (NSC 101-2113-M-002-012-MY3, NSC 102-2811-M-002-136) are gratefully acknowledged. F. Jin also acknowledges the supports of Natural Science Foundation, China (NSFC 21306143) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, Education Ministry (SEM), China. Acknowledgment is also extended to Ms. Y.Y. Yang and C.-Y. Chien of Instrumentation Center, National Taiwan University for the assistances in SEM and TEM experiments.	Adam W, 2000, J CATAL, V196, P339, DOI 10.1006/jcat.2000.3043; Farges F, 1997, PHYS REV B, V56, P1809, DOI 10.1103/PhysRevB.56.1809; Chen SY, 2011, J MATER CHEM, V21, P2255, DOI 10.1039/c0jm03111a; LEONOWICZ ME, 1994, SCIENCE, V264, P1910, DOI 10.1126/science.264.5167.1910; MILLER JB, 1994, J CATAL, V150, P311, DOI 10.1006/jcat.1994.1349; Wu P, 2004, CATAL SURV ASIA, V8, P137, DOI 10.1023/B:CATS.0000027015.37277.fb; Zhang B, 2012, APPL CATAL A-GEN, V443, P103, DOI 10.1016/j.apcata.2012.07.028; Cozzolino M, 2007, APPL CATAL A-GEN, V325, P256, DOI 10.1016/j.apcata.2007.02.032; Xu H, 2014, MICROPOR MESOPOR MAT, V189, P41, DOI 10.1016/j.micromeso.2013.09.041; LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6; Roth WJ, 2011, MICROPOR MESOPOR MAT, V142, P32, DOI 10.1016/j.micromeso.2010.11.007; Roth WJ, 2013, CATAL TODAY, V204, P8, DOI 10.1016/j.cattod.2012.07.040; NOTARI B, 1993, CATAL TODAY, V18, P163, DOI 10.1016/0920-5861(93)85029-Y; Roth WJ, 2007, STUD SURF SCI CATAL, V168, P221; Corma A, 2000, MICROPOR MESOPOR MAT, V38, P301, DOI 10.1016/S1387-1811(00)00149-9; Wu P, 2002, CHEM COMMUN, P1026, DOI 10.1039/b201170k; Roth WJ, 1995, STUD SURF SCI CATAL, V94, P301; Fan WB, 2004, ANGEW CHEM INT EDIT, V43, P236, DOI 10.1002/anie.200352723; Maheshwari S, 2008, J AM CHEM SOC, V130, P1507, DOI 10.1021/ja077711i; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Ruan JF, 2005, ANGEW CHEM INT EDIT, V44, P6719, DOI 10.1002/anie.200501939; HUTTER R, 1995, J CATAL, V153, P177, DOI 10.1006/jcat.1995.1119; Bellussi G.P.G., 1988, EU Patent, Patent No. 293032; CLERICI MG, 1993, J CATAL, V140, P71, DOI 10.1006/jcat.1993.1069; Corma C.C.A., 1995, ZEOLITES, V15, P2; Diaz U., 2012, CHEM ENG, V2012, P1; Fan WB, 2006, J CATAL, V243, P183, DOI 10.1016/j.jcat.2006.07.003; Fraile JM, 2001, CHEM COMMUN, P1510, DOI 10.1039/b103057b; HUYBRECHTS DRC, 1990, NATURE, V345, P240, DOI 10.1038/345240a0; Jones D.A., 1996, PRINCIPLES PREVENTIO, P20; Kim SY, 2007, CATAL LETT, V113, P160, DOI 10.1007/s10562-007-9022-z; Davis RJ, 1997, CHEM MATER, V9, P2311, DOI 10.1021/cm970314u; Lowell S., 2004, CHARACTERIZATION POR, P101; Miltenburg A., 2009, TOP CATAL, V52, P1190; Moliner M, 2012, CHEM MATER, V24, P4371, DOI 10.1021/cm302509m; Notari B, 1996, ADV CATAL, V41, P253, DOI 10.1016/S0360-0564(08)60042-5; Roth W. J., 2000, STUD SURF SCI CATAL, V129, P501; Schwartz V, 2007, J PHYS CHEM C, V111, P17322, DOI 10.1021/jp074426c; Song F, 2006, J CATAL, V237, P359, DOI 10.1016/j.jcat.2005.11.018; Stojanova M, 1996, APPL CATAL A-GEN, V143, P175, DOI 10.1016/0926-860X(96)00079-8; Taramasso M., 1983, U.S. Patent, Patent No. 4410501; TATSUMI T, 1990, J CHEM SOC CHEM COMM, P476, DOI 10.1039/c39900000476; Wu P., 2008, STUD SURF SCI CATAL, V174, P24	43	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	NOV	2014	319						247	257		10.1016/j.jcat.2014.09.009		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	AS7LK	WOS:000344437400027		
J	Park, S; Watanabe, Y; Nishita, Y; Fukuoka, T; Inagaki, S; Kubota, Y				Park, Sungsik; Watanabe, Yasuhiro; Nishita, Yuji; Fukuoka, Takuya; Inagaki, Satoshi; Kubota, Yoshihiro			Catalytic conversion of dimethyl ether into propylene over MCM-68 zeolite	JOURNAL OF CATALYSIS			English	Article						Dimethyl ether; Propylene; MSE zeolite; Catalyst; DTO reaction	METHANOL-TO-HYDROCARBONS; MSE-TYPE ZEOLITE; PRODUCT SELECTIVITY; PERFORMANCE; TOPOLOGY; H-ZSM-5; ZSM-5; SHAPE; SIZE; DEACTIVATION	Control of the acid site distribution on MCM-68 zeolite catalysts can be achieved by the acid treatment with nitric acid. Less coke is deposited during DTO reactions over dealuminated MCM-68 compared to the parent MCM-68 probably due to the selective removal of acid sites on the external surface of the parent MCM-68. The higher yields of propylene and butylenes are obtained with lower selectivity for ethylene and lower paraffins over dealuminated MCM-68, whereas ethylene and lower paraffins are predominant over parent MCM-68. The acid treatment may preferentially remove the strong acid sites, and thus the retained acid sites with moderate strength mainly convert dimethyl ether into propylene and butylenes with high propylene/ethylene (P/E) molar ratio. Besides the issue of high P/E ratio, the ratio is also widely controllable by changing the reaction temperature. (C) 2014 Elsevier Inc. All rights reserved.	[Park, Sungsik; Watanabe, Yasuhiro; Nishita, Yuji; Fukuoka, Takuya; Inagaki, Satoshi; Kubota, Yoshihiro] Yokohama Natl Univ, Div Mat Sci & Chem Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Kubota, Y (reprint author), Yokohama Natl Univ, Div Mat Sci & Chem Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	kubota@ynu.ac.jp		Inagaki, Satoshi/0000-0002-3183-4513	Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST) [A5231Z03507C]	This work was financially supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP, A5231Z03507C) from Japan Science and Technology Agency (JST). S. I. thanks Arai Science and Technology Foundation.	Jang HG, 2013, J CATAL, V299, P240, DOI 10.1016/j.jcat.2012.12.014; Ilias S, 2013, J CATAL, V303, P135, DOI 10.1016/j.jcat.2013.03.021; Song WG, 2001, J AM CHEM SOC, V123, P4749, DOI 10.1021/ja0041167; SULLIVAN RF, 1961, J AM CHEM SOC, V83, P1156, DOI 10.1021/ja01466a036; Bjorgen M, 2009, CATAL TODAY, V142, P90, DOI 10.1016/j.cattod.2009.01.015; Inagaki S, 2010, CHEM COMMUN, V46, P2662, DOI 10.1039/b925408k; CHANG CD, 1977, J CATAL, V47, P249, DOI 10.1016/0021-9517(77)90172-5; Yamazaki H, 2012, J PHYS CHEM C, V116, P24091, DOI 10.1021/jp307290z; Yamazaki H, 2011, ANGEW CHEM INT EDIT, V50, P1853, DOI 10.1002/anie.201007178; Olsbye U, 2012, ANGEW CHEM INT EDIT, V51, P5810, DOI 10.1002/anie.201103657; Park JW, 2008, APPL CATAL A-GEN, V339, P36, DOI 10.1016/j.apcata.2008.01.005; NAMBA S, 1986, ZEOLITES, V6, P107, DOI 10.1016/S0144-2449(86)80006-9; Li JZ, 2011, CATAL TODAY, V171, P221, DOI 10.1016/j.cattod.2011.02.027; Tawada S, 2000, CATAL TODAY, V60, P243, DOI 10.1016/S0920-5861(00)00341-2; Plotkin JS, 2005, CATAL TODAY, V106, P10, DOI 10.1016/j.cattod.2005.07.174; Shibata T, 2009, J MOL CATAL A-CHEM, V297, P80, DOI 10.1016/j.molcata.2008.09.016; Kubota Y, 2014, CATAL TODAY, V226, P109, DOI 10.1016/j.cattod.2013.10.032; CHANG CD, 1984, J CATAL, V86, P289, DOI 10.1016/0021-9517(84)90374-9; Dorset DL, 2006, J PHYS CHEM B, V110, P2045, DOI 10.1021/jp0565352; Chen JQ, 2005, CATAL TODAY, V106, P103, DOI 10.1016/j.cattod.2005.07.178; Koyama T, 2010, PHYS CHEM CHEM PHYS, V12, P2541, DOI 10.1039/b921927g; Elangovan SP, 2006, MICROPOR MESOPOR MAT, V96, P210, DOI 10.1016/j.micromeso.2006.06.038; Stocker M, 1999, MICROPOR MESOPOR MAT, V29, P3, DOI 10.1016/S1387-1811(98)00319-9; Keil FJ, 1999, MICROPOR MESOPOR MAT, V29, P49, DOI 10.1016/S1387-1811(98)00320-5; Sasaki M, 2014, ACS CATAL, V4, P2653, DOI 10.1021/cs5007926; Baerlocher Ch., 2007, ATLAS ZEOLITE FRAMEW; Calabro DC, 2000, US Patent, Patent No. 6049018; Ernst S., 2004, 14 INT ZEOL C, P982; Inagaki S, 2013, ACS CATAL, V3, P74, DOI 10.1021/cs300426k; Inagaki S, 2013, CHEM-EUR J, V19, P7780, DOI 10.1002/chem.201300125; Jang HG, 2012, APPL CATAL A-GEN, V437, P120, DOI 10.1016/j.apcata.2012.06.023; Koyama Y, 2008, ANGEW CHEM INT EDIT, V47, P1042, DOI 10.1002/anie.200704222; Kubota Y, 2008, CHEM COMMUN, P6224, DOI 10.1039/b814286f; Niwa M, 1997, CATAL SURV JPN, V1, P215, DOI DOI 10.1023/A:1019033115091; Shibata T, 2008, MICROPOR MESOPOR MAT, V116, P216, DOI 10.1016/j.micromeso.2008.04.006; Wang Q, 2014, RENEW SUST ENERG REV, V30, P1, DOI 10.1016/j.rser.2013.08.065	36	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	NOV	2014	319						265	273		10.1016/j.jcat.2014.09.002		9	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	AS7LK	WOS:000344437400029		
J	Kamoi, K; Mochizuki, M				Kamoi, Koju; Mochizuki, Manabu			Pre-surround division technique: Precise cracks surrounding the posterior opacity prior to phacoemulsification in posterior polar cataract surgery	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							MANAGEMENT	Three methods are currently used for posterior polar cataract surgery: intracapsular cataract extraction, posterior approach, and anterior approach. A high level of skill is required to divide the lens in the anterior approach, and few studies have investigated safer or simpler division methods. We focused on the division method in posterior polar cataract and developed a pre-surround division technique that divides the nucleus and avoids the posterior opacity. This technique creates precise cracks that surround the posterior opacity prior to phacoemulsification and does not cause intraoperative complications, resulting in successful intraocular lens implantation in all eyes. This pre-surround division method is a safe and easy technique that can be used in patients with posterior polar cataract.	[Kamoi, Koju; Mochizuki, Manabu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo 1138519, Japan	Kamoi, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	koju.oph@tmd.ac.jp					Akahoshi T., 1998, OPERATIVE TECH CATAR, V1, P69; Arshinoff SA, 1999, J CATARACT REFR SURG, V25, P167, DOI 10.1016/S0886-3350(99)80121-7; FINE IH, 1991, J CATARACT REFR SURG, V17, P366; Chee SP, 2007, J CATARACT REFR SURG, V33, P1509, DOI 10.1016/j.jcrs.2007.05.027; Fine IH, 2003, J CATARACT REFR SURG, V29, P16, DOI 10.1016/S0886-3350(02)01616-4; GIMBEL HV, 1991, J CATARACT REFR SURG, V17, P110; GIMBEL HV, 1991, J CATARACT REFR SURG, V17, P281; Hayashi K, 2003, J CATARACT REFR SURG, V29, P45, DOI 10.1016/S0883-3350(02)01692-9; OSHER RH, 1990, J CATARACT REFR SURG, V16, P157; OSHER RH, 1993, J CATARACT REFR SURG, V19, P667; Vasavada A, 1998, J CATARACT REFR SURG, V24, P156; Vasavada A, 1999, J CATARACT REFR SURG, V25, P238, DOI 10.1016/S0886-3350(99)80133-3; Vasavada AR, 2012, EYE, V26, P761, DOI 10.1038/eye.2012.33; Vasavada AR, 2004, J CATARACT REFR SURG, V30, P1167, DOI 10.1016/j.jcrs.2003.10.034	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	NOV	2014	40	11					1764	1767		10.1016/j.jcrs.2014.09.002		4	Ophthalmology; Surgery	Ophthalmology; Surgery	AS9SC	WOS:000344580800003		
J	Takamura, Y; Tomomatsu, T; Yokota, S; Matsumura, T; Takihara, Y; Inatani, M				Takamura, Yoshihiro; Tomomatsu, Takeshi; Yokota, Satoshi; Matsumura, Takehiro; Takihara, Yuji; Inatani, Masaru			Large capsulorhexis with implantation of a 7.0 mm optic intraocular lens during cataract surgery in patients with diabetes mellitus	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							ANTERIOR CAPSULE CONTRACTION; EDGE DESIGN; OPACIFICATION; EYES; MICROINCISION; DISLOCATION	PURPOSE: To evaluate the efficacy of a large capsulorhexis and intraocular lens (IOL) in obtaining a larger anterior capsule opening after cataract surgery in patients with diabetes mellitus (DM). SETTING: Department of Ophthalmology, University of Fukui, Fukui, Japan. DESIGN: Prospective clinical trial. METHODS: Patients with DM had bilateral cataract surgery with a 2.8 or 3.0 mm scleral incision, a capsulorhexis with a diameter of approximately 5.0 or 6.0 mm, and implantation of a 6.0 mm optic (Eternity X-60) or 7.0 mm optic (Eternity X-70) IOL. The anterior capsule opening area, aqueous flare intensity, surgically induced astigmatism (SIA), corneal endothelial cell density (ECD), and central corneal thickness (CCT) were measured 1 day, 1 week, and 1, 3, and 6 months after surgery. RESULTS: Thirty-one patients (62 eyes) with DM were enrolled. At all postoperative timepoints, the anterior capsule opening was significantly larger in eyes with the 7.0 mm optic IOL than in eyes with the 6.0 mm optic IOL (P<.05, Mann-Whitney U test). There were no significant differences in postoperative aqueous flare intensity, SIA, ECD, or OCT based on the size of the capsulorhexis and IOL. CONCLUSION: A larger capsulorhexis and implantation of a 7.0 mm IOL resulted in a larger anterior capsule opening after cataract surgery in patients with DM.	[Takamura, Yoshihiro; Tomomatsu, Takeshi; Yokota, Satoshi; Matsumura, Takehiro; Takihara, Yuji; Inatani, Masaru] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Eiheiji, Fukui 9101193, Japan; [Yokota, Satoshi] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Takamura, Y (reprint author), Univ Fukui, Fac Med Sci, Dept Ophthalmol, Eiheiji, Fukui 9101193, Japan.	ytakamura@hotmail.com					GIMBEL HV, 1990, J CATARACT REFR SURG, V16, P31; Hayashi H, 1998, BRIT J OPHTHALMOL, V82, P1429, DOI 10.1136/bjo.82.12.1429; DAVISON JA, 1993, J CATARACT REFR SURG, V19, P582; Tadros A, 2005, J CATARACT REFR SURG, V31, P1569, DOI 10.1016/j.jcrs.2005.01.027; Linebarger EJ, 1999, SURV OPHTHALMOL, V44, P123, DOI 10.1016/S0039-6257(99)00085-5; Cochener B, 1999, J CATARACT REFR SURG, V25, P1362, DOI 10.1016/S0886-3350(99)00227-8; Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024; Shah SK, 2009, EYE, V23, P1702, DOI 10.1038/eye.2008.355; Marcantonio JM, 1999, EYE, V13, P484; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831; ASSIA EI, 1991, OPHTHALMOLOGY, V98, P432; ASSIA EI, 1991, ARCH OPHTHALMOL-CHIC, V109, P642; Berdahl JP, 2008, J CATARACT REFR SURG, V34, P2091, DOI 10.1016/j.jcrs.2008.08.025; Buehl W, 2005, J CATARACT REFR SURG, V31, P954, DOI 10.1016/j.jcrs.2004.09.053; Dahlhauser KE, 1998, J CATARACT REFR SURG, V24, P1216; Hayashi H, 1998, J CATARACT REFR SURG, V24, P1105; Hayashi K, 2008, AM J OPHTHALMOL, V146, P23, DOI 10.1016/j.ajo.2008.02.015; Hayashi K, 1998, OPHTHALMOLOGY, V105, P1239, DOI 10.1016/S0161-6420(98)97028-2; Kato S, 2001, BRIT J OPHTHALMOL, V85, P21, DOI 10.1136/bjo.85.1.21; Kim EC, 2011, J CATARACT REFR SURG, V37, P1799, DOI 10.1016/j.jcrs.2011.04.024; Miyata K, 2007, ACTA OPHTHALMOL SCAN, V85, P99, DOI 10.1111/j.1600-0420.2006.00758.x; Morikubo S, 2004, ARCH OPHTHALMOL-CHIC, V122, P966, DOI 10.1001/archopht.122.7.966; Sacu S, 2005, J CATARACT REFR SURG, V31, P1888, DOI 10.1016/j.jcrs.2005.03.072; Sacu S, 2004, J CATARACT REFR SURG, V30, P1875, DOI 10.1016/j.jcrs.2004.01.042; Tajima H, 2009, RINSHO GANKA, V63, P1109; Takamura Y, 2013, J CATARACT REFR SURG, V39, P716, DOI 10.1016/j.jcrs.2012.12.029	26	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	NOV	2014	40	11					1850	1856		10.1016/j.jcrs.2014.02.039		7	Ophthalmology; Surgery	Ophthalmology; Surgery	AS9SC	WOS:000344580800015		
J	Haruki, T; Miyazaki, D; Matsuura, K; Terasaka, Y; Noguchi, Y; Inoue, Y; Yamagami, S				Haruki, Tomoko; Miyazaki, Dai; Matsuura, Kazuki; Terasaka, Yuki; Noguchi, Yumiko; Inoue, Yoshitsugu; Yamagami, Satoru			Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							PROPHYLACTIC INTRACAMERAL MOXIFLOXACIN; CATARACT-SURGERY; POSTOPERATIVE ENDOPHTHALMITIS; PREVENTING ENDOPHTHALMITIS; SAFETY; INJECTION; CEFAZOLIN; INFLAMMATION; ANTIBIOTICS; MULTICENTER	PURPOSE: To evaluate and compare the toxic effects of moxifloxacin, cefuroxime, and levofloxacin on human corneal endothelial cells in vitro and determine the safe intracameral concentrations for them. SETTING: Tottori University, Tottori, Japan. DESIGN: Experimental study. METHODS: Human corneal endothelial cells in culture were exposed to moxifloxacin, cefuroxime, and levofloxacin at concentrations up to 2000 mu g/mL. Evaluation of membrane damage was determined by ethidium homodimer-1 uptake and cell viability, by intrinsic esterase activity. The inhibitory effects of the 3 antibiotics on the constitutive secretion of interleukin-6 (IL-6) by human corneal endothelial cells were determined by enzyme-linked immunosorbent assay. RESULTS: The acute effects (6 hour) of the 3 antibiotics on membrane damage and cell death were dose-dependent for moxifloxacin and levofloxacin (>= 500 mu g/mL). For cefuroxime, membrane damage was not observed at 6 hours and only slight damage was detected at 24 hours at concentrations higher than 500 mu g/mL. The half maximum inhibitory concentrations on cell viability of moxifloxacin, levofloxacin, and cefuroxime were 487 mu g/mL, 578 mu g/mL, and 1600 mu g/mL, respectively. The inhibitory effects of the 3 antibiotics on the constitutive secretion of IL-6 were observed at 15.6 mu g/mL or higher, indicating the antibiotics can impair the secretion of the protective cytokine even at low concentrations. CONCLUSIONS: Moxifloxacin at more than 500 mu g/mL caused damage to the cell membranes of corneal endothelial cells; even higher concentrations decreased cell viability. Considering the lower minimum inhibitory concentration for inhibiting 90% growth by moxifloxacin, intracameral moxifloxacin at 500 mu g/mL or less is recommended for prophylactic use.	[Haruki, Tomoko; Miyazaki, Dai; Matsuura, Kazuki; Terasaka, Yuki; Noguchi, Yumiko; Inoue, Yoshitsugu] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Yonago, Tottori 6838504, Japan; [Yamagami, Satoru] Univ Tokyo, Grad Sch Med, Corneal Transplantat Sect, Tokyo, Japan	Miyazaki, D (reprint author), Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	dm@grape.med.tottori-u.ac.jp					Friling E, 2013, J CATARACT REFR SURG, V39, P15, DOI 10.1016/j.jcrs.2012.10.037; Miyazaki D, 2011, INVEST OPHTH VIS SCI, V52, P4282, DOI 10.1167/iovs.10-6911; Kernt M, 2008, J CATARACT REFR SURG, V34, P480, DOI 10.1016/j.jcrs.2007.10.046; Chang DF, 2007, J CATARACT REFR SURG, V33, P1801, DOI 10.1016/j.jcrs.2007.07.009; Barreau G, 2012, J CATARACT REFR SURG, V38, P1370, DOI 10.1016/j.jcrs.2012.03.024; Lane SS, 2008, J CATARACT REFR SURG, V34, P1451, DOI 10.1016/j.jcrs.2008.05.034; Yao K, 2013, BRIT J OPHTHALMOL, V97, P1312, DOI 10.1136/bjophthalmol-2013-303282; Tan CSH, 2012, J CATARACT REFR SURG, V38, P425, DOI 10.1016/j.jcrs.2011.09.040; Montan PG, 2002, J CATARACT REFR SURG, V28, P982, DOI 10.1016/S0886-3350(01)01270-6; Takeda S, 2011, INVEST OPHTH VIS SCI, V52, P6729, DOI 10.1167/iovs.11-7805; Shorstein NH, 2013, J CATARACT REFR SURG, V39, P8, DOI 10.1016/j.jcrs.2012.07.031; FICKER L, 1990, INVEST OPHTH VIS SCI, V31, P502; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; Matsuura K, 2013, J CATARACT REFR SURG, V39, P1702, DOI 10.1016/j.jcrs.2013.05.036; Espiritu CRG, 2007, J CATARACT REFR SURG, V33, P63, DOI 10.1016/j.jcrs.2006.09.019; Yoeruek E, 2008, J CATARACT REFR SURG, V34, P2139, DOI 10.1016/j.jcrs.2008.08.022; Montan PG, 2002, J CATARACT REFR SURG, V28, P977, DOI 10.1016/S0886-3350(01)01269-X; Garcia-Saenz MC, 2010, J CATARACT REFR SURG, V36, P203, DOI 10.1016/j.jcrs.2009.08.023; Kim SY, 2008, CLIN EXP OPHTHALMOL, V36, P367, DOI 10.1111/j.1442-9071.2008.01771.x; Arshinoff SA, 2011, J CATARACT REFR SURG, V37, P2105, DOI 10.1016/j.jcrs.2011.06.036; Arbisser LB, 2008, J CATARACT REFR SURG, V34, P1114, DOI 10.1016/j.jcrs.2008.03.017; Barry P, 2013, ESCRS GUIDELINES PRE; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Garat M, 2005, J CATARACT REFR SURG, V31, P2230, DOI 10.1016/j.jcrs.2005.08.053; GATTI G, 1995, ANTIMICROB AGENTS CH, V39, P549; Kernt M, 2009, CORNEA, V28, P553, DOI 10.1097/ICO.0b013e318191447b; Matsuura K, 2013, GRAEF ARCH CLIN EXP, V251, P1955, DOI 10.1007/s00417-013-2294-7; O'Brien TP, 2007, J CATARACT REFR SURG, V33, P1790, DOI 10.1016/j.jcrs.2007.06.026; Pathengay A, 2012, J CATARACT REFR SURG, V38, P1278, DOI 10.1016/j.jcrs.2012.04.021; Rodriguez-Caravaca G, 2013, J CATARACT REFR SURG, V39, P1399, DOI 10.1016/j.jcrs.2013.03.031	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	NOV	2014	40	11					1872	1878		10.1016/j.jcrs.2014.08.027		7	Ophthalmology; Surgery	Ophthalmology; Surgery	AS9SC	WOS:000344580800019		
J	Kawano, H; Sakamoto, T; Ito, T; Miyata, K; Hashiguchi, T; Maruyama, I				Kawano, Hiroki; Sakamoto, Taiji; Ito, Takashi; Miyata, Kazunori; Hashiguchi, Teruto; Maruyama, Ikuro			Hyaluronan protection of corneal endothelial cells against extracellular histones after phacoemulsification	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							RETINAL-DETACHMENT; PIGMENT EPITHELIUM; LIVER-INJURY; TLR4; MORPHOLOGY; MEDIATORS; CYTOKINE; SYSTEM; DEATH	PURPOSE: To determine the effect of histones on corneal endothelial cells generated during cataract surgery. SETTING: Kagoshima University Hospital, Kagoshima, Japan. DESIGN: Experimental study. METHODS: Standard phacoemulsification was performed on enucleated pig eyes. Histones in the anterior segment of the eye were determined by immunohistochemistry. Cultured human corneal endothelial cells were exposed to histones for 18 hours, and cell viability was determined by 2-(2-methoxy-4-nitrophenyl)-3-(4-nitro-phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt assay. The concentration of interleukin-6 (IL-6) in the culture medium of human corneal endothelial cells was measured using enzyme-linked immunosorbent assay. The effects of signal inhibitors U0126, SB203580, and SP600125 were evaluated. The protective effect of hyaluronan against histones was evaluated in human corneal endothelial cells with and without hyaluronan. RESULTS: Cellular debris containing histones was observed in the anterior chamber of pig eyes after phacoemulsification. Exposure of human corneal endothelial cells to 50 mu g/mL of histones or more led to cytotoxic effects. The IL-6 concentration was significantly increased dose dependently after exposure of human corneal endothelial cells to histones (P<.01). The histone-induced IL-6 production was significantly decreased by extracellular signal-regulated kinases 1/2 and p-38 mitogen-activated protein kinase inhibitors (P<.01). Co-incubation of hyaluronan and histones caused formation of histone aggregates, decreased the cytotoxic effects of the histones, and blocked the increase in IL-6 (P<.01). CONCLUSIONS: Histones were released extracellularly during phacoemulsification and exposure of human corneal endothelial cells to histones increased the IL-6 secretion. The intraoperative use of hyaluronan may decrease the cytotoxic effects of histones released during cataract surgery.	[Kawano, Hiroki; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 8908520, Japan; [Hashiguchi, Teruto] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 8908520, Japan; [Ito, Takashi; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 8908520, Japan; [Miyata, Kazunori] Miyata Eye Hosp, Miyakonojo, Japan	Sakamoto, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Research Committee on Chorioretinal Degeneration and Optic Atrophy; Ministry of Health, Labor, and Welfare; Ministry of Education, Science, and Culture of the Japanese government [20390450]	Supported in part by a grant from the Research Committee on Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare (Dr. Sakamoto), and by a grant-in-aid for Scientific Research (20390450) from the Ministry of Education, Science, and Culture of the Japanese government.	Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Abrams ST, 2013, J IMMUNOL, V191, P2495, DOI 10.4049/jimmunol.1203181; Sonawane S, 2012, INVEST OPHTH VIS SCI, V53, P8253, DOI 10.1167/iovs.12-10430; Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; TREFFERS WF, 1982, OPHTHALMOLOGY, V89, P605; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Kawano H, 2014, LAB INVEST, V94, P569, DOI 10.1038/labinvest.2014.46; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Shirasawa M, 2013, EXP EYE RES, V110, P59, DOI 10.1016/j.exer.2013.02.012; Faramarzi A, 2011, J CATARACT REFR SURG, V37, P1971, DOI 10.1016/j.jcrs.2011.05.034; Pemberton AD, 2010, PROTEOMICS, V10, P1484, DOI 10.1002/pmic.200900818; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; LANDSHMAN N, 1988, INVEST OPHTH VIS SCI, V29, P1100; Leonardi A, 2009, J CATARACT REFR SURG, V35, P240, DOI 10.1016/j.jcrs.2008.10.030; LING TL, 1988, INVEST OPHTH VIS SCI, V29, P1407; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075961; Otsuka H, 2010, AM J PATHOL, V177, P2268, DOI 10.2353/ajpath.2010.100134; Terasaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069994; Yao X, 2014, AM J PHYSIOL-HEART C, V306, pH882, DOI 10.1152/ajpheart.00475.2013	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	NOV	2014	40	11					1885	1893		10.1016/j.jcrs.2014.07.026		9	Ophthalmology; Surgery	Ophthalmology; Surgery	AS9SC	WOS:000344580800021		
J	Kakisaka, Y; Kikuchi, A; Hino-Fukuyo, N; Uematsu, M; Kure, S				Kakisaka, Yosuke; Kikuchi, Atsuo; Hino-Fukuyo, Naomi; Uematsu, Mitsugu; Kure, Shigeo			Correspondence on "Clinical Characterization of Gastroenteritis-Related Seizures in Children: Impact of Fever and Serum Sodium Levels"	JOURNAL OF CHILD NEUROLOGY			English	Letter									[Kakisaka, Yosuke] South Miyagi Med Ctr, Dept Pediat, Ogawara, Japan; [Kakisaka, Yosuke; Kikuchi, Atsuo; Hino-Fukuyo, Naomi; Uematsu, Mitsugu; Kure, Shigeo] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan	Kakisaka, Y (reprint author), South Miyagi Med Ctr, Dept Pediat, Ogawara, Japan.						Tanabe T, 2011, BRAIN DEV-JPN, V33, P120, DOI 10.1016/j.braindev.2010.02.007; Dsura-Trave T, 2011, EUR J NEUROL, V18, P273; Verrotti A, 2011, EPILEPSY RES, V93, P107, DOI 10.1016/j.eplepsyres.2010.11.004; Zifman E, 2011, J CHILD NEUROL, V26, P1397, DOI 10.1177/0883073811409222	4	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	NOV	2014	29	11					1578	1579		10.1177/0883073813497428		2	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AT0XB	WOS:000344655400033		
J	Kawai, T; Watanabe, N; Yokoyama, M; Nakazawa, Y; Goto, F; Uchiyama, T; Higuchi, M; Maekawa, T; Tamura, E; Nagasaka, S; Hojo, M; Onodera, M				Kawai, Toshinao; Watanabe, Nobuyuki; Yokoyama, Midori; Nakazawa, Yumiko; Goto, Fumihiro; Uchiyama, Toru; Higuchi, Masataka; Maekawa, Takanobu; Tamura, Eiichiro; Nagasaka, Satoshi; Hojo, Masayuki; Onodera, Masafumi			Interstitial Lung Disease with Multiple Microgranulomas in Chronic Granulomatous Disease	JOURNAL OF CLINICAL IMMUNOLOGY			English	Article						Chronic granulomatous disease; interstitial lung disease; inflammation; granuloma; hypersensitivity pneumonia	INVASIVE FUNGAL-INFECTIONS; HYPERSENSITIVITY PNEUMONITIS; THALIDOMIDE; ACTIVATION; INFLAMMASOME; DIAGNOSIS; FEATURES	Chronic granulomatous disease (CGD) is a primary immunodeficiency disease that is characterized by susceptibility to bacterial and fungal infections. CGD patients also suffer from immune regulatory disorders, such as CGD-associated bowel inflammation with granuloma, which could be caused by excessive inflammation without demonstrable infection. We investigated the clinical manifestation of interstitial lung disease (ILD) resulting from excessive inflammation in X-linked CGD patients. Pulmonary CT images and testing of serum KL-6 levels were performed to assess ILD in the patients. For this study, patients with pulmonary lesions due to demonstrable infections were excluded from among ILD patients. Among 33 CGD patients, four developed ILD; they had increased reticulo-nodular opacities on CT images and elevated serum KL-6 levels. Histopathological examinations revealed multiple homogeneous microgranulomas in the lesions of inflammatory cell infiltration. Mononuclear cells obtained from their pulmonary lesions produced higher amounts of inflammatory cytokines than the peripheral blood mononuclear cells of CGD patients, suggesting that the only infiltrating cells in the pulmonary lesions were activated and produced large amounts of inflammatory cytokines in ILD patients. Interestingly, an anti-inflammatory drug, such as a corticosteroid or thalidomide, but not anti-bacterial or anti-fungal drugs, improved CT image findings and reduced their KL-6 levels. CGD patients' daily exposures to inhaled antigens may induce excessive reactions with the production of inflammatory cytokines leading to the development of ILD with multiple microgranulomas, which could be due to an inadequate production of reactive oxygen species in CGD.	[Kawai, Toshinao; Watanabe, Nobuyuki; Yokoyama, Midori; Nakazawa, Yumiko; Goto, Fumihiro; Uchiyama, Toru; Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, Tokyo 1578535, Japan; [Higuchi, Masataka] Natl Ctr Child Hlth & Dev, Div Pulmonol, Tokyo 1578535, Japan; [Maekawa, Takanobu] Natl Ctr Child Hlth & Dev, Dept Pediat, Tokyo 1578535, Japan; [Tamura, Eiichiro] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Nagasaka, Satoshi] Natl Ctr Global Hlth & Med Japan, Div Gen Thorac Surg, Tokyo, Japan; [Hojo, Masayuki] Natl Ctr Global Hlth & Med Japan, Div Resp Med, Tokyo, Japan	Kawai, T (reprint author), Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kawai-t@ncchd.go.jp			National Center for Child Health and Development	We are grateful to the CGD patients and blood donors for their participation in this study. The manuscript was proofread and edited by Dr. Julian Tang of the Department of Clinical Research Education, National Center for Child Health and Development. This study was supported by a Grant from the National Center for Child Health and Development.	Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Kawai T, 2013, CLIN IMMUNOL, V147, P122, DOI 10.1016/j.clim.2013.03.004; Lacasse Y, 2009, INT ARCH ALLERGY IMM, V149, P161, DOI 10.1159/000189200; Uzel G, 2010, CLIN INFECT DIS, V51, P1429, DOI 10.1086/657308; Yasui K, 2010, ARTHRITIS RHEUM-US, V62, P250, DOI 10.1002/art.25035; Keller M, 2009, J IMMUNOL, V183, P5593, DOI 10.4049/jimmunol.0900476; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Van Hoeyveld E, 2006, CLIN CHEM, V52, P1785, DOI 10.1373/clinchem.2006.067546; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Kang EM, 2011, J ALLERGY CLIN IMMUN, V127, P1319, DOI 10.1016/j.jaci.2011.03.028; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Kawai T, 2011, INFECTION, V39, P171, DOI 10.1007/s15010-011-0080-1; Buchvald F, 2011, PEDIATR PULM, V46, P1098, DOI 10.1002/ppul.21479; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Persat F, 2008, J CLIN MICROBIOL, V46, P1009, DOI 10.1128/JCM.02091-07; Bogaert P, 2009, AM J PATHOL, V174, P3, DOI 10.2353/ajpath.2009.071151; Eski M, 2008, BURNS, V34, P104, DOI 10.1016/j.burns.2007.01.007; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Khaldi H, 2009, EUR RESPIR J, V33, P1498, DOI 10.1183/09031936.00138107; Kobayashi S, 2008, EUR J PEDIATR, V167, P1389, DOI 10.1007/s00431-008-0680-7; Meierhofer C, 2003, CURR OPIN DRUG DISC, V6, P92; Olsson S, 2007, MOL IMMUNOL, V44, P1509, DOI 10.1016/j.molimm.2006.09.004; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Senn L, 2008, CLIN INFECT DIS, V46, P878, DOI 10.1086/527382; Shah Ashok, 2008, Indian J Chest Dis Allied Sci, V50, P117	31	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0271-9142	1573-2592		J CLIN IMMUNOL	J. Clin. Immunol.	NOV	2014	34	8					933	940		10.1007/s10875-014-0089-1		8	Immunology	Immunology	AT2QU	WOS:000344780000008		
J	Mine, S; Suzuki, K; Sato, Y; Fukumoto, H; Kataoka, M; Inoue, N; Ohbayashi, C; Hasegawa, H; Sata, T; Fukayama, M; Katano, H				Mine, Sohtaro; Suzuki, Koyu; Sato, Yuko; Fukumoto, Hitomi; Kataoka, Michiyo; Inoue, Naoki; Ohbayashi, Chiho; Hasegawa, Hideki; Sata, Tetsutaro; Fukayama, Masashi; Katano, Harutaka			Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: A case report	JOURNAL OF CLINICAL VIROLOGY			English	Article						Human herpesvirus 6; DRESS syndrome; Drug-induced hypersensitivity syndrome; Regulatory T-cells; Lymphadenit is; Over-the-counter medicine	INDUCED HYPERSENSITIVITY SYNDROME; CLINICAL-SAMPLES; DRESS-SYNDROME; IDENTIFICATION; HUMAN-HERPESVIRUS-6; VIRUSES; CD4(+); HHV-6B; GENE	We describe a fatal case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with human herpesvirus-6B (HHV-6B)-associated lymphadenitis and virus-associated hemophagocytic syndrome triggered by an over-the-counter medication to treat respiratory and influenza-like symptoms. Histologically, the structure of the lymph node was disrupted with infiltration of large lymphocytes carrying intranuclear acidophilic inclusion bodies. Immunohistochemistry and real-time PCR analysis revealed that these large lymphocytes were positive for HHV-6B. Numerous HHV-6 particles were detected in the inclusion body of the lymphocytes by electron microscopy. Interestingly, immunohistochemistry revealed that HHV-6B-infected cells in the lymph node were CD3(+), CD4(+), CD25(+), and FoxP3(+) T cells, indicating a phenotypic resemblance to regulatory T-cells. This case provides direct evidence of HHV-6 infection in CD25(+)/FoxP3(+) T cells in a case of acute lymphadenitis of DRESS syndrome, suggesting a significant role of HHV-6 infection of regulatory T-cells in the pathogenesis of DRESS syndrome. (C) 2014 Elsevier B.V. All rights reserved.	[Mine, Sohtaro; Sato, Yuko; Fukumoto, Hitomi; Kataoka, Michiyo; Hasegawa, Hideki; Sata, Tetsutaro; Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Mine, Sohtaro; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Koyu] St Lukes Int Hosp, Dept Pathol, Chuo Ku, Tokyo 1048560, Japan; [Inoue, Naoki] Gifu Pharmaceut Univ, Dept Microbiol & Immunol, Gifu 5011196, Japan; [Ohbayashi, Chiho] Nara Medial Univ, Dept Diagnost Pathol, Kashihara, Nara 6348521, Japan; [Sata, Tetsutaro] Toyama Inst Hlth, Imizu, Toyama 9390363, Japan	Katano, H (reprint author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	katano@nih.go.jp			Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan [H25-Shinko-Ippan-015, H25-Shinko-Shitei-006]	Partial support from Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan, to HK (No. H25-Shinko-Ippan-015 and H25-Shinko-Shitei-006).	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Tanaka N, 2000, BONE MARROW TRANSPL, V26, P1193, DOI 10.1038/sj.bmt.1702710; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Cassina G, 2013, J VIROL METHODS, V189, P172, DOI 10.1016/j.jviromet.2013.01.018; YAMANISHI K, 1988, LANCET, V1, P1065; Shiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Fernando SL, 2014, AUSTRALAS J DERMATOL, V55, P15, DOI 10.1111/ajd.12085; Hanafusa T, 2012, J DERMATOL SCI, V65, P213, DOI 10.1016/j.jdermsci.2011.12.002; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Maric I, 2004, MODERN PATHOL, V17, P1427, DOI 10.1038/modpathol.3800179; Morito H, 2014, CLIN EXP DERMATOL, V39, P284, DOI 10.1111/ced.12246; Otani N, 2007, MICROBIOL IMMUNOL, V51, P993; Papanikolaou E, 2002, VIRUS RES, V89, P89, DOI 10.1016/S0168-1702(02)00126-0; PELLETT PE, 1993, VIROLOGY, V195, P521, DOI 10.1006/viro.1993.1403; Saraya T, 2013, J CLIN MICROBIOL, V51, P1979, DOI 10.1128/JCM.00097-13; Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46; Wang F, 2014, J VIROL, V88, P1011, DOI 10.1128/JVI.02586-13	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	NOV	2014	61	3					448	452		10.1016/j.jcv.2014.08.025		5	Virology	Virology	AT2GB	WOS:000344750100026		
J	Yamamura, E				Yamamura, Eiji			The effect of young children on their parents' anime-viewing habits: evidence from Japanese microdata	JOURNAL OF CULTURAL ECONOMICS			English	Article						Anime; Japan; Externality; Contemporary culture; Otaku; Cool Japan	DAUGHTERS; BEHAVIOR; DEMAND; VALUES; CINEMA	Anime is now considered an accepted form of animation and is considered to represent Japanese contemporary culture worldwide. There are many fans of anime and manga, creating a community known as otaku world. However, Japanese anime and manga have gained popularity in Western countries as well as in Japan. This paper attempts to ascertain the determinants of watching anime in Japan based on individual-level data from Japan. Despite the growth in the number of adult anime fans, children are still more likely to watch anime than adults are. Hence, this study investigates how adults are influenced by the presence of their children. After controlling for individual characteristics, it was found that people are more likely to watch anime when they have children aged less than 12 years who have not yet entered junior high school. Such an effect is larger for parents who belong to an older generation where people are less likely to prefer anime. This implies that the externality coming from children results in parents watching anime. The findings of this study show that externalities from surrounding people play a critical role in enlarging the market of modern cultural goods representing "Cool Japan.".	Seinan Gakuin Univ, Dept Econ, Sawara Ku, Fukuoka 8148511, Japan	Yamamura, E (reprint author), Seinan Gakuin Univ, Dept Econ, Sawara Ku, 6-2-92 Nishijin, Fukuoka 8148511, Japan.	cyl02111@nifty.com					Abe Y, 2009, CONTEMP ECON POLICY, V27, P147, DOI 10.1111/j.1465-7287.2008.00115.x; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Calvo-Armengol A, 2009, AM ECON J-MICROECON, V1, P124, DOI 10.1257/mic.1.1.124; [Anonymous], 2008, DAILY YOMIURI; Washington EL, 2008, AM ECON REV, V98, P311, DOI 10.1257/aer.98.1.311; [Anonymous], 2011, DAILY YOMIURI; Abe Y, 2011, J JPN INT ECON, V25, P39, DOI 10.1016/j.jjie.2010.06.003; Asai S, 2011, J CULT ECON, V35, P101, DOI 10.1007/s10824-011-9139-1; Banos J, 1997, J CULTURAL EC, V21, P57; Becker Gary S., 1996, ACCOUNTING TASTES; BELK RW, 1987, J CONSUM RES, V14, P26, DOI 10.1086/209090; Cameron S., 1988, Journal of Cultural Economics, V12, P73; Cameron S., 1990, Journal of Cultural Economics, V14, P35, DOI 10.1007/BF02268196; Cameron S, 1999, APPL ECON LETT, V6, P617, DOI 10.1080/135048599352736; Cameron S., 1986, Journal of Cultural Economics, USA, V10, P38; Cheng S. W., 2006, J CULTURAL EC, V30, P263, DOI 10.1007/s10824-006-9023-6; Denison R, 2008, ANIMATION, V3, P129, DOI 10.1177/1746847708091891; Dewally M, 2006, J BUS, V79, P693, DOI 10.1086/499169; Dewenter R., 2005, J CULTURAL EC, V29, P213, DOI 10.1007/s10824-005-6421-0; Fernandez R, 2004, Q J ECON, V119, P1249, DOI 10.1162/0033553042476224; Cuadrado M., 1999, Journal of Cultural Economics, V23, P257, DOI 10.1023/A:1007538005838; Greene W. H., 2008, ECONOMETRIC ANAL; Halloway S. D., 2010, WOMEN FAMILY CONT JA; HOGE DR, 1982, J MARRIAGE FAM, V44, P569, DOI 10.2307/351580; Japan External Trade Organization (JETRO), 2005, JAPAN EC MONTHLY; Jepsen L. K., 2005, REV ECON HOUSEHOLD, V3, P197, DOI DOI 10.1007/S11150-005-0710-4; Lu AS, 2008, ANIMATION, V3, P169, DOI 10.1177/1746847708091893; Macmillan P., 2001, Journal of Cultural Economics, V25, P91, DOI 10.1023/A:1007630400082; MECSST (Ministry of Education Culture Sports Science and Technology), 2000, JAP GOV POL ED SCI S; MOULTON BR, 1990, REV ECON STAT, V72, P334, DOI 10.2307/2109724; Nakamura I., 2006, JAP POP PAW; Napier S. J., 2000, ANIME AKIRA PRINCESS; Oswald AJ, 2010, REV ECON STAT, V92, P213, DOI 10.1162/rest.2010.11436; Sakurai T., 2009, HIST JAPANS ANIME FO; Sakurai T., 2010, WHAT MAKES JAPANS CU; Shiraishi S., 1997, NETWORK POWER JAPAN; Shiraishi S., 2013, GLOBALIZATION JAPANS; Sugiyama T., 2006, COOL JAPAN; Takekuma K., 2004, WHY IS PAYMENT COPY; Wyburn J, 2012, J CULT ECON, V36, P309, DOI 10.1007/s10824-012-9166-6; Yamamura E., 2008, J SOCIOECONOMICS, V37, P2546, DOI 10.1016/j.socec.2008.04.015; Yamamura E, 2009, APPL ECON LETT, V16, P693, DOI 10.1080/13504850701221782; Yamamura E., 2010, ATLANTIC ECON J, V38, P359; Yoon H, 2010, IND CORP CHANGE, V19, P239, DOI 10.1093/icc/dtp040	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0885-2545	1573-6997		J CULT ECON	J. Cult. Econ.	NOV	2014	38	4					331	349		10.1007/s10824-013-9213-y		19	Economics	Business & Economics	AS9ZZ	WOS:000344598000003		
J	Bakry, AS; Marghalani, HY; Amin, OA; Tagami, J				Bakry, Ahmed Samir; Marghalani, Hanadi Y.; Amin, Omayma A.; Tagami, Junji			The effect of a bioglass paste on enamel exposed to erosive challenge	JOURNAL OF DENTISTRY			English	Article						45S5 bioglass; Remineralization; Micro-indentation; Erosion	DENTAL EROSION; CARIES LESIONS; FLUORIDE; TOOTHPASTES; SALIVA; REMINERALIZATION; CYTOTOXICITY; ACID	Objectives: The current study is evaluating the effect of using a 45S5 bioglass paste and topical fluoride application on the cross sectional micro-hardness and the chemical surface changes of eroded enamel. Methods: Enamel discs were obtained from the buccal surface of one hundred extracted human non-carious third molars. The enamel surfaces were ground flat and each disc was coated with two layers of acid resistant nail varnish except for an exposed treatment window (3 mm x 2 mm) on the buccal surface of the tooth. All specimens were challenged for 60 min by orange juice (Tropicana, Chicago, USA) pH 3.85 + 0.5. The specimens were divided into four groups: the 45S5 bioglass paste group, fluoride gel group (5 min application), fluoride gel group (24 h application) while the rest of specimens served as control. The cross-sectional micro-hardness of 20 specimens from each group was measured. Five specimens from each group had their top eroded enamel surfaces examined by SEM-EDS. One-way ANOVA was used to compare the cross-sectional micro-hardness of the three groups p < 0.05. Results: 45S5 bioglass paste application significantly improved the sub-surface eroded enamel when compared to fluoride and control specimens (p < 0.05). Conclusion: 45S5 bioglass paste can efficiently improve the micro-hardness of the subsurface eroded enamel surface. Clinical significance: The use of the 45S5 Bioglass paste can be used efficiently as a potent remineralizing agent for the sub-surface enamel lesions resulting from erosive challenges. (C) 2014 Elsevier Ltd. All rights reserved.	[Bakry, Ahmed Samir; Marghalani, Hanadi Y.] King Abdulaziz Univ, Fac Dent, Dept Operat Dent, Jeddah 21413, Saudi Arabia; [Bakry, Ahmed Samir] Univ Alexandria, Fac Dent, Conservat Dent Dept, Alexandria, Egypt; [Bakry, Ahmed Samir] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Japan Soc Promot Sci Cariol & Operat Dent, Dept Restorat Sci,Bunkyo ku, Tokyo 1138549, Japan; [Amin, Omayma A.] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut Chem, Jeddah 21413, Saudi Arabia; [Amin, Omayma A.] Univ Alexandria, Fac Pharm, Dept Pharmaceut Analyt Chem, Alexandria, Egypt; [Tagami, Junji] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Cariol & Operat Dent Dept, Tokyo 1138549, Japan	Bakry, AS (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Japan Soc Promot Sci Cariol & Operat Dent, Dept Restorat Sci,Bunkyo ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	drahmedbakry@gmail.com			Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia [4/33/RG]; DSR	This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia, under grant no. 4/33/RG. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Amaechi BT, 2001, ARCH ORAL BIOL, V46, P697, DOI 10.1016/S0003-9969(01)00034-6; Magalhaes AC, 2009, CARIES RES, V43, P474, DOI 10.1159/000264685; Lussi A, 2000, CARIES RES, V34, P182, DOI 10.1159/000016587; Sauro S, 2012, J DENT, V40, P896, DOI 10.1016/j.jdent.2012.07.004; Honorio HM, 2010, CARIES RES, V44, P29, DOI 10.1159/000275571; Moretto MJ, 2013, J DENT, V41, P1302, DOI 10.1016/j.jdent.2013.09.008; Reynolds EC, 2008, J DENT RES, V87, P344; Amaechi BT, 2005, J DENT, V33, P243, DOI 10.1016/j.jdent.2004.10.014; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Bakry AS, 2011, J DENT, V39, P599, DOI 10.1016/j.jdent.2011.06.003; Amaechi BT, 2001, J DENT, V29, P371, DOI 10.1016/S0300-5712(01)00026-4; Diamanti I, 2010, J DENT, V38, P671, DOI 10.1016/j.jdent.2010.05.010; Bakry AS, 2014, DENT MATER, V30, P314, DOI 10.1016/j.dental.2013.12.002; Bakry AS, 2011, J DENT RES, V90, P246, DOI 10.1177/0022034510387793; Bakry AS, 2013, DENT MATER, V29, P357, DOI 10.1016/j.dental.2012.12.002; Baysan A, 2001, CARIES RES, V35, P41; Beletskii BI, 2009, GLASS CERAM+, V66, P104, DOI 10.1007/s10717-009-9136-4; BUNKER BC, 1988, PHYS CHEM GLASSES, V29, P106; Diamanti I, 2011, J DENT, V39, P619, DOI 10.1016/j.jdent.2011.06.009; Field J, 2013, J DENT, V41, P1060, DOI 10.1016/j.jdent.2013.08.015; Ganss C, 2012, J DENT, V40, P1036, DOI 10.1016/j.jdent.2012.08.005; HUME WR, 1981, ARCH ORAL BIOL, V26, P467, DOI 10.1016/0003-9969(81)90002-9; Jager DHJ, 2012, J DENT, V40, P1103, DOI 10.1016/j.jdent.2012.09.004; Jeng JH, 1998, CELL BIOL TOXICOL, V14, P383, DOI 10.1023/A:1007591426267; Lata S, 2010, J Conserv Dent, V13, P42, DOI 10.4103/0972-0707.62634; Lussi A, 2008, CLIN ORAL INVEST S1, V12, P5, DOI DOI 10.1007/S00784-007-0179-Z; Qi Yi-pin, 2012, Acta Biomater, V8, P836, DOI 10.1016/j.actbio.2011.10.033; Sirimaharaj V, 2002, AUST DENT J, V47, P228, DOI 10.1111/j.1834-7819.2002.tb00334.x; Tschoppe P, 2012, ARCH ORAL BIOL, V57, P931, DOI 10.1016/j.archoralbio.2012.02.010	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	NOV	2014	42	11					1458	1463		10.1016/j.jdent.2014.05.014		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT0HQ	WOS:000344618000012		
J	Furuta, M; Kawaharamura, T; Uchida, T; Wang, DP; Sanada, M				Furuta, Mamoru; Kawaharamura, Toshiyuki; Uchida, Takayuki; Wang, Dapeng; Sanada, Masaru			High-Performance Solution-Processed InGaZnO Thin-Film Transistor Fabricated by Ozone-Assisted Atmospheric Pressure Mist Deposition	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Aluminium oxide; atmospheric pressure deposition (APD); indium-gallium-zinc-oxide (IGZO); mist chemical vapor deposition (mist-CVD); ozone O-3; solution process; thin-film transistor (TFT)	TEMPERATURE; CHANNEL	High-performance amorphous indium-gallium-zinc oxide thin-film transistors (IGZO TFTs) were demonstrated at 360 degrees C with the IGZO channel and aluminium oxide (AlOx) gate dielectric stack that was deposited by ozone O-3-assisted atmospheric pressure chemical vapor deposition (AP-CVD) using an ultrasonic atomized solution mist. The AlOx gate dielectric with a breakdown electric field of over 8 MV/cm and dielectric constant of 7.0 was obtained. In addition, the introduction of O-3 oxidant during the IGZO deposition decreases the carbon and hydrogen contamination in the film. Field effect mobility and the sub-threshold swing of the IGZO TFT with AP-deposited IGZO/AlOx stack were significantly improved to 7.5 cm(2) Vs and 0.38 V/dec, respectively, by the O-3 oxidant introduced in the IGZO and AlOx depositions. The O-3 oxidant is very effective in improving the electrical properties of solution-processed oxide TFTs.	[Furuta, Mamoru; Wang, Dapeng] Kochi Univ Technol, Dept Environm Sci & Engn, Kami City, Kochi 7828502, Japan; [Kawaharamura, Toshiyuki] Kochi Univ Technol, Inst Nanotechnol, Kami City, Kochi 7828502, Japan; [Uchida, Takayuki; Sanada, Masaru] Kochi Univ Technol, Dept Syst Engn, Kami City, Kochi 7828502, Japan	Furuta, M (reprint author), Kochi Univ Technol, Dept Environm Sci & Engn, Kami City, Kochi 7828502, Japan.	furuta.mamoru@kochi-tech.ac.jp; kawaharamura.toshiyuki@kochi-tech.ac.jp; uchida.takayuki.56m@st.kyoto-u.ac.jp; wang.dapeng@kochi-tech.ac.jp; sanada.masaru@kochi-tech.ac.jp			Japan Society for the Promotion of Science [23560408]	This work was supported in part by the grant from the Japan Society for the Promotion of Science under Grant-in-Aid for Scientific Research (C)23560408.	Carcia PF, 2003, APPL PHYS LETT, V82, P1117, DOI 10.1063/1.1553997; Choi CG, 2008, ELECTROCHEM SOLID ST, V11, pH7, DOI 10.1149/1.2800562; Han SY, 2011, J AM CHEM SOC, V133, P5166, DOI 10.1021/ja104864j; Hoffman RL, 2003, APPL PHYS LETT, V82, P733, DOI 10.1063/1.1542677; Yang YH, 2010, IEEE ELECTR DEVICE L, V31, P969, DOI 10.1109/LED.2010.2055821; Hirao T, 2008, IEEE T ELECTRON DEV, V55, P3136, DOI 10.1109/TED.2008.2003330; Furuta M, 2012, IEEE ELECTR DEVICE L, V33, P851, DOI 10.1109/LED.2012.2192902; Kim KM, 2011, IEEE ELECTR DEVICE L, V32, P1242, DOI 10.1109/LED.2011.2160612; Tue PT, 2013, IEEE T ELECTRON DEV, V60, P320, DOI 10.1109/TED.2012.2227483; Kawaharamura T, 2008, JPN J APPL PHYS, V47, P4669, DOI 10.1143/JJAP.47.4669; Park KB, 2010, IEEE ELECTR DEVICE L, V31, P311, DOI 10.1109/LED.2010.2040130; Avis C, 2011, J MATER CHEM, V21, P10649, DOI 10.1039/c1jm12227d; Chen RS, 2012, THIN SOLID FILMS, V520, P6681, DOI 10.1016/j.tsf.2012.06.066; Kamiya Toshio, 2009, Journal of Display Technology, V5, DOI 10.1109/JDT.2009.2034559; Kawaharamura T, 2013, AIP ADV, V3, DOI 10.1063/1.4798303; Kim G. H., 2009, APPL PHYS LETT, V94; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kim SJ, 2010, PHYS STATUS SOLIDI A, V207, P1668, DOI 10.1002/pssa.200983724; Nayak P. K., 2010, APPL PHYS LETT, V97; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Norris BJ, 2003, J PHYS D APPL PHYS, V36, pL105, DOI 10.1088/0022-3727/36/20/L02; Park SK, 2009, ELECTROCHEM SOLID ST, V12, pH256, DOI 10.1149/1.3119037; Rim Y. S., 2010, APPL PHYS LETT, V97	23	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	NOV	2014	10	11					934	938		10.1109/JDT.2013.2294967		5	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AS9CB	WOS:000344539800004		
J	Naito, M				Naito, Mariko			Utilization and Application of Public Health Data in Descriptive Epidemiology	JOURNAL OF EPIDEMIOLOGY			English	Editorial Material						utilization; application; public health data; descriptive epidemiology; Japan			[Naito, Mariko] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4668550, Japan	Naito, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Prevent Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mnaito@med.nagoya-u.ac.jp					Weil AR, 2014, HEALTH AFFAIR, V33, P1110, DOI 10.1377/hlthaff.2014.0689; Boyle P, 1996, ANN ONCOL, V7, P439; Chihara D, 2014, J EPIDEMIOL, V24, P469, DOI 10.2188/jea.JE20140042; Doi Y, 2014, J EPIDEMIOL IN PRESS, DOI [10.2188/jea.JE201400509, DOI 10.2188/JEA.JE201400509]; Ito H, 2011, VALUE NATL DATABASE; Kabeya Y, 2014, J EPIDEMIOL, V24, P460, DOI 10.2188/jea.JE20130196; NASCA PC, 1986, NEW YORK STATE J MED, V86, P231; Porta M, 2008, DICT EPIDEMIOLOGY, P64; Savitz AD, 1998, CHRONIC DIS EPIDEMIO, P27; Tanaka H, 2014, ACT EUR J C IN PRESS	10	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					435	436		10.2188/jea.JE20140182		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000001		
J	Nakamura, K				Nakamura, Koshi			Impact of Cardiovascular Risk Factors on Medical Expenditure: Evidence From Epidemiological Studies Analysing Data on Health Checkups and Medical Insurance	JOURNAL OF EPIDEMIOLOGY			English	Article						cardiovascular risk factor; medical expenditure; cohort study	HYPERTENSION AND/OR; INSULIN-RESISTANCE; JAPAN; SHIGA; COSTS; INDIVIDUALS; MORTALITY; SMOKING; OBESITY; DISEASE	Concerns have increasingly been raised about the medical economic burden in Japan, of which approximately 20% is attributable to cardiovascular disease, including coronary heart disease and stroke. Because the management of risk factors is essential for the prevention of cardiovascular disease, it is important to understand the relationship between cardiovascular risk factors and medical expenditure in the Japanese population. However, only a few Japanese epidemiological studies analysing data on health checkups and medical insurance have provided evidence on this topic. Patients with cardiovascular risk factors, including obesity, hypertension, and diabetes, may incur medical expenditures through treatment of the risk factors themselves and through procedures for associated diseases that usually require hospitalization and sometimes result in death. Untreated risk factors may cause medical expenditure surges, mainly due to long-term hospitalization, more often than risk factors preventively treated by medication. On an individual patient level, medical expenditures increase with the number of concomitant cardiovascular risk factors. For single risk factors, personal medical expenditure may increase with the severity of that factor. However, on a population level, the medical economic burden attributable to cardiovascular risk factors results largely from a single, particularly prevalent risk factor, especially from mildly-to-moderately abnormal levels of the factor. Therefore, cardiovascular risk factors require management on the basis of both a cost-effective strategy of treating high-risk patients and a population strategy for reducing both the ill health and medical economic burdens that result from cardiovascular disease.	Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 9200293, Japan	Nakamura, K (reprint author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	knaka@kanazawa-med.ac.jp			Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan [H17-kenko-007, H18-junkankitou [seishuu]-ippan-012, H20-junkankitou [seishuu]-ippan-013, H22-junkankitou [seishuu]-ippan-012, H23-junkankitou [seishuu]-ippan-005, 20K-6, H20-seisaku-ippan-014, H23-seisaku-ippan-003]	These studies were supported by a Grant-in-Aid from the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan (Comprehensive Research on Cardiovascular and Life-Style Related Disease: H17-kenko-007, H18-junkankitou [seishuu]-ippan-012, H20-junkankitou [seishuu]-ippan-013, H22-junkankitou [seishuu]-ippan-012, H23-junkankitou [seishuu]-ippan-005; Research on Cardiovascular Disease: 20K-6; Research on Policy Planning and Evaluation: H20-seisaku-ippan-014, and H23-seisaku-ippan-003).	STERN JS, 1972, LANCET, V2, P948; LUDVIK B, 1995, DIABETES, V44, P1121, DOI 10.2337/diabetes.44.9.1121; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; ZAVARONI I, 1989, NEW ENGL J MED, V320, P702, DOI 10.1056/NEJM198903163201105; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V290, P197; Fitzmaurice G., 2011, APPL LONGITUDINAL AN; Health and Welfare Statistics Association, 2013, 2013 2014 KOK EIS NO; Kanda Hideyuki, 2005, Nihon Arukoru Yakubutsu Igakkai Zasshi, V40, P171; Mancia G, 2007, J HYPERTENS, V25, P1749; Ministry of Health Labour and Welfare of Japan, 2007, BAS GUID HLTH CHECK; Moturu Sai T, 2010, International Journal of Biomedical Engineering and Technology, V3, DOI 10.1504/IJBET.2010.029654; Murakami Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002234; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055836; Nakamura K, 2013, J HYPERTENS, V31, P1032, DOI 10.1097/HJH.0b013e32835f5747; Nakamura K, 2007, PUBLIC HEALTH, V121, P174, DOI 10.1016/j.puhe.2006.07.024; Nakamura K, 2007, EUR J PUBLIC HEALTH, V17, P424, DOI 10.1093/eurpub/ckl271; Nakamura K, 2008, PUBLIC HEALTH, V122, P1226, DOI 10.1016/j.puhe.2007.12.004; Nakamura K, 2005, HYPERTENS RES, V28, P859, DOI 10.1291/hypres.28.859; Nakamura K, 2006, J EPIDEMIOL, V16, P15, DOI 10.2188/jea.16.15; Nakamura K, 2010, HYPERTENS RES, V33, P802, DOI 10.1038/hr.2010.81; Nakamura K, 2006, J HYPERTENS, V24, P2305, DOI 10.1097/01.hjh.0000249711.28769.80; Okamura S, 2005, HEALTH POLICY, V74, P282, DOI 10.1016/j.healthpol.2005.01.009; Okamura T, 2007, CIRC J, V71, P807, DOI 10.1253/circj.71.807; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Matsuzawa Y, 2002, CIRC J, V66, P987; Wannamethee SG, 2001, INT J EPIDEMIOL, V30, P777, DOI 10.1093/ije/30.4.777; World Health Organization, 2000, WHO TECHN REP SER, V894; Yoshida M, 2010, J HEPATO-BIL-PAN SCI, V17, P13, DOI 10.1007/s00534-009-0215-2	31	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					437	443		10.2188/jea.JE20140096		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000002		
J	Tsujimoto, T; Sairenchi, T; Iso, H; Irie, F; Yamagishi, K; Watanabe, H; Tanaka, K; Muto, T; Ota, H				Tsujimoto, Takehiko; Sairenchi, Toshimi; Iso, Hiroyasu; Irie, Fujiko; Yamagishi, Kazumasa; Watanabe, Hiroshi; Tanaka, Kiyoji; Muto, Takashi; Ota, Hitoshi			The Dose-Response Relationship Between Body Mass Index and the Risk of Incident Stage >= 3 Chronic Kidney Disease in a General Japanese Population: The Ibaraki Prefectural Health Study (IPHS)	JOURNAL OF EPIDEMIOLOGY			English	Article						chronic kidney disease; body mass index; obesity; dose-response relationship; epidemiology	OBESITY-RELATED GLOMERULOPATHY; COMMUNITY-BASED POPULATION; HYPERTENSION; CKD; ASSOCIATION; OUTCOMES	Purpose: To examine the relationship between body mass index (BMI) and the risk of stage >= 3 chronic kidney disease (CKD) in a general Japanese population. Methods: A total of 105 611 participants aged 40-79 years who completed health checkups in Ibaraki Prefecture, Japan, and were free of CKD in 1993 were followed-up through 2006. Stage >= 3 CKD was defined by an estimated glomerular filtration rate <60 mL/min/1.73m(2) reported during at least 2 successive annual surveys or as treatment for kidney disease. Hazard ratios (HRs) for the development of stage >= 3 CKD relative to the BMI categories were calculated using the Cox proportional hazards regression model, which was adjusted for possible confounders and mediators. Results: During a mean follow-up of 5 years, 19 384 participants (18.4%) developed stage >= 3 CKD. Compared to a BMI of 21.0-22.9 kg/m(2), elevated multivariable-adjusted HRs were observed among men with a BMI >= 23.0 kg/m(2) and women with a BMI >= 27.0 kg/m(2). Significant dose-response relationships between BMI and the incidence of stage >= 3 CKD were observed in both sexes (P for trend <0.001). Conclusions: Obesity was associated with the risk of developing stage >= 3 CKD among men and women.	[Tsujimoto, Takehiko; Tanaka, Kiyoji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Tsujimoto, Takehiko; Sairenchi, Toshimi; Yamagishi, Kazumasa; Watanabe, Hiroshi; Tanaka, Kiyoji; Ota, Hitoshi] Ibaraki Hlth Serv Assoc, Ibaraki, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Irie, Fujiko] Ibaraki Prefectural Off, Dept Hlth & Welf, Ibaraki, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan	Tsujimoto, T (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, Ibaraki Hlth Serv Assoc, Ibaraki Hlth Plaza,1-1-1 Ten Nodai, Tsukuba, Ibaraki, Japan.	tsujimoto@stat.taiiku.tsukuba.ac.jp			Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [H17-Kenkou-007, H18-Junkankitou[Seishuu]-Ippan-012, H20-Junkankitou[Seishuu]-Ippan-013, H21-Nanchi-Ippan-059, H23-Junkankitou[Seishuu]-Ippan-005]	This research was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou[Seishuu]-Ippan-005).	Aneja A, 2004, RECENT PROG HORM RES, V59, P169, DOI 10.1210/rp.59.1.169; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-2; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06007; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Nickenig G, 1998, CIRCULATION, V97, P2197; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Levey AS, 1999, ANN INTERN MED, V130, P461; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Gallagher PE, 1999, HYPERTENSION, V33, P323; Hu DS, 2000, OBES RES, V8, P411, DOI 10.1038/oby.2000.51; Matsuzawa Y, 1990, DIABETES RES CLIN S, V10, pS159; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145; Sasai H, 2010, MAYO CLIN PROC, V85, P36, DOI 10.4065/mcp.2009.0230; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Tsujimoto T, 2012, J HYPERTENS, V30, P1122, DOI 10.1097/HJH.0b013e328352b879; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586	26	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					444	451		10.2188/jea.JE20140028		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000003		
J	Kabeya, Y; Kato, M; Isogawa, A; Takahashi, Y; Matsushita, Y; Goto, A; Iso, H; Inoue, M; Mizoue, T; Tsugane, S; Kadowaki, T; Noda, M				Kabeya, Yusuke; Kato, Masayuki; Isogawa, Akihiro; Takahashi, Yoshihiko; Matsushita, Yumi; Goto, Atsushi; Iso, Hiroyasu; Inoue, Manami; Mizoue, Tetsuya; Tsugane, Shoichiro; Kadowaki, Takashi; Noda, Mitsuhiko			Descriptive Epidemiology of Diabetes Prevalence and HbA1c Distributions Based on a Self-Reported Questionnaire and a Health Checkup in the JPHC Diabetes Study	JOURNAL OF EPIDEMIOLOGY			English	Article						diabetes mellitus; prevalence; self-report; HbA1c	PLASMA-GLUCOSE; JAPAN	Background: The present study examined the prevalence of diabetes in Japan during the late 1990s and early 2000s using the Japan Public Health Center-based Prospective Diabetes cohort. We also investigated the distributions of HbA1c values in noncompliant diabetic participants in the cohort. Methods: A total of 28 183 registered inhabitants aged 46-75 years from 10 public health center areas were included in the initial survey. The 5-year follow-up survey included 20 129 participants. The prevalence of diabetes was estimated using both a self-reported questionnaire and laboratory measurements. Among the participants who reported the presence of diabetes on the questionnaire (self-reported diabetes), the distributions of HbA1c values were described according to their treatment status. Results: The age-standardized prevalence of diabetes in 55- to 74-year-old adults was 8.2% at the initial survey and 10.6% at the 5-year follow-up. At the initial survey, among participants with self-reported diabetes, the mean HbA1c values in the participants who had never and who had previously received diabetes treatment were 7.01% (standard deviation [SD] 1.56%) and 6.56% (SD 1.46%), respectively. Approximately 15% of the participants who had self-reported diabetes but had never received diabetes treatment had an HbA1c >= 8.4%. Conclusions: The prevalence of diabetes increased in the JPHC cohort between the late 1990s and early 2000s. A certain proportion of participants who were aware of their diabetes but were not currently receiving treatment had poor diabetic control. Efforts to promote continuous medical attendance for diabetes care may be necessary.	[Kabeya, Yusuke; Kato, Masayuki; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Kabeya, Yusuke] Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Kato, Masayuki] Fiore Kenshin Clin, Tokyo, Japan; [Isogawa, Akihiro] Mitsui Mem Hosp, Dept Internal Med, Tokyo 101, Japan; [Takahashi, Yoshihiko] Iwate Med Univ, Sch Med, Div Diabet & Metab, Morioka, Iwate 020, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res Coordinat, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan	Noda, M (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, 1-21-1 Toyama, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Tsugane, Shocichiro/A-2424-2015; 	Iso, Hiroyasu/0000-0002-9241-7289	Health Sciences Research Grants [H10-074, H13-008, H14-008, H15-006, H16-019, H17-019, H18-028, H19-016, H25-016]; Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan	This study was supported by Health Sciences Research Grants (Research on Health Services H10-074, Medical Frontier Strategy Research H13-008, Clinical Research for Evidence-based Medicine H14-008 and H15-006, and Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H16-019, H17-019, H18-028, H19-016, and H25-016) and a grant-in-aid for Cancer Research and a grant-in-aid for the Third Term Comprehensive Ten-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan.	Sekikawa A, 2000, J DIABETES COMPLICAT, V14, P78, DOI 10.1016/S1056-8727(00)00074-X; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; [Anonymous], 2002, REPORT NATL DIABETES; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; [Anonymous], 2007, REPORT RESULTS NATL; Goto A, 2013, J EPIDEMIOL, V23, P295, DOI 10.2188/jea.JE20120221; Igari Yoshimasa, 2006, Nihon Rinsho, V64, P12; Islam M M, 1999, J Epidemiol, V9, P155; Noda M, 2010, ENDOCR J, V57, P629; Takahashi Y, 2000, DIABETES CARE, V23, P1092, DOI 10.2337/diacare.23.8.1092; Tsugane S, 2001, J Epidemiol, V11, pS24; Yamamoto S, 2001, J Epidemiol, V11, pS8	15	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					460	468		10.2188/jea.JE20130196		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000005		
J	Chihara, D; Ito, H; Katanoda, K; Shibata, A; Matsuda, T; Sobue, T; Matsuo, K				Chihara, Dai; Ito, Hidemi; Katanoda, Kota; Shibata, Akiko; Matsuda, Tomohiro; Sobue, Tomotaka; Matsuo, Keitaro			Incidence of Myelodysplastic Syndrome in Japan	JOURNAL OF EPIDEMIOLOGY			English	Article						myelodysplastic syndrome; MDS; incidence; epidemiology; Asia	CANCER REGISTRIES; UNITED-STATES; INCIDENCE RATES; MCIJ PROJECT; MALIGNANCIES; PREVALENCE; RISK; CARE	Background: Myelodysplastic syndromes (MDS) are a diverse group of clonal hematopoietic stem cell malignancies that primarily affect the elderly. Although the incidence of MDS in western countries has been well investigated, little is known about the incidence in Asian populations. Methods: To identify the incidence of MDS in Japan, we used population-based registry data from 1993 to 2008. The data represented 33.1% of the Japanese population. A total of 7995 patients were reported to the registry with newly diagnosed MDS during the study period. Results: Median age at diagnosis was 76 years. Incidence sharply increased with age, particularly in those aged over 70 years. The most recent crude incidence rate of MDS was 3.8 (95% CI 3.6-4.1) cases per 100 000 for men and 2.4 (95% CI 2.2-2.6) cases per 100 000 for women in 2008. Age-adjusted incidences of MDS in 2008, standardized by the world standard population, were 1.6 and 0.8 cases per 100 000 for men and women, respectively, while incidences standardized by the 1985 Japanese population were 2.5 and 1.2 cases per 100 000 for men and women, respectively. Conclusions: Our study reveals that some elderly patients suffer from MDS in Japan, but the incidence is lower than in Western countries. In current clinical practice, many elderly MDS patients are treated with supportive therapy based on an incomplete diagnosis, suggesting that the incidence estimated in this study might still be substantially underestimated. Accurate evaluation of the health impact of MDS requires evaluation of the mortality of the disease, continued surveillance, and improvement in the quality of cancer registry data.	[Chihara, Dai; Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Osaka, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan	Matsuo, K (reprint author), Kyushu Univ, Dept Prevent Med, Fac Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 812, Japan.	keitarom@med.kyushu-u.ac.jp			National Center for Geriatrics and Gerontology (NCGG), Japan [22-9]; Takeda Science Foundation	We thank all of the staff of the MCIJ project. This study was partly supported by the 3rd-term Comprehensive Ten-year Strategy for Cancer Control and by the Research Funding for Longevity Sciences (22-9) from the National Center for Geriatrics and Gerontology (NCGG), Japan, and also by a grant from the Takeda Science Foundation.	Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Matsuda A, 2005, BLOOD, V106, P2633, DOI 10.1182/blood-2005-01-0040; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Germing U, 2004, HAEMATOLOGICA, V89, P905; Ma XM, 2009, AM J EPIDEMIOL, V169, P1492, DOI 10.1093/aje/kwp074; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Disperati P, 2006, LEUKEMIA RES, V30, P233, DOI 10.1016/j.leukres.2005.06.011; Neukirchen J, 2011, LEUKEMIA RES, V35, P1591, DOI 10.1016/j.leukres.2011.06.001; Ma X, 2007, CANCER, V109, P1536, DOI 10.1002/cncr.22570; OGUMA S, 1995, LEUKEMIA RES, V19, P219, DOI 10.1016/0145-2126(94)00135-W; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Goldberg SL, 2010, J CLIN ONCOL, V28, P2847, DOI 10.1200/JCO.2009.25.2395; Wang W, 2012, ANN HEMATOL, V91, P1321, DOI 10.1007/s00277-011-1389-7; Higashi T, 2014, JPN J CLIN ONCOL, V44, P2, DOI 10.1093/jjco/hyt013; Sant M, 2010, BLOOD, V116, P3724, DOI 10.1182/blood-2010-05-282632; Du Y, 2010, LEUKEMIA RES, V34, P1, DOI 10.1016/j.leukres.2009.08.006; Kantarjian H.M., 1987, CANCER, V40, P435; Katanoda K, 2012, CANCER SCI, V103, P360, DOI 10.1111/j.1349-7006.2011.02145.x; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; SHIMIZU H, 1995, INT J HEMATOL, V61, P17; Swerdlow S, 2008, WHO CLASSIFICATION T	22	5	5	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					469	473		10.2188/jea.JE20140042		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000006		
J	Kamada, M; Kitayuguchi, J; Lee, IM; Hamano, T; Imamura, F; Inoue, S; Miyachi, M; Shiwaku, K				Kamada, Masamitsu; Kitayuguchi, Jun; Lee, I-Min; Hamano, Tsuyoshi; Imamura, Fumiaki; Inoue, Shigeru; Miyachi, Motohiko; Shiwaku, Kuninori			Relationship Between Physical Activity and Chronic Musculoskeletal Pain Among Community-Dwelling Japanese Adults	JOURNAL OF EPIDEMIOLOGY			English	Article						exercise; musculoskeletal pain; arthritis; epidemiology; public health	LOW-BACK-PAIN; BRIEF SCREENING TOOL; KNEE OSTEOARTHRITIS; GENERAL-POPULATION; SYSTEMATIC ANALYSIS; ENERGY-EXPENDITURE; GLOBAL BURDEN; PRIMARY-CARE; EXERCISE; RISK	Background: Both little and excessive physical activity (PA) may relate to chronic musculoskeletal pain. The primary objective of this study was to characterize the relationship of PA levels with chronic low back pain (CLBP) and chronic knee pain (CKP). Methods: We evaluated 4559 adults aged 40-79 years in a community-based cross-sectional survey conducted in 2009 in Shimane, Japan. We used self-administered questionnaires to assess sociodemographics and health status: PA was assessed by the International Physical Activity Questionnaire, and CLBP and CKP were assessed by a modified version of the Knee Pain Screening Tool. We examined relationships of PA with prevalence of CLBP and CKP using Poisson regression, controlling for potential confounders. Results: CLBP and CKP were both prevalent (14.1% and 10.7%, respectively) and associated with history of injury, medication use, and consultation with physicians. PA was not significantly related to CLBP or CKP (P > 0.05) before or after adjustment for potential confounders. For example, compared with adults reporting moderate PA (8.25-23.0 MET-hours/week), prevalence ratios for CKP adjusted for sex, age, education years, self-rated health, depressive symptom, smoking, chronic disease history, and body-mass index were 1.12 (95% confidential interval [CI] 0.84-1.50) among those with the lowest PA and 1.26 (95% CI 0.93-1.70) among those with the highest PA (P quadratic = 0.08). The prevalence ratios were further attenuated toward the null after additional adjustment for history of injury, medication use, and consultation (P quadratic = 0.17). Conclusions: This cross-sectional study showed that there were no significant linear or quadratic relationships of self-reported PA with CLBP and CKP. Future longitudinal study with objective measurements is needed.	[Kamada, Masamitsu; Miyachi, Motohiko] Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Shinjuku Ku, Tokyo 1628636, Japan; [Kamada, Masamitsu] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Kamada, Masamitsu; Kitayuguchi, Jun] Phys Educ & Med Res Ctr UNNAN, Unnan, Shimane, Japan; [Kamada, Masamitsu; Lee, I-Min] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Hamano, Tsuyoshi] Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ COHRE, Izumo, Shimane, Japan; [Imamura, Fumiaki] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Inoue, Shigeru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo 1608402, Japan; [Shiwaku, Kuninori] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan	Kamada, M (reprint author), Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	kamada@gakushikai.jp	Kamada, Masamitsu/H-4411-2011	Kamada, Masamitsu/0000-0003-1703-076X	Ministry of Health, Labour and Welfare of Japan [H20-Junkankitou-Ippan-001]; Meiji Yasuda Life Foundation of Health and Welfare; Japan Society for the Promotion of Science; Medical Research Council Epidemiology Unit, UK [MC_UU_12015/1, MC_UU_12015/5]	We appreciate the cooperation of the participants and staff members of this study. In this research work we used the supercomputer of ACCMS, Kyoto University. This study was supported by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (H20-Junkankitou-Ippan-001) and Meiji Yasuda Life Foundation of Health and Welfare (2010-2011). MK received a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. FI received funding from the Medical Research Council Epidemiology Unit, UK, MC_UU_12015/1 and MC_UU_12015/5.	Katz P, 2001, J AM GERIATR SOC, V49, P808; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; [Anonymous], 2003, BURD MUSC COND START; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; van Dijk GM, 2006, ARTHRIT RHEUM-ARTHR, V55, P779, DOI 10.1002/art.22244; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Urquhart DM, 2011, MED SCI SPORT EXER, V43, P432, DOI 10.1249/MSS.0b013e3181ef5bf8; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Macfarlane GJ, 2011, RHEUMATOLOGY, V50, P2251, DOI 10.1093/rheumatology/ker276; Leveille SG, 2009, JAMA-J AM MED ASSOC, V302, P2214, DOI 10.1001/jama.2009.1738; Hayden JA, 2005, ANN INTERN MED, V142, P776; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Vuori IM, 2001, MED SCI SPORT EXER, V33, pS551, DOI 10.1097/00005768-200106001-00026; Rogers LQ, 2002, OSTEOARTHR CARTILAGE, V10, P617, DOI 10.1053/joca.2002.0802; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Spector TD, 1996, ARTHRITIS RHEUM, V39, P988, DOI 10.1002/art.1780390616; Campello M, 1996, SCAND J MED SCI SPOR, V6, P63; Resnick B, 2011, J AGING PHYS ACTIV, V19, P373; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1249/01.MSS.0000038974.76900.92; Hamano T, 2011, STRESS HEALTH, V27, P163, DOI 10.1002/smi.1324; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Tsuritani I, 2002, MATURITAS, V42, P23, DOI 10.1016/S0378-5122(02)00025-7; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Hootman JM, 2001, AM J EPIDEMIOL, V154, P251, DOI 10.1093/aje/154.3.251; FELSON DT, 1988, ANN INTERN MED, V109, P18; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Brooks P, 2005, RHEUMATOLOGY, V44, P831, DOI 10.1093/rheumatology/keh648; Ceroni D, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-131; Crane DA, 2011, J SPINAL CORD MED, V34, P227, DOI 10.1179/2045772311Y.0000000001; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Harkness EF, 2005, RHEUMATOLOGY, V44, P890, DOI 10.1093/rheumatology/keh599; Jinks C, 2001, RHEUMATOLOGY, V40, P528, DOI 10.1093/rheumatology/40.5.528; Kamada M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-44; Murase N, 2002, J HLTH WELFARE STAT, V49, P1; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517; Sampere M, 2012, OCCUP MED-OXFORD, V62, P60, DOI 10.1093/occmed/kqr141; Suka Machi, 2005, Mod Rheumatol, V15, P41, DOI 10.1007/s10165-004-0362-x; Suka Machi, 2005, Mod Rheumatol, V15, P48, DOI 10.1007/s10165-004-0363-9; Thiese MS, 2011, J OCCUP ENVIRON MED, V53, P364, DOI 10.1097/JOM.0b013e31820d1633; Tokuda Y, 2007, RHEUMATOL INT, V28, P7, DOI 10.1007/s00296-007-0368-8; Urquhart DM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2343; Wijnhoven HAH, 2006, PAIN, V124, P158, DOI 10.1016/j.pain.2006.04.012; World Health Organization, 2010, GLOB REC PHYS ACT HL	55	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					474	483		10.2188/jea.JE20140025		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000007		
J	Doi, Y; Atsuta, N; Sobue, G; Morita, M; Nakano, I				Doi, Yuriko; Atsuta, Naoki; Sobue, Gen; Morita, Mitsuya; Nakano, Imaharu		Res Comm CNS Degenerative Dis Japa	Prevalence and Incidence of Amyotrophic Lateral Sclerosis in Japan	JOURNAL OF EPIDEMIOLOGY			English	Article						ALS; amyotrophic lateral sclerosis; epidemiology; incidence; Japan	MOTOR-NEURON DISEASE; KII PENINSULA; DIAGNOSIS; CRITERIA	Background: Previous studies have reported a high incidence of amyotrophic lateral sclerosis (ALS) in endemic foci in the Kii Peninsula, Japan. However, little is known about the ALS frequency in the whole country. Furthermore, the presence of ethnic variation in the incidence of ALS remains unknown. Methods: We conducted a nationwide survey of ALS frequency in 2013 to estimate its annual prevalence and incidence. ALS was diagnosed based on the El Escorial Criteria. The study period was the 2009 fiscal year, from April 2009 to March 2010. To compare the incidence of ALS among prefectures, standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were calculated under the assumption of Poisson distribution. Results: The annual crude prevalence and incidence rates per 100 000 people per year were 9.9 (95% CI 9.7-10.1) and 2.2 (95% CI 2.1-2.3), respectively. The age group with the highest prevalence as well as incidence was 70-79 years, and the male-female ratio was approximately 1.5. The annual incidence rate adjusted for age and sex using the 2000 U. S. standard population was 2.3 (95% CI 2.2-2.4) per 100 000 people. Some prefectures had significantly high SIRs: Okinawa, Nara and Wakayama in the Kii Peninsula, and Niigata for males; Kumamoto for females. Conclusions: This is the first report on the annual prevalence and incidence of ALS in the representative population of Japan. We identified some prefectures with a high incidence of ALS. However, the incidence of ALS in the Japanese population was much lower than in the Caucasian populations of Europe and North America.	[Doi, Yuriko] Natl Inst Publ Hlth, Area Epidemiol Res, Wako, Saitama 3510197, Japan; [Atsuta, Naoki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Morita, Mitsuya] Jichi Med Univ, Sch Med, Dept Med, Div Neurol, Shimotsuke, Tochigi, Japan; [Nakano, Imaharu] Tokyo Metropolitan Neurol Hosp, Tokyo, Japan	Doi, Y (reprint author), Natl Inst Publ Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	yuriko@niph.go.jp			Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25461277]; Inochinoiro Foundation of Japan	This work was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan. Dr. Atsuta was funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant number 25461277) and the Inochinoiro Foundation of Japan.	BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; NEILSON S, 1994, J NEUROL, V241, P448, DOI 10.1007/BF00900964; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Kuzuhara S, 2005, MOVEMENT DISORD, V20, pS108, DOI 10.1002/mds.20548; Fay MP, 1997, STAT MED, V16, P791; Atsuta N, 2009, J NEUROL SCI, V276, P163, DOI 10.1016/j.jns.2008.09.024; Doi Y, 2010, J NEUROL SCI, V298, P78, DOI 10.1016/j.jns.2010.08.004; Hioki A, 2000, J Epidemiol, V10, P94; Ishiura H, 2012, ARCH NEUROL-CHICAGO, V69, P1154, DOI 10.1001/archneurol.2012.1219; Kihira T, 2005, AMYOTROPH LATERAL SC, V6, P155, DOI 10.1080/14660820510030031; Kuzuhara Shigeki, 2009, Rinsho Shinkeigaku, V49, P968; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; MORIWAKA F, 1993, J NEUROL, V240, P13, DOI 10.1007/BF00838439; Nakagawa Masanori, 2009, Rinsho Shinkeigaku, V49, P950; SCHOENBERG B S, 1983, Neuroepidemiology, V2, P257, DOI 10.1159/000110529; Statistics and Information Department the Ministry of Health, 2008, SURV PHYS DENT PHARM; Takashima H, 1997, ANN NEUROL, V41, P771, DOI 10.1002/ana.410410613; Yoshida S, 1998, J NEUROL SCI, V155, P146, DOI 10.1016/S0022-510X(97)00300-6	20	2	3	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					494	499		10.2188/jea.JE20140059		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000009		
J	Doi, Y; Ishihara, K; Uchiyama, M				Doi, Yuriko; Ishihara, Kaneyoshi; Uchiyama, Makoto			Reliability of the Strengths and Difficulties Questionnaire in Japanese Preschool Children Aged 4-6 Years	JOURNAL OF EPIDEMIOLOGY			English	Article						strengths and difficulties questionnaire; SDQ; reliability; preschool children; Japan		Background: The Strengths and Difficulties Questionnaire (SDQ) has been widely used as a brief behavioral screening. The aim of this study was to examine the internal consistency and test-retest reliability of the 3- to 4-year-old version of the SDQ (SDQ 3-4) in Japanese preschool children. Methods: The SDQ 3-4 was administered to 754 parents who had 4- to 6-year-old children attending kindergartens or childcare centers in Wako City, Japan, at 2 different times (Time 1 and Time 2) over a 2-week interval between June and July 2012. Cronbach's a and correlation coefficients were used to examine internal consistency and test-retest reliability, respectively. Results: Of 393 parents who returned their responses at Time 1 (response rate 52.1%), 383 were used for analysis after excluding 10 responses with missing data. Their children's mean age was 4.7 (standard deviation 0.7) years. The internal consistency (Cronbach's a) was good for the total difficulties score (0.74) and the prosocial behavior scale (0.70). However, it was slightly worse for the emotional symptoms, conduct problems, and hyperactivity scales (0.61-0.66) and poor for the peer problems scale (0.45). Of the 383 included respondents at Time 1, 211 parents returned their responses at Time 2 (response rate: 55.1%). Test-retest reliability (correlation coefficients) was good (0.73-0.82), except for the peer problems scale (0.58). Conclusions: The results support the reliability of the SDQ 3-4 being satisfactory for the total difficulties score and prosocial behavior scale and being acceptable for the emotional symptoms, conduct problems, and hyperactivity scales in Japanese preschool children aged 4-6 years.	[Doi, Yuriko] Natl Inst Publ Hlth, Area Epidemiol Res, Wako, Saitama 3510197, Japan; [Ishihara, Kaneyoshi] Notre Dame Seishin Univ, Dept Child Welf, Okayama, Japan; [Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Tokyo, Japan	Doi, Y (reprint author), Natl Inst Publ Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	yuriko@niph.go.jp			JSPS KAKENHI [23390181]	The present study was supported by JSPS KAKENHI Grant (No. 23390181).	Borg AM, 2012, NORD J PSYCHIAT, V66, P403, DOI 10.3109/08039488.2012.660706; Theunissen MHC, 2013, PEDIATRICS, V131, pE446, DOI 10.1542/peds.2012-0089; Davis E, 2010, ACAD PEDIATR, V10, P41, DOI 10.1016/j.acap.2009.08.007; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Werner H, 2009, CHRONOBIOL INT, V26, P992, DOI 10.1080/07420520903044505; CARSKADON MA, 1993, SLEEP, V16, P258; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Mieloo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036805; Doi Y, 2013, JPN J SLEEP MED, V7, P486; Doi Y, 2014, CHRONOBIOL INT, V31, P328, DOI 10.3109/07420528.2013.852103; Moriwaki Aiko, 2014, Child Adolesc Psychiatry Ment Health, V8, P1, DOI 10.1186/1753-2000-8-1; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Streiner D. L., 1995, HLTH MEASUREMENT SCA	14	2	2	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					514	518		10.2188/jea.JE20140050		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000012		
J	Murayama, H; Nofuji, Y; Matsuo, E; Nishi, M; Taniguchi, Y; Fujiwara, Y; Shinkai, S				Murayama, Hiroshi; Nofuji, Yu; Matsuo, Eri; Nishi, Mariko; Taniguchi, Yu; Fujiwara, Yoshinori; Shinkai, Shoji			The Yabu Cohort Study: Design and Profile of Participants at Baseline	JOURNAL OF EPIDEMIOLOGY			English	Article						cohort profile; community-dwelling elderly; population approach; social relationship; Yabu Cohort Study	SOCIAL CAPITAL AFFECT; SELF-RATED HEALTH; OLDER JAPANESE; FUNCTIONAL DISABILITY; UNITED-STATES; VALIDITY; INDEX; RELIABILITY; DEPRESSION; COMMITMENT	Background: Further evidence into the effects of social relationships on health (including those at both the individual and community levels) is needed in Japan. The Yabu Cohort Study was launched in 2012 to identify the associations between social relationships and health among community-dwelling older Japanese people and to evaluate population approaches for preventive long-term care in the community. This report describes the study design and the profile of the participants at baseline. Methods: The Yabu Cohort Study is a prospective study of community-dwelling individuals aged 65 years and older in Yabu, Hyogo Prefecture, Japan. The baseline survey, using a mailed self-administered questionnaire, was conducted from July through August 2012. It included information on socioeconomic status, general and psychological health, and social relationships (social network, social support, and social capital). Survival time, long-term care insurance certification, and medical and long-term care costs after the baseline survey will be followed. Results: Of 7271 questionnaires distributed, a total of 6652 were returned (91.5% response rate), and 6241 were included in the analysis. Mean age was 71.9 +/- 5.2 years, 43.2% were men, and 83.8% had lived in their neighborhood for more than 40 years. Approximately 45.2% expressed general trust. About 82.4%, 49.9%, and 55.5% have participated in neighborhood association activities, municipal seminars for preventive long-term care, and salon activities in the community, respectively. Conclusions: The study is expected to provide valuable evidence on the effects of social relationships on health and to suggest the usefulness of population approaches for preventive long-term care in Japanese communities.	[Murayama, Hiroshi; Nofuji, Yu; Matsuo, Eri; Nishi, Mariko; Taniguchi, Yu; Fujiwara, Yoshinori; Shinkai, Shoji] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo 1730015, Japan; [Murayama, Hiroshi] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Murayama, H (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	murayama@tmig.or.jp			Research Institute of Science and Technology for Society (RISTEX); Japan Science and Technology Agency; city of Yabu	This study was supported by research grants from the Research Institute of Science and Technology for Society (RISTEX), the Japan Science and Technology Agency, and the city of Yabu.	Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Aida J, 2013, J EPIDEMIOL COMMUN H, V67, P42, DOI 10.1136/jech-2011-200307; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Kondo N, 2007, SOC SCI MED, V64, P2311, DOI 10.1016/j.socscimed.2007.02.009; Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x; Murayama H, 2013, SOC SCI MED, V98, P247, DOI 10.1016/j.socscimed.2013.09.026; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Awata S, 2007, INT PSYCHOGERIATR, V19, P77, DOI 10.1017/S1041610206004212; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kondo N, 2012, J EPIDEMIOL, V22, P543, DOI 10.2188/jea.JE20120025; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Kuriyama S, 2010, J EPIDEMIOL, V20, P253, DOI 10.2188/jea.JE20090093; Ministry of Internal Affairs and Communications, 2014, 2010 POP CENS; Ministry of Internal Affairs and Communications, 2014, REP INT MIGR JAP; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Nakane Chie, 1970, JAPANESE SOC; Shinkai Shoji, 2013, Nihon Koshu Eisei Zasshi, V60, P262; Shinkai Shoji, 2010, Nihon Koshu Eisei Zasshi, V57, P345; Wilkinson R, 2003, SOCIAL DETEMINANTS H; World Health Organization, 2008, CLOS GAP GEN HLTH EQ; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamazaki M, 1990, NIHON BUNKA KOJIN SH	28	1	1	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	NOV	2014	24	6					519	525		10.2188/jea.JE20140065		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AS8AY	WOS:000344474000013		
J	Yoshinari, T; Takeuchi, H; Aoyama, K; Taniguchi, M; Hashiguchi, S; Kai, S; Ogiso, M; Sato, T; Akiyama, Y; Nakajima, M; Tabata, S; Tanaka, T; Ishikuro, E; Sugita-Konishi, Y				Yoshinari, Tomoya; Takeuchi, Hiroshi; Aoyama, Koji; Taniguchi, Masaru; Hashiguchi, Shigeki; Kai, Shigemi; Ogiso, Motoki; Sato, Takashi; Akiyama, Yu; Nakajima, Masahiro; Tabata, Setsuko; Tanaka, Toshitsugu; Ishikuro, Eiichi; Sugita-Konishi, Yoshiko			Occurrence of Four Fusarium Mycotoxins, Deoxynivalenol, Zearalenone, T-2 Toxin, and HT-2 Toxin, in Wheat, Barley, and Japanese Retail Food	JOURNAL OF FOOD PROTECTION			English	Article							MASS-SPECTROMETRY; B TRICHOTHECENES; CHROMATOGRAPHY; EXTRACTION; CEREALS; CLEANUP; GRAINS	A survey of the contamination of wheat, barley, and Japanese retail food by four Fusarium mycotoxins, deoxynivalenol (DON), zearalenone (ZEN), T-2 toxin (T-2), and HT-2 toxin (HT-2), was performed between 2010 and 2012. A method for the simultaneous determination of the four mycotoxins by liquid chromatography-tandem mass spectrometry was validated by a small-scale interlaboratory study using two spiked wheat samples (DON was spiked at 20 and 100 mu g/kg and ZEN, T-2, and HT-2 at 6 and 20 mu g/kg in the respective samples). The recovery of the four mycotoxins ranged from 77.3 to 107.2%. A total of 557 samples of 10 different commodities were analyzed over 3 years by this validated method. Both T-2 and HT-2 were detected in wheat, wheat flour, barley, Job's tears products, beer, corn grits, azuki beans, soybeans, and rice with mixed grains. Only T-2 toxin was detected in sesame seeds. The highest concentrations of T-2 toxin (48.4 mu g/kg) and HT-2 toxin (85.0 mu g/kg) were present in azuki beans and wheat, respectively. DON was frequently detected in wheat, wheat flour, beer, and corn grits. The contamination level of wheat was below the provisional standard in Japan (1,100 mu g/kg). The maximum contamination level of DON was present in a sample of a Job's tears product (1,093 mu g/kg). ZEN was frequently detected in Job's tears products, corn grits, azuki beans, rice with mixed grains, and sesame seeds. A sample of a Job's tears product presented the highest ZEN contamination (153 mu g/kg). These results indicate that continuous monitoring by multiple laboratories is effective and necessary due to the percentage of positive samples detected.	[Yoshinari, Tomoya] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Takeuchi, Hiroshi] Mie Prefecture Hlth & Environm Res Inst, Yokaichi, Mie 5121211, Japan; [Aoyama, Koji] Sendai Reg Ctr, Food & Agr Mat Inspect Ctr, Miyagino Ku, Sendai, Miyagi 9830842, Japan; [Taniguchi, Masaru; Nakajima, Masahiro] Nagoya City Publ Hlth Res Inst, Mizuho Ku, Nagoya, Aichi 4678615, Japan; [Hashiguchi, Shigeki] Kawasaki City Inst Publ Hlth, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Kai, Shigemi] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa 2530087, Japan; [Ogiso, Motoki; Ishikuro, Eiichi] Japan Food Res Labs, Shibuya Ku, Tokyo 1510062, Japan; [Sato, Takashi] Food Anal Technol Ctr SUNATEC, Yokaichi, Mie 5100826, Japan; [Akiyama, Yu] Japan Frozen Foods Inspect Corp, Minato Ku, Tokyo 1050012, Japan; [Tabata, Setsuko] Tokyo Metropolitan Inst Publ Hlth, Shinjuku Ku, Tokyo 1690073, Japan; [Tanaka, Toshitsugu] Kobe Inst Hlth, Chuo Ku, Kobe, Hyogo 6500046, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Sugita-Konishi, Y (reprint author), Azabu Univ, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	y-konishi@azabu-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a research grant from the Ministry of Health, Labor and Welfare of Japan.	Klotzel M, 2006, MOL NUTR FOOD RES, V50, P261, DOI 10.1002/mnfr.200500234; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Visconti A, 2005, J CHROMATOGR A, V1075, P151, DOI 10.1016/j.chroma.2005.04.009; Tanaka T, 2000, J CHROMATOGR A, V882, P23, DOI 10.1016/S0021-9673(00)00063-7; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Sugita-Konishi Y, 2010, FOOD ADDIT CONTAM A, V27, P365, DOI 10.1080/19440040903317497; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; Thompson M, 2000, ANALYST, V125, P385, DOI 10.1039/b000282h; Schollenberger M, 2006, MYCOPATHOLOGIA, V161, P43, DOI 10.1007/s11046-005-0199-7; AOAC International, 2002, AOAC OFF METH AN, P1; Biancardi A, 2005, FOOD ADDIT CONTAM, V22, P251, DOI 10.1080/02652030500110923; Commission of the European Communities, 2006, OFF J EUR UNION L, V70, P12; European Food Safety Authority, 2011, EFSA J, V9, P2481; International Agency for Research on Cancer, 1993, IARC MON EV CARC RIS, V56, P397; Joint FAO/WHO Expert Committee on Food Additives, 2000, WHO FOOD ADDITIVES S, V44; Joint FAO/WHO Expert Committee on Food Additives, 2001, WHO FOOD ADDITIVES S, V47; Scudamore KA, 2009, FOOD ADDIT CONTAM A, V26, P363, DOI 10.1080/02652030802406219; Tanaka H, 2010, RAPID COMMUN MASS SP, V24, P2445, DOI 10.1002/rcm.4663; Tutelyan VA, 2013, FOOD ADDIT CONTAM B, V6, P139, DOI 10.1080/19393210.2013.767862; van der Fels-Klerx HJ, 2012, FOOD ADDIT CONTAM A, V29, P1716, DOI 10.1080/19440049.2012.685891; WHO, 2002, WHO GLOB STRAT FOOD	21	2	2	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	NOV	2014	77	11					1940	1946		10.4315/0362-028X.JFP-14-185		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	AT1TS	WOS:000344717400013		
J	Shimamura, Y; Aoki, N; Sugiyama, Y; Nakayama, T; Masuda, S				Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Nakayama, Tsutomu; Masuda, Shuichi			Screening of Tea Extract and Theaflavins for Inhibitory Effects on the Biological Activity and Production of Staphylococcal Enterotoxin A	JOURNAL OF FOOD SCIENCE			English	Article						epitheaflagallin; staphylococcal enterotoxin A; tea; theaflavin	GENE SEA EXPRESSION; GREEN TEA; ANTIMICROBIAL ACTIVITY; HPLC ANALYSIS; AUREUS; FOOD; ANTIOXIDANT; CATECHINS; OUTBREAK; BLACK	This study aimed to develop a novel method with tea extracts and its components, to reduce the risk of foodborne illnesses caused by the bacterial toxin staphylococcal enterotoxin A (SEA). The potential effect of tea extracts, theaflavins, and epitheaflagallin on staphylococcal growth was studied. A broth microdilution method was used to determine the minimum inhibitory concentration of these samples against an SEA-producing strain, Staphylococcus aureus C-29. The following assays were performed to evaluate various effects on concentrations of no effect on staphylococcal growth. The interactions of theaflavin-rich green tea extracts (TGE), theaflavins, and epitheaflagallin to cultured S. aureus C-29 were determined using Western blot analysis. As a result, all samples suppressed the binding affinity of the anti-SEA antibody to SEA. Since these samples could react directly with SEA, we examined whether they could bind to SEA. Our results demonstrated that binding of the anti-SEA antibody to 4 theaflavins-treated SEA was inhibited in a dose-dependent manner. On the other hand, the production of SEA was significantly decreased by treatment with TGE and epitheaflagallin. Based on the finding that TGE and epitheaflagallin inhibit the production of SEA, we further examined the relative expression levels of sea toxin-encoding genes after treatment with TGE and epitheaflagallin with real-time RT-PCR. TGE and epitheaflagallin significantly supressed the gene transcription of SEA in S. aureus C-29. We then tested whether the samples block the biological activity of SEA in murine spleen cells. TGE, theaflavins, and epitheaflagallin became inactivated the biological activity of SEA. These results suggest that edible and safe compounds in tea can be used to inactivate both pathogens and toxins. Practical Application The experimental findings suggest that tea including theaflavins can inhibit the biological activity of SEA. Therefore, formulations containing these food ingredients merit further study to inhibit emetogenic- and T-cell-stimulating activities of S. aureus.	[Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Nakayama, Tsutomu; Masuda, Shuichi] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Nakayama, Tsutomu] Nippon Vet & Life Sci Univ, Dept Food Sci & Technol, Musashino, Tokyo 1808602, Japan	Masuda, S (reprint author), Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	masudas@u-shizuoka-ken.ac.jp			JSPS KAKENHI [24700806]; SKYLARK Food Science Inst. grant; Shizuoka Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency on "Shizuoka to the World: Research and development of next-generation bottled tea drinks and tea extracts"	This study was supported by JSPS KAKENHI Grant Number 24700806, SKYLARK Food Science Inst. grant, and Shizuoka Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency on "Shizuoka to the World: Research and development of next-generation bottled tea drinks and tea extracts." We are very grateful to Drs. Yukihiko Hara and Takashi Tanaka for providing theaflavin-rich green tea extracts and epitheaflagallin respectively.	Nishimura M, 2007, J AGR FOOD CHEM, V55, P7252, DOI 10.1021/jf070312m; Li SJ, 2011, J APPL MICROBIOL, V110, P729, DOI 10.1111/j.1365-2672.2010.04927.x; Chan PF, 1998, J BACTERIOL, V180, P6232; Itoh N, 2007, TETRAHEDRON, V63, P9488, DOI 10.1016/j.tet.2007.06.093; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Klotz M, 2003, J CLIN MICROBIOL, V41, P4683, DOI 10.1128/JCM.41.10.4683-4687.2003; BORST DW, 1994, INFECT IMMUN, V62, P113; HAMILTONMILLER JMT, 1995, ANTIMICROB AGENTS CH, V39, P2375; Rasooly R, 2010, J AGR FOOD CHEM, V58, P5421, DOI 10.1021/jf904021b; Maisch T, 2004, PHOTOCH PHOTOBIO SCI, V3, P907, DOI 10.1039/b407622b; Hu DL, 2014, EUR J PHARMACOL, V722, P95, DOI 10.1016/j.ejphar.2013.08.050; EVENSON ML, 1988, INT J FOOD MICROBIOL, V7, P311, DOI 10.1016/0168-1605(88)90057-8; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040; Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; TREMAINE MT, 1993, INFECT IMMUN, V61, P356; Rasooly A, 1998, INT J FOOD MICROBIOL, V41, P205, DOI 10.1016/S0168-1605(98)00050-6; Bancirova M, 2010, FOOD RES INT, V43, P1379, DOI 10.1016/j.foodres.2010.04.020; Chan Eric W C, 2011, Pharmacognosy Res, V3, P266, DOI 10.4103/0974-8490.89748; DAVIS AL, 1995, MAGN RESON CHEM, V33, P549, DOI 10.1002/mrc.1260330709; Friedman M, 2013, J FOOD SCI, V78, pM270, DOI 10.1111/1750-3841.12021; Friedman M, 2006, J FOOD SCI, V71, pC328, DOI 10.1111/j.1750-3841.2006.00090.x; Hisano M, 2003, ARCH DERMATOL RES, V295, P183, DOI 10.1007/s00403-003-0411-x; Palmer A, 2004, J MED MICROBIOL, V53, P1023; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Shimamura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1571, DOI 10.1271/bbb.50617; Shimamura Y, 2008, FOOD SCI TECHNOL RES, V14, P513, DOI 10.3136/fstr.14.513; Tiwari RP, 2005, INDIAN J MED RES, V122, P80; TODA M, 1989, LETT APPL MICROBIOL, V8, P123, DOI 10.1111/j.1472-765X.1989.tb00255.x; Wang CX, 2006, AFR J BIOTECHNOL, V5, P213	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	NOV	2014	79	11					M2294	M2300		10.1111/1750-3841.12566		7	Food Science & Technology	Food Science & Technology	AT2XB	WOS:000344796500020		
J	Horita, M; Tsuchiya, K; Suga, Y; Yano, K; Waki, T; Kurose, D; Furuya, N				Horita, Mitsuo; Tsuchiya, Kenichi; Suga, Yasuhiro; Yano, Kazutaka; Waki, Takamitsu; Kurose, Daisuke; Furuya, Naruto			Current classification of Ralstonia solanacearum and genetic diversity of the strains in Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Review						Ralstonia solanacearum; Genetic diversity; Japan; Zingiberaceae strain; Phylotype; Sequevar	PSEUDOMONAS-SOLANACEARUM; BACTERIAL WILT; SPECIES COMPLEX; PATHOGENS; PLANT; BURKHOLDERIA; BIOVAR-2; EUTROPHA; PROPOSAL; AMERICA	Ralstonia solanacearum is the causal organism of bacterial wilt of more than 200 species representing 50 families of plants in tropical, subtropical, and warm temperate regions in the world. Traditionally classified into five races based on differences in host range, R. solanacearum has also been grouped into six biovars on the basis of biochemical properties. With recent developments in molecular biology, various DNA-based analyses have been introduced and used to confirm that this binary system does not completely represent the diversity within R. solanacearum strains. Therefore, a new hierarchical classification scheme has been suggested, which defines R. solanacearum as a species complex and reorganized the concept of the species as a monophyletic cluster according to a phylogenetic analysis based on genomic sequence data. Here we discuss the current bacterial wilt situation and genetic relationships based on the recent classification system of Japanese R. solanacearum strains as well as worldwide strains. We also review the genetic, biochemical, and pathological characteristics of R. solanacearum strains, in particular, those affecting potato and Zingiberaceae plants as distinctly important pathogens in relation to continuously problematic and recent emergent diseases in Japan.	[Horita, Mitsuo; Kurose, Daisuke] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Tsuchiya, Kenichi; Furuya, Naruto] Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan; [Suga, Yasuhiro] Nagasaki Pest Control Stn, Isahaya, Nagasaki 8540062, Japan; [Yano, Kazutaka] Kochi Agr Res Ctr, Nankoku, Kochi 7830023, Japan; [Waki, Takamitsu] Tochigi Prefectural Agr Expt Stn, Utsunomiya, Tochigi 3200002, Japan	Tsuchiya, K (reprint author), Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan.	kentsuch@agr.kyushu-u.ac.jp					Horita M, 2005, J PHYTOPATHOL, V153, P209, DOI 10.1111/j.1439-0434.2005.00954.x; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; GILLINGS M, 1993, PLANT PATHOL, V42, P744, DOI 10.1111/j.1365-3059.1993.tb01561.x; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Taghavi M, 1996, INT J SYST BACTERIOL, V46, P10; HE LY, 1983, PLANT DIS, V67, P1357, DOI 10.1094/PD-67-1357; Horita M, 2010, J GEN PLANT PATHOL, V76, P196, DOI 10.1007/s10327-010-0229-2; Xue QY, 2011, FEMS MICROBIOL ECOL, V75, P507, DOI 10.1111/j.1574-6941.2010.01026.x; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Poussier S, 2000, MICROBIOL-UK, V146, P1679; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Castillo JA, 2007, APPL ENVIRON MICROB, V73, P1225, DOI 10.1128/AEM.01253-06; Jaunet TX, 1999, PHYTOPATHOLOGY, V89, P320, DOI 10.1094/PHYTO.1999.89.4.320; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Nouri S, 2009, PLANT PATHOL, V58, P243, DOI 10.1111/j.1365-3059.2008.01944.x; Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Ivey MLL, 2007, PHYTOPATHOLOGY, V97, P1467, DOI 10.1094/PHYTO-97-11-1467; Thwaites R, 1999, PLANT PATHOL, V48, P121, DOI 10.1046/j.1365-3059.1999.00321.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Xu J, 2009, EUR J PLANT PATHOL, V125, P641, DOI 10.1007/s10658-009-9512-5; Horita M, 2001, PHYTOPATHOLOGY, V91, P399, DOI 10.1094/PHYTO.2001.91.4.399; Poussier S, 2000, SYST APPL MICROBIOL, V23, P479; Norman DJ, 2009, PHYTOPATHOLOGY, V99, P1070, DOI 10.1094/PHYTO-99-9-1070; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; BoShou L., 2005, BACTERIAL WILT DIS R, P225; BUDDENHAGEN IVAN, 1964, ANN REV PHYTOPATHOL, V2, P203, DOI 10.1146/annurev.py.02.090164.001223; COOK D, 1989, Molecular Plant-Microbe Interactions, V2, P113, DOI 10.1094/MPMI-2-113; COOK D, 1994, BACTERIAL WILT, P77; Denny TP, 2001, LAB GUIDE IDENTIFICA, P151; EDEN-GREEN S J, 1990, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V38, P49; Elphinstone J. G., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P9; Fegan M., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P19; GILLINGS MR, 1994, BACTERIAL WILT, P95; HAYWARD AC, 1994, BACTERIAL WILT, P123; HAYWARD AC, 1964, J APPL BACTERIOL, V27, P265, DOI 10.1111/j.1365-2672.1964.tb04912.x; Hayward AC, 1998, BACTERIAL WILT DISEASE, P420; HAYWARD AC, 1994, BACTERIAL WILT, P9; Hayward AC, 2013, AUSTRALAS PLANT PATH, V42, P235, DOI 10.1007/s13313-012-0174-y; Hayward AC, 1967, OLD J AGR ANIM SCI, V24, P1; He LY, 1986, ACIAR P, V13, P40; Hong JC, 2012, PHYTOPATHOLOGY, V102, P924, DOI 10.1094/PHYTO-12-11-0342; Horita M, 2012, MAFF MICROORGANISM G, P1; Horita Mitsuo, 2000, Journal of General Plant Pathology, V66, P132, DOI 10.1007/PL00012934; Horita M, 2002, BACTERIAL WILT NEWSL, V17, P23; Horita M., 2009, Japanese Journal of Phytopathology, V75, P297; Horita Mitsuo, 2004, Journal of General Plant Pathology, V70, P278, DOI 10.1007/s10327-004-0126-7; Jeong Y, 2007, PLANT DIS, V91, P1277, DOI 10.1094/PDIS-91-10-1277; Katayama K, 1986, B NAGASAKI PREF AGR, V14, P1; Kumar A., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P185; Lapage SP, 1992, INT CODE NOMENCLACTU; Liu YQ, 2009, J GEN PLANT PATHOL, V75, P369, DOI 10.1007/s10327-009-0188-7; Lum K. Y., 1973, MARDI Research Bulletin, V1, P15; Morita Y, 1996, P ASS PL PROTEC SHIK, V31, P1; Narita T, 1958, REP HOKKAIDO PREF AG, V8, P1; Okabe N, 1965, ANN PHYTOPATH SOC JA, V31, P152; Ooshiro A, 2008, PLANT PROTECT, V62, P90; Ozaki K, 1992, B CHUGOKU NATL AGR E, V10, P49; PALLERON.NJ, 1971, J BACTERIOL, V107, P690; PEGG K G, 1971, Australian Journal of Experimental Agriculture and Animal Husbandry, V11, P696, DOI 10.1071/EA9710696; Prior P, 2005, ACTA HORTIC, P127; QUINON VL, 1964, PHYTOPATHOLOGY, V54, P1096; Remenant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024356; Remenant B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-379; Suga Y, 2000, PHYTOPATHOL SOC JAPA, V20, P174; Suga Y, 2013, J GEN PLANT PATHOL, V79, P110, DOI 10.1007/s10327-013-0429-7; Titatarn V, 1986, ACIAR P, V13, P65; Toukam GMS, 2009, PLANT DIS, V93, P1123, DOI 10.1094/PDIS-93-11-1123; Tsuchiya K, 1999, ANN PHYTOPATHOL SOC, V65, P363; Tsuchiya K., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P463; Tsuchiya K, 2008, PLANT PROTECT, V62, P72; Uematsu T, 1983, BACTERIAL DIS EC CRO, P1; Villa Joselito E., 2005, Journal of General Plant Pathology, V71, P39, DOI 10.1007/s10327-004-0156-1; Waki T, 2013, JARQ-JPN AGR RES Q, V47, P283; Yano K., 2011, Japanese Journal of Phytopathology, V77, P88; Yano K., 2005, Japanese Journal of Phytopathology, V71, P179; Yu Q, 2003, PHYTOPATHOLOGY, V93, P1124, DOI 10.1094/PHYTO.2003.93.9.1124; ZEHR E I, 1969, Philippine Agriculturist, V53, P224	80	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					455	465		10.1007/s10327-014-0537-z		11	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200001		
J	Takikawa, Y; Takahashi, F				Takikawa, Yuichi; Takahashi, Fuyumi			Bacterial leaf spot and blight of crucifer plants (Brassicaceae) caused by Pseudomonas syringae pv. maculicola and P-cannabina pv. alisalensis	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Review						Pseudomonas syringae pv. maculicola; Pseudomonas cannabina pv. alisalensis; Leaf spot; Blight; Crucifer plants; Japanese radish	1ST REPORT; BROCCOLI RAAB; CALIFORNIA; DISEASE; TOMATO; ARUGULA; CABBAGE; CAULIFLOWER; AUSTRALIA; PATHOGEN	Bacterial leaf spot and blight diseases caused by Pseudomonas syringae pv. maculicola (Psm) and P. cannabina pv. alisalensis (Pcal) are becoming a significant concern for producers of crucifer crops worldwide. Since Psm was first described in 1911, many have reported on its diverse phenotypic, genetic and pathogenic characteristics. Japanese isolates of Psm are also heterogeneous and differ in their host preferences. Pcal was first described in 2002 and has quickly spread globally. Recent work demonstrated that some isolates that had been identified as Psm are actually Pcal. Pcal was also shown to be split into two groups, A and B, based on bacteriological properties, genetic traits and pathogenicity. Group A of Pcal consists mostly of isolates from Japanese radish and radish, isolated before 1990s, that are more aggressive on radish leaves but less aggressive on other Brassica plants compared with group B. Group B of Pcal consists of recent isolates from various crucifer plants including the pathotype of Pcal. In this review, we suggest that group A of Pcal may have existed since the 1950s and survived as a relatively minor pathogen on radish or Japanese radish, whereas group B emerged in the late 1990s, causing global epidemics because of its stronger virulence on various Brassica crops. We also suggest that emergence of a new group of a pathogenic bacterium may cause a re-emergence or new epidemics of a disease that previously was of minor importance.	[Takikawa, Yuichi; Takahashi, Fuyumi] Grad Sch Sci & Technol, Plant Pathol Lab, Shizuoka 4228529, Japan; [Takikawa, Yuichi; Takahashi, Fuyumi] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Takahashi, Fuyumi] Shizuoka Prefectural Res Inst Agr & Forestry, Tea Res Ctr, Shizuoka 4390002, Japan	Takikawa, Y (reprint author), Grad Sch Sci & Technol, Plant Pathol Lab, 836 Ohya, Shizuoka 4228529, Japan.	abytaki@ipc.shizuoka.ac.jp					Gironde S, 2012, APPL ENVIRON MICROB, V78, P3266, DOI 10.1128/AEM.06655-11; YOUNG JM, 1978, NEW ZEAL J AGR RES, V21, P153; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; Bradbury JF, 1986, GUIDE PLANT PATHOGEN, P165; Bull CT, 2004, PLANT DIS, V88, P1384, DOI 10.1094/PDIS.2004.88.12.1384A; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; Bull CT, 2009, PLANT DIS, V93, P109, DOI 10.1094/PDIS-93-1-0109A; Bull CT, 2010, PLANT DIS, V94, P1375, DOI 10.1094/PDIS-07-10-0538; Bull CT, 2011, PLANT DIS, V95, P1027, DOI 10.1094/PDIS-11-10-0804; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cintas NA, 2002, PLANT DIS, V86, P992, DOI 10.1094/PDIS.2002.86.9.992; Cintas NA, 2006, PLANT DIS, V90, P1077, DOI 10.1094/PD-90-1077; Cintas N. A., 2001, Plant Disease, V85, P1207, DOI 10.1094/PDIS.2001.85.11.1207A; Elliott C, 1951, MANUAL BACTERIAL PLA, P69; HENDSON M, 1992, J APPL BACTERIOL, V73, P455, DOI 10.1111/j.1365-2672.1992.tb05005.x; Horinouchi H, 2012, JPN J PHYTOPATHOL, V78, P285; Horinouchi H, 2010, PLANT PROT, V64, P220; Horinouchi H., 2009, Annual Report of the Kansai Plant Protection Society, P45, DOI 10.4165/kapps.51.45; Ikata S, 1933, J PLANT PROTECT TOKY, V20, P126; Inoue Yasuhiro, 2006, Journal of General Plant Pathology, V72, P26, DOI 10.1007/s10327-005-0240-1; Ishiyama Y, 2012, NOUYAKU SHUNJU, V89, P2; Ishiyama Y, 2013, J GEN PLANT PATHOL, V79, P155, DOI 10.1007/s10327-013-0427-9; Koike ST, 1998, PLANT DIS, V82, P727, DOI 10.1094/PDIS.1998.82.7.727; Koike S. T., 2000, Plant Disease, V84, P370, DOI 10.1094/PDIS.2000.84.3.370B; Koike ST, 2007, VEGETABLE DIS; Koike ST, 2006, PLANT DIS, V90, P1551, DOI 10.1094/PD-90-1551B; Koike ST, 1996, PLANT DIS, V80, P464; Koike ST, 2007, PLANT DIS, V91, P112, DOI 10.1094/PD-91-0112C; Ivey M. L. Lewis, 2002, Plant Disease, V86, P186, DOI 10.1094/PDIS.2002.86.2.186A; Matsuda D, 2003, JPN J PHYTOPATHOL, V69, P302; Mauzey SJ, 2011, PLANT DIS, V95, P71, DOI 10.1094/PDIS-09-10-0642; McCann HC, 2013, PLOS PATHOG, V9; McCulloch L, 1911, USDA BUR PLANT IND B, V225, P1; Nishiyama N, 1985, THESIS SHIZUOKA U; Nishiyama N, 1985, ANN PHYTOPATH SOC JA, V51, P342; Obayashi N, 1984, KONGETSU NO NOUYAKU, V28, P74; OKABE NORIO, 1932, JOUR SOC TROP AGRIC, V4, P470; Okabe N, 1956, B FAC AGR SHIZUOKA U, V6, P5; Perez LV, 1983, ANN PHYTOPATH SOC JA, V49, P414; Peters BJ, 2004, PLANT PATHOL, V53, P73, DOI 10.1046/j.1365-3059.2003.00946.x; Rimmer S.R., 2007, COMPENDIUM BRASSICA; Rubio I, 2012, PLANT DIS, V96, P904, DOI 10.1094/PDIS-01-12-0043-PDN; Sarris PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059366; Sarris P. F., 2010, New Disease Reports, V22, P22, DOI 10.5197/j.2044-0588.2010.022.022; Schofield DA, 2012, APPL ENVIRON MICROB, V78, P3592, DOI 10.1128/AEM.00252-12; SHACKLET.DA, 1966, NEW ZEAL J SCI, V9, P872; SMITH MA, 1953, PHYTOPATHOLOGY, V43, P583; Stevens FL, 1913, FUNGI WHICH CAUSE PL, P28; Takahashi F, 2013, J GEN PLANT PATHOL, V79, P260, DOI 10.1007/s10327-013-0458-2; Takahashi F, 2013, JPN J PHYTOPATHOL, V79, P35; Takahashi F, 2012, JPN J PHYTOPATHOL, V78, P274; Takahashi F, 2013, ACTA PHYTOPATH SIN S, V43, P539; Takahashi F, 2013, JPN J PHYTOPATHOL, V79, P247; Takeuchi T, 1989, P KANTO TOSAN PLANT, V36, P60; TAKIKAWA Y, 1994, COLLOQ INRA, V66, P199; TAKIMOTO SEITO, 1931, BULTENO SCI FAKULT TERKULT KJUSU IMP UNIV FUKUOKA JAPAN, V4, P545; Takimoto S, 1931, AGR HORTIC TOKYO NOG, V6, P1233; Tanahashi M, 2000, P ASS PL PROT HOKURI, V48, P33; Wechter WP, 2010, PLANT DIS, V94, P132, DOI 10.1094/PDIS-94-1-0132C; WEHLBURG C, 1965, PHYTOPATHOLOGY, V55, P1082; WIEBE WL, 1993, PLANT DIS, V77, P414; WILLIAMS PAUL H., 1966, PLANT DIS REPORTER, V50, P192; Zhao YF, 2002, PLANT DIS, V86, P883, DOI 10.1094/PDIS.2002.86.8.883; Zhao YF, 2000, PLANT DIS, V84, P1015, DOI 10.1094/PDIS.2000.84.9.1015	64	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					466	474		10.1007/s10327-014-0540-4		9	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200002		
J	Shiraishi, T; Sakai, H; Ikeda, K; Urushibara, T				Shiraishi, Toshimasa; Sakai, Hiroshi; Ikeda, Kentaro; Urushibara, Toshihiko			A useful method for preparing microsclerotial inoculum of Verticillium dahliae	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Verticillium dahliae; Microsclerotia; Inoculum; Aralia cordata	ALBO-ATRUM; SURVIVAL; SOIL	Various methods of inoculating plants with Verticillium dahliae have been described; however, so far, there are no effective preparations of its microsclerotia, a major source of infection under natural field conditions. In this study, we developed a simple and effective method to prepare microsclerotial inoculum of V. dahliae using a cellophane medium that effectively promoted microsclerotia formation. In addition, a sieving process allowed the preparation of inoculum exclusively composed of microsclerotia. Our novel method provides a reproducible and stable inoculum for disease induction by V. dahliae under conditions that approximate natural infections.	[Shiraishi, Toshimasa; Ikeda, Kentaro] Gunma Agr Technol Ctr, Gunma 3792224, Japan; [Sakai, Hiroshi; Urushibara, Toshihiko] Gunma Prefectural Off, Gunma 3718570, Japan	Shiraishi, T (reprint author), Gunma Agr Technol Ctr, 493 Nishiobokata, Gunma 3792224, Japan.	shira-to@ktv.ne.jp					Hashimoto K, 1989, B SAITAMA HORTIC EXP, V2, P1; Hashimoto K, 1989, SOIL MICROORG, V33, P35; Iijima T, 1983, B TOKYO METROP AGR E, V16, P63; ISAAC IVOR, 1949, TRANS BRIT MYCOL SOC, V32, P137; LEACH CHARLES M., 1962, CANADIAN JOUR BOT, V40, P151; MENZIES JD, 1967, PHYTOPATHOLOGY, V57, P703; Pegg G. F., 2002, Verticillium wilts, P293, DOI 10.1079/9780851995298.0293; SCHNATHO.WC, 1966, PHYTOPATHOLOGY, V56, P1155; SCHREIBER LR, 1962, PHYTOPATHOLOGY, V52, P288; Shiraishi T, 1994, GUNMA J AGR RES D, V8, P35	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					475	478		10.1007/s10327-014-0549-8		4	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200003		
J	Miyake, N; Nagai, H; Kageyama, K				Miyake, Noriyuki; Nagai, Hirofumi; Kageyama, Koji			Wilt and root rot of poinsettia caused by three high-temperature-tolerant Pythium species in ebb-and-flow irrigation systems	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Pythium aphanidermatum; Pythium helicoides; Pythium myriotylum; Poinsettia; Root rots; High temperature	NUTRIENT SOLUTION; 1ST REPORT; PHYTOPHTHORA; SPP.; APHANIDERMATUM; IDENTIFICATION; HYDROPONICS; PLANTS; JAPAN	Poinsettia plants growing in ebb-and-flow irrigation systems developed wilting and root rot during the summer growing seasons of 2010 in Gifu Prefecture and 2011 in Aichi Prefecture. Pythium species were isolated from roots with rot symptoms. The isolates were identified as P. helicoides and P. myriotylum on the basis of morphological characteristics and sequence homologies in the rDNA internal transcribed spacer regions. In pathogenicity tests, these isolates caused severe wilting and root rot. This is the first report of poinsettia root rot disease caused by P. helicoides and P. myriotylum, although P. aphanidermatum was reported as a pathogen of poinsettia root rot. To better understand these diseases, we performed an epidemiological study of three high-temperature-tolerant Pythium species, P. aphanidermatum, P. helicoides and P. myriotylum. Disease incidence as a percentage of diseased plants was greatest at 35 A degrees C for all three species. Disease severity using the rating scale of root rot was also highest at 35 A degrees C, particularly with high zoospore inoculum densities (100.0 zoospores/mL). Although the disease incidence and severity were reduced at lower temperatures, the three Pythium species were able to cause disease at temperatures as low as 20 A degrees C.	[Miyake, Noriyuki] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Miyake, Noriyuki; Nagai, Hirofumi] Aichi Agr Res Ctr, Nagakute, Aichi 4801193, Japan; [Kageyama, Koji] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan	Miyake, N (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	noriyuki_miyake@pref.aichi.lg.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industries, Ministry of Agriculture, Forestry and Fisheries, Japan	This work was supported by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industries from the Ministry of Agriculture, Forestry and Fisheries, Japan.	Anderson MG, 1997, PLANT DIS, V81, P227, DOI 10.1094/PDIS.1997.81.2.227D; Morita Y, 2007, PLANT DIS, V91, P1591, DOI 10.1094/PDIS-91-12-1591; Kageyama K, 2003, J PHYTOPATHOL, V151, P485, DOI 10.1046/j.1439-0434.2003.00757.x; Chellemi DO, 2000, PLANT DIS, V84, P1271, DOI 10.1094/PDIS.2000.84.12.1271; STANGHELLINI ME, 1994, PLANT DIS, V78, P1129; Moorman GW, 2002, PLANT DIS, V86, P1227, DOI 10.1094/PDIS.2002.86.11.1227; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; THINGGAARD K, 1995, PLANT DIS, V79, P259; SANOGO S, 1993, PLANT DIS, V77, P287; THINGGAARD K, 1989, J PHYTOPATHOL, V125, P343, DOI 10.1111/j.1439-0434.1989.tb01079.x; Stanghellini ME, 2000, PLANT DIS, V84, P1147, DOI 10.1094/PDIS.2000.84.10.1147; BOLTON AT, 1978, CAN J PLANT SCI, V58, P569; Chikuo Y, 2008, JPN J PHYTOPATHOL, V74, P177; Jenkins JRSF, 1983, PLANT DIS, V67, P968; Kageyama Koji, 2002, Journal of General Plant Pathology, V68, P15, DOI 10.1007/PL00013047; Kageyama K, 2012, JPN J PHYTOPATHOL, V78, P184; KO WH, 1973, PHYTOPATHOLOGY, V63, P1206; Miyake N, 2010, JPN J PHYTOPATHOL, V76, P65; Miyazaki A., 2009, Annual Report of the Kansai Plant Protection Society, P53, DOI 10.4165/kapps.51.53; MOULIN F, 1994, EUR J PLANT PATHOL, V100, P3, DOI 10.1007/BF01871963; Ono T, 2011, ANN REPT KANTO PL PR, V58, P61; Stanghellini M. E., 2000, Plant Disease, V84, P811, DOI 10.1094/PDIS.2000.84.7.811A; Sugawara K, 2010, JPN J PHYTOPATHOL, V76, P44; Suzuki M, 2009, JPN J PHYTOPATHOL, V75, P237; Tojo M, 1993, P KANSAI PLANT PROT, V35, P1; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Watanabe Hideki, 2007, Journal of General Plant Pathology, V73, P81, DOI 10.1007/s10327-006-0338-0; Watanabe H, 2008, JPN J PHYTOPATHOL, V74, P178; Waterhouse GM, 1967, MYCOL PAP, V109, P1; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					479	489		10.1007/s10327-014-0542-2		11	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200004		
J	Kishigami, R; Yamagishi, N; Ito, T; Yoshikawa, N				Kishigami, Ryusuke; Yamagishi, Noriko; Ito, Tsutae; Yoshikawa, Nobuyuki			Detection of apple latent spherical virus in seeds and seedlings from infected apple trees by reverse transcription quantitative PCR and deep sequencing: evidence for lack of transmission of the virus to most progeny seedlings	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Apple latent spherical virus; Seed transmission; RT-qPCR; Deep sequence analysis	ARABIDOPSIS-THALIANA; NEXT-GENERATION; TIME; VECTORS; EXPRESSION	We used reverse transcription quantitative PCR (RT-qPCR) to test for apple latent spherical virus (ALSV) in cotyledons of seeds and true leaves of seedlings from apple trees infected with ALSV to accurately determine the status of infection in seedlings from ALSV-infected trees. The amplification curves of ALSV-RNAs from cotyledons were classified into three patterns: fast (F), slow (S), and no amplification (N/A). Viral RNA was detected in high concentrations (F pattern) in cotyledons from approximately 1 % of the seeds, a proportion broadly consistent with previously reported ALSV seed transmission rates (from zero to a few percent). In the majority of seeds (94.4 %); however, minute amounts of RNA related to the virus were detected (S pattern). Minute amounts of viral-related RNA were also detected by siRNA analysis using a next-generation sequencer. After the seeds germinated, however, no viral RNA was detected in the true leaves, so we concluded that the viral RNA in the seeds lacked the capacity to replicate. No ALSV-RNA at all was detected (N/A pattern) in the remaining 4.6 % of seeds. We concluded that almost all apple seedlings from ALSV-infected trees (approx. 99 %) can be considered as virus-free. Therefore, we think that apple seedlings from the generation obtained after the use of ALSV vector technology can be exempted from restrictions on genetically modified plants after they have been confirmed to be virus-free by virus testing.	[Kishigami, Ryusuke; Yamagishi, Noriko; Ito, Tsutae; Yoshikawa, Nobuyuki] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Ito, Tsutae] Natl Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan	Yoshikawa, N (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	yoshikawa@iwate-u.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from the Ministry of Agriculture, Forestry and Fisheries	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from the Ministry of Agriculture, Forestry and Fisheries.	Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Yamagishi N, 2009, PLANT MOL BIOL, V71, P15, DOI 10.1007/s11103-009-9505-y; Yamagishi N, 2011, PLANTA, V233, P561, DOI 10.1007/s00425-010-1318-3; Quito-Avila DF, 2012, J VIROL METHODS, V179, P38, DOI 10.1016/j.jviromet.2011.09.016; Yamagishi N, 2011, PLANT MOL BIOL, V75, P193, DOI 10.1007/s11103-010-9718-0; Li CJ, 2000, J GEN VIROL, V81, P541; Li C, 2004, ARCH VIROL, V149, P1541, DOI 10.1007/s00705-004-0310-2; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Nakamura K, 2011, J GEN PLANT PATHOL, V77, P48, DOI 10.1007/s10327-010-0275-9; Sasaki S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-15; Shiller JB, 2010, J PHYTOPATHOL, V158, P758, DOI 10.1111/j.1439-0434.2010.01693.x; Toyoda K, 2013, J GEN PLANT PATHOL, V79, P321, DOI 10.1007/s10327-013-0460-8; Yamagishi N, 2014, PLANT BIOTECHNOL J, V12, P60, DOI 10.1111/pbi.12116; Yamagishi N., 2010, JULIUS KUHN ARCH, V427, P226	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					490	498		10.1007/s10327-014-0541-3		9	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200005		
J	Kitazawa, Y; Netsu, O; Nijo, T; Yoshida, T; Miyazaki, A; Hara, S; Okano, Y; Maejima, K; Namba, S				Kitazawa, Yugo; Netsu, Osamu; Nijo, Takamichi; Yoshida, Tetsuya; Miyazaki, Akio; Hara, Shinichiro; Okano, Yukari; Maejima, Kensaku; Namba, Shigetou			First report of bacterial leaf blight on cosmos (Cosmos bipinnatus Cav.) caused by Pseudomonas cichorii in Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Bacterial leaf blight; Pseudomonas cichorii; Cosmos bipinnatus Cav.		Since 2006, a commercial grower in Japan has noted a leaf blight symptom on potted cosmos plants grown in a field. In August 2012, a Pseudomonas-like bacterium was isolated from the symptomatic leaves and found to cause the same symptom on cosmos seedlings after inoculation. On the basis of bacteriological and phylogenetic analyses, the causative bacterium was identified as Pseudomonas cichorii. This is the first report of bacterial leaf blight on cosmos caused by P. cichorii in Japan.	[Kitazawa, Yugo; Netsu, Osamu; Nijo, Takamichi; Yoshida, Tetsuya; Miyazaki, Akio; Hara, Shinichiro; Okano, Yukari; Maejima, Kensaku; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	Namba, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Netsu, Osamu/O-1225-2015				Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Goto M, 1984, SHOKUBUTSU BOEKI, V38, P385; Goto M, 1954, REP FAC AGR SHIZUOKA, V4, P7; Goto M, 1984, SHOKUBUTSU BOEKI, V38, P339; Goto M, 1984, SHOKOBUTSU BOEKI, V38, P479; Goto M, 1984, SHOKOBUTSU BOEKI, V38, P432; Hikichi Y, 2013, J GEN PLANT PATHOL, V79, P379, DOI 10.1007/s10327-013-0461-7; Inoue T., 2013, Japanese Journal of Phytopathology, V79, P99, DOI 10.3186/jjphytopath.79.99; Kawakubo Y, 1987, ANN PHYTOPATH SOC JA, V53, P404; Kawarabayashi S, 1984, ANN PHYTOPATH SOC JA, V50, P421; Kubo H, 2009, JPN J PHYTOPATHOL, V75, P53; Nishiyama K, 1978, SHOKUBUTSU BOEKI, V32, P283; Okuda S, 1976, ANN PHYTOPATH SOC JA, V42, P389; PERNEZNY K, 1994, PLANT DIS, V78, P917; Sawayanagi T, 2002, JPN J PHYTOPATHOL, V68, P258; Shiraishi T, 2013, J GEN PLANT PATHOL, V79, P214, DOI 10.1007/s10327-013-0444-8; Suenaga H, 2006, JPN J PHYTOPATHOL, V72, P77; Suzuki Ayumi, 2002, Journal of General Plant Pathology, V68, P398, DOI 10.1007/PL00013110; Tanaka M, 2012, GENES-BASEL, V3, P62, DOI 10.3390/genes3010062; Tsuchiya Y, 1979, B NATIONAL I AGR S C, V33, P77; Tsuchiya Y, 1976, ANN PHYTOPATH SOC JA, V42, P365; Tsurumaki N, 2005, JPN J PHYTOPATHOL, V71, P289; Wakibe H., 1995, Proceedings of the Association for Plant Protection of Kyushu, V41, P51	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					499	503		10.1007/s10327-014-0553-z		5	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200006		
J	Tsuchiya, K				Tsuchiya, Kenichi			Genetic diversity of Ralstonia solanacearum and disease management strategy	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article							BACTERIAL WILT; PSEUDOMONAS-SOLANACEARUM; INDUCED RESISTANCE; SPECIES COMPLEX; STRAINS; REGION; ASIA		Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan	Tsuchiya, K (reprint author), Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan.	kentsuch@agr.kyushu-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Society for the Promotion of Science	I express my deepest gratitude to all my colleagues, staff and students for their enthusiastic collaboration and cooperation in this research. The research was supported in part by Grant-in-Aid for Research projects from the Ministry of Agriculture, Forestry and Fisheries of Japan, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Japanese Society for the Promotion of Science.	Horita M, 2005, J PHYTOPATHOL, V153, P209, DOI 10.1111/j.1439-0434.2005.00954.x; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Horita M, 2010, J GEN PLANT PATHOL, V76, P196, DOI 10.1007/s10327-010-0229-2; Takahashi H, 2006, PHYTOPATHOLOGY, V96, P908, DOI 10.1094/PHYTO-96-0908; Poussier S, 2000, MICROBIOL-UK, V146, P1679; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Castillo JA, 2007, APPL ENVIRON MICROB, V73, P1225, DOI 10.1128/AEM.01253-06; Nouri S, 2009, PLANT PATHOL, V58, P243, DOI 10.1111/j.1365-3059.2008.01944.x; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897; Horita M, 2001, PHYTOPATHOLOGY, V91, P399, DOI 10.1094/PHYTO.2001.91.4.399; Poussier S, 2000, SYST APPL MICROBIOL, V23, P479; BoShou L., 2005, BACTERIAL WILT DIS R, P225; BUDDENHAGEN IVAN, 1964, ANN REV PHYTOPATHOL, V2, P203, DOI 10.1146/annurev.py.02.090164.001223; COOK D, 1989, Molecular Plant-Microbe Interactions, V2, P113, DOI 10.1094/MPMI-2-113; Denny TP, 2001, LAB GUIDE IDENTIFICA, P151; Elphinstone J. G., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P9; Fegan M., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P19; GILLINGS MR, 1994, BACTERIAL WILT, P95; HAYWARD AC, 1964, J APPL BACTERIOL, V27, P265, DOI 10.1111/j.1365-2672.1964.tb04912.x; HAYWARD AC, 1994, BACTERIAL WILT, P9; He LY, 1986, ACIAR P, V13, P40; Hoang H, 2011, PHYTOPATHOLOGY, V101, pS72; Horita M, 2012, MAFF MICROORGANISM G, P1; Horita M, 2002, BACTERIAL WILT NEWSL, V17, P23; Horita M., 2009, Japanese Journal of Phytopathology, V75, P297; Horita Mitsuo, 2004, Journal of General Plant Pathology, V70, P278, DOI 10.1007/s10327-004-0126-7; Horita M, 2012, PLANT PROTECT, V66, P274; Jeong Y, 2007, PLANT DIS, V91, P1277, DOI 10.1094/PDIS-91-10-1277; Kajihara H, 2014, PLANT PROTECT, V68, P75; Katayama K, 1986, B NAGASAKI PREF AGR, V14, P1; Momma N, 2013, PLANT PROTECT, V67, P210; Morita Y, 1996, P ASS PL PROTEC SHIK, V31, P1; Ooshiro A, 2008, PLANT PROTECT, V62, P90; PALLERON.NJ, 1971, J BACTERIOL, V107, P690; Remenant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024356; Suga Y, 2013, J GEN PLANT PATHOL, V79, P110, DOI 10.1007/s10327-013-0429-7; Tsuchiya K., 2005, Bacterial wilt disease and the  Ralstonia solanacearum species complex, P463; Tsuchiya K, 2008, PLANT PROTECT, V62, P72; Villa Joselito E., 2005, Journal of General Plant Pathology, V71, P39, DOI 10.1007/s10327-004-0156-1; Waki T, 2013, JARQ-JPN AGR RES Q, V47, P283; Yano K., 2011, Japanese Journal of Phytopathology, V77, P88; Yano K., 2005, Japanese Journal of Phytopathology, V71, P179	44	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					504	509		10.1007/s10327-014-0550-2		6	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200007		
J	Kawakita, K				Kawakita, Kazuhito			Studies on NO functions in plant defense responses	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article							S-NITROSYLATED PROTEINS; NITRIC-OXIDE PRODUCTION; ARABIDOPSIS-THALIANA; PROTEOMIC IDENTIFICATION; NICOTIANA-BENTHAMIANA; PSEUDOMONAS-SYRINGAE; INVOLVEMENT; POTATO		Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Kawakita, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	kkawakit@agr.nagoya-u.ac.jp					Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Noritake T, 1996, PLANT CELL PHYSIOL, V37, P113; Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Modolo LV, 2005, FEBS LETT, V579, P3814, DOI 10.1016/j.febslet.2005.05.078; Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Alamillo JM, 2001, PLANT J, V25, P529, DOI 10.1046/j.1365-313x.2001.00984.x; Schoof H, 2002, NUCLEIC ACIDS RES, V30, P91, DOI 10.1093/nar/30.1.91; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Butt YKC, 2003, PLANTA, V216, P762, DOI 10.1007/s00425-002-00926-y; Kato H, 2013, PHYSIOL PLANTARUM, V148, P371, DOI 10.1111/j.1399-3054.2012.01684.x; Kato H, 2008, J GEN PLANT PATHOL, V74, P15, DOI 10.1007/s10327-007-0054-4; Monjil MS, 2014, J GEN PLANT PATHOL, V80, P38, DOI 10.1007/s10327-013-0493-z; Monjil Mohammad Shahjahan, 2013, Nitric Oxide, V29, P34, DOI 10.1016/j.niox.2012.12.004; Saito S, 2006, PLANT CELL PHYSIOL, V47, P689, DOI 10.1093/pcp/pcj038; Yamamoto Ayako, 2003, Journal of General Plant Pathology, V69, P218, DOI 10.1007/s10327-003-0039-x; Yamamoto Ayako, 2004, Journal of General Plant Pathology, V70, P85, DOI 10.1007/s10327-003-0094-3; Yamamoto-Katou A, 2006, PLANT CELL PHYSIOL, V47, P726, DOI 10.1093/pcp/pcj044	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					510	513		10.1007/s10327-014-0552-0		4	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200008		
J	Masuta, C				Masuta, Chikara			Molecular biology of Cucumber mosaic virus and its satellite RNA	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article							2B PROTEIN; SILENCING SUPPRESSOR; DISTINCT DOMAINS; PLANT-VIRUSES; GENE; TOBACCO; PATHOGENICITY; INDUCTION; SYMPTOMS; MOVEMENT		Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Masuta, C (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan.	masuta@res.agr.hokudai.ac.jp	Masuta, Chikara/A-6689-2012				Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; [Anonymous], 1981, VIROLOGY, V109, P120; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; DING SW, 1995, EMBO J, V14, P5762; Ye J, 2009, FEBS LETT, V583, P101, DOI 10.1016/j.febslet.2008.11.031; SLEAT DE, 1992, PLANT J, V2, P43, DOI 10.1111/j.1365-313X.1992.00043.x; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Simon AE, 2004, ANNU REV PHYTOPATHOL, V42, P415, DOI 10.1146/annurev.phyto.42.040803.140402; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Choi SH, 2012, J VIROL, V86, P4823, DOI 10.1128/JVI.00018-12; Roossinck MJ, 2002, J VIROL, V76, P3382, DOI 10.1128/JVI.76.7.3382-3387.2002; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Bian XY, 2004, P NATL ACAD SCI US, V101, P3275; DEVIC M, 1989, J GEN VIROL, V70, P2765, DOI 10.1099/0022-1317-70-10-2765; Fujiwara A, 2013, J GEN PLANT PATHOL, V79, P198, DOI 10.1007/s10327-013-0439-5; Garcia-Arenal F, 1999, CURR TOP MICROBIOL, V239, P37; Hajimorad MR, 2009, ARCH VIROL, V154, P137, DOI 10.1007/s00705-008-0280-x; Inaba J, 2011, PLANT PHYSIOL, V156, P2026, DOI 10.1104/pp.111.180042; JAEGLE M, 1990, J GEN VIROL, V71, P1905, DOI 10.1099/0022-1317-71-9-1905; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; KUWATA S, 1991, J GEN VIROL, V72, P2385, DOI 10.1099/0022-1317-72-10-2385; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Masuta Chikara, 2012, Plant Signal Behav, V7, P43, DOI 10.4161/psb.7.1.18526; MASUTA C, 1992, NUCLEIC ACIDS RES, V20, P2885, DOI 10.1093/nar/20.11.2885; MASUTA C, 1989, PLANT CELL, V1, P1165; Masuta C, 2013, J GEN PLANT PATHOL, V79, P227, DOI 10.1007/s10327-013-0448-4; MASUTA C, 1993, PHYTOPATHOLOGY, V83, P411, DOI 10.1094/Phyto-83-411; Shi BJ, 2003, MOL PLANT MICROBE IN, V16, P261, DOI 10.1094/MPMI.2003.16.3.261; Shimura H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002021; Shimura H, 2008, FEBS LETT, V582, P4047, DOI 10.1016/j.febslet.2008.10.046; Shimura H, 2010, FEBS LETT, V584, P945; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Xu P, 2000, PLANT CELL, V12, P1079, DOI 10.1105/tpc.12.7.1079; Yuan Y-R, 2006, GENES DEV, V20, P3255	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					514	518		10.1007/s10327-014-0547-x		5	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200009		
J	Sawada, H				Sawada, Hiroyuki			Studies on the classification and evolution of phytopathogenic bacteria of the genera Agrobacterium and Pseudomonas	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article							SYRINGAE PV. ACTINIDIAE; ARGK; PATHOVARS; RADIOBACTER; RHIZOGENES; CLUSTER; GENUS		Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Sawada, H (reprint author), Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	sawada@affrc.go.jp					SAWADA H, 1993, INT J SYST BACTERIOL, V43, P694; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; SAWADA H, 1995, APPL ENVIRON MICROB, V61, P828; Sawada H, 2003, J GEN APPL MICROBIOL, V49, P155, DOI 10.2323/jgam.49.155; Sawada H, 1997, APPL ENVIRON MICROB, V63, P282; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; Young JM, 2001, INT J SYST EVOL MICR, V51, P89; Genka H, 2006, J MOL EVOL, V63, P401, DOI 10.1007/s00239-005-0271-4; Ichiman Y, 2006, JPN J PHYTOPATHOL, V72, P305; Kersters K, 1984, BERGEYS MANUAL SYSTE, V1, P244; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P325; Miyoshi T., 2012, Japanese Journal of Phytopathology, V78, P92, DOI 10.3186/jjphytopath.78.92; Sawada H., 2014, Japanese Journal of Phytopathology, V80, P98, DOI 10.3186/jjphytopath.80.98; SAWADA H, 1990, Annals of the Phytopathological Society of Japan, V56, P199; SAWADA H, 1992, Annals of the Phytopathological Society of Japan, V58, P91; Sawada H, 2002, J MOL EVOL, V54, P437, DOI 10.1007/s00239-001-0023-y; SAWADA H, 1992, Annals of the Phytopathological Society of Japan, V58, P46; SAWADA H, 1992, Annals of the Phytopathological Society of Japan, V58, P52; Sawada H, 2014, MICROBIOL CULT COLLE, V30, P13; Sawada H, 2014, JPN J PHYTO IN PRESS, V80; Sawada H., 2003, Japanese Journal of Phytopathology, V69, P349; SAWADA H, 1992, Annals of the Phytopathological Society of Japan, V58, P37; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437; Tsunoda A, 2004, JPN J PHYTOPATHOL, V70, P289; Young J.M., 2005, BERGEYS MANUAL SYSTE, V2, P340	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					519	522		10.1007/s10327-014-0544-0		4	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200010		
J	Fujikawa, T				Fujikawa, Takashi			Studies on early and highly sensitive detection of citrus greening pathogenic bacterium	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article									NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Fujikawa, T (reprint author), NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan.	ftakashi@affrc.go.jp					Bove JM, 2006, J PLANT PATHOL, V88, P7; Fujikawa T, 2014, JPN J PHYTOPATHOL, V80, P25; Fujikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057011; Fujikawa T, 2012, MOL CELL PROBE, V26, P194, DOI 10.1016/j.mcp.2012.06.001; Hamashima A, 2003, JPN J PHYTOPATHOL, V69, P307; National Research Council, 2010, STRAT PLANN FLOR CIT	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					523	524		10.1007/s10327-014-0545-z		2	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200011		
J	Mochizuki, T				Mochizuki, Tomofumi			Molecular biological and histochemical studies on the mechanism of symptom expression upon plant viral infection	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article									Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Mochizuki, T (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	tomochi@plant.osakafu-u.ac.jp					Mochizuki T, 2009, VIROLOGY, V390, P239, DOI 10.1016/j.virol.2009.05.012; Mochizuki T, 2014, MOL PLANT PATHOL, V15, P242, DOI 10.1111/mpp.12081; Mochizuki T, 2011, ARCH VIROL, V156, P881, DOI 10.1007/s00705-010-0910-y; Sunpapao A, 2011, AUSTRALAS PLANT PATH, V40, P215, DOI 10.1007/s13313-010-0027-5; Sunpapao A, 2009, J GEN VIROL, V90, P3015, DOI 10.1099/vir.0.013219-0	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					525	526		10.1007/s10327-014-0546-y		2	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200012		
J	Takeda, A				Takeda, Atsushi			Studies on molecular mechanisms of RNA silencing-mediated anti-virus defense in plants and RNA silencing suppression by plant viruses	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article							PROTEINS; NSS		Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan	Takeda, A (reprint author), Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan.	atakeda@fc.ritsumei.ac.jp					Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Mine A, 2010, J VIROL, V84, P6070, DOI 10.1128/JVI.00054-10; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2014	80	6					527	528		10.1007/s10327-014-0548-9		2	Plant Sciences	Plant Sciences	AT2DQ	WOS:000344742200013		
J	Inagaki, T; Ahmed, B; Hartley, ID; Tsuchikawa, S; Reid, M				Inagaki, Tetsuya; Ahmed, Belal; Hartley, Ian D.; Tsuchikawa, Satoru; Reid, Matthew			Simultaneous prediction of density and moisture content of wood by terahertz time domain spectroscopy	JOURNAL OF INFRARED MILLIMETER AND TERAHERTZ WAVES			English	Article						Terahertz time-domain spectroscopy; wood; density; moisture content; effective medium theory; non-destructive evaluation	NORWAY SPRUCE; WATER; COMPOSITE; PAPER	In this study, demonstration of simultaneous prediction of solid wood density and moisture content, both of which are critical in manufacturing operations, of 4 species (Aspen, Birch, Hemlock and Maple) was accomplished using terahertz time-domain spectroscopy (THz-TDS). THz measurements of wood at various moisture contents were taken for two orientations of the THz field (parallel and perpendicular) with respect to the visible grain. The real and imaginary parts of the dielectric function averaged over the frequency range of 0.1 to 0.2 THz had strong correlation with density and moisture content of the wood. We extend a model that has been applied previously to oven-dry wood to include the effects of moisture below the fiber saturation point by combining two effective medium models, which allows the dielectric function of water, air and oven-dry cell wall material to be modeled to give an effective dielectric function for the wood. A strong correlation between measured and predicted values for density and moisture content were observed.	[Inagaki, Tetsuya; Tsuchikawa, Satoru] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ahmed, Belal; Hartley, Ian D.; Reid, Matthew] Univ British Columbia, Dept Phys, Prince George, BC V2N 4Z9, Canada; [Hartley, Ian D.] Univ British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2N 4Z9, Canada	Inagaki, T (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	inatetsu@agr.nagoya-u.ac.jp			Natural Sciences and Engineering Research Council of Canada; Western Economic Diversification Canada; Northern Development Initiatives Trust; JSPS (KAKENHI) [2524102]	The authors would like to acknowledge the financial support from the Natural Sciences and Engineering Research Council of Canada, Western Economic Diversification Canada, the Northern Development Initiatives Trust, and the JSPS (KAKENHI, No. 2524102).	Lundgren N, 2007, WOOD FIBER SCI, V39, P167; Duvillaret L, 1996, IEEE J SEL TOP QUANT, V2, P739, DOI 10.1109/2944.571775; Koch M, 1998, WOOD SCI TECHNOL, V32, P421; HARTLEY ID, 1992, WOOD SCI TECHNOL, V26, P83; Tielrooij KJ, 2009, BIOPHYS J, V97, P2484, DOI 10.1016/j.bpj.2009.08.024; Jordens C, 2010, POLYM TEST, V29, P209, DOI 10.1016/j.polymertesting.2009.11.003; Oyama Y, 2009, NDT&E INT, V42, P28, DOI 10.1016/j.ndteint.2008.08.002; Reid M, 2006, APPL OPTICS, V45, P2766, DOI 10.1364/AO.45.002766; ASPNES DE, 1982, THIN SOLID FILMS, V89, P249, DOI 10.1016/0040-6090(82)90590-9; Jackson JB, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/075502; Edlund J, 2006, HOLZ ROH WERKST, V64, P273, DOI 10.1007/s00107-005-0091-7; Mwaikambo LY, 2001, J MATER SCI LETT, V20, P2095, DOI 10.1023/A:1013703809964; Aspnes DE, 2011, THIN SOLID FILMS, V519, P2571, DOI 10.1016/j.tsf.2010.12.081; Dinulovi M, 2009, FME T, V37, P117; Federici JF, 2012, J INFRARED MILLIM TE, V33, P97, DOI 10.1007/s10762-011-9865-7; HASHIN Z, 1968, J COMPOS MATER, V2, P284, DOI 10.1177/002199836800200302; HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481; Inagaki Tetsuya, 2013, Holzforschung, V68, DOI 10.1515/hf-2013-0013; Jepsen PU, 2007, OPT EXPRESS, V15, P14717, DOI 10.1364/OE.15.014717; Mousavi P, 2009, APPL OPTICS, V48, P6541, DOI 10.1364/AO.48.006541; National Lumber Grades Authority, 2014, STAND GRAD RUL CAN L; Scheller M, 2010, RECENT OPTICAL AND PHOTONIC TECHNOLOGIES, P231; Shmulsky R., 2011, FOREST PRODUCTS WOOD, p[197, 289]; Skaar C., 1988, WOOD WATER RELATIONS, P1; Tanaka S., 2014, J WOOD SCI, V60, P192; Tanaka S, 2014, J WOOD SCI, V60, P111, DOI 10.1007/s10086-013-1386-7; Teti AJ, 2011, J INFRARED MILLIM TE, V32, P513, DOI 10.1007/s10762-011-9769-6; Todoruk TM, 2012, IEEE T THZ SCI TECHN, V2, P123, DOI 10.1109/TTHZ.2011.2177692; Via BK, 2005, J NEAR INFRARED SPEC, V13, P201	29	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6892	1866-6906		J INFRARED MILLIM TE	J. Infrared Millim. Terahertz Waves	NOV	2014	35	11					949	961		10.1007/s10762-014-0095-7		13	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AT2HP	WOS:000344754900006		
J	Iwanaga, M; Taikui, K; Uchiyama, K; Katsuma, S; Imanishi, S; Kawasaki, H				Iwanaga, Masashi; Taikui, Keita; Uchiyama, Koudai; Katsuma, Susumu; Imanishi, Shigeo; Kawasaki, Hideki			Expression of recombinant proteins by BEVS in a macula-like virus-free silkworm cell line	JOURNAL OF INVERTEBRATE PATHOLOGY			English	Article						Baculovirus; Maculavirus; Nucleopolyhedrovirus; BmNPV; BmMLV; BEVS	BOMBYX-MORI; BACULOVIRUS VECTOR; INFECTION	We previously established the first Bombyx mori macula-like virus (BmMLV)-free cell line (BmVF cells) from a B. mori embryo. In this study, we evaluated the expression of recombinant proteins in BmVF cells using a B. mori nucleopolyhedrovirus (BmNPV)-derived expression vector. Our results showed that BmVF cells are susceptible to BmNPV, and both the promoter activity of the polyhedrin gene and the post-translated modifications of a recombinant protein are equivalent between BmMLV-negative BmVF and -positive BmN4 cells. These findings indicate that persistent infection with BmMLV has no discernible effect on BmNPV-mediated protein production in B. mori cells. (C) 2014 Elsevier Inc. All rights reserved.	[Iwanaga, Masashi; Taikui, Keita; Uchiyama, Koudai; Kawasaki, Hideki] Utsunomiya Univ, Fac Agr, Dept Agrobiol & Bioresources, Utsunomiya, Tochigi 3218505, Japan; [Katsuma, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Imanishi, Shigeo] Natl Inst Agrobiol Sci, Genebank, Tsukuba, Ibaraki 3058602, Japan	Iwanaga, M (reprint author), Utsunomiya Univ, Fac Agr, Dept Agrobiol & Bioresources, Mine Machi 350, Utsunomiya, Tochigi 3218505, Japan.	iwanaga@cc.utsunomiya-u.ac.jp			Ministry of Education, Science and Culture of Japan [20780045, 25450482]; Japan Science and Technology Agency - Japan (JST) [241FT0093]	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan (to MI; 20780045, 25450482) and the A-step feasibility study program from Japan Science and Technology Agency - Japan (JST) (to MI; 241FT0093).	MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; Iwanaga M, 2014, VIRUS RES, V179, P113, DOI 10.1016/j.virusres.2013.10.028; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Imanishi S, 2012, IN VITRO CELL DEV-AN, V48, P137, DOI 10.1007/s11626-011-9465-9; Iwanaga M, 2004, BIOCHEM BIOPH RES CO, V323, P599, DOI 10.1016/j.bbrc.2004.08.114; lwanaga M., 2014, IN VITRO CELL DEV BI; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; Nakanishi T, 2010, J VIROL, V84, P5191, DOI 10.1128/JVI.00099-10; Rohrmann G.F., 2008, BACULOVIRUS MOL BIOL; Shimada Toru, 1994, Journal of Sericultural Science of Japan, V63, P353	11	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2011	1096-0805		J INVERTEBR PATHOL	J. Invertebr. Pathol.	NOV	2014	123						34	37		10.1016/j.jip.2014.09.004		4	Zoology	Zoology	AT1XP	WOS:000344724600006		
J	Nakajima, M; Endo, Y				Nakajima, Masakazu; Endo, Yasuki			Excitation spectra of the d(3)Pi(g) - c(3)Sigma(+)(u) band system of C-2 (vol 302, pg 9, 2014)	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Correction									[Nakajima, Masakazu; Endo, Yasuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Endo, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	endo@bunshi.c.u-tokyo.ac.jp					Nakajima M, 2014, J MOL SPECTROSC, V302, P9, DOI 10.1016/j.jms.2014.06.002	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	NOV	2014	305						48	48		10.1016/j.jms.2014.10.002		1	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	AT6NQ	WOS:000345056500008		
J	Jarilla, BR; Uda, K; Suzuki, T; Acosta, LP; Urabe, M; Agatsuma, T				Jarilla, Blanca R.; Uda, Kouji; Suzuki, Tomohiko; Acosta, Luz P.; Urabe, Misako; Agatsuma, Takeshi			Characterization of arginine kinase from the caenogastropod Semisulcospira libertina, an intermediate host of Paragonimus westermani	JOURNAL OF MOLLUSCAN STUDIES			English	Article							AMINO-ACID-RESIDUES; PHOSPHAGEN KINASES; GENE STRUCTURE; TAUROCYAMINE KINASE; CREATINE-KINASE; PSEUDOCARDIUM-SACHALINENSIS; ANTHOPLEURA-JAPONICUS; CORBICULA-JAPONICA; TOXOCARA-CANIS; EVOLUTION	Arginine kinase (AK) belongs to the phosphagen kinase (PK) family of enzymes that have a significant role in the maintenance of energy homeostasis. In this study, cDNA of Semisulcospira libertina AK was determined, cloned and the recombinant protein was expressed as fusion protein with maltose-binding protein. The protein has a theoretical molecular mass of 39,412 Da and an estimated isoelectric point (pI) of 6.37. The recombinant enzyme showed high affinity and significant activity only for the substrate l-arginine (K-m = 0.53 mM; V-max = 61.30 mu mol/min mg protein). Phylogenetic analyses showed that S. libertina AK clusters with gastropod and cephalopod AKs. Comparison of gene structure showed that all intron positions of S. libertina AK are shared with molluscan AKs. Certain intron positions are also shared with trematode TK and sipunculid HTK. Semisulcospira libertina AK can be utilized in the control of paragonimiasis since it is absent in mammalian hosts.	[Jarilla, Blanca R.; Agatsuma, Takeshi] Kochi Univ, Dept Environm Hlth Sci, Kochi 7838505, Japan; [Jarilla, Blanca R.; Acosta, Luz P.] Res Inst Trop Med, Dept Immunol, Alabang 1781, Muntinlupa, Philippines; [Uda, Kouji; Suzuki, Tomohiko] Kochi Univ, Biochem Lab, Fac Sci, Kochi 7838505, Japan; [Urabe, Misako] Univ Shiga Prefecture, Dept Ecosyst Studies, Sch Environm Sci, Hikone, Shiga 5228533, Japan	Agatsuma, T (reprint author), Kochi Univ, Dept Environm Hlth Sci, Kochi 7838505, Japan.	agatsuma@kochi-u.ac.jp					Agatsuma Takeshi, 2011, Medical Entomology and Zoology, V62, P1; Suzuki T, 1998, BBA-PROTEIN STRUCT M, V1388, P253, DOI 10.1016/S0167-4838(98)00167-8; Plazzi F, 2010, MOL PHYLOGENET EVOL, V57, P641, DOI 10.1016/j.ympev.2010.08.032; Compaan DM, 2003, J EXP BIOL, V206, P1545, DOI 10.1242/jeb.00299; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Blair David, 2007, V11, P117; Uda K, 2006, COMP BIOCHEM PHYS D, V1, P209, DOI 10.1016/j.cbd.2005.10.007; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cleland W W, 1979, Methods Enzymol, V63, P103; Edmiston PL, 2001, BBA-PROTEIN STRUCT M, V1546, P291, DOI 10.1016/S0167-4838(01)00159-5; ELLINGTON W.R., 2006, MOL ANATOMY PHYSL PR, P1; Fujimoto N, 2005, FEBS LETT, V579, P1688, DOI 10.1016/j.febslet.2005.02.026; Jarilla BR, 2009, FEBS LETT, V583, P2218, DOI 10.1016/j.febslet.2009.05.049; Jarilla BR, 2013, FEBS LETT, V587, P2278, DOI 10.1016/j.febslet.2013.05.061; Jarilla BR, 2010, KOREAN J PARASITOL, V48, P281, DOI 10.3347/kjp.2010.48.4.281; Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012; LUSTIGMAN S., 2012, PLOS NEGLECT TROP D, V6, P1; MORRISON JF, 1965, BIOCHEM J, V97, P37; NAGATAKI M., 2011, J HELMINTHOL, V86, P276; Suzuki T, 2000, BIOCHEM J, V351, P579, DOI 10.1042/0264-6021:3510579; Suzuki T, 2000, COMP BIOCHEM PHYS B, V127, P513, DOI 10.1016/S0305-0491(00)00281-9; Suzuki T, 2002, INT J BIOCHEM CELL B, V34, P1221, DOI 10.1016/S1357-2725(02)00050-X; Suzuki T, 1997, BBA-PROTEIN STRUCT M, V1343, P152, DOI 10.1016/S0167-4838(97)00128-3; Suzuki T, 2003, FEBS LETT, V533, P95, DOI 10.1016/S0014-5793(02)03765-1; Suzuki T, 2000, COMP BIOCHEM PHYS B, V127, P505, DOI 10.1016/S0305-0491(00)00280-7; Suzuki T, 2000, J BIOL CHEM, V275, P23884, DOI 10.1074/jbc.M002926200; Suzuki T, 1997, BIOCHEM J, V328, P301; Takeuchi M, 2004, CELL MOL LIFE SCI, V61, P110, DOI 10.1007/s00018-003-3384-1; Tanaka K, 2004, FEBS LETT, V573, P78, DOI 10.1016/j.febslet.2004.07.061; Tokuhiro S, 2013, MOL BIOCHEM PARASIT, V188, P91, DOI 10.1016/j.molbiopara.2013.04.001; Uda K, 2005, FEBS J, V272, P3521, DOI 10.1111/j.1742-4658.2005.04767.x; Uda K, 2013, COMP BIOCHEM PHYS B, V165, P42, DOI 10.1016/j.cbpb.2013.03.003; Uda K, 2005, FEBS LETT, V579, P6756, DOI 10.1016/j.febslet.2005.11.006; Uda K, 2004, PROTEIN J, V23, P53, DOI 10.1023/B:JOPC.0000016258.55991.8a; Uda K, 2008, COMP BIOCHEM PHYS B, V151, P176, DOI 10.1016/j.cbpb.2008.06.012; Urabe M, 2001, PARASITOL INT, V50, P191, DOI 10.1016/S1383-5769(01)00079-4; Waller Thomas R., 1998, P1; Wickramasinghe S, 2008, PARASITOL RES, V103, P853, DOI 10.1007/s00436-008-1067-4; Wickramasinghe S, 2007, EXP PARASITOL, V117, P124, DOI 10.1016/j.exppara.2007.03.015; WORLD HEALTH ORGANIZATION, 2002, JOINT WHO FAO WORKSH; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0005-2728(92)90096-K; XIAO J.Y., 2013, PLOS NEGLECT TROP D, V7, P1; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449	47	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0260-1230	1464-3766		J MOLLUS STUD	J. Molluscan Stud.	NOV	2014	80		4				444	451		10.1093/mollus/eyu053		8	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	AT0JU	WOS:000344623400011		
J	Nakanishi, K; Takakura, KI; Kanai, R; Tawa, K; Murakami, D; Sawada, H				Nakanishi, Kosuke; Takakura, Koh-Ichi; Kanai, Ryosuke; Tawa, Kota; Murakami, Daisuke; Sawada, Hiroichi			Impacts of environmental factors in rice paddy fields on abundance of the mud snail (Cipangopaludina chinensis laeta)	JOURNAL OF MOLLUSCAN STUDIES			English	Article							PESTICIDE MANAGEMENT; NITROGEN-FERTILIZER; FLOODWATER ECOLOGY; WETLAND RICEFIELD; DYNAMICS; JAPAN		[Nakanishi, Kosuke; Takakura, Koh-Ichi; Kanai, Ryosuke; Tawa, Kota; Murakami, Daisuke; Sawada, Hiroichi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga 5228533, Japan; [Nakanishi, Kosuke] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Takakura, Koh-Ichi] Osaka City Inst Publ Hlth & Environm Sci, Tennoji Ku, Osaka 5430026, Japan	Nakanishi, K (reprint author), Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan.	k_mw_newt@hotmail.com			Japan Society for the Promotion of Science (JSPS) KAKENHI [23405045, 24241011]	We are grateful to S. Inoue and the other local farmers in Mukugawa, and K. Nakae, K. Nishijima and M. Furukawa for supporting the field survey and data analysis. We also thank Dr T. Nishida and Dr S. Ban for their helpful comments. This work was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23405045, 24241011.	Lawler SP, 2001, ISRAEL J ZOOL, V47, P513, DOI 10.1560/X7K3-9JG8-MH2J-XGX1; SIMPSON IC, 1994, BIOL FERT SOILS, V17, P138, DOI 10.1007/BF00337746; KURIHARA Y, 1988, BIOL FERT SOILS, V6, P292; Chiu YW, 2002, ZOOL STUD, V41, P321; Fujita Yuko, 1999, Japanese Journal of Limnology, V60, P67; Gelman A., 2004, BAYESIAN DATA ANAL; HABE T, 1973, FRESHWATER BIOL JAPA, P309; Hanski IH, 1997, METAPOPULATION BIOL; Havel JE, 2014, HYDROBIOLOGIA, V741, P89, DOI 10.1007/s10750-014-1839-z; Kery M., 2010, INTRO WINBUGS ECOLOG; Kiritani Keizi, 2000, Integrated Pest Management Reviews, V5, P175, DOI 10.1023/A:1011315214598; KUREMATSU F., 1979, MUD SNAILS METHODS A; KURIHARA Y, 1989, INT REV GES HYDROBIO, V74, P507, DOI 10.1002/iroh.19890740506; MASUDA O., 2007, ENDANGERED SPECIES W, P69; MATSUDA M., 2011, RED DATA BOOK SHIGA, P520; MINISTRY OF AGRICULTURE FORESTRY AND FISHERIES, 2012, STAT CROPS; MINISTRY OF THE ENVIRONMENT, 2012, RED LIST MOLL; Mukai Y, 2007, APPL ENTOMOL ZOOL, V42, P595, DOI 10.1303/aez.2007.595; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; R Core Team, 2012, R LANG ENV STAT COMP; Roger P. A., 1994, Rice pest science and management., P255; SIMPSON IC, 1994, BIOL FERT SOILS, V17, P129, DOI 10.1007/BF00337745; SIMPSON IC, 1994, BIOL FERT SOILS, V18, P219, DOI 10.1007/BF00647670; SPIEGELHALTER D.J, 2004, WINBUGS VER 2 0 USER; TAIRA M, 1987, Japanese Journal of Limnology, V48, P77; Washitani I., 2007, GLOB ENV RES, V11, P135; Wilson AL, 2008, ECOL RES, V23, P565, DOI 10.1007/s11284-007-0410-z; YAMAZAKI F., 1996, STORIES PADDY FIELDS	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0260-1230	1464-3766		J MOLLUS STUD	J. Molluscan Stud.	NOV	2014	80		4				460	463		10.1093/mollus/eyu054		4	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	AT0JU	WOS:000344623400014		
J	Nakada, T; Yoshida, T; Suga, K; Kato, M; Otake, H; Kato, K; Teranishi, M; Sone, M; Sugiura, S; Kuno, K; Pyykko, I; Naganawa, S; Watanabe, H; Sobue, G; Nakashima, T				Nakada, Takafumi; Yoshida, Tadao; Suga, Kenji; Kato, Masahiro; Otake, Hironao; Kato, Ken; Teranishi, Masaaki; Sone, Michihiko; Sugiura, Saiko; Kuno, Kayao; Pyykko, Ilmari; Naganawa, Shinji; Watanabe, Hirohisa; Sobue, Gen; Nakashima, Tsutomu			Endolymphatic space size in patients with vestibular migraine and Meniere's disease	JOURNAL OF NEUROLOGY			English	Article						Endolymphatic hydrops; MRI; Vestibular migraine; Vestibular Meniere's disease	DIAGNOSTIC-CRITERIA; HYDROPS; VERTIGO; PATHOPHYSIOLOGY; PREVALENCE; SYMPTOMS; VISUALIZATION; DIZZINESS; GLAUCOMA; JAPANESE	M,niSre's disease (MD) is characterized by episodic vertigo, fluctuating hearing loss and tinnitus. Vestibular migraine (VM) is a relatively new disorder that is characterized by episodic vertigo or dizziness, coexisting migraine and absence of hearing loss. It is occasionally difficult to distinguish between VM and vestibular MD with headache. Because endolymphatic hydrops (EH) is a characteristic sign of MD, we attempted to evaluate endolymphatic space size in both diseases. Endolymphatic space size in the vestibule and the cochlea was evaluated in seven patients with VM and in seven age- and sex-matched patients with vestibular MD. For visualization of the endolymphatic space, 3T magnetic resonance imaging was taken 4 h after intravenous injection of gadolinium contrast agents using three-dimensional fluid-attenuated inversion recovery and HYbriD of reversed image of positive endolymph signal and native image of positive perilymph signal techniques. In the vestibule of VM patients, EH was not observed, with the exception of two patients with unilateral or bilateral EH. In contrast, in the vestibule of patients with vestibular MD, all patients had significant EH, bilaterally or unilaterally. These results indicate that endolymphatic space size is significantly different between patients with VM and vestibular MD.	[Nakada, Takafumi; Yoshida, Tadao; Suga, Kenji; Kato, Masahiro; Otake, Hironao; Kato, Ken; Teranishi, Masaaki; Sone, Michihiko; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Otake, Hironao] Nagoya Univ, Grad Sch Med, Dept Sleep Med, Nagoya, Aichi 4668550, Japan; [Sugiura, Saiko; Nakashima, Tsutomu] Natl Ctr Geriatr & Gerontol, Dept Otorhinolaryngol, Obu, Japan; [Kuno, Kayao] Kamiida Daiich Gen Hosp, Dept Otorhinolaryngol, Nagoya, Aichi, Japan; [Pyykko, Ilmari] Univ Tampere, Dept Otolaryngol, FIN-33101 Tampere, Finland; [Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4668550, Japan; [Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan; [Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Brain & Mind Res Ctr, Nagoya, Aichi 4668550, Japan	Nakada, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tnakada@med.nagoya-u.ac.jp	Nakashima, Tsutomu/B-8259-2012; Naganawa, Shinji/I-1572-2012; Yoshida, Tadao/I-1619-2012	Nakashima, Tsutomu/0000-0003-3930-9120; Naganawa, Shinji/0000-0002-0214-613X; 	Ministry of Education, Culture, Sports, Science and Technology in Japan [Kiban B-25293263, Kiban C-25462634, B 25861548]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (Kiban B-25293263, Kiban C-25462634 and Yong Scientists B 25861548).	ALFORD B R, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P1462; Jerin C, 2014, HEARING RES, V310, P54, DOI 10.1016/j.heares.2014.02.001; Zuniga MG, 2012, OTOLARYNG HEAD NECK, V146, P788, DOI 10.1177/0194599811434073; Neuhauser H, 2001, NEUROLOGY, V56, P436; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P5, DOI 10.1080/00016480902729827; Huppert D, 2010, ACTA OTO-LARYNGOL, V130, P644, DOI 10.3109/00016480903382808; Best C, 2009, J NEUROL, V256, P58, DOI 10.1007/s00415-009-0038-8; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Radtke A, 2012, NEUROLOGY, V79, P1607, DOI 10.1212/WNL.0b013e31826e264f; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; Strupp M, 2013, CURR OPIN NEUROL, V26, P81, DOI 10.1097/WCO.0b013e32835c5fd4; Foster CA, 2013, OTOL NEUROTOL, V34, P1210, DOI 10.1097/MAO.0b013e31829e83df; Brandt T, 2014, J NEUROL, V261, P229, DOI 10.1007/s00415-013-7190-x; Neff BA, 2012, OTOL NEUROTOL, V33, P1235, DOI 10.1097/MAO.0b013e31825d644a; Baier B, 2009, J NEUROL, V256, P1447, DOI 10.1007/s00415-009-5132-4; Brantberg K, 2005, ACTA OTO-LARYNGOL, V125, P276, DOI 10.1080/00016480510003165; Celebisoy N, 2008, CEPHALALGIA, V28, P72, DOI 10.1111/j.1468-2982.2007.01474.x; Eklund S, 1999, Auris Nasus Larynx, V26, P427, DOI 10.1016/S0385-8146(99)00022-X; Fiorino F, 2011, OTOL NEUROTOL, V32, P472, DOI 10.1097/MAO.0b013e31820e7614; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Kahmke R, 2012, LARYNGOSCOPE, V122, P1885, DOI 10.1002/lary.23335; Kato M, 2013, ACTA OTO-LARYNGOL, V133, P123, DOI 10.3109/00016489.2012.726374; Lee H, 2000, ARCH NEUROL-CHICAGO, V57, P1631, DOI 10.1001/archneur.57.11.1631; Murdin L, 2009, NEUROLOGY, V73, P638, DOI 10.1212/WNL.0b013e3181b38a04; Naganawa S, 2010, MAGN RESON MED SCI, V9, P237, DOI 10.2463/mrms.9.237; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213; Pyykko I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001555; Radtke A, 2002, NEUROLOGY, V59, P1700; Salt AN, 2010, OTOLARYNG CLIN N AM, V43, P971, DOI 10.1016/j.otc.2010.05.007; Sharon JD, 2014, LARYNGOSCOPE, V124, P969, DOI 10.1002/lary.24285; Shin JE, 2013, ACTA OTO-LARYNGOL, V133, P154, DOI 10.3109/00016489.2012.727469; Strupp Michael, 2010, Handb Clin Neurol, V97, P755, DOI 10.1016/S0072-9752(10)97062-0	40	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2014	261	11					2079	2084		10.1007/s00415-014-7458-9		6	Clinical Neurology	Neurosciences & Neurology	AT3AZ	WOS:000344808400003		
J	Nishimura, K; Omori, M; Sato, E; Katsumata, Y; Gono, T; Kawaguchi, Y; Harigai, M; Yamanaka, H; Ishigooka, J				Nishimura, Katsuji; Omori, Masako; Sato, Eri; Katsumata, Yasuhiro; Gono, Takahisa; Kawaguchi, Yasushi; Harigai, Masayoshi; Yamanaka, Hisashi; Ishigooka, Jun			New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study	JOURNAL OF NEUROLOGY			English	Article						Corticosteroid therapy; Corticosteroid-induced psychiatric disorders; Neuropsychiatric lupus; Systemic lupus erythematosus	NEUROPSYCHIATRIC SYNDROMES; STEROID PSYCHOSIS; MOOD; MANIFESTATIONS; COMPLICATIONS; INVOLVEMENT; PREVALENCE; MANAGEMENT; MEMORY; STATE	The objective of this study was to clarify the incidence, clinical characteristics, and courses of new-onset psychiatric manifestations after corticosteroid therapy in patients with systemic lupus erythematosus (SLE), including possible ways of differentiating between corticosteroid-induced psychiatric disorders (CIPDs) and central nervous system manifestations of SLE (CNS-SLE). We prospectively followed for 8 weeks 139 consecutive episodes in 135 in-patients who had a non-CNS-SLE flare treated with corticosteroids. Psychiatric events were evaluated once a week using DSM-IV criteria. We then conducted a post hoc etiological analysis of any newly developed psychiatric events during this follow-up period. In the 8 weeks of corticosteroid administration, new psychiatric events occurred in 20 (14.4 %) of the 139 episodes. The mean dosage of corticosteroids administered was prednisolone at 0.98 (range 0.24-1.39) mg/kg/day. Of the 20 psychiatric events, 14 (10.1 %) were suitable for the strict definition of CIPDs, accompanied by mood disorders in 13 (depressive in 2, manic in 9, and mixed in 2) and psychotic disorder in one. Two (1.4 %), both presenting delirium, were diagnosed as CNS-SLE on the basis of evidence of abnormal CNS findings even before psychiatric manifestations, all of which improved in parallel with these patients' recoveries through augmentation of immunosuppressive therapy. The other four events (2.9 %) could not be etiologically identified. This study suggests that corticosteroid therapy triggers CIPDs and CNS-SLE in patients with SLE. Delirium may be suggestive of CNS-SLE, while mood disorders may be more suggestive of CIPDs. Electroencephalographic abnormalities may possibly be predictive of CNS-SLE.	[Nishimura, Katsuji; Ishigooka, Jun] Tokyo Womens Med Univ, Dept Psychiat, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Omori, Masako] Kanagawa Psychiat Ctr, Yokohama, Kanagawa, Japan; [Sato, Eri; Katsumata, Yasuhiro; Gono, Takahisa; Kawaguchi, Yasushi; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1628666, Japan; [Harigai, Masayoshi] Tokyo Med & Dent Univ, Grad Sch, Dept Pharmacovigilance, Tokyo, Japan	Nishimura, K (reprint author), Tokyo Womens Med Univ, Dept Psychiat, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	nishimura.katsuji@twmu.ac.jp					ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature, 1999, ARTHRITIS RHEUM, V42, P599; American Psychiatric Association, 1994, DSM 4; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Naber D, 1996, PSYCHONEUROENDOCRINO, V21, P25, DOI 10.1016/0306-4530(95)00031-3; SHIOZAWA S, 1992, ARTHRITIS RHEUM, V35, P417, DOI 10.1002/art.1780350410; Nishimura K, 2008, PSYCHONEUROENDOCRINO, V33, P395, DOI 10.1016/j.psyneuen.2007.12.007; Toledano P, 2013, AUTOIMMUN REV, V12, P1166, DOI 10.1016/j.autrev.2013.07.004; Brey RL, 2002, NEUROLOGY, V58, P1214; HIROHATA S, 1990, ARTHRITIS RHEUM, V33, P644, DOI 10.1002/art.1780330506; Patten SB, 2000, DRUG SAFETY, V22, P111, DOI 10.2165/00002018-200022020-00004; DENBURG SD, 1994, ARTHRITIS RHEUM, V37, P1311, DOI 10.1002/art.1780370907; Wolkowitz OM, 1997, ANN NY ACAD SCI, V823, P81, DOI 10.1111/j.1749-6632.1997.tb48381.x; Dubovsky AN, 2012, PSYCHOSOMATICS, V53, P103, DOI 10.1016/j.psym.2011.12.007; Bhangle SD, 2013, RHEUMATOL INT, V33, P1923, DOI 10.1007/s00296-013-2750-z; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; Chau SY, 2003, NEUROLOGY, V61, P104; Brown ES, 2009, ANN NY ACAD SCI, V1179, P41, DOI 10.1111/j.1749-6632.2009.04981.x; Ainiala H, 2001, NEUROLOGY, V57, P496; Trysberg E, 2000, LUPUS, V9, P498, DOI 10.1177/096120330000900704; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; Wada K, 2000, J CLIN PSYCHIAT, V61, P261; Brown ES, 2002, J CLIN PSYCHOPHARM, V22, P55, DOI 10.1097/00004714-200202000-00009; KOHEN M, 1993, CLIN EXP RHEUMATOL, V11, P323; Nishimura K, 2003, INT J PSYCHIAT MED, V33, P299, DOI 10.2190/P2T8-Y12E-ANKM-8MWF; Postal M, 2011, CNS DRUGS, V25, P721, DOI 10.2165/11591670-000000000-00000; Tabata Y, 2002, EUR J PEDIATR, V161, P503, DOI 10.1007/s00431-002-1023-8; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; The Boston Collaborative Drug Surveillance Program, 1972, CLIN PHARMACOL THER, V13, P694; West SG, 2013, DUBOIS LUPUS ERYTHEM, P368; WYSENBEEK AJ, 1990, J RHEUMATOL, V17, P1695	30	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2014	261	11					2150	2158		10.1007/s00415-014-7472-y		9	Clinical Neurology	Neurosciences & Neurology	AT3AZ	WOS:000344808400012		
J	Yamashita, S; Sakashita, N; Yamashita, T; Tawara, N; Tasaki, M; Kawakami, K; Komohara, Y; Fujiwara, Y; Kamikawa, M; Nakagawa, T; Hirano, T; Maeda, Y; Hasegawa, M; Takeya, M; Ando, Y				Yamashita, Satoshi; Sakashita, Naomi; Yamashita, Taro; Tawara, Nozomu; Tasaki, Masayoshi; Kawakami, Kensuke; Komohara, Yoshihiro; Fujiwara, Yukio; Kamikawa, Masashi; Nakagawa, Takenobu; Hirano, Teruyuki; Maeda, Yasushi; Hasegawa, Masato; Takeya, Motohiro; Ando, Yukio			Concomitant accumulation of alpha-synuclein and TDP-43 in a patient with corticobasal degeneration	JOURNAL OF NEUROLOGY			English	Article						Corticobasal degeneration; Tauopathy; Synucleinopathy; TDP-43 proteinopathy; Cross-seeding	PROGRESSIVE SUPRANUCLEAR PALSY; LEWY BODIES; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; TAU-SYNUCLEIN; BRAIN PATHOLOGY; DOWNS-SYNDROME; CLASSIFICATION	Pathological changes in corticobasal degeneration (CBD) consist of abnormal deposition of the microtubule-associated protein tau. However, the simultaneous accumulation of different misfolded proteins in the brain can be observed in many neurodegenerative diseases with significantly longer disease durations. We encountered a patient with CBD who survived for an extremely long period (18 years) after the diagnosis. We performed an autopsy to elucidate the effect of the longer survival on the pathology of CBD. We observed abnormal aggregation of trans-activating response region DNA-binding protein of 43 kDa (TDP-43) and alpha-synuclein, as well as phosphorylated tau, in neurons of broader regions of the brain, beyond the amygdala and other limbic areas. We found that phosphorylated tau, alpha-synuclein, and TDP-43 partially co-existed in the same cellular aggregates. The triple pathologic changes might be related to the longer survival of the patient compared with the typical clinical course of patients with CBD. Further investigations are required to support the hypothesis that tauopathy, synucleinopathy, and TDP-43 proteinopathy might share common pathogenic mechanisms in terms of cross-seeding of the pathologic proteins.	[Yamashita, Satoshi; Yamashita, Taro; Tawara, Nozomu; Tasaki, Masayoshi; Kawakami, Kensuke; Hirano, Teruyuki; Maeda, Yasushi; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 8608556, Japan; [Sakashita, Naomi; Komohara, Yoshihiro; Fujiwara, Yukio; Kamikawa, Masashi; Nakagawa, Takenobu; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; [Sakashita, Naomi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Pathol, Tokushima 7708503, Japan; [Hirano, Teruyuki] Oita Univ, Dept Internal Med, Fac Med 3, Hasama, Yufu 8795593, Japan; [Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan	Yamashita, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	y-stsh@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Amyloidosis Research Committee, the Ministry of Health, Labour and Welfare of Japan	We would like to thank Ms. Mika Oka and the members of Department of Neurology, Kumamoto University Hospital for technical help with autopsy analyses and clinical data collection. This work was supported by a Grant-in-Aid for Scientific Research, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid from the Amyloidosis Research Committee, the Ministry of Health, Labour and Welfare of Japan.	Aiba Ikuko, 2012, Brain and Nerve (Tokyo), V64, P462; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; FEANY MB, 1995, AM J PATHOL, V146, P1388; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Kouri N, 2011, BRAIN, V134, P3264, DOI 10.1093/brain/awr234; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Jellinger KA, 2011, THESCIENTIFICWORLDJO, V11, P1893, DOI 10.1100/2011/371893; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Wenning GK, 1998, J NEUROL NEUROSUR PS, V64, P184, DOI 10.1136/jnnp.64.2.184; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; GALLOWAY PG, 1988, J NEUROPATH EXP NEUR, V47, P654, DOI 10.1097/00005072-198811000-00008; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; REBEIZ JJ, 1968, ARCH NEUROL-CHICAGO, V18, P20; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; Clarimon J, 2009, J NEUROPATH EXP NEUR, V68, P73, DOI 10.1097/NEN.0b013e3181927577; Iseki E, 1999, NEUROSCI LETT, V265, P9, DOI 10.1016/S0304-3940(99)00178-0; Judkins AR, 2002, ACTA NEUROPATHOL, V103, P526, DOI 10.1007/s00401-001-0483-7; Kouri N, 2013, ACTA NEUROPATHOL, V125, P741, DOI 10.1007/s00401-013-1087-8; Mooney T, 2011, NEUROL INDIA, V59, P887, DOI 10.4103/0028-3886.91371; RAGHAVAN R, 1993, CAN J NEUROL SCI, V20, P48; Schmidt ML, 1996, ACTA NEUROPATHOL, V91, P475; Terni B, 2007, ACTA NEUROPATHOL, V113, P403, DOI 10.1007/s00401-006-0192-3; Wilhelmsen KC, 2004, ARCH NEUROL-CHICAGO, V61, P398, DOI 10.1001/archneur.61.3.398; Yancopoulou D, 2005, J NEUROPATH EXP NEUR, V64, P245	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2014	261	11					2209	2217		10.1007/s00415-014-7491-8		9	Clinical Neurology	Neurosciences & Neurology	AT3AZ	WOS:000344808400021		
J	Ebina, Y; Minematsu, T; Sonoyama, A; Morioka, I; Inoue, N; Tairaku, S; Nagamata, S; Tanimura, K; Morizane, M; Deguchi, M; Yamada, H				Ebina, Yasuhiko; Minematsu, Toshio; Sonoyama, Ayako; Morioka, Ichiro; Inoue, Naoki; Tairaku, Shinya; Nagamata, Satoshi; Tanimura, Kenji; Morizane, Mayumi; Deguchi, Masashi; Yamada, Hideto			The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study	JOURNAL OF PERINATAL MEDICINE			English	Article						Congenital infection; cytomegalovirus; IgG avidity	PRIMARY CMV INFECTION; PREGNANT-WOMEN; DIAGNOSIS	Background: Cytomegalovirus (CMV) causes congenital infection with high mortality and morbidity rates in affected neonates. Objectives: To evaluate the maternal IgG avidity value for the prediction of congenital CMV infection. Study design: The serum IgG avidity in all mothers was measured, and the urine of their neonates was assessed for CMV DNA in a prospective cohort study. Results: Of 759 women with a positive test for CMV IgG, 14 had congenital CMV infection. CMV IgG avidity indices in the congenital infection group (median 35.1%) were significantly lower than those in the non-congenital infection group (70.4%). A cutoff value of <40% IgG avidity index with 96.1% specificity and 64.3% sensitivity for congenital infection was determined by receiver operating characteristic curve analyses. The highest sensitivity (88.9%), 96.2% specificity, 27.6% positive predictive value, 99.8% negative predictive value, and 96.1% accuracy were found when IgG avidity was measured in < 28 weeks of gestation. Conclusion: The IgG avidity measurement with a cutoff value of < 40% IgG avidity index might be helpful in predicting congenital CMV infection, especially in < 28 weeks of gestation.	[Ebina, Yasuhiko] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Minematsu, Toshio] Aisenkai Nichinan Hosp, Res Ctr Dis Control, Miyazaki, Japan; [Sonoyama, Ayako; Tairaku, Shinya; Nagamata, Satoshi; Tanimura, Kenji; Morizane, Mayumi; Deguchi, Masashi; Yamada, Hideto] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 6500017, Japan; [Morioka, Ichiro] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Inoue, Naoki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan	Ebina, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ebiyas@med.kobe-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [H23-Jisedai-Ippan-001]; Japan Association of Obstetricians and Gynecologists [H22-Ogyah-Kenkin]	This work was supported in part by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (grant no. H23-Jisedai-Ippan-001) and the Japan Association of Obstetricians and Gynecologists (grant no. H22-Ogyah-Kenkin).	Bodeus M, 1998, CLIN DIAGN VIROL, V9, P9, DOI 10.1016/S0928-0197(97)10016-2; GrangeotKeros L, 1997, J INFECT DIS, V175, P944; Lazzarotto T, 1997, CLIN DIAGN LAB IMMUN, V4, P469; BLACKBURN NK, 1991, J MED VIROL, V33, P6, DOI 10.1002/jmv.1890330103; Enders G, 2013, J CLIN VIROL, V56, P102, DOI 10.1016/j.jcv.2012.09.015; Koyano S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000118; Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x; Lazzarotto T, 2000, VIRAL IMMUNOL, V13, P137, DOI 10.1089/vim.2000.13.137; Numazaki Kei, 2002, International Journal of Infectious Diseases, V6, P147, DOI 10.1016/S1201-9712(02)90078-0; Sonoyama A, 2012, J MED VIROL, V84, P1928, DOI 10.1002/jmv.23387; STAGNO S, 1985, NEW ENGL J MED, V313, P1270, DOI 10.1056/NEJM198511143132006; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; Tagawa M, 2010, PEDIATR INT, V52, P459, DOI 10.1111/j.1442-200X.2009.03005.x	13	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	NOV	2014	42	6					755	759		10.1515/jpm-2013-0333		5	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	AT4WM	WOS:000344942500012		
J	Yamashita, A; Ishii, K; Taguchi, T; Mabuchi, A; Ota, S; Sasahara, J; Hayashi, S; Mitsuda, N				Yamashita, Akiko; Ishii, Keisuke; Taguchi, Takako; Mabuchi, Aki; Ota, Shiyo; Sasahara, Jun; Hayashi, Syusaku; Mitsuda, Nobuaki			Adverse perinatal outcomes related to the delivery mode in women with monochorionic diamniotic twin pregnancies	JOURNAL OF PERINATAL MEDICINE			English	Article						Acute feto-fetal hemorrhage; hypoxic ischemic encephalopathy; monochorionic diamniotic twin; perinatal outcomes; trial of labor	TRANSFUSION SYNDROME; RETROSPECTIVE-COHORT; VAGINAL DELIVERY; BIRTH-WEIGHT; MORTALITY; MORBIDITY; RISK; TERM; GESTATIONS; MANAGEMENT	Aims: The association between the planned delivery mode and adverse perinatal outcomes of monochorionic diamniotic (MCDA) twin pregnancies at >= 36 weeks' gestation was evaluated. Methods: This retrospective cohort study included uncomplicated MCDA twin pregnancies delivered after 36 weeks' gestation during a 10-year period. Cases were classified into the trial of labor (TOL) or cesarean section (CS) group according to the planned delivery mode. The primary outcome was a composite of adverse outcomes for at least one twin, including intrauterine fetal death (IUFD) after 36 weeks, neonatal death, umbilical artery pH <7.1, 5-min Apgar scores < 7, hypoxic ischemic encephalopathy (HIE), meconium aspiration syndrome (MAS), respiratory distress syndrome (RDS), or acute feto-fetal hemorrhage (AFFH). The relationship between outcomes and the planned delivery mode was evaluated using a multiple logistic regression analysis. Results: We included the 310 pregnancies delivered after 36 weeks' gestation. After excluding 15 patients, the final analysis included 295 MCDA pregnancies: 63% had delivered through TOL and 37% through CS. The incidences of composite adverse outcomes in the TOL and CS groups were 4.3% and 1.9%, respectively. No IUFD, neonatal death, MAS, RDS, or AFFH was observed; two infants in each group developed HIE. Adverse outcomes were not significantly associated with any risk factor, including delivery through TOL. Conclusion: TOL may not influence the perinatal outcomes of MCDA twin pregnancies delivered at >= 36 weeks' gestation.	[Ishii, Keisuke] Osaka Med Ctr & Res, Dept Maternal Fetal Med, Izumi, Osaka, Japan; [Yamashita, Akiko; Taguchi, Takako; Mabuchi, Aki; Ota, Shiyo; Sasahara, Jun; Hayashi, Syusaku; Mitsuda, Nobuaki] Osaka Med Ctr & Res, Inst Maternal & Child Hlth, Dept Maternal Fetal Med, Izumi, Osaka, Japan	Ishii, K (reprint author), Osaka Med Ctr & Res, Dept Maternal Fetal Med, 840 Murodo, Izumi, Osaka, Japan.	keisui@mch.pref.osaka.jp					Angel JL, 1999, AM J OBSTET GYNECOL, V181, P253, DOI 10.1016/S0002-9378(99)70544-2; Bleker OP, 1997, J REPROD MED, V42, P715; Yang QY, 2005, AM J OBSTET GYNECOL, V192, P840, DOI 10.1016/j.ajog.2004.09.132; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; GHAI V, 1988, CLIN PERINATOL, V15, P123; Denbow ML, 2000, AM J OBSTET GYNECOL, V182, P417, DOI 10.1016/S0002-9378(00)70233-X; Slaghekke F, 2010, FETAL DIAGN THER, V27, P181, DOI 10.1159/000304512; Smith GCS, 2007, BRIT MED J, V334, P576, DOI 10.1136/bmj.39118.483819.55; Lopriore E, 2014, J OBSTET GYNAECOL RE, V40, P18, DOI 10.1111/jog.12114; Hack KE, 2008, BJOG-INT J OBSTET GY, V115, P58, DOI 10.1111/j.1471-0528.2007.01556.x; Fox NS, 2010, OBSTET GYNECOL, V115, P229, DOI 10.1097/AOG.0b013e3181c8b462; Skupski DW, 2012, J MATERN-FETAL NEO M, V25, P456, DOI 10.3109/14767058.2011.637146; Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939; Ei-Jallad M F, 1998, J Obstet Gynaecol, V18, P133; Hack KEA, 2011, BJOG-INT J OBSTET GY, V118, P1090, DOI 10.1111/j.1471-0528.2011.02955.x; Hartley H, 2005, J HEALTH CARE POOR U, V16, P536, DOI 10.1353/hpu.2005.0051; Hoffmann E, 2012, AM OBSTET GYNECOL SO, V91, P5463; KIELY JL, 1990, B NEW YORK ACAD MED, V66, P618; Lopriore E, 2005, PRENATAL DIAG, V25, P844, DOI 10.1002/pd.1175; Pestana I, 2013, J REPROD MED, V58, P15; Sau A, 2006, BJOG-INT J OBSTET GY, V113, P602, DOI 10.1111/j.1471-0528.2006.00887.x; Sheay W, 2004, OBSTET GYNECOL, V103, P63, DOI 10.1097/01.AOG.0000101291.14773.FO; SHERER DM, 1992, J REPROD MED, V37, P184; Skrablin S, 2002, EUR J OBSTET GYN R B, V104, P26, DOI 10.1016/S0301-2115(02)00053-2; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Usta Ihab M, 2002, J Perinatol, V22, P391, DOI 10.1038/sj.jp.7210752; Weisz B, 2012, J MATERN-FETAL NEO M, V25, P2721, DOI 10.3109/14767058.2012.712560; Wen SW, 2004, AM J OBSTET GYNECOL, V19, P1778; Wen SW, 2004, AM J OBSTET GYNECOL, V19, P1773; Yang Q, 2006, J PERINATOL, V26, P3, DOI 10.1038/sj.jp.7211408	30	2	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	NOV	2014	42	6					769	775		10.1515/jpm-2014-0072		7	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	AT4WM	WOS:000344942500014		
J	Kobayashi, T; Yokoyama, T; Ito, S; Kobayashi, D; Yamagata, A; Okada, M; Oofusa, K; Narita, I; Murasawa, A; Nakazono, K; Yoshie, H				Kobayashi, Tetsuo; Yokoyama, Tomoko; Ito, Satoshi; Kobayashi, Daisuke; Yamagata, Akira; Okada, Moe; Oofusa, Ken; Narita, Ichiei; Murasawa, Akira; Nakazono, Kiyoshi; Yoshie, Hiromasa			Periodontal and Serum Protein Profiles in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitor Adalimumab	JOURNAL OF PERIODONTOLOGY			English	Article						Arthritis; rheumatoid; immunotherapy; periodontitis; proteomics; serum; tumor necrosis factor-alpha	FACTOR-ALPHA THERAPY; FACTOR TNF; DISEASE; ASSOCIATION; PARAMETERS; INFLIXIMAB; ANTIBODY; PLASMA; CLASSIFICATION; INTERLEUKIN-1	Background: Tumor necrosis factor (TNF)-alpha inhibitor has been shown to affect the periodontal condition of patients with rheumatoid arthritis (RA). The aim of the present study is to assess the effect of a fully humanized anti-TNF-alpha monoclonal antibody, adalimumab (ADA), on the periodontal condition of patients with RA and to compare serum protein profiles before and after ADA therapy. Methods: The study participants consisted of 20 patients with RA treated with ADA. Clinical periodontal and rheumatologic parameters and serum cytokine levels were evaluated at baseline and 3 months later. Serum protein spot volume was examined with two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis. Proteins with significant difference in abundance before and after ADA therapy were found and identified using mass spectrometry and protein databases. Results: The patients showed a significant decrease in gingival index (P = 0.002), bleeding on probing (P = 0.003), probing depth (P = 0.002), disease activity score including 28 joints using C-reactive protein (P < 0.001), and serum levels of TNF-alpha (P < 0.001) and interleukin-6 (P < 0.001) after ADA medication, although plaque levels were comparable. Among a total of 495 protein spots obtained, nine spots were significantly decreased in abundance at reassessment, corresponding to complement factor H, phospholipase D, serum amyloid A, complement component 4, and alpha-1-acid glycoprotein (P < 0.01). Conclusion: These results suggest a beneficial effect of ADA therapy on the periodontal condition of patients with RA, which might be related to differences in serum protein profiles before and after ADA therapy.	[Kobayashi, Tetsuo; Yokoyama, Tomoko; Okada, Moe; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol, Niigata 9518514, Japan; [Kobayashi, Tetsuo] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata 9518514, Japan; [Ito, Satoshi; Kobayashi, Daisuke; Murasawa, Akira; Nakazono, Kiyoshi] Niigata Rheumat Ctr, Shibata, Japan; [Kobayashi, Daisuke; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat Dev, Div Clin Nephrol & Rheumatol, Niigata 9518514, Japan; [Yamagata, Akira; Oofusa, Ken] Towa Environm Sci Co, ProPhoenix Div, Osaka, Japan	Kobayashi, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Periodontol,Chou Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	kotetsuo@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science, Kojimachi, Chiyodaku, Tokyo, Japan [25253104, 22592309, 24659922]	This work was supported by Grant-in Aid for Scientific Research A No. 25253104) and C No. 22592309) and Grant-in Aid for Challenging Exploratory Research No. 24659922) from the Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyodaku, Tokyo 102-0083, Japan. Dr. Oofusa is a division manager and Dr. Yamagata is a chief researcher at ProPhoenix Division, Towa Environment Science, Osaka, Japan. The authors report no conflict of interest related to this study.	McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Assuma R, 1998, J IMMUNOL, V160, P403; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Weinblatt ME, 2003, ARTHRITIS RHEUM, V48, P35, DOI 10.1002/art.10697; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Mayer Y, 2013, J PERIODONTOL, V84, P136, DOI 10.1902/jop.2012.120009; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI 10.1902/jop.2008.070501 ; Bandow JE, 2010, PROTEOMICS, V10, P1416, DOI 10.1002/pmic.200900431; Mayer Y, 2009, J PERIODONTOL, V80, P1414, DOI 10.1902/jop.2009.090015; Kobayashi T, 2014, J PERIODONTOL, V85, P57, DOI 10.1902/jop.2013.120696; Park MK, 2011, IMMUNOL LETT, V139, P42, DOI 10.1016/j.imlet.2011.04.013; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Delima AJ, 2001, J CLIN PERIODONTOL, V28, P233, DOI 10.1034/j.1600-051x.2001.028003233.x; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Pers JO, 2008, J PERIODONTOL, V79, P1645, DOI 10.1902/jop.2008.070616 ; Mitoma H, 2008, ARTHRITIS RHEUM, V58, P1248, DOI 10.1002/art.23447; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.3.CO;2-Y; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Sekigawa I, 2008, CLIN EXP RHEUMATOL, V26, P261; Dissick A, 2010, J PERIODONTOL, V81, P223, DOI 10.1902/jop.2009.090309; Olewicz-Gawlik A, 2007, CLIN RHEUMATOL, V26, P1679, DOI 10.1007/s10067-007-0572-7; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Atzeni F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1851; Cho SY, 2005, PROTEOMICS, V5, P3386, DOI 10.1002/pmic.200401310; DEBETS JMH, 1989, CLIN EXP IMMUNOL, V78, P224; Familian A, 2005, ANN RHEUM DIS, V64, P1003, DOI 10.1136/ard.2004.029124; Gerashchenko BI, 2007, PROTEOMICS, V7, P2000, DOI 10.1002/pmic.200600948; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Herenius MMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057802; Kuroda T, 2006, CLIN RHEUMATOL, V25, P498, DOI 10.1007/s10067-005-0079-z; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Mercado FB, 2003, J CLIN PERIODONTOL, V30, P761, DOI 10.1034/j.1600-051X.2003.00371.x; Pinho Márcia de Noronha, 2009, Braz. Dent. J., V20, P355, DOI 10.1590/S0103-64402009000500001; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Renvert S, 2009, J PERIODONTOL, V80, P892, DOI 10.1902/jop.2009.080552; stun K, 2013, INFLAMMATION, V36, P1171; Vuletic S, 2008, ORAL DIS, V14, P514, DOI 10.1111/j.1601-0825.2007.01411.x; Weinkauf M, 2006, ELECTROPHORESIS, V27, P4555, DOI 10.1002/elps.200600207; Williams RO, 2000, ANN RHEUM DIS, V59, P75; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Yanagida M, 2012, INT J RHEUM DIS, V15, P486, DOI 10.1111/j.1756-185X.2012.01816.x; Yokoyama T, 2014, J PERIODONTOL, V85, P103, DOI 10.1902/jop.2013.120741	49	2	2	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	NOV	2014	85	11					1480	1488		10.1902/jop.2014.140194		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT0WF	WOS:000344652200008		
J	Thanakun, S; Watanabe, H; Thaweboon, S; Izumi, Y				Thanakun, Supanee; Watanabe, Hisashi; Thaweboon, Sroisiri; Izumi, Yuichi			Association of Untreated Metabolic Syndrome With Moderate to Severe Periodontitis in Thai Population	JOURNAL OF PERIODONTOLOGY			English	Article						Adiponectin; Asian Continental Ancestry Group; leptin; metabolic syndrome X; periodontitis; waist circumference	SERUM-LEVELS; DISEASE; PREVALENCE; ADIPONECTIN; JAPANESE; HEALTH; ADULTS; HISAYAMA; ACTINOMYCETEMCOMITANS; LIPOPOLYSACCHARIDE	Background: Metabolic syndrome (MetS) correlates with systemic inflammation. A relation of MetS to periodontitis has been reported. This study aims to evaluate whether periodontitis is associated with untreated MetS, plasma adiponectin, and leptin among Thai people. Methods: One hundred twenty-five participants (aged 35 to 76 years) were recruited. Demographic and biologic data, bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL) of all teeth were examined. Plasma adiponectin and leptin levels were measured. Results: Forty-four participants (35.2%) were healthy, and 81 (64.8%) had MetS. All periodontal conditions (BOP, PD, and CAL) were significantly worse in patients with MetS than healthy participants. After adjustment for confounders, MetS was strongly associated with severe periodontitis (odds ratio [OR] = 3.60, 95% confidence interval [CI]: 1.34 to 9.65). MetS with four to five components had a higher association with periodontitis than did MetS with three components (OR = 5.49, 95% CI: 1.75 to 17.19), whereas each separate component had no association with periodontitis, except for high diastolic blood pressure. Periodontitis was also associated with age (OR = 1.08, 95% CI: 1.01 to 1.14) and education (OR = 3.76, 95% CI: 1.05 to 13.40). The risk of MetS was predicted by body mass index and plasma adiponectin (OR = 1.90, 95% CI: 1.24 to 2.92 and OR = 0.93, 95% CI: 0.88 to 0.98, respectively). Conclusions: There may be a relationship between untreated MetS and periodontitis in Thai people. Periodontal diagnosis should be regularly conducted in patients with MetS.	[Thanakun, Supanee] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand; [Watanabe, Hisashi; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo 1138549, Japan; [Thaweboon, Sroisiri] Mahidol Univ, Fac Dent, Dept Oral Microbiol, Bangkok 10700, Thailand; [Izumi, Yuichi] Tokyo Med & Dent Univ, Global Ctr Excellence Program Tooth & Bone Res, Tokyo, Japan	Izumi, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	y-izumi.peri@tmd.ac.jp			Mahidol University, Thailand [05/2552]; Japan Society for Promotion of Science (JSPS) Ronpaku Program, Japan [NRCT-11123]	Assoc. Prof. Penpan Laohapand, Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand, is gratefully acknowledged for her kind help with statistical analyses. This study was supported by a grant from Mahidol University (No. 05/2552), Thailand, in 2010 and the Japan Society for Promotion of Science (JSPS) Ronpaku Program Grant (No. NRCT-11123), Japan, in 2011. The authors report no conflicts of interest related to this study.	Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Furuta M, 2013, J CLIN PERIODONTOL, V40, P743, DOI 10.1111/jcpe.12119; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Saito T, 2008, J DENT RES, V87, P319; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Pongchaiyakul Chatlert, 2007, Journal of the Medical Association of Thailand, V90, P459; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Janket SJ, 2008, ORAL SURG ORAL MED O, V105, P173, DOI 10.1016/j.tripleo.2007.06.027; Morita T, 2010, J PERIODONTOL, V81, P512, DOI 10.1902/jop.2010.090594; Bullon P, 2009, J DENT RES, V88, P503, DOI 10.1177/0022034509337479; Taylor JJ, 2013, J CLIN PERIODONTOL, V40, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Timonen P, 2010, J DENT RES, V89, P1068, DOI 10.1177/0022034510376542; Karthikeyan BV, 2007, J PERIODONTAL RES, V42, P300, DOI 10.1111/j.1600-0765.2006.00948.x; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; D'Aiuto F, 2008, J CLIN ENDOCR METAB, V93, P3989, DOI 10.1210/jc.2007-2522; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070; Lohsoonthorn Vitool, 2007, Journal of the Medical Association of Thailand, V90, P1908; Shimazaki Y, 2007, J DENT RES, V86, P271; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BAELUM V, 1993, COMMUNITY DENT ORAL, V21, P354, DOI 10.1111/j.1600-0528.1993.tb01098.x; Benguigui C, 2010, J CLIN PERIODONTOL, V37, P601, DOI 10.1111/j.1600-051X.2010.01571.x; Boillot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021508; Chomkhakhai U, 2009, DIABETES METAB SYNDR, V3, P192; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fukui N, 2012, J PERIODONTOL, V83, P1363, DOI 10.1902/jop.2012.110605; Furugen R, 2008, J PERIODONTAL RES, V43, P556, DOI 10.1111/j.1600-0765.2008.01085.x; Han DH, 2010, J CLIN PERIODONTOL, V37, P609, DOI 10.1111/j.1600-051X.2010.01580.x; Han DH, 2012, J CLIN PERIODONTOL, V39, P30, DOI 10.1111/j.1600-051X.2011.01806.x; Kamio N, 2009, FEMS IMMUNOL MED MIC, V56, P241, DOI 10.1111/j.1574-695X.2009.00573.x; Karels A, 2007, INTERNET J ALLIED HL, V5, P1; Khader Y, 2008, J PERIODONTOL, V79, P2048, DOI 10.1902/jop.2008.080022 ; Khosravi R, 2013, MEDIAT INFLAMM, V2013, P1; Kushiyama M, 2009, J PERIODONTOL, V80, P1610, DOI 10.1902/jop.2009.090218; Leroy R, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-8; Li P, 2009, J PERIODONTOL, V80, P541, DOI 10.1902/jop.2009.080387; Pischon N, 2007, J DENT RES, V86, P400; Samnieng P, 2012, COMMUNITY DENT HLTH, V29, P117, DOI 10.1922/CDH_2690Ueno07; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, pS51, DOI [10.1111/jcpe.12060, 10.1902/jop.2013.134006]; Singh B, 2009, DIABETES METAB SYNDR, V3, P240; Sora ND, 2013, J CLIN PERIODONTOL, V40, P599, DOI 10.1111/jcpe.12104; Tu YK, 2013, J CLIN PERIODONTOL, V40, P994, DOI 10.1111/jcpe.12157; Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x	45	1	1	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	NOV	2014	85	11					1502	1514		10.1902/jop.2014.140105		13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT0WF	WOS:000344652200010		
J	Kusahara, K; Ohshima, KI				Kusahara, Kazuya; Ohshima, Kay I.			Kelvin Waves around Antarctica	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							GLOBAL OCEAN; DRAKE PASSAGE; WIND; PRESSURE; SHELF; MODES; FLOW	The Southern Ocean allows circumpolar structure and the Antarctic coastline plays a role as a waveguide for oceanic Kelvin waves. Under the cyclic conditions, the horizontal wavenumbers and frequencies for circum-polarly propagating waves are quantized, with horizontal wavenumbers 1, 2, and 3, corresponding to periods of about 32, 16, and 11 h, respectively. At these frequencies, westward-propagating signals are detected in sea level variation observed at Antarctic coastal stations. The occurrence frequency of westward-propagating signals far exceeds the statistical significance, and the phase speed of the observed signal agrees well with the theoretical phase speed of external Kelvin waves. Therefore, this study concludes that the observed, westward-propagating sea level variability is a signal of the external Kelvin waves of wavenumbers 1, 2, and 3 around Antarctica. A series of numerical model experiments confirms that Kelvin waves around Antarctica are driven by surface air pressure and that these waves are excited not only by local forcing over the Southern Ocean, but also by remote forcing over the Pacific Ocean. Sea level variations generated over the Pacific Ocean can travel to the western side of the South American coast and cross over Drake Passage to the Antarctic continent, constituting a part of the Kelvin waves around Antarctica.	[Kusahara, Kazuya; Ohshima, Kay I.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Kusahara, K (reprint author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19W8, Sapporo, Hokkaido 0600819, Japan.	kazuya.kusahara@lowtem.hokudai.ac.jp	Ohshima, Kay/D-6909-2012		Japan Society for the Promotion of Science (JSPS) [25241001, 26247080, 23340138, 25887001]; Canon Foundation	We thank Dr. A. D. Fraser for his careful proofreading of the manuscript. This study was supported by Grant-in-Aids for Scientific Research A (25241001 and 26247080) and B (23340138) and the Research Activity Startup (25887001) from the Japan Society for the Promotion of Science (JSPS) and by the Canon Foundation. We are grateful to the two anonymous reviewers for their careful reading and constructive comments on the manuscript.	CALDWELL DR, 1972, J MAR RES, V30, P39; Hughes CW, 1999, J PHYS OCEANOGR, V29, P1971, DOI 10.1175/1520-0485(1999)029<1971:WDTFTD>2.0.CO;2; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Carrere L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016473; Aoki S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015733; CHAPMAN DC, 1986, J PHYS OCEANOGR, V16, P758, DOI 10.1175/1520-0485(1986)016<0758:OTCOMF>2.0.CO;2; Emery WJ, 2001, DATA ANAL METHODS PH; Gill A. E., 1982, ATMOSPHERE OCEAN DYN; Hayashi Y., 1971, J METEOR SOC JAPAN, V49, P125; Holton J., 2004, INT GEOPHYS SERIES, V88; Hughes CW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017240; Koopmans L.H., 1974, SPECTRAL ANAL TIME S; Kusahara K, 2009, J PHYS OCEANOGR, V39, P658, DOI 10.1175/2008JPO3982.1; LeBlond P., 1978, ELSEVIER OCEANOGRAPH, V20; Meredith MP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000348; Muller M, 2009, HAMB STUD MARIT AFF, V14, P3; PLATZMAN GW, 1981, J PHYS OCEANOGR, V11, P579, DOI 10.1175/1520-0485(1981)011<0579:NMOTWO>2.0.CO;2; Ponte RM, 2004, J PHYS OCEANOGR, V34, P284, DOI 10.1175/1520-0485(2004)034<0284:PBPSAA>2.0.CO;2; Ponte RM, 2007, J PHYS OCEANOGR, V37, P245, DOI 10.1175/JPO3010.1; Swarztrauber P. N., 1982, PARALLEL COMPUT, P51, DOI 10.1016/B978-0-12-592101-5.50007-5; Wallace J. M., 1972, Journal of Applied Meteorology, V11, DOI 10.1175/1520-0450(1972)011<0887:EOROTS>2.0.CO;2; Zahel W, 2005, OCEAN DYNAM, V55, P137, DOI 10.1007/s10236-005-0029-y	22	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	NOV	2014	44	11					2909	2920		10.1175/JPO-D-14-0051.1		12	Oceanography	Oceanography	AT1TZ	WOS:000344718000006		
J	Nakayama, Y; Ohshima, KI; Matsumura, Y; Fukamachi, Y; Hasumi, H				Nakayama, Yoshihiro; Ohshima, Kay I.; Matsumura, Yoshimasa; Fukamachi, Yasushi; Hasumi, Hiroyasu			A Numerical Investigation of Formation and Variability of Antarctic Bottom Water off Cape Darnley, East Antarctica	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							PRYDZ BAY-REGION; DENSE WATER; SUBMARINE CANYONS; SLOPING BOTTOM; DENMARK STRAIT; OCEAN MODEL; WEDDELL SEA; TRANSPORT; RIDGES; SHELF	At several locations around Antarctica, dense water is formed as a result of intense sea ice formation. When this dense water becomes sufficiently denser than the surrounding water, it descends the continental slope and forms Antarctic Bottom Water (AABW). This study presents the AABW formation off the coast of Cape Darnley [Cape Darnley Bottom Water (CDBW)] in East Antarctica, using a nonhydrostatic model. The model is forced for 8 months by a temporally uniform surface salt flux (because of sea ice formation) estimated from Advanced Microwave Scanning Radiometer for Earth Observing System (EOS; AMSR-E) data and a heat budget calculation. The authors reproduce AABW formation and associated periodic downslope flows of dense water. Descending pathways of dense water are largely determined by the topography; most dense water flows into depressions on the continental shelf, advects onto the continental slope, and is steered downslope to greater depths by the canyons. Intense sea ice formation is the most important factor in the formation of AABW off Cape Darnley, and the existence of depressions is of only minor importance for the flux of CDBW. The mechanism responsible for the periodic downslope flow of dense water is further analyzed using an idealized model setup. The period of dense water outflow is regulated primarily by the topographic beta effect.	[Nakayama, Yoshihiro; Ohshima, Kay I.; Matsumura, Yoshimasa; Fukamachi, Yasushi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Hasumi, Hiroyasu] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Nakayama, Y (reprint author), Alfred Wegener Inst, Bussestr 24, D-27570 Bremerhaven, Germany.	yoshihiro.nakayama@awi.de	Ohshima, Kay/D-6909-2012		Ministry of Education, Culture, Sports, Science, and Technology in Japan [20221001, 20540419, 23340135, 25241001]; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency	We thank A. Kubokawa, H. Mitsudera, S. Aoki, D. Simizu, and T. Tamura for their comments and suggestions. We also thank the officers, crew, and scientists on board the TR/V Umitaka-maru, R/V Hakuho-maru, and Icebreaker Shirase. We acknowledge T. Nakanowatari and K. Ono for their support on the PORC information system at the Institute of Low Temperature Science and the high performance computing system in Hokkaido University. The AMSR-E data were provided by the National Snow and Ice Data Center (NSIDC), and annual sea ice formation data were calculated by S. Nihashi. Insightful comments from the two anonymous reviewers were very helpful for improvement of the manuscript. This work was supported by Grants-in-Aids for Scientific Research (20221001, 20540419, 23340135, and 25241001) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and the Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency.	Lane-Serff GF, 1998, J FLUID MECH, V363, P229, DOI 10.1017/S0022112098001013; Adcroft A, 1997, MON WEATHER REV, V125, P2293, DOI 10.1175/1520-0493(1997)125<2293:ROTBSC>2.0.CO;2; Padman L, 2002, ANN GLACIOL, V34, P247, DOI 10.3189/172756402781817752; Galton-Fenzi BK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008214; Hoppema M, 2001, J MAR RES, V59, P257, DOI 10.1357/002224001762882655; MANTISI F, 1991, MAR CHEM, V35, P151; Spall MA, 1998, J PHYS OCEANOGR, V28, P1598, DOI 10.1175/1520-0485(1998)028<1598:MVIDST>2.0.CO;2; Tamura T, 2007, J ATMOS OCEAN TECH, V24, P1757, DOI 10.1175/JTECH2113.1; Meredith MP, 2000, J GEOPHYS RES-OCEANS, V105, P1093, DOI 10.1029/1999JC900263; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Marques GM, 2014, GEOPHYS RES LETT, V41, P1247, DOI 10.1002/2013GL059153; Matsumura Y, 2008, OCEAN MODEL, V24, P15, DOI 10.1016/j.ocemod.2008.05.001; Foldvik A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002008; Geyer F, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003693; Jensen MF, 2013, J GEOPHYS RES-OCEANS, V118, P4256, DOI 10.1002/jgrc.20309; NOF D, 1983, DEEP-SEA RES, V30, P171, DOI 10.1016/0198-0149(83)90067-5; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; Yabuki T, 2006, J OCEANOGR, V62, P649, DOI 10.1007/s10872-006-0083-1; Brolsma H, 2012, BATHYMETRIC DATA COL; CAVALIERI DJ, 1994, J GEOPHYS RES-OCEANS, V99, P18343, DOI 10.1029/94JC01169; Darelius E, 2008, DEEP-SEA RES PT I, V55, P1021, DOI 10.1016/j.dsr.2008.04.008; GAWARKIEWICZ G, 1995, J GEOPHYS RES-OCEANS, V100, P4489, DOI 10.1029/94JC01742; Guo CC, 2014, J PHYS OCEANOGR, V44, P2698, DOI 10.1175/JPO-D-14-0080.1; Hasumi H., 2011, NAT COMMUN, V2, P159, DOI [10.1038/ncomms1156., DOI 10.1038/NC0MMS1156]; Holland PR, 2011, J PHYS OCEANOGR, V41, P1465, DOI 10.1175/2011JPO4532.1; Ilicak M, 2011, OCEAN MODEL, V38, P71, DOI 10.1016/j.ocemod.2011.02.004; Jacobs S S, 1977, VOYAGE DISCOVERY, P43; Kase RH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001548; Kusahara K, 2009, J PHYS OCEANOGR, V39, P658, DOI 10.1175/2008JPO3982.1; Matsumura Y, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005841; Matsumura Y, 2011, J PHYS OCEANOGR, V41, P2402, DOI 10.1175/JPO-D-10-05014.1; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; MIDDLETON JH, 1989, DEEP-SEA RES, V36, P1255, DOI 10.1016/0198-0149(89)90104-0; Vaz RAN, 1996, DEEP-SEA RES PT I, V43, P603, DOI 10.1016/0967-0637(96)00028-3; Ohshima K. I, 1987, J OCEANOGRAPHICAL SO, V43, P49, DOI 10.1007/BF02110633; Orsi A. H., 2005, SO OCEAN, V1; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; Schmitz J. W. J., 1995, REV GEOPHYS, V33, P151, DOI [10.1029/95RG00879, DOI 10.1029/95RG00879]; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Tanaka K, 2001, J GEOPHYS RES-OCEANS, V106, P2621, DOI 10.1029/2000JC000214; Tanaka K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JA011968; Wahlin AK, 2004, DEEP-SEA RES PT I, V51, P577, DOI 10.1016/j.dsr.2003.11.002; Wahlin AK, 2008, DEEP-SEA RES PT I, V55, P737, DOI 10.1016/j.dsr.2008.02.007; Wahlin AK, 2002, DEEP-SEA RES PT I, V49, P305, DOI 10.1016/S0967-0637(01)00058-9; Wang Q, 2009, OCEAN MODEL, V28, P50, DOI 10.1016/j.ocemod.2008.08.003; Wilchinsky AV, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005013; Williams GD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004346; Williams GD, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005812	49	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	NOV	2014	44	11					2921	2937		10.1175/JPO-D-14-0069.1		17	Oceanography	Oceanography	AT1TZ	WOS:000344718000007		
J	Keceli, B; Kubo, Y				Keceli, Batu; Kubo, Yoshihiro			Voltage- and ATP-dependent structural rearrangements of the P2X2 receptor associated with the gating of the pore	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							PROTEIN-COUPLED RECEPTOR; SWISS-MODEL WORKSPACE; ION-CHANNEL; MOLECULAR PHYSIOLOGY; GATED CHANNELS; P2X(2); BINDING; COORDINATION; INACTIVATION; ACTIVATION	We previously reported that the ATP receptor channel P2X2 shows gating which depends not only on ATP but also on membrane voltage, in spite of the absence of a canonical voltage sensor. The purpose of the present study was to capture the structural rearrangements of P2X2 associated with voltage- and ATP-dependent gating. Cysteine residues were introduced by mutation at Asp315 and Ile67 in the linker region located between the ATP binding site and the channel pore. We analysed the modification rate of cysteine residues by Cd2+ by recording current under two-electrode voltage clamp using Xenopus oocytes. Two cysteine residues at 315 and 67 were bridged by Cd2+ resulting in current decline, and the speed of modification was faster at hyperpolarized than at depolarized potential, and also faster in the presence than in the absence of ATP. The bridging by Cd2+ between 315 and 67 was not intra- but inter-subunit. The results demonstrate the structural rearrangements in the linker region of P2X2 associated with voltage- and ATP-dependent gating of the pore. AbstractP2X2 is an extracellular ATP-gated cation channel which has a voltage-dependent gating property even though it lacks a canonical voltage sensor. It is a trimer in which each subunit has two transmembrane helices and a large extracellular domain. The three inter-subunit ATP binding sites are linked to the pore forming transmembrane (TM) domains by -strands. We analysed structural rearrangements of the linker strands between the ATP binding site and TM domains upon ligand binding and voltage change, electrophysiologically in Xenopus oocytes, using mutants carrying engineered thiol-modifiable cysteine residues. (1) We demonstrated that the double mutant D315C&I67C (at -14 and -1, respectively) shows a 2- to 4-fold increase in current amplitude after treatment with a reducing reagent, dithiothreitol (DTT). Application of the thiol-reactive metal Cd2+ induced current decline due to bond formation between D315C and I67C. This effect was not observed in wild type (WT) or in single point mutants. (2) Cd2+-induced current decline was analysed in hyperpolarized and depolarized conditions with different pulse protocols, and also in the presence and absence of ATP. (3) Current decline induced by Cd2+ could be clearly observed in the presence of ATP, but was not clear in the absence of ATP, showing a state-dependent modification. (4) In the presence of ATP, Cd2+ modification was significantly faster in hyperpolarized than in depolarized conditions, showing voltage-dependent structural rearrangements of the linker strands. (5) Experiments using tandem trimeric constructs (TTCs) with controlled number and position of mutations in the trimer showed that the bridging by Cd2+ between 315 and 67 was not intra- but inter-subunit. (6) Finally, we performed similar analyses of a pore mutant T339S, which makes the channel activation voltage insensitive. Cd2+ modification rates of T339S were similar in hyperpolarized and depolarized conditions. Taking these results together, we demonstrated that structural rearrangements of the linker region of the P2X2 receptor channel are induced not only by ligand binding but also by membrane potential change.	[Keceli, Batu; Kubo, Yoshihiro] Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Sch Life Sci, Hayama, Kanagawa 2400155, Japan	Keceli, B (reprint author), Natl Inst Physiol Sci, Dept Mol Physiol, Okazaki, Aichi 4448585, Japan.	ykubo@nips.ac.jp			Japan Society for Promotion of Science	This work was supported in part by research grants from the Japan Society for Promotion of Science to B. K. and to Y.K.	BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Stelmashenko O, 2012, MOL PHARMACOL, V82, P760, DOI 10.1124/mol.112.080903; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; CHARNET P, 1992, J PHYSIOL-LONDON, V450, P375; Figl A, 1996, J GEN PHYSIOL, V107, P369, DOI 10.1085/jgp.107.3.369; Fujiwara Y, 2009, J GEN PHYSIOL, V133, P93, DOI 10.1085/jgp.200810002; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Keceli B, 2009, J PHYSIOL-LONDON, V587, P5801, DOI 10.1113/jphysiol.2009.182824; Keceli B, 2014, J GEN PHYSIOL, V143, P760, DOI 10.1085/jgp.201411166; Kubo Y, 2009, J PHYSIOL-LONDON, V587, P5317, DOI 10.1113/jphysiol.2009.179309; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; NARULA SS, 1995, BIOCHEMISTRY-US, V34, P620, DOI 10.1021/bi00002a029; Raghuraman H, 2012, STRUCTURE, V20, P1332, DOI 10.1016/j.str.2012.03.027; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; YELLEN G, 1994, BIOPHYS J, V66, P1068; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P353, DOI 10.1111/j.1469-7793.1998.353bt.x	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	NOV 1	2014	592	21					4657	4676		10.1113/jphysiol.2014.278507		20	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AT0US	WOS:000344650800007		
J	Kito, Y; Kurahashi, M; Mitsui, R; Ward, SM; Sanders, KM				Kito, Yoshihiko; Kurahashi, Masaaki; Mitsui, Retsu; Ward, Sean M.; Sanders, Kenton M.			Spontaneous transient hyperpolarizations in the rabbit small intestine	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							FIBROBLAST-LIKE CELLS; MOUSE SMALL-INTESTINE; CA2+-ACTIVATED K+ CHANNEL; SMOOTH-MUSCLE-CELLS; GUINEA-PIG ILEUM; INHIBITORY NEUROMUSCULAR-TRANSMISSION; INTRAMUSCULAR INTERSTITIAL-CELLS; FORMING GAP-JUNCTIONS; ALPHA-POSITIVE CELLS; GASTROINTESTINAL-TRACT	Recently, it was shown that fibroblast-like cells (FLCs) possess the apparatus to mediate purinergic motor neurotransmission in the gastrointestinal tract. However, the electrophysiological properties of FLCs in situ have not been determined. We recorded two patterns of slow waves from longitudinal smooth muscle cells and circular smooth muscle cells, large amplitude slow waves from interstitial cells of Cajal, and spontaneous transient hyperpolarizations (STHs) from FLCs in the rabbit small intestine using intracellular recording combined with dye injection to identify the cellular morphology of impaled cells. Drugs that inhibit the signalling pathway involved in purinergic neurotransmission inhibited STHs in FLCs. Small amplitude STHs were recorded in smooth muscle cells but not in interstitial cells of Cajal, suggesting that STHs from FLCs were conducted passively to smooth muscle cells. We conclude that FLCs display the molecular apparatus necessary to mediate purinergic neurotransmission and may tonically dampen smooth muscle excitability in the rabbit small intestine by an ongoing discharge of STHs. AbstractFour types of electrical activity were recorded and related to cell structure by intracellular recording and dye injection into impaled cells in muscles of rabbit small intestine. The specific cell types from which recordings were made were longitudinal smooth muscle cells (LSMCs), circular smooth muscle cells (CSMCs), interstitial cells of Cajal distributed in the myenteric region (ICC-MY) and fibroblast-like cells (FLCs). Slow waves (slow waves(SMC)) were recorded from LSMCs and CSMCs. Slow waves (slow waves(ICC)) were of greatest amplitude (>50mV) and highest maximum rate of rise (>10Vs(-1)) in ICC-MY. The dominant activity in FLCs was spontaneous transient hyperpolarizations (STHs), with maximum amplitudes above 30mV. STHs were often superimposed upon small amplitude slow waves (slow waves(FLC)). STHs displayed a cyclical pattern of discharge irrespective of background slow wave activity. STHs were inhibited by MRS2500 (3m), a P2Y1 antagonist, and abolished by apamin (0.3m), a blocker of small conductance Ca2+-activated K+ channels. Small amplitude STHs (<15mV) were detected in smooth muscle layers, whereas STHs were not resolved in cells identified as ICC-MY. Electrical field stimulation evoked purinergic inhibitory junction potentials (IJPs) in CSMCs. Purinergic IJPs were not recorded from ICC-MY. These results suggest that FLCs may regulate smooth muscle excitability in the rabbit small intestine via generation of rhythmic apamin-sensitive STHs. Stimulation of P2Y1 receptors modulates the amplitudes of STHs. Our results also suggest that purinergic inhibitory motor neurons regulate the motility of the rabbit small intestine by causing IJPs in FLCs that conduct to CSMCs.	[Kito, Yoshihiko] Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan; [Kito, Yoshihiko; Mitsui, Retsu] Nagoya City Univ, Dept Cell Physiol, Sch Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Kurahashi, Masaaki; Ward, Sean M.; Sanders, Kenton M.] Univ Nevada, Dept Physiol & Cell Biol, Sch Med, Reno, NV 89557 USA	Kito, Y (reprint author), Saga Univ, Dept Pharmacol, Fac Med, Saga 8498501, Japan.	ykito@cc.saga-u.ac.jp			24th General Assembly of the Japanese Association of Medical Sciences	This project was supported by the 24th General Assembly of the Japanese Association of Medical Sciences to Y.K.	HUIZINGA JD, 1995, NATURE, V373, P347; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Wang GD, 2007, AM J PHYSIOL-GASTR L, V292, pG1483, DOI 10.1152/ajpgi.00450.2006; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; THUNEBERG L, 1982, ADV ANAT EMBRYOL CEL, V71, P1; Hwang SJ, 2012, J PHYSIOL-LONDON, V590, P1957, DOI 10.1113/jphysiol.2011.224634; Peri LE, 2013, NEUROGASTROENT MOTIL, V25, pE609, DOI 10.1111/nmo.12174; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; STARK ME, 1991, J PHYSIOL-LONDON, V444, P743; Burns AJ, 1996, P NATL ACAD SCI USA, V93, P12008, DOI 10.1073/pnas.93.21.12008; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91; Burns AJ, 2007, J PEDIATR GASTR NUTR, V45, pS103, DOI 10.1097/MPG.0b013e31812e65e0; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Fujita A, 2003, J PHARMACOL SCI, V92, P35; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Vanderwinden JM, 2002, CELL TISSUE RES, V310, P349, DOI 10.1007/s00441-002-0638-4; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; Klemm MF, 2002, CLIN EXP PHARMACOL P, V29, P18, DOI 10.1046/j.1440-1681.2002.03601.x; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; SANDERS KM, 1992, AM J PHYSIOL, V262, pG379; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; WARD SM, 1992, BRIT J PHARMACOL, V107, P1075; WOOD JD, 1972, AM J PHYSIOL, V222, P118; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Baker SA, 2013, J PHYSIOL-LONDON, V591, P6193, DOI 10.1113/jphysiol.2013.264747; Cajal SR, 1911, HISTOLOGIE SYSTEME N, V2, P891; CHEUNG DW, 1980, J PHYSIOL-LONDON, V309, P13; Cobine CA, 2011, CELL TISSUE RES, V344, P17, DOI 10.1007/s00441-011-1138-1; CRIST JR, 1992, J PHYSIOL-LONDON, V447, P119; Dickens EJ, 2000, AM J PHYSIOL-GASTR L, V279, pG388; Duffy AM, 2012, NEUROGASTROENT MOTIL, V24, pE41, DOI 10.1111/j.1365-2982.2011.01806.x; GABELLA G, 1979, J CELL BIOL, V82, P239, DOI 10.1083/jcb.82.1.239; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P159, DOI 10.1111/j.1365-2982.2007.01004.x; HE XD, 1993, J PHYSIOL-LONDON, V461, P485; HENDERSO.RM, 1971, AM J PHYSIOL, V221, P564; Horiguchi K, 2000, J AUTONOM NERV SYST, V80, P142, DOI 10.1016/S0165-1838(00)00089-8; Iino S, 2009, ARCH HISTOL CYTOL, V72, P107; Kito Y, 2012, NEUROGASTROENTERO S2, V24; Kito Y, 2009, AM J PHYSIOL-GASTR L, V297, pG814, DOI 10.1152/ajpgi.00118.2009; Kito Y, 2007, PFLUG ARCH EUR J PHY, V455, P505, DOI 10.1007/s00424-007-0306-3; Kurahashi M, 2012, J CELL MOL MED, V16, P1397, DOI 10.1111/j.1582-4934.2011.01510.x; Mutafova-Yambolieva VN, 2007, P NATL ACAD SCI USA, V104, P16359, DOI 10.1073/pnas.0705510104; Spencer NJ, 1998, J AUTONOM NERV SYST, V71, P37, DOI 10.1016/S0165-1838(98)00063-0; Suzuki H, 2003, J PHYSIOL-LONDON, V546, P751, DOI 10.1113/jphysiol.2002.033365; Vanderwinden JM, 1999, MICROSC RES TECHNIQ, V47, P344, DOI 10.1002/(SICI)1097-0029(19991201)47:5<344::AID-JEMT6>3.0.CO;2-1; WATERMAN SA, 1994, J PHYSIOL-LONDON, V477, P459	48	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	NOV 1	2014	592	21					4733	4745		10.1113/jphysiol.2014.276337		13	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AT0US	WOS:000344650800011		
J	Wakabayashi, T; Oh, H; Kawaguchi, M; Harada, K; Sato, S; Ikeda, H; Hiroaki, S				Wakabayashi, Tomomi; Oh, Hana; Kawaguchi, Masayoshi; Harada, Kyuya; Sato, Shusei; Ikeda, Hajime; Hiroaki, Setoguchi			Polymorphisms of E1 and GIGANTEA in wild populations of Lotus japonicus	JOURNAL OF PLANT RESEARCH			English	Article						GIGANTEA; E1; Circadian clock; Lotus japonicus; Nonsynonymous change	MAP-BASED CLONING; CIRCADIAN CLOCK; SOYBEAN MATURITY; ARABIDOPSIS-THALIANA; DNA POLYMORPHISM; GENE; GENOME; TIME; DIVERSITY; ROLES	In plants, timing of flowering is an essential factor that controls the survival rates of descendants. The circadian clock genes E1 and GIGANTEA (GI) play a central role in transmitting signals to FLOWERING LOCUS T (FT) in leguminous plants. Lotus japonicus is a wild Japanese species that ranges from northern Hokkaido to the southern Ryukyus and exhibits a wide range in terms of the time between seeding and first flowering. In this study, we first identified LjGI and analyzed polymorphisms of LjE1 and LjGI among wild populations covering the entire distribution range of this species in Japan. LjGI had a coding sequence (CDS) length of 3495 bp and included 14 exons. The homologies of DNA and amino acid sequences between LjGI and GmGI were 89 and 88 % (positive rate was 92 %), respectively. LjE1 harbored five nucleic acid changes in a 552 bp CDS, all of which were nonsynonymous; four of the changes were located in the core function area. LjE1 alleles exhibited partial north-south differentiation and non-neutrality. In contrast, the LjGI harbored one synonymous and one nonsynonymous change. Thus, our study suggests that LjE1 may be involved in the control of flowering times, whereas LjGI may be under strong purifying selection.	[Wakabayashi, Tomomi; Hiroaki, Setoguchi] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Oh, Hana; Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Harada, Kyuya] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Ikeda, Hajime] Okayama Univ, Inst Plant Sci & Resources, Okayama 7100046, Japan	Wakabayashi, T (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	wakabayashi.tomomi.75x@st.kyoto-u.ac.jp	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366	Japan Society for the Promotion of Science [24247013, 23128508, 25128708]; Japan Society	We express our appreciation to the National Bioresource Project (Legume Base), University of Miyazaki, Japan, for providing the seeds of Lotus japonicus, and members of the Setoguchi laboratory for their support. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science Nos. 24247013, 23128508, and 25128708 to H. S and a Grant-in-Aid for Scientific Research on Innovative Areas, "Genetic Bases for the Evolution of Complex Adaptive Traits" from the Japan Society.	Allard HA, 1920, J AGR RES, V18, P553; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Ono N, 2010, PLANT CELL PHYSIOL, V51, P1800, DOI 10.1093/pcp/pcq140; Yamashino T, 2013, BIOSCI BIOTECH BIOCH, V77, P747, DOI 10.1271/bbb.120871; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; TAJIMA F, 1989, GENETICS, V123, P585; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Cober ER, 2001, CROP SCI, V41, P698; MCBLAIN BA, 1987, J HERED, V78, P160; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; BERNARD RL, 1971, CROP SCI, V11, P242; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Zhou XYE, 2004, J MOL BIOL, V335, P307, DOI 10.1016/j.jmb.2003.10.030; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Levy YY, 1998, PLANT CELL, V10, P1973; Buzzell R., 1980, SOYBEAN GENET NEWSL, V7, P26; Dodd NA, 2005, SCIENCE, V309, P630; Doyle JJ, 1990, FOCUS, V12, P13; Farre EM, 2012, PLANT BIOLOGY, V14, P401, DOI 10.1111/j.1438-8677.2011.00548.x; Kai S, 2010, BREEDING SCI, V60, P436, DOI 10.1270/jsbbs.60.436; Kawaguchi M, 2000, J PLANT RES, V113, P507, DOI 10.1007/PL00013961; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Sato S, 2001, DNA RES, V8, P311, DOI 10.1093/dnares/8.6.311; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Whitelam GC, 1997, PLANT CELL ENVIRON, V20, P752, DOI 10.1046/j.1365-3040.1997.d01-100.x	42	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					651	660		10.1007/s10265-014-0649-8		10	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900001		
J	Hori, K; Tono, A; Fujimoto, K; Kato, J; Ebihara, A; Watano, Y; Murakami, N				Hori, Kiyotaka; Tono, Akitaka; Fujimoto, Kazuto; Kato, Juntaro; Ebihara, Atsushi; Watano, Yasuyuki; Murakami, Noriaki			Reticulate evolution in the apogamous Dryopteris varia complex (Dryopteridaceae, subg. Erythrovariae, sect. Variae) and its related sexual species in Japan	JOURNAL OF PLANT RESEARCH			English	Article						Apogamy; Fern; PgiC; rbcL; Reticulate evolution; Single-strand conformation polymorphism (SSCP)	GENETIC-VARIATION; CHLOROPLAST DNA; NUCLEAR-DNA; FERNS; ORIGINS; PTERIDACEAE; POLYPLOIDS; SEQUENCES; TREES; KOREA	Apogamous fern species are often difficult to distinguish from related species because of their continuous morphological variations. To clarify the genetic relationships among the members of the Dryopteris varia complex, we analyzed the nucleotide sequences of the plastid gene rbcL and the nuclear gene PgiC. We also analyzed the diploid sexual species D. caudipinna and D. chinensis, which have not been included in the complex, but were recently shown to be closely related to the complex in a molecular phylogenetic study. The PgiC sequences of the diploid sexual species, D. varia, D. saxifraga, D. sp. 'protobissetiana' (undescribed diploid sexual species), D. caudipinna, and D. chinensis, were well differentiated and hence designated A, B, C, D, and E, respectively. Thus, the PgiC constitution of apogamous species in the complex was as follows: D. bissetiana, B + C; D. kobayashii, B + C + E); D. pacifica, A + C, A + B + C, or A + C + D; D. sacrosancta, A + C + E; and D. saxifragivaria, B + C. These results suggest that these apogamous species are formed by hybridizations of species including not only the three diploid sexual species of the D. varia complex (A, B, and C) but also the two diploid sexual species D. caudipinna (D) and D. chinensis (E), which do not belong to the complex.	[Hori, Kiyotaka; Tono, Akitaka; Murakami, Noriaki] Tokyo Metropolitan Univ, Makino Herbarium, Hachioji, Tokyo 1920397, Japan; [Fujimoto, Kazuto; Watano, Yasuyuki] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba 2638522, Japan; [Kato, Juntaro] Aichi Univ Educ, Dept Biol, Kariya, Aichi 4488542, Japan; [Ebihara, Atsushi] Nat Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Hori, K (reprint author), Tokyo Metropolitan Univ, Makino Herbarium, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	hori-kiyotaka@ed.tmu.ac.jp			Ministry of the Environment, Japan [S-9];  [25291089]	We are grateful to the following persons for their assistance in collecting plant material: Chun-Ming Chen of the Koo Botanic Conservation Center (Taiwan); Li-Yaung Kuo of the Taiwan Forestry Research Institute; W. Shinohara of Kagawa University; J. Yamashita of Okayama University; S. J. Lin of Shimane University; S. Tagane of Kyushu University; S. Saito and S. Kariyama of the Kurashiki Museum of Natural History; and S. Fujimoto, Y. Inoue, T. Kuramata, S. Mitani, K. Mizote, K. Mizunashi, K. Ohora, T. Oka, H. Takae, T. Tamaru, K. Tanaka, and I. Yamazumi of the Nippon Fernist Club. We are also grateful to S. Nakamura, T. Sugawara, H. Kato, and Y. Kakugawa of the Makino Herbarium, Tokyo Metropolitan University; S. Serizawa and S. Tsuneki of the Aichi University of Education; and K. Yamamoto of the National Museum of Nature and Science, Japan for their valuable suggestions and advice during the course of this study. This study is partly supported by Grants-in-Aid for Scientific Research No. 25291089 and by the Environment Research and Technology Development Fund (S-9) of the Ministry of the Environment, Japan for N. Murakami. We would like to thank Enago (http://www.enago.jp) for the English language review.	Adjie B, 2007, J PLANT RES, V120, P129, DOI 10.1007/s10265-006-0032-5; Dyer RJ, 2012, ANN BOT-LONDON, V110, P1515, DOI 10.1093/aob/mcs202; Sessa EB, 2012, MOL PHYLOGENET EVOL, V64, P563, DOI 10.1016/j.ympev.2012.05.009; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Lin SJ, 1995, J PLANT RES, V108, P451, DOI 10.1007/BF02344233; Huber KT, 2006, MOL BIOL EVOL, V23, P1784, DOI 10.1093/molbev/msl045; Lee SJ, 2006, PLANT SYST EVOL, V262, P37, DOI 10.1007/s00606-006-0455-4; DARNAEDI D, 1990, BOT MAG TOKYO, V103, P1, DOI 10.1007/BF02488406; LIN SJ, 1992, BOT MAG TOKYO, V105, P443, DOI 10.1007/BF02497659; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Lee SJ, 2013, BIOCHEM SYST ECOL, V50, P371, DOI 10.1016/j.bse.2013.05.008; Ebihara A, 2005, AM J BOT, V92, P1535, DOI 10.3732/ajb.92.9.1535; Grusz AL, 2009, AM J BOT, V96, P1636, DOI 10.3732/ajb.0900019; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BRAITHWA.AF, 1964, NEW PHYTOL, V63, P293, DOI 10.1111/j.1469-8137.1964.tb07383.x; DOPP W., 1939, PLANTA, V29, P481; Doyle JJ, 1990, FOCUS, V12, P13; Dyer RJ, 2013, BMC PLANT BIOL, V2013, P219; Ebihara A., 2011, B NATL MUSEUM NATU B, V37, P63; Ebihara A, 2012, J PLANT RES, V125, P499, DOI 10.1007/s10265-012-0474-x; Ebihara A, 2014, B NATL MUS IN PRESS; Fraser-Jenkins CR, 1986, B BRIT MUS NAT HIST, V14, P183; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Hirabayashi H, 1969, J JPN BOT, V44, P85; Hirabayashi H, 1967, J JAP BOT, V42, P44; Hirabayashi H, 1970, J JAPANESE BOT, V45, P11; Hirabayashi H., 1974, CYTOGEOGRAPHIC STUDI; Hirabayashi H, 1966, J JPN BOT, V41, P11; Iwatsuki K, 1995, FLORA JAPAN, VI; Jaruwattanaphan T, 2013, SYST BOT, V38, P15, DOI 10.1600/036364413X661980; Kurata S, 1966, J GEOBOT, V14, P82; Kurita S, 1961, BOT MAG TOKYO, V74, P395; Lin SJ, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P217; Liu HM, 2012, J BOT, DOI DOI 10.1155/2012/510478; Lott M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-216; Lott M, 2009, BIOINFORMATICS, V25, P1199, DOI 10.1093/bioinformatics/btp133; Lovis J.D., 1977, ADV BOT RES, V4, P229; Manton I, 1950, PROBLEMS CYTOLOGY EV; Mitui K, 1968, SCI REP TOKYO KYOI B, V13, P285; Mitui K, 1975, B NIPPON DENTAL COLL, V4, P221; Mitui K, 1966, J JAP BOT, V41, P60; Mitui K, 1965, J JAP BOT, V40, P117; Nakai T, 1942, J JPN BOT, V18, P281; Nakato Narumi, 1995, Journal of Japanese Botany, V70, P194; NARAYAN RKJ, 1987, PLANT SYST EVOL, V157, P161, DOI 10.1007/BF00936195; Nei M., 2000, MOL EVOLUTION PHYLOG; Rambaut A, 2009, TRACER V1 5 COMPUTER; Serizawa S, 2009, SHIDEKOBUSHI, V1, P97; SUZUKI T, 1990, HEREDITY, V65, P221, DOI 10.1038/hdy.1990.90; Tagawa M, 1959, COLOURED ILLUSTRATIO; Takamiya M, 1996, INDEX CHROMOSOMES JA; Takamiya M, 2001, INT J PLANT SCI, V162, P625, DOI 10.1086/320144; Tanaka K, 1999, J NIPPON FERN CLUB, V3, P1; Tsai J.L., 1985, J SCI ENG, V40, P121; Tsai JL, 1975, J SCI ENG, V12, P321; WAGNER WH, 1954, EVOLUTION, V8, P103, DOI 10.2307/2405636; WALKER TG, 1958, EVOLUTION, V12, P82, DOI 10.2307/2405906; WATANO Y, 1988, BOT MAG TOKYO, V101, P213, DOI 10.1007/BF02488600	60	2	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					661	684		10.1007/s10265-014-0652-0		24	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900002		
J	Yamato, M; Ogura-Tsujita, Y; Takahashi, H; Yukawa, T				Yamato, Masahide; Ogura-Tsujita, Yuki; Takahashi, Hiroshi; Yukawa, Tomohisa			Significant difference in mycorrhizal specificity between an autotrophic and its sister mycoheterotrophic plant species of Petrosaviaceae	JOURNAL OF PLANT RESEARCH			English	Article						Arbuscular mycorrhiza; Glomeromycota; Japonolirion osense; Petrosavia sakuraii; SSU rDNA	COMMUNITY STRUCTURE; FUNGAL COMMUNITIES; ROOTS; IDENTIFICATION; JAPONOLIRION; TRIURIDACEAE; MYCOTROPHY	Petrosaviaceae is a monocotyledonous plant family that comprises two genera: the autotrophic Japonolirion and the mycoheterotrophic Petrosavia. Accordingly, this plant family provides an excellent system to examine specificity differences in mycobionts between autotrophic and closely related mycoheterotrophic plant species. We investigated mycobionts of Japonolirion osense, the sole species of the monotypic genus, from all known habitats of this species by molecular identification and detected 22 arbuscular mycorrhizal (AM) fungal phylotypes in Archaesporales, Diversisporales, and Glomerales. In contrast, only one AM fungal phylotype in Glomerales was predominantly detected from the mycoheterotrophic Petrosavia sakuraii in a previous study. The high mycobiont diversity in J. osense and in an outgroup plant, Miscanthus sinensis (Poaceae), indicates that fungal specificity increased during the evolution of mycohetrotrophy in Petrosaviaceae. Furthermore, some AM fungal sequences of J. osense showed >99 % sequence similarity to the dominant fungal phylotype of P. sakuraii, and one of them was nested within a clade of P. sakuraii mycobionts. These results indicate that fungal partners are not necessarily shifted, but rather selected for in the course of the evolution of mycoheterotrophy. We also confirmed the Paris-type mycorrhiza in J. osense.	[Yamato, Masahide] Chiba Univ, Dept Sci Educ, Fac Educ, Inage Ku, Chiba 2638522, Japan; [Ogura-Tsujita, Yuki] Saga Univ, Fac Agr, Dept Appl Biol Sci, Saga 8408502, Japan; [Takahashi, Hiroshi] Gifu Univ, Fac Educ, Dept Biol, Gifu 5011193, Japan; [Yukawa, Tomohisa] Natl Museum Nat & Sci, Tsukuba Bot Garden, Tsukuba, Ibaraki 3050005, Japan	Yamato, M (reprint author), Chiba Univ, Dept Sci Educ, Fac Educ, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	myamato@chiba-u.jp			Global COE Program "Advanced utilization of fungus/mushroom resources for sustainable society in harmony with nature"; Ministry of Education, Culture, Sports, Science and Technology, Japan [24370040]	We thank Teshio Experimental Forest, Hokkaido University for providing facilities, Takehiro Omori and Taiga Kuhara for providing information on the ecology and distribution of Japonolirion osense, and Chikara Kozuka and Mihoko Watanabe for assistance in field surveys. Part of this study was supported by the Global COE Program "Advanced utilization of fungus/mushroom resources for sustainable society in harmony with nature" and a Grant-in-Aid for Scientific Research (24370040 to T.Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	An GH, 2008, SOIL SCI PLANT NUTR, V54, P517, DOI 10.1111/j.1747-0765.2008.00267.x; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AFM.00987-07; Imhof S, 1999, MYCORRHIZA, V9, P33, DOI 10.1007/s005720050260; Cameron KM, 2003, BRITTONIA, V55, P214, DOI 10.1663/0007-196X(2003)055[0214:ROTMFP]2.0.CO;2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Merckx V, 2008, P R SOC B, V275, P1029, DOI 10.1098/rspb.2007.1622; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Chase Mark W., 2006, Aliso, V22, P63; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Merckx V, 2009, ANN BOT-LONDON, V104, P1255, DOI 10.1093/aob/mcp235; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bremer B, 2009, BOT J LINN SOC, V161, P105; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Franke T, 2006, MYCOL PROG, V5, P24, DOI 10.1007/s11557-006-0500-2; Hooland SM, 2003, ANAL RAREFACTION 1 3; Imhof S, 1998, CAN J BOT, V76, P2011; Kawahara A, 2013, OECOLOGIA, V173, P533, DOI 10.1007/s00442-013-2622-y; Kawase Daiju, 2006, APG Acta Phytotaxonomica et Geobotanica, V57, P183; Merckx V, 2010, NEW PHYTOL, V188, P590, DOI 10.1111/j.1469-8137.2010.03365.x; Merckx V. S. F. T., 2013, MYCOHETEROTROPHY BIO, P19, DOI DOI 10.1007/978-1-4614-5209-6_; Merckx VSFT, 2012, MOL ECOL, V21, P1524, DOI 10.1111/j.1365-294X.2012.05472.x; Ministry of the Environment, 2012, RED LIST; Ogura-Tsujita Y, 2013, MYCOSCIENCE, V54, P444, DOI 10.1016/j.myc.2013.02.004; Ogura-Tsujita Y, 2012, AM J BOT, V99, P1158, DOI 10.3732/ajb.1100464; Ohashi Hiroyoshi, 2000, Taiwania, V45, P263; pik M, 2010, NEW PHYTOL, V188, P223; Saito K, 2004, MYCORRHIZA, V14, P363, DOI 10.1007/s00572-003-0286-x; Saitou N, 1987, MOL BIOL EVOL, V4, P404; Smith FA, 1997, NEW PHYTOL, V137, P373, DOI 10.1046/j.1469-8137.1997.00848.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Waterman R., 2013, MYCOHETEROTROPHY BIO, P267; Yamato M, 2002, MYCORRHIZA, V12, P291, DOI 10.1007/s00572-002-0187-4; Yamato M, 2011, MYCOSCIENCE, V52, P217, DOI 10.1007/s10267-010-0084-1; Yamato M, 2001, MYCORRHIZA, V11, P83, DOI 10.1007/s005720100099; Yamato M, 2011, MYCORRHIZA, V21, P631, DOI 10.1007/s00572-011-0373-3	40	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					685	693		10.1007/s10265-014-0661-z		9	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900003		
J	Watanabe, S; Kaneko, Y; Maesako, Y; Noma, N				Watanabe, Shuntaro; Kaneko, Yuko; Maesako, Yuri; Noma, Naohiko			Range expansion and lineage admixture of the Japanese evergreen tree Machilus thunbergii in central Japan	JOURNAL OF PLANT RESEARCH			English	Article						Founder effect; Lineage admixture; Nuclear microsatellite; Machilus thunbergii	MULTILOCUS GENOTYPE DATA; CRYPTOMERIA-JAPONICA; POPULATION-STRUCTURE; GENETIC DIVERSITY; GLACIAL REFUGIA; NATURAL-POPULATIONS; ALLELIC RICHNESS; ICE AGES; COLONIZATION; MICROSATELLITES	We investigated the range expansion histories of Machilus thunbergii populations in the Kinki region of central Japan on the basis of nuclear microsatellite data. In the Kinki region, M. thunbergii is typically found in the coastal area, with some fragmented populations inland, around Lake Biwa. Phylogenetic and Bayesian clustering analysis (STRUCTURE analysis) revealed that the inland populations have different genetic components between the west and east sides of Lake Biwa. The population located on the north side of the lake has an admixture of the two genetically differentiated lineages, contributing to an increase in the genetic diversity of the population. Populations around Lake Biwa had lost rare alleles and the F value obtained from STRUCTURE analysis was lower in the coastal populations than in the lake populations. These results suggest that populations around Lake Biwa experienced a bottleneck due to a founder effect during the initial migration to the lake and that glacial refugia of M. thunbergii in the Kinki region existed along the coast.	[Watanabe, Shuntaro; Noma, Naohiko] Univ Shiga Prefecture, Hikone, Shiga, Japan; [Kaneko, Yuko] Lake Biwa Environm Res Inst, Otsu, Shiga 5200022, Japan; [Maesako, Yuri] Osaka Sangyo Univ, Osaka, Japan	Kaneko, Y (reprint author), Lake Biwa Environm Res Inst, 5-34 Yanagasaki, Otsu, Shiga 5200022, Japan.	kaneko-y@lberi.jp			Ministry of Education, Culture, Sports, Science and Technology [21310152]	We thank S. Tsukiyama and D. Kado for their help in collecting samples, and M. Yokogawa for helpful comments on data analysis. We are indebt to E. Hamabata for provision of reference documents. We also thank T. Nishida and two anonymous reviewers for helping to improve the manuscript. This research was supported by a Grant-in-Aid for Scientific Research (No. 21310152) from the Ministry of Education, Culture, Sports, Science and Technology.	MANTEL N, 1967, CANCER RES, V27, P209; Cornuet JM, 1996, GENETICS, V144, P2001; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Aoki K, 2004, J PLANT RES, V117, P77, DOI 10.1007/s10265-003-0132-4; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Pritchard JK, 2000, GENETICS, V155, P945; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Sakaguchi S, 2011, HEREDITY, V107, P338, DOI 10.1038/hdy.2011.20; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Walter R, 2001, MOL ECOL, V10, P103, DOI 10.1046/j.1365-294x.2001.01177.x; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Rousset F, 1996, GENETICS, V142, P1357; HATTORI T, 1985, BOT MAG TOKYO, V98, P317, DOI 10.1007/BF02488498; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Heuertz M, 2004, EVOLUTION, V58, P976; MARUYAMA T, 1985, GENETICS, V111, P675; Hiraoka K, 2009, J PLANT RES, V122, P269, DOI 10.1007/s10265-009-0217-9; Fujii N, 2002, PLANT SYST EVOL, V232, P21, DOI 10.1007/s006060200024; Comps B, 2001, GENETICS, V157, P389; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Falush D, 2003, GENETICS, V164, P1567; Wright S, 1943, GENETICS, V28, P114; Aoki Kyoko, 2011, Insects, V2, P128, DOI 10.3390/insects2020128; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hattori, 2011, ENV VEGETATION, P24; HATTORI T, 1987, Japanese Journal of Ecology, V37, P1; Hattori T, 2001, SHUSEIBUTSUGAKU KENK, V24, P203; Hattori Tamotsu, 1992, Japanese Journal of Ecology (Sendai), V42, P215; Horikawa Y, 1972, ATLAS JAPANESE FLORA; Kamei T., 1981, Quaternary Research (Tokyo), V20, P191; Kaneko Y, 2012, AM J BOT, V99, pE265, DOI 10.3732/ajb.1100560; Kitamura S, 1968, FLORA SHIGA PREFECTU; Langella O, 1999, POPULATIONS 1 2 30 P; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Matsushita M, 1984, QUADRANGLE SERIES, V11, P85; Matsusue K, 2000, JNC TECH REV, V6, P93; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; Nei M., 1987, MOL EVOLUTIONARY GEN; Noda A, 2009, BIOL J LINN SOC, V102, P51; Noma N, 1997, ECOL RES, V12, P119, DOI 10.1007/BF02523777; Ohtsuki T, 2011, AOB PLANTS, DOI [10.1093/aobpla/plr021, DOI 10.1093/A0BPLA/PLR021]; Ooi N, 1989, J PHYTOGEOGRAPHY TAX, V37, P37; PIRY S, 1999, J HERED, V90, P499; Pritchard JK, 2009, DOCUMENTATIONS STRUC; Tagawa H, 1973, REPORTS EBINO BIOL L, V1, P73; Takahara H, 1998, VEGETATION HIST JAPA, P114; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; TSUKADA M, 1982, ECOLOGY, V63, P1091, DOI 10.2307/1937247; TSUKADA M, 1983, QUATERNARY RES, V19, P212, DOI 10.1016/0033-5894(83)90006-6; TSUKADA M, 1984, Japanese Journal of Ecology, V34, P203; Tsumura Y, 2007, GENETICS, V176, P2393, DOI 10.1534/genetics.107.072652; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Widmer A, 2001, TRENDS ECOL EVOL, V16, P267, DOI 10.1016/S0169-5347(01)02163-2; Yumoto T., 1987, Ecological Research, V2, P133, DOI 10.1007/BF02346922	57	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					709	720		10.1007/s10265-014-0650-2		12	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900005		
J	Hasegawa, A; Oyanagi, T; Minagawa, R; Fujii, Y; Sasamoto, H				Hasegawa, Ai; Oyanagi, Tomoya; Minagawa, Reiko; Fujii, Yoshiharu; Sasamoto, Hamako			An inverse relationship between allelopathic activity and salt tolerance in suspension cultures of three mangrove species, Sonneratia alba, S. caseolaris and S. ovata: development of a bioassay method for allelopathy, the protoplast co-culture method	JOURNAL OF PLANT RESEARCH			English	Article						Allelopathy; Bioassay; Mangrove forest; Protoplast culture; Salt tolerance; Suspension culture	GROWTH; CELLS	A bioassay method for allelopathy, the 'protoplast co-culture method' was developed to study the relationship between salt tolerance and allelopathy of three mangrove species, Sonneratia alba, S. caseolaris, and S. ovata. Plants of S. alba grow in the seaward-side high salinity region and plants of the latter two species grow in upstream-side regions of a mangrove forest, respectively. Effects of five sea salts (NaCl, KCl, MgCl2, MgSO4 and CaCl2) on the growth of the suspension cells of the latter two species were first investigated by a small-scale method using 24-well culture plates. S. ovata cells showed higher tolerance than S. caseolaris cells to NaCl and other salts, but were not as halophilic as S. alba cells. Protoplasts isolated from suspension cells were co-cultured with lettuce protoplasts in Murashige and Skoog's (MS) basal medium containing 1 mu M 2,4-dichlorophenoxyacetic acid, 0.1 mu M benzyladenine, 3 % sucrose and 0.6-0.8 M os-moticum. S. caseolaris protoplasts had a higher inhibitory effect on lettuce protoplast cell divisions than S. alba protoplasts at any lettuce protoplast density, and the effect of S. ovata was intermediate between the two. These results were similar to those obtained from a different in vitro bioassay method for allelopathy, the 'sandwich method' with dried leaves. The inverse relationship between allelopathic activity and salt tolerance in suspension cells of Sonneratia mangroves is discussed.	[Hasegawa, Ai; Oyanagi, Tomoya] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Minagawa, Reiko] Tokyo Univ Agr, Tokyo 1568502, Japan; [Fujii, Yoshiharu] Tokyo Univ Agr & Technol, Tokyo 1838509, Japan; [Sasamoto, Hamako] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Sasamoto, H (reprint author), Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan.	sasamoto@ynu.ac.jp	FUJII, Yoshiharu/C-8800-2013	FUJII, Yoshiharu/0000-0002-5412-395X			Sasamoto H, 2014, PHYTOCHEM LETT, V7, P38, DOI 10.1016/j.phytol.2013.09.008; Wu SB, 2009, BIOCHEM SYST ECOL, V37, P1, DOI 10.1016/j.bse.2009.01.002; Chou CH, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P1, DOI 10.1007/1-4020-4280-9_1; Duke NC, 1992, COASTAL ESTUARINE ST, P63; Fujii Yoshiharu, 2003, Weed Biology and Management, V3, P233, DOI 10.1046/j.1444-6162.2003.00111.x; Fujii Yoshiharu, 2004, Weed Biology and Management, V4, P19, DOI 10.1111/j.1445-6664.2003.00113.x; Fujii Y, 2003, BIOL SCI SPACE, V17, P1; Fukumoto T, 2004, PLANT BIOTECHNOL, V21, P177, DOI 10.5511/plantbiotechnology.21.177; Hasegawa A, 2012, P 18 ANN M JAP MANGR, P18; Hasegawa A, 2013, PLANT BIOTECHNOL REP, V7, P205, DOI 10.1007/s11816-012-0251-2; Hasegawa A, 2011, P 75 ANN M BOT SOC J, P219; Hayashi S, 2009, PLANT BIOTECHNOL, V26, P561, DOI 10.5511/plantbiotechnology.26.561; Kawana Y, 2008, PLANT BIOTECHNOL, V25, P151, DOI 10.5511/plantbiotechnology.25.151; Kawana Y, 2009, MANGROVE SCI, V6, P9; Kawana Y, 2007, PLANT BIOTECHNOL REP, V1, P219, DOI 10.1007/s11816-007-0035-2; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Sasamoto H., 2013, Journal of Plant Studies, V2, P71; Spalding M., 2010, WORLD ATLAS MANGROVE; Tomlinson PB, 1986, BOT MANGROVES; Xin K, 2013, J TROP FOR SCI, V25, P70; Yamamoto R, 2009, MANGROVE SCI, V6, P1	21	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					755	761		10.1007/s10265-014-0651-1		7	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900009		
J	Katsuhara, M; Tsuji, N; Shibasaka, M; Panda, SK				Katsuhara, Maki; Tsuji, Nobuya; Shibasaka, Mineo; Panda, Sanjib Kumar			Osmotic stress decreases PIP aquaporin transcripts in barley roots but H2O2 is not involved in this process	JOURNAL OF PLANT RESEARCH			English	Article						Barley; H2O2; Osmotic stress; PIP aquaporin; Salt stress	WATER TRANSPORT; PLANT AQUAPORINS; PLASMA-MEMBRANE; SALINITY; CHANNELS; MECHANISMS; TOLERANCE; PROTEINS	Previous reports indicate that salt stress reduces the root hydraulic conductance and the expression of plasmamembrane-type aquaporins (PIPs). As a molecular mechanism for this phenomenon, the present study found evidence that the osmotic component, but probably not an ion-specific component, decreases PIP transcripts. Eight of ten PIP transcripts were reduced to less than half by 360 mM mannitol treatment for 12 h in comparison with control samples. A large decrease of HvPIP2; 1 protein was also recorded. This reduction of both transcripts and proteins of HvPIP2s should be physiologically effective for preventing or reducing dehydration at an initial phase of severe salt/osmotic stress. Root cell sap osmolality increased from 278 to 372 mOsm 24 h after 360 mM mannitol treatment. These steps can secure survival and growth recovery with water reabsorption in barley. Our data also suggest that H2O2 seems not to be the main cause of osmotic stress-induced transcriptional down-regulation within the concentrations (20-500 mu M) and time periods (24 h) examined, although H2O2 was previously proposed to be involved in the mechanisms of salinity/osmotic tolerance.	[Katsuhara, Maki; Tsuji, Nobuya; Shibasaka, Mineo] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Panda, Sanjib Kumar] Assam Univ, Dept Life Sci & Bioinformat, Plant Mol Biotechnol Lab, Silchar 788011, India; [Panda, Sanjib Kumar] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Katsuhara, M (reprint author), Okayama Univ, Inst Plant Sci & Resources, 20-1,Chuo 2 Chome, Kurashiki, Okayama 7100046, Japan.	kmaki@rib.okayama-u.ac.jp		Panda, Sanjib/0000-0001-5131-9693	Program for Promotion of Basic Research Activities for Innovative Biosciences	The present work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences to M.K.	Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Benabdellah K, 2009, PLANT MOL BIOL, V70, P647, DOI 10.1007/s11103-009-9497-7; Pongprayoon W, 2013, PLANT GROWTH REGUL, V70, P159, DOI 10.1007/s10725-013-9789-4; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Suga S, 2001, PLANTA, V212, P294, DOI 10.1007/s004250000396; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Fedina IS, 2009, BIOL PLANTARUM, V53, P321, DOI 10.1007/s10535-009-0058-3; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Katsuhara M, 2008, FUNCT PLANT BIOL, V35, P1, DOI 10.1071/FP07130; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Rhee JY, 2007, PHYSIOL PLANTARUM, V130, P177, DOI 10.1111/j.1399-3054.2007.00895.x; Shibasaka M, 2012, PLANT SIG BEHAV, V7, P1842; Tsuchihira A, 2010, TREE PHYSIOL, V30, P413	21	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2014	127	6					787	792		10.1007/s10265-014-0662-y		6	Plant Sciences	Plant Sciences	AS8EM	WOS:000344482900012		
J	Okayama, A; Miyagi, Y; Oshita, F; Nishi, M; Nakamura, Y; Nagashima, Y; Akimoto, K; Ryo, A; Hirano, H				Okayama, Akiko; Miyagi, Yohei; Oshita, Fumihiro; Nishi, Mayuko; Nakamura, Yoshiyasu; Nagashima, Yoji; Akimoto, Kazunori; Ryo, Akihide; Hirano, Hisashi			Proteomic Analysis of Proteins Related to Prognosis of Lung Adenocarcinoma	JOURNAL OF PROTEOME RESEARCH			English	Article						lung adenocarcinoma; prognosis-related protein; shotgun LC-MS/MS analysis; label-free protein relative quantification; laser capture microdissection (LCM); 14-3-3 beta/alpha; calnexin	QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; CANCER TISSUES; ALPHA-CATENIN; CELLS; 14-3-3-PROTEINS; ASSOCIATION; EXPRESSION; BIOMARKERS; CALNEXIN	We attempted to identify prognosis-related proteins expressed in early resection lung adenocarcinomas that had higher metastatic potential. Early resection of lung adenocarcinoma tissues were collected from patients who experienced recurrence within 5 years after surgery; these patients are defined here as the poor prognosis group. From these samples, we prepared frozen tissue sections and then isolated cancerous areas by laser capture microdissection to allow extraction of cancer tissue-derived soluble proteins. Shotgun LC-MS/MS analysis detected and identified a total of 875 proteins in these cancer tissues. Relative quantitative analysis revealed that 17 proteins were preferentially expressed in the poor prognosis group relative to the good prognosis group, which consisted of patients who did not exhibit recurrence. Among them, 14-3-3 beta/alpha and calnexin were reported to be potentially involved in tumor recurrence and the malignant properties of lung cancer. Here immunological analyses confirmed disease-associated expression of these proteins. In a cell-culture model using A549, targeted depletion of either 14-3-3 beta/alpha or calnexin reduced proliferation, invasion, and migration, suggesting that both proteins are involved in determining the malignant properties of lung cancer that contribute to poor prognosis.	[Okayama, Akiko; Hirano, Hisashi] Yokohama City Univ, Grad Sch Med Life Sci, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Okayama, Akiko; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Miyagi, Yohei; Oshita, Fumihiro; Nakamura, Yoshiyasu] Kanagawa Canc Ctr, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Nishi, Mayuko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nagashima, Yoji] Yokohama City Univ, Grad Sch Med, Dept Mol Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Akimoto, Kazunori] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Med Sci, Noda, Chiba 2788510, Japan	Ryo, A (reprint author), Yokohama City Univ, Grad Sch Med, Dept Microbiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp; hirano@yokohama-cu.ac.jp			Special Coordination Funds for Promoting Science and Technology "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" in "Project for Developing Innovation Systems"	This work was partially supported by Special Coordination Funds for Promoting Science and Technology "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" in "Project for Developing Innovation Systems".	BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Jhaveri K, 2012, CLIN CANCER RES, V18, P5090, DOI 10.1158/1078-0432.CCR-11-3200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; PALLAS DC, 1994, SCIENCE, V265, P535, DOI 10.1126/science.8036498; Kuramitsu Y, 2006, PROTEOMICS, V6, P5650, DOI 10.1002/pmic.200600218; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Naruke T, 2001, ANN THORAC SURG, V71, P1759, DOI 10.1016/S0003-4975(00)02609-6; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Kondo T, 2002, LUNG CANCER-J IASLC, V36, P49, DOI 10.1016/S0169-5002(01)00448-2; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Ha ES, 2013, CLIN BIOCHEM, V46, P369, DOI 10.1016/j.clinbiochem.2012.11.014; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Safadi Rima A, 2010, Head Neck Pathol, V4, P282, DOI 10.1007/s12105-010-0210-6; Tanaka Y, 2006, PROTEOMICS, V6, P4845, DOI 10.1002/pmic.200500774	31	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2014	13	11					4686	4694		10.1021/pr4012969		9	Biochemical Research Methods	Biochemistry & Molecular Biology	AT0PA	WOS:000344636500019		
J	Hirao, Y; Matsuzaki, H; Iwaki, J; Kuno, A; Kaji, H; Ohkura, T; Togayachi, A; Abe, M; Nomura, M; Noguchi, M; Ikehara, Y; Narimatsu, H				Hirao, Yoshitoshi; Matsuzaki, Hideki; Iwaki, Jun; Kuno, Atsushi; Kaji, Hiroyuki; Ohkura, Takashi; Togayachi, Akira; Abe, Minako; Nomura, Masaharu; Noguchi, Masayuki; Ikehara, Yuzuru; Narimatsu, Hisashi			Glycoproteomics Approach for Identifying Glycobiomarker Candidate Molecules for Tissue Type Classification of Non-small Cell Lung Carcinoma	JOURNAL OF PROTEOME RESEARCH			English	Article						Biomarker; glycoproteomics; glycosylation; lectin microarray; lung cancer; tissue	WISTERIA-FLORIBUNDA AGGLUTININ; MONOCLONAL-ANTIBODY FDC-6; LECTIN MICROARRAY; HEPATOCELLULAR-CARCINOMA; PROTEOMIC ANALYSIS; CANCER BIOMARKERS; MASS-SPECTROMETRY; AFFINITY CAPTURE; GLYCO-ALTERATION; IDENTIFICATION	Histopathological classification of lung cancer has important implications in the application of clinical practice guidelines and the prediction of patient prognosis. Thus, we focused on discovering glycobiomarker candidates to classify the types of lung cancer tissue. First, we performed lectin microarray analysis of lung cancer tissue specimens and cell lines and identified Aleuria aurantia lectin (AAL), Hippeastrum hybrid lectin (HHL), and Concanavalia ensiformis agglutinin (ConA) as lectin probes specific to non-small cell lung carcinoma (NSCLC). LC-MS-based analysis was performed for the comprehensive identification of glycoproteins and N-linked glycosylation sites using lectin affinity capture of NSCLC-specific glycoforms of glycoproteins. This analysis identified 1092 AAL-bound glycoproteins (316 gene symbols) and 948 HHL/ConA-bound glycoproteins (279 gene symbols). The lectin microarray-assisted verification using 15 lung cancer cell lines revealed the NSCLC-specific expression of fibronectin. The glycosylation profiling of fibronectin indicated that the peanut agglutinin (PNA) signal appeared to differentiate two NSCLC types, adenocarcinoma and large cell carcinoma, whereas the protein expression level was similar between these types. Our glycoproteomics approach together with the concurrent use of an antibody and lectin is applicable to the quantitative and qualitative monitoring of variations in glycosylation of fibronectin specific to certain types of lung cancer tissue.	[Hirao, Yoshitoshi; Matsuzaki, Hideki; Iwaki, Jun; Kuno, Atsushi; Kaji, Hiroyuki; Ohkura, Takashi; Togayachi, Akira; Abe, Minako; Ikehara, Yuzuru; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan; [Nomura, Masaharu] Tokyo Med Univ, Dept Surg 1, Shinjuku Ku, Tokyo 1600023, Japan; [Noguchi, Masayuki] Univ Tsukuba, Graduated Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan	Narimatsu, H (reprint author), Natl Inst Adv Ind Sci & Technol, RCMG, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp			"Medical Glycomics: MG Project" of the New Energy and Industrial Technology Development Organization (NEDO) in Japan	This work was supported by a "Medical Glycomics: MG Project" of the New Energy and Industrial Technology Development Organization (NEDO) in Japan. The authors thank M. Sogabe, Y. Tsunoda, and T. Nakagawa for technical assistance. We also thank A. Takahashi for assistance in the preparation of the manuscript.	Abbott KL, 2010, METHOD ENZYMOL, V480, P461, DOI 10.1016/S0076-6879(10)80020-5; Ueda K, 2010, MOL CELL PROTEOMICS, V9, P1819, DOI 10.1074/mcp.2010/000893; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Dai Z, 2009, ELECTROPHORESIS, V30, P2957, DOI 10.1002/elps.200900064; Tsai HY, 2011, PROTEOMICS, V11, P2162, DOI 10.1002/pmic.201000319; Rothenberg ML, 2001, ONCOLOGIST, V6, P66, DOI 10.1634/theoncologist.6-1-66; Arnold JN, 2011, J PROTEOME RES, V10, P1755, DOI 10.1021/pr101034t; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Chapman S, 2002, BIOINFORMATICS, V18, P202, DOI 10.1093/bioinformatics/18.1.202; Sogabe M, 2014, J PROTEOME RES, V13, P1624, DOI 10.1021/pr401109n; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kuno A, 2009, MOL CELL PROTEOMICS, V8, P99, DOI 10.1074/mcp.M800308-MCP200; Kameyama A, 2005, ANAL CHEM, V77, P4719, DOI 10.1021/ac048350h; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Ueda K, 2007, J PROTEOME RES, V6, P3475, DOI 10.1021/pr070103h; SINGHAL A, 1990, BIOESSAYS, V12, P223, DOI 10.1002/bies.950120506; Kuno A, 2011, CLIN CHEM, V57, P48, DOI 10.1373/clinchem.2010.151340; Han JY, 2003, LUNG CANCER-J IASLC, V41, P65, DOI 10.1016/S0169-5002(03)00146-6; Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Matsuda A, 2013, J PROTEOMICS, V85, P1, DOI 10.1016/j.jprot.2013.04.017; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Ito H, 2007, NAT METHODS, V4, P577, DOI 10.1038/NMETH1050; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Ocho M, 2014, J PROTEOME RES, V13, P1428, DOI 10.1021/pr400986t; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Patwa T, 2010, MASS SPECTROM REV, V29, P830, DOI 10.1002/mas.20269; Sung HJ, 2008, BMB REP, V41, P615; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; Kaji H, 2013, J PROTEOME RES, V12, P2630, DOI 10.1021/pr301217b; Narimatsu H, 2010, FEBS J, V277, P95, DOI 10.1111/j.1742-4658.2009.07430.x; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Li QK, 2012, PROTEOM CLIN APPL, V6, P244, DOI 10.1002/prca.201100042; Hoagland LFM, 2007, CANCER, V110, P2260, DOI 10.1002/cncr.23049; DENNIS JW, 1989, CANCER CELL-MON REV, V1, P87; GIACCONE G, 1992, CANCER RES, V52, pS2732; Han SW, 2004, INT J CANCER, V111, P322, DOI 10.1002/ijc.20281; Horynova MS, 2013, CELL MOL LIFE SCI, V70, P829, DOI 10.1007/s00018-012-1082-6; Jakowlew SB, 1997, BBA-GENE STRUCT EXPR, V1353, P157, DOI 10.1016/S0167-4781(97)00068-7; Kuno A, 2010, METHOD ENZYMOL, V478, P165, DOI 10.1016/S0076-6879(10)78007-1; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Matsuda A, 2008, BIOCHEM BIOPH RES CO, V370, P259, DOI 10.1016/j.bbrc.2008.03.090; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; MATSUURA H, 1985, P NATL ACAD SCI USA, V82, P6517, DOI 10.1073/pnas.82.19.6517; Mechref Y, 2012, BIOANALYSIS, V4, P2457, DOI [10.4155/bio.12.246, 10.4155/BIO2.246]; MIYAKE M, 1988, CANCER RES, V48, P7150; PLEBANI M, 1995, BRIT J CANCER, V72, P170, DOI 10.1038/bjc.1995.296; RINDERLE SJ, 1989, J BIOL CHEM, V264, P16123; Shiota T, 1989, Nihon Gan Chiryo Gakkai Shi, V24, P1067; Tan B., 2013, MOL BIOSYST, V10, P201	56	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2014	13	11					4705	4716		10.1021/pr5006668		12	Biochemical Research Methods	Biochemistry & Molecular Biology	AT0PA	WOS:000344636500021		
J	Taoka, M; Morofuji, N; Yamauchi, Y; Ojima, H; Kubota, D; Terukina, G; Nobe, Y; Nakayama, H; Takahashi, N; Kosuge, T; Isobe, T; Kondo, T				Taoka, Masato; Morofuji, Noriaki; Yamauchi, Yoshio; Ojima, Hidenori; Kubota, Daisuke; Terukina, Goro; Nobe, Yuko; Nakayama, Hiroshi; Takahashi, Nobuhiro; Kosuge, Tomoo; Isobe, Toshiaki; Kondo, Tadashi			Global PROTOMAP Profiling to Search for Biomarkers of Early-Recurrent Hepatocellular Carcinoma	JOURNAL OF PROTEOME RESEARCH			English	Article						hepatocellular carcinoma; biomarker; PROTOMAP; proteomics; mass spectrometry	GENE-EXPRESSION; MICROVASCULAR INVASION; LIVER-TRANSPLANTATION; DECREASED EXPRESSION; TUMOR RECURRENCE; DOWN-REGULATION; POOR-PROGNOSIS; CANCER; PROTEASES; RESECTION	This study used global protein expression profiling to search for biomarkers to predict early recurrent hepatocellular carcinoma (HCC). HCC tissues surgically resected from patients with or without recurrence within 2 years (early recurrent) after surgery were compared with adjacent nontumor tissue and with normal liver tissue. We used the PROTOMAP strategy for comparative profiling, which integrates denaturing polyacrylamide gel electrophoresis migratory rates and high-resolution, semiquantitative mass-spectrometry-based identification of in-gel-digested tryptic peptides. PROTOMAP allows examination of global changes in the size, topography, and abundance of proteins in complex tissue samples. This approach identified 8438 unique proteins from 45 708 nonredundant peptides and generated a proteome-wide map of changes in expression and proteolytic events potentially induced by intrinsic apoptotic/necrotic pathways. In the early recurrent HCC tissue, 87 proteins were differentially expressed (>= 20-fold) relative to the other tissues, 46 of which were up-regulated or specifically proteolyzed and 41 of which were down-regulated. This data set consisted of proteins that fell into various functional categories, including signal transduction and cell organization and, notably, the major catalytic pathways responsible for liver function, such as the urea cycle and detoxification metabolism. We found that aberrant proteolysis appeared to occur frequently during recurrence of HCC in several key signal transducers, including STAT1 and delta-catenin. Further investigation of these proteins will facilitate the development of novel clinical applications.	[Taoka, Masato; Yamauchi, Yoshio; Terukina, Goro; Nobe, Yuko; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Morofuji, Noriaki; Kubota, Daisuke; Kondo, Tadashi] Natl Canc Ctr, Res Inst, Div Pharmacoprote, Tokyo 1040045, Japan; [Ojima, Hidenori] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan; [Nakayama, Hiroshi] RIKEN, Adv Sci Inst, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Takahashi, Nobuhiro] Tokyo Univ Agr & Technol, United Grad Sch Agr, Dept Biotechnol, Fuchu, Tokyo 1838509, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo 1040045, Japan	Isobe, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	isobe-toshiaki@tmu.ac.jp; takondo@ncc.go.jp	TAKAHASHI, Nobuhiro/G-1129-2013		Tokyo Metropolitan Government	This work was supported by a grant for Advanced Scientific Research from the Tokyo Metropolitan Government.	Abiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069578; Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Taoka M, 2000, ELECTROPHORESIS, V21, P1872, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1872::AID-ELPS1872>3.0.CO;2-#; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Ho JC, 2004, INT J CANCER, V111, P494, DOI 10.1002/ijc.20282; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Liu ZH, 2011, OMICS, V15, P61, DOI 10.1089/omi.2010.0061; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Sigruener A, 2007, HORM METAB RES, V39, P781, DOI 10.1055/s-2007-992129; Torbenson M, 2002, MODERN PATHOL, V15, P826, DOI 10.1097/01.MP.0000024257.83046.7C; Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884; Menke A, 2012, ARCH BIOCHEM BIOPHYS, V524, P48, DOI 10.1016/j.abb.2012.04.019; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Wei RR, 2012, MED ONCOL, V29, P2737, DOI 10.1007/s12032-011-0126-3; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Butler SL, 2008, LAB INVEST, V88, P78, DOI 10.1038/labinvest.3700699; Yokota S, 2001, CELL STRESS CHAPERON, V6, P345, DOI 10.1379/1466-1268(2001)006<0345:IEOCCC>2.0.CO;2; Matsui S, 1997, J HEPATOL, V27, P843, DOI 10.1016/S0168-8278(97)80322-4; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; SATO K, 1992, MOL CELL BIOL, V12, P2525; Abdel-Rahman HM, 2004, BIOL CHEM, V385, P1035, DOI 10.1515/BC.2004.134; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Streckfus C, 2000, CANCER INVEST, V18, P101, DOI 10.3109/07357900009038240; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; Qiu WH, 2003, AM J PATHOL, V162, P1961, DOI 10.1016/S0002-9440(10)64329-5; Luk JM, 2006, PROTEOMICS, V6, P1049, DOI 10.1002/pmic.200500306; Shinkawa T, 2005, J PROTEOME RES, V4, P1826, DOI 10.1021/pr050167x; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Cardona DM, 2009, AM J CLIN PATHOL, V132, P877, DOI 10.1309/AJCP74XGRFWTFLJU; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chen X. L., 2011, MOL MED REP, V3, P589; Chen XQ, 2012, MED ONCOL, V29, P1843, DOI 10.1007/s12032-011-0075-x; CORROCHER R, 1986, CANCER, V58, P1658, DOI 10.1002/1097-0142(19861015)58:8<1658::AID-CNCR2820580814>3.0.CO;2-7; Du Y, 2012, WORLD J GASTROENTERO, V18, P3941, DOI 10.3748/wjg.v18.i30.3941; Dudek K, 2009, TRANSPL P, V41, P3135, DOI 10.1016/j.transproceed.2009.08.016; Haglund C, 1997, BRIT J CANCER, V76, P777, DOI 10.1038/bjc.1997.461; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; Matos JM, 2009, J SURG RES, V155, P237, DOI 10.1016/j.jss.2008.06.008; Mazzoferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Ngoka LCM, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-29; Nisman B, 2008, BRIT J CANCER, V98, P77, DOI 10.1038/sj.bjc.6604157; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Shen CP, 2012, PROTEOMICS, V12, P1917, DOI 10.1002/pmic.201200027; SUN Y, 1993, CARCINOGENESIS, V14, P1457, DOI 10.1093/carcin/14.7.1457; Taoka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp732; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; Volkmann M, 2001, J MOL MED-JMM, V79, P594, DOI 10.1007/s001090100244; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	62	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2014	13	11					4847	4858		10.1021/pr500262p		12	Biochemical Research Methods	Biochemistry & Molecular Biology	AT0PA	WOS:000344636500032		
J	Azuma, K; Serada, S; Takamatsu, S; Terao, N; Takeishi, S; Kamada, Y; Naka, T; Miyoshi, E				Azuma, Kanako; Serada, Satoshi; Takamatsu, Shinji; Terao, Naoko; Takeishi, Shunsaku; Kamada, Yoshihiro; Naka, Tetsuji; Miyoshi, Eiji			Identification of Sialylated Glycoproteins in Doxorubicin-Treated Hepatoma Cells with Glycoproteomic Analyses	JOURNAL OF PROTEOME RESEARCH			English	Article						sialylation; cancer stem cells; doxorubicin; hepatoma; glycoproteomics	CANCER STEM-CELLS; HUMAN LIVER-CANCER; BREAST-CANCER; SURFACE SIALYLATION; ALPHA-2-HS GLYCOPROTEIN; PANCREATIC-CANCER; SIALIC-ACID; EXPRESSION; RESISTANCE; PROTEINS	Sialylation is one of the most important types of glycosylation involved in carcinogenesis and establishment of cancer stemness. We previously showed that increased sialylation is a characteristic glycan change in cancer stem cells (CSCs) from hepatocellular carcinoma. However, the identities of glycoproteins targeted for sialylation remain unknown. In the present study, we identified glycoproteins targeted for sialylation in doxorubicin (DXR)-treated hepatocarcinoma cell line, Huh7, using glycoproteomic analyses. Since CSCs constitute a small subset of cells within carcinoma cell lines, it is difficult to identify sialylated proteins using general glycoproteomic strategies. It is known that treatment with anticancer drug can condense CSCs, we used DXR to concentrate CSCs. In DXR-treated Huh7 cells, isobaric tag for relative and absolute quantitation (iTRAQ) analysis identified 17 sialylated glycoproteins. Most of the identified glycoproteins were cancer-associated proteins. Furthermore, two proteins of approximately 70 kDa were detected using Sambucus sieboldoana agglutinin (SSA) blot analysis and identified as beta-galactosidase and alpha-2-HS-glycoprotein (fetuin-A) by SSA precipitation followed by liquid chromatography-tandem mass spectrometry analyses. Sialylation levels of fetuin-A were increased in DXR-treated Huh7 cell lysates. These changes in sialylation of glycoproteins might be involved in the establishment of cancer stemness.	[Azuma, Kanako; Takamatsu, Shinji; Terao, Naoko; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka 5670085, Japan; [Takeishi, Shunsaku] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gastroenterol & Oncol, Tokushima 7700855, Japan	Miyoshi, E (reprint author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [21249038]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by a Grant-in-Aid for Scientific Research (A), No. 21249038, from the Japan Society for the Promotion of Science, and partially supported as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan.	Allies L. E., 2007, CURR OPIN BIOTECH, V18, P460; Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Babal P, 2006, ACTA HISTOCHEM, V108, P133, DOI 10.1016/j.acthis.2006.03.003; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Baumann M, 2009, INT J RADIAT BIOL, V85, P391, DOI 10.1080/09553000902836404; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Taniguchi N, 2001, PROTEOMICS, V1, P239; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Akar U, 2008, AUTOPHAGY, V4, P669; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; von Mach T, 2014, BIOCHEM J, V457, P107, DOI 10.1042/BJ20130933; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; EDGE ASB, 1987, J BIOL CHEM, V262, P16135; FOGEL M, 1983, J EXP MED, V157, P371, DOI 10.1084/jem.157.1.371; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; HAYASE T, 1992, BIOCHEMISTRY-US, V31, P4915, DOI 10.1021/bi00135a024; He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x; INOHARA H, 1994, BIOCHEM BIOPH RES CO, V201, P1366, DOI 10.1006/bbrc.1994.1854; Kojima K, 2003, GASTROENTEROLOGY, V124, P1395, DOI 10.1016/S0016-5085(03)00215-4; Kuwamoto K, 2010, MOL MED REP, V3, P651, DOI 10.3892/mmr_00000311; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Mertins SD, 2014, ANTI-CANCER DRUG, V25, P353, DOI 10.1097/CAD.0000000000000075; Moriwaki K, 2011, CANCER SCI, V102, P1164, DOI 10.1111/j.1349-7006.2011.01923.x; OHNISHI T, 1993, J BONE MINER RES, V8, P367; PASSANITI A, 1988, J BIOL CHEM, V263, P7591; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Serada S, 2007, PROTEOM CLIN APPL, V1, P185, DOI 10.1002/prca.200600497; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; Wang H, 2012, CURR MOL MED, V12, P625	47	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2014	13	11					4869	4877		10.1021/pr5004399		9	Biochemical Research Methods	Biochemistry & Molecular Biology	AT0PA	WOS:000344636500034		
J	Kimura, A; Arakawa, N; Hirano, H				Kimura, Ayuko; Arakawa, Noriaki; Hirano, Hisashi			Mass Spectrometric Analysis of the Phosphorylation Levels of the SWI/SNF Chromatin Remodeling/Tumor Suppressor Proteins ARID1A and Brg1 in Ovarian Clear Cell Adenocarcinoma Cell Lines	JOURNAL OF PROTEOME RESEARCH			English	Article						phosphorylation; ovarian cancer; clear cell adenocarcinoma; multiple reaction monitoring; ARID1A; Brg1	LARGE GENE LISTS; BREAST-CANCER; TUMOR-SUPPRESSOR; CARCINOMA; IDENTIFICATION; RESISTANCE; MUTATIONS; PHOSPHOPROTEOMICS; QUANTIFICATION; MECHANISMS	Protein phosphorylation is one of the major factors involved in tumor progression and malignancy. We performed exploratory studies aimed at identifying phosphoproteins characteristic to cell lines derived from ovarian clear cell adenocarcinoma (CCA), a highly malignant type of ovarian cancer. Comparative phosphoproteome analysis revealed that the phosphopeptides of five SWI/SNF chromatin remodeling/tumor suppressor components, including ARID1A and BRG1, were significantly down-regulated in CCA cells. We then quantitatively determined the phosphorylation levels of ARID1A and BRG1 by immunoprecipitationmultiple reaction monitoring (IPMRM) that we used for analysis of the cognate phospho- and nonphosphopeptides of low-abundance proteins. The phosphorylation level of Brg1 at Ser1452 was down-regulated in CCA cells, whereas the phosphorylation level of ARID1A at Ser696 did not significantly differ between CCA and non-CCA cells. These results were consistent with the results of immunoblotting showing that Brg1 levels were comparable, but ARID1A levels were lower, in CCA cells relative to non-CCA cells. This is the first report to demonstrate reduced phosphorylation of Brg1 in CCA-derived cells. Our data also indicated that the IPMRM/MS method we used is a powerful tool for validation of the phosphoproteins detected by shotgun analysis of phosphopeptides.	[Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2360004, Japan	Hirano, H (reprint author), Yokohama City Univ, Adv Med Res Ctr, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	hirano@yokohama-cu.ac.jp	Kimura, Ayuko/M-4027-2015	Kimura, Ayuko/0000-0003-1315-1118	Special Coordination Fund for Promoting Science and Technology "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas"; JSPS KAKENHI [25840039]	This work was partially supported by Special Coordination Fund for Promoting Science and Technology "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" (to H.H.) and by JSPS KAKENHI Grant Number 25840039 (to A.K.). We thank Kazunori Sakai, Ayako Nomura, Akiko Okayama, and Yoko Ino for their technical assistance with the MS analysis and Tosifusa Toda, Takao Kawakami, and Yayoi Kimura for useful discussions.	Anglesio MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072162; Arakawa N, 2013, J PROTEOME RES, V12, P4340, DOI 10.1021/pr400282j; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Lam MPY, 2012, J PROTEOMICS, V75, P4602, DOI 10.1016/j.jprot.2012.02.014; Zhang GL, 2011, J PROTEOME RES, V10, P305, DOI 10.1021/pr1006203; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Tan DSP, 2007, J CLIN PATHOL, V60, P355, DOI 10.1136/jcp.2006.040030; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Tan DSP, 2013, BRIT J CANCER, V108, P1553, DOI 10.1038/bjc.2013.126; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Harsha HC, 2010, MOL ONCOL, V4, P482, DOI 10.1016/j.molonc.2010.09.004; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Domanski D, 2010, ANAL CHEM, V82, P5610, DOI 10.1021/ac1005553; Itamochi H, 2002, JPN J CANCER RES, V93, P723; Liu XQ, 2013, METHODS, V61, P304, DOI 10.1016/j.ymeth.2013.03.006; Eissler CL, 2011, ANAL BIOCHEM, V418, P267, DOI 10.1016/j.ab.2011.07.015; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Itamochi H, 2002, ONCOLOGY-BASEL, V62, P349, DOI 10.1159/000065067; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Chou M. F., 2011, CURR PROTOC BIOINFOR, P15; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Hahn B, 2013, J PROTEOME RES, V12, P637, DOI 10.1021/pr3007232; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin LL, 2010, J PROTEOME RES, V9, P2752, DOI 10.1021/pr100024a; Kuyama H, 2003, RAPID COMMUN MASS SP, V17, P1493, DOI 10.1002/rcm.1078; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Ohta I, 2001, CANCER LETT, V162, P39, DOI 10.1016/S0304-3835(00)00605-4; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119	42	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2014	13	11					4959	4969		10.1021/pr500470h		11	Biochemical Research Methods	Biochemistry & Molecular Biology	AT0PA	WOS:000344636500042		
J	Okubo, T; Picard, PM; Thisse, JF				Okubo, Toshihiro; Picard, Pierre M.; Thisse, Jacques-Francois			ON THE IMPACT OF COMPETITION ON TRADE AND FIRM LOCATION	JOURNAL OF REGIONAL SCIENCE			English	Article							NONTRADED GOODS; MARKET-SIZE; ENTRY	We study how the level of trade costs and the intensity of competition interact to explain the nature and intensity of trade within a given industry and the location of firms across countries. As trade costs decrease from very high to very low values, the global economy moves from autarky to two-way trade, through one-way trade from the larger to the smaller region. By exploring the intensive and extensive margins of exports, we investigate how the intensity of trade reacts to the degree of competitiveness. Furthermore, when firms are free to change location, they flow from the small to the large country, and the larger country is always a net exported on the manufactured good. Firms located in the big country have a bigger size than those located in the small one. Under one-way trade, the relocation of firms changes their attitude toward export.	[Okubo, Toshihiro] Keio Univ, Minato Ku, Tokyo, Japan; [Picard, Pierre M.] Univ Luxembourg, CREA, L-1511 Luxembourg, Luxembourg; [Picard, Pierre M.; Thisse, Jacques-Francois] Catholic Univ Louvain, Ctr Operat Res & Econometr, B-1348 Louvain La Neuve, Belgium; [Thisse, Jacques-Francois] Univ Luxembourg, L-1511 Luxembourg, Luxembourg; [Thisse, Jacques-Francois] Ctr Econ & Policy Res, Washington, DC USA	Okubo, T (reprint author), Keio Univ, Minato Ku, 2-15-45 Mita, Tokyo, Japan.	okubo@econ.keio.ac.jp; pierre.picard@uni.lu; jacques.thisse@uclouvain.be					Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Baldwin R, 2011, AM ECON J-MICROECON, V3, P60, DOI 10.1257/mic.3.2.60; Picard PM, 2012, REG SCI URBAN ECON, V42, P961, DOI 10.1016/j.regsciurbeco.2012.05.001; Okubo T, 2010, J INT ECON, V82, P230, DOI 10.1016/j.jinteco.2010.07.003; Behrens K, 2005, REG SCI URBAN ECON, V35, P471, DOI 10.1016/j.regsciurbeco.2004.06.002; Melitz MJ, 2008, REV ECON STUD, V75, P295, DOI 10.1111/j.1467-937X.2007.00463.x; Disdier AC, 2008, REV ECON STAT, V90, P37, DOI 10.1162/rest.90.1.37; Behrens K, 2005, J URBAN ECON, V58, P24, DOI 10.1016/j.jue.2005.01.002; Chen N, 2009, J INT ECON, V77, P50, DOI 10.1016/j.jinteco.2008.10.003; Behrens K, 2004, J URBAN ECON, V55, P68, DOI 10.1016/j.jue.2003.06.003; BRESNAHAN TF, 1991, J POLIT ECON, V99, P977, DOI 10.1086/261786; Helpman E, 2008, Q J ECON, V123, P441, DOI 10.1162/qjec.2008.123.2.441; Irarrazabal A., 2013, 19236 NBER; Manning, 2010, J ECON GEOGR, V10, P1717; MARTIN P, 1995, J INT ECON, V39, P335, DOI 10.1016/0022-1996(95)01376-6; Nocke V, 2006, J EUR ECON ASSOC, V4, P929, DOI 10.1162/JEEA.2006.4.5.929; Ottaviano Gianmarco, 2004, HDB REGIONAL URBAN E, V4, P2563; WEINSTEIN DE, 1992, J INT ECON, V32, P379, DOI 10.1016/0022-1996(92)90027-H	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4146	1467-9787		J REGIONAL SCI	J. Reg. Sci.	NOV	2014	54	5					731	754		10.1111/jors.12139		24	Economics; Environmental Studies; Planning & Development	Business & Economics; Environmental Sciences & Ecology; Public Administration	AS9IJ	WOS:000344556200001		
J	Berliant, M; Tabuchi, T				Berliant, Marcus; Tabuchi, Takatoshi			LOCAL POLITICS AND ECONOMIC GEOGRAPHY: INFORMATION AGGREGATION AND POLARIZATION	JOURNAL OF REGIONAL SCIENCE			English	Article							EQUILIBRIUM	We consider information aggregation in national and local elections when voters are mobile and might sort themselves into local districts. Using a standard model of private information for voters in elections in combination with a new economic geography model, agglomeration occurs for economic reasons, whereas voter stratification occurs due to political preferences. When trade is more costly, people tend to agglomerate for economic reasons, resulting in full information equivalence in the political sector. Under free trade, people sort themselves into districts, most of which are polarized, resulting in no full information equivalence in these districts.	[Berliant, Marcus] Washington Univ, Dept Econ, St Louis, MO 63130 USA; [Tabuchi, Takatoshi] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Berliant, M (reprint author), Washington Univ, Dept Econ, Campus Box 1208,1 Brookings Dr, St Louis, MO 63130 USA.	berliant@artsci.wustl.edu; ttabuchi@e.u-tokyo.ac.jp					Epple D, 1998, J URBAN ECON, V43, P23, DOI 10.1006/juec.1996.2030; Ago T, 2006, ANN REGIONAL SCI, V40, P819, DOI 10.1007/s00168-005-0030-x; Feddersen T, 1997, ECONOMETRICA, V65, P1029, DOI 10.2307/2171878; Kim S, 2012, J REGIONAL SCI, V52, P10, DOI 10.1111/j.1467-9787.2011.00751.x; Auffhammer M, 2009, J REGIONAL SCI, V49, P243, DOI 10.1111/j.1467-9787.2008.00583.x; AustenSmith D, 1996, AM POLIT SCI REV, V90, P34, DOI 10.2307/2082796; BENDER B, 1989, J REGIONAL SCI, V29, P29, DOI 10.1111/j.1467-9787.1989.tb01220.x; Bosker M, 2010, J ECON GEOGR, V10, P793, DOI 10.1093/jeg/lbq003; Castanheira M, 2003, J EUR ECON ASSOC, V1, P1207, DOI 10.1162/154247603770383424; COUCH JF, 1992, PUBLIC CHOICE, V73, P135, DOI 10.1007/BF00145088; Davis Donald R., 1998, AM ECON REV, V88, P1264; Hildenbrand W., 1974, CORE EQUILIBRIA LARG; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Maug E, 2002, AM ECON REV, V92, P1448, DOI 10.1257/000282802762024584; Tabuchi T, 2004, J REGIONAL SCI, V44, P641, DOI 10.1111/j.0022-4146.2004.00352.x	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4146	1467-9787		J REGIONAL SCI	J. Reg. Sci.	NOV	2014	54	5					806	827		10.1111/jors.12118		22	Economics; Environmental Studies; Planning & Development	Business & Economics; Environmental Sciences & Ecology; Public Administration	AS9IJ	WOS:000344556200004		
J	Shimizu, M; Nakagishi, Y; Yoshida, A; Yachie, A				Shimizu, Masaki; Nakagishi, Yasuo; Yoshida, Akira; Yachie, Akihiro			Serum Interleukin 18 as a Diagnostic Remission Criterion in Systemic Juvenile Idiopathic Arthritis	JOURNAL OF RHEUMATOLOGY			English	Letter							MACROPHAGE ACTIVATION SYNDROME; SELECT CATEGORIES; CYTOKINE PROFILES; DISEASE; TOCILIZUMAB		[Shimizu, Masaki; Yachie, Akihiro] Kanazawa Univ, Dept Pediat, Sch Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9208641, Japan; [Nakagishi, Yasuo] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Rheumatol, Kobe, Hyogo, Japan; [Yoshida, Akira] Japanese Red Cross Wakayama Med Ctr, Dept Pediat, Wakayama, Japan	Shimizu, M (reprint author), Kanazawa Univ, Dept Pediat, Sch Med, Inst Med Pharmaceut & Hlth Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp	Yachie, Akihiro/C-4660-2015				Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Shimizu M, 2013, CYTOKINE, V61, P345, DOI 10.1016/j.cyto.2012.11.025; Shimizu M, 2012, CYTOKINE, V58, P287, DOI 10.1016/j.cyto.2012.02.006; Shimizu M, 2012, CLIN IMMUNOL, V143, P273, DOI 10.1016/j.clim.2012.03.004; Wallace CA, 2011, ARTHRIT CARE RES, V63, P929, DOI 10.1002/acr.20497	7	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	NOV	2014	41	11					2328	+		10.3899/jrheum.140025		3	Rheumatology	Rheumatology	AT0AI	WOS:000344598900040		
J	Takada, Y; Matsuo, H; Nakayama, A; Sakiyama, M; Hishida, A; Okada, R; Sakurai, Y; Shimizu, T; Ichida, K; Shinomiya, N				Takada, Yuzo; Matsuo, Hirotaka; Nakayama, Akiyoshi; Sakiyama, Masayuki; Hishida, Asahi; Okada, Rieko; Sakurai, Yutaka; Shimizu, Toru; Ichida, Kimiyoshi; Shinomiya, Nariyoshi			Common Variant of PDZK1, Adaptor Protein Gene of Urate Transporters, is Not Associated with Gout	JOURNAL OF RHEUMATOLOGY			English	Letter							SUSCEPTIBILITY; INSIGHTS		[Takada, Yuzo] Natl Def Med Coll, Cent Res Inst, Tokorozawa, Saitama 3598513, Japan; [Matsuo, Hirotaka; Nakayama, Akiyoshi; Sakiyama, Masayuki; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 3598513, Japan; [Hishida, Asahi; Okada, Rieko] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Sakurai, Yutaka] Natl Def Med Coll, Dept Prevent Med & Publ Hlth, Tokorozawa, Saitama 3598513, Japan; [Shimizu, Toru] Midorigaoka Hosp, Osaka, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo, Japan; [Ichida, Kimiyoshi] Jikei Univ, Sch Med, Div Kidney & Hypertens, Dept Internal Med, Tokyo, Japan	Matsuo, H (reprint author), Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	hmatsuo@ndmc.ac.jp					Sakiyama M, 2014, HUM CELL, V27, P1, DOI 10.1007/s13577-013-0081-8; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; [Anonymous], 2009, PLOS GENET, V5; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Shimizu T, 2011, DRUG METAB DISPOS, V39, P2148, DOI 10.1124/dmd.111.040295; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Ichida K, 2009, GENOME MED, V1, DOI 10.1186/gm118; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakayama A, 2013, HUM CELL, V26, P133, DOI 10.1007/s13577-013-0073-8; Sakiyama M, 2014, DRUG METAB PHARMACOK, V29, P208, DOI 10.2133/dmpk.DMPK-13-NT-070	11	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	NOV	2014	41	11					2330	2331		10.3899/jrheum.140573		2	Rheumatology	Rheumatology	AT0AI	WOS:000344598900041		
J	Zhou, L; Qi, W; Xu, C; Makino, T; Yuan, D				Zhou, Lei; Qi, Wen; Xu, Cong; Makino, Toshiaki; Yuan, Dan			A rapid method for simultaneous determination of 52 marker compounds in Xiao-Qing-Long-Tang by ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry	JOURNAL OF SEPARATION SCIENCE			English	Article						Mass spectrometry; Quantification; Traditional Chinese medicine; Ultra high performance liquid chromatography; Xiao-Qing-Long-Tang	CHEMICAL-CONSTITUENTS; AIRWAY INFLAMMATION; KAMPO MEDICINES; EPHEDRINE; MODEL	Xiao-Qing-Long-Tang (XQLT) is a classical Chinese medicine formula. It is generally used for the treatment of common cold, bronchial asthma, and allergic rhinitis in Asia. In this study, a multicomponent quantification fingerprinting approach based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry has been developed for the analysis of compounds in XQLT in 14.5 min. A total of 52 compounds were identified by co-chromatography of sample extract with authentic standards and comparing the retention time, UV spectra, molecular ions and characteristic fragment ions with those of authentic standards, or tentatively identified by MSE determination along with Mass Fragment software. Moreover, the method was validated for the simultaneous quantification of 16 components in XQLT commercial products. The method is practical for comprehensive standardization of XQLT and holistic comparison of its commercial products from different manufacturers.	[Zhou, Lei; Qi, Wen; Xu, Cong; Yuan, Dan] Shenyang Pharmaceut Univ, Dept Tradit Chinese Med, Shenyang 110016, Peoples R China; [Makino, Toshiaki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Nagoya, Aichi, Japan	Yuan, D (reprint author), Shenyang Pharmaceut Univ, Dept Tradit Chinese Med, Shenyang 110016, Peoples R China.	yuandan_kampo@163.com			National Science and Technology Support Program during the Twelfth Five-Year Plan the Ministry of Science and Technology of the People's Republic of China [2011BAI03B05]; Distinguished Professor Foundation from Liaoning Province China; Innovative Drug Incubation Base Plan Project from Liaoning Province, China [2013226027]	This work was supported by the National Science and Technology Support Program during the Twelfth Five-Year Plan the Ministry of Science and Technology of the People's Republic of China (2011BAI03B05), the Distinguished Professor Foundation in 2011 from Liaoning Province China, and Innovative Drug Incubation Base Plan Project in 2013 from Liaoning Province, China (2013226027).	Wang SD, 2012, J ETHNOPHARMACOL, V142, P531, DOI 10.1016/j.jep.2012.05.033; Lou ZY, 2009, RAPID COMMUN MASS SP, V23, P831, DOI 10.1002/rcm.3931; Xie YY, 2012, J AGR FOOD CHEM, V60, P12574, DOI 10.1021/jf304080v; Yan Y, 2013, J PHARMACEUT BIOMED, V80, P192, DOI 10.1016/j.jpba.2013.03.008; Okamura N, 1999, J PHARMACEUT BIOMED, V20, P363, DOI 10.1016/S0731-7085(99)00065-5; Lu J, 2013, CHEM PHARM BULL, V61, P941; Marchei E, 2006, J PHARMACEUT BIOMED, V41, P1633, DOI 10.1016/j.jpba.2006.02.043; Ye M, 2007, RAPID COMMUN MASS SP, V21, P3593, DOI 10.1002/rcm.2832; Nagai T, 2004, INT IMMUNOPHARMACOL, V4, P1353, DOI 10.1016/j.intimp.2004.05.021; Liang XM, 2009, J CHROMATOGR A, V1216, P2033, DOI 10.1016/j.chroma.2008.07.026; Jiang DX, 2011, J ETHNOPHARMACOL, V137, P914, DOI 10.1016/j.jep.2011.07.020; Xiao S, 2014, J PHARMACEUT BIOMED, V92, P82, DOI 10.1016/j.jpba.2013.12.042; Bensky D., 1990, FORMULAS STRATEGIES; Byun J. S., 2011, J ETHNOPHARMACOL, V113, P642; Chang JS, 2013, J ETHNOPHARMACOL, V147, P481, DOI 10.1016/j.jep.2013.03.044; Chen P, 2006, J CHROMATOGR B, V843, P183, DOI 10.1016/j.jchromb.2006.05.028; Chinese Pharmacopoeia Committee, 2010, CHINESE PHARMACOPOEI, VI; Gao X, 2014, J SEP SCI, V37, P53, DOI 10.1002/jssc.201300969; He XG, 1998, J CHROMATOGR A, V796, P327, DOI 10.1016/S0021-9673(97)01013-3; Japanese Pharmacopeia Commission, 2012, JAP PHARM; Musso L, 2010, CHEM BIODIVERS, V7, P887, DOI 10.1002/cbdv.200900263; Okamura N, 1999, J PHARMACEUT BIOMED, V19, P603, DOI 10.1016/S0731-7085(98)00262-3; Wang P, 2013, J SEP SCI, V36, P3511, DOI 10.1002/jssc.201300742; YASUDA I, 1981, CHEM PHARM BULL, V29, P564; Zhang J. S., 1989, Acta Pharmaceutica Sinica, V24, P865; Zhuo RJ, 2013, ANAL METHODS-UK, V5, P2046, DOI 10.1039/c3ay26501c	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	NOV	2014	37	22					3260	3267		10.1002/jssc.201400669		8	Chemistry, Analytical	Chemistry	AT2YH	WOS:000344799900008		
J	Mercer, JA; Applequist, BC; Masumoto, K				Mercer, John A.; Applequist, Bryon C.; Masumoto, Kenji			Muscle Activity During Running With Different Body-Weight-Support Mechanisms: Aquatic Environment Versus Body-Weight-Support Treadmill	JOURNAL OF SPORT REHABILITATION			English	Article						overuse injuries; rehabilitation; cross-training	GROUND REACTION FORCES; WATER; RUNNERS; INJURIES; PARAMETERS; STYLES	Background: Body-weight (BW) support during running can be accomplished using deep-water running (DWR; 100% BW support) and a lower-body positive-pressure (LBPP) treadmill. Purpose: To compare lower-extremity muscle activity during DWR and running on an LBPP treadmill at matched stride frequency. Methods: Eight subjects (40 +/- 6.5 y, 173 +/- 7.2 cm, 66.9 +/- 11.7 kg) completed 4 running conditions all at a preferred stride frequency that was determined while running with no support. Two conditions were running on the LBPP treadmill at 60% and 80% of BW, and the other 2 conditions were different DWR styles: high knee (DWR-HK) and cross-country (DWR-CC). Average (AVG) and root-mean-square (RMS) electromyography (rectus femoris, biceps femoris, gastrocnemius, and tibialis anterior) were each compared among conditions (repeated-measures analysis of variance). Results: Results for AVG and RMS variables were identical for statistical tests for each muscle. Rectus femoris electromyography during DWR-HK was lower than that of DWR-CC (P < .05) but not different than either 60% BW or 80% BW (P > .05). Biceps femoris electromyography was less during DWR-HK than DWR-CC (P < .05) but greater during DWR-HK than either BW 60% or BW 80% (P < .05). Neither gastrocnemius nor tibialis anterior electromyography differed between conditions (P > .05). Conclusion: Neither the mechanism of BW support nor style of DWR influenced gastrocnemius or tibialis anterior muscle activity during running at the same stride frequency. However, rectus femoris and biceps femoris muscle activity were influenced by not only the mechanism of BW support but also the style of DWR.	[Mercer, John A.; Applequist, Bryon C.] Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA; [Masumoto, Kenji] Fukuoka Prefectural Univ, Fac Integrated Human Studies & Social Sci, Tagawa, Japan	Mercer, JA (reprint author), Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV 89154 USA.	john.mercer@unlv.edu			Japanese Society for the Promotion of Science [22700697]	The lower-body positive-pressure treadmill was provided by Alter-G, Inc. This study was in part supported by a Grant-in-Aid for Young Scientists (B) from the Japanese Society for the Promotion of Science (grant no. 22700697).	Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Mercer JA, 2005, J SPORT SCI MED, V4, P144; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; JACOBS SJ, 1986, AM J SPORT MED, V14, P151, DOI 10.1177/036354658601400211; Grabowski AM, 2008, J APPL BIOMECH, V24, P288; MUNRO CF, 1987, J BIOMECH, V20, P147, DOI 10.1016/0021-9290(87)90306-X; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; MESSIER SP, 1988, MED SCI SPORT EXER, V20, P501; Liebenberg J, 2011, J SPORT SCI, V29, P207, DOI 10.1080/02640414.2010.534806; Reilly T, 2003, J SPORT SCI, V21, P959, DOI 10.1080/02640410310001641368; Masumoto K, 2008, EXERC SPORT SCI REV, V36, P160, DOI 10.1097/JES.0b013e31817bfe73; Gojanovic B, 2012, MED SCI SPORT EXER, V44, P1935, DOI 10.1249/MSS.0b013e31825a5d1f; [Anonymous], 1996, J STRENGTH COND RES; Brown SP, 1997, J STRENGTH COND RES, V11, P107; CASPERSEN CJ, 1984, MED SCI SPORT EXER, V16, P113, DOI 10.1249/00005768-198404000-00050; HAMILL J, 1983, HUM MOVEMENT SCI, V2, P47, DOI 10.1016/0167-9457(83)90005-2; James S L, 1978, Am J Sports Med, V6, P40, DOI 10.1177/036354657800600202; Killgore GL, 2006, J STRENGTH COND RES, V20, P919; Masumoto K, 2013, GAIT POSTURE, V37, P558, DOI 10.1016/j.gaitpost.2012.09.019; Masumoto K, 2009, MED SCI SPORT EXER, V41, P1958, DOI 10.1249/MSS.0b013e3181a615ad; Mercer JA, 2005, AQUATIC FITNESS RES, V2, P9; Mercer JA, 1997, MEASUREMENT PHYS ED, V1, P213, DOI 10.1207/s15327841mpee0104_2; Mercer JA, 1998, J STRENGTH COND RES, V12, P161; Mercer JA, RES SPORTS IN PRESS; WARREN BL, 1987, MED SCI SPORT EXER, V19, P71; WILDER RP, 1993, AM J SPORT MED, V21, P45, DOI 10.1177/036354659302100108	28	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2014	23	4					300	306		10.1123/JSR.2013-0032		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AT2YN	WOS:000344800700004		
J	Sorzano, COS; de la Rosa-Trevin, JM; Tama, F; Jonic, S				Sorzano, Carlos Oscar S.; de la Rosa-Trevin, Jose Miguel; Tama, Florence; Jonic, Slavica			Hybrid Electron Microscopy Normal Mode Analysis graphical interface and protocol	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						Single particle analysis; Normal Mode Analysis; Continuous conformational changes; Structure; Dynamics; Software	FREQUENCY NORMAL-MODES; DENSITY MAPS; UCSF CHIMERA; CRYOELECTRON MICROSCOPY; SINGLE PARTICLES; MACROMOLECULES; DYNAMICS; XMIPP; CLASSIFICATION; TRANSLOCATION	This article presents an integral graphical interface to the Hybrid Electron Microscopy Normal Mode Analysis (HEMNMA) approach that was developed for capturing continuous motions of large macromolecular complexes from single-particle EM images. HEMNMA was shown to be a good approach to analyze multiple conformations of a macromolecular complex but it could not be widely used in the EM field due to a lack of an integral interface. In particular, its use required switching among different software sources as well as selecting modes for image analysis was difficult without the graphical interface. The graphical interface was thus developed to simplify the practical use of HEMNMA. It is implemented in the open-source software package Xmipp 3.1 (http://xmipp.cnb.csic.es) and only a small part of it relies on MATLAB that is accessible through the main interface. Such integration provides the user with an easy way to perform the analysis of macromolecular dynamics and forms a direct connection to the single-particle reconstruction process. A step-by-step HEMNMA protocol with the graphical interface is given in full details in Supplementary material. The graphical interface will be useful to experimentalists who are interested in studies of continuous conformational changes of macromolecular complexes beyond the modeling of continuous heterogeneity in single particle reconstruction. (C) 2014 Elsevier Inc. All rights reserved.	[Sorzano, Carlos Oscar S.; de la Rosa-Trevin, Jose Miguel] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, E-28049 Madrid, Spain; [Tama, Florence] RIKEN, Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Jonic, Slavica] Univ Paris 06, Univ Paris 04, CNRS, IMPMC,MNHN,IRD UMR 206,UMR 7590, F-75005 Paris, France	Jonic, S (reprint author), Univ Paris 06, IMPMC, UMR 7590, Case Courtier 115,4 Pl Jussieu, F-75005 Paris, France.	Slavica.Jonic@impmc.upmc.fr			CNRS (France); CSIC (Spain); French National Research Agency ANR [ANR-11BSV8-010-04]; European Social Fund; Ministerio de Educacion y Ciencia; Spanish Ministry of Economy and Competitiveness [AIC-A-2011-0638, BIO2010-16566]; Comunidad de Madrid [S2010/BMD-2305]; FOCUS	The work was partially funded by the CNRS (France) and the CSIC (Spain) [Projet International de Cooperation Scientifique PICS 2011]; the French National Research Agency ANR [ANR-11BSV8-010-04]; the European Social Fund and the Ministerio de Educacion y Ciencia ["Ramon y Cajal" fellowship to COSS]; the Spanish Ministry of Economy and Competitiveness [AIC-A-2011-0638 and BIO2010-16566]; the Comunidad de Madrid [CAM S2010/BMD-2305]; and FOCUS Establishing Supercomputing Center of Excellence (Japan).	Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tama F, 2002, J MOL BIOL, V321, P297, DOI 10.1016/S0022-2836(02)00627-7; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; DURAND P, 1994, BIOPOLYMERS, V34, P759, DOI 10.1002/bip.360340608; Powell MJD, 2002, MATH PROGRAM, V92, P555, DOI 10.1007/s101070100290; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Tama F, 2000, PROTEINS, V41, P1; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Stember JN, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167410; Tama F, 2004, J MOL BIOL, V337, P985, DOI 10.1016/j.jmb.2004.01.048; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Berghen F. V., 2005, J COMPUTATIONAL APPL, V181, P157; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396; Chacon P, 2003, J MOL BIOL, V326, P485, DOI 10.1016/S0022-2836(02)01426-2; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Eaton J.W., 2009, GNU OCTAVE VERSION 3; Fu J, 2007, J STRUCT BIOL, V157, P226, DOI 10.1016/j.jsb.2006.06.012; Fu J, 2011, P NATL ACAD SCI USA, V108, P4817, DOI 10.1073/pnas.1101503108; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Hsin J., 2008, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi0507s24; Jin QY, 2014, STRUCTURE, V22, P496, DOI 10.1016/j.str.2014.01.004; Jonic S, 2005, ULTRAMICROSCOPY, V103, P303, DOI 10.1016/j.ultramic.2005.02.002; Lehoucq R.B., 1998, ARPACK USERS GUIDE S; Nogales-Cadenas R, 2013, NUCLEIC ACIDS RES, V41, pW363, DOI 10.1093/nar/gkt385; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Sorzano COS, 2004, J STRUCT BIOL, V146, P381, DOI 10.1016/j.jsb.2004.01.006; van der Maaten L.P.J., 2009, DIMENSIONALITY REDUC; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006	39	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	NOV	2014	188	2					134	141		10.1016/j.jsb.2014.09.005		8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AT3MO	WOS:000344839100006		
J	Ogura, T; Yajima, H; Nitta, R; Hirokawa, N; Sato, C				Ogura, Toshihiko; Yajima, Hiroaki; Nitta, Ryo; Hirokawa, Nobutaka; Sato, Chikara			New simulated annealing approach considering helix bending applied to determine the 8.8 angstrom structure of 15-protofilament microtubules	JOURNAL OF STRUCTURAL BIOLOGY			English	Article						alpha- and beta-Tubulin; Single particle analysis; Helical reconstruction; Image analysis; Cryo-electron microscopy	PARTICLE ELECTRON CRYOMICROSCOPY; SPACE RECONSTRUCTION METHOD; CRYOELECTRON MICROSCOPY; CONFORMATIONAL-CHANGES; SURFACE LATTICE; RESOLUTION; TUBULIN; NUCLEOTIDE; ALGORITHM; PROTEINS	The helix is an important motif in biological architectures. The helical structures of nanoscale proteins are principally determined by three-dimensional (3D) reconstruction from electron micrographs. However, bending or distortion of flexible helices and the low contrast of the images recorded by cryo-electron microscopy, prevent the analysis from reaching high resolution. We have developed a novel helical reconstruction method that overcomes these issues, and present the processing of microtubule images to demonstrate its application. Cropping long helical structures into small square pieces allows bending or distortion of the helices to be accounted for. The initial image-frames are automatically positioned assuming perfect helical symmetry. A simulated annealing (SA)-based algorithm is then used to adjust the framing. This is guided by the contrast of 2D averages, which serve as an accuracy index. After the initial 3D reconstruction, the position and orientation of each average image is iteratively adjusted to give the best match between the input average and the reprojection from the reconstruction. Finally, reconstructions from images recorded at different defocus values, are aligned and averaged to compensate the contrast transfer modulation and improve the resolution. The method successfully determined the structure of a 15-protofilament microtubule. The 8.8 angstrom resolution (7.8 angstrom using the 0.143 FSC criterion) attained allows differences between the alpha- and beta- tubulins to be discerned in the absence of a molecular landmark such as microtubule-associated proteins, for the first time by electron microscopy. The SA-based method is applicable to other helical protein complexes and in general to helical structures. (C) 2014 Elsevier Inc. All rights reserved.	[Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Yajima, Hiroaki; Nitta, Ryo; Hirokawa, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Hongo, Tokyo 1130033, Japan; [Yajima, Hiroaki; Nitta, Ryo; Hirokawa, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Mol Struct & Dynam, Hongo, Tokyo 1130033, Japan	Sato, C (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Cent 2, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by KAKENHI Grant-in-Aid for Scientific Research (B) and Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science, Grants from the Ministry of Education, Culture, Sports, Science, and Technology and CREST to T. Ogura and C. Sato and Grants to N. Hirokawa from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid for Specially Promoted Research.	CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Verhey KJ, 2007, CELL CYCLE, V6, P2152; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; AAMODT EJ, 1986, J CELL BIOL, V103, P23, DOI 10.1083/jcb.103.1.23; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; MANDELKOW EM, 1986, J CELL BIOL, V102, P1067, DOI 10.1083/jcb.102.3.1067; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; BLUEMKE DA, 1988, ULTRAMICROSCOPY, V26, P255, DOI 10.1016/0304-3991(88)90226-4; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Burgess S.A., 2000, BIOPHYS J, V78, pLA47; Chretien D, 1996, STRUCTURE, V4, P1031, DOI 10.1016/S0969-2126(96)00110-4; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; KIKKAWA M, 1994, J CELL BIOL, V127, P1965, DOI 10.1083/jcb.127.6.1965; LANGFORD GM, 1980, J CELL BIOL, V87, P521, DOI 10.1083/jcb.87.2.521; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; PIERSON GB, 1978, J CELL BIOL, V76, P223, DOI 10.1083/jcb.76.1.223; Pomfret AJ, 2007, J STRUCT BIOL, V157, P106, DOI 10.1016/j.jsb.2006.05.012; Ramey VH, 2009, J STRUCT BIOL, V167, P97, DOI 10.1016/j.jsb.2009.05.002; Sosa H, 1997, J STRUCT BIOL, V118, P149, DOI 10.1006/jsbi.1997.3851; Wang HW, 2005, J STRUCT BIOL, V149, P65, DOI 10.1016/j.jsb.2004.08.006	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1047-8477	1095-8657		J STRUCT BIOL	J. Struct. Biol.	NOV	2014	188	2					165	176		10.1016/j.jsb.2014.08.009		12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AT3MO	WOS:000344839100009		
J	Koizumi, H; Okazaki, A; Abou Ghantous, M; Tachiki, M				Koizumi, Hiroyasu; Okazaki, Akira; Abou Ghantous, Michel; Tachiki, Masashi			Supercurrent Flow Through the Network of Spin-Vortices in Cuprates	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Cuprate; Spin-vortex; Spin-vortex-induced loop currents	PSEUDOGAP STATE; SUPERCONDUCTORS; PHASE; EXCITATIONS; SYMMETRY; STRIPES	We propose a novel supercurrent generation mechanism in the cuprate. The supercurrent is generated as a collection of the spin-vortex-induced loop currents created with the doped holes at their centers. A quartet of the spin-vortices with width 4a (a is the lattice constant of the CuO2 plane) is the stable unit of the spin-vortices, and an assembly of them creates a network channel for the supercurrent flow. A macroscopic supercurrent flows when they cover the whole CuO2 plane. The Ginzburg-Landau macroscopic wave function formalism is also derived from the present supercurrent generation mechanism.	[Koizumi, Hiroyasu; Okazaki, Akira] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Abou Ghantous, Michel] Texas A&M Univ Qatar, Dept Phys, Doha, Qatar; [Tachiki, Masashi] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Koizumi, H (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.	koizumi@ims.tsukuba.ac.jp					Hashimoto M, 2010, NAT PHYS, V6, P414, DOI 10.1038/NPHYS1632; Bianconi A, 1996, PHYS REV LETT, V76, P3412, DOI 10.1103/PhysRevLett.76.3412; Koizumi H, 2014, J SUPERCOND NOV MAGN, V27, P121, DOI 10.1007/s10948-013-2277-2; Fujita M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104517; Norman MR, 1998, NATURE, V392, P157; EMERY VJ, 1995, NATURE, V374, P434, DOI 10.1038/374434a0; Xu ZA, 2000, NATURE, V406, P486; Xia J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127002; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; ANDERSON PW, 1959, PHYS REV, V115, P2, DOI 10.1103/PhysRev.115.2; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Kohsaka Y, 2012, NAT PHYS, V8, P534, DOI 10.1038/nphys2321; Hidekata R, 2011, J SUPERCOND NOV MAGN, V24, P2253, DOI 10.1007/s10948-011-1194-5; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Miyaki S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.034702; Berry M. V., 1984, SOC PROC ROY LONDO A, V391, P45; Kivelson SA, 2003, REV MOD PHYS, V75, P1201, DOI 10.1103/RevModPhys.75.1201; Koizumi H, 2011, J SUPERCOND NOV MAGN, V24, P1997, DOI 10.1007/s10948-011-1159-8; Koizumi H, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.104704; LONDON F, 1948, PHYS REV, V74, P562, DOI 10.1103/PhysRev.74.562; VERGES JA, 1991, PHYS REV B, V43, P6099, DOI 10.1103/PhysRevB.43.6099; Yamaji K, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.083702	22	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	NOV	2014	27	11					2435	2446		10.1007/s10948-014-2626-9		12	Physics, Applied; Physics, Condensed Matter	Physics	AS9BX	WOS:000344539400006		
J	Ye, JT; Zhang, YJ; Yoshida, M; Saito, Y; Iwasa, Y				Ye, J. T.; Zhang, Y. J.; Yoshida, M.; Saito, Y.; Iwasa, Y.			Field-Induced Superconductivity in MoS2 (Retraction of vol 27, pg 981, 2014)	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Correction									[Ye, J. T.; Zhang, Y. J.; Yoshida, M.; Saito, Y.; Iwasa, Y.] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Ye, J. T.; Zhang, Y. J.; Yoshida, M.; Saito, Y.; Iwasa, Y.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Ye, J. T.] Univ Groningen, Zernike Inst Adv Mat, NL-9700 AE Groningen, Netherlands; [Iwasa, Y.] RIKEN, CERG, Wako, Saitama 3510198, Japan	Ye, JT (reprint author), Univ Groningen, Zernike Inst Adv Mat, Device Phys Complex Mat,Nijenborgh 4, NL-9700 AE Groningen, Netherlands.	j.ye@rug.nl					Ye JT, 2014, J SUPERCOND NOV MAGN, V27, P981, DOI 10.1007/s10948-013-2422-y	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	NOV	2014	27	11					2645	2645		10.1007/s10948-014-2750-6		1	Physics, Applied; Physics, Condensed Matter	Physics	AS9BX	WOS:000344539400033		
J	Komatsuda, T				Komatsuda, Takao			The genetics of inflorescence architecture in Hordeum	JOURNAL OF SYSTEMATICS AND EVOLUTION			English	Review						flower morphology; genomics; plant morphology and anatomy; Poaceae	BARLEY; DOMESTICATION	The barley (Hordeum vulgare) spike exists in two alternative forms: six-rowed or two rowed. The genetic basis of this difference lies in the single gene Vrs1, the recessive allele of which is responsible for the six-rowed phenotype. The gene encodes a homeodomain-leucine zipper I class transcription factor. Its paralog HvHox2 is well conserved among the cereals, whereas Vrs1 acquired its function after the speciation of barley. To determine whether it is the mode of expression or neofunctionalization which accounts for the action of Vrs1, a comparative analysis was carried out between HvHox2 and Vrs1. This revealed that HvHOX2 and VRS1 share the same transcriptional activation activity. In situ hybridization analysis showed that HvHox2 mRNA is concentrated in the vascular bundles of the immature spike, whereas Vrs1 message is deposited exclusively in the pistil, lemma, palea, and lodicule of the lateral spikelets. The transcript abundance of Vrs1 was over 10-fold higher than that of HvHox2 during the pistil developmental stage, suggesting that the key function of Vrs1 is to inhibit gynoecial development. An analysis of six-rowed spike mutants which are non-allelic to vrs1 showed that Vrs1 was up-regulated by Vrs4, whereas HvHox2 expression was not. These data demonstrate that it is most likely a divergence in gene expression which has determined the function of Vrs1.	Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Komatsuda, T (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan.	takao@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [TRG1004]	This work was supported by grants from Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation, Grants No. TRG1004).	Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Sakuma S, 2013, NEW PHYTOL, V197, P939, DOI 10.1111/nph.12068; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Forster BP, 2007, ANN BOT-LONDON, V100, P725, DOI 10.1093/aob/mcm183; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; VEGETTI A, 1995, FLORA, V190, P225	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1674-4918	1759-6831		J SYST EVOL	J. Syst. Evol.	NOV	2014	52	6			SI		779	782		10.1111/jse.12121		4	Plant Sciences	Plant Sciences	AT2RO	WOS:000344782700013		
J	Belalcazar, LM; Anderson, AM; Lang, W; Schwenke, DC; Haffner, SM; Yatsuya, H; Rushing, J; Vitolins, MZ; Reeves, R; Pi-Sunyer, X; Tracy, RP; Ballantyne, CM				Belalcazar, L. Maria; Anderson, Andrea M.; Lang, Wei; Schwenke, Dawn C.; Haffner, Steven M.; Yatsuya, Hiroshi; Rushing, Julia; Vitolins, Mara Z.; Reeves, Rebecca; Pi-Sunyer, Xavier; Tracy, Russell P.; Ballantyne, Christie M.		Look AHEAD Action Hlth Diabetes R	Fiber Intake and Plasminogen Activator Inhibitor-1 in Type 2 Diabetes: Look AHEAD (Action for Health in Diabetes) Trial Findings at Baseline and Year 1	JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS			English	Article						Lifestyle intervention; Weight loss; Cardiovascular disease risk; Fibrinolysis; Obesity	CORONARY-HEART-DISEASE; HUMAN ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; DIETARY FIBER; RISK-FACTORS; WEIGHT-LOSS; MYOCARDIAL-INFARCTION; HEMOSTATIC FACTORS; OVERWEIGHT ADULTS; PREVENTION	Plasminogen activator inhibitor 1 (PAI-1) is elevated in obese individuals with type 2 diabetes and may contribute, independently of traditional factors, to increased cardiovascular disease risk. Fiber intake may decrease PAI-1 levels. We examined the associations of fiber intake and its changes with PAI-1 before and during an intensive lifestyle intervention (ILI) for weight loss in 1,701 Look AHEAD (Action for Health in Diabetes) participants with dietary, fitness, and PAI-1 data at baseline and 1 year. Look AHEAD was a randomized cardiovascular disease trial in 5,145 overweight/obese patients with type 2 diabetes, comparing ILI (goal of >= 7% reduction in baseline weight) with a control arm of diabetes support and education. ILI participants were encouraged to consume vegetables, fruits, and grain products low in sugar and fat. At baseline, median fiber intake was 17.9 g/day. Each 8.3 g/day higher fiber intake was associated with a 9.2% lower PAI-1 level (P = 0.008); this association persisted after weight and fitness adjustments (P = 0.03). Higher baseline intake of fruit (P = 0.019) and high-fiber grain and cereal (P = 0.029) were related to lower PAI-1 levels. Although successful in improving weight and physical fitness at 1 year, the ILI in Look AHEAD resulted in small increases in fiber intake (4.1 g/day, compared with -2.35 g/day with diabetes support and education) that were not related to PAI-1 change (P = 0.34). Only 31.3% of ILI participants (39.8% of women, 19.1% of men) met daily fiber intake recommendations. Increasing fiber intake in overweight/obese individuals with diabetes interested in weight loss is challenging. Future studies evaluating changes in fiber consumption during weight loss interventions are warranted.	[Belalcazar, L. Maria] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Anderson, Andrea M.; Lang, Wei; Rushing, Julia] Wake Forest Univ, Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Vitolins, Mara Z.] Wake Forest Univ, Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Schwenke, Dawn C.] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Haffner, Steven M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Yatsuya, Hiroshi] Fujita Hlth Univ, Dept Publ Hlth, Toyoake, Aichi, Japan; [Reeves, Rebecca; Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Pi-Sunyer, Xavier] Columbia Univ, St Lukes Roosevelt Hosp, Dept Med, New York, NY USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Ballantyne, Christie M.] Methodist Bakey Heart & Vasc Ctr, Ctr Cardiovascular Dis Prevent, Houston, TX USA	Belalcazar, LM (reprint author), Univ Texas Med Branch, Dept Med, Div Endocrinol & Metab, 301 Univ Blvd, Galveston, TX 77555 USA.	lmbelalc@utmb.edu			National Heart, Lung, and Blood Institute [HL090514]; National Institute of Diabetes and Digestive and Kidney Diseases; National, Heart, Lung, and Blood Institute; National Institute of Nursing Research; Office of Research on Women's Health; National Center on Minority Health and Health Disparities; Centers for Disease Control and Prevention	This work was supported by the National Heart, Lung, and Blood Institute (grant no. HL090514 [C. M. Ballantyne and L. M. Belalcazar]). Look AHEAD is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases and cosponsored by the National, Heart, Lung, and Blood Institute, National Institute of Nursing Research, Office of Research on Women's Health, National Center on Minority Health and Health Disparities, and the Centers for Disease Control and Prevention, as detailed below in the Acknowledgements section under the Look AHEAD (Action for Health in Diabetes) Research Group at Year 1. Additional sources of funding for Look AHEAD are also listed in the Acknowledgements section below. clinicaltrials.gov Identifier: NCT00017953.	Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Hu FB, 1999, AM J EPIDEMIOL, V149, P531; King DE, 2012, J ACAD NUTR DIET, V112, P642, DOI 10.1016/j.jand.2012.01.019; JuhanVague I, 1996, CIRCULATION, V94, P2057; Mozaffarian D, 2003, JAMA-J AM MED ASSOC, V289, P1659, DOI 10.1001/jama.289.13.1659; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P162; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; Thogersen AM, 1998, CIRCULATION, V98, P2241; Jenkins DJA, 2002, DIABETES CARE, V25, P1522, DOI 10.2337/diacare.25.9.1522; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Rizkalla SW, 2012, AM J CLIN NUTR, V95, P49, DOI 10.3945/ajcn.111.017277; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998; Belalcazar LM, 2011, ARTERIOSCL THROM VAS, V31, P1689, DOI 10.1161/ATVBAHA.111.224386; Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132; McBane RD, 2010, AM J CARDIOL, V105, P17, DOI 10.1016/j.amjcard.2009.08.643; Morange PE, 1999, ARTERIOSCL THROM VAS, V19, P1361; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Bray G, 2006, DIABETES VASC DIS RE, V3, P202, DOI DOI 10.3132/DVDR.2006.031; Hamalainen H, 2005, DIABETOLOGIA, V48, P2248, DOI 10.1007/s00125-005-1938-5; Institute of Medicine (US), 2005, DIET REF INT EN CARB, P339; Mayer-Davis EJ, 2004, ANN EPIDEMIOL, V14, P763, DOI 10.1016/j.annepidem.2004.02.004; Pietinen P, 1996, CIRCULATION, V94, P2720; Espeland M, 2007, DIABETES CARE, V30, P1374; Raynor HA, 2008, DIABETES CARE, V31, P1299, DOI 10.2337/dc07-2295; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; SUNDELL IB, 1993, HAEMOSTASIS, V23, P45; Turpeinen AM, 2000, EUR J CLIN NUTR, V54, P418, DOI 10.1038/sj.ejcn.1600975; Vitolins MZ, 2009, J AM DIET ASSOC, V109, P1367, DOI 10.1016/j.jada.2009.05.016	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-2672	2212-2680		J ACAD NUTR DIET	J. Acad. Nutr. Diet.	NOV	2014	114	11					1800	+		10.1016/j.jand.2014.06.357		13	Nutrition & Dietetics	Nutrition & Dietetics	AS8CE	WOS:000344477100014		
J	Higgs, ND; Glover, AG; Dahlgren, TG; Smith, CR; Fujiwara, Y; Pradillon, F; Johnson, SB; Vrijenhoek, RC; Little, CTS				Higgs, Nicholas D.; Glover, Adrian G.; Dahlgren, Thomas G.; Smith, Craig R.; Fujiwara, Yoshihiro; Pradillon, Florence; Johnson, Shannon B.; Vrijenhoek, Robert C.; Little, Crispin T. S.			The morphological diversity of Osedax worm borings (Annelida: Siboglinidae)	JOURNAL OF THE MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM			English	Article						bioerosion; deep-sea; whale-fall; Polychaeta; taphonomy; trace fossil; computed tomography	EATING MARINE WORMS; SEA WHALE FALLS; TEMPORAL VARIATION; COMMUNITY ECOLOGY; DWARF MALES; BONE; JAPAN; SPECIALISTS; MUCOFLORIS; BIOEROSION	Marine worms in the genus Osedax, have specialized 'root' tissues used to bore into the bones of decomposing vertebrate skeletons and obtain nutrition. We investigated the borings of nine Osedax species, using micro computed tomography to quantitatively describe the morphology of the borings and provide three-dimensional reconstructions of the space occupied by Osedax root tissues inside the bone. Each Osedax species displayed a consistent boring morphology in any given bone, but these differed between bones. In bones where multiple species coexisted there was limited evidence for spatial niche partitioning by Osedax root tissues inside the bones investigated here. The new morphological data may be applied to Osedax traces in fossil bones, showing that borings can be used to indicate minimum species richness in these bones.	[Higgs, Nicholas D.; Glover, Adrian G.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Higgs, Nicholas D.; Little, Crispin T. S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Dahlgren, Thomas G.] Uni Res, N-5020 Bergen, Norway; [Smith, Craig R.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Fujiwara, Yoshihiro; Pradillon, Florence] Japan Agcy Marine Earth Sci & Technol, Marine Biodivers Res Program, Yokosuka, Kanagawa 2370061, Japan; [Pradillon, Florence] IFREMER, Ctr Brest, Dept Ressources Phys & Ecosyst Fond Mer, F-29280 Plouzane, France; [Johnson, Shannon B.; Vrijenhoek, Robert C.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Higgs, ND (reprint author), Plymouth Univ Drake Circus, Inst Marine, Plymouth PL4 8AA, Devon, England.	nicholas.higgs@plymouth.ac.uk			Natural Environment Research Council UK [NE/G523755/1]; Marine Institute, Plymouth University	This work was funded by a CASE studentship from the Natural Environment Research Council UK (NE/G523755/1) to N.D.H. Writing of the paper was facilitated by a Postdoctoral Research Fellowship to N.D.H. from the Marine Institute, Plymouth University. This is publication no. 9126 from SOEST, University of Hawaii at Manoa. The manuscript was greatly improved by thoughtful comments and suggestions from Robert Boessenecker and an anonymous referee.	Amano K, 2007, PALAEOGEOGR PALAEOCL, V247, P236, DOI 10.1016/j.palaeo.2006.10.017; Tresguerres M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0625; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Katz S, 2010, J MORPHOL, V271, P1272, DOI 10.1002/jmor.10873; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Schuller D, 2004, EARTH PLANET SC LETT, V218, P277, DOI 10.1016/S0012-821X(03)00690-3; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Higgs ND, 2011, BIOL BULL-US, V221, P307; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Rouse GW, 2008, BIOL BULL-US, V214, P67; Glover AG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1390; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Kiel S, 2010, P NATL ACAD SCI USA, V107, P8656, DOI 10.1073/pnas.1002014107; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Vrijenhoek RC, 2008, MOL ECOL, V17, P4535, DOI 10.1111/j.1365-294X.2008.03937.x; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Higgs ND, 2011, P ROY SOC B-BIOL SCI, V278, P9, DOI 10.1098/rspb.2010.1267; Bromley Richard G., 1994, P134; Higgs N.D., 2012, THESIS U LEEDS UK; Higgs ND, 2010, CAH BIOL MAR, V51, P401; Huusgaard RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035975; Jones WJ, 2008, P R SOC B, V275, P387, DOI 10.1098/rspb.2007.1437; Kiel S., 2012, PALAEONTOL Z, V87, P161; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; Pirrone CA, 2014, J PALEONTOL, V88, P195, DOI 10.1666/11-058; Pradillon F., 2009, ABSTRACTS BOOK, P45; Salathe RM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-189; Smith CR, 2002, CAH BIOL MAR, V43, P293; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Vrijenhoek RC, 2008, P ROY SOC B-BIOL SCI, V275, P1963, DOI 10.1098/rspb.2008.0350; Warme J.E., 1975, STUDY TRACE FOSSILS, P181	40	3	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0025-3154	1469-7769		J MAR BIOL ASSOC UK	J. Mar. Biol. Assoc. U.K.	NOV	2014	94	7					1429	1439		10.1017/S0025315414000770		11	Marine & Freshwater Biology	Marine & Freshwater Biology	AS9FI	WOS:000344548100007		
J	Poli, L; Oliveri, G; Ding, PP; Moriyama, T; Massa, A				Poli, Lorenzo; Oliveri, Giacomo; Ding, Ping Ping; Moriyama, Toshifumi; Massa, Andrea			Multifrequency Bayesian compressive sensing methods for microwave imaging	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							INVERSE SCATTERING PROBLEMS; SHAPE RECONSTRUCTION; BURIED OBJECTS; ARRAYS	The Bayesian retrieval of sparse scatterers under multifrequency transverse magnetic illuminations is addressed. Two innovative imaging strategies are formulated to process the spectral content of microwave scattering data according to either a frequency-hopping multistep scheme or a multifrequency one-shot scheme. To solve the associated inverse problems, customized implementations of single-task and multitask Bayesian compressive sensing are introduced. A set of representative numerical results is discussed to assess the effectiveness and the robustness against the noise of the proposed techniques also in comparison with some state-of-the-art deterministic strategies. (C) 2014 Optical Society of America	[Poli, Lorenzo; Oliveri, Giacomo; Massa, Andrea] Univ Trento, Dept Informat Engn & Comp Sci, ELEDIA Res Ctr, I-38123 Trento, Italy; [Ding, Ping Ping] Univ Paris Sud, CNRS, SUPELEC, L2S, F-91192 Gif Sur Yvette, France; [Moriyama, Toshifumi] Nagasaki Univ, Dept Elect & Elect Engn, Nagasaki 8528521, Japan	Massa, A (reprint author), Univ Trento, Dept Informat Engn & Comp Sci, ELEDIA Res Ctr, Via Sommarive 5, I-38123 Trento, Italy.	andrea.massa@unitn.it	Oliveri, Giacomo/F-1030-2011; Massa, Andrea/F-3276-2013	Oliveri, Giacomo/0000-0002-5238-358X; 			Oliveri G, 2011, J OPT SOC AM A, V28, P2057, DOI 10.1364/JOSAA.28.002057; Viani F, 2013, IEEE T ANTENN PROPAG, V61, P4577, DOI 10.1109/TAP.2013.2267195; Johnson JE, 2009, IEEE T BIO-MED ENG, V56, P2232, DOI 10.1109/TBME.2009.2022635; Hassan AM, 2013, IEEE T ANTENN PROPAG, V61, P3765, DOI 10.1109/TAP.2013.2254444; Tijhuis AG, 2001, IEEE T GEOSCI REMOTE, V39, P1316, DOI 10.1109/36.927455; Oliveri G, 2014, IEEE T ANTENN PROPAG, V62, P1681, DOI 10.1109/TAP.2013.2287894; Poli L, 2012, IEEE T ANTENN PROPAG, V60, P2865, DOI 10.1109/TAP.2012.2194676; Ji SH, 2009, IEEE T SIGNAL PROCES, V57, P92, DOI 10.1109/TSP.2008.2005866; Rekanos IT, 1999, IEEE T MED IMAGING, V18, P1108, DOI 10.1109/42.816074; Oliveri G, 2011, IEEE T ANTENN PROPAG, V59, P467, DOI 10.1109/TAP.2010.2096400; Poli L, 2013, IEEE T ANTENN PROPAG, V61, P4722, DOI 10.1109/TAP.2013.2265254; Oliveri G, 2012, IEEE T ANTENN PROPAG, V60, P971, DOI 10.1109/TAP.2011.2173131; Bermani E, 2003, IEEE T GEOSCI REMOTE, V41, P927, DOI 10.1109/TGRS.2003.810928; Lobel P, 1997, INVERSE PROBL, V13, P403, DOI 10.1088/0266-5611/13/2/013; Massa A, 2004, INVERSE PROBL, V20, pS135, DOI 10.1088/0266-5611/20/6/S09; Ji SH, 2008, IEEE T SIGNAL PROCES, V56, P2346, DOI 10.1109/TSP.2007.914345; Oliveri G, 2012, OPT LETT, V37, P1760, DOI 10.1364/OL.37.001760; Poli L, 2013, J OPT SOC AM A, V30, P1261, DOI 10.1364/JOSAA.30.001261; Oliveri G, 2012, IEEE T ANTENN PROPAG, V60, P2309, DOI 10.1109/TAP.2012.2189742; Oliveri G, 2011, IEEE T GEOSCI REMOTE, V49, P3993, DOI 10.1109/TGRS.2011.2128329; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Hagness SC, 2012, IEEE ANTENN WIREL PR, V11, P1592, DOI 10.1109/LAWP.2013.2240569; El-Shenawee M, 2009, IEEE T ANTENN PROPAG, V57, P520, DOI 10.1109/TAP.2008.2011195; Poli L, 2013, IEEE T GEOSCI REMOTE, V51, P2920, DOI 10.1109/TGRS.2012.2218613; CHEW WC, 1995, IEEE MICROW GUIDED W, V5, P439, DOI 10.1109/75.481854; Benedetti M, 2010, IEEE T GEOSCI REMOTE, V48, P2330, DOI 10.1109/TGRS.2009.2039144; Belkebir K, 1997, IEEE T MICROW THEORY, V45, P469, DOI 10.1109/22.566625; Bertero M., 1998, INTRO INVERSE PROBLE; Bucci OM, 2000, IEEE T GEOSCI REMOTE, V38, P1749, DOI 10.1109/36.851974; Carlin M., IEEE T ANTENNAS PROP, V61, P3828; Firoozabadi R., IEEE T GEOSCI REMOTE, V45, P104; Franceschini D, 2007, IEEE T ANTENN PROPAG, V55, P2412, DOI 10.1109/TAP.2007.901909; Haddadin OS, 1998, IEEE T ULTRASON FERR, V45, P1485, DOI 10.1109/58.738288; Johnson J. E., IEEE T BIOMED ENG, V55, P1941; Lasri T., 2001, SUBSURF SENS TECHNOL, V4, P1; Lesselier D., 2002, INVERSE PROBL, V6, P1732; Viani F., MICROW OPT TECHNOL L, V55, P1553	37	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	NOV	2014	31	11					2415	2428		10.1364/JOSAA.31.002415		14	Optics	Optics	AT2RM	WOS:000344782300012		
J	Amemiya, T; Murai, E; Gu, ZC; Nishiyama, N; Arai, S				Amemiya, Tomohiro; Murai, Eijun; Gu, Zhichen; Nishiyama, Nobuhiko; Arai, Shigehisa			GaInAsP/InP-based optical modulator consisting of gap-surface-plasmon-polariton waveguide: theoretical analysis	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							PHOTONIC INTEGRATED-CIRCUITS; OXIDE-FILMS; ON-CHIP; SILICON; INTERCONNECTS; RESONANCE; LASERS	We propose a III-V-based electro-absorption plasmon modulator that can be used to construct fully monolithic plasmonic integrated circuits. Our device consists of a GaInAsP/InP gap-surface-plasmon-polariton waveguide with TiO2/ITO layers on both sides of the InGaAsP core. Using this design, the intensity of transmitted light can be modulated by controlling the carrier concentration of the ITO layer, as a positive gate voltage induces electron accumulation in the ITO layer ( this is similar to the operation of FinFETs). The extinction ratio was 4.5 dB/mu m with a gate voltage swing of 0-5, and the insertion loss was found to be 1.5 dB/mu m. The figure of merit ( ratio of extinction ratio to transmission loss) is 3, a result that is far superior to other conventional Si-based plasmonic photomodulators. (C) 2014 Optical Society of America	[Amemiya, Tomohiro; Arai, Shigehisa] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 1528552, Japan; [Murai, Eijun; Gu, Zhichen; Nishiyama, Nobuhiko; Arai, Shigehisa] Tokyo Inst Technol, Dept Elect & Elect Engn, Meguro Ku, Tokyo 1528552, Japan	Amemiya, T (reprint author), Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	amemiya.t.ab@m.titech.ac.jp	Nishiyama, Nobuhiko/B-9386-2015; Amemiya, Tomohiro/J-7999-2014	Nishiyama, Nobuhiko/0000-0001-8288-6690; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [24246061, 25420321, 25709026]; Konica Minolta Science and Technology Foundation	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI Grant Nos. 24246061, 25420321, and 25709026. One of the authors (T. A.) acknowledges support from the Konica Minolta Science and Technology Foundation.	Takahara J, 1997, OPT LETT, V22, P475, DOI 10.1364/OL.22.000475; Liang D, 2009, APPL PHYS A-MATER, V95, P1045, DOI 10.1007/s00339-009-5118-1; PISARKIEWICZ T, 1989, THIN SOLID FILMS, V174, P217, DOI 10.1016/0040-6090(89)90892-4; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; SOREF RA, 1993, P IEEE, V81, P1687, DOI 10.1109/5.248958; Brehme S, 1999, THIN SOLID FILMS, V342, P167, DOI 10.1016/S0040-6090(98)01490-4; Coldren LA, 2011, J LIGHTWAVE TECHNOL, V29, P554, DOI 10.1109/JLT.2010.2100807; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Rovira PI, 1999, J APPL PHYS, V85, P2015, DOI 10.1063/1.369496; Analui B, 2006, IEEE J SOLID-ST CIRC, V41, P2945, DOI 10.1109/JSSC.2006.884388; Babicheva VE, 2013, OPT EXPRESS, V21, P27326, DOI 10.1364/OE.21.027326; Melikyan A, 2011, OPT EXPRESS, V19, P8855, DOI 10.1364/OE.19.008855; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; SOREF RA, 1987, IEEE J QUANTUM ELECT, V23, P123, DOI 10.1109/JQE.1987.1073206; Nagarajan R, 2005, IEEE J SEL TOP QUANT, V11, P50, DOI 10.1109/JSTQE.2004.841721; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Ellmer K, 2001, J PHYS D APPL PHYS, V34, P3097, DOI 10.1088/0022-3727/34/21/301; Guske JT, 2012, OPT EXPRESS, V20, P23215, DOI 10.1364/OE.20.023215; Roelkens G, 2010, LASER PHOTONICS REV, V4, P751, DOI 10.1002/lpor.200900033; Assefa S., 2011, OPT FIB COMM C NAT F; Ding K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.041301; Hill MT, 2010, J OPT SOC AM B, V27, pB36, DOI 10.1364/JOSAB.27.000B36; Kim JT, 2013, J LIGHTWAVE TECHNOL, V31, P2974, DOI 10.1109/JLT.2013.2276761; Knight M. W., SCIENCE, V332, P702; Melikyan A., 2012, P 14 INT C TRANSP OP; Neutens P., NAT PHOTONICS, V3, P283; Singh V., 2004, J APPL PHYS, V95, P3640; Sorger V. J., 2012, NANOPHOTONICS, V1, P1; Urino Y., 2013, OP FIB COMM C NAT FI; van der Tol J. J. G. M., PROG QUANTUM ELECT, V34, P135; Van Thourhout D, 2010, IEEE J SEL TOP QUANT, V16, P1363, DOI 10.1109/JSTQE.2010.2040711	32	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	NOV	2014	31	11					2908	2913		10.1364/JOSAB.31.002908		6	Optics	Optics	AT2JM	WOS:000344760800059		
J	Suzuki, K; Matsushita, S; Suzuki, H; Kuroda, K; Inaba, H; Arakawa, A; Hayashi, T; Amano, A; Kuwatsuru, R				Suzuki, Kazuhiro; Matsushita, Satoshi; Suzuki, Hiromasa; Kuroda, Kishio; Inaba, Hirotaka; Arakawa, Atsushi; Hayashi, Takuo; Amano, Atsushi; Kuwatsuru, Ryohei			Cystic Tumor of the Atrioventricular Node Computed Tomography and Magnetic Resonance Imaging Findings	JOURNAL OF THORACIC IMAGING			English	Article						cardiac tumor; cystic tumor of the atrioventricular node; computed tomography; magnetic resonance imaging			[Suzuki, Kazuhiro; Kuwatsuru, Ryohei] Juntendo Univ, Dept Radiol, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan; [Matsushita, Satoshi; Kuroda, Kishio; Inaba, Hirotaka; Amano, Atsushi] Juntendo Univ, Dept Cardiovasc Surg, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan; [Suzuki, Hiromasa] Juntendo Univ, Dept Cardiovasc Med, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan; [Arakawa, Atsushi; Hayashi, Takuo] Juntendo Univ, Dept Human Pathol, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan	Suzuki, K (reprint author), Juntendo Univ, Dept Radiol, Fac Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ka-suzz@juntendo.ac.jp					Guo Jialong, 2009, Interact Cardiovasc Thorac Surg, V8, P592, DOI 10.1510/icvts.2008.191866; Kaminishi Yuichiro, 2002, Jpn J Thorac Cardiovasc Surg, V50, P37; Law KB, 2012, CARDIOVASC PATHOL, V21, P120, DOI 10.1016/j.carpath.2011.05.004; Paniagua J R, 2000, Heart, V83, pE6, DOI 10.1136/heart.83.4.e6; Saito S, 2005, CIRC J, V69, P1293, DOI 10.1253/circj.69.1293	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0883-5993	1536-0237		J THORAC IMAG	J. Thorac. Imaging	NOV	2014	29	6					W97	W99				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT0EA	WOS:000344608800004		
J	Terada, A; Higashino, T; Nakahara, Y; Mochizuki, Y; Kobashi, Y				Terada, Akiko; Higashino, Takanori; Nakahara, Yasuharu; Mochizuki, Yoshiro; Kobashi, Yoichiro			Familial Interstitial Pneumonia Complicated by Lung Cancer in 2 Sisters	JOURNAL OF THORACIC IMAGING			English	Article						familial interstitial pneumonia; lung cancer; radiologic-pathologic correlation	IDIOPATHIC PULMONARY-FIBROSIS	A 29-year-old woman was referred to our hospital because of progressive dyspnea on exertion, and her 36-year-old sister was also referred for the evaluation of an abnormal chest radiograph. Radiologic and pathologic findings of the 2 sisters resembled each other closely. In both cases, computed tomography revealed diffuse reticulation, micronodules, diffusely distributed interlobular septal thickening, and an ill-defined nodule in the left lower lobe. Radiologic-pathologic correlation revealed that the reticulation and micronodules corresponded to centrilobular and perilobular fibrosis without architectural lung distortion and that the nodules represented pulmonary adenocarcinoma. To our knowledge, this is the first report of familial interstitial pneumonia complicated by lung cancer in 2 family members, suggesting a possible etiologic association between familial interstitial pneumonia and lung cancer.	[Terada, Akiko; Higashino, Takanori] Natl Hosp Org Himeji Med Ctr, Dept Radiol, Himeji, Hyogo 6700012, Japan; [Nakahara, Yasuharu; Mochizuki, Yoshiro] Natl Hosp Org Himeji Med Ctr, Dept Resp Med, Himeji, Hyogo 6700012, Japan; [Kobashi, Yoichiro] Tenri Hosp, Dept Pathol, Nara, Japan	Terada, A (reprint author), Natl Hosp Org Himeji Med Ctr, Dept Radiol, 68 Honmachi, Himeji, Hyogo 6700012, Japan.	white_sweet_pea109@hotmail.com					Lee HY, 2012, CHEST, V142, P1577, DOI 10.1378/chest.11-2812; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Lee HL, 2005, CHEST, V127, P2034, DOI 10.1378/chest.127.6.2034; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Nishiyama O, 2004, J COMPUT ASSIST TOMO, V28, P443, DOI 10.1097/00004728-200407000-00002	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0883-5993	1536-0237		J THORAC IMAG	J. Thorac. Imaging	NOV	2014	29	6					W94	W96				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT0EA	WOS:000344608800003		
J	Ujita, M; Sato, H; Yamaguchi, M; Toba, K; Kobayashi, H				Ujita, Masuo; Sato, Hideo; Yamaguchi, Misako; Toba, Ken; Kobayashi, Hiroshi			Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue of the Central Bronchi	JOURNAL OF THORACIC IMAGING			English	Article						bronchial neoplasms; mucosa-associated lymphoid tissue lymphoma; computed tomography; immunosuppression	CT FINDINGS		[Ujita, Masuo] Tachikawa Gen Hosp, Dept Radiol, Nagaoka, Niigata 9408621, Japan; [Sato, Hideo; Yamaguchi, Misako] Tachikawa Gen Hosp, Dept Resp Med, Nagaoka, Niigata 9408621, Japan; [Toba, Ken] Tachikawa Gen Hosp, Dept Haematol, Nagaoka, Niigata 9408621, Japan; [Kobayashi, Hiroshi] Tachikawa Gen Hosp, Dept Histopathol, Nagaoka, Niigata 9408621, Japan	Ujita, M (reprint author), Tachikawa Gen Hosp, Dept Radiol, 3-2-11 Kandamachi, Nagaoka, Niigata 9408621, Japan.	m.ujita@jikei.ac.jp					Yoon RG, 2013, KOREAN J RADIOL, V14, P366, DOI 10.3348/kjr.2013.14.2.366; Egashira R, 2013, RADIOGRAPHICS, V33, P1933, DOI 10.1148/rg.337125107; LI W, 1990, CANCER, V66, P894, DOI 10.1002/1097-0142(19900901)66:5<894::AID-CNCR2820660514>3.0.CO;2-W; Prince JS, 2002, RADIOGRAPHICS, V22, pS215; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343; Yamamoto AK, 2012, RADIOLOGY, V264, P609, DOI 10.1148/radiol.12110413	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0883-5993	1536-0237		J THORAC IMAG	J. Thorac. Imaging	NOV	2014	29	6					W91	W93				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT0EA	WOS:000344608800002		
J	Shapiro, AD; Ragni, MV; Kulkarni, R; Oldenberg, J; Srivastava, A; Quon, DV; Pasi, KJ; Hanabusa, H; Pabinger, I; Mahlangu, J; Fogarty, P; Lillicrap, D; Kulke, S; Potts, J; Neelakantan, S; Nestorov, I; Li, S; Dumont, JA; Jiang, H; Brennan, A; Pierce, GF				Shapiro, A. D.; Ragni, M. V.; Kulkarni, R.; Oldenberg, J.; Srivastava, A.; Quon, D. V.; Pasi, K. J.; Hanabusa, H.; Pabinger, I.; Mahlangu, J.; Fogarty, P.; Lillicrap, D.; Kulke, S.; Potts, J.; Neelakantan, S.; Nestorov, I.; Li, S.; Dumont, J. A.; Jiang, H.; Brennan, A.; Pierce, G. F.			Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						drug; administration schedule; factorVIII; hemophiliaA; pharmacokinetics; recombinant fusion proteins	COAGULATION-FACTOR VIII; SEVERE HEMOPHILIA-A; PROPHYLACTIC TREATMENT; BLOOD-GROUP; PROLONGED ACTIVITY; PRACTICE PATTERNS; ON-DEMAND; PHARMACOKINETICS; SAFETY; CARE	BackgroundRoutine prophylaxis with replacement factorVIII (FVIII) - the standard of care for severe hemophiliaA - often requires frequent intravenous infusions (three or four times weekly). An FVIII molecule with an extended half-life could reduce infusion frequency. The A-LONG study established the safety, efficacy and prolonged pharmacokinetics of recombinant FVIII Fc fusion protein (rFVIIIFc) in previously treated adolescents and adults with severe hemophiliaA. ObjectiveIn this posthoc analysis, we investigated the relationship between subjects' prestudy (FVIII) and on-study (rFVIIIFc) regimens. MethodsWe analyzed two subgroups of subjects: prior prophylaxis and on-study individualized prophylaxis (n=80), and prior episodic treatment and on-study weekly prophylaxis (n=16). Subjects' prestudy dosing regimens and bleeding rates were compared with their final rFVIIIFc regimens and annualized bleeding rates (ABRs) in the last 3months on-study. Dosing regimen simulations based on population pharmacokinetics models for rFVIII and rFVIIIFc were performed. ResultsAs compared with their prestudy regimen, 79 of 80 (98.8%) subjects on individualized rFVIIIFc prophylaxis decreased their infusion frequency. Overall ABRs were low, with comparable factor consumption. Longer dosing intervals, including 5-day dosing, were associated with higher baseline von Willebrand factor antigen levels. Simulated dosing regimens predicted a greater proportion of subjects with steady-state FVIII activity trough levels of 1IUdL(-1) (1%) with rFVIIIFc than with equivalent rFVIII regimens. ConclusionThese results suggest that patients on rFVIIIFc prophylaxis can reduce their infusion frequency as compared with their prior FVIII regimen while maintaining low bleeding rates, affording more patients trough levels of 1IUdL(-1) than with rFVIII products requiring more frequent dosing regimens.	[Shapiro, A. D.] Indiana Hemophilia & Thrombosis Ctr, Dept Hematol, Indianapolis, IN USA; [Ragni, M. V.] Univ Pittsburgh, Pittsburgh, PA USA; [Ragni, M. V.] Hemophilia Ctr Western Pennsylvania, Pittsburgh, PA USA; [Kulkarni, R.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Oldenberg, J.] Univ Klinikum Bonn, Inst Expt Haematol & Transfusionsmed, Bonn, Germany; [Srivastava, A.] Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India; [Quon, D. V.] Orthoped Inst Children, Orthoped Hemophilia Treatment Ctr, Los Angeles, CA USA; [Pasi, K. J.] Barts & London Comprehens Care Ctr, London, England; [Hanabusa, H.] Ogikubo Hosp, Dept Hematol, Suginami Ku, Tokyo, Japan; [Pabinger, I.] Med Univ Wien, Univ Klin Innere Med 1, Vienna, Austria; [Mahlangu, J.] Univ Witwatersrand, Haemophilia Comprehens Care Ctr, Fac Hlth Sci, Johannesburg, South Africa; [Mahlangu, J.] NHLS, Johannesburg, South Africa; [Fogarty, P.] Hosp Univ Penn, Penn Comprehens Hemostasis & Thrombosis Program, Philadelphia, PA 19104 USA; [Lillicrap, D.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Kulke, S.; Potts, J.; Neelakantan, S.; Nestorov, I.; Li, S.; Dumont, J. A.; Jiang, H.; Brennan, A.; Pierce, G. F.] Biogen Idec Inc, Cambridge, MA 02142 USA	Pierce, GF (reprint author), Biogen Idec Inc, 225 Binney St, Cambridge, MA 02142 USA.	glennfpierce@gmail.com			Biogen Idec	This study was funded by Biogen Idec. Biogen Idec provided funding for editorial support in the development of this paper. M. E. Carlile Klusacek of Biogen Idec provided writing support based on input from all authors. Biogen Idec reviewed and provided feedback on the paper to the authors. The authors had full editorial control of the paper and gave their final approval of all content.	Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Valentino LA, 2012, J THROMB HAEMOST, V10, P359, DOI 10.1111/j.1538-7836.2011.04611.x; Soucie JM, 2000, BLOOD, V96, P437; Dumont JA, 2012, BLOOD, V119, P3024, DOI 10.1182/blood-2011-08-367813; MATSUI T, 1993, BLOOD, V82, P663; Lalezari S, 2014, HAEMOPHILIA, V20, pE15, DOI 10.1111/hae.12294; Geraghty S, 2006, HAEMOPHILIA, V12, P75, DOI 10.1111/j.1365-2516.2006.01189.x; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; Recht M, 2009, HAEMOPHILIA, V15, P869, DOI 10.1111/j.1365-2516.2009.02027.x; GILL JC, 1987, BLOOD, V69, P1691; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Denis CV, 2001, P NATL ACAD SCI USA, V98, P4072, DOI 10.1073/pnas.061307098; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Ahn JE, 2008, J PHARMACOKINET PHAR, V35, P401, DOI 10.1007/s10928-008-9094-4; Johnson KA, 2011, HEMATOL-AM SOC HEMAT, P413, DOI 10.1182/asheducation-2011.1.413; Fogarty PF, 2011, HEMATOL-AM SOC HEMAT, P397, DOI 10.1182/asheducation-2011.1.397; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Globe DR, 2004, HAEMOPHILIA, V10, P63, DOI 10.1111/j.1355-0691.2004.00881.x; Mannucci PM, 2013, BLOOD, V122, P648, DOI 10.1182/blood-2013-01-479527; Dobrkovska A, 1998, HAEMOPHILIA, V4, P33; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Bjorkman S, 2010, HAEMOPHILIA, V16, P597, DOI 10.1111/j.1365-2516.2009.02191.x; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Goudemand J, 2005, J THROMB HAEMOST, V3, P2219, DOI 10.1111/j.1538-7836.2005.01435.x; Collins PW, 2011, HAEMOPHILIA, V17, P2, DOI 10.1111/j.1365-2516.2010.02370.x; Manco-Johnson MJ, 2013, J THROMB HAEMOST, V11, P1119, DOI 10.1111/jth.12202; Bolon-Larger M, 2007, THER DRUG MONIT, V29, P20, DOI 10.1097/FTD.0b013e3180311384; Carlsson M., 1993, European Journal of Haematology, V51, P247; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Helixate FS, 2013, ANTIHEMOPHILIC FACTO; Ho S, 2014, HAEMOPHILIA, V20, P39, DOI 10.1111/hae.12235; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Mahlangu J, 2013, BLOOD, V123, P317; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Mohlke KL, 1997, J LAB CLIN MED, V130, P252, DOI 10.1016/S0022-2143(97)90019-6; National Hemophilia Foundation, 2007, MED SCI ADV COUNC MA; Neelakantan S, 2013, J THROMB HAEMOST S2, V11; Nestorov I, 2014, CLIN PHARM IN PRESS; Nilsson T, 1976, Wis Med J, V75, pS121; Rath T., 2013, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2013.834293, DOI 10.3109/07388551.2013.834293]; Shapiro AD, 2005, HAEMOPHILIA, V11, P571, DOI 10.1111/j.1365-2516.2005.01149.x; Stass H, 2006, HAEMOPHILIA, V12, P50, DOI 10.1111/j.1365-2516.2006.01334.x; vansBladel ER, 2011, HAEMATOLOGICA, V96, P888; Wang QY, 2013, J THROMB HAEMOST, V11, P261, DOI 10.1111/jth.12093; XYNTHA, 2012, ANT FACT REC PLASM A; Zappa S, 2012, HAEMOPHILIA, V18, pe140, DOI 10.1111/j.1365-2516.2012.02770.x	48	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	NOV	2014	12	11					1788	1800		10.1111/jth.12723		13	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AT1IN	WOS:000344686700004		
J	Ahmed, M; Solbiati, L; Brace, CL; Breen, DJ; Callstrom, MR; Charboneau, JW; Chen, MH; Choi, BI; de Baere, T; Dodd, GD; Gervais, DA; Gianfelice, D; Gillams, AR; Lee, FT; Leen, E; Lencioni, R; Littrup, PJ; Livraghi, T; Lu, DS; McGahan, JP; Meloni, MF; Nikolic, B; Pereira, PL; Liang, P; Rhim, H; Rose, SC; Salem, R; Sofocleous, CT; Solomon, SB; Soulen, MC; Tanaka, M; Vogl, TJ; Wood, BJ; Goldberg, SN				Ahmed, Muneeb; Solbiati, Luigi; Brace, Christopher L.; Breen, David J.; Callstrom, Matthew R.; Charboneau, J. William; Chen, Min-Hua; Choi, Byung Ihn; de Baere, Thierry; Dodd, Gerald D., III; Gervais, Debra A.; Gianfelice, David; Gillams, Alice R.; Lee, Fred T., Jr.; Leen, Edward; Lencioni, Riccardo; Littrup, Peter J.; Livraghi, Tito; Lu, David S.; McGahan, John P.; Meloni, Maria Franca; Nikolic, Boris; Pereira, Philippe L.; Liang, Ping; Rhim, Hyunchul; Rose, Steven C.; Salem, Riad; Sofocleous, Constantinos T.; Solomon, Stephen B.; Soulen, Michael C.; Tanaka, Masatoshi; Vogl, Thomas J.; Wood, Bradford J.; Goldberg, S. Nahum		Int Working Grp Image-Guided Tumor	Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria-A 10-Year Update	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							PERCUTANEOUS RADIOFREQUENCY ABLATION; RENAL-CELL CARCINOMA; VIVO PORCINE LIVER; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; IRREVERSIBLE ELECTROPORATION ABLATION; CONTRAST-ENHANCED ULTRASOUND; INTERNALLY COOLED ELECTRODES; LONG-TERM SURVIVAL; QUALITY-OF-LIFE; HEPATOCELLULAR-CARCINOMA	Image-guided tumor ablation has become a well-established hallmark of local cancer therapy. The breadth of options available in this growing field increases the need for standardization of terminology and reporting criteria to facilitate effective communication of ideas and appropriate comparison among treatments that use different technologies, such as chemical (eg, ethanol or acetic acid) ablation, thermal therapies (eg, radiofrequency, laser, microwave, focused ultrasound, and cryoablation) and newer ablative modalities such as irreversible electroporation. This updated consensus document provides a framework that will facilitate the clearest communication among investigators regarding ablative technologies. An appropriate vehicle is proposed for reporting the various aspects of image-guided ablation therapy including classification of therapies, procedure terms, descriptors of imaging guidance, and terminology for imaging and pathologic findings. Methods are addressed for standardizing reporting of technique, follow-up, complications, and clinical results. As noted in the original document from 2003, adherence to the recommendations will improve the precision of communications in this field, leading to more accurate comparison of technologies and results, and ultimately to improved patient outcomes.	[Ahmed, Muneeb] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Solbiati, Luigi] Osped Generale, Dept Radiol, Busto Arsizio, Italy; [Brace, Christopher L.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brace, Christopher L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI USA; [Brace, Christopher L.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Breen, David J.] Southampton Univ Hosp, Dept Radiol, Southampton, Hants, England; [Callstrom, Matthew R.; Charboneau, J. William] Mayo Clin, Dept Radiol, Rochester, MN USA; [Chen, Min-Hua] Peking Univ, Sch Oncol, Dept Ultrasound, Beijing 100871, Peoples R China; [Choi, Byung Ihn] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [de Baere, Thierry] Inst Cancerol Gustave Roussy, Dept Imaging, Villejuif, France; [Dodd, Gerald D., III] Univ Colorado Anschutz Med Campus, Sch Med, Dept Radiol, Aurora, CO USA; Rhode Isl Hosp, Dept Diagnost Fladiol, Providence, RI USA; [Gervais, Debra A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Gianfelice, David] Univ Hlth Network, Laval, PQ, Canada; [Gillams, Alice R.] London Clin, Dept Imaging, London, England; [Lee, Fred T., Jr.] Univ Wisconsin Hosp & Clin, Dept Radiol, Madison, WI 53792 USA; [Leen, Edward] Royal Infirm, Dept Radiol, Glasgow G31 2ER, Lanark, Scotland; [Lencioni, Riccardo] Univ Pisa, Pisa Univ Hosp, Cisanello Hosp, Dept Diagnost Imaging & Intervent, Pisa, Italy; [Lencioni, Riccardo] Univ Pisa, Sch Med, I-56100 Pisa, Italy; [Littrup, Peter J.] Wayne State Univ, Karmonos Canc Inst, Dept Radiol, Detroit, MI USA; [Lu, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA; [McGahan, John P.] Univ Calif Davis, Med Ctr, Ctr Ambulatory Care, Dept Radiol, Sacramento, CA 95817 USA; [Meloni, Maria Franca] Osped Valduce, Dept Radiol, Como, Italy; [Nikolic, Boris] Albert Einstein Med Ctr, Dept Radiol, Philadelphia, PA 19141 USA; [Pereira, Philippe L.] Heidelberg Univ, Acad Hosp, Clin Radiol Minimally Invas Therapies & Nucl Med, Heilbronn, Germany; [Liang, Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Ultrasound, Beijing, Peoples R China; [Rhim, Hyunchul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Diagnost Radiol, Seoul, South Korea; [Rose, Steven C.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Salem, Riad] Northwestern Univ, Dept Radiol, Chicago, IL USA; [Sofocleous, Constantinos T.; Solomon, Stephen B.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Soulen, Michael C.] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Tanaka, Masatoshi] Yokokura Hosp, Dept Hepatol, Miyama, Japan; [Vogl, Thomas J.] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Diagnost & Intervent Radiol, D-60054 Frankfurt, Germany; [Wood, Bradford J.] NIH, Bethesda, MD 20892 USA; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol ImageGuided Therapy, Jerusalem, Israel; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Intervent Oncol Unit, Jerusalem, Israel	Ahmed, M (reprint author), Beth Israel Deaconess Med Ctr, Dept Radiol, 1 Deaconess Rd,WCC-308B, Boston, MA 02215 USA.	mahmed@bidmc.harvard.edu		Solbiati, Luigi/0000-0002-3109-1449	NeuWave Medical; University of Wisconsin; Galil Medical; Siemens Medical; GE Medical; Thermedical; Samsung Electronics; Terumo; HS-Medical; Boston-Scientific; BSD Medical; Covidien; Covidien/Valleylab; Endocare; Ethicon Endo-Surgery; Philips; Celon Olympus; Siemens Medical Solutions; GE Healthcare; AngioDyamics; Guerbet LLC; BTG; Merit Medical; Sirtex; Cooperative Research and Development Agreement (CRADA) Philips Healthcare; CRADA Biocompatibles BTG; CRADA Perfint; CRADA Celsion; CRADA Invivo; AngioDynamics; Cosman Medical	M.A. No relevant conflicts of interest to disclose. L.S. No relevant conflicts of interest to disclose. C.L.B. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: received consultancy fees from NeuWave Medical, author and institution received payment for patents (planned, pending, or issued) from University of Wisconsin and NeuWave Medical, received payment for stock/stock options from NeuWave Medical Other relationships: none to disclose. D.J.B. Financial activities related to the present article: paid for occasional proctoring by Galli Medical. Financial activities not related to the present article: none to disclose. Other relationships: none to disclose. M.R.C. Financial activities related to the present article: none to disclose. Financial activities not related to the present article. received grants from Galil Medical, Siemens Medical, GE Medical, Thermedical. Other relationships: none to disclose. J.W.C. No relevant conflicts of interest to disclose. M.H.C. No relevant conflicts of interest to disclose. B.I.C. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: institution received a research grant from Samsung Electronics. Other relationships: none to disclose. T.d.B. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: received personal fees from Terumo, a grant from HS-Medical, and payment for travel to a meeting from Boston-Scientific. Other relationships: none to disclose. G.D.D. No relevant conflicts of interest to disclose. D.E.D. Financial activities related to the present article. none to disclose. Financial activities not related to the present article: paid for board membership by BSD Medical, received consultancy fees from BSD Medical and Covidien, received grants or has grants pending from NeuWave Medical, received payment for lectures including service on speakers bureaus from BSD Medical, was paid royalties by Springer Verlag and UpToDate, received stock or stock options from BSD Medical. Other relationships: none to disclose. D.A.G. Financial activities related to the present article: none to disclose. Financial activities not related to the present article. received a research grant from Covidien/Valleylab. Other relationships: none to disclose. D.G. No relevant conflicts of interest to disclose. A.R.G. Financial activities related to the present article: received consulting fee or honorarium from Covidien, received fees for participatient in review activities such as data monitoring boards, statistical analysis, end point committees, and the like from Covidien Financial activities not related to the present article: was paid for board membership, consultancy, and lectures including service on speakers bureaus by Covidien Other relationships: none to disclose. F.T.L. Financial activities related to the present article: received payment from NeuWave Medical. Financial activities not related to the present article: received royalties from Covidien, is a stockholder and on the Board of Directors for NeuWave Medical, has a patent on the Switching Controller with royalties paid from Covidien, has multiple patents on heat-based thermal therapies for microwave ablation systems licensed to NeuWave Medical. Other relationships: none to disclose. E.L. No relevant conflicts of interest to disclose. R.L. No relevant conflicts of interest to disclose. P.J.L.; No relevant conflicts of interest to disclose T.L. No relevant conflicts of interest to disclose. D.S.L. Financial activities related to the present article. none to disclose. Financial activities not related to the present article: institution received grants or has grants pending from Endocare and Ethicon Endo-Surgery, received payment for lectures including service on speakers bureaus from Philips. Other relationships: none to disclose. J.P.M. No relevant conflicts of interest to disclose. M.F.M. No relevant conflicts of interest to disclose. B.N. No relevant conflicts of interest to disclose. P.L.P. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: received a grant from Celon Olympus; fees for conferences from Siemens Medical Solutions; consultant's honoraries from Terumo Europe, Terumo Germany, and Microsulis; materials from AngioDynamics. Other relationships: none to disclose. P.L. No relevant conflicts of interest to disclose. H.R. No relevant conflicts of interest to disclose. S.C.R. No relevant conflicts of interest to disclose. R.S. No relevant conflicts of interest to disclose. C.T.S. No relevant conflicts of interest to disclose. S.B.S. Financial activities related to the present article: institution received a grant from GE Healthcare, author received consulting fee or honorarium from AngioDyamics, Covidien, and GE Healthcare. Financial activities not related to the present article: none to disclose. Other relationships: none to disclose. M.C.S. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: author received consultancy fees from Guerbet LLC, BTG, Merit Medical; institution received grants or has grants pending from Guerbet LLC and BTG; author received payment for lectures including service on speakers bureaus from Sirtex; author received royalties from Cambridge University Press. Other relationships: none to disclose. M.T. No relevant conflicts of interest to disclose. T.J.V. No relevant conflicts of interest to disclose. B.J.W. Financial activities related to the present article: none to disclose. Financial activities not related to the present article: institution received grants or has grants pending from Cooperative Research and Development Agreement (CRADA) Philips Healthcare, CRADA Biocompatibles BTG, CRADA Perfint, CRADA Celsion, CRADA Invivo; the National Institutes of Health has intellectual property in the field. Other relationships: none to disclose. S.N.G. Financial activities related to the present article. institution received a grant for sponsored research from AngioDynamics; author received consulting fee or honorarium from AngioDynamics. Financial activities not related to the present article: author received consultancy fees from Cosman Medical and institution received grants or has grants pending from Cosman Medical. Other relationships: none to disclose.	Motoyoshi A, 2010, J SURG ONCOL, V102, P385, DOI 10.1002/jso.21429; Goldberg SN, 1998, J VASC INTERV RADIOL, V9, P101, DOI 10.1016/S1051-0443(98)70491-9; Laeseke PF, 2006, RADIOLOGY, V241, P116, DOI 10.1148/radiol.2411051271; Callstrom MR, 2013, CANCER-AM CANCER SOC, V119, P1033, DOI 10.1002/cncr.27793; Merckel LG, 2013, CARDIOVASC INTER RAD, V36, P292, DOI 10.1007/s00270-012-0526-6; Goldberg SN, 2000, AM J ROENTGENOL, V174, P323; Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Groeschl RT, 2014, ANN SURG, V259, P1195, DOI 10.1097/SLA.0000000000000234; GUYATT GH, 1993, ANN INTERN MED, V118, P622; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Sainani NI, 2013, AM J ROENTGENOL, V200, P184, DOI 10.2214/AJR.12.8478; Psutka SP, 2013, EUR UROL, V63, P486, DOI 10.1016/j.eururo.2012.08.062; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287; Shock SA, 2004, RADIOLOGY, V231, P143, DOI 10.1148/radiol.2311021342; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Ahmed M, 2012, CHEM PHYS LIPIDS, V165, P424, DOI 10.1016/j.chemphyslip.2011.12.002; Narayanan G, 2012, J VASC INTERV RADIOL, V23, P1613, DOI 10.1016/j.jvir.2012.09.012; Kim YS, 2013, J HEPATOL, V58, P89, DOI 10.1016/j.jhep.2012.09.020; Goldberg SN, 1998, RADIOLOGY, V209, P371; Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Dodd GD, 2000, RADIOGRAPHICS, V20, P9; Tsivian M, 2012, J ENDOUROL, V26, P330, DOI 10.1089/end.2011.0337; Pelayo-Alvarez M, 2013, J PALLIAT MED, V16, P867, DOI 10.1089/jpm.2012.0625; Hamamoto S, 2013, RADIOLOGY, V267, P405, DOI 10.1148/radiol.13120249; Brace CL, 2009, J VASC INTERV RADIOL, V20, P118, DOI 10.1016/j.jvir.2008.09.021; Golberg A, 2013, IEEE T BIO-MED ENG, V60, P707, DOI 10.1109/TBME.2013.2238672; Forner A, 2009, CANCER, V115, P616, DOI 10.1002/cncr.24050; Livraghi T, 2000, RADIOLOGY, V214, P761; Dodd GD, 2001, AM J ROENTGENOL, V177, P777; Kawamoto S, 2009, SEMIN ULTRASOUND CT, V30, P67, DOI 10.1053/j.sult.2008.12.005; Brace CL, 2007, RADIOLOGY, V244, P151, DOI 10.1148/radiol.2441052054; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499; Solomon SB, 2010, RADIOLOGY, V257, P624, DOI 10.1148/radiol.10081490; Abi-Jaoudeh N, 2012, CARDIOVASC INTER RAD, V35, P986, DOI 10.1007/s00270-012-0446-5; Vogl TJ, 2011, RADIOLOGY, V261, P643, DOI 10.1148/radiol.11101643; Vogl TJ, 2014, INVEST RADIOL, V49, P48, DOI 10.1097/RLI.0b013e3182a6094e; Stafford R. Jason, 2010, Critical Reviews in Biomedical Engineering, V38, P79; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Kim YS, 2010, AM J ROENTGENOL, V195, P758, DOI 10.2214/AJR.09.2954; Coad JE, 2003, CLIN TRANSPLANT, V17, P377, DOI 10.1034/j.1399-0012.2003.00062.x; LIVRAGHI T, 1995, RADIOLOGY, V197, P101; Brace Christopher L., 2010, Critical Reviews in Biomedical Engineering, V38, P65; Georgiades C, 2013, CARDIOVASC INTER RAD, V36, P783, DOI 10.1007/s00270-012-0470-5; Wang XD, 2013, CARDIOVASC INTER RAD, V36, P166, DOI 10.1007/s00270-012-0377-1; Laeseke PF, 2009, J VASC INTERV RADIOL, V20, P1224, DOI 10.1016/j.jvir.2009.05.029; Kaufman CS, 2002, AM J SURG, V184, P394, DOI 10.1016/S0002-9610(02)01010-3; Georgiades CS, 2008, J VASC INTERV RADIOL, V19, P1302, DOI 10.1016/j.jvir.2008.05.015; Goldberg SN, 2000, CANCER, V88, P2452, DOI 10.1002/1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3; Mulier S, 2008, ANN SURG ONCOL, V15, P144, DOI 10.1245/s10434-007-9478-5; Grieco CA, 2006, J VASC INTERV RADIOL, V17, P1117, DOI 10.1097/01.RVI.0000228373.58498.6E; Brace CL, 2010, J VASC INTERV RADIOL, V21, P1280, DOI 10.1016/j.jvir.2010.02.038; Alexander ES, 2013, J VASC INTERV RADIOL, V24, P476, DOI 10.1016/j.jvir.2012.12.016; Mendiratta-Lala M, 2011, RADIOLOGY, V258, P308, DOI 10.1148/radiol.10100690; Chen MH, 2007, CLIN RADIOL, V62, P752, DOI 10.1016/j.crad.2006.12.013; Faroja M, 2013, RADIOLOGY, V266, P462, DOI 10.1148/radiol.12120609; Lu DSK, 2002, AM J ROENTGENOL, V178, P47; Solbiati L, 2012, RADIOLOGY, V265, P958, DOI 10.1148/radiol.12111851; Clasen S, 2008, J MAGN RESON IMAGING, V27, P421, DOI 10.1002/jmri.21264; Froeling V, 2013, EUR J RADIOL, V82, P2265, DOI 10.1016/j.ejrad.2013.08.045; Levinson AW, 2008, J UROLOGY, V180, P499, DOI 10.1016/j.juro.2008.04.031; Ben-David E, 2012, AM J ROENTGENOL, V198, pW62, DOI 10.2214/AJR.11.6940; Brace Christopher L, 2009, Curr Probl Diagn Radiol, V38, P135, DOI 10.1067/j.cpradiol.2007.10.001; Cabassa P, 2006, AM J ROENTGENOL, V186, pS316, DOI 10.2214/AJR.05.0243; Callstrom MR, 2009, J VASC INTERV RADIOL, V20, P1527, DOI 10.1016/j.jvir.2009.08.009; Cressman ENK, 2013, INT J HYPERTHER, V29, P71, DOI 10.3109/02656736.2012.756124; Cua IHY, 2007, ONCOLOGY-BASEL, V72, P76, DOI 10.1159/000111711; Dodd GD, 2013, RADIOLOGY, V267, P129, DOI 10.1148/radiol.12120486; Fartoux L, 2005, GASTROEN CLIN BIOL, V29, P1213, DOI 10.1016/S0399-8320(05)82203-1; Ginat Daniel T, 2010, Tech Vasc Interv Radiol, V13, P66, DOI 10.1053/j.tvir.2010.02.002; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; GOLDBERG SN, 1995, ACAD RADIOL, V2, P399; Grunkemeier G L, 1992, J Heart Valve Dis, V1, P142; Haar Gail Ter, 2007, Int J Hyperthermia, V23, P89, DOI 10.1080/02656730601186138; Herbold T, 2013, LANGENBECK ARCH SURG, V398, P47, DOI 10.1007/s00423-012-1018-5; Kim SK, 2007, J VASC INTERV RADIOL, V18, P1417, DOI 10.1016/j.jvir.2007.08.010; Lafon C, 2007, INT J HYPERTHER, V23, P153, DOI 10.1080/02656730601173029; Lencioni R, 2010, J VASC INTERV RADIOL, V21, P1533, DOI 10.1016/j.jvir.2010.06.019; Lubner MG, 2012, J VASC INTERV RADIOL, V23, P405, DOI 10.1016/j.jvir.2011.11.003; National Cancer Institute, COMM TERM CRIT ADV E; Oshima F, 2004, J VASC INTERV RADIOL, V15, P1451, DOI 10.1097/01.RVI.0000140640.87399.58; Park MJ, 2011, J VASC INTERV RADIOL, V22, P771, DOI 10.1016/j.jvir.2011.02.005; Rendon RA, 2002, J UROLOGY, V167, P1587, DOI 10.1016/S0022-5347(05)65159-2; Rosenberg C, 2009, AM J ROENTGENOL, V192, P785, DOI 10.2214/AJR.08.1425; Rosenthal DI, 2003, RADIOLOGY, V229, P171, DOI 10.1148/radiol.2291021053; RUBINSKY B, 1990, CRYOBIOLOGY, V27, P85, DOI 10.1016/0011-2240(90)90055-9; Sacks David, 2003, J Vasc Interv Radiol, V14, pS199; Sacks David, 2003, J Vasc Interv Radiol, V14, pS391; Shetty SK, 2001, J VASC INTERV RADIOL, V12, P823, DOI 10.1016/S1051-0443(07)61507-3; Sofocleous CT, 2008, RADIOLOGY, V249, P364, DOI 10.1148/radiol.2491071752; Sommer CM, 2013, INT J HYPERTHER, V29, P21, DOI 10.3109/02656736.2012.750015; Spalding AC, 2006, CANCER INVEST, V24, P444, DOI 10.1080/07357900600705706; STEELE G, 1991, J CLIN ONCOL, V9, P1105; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825; Vavra P, 2009, DIS COLON RECTUM, V52, P355, DOI 10.1007/DCR.0b013e31819a3e09; Wang YB, 2007, QUAL LIFE RES, V16, P389, DOI 10.1007/s11136-006-9133-9; Wood BJ, 2010, J VASC INTERV RADIOL, V21, pS257, DOI 10.1016/j.jvir.2010.05.003; Yan K, 2008, EUR J RADIOL, V67, P336, DOI 10.1016/j.ejrad.2007.07.007; yer RS, 2010, J COMPUT ASSIST TOMO, V34, P226	99	11	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2014	25	11					1691	1705		10.1016/j.jvir.2014.08.027		15	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AT1UZ	WOS:000344720500005		
J	Tanaka, K; Maeda, N; Osuga, K; Higashi, Y; Hayashi, A; Hori, Y; Kishimoto, K; Morii, E; Ohashi, F; Tomiyama, N				Tanaka, Kaishu; Maeda, Noboru; Osuga, Keigo; Higashi, Yoshiyuki; Hayashi, Akiyoshi; Hori, Yumiko; Kishimoto, Kentaro; Morii, Eiichi; Ohashi, Fumihito; Tomiyama, Noriyuki			In Vivo Evaluation of Irinotecan-Loaded QuadraSphere Microspheres for Use in Chemoembolization of VX2 Liver Tumors	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							ADVANCED COLORECTAL-CANCER; DRUG-ELUTING BEADS; ARTERIAL CHEMOEMBOLIZATION; PRECLINICAL ASSESSMENT; RABBIT LIVER; PHASE-III; MODEL; METASTASES; FOLFIRI; TRIAL	Purpose: To investigate the pharmacokinetics and chemoembolization efficacy of irinotecan-loaded Quadra Sphere microspheres (QSMs) in a rabbit VX2 liver tumor model. Materials and Methods: Fourteen rabbits with VX2 liver tumors were divided into two groups. In the irinotecan-loaded QSM group (n = 7), 3 mg of QSMs (30-60 mu m) containing 12 mg of irinotecan (0.6 mL; 20 mg/mL) were injected into the left hepatic artery. In the control group (hepatic arterial infusion [HAI] and QSMs; n = 7), 3 mg of QSMs suspended in ioxaglic acid were injected following a bolus injection of 0.6 mL of irinotecan solution (20 mg/mL). Sequential irinotecan, SN-38, and SN-38G concentration changes were measured in plasma within 24 hours and at 1 week and in tissues at 1 week. The VX2 tumor growth rates at 1 and 2 weeks were calculated from computed tomographic images. Results: All rabbits underwent successful embolization. Plasma irinotecan, SN-38, and SN-38G concentrations in the irinotecan-loaded QSM group showed significantly sustained release compared with the control group (P = .01). Compared with the control group, the irinotecan-loaded QSM group had significantly higher irinotecan concentration in liver tumors (P = .03) and a tendency toward higher SN-38 concentration in liver tumors (P = .29). The SN-38G tissue concentrations were below the limits of quantification. The tumor growth rate was significantly lower and the tumor necrosis rate significantly higher in the irinotecan-loaded QSM group (P = .02 and P = .01, respectively). Conclusion: Chemoembolization via irinotecan-loaded QSMs more effectively suppresses tumor growth than chemoembolization with unloaded QSMs after HAI. A clinical feasibility study is warranted.	[Tanaka, Kaishu; Maeda, Noboru; Osuga, Keigo; Kishimoto, Kentaro; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka 5650871, Japan; [Higashi, Yoshiyuki; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Higashi, Yoshiyuki; Hayashi, Akiyoshi; Ohashi, Fumihito] Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Surg, Lzumisano, Japan	Tanaka, K (reprint author), Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ushuika@yahoo.co.jp			MEXT KAKENHI Grant [22791195]	This work was supported by the MEXT KAKENHI Grant 22791195. The authors thank Shinichi Ohta, MD, PhD, and Norihisa Nitta, MD, PhD (Shiga University of Medical Science), for help in the preparation of a rabbit VX2 liver tumor model; and Masahisa Nakamura, MD, Yusuke Ono, MD, and Hiroki Higashihara, MD, PhD (Osaka University Graduate School of Medicine), for their assistance in this study.	Fiorentini G, 2012, ANTICANCER RES, V32, P1387; Martin RCG, 2012, J GASTROINTEST SURG, V16, P1531, DOI 10.1007/s11605-012-1892-8; Aliberti C, 2011, ANTICANCER RES, V31, P4581; Richardson AJ, 2013, J VASC INTERV RADIOL, V24, P1209, DOI 10.1016/j.jvir.2013.05.055; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; de Luis E, 2008, CARDIOVASC INTER RAD, V31, P367, DOI 10.1007/s00270-007-9240-1; Jordan O, 2010, J VASC INTERV RADIOL, V21, P1084, DOI 10.1016/j.jvir.2010.02.042; Eichler K, 2012, INT J ONCOL, V41, P1213, DOI 10.3892/ijo.2012.1572; Kim TW, 2007, THER DRUG MONIT, V29, P265, DOI 10.1097/FTD.0b013e318068623b; Hong K, 2006, CLIN CANCER RES, V12, P2563, DOI 10.1158/1078-0432.CCR-05-2225; Huppert P, 2014, CARDIOVASC INTER RAD, V37, P154, DOI 10.1007/s00270-013-0632-0; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Guichard S, 1999, BRIT J CANCER, V80, P364, DOI 10.1038/sj.bjc.6690364; Jiaqi Y, 1996, Nihon Igaku Hoshasen Gakkai Zasshi, V56, P19; Maeda N, 2012, J VASC INTERV RADIOL, V23, P397, DOI 10.1016/j.jvir.2011.10.024; Maeda N, 2014, ANN M CARD INT RAD S; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Rao PP, 2012, CARDIOVASC INTER RAD, V35, P1448, DOI 10.1007/s00270-012-0343-y; Seki A, 2011, INT J CLIN ONCOL, V16, P613, DOI 10.1007/s10147-010-0181-3; Seo TS, 2001, INVEST RADIOL, V36, P186, DOI 10.1097/00004424-200103000-00008; Shitara Kohei, 2011, Gastrointest Cancer Res, V4, P168; Tanaka T, 2014, J VASC INTERV RADIOL, V25, P1037, DOI 10.1016/j.jvir.2014.04.005	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2014	25	11					1727	1735		10.1016/j.jvir.2014.07.012		9	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AT1UZ	WOS:000344720500010		
J	Kishimoto, K; Osuga, K; Maeda, N; Higashi, Y; Hayashi, A; Hori, Y; Nakamura, M; Ohashi, F; Morii, E; Tomiyama, N				Kishimoto, Kentaro; Osuga, Keigo; Maeda, Noboru; Higashi, Yoshiyuki; Hayashi, Akiyoshi; Hori, Yumiko; Nakamura, Masahisa; Ohashi, Fumihito; Morii, Eiichi; Tomiyama, Noriyuki			Embolic Effects of Transcatheter Mesenteric Arterial Embolization with Microspheres on the Small Bowel in a Dog Model	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							LOWER GASTROINTESTINAL HEMORRHAGE; N-BUTYL CYANOACRYLATE; TRIS-ACRYL GELATIN; POLYVINYL-ALCOHOL; SWINE MODEL; EMBOLOTHERAPY; PARTICLES; BRANCHES; SHEEP	Purpose: To determine the arterial distribution and ischemic effects of various particle sizes after transcatheter embolization of the small bowel in a dog model. Materials and Methods: In 10 dogs, selective microsphere epabolization was performed in six branches of the superior mesenteric artery. Microspheres were allocated into three size ranges (100-300 mu m, 300-500 mu m, and 500-700 mu m) and four volume concentrations (0.625%, 1.25%, 2.5%, and 5%). For each size and volume concentration, embolization was performed of five branches at the origin of the last arcade. The distribution of microspheres and the range of ischemic changes of mucosa were evaluated histologically. Angiograms were categorized into two groups: group A, only the vasa recta nonepacified; group B, the last arcade or more proximal branches nonopacified. Results: Microspheres sized 100-300 mu m penetrated into intramural arteries and 500-700 mu m microspheres mainly blocked arteries in the mesentery. There was a significant difference among three sizes in terms of the locations Within the vasculature (P < .0001). The larger volume and the smaller size resulted in more ischemia. The range of ischemic changes among three sizes and among four volume concentrations was significantly different (P = .004 and P < .0001, respectively). The range of ischemic changes with 500-700 mu m microspheres in group B was significantly greater than in group A (0% in group A vs 83% in group B, P = .001). Conclusions: In. a dog model,. embolization of the small bowel limited to the vasa recta with the use if 500-700 mu m microspheres reduced the range of ischemic changes.	[Kishimoto, Kentaro; Osuga, Keigo; Maeda, Noboru; Nakamura, Masahisa; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka 5650871, Japan; [Hori, Yumiko; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka 5650871, Japan; [Higashi, Yoshiyuki; Hayashi, Akiyoshi; Ohashi, Fumihito] Osaka Prefecture Univ, Dept Grad Sch Life & Environm Sci, Lab Vet Surg, Osaka, Japan	Kishimoto, K (reprint author), Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, 2-2 Yamadaoka Suita, Osaka 5650871, Japan.	k-kishimoto@radiol.med.osaka-u.ac.jp			JSPS KAKENHI Grant [23591819]	This study was supported by JSPS KAKENHI Grant Number 23591819. We thank Kaishu Tanaka, MD, Yusuke Ono, MD, and Hiroki Higashihara, MD, PhD, of the Department of Diagnostic and Interventional Radiology of Osaka University Graduate School of Medicine for technical support.	Andrews RT, 2003, J VASC INTERV RADIOL, V14, P1311; Weldon DT, 2008, EUR RADIOL, V18, P857, DOI 10.1007/s00330-007-0844-2; Stampfl S, 2009, J VASC INTERV RADIOL, V20, P1597, DOI 10.1016/j.jvir.2009.08.018; Laurent A, 1996, AM J NEURORADIOL, V17, P533; Kuo WT, 2003, J VASC INTERV RADIOL, V14, P1503, DOI 10.1097/01.RV1.0000099780.23569.E6; Evangelista PT, 2000, J VASC INTERV RADIOL, V11, P601, DOI 10.1016/S1051-0443(07)61612-1; Jae HJ, 2008, J VASC INTERV RADIOL, V19, P755, DOI 10.1016/j.jvir.2008.01.024; Pelage JP, 2002, RADIOLOGY, V224, P436, DOI 10.1148/radiol.2242010847; Hidaka K, 2011, J MECH BEHAV BIOMED, V4, P2161, DOI 10.1016/j.jmbbm.2011.08.001; Siskin GP, 2003, J VASC INTERV RADIOL, V14, P89, DOI 10.1097/01.RVI.000052296.26939.4c; Laurent A, 2006, INVEST RADIOL, V41, P8, DOI 10.1097/01.rli.0000188027.34400.f3; Derdeyn CP, 1997, AM J NEURORADIOL, V18, P647; Darcy M, 2006, MED RAD DIA IMG, P73; Han YM, 1999, INVEST RADIOL, V34, P629, DOI 10.1097/00004424-199910000-00004; Ikoma A, 2010, CARDIOVASC INTER RAD, V33, P1009, DOI 10.1007/s00270-010-9867-1; Khankan Azzam A, 2004, Radiat Med, V22, P384; KUSANO S, 1987, INVEST RADIOL, V22, P388, DOI 10.1097/00004424-198705000-00006; Laurent A, 2007, Tech Vasc Interv Radiol, V10, P248, DOI 10.1053/j.tvir.2008.03.010; Maleux G, 2009, AM J GASTROENTEROL, V104, P2042, DOI 10.1038/ajg.2009.186; Millward Steven F, 2008, J Am Coll Radiol, V5, P550, DOI 10.1016/j.jacr.2008.01.010; REUTER SR, 1975, AM J ROENTGENOL, V125, P119; ROSS JA, 1952, BRIT J SURG, V39, P330, DOI 10.1002/bjs.18003915612	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2014	25	11					1767	1773		10.1016/j.jvir.2014.06.020		7	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AT1UZ	WOS:000344720500015		
J	Ueshima, E; Yamaguchi, M; Muradi, A; Okada, T; Idoguchi, K; Sofue, K; Nomura, Y; Okita, Y; Sugimoto, K				Ueshima, Eisuke; Yamaguchi, Masato; Muradi, Akhmadu; Okada, Takuya; Idoguchi, Koji; Sofue, Keitaro; Nomura, Yoshikatsu; Okita, Yutaka; Sugimoto, Koji			Management of Type II Endoleak after Endovascular Repair of Arteriocaval Fistula Complicating Aortoiliac Aneurysm: Case Report and Literature Review	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							INFERIOR VENA-CAVA; ABDOMINAL AORTIC-ANEURYSM; STENT-GRAFT REPAIR; AORTOCAVAL FISTULA; TREAT	Endovascular treatment-for arteriocaval fistula (ACF) has become the preferred alternative to open repair. However, endoleaks sometimes occur and maintain the ACF. A 64-year-old man presented with persistent fistula after placement of a bifurcated stent-graft for ACF complicating an aortoiliac aneutysm that was maintained by endoleaks from the inferior mesenteric and lumbar arteries. Transarterial embolization of the aneurysm sac and inferior mesenteric artery successfully resolved the problem Without any Complications observed. over 16 months of follow-up. A literature review and discussion of the management options for this entity are presented. A combination of inflow and outflow control is important to obtain better long-term outcomes.	[Ueshima, Eisuke; Yamaguchi, Masato; Muradi, Akhmadu; Okada, Takuya; Idoguchi, Koji; Nomura, Yoshikatsu; Sugimoto, Koji] Kobe Univ Hosp, Ctr Endovasc Therapy, Kobe, Hyogo, Japan; [Ueshima, Eisuke; Yamaguchi, Masato; Okada, Takuya; Sofue, Keitaro; Sugimoto, Koji] Kobe Univ, Grad Sch Med, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nomura, Yoshikatsu; Okita, Yutaka] Kobe Univ, Grad Sch Med, Dept Surg, Cardiovasc Div,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nomura, Yoshikatsu; Okita, Yutaka] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Surg,Vasc & Endovasc Div, Jakarta, Indonesia	Ueshima, E (reprint author), Kobe Univ Hosp, Ctr Endovasc Therapy, Kobe, Hyogo, Japan.	eisukeueshima@yahoo.co.jp					Akamatsu D, 2014, ANN VASC SURG, V28; Melas N, 2011, J ENDOVASC THER, V18, P250, DOI 10.1583/10-3296.1; Beveridge CJ, 1998, CARDIOVASC INTER RAD, V21, P244, DOI 10.1007/s002709900253; Akwei S, 2011, VASC ENDOVASC SURG, V45, P442, DOI 10.1177/1538574411407087; Sfyroeras GS, 2010, VASA, V39, P98, DOI 10.1024/0301-1526/a000011; Antoniou GA, 2009, J ENDOVASC THER, V16, P514, DOI 10.1583/09-2725.1; Briggs CS, 2014, ANN VA IN PRESS 0521; Burke C, 2003, J VASC INTERV RADIOL, V14, P813, DOI 10.1097/01.RVI.0000079996.80153.79; de Naeyer G, 2005, J VASC SURG, V41, P552, DOI 10.1016/j.jvs.2004.11.039; Falkowski A, 2013, J ENDOVASC THER, V20, P714, DOI 10.1583/13-4368R.1; Guzzardi G, 2010, CARDIOVASC INTER RAD, V33, P853, DOI 10.1007/s00270-009-9640-5; Jeunens-van de Ven SAH, 2011, ANN VASC SURG, V25; Kopp R, 2006, ANN VASC SURG, V20, P525, DOI 10.1007/s10016-006-9061-8; LaBarbera M, 2011, J INVASIVE CARDIOL, V23, P343; Lau LL, 2001, J VASC SURG, V33, P425, DOI 10.1067/mva.2001.111485; Scali ST, 2013, J VASC SURG, V57, P869, DOI 10.1016/j.jvs.2012.09.021; Shah TR, 2013, VASC ENDOVASC SURG, V47, P51, DOI 10.1177/1538574412462633; Stavropoulos SW, 2009, J VASC INTERV RADIOL, V20, P1299, DOI 10.1016/j.jvir.2009.07.003; van de Luijtgaarden KM, 2013, J VASC SURG, V58, P1080, DOI 10.1016/j.jvs.2012.10.138; Vetrhus M, 2005, EUR J VASC ENDOVASC, V30, P640, DOI 10.1016/j.ejvs.2005.07.017	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2014	25	11					1809	1815		10.1016/j.jvir.2014.06.021		7	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AT1UZ	WOS:000344720500023		
J	Hiraki, T; Gobara, H; Iguchi, T; Fujiwara, H; Matsui, Y; Kanazawa, S				Hiraki, Takao; Gobara, Hideo; Iguchi, Toshihiro; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu			Creation of an Artificial Hydromediastinum for Radiofrequency Ablation of Lung Tumor: A Report of Two Cases	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter									[Hiraki, Takao; Gobara, Hideo; Iguchi, Toshihiro; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Shikatacho, Okayama 7008558, Japan	Hiraki, T (reprint author), Okayama Univ, Sch Med, Dept Radiol, 2-5-1 Kitaku, Shikatacho, Okayama 7008558, Japan.						Iguchi T, 2007, J VASC INTERV RADIOL, V18, P733, DOI 10.1016/j.jvir.2007.02.024; Hiraki T, 2011, J VASC INTERV RADIOL, V22, P503, DOI 10.1016/j.jvir.2010.12.018; Günther R W, 1992, J Vasc Interv Radiol, V3, P379, DOI 10.1016/S1051-0443(92)72048-X; Hiraki T, 2013, SEMIN INTERVENT RAD, V30, P169, DOI 10.1055/s-0033-1342958	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2014	25	11					1834	1837		10.1016/j.jvir.2014.03.035		4	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	AT1UZ	WOS:000344720500030		
J	Tanaka, T; Kasai, H; Yamashita, A; Okuyama-Dobashi, K; Yasumoto, J; Maekawa, S; Enomoto, N; Okamoto, T; Matsuura, Y; Morimatsu, M; Manabe, N; Ochiai, K; Yamashita, K; Moriishi, K				Tanaka, Tomohisa; Kasai, Hirotake; Yamashita, Atsuya; Okuyama-Dobashi, Kaori; Yasumoto, Jun; Maekawa, Shinya; Enomoto, Nobuyuki; Okamoto, Toru; Matsuura, Yoshiharu; Morimatsu, Masami; Manabe, Noboru; Ochiai, Kazuhiko; Yamashita, Kazuto; Moriishi, Kohji			Hallmarks of Hepatitis C Virus in Equine Hepacivirus	JOURNAL OF VIROLOGY			English	Article							SIGNAL PEPTIDE PEPTIDASE; RNA REPLICATION COMPLEX; RIBOSOME ENTRY SITE; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; MEDIATED TRANSLATION; UNTRANSLATED REGION; SECONDARY STRUCTURE; VIRAL REPLICATION; LIPID DROPLETS	Equine hepacivirus (EHcV) has been identified as a closely related homologue of hepatitis C virus (HCV) in the United States, the United Kingdom, and Germany, but not in Asian countries. In this study, we genetically and serologically screened 31 serum samples obtained from Japanese-born domestic horses for EHcV infection and subsequently identified 11 PCR-positive and 7 seropositive serum samples. We determined the full sequence of the EHcV genome, including the 3' untranslated region (UTR), which had previously not been completely revealed. The polyprotein of a Japanese EHcV strain showed approximately 95% homology to those of the reported strains. HCV-like cis-acting RNA elements, including the stem-loop structures of the 3' UTR and kissing-loop interaction were deduced from regions around both UTRs of the EHcV genome. A comparison of the EHcV and HCV core proteins revealed that Ile(190) and Phe(191) of the EHcV core protein could be important for cleavage of the core protein by signal peptide peptidase (SPP) and were replaced with Ala and Leu, respectively, which inhibited intramembrane cleavage of the EHcV core protein. The loss-of-function mutant of SPP abrogated intramembrane cleavage of the EHcV core protein and bound EHcV core protein, suggesting that the EHcV core protein may be cleaved by SPP to become a mature form. The wild-type EHcV core protein, but not the SPP-resistant mutant, was localized on lipid droplets and partially on the lipid raft-like membrane in a manner similar to that of the HCV core protein. These results suggest that EHcV may conserve the genetic and biological properties of HCV. IMPORTANCE EHcV, which shows the highest amino acid or nucleotide homology to HCV among hepaciviruses, was previously reported to infect horses from Western, but not Asian, countries. We herein report EHcV infection in Japanese-born horses. In this study, HCV-like RNA secondary structures around both UTRs were predicted by determining the whole-genome sequence of EHcV. Our results also suggest that the EHcV core protein is cleaved by SPP to become a mature form and then is localized on lipid droplets and partially on lipid raft-like membranes in a manner similar to that of the HCV core protein. Hence, EHcV was identified as a closely related homologue of HCV based on its genetic structure as well as its biological properties. A clearer understanding of the epidemiology, genetic structure, and infection mechanism of EHcV will assist in elucidating the evolution of hepaciviruses as well as the development of surrogate models for the study of HCV.	[Tanaka, Tomohisa; Kasai, Hirotake; Yamashita, Atsuya; Okuyama-Dobashi, Kaori; Yasumoto, Jun; Moriishi, Kohji] Univ Yamanashi, Fac Med, Dept Microbiol, Yamanashi, Japan; [Maekawa, Shinya; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Yamanashi, Japan; [Okamoto, Toru; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan; [Morimatsu, Masami] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido, Japan; [Manabe, Noboru] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Kasama, Ibaraki, Japan; [Ochiai, Kazuhiko] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Nursing & Technol, Dept Basic Sci, Tokyo, Japan; [Yamashita, Kazuto] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 069, Japan	Moriishi, K (reprint author), Univ Yamanashi, Fac Med, Dept Microbiol, Yamanashi, Japan.	kmoriishi@yamanashi.ac.jp	Morimatsu, Masami/A-6698-2012	Morimatsu, Masami/0000-0003-0740-0157	Ministry of Health, Labor, and Welfare, Japan [H24-Kanen-008, H25-Kanen-002]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency (JST) [Houga-24659204]	This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Japan (H24-Kanen-008 and H25-Kanen-002 and -008); the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Japan Science and Technology Agency (JST) (Houga-24659204).	Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lourenco S, 2008, FEBS J, V275, P4179, DOI 10.1111/j.1742-4658.2008.06566.x; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Blight KJ, 1997, J VIROL, V71, P7345; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Bukh J, 2001, J MED VIROL, V65, P694, DOI 10.1002/jmv.2092; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; Diviney S, 2008, J VIROL, V82, P9008, DOI 10.1128/JVI.02326-07; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Babaylova E, 2009, NUCLEIC ACIDS RES, V37, P1141, DOI 10.1093/nar/gkn1026; Beames B, 2001, ILAR J, V42, P152; Cristina J, 2007, VIRUS RES, V127, P185, DOI 10.1016/j.virusres.2007.02.023; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; Fieten H, 2014, J VIRAL HEPAT; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Honda M, 1996, RNA, V2, P955; Hope RG, 2000, J GEN VIROL, V81, P1913; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Katsume A, 2013, GASTROENTEROLOGY, V145, P865, DOI 10.1053/j.gastro.2013.06.012; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Ogino T, 2004, J VIROL, V78, P11766, DOI 10.1128/JVI.78.21.11766-11777.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Stewart H, 2013, J GEN VIROL, V94, P2657, DOI 10.1099/vir.0.055764-0; Tajima S, 2005, VIROLOGY, V332, P38, DOI 10.1016/j.virol.2004.06.052; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004	55	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	NOV	2014	88	22					13352	13366		10.1128/JVI.02280-14		15	Virology	Virology	AT3CG	WOS:000344812500036		
J	Katsura, H; Piao, Z; Iwatsuki-Horimoto, K; Akeda, Y; Watanabe, S; Horimoto, T; Oishi, K; Kawaoka, Y				Katsura, Hiroaki; Piao, Zhenyu; Iwatsuki-Horimoto, Kiyoko; Akeda, Yukihiro; Watanabe, Shinji; Horimoto, Taisuke; Oishi, Kazunori; Kawaoka, Yoshihiro			A Bivalent Vaccine Based on a Replication-Incompetent Influenza Virus Protects against Streptococcus pneumoniae and Influenza Virus Infection	JOURNAL OF VIROLOGY			English	Article							PNEUMOCOCCAL SURFACE; ATTENUATED INFLUENZA; PANDEMIC INFLUENZA; CONJUGATE VACCINE; IMMUNE-RESPONSE; RIG-I; ANTIBODIES; PSPA; COLONIZATION; IMMUNIZATION	Streptococcus pneumoniae is a major causative pathogen in community-acquired pneumonia; together with influenza virus, it represents an important public health burden. Although vaccination is the most effective prophylaxis against these infectious agents, no single vaccine simultaneously provides protective immunity against both S. pneumoniae and influenza virus. Previously, we demonstrated that several replication-incompetent influenza viruses efficiently elicit IgG in serum and IgA in the upper and lower respiratory tracts. Here, we generated a replication-incompetent hemagglutinin knockout (HA-KO) influenza virus possessing the sequence for the antigenic region of pneumococcal surface protein A (PspA). Although this virus (HA-KO/PspA virus) could replicate only in an HA-expressing cell line, it infected wild-type cells and expressed both viral proteins and PspA. PspA- and influenza virus-specific antibodies were detected in nasal wash and bronchoalveolar lavage fluids and in sera from mice intranasally inoculated with HA-KO/PspA virus, and mice inoculated with HA-KO/PspA virus were completely protected from lethal challenge with either S. pneumoniae or influenza virus. Further, bacterial colonization of the nasopharynx was prevented in mice immunized with HA-KO/PspA virus. These results indicate that HA-KO/PspA virus is a promising bivalent vaccine candidate that simultaneously confers protective immunity against both S. pneumoniae and influenza virus. We believe that this strategy offers a platform for the development of bivalent vaccines, based on replication-incompetent influenza virus, against pathogens that cause respiratory infectious diseases. IMPORTANCE Streptococcus pneumoniae and influenza viruses cause contagious diseases, but no single vaccine can simultaneously provide protective immunity against both pathogens. Here, we used reverse genetics to generate a replication-incompetent influenza virus carrying the sequence for the antigenic region of pneumococcal surface protein A and demonstrated that mice immunized with this virus were completely protected from lethal doses of infection with either influenza virus or Streptococcus pneumoniae. We believe that this strategy, which is based on a replication-incompetent influenza virus possessing the antigenic region of other respiratory pathogens, offers a platform for the development of bivalent vaccines.	[Katsura, Hiroaki; Iwatsuki-Horimoto, Kiyoko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Piao, Zhenyu; Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Lab Clin Res Infect Dis, Osaka, Japan; [Watanabe, Shinji; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan; [Watanabe, Shinji] Miyazaki Univ, Dept Vet Sci, Lab Vet Microbiol, Miyazaki, Japan; [Horimoto, Taisuke] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Tokyo, Japan; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Special Pathogens, Tokyo, Japan	Oishi, K (reprint author), Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Lab Clin Res Infect Dis, Osaka, Japan.	oishik@nih.go.jp; kawaoka@ims.u-tokyo.ac.jp			Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Ministry of Health, Labor and Welfare, Japan; ERATO (Japan Science and Technology Agency); Strategic Basic Research Programs of the Japan Science and Technology Agency; National Institute of Allergy and Infectious Diseases Public Health Service research grants; Japan Society for the Promotion of Science	This work was supported by the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), by grants-in-aid from the Ministry of Health, Labor and Welfare, Japan, by ERATO (Japan Science and Technology Agency), by the Strategic Basic Research Programs of the Japan Science and Technology Agency, and by National Institute of Allergy and Infectious Diseases Public Health Service research grants. H.K. is supported by a Grant-in-Aid from the Japan Society for the Promotion of Science.	Jambo KC, 2010, TRENDS MICROBIOL, V18, P81, DOI 10.1016/j.tim.2009.12.001; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Carragher DM, 2008, J IMMUNOL, V181, P4168; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Jedrzejas MJ, 2007, CELL MOL LIFE SCI, V64, P2799, DOI 10.1007/s00018-007-7125-8; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Dagan R, 1996, J INFECT DIS, V174, P1271; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Abramson JS, 2000, PEDIATRICS, V106, P362; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Ezoe H, 2011, VACCINE, V29, P1754, DOI 10.1016/j.vaccine.2010.12.117; Ferreira DM, 2008, CLIN VACCINE IMMUNOL, V15, P499, DOI 10.1128/CVI.00400-07; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; Katsura H, 2012, VACCINE, V30, P6027, DOI 10.1016/j.vaccine.2012.07.059; KIDA H, 1982, VIROLOGY, V122, P38, DOI 10.1016/0042-6822(82)90375-0; Moffitt KL, 2011, CURR OPIN IMMUNOL, V23, P407, DOI 10.1016/j.coi.2011.04.002; Ochs MM, 2008, MICROB PATHOGENESIS, V44, P204, DOI 10.1016/j.micpath.2007.09.007; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047	42	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	NOV	2014	88	22					13410	13417		10.1128/JVI.01205-14		8	Virology	Virology	AT3CG	WOS:000344812500040		
J	Nishida, T; Doi, T				Nishida, Toshirou; Doi, Toshihiko			Improving prognosis after surgery for gastric cancer	LANCET ONCOLOGY			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ADJUVANT CHEMOTHERAPY; S-1; METAANALYSIS		[Nishida, Toshirou; Doi, Toshihiko] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan	Nishida, T (reprint author), Natl Canc Ctr Hosp East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tnishida@east.ncc.go.jp					Oba K, 2013, JNCI-J NATL CANCER I, V105, P1600, DOI 10.1093/jnci/djt270; Tsuburaya A, 2014, LANCET ONCOL, V15, P886, DOI 10.1016/S1470-2045(14)70025-7; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Bajetta E, 2014, ANN ONCOL, V25, P1373, DOI 10.1093/annonc/mdu146; Noh SH, 2014, LANCET ONCOL; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	NOV	2014	15	12					1290	1292		10.1016/S1470-2045(14)71019-8		4	Oncology	Oncology	AS9ER	WOS:000344546400034		
J	Ikeo, R				Ikeo, Reiko			Connectives 'but' and 'for' in viewpoint shifting in Woolf's To the Lighthouse	LANGUAGE AND LITERATURE			English	Article						But; connectives; corpus stylistics; for; free indirect discourse; speech presentation; thought presentation; To the Lighthouse; viewpoint shifting; Woolf		The narrative world of Woolf's To the Lighthouse (1992 [1927]) is primarily composed of its characters' thought and speech presentation. One character's flow of thoughts is connected with another character's thoughts, and viewpoint shifts occur very quickly and frequently. This article analyses how the two connectives but' and for' contribute to viewpoint shifting by comparing their stylistic, pragmatic functions in contexts where similar types of viewpoint shifting occur. Adopting a corpus-assisted approach, sentences and clauses before and after but' and for' are compared when these sentences and clauses are identified as being in similar discourse presentation categories such as free direct thought and direct speech. But' emphasizes the distinction between the narration and a character's discourse or between two characters' discourse, whereas for' helps viewpoint shifting to take place more implicitly, as a result of which the boundary between the different voices tends to be blurred.	[Ikeo, Reiko] Senshu Univ, Sch Commerce, Kawasaki, Kanagawa 2148580, Japan	Ikeo, R (reprint author), Senshu Univ, Sch Commerce, Tama Ku, 2-1-1 Higashimita, Kawasaki, Kanagawa 2148580, Japan.	rikeo0919@gmail.com					Auerbach Erich, 1953, MIMESIS REPRESENTATI; Daiches D, 1963, V WOOLF; Ehrlich S, 1990, POINT VIEW LINGUISTI; Leaska MA, 1970, VIRGINIA WOOLFS LIGH; Leech G., 1981, STYLE FICTION; MATRO TG, 1984, PMLA, V99, P212, DOI 10.2307/462162; Quirk R., 1985, COMPREHENSIVE GRAMMA; Semino E, 2004, CORPUS STYLISTICS SP; Sotirova V, 2011, DH LAWRENCE NARRATIV; Sotirova V., 2004, LANG LIT, V13, P216, DOI 10.1177/0963947004044872; Sotirova V, 2013, CONSCIOUSNESS IN MODERNIST FICTION: A STYLISTIC STUDY, P1, DOI 10.1057/9781137307255; van Dijk Teun A., 1977, TEXT CONTEXT EXPLORA; Woolf Virginia, 1992, LIGHTHOUSE	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0963-9470	1461-7293		LANG LIT	Lang. Lit.	NOV	2014	23	4					331	346		10.1177/0963947014534125		16	Linguistics; Language & Linguistics	Linguistics	AT1KN	WOS:000344692400003		
J	Kaminskii, AA; Lux, O; Hanuza, J; Rhee, H; Eichler, HJ; Yoneda, H; Zhang, J; Tang, DY; Shirakawa, A				Kaminskii, Alexander A.; Lux, Oliver; Hanuza, Jerzy; Rhee, Hanjo; Eichler, Hans Joachim; Yoneda, Hitoki; Zhang, Jian; Tang, Dingyuan; Shirakawa, Akira			Orthorhombic YAIO(3) - a novel many-phonon SRS-active crystal	LASER & PHOTONICS REVIEWS			English	Article						Orthorhombic YAlO3; laser host crystal; stimulated Raman scattering; cascaded and cross-cascaded ((3))-nonlinear processes; "combined" SRS phonons	STIMULATED RAMAN-SCATTERING; SINGLE-CRYSTALS; ROOM-TEMPERATURE; LASER ACTION; WAVE-GUIDE; EMISSION; IONS; SPECTROSCOPY; OPERATION; MU	In single crystals of orthorhombic YAlO3, widely known as a host-matrix for Ln(3+)-lasant ions, many-phonon stimulated Raman scattering interactions as well as different manifestations of cascaded and cross-cascaded nonlinear ((3)(3)) processes are initiated by picosecond laser pulses. The scientific and applicative potential of YAlO3 crystals is considerably expanded by the demonstration of its SRS properties. In particular, the studies revealed the manifestation of eight ((3))-active vibrational modes. The corresponding Stokes and anti-Stokes lines have been assigned and the steady-state Raman gain coefficients related to the strongest phonon mode have been estimated. In addition, a short review presents the stimulated emission channels of its Ln(3+)-ions together with some ((3))-nonlinear laser properties of crystals belonging to the binary Y2O3-Al2O3 system.	[Kaminskii, Alexander A.] Russian Acad Sci, Inst Crystallog, Moscow 119, Russia; [Lux, Oliver; Rhee, Hanjo; Eichler, Hans Joachim] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany; [Hanuza, Jerzy] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan; [Yoneda, Hitoki; Shirakawa, Akira] Polish Acad Sci, Inst Low Temp & Struct Res, PL-50950 Wroclaw, Poland; [Zhang, Jian; Tang, Dingyuan] Jiangsu Normal Univ, Lab Adv Laser Mat & Devices, Xuzhou 221116, Peoples R China	Kaminskii, AA (reprint author), Russian Acad Sci, Inst Crystallog, Leninsky Prospect 59, Moscow 119, Russia.	kaminalex@mail.ru; oliver.lux@physik.tu-berlin.de	Zhang, Jian/G-8296-2011	Zhang, Jian/0000-0001-9061-3940			SILVERSMITH AJ, 1987, APPL PHYS LETT, V51, P1977, DOI 10.1063/1.98316; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; Chopelas A, 2011, PHYS CHEM MINER, V38, P709, DOI 10.1007/s00269-011-0444-1; DIEHL R, 1975, MATER RES BULL, V10, P85, DOI 10.1016/0025-5408(75)90125-7; Kaminskii AA, 2001, OPT COMMUN, V194, P201, DOI 10.1016/S0030-4018(01)01274-3; Grasyuk AZ, 1998, QUANTUM ELECTRON+, V28, P162, DOI 10.1070/QE1998v028n02ABEH001162; Szela JW, 2013, OPT EXPRESS, V21, P12460, DOI 10.1364/OE.21.012460; STONE J, 1978, J APPL PHYS, V49, P2281, DOI 10.1063/1.325112; Kaminskii AA, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/073001; BAGDASAR.KS, 1969, JETP LETT-USSR, V9, P303; BIRNBAUM M, 1973, IEEE J QUANTUM ELECT, VQE 9, P46, DOI 10.1109/JQE.1973.1077384; Bohaty L, 2013, PHYS STATUS SOLIDI-R, V7, P429, DOI 10.1002/pssr.201307143; CAIRD JA, 1975, IEEE J QUANTUM ELECT, V11, P864; DANER T, 1994, APPL PHYS B, V58, P413; Gupta HC, 1999, J SOLID STATE CHEM, V146, P287, DOI 10.1006/jssc.1999.8323; Jelinkova H, 2002, OPT ENG, V41, P1976, DOI 10.1117/1.1488161; Kaiser W., 1972, LASER HDB, V2, P1077; Kaminskii A. A, 1996, CRYSTALLINE LASERS P; Kaminskii AA, 2014, DOKL PHYS, V59, P115, DOI 10.1134/S1028335814030021; Kaminskii AA, 2004, LASER PHYS LETT, V1, P6, DOI 10.1002/lapl.200310004; KAMINSKII AA, 1987, SOV PHYS DOKL, V32, P91; KAMINSKII AA, 1983, PHYS STATUS SOLIDI A, V77, pK173, DOI 10.1002/pssa.2210770268; KAMINSKII AA, 1982, INORG MATER+, V18, P1645; KAMINSKII AA, 1988, PHYS STATUS SOLIDI A, V105, pK155, DOI 10.1002/pssa.2211050259; Kaminskii A. A., 1981, Bulletin of the Academy of Sciences of the USSR, Physical Series, V45; Kaminskii AA, 2013, PHYS STATUS SOLIDI B, V250, P1837, DOI 10.1002/pssb.201349201; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1045, DOI 10.1002/pssb.201451009; Kaminskii AA, 1997, PHYS STATUS SOLIDI B, V199, pR3, DOI 10.1002/1521-3951(199701)199:1<R3::AID-PSSB99993>3.0.CO;2-8; KAMINSKII AA, 1976, SOV PHYS JETP, V44, P516; KAMINSKII AA, 1978, PHYS STATUS SOLIDI A, V51, P509; KAMINSKII AA, 1980, LASER CRYSTALS THEIR; Kaminskii A., 1976, SOV TECH PHYS LETT, V2, P308; Kaminskii AA, 2000, PHYS STATUS SOLIDI A, V181, pR19, DOI 10.1002/1521-396X(200010)181:2<R19::AID-PSSA999919>3.0.CO;2-F; Kaminskii A. A., 1986, Soviet Physics - Doklady, V31; Kaminskii AA, 2013, LASER PHOTONICS REV, V7, P425, DOI 10.1002/lpor.201200123; Kisel VE, 2008, OPT LETT, V33, P2194, DOI 10.1364/OL.33.002194; KUWANO Y, 1978, J APPL PHYS, V49, P4223, DOI 10.1063/1.325335; KVAPIL J, 1988, CZECH J PHYS, V38, P237, DOI 10.1007/BF01596501; MARTIN KW, 1973, APPL OPTICS, V12, P941, DOI 10.1364/AO.12.000941; MASSEY GA, 1971, APPL PHYS LETT, V18, P576, DOI 10.1063/1.1653547; SHIMANOUCHI T, 1961, J CHEM PHYS, V35, P1597, DOI 10.1063/1.1732116; SUDA S, 2003, J PHYS SOC JPN, V72, P1418; Vali R, 2007, J LUMIN, V127, P727, DOI 10.1016/j.jlumin.2007.04.009; Weber M. J., 2001, HDB LASERS; WEBER MJ, 1970, IEEE J QUANTUM ELECT, VQE 6, P654, DOI 10.1109/JQE.1970.1076333; WEBER MJ, 1971, IEEE J QUANTUM ELECT, VQE 7, P497, DOI 10.1109/JQE.1971.1076555; WEBER MJ, 1973, IEEE J QUANTUM ELECT, VQE 9, P1079, DOI 10.1109/JQE.1973.1077426; Weber M.J., 1999, HDB LASER WAVELENGTH; ZENG ZD, 1990, APPL OPTICS, V29, P1281, DOI 10.1364/AO.29.001281	49	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1863-8880	1863-8899		LASER PHOTONICS REV	Laser Photon. Rev.	NOV	2014	8	6					904	915		10.1002/lpor.201400058		12	Optics; Physics, Applied; Physics, Condensed Matter	Optics; Physics	AT0UB	WOS:000344649100010		
J	Miyazaki, H; Romeo, U; Ohshiro, T; Kudo, T; Makiguchi, T; Kawachi, N; Ogawa, M; Inoue, Y; Yokoo, S				Miyazaki, Hidetaka; Romeo, Umberto; Ohshiro, Takafumi; Kudo, Toshifumi; Makiguchi, Takaya; Kawachi, Naoko; Ogawa, Masaru; Inoue, Yoshinori; Yokoo, Satoshi			Treatment strategies for large oral venous malformations using intralesional laser photocoagulation	LASERS IN MEDICAL SCIENCE			English	Article						Vascular lesion; Venous malformation; Intralesional photocoagulation; Multiple spot irradiation; Compartmentalization; Serial step treatment	VASCULAR MALFORMATIONS; HEMANGIOMAS; CAVITY	We report two treatment strategies using intralesional laser photocoagulation (ILP) for large venous malformations (VMs) in the oral cavity. ILP is considered to be an effective technique for massive vascular lesion. The satisfactory results could have been obtained, since we started ILP for the treatment of large VMs. Recently, to improve the safety, reliability, and effectiveness of the treatment, we developed modifications of ILP that include a combination of ILP and transmucosal irradiation; and compartmentalization and serial step irradiation. In the former, ILP is performed for a deep layer lesion and transmucosal irradiation with multiple spots fashioned using a single pulse is added for the superficial layer in the same session, to increase the efficacy of regression. In the latter, the lesion is divided by virtual compartment and each area will be sequentially treated by ILP. The irradiated area and total energy in a session should be limited to avoid severe reactions and excessive thermal destruction of surrounding tissue. All treatment outcomes by each technique were satisfactory without serious complications, such as deep ulcer formation, bleeding, or severe swelling developing obstruction. Both treatment strategies improve the safety, reliability, and effectiveness of ILP and make the method less traumatic for patients.	[Miyazaki, Hidetaka; Makiguchi, Takaya; Kawachi, Naoko; Ogawa, Masaru; Yokoo, Satoshi] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan; [Romeo, Umberto] Univ Roma La Sapienza, Dept Oral Sci & Maxillofacial Surg, I-00161 Rome, Italy; [Ohshiro, Takafumi] Ohshiro Clin, Shinjuku Ku, Tokyo 1600016, Japan; [Kudo, Toshifumi; Inoue, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Vasc Surg, Dept Surg,Bunkyo Ku, Tokyo 1138519, Japan	Miyazaki, H (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	miyaosur@gunma-u.ac.jp					APFELBERG DB, 1995, ANN PLAS SURG, V35, P144, DOI 10.1097/00000637-199508000-00004; Burstein FD, 2006, J CRANIOFAC SURG, V17, P756, DOI 10.1097/00001665-200607000-00029; DIXON JA, 1986, LARYNGOSCOPE, V96, P537, DOI 10.1288/00005537-198605000-00013; Enjolars O, 2007, COLOR ATLAS VASCULAR; Jackson IT, 2005, PLAST RECONSTR SURG, V115, P10, DOI 10.1097/01.PRS.0000145667.57631.8B; Laranne J, 1997, ACTA OTO-LARYNGOL, V117, P909, DOI 10.3109/00016489709114223; Miyazaki H, 2013, INT J ORAL MAX SURG, V42, P281, DOI 10.1016/j.ijom.2012.06.011; Miyazaki H, 2009, ORAL SURG ORAL MED O, V107, P164, DOI 10.1016/j.tripleo.2008.08.004; Ohshiro T, 1996, LASER TREATMENT NAEV, P174	9	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	NOV	2014	29	6					1987	1990		10.1007/s10103-013-1394-2		4	Engineering, Biomedical; Surgery	Engineering; Surgery	AS9CA	WOS:000344539700028		
J	Shitara, M; Okuda, K; Suzuki, A; Tatematsu, T; Hikosaka, Y; Moriyama, S; Sasaki, H; Fujii, Y; Yano, M				Shitara, Masayuki; Okuda, Katsuhiro; Suzuki, Ayumi; Tatematsu, Tsutomu; Hikosaka, Yu; Moriyama, Satoru; Sasaki, Hidefumi; Fujii, Yoshitaka; Yano, Motoki			Genetic profiling of thymic carcinoma using targeted next-generation sequencing	LUNG CANCER			English	Article						Thymic carcinoma; Squamous cell carcinoma; Targeted next-generation sequencing; Genetic profiling; Tyrosine kinase gene mutation; Heterogeneous	SQUAMOUS-CELL CARCINOMA; EPITHELIAL TUMORS; EXPRESSION; MUTATION; THYMOMA; KIT; IMATINIB; RECEPTOR; THERAPY; HEAD	Objectives: Thymic carcinoma is a rare mediastinal neoplasm and little is known about its tumorigenesis. There is no effective treatment except for complete resection, and the prognosis of advanced cases is poor. To identify the mutations associated with tumorigenesis, we analyzed genetic profile of thymic carcinoma using targeted next-generation sequencing. Materials and methods: We sequenced about 409 cancer-related genes in 12 thymic squamous cell carcinoma tissues including 10 tumor/normal tissue pairs using Ion AmpliSeq Cancer Panel and Ion PGM Sequencer. We filtered the mutations with Ingenuity Variant Analysis, SIFT, PolyPhen-2, and PROVEAN. Results and conclusion: Twenty-five candidate mutations in 24 genes were identified, including five tyrosine kinase genes (KIT, DDR2, PDGFRA, ROS1, IGF1R). There was no recurrent mutation among the samples studied. The KIT exon 11 deletion mutation in 1 patient was an activating mutation and may be an oncogenic driver mutation. Genetic profiling of thymic carcinoma using targeted next-generation sequencing was performed. The mutation status of thymic squamous cell carcinoma is highly heterogeneous. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Shitara, Masayuki; Okuda, Katsuhiro; Suzuki, Ayumi; Tatematsu, Tsutomu; Hikosaka, Yu; Moriyama, Satoru; Sasaki, Hidefumi; Fujii, Yoshitaka; Yano, Motoki] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi 4678601, Japan	Okuda, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	kokuda@med.nagoya-cu.ac.jp					Weissferdt A, 2012, LUNG CANCER, V77, P515, DOI 10.1016/j.lungcan.2012.05.108; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Suzuki E, 2006, JPN J CLIN ONCOL, V36, P351, DOI 10.1093/jjco/hyl028; Strobel P, 2004, NEW ENGL J MED, V350, P2625, DOI 10.1056/NEJM200406173502523; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hirabayashi H, 1997, INT J CANCER, V73, P639; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; YAMAKAWA Y, 1991, CANCER, V68, P1984, DOI 10.1002/1097-0142(19911101)68:9<1984::AID-CNCR2820680923>3.0.CO;2-P; Yoh K, 2008, LUNG CANCER, V62, P316, DOI 10.1016/j.lungcan.2008.03.013; Yano M, 2008, J THORAC ONCOL, V3, P265, DOI 10.1097/JTO.0b013e3181653c71; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006; Pan CC, 2003, HISTOPATHOLOGY, V43, P165, DOI 10.1046/j.1365-2559.2003.01663.x; Hagemann IS, 2014, J THORAC ONCOL, V9, pE12, DOI 10.1097/JTO.0b013e3182a7d22e; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Sasaki H, 2010, J THORAC ONCOL, V5, P1715, DOI 10.1097/JTO.0b013e3181f1cab3; Stadler ZK, 2014, J CLIN ONCOL; TATEYAMA H, 1995, AM J CLIN PATHOL, V104, P375; Weissferdt A, 2012, AM J CLIN PATHOL, V138, P103, DOI 10.1309/AJCP88FZTWANLRCB; Weissferdt A, 2012, LUNG CANCER, V78, P127, DOI 10.1016/j.lungcan.2012.08.002	24	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	NOV	2014	86	2					174	179		10.1016/j.lungcan.2014.08.020		6	Oncology; Respiratory System	Oncology; Respiratory System	AS7LU	WOS:000344438400011		
J	Kishimoto, M; Iwano, S; Ito, S; Kato, K; Ito, R; Naganawa, S				Kishimoto, Mariko; Iwano, Shingo; Ito, Shinji; Kato, Katsuhiko; Ito, Rintaro; Naganawa, Shinji			Prognostic evaluations of small size lung cancers by F-18-FDG PET/CT and thin-section CT	LUNG CANCER			English	Article						Lung cancer; Prognosis; Computed tomography; Consolidation/tumor ratio; Positron emission tomography; SUVmax; Non-small cell carcinoma; Imaging biomarker	RESOLUTION COMPUTED-TOMOGRAPHY; ONCOLOGY GROUP 0201; IASLC/ATS/ERS CLASSIFICATION; SUBLOBAR RESECTION; ADENOCARCINOMA; MULTICENTER; RECURRENCE; SURVIVAL; PREDICTION; TUMORS	Purpose: Primary lung cancers have varying prognoses, even for tumors <= 3 cm in diameter. Thus, a thorough evaluation is necessary for therapeutic planning. Two imaging biomarkers have been shown to be useful for predicting primary lung cancer prognosis: maximum standardized uptake values (SUVmax) on fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and the consolidation/tumor (C/T) ratio defined as the maximum diameter of consolidation within a tumor to the maximum tumor diameter on thin-section computed tomography (TSCT). We compared these biomarkers for predicting post-surgical recurrence in patients with small lung cancers. Materials and methods: Clinical records, post-operative pathologic findings, and pre-operative PET/CT and TSCT images were reviewed. Solitary primary lung cancers of <= 3 cm in diameter after surgical resection were selected for analysis. SUVmax and C/T ratios were recorded. Kaplan-Meier survival curves and Cox hazards ratios were used to identify independent predictors of lung cancer recurrence from among age, gender, surgical procedure, lesion size, C/T ratio, and SUVmax. Results: A total of 169 patients (114 males and 55 females; age range: 34-87 years) with solitary lung cancers were evaluated. The median post-operative follow-up period was 42 months. Twenty-eight patients had cancer recurrence with significantly higher SUVmax (p < 0.001) and C/T ratios (p < 0.001) than patients without recurrence. Disease-free survival was significantly reduced for SUVmax of >= 2.5 vs. SUVmax of <2.5 (p < 0.001) or for a C/T ratio of >= 50% vs. a C/T ratio of <50% (p = 0.030). For 19 patients with C/T ratios of <50%, none had a post-operative recurrence. A Cox hazards ratio model showed that only SUVmax was an independent predictor of recurrence (hazards ratio = 1.324; p < 0.001). Conclusion: SUVmax on FDG-PET/CT was a significant imaging biomarker relevant to the prognosis of patients with lung cancers, and was superior to the C/T ratio on TSCT for predicting postoperative recurrence, particularly for solid type lung cancer. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kishimoto, Mariko; Iwano, Shingo; Ito, Shinji; Ito, Rintaro; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kato, Katsuhiko] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan	Iwano, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	iwano45@med.nagoya-u.ac.jp	Kato, Katsuhiko/D-7965-2013; IWANO, Shingo/I-7355-2014	Kato, Katsuhiko/0000-0002-2083-9319; 			Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; De Zoysa MK, 2012, INTERACT CARDIOV TH, V14, P816, DOI 10.1093/icvts/ivs031; Tsutani Y, 2012, J THORAC CARDIOV SUR, V144, P1365, DOI 10.1016/j.jtcvs.2012.07.012; Shimada Y, 2012, J THORAC ONCOL, V7, P1263, DOI 10.1097/JTO.0b013e31825cca6e; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Woo T, 2012, PATHOL INT, V62, P785, DOI 10.1111/pin.12016; Tsutani Y, 2012, J THORAC CARDIOV SUR, V143, P607, DOI 10.1016/j.jtcvs.2011.10.037; Lee HY, 2013, J MAGN RESON IMAGING, V38, P905, DOI 10.1002/jmri.24080; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; Okada M, 2007, J THORAC CARDIOV SUR, V133, P1448, DOI 10.1016/j.jtcvs.2007.02.023; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Keenan RJ, 2004, ANN THORAC SURG, V78, P228, DOI 10.1016/j.athoracsur.2004.01.024; Iwano S, 2013, LUNG CANCER, V79, P132, DOI 10.1016/j.lungcan.2012.10.018; Jiang BH, 2013, EUR J RADIOL, V82, pE623, DOI 10.1016/j.ejrad.2013.06.010; Koike T, 2012, ANN THORAC SURG, V93, P1788, DOI 10.1016/j.athoracsur.2012.02.093; Maeda R, 2010, CHEST, V138, P357, DOI 10.1378/chest.09-3046; Matsuguma H, 2013, ANN THORAC SURG, V95, P1878, DOI 10.1016/j.athoracsur.2013.02.022; Nitadori J, 2013, ANN SURG ONCOL, V20, P4282, DOI 10.1245/s10434-013-3212-2	19	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	NOV	2014	86	2					180	184		10.1016/j.lungcan.2014.09.006		5	Oncology; Respiratory System	Oncology; Respiratory System	AS7LU	WOS:000344438400012		
J	Matsumoto, Y; Maemondo, M; Ishii, Y; Okudera, K; Demura, Y; Takamura, K; Kobayashi, K; Morikawa, N; Gemma, A; Ishimoto, O; Usui, K; Harada, M; Miura, S; Fujita, Y; Sato, I; Saijo, Y				Matsumoto, Yoshifumi; Maemondo, Makoto; Ishii, Yoshiki; Okudera, Koichi; Demura, Yoshiki; Takamura, Kei; Kobayashi, Kunihiko; Morikawa, Naoto; Gemma, Akihiko; Ishimoto, Osamu; Usui, Kazuhiro; Harada, Masao; Miura, Satoru; Fujita, Yuka; Sato, Ikuro; Saijo, Yasuo		North-East Japan Study Grp	A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)	LUNG CANCER			English	Article						EGFR-TKI; Wild type EGFR; Re-evaluation; Erlotinib; HGF	GROWTH-FACTOR-RECEPTOR; ACTIVATING MUTATIONS; JAPANESE PATIENTS; GEFITINIB; ADENOCARCINOMA; CHEMOTHERAPY; MULTICENTER; RESISTANCE; THERAPY; NSCLC	Objectives: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are particularly effective in non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations. However, some studies have reported survival benefits in NSCLC patients with wild-type EGFR upon erlotinib treatment. This trial was conducted to evaluate the efficacy of erlotinib monotherapy and investigate the predictive values of several biomarkers. Patients and methods: Patients with previously treated NSCLC but without EGFR gene mutations that had never or light smoked were eligible for this study. Gene status screening was performed using the PNA-LNA PCR clamp method. Erlotinib was administered until disease progression or unacceptable toxicities occurred. EGFR gene status was re-evaluated using the fragment method to detect exon 19 deletions and the Cycleave-PCR method to detect point mutations. Expression of hepatocyte growth factor (HGF), Met, and thymidylate synthase (TS) were evaluated using immunohistochemistry. Results: Forty-seven patients were enrolled in the study between March 2010 and November 2011. Objective response rate (ORR) and disease control rate (DCR) were 15.2% and 41.3%. Re-evaluations for EGFR gene were performed in 32 tumor samples. EGFR gene mutations were found in eight samples (5:exon 19 deletion, 2:G719X, 1:L858R). Six patients had PR and two had SD among these eight patients. A total of 24 patients were confirmed as wild-type EGFR using different methods. ORR and DCR were 4.2% and 41.7%. The median progression free survival (PFS) and median survival times were 2.0 and 6.0 months, respectively. Patients with tumors expressing HGF showed shorter PFS but not MET or TS. Conclusions: Re-examination of EGFR gene status using different detecting method or different sample should be considered to grasp a chance of erlotinib treatment after first line treatment. In confirmed EGFR wild NSCLC, negative HGF staining could be a biomarker for longer PFS by erlotonib treatment. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Matsumoto, Yoshifumi; Saijo, Yasuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Oncol, Niigata 9518510, Japan; [Matsumoto, Yoshifumi; Saijo, Yasuo] Hirosaki Univ, Grad Sch Med, Dept Med Oncol, Hirosaki, Aomori, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Ishii, Yoshiki] Dokkyo Med Univ, Sch Med, Dept Pulm Med & Clin Immunol, Mibu, Tochigi, Japan; [Okudera, Koichi] Hirosaki Cent Hosp, Hirosaki, Aomori, Japan; [Demura, Yoshiki] Ishikawa Prefectural Cent Hosp, Div Resp Med, Kanazawa, Ishikawa, Japan; [Takamura, Kei] Obihiro Kousei Gen Hosp, Obihiro, Hokkaido, Japan; [Kobayashi, Kunihiko] Saitama Med Univ, Dept Resp Med, Saitama, Japan; [Morikawa, Naoto] Iwate Med Univ, Sch Med, Dept Internal Med, Div Pulm Med Allergy & Rheumatol, Morioka, Iwate 020, Japan; [Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan; [Ishimoto, Osamu] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Usui, Kazuhiro] NIT Med Ctr Tokyo, Div Respirol, Tokyo, Japan; [Harada, Masao] Natl Hosp Org, Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; [Miura, Satoru] Niigata Univ, Med & Dent Hosp, Div Resp Med, Niigata, Japan; [Fujita, Yuka] Natl Hosp Org, Asahikawa Med Ctr, Asahikawa, Hokkaido, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Dept Pathol, Natori, Miyagi 9811293, Japan	Saijo, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Oncol, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	yasosj@med.niigata-u.ac.jp			Tokyo Cooperative Oncology Group	This study was supported by The Tokyo Cooperative Oncology Group.	Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; [Anonymous], 2004, N ENGL J MED, V350, P2129; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Brugger W, 2011, J CLIN ONCOL, V29, P4113, DOI 10.1200/JCO.2010.31.8162; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kasahara K, 2010, CLIN CANCER RES, V16, P4616, DOI 10.1158/1078-0432.CCR-10-0383; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Yoshioka H, 2010, J THORAC ONCOL, V5, P99, DOI 10.1097/JTO.0b013e3181c20063; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Wu JY, 2011, LUNG CANCER, V72, P205, DOI 10.1016/j.lungcan.2010.08.013; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Yoshida K, 2007, J THORAC ONCOL, V2, P22, DOI 10.1097/01243894-200701000-00006; Kobayashi T, 2012, CANCER CHEMOTH PHARM, V69, P1241, DOI 10.1007/s00280-012-1831-0; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924; Garassino MC, 2013, LANCET ONCOL; Okano Y, 2013, J CLIN ONCOL S, V31; Schneider CP, 2008, J THORAC ONCOL, V3, P1446, DOI 10.1097/JTO.0b013e31818ddcaa	26	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	NOV	2014	86	2					195	200		10.1016/j.lungcan.2014.08.019		6	Oncology; Respiratory System	Oncology; Respiratory System	AS7LU	WOS:000344438400015		
J	Yoshioka, H; Komuta, K; Imamura, F; Kudoh, S; Seki, A; Fukuoka, M				Yoshioka, Hiroshige; Komuta, Kiyoshi; Imamura, Fumio; Kudoh, Shoji; Seki, Akihiro; Fukuoka, Masahiro			Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer	LUNG CANCER			English	Article						Non-small-cell lung cancer; Geriatric; Erlotinib; Epidermal growth factor receptor; Tyrosine-kinase inhibitor; Interstitial lung disease	CLINICAL-TRIALS; NSCLC; AGE; DATABASE; RATES; OLDER	Objective: More tolerable treatment options are needed for the large number of elderly patients with non-small-cell lung cancer (NSCLC). An analysis of the phase IV POLARSTAR surveillance study examined the safety and efficacy of erlotinib in elderly Japanese patients with previously treated NSCLC. Materials and methods: From December 2007 to October 2009, all erlotinib-treated patients with unresectable, recurrent/advanced NSCLC in Japan were enrolled. Efficacy and safety data were stratified by age (<75 years, 75-84 years, >= 85 years). Kaplan-Meier methodology was used to estimate median progression-free survival (PFS). Safety data were collected with a focus on interstitial lung disease (ILD). Results: A total of 9907 patients were eligible for safety assessment (<75 years, n = 7848; 75-84 years, n = 1911; >= 85 years, n = 148) and 9651 for efficacy assessment (<75 years, n = 7701; 75-84 years, n =1815; >= 85 years, n = 135). Other baseline characteristics were balanced. The incidence of ILD (all grades) was 4.2% (<75 years), 5.1% (75-84 years), and 3.4% (>= 85 years). The mortality rate due to ILD was <= 1.7% in all age groups. Other toxicities (including rash) were similar between age groups. The median PFS was 65 days (95% confidence interval [CI], 62-68) for patients aged <75 years, 74 days (95% CI, 69-82) for patients aged 75-84 years, and 72 days (95% CI, 56-93) for patients aged >= 85 years. Conclusions: Efficacy and tolerability of erlotinib for elderly patients was not numerically inferior to that reported in younger patients. Erlotinib could be considered for elderly patients with recurrent/advanced NSCLC. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Yoshioka, Hiroshige] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama 7108602, Japan; [Komuta, Kiyoshi] Osaka Police Hosp, Dept Resp Med, Tennoji Ku, Osaka 5430035, Japan; [Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Higashinari Ku, Osaka 5378511, Japan; [Kudoh, Shoji] Double Barred Cross Hosp, Japan Anti TB Assoc, Tokyo 2048522, Japan; [Seki, Akihiro] Chugai Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038324, Japan; [Fukuoka, Masahiro] Izumi Municipal Hosp, Izumi Ku, Osaka 5940071, Japan	Yoshioka, H (reprint author), Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	hirotin@kchnet.or.jp			Chugai Pharmaceutical Co. Ltd.	This trial was designed, funded, and monitored by Chugai Pharmaceutical Co., Ltd. Data were gathered, analyzed, and interpreted by Chugai with input from all authors. The corresponding author had full access to the relevant data and took full responsibility for the final decision to submit the report for publication.	Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Goto K, 2013, LUNG CANCER, V82, P109, DOI 10.1016/j.lungcan.2013.07.003; YELLEN SB, 1994, J NATL CANCER I, V86, P1766, DOI 10.1093/jnci/86.23.1766; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Kubota K, 2008, J THORAC ONCOL, V3, P1439, DOI 10.1097/JTO.0b013e31818d6702; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Yamamoto N, 2008, CANCER CHEMOTH PHARM, V61, P489, DOI 10.1007/s00280-007-0494-8; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Costa GJ, 2006, LUNG CANCER-J IASLC, V53, P171, DOI 10.1016/j.lungcan.2006.04.006; Giuliani J, 2013, ARCH DERMATOL RES, V305, P653, DOI 10.1007/s00403-013-1345-6; Katanoda K, 2011, JPN J CLIN ONCOL, V41, P1046, DOI 10.1093/jjco/hyr109; Kuwano K, 2013, J THORAC ONCOL, V8, pS142; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Takahashi T, 2010, ANTICANCER RES, V30, P557; Tsao AS, 2012, J THORAC ONCOL, V7, P1645, DOI 10.1097/JTO.0b013e31826910ff	18	3	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	NOV	2014	86	2					201	206		10.1016/j.lungcan.2014.09.015		6	Oncology; Respiratory System	Oncology; Respiratory System	AS7LU	WOS:000344438400016		
J	Kaneda, T; Hata, A; Tomioka, H; Tanaka, K; Kaji, R; Fujita, S; Tomii, K; Katakami, N				Kaneda, Toshihiko; Hata, Akito; Tomioka, Hiromi; Tanaka, Kosuke; Kaji, Reiko; Fujita, Shiro; Tomii, Keisuke; Katakami, Nobuyuki			Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer	LUNG CANCER			English	Article						EGFR mutation; Exon 19 deletion; EGFR-TKI; Subtype; Progression-free survival; Insertion	GROWTH-FACTOR RECEPTOR; 1ST-LINE TREATMENT; OPEN-LABEL; MUTATIONS; GEFITINIB; ERLOTINIB; CHEMOTHERAPY; MULTICENTER; SURVIVAL; PHASE-3	Background: Exon 19 deletion mutations (Del-19s) and the exon 21 L858R point mutation are the most common epidermal growth factor receptor (EGFR) mutations. In Del-19, several subtypes actually exist, consisting of the deletional location with or without amino acid insertion/substitution. Little evidence has been described whether the Del-19 subtype affects EGFR-tyrosine kinase inhibitor (TKI) efficacy. Methods: Between December 2005 and July 2012, we investigated 105 patients harboring a Del-19 who had received EGFR-TKIs. Efficacies of EGFR-TKIs such as response rate (RR), progression-free survival (PFS), and overall survival (OS) were retrospectively evaluated among various patient characteristics. Results: Among these 105 patients with Del-19s, 78(74%) patients had a deletion from E746 (Del-E746), and 27 (26%) exhibited a deletion from L747 (Del-L747). Median PFS of Del-E746 (11.7 months, 95% confidence interval [CI]: 9.3-15.6) was significantly longer than Del-L747 (10.0 months, 95% CI: 6.4-12.7) (p = 0.022). Insertions/substitutions were found in 19 patients (18%), and 91 patients (82%) were without insertions/substitutions. Median PFS without insertions/substitutions (11.7 months, 95% CI 9.3-15.2) was significantly longer than with insertions/substitutions (10.0 months, 95% CI: 4.0-10.6) (p = 0.024). No relationships were found for RR among all patient characteristics. In multivariate analysis, performance status (PS) (0/1 vs 2/3) and initial deletion site (Del-E746 vs Del-L747) were significant factors for longer PFS, whereas PS, gender (male vs female) and histology (adeno vs squamous) for longer OS. Conclusions: Our data indicated better efficacy of EGFR-TKI in Del-E746 than Del-L747. Deletional locations may affect EGFR-TKI efficacy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kaneda, Toshihiko; Tomioka, Hiromi] Kobe City Med Ctr West Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Hata, Akito; Tanaka, Kosuke; Kaji, Reiko; Fujita, Shiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo 6500047, Japan; [Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org					Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Lee VHF, 2013, J THORAC ONCOL, V8, P1148, DOI 10.1097/JTO.0b013e31829f684a; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Chung KP, 2012, CLIN CANCER RES, V18, P3470, DOI 10.1158/1078-0432.CCR-11-2353; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Costa EC, 2012, J CLIN ONCOL S, V30; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Taron M, 2010, J CLIN ONTOL S15, V28	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	NOV	2014	86	2					213	218		10.1016/j.lungcan.2014.09.014		6	Oncology; Respiratory System	Oncology; Respiratory System	AS7LU	WOS:000344438400018		
J	Jeffries, EM; Nakamura, S; Lee, KW; Clampffer, J; Ijima, H; Wang, YD				Jeffries, Eric M.; Nakamura, Shintaro; Lee, Kee-Won; Clampffer, Jimmy; Ijima, Hiroyuki; Wang, Yadong			Micropatterning Electrospun Scaffolds to Create Intrinsic Vascular Networks	MACROMOLECULAR BIOSCIENCE			English	Article						3D printing; additive manufacturing; electrospinning; endothelial cells; microcirculation	IN-VITRO; ENGINEERED TISSUES; BIOMEDICAL APPLICATIONS; MICROVASCULAR NETWORKS; MICROCHANNEL NETWORKS; HYDROGELS; FABRICATION; MICROFABRICATION; CONSTRUCTS; GELATIN	Sufficient vascularization is critical to sustaining viable tissue-engineered (TE) constructs after implantation. Despite significant progress, current approaches lack suturability, porosity, and biodegradability, which hinders rapid perfusion and remodeling in vivo. Consequently, TE vascular networks capable of direct anastomosis to host vasculature and immediate perfusion upon implantation still remain elusive. Here, a hybrid fabrication method is presented for micropatterning fibrous scaffolds that are suturable, porous, and biodegradable. Fused deposition modeling offers an inexpensive and automated approach to creating sacrificial templates with vascular-like branching. By electrospinning around these poly(vinyl alcohol) templates and dissolving them in water, microvascular patterns were transferred to fibrous scaffolds. Results indicated that these scaffolds have sufficient suture retention strength to permit direct anastomosis in future studies. Vascularization of these scaffolds is demonstrated by in vitro endothelialization and perfusion.	[Jeffries, Eric M.; Lee, Kee-Won; Clampffer, Jimmy; Wang, Yadong] McGowan Inst Regenerat Med, Dept Bioengn, Pittsburgh, PA 15261 USA; [Nakamura, Shintaro; Ijima, Hiroyuki] Kyushu Univ, Grad Sch, Dept Chem Engn, Fac Engn,Nishi Ku, Fukuoka 8190395, Japan	Wang, YD (reprint author), McGowan Inst Regenerat Med, Dept Bioengn, Pittsburgh, PA 15261 USA.	yaw20@pitt.edu			NHLBI [HL089658]; NSF [DMR-1206589]; University of Pittsburgh	We would like to thank the University of Pittsburgh Center for Biologic Imaging (CBI) for access to SEM. Funding is provided in part by the NHLBI Grant # HL089658, the NSF Grant #DMR-1206589, and the University of Pittsburgh.	Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Huang ZC, 2012, BIOMED MICRODEVICES, V14, P873, DOI 10.1007/s10544-012-9667-2; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/nmat3357, 10.1038/NMAT3357]; Morgan JP, 2013, NAT PROTOC, V8, P1820, DOI 10.1038/nprot.2013.110; Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203; Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662; Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com; Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585; Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Seto Y, 2010, BIOMATERIALS, V31, P2209, DOI 10.1016/j.biomaterials.2009.11.104; Brown TD, 2011, ADV MATER, V23, P5651, DOI 10.1002/adma.201103482; Bellan LM, 2012, ADV MATER, V24, P5187, DOI 10.1002/adma.201200810; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002; Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056; Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302; Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912; Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8; Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c; Jeffries EM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035015; Uygun BE, 2012, NAT REV GASTRO HEPAT, V9, P738, DOI 10.1038/nrgastro.2012.140; Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.TEC.2012.0430, 10.1089/ten.tec.2012.0430]; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; Ortega I, 2013, ACTA BIOMATER, V9, P5511, DOI 10.1016/j.actbio.2012.10.039; Hakimi O, 2012, EUR CELLS MATER, V24, P344; Rnjak-Kovacina J, 2011, TISSUE ENG PART B-RE, V17, P365, DOI 10.1089/ten.teb.2011.0235; Lokmic Z, 2008, TISSUE ENG PT B-REV, V14, P87, DOI 10.1089/teb.2007.0299; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158; Hong Y, 2012, TISSUE ENG PART C-ME, V18, P122, DOI [10.1089/ten.TEC.2011.0295, 10.1089/ten.tec.2011.0295]; Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003; Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926; Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8; Park JH, 2010, BIOTECHNOL BIOENG, V106, P138, DOI 10.1002/bit.22667; Dalton PD, 2006, BIOMACROMOLECULES, V7, P686, DOI 10.1021/bm050777q; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; He JK, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025002; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; BURTON AC, 1951, AM J PHYSIOL, V164, P319; Ashammakhi N, 2008, REGEN MED, V3, P547, DOI 10.2217/17460751.3.4.547; Bellan LM, 2012, ADV HEALTHC MATER, V1, P164, DOI 10.1002/adhm.201100052; BLACK MJM, 1978, BRIT J PLAST SURG, V31, P295, DOI 10.1016/S0007-1226(78)90114-5; Blaeser Andreas, 2013, Biores Open Access, V2, P374, DOI 10.1089/biores.2013.0031; Chen R., 2009, FRONT MAT SCI CHINA, V3, P359; Esch MB, 2011, TISSUE ENG PT A, V17, P2965, DOI 10.1089/ten.tea.2010.0371; Finne-Wistrand A, 2008, MACROMOL BIOSCI, V8, P951, DOI 10.1002/mabi.200700328; Hammer J, 2014, TISSUE ENG PART C-ME, V20, P169, DOI [10.1089/ten.TEC.2013.0176, 10.1089/ten.tec.2013.0176]; Kim G. H., 2008, MACROMOL RAPID COMM, P1577; Lee W., 2009, BIOTECHNOL BIOENG, V105, P1178; Liu YX, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/1/015004; Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894; Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023; Muller D, 2011, STEM CELLS INT, V2011; Naik N., 2011, C P IEEE ENG MED BIO, V2011, P290; Shi J, 2009, LANGMUIR, V25, P6015, DOI 10.1021/la900811k; Stevens KR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2853; Sun JX, 2011, J MATER SCI-MATER M, V22, P2565, DOI 10.1007/s10856-011-4426-0; Tirella A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045002; Wang X.-Y., 2014, LAB CHIP; Wei C, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/2/025017; Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001; Ye XF, 2013, BIOMATERIALS, V34, P10007, DOI 10.1016/j.biomaterials.2013.09.039; Zheng Y., 2013, P NATL ACAD SCI USA, V109, P9342	69	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	NOV	2014	14	11					1514	1520		10.1002/mabi.201400306		7	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	AT2FT	WOS:000344749200001		
J	Baker, PJ; Patwardhan, SV; Numata, K				Baker, Peter J.; Patwardhan, Siddharth V.; Numata, Keiji			Synthesis of Homopolypeptides by Aminolysis Mediated by Proteases Encapsulated in Silica Nanospheres	MACROMOLECULAR BIOSCIENCE			English	Article						encapsulation; hydrophobic amino acids; peptide synthesis; protease; silica	ACID DIETHYL ESTER; PEPTIDE-SYNTHESIS; CATALYZED OLIGOMERIZATION; CHEMOENZYMATIC SYNTHESIS; ENZYME IMMOBILIZATION; ALPHA-CHYMOTRYPSIN; ETHYL-ESTER; L-LYSINE; PAPAIN; ENTRAPMENT	We report the encapsulation of three different proteases in bioinspired silica. Silica particles were formed under mild reaction conditions using cationic amine-rich ethyleneamines as initiators, which resulted in aggregations of nanoscale spheres. Following encapsulation, the proteases were characterized for their hydrolytic and aminolytic activities. The encapsulation resulted in an increase in the thermal stability of the proteases for both hydrolysis and aminolysis reactions. The enhanced thermal stability of the encapsulated proteases increased the production of poly-L-leucine by aminolysis. Furthermore, the encapsulation of papain resulted in an increase in the production of poly-L-alanine and poly-L-valine at 50 degrees C.	[Baker, Peter J.; Numata, Keiji] RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Enzyme Res Team, Wako, Saitama 3510198, Japan; [Patwardhan, Siddharth V.] Univ Strathclyde, Dept Chem & Proc Engn, Glasgow G1 1XJ, Lanark, Scotland	Numata, K (reprint author), RIKEN, Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji.numata@riken.jp	Patwardhan, Siddharth/B-5037-2009; Numata, Keiji/H-9751-2012	Patwardhan, Siddharth/0000-0002-4958-8840; 	RIKEN Biomass Engineering Program	K. N. acknowledges funding from RIKEN Biomass Engineering Program.	Ageitos JM, 2013, BIOMACROMOLECULES, V14, P3635, DOI 10.1021/bm4009974; ANDERSON G, 1979, HELV CHIM ACTA, V62, P488, DOI 10.1002/hlca.19790620214; Forsyth C, 2013, CHEM COMMUN, V49, P3191, DOI 10.1039/c2cc38225c; Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; Li G, 2006, MACROMOLECULES, V39, P7915, DOI 10.1021/ma061419y; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Reetz MT, 1996, BIOTECHNOL BIOENG, V49, P527, DOI 10.1002/(SICI)1097-0290(19960305)49:5<527::AID-BIT5>3.0.CO;2-L; KLIBANOV AM, 1983, SCIENCE, V219, P722, DOI 10.1126/science.219.4585.722; Naik RR, 2004, CHEM COMMUN, P1684, DOI 10.1039/b404586f; Qin X, 2011, ACS CATAL, V1, P1022, DOI 10.1021/cs2002884; Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238; Forsyth C, 2013, J MATER CHEM B, V1, P1164, DOI 10.1039/c2tb00462c; Viswanathan K, 2010, BIOMACROMOLECULES, V11, P2152, DOI 10.1021/bm100516x; Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c; Ursoiu A, 2012, MOLECULES, V17, P13045, DOI 10.3390/molecules171113045; Li G, 2008, MACROMOLECULES, V41, P7003, DOI 10.1021/ma800946d; Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931; Hudson S, 2005, J PHYS CHEM B, V109, P19496, DOI 10.1021/jp052102n; Diaz JF, 1996, J MOL CATAL B-ENZYM, V2, P115, DOI 10.1016/S1381-1177(96)00017-3; Lin H, 2002, ENZYME MICROB TECH, V31, P588, DOI 10.1016/S0141-0229(02)00138-2; Baker PJ, 2012, BIOMACROMOLECULES, V13, P947, DOI 10.1021/bm201862z; Baker PJ, 2010, ACS SYM SER, V1043, P141; CHEN ST, 1991, BIOMED BIOCHIM ACTA, V50, pS181; David AE, 2011, METHODS MOL BIOL, V679, P49, DOI 10.1007/978-1-60761-895-9_6; Fagerland J, 2014, BIOMACROMOLECULES, V15, P735, DOI 10.1021/bm4015254; Fan J, 2003, CHEM COMMUN, P2140, DOI 10.1039/b304391f; FASTREZ J, 1973, BIOCHEMISTRY-US, V12, P2025, DOI 10.1021/bi00735a001; Harrach T, 1998, J PROTEIN CHEM, V17, P351, DOI 10.1023/A:1022507316434; Itoh T, 2010, COLLOID SURFACE B, V75, P478, DOI 10.1016/j.colsurfb.2009.09.022; Khan RH, 2003, J BIOSCIENCES, V28, P709, DOI 10.1007/BF02708431; Lin X, 1996, APPL ENVIRON MICROB, V62, P4273; Lombard C, 2005, PROTEIN PEPTIDE LETT, V12, P621, DOI 10.2174/0929866054696118; Madadlou A, 2010, BBA-GEN SUBJECTS, V1800, P459, DOI 10.1016/j.bbagen.2010.01.004; MORIHARA K, 1977, BIOCHEM J, V163, P531; Patwardhan SV, 2011, LANGMUIR, V27, P15135, DOI 10.1021/la204180r; SEARS PS, 1993, BIOTECHNOL BIOENG, V42, P118, DOI 10.1002/bit.260420116; SLUYTERM.LA, 1972, BIOCHIM BIOPHYS ACTA, V289, P194, DOI 10.1016/0005-2744(72)90122-2; Soeda Y, 2003, BIOMACROMOLECULES, V4, P196, DOI 10.1021/bm0200534; UI N, 1971, BIOCHIM BIOPHYS ACTA, V229, P582, DOI 10.1016/0005-2795(71)90273-X; Ungurean M., 2012, BIOPROC BIOSYST ENG, V36, P1327; van Unen DJ, 2001, BIOTECHNOL BIOENG, V75, P154, DOI 10.1002/bit.1173; Venkatesh R, 1998, PROTEIN ENG, V11, P691, DOI 10.1093/protein/11.8.691; Zamora P, 2009, BIOELECTROCHEMISTRY, V76, P100, DOI 10.1016/j.bioelechem.2009.05.006	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	NOV	2014	14	11					1619	1626		10.1002/mabi.201400295		8	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	AT2FT	WOS:000344749200012		
J	Thakur, A; Poonpong, S; Terano, M; Taniike, T				Thakur, Ashutosh; Poonpong, Supawadee; Terano, Minoru; Taniike, Toshiaki			New Quenching Method for Improving Large-Scale Stopped-Flow Technique	MACROMOLECULAR REACTION ENGINEERING			English	Article						kinetics; polyolefin; stopped-flow technique; Ziegler-Natta polymerization	MGCL2-SUPPORTED ZIEGLER CATALYST; ACTIVE-SITES; PROPENE POLYMERIZATION; OLEFIN POLYMERIZATION; CHAIN	The stopped-flow (SF) technique has been extensively used for active site analyses and kinetic investigations in heterogeneous Ziegler-Natta olefin polymerization catalysis, whereas a poor polymer yield due to a short polymerization period has been a major drawback of the conventional SF system, which later has been improved by the development of a large-scale SF (LSF) technique. In order to further improve the scalability of the LSF technique, the present paper reports a new polymerization quenching method, which has been established by applying a three-vessel-type analogue of the LSF system. The new quenching method endows identical kinetic profiles, but the scalability is successfully improved.	[Thakur, Ashutosh; Poonpong, Supawadee; Terano, Minoru; Taniike, Toshiaki] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Thakur, Ashutosh] Univ Delhi, Dept Chem, Delhi 110007, India	Taniike, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	taniike@jaist.ac.jp			Japan Polypropylene Corporation; Sumitomo Chemical Co., Ltd.; Toho Titanium Co., Ltd.; Tosoh Finechem Corporation	The authors thank Japan Polypropylene Corporation, Sumitomo Chemical Co., Ltd., Toho Titanium Co., Ltd. and Tosoh Finechem Corporation for their kind support.	Albizzati E., 1996, POLYPROPYLENE HDB; Liu BP, 2001, MACROMOL RAPID COMM, V22, P1, DOI 10.1002/1521-3927(20010101)22:1<1::AID-MARC1>3.0.CO;2-T; Mori H, 1998, MACROMOL CHEM PHYSIC, V199, P613, DOI 10.1002/(SICI)1521-3935(19980401)199:4<613::AID-MACP613>3.0.CO;2-H; Hiraoka Y, 2010, MACROMOL REACT ENG, V4, P510, DOI 10.1002/mren.200900070; KEII T, 1987, MAKROMOL CHEM-RAPID, V8, P583; Matsuoka H, 2001, MACROMOL RAPID COMM, V22, P326, DOI 10.1002/1521-3927(20010301)22:5<326::AID-MARC326>3.0.CO;2-G; Mori H, 1997, TRENDS POLYM SCI, V5, P314; MORI H, 1995, MACROMOL RAPID COMM, V16, P651, DOI 10.1002/marc.1995.030160903; Mori H, 2000, MACROMOL CHEM PHYSIC, V201, P289, DOI 10.1002/(SICI)1521-3935(20000201)201:3<289::AID-MACP289>3.0.CO;2-M; Mori H, 1998, MACROMOL CHEM PHYS, V199, P2709, DOI 10.1002/(SICI)1521-3935(19981201)199:12<2709::AID-MACP2709>3.3.CO;2-G; Taniike T, 2012, MACROMOL REACT ENG, V6, P275, DOI 10.1002/mren.201200003; Taniike T, 2011, MACROMOL CHEM PHYS, V212, P723, DOI 10.1002/macp.201000598; Terano M., 1989, [No title captured], Patent No. [US 4816433, 4816433]; Yamahiro M, 1999, MACROMOL CHEM PHYSIC, V200, P134, DOI 10.1002/(SICI)1521-3935(19990101)200:1<134::AID-MACP134>3.0.CO;2-S	14	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-832X	1862-8338		MACROMOL REACT ENG	Macromol. React. Eng.	NOV	2014	8	11					766	770		10.1002/mren.201400014		5	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	AT2DT	WOS:000344742600004		
J	Matsubayashi, H; Hanzawa, K; Kono, T; Ishige, T; Gakuhari, T; Lagan, P; Sunjoto, I; Sukor, JRA; Sinun, W; Ahmad, AH				Matsubayashi, Hisashi; Hanzawa, Kei; Kono, Tomohiro; Ishige, Taichiro; Gakuhari, Takashi; Lagan, Peter; Sunjoto, Indra; Sukor, Jum Rafiah Abdul; Sinun, Waidi; Ahmad, Abdul Hamid			First molecular data on Bornean banteng Bos javanicus lowi (Cetartiodactyla, Bovidae) from Sabah, Malaysian Borneo	MAMMALIA			English	Article						Bovinae; conservation; fecal samples; mitochondrial DNA; wild cattle	MITOCHONDRIAL GENOMES; NORTHERN-AUSTRALIA; CAMBODIAN BANTENG; TAXONOMIC STATUS; SATELLITE DNA; CATTLE; PHYLOGENY; KOUPREY; HYBRIDIZATION; EVOLUTION	Phylogenetic relationships among three subspecies of banteng, Burma banteng Bos javanicus birmanicus in mainland Southeast Asia, Javan banteng Bos javanicus javanicus in Java, and Bornean banteng Bos javanicus lowi in Borneo, and the presence/absence of interbreeding between wild Bornean banteng and domestic cattle in Sabah, Malaysia, were investigated by partial sequences of cytochrome b and D-loop of mitochondrial DNA. The results show that genetic distance of the Bornean banteng are relatively close to the gaur Bos gaurus/gayal Bos frontalis (the cytochrome b, 0.004-0.025; the D-loop, 0.012-0.021) followed by Burma banteng (the cytochrome b, 0.027-0.035; the D-loop, 0.040-0.045), and kouprey Bos sauveli (the cytochrome b, 0.031-0.035; the D-loop, 0.037-0.042). There are much greater distances between Bornean banteng and domestic cattle, Bos taurus and Bos indicus (the cytochrome b, 0.059-0.076; the D-loop, 0.081-0.090). These results suggest that the Bornean banteng diverged genetically from other banteng subspecies and that the wild Bornean banteng from this study are pure strain and have high conservation value.	[Matsubayashi, Hisashi] Tokyo Univ Agr, Dept Forest Sci, Setagaya Ku, Tokyo 1568502, Japan; [Ahmad, Abdul Hamid] Univ Malaysia Sabah, Jalan UMS, Inst Trop Biol & Conservat, Kota Kinabalu 88400, Sabah, Malaysia; [Hanzawa, Kei] Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa 2430034, Japan; [Kono, Tomohiro; Ishige, Taichiro] Tokyo Univ Agr, Genome Res Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Gakuhari, Takashi] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Lagan, Peter; Sunjoto, Indra] Sabah Forestry Dept, Sandakan 90006, Sabah, Malaysia; [Sukor, Jum Rafiah Abdul] Wisma MUIS, Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia; [Sinun, Waidi] Sabah Fdn, Kota Kinabalu 88813, Sabah, Malaysia	Matsubayashi, H (reprint author), Tokyo Univ Agr, Dept Forest Sci, Setagaya Ku, Sakuragaoka1-1-1, Tokyo 1568502, Japan.	matsubayashi.hisashi@gmail.com; midahmad@gmail.com			Fundamental Research Grant Scheme in Malaysia [FRG0243-NSNH-2010]; Ministry of Education, Culture, Sports, Science and Technology in Japan [S0801025]	We thank Datuk S. Mannan, Mr. A. Ahmad, Mr. A. Bagoi, Mr. B. Rayner, staff of Deramakot and Malua Forest Reserve, staff of Institute for Tropical Biology and Conservation, Universiti Malaysia Sabah. We also thank the editor and two anonymous reviewers for their constructive comments, which helped us to improve the manuscript. This study was supported in part by the Fundamental Research Grant Scheme in Malaysia (Project code: FRG0243-NSNH-2010) and by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (Project code: S0801025).	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; Matsubayashi Hisashi, 2007, Malayan Nature Journal, V59, P297; Verkaar ELC, 2004, MOL BIOL EVOL, V21, P1165, DOI 10.1093/molbev/msh064; Verkaar ELC, 2002, MEAT SCI, V60, P365, DOI 10.1016/S0309-1740(01)00144-9; Douglas KC, 2011, MITOCHONDRION, V11, P166, DOI 10.1016/j.mito.2010.09.005; Nijman IJ, 2003, HEREDITY, V90, P10, DOI 10.1038/sj.hdy.6800174; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Kikkawa Y, 2003, ANIM GENET, V34, P96, DOI 10.1046/j.1365-2052.2003.00956.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bradshaw CJA, 2006, CONSERV BIOL, V20, P1306, DOI 10.1111/j.1523-1739.2006.00428.x; CALABY JH, 1975, AUST VET J, V51, P108, DOI 10.1111/j.1751-0813.1975.tb09428.x; CALDECOTT J, 1988, HUNTING WILDLIFE MAN, P168; DAVIES G, 1982, FAUNAL SURVEY SABAH, P279; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Handschuh Markus, 2013, Natural History Bulletin of the Siam Society, V59, P57; Hassanin A, 2004, MOL PHYLOGENET EVOL, V33, P896, DOI 10.1016/j.ympev.2004.08.009; Hassanin A, 2013, MOL PHYLOGENET EVOL, V66, P766, DOI 10.1016/j.ympev.2012.11.003; Hassanin A, 2007, J ZOOL, V271, P246; Hassanin A, 2007, P ROY SOC B-BIOL SCI, V274, P2849, DOI 10.1098/rspb.2007.0830; HOOGERWERF A, 1970, P512; Lydekker R, 1912, P ZOOL SOC LOND, V1912, P902; *NAT RES COUNC, 1983, LITTL KNOWN AS AN PR, P144; PAYNE J, 1985, FIELD GUIDE MAMMALS, P332; Ropiquet A, 2008, CHROMOSOME RES, V16, P1107, DOI 10.1007/s10577-008-1262-2; Tanaka K, 2011, ANIM SCI J, V82, P52, DOI 10.1111/j.1740-0929.2010.00819.x; Timmins R. J., 2008, IUCN 2013 IUCN RED L; VANDERMAAREL FH, 1932, WETENSCHAPPELIJKE ME, V15, P1	29	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0025-1461	1864-1547		MAMMALIA	Mammalia	NOV	2014	78	4					523	531		10.1515/mammalia-2013-0052		9	Zoology	Zoology	AT0KD	WOS:000344624200011		
J	Moribe, J; Yasui, K; Inagaki, N; Watanabe, R; Satoh, K; Kogaya, Y; Ejiri, S				Moribe, Junji; Yasui, Kensuke; Inagaki, Noritoshi; Watanabe, Ryuta; Satoh, Kazuhiko; Kogaya, Yasutoku; Ejiri, Sadakazu			Partial albinism in the Japanese shrew mole, Urotrichus talpoides, from Aichi, Japan	MAMMALIA			English	Article						albinism; shrew mole; Soricomorpha; Urotrichus talpoides; white-belted		We describe partial albinism (a white-belted coloration) in the Japanese shrew mole (Urotrichus talpoides) from Aichi Prefecture, Japan. This shrew-mole did not present symptoms of generalized types of vitiligo vulgaris. The white-belted coloration may have occurred because of a lack of melanocyte formation due to a deficit of or to abnormalities in neural crest cells during ontogeny.	[Moribe, Junji] Gifu Univ, Res Ctr Wildlife Management, Gifu 5011193, Japan; [Yasui, Kensuke] Toyohashi Museum Nat Hist, Toyohashi, Aichi 4413147, Japan; [Inagaki, Noritoshi] Kozakainishi Elementary Sch, Toyokawa, Aichi 4410105, Japan; [Watanabe, Ryuta; Satoh, Kazuhiko; Kogaya, Yasutoku; Ejiri, Sadakazu] Asahi Univ, Sch Dent, Dept Oral Anat, Mizuho City, Gifu 5010296, Japan	Moribe, J (reprint author), Gifu Univ, Res Ctr Wildlife Management, 1-1 Yanagido, Gifu 5011193, Japan.	jmoribe@gifu-u.ac.jp					BROOKS RT, 1994, CAN FIELD NAT, V108, P491; CARRAWAY LN, 1991, NORTHWEST SCI, V65, P16; Cockrum E.L., 1942, J MAMMAL, V23, P451; Fujiwara M., 1960, J HIBA SOC NATURAL H, V54, P19; Fujiwara M., 1961, MISCELLANEOUS REPORT, V4, P28; Godfrey G., 1960, LIFE MOLE, P152; Imaizumi Y., 1960, Natural Science and Museums Tokyo, V27, P20; Ishimura Y., 1987, MAMM STUDY, V27, P73; Jogahara Takamichi, 2008, Mammal Study, V33, P121, DOI 10.3106/1348-6160(2008)33[121:SACOAH]2.0.CO;2; Kamm AA, 2008, NORTHEAST NAT, V15, P303, DOI 10.1656/1092-6194(2008)15[303:PSASIE]2.0.CO;2; Klein Margaret, 1944, MURRELET, V25, P10; Merryl G., 2003, MAMMAL REV, V33, P189; MIYAO T, 1983, Journal of the Mammalogical Society of Japan, V9, P128; Miyao T., 1981, Journal of the Mammalogical Society of Japan, V8, P203; SKOCZE STANISAW, 1961, ACTA THERIOL, V5, P290; Svihla A., 1939, MURRELET, V20, P70; Svihla A., 1941, MURRELET, V22, P36; Tsuchihashi A, 2011, MAMM STUDY, V36, P141, DOI 10.3106/041.036.0304	18	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0025-1461	1864-1547		MAMMALIA	Mammalia	NOV	2014	78	4					543	545		10.1515/mammalia-2013-0140		3	Zoology	Zoology	AT0KD	WOS:000344624200014		
J	Kotobuki, M; Kobayashi, B; Koishi, M; Mizushima, T; Kakuta, N				Kotobuki, M.; Kobayashi, B.; Koishi, M.; Mizushima, T.; Kakuta, N.			Preparation of Li1.5Al0.5Ti1.5(PO4)(3) solid electrolyte via coprecipitation using various PO4 sources	MATERIALS TECHNOLOGY			English	Article						Solid electrolyte; Coprecipitation method; Lithium battery; NASICON type solid electrolyte	LITHIUM-ION BATTERIES; GLASS-CERAMICS; METAL ANODE; LI7LA3ZR2O12; COMPATIBILITY; CONDUCTIVITY; FABRICATION	Li1.5Al0.5Ti1.5(PO4)(3) (LATP) solid electrolyte is prepared via coprecipitation using H3PO4, NH4H2PO4 or (NH4)(2)HPO4 as a PO4 source. Field emission scanning electron microscope (FE-SEM) and X-ray diffraction (XRD) measurements clearly show the PO4 source influences crystal structure and morphology of LATP after sintering at 1000 degrees C. AlPO4 impurity formation is observed only in the LATP prepared using H3PO4. In terms of the morphology difference, the LATP dense pellet prepared from H3PO4 and (NH4)(2)HPO4 is composed of many small grains. Contrary, the grain boundary is hardly observed in the LATP prepared from NH4H2PO4. The LATP prepared using NH4H2PO4 reveals the highest Li ion conductivity due to no impurity formation and less grain boundaries which lead to lower resistance at the grain boundaries. It is concluded that usage of suitable PO4 source is a vital point of the LATP preparation via coprecipitation.	[Kotobuki, M.; Koishi, M.] Hakodate Natl Coll Technol, Dept Mat & Environm Engn, Hakodate, Hokkaido 0428501, Japan; [Kobayashi, B.; Mizushima, T.; Kakuta, N.] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Kotobuki, M (reprint author), Hakodate Natl Coll Technol, Dept Mat & Environm Engn, 14-1 Tokura Cho, Hakodate, Hokkaido 0428501, Japan.	kotobuki@hakodate-ct.ac.jp					Rangasamy E, 2013, J POWER SOURCES, V230, P261, DOI 10.1016/j.jpowsour.2012.12.076; Kotobuki M, 2010, J ELECTROCHEM SOC, V157, pA1076, DOI 10.1149/1.3474232; Kotobuki M, 2013, CERAM INT, V39, P4645, DOI 10.1016/j.ceramint.2012.10.206; Kotobuki M, 2011, J POWER SOURCES, V196, P7750, DOI 10.1016/j.jpowsour.2011.04.047; Kotobuki M, 2013, IONICS, V19, P1945, DOI 10.1007/s11581-013-1000-4; Abe T, 2004, J ELECTROCHEM SOC, V151, pA1950, DOI 10.1149/1.1804813; Li JG, 2000, J MATER RES, V15, P1514, DOI 10.1557/JMR.2000.0217; Fu J, 1998, J MATER SCI, V33, P1549, DOI 10.1023/A:1017559619391; Hoshina K, 2012, SOLID STATE IONICS, V209, P30, DOI 10.1016/j.ssi.2011.12.018; Fu J, 1997, SOLID STATE IONICS, V96, P195, DOI 10.1016/S0167-2738(97)00018-0; Feng JK, 2010, J ALLOY COMPD, V501, P255, DOI 10.1016/j.jallcom.2010.04.084; Thangadurai V, 2005, J POWER SOURCES, V142, P339, DOI 10.1016/j.jpowsour.2004.11.001; Amiki Y, 2013, J POWER SOURCES, V241, P583, DOI 10.1016/j.jpowsour.2013.05.006; Fergus JW, 2010, J POWER SOURCES, V195, P4554, DOI 10.1016/j.jpowsour.2010.01.076; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Murugan R, 2007, ANGEW CHEM INT EDIT, V46, P7778, DOI 10.1002/anie.200701144; Kotobuki M, 2010, ELECTROCHIM ACTA, V55, P6892, DOI 10.1016/j.electacta.2010.05.074; Naraez-Semanate J. L., 2010, SOLID STATE IONICS, V181, P1197; Pradhan AK, 2004, MATER RES BULL, V39, P1291, DOI 10.1016/j.materresbull.2004.04.005	19	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1066-7857	1753-5557		MATER TECHNOL	Mater. Technol.	NOV	2014	29	A2			SI		A93	A97		10.1179/1753555714Y.0000000181		5	Materials Science, Multidisciplinary	Materials Science	AT1SR	WOS:000344714800007		
J	Abe, M; Kimura, M; Araoka, H; Taniguchi, S; Yoneyama, A				Abe, Masahiro; Kimura, Muneyoshi; Araoka, Hideki; Taniguchi, Shuichi; Yoneyama, Akiko			Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia	MEDICAL MYCOLOGY			English	Article						breakthrough candidemia; (1,3)-beta-D-glucan; candidemia; preemptive therapy	INVASIVE FUNGAL-INFECTIONS; BLOOD-STREAM INFECTIONS; D-GLUCAN ASSAY; ATTRIBUTABLE MORTALITY; NEUTROPENIC PATIENTS; ANTIFUNGAL THERAPY; MATCHED COHORT; DIAGNOSIS; CANCER; GALACTOMANNAN	The aim of this study was to evaluate the usefulness of serum (1,3)-beta-D-glucan (BDG) for earlier detection of breakthrough candidemia. We reviewed the medical records of patients with candidemia from January 2008 to March 2013. Serum BDG was measured by Wako turbidimetric assay. During the study period, a total of 147 cases of candidemia were identified, and 31 patients met the criteria for breakthrough candidemia. Serum BDG levels were measured in 25 patients with breakthrough candidemia and 67 patients with nonbreakthrough candidemia. Almost all of the patients with breakthrough candidemia had hematological malignancies. More candidemia were caused by non-C. albicans Candida in the breakthrough group than in the nonbreakthrough group (92.0% vs. 61.8%, p = .005). The median BDG value was significantly lower in breakthrough episodes than in non-breakthrough episodes (18.5 pg/ml vs. 90.4 pg/ml, p = .01). Moreover, BDG values under the cutoff was significantly higher in patients with breakthrough candidemia than in those with nonbreakthrough candidemia (44% vs. 19%, p = .03). In summary, BDG alone was insufficient to detect breakthrough candidemia, and candidemia could occur in patients being treated with antifungal agents, even when the BDG value was under the cutoff value.	[Abe, Masahiro; Kimura, Muneyoshi; Araoka, Hideki; Yoneyama, Akiko] Toranomon Gen Hosp, Dept Infect Dis, Tokyo 1058470, Japan; [Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo 1058470, Japan; [Araoka, Hideki; Yoneyama, Akiko] Okinaka Mem Inst Med Res, Tokyo, Japan	Araoka, H (reprint author), Toranomon Gen Hosp, Dept Infect Dis, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	h-araoka@toranomon.gr.jp			Ministry of Health, Labor and Welfare of Japan [H25-Shinko-Ippan-006]	This study was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (H25-Shinko-Ippan-006).	Alam FF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-103; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Marr KA, 2005, CLIN INFECT DIS, V40, P1762, DOI 10.1086/429921; Akamatsu N, 2007, INFECTION, V35, P346, DOI 10.1007/s15010-007-6240-7; Koo S, 2009, CLIN INFECT DIS, V49, P1650, DOI 10.1086/647942; Blot SI, 2003, EUR J CLIN MICROBIOL, V22, P132, DOI 10.1007/s10096-003-0885-7; Antoniadou A, 2003, MEDICINE, V82, P309, DOI 10.1097/01.md.0000091182.93122.8e; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Malani A, 2005, CLIN INFECT DIS, V41, P975, DOI 10.1086/432939; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Pfeiffer CD, 2010, J CLIN MICROBIOL, V48, P2373, DOI 10.1128/JCM.02390-09; Leventakos K, 2010, CLIN INFECT DIS, V50, P405, DOI 10.1086/649879; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Uzun O, 2001, CLIN INFECT DIS, V32, P1713, DOI 10.1086/320757; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Del Bono V, 2011, CLIN VACCINE IMMUNOL, V18, P2113, DOI 10.1128/CVI.05408-11; Sipsas NV, 2009, CANCER, V115, P4745, DOI 10.1002/cncr.24507; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Blumberg EA, 1996, CLIN INFECT DIS, V22, P462; Fujita S, 2006, J MED MICROBIOL, V55, P537, DOI 10.1099/jmm.0.46314-0; Hanson KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042282; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Minari A, 2001, CLIN INFECT DIS, V32, P186, DOI 10.1086/318473; Moro Hiroshi, 2003, Kansenshogaku Zasshi, V77, P219; Nucci M, 1997, CLIN INFECT DIS, V24, P275; Ostrosky-Zeichner L, 2005, CLIN INFECT DIS, V41, P654, DOI 10.1086/432470; VERFAILLIE C, 1991, BONE MARROW TRANSPL, V8, P177	29	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1369-3786	1460-2709		MED MYCOL	Med. Mycol.	NOV	2014	52	8					835	840		10.1093/mmy/myu066		6	Infectious Diseases; Mycology; Veterinary Sciences	Infectious Diseases; Mycology; Veterinary Sciences	AT0GE	WOS:000344614300008		
J	Zolensky, M; Mikouchi, T; Fries, M; Bodnar, R; Jenniskens, P; Yin, QZ; Hagiya, K; Ohsumi, K; Komatsu, M; Colbert, M; Hanna, R; Maisano, J; Ketcham, R; Kebukawa, Y; Nakamura, T; Matsuoka, M; Sasaki, S; Tsuchiyama, A; Gounelle, M; Le, L; Martinez, J; Ross, K; Rahman, Z				Zolensky, Michael; Mikouchi, Takashi; Fries, Marc; Bodnar, Robert; Jenniskens, Peter; Yin, Qing-zhu; Hagiya, Kenji; Ohsumi, Kazumasa; Komatsu, Mutsumi; Colbert, Matthew; Hanna, Romy; Maisano, Jessie; Ketcham, Richard; Kebukawa, Yoko; Nakamura, Tomoki; Matsuoka, Moe; Sasaki, Sho; Tsuchiyama, Akira; Gounelle, Matthieu; Le, Loan; Martinez, James; Ross, Kent; Rahman, Zia			Mineralogy and petrography of C asteroid regolith: The Sutter's Mill CM meteorite	METEORITICS & PLANETARY SCIENCE			English	Article							162173 1999 JU3; CARBONACEOUS CHONDRITE; THERMAL METAMORPHISM; PONDED DEPOSITS; LITHIC CLASTS; 433-EROS; FEATURES; TARGET; TYPE-2; EROS	Based upon our characterization of three separate stones by electron and X-ray beam analyses, computed X-ray microtomography, Raman microspectrometry, and visible-IR spectrometry, Sutter's Mill is a unique regolith breccia consisting mainly of various CM lithologies. Most samples resemble existing available CM2 chondrites, consisting of chondrules and calcium-aluminum-rich inclusion (CAI) set within phyllosilicate-dominated matrix (mainly serpentine), pyrrhotite, pentlandite, tochilinite, and variable amounts of Ca-Mg-Fe carbonates. Some lithologies have witnessed sufficient thermal metamorphism to transform phyllosilicates into fine-grained olivine, tochilinite into troilite, and destroy carbonates. One finely comminuted lithology contains xenolithic materials (enstatite, Fe-Cr phosphides) suggesting impact of a reduced asteroid (E or M class) onto the main Sutter's Mill parent asteroid, which was probably a C class asteroid. One can use Sutter's Mill to help predict what will be found on the surfaces of C class asteroids such as Ceres and the target asteroids of the OSIRIS-REx and Hayabusa 2 sample return missions (which will visit predominantly primitive asteroids). C class asteroid regolith may well contain a mixture of hydrated and thermally dehydrated indigenous materials as well as a significant admixture of exogenous material would be essential to the successful interpretation of mineralogical and bulk compositional data.	[Zolensky, Michael; Fries, Marc] NASA, ARES, Johnson Space Ctr, Houston, TX 77058 USA; [Mikouchi, Takashi] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Bodnar, Robert] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [Jenniskens, Peter] SETI Inst, Mountain View, CA 94043 USA; [Yin, Qing-zhu] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Hagiya, Kenji] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Ohsumi, Kazumasa] JASRI, Sayo, Hyogo 6795198, Japan; [Komatsu, Mutsumi] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Colbert, Matthew; Hanna, Romy; Maisano, Jessie; Ketcham, Richard] Univ Texas Austin, High Resolut Xray CT Facil, Austin, TX 78712 USA; [Kebukawa, Yoko] Hokkaido Univ, Sapporo, Hokkaido 0600810, Japan; [Nakamura, Tomoki; Matsuoka, Moe] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808578, Japan; [Sasaki, Sho] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Tsuchiyama, Akira] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Gounelle, Matthieu] Museum Natl Hist Nat, F-70005 Paris, France; [Le, Loan; Martinez, James; Ross, Kent; Rahman, Zia] ESCG Jacobs, Houston, TX 77058 USA	Zolensky, M (reprint author), NASA, ARES, Johnson Space Ctr, Houston, TX 77058 USA.	michael.e.zolensky@nasa.gov	Yin, Qing-Zhu/B-8198-2009; Ketcham, Richard/B-5431-2011	Yin, Qing-Zhu/0000-0002-4445-5096; Ketcham, Richard/0000-0002-2748-0409	NASA Cosmochemistry Program; NASA NEO Observation Program	We thank Mr. Charles Farley for setting up and calibrating the Raman microprobe and for assisting with Raman analyses at Virginia Tech. Reviews of the first version of this paper by Neyda Abreu and an anonymous person greatly improved the text. MZ and QZY acknowledge support from the NASA Cosmochemistry Program. PJ is supported by the NASA NEO Observation Program.	Abreu NM, 2005, METEORIT PLANET SCI, V40, P609; Akai J, 1990, P NIPR S ANTARCTIC M, V3, P55; KROT AN, 1995, METEORITICS, V30, P748; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095; Rubin AE, 1997, METEORIT PLANET SCI, V32, P231; Zolensky M, 2003, CHEM ERDE-GEOCHEM, V63, P185, DOI 10.1078/0009-2819-00038; Tonui E, 2014, GEOCHIM COSMOCHIM AC, V126, P284, DOI 10.1016/j.gca.2013.10.053; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; Fries M, 2009, METEORIT PLANET SCI, V44, P1465, DOI 10.1111/j.1945-5100.2009.tb01186.x; Zolensky ME, 1997, GEOCHIM COSMOCHIM AC, V61, P5099, DOI 10.1016/S0016-7037(97)00357-8; Rubin AE, 2007, GEOCHIM COSMOCHIM AC, V71, P2361, DOI 10.1016/j.gca.2007.02.008; Ketcham RA, 2005, GEOSPHERE, V1, P32, DOI 10.1130/GES00001.1; Veverka J, 2001, NATURE, V413, P390, DOI 10.1038/35096507; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Vilas F, 2008, ASTRON J, V135, P1101, DOI 10.1088/0004-6256/135/4/1101; Nakamura T, 2005, J MINER PETROL SCI, V100, P260, DOI 10.2465/jmps.100.260; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; MULLER WF, 1979, TSCHER MINER PETROG, V26, P293, DOI 10.1007/BF01089843; Binzel R. P., 2002, ASTEROIDS 3; Bonal L, 2010, GEOCHIM COSMOCHIM AC, V74, P2500, DOI 10.1016/j.gca.2010.01.029; Briani G., 2009, P NATL ACAD SCI USA, V106, P10; Chao P, 1974, GEOCHIMICA BEIJING, V3, P196; Ebel D. S., 2012, 2012 MET SOC M; Enlows H.E., 1966, AAPG BULL, V50, P1918; Fuchs L. H., 1973, SMITHSONIAN CONTRIBS, V10, P39; Goehner RP, 1996, J RES NATL INST STAN, V101, P301, DOI 10.6028/jres.101.031; Greshake A, 2002, METEORIT PLANET SCI, V37, P281; Hasegawa S, 2008, PUBL ASTRON SOC JPN, V60, pS399; Huss G.R., 2006, METEORITES EARLY SOL, V943, P567; Ikeda Y., 1992, P NIPR S ANTARCT MET, V5, P49; Ivanov AV, 2000, AM MINERAL, V85, P1082; Jenniskens P., 2012, SCIENCE, V338, P1521; Kitajima F, 2002, GEOCHIM COSMOCHIM AC, V66, P163, DOI 10.1016/S0016-7037(01)00758-X; Lipschutz M. E., 1999, P NIPR S ANTARCTIC M, V12, P57; MACKINNON IDR, 1984, NATURE, V309, P240, DOI 10.1038/309240a0; Matsuoka K., 1996, P NIPR S ANT MET, V9, P20; Mueller T., 2010, ASTRON ASTROPHYS, V525, P1; Nagashima K., 2012, 2012 MET SOC M; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nittler LR, 2001, METEORIT PLANET SCI, V36, P1673; Pinilla-Alonso N, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201221015; Sears D. W. G., 2012, 2012 MET SOC M; Trombka JI, 2001, METEORIT PLANET SCI, V36, P1605; Wasson JT, 2009, GEOCHIM COSMOCHIM AC, V73, P1436, DOI 10.1016/j.gca.2008.11.044; Yin Q.-Z., 2012, METEORITICS PLANETAR, V47; Zolensky M, 2003, METEORIT PLANET SCI, V38, P305; Zolensky M., 2004, ANT MET 28 28 S ANT, P95; Zolensky ME, 2002, METEORIT PLANET SCI, V37, P737; Zolensky M. E., 2002, 33 LUN PLAN SCI C; Zolensky M. E., 2009, 39 LUN PLAN SCI C	52	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	NOV	2014	49	11					1997	2016		10.1111/maps.12386		20	Geochemistry & Geophysics	Geochemistry & Geophysics	AT1ZZ	WOS:000344731500003		
J	Yesiltas, M; Kebukawa, Y; Peale, RE; Mattson, E; Hirschmugl, CJ; Jenniskens, P				Yesiltas, Mehmet; Kebukawa, Yoko; Peale, Robert E.; Mattson, Eric; Hirschmugl, Carol J.; Jenniskens, Peter			Infrared imaging spectroscopy with micron resolution of Sutter's Mill meteorite grains	METEORITICS & PLANETARY SCIENCE			English	Article							DIFFUSE INTERSTELLAR-MEDIUM; INSOLUBLE ORGANIC-MATTER; CARBONACEOUS CHONDRITES; HYDROUS COMPONENTS; COMET 81P/WILD-2; SOLAR-SYSTEM; MICROSPECTROSCOPY; ASTEROIDS; STARDUST; ORIGIN	Synchrotron-based Fourier transform infrared spectroscopy and Raman spectroscopy are applied with submicrometer spatial resolution to multiple grains of Sutter's Mill meteorite, a regolith breccia with CM1 and CM2 lithologies. The Raman and infrared active functional groups reveal the nature and distribution of organic and mineral components and confirm that SM12 reached higher metamorphism temperatures than SM2. The spatial distributions of carbonates and organic matter are negatively correlated. The spatial distributions of aliphatic organic matter and OH relative to the distributions of silicates in SM2 differ from those in SM12, supporting a hypothesis that the parent body of Sutter's Mill is a combination of multiple bodies with different origins. The high aliphatic CH2/CH3 ratios determined from band intensities for SM2 and SM12 grains are similar to those of IDPs and less altered carbonaceous chondrites, and they are significantly higher than those in other CM chondrites and diffuse ISM objects.	[Yesiltas, Mehmet; Peale, Robert E.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Kebukawa, Yoko] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Mattson, Eric; Hirschmugl, Carol J.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Jenniskens, Peter] SETI Inst, Mountain View, CA 94043 USA; [Jenniskens, Peter] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Yesiltas, M (reprint author), Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.	myesiltas@knights.ucf.edu			Turkish government [1416]; University of Wisconsin-Madison; University of Wisconsin-Milwaukee; NSF MRI [0619759]; NSF CHE [1112433]	We thank NASA Ames Research Center and the Sutter's Mill meteorite consortium for providing the meteorite samples. Mr. Yesiltas is primarily supported through Graduate Fellowship Program #1416 by the Turkish government. SRC is primarily funded by the University of Wisconsin-Madison with supplemental support from facility users and the University of Wisconsin-Milwaukee. IRENI beamline's construction and development was supported by NSF MRI award #0619759, and CJH is funded by NSF CHE award #1112433. We are also grateful to associate editor Dr. S. Sandford and the reviewers for constructive comments on this manuscript.	Akai J, 1992, P NIPR S ANT MET, V5, P120; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; Osawa T, 2005, METEORIT PLANET SCI, V40, P71; Pearson VK, 2007, PLANET SPACE SCI, V55, P1310, DOI 10.1016/j.pss.2007.04.005; Nasse MJ, 2011, NUCL INSTRUM METH A, V649, P172, DOI 10.1016/j.nima.2010.12.095; Pearson VK, 2002, METEORIT PLANET SCI, V37, P1829; Beck P, 2010, GEOCHIM COSMOCHIM AC, V74, P4881, DOI 10.1016/j.gca.2010.05.020; Kebukawa Y, 2010, METEORIT PLANET SCI, V45, P394, DOI 10.1111/j.1945-5100.2010.01030.x; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; Zolensky M, 2014, METEORIT PLANET SCI, V49, P1997, DOI 10.1111/maps.12386; Pizzarello S, 2013, P NATL ACAD SCI USA, V110, P15614, DOI 10.1073/pnas.1309113110; Nakamura T, 2005, J MINER PETROL SCI, V100, P260, DOI 10.2465/jmps.100.260; Matrajt G, 2004, ASTRON ASTROPHYS, V416, P983, DOI 10.1051/0004-6361:20034526; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; Nakato A, 2008, EARTH PLANETS SPACE, V60, P855; Igisu M, 2009, PRECAMBRIAN RES, V173, P19, DOI 10.1016/j.precamres.2009.03.006; Alexander CMO, 2014, METEORIT PLANET SCI, V49, P503, DOI 10.1111/maps.12282; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Kebukawa Y, 2009, METEORIT PLANET SCI, V44, P545; Burton AS, 2014, METEORIT PLANET SCI, V49, P2074, DOI 10.1111/maps.12281; Busemann H, 2007, METEORIT PLANET SCI, V42, P1387, DOI 10.1111/j.1945-5100.2007.tb00581.x; Flynn G. J., 2013, 44 LUN PLAN SCI C; Fries M, 2014, METEORIT PLANET SCI, V49, P1989, DOI 10.1111/maps.12249; Haack H, 2010, METEORIT PLANET SCI, V45, pA72; Huss G.R., 2006, METEORITES EARLY SOL, V943, P567; Kebukawa Y, 2009, CHEM LETT, V38, P22, DOI 10.1246/cl.2009.22; Merouane S, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/154; Nasse MJ, 2007, NUCL INSTRUM METH A, V582, P107, DOI 10.1016/j.nima.2007.08.073; Nuevo M, 2014, METEORIT PLANET SCI, V49, P2017, DOI 10.1111/maps.12269; Salisbury J.W., 1991, INFRARED 2 1 25 MUM; Sandford S., 2013, 44 LUN PLAN SCI C; SANDFORD SA, 1984, ICARUS, V60, P115, DOI 10.1016/0019-1035(84)90141-6; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Suzuki A, 2010, EARTH PLANETS SPACE, V62, P33, DOI 10.5047/eps.2008.11.001; Yesiltas M., 2013, METEORITICS PLANETAR, V48	37	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	NOV	2014	49	11					2027	2037		10.1111/maps.12321		11	Geochemistry & Geophysics	Geochemistry & Geophysics	AT1ZZ	WOS:000344731500005		
J	Nishiizumi, K; Caffee, MW; Hamajima, Y; Reedy, RC; Welten, KC				Nishiizumi, K.; Caffee, M. W.; Hamajima, Y.; Reedy, R. C.; Welten, K. C.			Exposure history of the Sutter's Mill carbonaceous chondrite	METEORITICS & PLANETARY SCIENCE			English	Article							AMS STANDARDS; METEORITES; BE-10; AL-26	The Sutter's Mill (SM) carbonaceous chondrite fell in California on April 22, 2012. The cosmogenic radionuclide data indicate that Sutter's Mill was exposed to cosmic rays for 0.082 +/- 0.008 Myr, which is one of the shortest ages for C chondrites, but overlaps with a small cluster at approximately 0.1 Myr. The age is significantly longer than proposed ages that were obtained from cosmogenic noble gas concentrations, which have large uncertainties due to trapped noble gas corrections. The presence of neutron-capture Co-60 and 36 Cl in SM indicates a minimum preatmospheric radius of approximately 50 cm, and is consistent with a radius of 1-2 m, as derived from the fireball observations. Although a large preatmospheric size was proposed, one fragment (SM18) contains solar cosmic ray-produced short-lived radionuclides, such as Co-56 and Cr-51. This implies that this specimen was less than 2 cm from the preatmospheric surface of Sutter's Mill. Although this conclusion seems surprising, it is consistent with the observation that the meteoroid fragmented high in the atmosphere. The presence of SCR-produced nuclides is consistent with the high SCR fluxes observed during the last few months before the meteorite's fall, when its orbit was less than 1 AU from the Sun.	[Nishiizumi, K.; Welten, K. C.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Caffee, M. W.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Hamajima, Y.] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Reedy, R. C.] Planetary Sci Inst, Los Alamos, NM 87544 USA	Nishiizumi, K (reprint author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	kuni@ssl.berkeley.edu	Caffee, Marc/K-7025-2015; HAMAJIMA, Yasunori/L-3802-2015	Caffee, Marc/0000-0002-6846-8967; HAMAJIMA, Yasunori/0000-0002-8485-4606	NASA [NNX11AC69G, NNX12 AK65G]; LARS grant	We thank Greg Jorgensen (SM18), Sandy VanderPol and Emily (SM43), Field Museum of Natural History (SM47), Rick Patrinellis (SM51), and Jason Utas (SM77) for providing Sutter's Mill meteorite; Qing-Zhu Yin for coordinating allocation of samples of SM 18, 43, and 51; and Karen Ziegler for providing unpublished H<INF>2</INF>O abundance in Sutter's Mill. We also thank Lindsey Boyle McKee for helping the chemical procedures. We are grateful to Rainer Wieler, Tim Jull, and an anonymous reviewer for the careful review of this manuscript. This work was supported by NASA Cosmochemistry grants NNX11AC69G and NNX12 AK65G (RCR) and LARS grant.	Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Scherer P, 2000, METEORIT PLANET SCI, V35, P145; Bottke WF, 2000, ICARUS, V145, P301, DOI 10.1006/icar.2000.6361; SHARMA P, 1990, NUCL INSTRUM METH B, V52, P410, DOI 10.1016/0168-583X(90)90447-3; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; MAZOR E, 1970, GEOCHIM COSMOCHIM AC, V34, P781, DOI 10.1016/0016-7037(70)90031-1; Sharma P, 2000, NUCL INSTRUM METH B, V172, P112, DOI 10.1016/S0168-583X(00)00132-4; MASARIK J, 1994, GEOCHIM COSMOCHIM AC, V58, P5307, DOI 10.1016/0016-7037(94)90314-X; Borovicka J, 2003, METEORIT PLANET SCI, V38, P1023; Eberhardt P., 1963, EARTH SCI METEORITIC, P143; Ferko TE, 2000, METEORIT PLANET SCI, V35, P1215; Hamajima Y., 2012, 75 ANN MET SOC M, V5354; Hamajima Y, 2004, APPL RADIAT ISOTOPES, V61, P179, DOI 10.1016/j.apradiso.2004.03.041; LINGENFE.R, 1961, J GEOPHYS RES, V66, P2665, DOI 10.1029/JZ066i009p02665; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221; Morbidelli A, 2006, METEORIT PLANET SCI, V41, P875; Murty S. V. S., 2013, METEORITICS PLANETAR, V48; NISHIIZUMI K, 1992, METEORITICS, V27, P269; Nishiizumi K., 2012, 43 LUN PLAN SCI C; Nishiizumi K, 2004, NUCL INSTRUM METH B, V223, P388, DOI 10.1016/j.nimb.2004.04.075; Nishiizumi K., 1993, P 24 LUN PLAN SCI C, P1085; Ott U., 2013, 44 LUN PLAN SCI C; Reedy R. C., 2013, 44 LUN PLAN SCI C; Reedy R. C., 1993, P 24 LUN PLAN SCI C, P1195; SPERGEL MS, 1986, J GEOPHYS RES-SOLID, V91, pD483, DOI 10.1029/JB091iB04p0D483	26	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	NOV	2014	49	11					2056	2063		10.1111/maps.12297		8	Geochemistry & Geophysics	Geochemistry & Geophysics	AT1ZZ	WOS:000344731500008		
J	Kebukawa, Y; Zolensky, ME; Kilcoyne, ALD; Rahman, Z; Jenniskens, P; Cody, GD				Kebukawa, Yoko; Zolensky, Michael E.; Kilcoyne, A. L. David; Rahman, Zia; Jenniskens, Peter; Cody, George D.			Diamond xenolith and matrix organic matter in the Sutter's Mill meteorite measured by C-XANES	METEORITICS & PLANETARY SCIENCE			English	Article							RAY-ABSORPTION SPECTROSCOPY; INTERSTELLAR DIAMONDS; CHONDRITE; CARBON; FILMS; EXCITATION; RESOLUTION; POLYMERS; ORIGIN; PLASMA	The Sutter's Mill (SM) meteorite fell in El Dorado County, California, on April 22, 2012. This meteorite is a regolith breccia composed of CM chondrite material and at least one xenolithic phase: oldhamite. The meteorite studied here, SM2 (subsample 5), was one of three meteorites collected before it rained extensively on the debris site, thus preserving the original asteroid regolith mineralogy. Two relatively large (10 mu m sized) possible diamond grains were observed in SM2-5 surrounded by fine-grained matrix. In the present work, we analyzed a focused ion beam (FIB) milled thin section that transected a region containing these two potential diamond grains as well as the surrounding fine-grained matrix employing carbon and nitrogen X-ray absorption near-edge structure (C-XANES and N-XANES) spectroscopy using a scanning transmission X-ray microscope (STXM) (Beamline 5.3.2 at the Advanced Light Source, Lawrence Berkeley National Laboratory). The STXM analysis revealed that the matrix of SM2-5 contains C-rich grains, possibly organic nanoglobules. A single carbonate grain was also detected. The C-XANES spectrum of the matrix is similar to that of insoluble organic matter (IOM) found in other CM chondrites. However, no significant nitrogen-bearing functional groups were observed with N-XANES. One of the possible diamond grains contains a Ca-bearing inclusion that is not carbonate. C-XANES features of the diamond-edges suggest that the diamond might have formed by the CVD process, or in a high-temperature and -pressure environment in the interior of a much larger parent body.	[Kebukawa, Yoko; Cody, George D.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Kebukawa, Yoko] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Zolensky, Michael E.] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Kilcoyne, A. L. David] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Rahman, Zia] Jacobs Sverdrup, Houston, TX 77058 USA; [Jenniskens, Peter] SETI Inst, Mountain View, CA 94043 USA; [Jenniskens, Peter] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Kebukawa, Y (reprint author), Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan.	kebukawa@ynu.ac.jp			Office of Science, Department of Energy [DE-AC02-05CH11231]; NASA; JSPS; NASA Ames Research Center	We thank George Flynn, Monica Grady, Hikaru Yabuta, and the Associate Editor Christine Floss for their careful reviews and constructive comments. STXM-XANES data were acquired at beamline 5.3.2.2 at the ALS, which is supported by the Director of the Office of Science, Department of Energy, under Contract No. DE-AC02-05CH11231. We gratefully acknowledge support from NASA Astrobiology and Origins of the Solar System Programs. Y. K. gratefully acknowledges support through the JSPS Postdoctoral Fellowships. The Sutter's Mill recovery was supported by NASA Ames Research Center.	Lenardi C, 1999, J APPL PHYS, V85, P7159, DOI 10.1063/1.370527; Guenette MC, 2013, DIAM RELAT MATER, V34, P45, DOI 10.1016/j.diamond.2013.02.003; Jacobsen C, 2000, J MICROSC-OXFORD, V197, P173; BERKLEY JL, 1976, GEOCHIM COSMOCHIM AC, V40, P1429, DOI 10.1016/0016-7037(76)90079-X; Tonui EK, 2003, METEORIT PLANET SCI, V38, P269; Dhez O, 2003, J ELECTRON SPECTROSC, V128, P85, DOI 10.1016/S0368-2048(02)00237-2; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; Shard AG, 2004, J PHYS CHEM B, V108, P12472, DOI 10.1021/jp048250f; HITCHCOCK AP, 1977, J ELECTRON SPECTROSC, V10, P317, DOI 10.1016/0368-2048(77)85029-9; Zolensky M, 2014, METEORIT PLANET SCI, V49, P1997, DOI 10.1111/maps.12386; Garvie LAJ, 2006, METEORIT PLANET SCI, V41, P667; Yabuta H, 2010, METEORIT PLANET SCI, V45, P1446, DOI 10.1111/j.1945-5100.2010.01117.x; Daulton TL, 1996, GEOCHIM COSMOCHIM AC, V60, P4853, DOI 10.1016/S0016-7037(96)00223-2; Nakamura T, 2005, J MINER PETROL SCI, V100, P260, DOI 10.2465/jmps.100.260; Chang YK, 1999, PHYS REV LETT, V82, P5377, DOI 10.1103/PhysRevLett.82.5377; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; APEN E, 1993, J PHYS CHEM-US, V97, P6859, DOI 10.1021/j100128a019; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Cody GD, 2008, METEORIT PLANET SCI, V43, P353; De Gregorio BT, 2013, METEORIT PLANET SCI, V48, P904, DOI 10.1111/maps.12109; Berg T, 2008, J APPL PHYS, V104, DOI 10.1063/1.2978217; CARTER NL, 1964, J GEOPHYS RES, V69, P2403, DOI 10.1029/JZ069i012p02403; Chabot N. L., 2006, METEORITES EARLY SOL, P747; CLAYTON DD, 1995, ASTROPHYS J, V447, P894, DOI 10.1086/175927; Duda LC, 2008, TRIBOL LETT, V32, P31, DOI 10.1007/s11249-008-9357-7; ERLICH EI, 2002, DIAMOND DEPOSIT ORIG, P74; FESER M, 2003, 34 LUN PLAN SCI C; FLYNN GJ, 1904, 31 LUN PLAN SCI C; Grady MM, 1995, EARTH PLANET SC LETT, V136, P677, DOI 10.1016/0012-821X(95)00162-6; Hilton J. L., 2002, ASTEROIDS, P103; JAOUEN M, 1995, DIAM RELAT MATER, V4, P200, DOI 10.1016/0925-9635(94)00252-5; Marvin U. B., 1972, Meteoritics, V7; Mittlefehldt D. W., 1998, PLANETARY MAT, P195; NAKAMURAMESSENG.K, 2013, 44 LUN PLAN SCI C; NUTH JA, 1992, ASTROPHYS SPACE SCI, V196, P117, DOI 10.1007/BF00645245; Rubin AE, 1997, GEOCHIM COSMOCHIM AC, V61, P425, DOI 10.1016/S0016-7037(96)00335-3; RUSSELL SS, 1992, SCIENCE, V256, P206, DOI 10.1126/science.256.5054.206; Stohr J., 1992, NEXAFS SPECTROSCOPY; TIELENS AGGM, 1987, ASTROPHYS J, V319, pL109, DOI 10.1086/184964; YABUTA H, 2010, ASTR SCI C LEAG CIT	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	NOV	2014	49	11					2095	2103		10.1111/maps.12312		9	Geochemistry & Geophysics	Geochemistry & Geophysics	AT1ZZ	WOS:000344731500012		
J	Jilly, CE; Huss, GR; Krot, AN; Nagashima, K; Yin, QZ; Sugiura, N				Jilly, Christine E.; Huss, Gary R.; Krot, Alexander N.; Nagashima, Kazuhide; Yin, Qing-Zhu; Sugiura, Naoji			Mn-53-Cr-53 dating of aqueously formed carbonates in the CM2 lithology of the Sutter's Mill carbonaceous chondrite	METEORITICS & PLANETARY SCIENCE			English	Article							EARLY SOLAR-SYSTEM; CHROMIUM ISOTOPE SYSTEMATICS; RELATIVE SENSITIVITY FACTORS; METEORITE PARENT BODIES; ION MICROPROBE; CORE FORMATION; CI CHONDRITES; CHRONOLOGY; ANGRITES; AGES	Radiometric dating of secondary minerals can be used to constrain the timing of aqueous alteration on meteoritic parent bodies. Dolomite is a well-documented secondary mineral in CM chondrites, and is thought to have formed by precipitation from an aqueous fluid on the CM parent body within several million years of accretion. The petrographic context of crosscutting dolomite veins indicates that aqueous alteration occurred in situ, rather than in the nebular setting. Here, we present Mn-53-Cr-53 systematics for dolomite grains in Sutter's Mill section SM51-1. The Mn-Cr isotope data show well-resolved excesses of Cr-53 correlated with Mn-55/Cr-52 ratio, which we interpret as evidence for the in situ decay of radioactive Mn-53. After correcting for the relative sensitivities of Mn and Cr using a synthetic Mn- and Cr-bearing calcite standard, the data yield an isochron with slope corresponding to an initial Mn-53/Mn-55 ratio of 3.42 +/- 0.86 x 10(-6). The reported error includes systematic uncertainty from the relative sensitivity factor. When calculated relative to the U-corrected Pb-Pb absolute age of the D'Orbigny angrite, Sutter's Mill dolomites give a formation age between 4564.8 and 4562.2 Ma (2.4-5.0 Myr after the birth of the solar system). This age is contemporaneous with previously reported ages for secondary carbonates in CM and CI chondrites. Consistent carbonate precipitation ages between the carbonaceous chondrite groups suggest that aqueous alteration was a common process during the early stages of parent body formation, probably occurring via heating from internal Al-26 decay. The high-precision isochron for Sutter's Mill dolomite indicates that late-stage processing did not reach temperatures that were high enough to further disturb the Mn-Cr isochron.	[Jilly, Christine E.; Huss, Gary R.; Krot, Alexander N.; Nagashima, Kazuhide] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Yin, Qing-Zhu] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Sugiura, Naoji] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Jilly, CE (reprint author), Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	cjilly@hawaii.edu	Yin, Qing-Zhu/B-8198-2009; Sugiura, Naoji/A-1855-2009	Yin, Qing-Zhu/0000-0002-4445-5096; 	NASA through NASA [NNX11AG78G]; NASA through NAI [NNA04CC08A, NNX11AJ51G]	This research is supported by NASA through NASA grant NNX11AG78G (G. R. Huss, PI), NAI cooperative agreement NNA04CC08A (K. Meech, PI), and NNX11AJ51G (Q. Z. Yin, PI). The authors would like to thank C. Alexander, W. Fujiya, and Y. Guan for their reviews, which helped to significantly improve this manuscript. This is Hawaii Institute of Geophysics and Planetology publication #2029, and School of Ocean and Earth Science and Technology publication #9089.	Alexander CMO, 2012, METEORIT PLANET SCI, V47, P1157, DOI 10.1111/j.1945-5100.2011.01308.x; Amelin Y, 2008, GEOCHIM COSMOCHIM AC, V72, P221, DOI 10.1016/j.gca.2007.09.034; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; Endress M, 1996, NATURE, V379, P701, DOI 10.1038/379701a0; Fujiya W, 2013, EARTH PLANET SC LETT, V362, P130, DOI 10.1016/j.epsl.2012.11.057; Qin LP, 2008, EARTH PLANET SC LETT, V273, P94, DOI 10.1016/j.epsl.2008.06.018; Glavin DP, 2004, METEORIT PLANET SCI, V39, P693; Kleine T, 2012, GEOCHIM COSMOCHIM AC, V84, P186, DOI 10.1016/j.gca.2012.01.032; Rubin AE, 2007, GEOCHIM COSMOCHIM AC, V71, P2361, DOI 10.1016/j.gca.2007.02.008; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P4187, DOI 10.1016/S0016-7037(02)01003-7; Keil K, 2012, CHEM ERDE-GEOCHEM, V72, P191, DOI 10.1016/j.chemer.2012.06.002; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Guo W, 2007, GEOCHIM COSMOCHIM AC, V71, P5565, DOI 10.1016/j.gca.2007.07.029; Kita NT, 2012, METEORIT PLANET SCI, V47, P1108, DOI 10.1111/j.1945-5100.2011.01264.x; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; de Leuw S, 2010, METEORIT PLANET SCI, V45, P513, DOI 10.1111/j.1945-5100.2010.01037.x; Hoppe P, 2007, METEORIT PLANET SCI, V42, P1309, DOI 10.1111/j.1945-5100.2007.tb00576.x; Brennecka GA, 2012, P NATL ACAD SCI USA, V109, P9299, DOI 10.1073/pnas.1114043109; Scott ERD, 2009, GEOCHIM COSMOCHIM AC, V73, P5137, DOI 10.1016/j.gca.2009.02.037; Connelly JN, 2012, SCIENCE, V338, P651, DOI 10.1126/science.1226919; Lee MR, 2012, GEOCHIM COSMOCHIM AC, V92, P148, DOI 10.1016/j.gca.2012.06.005; Mittlefehldt DW, 2002, METEORIT PLANET SCI, V37, P345; Shukolyukov A, 2006, EARTH PLANET SC LETT, V250, P200, DOI 10.1016/j.epsl.2006.07.036; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Ogliore RC, 2011, NUCL INSTRUM METH B, V269, P1910, DOI 10.1016/j.nimb.2011.04.120; Baum E. M., 2002, NUCL ISOTOPES; Benedix GK, 2003, GEOCHIM COSMOCHIM AC, V67, P1577, DOI 10.1016/S0016-7037(02)01078-5; BIRCK JL, 1988, NATURE, V331, P579, DOI 10.1038/331579a0; Bland P. A., 2006, METEORITES EARLY SOL, VII, P853; de Leuw S, 2009, GEOCHIM COSMOCHIM AC, V73, P7433, DOI 10.1016/j.gca.2009.09.011; Doyle P. M., 2013, 76 ANN MET SOC M MET, V48; Fujiya W, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1635; Garvie L. A. J., 2013, 44 LUN PLAN SCI C; Grady M. M., 2013, 44 LUN PLAN SCI C; Krot A. N., 2006, METEORITES EARLY SOL, P525; Krot A. N., 2013, 76 ANN MET SOC M, P5161; McKibbin SJ, 2013, GEOCHIM COSMOCHIM AC, V110, P216, DOI 10.1016/j.gca.2013.02.025; Nagashima K., 2008, 39 LUN PLAN SCI C; Nakamura T., 2003, METEORIT PLANET SCI, V38, pA47; PAPANASTASSIOU DA, 1986, ASTROPHYS J, V308, pL27, DOI 10.1086/184737; Petitat M, 2011, METEORIT PLANET SCI, V46, P275, DOI 10.1111/j.1945-5100.2010.01150.x; Petitat M., 2009, 40 LUN PLAN SCI C; PINGITORE NE, 1988, MAR CHEM, V25, P107, DOI 10.1016/0304-4203(88)90059-X; RICIPUTI LR, 1994, GEOCHIM COSMOCHIM AC, V58, P1343, DOI 10.1016/0016-7037(94)90386-7; Sugiura N, 2010, GEOCHEM J, V44, pE11; Tyra M. A., 2009, 40 LUN PLAN SCI C; Walker R. J., 2013, 44 LUN PLAN SCI C; Yamakawa A., 2013, 44 LUN PLAN SCI C; Ziegler K., 2013, METEORITICS PLANETAR, V48	51	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	NOV	2014	49	11					2104	2117		10.1111/maps.12305		14	Geochemistry & Geophysics	Geochemistry & Geophysics	AT1ZZ	WOS:000344731500013		
J	Kudo, M; Nomura, T; Yomoda, S; Tanimoto, K; Tomita, H				Kudo, Michiaki; Nomura, Takahiro; Yomoda, Sachie; Tanimoto, Koichi; Tomita, Haruyoshi			Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Enterococcus faecalis; multidrug resistance; non-vancomycin-resistant enterococci; nosocomial infection	GENTAMICIN RESISTANCE; PHEROMONE RESPONSE; IDENTIFICATION	Compared with other developed countries, vancomycin-resistant enterococci (VRE) are not widespread in clinical environments in Japan. There have been no VRE outbreaks and only a few VRE strains have sporadically been isolated in our university hospital in Gunma, Japan. To examine the drug susceptibility of Enterococcus faecalis and nosocomial infection caused by non-VRE strains, a retrospective surveillance was conducted in our university hospital. Molecular epidemiological analyses were performed on 1711 E. faecalis clinical isolates collected in our hospital over a 6-year period [1998-2003]. Of these isolates, 1241 (72.5%) were antibiotic resistant and 881 (51.5%) were resistant to two or more drugs. The incidence of multidrug resistant E. faecalis (MDR-Ef) isolates in the intensive care unit increased after enlargement and restructuring of the hospital. The major group of MDR-Ef strains consisted of 209 isolates (12.2%) resistant to the five drug combination tetracycline/erythromycin/kanamycin/streptomycin/gentamicin. Pulsed-field gel electrophoresis analysis of the major MDR-Ef isolates showed that nosocomial infections have been caused by MDR-Ef over a long period (more than 3 years). Multilocus sequence typing showed that these strains were mainly grouped into ST16 (CC58) or ST64 (CC8). Mating experiments suggested that the drug resistances were encoded on two conjugative transposons (integrative conjugative elements), one encoded tetracycline-resistance and the other erythromycin/kanamycin/streptomycin/gentamicin-resistance. To our knowledge, this is the first report of nosocomial infection caused by vancomycin-susceptible MDR-Ef strains over a long period in Japan.	[Kudo, Michiaki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Maebashi, Gunma 3718511, Japan; [Kudo, Michiaki; Nomura, Takahiro; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Maebashi, Gunma 3718511, Japan; [Yomoda, Sachie] Gunma Univ, Grad Sch Med, Dept Lab Med, Maebashi, Gunma 3718511, Japan; [Yomoda, Sachie] Gunma Univ, Grad Sch Med, Clin Lab Ctr, Maebashi, Gunma 3718511, Japan; [Tanimoto, Koichi; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Lab Bacterial Drug Resistance, Maebashi, Gunma 3718511, Japan	Tomita, H (reprint author), Gunma Univ, Grad Sch Med, Dept Bacteriol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	tomitaha@gunma-u.ac.jp			Japanese Ministry of Education, Culture, Sport, Science and Technology (Gunma University Operation Grants); Japanese Ministry of Health, Labour and Welfare [H24-Shinkou-Ippan-010, H24-Shokuhin-Ippan-008]	We thank SE Flannagan (University of Michigan, Ann Arbor, MI, USA) for helpful advice on the manuscript. This study was supported by grants from the Japanese Ministry of Education, Culture, Sport, Science and Technology (Gunma University Operation Grants) and the Japanese Ministry of Health, Labour and Welfare (Grants H24-Shinkou-Ippan-010 and H24-Shokuhin-Ippan-008).	Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; UTTLEY AHC, 1988, LANCET, V1, P57; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Arakawa Y, 2000, EMERG INFECT DIS, V6, P572; Castillo-Rojas G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059491; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Clewell D.B., 2011, MOB GENET ELEMENTS, V1, P38, DOI DOI 10.4161/MGE.1.1.15409; Fujimoto S, 1998, P NATL ACAD SCI USA, V95, P6430, DOI 10.1073/pnas.95.11.6430; Fujita N, 1998, ANTIMICROB AGENTS CH, V42, P2150; GORDON S, 1992, J CLIN MICROBIOL, V30, P2373; Ma XH, 1998, J CLIN MICROBIOL, V36, P2460; Malani PN, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P385; Ozawa Y, 2002, APPL ENVIRON MICROB, V68, P6457, DOI 10.1128/AEM.68.12.6457-6461.2002; Quinones D, 2009, MICROB DRUG RESIST, V15, P287, DOI 10.1089/mdr.2009.0028; Sambrook J., 1989, MOL CLONING LAB MANU; Shiojima M, 1997, ANTIMICROB AGENTS CH, V41, P702; Del Campo R, 2003, MICROB DRUG RESIST, V9, P47, DOI 10.1089/107662903764736346; Werner G., 2008, EURO SURVEILL	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	NOV	2014	58	11					607	614		10.1111/1348-0421.12190		8	Immunology; Microbiology	Immunology; Microbiology	AS9WX	WOS:000344590300001		
J	Senoh, M; Kato, H; Murase, T; Hagiya, H; Tagashira, Y; Fukuda, T; Iwaki, M; Yamamoto, A; Shibayama, K				Senoh, Mitsutoshi; Kato, Haru; Murase, Tomoko; Hagiya, Hideharu; Tagashira, Yasuaki; Fukuda, Tadashi; Iwaki, Masaaki; Yamamoto, Akihiko; Shibayama, Keigo			Reverse transcription polymerase chain reaction-based method for selectively detecting vegetative cells of toxigenic Clostridium difficile	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Clostridium difficile; Detection method; RT-PCR; Vegetative cells	REAL-TIME PCR; TOXIN-B; ENZYME-IMMUNOASSAY; INFECTION; DIAGNOSIS; IDENTIFICATION; DISEASE; ASSAYS	The laboratory diagnostic methods for Clostridium difficile infection (CDI) include toxigenic culture, enzyme immunoassays (EIAs) to detect the toxins of C. difficile, and nucleic acid amplification tests (NAATs) to detect C. difficile toxin genes, but each of these methods has disadvantages; toxigenic cultures require a long time to produce results, EIAs have low sensitivity, and NAATs that target DNA cannot distinguish vegetative cells from spores and dead cells. Here we report a new detection method that uses reverse transcription polymerase chain reaction to target the toxin-gene transcripts. This method was able to specifically detect the vegetative cells of toxigenic C. difficile in fecal samples in spike tests, with a minimum detection limit of 5x10(2) colony-forming units per 100mg of stool specimen. The performance of this method was also demonstrated in a pilot scale evaluation using clinical fecal specimens, which showed that this method may be more sensitive than EIA and requires a shorter time than toxigenic culture. This method could potentially be applied in the clinical laboratory to detect C. difficile in fecal specimens. The ability of this method to discriminate the presence of vegetative cells from spores and dead cells could help to further the understanding of CDI.	[Senoh, Mitsutoshi; Kato, Haru; Fukuda, Tadashi; Iwaki, Masaaki; Yamamoto, Akihiko; Shibayama, Keigo] Natl Inst Infect Dis, Tokyo 2080011, Japan; [Murase, Tomoko] Tsuyama Chuo Hosp, Tsuyama, Okayama, Japan; [Hagiya, Hideharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayamaa, Japan; [Tagashira, Yasuaki] Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan	Senoh, M (reprint author), Natl Inst Infect Dis, Dept Bacteriol 2, 4-7-1 Gakuen, Tokyo 2080011, Japan.	senoh@nih.go.jp			Ministry of Health, Labor, and Welfare, Japan [H23-Shinko-Shitei-020]	This study was supported by a grant from the Ministry of Health, Labor, and Welfare, Japan (H23-Shinko-Shitei-020).	Alcala L, 2008, J CLIN MICROBIOL, V46, P3833, DOI 10.1128/JCM.01060-08; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Dubberke ER, 2011, J CLIN MICROBIOL, V49, P2887, DOI 10.1128/JCM.00891-11; Sharp SE, 2010, J CLIN MICROBIOL, V48, P2082, DOI 10.1128/JCM.00129-10; KATO N, 1991, J CLIN MICROBIOL, V29, P33; Kato H, 1998, J CLIN MICROBIOL, V36, P2178; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Humphries RM, 2013, J CLIN MICROBIOL, V51, P869, DOI 10.1128/JCM.02970-12; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Chapin KC, 2011, J MOL DIAGN, V13, P395, DOI 10.1016/j.jmoldx.2011.03.004; Gerding Dale N, 2014, Gut Microbes, V5, P15, DOI 10.4161/gmic.26854; GUMERLOCK PH, 1991, REV INFECT DIS, V13, P1053; Kim H, 2012, J MED MICROBIOL, V61, P274, DOI 10.1099/jmm.0.035618-0; PALLIS A, 2013, J MED MICROBIOL 9, V63, P1350; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; TAYLOR NS, 1979, REV INFECT DIS, V1, P379; YOLKEN RH, 1981, J INFECT DIS, V144, P378	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	NOV	2014	58	11					615	620		10.1111/1348-0421.12189		6	Immunology; Microbiology	Immunology; Microbiology	AS9WX	WOS:000344590300002		
J	Kihira, S; Uematsu, J; Kawano, M; Itoh, A; Ookohchi, A; Satoh, S; Maeda, Y; Sakai, K; Yamamoto, H; Tsurudome, M; O'Brien, M; Komada, H				Kihira, Sahoko; Uematsu, Jun; Kawano, Mitsuo; Itoh, Ai; Ookohchi, Ayumi; Satoh, Saemi; Maeda, Yurie; Sakai, Kae; Yamamoto, Hidetaka; Tsurudome, Masato; O'Brien, Myles; Komada, Hiroshi			Ribavirin inhibits human parainfluenza virus type 2 replication in vitro	MICROBIOLOGY AND IMMUNOLOGY			English	Article						antiviral drugs; recombinant green fluorescence protein expressing hPIV-2 without matrix protein; human parainfluenza virus type 2	PREDOMINANT MECHANISM; ANTIVIRAL ACTIVITY; HEPATITIS-C; GENE; SEQUENCE; PARAMYXOVIRUSES; PROTEIN; METABOLISM; INFECTION; EXERTS	The antiviral activities of eight nucleoside analog antiviral drugs (ribavirin, acyclovir, lamivudine, 3-azido-3-deoxythymidine, emtricitabine, tenofovir, penciclovir and ganciclovir) against human parainfluenza virus type 2 (hPIV-2) were investigated. Only ribavirin (RBV) inhibited both cell fusion and hemadsorption induced by hPIV-2. RBV considerably reduced the number of viruses released from the cells. Virus genome synthesis was inhibited by RBV, as determined by real time PCR. An indirect immunofluorescence study showed that RBV largely inhibited viral protein synthesis. mRNAs of the proteins were not detected, indicating that inhibition of protein synthesis was caused by transcription inhibition by RBV. Using a recombinant green fluorescence protein-expressing hPIV-2 without matrix protein, it was found that RBV did not completely inhibit virus entry into the cells; however, it almost completely blocked multinucleated giant cell formation. RBV did not disrupt actin microfilaments and microtubules. These results indicate that the inhibitory effect of RBV is caused by inhibition of both virus genome and mRNA synthesis, resulting in inhibition of virus protein synthesis, viral replication and multinucleated giant cell formation (extensive cell-to-cell spreading of the virus).	[Kihira, Sahoko; Itoh, Ai; Ookohchi, Ayumi; Satoh, Saemi; Maeda, Yurie; Sakai, Kae] Suzuka Univ Med Sci, Fac Hlth Sci, Dept Clin Nutr, Suzuka, Mie 5100293, Japan; [Uematsu, Jun; Komada, Hiroshi] Suzuka Univ Med Sci, Grad Sch, Dept Clin Nutr, Microbiol & Immunol Sect, Suzuka, Mie 5100293, Japan; [Kawano, Mitsuo; Tsurudome, Masato] Mie Univ, Grad Sch Med, Dept Microbiol, Tsu, Mie 5148507, Japan; [Yamamoto, Hidetaka] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [O'Brien, Myles] Mie Prefectural Coll Nursing, Grad Sch, Tsu, Mie 5140116, Japan	Komada, H (reprint author), Suzuka Univ Med Sci, Grad Sch, Dept Clin Nutr, Microbiol & Immunol Sect, 1001-1 Kishioka, Suzuka, Mie 5100293, Japan.	komada@suzuka-u.ac.jp					Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057; De BP, 1999, MICROSC RES TECHNIQ, V47, P114, DOI 10.1002/(SICI)1097-0029(19991015)47:2<114::AID-JEMT4>3.0.CO;2-E; Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006; Martin P, 2008, J GASTROEN HEPATOL, V23, P844, DOI 10.1111/j.1440-1746.2008.05398.x; TSURUDOME M, 1989, VIROLOGY, V171, P38, DOI 10.1016/0042-6822(89)90508-4; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; MOYER SA, 1986, P NATL ACAD SCI USA, V83, P5405, DOI 10.1073/pnas.83.15.5405; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; KAWANO M, 1990, VIROLOGY, V178, P289, DOI 10.1016/0042-6822(90)90406-H; KAWANO M, 1990, VIROLOGY, V179, P857, DOI 10.1016/0042-6822(90)90155-K; KAWANO M, 1990, VIROLOGY, V174, P308, DOI 10.1016/0042-6822(90)90081-2; KAWANO M, 1991, NUCLEIC ACIDS RES, V19, P2739, DOI 10.1093/nar/19.10.2739; Kawano M, 2001, VIROLOGY, V284, P99, DOI 10.1006/viro.2001.0864; Kitagawa H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066614; Lamb R., 2007, FIELDS VIROLOGY, P1449; OHGIMOTO S, 1990, VIROLOGY, V177, P116, DOI 10.1016/0042-6822(90)90465-4; Safronetz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023560; Shah NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011265; SMEE DF, 1986, ANTIMICROB AGENTS CH, V30, P117; Taoda N, 2008, BIOMED RES-TOKYO, V29, P331, DOI 10.2220/biomedres.29.331; Uematsu J, 2012, VIRUSES-BASEL, V4, P1104, DOI 10.3390/v4071104; YUASA T, 1990, VIROLOGY, V179, P777, DOI 10.1016/0042-6822(90)90145-H	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	NOV	2014	58	11					628	635		10.1111/1348-0421.12192		8	Immunology; Microbiology	Immunology; Microbiology	AS9WX	WOS:000344590300004		
J	Kojima, S; Honda, T; Matsumoto, Y; Tomonaga, K				Kojima, Shohei; Honda, Tomoyuki; Matsumoto, Yusuke; Tomonaga, Keizo			Heat stress is a potent stimulus for enhancing rescue efficiency of recombinant Borna disease virus	MICROBIOLOGY AND IMMUNOLOGY			English	Article						animal RNA virus; Borna disease virus; heat stress; viral vector	MOLECULAR CHAPERONES; RNA-POLYMERASE; IN-VIVO; PROTEINS; EXPRESSION; INFECTION; GENE; ASSOCIATION; VECTOR; SYSTEM	Recently developed vector systems based on Borna disease virus (BDV) hold promise as platforms for efficient and stable gene delivery to the central nervous system (CNS). However, because it currently takes several weeks to rescue recombinant BDV (rBDV), an improved rescue procedure would enhance the utility of this system. Heat stress reportedly enhances the rescue efficiency of other recombinant viruses. Here, heat stress was demonstrated to increase the amount of BDV genome in persistently BDV-infected cells without obvious cytotoxicity. Further analyses suggested that the effect of heat stress on BDV infection is not caused by an increase in the activity of BDV polymerase. More cells in which BDV replication occurs were obtained in the initial phase of rBDV rescue by using heat stress than when it was not used. Thus, heat stress is a useful improvement on the published rescue procedure for rBDV. The present findings may accelerate the practical use of BDV vector systems in basic science and the clinic and thus enable broader adoption of this viral vector, which is uniquely suited for gene delivery to the CNS.	[Kojima, Shohei; Honda, Tomoyuki; Matsumoto, Yusuke; Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan; [Matsumoto, Yusuke] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama 6418509, Japan	Honda, T (reprint author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	thonda@virus.kyoto-u.ac.jp; tomonaga@virus.kyoto-u.ac.jp		Matsumoto, Yusuke/0000-0003-3500-2279	Funding Program for Next Generation World-Leading Researchers [LS068]; Japan Society for the Promotion of Science (JSPS) [26253027]; JSPS for Young Scientists [25860336]; Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan [24115709, 25115508]; Takeda Science Foundation	We thank Nicholas F. Parrish (Kyoto University, Kyoto, Japan) for editing the manuscript. This study was supported in part by the Funding Program for Next Generation World-Leading Researchers (LS068) (KT) and a Grant-in-Aid for Scientific Research (A) (26253027) from the Japan Society for the Promotion of Science (JSPS) (KT), a Grant-in-Aid for Research Fellowship of JSPS for Young Scientists (25860336) (TH), a Grant-in-Aid for Scientific Research in Innovative Areas (24115709 and 25115508) (TH) from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan, and a grant from the Takeda Science Foundation (TH).	Yanai H, 2006, MICROBES INFECT, V8, P1522, DOI 10.1016/j.micinf.2006.01.010; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Carsillo T, 2006, J VIROL, V80, P11031, DOI 10.1128/JVI.01438-06; SLEAT DE, 1993, J VIROL, V67, P1334; Sauder C, 1996, J VIROL, V70, P7713; BODE L, 1994, VET REC, V135, P283; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Honda T, 2013, VIRUSES-BASEL, V5, P1978, DOI 10.3390/v5081978; Gething MJ, 1996, CURR BIOL, V6, P1573, DOI 10.1016/S0960-9822(02)70775-6; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; GUNTHER E, 1994, EXPERIENTIA, V50, P987; OGLESBEE MJ, 1993, VIROLOGY, V192, P556, DOI 10.1006/viro.1993.1072; Daito T, 2011, J VIROL, V85, P12170, DOI 10.1128/JVI.05554-11; CRIPE TP, 1995, J VIROL, V69, P7807; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Hayashi Y, 2009, MICROBES INFECT, V11, P394, DOI 10.1016/j.micinf.2009.01.006; Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09; LUND PA, 1995, ESSAYS BIOCHEM, V29, P113; MACEJAK DG, 1992, J VIROL, V66, P1520; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Parks CL, 1999, J VIROL, V73, P3560; Parks CL, 2002, VIRUS RES, V83, P131, DOI 10.1016/S0168-1702(01)00430-0; Schneider U, 2007, J VIROL, V81, P7293, DOI 10.1128/JVI.02467-06; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	NOV	2014	58	11					636	642		10.1111/1348-0421.12193		7	Immunology; Microbiology	Immunology; Microbiology	AS9WX	WOS:000344590300005		
J	Arimitsu, H; Sasaki, K; Kohda, T; Shimizu, T; Tsuji, T				Arimitsu, Hideyuki; Sasaki, Keiko; Kohda, Tomoko; Shimizu, Toshiyasu; Tsuji, Takao			Evaluation of Shiga toxin 2e-specific chicken egg yolk immunoglobulin: Production and neutralization activity	MICROBIOLOGY AND IMMUNOLOGY			English	Article						chicken IgY; edema disease; Shiga toxin 2e	ESCHERICHIA-COLI; EDEMA DISEASE; NUCLEOTIDE-SEQUENCE; II VARIANT; ANTIBODIES; IGY; PIGS; CYTOTOXICITY; PURIFICATION; EFFICACY	Chicken egg yolk immunoglobulin (IgY) against Shiga toxin 2e (Stx2e), a major cause of swine edema disease, was prepared to evaluate its possible clinical applications. The titer of Stx2e-specific IgY in egg yolk derived from three chickens that had been immunized with an Stx2e toxoid increased 2 weeks after primary immunization and remained high until 90 days after this immunization. Anti-Stx2e IgY was found to neutralize the toxicity of Stx2e by reacting with its A and B subunits, indicating that IgY is a cost-effective agent to develop for prophylactic foods or diagnosis kits for edema disease.	[Arimitsu, Hideyuki; Sasaki, Keiko; Shimizu, Toshiyasu; Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 4701192, Japan; [Kohda, Tomoko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Epidemiol, Izumisano, Osaka 5988531, Japan	Arimitsu, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Microbiol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	arimitsu@fujita-hu.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [24590539]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was partially supported by a Japan Society for the Promotion of Science KAKENHI Grant (No. 24590539; http://www.jsps.g.jp/) and a grant from the Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aarestrup FM, 1997, J CLIN MICROBIOL, V35, P20; Carlander D, 1999, UPSALA J MED SCI, V104, P179; IMBERECHTS H, 1992, INFECT IMMUN, V60, P1963; Yamada K, 2013, JPN J INFECT DIS, V66, P103; Jin WC, 2013, J MICROBIOL METH, V92, P323, DOI 10.1016/j.mimet.2013.01.001; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Takeda M, 2006, J VET MED SCI, V68, P325, DOI 10.1292/jvms.68.325; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Davalos-Pantoja L, 2000, J BIOMAT SCI-POLYM E, V11, P657, DOI 10.1163/156856200743931; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361; SAMUEL JE, 1990, INFECT IMMUN, V58, P611; Gandhi S, 2009, BIOSENS BIOELECTRON, V25, P502, DOI 10.1016/j.bios.2009.07.018; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Bettelheim KA, 2003, J APPL MICROBIOL, V95, P205, DOI 10.1046/j.1365-2672.2003.02031.x; Kovacs-Nolan J, 2012, ANNU REV FOOD SCI T, V3, P163, DOI 10.1146/annurev-food-022811-101137; Arimitsu H, 2013, MICROBIOL IMMUNOL, V57, P38, DOI 10.1111/j.1348-0421.2012.12004.x; Arimitsu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083577; Feng YF, 2013, CURR MICROBIOL, V67, P448, DOI 10.1007/s00284-013-0384-8; GYLES CL, 1988, MICROB PATHOGENESIS, V5, P419, DOI 10.1016/0882-4010(88)90003-4; IMBERECHTS H, 1992, VET MICROBIOL, V31, P221, DOI 10.1016/0378-1135(92)90080-D; MACLEOD DL, 1990, INFECT IMMUN, V58, P1232; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175; Neri P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026526; Olbrich C, 2002, ATLA-ALTERN LAB ANIM, V30, P443; Parma YR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00084; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; Schade Ruediger, 2005, ATLA Alternatives to Laboratory Animals, V33, P129; Van Coillie E, 2004, J AGR FOOD CHEM, V52, P4975, DOI 10.1021/jf049593d	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	NOV	2014	58	11					643	648		10.1111/1348-0421.12197		6	Immunology; Microbiology	Immunology; Microbiology	AS9WX	WOS:000344590300006		
J	Tung, NH; Sun, K; Fan, JY; Shoyama, Y; Han, JY				Nguyen Huu Tung; Sun, Kai; Fan, Jing-Yu; Shoyama, Yukihiro; Han, Jing-Yan			Oregonin from the Bark of Alnus japonica Restrained Ischemia-Reperfusion-Induced Mesentery Oxidative Stress by Inhibiting NADPH Oxidase Activation	MICROCIRCULATION			English	Article						leukocyte adhesion; mast cell degranulation; DHR; p47(phox) subunit	RAT MESENTERY; MAST-CELLS; DIARYLHEPTANOIDS; EXPRESSION; ISCHEMIA/REPERFUSION; PATHOPHYSIOLOGY; DISTURBANCE; ADHESION; TARGETS; INJURY	ObjectiveNADPH oxidase activation results in ROS overproduction that is the pathological basis of I/R injury. This study aimed to investigate potential effects of ORG on I/R-induced ROS production in rat mesenteric microvasculature and underlying mechanisms. MethodsMesenteric I/R in Male Wistar rats (200 similar to 250g) was induced by ligation of the mesenteric artery and vein for 10minutes followed by reperfusion for 60minutes by releasing of the occlusion. The rats were infused intravenously with or without ORG (5mg/kg per hour) 10minutes before ischemia (pretreatment) or 20minutes after reperfusion (posttreatment). The DHR fluorescence intensity on, the leukocytes adherent to, and mast cell degranulation out of mesenteric venules were determined using an intravital microscope. NADPH oxidase subunit p47(phox) membrane translocation in intestine tissues was detected by Western blotting. ResultsPre- or posttreatment with ORG inhibited I/R-induced DHR fluorescence intensity on the venular walls and leukocytes adhesion, ORG pretreatment inhibited mast cell degranulation as well. Furthermore, the translocation of p47(phox) from cytosol to membrane was suppressed markedly by ORG after I/R. ConclusionsThe results suggested that ORG restrained I/R-induced ROS production, which might be correlated with its inhibitive effect on NADPH activation.	[Nguyen Huu Tung; Shoyama, Yukihiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki 8593298, Japan; [Sun, Kai; Fan, Jing-Yu; Han, Jing-Yan] Peking Univ Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing, Peoples R China; [Han, Jing-Yan] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing 100191, Peoples R China	Han, JY (reprint author), Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	shoyama@niu.ac.jp; hanjingyan@bjmu.edu.cn			Japan Society for the Promotion of Science (JSPS); National Natural Science Foundation of China [81270341]; JSPS; Ghanaian Medicinal Plans Project (JICA/JST)	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) and the National Natural Science Foundation of China grants 81270341. N.H.T is grateful to the JSPS for a Postdoctoral Research Fellowship at Nagasaki International University. Y.S acknowledges the support from the Ghanaian Medicinal Plans Project (JICA/JST). The authors appreciate the donation of A. japonica bark from Prof. Takao Setsu, Kyushu University.	Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Loukogeorgakis SP, 2010, CIRCULATION, V121, P2310, DOI 10.1161/CIRCULATIONAHA.108.814731; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Lee MW, 2000, BIOL PHARM BULL, V23, P517; Kuroyanagi M, 2005, CHEM PHARM BULL, V53, P1519, DOI 10.1248/cpb.53.1519; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; OTAMIRI T, 1989, SURGERY, V105, P593; ZIMMERMAN BJ, 1994, AM J MED SCI, V307, P284, DOI 10.1097/00000441-199404000-00009; STOLK J, 1994, AM J RESP CELL MOL, V11, P95; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Cerqueira Nereide Freire, 2005, Acta Cir Bras, V20, P336, DOI 10.1590/S0102-86502005000400013; Fraticelli A, 1996, BBA-MOL CELL RES, V1310, P251, DOI 10.1016/0167-4889(95)00169-7; Ge M, 2005, CHEM IMMUNOL ALLERGY, V87, P32; Han JM, 2007, J AGR FOOD CHEM, V55, P9457, DOI 10.1021/jf072157h; Han JY, 2009, AM J PHYSIOL-GASTR L, V296, pG36, DOI 10.1152/ajpgi.90284.2008; Kurose I, 1999, HYPERTENSION, V34, P212; Lee WS, 2005, PLANTA MED, V71, P295, DOI 10.1055/s-2005-864093; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Rocha MFG, 2003, TOXICON, V42, P183, DOI 10.1016/S0041-0101(03)00131-4; Suzuki Y, 2013, MOL MED REP, V8, P401; Tung NH, 2010, PLANTA MED, V76, P629; Wang MX, 2010, WORLD J GASTROENTERO, V16, P5306, DOI 10.3748/wjg.v16.i42.5306; Wierzbicki M, 2008, POSTEP HIG MED DOSW, V62, P642	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	NOV	2014	21	8					688	695		10.1111/micc.12147		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AT2TQ	WOS:000344789400002		
J	Shitanishi, K; Hasegawa, K; Kaneko, A; Abe, Y				Shitanishi, Kuniharu; Hasegawa, Koji; Kaneko, Akiko; Abe, Yutaka			Study on Heat Transfer and Flow Characteristic Under Phase-Change Process of an Acoustically Levitated Droplet	MICROGRAVITY SCIENCE AND TECHNOLOGY			English	Article						Container-less processing; Acoustic levitation; Droplet; Heat transfer; External flow		Acoustic levitation is one of the levitation technique which is expected to be used for analytical chemistry and manufacturing new materials. Thus, it is important to gather the knowledge about acoustically levitated droplet. The purpose of this study is to investigate the heat transfer and flow behavior under phase change process of an acoustically levitated droplet. The following results were obtained from experiments. Evaporation process and external flow structure of the levitated droplet is visualized by a high speed camera and it is found that they differ by the type of fluid. Toroidal vortices are observed near the surface of the ethanol solution droplet. Heat transfer coefficient is estimated from the volume change and temperature gradient. It is substantially higher than that estimated by the existing experimental correlation.	[Kaneko, Akiko; Abe, Yutaka] Univ Tsukuba, Inst Engn Mech & Syst, Tsukuba, Ibaraki 3058573, Japan; [Shitanishi, Kuniharu] Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Hasegawa, Koji] Kogakuin Univ, Dept Mech Engn, Hachioji, Tokyo 1920015, Japan	Abe, Y (reprint author), Univ Tsukuba, Inst Engn Mech & Syst, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	s1220880@u.tsukuba.ac.jp; kojihasegawa@cc.kogakuin.ac.jp; kaneko@kz.tsukuba.ac.jp; abe@kz.tsukuba.ac.jp					WHITAKER S, 1972, AICHE J, V18, P361, DOI 10.1002/aic.690180219; TRINH EH, 1985, REV SCI INSTRUM, V56, P2059, DOI 10.1063/1.1138419; Brandt EH, 2001, NATURE, V413, P474, DOI 10.1038/35097192; Hasegawa K, 2008, MICROGRAVITY SCI TEC, V20, P261, DOI 10.1007/s12217-008-9025-4; Ishii H., 2012, T JPN SOC MECH ENG, V78, P1696; RANZ WE, 1952, CHEM ENG PROG, V48, P173; Santesson S, 2004, ANAL BIOANAL CHEM, V378, P1704, DOI 10.1007/s00216-003-2403-2; Xie W. J., 2002, PHYS REV E, V66, P1; Xie WJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061601; Yamamoto Y, 2008, MICROGRAVITY SCI TEC, V20, P277, DOI 10.1007/s12217-008-9070-z	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-0108	1875-0494		MICROGRAVITY SCI TEC	Microgravity Sci. Technol.	NOV	2014	26	5					305	312		10.1007/s12217-014-9401-1		8	Engineering, Aerospace; Thermodynamics; Mechanics	Engineering; Thermodynamics; Mechanics	AT3WS	WOS:000344865400003		
J	Iwahashi, M; Inoue, H; Matsubara, T; Tanaka, T; Amano, K; Kanamono, T; Nakano, T; Uchimura, S; Izumihara, T; Yamazaki, A; Karyekar, CS; Takeuchi, T				Iwahashi, Mitsuhiro; Inoue, Hiroshi; Matsubara, Tsukasa; Tanaka, Takaaki; Amano, Koichi; Kanamono, Toshihisa; Nakano, Teruaki; Uchimura, Shoichi; Izumihara, Tomomaro; Yamazaki, Akira; Karyekar, Chetan S.; Takeuchi, Tsutomu			Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study	MODERN RHEUMATOLOGY			English	Article						Rheumatoid arthritis; Japan; Abatacept; Subcutaneous injection; Intravenous infusion	LONG-TERM SAFETY; RADIOGRAPHIC PROGRESSION; MODULATOR ABATACEPT; REVISED CRITERIA; DOUBLE-BLIND; IIIB; CLASSIFICATION; INHIBITION; THERAPY; PLACEBO	Objective. To evaluate efficacy and safety of subcutaneous (SC) and intravenous (IV) abatacept and background methotrexate (MTX) in Japanese patients with rheumatoid arthritis (RA) and inadequate response to MTX (MTX-IR). Methods. Double-dummy, double-blind study (NCT01001832); 118 adults with >= 10 swollen joints, >= 12 tender joints and C-reactive protein (CRP) >= 0.8 mg/dL randomized 1:1 to SC abatacept (125 mg weekly) with IV loading (similar to 10 mg/kg on Day 1), or IV abatacept (similar to 10 mg/kg monthly) for 169 days, both also receiving MTX (6-8 mg/week). Primary endpoint was Day 169 American College of Rheumatology (ACR) 20 response; other efficacy endpoints, safety and immunogenicity were assessed. Results. Similar proportions of patients achieved ACR20 responses at Day 169 with SC (91.5% [95% CI 81.3, 97.2]) and IV abatacept (83.1% [71.0, 91.6]). ACR50/70 responses, adjusted mean changes from baseline in Health Assessment Questionnaire-Disability Index scores and remission rates (28-joint Disease Activity Score [CRP] <2.6) were also comparable between groups. Serious adverse event frequencies (5.1% vs. 3.4%) were similar with both formulations. One patient per group tested seropositive for immunogenicity. Weekly SC abatacept dosing achieved mean serum concentrations >10 mu g/mL (minimum therapeutic target). Conclusions. SC abatacept demonstrated comparable efficacy and safety to IV abatacept, with low immunogenicity rates, in MTX-IR Japanese patients with RA.	[Iwahashi, Mitsuhiro] Higashi Hiroshima Mem Hosp, Dept Rheumatol, Higashihiroshima, Hiroshima 7390002, Japan; [Inoue, Hiroshi] Inoue Hosp, Gunma, Japan; [Matsubara, Tsukasa] Matsubara Mayflower Hosp, Dept Orthoped, Kato, Hyogo, Japan; [Tanaka, Takaaki] Utsunomiya Natl Hosp, Natl Hosp Org, Dept Orthoped Surg, Utsunomiya, Tochigi, Japan; [Amano, Koichi] Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol & Clin Immunol, Saitama, Japan; [Kanamono, Toshihisa] Nagano Red Coss Hosp, Nagano, Japan; [Nakano, Teruaki] St Marys Hosp, Dept Rheumatol & Internal Med, Fukuoka, Japan; [Uchimura, Shoichi] Kanzaki Municipal Gen Hosp, Kanzaki, Hyogo, Japan; [Izumihara, Tomomaro] Izumihara Rheumatoid Arthrit & Internal Med Clin, Kagoshima, Japan; [Yamazaki, Akira] Bristol Myers KK, Res & Dev, Tokyo, Japan; [Karyekar, Chetan S.] Bristol Myers Squibb Co, Global Clin Res, Princeton, NJ USA; [Takeuchi, Tsutomu] Keio Univ, Dept Internal Med, Div Rheumatol, Tokyo, Japan	Iwahashi, M (reprint author), Higashi Hiroshima Mem Hosp, Dept Rheumatol, 2214 Yoshiyuki,Saijyo Cho, Higashihiroshima, Hiroshima 7390002, Japan.	ajisu@hotmail.com	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Bristol-Myers K.K.	This study was funded by Bristol-Myers K.K.	Alten R, 2011, ANN RHEUM DIS     S3, V70, P617; Amano K, 2013, ANN RHEUM DIS, V72, P458; Nash P, 2013, ARTHRIT CARE RES, V65, P718, DOI 10.1002/acr.21876; [Anonymous], GUID CLIN EV ANT DRU; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Keystone EC, 2012, ANN RHEUM DIS, V71, P857, DOI 10.1136/annrheumdis-2011-200355; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Matsubara T, 2013, MOD RHEUMATOL, V23, P634, DOI 10.1007/s10165-012-0722-x; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Alten R, 2011, ARTHRITIS RHEUM-US, V63, pS150; WELLS GA, 1993, J RHEUMATOL, V20, P557; Kremer JM, 2008, ARTHRITIS RHEUM, V58, P953, DOI 10.1002/art.23397; Kaine J, 2012, ANN RHEUM DIS, V71, P38, DOI 10.1136/annrheumdis-2011-200344; Bathon J, 2011, ANN RHEUM DIS, V70, P1949, DOI 10.1136/ard.2010.145268; Westhovens R, 2009, J RHEUMATOL, V36, P736, DOI 10.3899/jrheum.080813; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P2854, DOI 10.1002/art.30463; Gordon Rachel, 2012, Skin Therapy Lett, V17, P1; Hochberg MC, 2010, ARTHRITIS RHEUM, V62, pS164; Sibilia J, 2007, CLIN EXP RHEUMATOL, V25, pS46; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Takeuchi T, 2012, MOD RHEUMATOL, V23, P226; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					885	891		10.3109/14397595.2014.881954		7	Rheumatology	Rheumatology	AS8FW	WOS:000344486300002		
J	Terai, C; Tsutsumi, T; Sakurai, T; Moriguchi, M; Azuma, T; Kaneko, M; Kawagoe, M; Hoshi, K; Yoshida, H; Matsui, T; Nakajima, K; Okuyama, A; Nishi, E; Amano, K; Ota, M; Mimura, T; Chino, K; Aoki, K; Handa, Y; Hirose, T; Kida, I; Kobayashi, S; Suzuki, K; Matsuzaki, T; Kuga, Y				Terai, Chihiro; Tsutsumi, Tomomi; Sakurai, Tadashi; Moriguchi, Masato; Azuma, Takanori; Kaneko, Motohide; Kawagoe, Mitsuhiro; Hoshi, Kenta; Yoshida, Hide; Matsui, Toshimichi; Nakajima, Kyoichi; Okuyama, Ayumi; Nishi, Eiko; Amano, Koichi; Ota, Muneo; Mimura, Toshihide; Chino, Kentaro; Aoki, Kazutoshi; Handa, Yuichi; Hirose, Tatsuo; Kida, Issei; Kobayashi, Shigeto; Suzuki, Kimihiro; Matsuzaki, Tsuyoshi; Kuga, Yoshiaki			The efficacy of mizoribine for the treatment of rheumatoid arthritis and its correlation with renal function	MODERN RHEUMATOLOGY			English	Article						Cystatin-C; DAS; Mizoribine; Renal function; Rheumatoid arthritis		Objectives. To evaluate the correlation between the efficacy of mizoribine (MZR) and the factors that might effect MZR concentration: renal function and dosage and administration of MZR in patients with rheumatoid arthritis (RA). Methods. The efficacy of MZR treatment was prospectively evaluated in 97 RA regardless of dosage, at the 14 participated institutions. The Disease Activity Score 28-CRP3 was used to assess RA activity. The renal function was evaluated based on the serum creatinine and serum cystatin-C (Cys-C). The patients were followed up for 24 weeks. Results. The patients with a mean age 66.2 years included 18 male. The renal function assessment showed increased creatinine in 16.4% of patients and increased Cys-C in 54.5%, suggesting the higher sensitivity of Cys-C to detect impaired renal function than creatinine. In patients with good or moderate response according to the European League against Rheumatism classification criteria, the Cys-C was significantly higher compared with those with no response. MZR treatment was significantly more effective in patients with an arithmetic product of the single MZR dose used and Cys-C of 179 or more. Conclusions. The efficacy of MZR may increase in proportion to its single dose, or increased Cys-C level in patients with impaired renal function.	[Terai, Chihiro; Tsutsumi, Tomomi; Sakurai, Tadashi; Moriguchi, Masato] Jichi Med Univ, Saitama Med Ctr, Dept Rheumatol, Saitama 3308503, Japan; [Azuma, Takanori] Azuma Rheumatol Clin, Saitama, Japan; [Kaneko, Motohide] Kaneko Clin, Saitama, Japan; [Kawagoe, Mitsuhiro] Kawagoe Clin, Saitama, Japan; [Hoshi, Kenta; Yoshida, Hide; Matsui, Toshimichi] Kitasato Univ, Med Ctr, Dept Rheumatol & Connect Tissue Dis, Saitama, Japan; [Nakajima, Kyoichi] Higashi Saitama Hosp, Natl Hosp Org, Dept Rheumatol, Saitama, Japan; [Okuyama, Ayumi; Nishi, Eiko; Amano, Koichi] Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol & Clin Immunol, Saitama, Japan; [Ota, Muneo; Mimura, Toshihide] Saitama Med Univ Hosp, Dept Rheumatol & Appl Immunol, Saitama, Japan; [Chino, Kentaro; Aoki, Kazutoshi] Saitama Social Insurance Hosp, Dept Internal Med, Saitama, Japan; [Handa, Yuichi] Saitama Red Cross Hosp, Dept Internal Med, Saitama, Japan; [Hirose, Tatsuo] Saitama City Hosp, Dept Internal Med, Saitama, Japan; [Kida, Issei; Kobayashi, Shigeto] Juntendo Univ, Koshigaya Hosp, Dept Internal Med, Saitama, Japan; [Suzuki, Kimihiro] Suzuhiro Clin, Saitama, Japan; [Matsuzaki, Tsuyoshi] Matsuzaki Orthopaed & Rheumatol Clin, Saitama, Japan; [Kuga, Yoshiaki] Wakaba Hosp, Dept Orthoped Surg, Saitama, Japan	Terai, C (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Rheumatol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	chihirot@jichi.ac.jp					Sato H, 2010, SCAND J RHEUMATOL, V39, P33, DOI 10.3109/03009740903042402; Ichinose K, 2010, INTERNAL MED, V49, P2211, DOI 10.2169/internalmedicine.49.3810; Ito S., 2008, JPN J JOINT DIS, V27, P39; Kasama T, 2009, MOD RHEUMATOL, V19, P395, DOI 10.1007/s10165-009-0179-8; Kohriyama K, 2003, CLIN RHEUMATOL, V15, P227; Moriguchi M, 2000, Mod Rheumatol, V10, P230, DOI 10.3109/s101650070008; Murai T, 2009, JPN J JOINT DIS, V28, P21; Nakamura S, 2011, CLIN RHEUMATOL, V23, P168; Nishimura K, 2006, PROG MED, V26, P2163; Nishimura K, 2011, MOD RHEUMATOL, V21, P158, DOI 10.1007/s10165-010-0373-8; Suzuki D, 2011, JPN J CLIN IMMUNOL, V34, P149	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					892	896		10.3109/14397595.2014.885376		5	Rheumatology	Rheumatology	AS8FW	WOS:000344486300003		
J	Iwamoto, K; Shi, K; Tomita, T; Hashimoto, J; Yamazaki, T; Yoshikawa, H; Sugamoto, K				Iwamoto, Keiji; Shi, Kenrin; Tomita, Tetsuya; Hashimoto, Jun; Yamazaki, Takaharu; Yoshikawa, Hideki; Sugamoto, Kazuomi			In vivo kinematics of three-component mobile-bearing total ankle replacement in rheumatoid ankle with talocalcaneal arthrodesis and spontaneous talocalcaneal fusion	MODERN RHEUMATOLOGY			English	Article						Mobile-bearing total ankle replacement; In vivo kinematics; Talocalcaneal arthrodesis; 2D/3D registration technique; rheumatoid arthritis	SINGLE-PLANE FLUOROSCOPY; KNEE-BENDING MOTION; HINDFOOT ALIGNMENT; JOINT COMPLEX; ARTHRITIS; SUBTALAR; WALKING; ARTHROPLASTY; GAIT; PROSTHESIS	Objective. It is often that patients with rheumatoid arthritis (RA) who require ankle surgeries already have the degeneration of talocalcaneal joints. When talocalcaneal joint was fused, whether operatively or spontaneously, ankle kinematics would be affected. The purpose of this paper was to study in vivo kinematics of mobile-bearing total ankle replacement (TAR) in rheumatoid ankle with concomitant talocalcaneal arthrodesis or with preexisting spontaneous talocalcaneal fusion. Methods. Thirteen TARs in ten patients with RA, in whom talocalcaneal joints had already been fused spontaneously or surgically, were studied. Fluoroscopic images were obtained while each patient was walking with full weightbearing on the implanted ankle. Thereafter tibio-talar motion was analyzed by 2D/3D registration technique. Results. Average tibio-talar motion was 4.0 +/- 5.3 degrees for plantarflexion and 6.6 +/- 0.3 degrees for dorsifl exion. Average range of internal/external rotation, inversion/eversion and AP translation was 3.8 +/- 1.3 degrees, 2.7 +/- 1.0 degrees and 1.6 +/- 0.6 mm, respectively. Conclusions. Mobility of mobile-bearing TAR with talocalcaneal fusion was small during the stance phase of gait, but clinically measured ROM was mostly preserved. The movements of internal/external rotation and AP translation were allowed to a certain degree, but not of inversion/eversion. Even though the movement of inversion/eversion is limited, talocalcaneal arthrodesis could be accompanied with mobile-bearing TAR in rheumatoid ankles.	[Iwamoto, Keiji; Tomita, Tetsuya; Sugamoto, Kazuomi] Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, Suita, Osaka 5650871, Japan; [Shi, Kenrin; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Hashimoto, Jun] Osaka Minami Med Ctr, Natl Hosp Org, Dept Rheumatol, Osaka, Japan; [Yamazaki, Takaharu] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Shi, K (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shi@ort.med.osaka-u.ac.jp					Buechel FF, 2004, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000132243.41419.59; Henricson A, 2007, ACTA ORTHOP, V78, P569, DOI 10.1080/17453670710014248; Baan H, 2012, SEMIN ARTHRITIS RHEU, V41, P768, DOI 10.1016/j.semarthrit.2011.11.009; Barg A, 2010, FOOT ANKLE INT, V31, P754, DOI 10.3113/FAI.2010.0754; Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; WRIGHT DG, 1964, J BONE JOINT SURG AM, V46, P361; Lundgren P, 2008, GAIT POSTURE, V28, P93, DOI 10.1016/j.gaitpost.2007.10.009; Fevang BTS, 2007, ACTA ORTHOP, V78, P575, DOI 10.1080/17453670710014257; Wood PLR, 2008, J BONE JOINT SURG BR, V90B, P605, DOI 10.1302/0301-620X.90B5.19677; Easley ME, 2000, J BONE JOINT SURG AM, V82A, P613; Brunner S, 2013, J BONE JOINT SURG AM, V95A, P711, DOI 10.2106/JBJS.K.01580; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Beyaert C, 2004, GAIT POSTURE, V20, P84, DOI 10.1016/j.gaitpost.2003.07.006; Frigg A, 2010, FOOT ANKLE INT, V31, P871, DOI 10.3113/FAI.2010.0871; Tanaka Y, 1999, FOOT ANKLE INT, V20, P640; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; KEENAN MAE, 1991, J BONE JOINT SURG AM, V73A, P237; Conti S, 2006, FOOT ANKLE INT, V27, P980; de Asla RJ, 2006, J ORTHOP RES, V24, P1019, DOI 10.1002/jor.20142; Komistek RD, 2000, FOOT ANKLE INT, V21, P343; LARSEN A, 1975, Scandinavian Journal of Rheumatology, V4, P225; Leszko F, 2008, FOOT ANKLE INT, V29, P1117, DOI 10.3113/FAI.2008.1117; List R, 2012, FOOT ANKLE INT, V33, P883, DOI 10.3113/FAI.2012.0883; Liu HB, 2007, J ORTHOP RES, V25, P330, DOI 10.1002/jor.20297; MARSHALL R, 1991, CLIN BIOMECH, V6, P51, DOI 10.1016/0268-0033(91)90042-O; SELTZER SE, 1985, ARTHRITIS RHEUM, V28, P1234, DOI 10.1002/art.1780281107; Shi K, 2000, J RHEUMATOL, V27, P84; Shi Kenrin, 2006, J Foot Ankle Surg, V45, P316, DOI 10.1053/j.jfas.2006.06.001; Tamaki M, 2008, J ARTHROPLASTY, V23, P879, DOI 10.1016/j.arth.2008.04.009; Watanabe T, 2004, J ORTHOPAED RES, V22, P1044, DOI 10.1016/j.orthres.2003.12.013; Wu WL, 2005, GAIT POSTURE, V21, P263, DOI 10.1016/j.gaitpost.2004.02.001; Yamaguchi S, 2012, J BIOMECH, V45, P2103, DOI 10.1016/j.jbiomech.2012.05.043; Yamaguchi S, 2011, J BIOMECH, V44, P955; Yamamoto K, 2011, J MED SOC TOHO, V58, P408; Yamazaki T, 2004, IEEE T MED IMAGING, V23, P602, DOI 10.1109/TMI.2004.826051	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					897	903				7	Rheumatology	Rheumatology	AS8FW	WOS:000344486300004		
J	Takahashi, S; Suzuki, A; Koike, T; Yamada, K; Yasuda, H; Tada, M; Sugioka, Y; Okano, T; Nakamura, H				Takahashi, Shinji; Suzuki, Akinobu; Koike, Tatsuya; Yamada, Kentaro; Yasuda, Hiroyuki; Tada, Masahiro; Sugioka, Yuko; Okano, Tadashi; Nakamura, Hiroaki			Current prevalence and characteristics of cervical spine instability in patients with rheumatoid arthritis in the era of biologics	MODERN RHEUMATOLOGY			English	Article						Cervical spine instability; Rheumatoid arthritis; Medication; Neck pain	INTERVERTEBRAL DISC DEGENERATION; ATLANTOAXIAL SUBLUXATION; LESIONS; PROGRESSION	Objectives. Cervical spine instability (CSI) is commonly involved in patients with rheumatoid arthritis (RA). Although the treatment for RA has dramatically changed due to methotrexate and biologics, it is unclear whether this change contributes to the prevalence of CSI or not. Our objectives were to update the current prevalence of CSI and to investigate the factors associated with CSI. Methods. A cross-sectional study of patients with RA was conducted in our outpatient clinic. Clinical information and symptoms related to CSI were obtained. Plain radiography and magnetic resonance imaging were performed. CSI included atlantoaxial subluxation (AAS), vertical subluxation (VS), and subaxial subluxation (SAS). Results. Two hundred and twenty patients were analyzed, 93 (42%) of whom had CSI. A >= 10-year disease duration, Steinbrocker stage III, and three or more narrowed disc spaces from C2/3 to C6/7 were significantly associated with CSI. A neck pain VAS was associated with VS, but not with AAS and SAS. In contrast, methotrexate and biologics had no effect on CSI. Conclusion. The prevalence of CSI in this study was lower compared to previous reports before the approval of biologic, although we failed to detect the effect of biologics. Further prospective studies are needed to elucidate the efficacy.	[Takahashi, Shinji; Suzuki, Akinobu; Yamada, Kentaro; Yasuda, Hiroyuki; Tada, Masahiro; Sugioka, Yuko; Okano, Tadashi; Nakamura, Hiroaki] Osaka City Univ, Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan; [Koike, Tatsuya] Osaka City Univ, Sch Med, Dept Rheumatosurg, Osaka 5458585, Japan	Suzuki, A (reprint author), Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	a-suzuki@msic.med.osaka-cu.ac.jp			Takeda Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Chugai Pharmaceutical; Eisai; Abbott Japan; Teijin Pharma; Banyu Pharmaceutical; Ono Pharmaceutical	No funding or conflict of interest from National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI) is declared. T. K. received research grants and/or speaking fees from Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical, Eisai, Abbott Japan, Teijin Pharma, Banyu Pharmaceutical, and Ono Pharmaceutical. For the remaining authors, no funding or conflict of interest is declared.	Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Miyazaki M, 2008, J SPINAL DISORD TECH, V21, P288, DOI 10.1097/BSD.0b013e31813c0e59; de Souza MC, 2011, CLIN RHEUMATOL, V30, P831, DOI 10.1007/s10067-011-1687-4; Kauppi MJ, 2009, J RHEUMATOL, V36, P273, DOI 10.3899/jrheum.080429; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c; ODA T, 1995, SPINE, V20, P1128, DOI 10.1097/00007632-199505150-00004; Yurube T, 2011, SPINE, V36, P647, DOI 10.1097/BRS.0b013e3181da21c5; RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003; Ahn JK, 2011, RHEUMATOL INT, V31, P1363, DOI 10.1007/s00296-010-1437-y; PELLICCI PM, 1981, J BONE JOINT SURG AM, V63, P342; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; CONLON PW, 1966, ANN RHEUM DIS, V25, P120; Fujiwara K, 2000, J SPINAL DISORD, V13, P519, DOI 10.1097/00002517-200012000-00010; Fujiwara K, 1998, SPINE, V23, P2052, DOI 10.1097/00007632-199810010-00003; Kaito T, 2012, SPINE, V37, P1742, DOI 10.1097/BRS.0b013e318256b584; Kanayama Y, 2010, MOD RHEUMATOL, V20, P273, DOI 10.1007/s10165-010-0276-8; Miyasaka N, 2011, INFLAM REGEN, V31, P25; NATHAN H., 1962, RADIOL CLIN, V31, P150; Neva MH, 2006, ANN RHEUM DIS, V65, P884, DOI 10.1136/ard.2005.042135; Paus AC, 2008, SPINE, V33, P2278, DOI 10.1097/BRS.0b013e31817f1a17; PINCUS T, 1983, ARTHRITIS RHEUM, V26, P1346, DOI 10.1002/art.1780261107; Pisitkun P, 2004, CLIN RHEUMATOL, V23, P14, DOI 10.1007/s10067-003-0782-6; SCHILS JP, 1989, J RHEUMATOL, V16, P291; SHICHIKAWA K, 1978, INT ORTHOP, V2, P53; SMITH PH, 1972, ANN RHEUM DIS, V31, P431, DOI 10.1136/ard.31.6.431; STISKAL MA, 1995, AM J ROENTGENOL, V165, P585; Zikou AK, 2005, J RHEUMATOL, V32, P801	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					904	909		10.3109/14397595.2014.895123		6	Rheumatology	Rheumatology	AS8FW	WOS:000344486300005		
J	Kanbe, K; Hara, R; Chiba, J; Inoue, Y; Taguchi, M; Tanaka, Y				Kanbe, Katsuaki; Hara, Ryota; Chiba, Junji; Inoue, Yasuo; Taguchi, Masashi; Tanaka, Yasuhito			Application of a new immunohistology scoring system (IH score): Analysis of TNF-alpha in synovium related to disease activity score in infliximab-treated patients with rheumatoid arthritis	MODERN RHEUMATOLOGY			English	Article						TNF-alpha; Histology; Synovium; Rheumatoid arthritis; Infliximab	PLASMA IL-6; BIOPSY; INFLAMMATION; MEMBRANE; TISSUE; NEEDLE	Objectives. This study aimed to analyze the relationship between the expression of tumor necrosis factor alpha (TNF-alpha) or interleukin-6 (IL-6) in synovium and the disease activity score (DAS) 28 (C-reactive protein, CRP) in treatment of infliximab for rheumatoid arthritis (RA). Methods. Synovial tissues were obtained from 16 infliximab-treated patients and assessed for TNF-alpha and IL-6 with a new immunohistology (IH) scoring system. The validation of IH score was performed and applied for the analysis of correlation between synovial TNF-alpha or IL-6 and DAS28 (CRP) in addition to Rooney score. Results. The IH score had high internal validity; the IH score of TNF-alpha strongly correlated with serum CRP and matrix metalloprotease-3 (MMP-3), as well as DAS28 (CRP) and the Rooney score. IL-6 did not correlate with DAS28 (CRP). Conclusions. This study indicates that the IH score is useful as a new procedure to assess the cytokine expression easily and TNF-alpha in synovium correlates with disease activity in patients with RA treated with infliximab.	[Kanbe, Katsuaki; Chiba, Junji; Inoue, Yasuo; Taguchi, Masashi] Tokyo Womens Med Univ, Dept Orthopaed Surg, Med Ctr East, Tokyo 1168567, Japan; [Hara, Ryota; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Ctr Rheumat Dis, Kashihara, Nara 634, Japan	Kanbe, K (reprint author), Tokyo Womens Med Univ, Dept Orthopaed Surg, Med Ctr East, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	kanbeor@dnh.twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24592284]; Japan Society for the Promotion of Science	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) (C) (24592284) from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science.	Kanbe K, 2002, ARTHRITIS RHEUM, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Youssef PP, 1998, BRIT J RHEUMATOL, V37, P1003; Takeuchi T, 2012, ANN RHEUM DIS, V71, P1583, DOI 10.1136/annrheumdis-2011-201069; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1039, DOI 10.1136/ard.2010.141234; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481; Sweeney SE, 2004, INT J BIOCHEM CELL B, V36, P372, DOI 10.1016/S1357-2725(03)00259-0; van der Heijde D, 2000, J RHEUMATOL, V27, P261; Kraan MC, 2001, ANN RHEUM DIS, V60, P296, DOI 10.1136/ard.60.3.296; Bresnihan B, 2000, ANN RHEUM DIS, V59, P506, DOI 10.1136/ard.59.7.506; Kanbe K, 2008, CLIN RHEUMATOL, V27, P777, DOI 10.1007/s10067-008-0850-z; Knudsen LS, 2006, SCAND J RHEUMATOL, V35, P489, DOI 10.1080/03009740600904300; PARKER RH, 1963, ARTHRITIS RHEUM, V6, P172, DOI 10.1002/art.1780060209; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Rooney Terence, 2007, Ann Rheum Dis, V66, P1656, DOI 10.1136/ard.2006.061143; Youssef PP, 1998, ARTHRITIS RHEUM, V41, P663, DOI 10.1002/1529-0131(199804)41:4<663::AID-ART13>3.0.CO;2-L	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					910	914		10.3109/14397595.2014.887047		5	Rheumatology	Rheumatology	AS8FW	WOS:000344486300006		
J	Gorai, M; Ogasawara, M; Matsuki, Y; Yamada, Y; Murayama, G; Sugisaki, N; Nemoto, T; Ando, S; Minowa, K; Kon, T; Tada, K; Matsushita, M; Yamaji, K; Tamura, N; Takasaki, Y				Gorai, Misa; Ogasawara, Michihiro; Matsuki, Yuko; Yamada, Yusuke; Murayama, Go; Sugisaki, Nagachika; Nemoto, Takuya; Ando, Seiichiro; Minowa, Kentaro; Kon, Takayuki; Tada, Kurisu; Matsushita, Masakazu; Yamaji, Ken; Tamura, Naoto; Takasaki, Yoshinari			Weighting with the Lansbury articular index improves the correlation of ultrasound score with serum matrix metalloproteinase-3 level in rheumatoid arthritis patients	MODERN RHEUMATOLOGY			English	Article						Lansbury articular index; Matrix metalloproteinase-3; Rheumatoid arthritis; Ultrasound	CLINICAL-DISEASE ACTIVITY; JOINT INFLAMMATION; ULTRASONOGRAPHIC ASSESSMENT; MUSCULOSKELETAL ULTRASOUND; PROGRESSION; OSTEOARTHRITIS; QUANTITATION; STROMELYSIN; BIOMARKERS; REMISSION	Objective. To determine whether weighting improves the correlation of ultrasound (US) score with serum matrix metalloproteinase-3 (MMP-3) level in rheumatoid arthritis (RA). Methods. As ultrasound examination was performed on 100 RA patients, and the severity of synovial effusion and synovial hypertrophy and the blood flow were semi-quantitatively graded from 0 to 3 by using the gray-scale (GS) and power Doppler (PD) modes. We then calculated the sums of the scores of the 28 joints of each patient in the 2 modes, that is, the GS28 and PD28 scores, as well as the respective scores weighted using the Lansbury articular index (LAI, shoulder and elbow, X 12; wrist, X 8; and knee, X 24) -Lans GS28 and Lans PD28 scores. Result. The Lans PD28 score showed a higher correlation with MMP-3 (r = 0.591; 95% confidence interval, 0.446-0.705, p < 0.0001) than the existing measures. The scores of the large joints-the knee, shoulder, and elbow-correlated well with the serum MMP-3 level. Conclusion. Weighting with the LAI can improve the correlation of US findings with serum MMP-3 level. Bidirectional approach based on both serum MMP-3 level and US scores can further improve the assessment of disease activity in RA patients.	[Gorai, Misa; Ogasawara, Michihiro; Matsuki, Yuko; Yamada, Yusuke; Murayama, Go; Sugisaki, Nagachika; Nemoto, Takuya; Ando, Seiichiro; Minowa, Kentaro; Kon, Takayuki; Tada, Kurisu; Matsushita, Masakazu; Yamaji, Ken; Tamura, Naoto; Takasaki, Yoshinari] Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo 1138431, Japan	Ogasawara, M (reprint author), Juntendo Univ, Fac Med, Dept Internal Med & Rheumatol, Tokyo 1138431, Japan.	miogasaw@juntendo.ac.jp					Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Naredo E, 2008, ARTHRITIS RHEUM, V58, P2248, DOI 10.1002/art.23682; Young-Min S, 2007, ARTHRITIS RHEUM, V56, P3236, DOI 10.1002/art.22923; Szkudlarek M, 2012, RHEUMATOLOGY, V51, P6, DOI 10.1093/rheumatology/kes334; Brown AK, 2009, NAT REV RHEUMATOL, V5, P698, DOI 10.1038/nrrheum.2009.227; Perricone C, 2012, RHEUMATOLOGY, V51, P866, DOI 10.1093/rheumatology/ker405; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Kawashiri SY, 2011, RHEUMATOLOGY, V50, P962, DOI 10.1093/rheumatology/keq415; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Naredo E, 2008, ARTHRIT RHEUM-ARTHR, V59, P515, DOI 10.1002/art.23529; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Gandjbakhch F, 2011, J RHEUMATOL, V38, P2039, DOI 10.3899/jrheum.110421; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Filippucci E, 2007, CLIN EXP RHEUMATOL, V25, P5; GRAVALLESE EM, 1991, ARTHRITIS RHEUM, V34, P1076, DOI 10.1002/art.1780340903; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3341; LANSBURY J, 1956, AM J MED SCI, V232, P300, DOI 10.1097/00000441-195609000-00009; LANSBURY J, 1956, AM J MED SCI, V232, P150, DOI 10.1097/00000441-195608000-00004; Posthumus MD, 2003, CLIN EXP RHEUMATOL, V21, P465; SASAKI S, 1994, CLIN RHEUMATOL, V13, P228; Sharif M, 1998, ARTHRITIS RHEUM, V41, P1203, DOI 10.1002/1529-0131(199807)41:7<1203::AID-ART9>3.0.CO;2-2; Shinozaki Mikiko, 2007, Mod Rheumatol, V17, P403, DOI 10.1007/s10165-007-0608-5; Wells AF, 2011, ULTRASOUND MED BIOL, V37, P1173, DOI 10.1016/j.ultrasmedbio.2011.04.009; YOSHIHARA Y, 1995, ARTHRITIS RHEUM, V38, P969, DOI 10.1002/art.1780380713	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					915	919		10.3109/14397595.2014.888794		5	Rheumatology	Rheumatology	AS8FW	WOS:000344486300007		
J	Nakajima, A; Aoki, Y; Shibata, O; Sonobe, M; Terajima, F; Takahashi, H; Saito, M; Taniguchi, S; Yamada, M; Nakagawa, K				Nakajima, Arata; Aoki, Yasuchika; Shibata, Oshifumi; Sonobe, Masato; Terajima, Fumiaki; Takahashi, Hiroshi; Saito, Masahiko; Taniguchi, Shinji; Yamada, Manabu; Nakagawa, Koichi			Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis	MODERN RHEUMATOLOGY			English	Article						Disease activity; Oxidative stress; Reactive oxygen metabolites; Rheumatoid arthritis	INTIMA-MEDIA THICKNESS; REACTIVE OXYGEN METABOLITES; DISEASE-ACTIVITY; LEVEL; ATHEROSCLEROSIS; PREDICTOR; RADICALS; CHILDREN; EVENTS; ARTERY	Objectives. Reactive oxygen species (ROS) are considered to be involved in the pathobiology of rheumatoid arthritis (RA); however, their association with disease activity has not been elucidated. In this study, we measured reactive oxygen metabolites (ROM) in patients with RA using a new Free Radical Analytical System and determined clinical parameters associated with ROM. Methods. One hundred and fifty-two patients with RA and 80 patients with diabetes mellitus (DM) were included in this observational study. To measure ROM, the d-ROM test was performed on blood samples drawn from all subjects. The correlation between ROM and biomarkers, disease activity, doses of methotrexate (MTX), and prednisolone (PSL) were investigated. Results. There were significant, positive correlations between ROM and CRP, matrix metalloproteinase 3 (MMP3), Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR), Clinical Disease Activity Index (CDAI), and the Simplified Disease Activity Index (SDAI). Multiple regression analysis revealed that CRP and DAS28-ESR were correlated with ROM. Conclusions. The serum level of ROM was associated with CRP and DAS28-ESR, suggesting that ROM, in conjunction with CRP and MMP3, may be able to be used as a new biological disease marker to evaluate the disease activity of RA.	[Nakajima, Arata; Aoki, Yasuchika; Shibata, Oshifumi; Sonobe, Masato; Terajima, Fumiaki; Takahashi, Hiroshi; Saito, Masahiko; Taniguchi, Shinji; Yamada, Manabu; Nakagawa, Koichi] Toho Univ Sakura Med Ctr, Dept Orthoped, Sakura, Chiba 2858741, Japan; [Nakajima, Arata] Toho Univ Sakura Med Ctr, Dept Rheumatol, Sakura, Chiba 2858741, Japan	Nakajima, A (reprint author), Toho Univ Sakura Med Ctr, Dept Orthoped & Rheumatol, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan.	a-nakaji@sf7.so-net.ne.jp					Amaral Sandra, 2008, Curr Diabetes Rev, V4, P46; Del Porto F, 2007, RHEUMATOLOGY, V46, P1111, DOI 10.1093/rheumatology/kem089; Yamanaka G, 2006, J NEUROL SCI, V243, P71, DOI 10.1016/j.jns.2005.11.029; Griffiths HR, 2005, REDOX REP, V10, P273, DOI 10.1179/135100005X83680; Funahashi K, 2009, MOD RHEUMATOL, V19, P507, DOI 10.1007/s10165-009-0203-z; BIEMOND P, 1984, ARTHRITIS RHEUM, V27, P760, DOI 10.1002/art.1780270706; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; del Rincon I, 2001, ARTHRITIS RHEUM, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; HALLIWELL B, 1995, ANN RHEUM DIS, V54, P505, DOI 10.1136/ard.54.6.505; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Van Doornum S, 2002, ARTHRITIS RHEUM, V46, P862, DOI 10.1002/art.10089; Carratelli M, 2001, INT J CLIN PHARM RES, V21, P79; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250; Ribbens C, 2002, ANN RHEUM DIS, V61, P161, DOI 10.1136/ard.61.2.161; Trotti R, 2001, HAEMATOLOGICA, V86, P85; Kotani K, 2010, MED PRIN PRACT, V19, P496, DOI 10.1159/000320312; Coaccioli S, 2010, CLIN TER, V161, P441; Faienza MF, 2012, HORM RES PAEDIAT, V78, P158, DOI 10.1159/000342642; Hassan SZ, 2011, INT J RHEUM DIS, V14, P325, DOI 10.1111/j.1756-185X.2011.01630.x; Hayashi H, 2012, NUTRITION, V28, P1109, DOI 10.1016/j.nut.2012.02.009; Hirao M, 2011, RHEUMATOL INT, V32, P4041; Jacobsson LTH, 2001, ARTHRITIS RHEUM, V44, P1170, DOI 10.1002/1529-0131(200105)44:5<1170::AID-ANR200>3.0.CO;2-T; Koutsokera A, 2009, PULM PHARMACOL THER, V22, P603, DOI 10.1016/j.pupt.2009.09.002; MAPP PI, 1995, BRIT MED BULL, V51, P419; Suzuki S, 2008, INT ARCH ALLERGY IMM, V146, P67, DOI 10.1159/000126064	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					926	930		10.3109/14397595.2014.891495		5	Rheumatology	Rheumatology	AS8FW	WOS:000344486300009		
J	Okazaki, H; Lin, QS; Nishikawa, K; Ohtsuji, N; Tsurui, H; Ohtsuji, M; Amano, H; Tada, N; Sudo, K; Nishimura, H; Shirai, T; Hirose, S				Okazaki, Hideki; Lin, Qingshun; Nishikawa, Keiko; Ohtsuji, Naomi; Tsurui, Hiromichi; Ohtsuji, Mareki; Amano, Hirofumi; Tada, Norihiro; Sudo, Katsuko; Nishimura, Hiroyuki; Shirai, Toshikazu; Hirose, Sachiko			TNF alpha but not IL-17 is critical in the pathogenesis of rheumatoid arthritis spontaneously occurring in a unique Fc gamma RIIB-deficient mouse model	MODERN RHEUMATOLOGY			English	Article						Fc gamma RIIB; Monocytosis; Osteoclastogenesis; RANKL; OPG	TUMOR-NECROSIS-FACTOR; IL-17-DEFICIENT MICE; IMMUNE-RESPONSES; HUMAN OSTEOCLAST; SYSTEMIC-LUPUS; MESSENGER-RNA; HOST-DEFENSE; TH17 CELLS; RECEPTOR; BONE	Objective. TNF alpha and IL-17 have been shown to be the major inflammatory cytokines involved in the pathogenesis of rheumatoid arthritis (RA). Here, we examined the effect of these cytokines on spontaneously occurring RA in our newly established arthritis-prone Fc gamma RIIB-deficient C57BL/6 (B6) mice, designated KO1, by introducing genetic deficiency of TNF a and IL-17 into KO1 mice. Methods. KO1. TNF alpha(-/-) and KO1.IL-17(-/-) mice were established by crossing KO1 with TNF alpha-deficient and IL-17-deficient B6 mice, respectively. The incidence and severity of RA, cartilage and bone destruction, immunological abnormalities, and transcription levels of receptor activator of NF-kappa B ligand (RANKL)/osteoprotegerin (OPG) and inflammatory cytokines/chemokines in ankle joints were compared among KO1, KO1. TNF alpha(-/-), and KO1.IL-17(-/)-mice. Results. The development of RA was completely inhibited in KO1. TNF alpha(-/-) mice. In contrast, KO1.IL-17(-/-) mice unexpectedly developed severe RA comparable to KO1. Compared with those in KO1 and KO1.IL-17(-/-) mice, frequencies of peripheral monocytes, known to be containing osteoclast precursors, were significantly decreased in KO1. TNFa(-/)-mice. Intriguingly, while RANKL expression levels in ankle joints did not diff er among the three strains, OPG expression levels were drastically decreased in arthritis-prone, but not arthritis-free, mice. The expression levels of inflammatory cytokines/chemokines, such as MCP-1, IL-6, and TNF alpha, were up-regulated in arthritis-prone mice. Conclusion. TNF alpha is indispensable while IL-17 is dispensable in the pathogenesis of RA in KO1 mice. In this model, TNF alpha may contribute to the development of arthritis, through mediating the increase in frequencies of osteoclast precursors in circulation and their migration into the joints, and the decrease in OPG expression, leading to the up-regulated osteoclastogenesis associated with severe cartilage and bone destruction.	[Okazaki, Hideki; Lin, Qingshun; Nishikawa, Keiko; Ohtsuji, Naomi; Tsurui, Hiromichi; Shirai, Toshikazu; Hirose, Sachiko] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 1138421, Japan; [Okazaki, Hideki] Musashigaoka Jr Coll, Saitama, Japan; [Ohtsuji, Mareki; Nishimura, Hiroyuki] Toin Univ Yokohama, Toin Human Sci & Technol Ctr, Dept Biomed Engn, Yokohama, Kanagawa, Japan; [Amano, Hirofumi] Juntendo Univ, Sch Med, Dept Internal Med, Tokyo 1138421, Japan; [Tada, Norihiro] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo 1608402, Japan	Hirose, S (reprint author), Juntendo Univ, Sch Med, Dept Pathol, Tokyo 1138421, Japan.	sacchi@juntendo.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [24590491]; Ministry of Health, Labour and Welfare of Japan; Strategic Japanese-Swiss Cooperative Program	We thank Dr A. Sato-Hayashizaki and Ms K. Kojo for excellent support in establishing IL-17-deficient and TNF alpha-deficient KO1 mice. We also thank Drs. T. Ikegami and T. Koga for excellent technical support in qRT-PCR and TRAP staining, respectively. This work was supported in part by a Grant-in-Aid (24590491) from the Ministry of Education, Science, Technology, Sports and Culture of Japan, a grant for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, and a grant from the Strategic Japanese-Swiss Cooperative Program.	Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Santiago-Raber ML, 2009, ARTHRITIS RHEUM, V60, P2408, DOI 10.1002/art.24787; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Yun TJ, 1998, J IMMUNOL, V161, P6113; Delgado-Vega A, 2010, CURR OPIN IMMUNOL, V22, P698, DOI 10.1016/j.coi.2010.09.002; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; MAINI RN, 1995, CLIN EXP IMMUNOL, V101, P207; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; van den Berg WB, 2013, SEMIN ARTHRITIS RHEU, V43, P158, DOI 10.1016/j.semarthrit.2013.04.006; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; CONNOR JR, 1995, J HISTOCHEM CYTOCHEM, V43, P1193; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Takayanagi H, 2000, NATURE, V408, P600; Nakae S, 2003, J IMMUNOL, V171, P6173; Sato-Hayashizaki A, 2011, ARTHRITIS RHEUM-US, V63, P2930, DOI 10.1002/art.30485; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Campbell IK, 2001, J CLIN INVEST, V107, P1519, DOI 10.1172/JCI12724; Catrina AI, 2006, ARTHRITIS RHEUM, V54, P76, DOI 10.1002/art.21528; Dodds RA, 1999, ARTHRITIS RHEUM, V42, P1588, DOI 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S; Doodes PD, 2008, J IMMUNOL, V181, P329; Kawano S, 2013, EUR J IMMUNOL, V43, P770, DOI 10.1002/eji.201243057; Kikuchi S, 2006, J IMMUNOL, V176, P3240; PIGUET PF, 1992, IMMUNOLOGY, V77, P510; Taniguchi T, 1997, LAB INVEST, V77, P647; Taylor PC, 2001, CURR OPIN RHEUMATOL, V13, P154; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Voll RE, 2005, ANN NY ACAD SCI, V1051, P799, DOI 10.1196/annals.1361.123; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P715	49	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					931	938		10.3109/14397595.2014.886351		8	Rheumatology	Rheumatology	AS8FW	WOS:000344486300010		
J	Hirohata, S; Kasama, T; Kawahito, Y; Takabayashi, K				Hirohata, Shunsei; Kasama, Tsuyoshi; Kawahito, Yutaka; Takabayashi, Katsuhiko			Efficacy of anti-ribosomal P protein antibody testing for diagnosis of systemic lupus erythematosus	MODERN RHEUMATOLOGY			English	Article						Anti-ribosomal P; Anti-DNA; Anti-Sm; Anti-cardiolipin; Diagnosis	ASSOCIATION	Objective. Anti-ribosomal P protein antibody (anti-P) is detected in a fraction of systemic lupus erythematosus (SLE) patients, especially with lupus psychosis, lupus nephritis, and lupus hepatitis. However, it has been unclear whether anti-P testing is specific for SLE. The current studies were designed to examine the efficacy of serum anti-P testing in diagnosis of SLE. Method. Multicenter retrospective study was performed with 102 SLE patients, 102 patients with non-SLE rheumatic diseases, and 100 normal healthy subjects, who gave informed consents. The diagnosis of SLE was confirmed according to the 1982 ACR revised criteria. Serum IgG anti-P was determined by ELISA using the C-terminal 22 amino-acids of ribosomal P protein conjugated to human serum albumin. The specificity and sensitivity of anti-P were compared with those of anti-DNA, anti-Sm, and anti-cardiolipin (CL) antibodies. Results. Serum anti-P was positive in 38 of 102 SLE patients (37.3%), in 4 of 102 patients with non-SLE rheumatic diseases (3.9%), and in none of 100 normal subjects. Receiver operating characteristic (ROC) curve analysis revealed that anti-P provided higher AUC (area under the curve) than anti-Sm or anti-CL. Consistently, the sensitivity of anti-P (37.3%) was superior to that of anti-Sm (27.5%) and anti-CL (24.5%), but inferior to that of anti-DNA (51.0%), whereas the specificity of anti-P (96.1%) was superior to that of anti-CL (86.3%) and comparable to that of anti-DNA (96.1%) and anti-Sm (96.1%). Conclusion. These results indicate that serum anti-P testing might be an effective measure in diagnosing SLE, providing better diagnostic efficiency than anti-Sm and anti-CL.	[Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 2520374, Japan; [Kasama, Tsuyoshi] Showa Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo 142, Japan; [Kawahito, Yutaka] Kyoto Prefectural Univ Med, Grad Sch Med, Kyoto, Japan; [Takabayashi, Katsuhiko] Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan	Hirohata, S (reprint author), Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	shunsei@med.kitasato-u.ac.jp			SRL, Inc., Tokyo, Japan	The authors wish to thank Dr. Tamiko Yanagida, Department of Internal Medicine, Teikyo University School of Medicine, for her assistance in collecting samples from healthy individuals and Mr. Takashi Tsunoda and Mr. Hidekazu Nasu, SRL, Inc., for their assistance in collecting and analyzing the data. This work was supported by grants from SRL, Inc., Tokyo, Japan. These grants have no influences on the study design, the collection, analysis, and interpretation of data, the writing of the report, and in the decision to submit the paper for publication.	Isshi K, 1996, ARTHRITIS RHEUM, V39, P1483, DOI 10.1002/art.1780390907; Karassa FB, 2006, ARTHRITIS RHEUM, V54, P312, DOI 10.1002/art.21539; Hirohata S, 2011, CLIN EXP NEPHROL, V15, P471, DOI 10.1007/s10157-011-0462-9; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; ELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419; Arinuma Y, 2008, ARTHRITIS RHEUM, V58, P1130, DOI 10.1002/art.23399; do Nascimento AP, 2006, ARTHRITIS RHEUM, V54, P1568, DOI 10.1002/art.21875; Haddouk S, 2009, RHEUMATOLOGY, V48, P953, DOI 10.1093/rheumatology/kep142; Kasukawa R, 1996, Rinsho Byori, V44, P1157; SCHNEEBAUM AB, 1991, AM J MED, V90, P54, DOI 10.1016/0002-9343(91)90506-S; Sugisaki K, 2002, INTERNAL MED, V41, P1047, DOI 10.2169/internalmedicine.41.1047; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tejima S, 2011, CLIN RHEUMATOL, V23, P288	13	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					939	944		10.3109/14397595.2014.884529		6	Rheumatology	Rheumatology	AS8FW	WOS:000344486300011		
J	Kang, EH; Kuwana, M; Okazaki, Y; Lee, EY; Lee, YJ; Lee, EB; Song, YW				Kang, Eun Ha; Kuwana, Masataka; Okazaki, Yuka; Lee, Eun Young; Lee, Yun Jong; Lee, Eun Bong; Song, Yeong Wook			Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients	MODERN RHEUMATOLOGY			English	Article						antibody specificities; autoantibodies; myositis	CLINICALLY AMYOPATHIC DERMATOMYOSITIS; INTERSTITIAL LUNG-DISEASE; IDIOPATHIC INFLAMMATORY MYOPATHIES; JAPANESE PATIENTS; GENE 5; ASSOCIATION; ANTIBODY; RNA; POLYPEPTIDE; AUTOANTIGEN	Background. To confirm the antigen specificities of autoantibodies that precipitate 140-kDa (anti-p140) or 155/140-kDa polypeptides (anti-p155/140) previously identified by radioimmunoprecipitation in Korean patients with dermatomyositis (DM) and to look into the relationship between each MSA and clinical features of DM. Methods. Seventeen serum samples of classic DM patients who had been found to have either anti-p140 antibodies (n = 9) or anti-p155/140 (n = 8) antibodies in our previous study were examined using enzyme-linked immunosorbent assay (for anti-MDA5 antibodies) and immunoblotting (for anti-MJ/NXP-2 and anti-TIF-1. antibodies). Results. Seven out of nine anti-p140 antibody positive patients were found to have anti-MDA5 antibodies. Two out of nine had anti-MJ/NXP-2 antibodies with no interstitial lung disease (ILD). All eight anti-p155/140 antibody positive patients were found to have anti-TIF-1. antibodies. Anti-TIF-1. and anti-MDA5 antibodies were simultaneously detected in one patient with anti-p155/140 antibody, who suffered HIV infection and non-Hodgkin's lymphoma. The associations between anti-MDA5 antibody and rapidly progressive ILD and between anti-TIF-1. antibody and cancer-associated DM were confirmed to be significant. Conclusions. Although radioimmunoprecipitation still looks to be a good screening tool, confirmation with antigen-specific assays seems mandatory. The associations between anti-MDA5 and rapidly progressive ILD and between anti-TIF-1. and cancer-associated DM were confirmed in Korean patients with DM.	[Kang, Eun Ha; Lee, Yun Jong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Rheumatol, Songnam, South Korea; [Kuwana, Masataka; Okazaki, Yuka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Lee, Eun Young; Lee, Eun Bong; Song, Yeong Wook] Seoul Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Seoul 110744, South Korea; [Song, Yeong Wook] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Song, Yeong Wook] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul, South Korea	Song, YW (reprint author), Seoul Natl Univ Hosp, Dept Internal Med, Div Rheumatol, 28 Yongun Dong, Seoul 110744, South Korea.	ysong@snu.ac.kr			MKE/KEIT RD Program [10035615]; World Class University program of MEST; NRF [R31-2008-000-10103-0]	This work was supported by the MKE/KEIT R&D Program (Grant No. 10035615) and the World Class University program of MEST and the NRF (Grant No. R31-2008-000-10103-0).	Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; LOVE LA, 1991, MEDICINE, V70, P360; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; Lu HL, 2013, J IMMUNOL, V191, P3264, DOI 10.4049/jimmunol.1300512; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12019; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Fujimoto M, 2012, ARTHRITIS RHEUM-US, V64, P513, DOI 10.1002/art.33403; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Ceribelli A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3822; Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502; Fujikawa K, 2009, SCAND J RHEUMATOL, V38, P263, DOI 10.1080/03009740802687455; Ichimura Y, 2012, ANN RHEUM DIS, V71, P710, DOI 10.1136/annrheumdis-2011-200697; Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161; Kang EH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-223; Muro Y, 2013, CLIN RHEUMATOL, V32, P395, DOI 10.1007/s10067-012-2142-x; Oddis C. V., 1997, Arthritis and Rheumatism, V40, pS139; Targoff IN, 2007, ARTHRITIS RHEUM, V56, pS787	22	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					945	948		10.3109/14397595.2014.896494		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300012		
J	Abe, A; Takano, K; Seki, N; Jitsukawa, S; Yamamoto, M; Takahashi, H; Himi, T				Abe, Ayumi; Takano, Kenichi; Seki, Nobuhiko; Jitsukawa, Sumito; Yamamoto, Motohisa; Takahashi, Hiroki; Himi, Tetsuo			The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells	MODERN RHEUMATOLOGY			English	Article						IgG4; Labial salivary gland; Mikulicz's disease; PET; sIL-2R	INTERLEUKIN-2 RECEPTOR; AUTOIMMUNE PANCREATITIS; SCLEROSING PANCREATITIS; MIKULICZS-DISEASE	Objectives. Mikulicz's disease (MD) is an immunoglobulin (Ig) G4-related disease with systemic symptoms. Submandibular gland (SMG) biopsy is recommended for patients with possible IgG4-related MD for accurate differential diagnosis; however, it is difficult for certain patients to undergo this procedure. In contrast, labial salivary gland (LSG) biopsy is more convenient. Here we present an analysis of patients with IgG4-related MD whose LSG specimens were infiltrated with abundant IgG4-positive plasma cells. Methods. Sixteen patients diagnosed with IgG4-related MD underwent simultaneous SMG and LSG biopsies. We evaluated patients' serological and F-18-fluoro-2-deoxyglucose-positron emission tomography/computed tomography (F-18-FDG-PET/CT) and grouped them as LSG + (LSG specimens with >40% IgG4-positive plasma cells/IgG-positive plasma cells, 11 patients) or LSG - (LSG specimens with >40% IgG4-positive plasma cells/IgG-positive plasma cells, 6 patients). Results. There were not significant differences in serum IgG and IgG4 levels between the two groups; however, serum concentrations of soluble interleuikin-2 receptor (sIL-2R) were significantly higher in the LSG + group. All patients with increased F-18-FDG uptake in their parotid glands were a part of the LSG + group. Conclusions. When a SMG biopsy is not possible, the serum concentration of sIL-2R and F-18-FDGPET/ CT findings may predict whether LSG biopsy will facilitate the diagnosis of IgG4-related MD.	[Abe, Ayumi; Takano, Kenichi; Seki, Nobuhiko; Jitsukawa, Sumito; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608543, Japan; [Yamamoto, Motohisa; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido 0608543, Japan	Takano, K (reprint author), Sapporo Med Univ, Sch Med, Dept Otolaryngol, Chuo Ku, S1 W16, Sapporo, Hokkaido 0608543, Japan.	kent@sapmed.ac.jp					Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ebbo M, 2014, ARTHRIT CARE RES, V66, P86, DOI 10.1002/acr.22058; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Himi T, 2012, AURIS NASUS LARYNX, V39, P9, DOI 10.1016/j.anl.2011.01.023; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; CAMPEN DH, 1988, ARTHRITIS RHEUM, V31, P1358, DOI 10.1002/art.1780311103; Chilosi M, AM J CLIN PATHOL, V92, P186; LEONARD WJ, 1985, SCIENCE, V230, P633, DOI 10.1126/science.2996141; Matsubayashi H, 2012, PANCREAS, V41, P493, DOI 10.1097/MPA.0b013e31823a0d4c; Nguyen Vien X, 2011, JOP, V12, P297; Takano K, 2010, AM J OTOLARYNG, V31, P429, DOI 10.1016/j.amjoto.2009.08.002; Takano K, 2014, MOD RHEUMATOL, V24, P1023, DOI 10.3109/14397595.2013.853336; Yamamoto Motohisa, 2006, Mod Rheumatol, V16, P335, DOI 10.1007/s10165-006-0518-Y	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					949	952		10.3109/14397595.2014.891964		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300013		
J	Tabeya, T; Yamamoto, M; Naishiro, Y; Ishigami, K; Shimizu, Y; Yajima, H; Suzuki, C; Seki, N; Takano, K; Himi, T; Imai, K; Takahashi, H; Shinomura, Y				Tabeya, Tetsuya; Yamamoto, Motohisa; Naishiro, Yasuyoshi; Ishigami, Keisuke; Shimizu, Yui; Yajima, Hidetaka; Suzuki, Chisako; Seki, Nobuhiko; Takano, Kenichi; Himi, Tetsuo; Imai, Kohzoh; Takahashi, Hiroki; Shinomura, Yasuhisa			The role of cytotoxic T cells in IgG4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease	MODERN RHEUMATOLOGY			English	Article						Programmed death-1; Granzyme B; Perforin; Cytotoxic T lymphocyte; IgG4-related dacryoadenitis and sialadenitis	REGULATORY IMMUNE-REACTIONS; HEPATITIS-B PATIENTS; PD-1 UP-REGULATION; SJOGRENS-SYNDROME; PROGRAMMED DEATH-1; INHIBITORY PATHWAY; EXPRESSION; BLOCKADE; ACTIVATION; INFECTION	Objectives. Immunoglobulin (Ig) G4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease (MD), is a chronic inflammatory disease. However, little is known about its pathogenesis and pathological condition. In the present study, we used immunohistological techniques to compare the roles of cytotoxic T lymphocytes (CTLs) in MD and primary Sjogren's syndrome (SS). We examined the state of CTLs [cytotoxic granule-positive rate and programmed death-1 (PD-1) expression rate] in the salivary glands. Methods. The study samples comprised 12 submaxillary glands from untreated MD patients and 12 labial glands from SS patients. We performed immunofluorescence and multicolor immunofluorescence to stain CD8, perforin (PRF), granzyme B (GZMB), and PD-1. We measured the total number of CTLs as well as the PRF (+)CTLs, GZMB (+)CTLs, and PD-1 (+)CTLs. Results. We found that the degree of infiltration of CTLs was equal in MD and SS, but the rate of CTLs with cytotoxic granules, especially PRF, in MD was less than in SS. In addition, the frequency of PD-1 (+)CTLs in MD was higher than that in SS. Conclusions. Cytotoxic granule-positive CTLs were in the minority in MD salivary glands, and this regulation might relate to PD-1 signals like the state of exhaustion and anergy.	[Tabeya, Tetsuya] Dohkohkai Hosp, Dept Internal Med, Sapporo, Hokkaido 0600062, Japan; [Tabeya, Tetsuya; Yamamoto, Motohisa; Naishiro, Yasuyoshi; Ishigami, Keisuke; Shimizu, Yui; Yajima, Hidetaka; Suzuki, Chisako; Takahashi, Hiroki; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Seki, Nobuhiko; Takano, Kenichi; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Tabeya, T (reprint author), Dohkohkai Hosp, Dept Internal Med, Chuo Ku, South 2,West 19, Sapporo, Hokkaido 0600062, Japan.	tabeya.tetsuya@sapmed.ac.jp					Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Polihronis M, 1998, CLIN EXP IMMUNOL, V114, P485; Janas ML, 2005, J IMMUNOL, V175, P8003; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; ISHIDA Y, 1992, EMBO J, V11, P3887; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Tsubota K, 2000, INVEST OPHTH VIS SCI, V41, P1666; Kinter AL, 2008, J IMMUNOL, V181, P6738; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Reynolds J, 2012, NEPHROL DIAL TRANSPL, V27, P1343, DOI 10.1093/ndt/gfr529; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Czystowska M, 2010, J MOL MED, V88, P577, DOI 10.1007/s00109-010-0602-9; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Vayrynen JP, 2012, VIRCHOWS ARCH, V460, P455, DOI 10.1007/s00428-012-1232-0; Dong HD, 1999, NAT MED, V5, P1365; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.012; Kudo-Tanaka E, 2009, MOD RHEUMATOL, V19, P691, DOI 10.1007/s10165-009-0214-9; Hatachi S, 2003, J RHEUMATOL, V30, P1410; Brown JA, 2003, J IMMUNOL, V170, P1257; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Li CH, 2011, IMMUNOL RES, V51, P71, DOI 10.1007/s12026-011-8242-x; Oestreich KJ, 2008, J IMMUNOL, V181, P4832; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Shimizu Y, 2013, RHEUMATOLOGY, V52, P679, DOI 10.1093/rheumatology/kes358; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Raptopoulou AP, 2010, ARTHRITIS RHEUM-US, V62, P1870, DOI 10.1002/art.27500; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Li YQ, 2005, J IMMUNOL, V175, P2261; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Kobayashi M, 2005, J RHEUMATOL, V32, P2156; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ozkaynak E, 2002, J IMMUNOL, V169, P6546; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.0177-06; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Fujihara T, 1999, J IMMUNOL, V163, P2226; Liu YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-274; Parmigiani A, 2011, HUM IMMUNOL, V72, P115, DOI 10.1016/j.humimm.2010.10.015; Uchida K, 2012, INT J RHEUMATOL, V2012; Yamamoto Motohisa, 2006, Mod Rheumatol, V16, P335, DOI 10.1007/s10165-006-0518-Y; Yamamoto Motohisa, 2011, Current Immunology Reviews, V7, P162; Yamamoto M, 2005, RHEUMATOLOGY, V44, P1322, DOI 10.1093/rheumatology/kei026	69	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					953	960		10.3109/14397595.2014.882045		8	Rheumatology	Rheumatology	AS8FW	WOS:000344486300014		
J	Hirohata, S; Kikuchi, H; Sawada, T; Nagafuchi, H; Kuwana, M; Takeno, M; Ishigatsubo, Y				Hirohata, Shunsei; Kikuchi, Hirotoshi; Sawada, Tetsuji; Nagafuchi, Hiroko; Kuwana, Masataka; Takeno, Mitsuhiro; Ishigatsubo, Yoshiaki			Analysis of various factors on the relapse of acute neurological attacks in Behcet's disease	MODERN RHEUMATOLOGY			English	Article						Behcet's disease; Central nervous system; Colchicine; Cyclosporine; Relapse	NERVOUS-SYSTEM SYMPTOMS; RETROSPECTIVE ANALYSIS; CYCLOSPORINE-A; DOUBLE-BLIND; UVEITIS; INVOLVEMENT; TRIAL; COMPLICATIONS; COLCHICINE; THERAPY	Objectives. To investigate the influences of various factors on the relapse of acute neurological attacks in patients with Behcet's disease (BD). Methods. Sixty-one patients, who met the international classification criteria for BD, had attacks of acute neuro-Behcet's disease (NBD) and could be followed up at least for 2 months, including 60 patients in our multicenter retrospective survey on BD patients in 2011. The factors associated with relapse of acute neurological attacks were assessed. Results. Twenty-one of 61 patients had been taking cyclosporine A (CyA) at the onset of acute NBD. All the 21 patients with CyA and 33 of the 40 patients without CyA had eye involvement. There were no significant differences in demographic features, clinical symptoms, MRI findings, the need for, and responses to corticosteroid therapy including pulse therapy between patients with CyA and those without CyA. CyA was withdrawn in 19 of 21 patients with CyA. Of note, patients with CyA showed significantly lower relapse rates than those without CyA (HR 0.1283, 95% CI: 0.0788-0.7836, p = 0.0186 as calculated by log-rank test). Moreover, colchicine was found to reduce the relapse rates in patients with acute NBD without CyA (HR 0.2771, 95% CI: 0.0827-0.9422, p = 0.0450 [log-rank test]). Conclusion. These results indicate that CyA-related acute neurological manifestations are almost identical with CyA-unrelated acute events of NBD, except for the paucity of relapse on withdrawal of CyA. The data also demonstrate that colchicine is effective to prevent relapses of acute neurological attacks especially in patients with CyA-unrelated acute NBD.	[Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 2520374, Japan; [Kikuchi, Hirotoshi] Teikyo Univ, Sch Med, Dept Microbiol & Immunol, Itabashi Ku, Tokyo 173, Japan; [Sawada, Tetsuji] Tokyo Med Univ, Dept Internal Med 3, Shinjuku Ku, Tokyo 1608402, Japan; [Nagafuchi, Hiroko] St Marianna Univ, Sch Med, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Takeno, Mitsuhiro; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan	Hirohata, S (reprint author), Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	shunsei_tenpoint@yahoo.co.jp			Behcet's Disease Research Committee of the Ministry of Health, Labor and Welfare of the Japanese Government	This work was supported by grants from the Behcet's Disease Research Committee of the Ministry of Health, Labor and Welfare of the Japanese Government.	Akman-Demir G, 2008, CLIN EXP RHEUMATOL, V26, pS84; Hirohata S, 1997, CLIN IMMUNOL IMMUNOP, V82, P12, DOI 10.1006/clin.1996.4268; Akman-Demir G, 1999, BRAIN, V122, P2171, DOI 10.1093/brain/122.11.2171; Deuter CME, 2010, ARTHRITIS RHEUM-US, V62, P2796, DOI 10.1002/art.27581; Tugal-Tutkun I, 2005, ARTHRITIS RHEUM, V52, P2478, DOI 10.1002/art.21231; Kotter I, 2006, CLIN RHEUMATOL, V25, P482, DOI 10.1007/s10067-005-0070-8; Davatchi F, 2009, MOD RHEUMATOL, V19, P542, DOI 10.1007/s10165-009-0200-2; Siva A, 2004, CURR OPIN NEUROL, V17, P347, DOI 10.1097/01.wco.0000130304.36646.d4; Yurdakul S, 2001, ARTHRITIS RHEUM, V44, P2686, DOI 10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H; Shapiro LS, 2012, CLIN NEUROL NEUROSUR, V114, P297, DOI 10.1016/j.clineuro.2011.10.024; Kidd D, 1999, BRAIN, V122, P2183, DOI 10.1093/brain/122.11.2183; Aramaki Kaori, 2007, Mod Rheumatol, V17, P81, DOI 10.1007/s10165-006-0541-z; SILMAN AJ, 1990, LANCET, V335, P1078; Hirano T, 2012, MOD RHEUMATOL, V22, P98; Hirohata S, 2003, ARTHRITIS RES THER, V5, P139, DOI 10.1186/ar757; Hirohata S, 2007, CURR RHEUMATOL REV, V3, P297, DOI 10.2174/157339707782408973; Hirohata S, 2012, MOD RHEUMATOL, V22, P405, DOI 10.1007/s10165-011-0533-5; Hirohata S, 1998, J NEUROL SCI, V159, P181, DOI 10.1016/S0022-510X(98)00165-8; Kato Y, 2001, CLIN EXP OPHTHALMOL, V29, P335; Kotake S, 1999, OPHTHALMOLOGY, V106, P586, DOI 10.1016/S0161-6420(99)90120-3; Matsui T, 2010, MOD RHEUMATOL, V20, P621, DOI 10.1007/s10165-010-0332-4; Melillo N, 2007, CLIN RHEUMATOL, V26, P1365, DOI 10.1007/s10067-006-0385-0; Serdaroglu P, 1998, J NEUROL, V245, P197, DOI 10.1007/s004150050205; Siva A, 2010, BEHCET'S SYNDROME, P95, DOI 10.1007/978-1-4419-5641-5_6	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					961	965		10.3109/14397595.2014.891496		5	Rheumatology	Rheumatology	AS8FW	WOS:000344486300015		
J	Muraki, S; Akune, T; Nagata, K; Ishimoto, Y; Yoshida, M; Tokimura, F; Tanaka, S; Oka, H; Kawaguchi, H; Nakamura, K; Yoshimura, N				Muraki, Shigeyuki; Akune, Toru; Nagata, Keiji; Ishimoto, Yuyu; Yoshida, Munehito; Tokimura, Fumiaki; Tanaka, Sakae; Oka, Hiroyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Yoshimura, Noriko			Association of knee osteoarthritis with onset and resolution of pain and physical functional disability: The ROAD study	MODERN RHEUMATOLOGY			English	Article						Knee joint; Osteoarthritis; Epidemiology; Longitudinal studies	RADIOGRAPHIC OSTEOARTHRITIS; UNITED-STATES; BONE-MARROW; PREVALENCE; COHORT; POPULATION; VALIDATION; ARTHRITIS; SYMPTOMS; HEALTH	Objectives. To examine the onset and resolution of pain and physical functional disability using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and their association with knee osteoarthritis (OA) in the longitudinal large-scale population of the nationwide cohort study, Research on Osteoarthritis/osteoporosis Against Disability (ROAD). Methods. Subjects from the ROAD study who had been recruited during 2005-2007 were followed up 3 years later. A total of 1,578 subjects completed the WOMAC questionnaire at baseline and follow up, and the onset and resolution rate of pain and physical functional disability were examined. We also examined the association of onset of pain and physical functional disability and their resolution with severity of knee OA as well as age, body-mass index and grip strength. Results. After a 3.3-year follow-up, the onset rate of pain was 35.0% and 35.3% in men and women, respectively, and the onset rate of physical functional disability was 38% and 40%, respectively. Resolution rate of pain was 20.3% and 26.2% in men and women, respectively, and resolution rate of physical functional disability was 16% and 14% in men and women, respectively. Knee OA was significantly associated with onset and resolution of pain and physical functional disability in women, but there was no significant association of knee OA with onset of pain and resolution of physical functional disability in men. Conclusions. The present longitudinal study revealed the onset rate of pain and physical functional disability as well as their resolution, and their association with knee OA.	[Muraki, Shigeyuki; Akune, Toru] Univ Tokyo, Fac Med, Dept Clin Motor Syst Med, 22nd Century Med & Res Ctr, Tokyo 113, Japan; [Nagata, Keiji; Ishimoto, Yuyu; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Japan; [Tokimura, Fumiaki] Tokyo Metropolitan Geriatr Med Ctr, Dept Orthopaed Surg, Tokyo, Japan; [Tanaka, Sakae; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Oka, Hiroyuki; Yoshimura, Noriko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res, Tokyo 113, Japan; [Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Saitama, Japan	Muraki, S (reprint author), Univ Tokyo, Fac Med, Dept Clin Motor Syst Med, 22nd Century Med & Res Ctr, Tokyo 113, Japan.	murakis-ort@h.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [S19109007, B20390182, C20591737, C20591774, A18689031, 19659305]; Ministry of Health, Labor and Welfare [H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011, H22-Chouju-Wakate-007]; Japanese Orthopaedic Association (JOA) [2006-1, 2010-2]; Japan Orthopaedics and Traumatology Foundation [166]	This study was supported by Grants-in-Aid for Scientific Research (S19109007, B20390182, C20591737, C20591774), for Young Scientists (A18689031), and for Exploratory Research (19659305) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011 and H22-Chouju-Wakate-007 from the Ministry of Health, Labor and Welfare, Research Aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 & 2010-2), and Grant No. 166 from the Japan Orthopaedics and Traumatology Foundation.	Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Soni A, 2012, ARTHRITIS RHEUM-US, V64, P1145, DOI 10.1002/art.33434; Bollet AJ, 2001, ANN INTERN MED, V134, P591; Teichtahl AJ, 2006, J RHEUMATOL, V33, P1845; Woo J, 2004, J RHEUMATOL, V31, P2433; Sirola J, 2006, CALCIFIED TISSUE INT, V78, P218, DOI 10.1007/s00223-005-0298-y; Thorp LE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1254, DOI 10.1002/art.22991; Duncan R, 2007, ANN RHEUM DIS, V66, P86, DOI 10.1136/ard.2006.052548; Jordan JM, 2007, J RHEUMATOL, V34, P172, DOI 10.3899/jrheum.080677; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Thumboo J, 2001, OSTEOARTHR CARTILAGE, V9, P440, DOI 10.1053/joca.2000.0410; Yoshida S, 2002, J RHEUMATOL, V29, P1454; Felson DT, 2007, ARTHRITIS RHEUM, V56, P2986, DOI 10.1002/art.22851; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Saito T, 2000, CLIN ORTHOP RELAT R, P172; Linaker CH, 1999, BEST PRACT RES CL RH, V13, P197, DOI 10.1053/berh.1999.0016; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Kerr A, 2006, AGE AGEING, V35, P82, DOI 10.1093/ageing/afj010; BARR S, 1994, J RHEUMATOL, V21, P2106; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Hashimoto Hideki, 2003, J Orthop Sci, V8, P288, DOI 10.1007/s10776-002-0629-0; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; Ministry of Health Labour and Welfare, 2013, OUTL RES NAT LIV SUR; Muraki S, 2012, ARTHRITIS RHEUM-US, V64, P1447, DOI 10.1002/art.33508; Neogi T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2844; Roubenoff R, 2000, J NUTR HEALTH AGING, V4, P4140; Sharma L., 2007, OSTEOARTHRITIS DIAGN, P3	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					966	973		10.3109/14397595.2014.883055		8	Rheumatology	Rheumatology	AS8FW	WOS:000344486300016		
J	Takazawa, M; Nakamura, J; Abe, I; Ohtori, S; Watanabe, A; Sato, Y; Sasho, T; Orita, S; Suzuki, M; Motoori, K; Masuda, Y; Takahashi, K; Kishida, S				Takazawa, Makoto; Nakamura, Junichi; Abe, Isao; Ohtori, Seiji; Watanabe, Atsuya; Sato, Yasunori; Sasho, Takahisa; Orita, Sumihisa; Suzuki, Masahiko; Motoori, Ken; Masuda, Yoshitada; Takahashi, Kazuhisa; Kishida, Shunji			Predictive factors for acetabular labral lesions in osteoarthritis of the hip with radial magnetic resonance imaging - A cross-sectional study	MODERN RHEUMATOLOGY			English	Article						Acetabular labral lesions; Osteoarthritis of the hip; Prognostic factor; Radial magnetic resonance imaging	DEVELOPMENTAL DYSPLASIA; FEMORAL-HEAD; MRI; OSTEONECROSIS; ARTHROGRAPHY; PAIN	Objectives. To document the reliability of Abe's classification and to clarify the predictive factors for acetabular labral lesions in osteoarthritis of the hip with radial magnetic resonance (MR) imaging. Methods. Reliability trial for the classification of acetabular labral lesion was performed by six orthopedic surgeons, grading 20 radial MR images in a blinded fashion at an interval of 4-5 weeks. Radial MR images of 275 hips in 263 patients were prospectively analyzed to determine the relationship between acetabular labral lesions, their distribution, age, and the acetabular coverage. Results. Cohen's quadratic weighted kappa of inter-observer reliability was 0.784 for the grade and 0.812 for the shape category. The weighted kappa of intra-observer reliability was 0.852 for the grade and 0.90 for the shape category. Multiple regression analysis revealed that both the grade and the shape were associated with age, acetabular coverage, and location of the labrum. Conclusions. Abe's classification of labral lesions was reliable for both the grade and shape categories. Aging, acetabular dysplasia, and the anterosuperior portion would be predictive factors for degeneration of the acetabular labrum using radial MR imaging.	[Takazawa, Makoto; Nakamura, Junichi; Ohtori, Seiji; Watanabe, Atsuya; Sasho, Takahisa; Orita, Sumihisa; Takahashi, Kazuhisa; Kishida, Shunji] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba 2608677, Japan; [Abe, Isao] Chiba Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Chiba, Japan; [Sato, Yasunori] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Suzuki, Masahiko] Chiba Univ, Res Ctr Frontier Med Engn, Chiba 2608677, Japan; [Motoori, Ken; Masuda, Yoshitada] Chiba Univ Hosp, Dept Radiol, Chiba, Japan	Nakamura, J (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	njonedr@chiba-u.jp			 [23790638]	The corresponding author, Junichi Nakamura, received Grants-in-Aid for Scientific Research (Research Project Number: 23790638) for this work. The other authors do not have any conflicts of interest.	Abe I, 2000, RADIOLOGY, V216, P576; Shigemura T, 2012, RHEUMATOLOGY, V51, P701, DOI 10.1093/rheumatology/ker426; Nakamura J, 2013, MOD RHEUMATOL, V23, P119, DOI 10.1007/s10165-012-0638-5; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Tamai M, 2012, MOD RHEUMATOL, V22, P654, DOI 10.1007/s10165-011-0575-8; Takeshita M, 2012, RHEUMATOLOGY, V51, P1790, DOI 10.1093/rheumatology/kes173; Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9; Horii M, 2002, J PEDIATR ORTHOPED, V22, P222, DOI 10.1097/00004694-200203000-00019; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Noguchi Y, 1999, ARTHROSCOPY, V15, P496, DOI 10.1053/ar.1999.v15.015049; Horii M, 2003, ACTA ORTHOP SCAND, V74, P287, DOI 10.1080/00016470308540842; Nakamura J, 2007, J BONE JOINT SURG BR, V89B, P230, DOI 10.1302/0301-620X.89B2.18057; HEYMAN CH, 1950, J BONE JOINT SURG AM, V32-A, P767; Nakamura J, 2011, MOD RHEUMATOL, V21, P488, DOI 10.1007/s10165-011-0430-y; Horii M, 2000, J BONE JOINT SURG BR, V82B, P364, DOI 10.1302/0301-620X.82B3.9923; Shigemura T, 2011, RHEUMATOLOGY, V50, P2023, DOI 10.1093/rheumatology/ker277; SHARP IK, 1961, J BONE JOINT SURG BR, V43, P268; Hachiya Y, 2001, J PEDIATR ORTHOP B, V10, P169, DOI 10.1097/00009957-200107000-00002; Hasegawa Y, 1996, ARCH ORTHOP TRAUM SU, V115, P243, DOI 10.1007/BF00439047; Kubo T, 2000, PATHOPHYSIOLOGY, V7, P171, DOI 10.1016/S0928-4680(00)00048-1; Kubo T, 1999, J Orthop Sci, V4, P328, DOI 10.1007/s007760050112; Kubo T, 2000, J RHEUMATOL, V27, P1955; Okano K, 2014, MOD RHEUMATOL, V24, P340, DOI 10.3109/14397595.2013.854078; Plotz GMJ, 2001, ARCH ORTHOP TRAUM SU, V121, P450, DOI 10.1007/s004020100270; Ueshima K, 2006, MAGN RESON IMAGING, V24, P645, DOI 10.1016/j.mri.2005.12.009; Wiberg G, 1939, ACTA CHIR SCAND    S, V58, P83; Yamamoto Y, 2007, ARTHROSCOPY, V23, P1290, DOI 10.1016/j.arthro.2007.07.005; Yoon LS, 2007, SKELETAL RADIOL, V36, P1029, DOI 10.1007/s00256-007-0363-x	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					974	979		10.3109/14397595.2014.886542		6	Rheumatology	Rheumatology	AS8FW	WOS:000344486300017		
J	Ohtsuka, K; Takeuchi, K; Matsushita, M; Aramaki, T				Ohtsuka, Keiko; Takeuchi, Kimihiko; Matsushita, Masatoshi; Aramaki, Tetsuo			A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab	MODERN RHEUMATOLOGY			English	Article						Bilateral pleural effusion; Extra-articular manifestations; Rheumatoid pleuritis; Rheumatoid arthritis; Tocilizumab	PLEURAL EFFUSION; ARTHRITIS	The patient was a 77-year-old woman diagnosed as having rheumatoid arthritis (RA) in 1973. She was initiated on infliximab therapy in addition to methotrexate administration in 2009. The therapeutic response decreased after the fifth dose of infliximab, and the patient developed rheumatoid pleuritis due to increased RA disease activity. The therapy was switched from infliximab to tocilizumab, which resulted in amelioration of the arthralgias well as pleuritis. Our results suggest that tocilizumab is an effective treatment alternative for the treatment of rheumatoid pleuritis.	[Ohtsuka, Keiko] Isesaki Fukushima Hosp, Dept Orthoped, Kiryu, Gumma, Japan; Isesaki Fukushima Hosp, Dept Rheumatol, Kiryu, Gumma, Japan	Ohtsuka, K (reprint author), Isesaki Fukushima Hosp, Dept Orthoped, Kiryu, Gumma, Japan.	keikonbukeiko@yahoo.co.jp					Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; WALKER WC, 1967, ANN RHEUM DIS, V26, P467, DOI 10.1136/ard.26.6.467; Balbir-Gurman A, 2006, SEMIN ARTHRITIS RHEU, V35, P368, DOI 10.1016/j.semarthrit.2006.03.002; Nakahara H, 2011, MOD RHEUMATOL, V21, P655, DOI 10.1007/s10165-011-0448-1; JURIK AG, 1982, SCAND J RHEUMATOL, V11, P217; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Avnon LS, 2007, RHEUMATOL INT, V27, P919, DOI 10.1007/s00296-007-0322-9; CHAPMAN PT, 1992, J RHEUMATOL, V19, P478; FAURSCHOU P, 1984, EUR J RESPIR DIS, V65, P272; HORLER AR, 1959, ANN INTERN MED, V51, P1179; Huggins John T, 2004, CLIN CHEST MED, V25, P141; Kasai Shogo, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P366; Kelly CA, 1993, CLIN RHEUMATOL, V7, P1; Nakashita T, 2006, NIKKYO, V65, P749; OCANA I, 1988, ANN RHEUM DIS, V47, P394, DOI 10.1136/ard.47.5.394; Ozaki Y, 2011, MOD RHEUMATOL, V21, P302, DOI 10.1007/s10165-010-0377-4; Petterson T, 1984, CHEST, V86, P237; Takasaka Naoki, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P60; Takemura T, 2007, NIKKYOU, V66, P470; Tanoue LT, 1998, CLIN CHEST MED, V19, P667, DOI 10.1016/S0272-5231(05)70109-X; Tsukada T, 2010, KYUSYU RIUMACHI, V30, P94; Turesson C, 2004, CURR OPIN RHEUMATOL, V16, P204; Watanabe A, 2005, KOKYUU, V24, P985; Zrour SH, 2005, JOINT BONE SPINE, V72, P41, DOI 10.1016/j.jbspin.2004.02.001	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1001	1004		10.3109/14397595.2013.874745		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300022		
J	Naito, M; Nakamura, I; Ito, K				Naito, Masashi; Nakamura, Ichiro; Ito, Katsumi			Simultaneous bilateral posterior interosseous nerve palsy caused by rheumatoid synovitis of the elbows	MODERN RHEUMATOLOGY			English	Article						Bilateral; Posterior interosseous nerve palsy; Rheumatoid arthritis; Simultaneous; Synovitis	ARTHRITIS; ENTRAPMENT; NEUROPATHIES; COMPLICATION; CYSTS; JOINT	A 60-year-old woman with rheumatoid arthritis (RA) developed bilateral posterior interosseous nerve palsy. Her left side recovered after conservative treatment. However, her right side, which had been affected previously, did not recover and required surgery. Although conservative therapy, including administration of biologic agents, should be conducted for tight control of RA activity, we recommend surgical treatment when there is recurrence of the disease.	[Naito, Masashi] Tokyo Med & Dent Univ, Grad Sch, Dept Syst BioMed, Bunkyo Ku, Tokyo 1138519, Japan; [Naito, Masashi] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo 1138519, Japan; [Nakamura, Ichiro; Ito, Katsumi] Yugawara Kosei Nenkin Hosp, Dept Rheumatol, Ashigara Shimo, Kanagawa 2590314, Japan	Naito, M (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Syst BioMed, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	m-naito@syd.odn.ne.jp					Malipeddi A, 2011, SEMIN ARTHRITIS RHEU, V40, P576, DOI 10.1016/j.semarthrit.2010.07.011; MARMOR L, 1967, J BONE JOINT SURG AM, VA 49, P381; Chan JKK, 2009, J PLAST RECONSTR AES, V62, pE556, DOI 10.1016/j.bjps.2008.10.013; CHANG LW, 1972, ARTHRITIS RHEUM, V15, P350, DOI 10.1002/art.1780150405; FERNANDEZ AM, 1994, SEMIN ARTHRITIS RHEU, V24, P57, DOI 10.1016/0049-0172(94)90100-7; ISHIKAWA H, 1990, CLIN ORTHOP RELAT R, P134; KOLB LW, 1977, ILLINOIS MED J, V152, P221; Lanzillo B, 1998, ARTHRITIS RHEUM, V41, P1196, DOI 10.1002/1529-0131(199807)41:7<1196::AID-ART8>3.0.CO;2-R; MILLENDE.LH, 1973, J BONE JOINT SURG AM, VA 55, P753; Minami Michio, 2004, Mod Rheumatol, V14, P191; Muramatsu K, 2006, JCR-J CLIN RHEUMATOL, V12, P287, DOI 10.1097/01.rhu.0000249895.06942.30; NAKANO KK, 1975, ORTHOP CLIN N AM, V6, P837; Ogawa Hiroyasu, 2007, Mod Rheumatol, V17, P327, DOI 10.1007/s10165-007-0586-7; ROTH AI, 1986, J HAND SURG-BRIT EUR, V11B, P120, DOI 10.1016/0266-7681(86)90032-X; Westkaemper JG, 1999, J HAND SURG-AM, V24, P727; WHITE SH, 1988, J BONE JOINT SURG BR, V70, P468	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1005	1010		10.3109/14397595.2013.874747		6	Rheumatology	Rheumatology	AS8FW	WOS:000344486300023		
J	Ichinose, K; Iwanaga, N; Okada, A; Tamai, M; Yamasaki, S; Nakamura, H; Origuchi, T; Kawakami, A				Ichinose, Kunihiro; Iwanaga, Nozomi; Okada, Akitomo; Tamai, Mami; Yamasaki, Satoshi; Nakamura, Hideki; Origuchi, Tomoki; Kawakami, Atsushi			A case of microscopic polyangiitis in an elderly patient presenting predominantly with cholecystitis successfully treated with mizoribine	MODERN RHEUMATOLOGY			English	Article						Microscopic polyangiitis; Cholecystitis; Renal involvement; Mizoribine; Antineutrophil cytoplasmic antibodies	SYSTEMIC-LUPUS-ERYTHEMATOSUS; POLYARTERITIS-NODOSA; RHEUMATOID-ARTHRITIS; GALLBLADDER VASCULITIS; STRAUSS-SYNDROME; INVOLVEMENT; THERAPY; DISEASE	An 82-year-old woman was previously diagnosed with cholecystitis and treated with antibiotics at another hospital. Because her fever and inflammation persisted, therapeutic cholecystectomy was performed. Histopathology of the gallbladder revealed periarterial vasculitis. After transfer to our hospital, an elevated titer of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) was observed (47 U/mL). The patient's renal dysfunction had previously been thought to be sequelae of her cholecystectomy. We diagnosed microscopic polyangiitis (MPA) and began treatment with 40 mg orally of prednisolone daily. The titer of MPO-ANCA decreased with the treatment, but fever recurred with prednisolone taper. We, therefore, added 50 mg orally of mizoribine (MZR) daily as an immunosuppressant and increased the MZR to 100 mg daily while monitoring its blood peak concentration. The peak level of MZR was 1.58 mu g/mL at 6 h after administration. After adding MZR, we successfully tapered the orally dosed prednisolone without recurrent fever or complications. We describe this case of MPA in an elderly patient manifesting predominantly with cholecystitis and successfully treated with orally dosed prednisolone and MZR.	[Ichinose, Kunihiro; Iwanaga, Nozomi; Okada, Akitomo; Yamasaki, Satoshi; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 8528501, Japan; [Tamai, Mami] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 8528501, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Nagasaki 8528501, Japan	Ichinose, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	kichinos@nagasaki-u.ac.jp			 [24790999]	This work was supported by a Grant-in-Aid for Scientific Research (to K.I.; No. 24790999).	Aihara Y, 2002, PEDIATR INT, V44, P199, DOI 10.1046/j.1328-8067.2001.01534.x; Sonda K, 1996, TRANSPLANT P, V28, P3643; Ribi C, 2010, ARTHRITIS RHEUM-US, V62, P1186, DOI 10.1002/art.27340; Nishioka Y, 2006, NEPHROL DIAL TRANSPL, V21, P1087, DOI 10.1093/ndt/gfi295; Pagnoux C, 2005, MEDICINE, V84, P115, DOI 10.1097/01.md.0000158825.87055.0b; Canada R, 2006, AM J MED SCI, V331, P329, DOI 10.1097/00000441-200606000-00008; CHEN KTK, 1989, J CLIN GASTROENTEROL, V11, P537; Goritsas CP, 1997, J HEPATOL, V26, P727, DOI 10.1016/S0168-8278(97)80441-2; Hashimoto A, 2009, RHEUMATOL INT, V29, P441, DOI 10.1007/s00296-008-0727-0; Hegarty J, 2006, NEPHROL DIAL TRANSPL, V21, P792, DOI 10.1093/ndt/gfi299; Ichinose K, 2010, INTERNAL MED, V49, P2211, DOI 10.2169/internalmedicine.49.3810; Juliano J, 2009, JCR-J CLIN RHEUMATOL, V15, P75, DOI 10.1097/RHU.0b013e318194b299; LIVOLSI VA, 1973, GASTROENTEROLOGY, V65, P115; Manoharan Shobhan, 2004, Australas J Dermatol, V45, P216, DOI 10.1111/j.1440-0960.2004.00100.x; NEWBOLD KM, 1987, CLIN RHEUMATOL, V6, P287, DOI 10.1007/BF02201039; PAPAIOANNOU CC, 1979, J RHEUMATOL, V6, P71; Rajvanshi P, 2001, DIGEST DIS SCI, V46, P296, DOI 10.1023/A:1005648715013; Tanaka H, 2003, CLIN NEPHROL, V60, P390; Tatsukawa H, 2003, INTERNAL MED, V42, P893, DOI 10.2169/internalmedicine.42.893	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1011	1014		10.3109/14397595.2013.874742		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300024		
J	Takizawa, Y; Murota, A; Setoguchi, K; Suzuki, Y				Takizawa, Yasunobu; Murota, Atsuko; Setoguchi, Keigo; Suzuki, Yoshihisa			Severe inflammation associated with synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome was markedly ameliorated by single use of minocycline	MODERN RHEUMATOLOGY			English	Article						SAPHO; Tetracycline; Propionibacterium acnes	PROPIONIBACTERIUM-ACNES; LONG-TERM; MECHANISMS; EVOLUTION; THERAPY	We describe the case of a 63-year-old female who presented with severe inflammatory spondylitis, refractory to various antibiotics. Mycobacterial and fungal osteomyelitis were unlikely. Although asymptomatic, she also had osteomyelitis in the sternocostoclavicular region, and was suspected of having synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome, against which minocycline showed marked efficacy. The presence of severe inflammatory SAPHO, albeit rare, together with the marked efficacy of tetracycline, should be noted.	[Takizawa, Yasunobu; Murota, Atsuko; Setoguchi, Keigo] Tokyo Metropolitan Komagome Hosp, Dept Allergy & Immunol Dis, Tokyo, Japan; [Suzuki, Yoshihisa] Kyosai Tachikawa Hosp, Dept Orthoped, Tokyo, Japan	Takizawa, Y (reprint author), Dept Allergy & Immunol Dis, Tokyo, Japan.	ytaki-tky@umin.ac.jp					Ballara SC, 1999, ARTHRITIS RHEUM, V42, P819; Ferguson PJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0239-5; Colina M, 2007, CLIN EXP RHEUMATOL, V25, P457; Hurtado-Nedelec M, 2008, RHEUMATOLOGY, V47, P1160, DOI 10.1093/rheumatology/ken185; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/eri.11.137, 10.1586/ERI.11.137]; Pang T, 2012, BBA-GEN SUBJECTS, V1820, P503, DOI 10.1016/j.bbagen.2012.01.011; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Vittecoq O, 2000, ARTHRITIS RHEUM, V43, P109, DOI 10.1002/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3; Colina M, 2009, ARTHRIT RHEUM-ARTHR, V61, P813, DOI 10.1002/art.24540; CHAMOT AM, 1987, REV RHUM, V54, P187; Hayem G, 1999, SEMIN ARTHRITIS RHEU, V29, P159, DOI 10.1016/S0049-0172(99)80027-4; Assmann G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2812; Jansson A, 2007, RHEUMATOLOGY, V46, P154, DOI 10.1093/rheumatology/kel190; KAHN MF, 1994, BAILLIERE CLIN RHEUM, V8, P333, DOI 10.1016/S0950-3579(94)80022-7; Kalke S, 2001, RHEUMATOLOGY, V40, P170, DOI 10.1093/rheumatology/40.2.170; Rohekar G, 2006, ARTHRIT RHEUM-ARTHR, V55, P665, DOI 10.1002/art.22087; Rozin AP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2837; Schaeverbeke T, 1998, ARTHRITIS RHEUM, V41, P1889, DOI 10.1002/1529-0131(199810)41:10<1889::AID-ART23>3.0.CO;2-F; Takigawa T, 2008, EUR SPINE J, V17, P1391, DOI 10.1007/s00586-008-0722-x; Zhao ZG, 2011, J DERMATOL, V38, P155, DOI 10.1111/j.1346-8138.2010.00931.x	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1015	1018		10.3109/14397595.2013.874744		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300025		
J	Nakazato, Y; Mizoguchi, F; Kohsaka, H; Miyasaka, N				Nakazato, Yoko; Mizoguchi, Fumitaka; Kohsaka, Hitoshi; Miyasaka, Nobuyuki			A case of relapsing polychondritis initially presenting with bronchial chondritis	MODERN RHEUMATOLOGY			English	Article						Bronchial chondritis; Computed tomography; Polyarthritis; Relapsing polychondritis; Three-dimensional reconstruction	BONE-SCINTIGRAPHY	A 51-year-old woman presented with one-month history of fever, productive cough, dyspnea, hoarseness and polyarthritis. Computed tomography (CT) depicted diffuse bronchotracheal stenosis, which deteriorated in exhalation. Three-dimensional CT revealed airway stenosis from the trachea to the lobar bronchi. We made a diagnosis of relapsing polychondritis (RP). Administration of high-dose glucocorticoid and oral cyclophosphamide resolved the symptoms and the bronchial stenosis. It was noteworthy that all features presented were bronchial chondritis and polyarthritis. RP should be considered when patients have polyarthritis with respiratory symptoms. The dynamic expiratory CT and three-dimensional image reconstructions are useful for detecting and following up bronchotracheal involvement.	[Nakazato, Yoko; Mizoguchi, Fumitaka; Kohsaka, Hitoshi; Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Dept Med & Rheumatol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	Miyasaka, N (reprint author), Tokyo Med & Dent Univ, Dept Med & Rheumatol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	miya.rheu@tmd.ac.jp					DAMIANI JM, 1979, LARYNGOSCOPE, V89, P929; Trentham DE, 1998, ANN INTERN MED, V129, P114; Segel MJ, 2004, MAYO CLIN PROC, V79, P407; Lee KS, 2006, RADIOLOGY, V240, P565, DOI 10.1148/radiol.2401050562; FOIDART JM, 1978, NEW ENGL J MED, V299, P1203, DOI 10.1056/NEJM197811302992202; Zeuner M, 1997, J RHEUMATOL, V24, P96; Geeter F, 2008, NEW ENGL J MED, V358, P536; Imanishi Y, 1999, CLIN NUCL MED, V24, P511, DOI 10.1097/00003072-199907000-00008; Kent Peter D., 2004, Current Opinion in Rheumatology, V16, P56, DOI 10.1097/00002281-200401000-00011; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; Rafeq S, 2012, CLIN CHEST MED, V31, P513; Shi XH, 2006, CHINESE MED J-PEKING, V119, P1129; Watanabel Maiko, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P363	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1019	1022		10.3109/14397595.2013.874746		4	Rheumatology	Rheumatology	AS8FW	WOS:000344486300026		
J	Takano, K; Keira, Y; Seki, N; Abe, A; Yamamoto, M; Takahashi, H; Himi, T				Takano, Kenichi; Keira, Yoshiko; Seki, Nobuhiko; Abe, Ayumi; Yamamoto, Motohisa; Takahashi, Hiroki; Himi, Tetsuo			Evaluation of submandibular versus labial salivary gland fibrosis in IgG4-related disease	MODERN RHEUMATOLOGY			English	Article						IgG4-related disease; Mikuicz's disease; Salivary gland biopsy; Salivary gland fibrosis	MIKULICZS-DISEASE	The newly comprehensive diagnostic criteria in 2011 emphasize the importance of IgG4-positive plasmacyte infiltration along with storiform or swirling fibrosis and obliterative phlebitis in diagnosing IgG4-related disease(RD). Although labial salivary gland (LSG) biopsy is a minimally invasive and convenient procedure for obtaining tissues, LSG fibrosis is thought to be inconspicuous or absent in IgG4-RD cases. In this study we evaluated 15 patients with IgG4-RD, in whom both submandibular gland (SMG) and LSG biopsies were performed at the same time. Histological evaluation revealed fibrosis in all the SMG specimens but in only one LSG specimen (6.7%). The diagnosis of IgG4-RD is primarily based on its morphological appearance on biopsy. The results of this study demonstrated that although more invasive than LSG biopsy, SMG biopsy is recommended for accurate diagnosis of IgG4-related MD and to exclude malignant diseases.	[Takano, Kenichi; Keira, Yoshiko; Seki, Nobuhiko; Abe, Ayumi; Yamamoto, Motohisa; Takahashi, Hiroki; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608543, Japan	Takano, K (reprint author), Sapporo Med Univ, Sch Med, Dept Otolaryngol, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	kent@sapmed.ac.jp					Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Takahashi H, 2010, AUTOIMMUN REV, V9, P591, DOI 10.1016/j.autrev.2010.05.003; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Himi T, 2012, AURIS NASUS LARYNX, V39, P9, DOI 10.1016/j.anl.2011.01.023; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Tsuboi H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3924	10	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1023	1025		10.3109/14397595.2013.853336		3	Rheumatology	Rheumatology	AS8FW	WOS:000344486300027		
J	Taniguchi, Y; Matsumoto, T; Tsugita, M; Fujimoto, S; Terada, Y				Taniguchi, Yoshinori; Matsumoto, Tatsuki; Tsugita, Makoto; Fujimoto, Shimpei; Terada, Yoshio			Spondylodiscitis and Achilles tendonitis due to gout	MODERN RHEUMATOLOGY			English	Article						Achilles tendonitis; gout; scintigraphy; spondylodiscitis; ultrasonography	HYPERURICEMIA; INVOLVEMENT	The patient, a 62-year-old man with a 3-year history of hyperuricemia, presented with severe neck pain, Achilles enthesopathy and polyarthralgia. He consumed alcohol heavily. The biochemical profile was normal except for elevated levels of CRP (3.6 mg/dl; normal <0.3), uric acid (UA) (10.9 mg/dl; normal 2.5-7.5) and creatinine (1.7 mg/dl; normal 0.5-1.0). Bone scintigraphy showed polyarthritis at the right elbow, wrist and bilateral first MTP joints. Notably, bone scintigraphy with computed tomography also revealed spondylodiscitis of C5-C6, which was confirmed by MRI, and left Achilles tendonitis. Moreover, left Achilles tendonitis was also confirmed by ultrasonography, indicating enthesitis with low-echoic lesion and calcification. Needle aspiration yielded a white viscous liquid, with numerous urate crystals identified on polarized light microscopy. He was diagnosed with gouty arthritis associated with spondylodiscitis and Achilles tendonitis. After the treatment with allopurinol, colchicine and predonisolone, his symptoms were improved, and serum CRP and UA levels were normalized. The cervical spine and Achilles tendon are rare and notable sites of involvements in gout, and differential diagnosis of gouty arthritis from spondyloarthritis, rheumatoid arthritis, tumor, pseudogout, and infection is necessary. When the patient was noted to have neck pain and Achilles enthesopathy, we should always recognize gouty arthritis.	[Taniguchi, Yoshinori; Matsumoto, Tatsuki; Tsugita, Makoto; Fujimoto, Shimpei; Terada, Yoshio] Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Kochi, Japan	Taniguchi, Y (reprint author), Kochi Univ, Dept Endocrinol Metab & Nephrol, Kochi Med Sch, Oko Cho, Nankoku, Kochi 7838505, Japan.	taniguchiy@kochi-u.ac.jp					Ahmad I, 2012, Neuroradiol J, V25, P621; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Wendling D, 2013, JOINT BONE SPINE, V80, P656, DOI 10.1016/j.jbspin.2013.06.002; Dalbeth N, 2013, ANN RHEUM DIS, V72, P1545, DOI 10.1136/annrheumdis-2012-202786; Girish G, 2013, AM J ROENTGENOL, V201, P515, DOI 10.2214/AJR.13.10776; Girish G, 2013, ARTHRITIS, V2013; Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223	8	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1026	1027		10.3109/14397595.2013.877326		2	Rheumatology	Rheumatology	AS8FW	WOS:000344486300028		
J	Watanabe, R; Hirabayashi, Y; Okuno, H; Ishii, T; Harigae, H				Watanabe, Ryu; Hirabayashi, Yasuhiko; Okuno, Hiroshi; Ishii, Tomonori; Harigae, Hideo			Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis	MODERN RHEUMATOLOGY			English	Letter						Radiographic repair; Rheumatoid arthritis; Tocilizumab	INFLAMMATION; DIAGNOSIS; EROSIONS		[Watanabe, Ryu; Ishii, Tomonori; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Hirabayashi, Yasuhiko] Hikarigaoka Spellman Hosp, Dept Rheumatol, Sendai, Miyagi 9830833, Japan; [Okuno, Hiroshi] Tohoku Univ, Dept Orthopaed Surg, Grad Sch Med, Sendai, Miyagi 980, Japan	Hirabayashi, Y (reprint author), Hikarigaoka Spellman Hosp, Dept Rheumatol, Miyagino Ku, 6-7-1 Higashisendai, Sendai, Miyagi 9830833, Japan.	mr.hirabayashi@gmail.com					Turkcapar N, 2006, ARCH GERONTOL GERIAT, V42, P225, DOI 10.1016/j.archger.2005.07.003; Hirabayashi Y, 2010, RHEUMATOL INT, V30, P1041, DOI 10.1007/s00296-009-1095-0; Villa-Blanco JI, 2009, DRUG AGING, V26, P739, DOI 10.2165/11316740-000000000-00000; Smolen JS, 2012, ANN RHEUM DIS, V71, P687, DOI 10.1136/annrheumdis-2011-200395; Matzelle MM, 2012, ARTHRITIS RHEUM-US, V64, P1540, DOI 10.1002/art.33504; Lukas C, 2010, ANN RHEUM DIS, V69, P851, DOI 10.1136/ard.2009.119156; van der Linden MPM, 2010, ANN RHEUM DIS, V69, P727, DOI 10.1136/ard.2009.108332; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Calvo-Alen J, 2005, CLIN RHEUMATOL, V24, P485, DOI 10.1007/s10067-004-1067-4; Hirabayashi Y., 2011, RHEUMATOID ARTHRITIS, P51; Hirabayashi Y, 2013, CLIN RHEUMATOL, V32, P123, DOI 10.1007/s10067-012-2103-4; VANSCHAARDENBURG D, 1994, SEMIN ARTHRITIS RHEU, V23, P367, DOI 10.1016/0049-0172(94)90087-6	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	NOV	2014	24	6					1028	1029		10.3109/14397595.2013.844395		2	Rheumatology	Rheumatology	AS8FW	WOS:000344486300029		
J	Sato, T; Nakagome, S; Watanabe, C; Yamaguchi, K; Kawaguchi, A; Koganebuchi, K; Haneji, K; Yamaguchi, T; Hanihara, T; Yamamoto, K; Ishida, H; Mano, S; Kimura, R; Oota, H				Sato, Takehiro; Nakagome, Shigeki; Watanabe, Chiaki; Yamaguchi, Kyoko; Kawaguchi, Akira; Koganebuchi, Kae; Haneji, Kuniaki; Yamaguchi, Tetsutaro; Hanihara, Tsunehiko; Yamamoto, Ken; Ishida, Hajime; Mano, Shuhei; Kimura, Ryosuke; Oota, Hiroki			Genome-Wide SNP Analysis Reveals Population Structure and Demographic History of the Ryukyu Islanders in the Southern Part of the Japanese Archipelago	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						Japanese archipelago; Ryukyu Islanders; population structure; demographic history; genome-wide SNPs	PHYLOGENETIC NETWORKS; UNRELATED INDIVIDUALS; SAKISHIMA ISLANDERS; SUSCEPTIBILITY LOCI; ASIAN POPULATIONS; GENETIC-VARIATION; ASSOCIATION; OKINAWA; AINU; EVOLUTIONARY	The Ryukyu Islands are located to the southwest of the Japanese archipelago. Archaeological evidence has revealed the existence of prehistoric cultural differentiation between the northern Ryukyu islands of Amami and Okinawa, and the southern Ryukyu islands of Miyako and Yaeyama. To examine a genetic subdivision in the Ryukyu Islands, we conducted genome-wide single nucleotide polymorphism typing of inhabitants from the Okinawa Islands, the Miyako Islands, and the Yaeyama Islands. Principal component and cluster analyses revealed genetic differentiation among the island groups, especially between Okinawa and Miyako. No genetic affinity was observed between aboriginal Taiwanese and any of the Ryukyu populations. The genetic differentiation observed between the inhabitants of the Okinawa Islands and the Miyako Islands is likely to have arisen due to genetic drift rather than admixture with people from neighboring regions. Based on the observed genetic differences, the divergence time between the inhabitants of Okinawa and Miyako islands was dated to the Holocene. These findings suggest that the Pleistocene inhabitants, whose bones have been found on the southern Ryukyu Islands, did not make a major genetic contribution, if any, to the present-day inhabitants of the southern Ryukyu Islands.	[Sato, Takehiro; Watanabe, Chiaki; Yamaguchi, Kyoko; Kawaguchi, Akira; Ishida, Hajime; Kimura, Ryosuke] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Nishihara, Okinawa 90301, Japan; [Nakagome, Shigeki; Mano, Shuhei] Inst Stat Math, Dept Math Anal & Stat Inference, Tokyo, Japan; [Koganebuchi, Kae] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Chiba, Japan; [Koganebuchi, Kae] Kitasato Univ, Grad Sch Med Sci, Dept Human Anat, Sagamihara, Kanagawa, Japan; [Haneji, Kuniaki] Med Corp Hayamakai, Haneji Oral Surg Clin, Miyakojima, Okinawa, Japan; [Yamaguchi, Tetsutaro] Showa Univ, Sch Dent, Dept Orthodont, Tokyo 142, Japan; [Hanihara, Tsunehiko; Oota, Hiroki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Res Ctr Genet Informat, Div Genome Anal, Fukuoka 812, Japan; [Yamamoto, Ken] Kurume Univ, Sch Med, Dept Med Chem, Fukuoka, Japan	Kimura, R (reprint author), Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Nishihara, Okinawa 90301, Japan.	rkimura@med.u-ryukyu.ac.jp; hiroki_oota@med.kitasato-u.ac.jp	Kimura, Ryosuke/B-3354-2015		Japan Society for the Promotion of Science [25-2544, 24-3234, 22687023, 22370087, 21370108, 24370099]; Rising Star Program at University of the Ryukyus; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]	The authors thank all of the anonymous volunteers who donated DNA to this study. They are also grateful to Ms Michiko Komesu, Dr Takashi Toma, Mr Kei-Ichi Moromizato, and Ms Misaki Shindo for their assistance with sample collection. This work was supported by Grant-in-Aid for the Fellows of the Japan Society for the Promotion of Science (25-2544 to T. S. and 24-3234 to S.N.). This study was also supported in part by the Rising Star Program at University of the Ryukyus (to R. K.), Grant-in-Aid for Young Scientists (A) (22687023 to R. K.), Grant-in-Aid for Scientific Research (B) (22370087 to H. I.; 21370108 and 24370099 to H.O.) from the Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science" (221S0002) from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; Matsukusa H, 2010, AM J PHYS ANTHROPOL, V142, P211, DOI 10.1002/ajpa.21212; Nakagome S, 2013, STAT APPL GENET MOL, V12, P667, DOI 10.1515/sagmb-2012-0050; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Matsumura H, 2005, AM J PHYS ANTHROPOL, V127, P182, DOI 10.1002/ajpa.20067; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Koganebuchi K, 2012, ANTHROPOL SCI, V120, P199, DOI 10.1537/ase.120322; Horai S, 1996, AM J HUM GENET, V59, P579; Tajima A, 2002, HUM GENET, V110, P80, DOI 10.1007/s00439-001-0651-9; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Jinam T, 2012, J HUM GENET, V57, P787, DOI 10.1038/jhg.2012.114; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Nakagawa R, 2010, ANTHROPOL SCI, V118, P173, DOI 10.1537/ase.091214; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Asato S, 2003, HIST OKINAWA PREFECT; Fukumine T, 2006, ANTHROPOL SCI, V114, P141, DOI 10.1537/ase.050606; Fukumizu K, 2013, J MACH LEARN RES, P3753; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haga S, 2013, J HUM GENET, V58, P799, DOI 10.1038/jhg.2013.106; Haneji K, 2007, ANTHROPOL SCI, V115, P35, DOI 10.1537/ase.060206; Hanihara K, 1991, JAPAN REV, V2, P1; HANIHARA T, 1993, ANTHROPOL SCI, V101, P25; Hashimoto M., 2002, MINATOGAWA FISSURE S, P89; Ishida H, 2009, ANTHROPOL SCI, V117, P147, DOI 10.1537/ase.081219; Kishimoto Y, 2003, HIST OKINAWA PREFECT; Matsu'ura S, 1999, INTERDISCIPLINARY PE, P181; MATSUMURA H, 1994, ANTHROPOL SCI, V102, P93; Naito Y., 1976, OKINAWA NATURE CULTU, P77; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Omoto K, 1976, PEOPLE OKINAWA PREFE, P93; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakura H., 1985, REPORT EXCAVATION PI, P161; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; SUZUKI H, 1975, J ANTHROPOL SOC NIP, V83, P113; Takamiya H., 2006, J ISL COAST ARCHAEOL, V1, P49, DOI 10.1080/15564890600585855; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Toma T, 2007, ANTHROPOL SCI, V115, P119, DOI 10.1537/ase.061219	54	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	NOV	2014	31	11					2929	2940		10.1093/molbev/msu230		12	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	AT0JO	WOS:000344622800009		
J	Wakai, T; Harada, Y; Miyado, K; Kono, T				Wakai, Takuya; Harada, Yuichirou; Miyado, Kenji; Kono, Tomohiro			Mitochondrial dynamics controlled by mitofusins define organelle positioning and movement during mouse oocyte maturation	MOLECULAR HUMAN REPRODUCTION			English	Article						endoplasmic reticulum; meiosis; mitochondrial dynamics; oocyte maturation; spindle formation	ENDOPLASMIC-RETICULUM; MEIOTIC MATURATION; MAMMALIAN-CELLS; PROTEOLYTIC CLEAVAGE; CA2+ OSCILLATIONS; ATP PRODUCTION; SPINDLE POLES; PROTEIN DLP1; MORPHOLOGY; FUSION	Mitochondria are abundant in fully grown mammalian oocytes with a unique spherical morphology, but the mechanisms controlling mitochondria behavior are not well understood. Here we describe for the first time the control of mitochondrial behavior in mouse oocytes by a fusion/fission mechanism. Mitofusins (Mfn1 and Mfn2) and OPA1 proteins are required for outer and inner mitochondrial membrane fusion, respectively, whereas Drp1 is the key regulator of mitochondrial fission. We show that mouse oocytes express the Mfn1, Mfn2, Opa1 and Drp1 proteins, both in immature and mature oocytes at similar levels. Overexpression of Mfn1 or Mfn2 causes marked mitochondrial aggregation, particularly in the perinuclear region during meiotic progression. Tracking of mitochondria with chromosomes or endoplasmic reticulum (ER) throughout oocyte maturation demonstrates that Mfn1 and Mfn2-promoted mitochondrial aggregation disturbs the spatiotemporal dynamic of the chromosomes and ER, respectively. Our findings suggest that organelle dynamics are co-ordinately controlled during meiotic division, and an imbalance of mitochondrial fusion/fission leads to disorganization of the organelle compartments.	[Wakai, Takuya; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Harada, Yuichirou; Miyado, Kenji] Natl Ctr Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan	Kono, T (reprint author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [222228004]	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (Grant no. 222228004) to T.K.	Van Blerkom Jonathan, 2011, Mitochondrion, V11, P797, DOI 10.1016/j.mito.2010.09.012; de Bruin JP, 2004, BIOL REPROD, V70, P419, DOI 10.1095/biolreprod.103.015784; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Santel A, 2001, J CELL SCI, V114, P867; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; MEHLMANN LM, 1995, DEV BIOL, V170, P607, DOI 10.1006/dbio.1995.1240; Tarin JJ, 2001, BIOL REPROD, V65, P141, DOI 10.1095/biolreprod65.1.141; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; FitzHarris G, 2007, DEV BIOL, V305, P133, DOI 10.1016/j.ydbio.2007.02.006; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Stricker SA, 2006, SEMIN CELL DEV BIOL, V17, P303, DOI 10.1016/j.semcdb.2006.02.002; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Wakai T, 2013, J CELL SCI, V126, P5714, DOI 10.1242/jcs.136549; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; JONES KT, 1995, J BIOL CHEM, V270, P6671; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; VANBLERKOM J, 1991, P NATL ACAD SCI USA, V88, P5031; Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026; Yu YS, 2010, J CELL PHYSIOL, V224, P672, DOI 10.1002/jcp.22171; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Smirnova E, 2001, MOL BIOL CELL, V12, P2245; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Pitts KR, 1999, MOL BIOL CELL, V10, P4403; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Dalton CM, 2014, J CELL PHYSIOL, V229, P353, DOI 10.1002/jcp.24457; Wakai T, 2013, CELL CALCIUM, V53, P63, DOI 10.1016/j.ceca.2012.11.010; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Jansen R P, 2000, Hum Reprod, V15 Suppl 2, P112; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Sathananthan A H, 2000, Hum Reprod, V15 Suppl 2, P148; Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100	50	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1360-9947	1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	NOV	2014	20	11					1090	1100		10.1093/molehr/gau064		11	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AT0HW	WOS:000344618500005		
J	Ezoe, K; Daikoku, T; Yabuuchi, A; Murata, N; Kawano, H; Abe, T; Okuno, T; Kobayashi, T; Kato, K				Ezoe, Kenji; Daikoku, Takiko; Yabuuchi, Akiko; Murata, Nana; Kawano, Hiroomi; Abe, Takashi; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi			Ovarian stimulation using human chorionic gonadotrophin impairs blastocyst implantation and decidualization by altering ovarian hormone levels and downstream signaling in mice	MOLECULAR HUMAN REPRODUCTION			English	Article						embryo implantation; decidualization; hCG; ovarian stimulation; steroid receptor	FEMALE REPRODUCTIVE-TRACT; EPITHELIAL PROGESTERONE-RECEPTOR; MESSENGER-RIBONUCLEIC-ACID; ACTIVATED PROTEIN-KINASE; OVULATED IMMATURE RATS; MOUSE UTERUS; EMBRYO IMPLANTATION; ESTROGEN-RECEPTOR; INDIAN HEDGEHOG; ENDOMETRIAL RECEPTIVITY	Ovarian stimulation induced by follicle-stimulating hormone and human chorionic gonadotrophin (hCG) is commonly used in assisted reproductive technology to increase embryo production. However, recent clinical and animal studies have shown that ovarian stimulation disrupts endometrial function and embryo development and adversely affects pregnancy outcomes. How ovarian stimulation impairs pregnancy establishment and the precise mechanisms by which this stimulation reduces the chances of conception remain unclear. In this study, we first demonstrated that ovarian stimulation using hCG alone impairs implantation, decidualization and fetal development of mice by generating abnormal ovarian hormone levels. We also showed that ovarian hormone levels were altered because of changes in the levels of the enzymes involved in their synthesis in the follicles and corpora lutea. Furthermore, we determined that anomalous ovarian hormone secretion induced by ovarian stimulation alters the spatiotemporal expression of progesterone receptors and their downstream genes, especially in the uterine epithelium. Epithelial estrogenic signaling and cell proliferation were promoted on the day of implantation in stimulated mice and these changes led to the failure of uterine transition from the prereceptive to the receptive state. Collectively, our findings indicate that ovarian stimulation using hCG induces an imbalance in steroid hormone secretion, which causes a failure of the development of uterine receptivity and subsequent implantation and decidualization by altering the expression of steroid receptors and their downstream signaling associated with embryo implantation.	[Ezoe, Kenji; Yabuuchi, Akiko; Murata, Nana; Kawano, Hiroomi; Abe, Takashi; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi] Kato Ladies Clin, Shinjuku Ku, Tokyo 1600023, Japan; [Daikoku, Takiko] Univ Cincinnati Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA	Kato, K (reprint author), Kato Ladies Clin, Shinjuku Ku, 7-20-3 Nishishinjuku, Tokyo 1600023, Japan.	a-yabuuchi@towako-kato.com; k-kato@towako.net					PENTECOST BT, 1987, J BIOL CHEM, V262, P10134; Papanikolaou EG, 2005, HUM REPROD, V20, P1541, DOI 10.1093/humrep/deh793; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Oh SJ, 2013, BIOCHEM BIOPH RES CO, V441, P175, DOI 10.1016/j.bbrc.2013.10.037; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; ERTZEID G, 1992, J REPROD FERTIL, V96, P649; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; FOSSUM GT, 1989, J IN VITRO FERTIL EM, V6, P7, DOI 10.1007/BF01134574; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Su YQ, 2006, BIOL REPROD, V75, P859, DOI 10.1095/biolreprod.106.052613; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Devroey P, 2004, TRENDS ENDOCRIN MET, V15, P84, DOI 10.1016/j.tem.2004.01.009; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; de Mouzon J, 2012, HUM REPROD, V27, P954, DOI 10.1093/humrep/des023; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; LEJEUNE B, 1981, J REPROD FERTIL, V61, P235; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Spencer TE, 2004, BIOL REPROD, V71, P2, DOI 10.1095/biolreprod.103.024133; WELSH AO, 1991, AM J ANAT, V192, P215, DOI 10.1002/aja.1001920302; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Kurita T, 2000, BIOL REPROD, V62, P831, DOI 10.1095/biolreprod62.4.831; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; Takehara Y, 2013, LAB INVEST, V93, P181, DOI 10.1038/labinvest.2012.167; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Yin Y, 2008, MOL ENDOCRINOL, V22, P113, DOI 10.1210/me.2007-0295; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; PARR EL, 1987, BIOL REPROD, V36, P211, DOI 10.1095/biolreprod36.1.211; Kolibianakis EM, 2003, FERTIL STERIL, V80, P464, DOI 10.1016/S0015-0282(03)00663-0; PAULSON RJ, 1990, FERTIL STERIL, V53, P870; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Kolibianakis E, 2002, FERTIL STERIL, V78, P1025, DOI 10.1016/S0015-0282(02)03323-X; BEAUMONT HM, 1975, J REPROD FERTIL, V45, P437; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; DeSouza MM, 1998, BIOL REPROD, V58, P1503, DOI 10.1095/biolreprod58.6.1503; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683; Ertzeid G, 2001, HUM REPROD, V16, P221, DOI 10.1093/humrep/16.2.221; Ng EHY, 2000, HUM REPROD, V15, P250; FINN CA, 1974, J REPROD FERTIL, P195; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Franco HL, 2010, BIOL REPROD, V82, P783, DOI 10.1095/biolreprod.109.080259; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; DeSouza MM, 1999, J REPROD IMMUNOL, V45, P127, DOI 10.1016/S0165-0378(99)00046-7; Rubel CA, 2012, GENE EXPR PATTERNS, V12, P196, DOI 10.1016/j.gep.2012.03.004; Chai J, 2011, FERTIL STERIL, V96, P764, DOI 10.1016/j.fertnstert.2011.06.015; Jeong JW, 2005, ENDOCRINOLOGY, V146, P3490, DOI 10.1210/en.2005-0016; NEWBOLD RR, 1992, BIOL REPROD, V47, P903, DOI 10.1095/biolreprod47.5.903; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Das SK, 1995, MOL ENDOCRINOL, V9, P691; Das SK, 1998, ENDOCRINOLOGY, V139, P2905; Fernandez-Valdivia R, 2010, GENESIS, V48, P106, DOI 10.1002/dvg.20586; HALL K, 1969, J ENDOCRINOL, V44, P91, DOI 10.1677/joe.0.0440091; KAISER M, 1990, ENDOCRINOLOGY, V126, P2768; Kolibianakis EM, 2005, HUM REPROD, V20, P2453, DOI 10.1093/humrep/dei069; KRAMER B, 1990, J ANAT, V173, P177; Lee DS, 2006, J REPROD DEVELOP, V52, P781, DOI 10.1262/jrd.18034; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumoto Hiromichi, 2011, Reproductive Medicine and Biology, V10, P185, DOI 10.1007/s12522-011-0090-9; MILGROM E, 1973, J BIOL CHEM, V248, P6366; MILLER BG, 1981, BIOL REPROD, V25, P261, DOI 10.1095/biolreprod25.2.261; MILLER BG, 1982, BIOL REPROD, V26, P861, DOI 10.1095/biolreprod26.5.861; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Rashidi B, 2012, IRAN J BASIC MED SCI, V15, P1091; READ LD, 1989, MOL ENDOCRINOL, V3, P295; Sakurai T, 2003, BIOL REPROD, V69, P835, DOI 10.1095/biolreprod.102.010710; SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107; Sharma Alok, 2012, J Hum Reprod Sci, V5, P2, DOI 10.4103/0974-1208.97777; Sugino N, 2005, J CLIN ENDOCR METAB, V90, P6141, DOI 10.1210/jc.2005-0643; WALTON EA, 1982, BIOL REPROD, V27, P847, DOI 10.1095/biolreprod27.4.847; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	82	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1360-9947	1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	NOV	2014	20	11					1101	1116		10.1093/molehr/gau065		16	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AT0HW	WOS:000344618500006		
J	Miyazaki, Y; Taguchi, K; Sou, K; Watanabe, H; Ishima, Y; Miyakawa, T; Mitsuya, H; Fukagawa, M; Otagiri, M; Maruyama, T				Miyazaki, Yuri; Taguchi, Kazuaki; Sou, Keitaro; Watanabe, Hiroshi; Ishima, Yu; Miyakawa, Toshikazu; Mitsuya, Hiroaki; Fukagawa, Masafumi; Otagiri, Masaki; Maruyama, Toru			Therapeutic Impact of Erythropoietin-Encapsulated Liposomes Targeted to Bone Marrow on Renal Anemia	MOLECULAR PHARMACEUTICS			English	Article							ARTIFICIAL OXYGEN CARRIERS; CHRONIC KIDNEY-DISEASE; HEMOGLOBIN-VESICLES; RECOMBINANT ERYTHROPOIETIN; ERYTHROBLASTIC ISLANDS; PHOSPHOLIPID-VESICLES; STIMULATING AGENTS; HEART-FAILURE; IN-VIVO; MACROPHAGES	Bone marrow is a key element in the diagnosis of disorders of erythropoiesis, including anemia, and a potential target in their treatment. However, because efficient delivery of diagnostic and therapeutic agents to bone marrow is difficult, such delivery is achieved by administering drugs in large quantities that often have adverse effects. Here, we achieved selective delivery of recombinant human erythropoietin (rHuEPO) to bone marrow, via its encapsulation in liposomes with l-glutamic acid, N-(3-carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester (SA) (liposome-EPO). The result, in a rabbit model of renal anemia, was a beneficial effect on hematopoiesis, better than with rHuEPO alone. Also, we determined that liposome-EPO delivery to bone marrow depended on specific uptake by bone marrow macrophages because of the presence of SA. These results indicate both that liposome-EPO is a new, promising erythropoietin-stimulating agent and that liposomes with SA have potential for diagnostic and therapeutic applications in diseases originating from bone marrow.	[Miyazaki, Yuri; Watanabe, Hiroshi; Ishima, Yu; Otagiri, Masaki; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan; [Sou, Keitaro] Waseda Univ, Ctr Adv Biomed Sci TWIns, Tokyo 1628480, Japan; [Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Miyakawa, Toshikazu; Mitsuya, Hiroaki] Kumamoto Univ Hosp, Dept Hematol & Infect Dis, Kumamoto 8608556, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 2591193, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto 8600082, Japan	Maruyama, T (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp		Sou, Keitaro/0000-0002-5449-9084	Japan Society for the Promotion of Science (JSPS) [KAKENHI 25670085]; Japan Science and Technology Agency (JST) [AS232Z00010F]; The Kidney Foundation, Japan	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS) (KAKENHI 25670085) and Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST) (AS232Z00010F), and a grant for pathophysiological research conference in chronic kidney disease from The Kidney Foundation, Japan.	Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; PORTER CJH, 1992, FEBS LETT, V305, P62, DOI 10.1016/0014-5793(92)80655-Z; Lee JS, 2012, APPL MICROBIOL BIOT, V95, P1405, DOI 10.1007/s00253-012-4291-x; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Ludwig H, 2009, J CLIN ONCOL, V27, P2838, DOI 10.1200/JCO.2008.19.1130; Sou K, 2003, BIOTECHNOL PROGR, V19, P1547, DOI 10.1021/bp0201004; LAI PH, 1986, J BIOL CHEM, V261, P3116; Hara A, 2013, BRIT J HAEMATOL, V160, P244, DOI 10.1111/bjh.12105; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Sou K, 2007, BIOMATERIALS, V28, P2655, DOI 10.1016/j.biomaterials.2007.01.041; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Sou K, 2011, CHEM PHYS LIPIDS, V164, P211, DOI 10.1016/j.chemphyslip.2011.01.002; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Sou K, 2011, EXPERT OPIN DRUG DEL, V8, P317, DOI 10.1517/17425247.2011.553218; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Grotto HZW, 2008, MED ONCOL, V25, P12, DOI 10.1007/s12032-007-9000-8; Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Mann AP, 2011, ADV MATER, V23, pH278, DOI 10.1002/adma.201101541; Sakai H, 2004, J PHARMACOL EXP THER, V311, P874, DOI 10.1124/jpet.104.073049; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Silverberg DS, 2011, HEART FAIL REV, V16, P609, DOI 10.1007/s10741-010-9194-2; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Dmitrieva O, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-24; Erslev AJ, 1997, KIDNEY INT, V51, P622, DOI 10.1038/ki.1997.91; Gao LP, 2013, TOXICOL MECH METHOD, V23, P383, DOI 10.3109/15376516.2013.769656; Koulnis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021192; Lu KJ, 2013, AM J CARDIOL, V111, P1187, DOI 10.1016/j.amjcard.2012.12.049; Palazzuoli A, 2011, CLIN EXP MED, V11, P43, DOI 10.1007/s10238-010-0100-y; Sakai H, 2008, J INTERN MED, V263, P4, DOI 10.1111/j.1365-2796.2007.01893.x; Schettini DA, 2006, INT J PHARM, V315, P140, DOI 10.1016/j.ijpharm.2006.01.048; Solar P, 2008, MOL CANCER THER, V7, P2263, DOI 10.1158/1535-7163.MCT-08-0483; Sou K, 2010, NANOMEDICINE-UK, V5, P41, DOI [10.2217/nnm.09.78, 10.2217/NNM.09.78]; Szabo R, 2005, BIOCONJUGATE CHEM, V16, P1442, DOI 10.1021/bc050168f; Taguchi K, 2011, DRUG METAB REV, V43, P362, DOI 10.3109/03602532.2011.558094; WOOD PA, 1995, J CLIN INVEST, V95, P1650, DOI 10.1172/JCI117840	46	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	NOV	2014	11	11					4238	4248		10.1021/mp500453a		11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	AS5JP	WOS:000344307700048		
J	Ross, GW; Abbott, RD				Ross, G. Webster; Abbott, Robert D.			Living and Dying With Parkinson's Disease	MOVEMENT DISORDERS			English	Editorial Material							CORONARY-HEART-DISEASE; RISK; STROKE		[Ross, G. Webster] VA Pacific Isl Hlth Care Syst, Honolulu, HI 96819 USA; [Ross, G. Webster; Abbott, Robert D.] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Ross, G. Webster] Univ Hawaii John A Burns Sch Med, Dept Med, Honolulu, HI USA; [Ross, G. Webster; Abbott, Robert D.] Univ Hawaii John A Burns Sch Med, Honolulu, HI USA; [Abbott, Robert D.] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan	Ross, GW (reprint author), VA Pacific Isl Hlth Care Syst, 459 Patterson Rd, Honolulu, HI 96819 USA.	george.ross@va.gov					Abbott RD, 2007, AM J EPIDEMIOL, V166, P1280, DOI 10.1093/aje/kwm201; Park M, 2005, NEUROLOGY, V64, P1047; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Kalantzi OI, 2001, ENVIRON SCI TECHNOL, V35, P1013, DOI 10.1021/es0002464; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Abbott RD, 2003, J NEUROL, V250, P30, DOI 10.1007/s00415-003-1306-7; Baker MG, 2004, BRIT MED J, V329, P611, DOI 10.1136/bmj.329.7466.611; Macleod AD, 2014, MOVEMENT DISORD, V29, P1615, DOI 10.1002/mds.25898; National Institute of Neurological Disorders and Stroke, 2012, NINDS COMM DAT EL PA; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Xu J, 2014, ACTA NEUROL SCAND, V129, P71, DOI 10.1111/ane.12201; YANO K, 1984, AM J EPIDEMIOL, V119, P653	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	NOV	2014	29	13					1571	1573		10.1002/mds.25955		3	Clinical Neurology	Neurosciences & Neurology	AT0TT	WOS:000344648400001		
J	Sako, W; Murakami, N; Izumi, Y; Kaji, R				Sako, Wataru; Murakami, Nagahisa; Izumi, Yuishin; Kaji, Ryuji			Reduced Alpha-Synuclein in Cerebrospinal Fluid in Synucleinopathies: Evidence From a Meta-analysis	MOVEMENT DISORDERS			English	Article						alpha-synuclein; cerebrospinal fluid; synucleinopathy; progressive supranuclear palsy; meta-analysis	MULTIPLE SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; DIFFERENTIAL-DIAGNOSIS; FEATURES IMPROVE; ACCURACY; MUTATION; VARIANTS; DEMENTIA	Alpha-synuclein plays a key role in the pathology of synucleinopathies including Parkinson's disease (PD) and multiple system atrophy (MSA). However, whether alpha-synuclein level in cerebrospinal fluid (CSF) could distinguish synucleinopathies from progressive supranuclear palsy (PSP) is still a contentious issue. A comprehensive literature search yielded nine eligible studies. We expressed the between-group difference of the concentration of alpha-synuclein in CSF as the standardized mean difference. The proportion of variation attributable to heterogeneity was computed and expressed as I-2. Nine studies involved 537 controls, 843 PD, 130 MSA, and 98 PSP patients. The overall effect of PD on alpha-synuclein in CSF was significantly different from normal control or disease control (standardized mean difference = -0.67, P < 0.00001). These studies were heterogeneous (I-2 = 40%). Alpha-synuclein in CSF in MSA was significantly reduced relative to controls with heterogeneous studies (standardized mean difference = -0.75, P < 0.0001; I-2 = 62%). In contrast, no significant difference of alpha-synuclein in CSF was observed between PSP and controls with heterogeneous studies (standardized mean difference = -0.28, P = 0.13; I-2 = 53%). Alpha-synuclein in CSF was significantly reduced in synucleinopathies compared with PSP (PD vs. PSP: standardized mean difference = -0.38, P = 0.001; MSA vs. PSP: standardized mean difference = -0.66, P < 0.00001). The included studies were homogeneous (I-2 = 0%). Our study showed that alpha-synuclein levels in CSF in synucleinopathies was significantly lower than in PSP. This finding provides insights into the pathophysiological difference between synucleinopathies and PSP as well as possibility of development of a tool for differential diagnosis between MSA and PSP using enzyme-linked immunosorbent assay (ELISA) and similar methods. (c) 2014 International Parkinson and Movement Disorder Society	[Sako, Wataru; Murakami, Nagahisa; Izumi, Yuishin; Kaji, Ryuji] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Clin Neurosci, Tokushima, Japan; [Sako, Wataru] Feinstein Inst Med Res, Ctr Neurosci, Manhasset, NY USA	Sako, W (reprint author), 2-50-1 Kuramoto Cho, Tokushima 7708503, Japan.	dwsako@yahoo.co.jp					Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Sako W, 2014, PARKINSONISM RELAT D, V20, P873, DOI 10.1016/j.parkreldis.2014.04.028; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Williams DR, 2010, MOVEMENT DISORD, V25, P357, DOI 10.1002/mds.22977; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Egger M, 1997, BRIT MED J, V315, P629; Ubhi K, 2011, TRENDS NEUROSCI, V34, P581, DOI 10.1016/j.tins.2011.08.003; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Hughes AJ, 2001, NEUROLOGY, V57, pS34; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Antonini A, 1997, BRAIN, V120, P2187, DOI 10.1093/brain/120.12.2187; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Eckert T, 2005, NEUROIMAGE, V26, P912, DOI 10.1016/j.neuroimage.2005.03.012; Conway KA, 1998, NAT MED, V4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickson DW, 2012, COLD SPRING HARB PER, V2; Magdalinou N, 2014, J NEUROL NEUROSUR PS, V85, P1065, DOI 10.1136/jnnp-2013-307539; Mollenhauer B, 2012, MOVEMENT DISORD, V27, P644, DOI 10.1002/mds.24956; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sako W, 2014, J PARKINSON DIS, V4, P405, DOI 10.3233/JPD-130332; Sako W, 2014, J NEUROL NEUROSUR PS, V85, P982, DOI 10.1136/jnnp-2013-306090; vansDijk KD, 2013, EUR J NEUROL, DOI [10.1111/ene.12176, DOI 10.1111/ENE.12176]; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Wennstrom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053250	38	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	NOV	2014	29	13					1599	1605		10.1002/mds.26036		7	Clinical Neurology	Neurosciences & Neurology	AT0TT	WOS:000344648400006		
J	Alabouh, H; Corry, D; Oltean, S; Hagiwara, M; Morse, R; Ladomery, M				Alabouh, Hanan; Corry, David; Oltean, Sebastian; Hagiwara, Masatoshi; Morse, Ruth; Ladomery, Michael			Regulation of the alternative splicing of genes involved in leukaemia through the splice factor kinases CLK1 and SRPK1	MUTAGENESIS			English	Meeting Abstract									[Alabouh, Hanan; Corry, David; Morse, Ruth; Ladomery, Michael] Univ W England, Fac Hlth & Appl Sci, Bristol BS16 1QY, Avon, England; [Oltean, Sebastian] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TH, Avon, England; [Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					528	528				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700108		
J	Yamada, M; Matsui, K; Nohmi, T				Yamada, Masami; Matsui, Keiko; Nohmi, Takehiko			A new Ames tester strain for specific detection of the genotoxicity of polycyclic aromatic hydrocarbons	MUTAGENESIS			English	Meeting Abstract									[Yamada, Masami; Matsui, Keiko; Nohmi, Takehiko] Natl Inst Hlth Sci, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					539	539				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700143		
J	Uno, Y; Morita, T; Luijten, M; Beevers, C; Hamada, S; Itoh, S; Ohyama, W; Takasawa, H				Uno, Yoshifumi; Morita, Takeshi; Luijten, Mirjam; Beevers, Carol; Hamada, Shuichi; Itoh, Satoru; Ohyama, Wakako; Takasawa, Hironao			A report of the liver micronucleus test working group in the 6th IWGT	MUTAGENESIS			English	Meeting Abstract									[Uno, Yoshifumi] Mitsubishi Tanabe Pharma Co, Tokyo, Japan; [Morita, Takeshi] Natl Inst Hlth Sci, Res Triangle Pk, NC USA; [Beevers, Carol] Covance Labs Ltd, York, N Yorkshire, England; [Hamada, Shuichi; Takasawa, Hironao] LSI Medience, Tokyo, Japan; [Itoh, Satoru] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Ohyama, Wakako] Yakult Honsha Co Ltd, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					550	550				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700177		
J	Douglas, G; Yauk, CL; Van Benthem, J; Aardema, MJ; Bishop, JB; Dearfield, KL; DeMarini, DM; Dubrova, Y; Honma, M; Lupski, JR; Marchetti, F; Meistrich, M; Pacchierotti, F; Stewart, J; Waters, MD				Douglas, George; Yauk, Carole L.; Van Benthem, Jan; Aardema, Marilyn J.; Bishop, Jack B.; Dearfield, Kerry L.; DeMarini, David M.; Dubrova, Yuri; Honma, Masamitsu; Lupski, James R.; Marchetti, Francesco; Meistrich, Marvin; Pacchierotti, Francesca; Stewart, Jane; Waters, Michael D.			Approaches for Identifying Germ Cell Mutagens: Report of the 2013 IWGT Workshop on Germ Cell Assays	MUTAGENESIS			English	Meeting Abstract									[Van Benthem, Jan] RIVM, Bilthoven, Netherlands; [Aardema, Marilyn J.] BioReliance, Rockville, MD USA; [Dearfield, Kerry L.] USDA, Washington, DC USA; [DeMarini, David M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Dubrova, Yuri] Univ Leicester, Leicester LE1 7RH, Leics, England; [Honma, Masamitsu] NIHS, Tokyo, Japan; [Lupski, James R.] Baylor Coll Med, Houston, TX 77030 USA; [Marchetti, Francesco] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Pacchierotti, Francesca] ENEA, Rome, Italy; [Stewart, Jane] AstraZenica, London, England; [Waters, Michael D.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					551	551				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700179		
J	Fukushima, S; Gi, M; Kakehashi, A; Wanibuchi, H				Fukushima, Shoji; Gi, Min; Kakehashi, Anna; Wanibuchi, Hideki			Threshold of Genotoxic Carcinogens: Consideration from No-Effect Doses for Cancer-Related Markers in Chemical Carcinogenesis	MUTAGENESIS			English	Meeting Abstract									[Fukushima, Shoji] Japan Ind Safety & Hlth Assoc, Japan Bioassay Res Ctr, Tokyo, Japan; [Gi, Min; Kakehashi, Anna; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					554	554				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700189		
J	Honma, M; Yasui, M; Kanemaru, Y; Kamoshita, N; Suzuki, T; Arakawa, T				Honma, Masamitsu; Yasui, Manabu; Kanemaru, Yuki; Kamoshita, Nagisa; Suzuki, Tetsuya; Arakawa, Toshiya			Demonstration of non-threshold of 8-oxoG inducing genotoxicity by targeted mutagenesis	MUTAGENESIS			English	Meeting Abstract									[Honma, Masamitsu; Yasui, Manabu; Kanemaru, Yuki; Kamoshita, Nagisa; Suzuki, Tetsuya] Natl Inst Hlth Sci, Bethesda, MD USA; [Arakawa, Toshiya] Hlth Sci Univ Hokkaido, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357	1464-3804		MUTAGENESIS	Mutagenesis	NOV	2014	29	6					554	554				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AT0KI	WOS:000344624700190		
J	Chanut-Delalande, H; Hashimoto, Y; Pelissier-Monier, A; Spokony, R; Dib, A; Kondo, T; Bohere, J; Niimi, K; Latapie, Y; Inagaki, S; Dubois, L; Valenti, P; Polesello, C; Kobayashi, S; Moussian, B; White, KP; Plaza, S; Kageyama, Y; Payre, F				Chanut-Delalande, Helene; Hashimoto, Yoshiko; Pelissier-Monier, Anne; Spokony, Rebecca; Dib, Azza; Kondo, Takefumi; Bohere, Jerome; Niimi, Kaori; Latapie, Yvan; Inagaki, Sachi; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Kobayashi, Satoru; Moussian, Bernard; White, Kevin P.; Plaza, Serge; Kageyama, Yuji; Payre, Francois			Pri peptides are mediators of ecdysone for the temporal control of development	NATURE CELL BIOLOGY			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; DROSOPHILA-MELANOGASTER; EPIDERMIS DIFFERENTIATION; ECDYSTEROID BIOSYNTHESIS; MORPHOLOGICAL EVOLUTION; TRANSCRIPTION FACTOR; CELL MORPHOGENESIS; P450 ENZYME; ECR GENE	Animal development fundamentally relies on the precise control, in space and time, of genome expression. Whereas we have a wealth of information about spatial patterning, the mechanisms underlying temporal control remain poorly understood. Here we show that Pri peptides, encoded by small open reading frames, are direct mediators of the steroid hormone ecdysone for the timing of developmental programs in Drosophila. We identify a previously uncharacterized enzyme of ecdysone biosynthesis, GstE14, and find that ecdysone triggers pri expression to define the onset of epidermal trichome development, through post-translational control of the Shavenbaby transcription factor. We show that manipulating pri expression is sufficient to either put on hold or induce premature differentiation of trichomes. Furthermore, we find that ecdysone-dependent regulation of pri is not restricted to epidermis and occurs over various tissues and times. Together, these findings provide a molecular framework to explain how systemic hormonal control coordinates specific programs of differentiation with developmental timing.	[Chanut-Delalande, Helene; Pelissier-Monier, Anne; Dib, Azza; Bohere, Jerome; Latapie, Yvan; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Plaza, Serge; Payre, Francois] Univ Toulouse, UPS, Ctr Biol Dev, F-31062 Toulouse 9, France; [Chanut-Delalande, Helene; Pelissier-Monier, Anne; Dib, Azza; Bohere, Jerome; Latapie, Yvan; Dubois, Laurence; Valenti, Philippe; Polesello, Cedric; Plaza, Serge; Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, F-31062 Toulouse 9, France; [Hashimoto, Yoshiko; Kondo, Takefumi; Kobayashi, Satoru] Natl Inst Nat Sci Okazaki, Okazaki Inst Integrat Biosci, Aichi 4448787, Japan; [Spokony, Rebecca; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Spokony, Rebecca; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Niimi, Kaori; Inagaki, Sachi; Kageyama, Yuji] Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Genom, Kobe, Hyogo 657850, Japan; [Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Kageyama, Yuji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657850, Japan	Kageyama, Y (reprint author), Kobe Univ, Org Adv Sci & Technol, Res Ctr Environm Genom, Kobe, Hyogo 657850, Japan.	kageyama@ruby.kobe-u.ac.jp; francois.payre@univ-tlse3.fr	plaza, serge/F-5290-2015; 	Inagaki, Sachi/0000-0002-2365-9938	ANR (smORFpeptides and Chrononet); Association pour la Recherche sur le Cancer [12011669]; Azm & Saade Association; JST PRESTO program; MEXT KAKENHI [21115007]; Fondation RITC	We are grateful to FlyBase and the Bloomington,Vienna and Kyoto stock centres, as well as R. Niwa, M. Kamimura and J. Colombani for providing flies, and H. Bellen for bacterial artificial chromosome constructs. We thank B. Ronsin (Toulouse RIO Imaging) for help with microscopy and O. Bohner for technical assistance. We also thank A. Khila, A. Vincent, P. Leopold and E. France for critical reading of the manuscript, and are indebted to R. Niwa for sharing unpublished results. This work was supported by ANR (smORFpeptides and Chrononet), Association pour la Recherche sur le Cancer (12011669), Azm & Saade Association, JST PRESTO program, MEXT KAKENHI (21115007) and Fondation RITC.	ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Fluegel ML, 2006, GENETICS, V172, P185, DOI 10.1534/genetics.105.046565; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/nchembio.1120, 10.1038/NCHEMBIO.1120]; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Carney GE, 2000, GENETICS, V154, P1203; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Chavoshi TM, 2010, MECH DEVELOP, V127, P308, DOI 10.1016/j.mod.2010.01.003; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; McLean PF, 2013, SCIENCE, V340, P1445, DOI 10.1126/science.1234887; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Yamanaka N, 2013, SCIENCE, V341, P1113, DOI 10.1126/science.1241210; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Hanada K, 2013, P NATL ACAD SCI USA, V110, P2395, DOI 10.1073/pnas.1213958110; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Andrew DJ, 2008, DEV DYNAM, V237, P1198, DOI 10.1002/dvdy.21512; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pueyo JI, 2011, DEV BIOL, V355, P183, DOI 10.1016/j.ydbio.2011.03.033; Chavez VM, 2000, DEVELOPMENT, V127, P4115; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Aspden J. L., 2014, ELIFE; Chanut-Delalande H, 2012, SEMIN CELL DEV BIOL, V23, P341, DOI 10.1016/j.semcdb.2012.03.002; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; Dunne JC, 2002, DEV BIOL, V245, P172, DOI 10.1006/dbio.2002.0632; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Kamimura M, 2012, J BIOL CHEM, V287, P16488, DOI 10.1074/jbc.M112.341180; Menoret D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r86; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Pi HW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-42; POODRY CA, 1970, ROUX ARCH DEV BIOL, V166, P1; Riddiford Lynn M., 1993, P899; Talamillo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003473; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	66	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1035	+		10.1038/ncb3052		22	Cell Biology	Cell Biology	AT2EF	WOS:000344744000003		
J	Torisawa, T; Ichikawa, M; Furuta, A; Saito, K; Oiwa, K; Kojima, H; Toyoshima, YY; Furuta, K				Torisawa, Takayuki; Ichikawa, Muneyoshi; Furuta, Akane; Saito, Kei; Oiwa, Kazuhiro; Kojima, Hiroaki; Toyoshima, Yoko Y.; Furuta, Ken'ya			Autoinhibition and cooperative activation mechanisms of cytoplasmic dynein	NATURE CELL BIOLOGY			English	Article							IN-VITRO; CRYSTAL-STRUCTURE; KINESIN MOTORS; PROCESSIVITY; DYNACTIN; DOMAIN; LIS1; MICROTUBULES; COMPLEXES; DIFFUSION	Cytoplasmic dynein is a two-headed microtubule-based motor responsible for diverse intracellular movements, including minus-end-directed transport of organelles(1-3). The motility of cargo transporters is regulated according to the presence or absence of cargo(4-6); however, it remains unclear how cytoplasmic dynein achieves such regulation. Here, using a recombinant and native dynein complex in vitro, we show that lone, single dynein molecules are in an autoinhibited state, in which the two motor heads are stacked together. In this state, dynein moves diffusively along a microtubule with only a small bias towards the minus end of the microtubule. When the two heads were physically separated by a rigid rod, the movement of dynein molecules became directed and processive. Furthermore, assembly of multiple dynein molecules on a single cargo enabled them to move unidirectionally and generate force cooperatively. We thus propose a mechanism of autonomous on-off switching of cargo transport, in which single dynein molecules in the cell are autoinhibited through intramolecular head-head stacking and become active when they assemble as a team on a cargo.	[Torisawa, Takayuki; Ichikawa, Muneyoshi; Saito, Kei; Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Torisawa, Takayuki; Furuta, Akane; Oiwa, Kazuhiro; Kojima, Hiroaki; Furuta, Ken'ya] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Torisawa, Takayuki; Oiwa, Kazuhiro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Oiwa, Kazuhiro] Univ Hyogo, Grad Sch Life Sci, Harima, Hyogo 6781297, Japan	Toyoshima, YY (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp; furutak@nict.go.jp	Oiwa, Kazuhiro/D-7721-2011		JSPS; Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank K. H. Bui, T. Ishikawa and H. Sakakibara for technical instruction in electron microscopy, K. Sutoh for critical comments on the manuscript, K. Kawaguchi for helpful discussion, K. Yamamoto for early work on DNA nanotubes, M. Amino and Y. Watari for technical assistance, K. Shibata for constructing the monomeric yeast dynein construct and Y. Utsumi for the chicken alpha-actinin plasmid. This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) fellowship from JSPS, a JSPS Grant-in-Aid for Scientific Research (B), a JSPS Grant-in-Aid for Scientific Research (C) and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; [Anonymous], TE; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; AMOS LA, 1989, J CELL SCI, V93, P19; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; King SJ, 2000, NAT CELL BIOL, V2, P20; Ichikawa M, 2011, FEBS LETT, V585, P2419, DOI 10.1016/j.febslet.2011.06.026; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Shibata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042990; SHIMIZU T, 1995, BIOCHEMISTRY-US, V34, P1575, DOI 10.1021/bi00005a013; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865	44	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2014	16	11					1118	+		10.1038/ncb3048		28	Cell Biology	Cell Biology	AT2EF	WOS:000344744000010		
J	Kovtyukhova, NI; Wang, YX; Berkdemir, A; Cruz-Silva, R; Terrones, M; Crespi, VH; Mallouk, TE				Kovtyukhova, Nina I.; Wang, Yuanxi; Berkdemir, Ayse; Cruz-Silva, Rodolfo; Terrones, Mauricio; Crespi, Vincent H.; Mallouk, Thomas E.			Non-oxidative intercalation and exfoliation of graphite by Bronsted acids	NATURE CHEMISTRY			English	Article							HEXAGONAL BORON-NITRIDE; GRAPHENE; CARBON; SALTS	Graphite intercalation compounds are formed by inserting guest molecules or ions between sp(2)-bonded carbon layers. These compounds are interesting as synthetic metals and as precursors to graphene. For many decades it has been thought that graphite intercalation must involve host-guest charge transfer, resulting in partial oxidation, reduction or covalent modification of the graphene sheets. Here, we revisit this concept and show that graphite can be reversibly intercalated by non-oxidizing Bronsted acids (phosphoric, sulfuric, dichloroacetic and alkylsulfonic acids). The products are mixtures of graphite and first-stage intercalation compounds. X-ray photoelectron and vibrational spectra indicate that the graphene layers are not oxidized or reduced in the intercalation process. These observations are supported by density functional theory calculations, which indicate a dipolar interaction between the guest molecules and the polarizable graphene sheets. The intercalated graphites readily exfoliate in dimethylformamide to give suspensions of crystalline single- and few-layer graphene sheets.	[Kovtyukhova, Nina I.; Mallouk, Thomas E.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wang, Yuanxi; Berkdemir, Ayse; Terrones, Mauricio; Crespi, Vincent H.; Mallouk, Thomas E.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Mallouk, Thomas E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Cruz-Silva, Rodolfo] Shinshu Univ, Res Ctr Exot Nanocarbons, Nagano 3808553, Japan	Mallouk, TE (reprint author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	tem5@psu.edu	Mallouk, Thomas/K-7391-2012; Cruz-Silva, Rodolfo/A-2149-2012	Mallouk, Thomas/0000-0003-4599-4208; Cruz-Silva, Rodolfo/0000-0002-6120-9524	US Army Research Office MURI [W911NF-11-1-0362]	Electron and atomic force microscopy, FTIR and XPS were conducted at the Materials Characterization Laboratory of the Pennsylvania State University. The authors thank T. Clark and V. Bojan for help with TEM and XPS analysis and A. van Duin for help in developing the ReaxFF parameterization for modelling of the H<INF>3</INF>PO<INF>4</INF>/graphite system. This work is supported by US Army Research Office MURI grant W911NF-11-1-0362.	Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Viculis LM, 2003, SCIENCE, V299, P1361, DOI 10.1126/science.1078842; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI 10.1080/00018730110113644; Worsley KA, 2007, CHEM PHYS LETT, V445, P51, DOI 10.1016/j.cplett.2007.07.059; Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068; Muchharla B, 2013, NANO LETT, V13, P3476, DOI 10.1021/nl400721y; van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u; BARTLETT N, 1990, ADV CHEM SER, V226, P391; BOTTOMLEY M, 1963, J CHEM SOC, P5674, DOI 10.1039/jr9630005674; Brodie M. B. C., 1855, ANN CHIM PHYS, V45, P351; CARR KE, 1970, CARBON, V8, P155, DOI 10.1016/0008-6223(70)90110-7; Cullity B.D., 1978, ELEMENTS XRAY DIFFRA, P284; Hofmann U, 1938, T FARADAY SOC, V34, P1017, DOI 10.1039/tf9383401017; HOOLEY JG, 1973, CARBON, V11, P225, DOI 10.1016/0008-6223(73)90025-0; Kovtyukhova NI, 2013, J AM CHEM SOC, V135, P8372, DOI 10.1021/ja403197h; Levy F., 1979, INTERCALATED LAYERED; MCKELVY MJ, 1990, ANNU REV PHYS CHEM, V41, P497; Moissette A., 1992, MATER SCI FORUM, V91, P95; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Schafhaeutl C, 1840, J PRAKT CHEM, V21, P129, DOI 10.1002/prac.18400210117; SCHOLLHORN R, 1980, ANGEW CHEM INT EDIT, V19, P983, DOI 10.1002/anie.198009831; Shen CP, 1999, J SOLID STATE CHEM, V147, P74, DOI 10.1006/jssc.1999.8176; Wang C, 1996, J PHYS CHEM-US, V100, P19218, DOI 10.1021/jp9619548; Zhang ZW, 1996, CHEM MATER, V8, P257, DOI 10.1021/cm950355v	25	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	NOV	2014	6	11					957	963		10.1038/NCHEM.2054		7	Chemistry, Multidisciplinary	Chemistry	AS8BS	WOS:000344476000007		
J	Blackford, J; Stahl, H; Bull, JM; Berges, BJP; Cevatoglu, M; Lichtschlag, A; Connelly, D; James, RH; Kita, J; Long, D; Naylor, M; Shitashima, K; Smith, D; Taylor, P; Wright, I; Akhurst, M; Chen, BX; Gernon, TM; Hauton, C; Hayashi, M; Kaieda, H; Leighton, TG; Sato, T; Sayer, MDJ; Suzumura, M; Tait, K; Vardy, ME; White, PR; Widdicombe, S				Blackford, Jerry; Stahl, Henrik; Bull, Jonathan M.; Berges, Benoit J. P.; Cevatoglu, Melis; Lichtschlag, Anna; Connelly, Douglas; James, Rachael H.; Kita, Jun; Long, Dave; Naylor, Mark; Shitashima, Kiminori; Smith, Dave; Taylor, Peter; Wright, Ian; Akhurst, Maxine; Chen, Baixin; Gernon, Tom M.; Hauton, Chris; Hayashi, Masatoshi; Kaieda, Hideshi; Leighton, Timothy G.; Sato, Toru; Sayer, Martin D. J.; Suzumura, Masahiro; Tait, Karen; Vardy, Mark E.; White, Paul R.; Widdicombe, Steve			Detection and impacts of leakage from sub-seafloor deep geological carbon dioxide storage	NATURE CLIMATE CHANGE			English	Article							NORTH-SEA; MUD VOLCANO; BENTHIC RESPIRATION; COMMUNITY STRUCTURE; MARINE-SEDIMENTS; IN-SITU; CO2; FLUXES; WATER; EMISSIONS	Fossil fuel power generation and other industrial emissions of carbon dioxide are a threat to global climate(1), yet many economies will remain reliant on these technologies for several decades(2). Carbon dioxide capture and storage (CCS) in deep geological formations provides an effective option to remove these emissions from the climate system(3). In many regions storage reservoirs are located offshore(4,5), over a kilometre or more below societally important shelf seas(6). Therefore, concerns about the possibility of leakage(7,8) and potential environmental impacts, along with economics, have contributed to delaying development of operational CCS. Here we investigate the detectability and environmental impact of leakage from a controlled sub-seabed release of CO2. We show that the biological impact and footprint of this small leak analogue (<1 tonne CO2 d(-1)) is confined to a few tens of metres. Migration of CO2 through the shallow seabed is influenced by near-surface sediment structure, and by dissolution and re-precipitation of calcium carbonate naturally present in sediments. Results reported here advance the understanding of environmental sensitivity to leakage and identify appropriate monitoring strategies for full-scale carbon storage operations.	[Blackford, Jerry; Tait, Karen; Widdicombe, Steve] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; [Stahl, Henrik; Taylor, Peter; Sayer, Martin D. J.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Bull, Jonathan M.; Cevatoglu, Melis; James, Rachael H.; Gernon, Tom M.; Hauton, Chris; Vardy, Mark E.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Berges, Benoit J. P.; Leighton, Timothy G.; White, Paul R.] Univ Southampton, Inst Sound & Vibrat Res, Southampton SO17 1BJ, Hants, England; [Lichtschlag, Anna; Connelly, Douglas; Wright, Ian] Univ Southampton, Natl Oceanog Ctr, Southampton SO17 1BJ, Hants, England; [Kita, Jun] Res Inst Innovat Technol Earth, Kizugawa, Kyoto 6190292, Japan; [Long, Dave; Smith, Dave; Akhurst, Maxine] British Geol Survey, Edinburgh EH9 3LA, Midlothian, Scotland; [Naylor, Mark] Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland; [Shitashima, Kiminori] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan; [Chen, Baixin] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Hayashi, Masatoshi] Gen Environm Technos Co Ltd, Chuo Ku, Osaka 5410052, Japan; [Kaieda, Hideshi] CRIEPI, Abiko, Chiba 2701194, Japan; [Sato, Toru] Univ Tokyo, Dept Ocean Technol Policy & Environm, Kashiwa, Chiba 2778561, Japan; [Sayer, Martin D. J.] Scottish Assoc Marine Sci, NERC Natl Facil Sci Div, Oban PA37 1QA, Argyll, Scotland; [Suzumura, Masahiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Blackford, J (reprint author), Plymouth Marine Lab, Prospect Pl, Plymouth PL1 3DH, Devon, England.	jcb@pml.ac.uk	Wright, Ian/B-9643-2008; Naylor, Mark/B-8460-2008; 	Wright, Ian/0000-0002-6660-0493; Naylor, Mark/0000-0002-3761-5522; Chen, Baixin/0000-0003-0214-1715	NERC [NE/H013962/1]; Scottish Government; METI/MEXT of Japan	Funding was provided by NERC (NE/H013962/1), the Scottish Government and METI/MEXT of Japan. We thank the Tralee Bay Holiday Park, Lochnell Estates and the inhabitants of Benderloch for hosting the experiment. We acknowledge Marine Scotland and The Crown Estate for permissions to carry out the research. The NERC National Facility for Scientific Diving, the crew of the RV Seol Mara and J. Montgomery based at SAMS provided operational support. We thank A. Skinner of ACS coring services for advice on the drilling, and the design of the well screen; J. Davis for support of geophysical data acquisition; C. Wallace of Kongsberg Ltd for provision and processing of the multibeam bathymetry data; J. Gafiera (BGS) for interpretation of site survey seismic profiles and A. Monaghan (BGS) for construction of 3D geological models.	Algar CK, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008133; ANDERSON LG, 1986, LIMNOL OCEANOGR, V31, P319; Widdicombe S, 2013, MAR POLLUT BULL, V73, P399, DOI 10.1016/j.marpolbul.2013.05.044; Leighton TG, 2012, P ROY SOC A-MATH PHY, V468, P485, DOI 10.1098/rspa.2011.0221; Duan ZH, 2008, ENERG FUEL, V22, P1666, DOI 10.1021/ef700666b; Mucci A, 2000, DEEP-SEA RES PT II, V47, P733, DOI 10.1016/S0967-0645(99)00124-1; Dewar M, 2013, MAR POLLUT BULL, V73, P504, DOI 10.1016/j.marpolbul.2013.03.005; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315; Blackford JC, 2008, MAR POLLUT BULL, V56, P1461, DOI 10.1016/j.marpolbul.2008.04.048; Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Thomas H, 2005, BIOGEOSCIENCES, V2, P323; Van Noorden R, 2010, NATURE, V463, P871, DOI 10.1038/463871a; Caramanna G, 2011, GREENH GASES, V1, P200, DOI 10.1002/ghg.28; Boudreau BP, 2005, GEOLOGY, V33, P517, DOI 10.1130/G21259.1; Carey S, 2013, GEOLOGY, V41, P1035, DOI 10.1130/G34286.1; Janssen F, 2005, LIMNOL OCEANOGR, V50, P779; Monastersky R, 2013, NATURE, V504, P339, DOI 10.1038/504339a; Austen M. C., 2011, UK NATL ECOSYSTEM AS; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Decker C, 2012, MAR ECOL-EVOL PERSP, V33, P205, DOI 10.1111/j.1439-0485.2011.00503.x; Felden J, 2013, BIOGEOSCIENCES, V10, P3269, DOI 10.5194/bg-10-3269-2013; Gattuso J. P., 2011, OCEAN ACIDIFICATION, P326; Gruenke S., 2011, GEOBIOLOGY, V9, P330; IEA Greenhouse Gas R&D Programme (IEA GHG), 2008, ASS SUBS EC IMP; IPCC, 2001, 3 IPCC; Jain AK, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006002; Kruskal JB, 1978, MULTIDIMENSIONAL SCA; Lichtschlag A, 2010, GEOCHIM COSMOCHIM AC, V74, P5002, DOI 10.1016/j.gca.2010.05.031; Metz B.O., 2005, IPCC SPECIAL REPORT, P442; Nakanishi S, 2009, ENRGY PROCED, V1, P2639, DOI 10.1016/j.egypro.2009.02.031; Senior B., 2010, CO2 STORAGE UK IND P; Shitashima K, 2002, PROCEEDINGS OF THE 2002 INTERNATIONAL SYMPOSIUM ON UNDERWATER TECHNOLOGY, P106, DOI 10.1109/UT.2002.1002403	33	28	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-678X	1758-6798		NAT CLIM CHANGE	Nat. Clim. Chang.	NOV	2014	4	11					1011	1016		10.1038/NCLIMATE2381		6	Environmental Sciences; Environmental Studies; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AT0AD	WOS:000344598400026		
J	Patterson, MO; McKay, R; Naish, T; Escutia, C; Jimenez-Espejo, FJ; Raymo, ME; Meyers, SR; Tauxe, L; Brinkhuis, H				Patterson, M. O.; McKay, R.; Naish, T.; Escutia, C.; Jimenez-Espejo, F. J.; Raymo, M. E.; Meyers, S. R.; Tauxe, L.; Brinkhuis, H.		IODP Expedition 318 Scientists	Orbital forcing of the East Antarctic ice sheet during the Pliocene and Early Pleistocene	NATURE GEOSCIENCE			English	Article							SOUTHERN-OCEAN; CLIMATE; VARIABILITY; MARGIN; DEGLACIATION; CYCLES; DRIVEN; AGES; MA	The Pliocene and Early Pleistocene, between 5.3 and 0.8 million years ago, span a transition from a global climate state that was 2-3 degrees C warmer than present with limited ice sheets in the Northern Hemisphere to one that was characterized by continental-scale glaciations at both poles. Growth and decay of these ice sheets was paced by variations in the Earth's orbit around the Sun. However, the nature of the influence of orbital forcing on the ice sheets is unclear, particularly in light of the absence of a strong 20,000-year precession signal in geologic records of global ice volume and sea level. Here we present a record of the rate of accumulation of iceberg-rafted debris offshore from the East Antarctic ice sheet, adjacent to the Wilkes Subglacial Basin, between 4.3 and 2.2 million years ago. We infer that maximum iceberg debris accumulation is associated with the enhanced calving of icebergs during ice-sheet margin retreat. In the warmer part of the record, between 4.3 and 3.5 million years ago, spectral analyses show a dominant periodicity of about 40,000 years. Subsequently, the powers of the 100,000-year and 20,000-year signals strengthen. We suggest that, as the Southern Ocean cooled between 3.5 and 2.5 million years ago, the development of a perennial sea-ice field limited the oceanic forcing of the ice sheet. After this threshold was crossed, substantial retreat of the East Antarctic ice sheet occurred only during austral summer insolation maxima, as controlled by the precession cycle.	[Patterson, M. O.; McKay, R.; Naish, T.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand; [Escutia, C.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Armilla 18100, Spain; [Jimenez-Espejo, F. J.] Japan Agcy Marine Earth Sci & Technol, Dept Geochem, Yokosuka, Kanagawa 2370061, Japan; [Raymo, M. E.] Columbia Univ, Lamont Doherty Geol Observ, Palisades, NY 10964 USA; [Meyers, S. R.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Tauxe, L.] Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Brinkhuis, H.] Univ Utrecht, Lab Paleobot & Palynol, NL-3584 CD Utrecht, Netherlands	McKay, R (reprint author), Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand.	robert.mckay@vuw.ac.nz	Escutia, Carlota/B-8614-2015; McKay, Robert/N-2449-2015	Escutia, Carlota/0000-0002-4932-8619; McKay, Robert/0000-0002-5602-6985	US National Science Foundation (NSF); Royal Society of New Zealand Marsden Fund [VUW0903]; Rutherford Discovery Fellowship [RDF-13-VUW-003]; Ministry of Science and Innovation [CTM-2011-24079]; MEXT; US NSF [OCE-1003603, OCE-1202632]	This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). The IODP is sponsored by the US National Science Foundation (NSF) and participating countries under the management of Joint Oceanographic Institutions. Financial support for this study was provided to T.N. and R.M. from the Royal Society of New Zealand Marsden Fund Contract VUW0903, and Rutherford Discovery Fellowship (RDF-13-VUW-003) to R.M. Additional support was provided by the Ministry of Science and Innovation (Grant CTM-2011-24079) to C.E. and by MEXT to F.J.J-E., and by the US NSF (Grant OCE-1003603) to S.R.M. and US NSF (Grant OCE-1202632) to M.E.R.	Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Naafs BDA, 2012, EARTH PLANET SC LETT, V317, P8, DOI 10.1016/j.epsl.2011.11.026; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Escutia C, 2009, GLOBAL PLANET CHANGE, V69, P170, DOI 10.1016/j.gloplacha.2009.09.003; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Weber ME, 2014, NATURE, V510, P134, DOI 10.1038/nature13397; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI [10.1038/ngeo1061, 10.1038/NGEO1061]; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; EITTREIM SL, 1995, SEDIMENT GEOL, V96, P131, DOI 10.1016/0037-0738(94)00130-M; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Barrett PJ, 2013, EARTH ENV SCI T R SO, V104, P31, DOI 10.1017/S175569101300008X; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Meyers SR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001834; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Depoorter M., 2013, NATURE, V502, P82; Escutia C, 2005, GLOBAL PLANET CHANGE, V45, P51, DOI 10.1016/j.gloplacha.2004.09.010; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001463; IPCC, 2013, CLIM CHANG 2013 PHY; Krissek L., 1995, P OCEAN DRILLING PRO, V145, P179, DOI DOI 10.2973/ODP.PROC.SR.145.118.1995; Lucchi RG, 2002, MAR GEOL, V189, P343, DOI 10.1016/S0025-3227(02)00470-X; Meyers S.R., 2014, ASTROCHRON R PACKAGE; Tauxe L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002308; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Williams GD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004346	46	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	NOV	2014	7	11					841	847		10.1038/NGEO2273		7	Geosciences, Multidisciplinary	Geology	AT3CC	WOS:000344812100019		
J	Sun, J; He, LB; Lo, YC; Xu, T; Bi, HC; Sun, LT; Zhang, Z; Mao, SX; Li, J				Sun, Jun; He, Longbing; Lo, Yu-Chieh; Xu, Tao; Bi, Hengchang; Sun, Litao; Zhang, Ze; Mao, Scott X.; Li, Ju			Liquid-like pseudoelasticity of sub-10-nm crystalline silver particles	NATURE MATERIALS			English	Article							MELTING TEMPERATURE; MOLECULAR-DYNAMICS; SIZE; NANOPARTICLES; SHAPE; NANOCRYSTALS; CONDUCTANCE; PLASTICITY; DIFFUSION; METALS	In nanotechnology, small-volume metals with large surface area are used as electrodes, catalysts, interconnects and antennae(1-4). Their shape stability at room temperature has, however, been questioned. Using in situ high-resolution transmission electron microscopy, we find that Ag nanoparticles can be deformed like a liquid droplet but remain highly crystalline in the interior, with no sign of dislocation activity during deformation(5,6). Surface-diffusion-mediated pseudoelastic deformation is evident at room temperature, which can be driven by either an external force or capillary-energy minimization. Atomistic simulations confirm that such highly unusual Coble pseudoelasticity can indeed happen for sub-10-nm Ag particles at room temperature and at timescales from seconds to months.	[Sun, Jun; He, Longbing; Xu, Tao; Bi, Hengchang; Sun, Litao] Southeast Univ, SEU FEI Nanopico Ctr, Key Lab MEMS, Minist Educ, Nanjing 210096, Jiangsu, Peoples R China; [Lo, Yu-Chieh; Li, Ju] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Lo, Yu-Chieh; Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Lo, Yu-Chieh] Kyoto Univ, Ctr Elements Strategy Initiat Struct Mat ESISM, Sakyo Ku, Kyoto 6068501, Japan; [Zhang, Ze] Zhejiang Univ, Dept Mat Sci & Engn, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Mao, Scott X.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA	Sun, J (reprint author), Southeast Univ, SEU FEI Nanopico Ctr, Key Lab MEMS, Minist Educ, Nanjing 210096, Jiangsu, Peoples R China.	slt@seu.edu.cn; zezhang@zju.edu.cn; liju@mit.edu	Li, Ju/A-2993-2008	Li, Ju/0000-0002-7841-8058	National Basic Research Program of China [2011CB707601, 2012CB619402]; National Natural Science Foundation of China [61274114, 113279028, 51201032, 51071044]; Chinese Ministry of Education [311019]; Natural Science Foundation of Jiangsu Province [BK2011592, BK2012024]; NSF [DMR-1120901, DMR-1240933]; Extreme Science and Engineering Discovery Environment (XSEDE) [TG-DMR130038, TG-DMR140003, TG-PHY140014]	This work was supported by the National Basic Research Program of China under grant Nos. 2011CB707601 and 2012CB619402, the National Natural Science Foundation of China under grant Nos. 61274114, 113279028, 51201032 and 51071044, the Key Grant Project of Chinese Ministry of Education under grant No. 311019, and the Natural Science Foundation of Jiangsu Province under grant Nos. BK2011592 and BK2012024. Y-C.L. thanks E. Bitzek (Friedrich-Alexander-Universitat Erlangen-Nurnberg) and J. C. Huang (National Sun Yat-Sen University) for kind support. J. L. and Y-C.L. would like to acknowledge support from NSF DMR-1120901 and DMR-1240933. Computational time on the Extreme Science and Engineering Discovery Environment (XSEDE) under grants TG-DMR130038, TG-DMR140003 and TG-PHY140014 is gratefully acknowledged.	Aminpour M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035455; Bachels T, 2000, PHYS REV LETT, V85, P1250, DOI 10.1103/PhysRevLett.85.1250; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; IIJIMA S, 1986, PHYS REV LETT, V56, P616, DOI 10.1103/PhysRevLett.56.616; COUCHMAN PR, 1977, NATURE, V269, P481, DOI 10.1038/269481a0; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; MARKS LD, 1994, REP PROG PHYS, V57, P603, DOI 10.1088/0034-4885/57/6/002; Mordehai D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096101; Yu Q, 2010, NATURE, V463, P335, DOI 10.1038/nature08692; COBLE RL, 1963, J APPL PHYS, V34, P1679, DOI 10.1063/1.1702656; Wang BY, 2011, J PHYS CHEM C, V115, P11374, DOI 10.1021/jp201023x; Brinckmann S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155502; Liu N, 2011, NAT MATER, V10, P631, DOI [10.1038/nmat3029, 10.1038/NMAT3029]; Wang ZW, 2012, NANO LETT, V12, P91, DOI 10.1021/nl2037112; Wang ZW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.245502; Lai SL, 1998, APPL PHYS LETT, V72, P1098, DOI 10.1063/1.120946; Mullins WW, 2000, J AM CERAM SOC, V83, P214, DOI 10.1111/j.1151-2916.2000.tb01173.x; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Chen JY, 2009, NANO TODAY, V4, P81, DOI 10.1016/j.nantod.2008.09.002; Hara S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184114; Sheng HW, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134118; Rodrigues V, 2000, PHYS REV LETT, V85, P4124, DOI 10.1103/PhysRevLett.85.4124; Lu HM, 2009, J PHYS CHEM C, V113, P7598, DOI 10.1021/jp900314q; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Ala-Nissila T, 2002, ADV PHYS, V51, P949, DOI 10.1080/00018730110107902; Rodrigues V, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.073405; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Strachan DR, 2006, NANO LETT, V6, P441, DOI 10.1021/nl052302a; Asoro MA, 2009, MICROSC MICROANAL, V15, P706, DOI 10.1017/S1431927609097013; Combe N, 2000, PHYS REV LETT, V85, P110, DOI 10.1103/PhysRevLett.85.110; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0079-6425(89)90001-7; Kim SY, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245408; Kim SY, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245407; Miron RA, 2003, J CHEM PHYS, V119, P6210, DOI 10.1063/1.1603722; Yildirim H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165421; Yildirim H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235413; Zheng H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1149	38	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	NOV	2014	13	11					1007	1012		10.1038/NMAT4105		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AS8AC	WOS:000344471900006		
J	Senga, R; Komsa, HP; Liu, Z; Hirose-Takai, K; Krasheninnikov, AV; Suenaga, K				Senga, Ryosuke; Komsa, Hannu-Pekka; Liu, Zheng; Hirose-Takai, Kaori; Krasheninnikov, Arkady V.; Suenaga, Kazu			Atomic structure and dynamic behaviour of truly one-dimensional ionic chains inside carbon nanotubes	NATURE MATERIALS			English	Article							MONOLAYER MOLYBDENUM-DISULFIDE; ORGANIC-MOLECULES; ENCAPSULATION; NANOWIRES; MOTION	Materials with reduced dimensionality have attracted much interest in various fields of fundamental and applied science. True one-dimensional (1D) crystals with single-atom thickness have been realized only for few elemental metals (Au, Ag) or carbon, all of which showed very short lifetimes under ambient conditions. We demonstrate here a successful synthesis of stable 1D ionic crystals in which two chemical elements, one being a cation and the other an anion, align alternately inside carbon nanotubes. Unusual dynamical behaviours for different atoms in the 1D lattice are experimentally corroborated and suggest substantial interactions of the atoms with the nanotube sheath. Our theoretical studies indicate that the 1D ionic crystals have optical properties distinct from those of their bulk counterparts and that the properties can be engineered by introducing atomic defects into the chains.	[Senga, Ryosuke; Liu, Zheng; Hirose-Takai, Kaori; Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058562, Japan; [Komsa, Hannu-Pekka; Krasheninnikov, Arkady V.] Aalto Univ, Dept Appl Phys, Aalto 00076, Finland	Suenaga, K (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, AIST Cent 5, Tsukuba, Ibaraki 3058562, Japan.	suenaga-kazu@aist.go.jp	Suenaga, Kazu/E-2339-2014; Krasheninnikov, Arkady/M-3020-2013	Suenaga, Kazu/0000-0002-6107-1123; Krasheninnikov, Arkady/0000-0003-0074-7588	Japan Society for the Promotion of Science (JSAP); JST Research Acceleration Program; Academy of Finland [263416]; COMP Centre of Excellence	We thank A. Gloter and C. Ewels for fruitful discussions. Y. Sato and T. Saito are gratefully acknowledged for their assistance for specimen preparations. This work was supported by the Japan Society for the Promotion of Science (JSAP) and JST Research Acceleration Program. A. V. K. and H-P. K. acknowledge support from the Academy of Finland through projects 263416 and COMP Centre of Excellence, respectively, and further thank CSC Finland for generous grants of computer time.	Algara-Siller G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830036; Bettini J, 2006, NAT NANOTECHNOL, V1, P182, DOI 10.1038/nnano.2006.132; Takenobu T, 2003, NAT MATER, V2, P683, DOI 10.1038/nmat976; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Sloan J, 2003, CR PHYS, V4, P1063, DOI 10.1016/S1631-0705(03)00102-6; PENNYCOOK SJ, 1989, ULTRAMICROSCOPY, V30, P58, DOI 10.1016/0304-3991(89)90173-3; Guan L, 2008, J AM CHEM SOC, V130, P2162, DOI 10.1021/ja7103069; Cretu O, 2013, NANO LETT, V13, P3487, DOI 10.1021/nl4018918; Koshino M, 2007, SCIENCE, V316, P853, DOI 10.1126/science.1138690; Zhou W, 2013, NANO LETT, V13, P2615, DOI 10.1021/nl4007479; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; Fan X, 2000, PHYS REV LETT, V84, P4621, DOI 10.1103/PhysRevLett.84.4621; Chuvilin A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083019; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.205501; Krivanek OL, 2010, ULTRAMICROSCOPY, V110, P935, DOI 10.1016/j.ultramic.2010.02.007; Meyer RR, 2000, SCIENCE, V289, P1324, DOI 10.1126/science.289.5483.1324; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Hashimoto A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.045504; Hong B., SCIENCE, V294; Kitaura R, 2008, NANO RES, V1, P152, DOI 10.1007/s12274-008-8013-8; Liu Z, 2009, ACS NANO, V3, P1160, DOI 10.1021/nn9002727; Pies W., 1973, CRYSTAL STRUCTURE DA, P592; Sloan J, 2002, CHEM COMMUN, P1319, DOI 10.1039/b200537a; Suenaga K, 2003, NANO LETT, V3, P1395, DOI 10.1021/nl034621c; Warner JH, 2009, ACS NANO, V3, P3037, DOI 10.1021/nn900747r	28	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	NOV	2014	13	11					1050	1054		10.1038/NMAT4069		5	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AS8AC	WOS:000344471900013		
J	Endo, K; Parr, C; Saito, H				Endo, Kei; Parr, Callum; Saito, Hirohide			Expanding the synthetic ribonucleoprotein world in cells	NATURE METHODS			English	Editorial Material							RNA		[Endo, Kei; Parr, Callum; Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan	Endo, K (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan.	hirohide.saito@cira.kyoto-u.ac.jp	Endo, Kei/C-7325-2015	Endo, Kei/0000-0003-1020-7884			Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/nchembio.273, 10.1038/NCHEMBIO.273]; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Stapleton JA, 2012, ACS SYNTH BIOL, V1, P83, DOI 10.1021/sb200005w; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Auslander S., NAT METHODS, V11, P1154; Beal J, 2015, ACS SYNTH BIOL, V4, P48, DOI 10.1021/sb500173f; Endo K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt347; Endo K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3393; Kennedy A.B., 2014, NUCLEIC ACIDS RES, DOI [10.1093/nar/gku875, DOI 10.1093/NAR/GKU875]; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	NOV	2014	11	11					1105	1106				2	Biochemical Research Methods	Biochemistry & Molecular Biology	AS9SA	WOS:000344580600013		
J	Shigekawa, H; Yoshida, S; Takeuchi, O				Shigekawa, Hidemi; Yoshida, Shoji; Takeuchi, Osamu			SPECTROSCOPY Nanoscale terahertz spectroscopy	NATURE PHOTONICS			English	News Item							CARRIER DYNAMICS; MICROSCOPY		[Shigekawa, Hidemi; Yoshida, Shoji; Takeuchi, Osamu] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Shigekawa, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	hidemi@ims.tsukuba.ac.jp					Cocker TL, 2013, NAT PHOTONICS, V7, P620, DOI [10.1038/nphoton.2013.151, 10.1038/NPHOTON.2013.151]; Lucas M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4720102; Yoshida S, 2014, NAT NANOTECHNOL, V9, P588, DOI [10.1038/nnano.2014.125, 10.1038/NNANO.2014.125]; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151; Neacsu CC, 2010, NANO LETT, V10, P592, DOI 10.1021/nl903574a; Ulbricht R, 2011, REV MOD PHYS, V83, P543, DOI 10.1103/RevModPhys.83.543; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Eisele L., 2014, NATURE PHOTON, V8, P841; Krausz E, 2009, REV MOD PHYS, V81, P163; Shah J., 1999, ULTRAFAST SPECTROSCO; Terada Y, 2010, NAT PHOTONICS, V4, P869, DOI 10.1038/nphoton.2010.235; Wu HJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.062002; Wu SW, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085444	13	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	NOV	2014	8	11					815	817				3	Optics; Physics, Applied	Optics; Physics	AT3NC	WOS:000344840400004		
J	Horiuchi, N				Horiuchi, Noriaki			VIEW FROM ... IQCLSW 2014 Frequency comb cascade	NATURE PHOTONICS			English	News Item									Nat Photon, Shinjuku Ku, Tokyo 1620843, Japan	Horiuchi, N (reprint author), Nat Photon, Shinjuku Ku, 2-37 Ichigayatamachi, Tokyo 1620843, Japan.	n.horiuchi@nature.com						0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	NOV	2014	8	11					819	820				2	Optics; Physics, Applied	Optics; Physics	AT3NC	WOS:000344840400007		
J	Byrnes, T; Kim, NY; Yamamoto, Y				Byrnes, Tim; Kim, Na Young; Yamamoto, Yoshihisa			Exciton-polariton condensates	NATURE PHYSICS			English	Review							BOSE-EINSTEIN CONDENSATION; SOLID-STATE PHYSICS; LONG-RANGE ORDER; SEMICONDUCTOR MICROCAVITY; 2-DIMENSIONAL SYSTEMS; QUANTIZED VORTICES; ROOM-TEMPERATURE; QUANTUM FLUIDS; SUPERFLUID; SCATTERING	Recently a new type of system exhibiting spontaneous coherence has emerged-the exciton-polariton condensate. Exciton-polaritons (or polaritons for short) are bosonic quasiparticles that exist inside semiconductor microcavities, consisting of a superposition of an exciton and a cavity photon. Above a threshold density the polaritons macroscopically occupy the same quantum state, forming a condensate. The polaritons have a lifetime that is typically comparable to or shorter than thermalization times, giving them an inherently non-equilibrium nature. Nevertheless, they exhibit many of the features that would be expected of equilibrium Bose-Einstein condensates (BECs). The non-equilibrium nature of the system raises fundamental questions as to what it means for a system to be a BEC, and introduces new physics beyond that seen in other macroscopically coherent systems. In this review we focus on several physical phenomena exhibited by exciton-polariton condensates. In particular, we examine topics such as the difference between a polariton BEC, a polariton laser and a photon laser, as well as physical phenomena such as superfluidity, vortex formation, and Berezinskii-Kosterlitz-Thouless and Bardeen-Cooper-Schrieffer physics. We also discuss the physics and applications of engineered polariton structures.	[Byrnes, Tim] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Kim, Na Young; Yamamoto, Yoshihisa] Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA; [Yamamoto, Yoshihisa] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Byrnes, T (reprint author), Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	tbyrnes@nii.ac.jp			FIRST program through JSPS; Okawa Foundation; Transdisciplinary Research Integration Center; DARPA QuEST program through Navy/SPAWAR [N66001-09-1-2024]; Inamori Foundation; NTT Basic Laboratories; JSPS Kakenhi [26790061]	We thank B. Devaud-Pledran for providing valuable comments on the manuscript. This work is supported by the FIRST program through JSPS, the Okawa Foundation, the Transdisciplinary Research Integration Center, and DARPA QuEST program through Navy/SPAWAR Grant N66001-09-1-2024, the Inamori Foundation, NTT Basic Laboratories and JSPS Kakenhi Grant Number 26790061.	Wouters M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.020602; Horikiri T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.084709; Deveaud-Pledran B, 2008, NATURE, V453, P297, DOI 10.1038/453297a; Byrnes T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075130; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Keeling J, 2011, CONTEMP PHYS, V52, P131, DOI 10.1080/00107514.2010.550120; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Baumberg JJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136409; Amo A, 2010, NAT PHOTONICS, V4, P361, DOI 10.1038/NPHOTON.2010.79; Guillet T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3650268; Roumpos G, 2012, P NATL ACAD SCI USA, V109, P6467, DOI 10.1073/pnas.1107970109; Yamaguchi M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.026404; Amo A, 2011, SCIENCE, V332, P1167, DOI 10.1126/science.1202307; Kohnle V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.255302; Hadzibabic Z, 2011, RIV NUOVO CIMENTO, V34, P389, DOI 10.1393/ncr/i2011-10066-3; Cerda-Mendez EA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.116402; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Tempel JS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075318; Klaers J, 2010, NATURE, V468, P545, DOI 10.1038/nature09567; Greiner M, 2002, NATURE, V415, P39, DOI 10.1038/415039a; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Keeling J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.226403; SCHMITTRINK S, 1985, PHYS REV B, V32, P6601, DOI 10.1103/PhysRevB.32.6601; Jacqmin T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.116402; Demokritov SO, 2006, NATURE, V443, P430, DOI 10.1038/nature05117; Snoke D, 2010, PHYS TODAY, V63, P42, DOI 10.1063/1.3480075; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; Kena-Cohen S, 2010, NAT PHOTONICS, V4, P371, DOI [10.1038/nphoton.2010.86, 10.1038/NPHOTON.2010.86]; Nguyen HS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.236601; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Roumpos G, 2011, NAT PHYS, V7, P129, DOI [10.1038/nphys1841, 10.1038/NPHYS1841]; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Deng H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126403; Carusotto I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166401; Butov LV, 2012, NAT PHOTONICS, V6, P2; Deng H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146402; Byrnes T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.186402; Sanvitto D, 2010, NAT PHYS, V6, P527, DOI 10.1038/NPHYS1668; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Utsunomiya S, 2008, NAT PHYS, V4, P700, DOI 10.1038/nphys1034; Bhattacharya P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.206403; Tassone F, 1999, PHYS REV B, V59, P10830, DOI 10.1103/PhysRevB.59.10830; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; Liew TCH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.016402; Nardin G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045304; Lagoudakis KG, 2009, SCIENCE, V326, P974, DOI 10.1126/science.1177980; Cilibrizzi P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103901; Wouters M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.140402; Nelsen B, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041015; Nikuni T, 2000, PHYS REV LETT, V84, P5868, DOI 10.1103/PhysRevLett.84.5868; Keeling J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115320; Lagoudakis KG, 2008, NAT PHYS, V4, P706, DOI 10.1038/nphys1051; Deng H, 2003, P NATL ACAD SCI USA, V100, P15318, DOI 10.1073/pnas.2634328100; Bajoni D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047401; Love APD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.067404; Tassone F, 1997, PHYS REV B, V56, P7554, DOI 10.1103/PhysRevB.56.7554; Ciuti C, 1998, PHYS REV B, V58, P7926, DOI 10.1103/PhysRevB.58.7926; Amo A, 2009, NATURE, V457, P291, DOI 10.1038/nature07640; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; Masumoto N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/065002; Sich M, 2012, NAT PHOTONICS, V6, P50, DOI [10.1038/nphoton.2011.267, 10.1038/NPHOTON.2011.267]; Schneider C, 2013, NATURE, V497, P348, DOI 10.1038/nature12036; Kaitouni RI, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155311; Kim NY, 2011, NAT PHYS, V7, P681, DOI 10.1038/NPHYS2012; Kamide K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.056401; Wertz E, 2010, NAT PHYS, V6, P860, DOI [10.1038/nphys1750, 10.1038/NPHYS1750]; Lai CW, 2007, NATURE, V450, P529, DOI 10.1038/nature06334; de Lima MM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045501; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Backhaus S, 1998, NATURE, V392, P687, DOI 10.1038/33629; Imamoglu A, 1996, PHYS REV A, V53, P4250, DOI 10.1103/PhysRevA.53.4250; Kasprzak J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146404; Assmann M, 2011, P NATL ACAD SCI USA, V108, P1804, DOI 10.1073/pnas.1009847108; Amo A, 2009, NAT PHYS, V5, P805, DOI 10.1038/NPHYS1364; Ballarini D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2734; BEREZINS.VL, 1972, SOV PHYS JETP-USSR, V34, P610; Butov LV, 2007, NATURE, V447, P540, DOI 10.1038/447540a; Byrnes T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.201301; Carusotto I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.260403; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; COMTE C, 1982, J PHYS-PARIS, V43, P1069, DOI 10.1051/jphys:019820043070106900; Dang LS, 1998, PHYS REV LETT, V81, P3920, DOI 10.1103/PhysRevLett.81.3920; del Valle E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096404; Deveaud-Pledran B, 2012, NAT PHOTONICS, V6, P205, DOI 10.1038/nphoton.2012.52; Galbiati M., 2011, PHYS REV LETT, V108; Grosso G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.020509; HOHENBER.PC, 1967, PHYS REV, V158, P383, DOI 10.1103/PhysRev.158.383; Janot A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230403; Kavokin A, 2010, PHYS STATUS SOLIDI B, V247, P1898, DOI 10.1002/pssb.200983955; Keeling J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080402; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; Kim NY, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035032; Kira M, 1997, PHYS REV LETT, V79, P5170, DOI 10.1103/PhysRevLett.79.5170; Kusudo K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214503; Laussy F. P., 1997, PHYS REV LETT, V93; Leggett A. J., 2006, QUANTUM LIQUIDS BOSE; Manni F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.176401; Manni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2310; Nitsche W. H., 2014, PREPRINT; PAU S, 1995, PHYS REV B, V51, P7090, DOI 10.1103/PhysRevB.51.7090; Pigeon S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144513; Plumhof Johannes D, 2014, Nat Mater, V13, P247, DOI [10.1038/nmat3825, 10.1038/NMAT3825]; Richard M, 2010, INT J NANOTECHNOL, V7, P668, DOI 10.1504/IJNT.2010.031738; Sargent M, 1978, LASER PHYS; Snoke D., 2008, NAT PHYS, V4, P673, DOI DOI 10.1038/NPHYS1064; Snoke D., 2012, EXCITON POLARITONS M, V172, p307 ; Spano R, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/075018; Stringari S, 2003, BOSE EINSTEIN CONDEN; Tanese D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2760; Tilley D. R., 1990, SUPERFLUIDITY SUPERC; Timofeev V., 2012, EXCITON POLARITONS M, V172; Tosi G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2255; Tosi G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036401; Wouters M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125311; Yamamoto Y., 1999, MESOSCOPIC QUANTUM O	115	23	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	NOV	2014	10	11					803	813		10.1038/nphys3143		11	Physics, Multidisciplinary	Physics	AT3PP	WOS:000344846700010		
J	Fu, YS; Kawamura, M; Igarashi, K; Takagi, H; Hanaguri, T; Sasagawa, T				Fu, Ying-Shuang; Kawamura, M.; Igarashi, K.; Takagi, H.; Hanaguri, T.; Sasagawa, T.			Imaging the two-component nature of Dirac-Landau levels in the topological surface state of Bi2Se3	NATURE PHYSICS			English	Article							GRAPHENE; FERMIONS; INSULATORS; FIELD	Massless Dirac electrons in condensed matter(1-6) are, unlike conventional electrons, described by two-component wavefunctions associated with the spin degrees of freedom in the surface state of topological insulators(5,6). Hence, the ability to observe the two-component wavefunction is useful for exploring novel spin phenomena. Here we show that the two-component nature is manifest in Landau levels, the degeneracy of which is lifted by a Coulomb potential. Using spectroscopic-imaging scanning tunnelling microscopy, we visualize energy and spatial structures of Landau levels in Bi2Se3, a prototypical topological insulator. The observed Landau-level splitting and internal structures of Landau orbits are distinct from those in a conventional electron system(7) and are well reproduced by a two-component model Dirac Hamiltonian. Our model further predicts energy-dependent spin-magnetization textures in a potential variation and provides a way for manipulating spins in the topological surface state.	[Fu, Ying-Shuang; Kawamura, M.; Hanaguri, T.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Igarashi, K.; Sasagawa, T.] Tokyo Inst Technol, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan; [Takagi, H.] RIKEN, Magnet Mat Lab, Wako, Saitama 3510198, Japan; [Takagi, H.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Takagi, H.] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	Hanaguri, T (reprint author), RIKEN, Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hanaguri@riken.jp	Hanaguri, Tetsuo/I-6710-2012; Kawamura, Minoru/B-2834-2013; Sasagawa, Takao/E-6666-2014; Takagi, Hidenori/B-2935-2010	Hanaguri, Tetsuo/0000-0003-2896-0081; Kawamura, Minoru/0000-0003-0104-6257; Sasagawa, Takao/0000-0003-0149-6696; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [23103519]	The authors thank X. Chen, Y. L. Chen, K. Iwaya, Y. Kohsaka, K. Nomura, M. Ogata, Y. Okada and A. W. Rost for discussions. This work was partly supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 23103519).	Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Goerbig MO, 2011, REV MOD PHYS, V83, P1193, DOI 10.1103/RevModPhys.83.1193; MCCLURE JW, 1956, PHYS REV, V104, P666, DOI 10.1103/PhysRev.104.666; Miller DL, 2009, SCIENCE, V324, P924, DOI 10.1126/science.1171810; Hanaguri T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081305; Cheng P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.076801; Beidenkopf H, 2011, NAT PHYS, V7, P939, DOI [10.1038/nphys2108, 10.1038/NPHYS2108]; Hashimoto K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116805; Morgenstern M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.056804; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Niimi Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236804; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Ran Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014505; Okada Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166407; Miller DL, 2010, NAT PHYS, V6, P811, DOI 10.1038/NPHYS1736; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Hanaguri T, 2006, J PHYS CONF SER, V51, P514, DOI [10.1088/1742-6596/51/1/117, 10.1088/174-6596/51/1/117]; Hashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256802; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Luican-Mayer A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.036804; Qi X-L., 2010, REV MOD PHYS, V83, P1057; Tajima N, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/47002; Yoshioka D, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.024718; Zhang YB, 2009, NAT PHYS, V5, P722, DOI 10.1038/NPHYS1365	26	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	NOV	2014	10	11					815	819		10.1038/NPHYS3084		5	Physics, Multidisciplinary	Physics	AT3PP	WOS:000344846700012		
J	Riley, JM; Mazzola, F; Dendzik, M; Michiardi, M; Takayama, T; Bawden, L; Granerod, C; Leandersson, M; Balasubramanian, T; Hoesch, M; Kim, TK; Takagi, H; Meevasana, W; Hofmann, P; Bahramy, MS; Wells, JW; King, PDC				Riley, J. M.; Mazzola, F.; Dendzik, M.; Michiardi, M.; Takayama, T.; Bawden, L.; Granerod, C.; Leandersson, M.; Balasubramanian, T.; Hoesch, M.; Kim, T. K.; Takagi, H.; Meevasana, W.; Hofmann, Ph; Bahramy, M. S.; Wells, J. W.; King, P. D. C.			Direct observation of spin-polarized bulk bands in an inversion-symmetric semiconductor	NATURE PHYSICS			English	Article							LOCALIZED WANNIER FUNCTIONS; VALLEY POLARIZATION; ELECTRON-GAS; WSE2; TRANSISTOR; INSULATOR; PHASE; FIELD; MOS2	Methods to generate spin-polarized electronic states in nonmagnetic solids are strongly desired to enable all-electrical manipulation of electron spins for new quantum devices(1). This is generally accepted to require breaking global structural inversion symmetry(1-5). In contrast, here we report the observation from spin- and angle-resolved photoemission spectroscopy of spin-polarized bulk states in the centrosymmetric transition-metal dichalcogenide WSe2. Mediated by a lack of inversion symmetry in constituent structural units of the bulk crystal where the electronic states are localized(6), we show how spin splittings up to similar to 0.5 eV result, with a spin texture that is strongly modulated in both real and momentum space. Through this, our study provides direct experimental evidence for a putative locking of the spin with the layer and valley pseudospins in transition-metal dichalcogenides(7,8), of key importance for using these compounds in proposed valleytronic devices.	[Riley, J. M.; Bawden, L.; King, P. D. C.] Univ St Andrews, SUPA, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Mazzola, F.; Granerod, C.] Norwegian Univ Sci & Technol NTNU, Dept Phys, N-7491 Trondheim, Norway; [Dendzik, M.; Hofmann, Ph] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Takayama, T.; Takagi, H.] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; [Takayama, T.; Takagi, H.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Leandersson, M.; Balasubramanian, T.] Lund Univ, MAX Lab 4, S-22100 Lund, Sweden; [Hoesch, M.; Kim, T. K.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Meevasana, W.] Suranaree Univ Technol, Sch Phys, Nakhon Ratchasima 30000, Thailand; [Meevasana, W.] Suranaree Univ Technol, NANOTEC SUT Ctr Excellence Adv Funct Nanomat, Nakhon Ratchasima 30000, Thailand; [Bahramy, M. S.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Bahramy, M. S.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Bahramy, M. S.] RIKEN, CEMS, Wako, Saitama 3510198, Japan	King, PDC (reprint author), Univ St Andrews, SUPA, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	philip.king@st-andrews.ac.uk	Bahramy, Mohammad/B-2865-2013; Hofmann, Philip/B-5938-2008; Takagi, Hidenori/B-2935-2010; Wells, Justin/C-1217-2011; King, Philip/D-3809-2014	Bahramy, Mohammad/0000-0001-9024-6335; Wells, Justin/0000-0001-6366-366X; King, Philip/0000-0002-6523-9034	Engineering and Physical Sciences Research Council, UK; VILLUM foundation; Calipso program, TRF-SUT Grant [RSA5680052]; NANOTEC, Thailand through the CoE Network; Royal Society through a University Research Fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24224009]; Swedish Research Council; Knut and Alice Wallenberg Foundation	We gratefully acknowledge support from the Engineering and Physical Sciences Research Council, UK, the VILLUM foundation, the Calipso program, TRF-SUT Grant RSA5680052 and NANOTEC, Thailand through the CoE Network. P.D.C.K. acknowledges support from the Royal Society through a University Research Fellowship. M.S.B. was supported by a Grant-in-Aid for Scientific Research (S) (No. 24224009) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The experiments at the MAX IV Laboratory were made possible through funding from the Swedish Research Council and the Knut and Alice Wallenberg Foundation.	Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Zhu ZH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.076802; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Koo HC, 2009, SCIENCE, V325, P1515, DOI 10.1126/science.1173667; Murakawa H, 2013, SCIENCE, V342, P1490, DOI 10.1126/science.1242247; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; Mostofi AA, 2008, COMPUT PHYS COMMUN, V178, P685, DOI 10.1016/j.cpc.2007.11.016; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; DRESSELHAUS G, 1955, PHYS REV, V100, P580, DOI 10.1103/PhysRev.100.580; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Zhang XW, 2014, NAT PHYS, V10, P387, DOI 10.1038/NPHYS2933; Yuan HT, 2013, NAT PHYS, V9, P563, DOI 10.1038/NPHYS2691; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/nmat3051, 10.1038/NMAT3051]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/nnano.2013.151, 10.1038/NNANO.2013.151]; King PDC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096802; Finteis T, 1997, PHYS REV B, V55, P10400, DOI 10.1103/PhysRevB.55.10400; Kunes J, 2010, COMPUT PHYS COMMUN, V181, P1888, DOI 10.1016/j.cpc.2010.08.005; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; BYCHKOV YA, 1984, JETP LETT+, V39, P78; Ast CR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186807; Bahramy MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2162; Berntsen MH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3342120; Bihlmayer G, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195414; Blaha P., 2010, WIEN2K PACKAGE VERSI; Das T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2972; Gong ZR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3053; Jones AM, 2014, NAT PHYS, V10, P130, DOI [10.1038/nphys2848, 10.1038/NPHYS2848]; King PDC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4414; Souza I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035109; Zhou JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03841; Zhu ZH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216401	34	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	NOV	2014	10	11					835	839		10.1038/NPHYS3105		5	Physics, Multidisciplinary	Physics	AT3PP	WOS:000344846700016		
J	Kambe, S; Sakai, H; Tokunaga, Y; Lapertot, G; Matsuda, TD; Knebel, G; Flouquet, J; Walstedt, RE				Kambe, S.; Sakai, H.; Tokunaga, Y.; Lapertot, G.; Matsuda, T. D.; Knebel, G.; Flouquet, J.; Walstedt, R. E.			Degenerate Fermi and non-Fermi liquids near a quantum critical phase transition	NATURE PHYSICS			English	Article							NUCLEAR MAGNETIC RELAXATION; CRITICAL-POINT; HEAVY; ANTIFERROMAGNETICS; TEMPERATURE; METALS	Recently there is renewed interest in quantum critical phase transitions (QCPT) at T = 0 K in metallic strongly correlated electron systems. From early experimental results(1-4), the QCPT in the Kondo-lattice compound YbRh2Si2 is not a case of the ordinary spin density wave (SDW) instability observed in Ce-based Kondo lattices(5), but a candidate for a novel locally critical case(6-8). Here, we observe that coexisting, static Fermi liquid (FL) and non-Fermi liquid (NFL) states are a key feature of the QCPT in YbRh2Si2. By means of nuclear magnetic resonance (NMR) spin-lattice relaxation time (T-1) measurements on a single-crystalline sample, we find that the FL and NFL states are invariant, whereas their ratio in a crossover is field dependent near the QCPT. Such a pair of states has remained hidden in Ce compounds, owing presumably to the short lifetimes of the two states. We derive a scaling law for the occupation ratio of the two states, which could be widely applicable to Kondo-lattice systems.	[Kambe, S.; Sakai, H.; Tokunaga, Y.; Matsuda, T. D.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Lapertot, G.; Knebel, G.; Flouquet, J.] Univ Grenoble 1, CEA Grenoble, Inst Nanosci & Cryogenie, Serv Phys Stat Magnetisme & Supraconduct, F-38054 Grenoble, France; [Walstedt, R. E.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Kambe, S (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	kambe.shinsaku@jaea.go.jp	Knebel, Georg/A-3294-2012		MEXT [20102006, 20102007]; REIMEI Research Program of JAEA	We are grateful for stimulating discussions with S. Watanabe, K. Izawa, K. Ishida, H. Ikeda, J. P. Brison, Y-F. Yang, Z. Fisk and K. Kubo. A part of this work was supported by Grants-in-Aid for Scientific Research on Innovative Areas Heavy Electrons (No. 20102006 and No. 20102007) from MEXT, and the REIMEI Research Program of JAEA.	MILA F, 1989, PHYSICA C, V157, P561, DOI 10.1016/0921-4534(89)90286-4; Yang YF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096404; Watanabe S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.186403; Stock C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.127201; Johnston DC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.184430; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Friedemann S, 2010, P NATL ACAD SCI USA, V107, P14547, DOI 10.1073/pnas.1009202107; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Sichelschmidt J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.156401; Ishida K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107202; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Abrahams E, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.045105; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; Ishigaki A, 1998, J PHYS SOC JPN, V67, P3924, DOI 10.1143/JPSJ.67.3924; JOSS W, 1987, PHYS REV LETT, V59, P1609, DOI 10.1103/PhysRevLett.59.1609; Knebel G, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.114709; Kuramoto Y., 2000, DYNAMICS HEAVY ELECT; MORIYA T, 1956, PROG THEOR PHYS, V16, P641, DOI 10.1143/PTP.16.641; MORIYA T, 1956, PROG THEOR PHYS, V16, P23, DOI 10.1143/PTP.16.23; Nakatsuji S., 2008, PHYS REV LETT, V92; Pepin C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206401; Rourke PMC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.237205; Sakai H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137001; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626	28	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	NOV	2014	10	11					840	844		10.1038/NPHYS3101		5	Physics, Multidisciplinary	Physics	AT3PP	WOS:000344846700017		
J	Kawada, T				Kawada, Tomoyuki			Detection Limit of Saliva Cotinine Values and Statistical Validity	NICOTINE & TOBACCO RESEARCH			English	Letter							EXPOSURE; SMOKE		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Bernert JT, 2000, J ANAL TOXICOL, V24, P333; Martinez-Sanchez JM, 2009, PREV MED, V48, P218, DOI 10.1016/j.ypmed.2008.12.020; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450; Lawhorn NA, 2013, NICOTINE TOB RES, V15, P413, DOI 10.1093/ntr/nts144; St Helen Gideon, 2012, Environ Health Perspect, V120, P1010, DOI 10.1289/ehp.1104413	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-2203	1469-994X		NICOTINE TOB RES	Nicotine Tob. Res.	NOV	2014	16	11					1532	1532		10.1093/ntr/ntu021		1	Substance Abuse; Public, Environmental & Occupational Health	Substance Abuse; Public, Environmental & Occupational Health	AT0LO	WOS:000344627800017		
J	Abe, H; Kawamura, J; Sumita, K				Abe, Hiroyuki; Kawamura, Junichiro; Sumita, Keigo			The Higgs boson mass and SUSY spectra in 10D SYM theory with magnetized extra dimensions	NUCLEAR PHYSICS B			English	Article							SUPERSYMMETRY BREAKING; MODEL; MSSM; LHC	We study the Higgs boson mass and the spectrum of supersymmetric (SUSY) particles in the wellmotivated particle physics model derived from a ten-dimensional supersymmetric Yang Mills theory compactified on three factorizable tori with magnetic fluxes. This model was proposed in a previous work, where the flavor structures of the standard model including the realistic Yukawa hierarchies are obtained from non-hierarchical input parameters on the magnetized background. Assuming moduli- and anomaly-mediated contributions dominate the soft SUSY breaking terms, we study the precise SUSY spectra and analyze the Higgs boson mass in this mode, which are compared with the latest experimental data. (C) 2014 The Authors. Published by Elsevier B.V.	[Abe, Hiroyuki; Kawamura, Junichiro; Sumita, Keigo] Waseda Univ, Dept Phys, Tokyo 1698555, Japan	Sumita, K (reprint author), Waseda Univ, Dept Phys, Tokyo 1698555, Japan.	abe@waseda.jp; junichiro-k@ruri.waseda.jp; k.sumita@moegi.waseda.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [25800158]; Grant for Excellent Graduate Schools from the MEXT in Japan;  [25.4968]	H.A. was supported in part by the Grant-in-Aid for Scientific Research No. 25800158 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. J.K. was supported in part by the Grant for Excellent Graduate Schools from the MEXT in Japan. K.S. was supported in part by a Grant-in-Aid for JSPS Fellows No. 25.4968 and a Grant for Excellent Graduate Schools from the MEXT in Japan.	Abe H., ARXIV13071831HEPTH; Abe H., ARXIV14050779HEPPH; Abe H., 2013, PTEP PROCES TEH ENER, V2013; Arana-Catania M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.015026; Angelantonj C, 2000, PHYS LETT B, V489, P223, DOI 10.1016/S0370-2693(00)00907-2; YANAGIDA T, 1980, PROG THEOR PHYS, V64, P1103; Choi K, 2006, PHYS LETT B, V633, P355, DOI 10.1016/j.physletb.2005.11.078; MAKI Z, 1962, PROG THEOR PHYS, V28, P870, DOI 10.1143/PTP.28.870; Gambino P, 2001, NUCL PHYS B, V611, P338, DOI 10.1016/S0550-3213(01)00347-9; Carena M, 1996, NUCL PHYS B, V461, P407, DOI 10.1016/0550-3213(95)00665-6; Endo M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.015004; Abe H, 2012, NUCL PHYS B, V863, P1, DOI 10.1016/j.nuclphysb.2012.05.012; Choi K, 2005, NUCL PHYS B, V718, P113, DOI 10.1016/j.nuclphysb.2005.04.032; Abe H, 2013, NUCL PHYS B, V870, P30, DOI 10.1016/j.nuclphysb.2013.01.014; Kachru S, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.046005; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; MARCUS N, 1983, NUCL PHYS B, V224, P159, DOI 10.1016/0550-3213(83)90318-8; Kitano R, 2005, PHYS LETT B, V631, P58, DOI 10.1016/j.physletb.2005.10.003; Randall L, 1999, NUCL PHYS B, V557, P79, DOI 10.1016/S0550-3213(99)00359-4; Choi K, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.095012; Abe H, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.015002; Arkani-Hamed N., 2002, JHEP, V0203, P055; Bachas C., ARXIVHEPTH9503030; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Cremades D., 2004, JHEP, V0405; Gell-Mann M., 1979, Supergravity; Giudice G.F., 1998, JHEP, V9812; Green M.B., 1984, PHYS LETT B, V149, P117; Misiak M, 1998, ADV S DIR H, V15, P795; Okumura K. i., 2005, JHEP, V0509, P039; Polchinski J., 1998, STRING THEORY, VII; Pontecorvo B., 1968, SOV PHYS JETP, V26, p[984, 1717]; Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Chatrchyan S, 2012, PHYS LETT B, V716, P30, DOI 10.1016/j.physletb.2012.08.021	34	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	NOV	2014	888						194	213		10.1016/j.nuclphysb.2014.09.016		20	Physics, Particles & Fields	Physics	AT3GE	WOS:000344823100012		
J	Tanaka, K; Tokumiya, S; Ishihara, Y; Kohira, Y; Katafuchi, T				Tanaka, Kunihiko; Tokumiya, Shiori; Ishihara, Yumiko; Kohira, Yumiko; Katafuchi, Tetsuro			Compression Stocking Length Effects on Arterial Blood Pressure and Heart Rate Following Head-Up Tilt in Healthy Volunteers	NURSING RESEARCH			English	Article						baroreflex; gravity; lower body positive pressure; orthostatic hypotension; venous return	ORTHOSTATIC HYPOTENSION; HUMANS; BAROREFLEX; REFLEX	Background: Change in posture from supine to standing induces a footward fluid shift. This shift might decrease arterial pressure (AP) and induce orthostatic hypotension. To prevent decrease in AP, compression stockings are recommended, but the effects of various lengths have not been compared. Objective: The aim was to compare AP and heart rate (HR) by compression stocking length during head-up tilt (HUT). Methods: The effects of elastic compression stockings of three lengths on AP and HR were examined at the onset of HUT. The stockings were knee-high, compressing the foot and calf; thigh-high, compressing the toe to the thigh; and waist-high, compressing the toe to the waist. Results: AP did not significantly change at the onset of HUT without stockings or with any length of stockings compared with the AP in the supine position. HR was significantly higher at the onset of HUT without stockings and with the knee-high and thigh-high stockings than that during supine position. No significant difference in HR was observed among the three conditions. However, the HR increase was significantly depressed with the waist-high stockings. Discussion: These results suggest that the use of waist-high stockings that afford abdominal compression is needed to affect cardiovascular dynamics at the onset of HUT and may prevent orthostatic hypotension.	[Tanaka, Kunihiko; Tokumiya, Shiori; Ishihara, Yumiko; Katafuchi, Tetsuro] Gifu Univ Med Sci, Dept Radiol Technol, Gifu 5013892, Japan; [Kohira, Yumiko] Gifu Univ Med Sci, Dept Nursing, Gifu 5013892, Japan	Tanaka, K (reprint author), Gifu Univ Med Sci, Dept Radiol Technol, 795-1 Nagamine, Gifu 5013892, Japan.	ktanaka@u-gifu-ms.ac.jp			Gifu University of Medical Science	The authors acknowledge that the study was supported by a research grant form Gifu University of Medical Science.	Dipla K, 2013, EUR J APPL PHYSIOL, V113, P827, DOI 10.1007/s00421-012-2493-7; Tanaka K, 2009, AUTON NEUROSCI-BASIC, V148, P90, DOI 10.1016/j.autneu.2009.03.007; Aoki M, 2012, EXP BRAIN RES, V217, P251, DOI 10.1007/s00221-011-2989-0; RUTAN GH, 1992, HYPERTENSION, V19, P508; Abe C, 2011, J APPL PHYSIOL, V111, P1614, DOI 10.1152/japplphysiol.00501.2011; Podoleanu C, 2006, J AM COLL CARDIOL, V48, P1425, DOI 10.1016/j.jacc.2006.06.052; Denq JC, 1997, CLIN AUTON RES, V7, P321, DOI 10.1007/BF02267725; Larsen PN, 1996, SCAND J CLIN LAB INV, V56, P17, DOI 10.3109/00365519609088583; Motulsky H, 2010, INTUITIVE BIOSTATICS, P103; Protheroe CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028193; Sauder CL, 2008, J APPL PHYSIOL, V105, P65, DOI 10.1152/japplphysiol.90347.2008; Shortt TL, 1997, AM J PHYSIOL-HEART C, V272, pH1780; Tanaka K, 2012, AUTON NEUROSCI-BASIC, V166, P66, DOI 10.1016/j.autneu.2011.10.003; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Watenpaugh DE, 1996, HDB PHYSIOL SECT 4, VI, P631	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	NOV-DEC	2014	63	6					435	438		10.1097/NNR.0000000000000062		4	Nursing	Nursing	AT4UO	WOS:000344939000007		
J	Ueta, T				Ueta, Takashi			Protocol Systemic Vascular Safety of Ranibizumab for Age-related Macular Degeneration: Systematic Review and Meta-analysis of Randomized Trials	OPHTHALMOLOGY			English	Article							GROWTH-FACTOR INHIBITORS; CEREBROVASCULAR ACCIDENTS; EDEMA; LASER	Background: Vascular endothelial growth factor (VEGF) inhibitors have drastically changed the way to treat exudative age-related macular degeneration (AMD) since the appearance of ranibizumab in 2006.(1,2) Ranibizumab is a VEGF inhibitor that has been most intensively evaluated in various randomized trials. Other VEGF inhibitors including off-label bevacizumab and recently introduced aflibercept have established their usefulness in comparison with ranibizumab. Despite the unquestionable effectiveness, the increased risk of systemic vascular events has been hotly discussed but remained unclear.(3-6) Ranibizumab has also been tested for other pathologies including diabetic macular edema and retinal vein occlusion through phase III randomized trials. In those trials patients with high risk for systemic vascular events were excluded from the trials.(8-12) In contrast, in most of the trials for AMD, there has been no exclusion criterion for systemic vascular conditions. However, considering that a majority of patients with exudative AMD is considerably old (>75 years old), intensive treatment with ranibizumab might lead to increased systemic vascular risks. In that case we may also need to take systemic vascular risks into account to treat AMD patients with VEGF inhibitors. Review Objectives: To conduct a meta-analysis of randomized trials of ranibizumab for AMD and assess whether ranibizumab treatment affects the systemic vascular risk or mortality. Methods: The study will be conducted according to the PRISMA statement and will be reported according to the PRISMA reporting guideline.	[Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Ueta, Takashi] Univ Tokyo, Fac Med, Tokyo 113, Japan	Ueta, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	ueta-tky@umin.ac.jp					Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Kemp A, 2013, RETINA-J RET VIT DIS, V33, P920, DOI 10.1097/IAE.0b013e318276e07b; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Campbell RJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4203; ClinicalTrials.gov, EFF SAF RAN INTR INJ	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11										7	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400025		
J	Yamazaki, N; Kobayashi, A; Yokogawa, H; Ishibashi, Y; Oikawa, Y; Tokoro, M; Sugiyama, K				Yamazaki, Natsuko; Kobayashi, Akira; Yokogawa, Hideaki; Ishibashi, Yasuhisa; Oikawa, Yosaburo; Tokoro, Masaharu; Sugiyama, Kazuhisa			In Vivo Imaging of Radial Keratoneuritis in Patients with Acanthamoeba keratitis by Anterior-Segment Optical Coherence Tomography	OPHTHALMOLOGY			English	Article							CONFOCAL MICROSCOPY FINDINGS; DIAGNOSIS; MANAGEMENT; EYE	Purpose: To investigate in vivo corneal changes of radial keratoneuritis in early-stage Acanthamoeba keratitis (AK) using anterior-segment optical coherence tomography (AS-OCT). Design: Single-center, prospective clinical study. Participants: Four eyes (4 patients with a mean age of 28.5 years) with early-stage AK showing radial keratoneuritis were included in this study. Definitive diagnosis was made by confirmation of AK cysts using in vivo confocal microscopy and culture. Methods: Anterior-segment OCT examination was performed on the initial visit and at follow-up visits paying special attention to radial keratoneuritis. Main Outcome Measures: Selected AS-OCT images of the cornea were evaluated qualitatively for the shape and degree of light reflection of abnormal neurons. Results: With the use of AS-OCT, we successfully obtained high-resolution images of putative radial keratoneuritis in all patients as highly reflective bands or lines in the corneal stroma. The depth and width of the highly reflective bands/lines varied from case to case (anterior stroma to mid-stroma, from 20 to 200 mm). Some lines ran obliquely from the deep peripheral stroma toward the anterior stroma, and some were located at different depths (subepithelial and mid-stroma) and ran relatively parallel to the corneal layers. After appropriate treatment, radial keratoneuritis was resolved by both slit-lamp biomicroscopy and AS-OCT in all patients. Conclusions: High-resolution Fourier-domain AS-OCT provides novel and detailed visual information of radial keratoneuritis in patients with early-stage AK. Visualization of radial keratoneuritis by AS-OCT may be a useful adjunct to the diagnosis and follow-up of early-stage AK. (C) 2014 by the American Academy of Ophthalmology.	[Yamazaki, Natsuko; Kobayashi, Akira; Yokogawa, Hideaki; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa 9208641, Japan; [Ishibashi, Yasuhisa] Tsukuba Hosp, Dept Ophthalmol, Tsukuba, Ibaraki, Japan; [Oikawa, Yosaburo] Kanazawa Med Univ, Dept Med Zool, Kahoku, Ishikawa 92002, Japan; [Tokoro, Masaharu] Kanazawa Univ, Grad Sch Med Sci, Dept Parasitol, Kanazawa, Ishikawa 9208641, Japan	Kobayashi, A (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	kobaya@kenroku.kanazawa-u.ac.jp			 [22591934]	Funded by a Grant-in-Aid for Scientific Research (C) KAKENHI, Japan (No. 22591934).	Alfawaz Abdullah, 2011, Middle East Afr J Ophthalmol, V18, P252, DOI 10.4103/0974-9233.84062; Kobayashi A, 2008, CORNEA, V27, P439, DOI 10.1097/ICO.0b013e318163cc77; Hammersmith KM, 2006, CURR OPIN OPHTHALMOL, V17, P327, DOI 10.1097/01.icu.0000233949.56229.7d; Pfister DR, 1996, AM J OPHTHALMOL, V121, P119; CAVANAGH HD, 1993, OPHTHALMOLOGY, V100, P1444; STEHRGREEN JK, 1989, AM J OPHTHALMOL, V107, P331; JONES DB, 1975, T OPHTHAL SOC UK, V95, P221; CHEW S-J, 1992, CLAO Journal, V18, P197; Chin EK, 2012, OPHTHAL SURG LAS IM, V43, P97, DOI 10.3928/15428877-20111222-02; Kaufman SC, 2004, OPHTHALMOLOGY, V111, P396, DOI 10.1016/j.ophtha.2003.12.002; Kobayashi A, 2013, OPHTHALMOLOGY, V120, P1348, DOI 10.1016/j.ophtha.2012.12.038; Matsumoto Y, 2007, MOL VIS, V13, P1319; McCulley James P., 1995, CLAO Journal, V21, P73; MOORE MB, 1986, OPHTHALMOLOGY, V93, P1310; NAGINGTON J, 1974, LANCET, V2, P1537; Oikawa Y, 2005, KANAZAWA IKA DAIGAKU, V30, P67; Parmar DN, 2006, OPHTHALMOLOGY, V113, P538, DOI 10.1016/j.ophtha.2005.12.022; Shiraishi A, 2010, CORNEA, V29, P861, DOI 10.1097/ICO.0b013e3181ca36b6; Tu EY, 2011, CORNEA, V1, P1023; WINCHESTER K, 1995, CORNEA, V14, P10; Yamazaki Natsuko, 2012, Clin Ophthalmol, V6, P1365, DOI 10.2147/OPTH.S35258; Yokogawa Hideaki, 2012, Clin Ophthalmol, V6, P1245, DOI 10.2147/OPTH.S34695	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2153	2158		10.1016/j.ophtha.2014.04.043		6	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400019		
J	Ueta, T; Noda, Y; Toyama, T; Yamaguchi, T; Amano, S				Ueta, Takashi; Noda, Yasuo; Toyama, Taku; Yamaguchi, Takuhiro; Amano, Shiro			Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration	OPHTHALMOLOGY			English	Article							VERTEPORFIN PHOTODYNAMIC THERAPY; GROWTH-FACTOR INHIBITORS; POLYPOIDAL CHOROIDAL VASCULOPATHY; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; CEREBROVASCULAR ACCIDENTS; COMBINATION THERAPY; PLUS RANIBIZUMAB; DOSING REGIMEN; ANTI-VEGF	Background: We conducted a meta-analysis of randomized trials of ranibizumab for age-related macular degeneration (AMD) to elucidate systemic vascular risk. Clinical Relevance: Although intravitreal vascular endothelial growth factor inhibitors are widely used to treat AMD, whether they produce systemic adverse effects remains uncertain. Methods: We searched MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials through March 2014 to identify the randomized trials that compared systemic safety among different intensities of ranibizumab treatment for AMD. The outcome measures were the incidence of cerebrovascular accidents (CVAs), myocardial infarctions, nonocular hemorrhages, overall arterial thromboembolic events (ATEs), and all-cause mortality. We calculated the Peto odds ratio (OR) with 95% confidence interval for the comparisons between different intensities of regimens in terms of dose and retreatment frequency. Results: Eleven trials comprising 6596 patients with AMD were included in the meta-analysis. A significant increase was observed in the following comparisons: 0.5 versus 0.3/0.0 mg for CVA (OR, 1.86; 95% CI, 1.05e3.29; P = 0.03), monthly versus pro re nata (PRN)/0.0 mg for CVA (OR, 1.89; 95% CI, 1.06-3.38; P = 0.03), and 0.3/0.5 versus 0.0 mg for nonocular hemorrhage (OR, 1.57; 95% CI, 1.01-2.44; P = 0.04). A nonsignificant increase was observed in the following comparisons: 0.5 versus 0.0 mg for CVA (OR, 2.27; 95% CI, 0.90-5.69; P = 0.08), monthly versus PRN for CVA (OR, 2.04; 95% CI, 0.94-4.45; P = 0.07), 0.5 versus 0.0 mg for nonocular hemorrhage (OR, 1.68; 95% CI, 0.98-2.88; P = 0.06), 0.3 versus 0.0 mg for nonocular hemorrhage (OR, 1.68; 95% CI, 0.95-2.98; P = 0.07), monthly versus PRN/0.0 mg for nonocular hemorrhage (OR, 1.54; 95% CI, 0.98-2.42; P = 0.06), monthly versus PRN for ATE (OR, 1.58; 95% CI, 0.96-2.61; P = 0.07), and monthly versus PRN/0.0 mg for ATE (OR, 1.42; 95% CI, 0.99-2.05; P - 0.06). Among the other analyses, no protective or harmful effects of ranibizumab were observed. Conclusions: In ranibizumab treatment for patients with AMD, a possible relationship of more intensive treatment to more systemic vascular adverse events was identified, but no relationship with mortality was identified. (C) 2014 by the American Academy of Ophthalmology.	[Ueta, Takashi; Noda, Yasuo; Toyama, Taku; Amano, Shiro] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Ueta, Takashi; Noda, Yasuo; Toyama, Taku; Amano, Shiro] Univ Tokyo, Fac Med, Tokyo 1138655, Japan; [Yamaguchi, Takuhiro] Univ Tokyo, Grad Sch Med, Div Biostat, Tokyo 1138655, Japan	Ueta, T (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ueta-tky@umin.ac.jp					Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Kaiser PK, 2012, OPHTHALMOLOGY, V119, P1001, DOI 10.1016/j.ophtha.2012.02.003; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; Lexchin J, 2003, BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P1867, DOI 10.1016/j.ophtha.2012.03.043; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Larsen M, 2012, OPHTHALMOLOGY, V119, P992, DOI 10.1016/j.ophtha.2012.02.002; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kemp A, 2013, RETINA-J RET VIT DIS, V33, P920, DOI 10.1097/IAE.0b013e318276e07b; Schmucker C, 2011, BRIT J OPHTHALMOL, V95, P308, DOI 10.1136/bjo.2009.178574; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Flaxel C, 2012, RETINA-J RET VIT DIS, V32, P417, DOI 10.1097/IAE.0b013e318229b0af; Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004; Boyer DS, 2009, OPHTHALMOLOGY, V116, P1731, DOI 10.1016/j.ophtha.2009.05.024; Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; Dugel PU, 2013, OPHTHALMOLOGY, V120, P317, DOI 10.1016/j.ophtha.2012.07.068; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Kodjikian L, 2013, OPHTHALMOLOGY, V120, P2300, DOI 10.1016/j.ophtha.2013.06.020; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Heier JS, 2006, OPHTHALMOLOGY, V113, P633, DOI 10.1016/j.ophtha.2005.10.052; Bressler NM, 2012, RETINA-J RET VIT DIS, V32, P1821, DOI 10.1097/IAE.0b013e31825db6ba; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Campbell RJ, 2012, OPHTHALMOLOGY, V119, P1604, DOI 10.1016/j.ophtha.2012.05.028; Spielberg L, 2010, GRAEF ARCH CLIN EXP, V248, P943, DOI 10.1007/s00417-009-1256-6; Wong D, 2011, GRAEF ARCH CLIN EXP, V249, P161, DOI 10.1007/s00417-010-1603-7; Heier JS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1532, DOI 10.1001/archopht.124.11.1532; Beaumont PE, 2014, OPHTHALMOLOGY, V121, pE4, DOI 10.1016/j.ophtha.2013.09.020; Campbell RJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4203; Center for Drug Evaluation and Research, MED REV; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Cheng JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041325; Higgins JP, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184.CH8; Lundh A, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.MR000033.PUB2; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Ranchod TM, 2013, RETINA-J RET VIT DIS, V33, P1600, DOI 10.1097/IAE.0b013e318285cb71; Rosenfeld PJ, 2006, OPHTHALMOLOGY, V113, P623, DOI 10.1016/j.ophtha.2006.01.027; Schmidt-Erfurth U, 2008, BRIT J OPHTHALMOL, V92, P1628, DOI 10.1136/bjo.2007.135277; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Soderberg AC, 2012, BRIT J OPHTHALMOL, V96, P714, DOI 10.1136/bjophthalmol-2011-300721; Ueta T, 2014, OPHTHALMOLOGY, V121, pE5, DOI 10.1016/j.ophtha.2013.09.019	50	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2193	2203		10.1016/j.ophtha.2014.05.022		11	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400024		
J	Korobelnik, JF; Do, DV; Schmidt-Erfurth, U; Boyer, DS; Holz, FG; Heier, JS; Midena, E; Kaiser, PK; Terasaki, H; Marcus, DM; Nguyen, QD; Jaffe, GJ; Slakter, JS; Simader, C; Soo, Y; Schmelter, T; Yancopoulos, GD; Stahl, N; Vitti, R; Berliner, AJ; Zeitz, O; Metzig, C; Brown, DM				Korobelnik, Jean-Francois; Do, Diana V.; Schmidt-Erfurth, Ursula; Boyer, David S.; Holz, Frank G.; Heier, Jeffrey S.; Midena, Edoardo; Kaiser, Peter K.; Terasaki, Hiroko; Marcus, Dennis M.; Nguyen, Quan D.; Jaffe, Glenn J.; Slakter, Jason S.; Simader, Christian; Soo, Yuhwen; Schmelter, Thomas; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.; Zeitz, Oliver; Metzig, Carola; Brown, David M.			Intravitreal Aflibercept for Diabetic Macular Edema	OPHTHALMOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VEGF TRAP; RANIBIZUMAB; RETINOPATHY; LASER	Purpose: A head-to-head comparison was performed between vascular endothelial growth factor blockade and laser for treatment of diabetic macular edema (DME). Design: Two similarly designed, double-masked, randomized, phase 3 trials, VISTA(DME) and VIVIDDME. Participants: We included 872 patients (eyes) with type 1 or 2 diabetes mellitus who presented with DME with central involvement. Methods: Eyes received either intravitreal aflibercept injection (IAI) 2 mg every 4 weeks (2q4), IAI 2 mg every 8 weeks after 5 initial monthly doses (2q8), or macular laser photocoagulation. Main Outcome Measures: The primary efficacy endpoint was the change from baseline in best-corrected visual acuity (BCVA) in Early Treatment Diabetic Retinopathy Study (ETDRS) letters at week 52. Secondary efficacy endpoints at week 52 included the proportion of eyes that gained >= 15 letters from baseline and the mean change from baseline in central retinal thickness as determined by optical coherence tomography. Results: Mean BCVA gains from baseline to week 52 in the IAI 2q4 and 2q8 groups versus the laser group were 12.5 and 10.7 versus 0.2 letters (P < 0.0001) in VISTA, and 10.5 and 10.7 versus 1.2 letters (P < 0.0001) in VIVID. The corresponding proportions of eyes gaining >= 15 letters were 41.6% and 31.1% versus 7.8% (P < 0.0001) in VISTA, and 32.4% and 33.3% versus 9.1% (P < 0.0001) in VIVID. Similarly, mean reductions in central retinal thickness were 185.9 and 183.1 versus 73.3 mu m (P < 0.0001) in VISTA, and 195.0 and 192.4 versus 66.2 mu m (P < 0.0001) in VIVID. Overall incidences of ocular and nonocular adverse events and serious adverse events, including the Anti-Platelet Trialists' Collaboration-defined arterial thromboembolic events and vascular deaths, were similar across treatment groups. Conclusions: At week 52, IAI demonstrated significant superiority in functional and anatomic endpoints over laser, with similar efficacy in the 2q4 and 2q8 groups despite the extended dosing interval in the 2q8 group. In general, IAI was well-tolerated. (C) 2014 by the American Academy of Ophthalmology.	[Korobelnik, Jean-Francois] CHU Bordeaux, Hop Pellegrin, Serv Ophtalmol, F-33076 Bordeaux, France; [Korobelnik, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Korobelnik, Jean-Francois] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Do, Diana V.; Nguyen, Quan D.] Univ Nebraska, Med Ctr, Truhlsen Eye Inst, Omaha, NE USA; [Schmidt-Erfurth, Ursula; Simader, Christian] Med Univ Vienna, Vienna, Austria; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Heier, Jeffrey S.] Ophthalm Consultants Boston & Tufts Univ, Sch Med, Boston, MA USA; [Midena, Edoardo] Univ Padua, Dept Ophthalmol, Padua, Italy; [Kaiser, Peter K.] Cole Eye Inst, Cleveland, OH USA; [Terasaki, Hiroko] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Marcus, Dennis M.] Southeast Retina Ctr, Augusta, GA USA; [Jaffe, Glenn J.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Slakter, Jason S.] Vitreous Retina Macula Consultants New York, New York, NY USA; [Soo, Yuhwen; Yancopoulos, George D.; Stahl, Neil; Vitti, Robert; Berliner, Alyson J.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Schmelter, Thomas; Zeitz, Oliver; Metzig, Carola] Bayer HealthCare, Berlin, Germany; [Zeitz, Oliver] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Brown, David M.] Retina Consultants Houston, Houston, TX 77030 USA	Brown, DM (reprint author), Retina Consultants Houston, 6560 Fannin St,Suite 750, Houston, TX 77030 USA.	dmbmd@houstonretina.com			Bayer HealthCare; Genentech; Regeneron Pharmaceutical, Inc.; Allergan; Alcon; Novartis; Regeneron Pharmaceuticals, Inc.; Carl Zeiss Meditec; GSK; Heidelberg Engineering; Optos; Pfizer; Acucela; Aerpio; Alimera; Genzyme; Kato Pharmaceutical; Lpath; Ohr; Ophthotech; QLT; Santen; Senju; Wacamoto; Thrombogenics; Allergan,; Quark; AbbVie; Santen, Inc.; Fovea; Kanghong Biotech; Ohr Pharma; Oraya; Sanofi; XcoveryVision; Abbott; Ampio; Opthotech; pSivida; Xoma; Regeneron Pharmaceuticals, Inc., Tarrytown, NY; Bayer HealthCare, Berlin, Germany	The authors have made the following disclosures:; Jean-Francois Korobelnik: Advisory Board - Allergan, Alcon, Novartis; Consultant - Carl Zeiss Meditec, Roche, Thea; Fees (review activities) - Bayer HealthCare.; Diana V. Do: Research Funding - Genentech, Regeneron Pharmaceutical, Inc.; Ursula Schmidt-Erfurth - Consultant - Alcon, Bayer HealthCare, Boehringer, Novartis; Research Funding - Allergan, Alcon, Bayer HealthCare, Novartis; Travel Support - Bayer HealthCare.; David S. Boyer: Advisory Board Member - Alcon, Allergan, Neurotech; Consultant - Alcon, Allergo, Allergan, Bausch & Lomb, Bayer, KalVista, Neurotech, Novartis, Roche, ThromboGenics, GSK; Received Research funding - Genentech, Regeneron Pharmaceuticals, Inc.; Lecture Fee - Allergan.; Frank G. Holz: Consultant - Acucela, Alcon, Allergan, Bayer HealthCare, Boehringer-Ingelheim, Genentech, Heidelberg Engineering, Merz, Novartis, Pfizer; Research Funding - Alcon, Allergan, Bayer HealthCare, Carl Zeiss Meditec, GSK, Heidelberg Engineering, Novartis, Optos; Travel Support - Bayer HealthCare; Lecture Fees - Alcon, Bayer HealthCare, Heidelberg Engineering, Novartis, Pfizer.; Jeffrey S. Heier: Consultant - Acucela, Aerpio, Alcon, Allegro, Allergan, Bayer, Forsight Vision, Genentech, Genzyme, Kala Pharmaceutical, Liquidia, Merz, Neurotech, Ohr Pharmaceutical, Oraya, Regeneron Pharmaceuticals, Inc., Sanofi, Stealth Peptides, Thrombogenics, Xcovery; Research Funding - Acucela, Aerpio, Alcon, Alimera, Genentech, Genzyme, Kato Pharmaceutical, Lpath, Novartis, Ohr, Ophthotech, QLT, Regeneron Pharmaceuticals, Inc.; Dennis M. Marcus: Consultant - Genentech, Thrombogenics, Regeneron Pharmaceuticals, Inc.; Research Funding - Regeneron Pharmaceuticals, Inc., Genentech, Thrombogenics, Alcon, Allergan, Ophthotech, GSK, Pfizer, Acucela, LPath, Quark.; Quan D. Nguyen: Research Funding - AbbVie, Genentech, Optos, Regeneron Pharmaceuticals, Inc., Santen, Inc.; Jason S. Slakter: Research Funding - Acucela, Alimera, Bayer HealthCare, Fovea, Genentech, Genzyme, GSK, Kanghong Biotech, LPath, Ohr Pharma, Oraya, Regeneron Pharmaceuticals, Inc., Sanofi, XcoveryVision; Equity Owner - SKS Ocular.; David M. Brown: Consultant - Allergan, Bayer HealthCare, Genentech, Genzyme, Heidelberg Engineering, Notal Vision, Novartis, QLT, Regeneron, Thrombogenics; Research Funding - Abbott, Acucela, Alimera, Allergan, Ampio, Genentech, Genzyme, GSK, Novartis, Opthotech, Pfizer, pSivida, QLT, Quark, Regeneron Pharmaceuticals, Inc., Santen, Thrombogenics, Xoma; Travel Support - Regeneron Pharmaceuticals, Inc.; The VISTA and VIVID studies were funded by Regeneron Pharmaceuticals, Inc., Tarrytown, NY and Bayer HealthCare, Berlin, Germany. The sponsors participated in the design and conduct of the study, analysis of the data, and preparation of the manuscript.	Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; May O, 1997, CARDIOVASC RES, V34, P241, DOI 10.1016/S0008-6363(97)00046-1; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P823; Stitt AW, 2005, PHARMACOL REP, V57, P156	13	37	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2247	2254		10.1016/j.ophtha.2014.05.006		8	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400031		
J	Okamoto, F; Sugiura, Y; Okamoto, Y; Hiraoka, T; Oshika, T				Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro			Time Course of Changes in Aniseikonia and Foveal Microstructure after Vitrectomy for Epiretinal Membrane	OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OUTER SEGMENT TIPS; RETINAL-DETACHMENT; VISUAL-ACUITY; UNILATERAL APHAKIA; BINOCULAR FUNCTION; PROGNOSTIC-FACTORS; SURGERY; METAMORPHOPSIA; STEREOACUITY	Purpose: To quantify aniseikonia in patients undergoing vitrectomy for epiretinal membrane (ERM) and to investigate the relationship between the aniseikonia and the foveal microstructure by spectral-domain (SD) optical coherence tomography (OCT). Design: Prospective, consecutive, interventional case series. Subjects: This study included 44 eyes of 44 patients undergoing vitrectomy for idiopathic ERM. Methods: We examined visual acuity and aniseikonia using the New Aniseikonia Test and SD-OCT before and 3 and 6 months after surgery. On the basis of the obtained OCT image, we divided the 1.0 x 1.0-mm area centered on the fovea into 9 sections at 0.25-mm intervals and quantified the following parameters using an image-processing program: central foveal thickness and mean thickness of the ganglion cell layer, inner nuclear layer (INL), and outer retinal layer (outer nuclear layer + outer plexiform layer). The status of the photoreceptor inner segment/outer segment junction, external limiting membrane, and cone outer segment tips also was evaluated. Main Outcome Measures: Amount of aniseikonia 6 months after surgery. Results: Of 44 patients, 39 (89%) had macropsia, 1 (2%) had micropsia, and 4 (9%) had no aniseikonia preoperatively. Mean preoperative aniseikonia was 6.2%+/- 4.5%. Vitrectomy significantly improved visual acuity in patients with ERM but did not change the amount of aniseikonia. Multiple regression analysis revealed that preoperative aniseikonia at 6 months was significantly related to preoperative INL thickness, whereas postoperative aniseikonia at 6 months was associated with postoperative INL thickness at 6 months. Preoperative INL thickness was found to be of significant prognostic value for postoperative aniseikonia at 6 months. Conclusions: Most of the patients with ERM had macropsia. Aniseikonia was not reduced after surgery. The amount of aniseikonia was associated with INL thickness. (C) 2014 by the American Academy of Ophthalmology.	[Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Okamoto, F (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	Fumiki-o@md.tsukuba.ac.jp					Arichika S, 2010, RETINA-J RET VIT DIS, V30, P503, DOI 10.1097/IAE.0b013e3181bd2d65; KATSUMI O, 1986, INVEST OPHTH VIS SCI, V27, P601; Mitamura Y, 2009, BRIT J OPHTHALMOL, V93, P171, DOI 10.1136/bjo.2008.146381; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; Itoh Y, 2013, INVEST OPHTH VIS SCI, V54, P7302, DOI 10.1167/iovs.13-12702; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Kinoshita T, 2012, INVEST OPHTH VIS SCI, V53, P3592, DOI 10.1167/iovs.12-9493; Kim J, 2010, AM J OPHTHALMOL, V150, P701, DOI 10.1016/j.ajo.2010.05.037; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Tanikawa A, 1999, AM J OPHTHALMOL, V127, P559, DOI 10.1016/S0002-9394(98)00447-4; Kim JH, 2013, GRAEF ARCH CLIN EXP, V251, P1055, DOI 10.1007/s00417-012-2120-7; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shimada H, 2009, OPHTHALMOLOGY, V116, P1370, DOI 10.1016/j.ophtha.2009.01.024; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; PESIN SR, 1991, OPHTHALMOLOGY, V98, P1109; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Falkner-Radler CI, 2010, OPHTHALMOLOGY, V117, P798, DOI 10.1016/j.ophtha.2009.08.034; Gobin L, 2008, J CATARACT REFR SURG, V34, P1353, DOI 10.1016/j.jcrs.2008.04.023; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404; Inoue M, 2011, RETINA-J RET VIT DIS, V31, P1366, DOI 10.1097/IAE.0b013e318203c156; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; Bae SH, 2013, AM J OPHTHALMOL, V155, P109, DOI 10.1016/j.ajo.2012.07.007; Benegas NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P896; BERENS C, 1963, ARCH OPHTHALMOL-CHIC, V70, P181; CRONE RA, 1975, OPHTHALMOLOGICA, V171, P258; CURTIN BJ, 1959, AM J OPHTHALMOL, V47, P468; de Wit GC, 2006, OPHTHALMOLOGY, V113, P58, DOI 10.1016/j.ophtha.2005.10.027; FRISEN L, 1979, A GRAEF ARCH KLIN EX, V210, P69, DOI 10.1007/BF00409993; Haring G, 1999, J CATARACT REFR SURG, V25, P1151, DOI 10.1016/S0886-3350(99)00136-4; HISADA H, 1992, Nippon Ganka Gakkai Zasshi, V96, P369; KATSUMI O, 1992, OPHTHALMOLOGY, V99, P1270; KATSUMI O, 1988, OPHTHALMOLOGY, V95, P1088; Kramer P W, 1999, Binocul Vis Strabismus Q, V14, P183; Rutstein Robert P, 2012, Optom Vis Sci, V89, pe50; SJOSTRAND J, 1986, ACTA OPHTHALMOL, V64, P425; SNEAD MP, 1991, OPHTHAL PHYSL OPT, V11, P109, DOI 10.1111/j.1475-1313.1991.tb00208.x; Ugarte M, 2006, GRAEF ARCH CLIN EXP, V244, P1545, DOI 10.1007/s00417-006-0290-x; Ugarte M, 2005, BRIT J OPHTHALMOL, V89, P1576, DOI 10.1136/bjo.2005.077164	40	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2255	2260		10.1016/j.ophtha.2014.05.016		6	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400032		
J	Arao, K; Kuribara, A; Jinnouchi, H; Matsumoto, M; Fujiwara, T; Kinoshita, N; Kakehashi, A; Ako, J; Momomura, S				Arao, Kenshiro; Kuribara, Asuka; Jinnouchi, Hiroyuki; Matsumoto, Mitsunari; Fujiwara, Takayuki; Kinoshita, Nozomi; Kakehashi, Akihiro; Ako, Junya; Momomura, Shin-ichi			Transient Retinopathy in Acute Aortic Dissection	OPHTHALMOLOGY			English	Article							INTERNATIONAL REGISTRY; ATHEROSCLEROSIS RISK; HYPERTENSIVE RETINOPATHY; BLOOD-PRESSURE; COMMUNITIES; OUTCOMES; ABNORMALITIES; PROGRESSION; REGRESSION; INSIGHTS	Purpose: To explore the occurrence of transient retinopathy and its prognostic importance in patients with acute aortic dissection (AAD). Design: Prospective, observational study. Participants: Sixty-four patients with Stanford type B AAD were treated with conservative medical therapy. Methods: Retinopathy findings, such as cotton-wool spots and hemorrhage, were examined. Fundus photography was performed on hospital days 9 to 14 and after 2 or 3 months. The association between the appearance of retinopathy and the subsequent cardio-cerebrovascular events was investigated. Main Outcome Measures: The primary outcomes included the incidence of retinopathy and subsequent adverse cardio-cerebrovascular events. Results: Retinopathy was detected in 55% (35 of 64) of patients (cotton-wool spots alone, n = 31; dot hemorrhage alone, n = 1; and both, n = 3). These findings disappeared in all 12 patients who underwent follow-up fundus examinations. In the multivariate analysis, a history of hypertension and higher peak C-reactive protein level were independently associated with retinopathy. At a median follow-up of 911 days, adverse cardiocerebrovascular events were reported in 11 patients, of whom those with retinopathy experienced adverse events significantly more frequently than those without retinopathy (P = 0.045). Conclusions: Retinopathy occurred frequently in patients with AAD. This retinopathy was associated with a history of hypertension and higher peak C-reactive protein levels and was an important predictive factor for adverse cardio-cerebrovascular outcomes. (C) 2014 by the American Academy of Ophthalmology.	[Arao, Kenshiro; Jinnouchi, Hiroyuki; Matsumoto, Mitsunari; Fujiwara, Takayuki; Ako, Junya; Momomura, Shin-ichi] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama 3308503, Japan; [Kuribara, Asuka] Dokkyo Med Univ, Nikko Med Ctr, Div Cardiovasc Med, Mibu, Tochigi, Japan; [Kinoshita, Nozomi; Kakehashi, Akihiro] Jichi Med Univ, Saitama Med Ctr, Div Ophthalmol, Saitama 3308503, Japan	Arao, K (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	araon@omiya.jichi.ac.jp					Thom S, 2009, HYPERTENSION, V54, P405, DOI 10.1161/HYPERTENSIONAHA.109.133819; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Klein R, 1997, Trans Am Ophthalmol Soc, V95, P329; Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09; Tsai WC, 2005, CLIN SCI, V109, P39; Delles C, 2004, STROKE, V35, P1289, DOI 10.1161/01.STR.0000126597.11534.3b; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644; Grosso A, 2011, J HYPERTENS, V29, P1667, DOI 10.1097/HJH.0b013e3283496655; Wong TY, 2004, ANN INTERN MED, V140, P248; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Grosso A, 2005, BRIT J OPHTHALMOL, V89, P1646, DOI 10.1136/bjo.2005.072546; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; HAEFLIGER IO, 1994, SURV OPHTHALMOL, V39, P123, DOI 10.1016/0039-6257(94)90157-0; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Sakakura K, 2010, HYPERTENSION, V55, P422, DOI 10.1161/HYPERTENSIONAHA.109.143131; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Arao K, 2012, CIRC J, V77, P116; BOCK KD, 1984, HYPERTENSION, V6, P158; CROSSON CE, 1990, J OCUL PHARMACOL, V6, P293, DOI 10.1089/jop.1990.6.293; Dahlöf B, 1992, Blood Press, V1, P35, DOI 10.3109/08037059209065122; Gunn RM, 1892, T OPHTHAL SOC UK, V12, P124; Kinoshita N, 2004, BRIT J OPHTHALMOL, V88, P494, DOI 10.1136/bjo.2003.027136; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Prisant L Michael, 2005, J Clin Hypertens (Greenwich), V7, P367, DOI 10.1111/j.1524-6175.2005.04116.x; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; Ruggenenti P, 2010, J OPHTHALMOL, DOI 10.1155/2010/106384; Sugano Y, 2005, INT J CARDIOL, V102, P39, DOI 10.1016/j.ijcard.2004.03.076; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2006, AM J CARDIOL, V97, P1549, DOI 10.1016/j.amjcard.2005.12.003; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	NOV	2014	121	11					2261	2267		10.1016/j.ophtha.2014.06.002		7	Ophthalmology	Ophthalmology	AS8DM	WOS:000344480400033		
J	Fujimoto, E; Sasashige, Y; Masuda, Y; Tsuchida, Y; Hisatome, T; Kashiwagi, K; Sasaki, H; Touten, Y; Kazusa, H; Eguchi, A; Nagata, Y				Fujimoto, E.; Sasashige, Y.; Masuda, Y.; Tsuchida, Y.; Hisatome, T.; Kashiwagi, K.; Sasaki, H.; Touten, Y.; Kazusa, H.; Eguchi, A.; Nagata, Y.			Serial magnetic resonance imaging study of posterior cruciate ligament reconstruction or augmentation using hamstring tendons	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Posterior cruciate ligament reconstruction; Hamstring tendon; Magnetic resonance imaging; Augmentation; Remnant preservation	PATELLAR TENDON; STRESS RADIOGRAPHY; SHEEP MODEL; AUTOGRAFT; KNEE; IMPLANTATION; INSTABILITY; ACCURACY; FIBERS; BUNDLE	Purpose: The purpose of this study was to analyze serial changes in the magnetic resonance imaging( MRI) signals of autograft hamstrings single bundle posterior cruciate ligament (PCL) reconstruction and the effects of remnant preservation (augmentation). Material and methods: Twenty-two isolated PCL injuries were arthroscopically reconstructed or augmented with hamstring tendons. MRI scans were obtained at 3, 6, and 12 months, and prior to the second-look arthroscopy (average 20.7 months). The patients were divided into 2 groups by remnant preservation: five PCL reconstructions after PCL remnant resection (Group Rec) (23%), and 17 reconstructions preserving the remnant (Group Aug) (77%). The 22 patients were also divided in two groups depending on the location of the PCL tear. There were 9 knees with proximal tear (Type P) (41%) and 13 knees with distal tear (Type D) (59%). The signal intensity and fiber continuity of 4 zones (proximal, middle, distal intra-articular and tibial tunnel zones) were evaluated by the Mariani score. Results: The average MRI evaluation score gradually increased from 6 months through the final MRI. The intra-articular part of the graft exhibited slower maturation (12 months - final scan) as compared with the tibial tunnel (6-12 months). The distal zone underwent better maturation than the proximal or middle zones at all points. In the proximal zone, the score for Group Aug was significantly higher than Group Rec. In the proximal zone, the Type D score with a proximally-preserved remnant was significantly higher than Type P without a proximal remnant. Conclusions: The hamstring tendons require more than 1 year to achieve low-signal intensity. PCL remnant has a beneficial effect on the maturation of the hamstring graft. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Fujimoto, E.; Sasashige, Y.; Masuda, Y.; Tsuchida, Y.; Hisatome, T.; Kashiwagi, K.; Sasaki, H.; Touten, Y.; Kazusa, H.; Eguchi, A.; Nagata, Y.] Chugoku Rousai Hosp, Dept Orthoped Surg, Kure, Hiroshima 7370193, Japan; [Tsuchida, Y.] Chugoku Rousai Hosp, Dept Radiol, Kure, Hiroshima 7370193, Japan	Fujimoto, E (reprint author), Chugoku Rousai Hosp, Dept Orthoped Surg, 1-5-1 Hirotagaya, Kure, Hiroshima 7370193, Japan.	eisaku-fjm@umin.ac.jp					Akisue T, 2001, ARTHROSCOPY, V17, P264, DOI 10.1053/jars.2001.21540; Zhao JZ, 2008, ARTHROSCOPY, V24, P650, DOI 10.1016/j.arthro.2008.01.005; GROSS ML, 1992, AM J SPORT MED, V20, P732, DOI 10.1177/036354659202000615; FISCHER SP, 1991, J BONE JOINT SURG AM, V73A, P2; Ahn JH, 2006, AM J SPORT MED, V34, P194, DOI 10.1177/0363546505279915; Scapinelli R, 1997, CLIN ANAT, V10, P151, DOI 10.1002/(SICI)1098-2353(1997)10:3<151::AID-CA1>3.0.CO;2-X; Wang CJ, 2005, ARTHROSCOPY, V21, P1401, DOI 10.1016/j.arthro.2005.08.026; Mariani PP, 2005, ARTHROSCOPY, V21, P1354, DOI 10.1016/j.arthro.2005.07.028; BERG EE, 1995, ARTHROSCOPY, V11, P69, DOI 10.1016/0749-8063(95)90091-8; HOWELL SM, 1991, AM J SPORT MED, V19, P42, DOI 10.1177/036354659101900107; Jung YB, 2010, ARTHROSCOPY, V26, P223, DOI 10.1016/j.arthro.2009.07.017; Jung YB, 2008, J MAGN RESON IMAGING, V27, P1336, DOI 10.1002/jmri.21333; Yoon KH, 2011, AM J SPORT MED, V39, P474, DOI 10.1177/0363546510382206; Yoon KH, 2005, ARTHROSCOPY, V21, P1436, DOI 10.1016/j.arthro.2005.09.002; [Anonymous], 1997, CLIN ORTHOPAEDICS; Lahner M, 2012, ARCH ORTHOP TRAUM SU, V132, P363, DOI 10.1007/s00402-011-1403-5; Adachi N, 2003, ACTA ORTHOP SCAND, V74, P683, DOI 10.1080/00016470310018207; BOSCH U, 1992, AM J SPORT MED, V20, P558, DOI 10.1177/036354659202000513; GROVER JS, 1990, RADIOLOGY, V174, P527; HOWELL SM, 1995, AM J SPORT MED, V23, P42, DOI 10.1177/036354659502300107; KASPERCZYK WJ, 1993, CLIN ORTHOP RELAT R, P271; Kuhne JH, 1998, ORTHOPEDICS, V21, P39; Mariani PP, 2002, ARTHROSCOPY, V18, P38, DOI 10.1053/jarc.2002.29937; MOESER P, 1989, J COMPUT ASSIST TOMO, V13, P105, DOI 10.1097/00004728-198901000-00022; Murakami Y, 1999, MAGN RESON IMAGING, V17, P679, DOI 10.1016/S0730-725X(99)00007-7; Murakami Y, 1998, J COMPUT ASSIST TOMO, V22, P270, DOI 10.1097/00004728-199803000-00021; Ochi M, 1998, ARCH ORTHOP TRAUM SU, V118, P25, DOI 10.1007/s004020050304; RAK KM, 1991, RADIOLOGY, V178, P553; Shelbourne K D, 1999, Am J Knee Surg, V12, P209; Surendran S, 2007, ARTHROSCOPY, V23, pe1	30	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	NOV	2014	100	7					755	760		10.1016/j.otsr.2014.06.018		6	Orthopedics; Surgery	Orthopedics; Surgery	AT1HI	WOS:000344683500010		
J	Kamei, G; Ochi, M; Usman, MA; Mahmoud, EH				Kamei, G.; Ochi, M.; Usman, M. A.; Mahmoud, E. H.			A new technique to avoid articular cartilage injury in anterior cruciate ligament reconstruction through far antero-medial portal	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Anterior cruciate ligament reconstruction; Far antero-medial portal technique; Cartilage damage	ACL RECONSTRUCTION; SINGLE-BUNDLE; FOOTPRINT; TUNNEL	Far antero-medial (FAM) portal technique is usually used in our department in anterior cruciate ligament (ACL) reconstruction when drilling the femoral tunnel. Although the FAM portal technique carries potential risks, such as cartilage injury of the lateral femoral condyle, peroneal nerve injury and blow out of the lateral femoral condyle's posterior wall, these problems were resolved in a cadaveric study, in which 110 degrees-120 knee flexion was recommended when drilling the femoral tunnel. However, there is a potential risk of injuring the cartilage of the medial femoral condyle especially when drilling the postero-lateral bundle. A new method is proposed to ensure that the femoral tunnel drilling does not damage the cartilage of the medial femoral condyle. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Kamei, G.; Ochi, M.; Usman, M. A.; Mahmoud, E. H.] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, Hiroshima 7348551, Japan	Ochi, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	ochim@hiroshima-u.ac.jp					Gadikota HR, 2012, AM J SPORT MED, V40, P882, DOI 10.1177/0363546511434276; Adachi N, 2000, ARCH ORTHOP TRAUM SU, V120, P128, DOI 10.1007/s004020050028; Nakamura M, 2009, ARTHROSCOPY, V25, P481, DOI 10.1016/j.arthro.2008.11.010; Sonnery-Cottet B, 2010, KNEE SURG SPORT TR A, V18, P47, DOI 10.1007/s00167-009-0855-4; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Mae T, 2013, ARTHROSCOPY, V29, P213, DOI 10.1016/j.arthro.2012.08.012; Nakamae A, 2012, ARTHROSCOPY, V28, P658, DOI 10.1016/j.arthro.2011.10.025; Kopf S, 2012, KNEE SURG SPORT TR A, V20, P2200, DOI 10.1007/s00167-011-1851-z; Lubowitz JH, 2013, ARTHROSCOPY, V29, P522, DOI 10.1016/j.arthro.2012.10.007; Araki D, 2011, INT ORTHOP, V35, P439, DOI 10.1007/s00264-010-1110-9; Ochi M, 2009, ARTHROSCOPY, V25, P117, DOI 10.1016/j.arthro.2008.10.011; Ochi Mitsuo, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P30, DOI 10.1186/1758-2555-3-30; Ochi M, 2006, ARTHROSCOPY, V22, pe1; Ohkawa S, 2012, KNEE SURG SPORT TR A, V20, P778, DOI 10.1007/s00167-012-1900-2; Sonnery-Cottet B, 2012, ORTHOP TRAUMATOL-SUR, V98, pS165, DOI 10.1016/j.otsr.2012.10.001; Zantop T, 2008, ARCH ORTHOP TRAUM SU, V128, P509, DOI 10.1007/s00402-007-0480-y	16	1	1	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	NOV	2014	100	7					827	830		10.1016/j.otsr.2014.06.016		4	Orthopedics; Surgery	Orthopedics; Surgery	AT1HI	WOS:000344683500022		
J	Kato, H; Shimano, M; Sumi, T; Murakami, H; Kada, K; Inden, Y; Tsuboi, N; Murohara, T				Kato, Hiroyuki; Shimano, Masayuki; Sumi, Takuya; Murakami, Hisashi; Kada, Kenji; Inden, Yasuya; Tsuboi, Naoya; Murohara, Toyoaki			Acute Improvement of Left Ventricular Relaxation as a Predictor of Volume Reduction after Cardiac Resynchronization Therapy: A Pilot Study Assessing the Value of Left Ventricular Hemodynamic Parameter	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						diastolic function; tau; cardiac resynchronization therapy; responder; hemodynamic study	CONGESTIVE-HEART-FAILURE; DIASTOLIC FUNCTION; DILATED CARDIOMYOPATHY; CONDUCTION DELAY; DYSSYNCHRONY; MORTALITY; CONTRACTION; DYSFUNCTION; PROGNOSIS	BackgroundCardiac resynchronization therapy (CRT) improves cardiac function, but CRT recipients with advanced heart failure (HF) do not always respond well. Because the best parameters for the prediction of CRT response are not established, we investigated whether improvement of invasive left ventricular (LV) hemodynamic diastolic parameters could identify CRT responders. MethodsA total of 34 consecutive patients (age, 69 9 years; 70% men) who received CRT devices for HF were assessed as to whether acute invasive hemodynamic parameters with and without CRT function could predict LV volume responders. ResultsThese patients demonstrated an improvement in LV dP/dt(max) (11.1 +/- 11.7%), LV dP/dt(min) (4.6 +/- 12.1%), and tau (3.7 +/- 11.6%) by biventricular pacing. Nineteen patients (55%) were classified as CRT responders, which was defined by a >15% decrease in LV end-systolic volume (ESV) at the 6-month follow-up evaluation. The area under the receiver operator characteristic curve to detect CRT volume response was 0.93 for the shortening of tau, which was superior to any other hemodynamic parameter. The multivariate analysis revealed that this improvement in tau was the strongest predictive factor for identifying CRT volume responders. Of note, the magnitude of tau shortening during biventricular pacing was significantly correlated with the reduction in LVESV at the 6-month follow-up evaluation. ConclusionsThe extent of acute improvement in LV isovolumic relaxation time, as assessed by tau, was associated with favorable response to CRT. The assessment of invasive diastolic function could provide valuable information about CRT volume response.	[Kato, Hiroyuki; Shimano, Masayuki; Inden, Yasuya; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Kato, Hiroyuki; Sumi, Takuya; Murakami, Hisashi; Kada, Kenji; Tsuboi, Naoya] Japan Community Healthcare Org Chukyo Hosp, Div Cardiol, Nagoya, Aichi, Japan; [Shimano, Masayuki] Japanese Red Cross Nagoya Daiichi Hosp, Dept Cardiol, Nagoya, Aichi, Japan	Shimano, M (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	mshimano@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Japan Foundation for Applied Enzymology;  [B23790844]	This work was supported by a Grant-in-Aid for Young Scientists (B23790844) and the Japan Foundation for Applied Enzymology (granted to M.S).	Aksoy H, 2010, EUROPACE, V12, P1256, DOI 10.1093/europace/euq150; Anderson LJ, 2008, CIRCULATION, V117, P2009, DOI 10.1161/CIRCULATIONAHA.107.721332; Rivero-Ayerza M, 2006, EUR HEART J, V27, P2682, DOI 10.1093/eurheartj/ehl203; Di Biase L, 2008, EUR HEART J, V29, P2497, DOI 10.1093/eurheartj/ehn221; Shanks M, 2011, EUR J HEART FAIL, V13, P1133, DOI 10.1093/eurjhf/hfr115; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Auricchio A, 1999, CIRCULATION, V99, P2993; Yu CM, 2005, CIRCULATION, V112, P1580, DOI 10.1161/CIRCULATIONAHA.105.538272; Kass DA, 2008, J AM COLL CARDIOL, V51, P12, DOI 10.1016/j.jacc.2007.09.027; Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehj826; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; THOMAS JD, 1991, CIRCULATION, V84, P977; Momomura S, 2012, CIRC J, V76, P1911, DOI 10.1253/circj.CJ-11-1341; RIHAL CS, 1994, CIRCULATION, V90, P2772; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Shanks M, 2010, J AM COLL CARDIOL, V56, P1567, DOI 10.1016/j.jacc.2010.01.077; Saxon LA, 2002, CIRCULATION, V105, P1304, DOI 10.1161/hc1102.105730; Steendijk P, 2006, CIRCULATION, V113, P1295, DOI 10.1161/CIRCULATIONAHA.105.540435; Singh JP, 2011, CIRCULATION, V123, P1159, DOI 10.1161/CIRCULATIONAHA.110.000646; Spragg DD, 2010, J AM COLL CARDIOL, V56, P774, DOI 10.1016/j.jacc.2010.06.014; Duckett SG, 2011, J AM COLL CARDIOL, V58, P1128, DOI 10.1016/j.jacc.2011.04.042; Mottram PM, 2005, HEART, V91, P681, DOI 10.1136/hrt.2003.029413; Kass DA, 1999, CIRCULATION, V99, P1567; Derval N, 2010, J AM COLL CARDIOL, V56, P782, DOI 10.1016/j.jacc.2010.07.006; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Waggoner AD, 2005, J AM COLL CARDIOL, V46, P2244, DOI 10.1016/j.jacc.2005.05.094; Yu CM, 2002, CIRCULATION, V105, P438, DOI 10.1161/hc0402.102623; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; EICHHORN EJ, 1992, CIRCULATION, V85, P2132; Fornwalt BK, 2010, CIRCULATION, V121, P1985, DOI 10.1161/CIRCULATIONAHA.109.910778; Seo Y, 2011, CIRC J, V75, P1156, DOI 10.1253/circj.CJ-10-0861; Shimano M, 2007, EUROPACE, V9, P869, DOI 10.1093/europace/eum119; Shimano M, 2006, PACE, V29, P1069, DOI 10.1111/j.1540-8159.2006.00500.x; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Suzuki H, 2010, CLIN CARDIOL, V33, pE18, DOI 10.1002/clc.20683; vansGelder BM, 2005, J AM COLL CARDIOL, V46, P2305; Yu CM, 2006, AM J CARDIOL, V98, P1083, DOI 10.1016/j.amjcard.2006.05.028	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	NOV	2014	37	11					1544	1552		10.1111/pace.12478		9	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	AS9FX	WOS:000344549600017		
J	Yanagisawa, S; Inden, Y; Shimano, M; Yoshida, N; Fujita, M; Ohguchi, S; Ishikawa, S; Kato, H; Okumura, S; Miyoshi, A; Nagao, T; Yamamoto, T; Hirai, M; Murohara, T				Yanagisawa, Satoshi; Inden, Yasuya; Shimano, Masayuki; Yoshida, Naoki; Fujita, Masaya; Ohguchi, Shiou; Ishikawa, Shinji; Kato, Hiroyuki; Okumura, Satoshi; Miyoshi, Aya; Nagao, Tomoyuki; Yamamoto, Toshihiko; Hirai, Makoto; Murohara, Toyoaki			Clinical Characteristics and Predictors of Super-Response to Cardiac Resynchronization Therapy: A Combination of Predictive Factors	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						cardiac resynchronization therapy; super-responder; right ventricular pacing; upgrading; ventricular arrhythmia	LEFT-VENTRICULAR DYSSYNCHRONY; CONGESTIVE-HEART-FAILURE; IDENTIFICATION; IMPROVEMENT; UPGRADE; DEFIBRILLATOR; NONRESPONDERS; PROGNOSIS; SURVIVAL; OUTCOMES	BackgroundPatients with greater improvement of cardiac function after cardiac resynchronization therapy (CRT) implantation are identified as super-responders. However, it remains unclear which kind of preimplant assessments could accurately predict outcomes after CRT. Thus, we aimed to examine the essential predicting factors for super-response to CRT, and to construct an accurate predictable model. MethodsWe retrospectively analyzed the CRT patients who underwent implantation at Nagoya University Hospital. Super-responders are defined as those who show a relative reduction in left ventricular end-systolic volume 30% after 6 months of CRT. ResultsEighty patients (mean age, 67.8 10.2 years) were included. Twenty-two patients received upgrading procedure to CRT implantation. Six months after the implantation, 29 patients (36%) were super-responders. Multiple logistic regression analysis shows that consistent right ventricular pacing with a previous device (odds ratio [OR] 7.28, 95% confidence interval [CI] 1.52-34.9; P = 0.013), lack of prior history of ventricular arrhythmia (OR 5.32, 95% CI 1.52-18.6; P = 0.009), and smaller left atrial diameter (LAD) (OR 0.92, 95% CI 0.86-0.98; P = 0.014) are independent predictors for CRT super-responders. The use of a combination of these predictive factors could increase the certainty with which a greater response to CRT is predicted and the presence of such a combination could improve prognosis. ConclusionGreater response to biventricular pacing occurs more frequently in patients with consistent right ventricular pacing, lack of prior history of ventricular arrhythmia, and smaller LAD. An association between patient background characteristics and a super-response to CRT was also identified.	[Yanagisawa, Satoshi; Inden, Yasuya; Shimano, Masayuki; Yoshida, Naoki; Fujita, Masaya; Ohguchi, Shiou; Ishikawa, Shinji; Kato, Hiroyuki; Okumura, Satoshi; Miyoshi, Aya; Nagao, Tomoyuki; Yamamoto, Toshihiko; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Yanagisawa, Satoshi] Chunichi Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Hirai, Makoto] Nagoya Univ, Dept Cardiol, Grad Sch Hlth Sci, Nagoya, Aichi 4668550, Japan	Inden, Y (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	inden@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Yanagisawa, Satoshi/Q-1723-2015				Adelstein E, 2011, J CARDIOVASC ELECTR, V22, P905, DOI 10.1111/j.1540-8167.2011.02018.x; Ypenburg C, 2009, J AM COLL CARDIOL, V53, P483, DOI 10.1016/j.jacc.2008.10.032; Antonio N, 2009, EUROPACE, V11, P343, DOI 10.1093/europace/eup038; Rickard J, 2010, HEART RHYTHM, V7, P885, DOI 10.1016/j.hrthm.2010.04.005; De Sisti A, 2012, PACE, V35, P1035, DOI 10.1111/j.1540-8159.2012.03371.x; Frohlich G, 2010, EUR HEART J, V31, P1477, DOI 10.1093/eurheartj/ehq065; Marsan NA, 2008, J CARDIOVASC ELECTR, V19, P392, DOI 10.1111/j.1540-8167.2007.01056.x; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Wokhlu A, 2009, HEART RHYTHM, V6, P1439, DOI 10.1016/j.hrthm.2009.07.009; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Steffel J, 2011, HEART, V97, P1668, DOI 10.1136/heartjnl-2011-300222; Stefan L, 2012, EUROPACE, V14, P1608, DOI 10.1093/europace/eus075; Van Boven N, 2013, J CARDIOVASC ELECTR, V24, P316, DOI 10.1111/jce.12037; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Killu AM, 2014, J CARD FAIL, V20, P379, DOI 10.1016/j.cardfail.2014.03.001; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Hsu JC, 2012, J AM COLL CARDIOL, V59, P2366, DOI 10.1016/j.jacc.2012.01.065; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Baker CM, 2002, PACE, V25, P1166, DOI 10.1046/j.1460-9592.2002.01166.x; Blanc JJ, 2005, EUROPACE, V7, P604, DOI 10.1016/j.eupc.2005.06.005; Casteliant P, 2008, HEART RHYTHM, V5, P193, DOI 10.1016/j.hrthm.2007.09.023; Celebi O, 2012, PACE, V35, P870, DOI 10.1111/j.1540-8159.2012.03417.x; Chang PC, 2014, PACE, V37, P454, DOI 10.1111/pace.12291; Dilaveris P, 2006, EUROPACE, V8, P352, DOI 10.1093/europace/eul015; Inden Y, 2010, HEART RHYTHM, V7, P655, DOI 10.1016/j.hrthm.2010.01.015; JCS Joint Working Group, 2013, CIRC J, V77, P249; Lepillier A, 2009, EUROPACE, V11, P80, DOI 10.1093/europace/eun288; Marai I, 2006, PACE, V29, P880, DOI 10.1111/j.1540-8159.2006.00455.x; Reant P, 2010, AM J CARDIOL, V105, P1327, DOI 10.1016/j.amjcard.2009.12.058; Rickard J, 2014, HEART RHYTHM, V11, P412, DOI [10.1016/j.hrthm.2013.11.025, 10.1016/j.hrthm.2014.01.025]; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shan D. J., 1978, CIRCULATION, V58, P1072; vansBommel RJ, 2009, EUR HEART J, V30, P2470; Yu CM, 2005, J AM COLL CARDIOL, V45, P677, DOI 10.1016/j.jacc.2004.12.003	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	NOV	2014	37	11					1553	1564		10.1111/pace.12506		12	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	AS9FX	WOS:000344549600018		
J	Kameyama, T; Fujita, S; Furusawa, H; Torimoto, T				Kameyama, Tatsuya; Fujita, Shigetoshi; Furusawa, Hideaki; Torimoto, Tsukasa			Size-Controlled Synthesis of Ag8SnS6 Nanocrystals for Efficient Photoenergy Conversion Systems Driven by Visible and Near-IR Lights	PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION			English	Article							SENSITIZED SOLAR-CELLS; SOLID-SOLUTION NANOPARTICLES; SEMICONDUCTOR NANOCRYSTALS; CU2ZNSNS4 NANOCRYSTALS; SHAPE CONTROL; PBS; ELECTRODES; ENERGY; DYE		[Kameyama, Tatsuya; Fujita, Shigetoshi; Furusawa, Hideaki; Torimoto, Tsukasa] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kameyama, T (reprint author), Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	torimoto@apchem.nagoya-u.ac.jp			Japan Society for the Promotion of Science [25810133]; Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Young Scientists B (No. 25810133) and a Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science. PESA measurement, which was performed at Riken Keiki Co., Ltd., was kindly supported by Dr. Yoshiyuki Nakajima and Mr. Yoshiharu Iwai (Riken Keiki Co., Ltd.).	An CH, 2003, MATER RES BULL, V38, P823, DOI 10.1016/S0025-5408(03)00046-1; Wang J, 2013, J AM CHEM SOC, V135, P15913, DOI 10.1021/ja4079804; van Embden J, 2013, J AM CHEM SOC, V135, P11562, DOI 10.1021/ja402702x; Steinhagen C, 2009, J AM CHEM SOC, V131, P12554, DOI 10.1021/ja905922j; Castro SL, 2004, J PHYS CHEM B, V108, P12429, DOI 10.1021/jp049107p; Li Q, 2001, MATER RES BULL, V36, P2649, DOI 10.1016/S0025-5408(01)00759-0; Lai LH, 2014, PHYS CHEM CHEM PHYS, V16, P736, DOI 10.1039/c3cp54145b; Guo Q, 2010, J AM CHEM SOC, V132, P17384, DOI 10.1021/ja108427b; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Sasamura T, 2012, RSC ADV, V2, P552, DOI 10.1039/c1ra00423a; Hwang I, 2013, CHEMPHYSCHEM, V14, P364, DOI 10.1002/cphc.201200876; Khare A, 2011, CHEM COMMUN, V47, P11721, DOI 10.1039/c1cc14687d; Sambur JB, 2010, SCIENCE, V330, P63, DOI 10.1126/science.1191462; Tisdale WA, 2010, SCIENCE, V328, P1543, DOI 10.1126/science.1185509; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Sasamura T, 2012, CHEM LETT, V41, P1009, DOI 10.1246/cl.2012.1009; Torimoto T, 2007, J AM CHEM SOC, V129, P12388, DOI 10.1021/ja0750470; Hu WQ, 2012, CRYST GROWTH DES, V12, P3458, DOI 10.1021/cg201649d; Guo QJ, 2009, J AM CHEM SOC, V131, P11672, DOI 10.1021/ja904981r; Liu QH, 2011, CHEM COMMUN, V47, P964, DOI 10.1039/c0cc03560b; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Wang Y, 2013, ECS J SOLID STATE SC, V2, pQ95, DOI 10.1149/2.005307jss; Tao L, 2014, NANOSCALE, V6, P931, DOI 10.1039/c3nr04461k; Jasieniak J, 2011, ACS NANO, V5, P5888, DOI 10.1021/nn201681s; Klimov VI, 2006, J PHYS CHEM B, V110, P16827, DOI 10.1021/jp0615959; Kongkanand A, 2008, J AM CHEM SOC, V130, P4007, DOI 10.1021/ja0782706; Semonin OE, 2011, SCIENCE, V334, P1530, DOI 10.1126/science.1209845; Riha SC, 2009, J AM CHEM SOC, V131, P12054, DOI 10.1021/ja9044168; OSIPISHI.IS, 1972, SOV PHYS SEMICOND+, V6, P974; Tian L, 2006, CHEM COMMUN, P4276, DOI 10.1039/b607855a; Yang SM, 2001, SYNTHETIC MET, V123, P267, DOI 10.1016/S0379-6779(01)00300-9	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0934-0866	1521-4117		PART PART SYST CHAR	Part. Part. Syst. Charact.	NOV	2014	31	11					1122	1126		10.1002/ppsc.201400054		5	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AT1GP	WOS:000344681700002		
J	Sawada, A; Shimizu, M; Isaka, K; Higuchi, K; Mayumi, A; Yoshimoto, Y; Kikuchi, H; Kondo, O; Koyama-sato, M; Yasui, M; Kawa, K; Inoue, M				Sawada, Akihisa; Shimizu, Mariko; Isaka, Kanako; Higuchi, Kouhei; Mayumi, Azusa; Yoshimoto, Yuri; Kikuchi, Hiroaki; Kondo, Osamu; Koyama-sato, Maho; Yasui, Masahiro; Kawa, Keisei; Inoue, Masami			Feasibility of HLA-Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Advanced Pediatric Malignancies	PEDIATRIC HEMATOLOGY AND ONCOLOGY			English	Article						cyclophosphamide; HLA-haploidentical HSCT; pediatrics; PTCY	BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; ACUTE-LEUKEMIA; HIGH-RISK; PHASE-II; INTENSITY; RELAPSE; NEUROBLASTOMA; CHILDREN	Background. Patients with advanced malignancies in non-complete remission (CR) have a dismal prognosis after HLA-matched hematopoietic stem cell transplantation (HSCT). T-cell-replete HLA-haploidentical HSCT has remarkable anti-leukemia/tumor effects on these patients, but also a high risk of severe/extensive graft-versus-host disease (GHVD). Post-transplantation cyclophosphamide (PTCY) is regarded as a GVHD-specific immunosuppressant in adults, but its feasibility is unknown in children. Methods. We performed a prospective feasibility study of PTCY at 50 mg/kg on day 3 for children with advanced leukemias or malignant solid tumors: refractory to chemotherapy or relapsed after conventional allogeneic HSCT. Conditioning consisted of fludarabine (180 mg/m(2)) and melphalan (140-210 mg/m(2)). Results. Long-term engraftments were achieved in 11 patients (73.3%) after bone marrow transplantation (BMT, n = 13) or peripheral blood (PB) stem cell transplantation (n = 2). The incidence of severe acute GHVD was 25.0% and that of extensive chronic GVHD 0.0% after evaluable BMT. CR was achieved in 6/15 and partial response in 4/15 as the best response. Finally, 11/15 experienced disease progression/relapse, 2/15 suffered treatment-related mortality without evidence of disease, and 2/15 are alive in continuous CR. Conclusions. PTCY is feasible in children; however, for a better outcome in such patients with advanced malignancies, some modifications are anticipated.	[Sawada, Akihisa] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Osaka 5941101, Japan; [Sawada, Akihisa] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan	Sawada, A (reprint author), Osaka Med Ctr, Dept Hematol Oncol, 840 Murodo, Izumi, Osaka 5941101, Japan.	asawada@mch.pref.osaka.jp					Adriana S, 2013, BLOOD, V122, P5510; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Raiola AM, 2013, BIOL BLOOD MARROW TR, V19, P117, DOI 10.1016/j.bbmt.2012.08.014; Huang XJ, 2006, BONE MARROW TRANSPL, V38, P291, DOI 10.1038/sj.bmt.1705445; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ciurea SO, 2012, BIOL BLOOD MARROW TR, V18, P1835, DOI 10.1016/j.bbmt.2012.07.003; Grosso D, 2011, BLOOD, V118, P4732, DOI 10.1182/blood-2011-07-365338; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ogawa H, 2008, EXP HEMATOL, V36, P1, DOI 10.1016/j.exphem.2007.08.013; Lu DP, 2006, BLOOD, V107, P3065, DOI 10.1182/blood-2005-052146; Inoue M, 2006, BONE MARROW TRANSPL, V37, P601, DOI 10.1038/sj.bmt.1705285; Inoue Masami, 2007, Rinsho Ketsueki, V48, P1470; Inoue M, 2003, BONE MARROW TRANSPL, V32, P103, DOI 10.1038/sj.bmt.1704070; Kakodkar NC, 2012, PEDIATR BLOOD CANCER, V59, P642, DOI 10.1002/pbc.24004; Kobbe G, 2004, CYTOTHERAPY, V6, P533, DOI 10.1080/14653240410005375; Koscielniak Ewa, 2005, J Clin Oncol, V23, P242; Koyama M, 2007, INT J HEMATOL, V86, P466, DOI 10.1532/IJH97.07130; Martelli MF, 2014, BLOOD, V124, P638, DOI [10.1182/blood-2014-03-564401, 10.1182/blood-2014-03564401]; Miyakoshi S, 2004, CLIN CANCER RES, V10, P3586, DOI 10.1158/1078-0432.CCR-03-0754; Sawada A, 2011, PEDIATR INT, V53, P1010, DOI 10.1111/j.1442-200X.2011.03437.x; Solomon SR, 2012, BIOL BLOOD MARROW TR, V18, P1859, DOI 10.1016/j.bbmt.2012.06.019; Takagi S, 2009, BRIT J HAEMATOL, V147, P543, DOI 10.1111/j.1365-2141.2009.07863.x; Yamada K, 2013, PEDIATR BLOOD CANCER, V60, pE60, DOI 10.1002/pbc.24507	26	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0888-0018	1521-0669		PEDIATR HEMAT ONCOL	Pediatr. Hematol. Oncol.	NOV	2014	31	8					754	764		10.3109/08880018.2014.961214		11	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AT2ZE	WOS:000344802500008		
J	Akimoto, T; Cho, K; Hayasaka, I; Morioka, K; Kaneshi, Y; Furuta, I; Yamada, M; Ariga, T; Minakami, H				Akimoto, Takuma; Cho, Kazutoshi; Hayasaka, Itaru; Morioka, Keita; Kaneshi, Yosuke; Furuta, Itsuko; Yamada, Masafumi; Ariga, Tadashi; Minakami, Hisanori			Hereditary interstitial lung diseases manifesting in early childhood in Japan	PEDIATRIC RESEARCH			English	Article							SURFACTANT PROTEIN-C; ALVEOLAR-CAPILLARY DYSPLASIA; RESPIRATORY-DISTRESS; THYROID SYNDROME; GENE-MUTATIONS; B DEFICIENCY; SERUM KL-6; CHILDREN; DYSFUNCTION; INFANTS	BACKGROUND: Genetic variations associated with interstitial lung diseases (ILD) have not been extensively studied in Japanese infants. METHODS: Forty-three infants with unexplained lung dysfunction were studied. All 43, 22, and 17 infants underwent analyses of surfactant protein (SP)-C gene (SFTPC) and ATP-binding cassette A3 gene (ABCA3), SP-B gene (SFTPB), and SP-B western blotting, respectively. Two and four underwent assessment of granulocyte macrophage colony-stimulating factor-stimulating phosphorylation of signal transducer and activator of transcription-5 (pSTAT-5) and analyses of FOXF1 gene (FOXF1), respectively. RESULTS: ILD were diagnosed clinically in nine infants: four, three, and two had interstitial pneumonitis, hereditary pulmonary alveolar proteinosis (hPAP), and alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), respectively. Genetic variations considered responsible were detected in six (67%) of the nine infants with ILD: three with hPAP (SFTPC p.Leu45Arg and p.Gln145fs, and ABCA3 p.Arg1583Trp/p.Val1495CysfsX21), two with interstitial pneumonitis (SFTPC p.Lys63Glu and p.Ser72Asn/p.Gly100Ala), and one with ACD/MPV (FOXF1 p.Leu300ArgfsX79). None showed SFTPB mutations or defects in pSTAT-5. The 17 bron-choalveolar lavage or tracheal aspirates contained enough SP-B protein. CONCLUSION: The SP-C abnormality was most prevalent, and SP-B deficiency was rare in Japanese infants with hereditary-ILD.	[Akimoto, Takuma; Cho, Kazutoshi; Hayasaka, Itaru; Morioka, Keita; Kaneshi, Yosuke] Hokkaido Univ Hosp, Matern & Perinatal Care Ctr, Sapporo, Hokkaido 060, Japan; [Furuta, Itsuko; Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido, Japan; [Yamada, Masafumi; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan	Cho, K (reprint author), Hokkaido Univ Hosp, Matern & Perinatal Care Ctr, Sapporo, Hokkaido 060, Japan.	chotarou@med.hokudai.ac.jp			Ministry of Health, Labour and Welfare, Japan [H24-Nanchitou (Nanchi)-Ippan-035]	This study was partly supported by a grant for "Rare lung diseases (pulmonary alveolar proteinosis, congenital interstitial lung disease and hereditary hemorrhagic telangiectasia) (H24-Nanchitou (Nanchi)-Ippan-035)" from the Ministry of Health, Labour and Welfare, Japan.	Ahmed Sheikh, 2008, Pediatr Crit Care Med, V9, pe43, DOI 10.1097/PCC.0b013e31818e383e; Flamein F, 2012, HUM MOL GENET, V21, P765, DOI 10.1093/hmg/ddr508; Turcu S, 2013, ARCH DIS CHILD, V98, P490, DOI 10.1136/archdischild-2012-303166; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.08; Doan ML, 2009, THORAX, V64, P677, DOI 10.1136/thx.2008.107979; Hartl D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-32; Licht C, 2004, EUR J PEDIATR, V163, P181, DOI 10.1007/s00431-003-1385-6; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Ono S, 2011, EUR RESPIR J, V38, P861, DOI 10.1183/09031936.00143610; Guillot L, 2009, J MED GENET, V46, P490, DOI 10.1136/jmg.2009.066829; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Dirksen U, 1997, J CLIN INVEST, V100, P2211, DOI 10.1172/JCI119758; Wert SE, 2009, PEDIATR DEVEL PATHOL, V12, P253, DOI 10.2350/09-01-0586.1; Nogee LM, 2000, AM J RESP CRIT CARE, V161, P973; Hamvas A, 2006, SEMIN PERINATOL, V30, P316, DOI 10.1053/j.semperi.2005.11.002; Lawson WE, 2004, THORAX, V59, P977, DOI 10.1136/thx.2004.026336; Al-Salmi QA, 2005, CHEST, V127, P403, DOI 10.1378/chest.127.1.403; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Wegner DJ, 2007, ACTA PAEDIATR, V96, P516, DOI 10.1111/j.1651-2227.2006.00188.x; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Thouvenin G, 2010, ARCH DIS CHILD, V95, P449, DOI 10.1136/adc.2009.171553; Carre A, 2009, HUM MOL GENET, V18, P2266, DOI 10.1093/hmg/ddp162; Adam MP, 2005, CLIN GENET, V67, P209, DOI 10.1111/j.1399-0004.2004.00348.x; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Baekvad-Hansen M, 2010, RESP MED, V104, P418, DOI 10.1016/j.rmed.2009.10.012; Cho K, 2006, RESPIROLOGY, V11, pS74, DOI 10.1111/j.1440-1843.2006.00814.x; Deerojanawong J, 1997, PEDIATR PULM, V24, P324; Gower WA, 2011, PAEDIATR RESPIR REV, V12, P223, DOI 10.1016/j.prrv.2011.01.005; Guillot L, 2010, HUM MUTAT, V31, pE1146, DOI 10.1002/humu.21183; HERBST JJ, 1979, J PEDIATR-US, V95, P763, DOI 10.1016/S0022-3476(79)80733-7; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Poterjoy BS, 2010, J PERINATOL, V30, P151, DOI 10.1038/jp.2009.97; Rozen S, 2000, Methods Mol Biol, V132, P365; Sen P, 2013, HUM MUTAT, V34, P801, DOI 10.1002/humu.22313; Shimizu H, 2003, J JPN SOC PREMATURE, V15, P107	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	NOV	2014	76	5					453	458		10.1038/pr.2014.114		6	Pediatrics	Pediatrics	AS8QA	WOS:000344512200006		
J	Torabi, G; Arai, S; Abbasi, H				Torabi, Ghodrat; Arai, Shoji; Abbasi, Hamideh			Eocene continental dyke swarm from Central Iran (Khur area)	PETROLOGY			English	Article							CONFINING OCEANIC-CRUST; ISFAHAN PROVINCE; VOLCANIC-ROCKS; DISCRIMINATION; SHOSHONITES; SUBDUCTION; MINERALS; JANDAQ; EARTH; MARK	The Eocene dyke swarm with east-west general trend intrudes the Cretaceous sedimentary rocks in similar to 25 km north of the Khur city (Central Iran). Some of the studied dykes can be followed for over 7 km, but the majority of exposures in the area are less than 5 km long. The dykes commonly exhibit a chilled contact with the wall rocks. These dykes are trachybasalt and basalt in composition. The trachybasalt dykes are much more abundant. The basaltic dykes cross cut the trachybasalt dykes in some locations, indicating that trachybasalt dykes are older than the basaltic ones. Primary igneous minerals of the basaltic dykes are olivine (chrysolite), clinopyroxene (diopside, augite), plagioclase (labradorite), sanidine, magnetite, orthopyroxene (enstatite), spinel and phlogopite, and secondary minerals are zeolite (natrolite and mesolite), chlorite (diabantite), calcite and serpentine. The trachybasalt dykes are composed of clinopyroxene (diopside), plagioclase (labradorite), sanidine, mica (biotite and phlogopite), amphibole (magnesio-hastingsite) and magnetite as primary minerals, and chlorite and calcite as secondary ones. Whole rocks geochemical data of the studied dykes indicate their basic and calc-alkaline nature and suggest that these two set of dykes were derived from the same parental magma. The chondrite-normalized REE patterns and the primitive mantle-normalized multi-elemental diagram of the Khur dykes show enrichment of light rare earth elements (LREE) relative to heavy rare earth elements (HREE), and negative anomalies of high field strength elements (HFSE) (e.g. Ti, Nb and Ta). These rocks show enrichment of the large ion lithophile elements (LILE) (e.g. Cs, Ba, Th and U) and depletion of the HREE and Y relative to MREE, Zr and Hf. In the chondrite-normalized REE diagram, the basalts show elevated REE abundances relative to the trachybasalt samples. Geochemical analyses of the studied samples suggest a spinel lherzolite from the mantle as the source rock and confirm the role of subduction in their generation. The chemical characteristics of the Khur dykes resemble those of continental arc rocks, and they were possibly formed by subduction of the Central-East Iranian microcontinent (CEIM) confining oceanic crust and decompression melting of a lithospheric subcontinental mantle spinel lherzolite enriched by subduction.	[Torabi, Ghodrat; Abbasi, Hamideh] Univ Isfahan, Dept Geol, Esfahan 8174673441, Iran; [Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan	Torabi, G (reprint author), Univ Isfahan, Dept Geol, Azadi Sq, Esfahan 8174673441, Iran.	torabighodrat@yahoo.com			University of Isfahan; Kanazawa University	The authors acknowledge the University of Isfahan and Kanazawa University for financial supporting this work. We are also grateful to the reviewers for their helpful and constructive comments improving the manuscript. The authors would like to thank Professor Oleg A. Bogatikov (Editor in chief of Petrology) and Professor Andrey V. Girnis (Executive editor in chief) for their useful comments and editorial handling.	Aistov L., 1984, 20 TE GEOL SURV IR V; Almasian M., 1997, THESIS ISLAMIC AZAD; Guo F, 2004, LITHOS, V78, P291, DOI 10.1016/j.lithos.2004.05.001; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; CHEN CH, 1988, CHEM GEOL, V71, P355, DOI 10.1016/0009-2541(88)90059-9; WINCHESTER JA, 1977, CHEM GEOL, V20, P325, DOI 10.1016/0009-2541(77)90057-2; Tegner C, 1998, NATURE, V395, P591; PEARCE JA, 1973, EARTH PLANET SC LETT, V19, P290, DOI 10.1016/0012-821X(73)90129-5; MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2; Hirschmann MM, 1999, J PETROL, V40, P297, DOI 10.1093/petrology/40.2.297; Femenias O, 2008, INT J EARTH SCI, V97, P479, DOI 10.1007/s00531-007-0178-y; Groves D.I., 1995, POTASSIC IGNEOUS ROC; Hanski E., 2006, DYKE SWARMS TIME MAR; Heimann A., 1995, PHYS CHEM DYKES; Hollocher K., 2012, AM J SCI, V312, P312; Jaques A.L., 1985, T GEOL SOC S AFR, V88, P311; MIDDLEMOST EAK, 1989, CHEM GEOL, V77, P19, DOI 10.1016/0009-2541(89)90011-9; Murphy JB, 2007, GEOSCI CAN, V34, P7; Pearce J.A, 1982, ANDESITES, P525; Pirnia T, 2013, J GEOL, V121, P645, DOI 10.1086/673175; Reichert J., 2007, THESIS M LUTHER U HA; Rollinson H., 1993, USING GEOCHEMICAL DA; Shaw D.M., 1970, GEOCHIM COSMOCHIM AC, V34, P137; Srivastava R. K., 2011, DYKE SWARMS KEYS GEO; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Torabi G, 2013, NEUES JAHRB GEOL P-A, V267, P171, DOI 10.1127/0077-7749/2013/0303; Torabi G, 2009, TURK J EARTH SCI, V18, P583, DOI 10.3906/yer-0711-2; Torabi G, 2013, PETROLOGY+, V21, P393, DOI 10.1134/S0869591113040073; Torabi G, 2010, ISL ARC, V19, P277, DOI 10.1111/j.1440-1738.2009.00705.x; Torabi G, 2011, PETROLOGY+, V19, P690, DOI 10.1134/S0869591111070034; Torabi G, 2011, PETROLOGY+, V19, P675, DOI 10.1134/S0869591111030039; Wood D.A., 1980, EARTH PLANET SC LETT, V50, P1; Yan Y., 2008, J ASIAN EARTH SCI, V33, P106	34	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0869-5911	1556-2085		PETROLOGY+	Petrology	NOV	2014	22	6					617	632		10.1134/S086959111406006X		16	Geosciences, Multidisciplinary; Mineralogy	Geology; Mineralogy	AT0IO	WOS:000344620300006		
J	Tarumi, R; Suzuki, T; Tani, H; Den, R; Sawada, N; Sakurai, H; Tsutsumi-Ozawa, C; Ohtani, A; Mimura, M; Uchida, H				Tarumi, R.; Suzuki, T.; Tani, H.; Den, R.; Sawada, N.; Sakurai, H.; Tsutsumi-Ozawa, C.; Ohtani, A.; Mimura, M.; Uchida, H.			Timing of Adjunctive Therapy in the Treatment of Depression: A Chart Review	PHARMACOPSYCHIATRY			English	Review						antidepressants; adjunctive therapy; depression	DOPAMINE-D-2 RECEPTOR OCCUPANCY; GUIDELINES	Introduction: The objective of this study was to examine the evolution of antidepressant switch and adjunctive therapy. Methods: This chart review was conducted at 6 primary psychiatric clinics or hospitals, in Tokyo, Japan. A chart review of longitudinal prescriptions was conducted regarding 633 outpatients with major depressive disorder for up to 2 years after their first visit. Patients who had already received antidepressants prior to the visit were excluded. Results: 22.6% (N=143) of the patients completed or continued the outpatient treatment over the 2 years while 27 (4.3%), 23 (3.6%), and 439 (69.4%) patients discontinued it due to hospitalization, referral to another clinic, and loss to follow-up, respectively. A total of 597 episodes of antidepressant treatment were identified. Among them, 482 episodes (80.7%) were associated with the suggested dose ranges while antidepressant drugs were under-dosed in 19.3% (N=115) of the episodes. 50 patients (7.9%) received adjunctive therapy; it was employed after a median of only one antidepressant had been tried. Conclusion: Psychiatrists may be hasty in prescribing an adjunctive therapy in the treatment of depression.	[Tarumi, R.; Suzuki, T.; Tani, H.; Sakurai, H.; Tsutsumi-Ozawa, C.; Ohtani, A.; Mimura, M.; Uchida, H.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Suzuki, T.; Sakurai, H.] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Tani, H.] Umesato Mental Clin, Dept Psychiat, Chiba, Japan; [Den, R.; Tsutsumi-Ozawa, C.] Komagino Hosp, Dept Psychiat, Tokyo, Japan; [Sawada, N.] Asakadai Mental Clin, Dept Psychiat, Saitama, Japan; [Sawada, N.] Dept Ohizumi Hosp, Tokyo, Japan; [Uchida, H.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Uchida, H.] Ohizumi Mental Clin, Dept Psychiat, Saitama, Japan	Uchida, H (reprint author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hiroyuki.uchida.hu@gmail.com	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Astellas; Dainippon Sumitomo; Eli Lilly; Elsevier Japan; Meiji Seika; Novartis; Otsuka; Weily Japan; Pfizer; Astellas Pharmaceutical; Mochida Pharmaceutical; Meiji-Seika Pharma; GlaxoSmithKline; Janssen Pharmaceutical; Asahi Kasei Pharma; Daiichi Sankyo; Dainippon-Sumitomo Pharma; Eisai; MSD; Novartis Pharma; Otsuka Pharmaceutical; Shionogi; Takeda; Tanabe Mitsubishi Pharma; Yoshitomi Yakuhin	Yes: Dr. Suzuki has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Meiji Seika, Novartis, Otsuka, and Weily Japan. Dr. Den has received manuscript or speaker's fees from Eli Lilly, Pfizer, Astellas Pharmaceutical, Mochida Pharmaceutical, Meiji-Seika Pharma, GlaxoSmithKline and Janssen Pharmaceutical within the past 2 years. Dr. Mimura has received grants and/or speaker's honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi Pharma, and Yoshitomi Yakuhin within the past 2 years. Dr. Uchida has received grants from Pfizer, Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, GlaxoSmithKline, Shionogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, Janssen Pharmaceutical, and Yoshitomi Yakuhin and speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, Abbvie, and Janssen Pharmaceutical within the past 2 years. The other authors have nothing to disclose.	American Psychiatric Association, 2010, AM PSYCH ASS PRACT G; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P497, DOI 10.1097/JCP.0b013e3182214aad; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Zhang JP, 2013, INT J NEUROPSYCHOPH, V16, P1205, DOI 10.1017/S1461145712001277; Uchida H, 2008, AM J GERIAT PSYCHIAT, V16, P584, DOI 10.1097/JGP.0b013e318172b42d; Sakurai H, 2013, SCHIZOPHRENIA BULL, V39, P564, DOI 10.1093/schbul/sbr189; Kishi T, 2013, PSYCHOL MED, P1; Pinto LR, 2010, ARQ NEURO-PSIQUIAT, V68, P666, DOI 10.1590/S0004-282X2010000400038; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Sundell KA, 2013, INT J CLIN PRACT, V67, P1302, DOI 10.1111/ijcp.12263; Taylor D, 2012, MAUDSLEY PRESCRIBING; Uchida H, 2009, J ANXIETY DISORD, V23, P477, DOI 10.1016/j.janxdis.2008.10.003; VACCHERI A, 1984, PSYCHOPHARMACOLOGY, V83, P28, DOI 10.1007/BF00427417; World Health Organisation, 1992, ICD 10 CLASS MENT BE	14	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0176-3679	1439-0795		PHARMACOPSYCHIATRY	Pharmacopsychiatry	NOV	2014	47	7					259	262		10.1055/s-0034-1387784		4	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AT4OW	WOS:000344920500005		
J	Terao, T; Katayama, Y; Kamei, K				Terao, T.; Katayama, Y.; Kamei, K.			Katayama et al.: Therapeutic Window of Lamotrigine for Mood Disorders: A Naturalistic Retrospective Study. Pharmacopsychiatry 2014; 47: 111-114 Reply	PHARMACOPSYCHIATRY			English	Letter						bipolar disorder; depression; mood disorders		Professors Grunze and Walden sent a letter associated with our article. In this letter, we reply to their comments.	[Terao, T.; Katayama, Y.; Kamei, K.] Oita Univ, Fac Med, Dept Neuropsychiat, Yufu City, Oita 8795593, Japan	Terao, T (reprint author), Oita Univ, Fac Med, Dept Neuropsychiat, 1-1 Idaigaoka,Hasama Machi, Yufu City, Oita 8795593, Japan.	terao@oita-u.ac.jp					Chen H, 2010, CHEM RES TOXICOL, V23, P159, DOI 10.1021/tx9003243; Grunze H, 2014, PHARMACOPSYCHIATRY; Katayama Y, 2014, PHARMACOPSYCHIATRY, V47, P111, DOI 10.1055/s-0034-1375618	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0176-3679	1439-0795		PHARMACOPSYCHIATRY	Pharmacopsychiatry	NOV	2014	47	7					270	270		10.1055/s-0034-1387737		1	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AT4OW	WOS:000344920500008		
J	Knopf, A; Nil, S; Yohannes, I; Graeff, C; Dowdell, S; Kurz, C; Sonke, JJ; Biegun, AK; Lang, S; McClelland, J; Champion, B; Fast, M; Wolfelschneider, J; Gianoli, C; Rucinski, A; Baroni, G; Richter, C; van de Water, S; Grassberger, C; Weber, D; Poulsen, P; Shimizu, S; Bert, C				Knopf, Antje; Nill, Simeon; Yohannes, Indra; Graeff, Christian; Dowdell, Stephen; Kurz, Christopher; Sonke, Jan-Jakob; Biegun, Aleksandra K.; Lang, Stephanie; McClelland, Jamie; Champion, Benjamin; Fast, Martin; Wolfelschneider, Jens; Gianoli, Chiara; Rucinski, Antoni; Baroni, Guido; Richter, Christian; van de Water, Steven; Grassberger, Clemens; Weber, Damien; Poulsen, Per; Shimizu, Shinichi; Bert, Christoph			Challenges of radiotherapy: Report on the 4D treatment planning workshop 2013	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						Moving targets; Motion monitoring; Motion modeling; Motion mitigation; 4D dosimetry; 4D optimization	ION-BEAM THERAPY; LUNG-CANCER PATIENTS; PROOF-OF-CONCEPT; MOTION COMPENSATION; PROTON THERAPY; COLLIMATOR TRACKING; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; PARTICLE THERAPY; DOSE RECONSTRUCTION	This report, compiled by experts on the treatment of mobile targets with advanced radiotherapy, summarizes the main conclusions and innovations achieved during the 40 treatment planning workshop 2013. This annual workshop focuses on research aiming to advance 4D radiotherapy treatments, including all critical aspects of time resolved delivery, such as in-room imaging, motion detection, motion managing, beam application, and quality assurance techniques. The report aims to revise achievements in the field and to discuss remaining challenges and potential solutions. As main achievements advances in the development of a standardized 40 phantom and in the area of 4D-treatment plan optimization were identified. Furthermore, it was noticed that MR imaging gains importance and high interest for sequential 4DCT/MR data sets was expressed, which represents a general trend of the field towards data covering a longer time period of motion. A new point of attention was work related to dose reconstructions, which may play a major role in verification of 40 treatment deliveries. The experimental validation of results achieved by 4D treatment planning and the systematic evaluation of different deformable image registration methods especially for inter-modality fusions were identified as major remaining challenges. A challenge that was also suggested as focus for future 4D workshops was the adaptation of image guidance approaches from conventional radiotherapy into particle therapy. Besides summarizing the last workshop, the authors also want to point out new evolving demands and give an outlook on the focus of the next workshop. (C) 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Knopf, Antje; Nill, Simeon; Fast, Martin] ICR, London, England; [Yohannes, Indra; Wolfelschneider, Jens; Bert, Christoph] Univ Klinikum Erlangen, Erlangen, Germany; [Graeff, Christian] GSI Darmstadt, Darmstadt, Germany; [Dowdell, Stephen; Grassberger, Clemens] MGH, Boston, MA USA; [Kurz, Christopher] Uni Heidelberg, Heidelberg, Germany; [Sonke, Jan-Jakob] NKI, Amsterdam, Netherlands; [Biegun, Aleksandra K.] Univ Groningen, KVI Ctr Adv Radiat Technol, NL-9700 AB Groningen, Netherlands; [Lang, Stephanie] Unispital, Zurich, Switzerland; [McClelland, Jamie; Champion, Benjamin] UCL, London, England; [Gianoli, Chiara] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Gianoli, Chiara] Univ Heidelberg Hosp, Dept Radiat Oncol, Heidelberg, Germany; [Rucinski, Antoni] SLK Klin Heilbronn, Dept Radiat Oncol, Heilbronn, Germany; [Baroni, Guido] Politecn Milan, Dipartimento Elettron Informaz Bioingn, Pavia, Italy; [Baroni, Guido] CNAO Fdn, Bioengn Unit, Pavia, Italy; [Richter, Christian] Tech Univ Dresden, Oncoray Natl Ctr Radiat Res Oncol, Helmholtz Zentrum Dresden Rossendorf, Fac Med,DKTK, Dresden, Germany; [Richter, Christian] Tech Univ Dresden, Univ Hosp CG Carus, Helmholtz Zentrum Dresden Rossendorf, DKTK, Dresden, Germany; [van de Water, Steven] Erasmus MC, Rotterdam, Netherlands; [Weber, Damien] PSI, Villigen, Switzerland; [Poulsen, Per] Aarhus Univ, DK-8000 Aarhus C, Denmark; [Shimizu, Shinichi] Hokkaido Univ, Sapporo, Hokkaido, Japan	Knopf, A (reprint author), ICR, London, England.	antje.knopf@icr.ac.uk	Biegun, Aleksandra/J-8916-2013; Rucinski, Antoni/O-9620-2015	Graeff, Christian/0000-0002-5296-7649; 			Parodi K, 2009, MED PHYS, V36, P4230, DOI 10.1118/1.3196236; Crijns SPM, 2012, PHYS MED BIOL, V57, P7863, DOI 10.1088/0031-9155/57/23/7863; Boye D, 2013, MED PHYS, V40, DOI 10.1118/1.4801914; Graeff C, 2014, PHYS MEDICA, V30, P570, DOI 10.1016/j.ejmp.2014.03.011; Guckenberger Matthias, 2012, Critical Reviews in Biomedical Engineering, V40, P187, DOI 10.1615/CritRevBiomedEng.v40.i3.30; Shackleford JA, 2010, PHYS MED BIOL, V55, P6329, DOI 10.1088/0031-9155/55/21/001; Seppenwoolde Y, 2007, MED PHYS, V34, P2774, DOI 10.1118/1.2739811; Lagendijk JJW, 2008, RADIOTHER ONCOL, V86, P25, DOI 10.1016/j.radonc.2007.10.034; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Keall PJ, 2014, MED PHYS, V41, DOI 10.1118/1.4862509; Schwaab J, 2014, PHYS MEDICA, V30, P578, DOI 10.1016/j.ejmp.2014.03.003; Richter D, 2013, MED PHYS, V40, DOI 10.1118/1.4800802; Gadgeel SM, 2012, RADIOL CLIN N AM, V50, P961, DOI 10.1016/j.rcl.2012.06.003; Zhang Y, 2013, PHYS MED BIOL, V58, P8621, DOI 10.1088/0031-9155/58/24/8621; Ravkilde T, 2013, ACTA ONCOL, V52, P1497, DOI 10.3109/0284186X.2013.818248; von Siebenthal M, 2007, PHYS MED BIOL, V52, P1547, DOI 10.1088/0031-9155/52/6/001; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Fallone BG, 2009, MED PHYS, V36, P2084, DOI 10.1118/1.3125662; Shimizu S, 2014, PHYS MEDICA, V30, P555, DOI 10.1016/j.ejmp.2014.04.002; Krauss A, 2011, INT J RADIAT ONCOL, V79, P579, DOI 10.1016/j.ijrobp.2010.03.043; Richter D, 2014, INT J RADIAT ONCOL, V89, P175, DOI 10.1016/j.ijrobp.2014.01.043; Grills IS, 2012, J THORAC ONCOL, V7, P1382, DOI 10.1097/JTO.0b013e318260e00d; Wolthaus JWH, 2008, INT J RADIAT ONCOL, V70, P1229, DOI 10.1016/j.ijrobp.2007.11.042; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; Grassberger C, 2013, INT J RADIAT ONCOL, V86, P380, DOI 10.1016/j.ijrobp.2013.01.024; Depuydt T, 2013, RADIOTHER ONCOL, V106, P236, DOI 10.1016/j.radonc.2012.12.015; Baiter JM, 2005, INT J RADIAT ONCOL, V61, P933; Bert, 2014, TECHNOL CANCER RES T, V13, P485; Bert C, 2014, PHYS MEDICA, V30, P535, DOI 10.1016/j.ejmp.2014.04.011; Bjerre T, 2013, PHYS MED BIOL, V58, P4943, DOI 10.1088/0031-9155/58/14/4943; Brix L, 2014, MED PHYS, V41, DOI 10.1118/1.4867859; Chang JY, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-152; Dowdell S, 2013, MED PHYS, V40, DOI 10.1118/1.4829500; Dowdell S, 2013, PHYS MED BIOL, V58, P4137, DOI 10.1088/0031-9155/58/12/4137; Eley JG, 2014, PHYS MED BIOL, V59, P3431, DOI 10.1088/0031-9155/59/13/3431; Fast MF, 2013, MED PHYS, V40, DOI 10.1118/1.4817479; Fattori G, 2014, TECHNOL CANCER RES T, V13, P517, DOI 10.7785/tcrtexpress.2013.600275; Graeff C, 2013, RADIOTHER ONCOL, V109, P419, DOI 10.1016/j.radonc.2013.09.018; Graeff C, 2014, TECHNOL CANCER RES T, V13, P497, DOI 10.7785/tcrtexpress.2013.600277; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-59; Harada K, 2013, INT J RADIAT ONCOL, V87, pS67; Hoffmann Christoph, 2014, J Appl Clin Med Phys, V15, P4564, DOI 10.1120/jacmp.v15i1.4564; Knopf, 2010, MED PHYS, V37, P4608; Knopf AC, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/R131; Korreman S, 2012, INT J RADIAT ONCOL, V83, P1338, DOI 10.1016/j.ijrobp.2011.09.010; Lang S, 2014, MED PHYS, V41, DOI 10.1118/1.4862077; Laube K, 2013, PHYS MED BIOL, V58, P513, DOI 10.1088/0031-9155/58/3/513; Luchtenborg Robert, 2011, Med Phys, V38, P5448, DOI 10.1118/1.3633891; Meier G, 2013, 17 ANN SASRO M; Menten MJ, 2012, MED PHYS, V39, P7032, DOI 10.1118/1.4761868; Nichols RC, 2012, THORAC CANCER, V3, P109, DOI 10.1111/j.1759-7714.2011.00098.x; O'Brien RT, 2013, PHYS MED BIOL, V58, P1705, DOI 10.1088/0031-9155/58/6/1705; Parkel T, 2011, MOTION CONTROLLED PH; Pedroni Eros, 2004, Z Med Phys, V14, P25; Polf JC, 2014, PHYS MED BIOL, V59, P2325, DOI 10.1088/0031-9155/59/9/2325; Poulsen PR, 2012, MED PHYS, V39; Poulsen PR, 2012, INT J RADIAT ONCOL, V83, P265; Raaymakers BW, 2009, PHYS MED BIOL, V54, pN229, DOI 10.1088/0031-9155/54/12/N01; Raaymakers BW, 2008, PHYS MED BIOL, V53, P5615, DOI 10.1088/0031-9155/53/20/003; Rahmim A, 2013, PET CLIN, V8, P51; Riboldi M, 2012, LANCET ONCOL, V9, P383; Safai S, 2004, PHYS MED BIOL, V49, P4637, DOI 10.1088/0031-9155/49/19/013; Saito N, 2013, PHYS MEDICA, V29, P639, DOI 10.1016/j.ejmp.2012.08.003; Saleh ZH, 2014, PHYS MED BIOL, V59, P733, DOI 10.1088/0031-9155/59/3/733; Stanley Nick, 2013, J Appl Clin Med Phys, V14, P4363, DOI 10.1120/jacmp.v14i6.4363; Steidl P, 2012, PHYS MED BIOL, V57, P2235, DOI 10.1088/0031-9155/57/8/2235; Stutzer K, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5085; Szegedi Martin, 2013, J Appl Clin Med Phys, V14, P4012, DOI 10.1120/jacmp.v14i1.4012; Van der Voort van Zyp, 2009, RADIOTHER ONCOL, V91, P296; Veiga C, 2014, MED PHYS, V41, DOI 10.1118/1.4864240; Verburg JM, 2013, PHYS MED BIOL, V58, P137; Yun BJ, 2013, MED PHYS, V40	73	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	NOV	2014	30	7					809	815		10.1016/j.ejmp.2014.07.341		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS7FU	WOS:000344423400009		
J	Fujimoto, T; Monzen, H; Nakata, M; Okada, T; Yano, S; Takakura, T; Kuwahara, J; Sasaki, M; Higashimura, K; Hiraoka, M				Fujimoto, Takahiro; Monzen, Hajime; Nakata, Manabu; Okada, Takashi; Yano, Shinsuke; Takakura, Toru; Kuwahara, Junichi; Sasaki, Makoto; Higashimura, Kyoji; Hiraoka, Masahiro			Dosimetric shield evaluation with tungsten sheet in 4, 6, and 9 MeV electron beams	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						Tungsten paper; Electron beam; Transmission; Radiation shield	DOSE REDUCTION; MONTE-CARLO; LEAD; RADIOTHERAPY; THICKNESS; THERAPY	In electron radiotherapy, shielding material is required to attenuate beam and scatter. A newly introduced shielding material, tungsten functional paper (TFP), has been anticipated to become a very useful device that is lead-free, light, flexible, and easily processed, containing very fine tungsten powder at as much as 80% by weight. The purpose of this study was to investigate the dosimetric changes due to TFP shielding for electron beams. TFP (thickness 0-15 mm) was placed on water or a water-equivalent phantom. Percentage depth ionization and transmission were measured for 4, 6, and 9 MeV electron beams. Off-center ratio was also measured using film dosimetry at depth of dose maximum under similar conditions. Then, beam profiles and transmission with two shielding materials, TFP and lead, were evaluated. Reductions of 95% by using TFP at 0.5 cm depth occurred at 4, 9, and 15 mm with 4, 6, and 9 MeV electron beams, respectively. It is found that the dose tend to increase at the field edge shaped with TFP, which might be influenced by the thickness. TFP has several unique features and is very promising as a useful tool for radiation protection for electron beams, among others. (C) 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Fujimoto, Takahiro; Nakata, Manabu; Okada, Takashi; Yano, Shinsuke; Takakura, Toru; Kuwahara, Junichi; Sasaki, Makoto; Higashimura, Kyoji] Kyoto Univ Hosp, Clin Radiol Serv Div, Kyoto 6068397, Japan; [Monzen, Hajime; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, Kyoto 6068507, Japan	Monzen, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	hmon@kuhp.kyoto-u.ac.jp			JSPS KAKENHI [25461877]	This research was presented at the poster session of the European Cancer Congress in Amsterdam from September 27th-October 1st, 2013. This work was supported by JSPS KAKENHI grant number 25461877. The study sponsor had no involvement in the study design, or in the collection, analysis, or interpretation of data.	Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; GIARRATANO J C, 1975, Medical Physics (Woodbury), V2, P336, DOI 10.1118/1.594205; KHAN FM, 1981, MED PHYS, V8, P712, DOI 10.1118/1.594841; KHAN FM, 1976, BRIT J RADIOL, V49, P883; PRASAD SG, 1989, MED PHYS, V16, P807, DOI 10.1118/1.596432; PRASAD SG, 1988, MED PHYS, V15, P263, DOI 10.1118/1.596257; Shiomoto A, 2003, NIPPON HOSHASEN GIJU, V60, P429; STEWART R J J, 1983, Australasian Radiology, V27, P73, DOI 10.1111/j.1440-1673.1983.tb02346.x; Tajiri M, 2004, MED PHYS, V31, P3022, DOI 10.1118/1.1809767; Verhaegen F, 2001, PHYS MED BIOL, V46, P757, DOI 10.1088/0031-9155/46/3/311; Weaver RD, 1998, INT J RADIAT ONCOL, V41, P233, DOI 10.1016/S0360-3016(97)00905-X; Yue K, 2013, HEALTH PHYS, V104, P277, DOI 10.1097/HP.0b013e31827a7d5f; Yue K, 2009, RADIAT PROT DOSIM, V133, P256, DOI 10.1093/rpd/ncp053	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	NOV	2014	30	7					838	842		10.1016/j.ejmp.2014.05.009		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS7FU	WOS:000344423400014		
J	Yagi, M; Arentsen, L; Shanley, RM; Hui, SK				Yagi, Masashi; Arentsen, Luke; Shanley, Ryan M.; Hui, Susanta K.			High-throughput multiple-mouse imaging with micro-PET/CT for whole-skeleton assessment	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						High-throughput; Multiple-animal holder; Mouse hotel; Micro-PET/CT; Bone	SPATIAL-RESOLUTION; SCANNER	Recent studies have proven that skeleton-wide functional assessment is essential to comprehensively understand physiological aspects of the skeletal system. Therefore, in contrast to regional imaging studies utilizing a multiple-animal holder (mouse hotel), we attempted to develop and characterize a multiple-mouse imaging system with micro-PET/CT for high-throughput whole-skeleton assessment. Using items found in a laboratory, a simple mouse hotel that houses four mice linked with gas anesthesia was constructed. A mouse-simulating phantom was used to measure uniformity in a cross sectional area and flatness (A(max)/A(mm)*100) along the axial, radial and tangential directions, where A(max) and A(min) are maximum and minimum activity concentration in the profile, respectively. Fourteen mice were used for single- or multiple-micro-PET/CT scans. NaF uptake was measured at eight skeletal sites (skull to tibia). Skeletal F-18 activities measured with mice in the mouse hotel were within 1.6 +/- 4% (mean +/- standard deviation) of those measured with mice in the single-mouse holder. Single-holder scanning yields slightly better uniformity and flatness over the hotel. Compared to use of the single-mouse holder, scanning with the mouse hotel reduced study time (by 65%), decreased the number of scans (four-fold), reduced cost, required less computer storage space (40%), and maximized F-18 usage. The mouse hotel allows high-throughput, quantitatively equivalent scanning compared to the single-mouse holder for micro-PET/CT imaging for whole-skeleton assessment of mice. (C) 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Yagi, Masashi; Hui, Susanta K.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Arentsen, Luke] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Suita, Osaka, Japan; [Arentsen, Luke; Hui, Susanta K.] Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA; [Shanley, Ryan M.] Univ Minnesota, Mason Canc Ctr, Biostat Core, Minneapolis, MN 55455 USA	Hui, SK (reprint author), Univ Minnesota, Dept Therapeut Radiol, 420 Delaware St SE,Mayo Mail Code 494, Minneapolis, MN 55455 USA.	huixx019@umn.edu			National Institutes of Health [1R01CA154491-01, 1R03AR055333-01A1, 1K12-HD055887-01]; Japan Society for the Promotion of Science Core to Core Program [23003]	This work was supported by the National Institutes of Health (1R01CA154491-01, 1R03AR055333-01A1 and 1K12-HD055887-01) and Japan Society for the Promotion of Science Core to Core Program (23003).	Aide N, 2010, NUCL MED COMMUN, V31, P851, DOI 10.1097/MNM.0b013e32833dc61d; Visser EP, 2009, J NUCL MED, V50, P139, DOI 10.2967/jnumed.108.055152; Lodge MA, 2010, PHYS MED BIOL, V55, P1069, DOI 10.1088/0031-9155/55/4/011; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; [Anonymous], 2009, STRAT CLIN IMPL QUAL; Association NEM, 2008, NEMA STAND PUBL; Currie GM, 2010, J NUCL MED, V51, P823, DOI 10.2967/jnumed.109.071092; Habte F, 2013, MOL IMAGING BIOL, P1; Siepel FJ, 2010, NUCL INSTRUM METH A, V621, P605, DOI 10.1016/j.nima.2010.05.057; Yagi M, 2014, CALCIFIED TISSUE INT, V94, P544, DOI 10.1007/s00223-014-9839-6	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	NOV	2014	30	7					849	853		10.1016/j.ejmp.2014.06.003		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AS7FU	WOS:000344423400016		
J	Honda, W; Arie, T; Akita, S; Takei, K				Honda, Wataru; Arie, Takayuki; Akita, Seiji; Takei, Kuniharu			Printable and foldable electrodes based on a carbon nanotube-polymer composite	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						carbon nanotubes; flexible devices; foldable electrodes	ARTIFICIAL SKIN; MATRIX; CONDUCTORS; PAPER; TRANSISTORS; CIRCUITS; DEVICES; STRAIN; FILMS	Foldable components such as electrodes, transistors, and sensors are necessary to realize wearable electronics to be reliable use. In this paper, we propose a printable and foldable electrode using a composite ink of carbon nanotubes and polymer. Relative resistance change corresponding to the foldability by folding the electrode up to 1000 times is relatively small similar to 9.9 and similar to 1.7% for the folding directions of tensile and compressive stress in the electrodes, respectively. As a proof-of-concepts, a foldable calculator is demonstrated without malfunction. This electrode may lead to develop foldable electronics furthermore and can be applied to a wide range of applications.	[Honda, Wataru; Arie, Takayuki; Akita, Seiji; Takei, Kuniharu] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan	Takei, K (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	takei@pe.osakafu-u.ac.jp	akita, seiji/G-4679-2012	akita, seiji/0000-0002-2116-4034	Mazda Foundation; Foundation Advanced Technology Institute (ATI); JSPS KAKENHI [25889048, 26709026, 26630164]	This work was partially supported by the Mazda Foundation, the Foundation Advanced Technology Institute (ATI) and JSPS KAKENHI Grant (#25889048, #26709026, and #26630164).	Takei K, 2014, P NATL ACAD SCI USA, V111, P1703, DOI 10.1073/pnas.1317920111; Harada S, 2014, ACS NANO, V8, P3921, DOI 10.1021/nn500845a; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Xu F, 2012, ADV MATER, V24, P5117, DOI 10.1002/adma.201201886; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI 10.1038/NPHOTON.2013.242; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Hyun WJ, 2013, ADV MATER, V25, P4729, DOI 10.1002/adma.201302063; Park JY, 2014, J KOREAN RELIG, V5, P5, DOI 10.1353/jkr.2014.0003; Cheng Q, 2013, NANO LETT, V13, P4969, DOI 10.1021/nl4030374; Honda W, 2014, ADV FUNCT MATER, V24, P3299, DOI 10.1002/adfm.201303874; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Du JH, 2014, ADV MATER, V26, P1958, DOI 10.1002/adma.201304135; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Guo RS, 2013, ADV MATER, V25, P3343, DOI 10.1002/adma.201301184; Wu H, 2013, NAT NANOTECHNOL, V8, P421, DOI [10.1038/nnano.2013.84, 10.1038/NNANO.2013.84]; Kim DH, 2009, ADV MATER, V21, P3703, DOI 10.1002/adma.200900405; Lee H, 2014, ADV FUNCT MATER, V24, P3276, DOI 10.1002/adfm.201303276; Lee SW, 2011, J MATER CHEM, V21, P18804, DOI 10.1039/c1jm13079j; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Siegel A. C., 2012, ADV FUNCT MATER, V20, P28	20	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	NOV	2014	211	11					2631	2634		10.1002/pssa.201431481		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AS7WE	WOS:000344461800033		
J	Satake, T; Muto, M; Ko, S; Yasumura, K; Ishikawa, T; Maegawa, J				Satake, Toshihiko; Muto, Mayu; Ko, Seiko; Yasumura, Kazunori; Ishikawa, Takashi; Maegawa, Jiro			Breast Reconstruction Using Free Posterior Medial Thigh Perforator Flaps: Intraoperative Anatomical Study and Clinical Results	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							DONOR-SITE MORBIDITY; UPPER GRACILIS FLAP; ARTERY; TRAM; SKIN	Background: The free posterior medial thigh perforator flap is a fasciocutaneous flap on the posterior and medial thigh, based on perforators from the deep femoral vessels. In this study, the authors evaluated the anatomical basis of posterior and medial thigh perforators from the deep femoral vessels. Methods: Between June of 2006 and May of 2012, 67 patients underwent breast reconstruction using the posterior medial thigh flap. Perforators greater than or equal to 0.5 mm in this region were investigated. The following parameters were recorded intraoperatively: number of perforators, perforator diameters, perforator locations, pedicle length, and distance of the perforating point from the proximal thigh crease. Results: Of 70 flaps, 69 survived, but one developed total necrosis. The total number of perforators was 272, and the mean number was 3.9. The number of perforators coursing through the adductor magnus muscle was largest, followed by those coursing between the adductor magnus and semimembranosus muscle septocutaneously. Musculocutaneous perforators from the adductor magnus were located more proximally than the septocutaneous perforators between the adductor and semimembranosus muscle. Conclusions: The posterior medial thigh flap is suitable as a first-line option for breast reconstruction in women with a small to moderate breast size. This flap provides enough large perforators to support a soft-tissue transfer from the posterior and medial thigh. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.	[Satake, Toshihiko; Muto, Mayu; Ko, Seiko; Yasumura, Kazunori; Ishikawa, Takashi; Maegawa, Jiro] Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Minami Ku, Yokohama, Kanagawa 2320024, Japan	Satake, T (reprint author), Yokohama City Univ, Med Ctr, Dept Plast & Reconstruct Surg, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	toshi@yokohama-cu.ac.jp					Ahmadzadeh R, 2007, PLAST RECONSTR SURG, V119, P194, DOI 10.1097/01.prs.0000244848.10434.5f; Allen RJ, 2012, PLAST RECONSTR SURG, V129, p16E, DOI 10.1097/PRS.0b013e3182363d9f; Bajaj AK, 2006, PLAST RECONSTR SURG, V117, P737, DOI 10.1097/01.prs.000020062.97265.fb; Fansa H, 2008, PLAST RECONSTR SURG, V122, P1326, DOI 10.1097/PRS.0b013e318188205f; GROTTING JC, 1991, ANN PLAS SURG, V27, P351, DOI 10.1097/00000637-199110000-00011; Chevray PM, 2004, PLAST RECONSTR SURG, V114, P1077, DOI 10.1097/01.prs.0000135328.88101.53; LoTempio MM, 2010, PLAST RECONSTR SURG, V126, P393, DOI 10.1097/PRS.0b013e3181de236a; COLEN SR, 1986, PLAST RECONSTR SURG, V77, P948, DOI 10.1097/00006534-198606000-00013; CORMACK GC, 1985, PLAST RECONSTR SURG, V75, P342, DOI 10.1097/00006534-198503000-00008; Schoeller T, 2004, BRIT J PLAST SURG, V57, P481, DOI 10.1016/j.bjps.2004.02.016; Angrigiani C, 2001, PLAST RECONSTR SURG, V107, P1725, DOI 10.1097/00006534-200106000-00013; ALLEN RJ, 1995, PLAST RECONSTR SURG, V95, P1207, DOI 10.1097/00006534-199506000-00010; DEUTINGER M, 1995, PLAST RECONSTR SURG, V95, P1240, DOI 10.1097/00006534-199506000-00015; Fattah A, 2010, J PLAST RECONSTR AES, V63, P305, DOI 10.1016/j.bjps.2008.10.015; ALLEN RJ, 1994, ANN PLAS SURG, V32, P32, DOI 10.1097/00000637-199401000-00007; Vega SJ, 2009, PLAST RECONSTR SURG, V124, P1400, DOI 10.1097/PRS.0b013e3181babb19; Buntic RF, 2011, PLAST RECONSTR SURG, V128, p607E, DOI 10.1097/PRS.0b013e318230c2b6; Carr MM, 1995, MICROSURG, V16, P598, DOI 10.1002/micr.1920160904; Hupkens P, 2013, MICROSURG, V33, P376, DOI 10.1002/micr.22110; Peek A, 2002, Handchir Mikrochir Plast Chir, V34, P245, DOI 10.1055/s-2002-36292; Pulzl P, 2011, PLAST RECONSTR SURG, V128, p233E, DOI 10.1097/PRS.0b013e3182268a99; Saint-Cyr M, 2012, PLAST RECONSTR SURG, V129, p24E, DOI 10.1097/PRS.0b013e31823620cb; SONG YG, 1984, BRIT J PLAST SURG, V37, P149, DOI 10.1016/0007-1226(84)90002-X	23	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	NOV	2014	134	5					880	891		10.1097/PRS.0000000000000587		12	Surgery	Surgery	AS9EN	WOS:000344546000037		
J	Kato, H; Araki, J; Doi, K; Kuno, S; Kinoshita, K; Mineda, K; Kanayama, K; Yoshimura, K				Kato, Harunosuke; Araki, Jun; Doi, Kentaro; Kuno, Shinichiro; Kinoshita, Kahori; Mineda, Kazuhide; Kanayama, Koji; Yoshimura, Kotaro			Normobaric Hyperoxygenation Enhances Initial Survival, Regeneration, and Final Retention in Fat Grafting	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							HYPERBARIC-OXYGEN THERAPY; COMPLICATIONS; BREAST	Background: Fat grafting is a promising modality for soft-tissue augmentation/reconstruction. However, grafted fat tissue is not initially perfused and relies on plasmatic diffusion from the recipient bed until revascularization occurs. The authors evaluated the therapeutic effects of normobaric hyperoxygenation for enhancing fat graft retention. Methods: Aspirated human fat tissue was cultured under tissue hypoxia (1% oxygen), normoxia (6%), and hyperoxia (20%) levels, and evaluated for adipocyte viability. Inguinal fat pads were autografted under mouse scalps (n = 36), and mice were housed in either 20% (control) or 60% (normobaric hyperoxygenation) atmospheric oxygen for the first 3 days, and then returned to normoxia. Samples harvested at 0, 1, 2, 4, 8, and 12 weeks were analyzed immunohistochemically for adipocyte viability and regeneration. Results: Organ culture adipocytes died more quickly under lower oxygen tensions; thus, hyperoxygenation of recipient tissues may delay adipocyte death after fat grafting. Autografted mouse adipose tissue underwent dynamic remodeling, from ischemic degeneration to partial regeneration, over 12 weeks. Normobaric hyperoxygenation grafted samples showed significantly larger survival zones and engraftment scores (calculated using sample weight and adipocyte viability) at 1 and 12 weeks, respectively, than control samples. In addition, adipocyte regeneration (number of perilipin-positive preadipocytes), which peaked at 4 weeks, was significantly increased in normobaric hyperoxygenation samples. Conclusion: The normobaric hyperoxygenation protocol using 60% oxygen can be safely applied to enhance adipocyte survival, regeneration, and final engraftment after fat grafting.	[Kato, Harunosuke; Araki, Jun; Doi, Kentaro; Kuno, Shinichiro; Kinoshita, Kahori; Mineda, Kazuhide; Kanayama, Koji; Yoshimura, Kotaro] Univ Tokyo, Sch Med, Dept Plast Surg, Tokyo 1138655, Japan	Yoshimura, K (reprint author), Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kotaro-yoshimura@umin.ac.jp					Ambiru S, 2008, J CRIT CARE, V23, P295, DOI 10.1016/j.jcrc.2007.08.002; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Salgarello M, 2012, PLAST RECONSTR SURG, V129, P317, DOI 10.1097/PRS.0b013e31822b6619; Klinger M, 2013, J CRANIOFAC SURG, V24, P1610, DOI 10.1097/SCS.0b013e3182a24548; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; LAVAN FB, 1990, CLIN PLAST SURG, V17, P463; Araki J, PLAST RECON IN PRESS; Domachevsky L, 2013, NEUROSCIENCE, V247, P328, DOI 10.1016/j.neuroscience.2013.05.052; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Kessler L, 2003, DIABETES CARE, V26, P2378, DOI 10.2337/diacare.26.8.2378; Kling RE, 2013, PLAST RECONSTR SURG, V132, P35, DOI 10.1097/PRS.0b013e318290fad1; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Ueno C, 2006, PLAST RECONSTR SURG, V117, p59S, DOI 10.1097/01.prs.0000225438.86758.21	14	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	NOV	2014	134	5					951	959		10.1097/PRS.0000000000000600		9	Surgery	Surgery	AS9EN	WOS:000344546000045		
J	Sasaki, R; Matsumine, H; Watanabe, Y; Takeuchi, Y; Yamato, M; Okano, T; Miyata, M; Ando, T				Sasaki, Ryo; Matsumine, Hajime; Watanabe, Yorikatsu; Takeuchi, Yuichi; Yamato, Masayuki; Okano, Teruo; Miyata, Mariko; Ando, Tomohiro			Electrophysiologic and Functional Evaluations of Regenerated Facial Nerve Defects with a Tube Containing Dental Pulp Cells in Rats	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							CROSS-FACE NERVE; ONE-STAGE RECONSTRUCTION; LATISSIMUS-DORSI MUSCLE; NEURONS IN-VITRO; STEM-CELLS; PARALYZED FACE; MOTOR-NERVE; 2-STAGE PROCEDURES; SINGLE-STAGE; GRAFTS	Background: Dental pulp tissue contains Schwann and neural progenitor cells. Tissue-engineered nerve conduits with dental pulp cells promote facial nerve regeneration in rats. However, no nerve functional or electrophysiologic evaluations were performed. This study investigated the compound muscle action potential recordings and facial functional analysis of dental pulp cell regenerated nerve in rats. Methods: A silicone tube containing rat dental pulp cells in type I collagen gel was transplanted into a 7-mm gap of the buccal branch of the facial nerve in Lewis rats; the same defect was created in the marginal mandibular branch, which was ligatured. Compound muscle action potential recordings of vibrissal muscles and facial functional analysis with facial palsy score of the nerve were performed. Results: Tubulation with dental pulp cells showed significantly lower facial palsy scores than the autograft group between 3 and 10 weeks postoperatively. However, the dental pulp cell facial palsy scores showed no significant difference from those of autograft after 11 weeks. Amplitude and duration of compound muscle action potentials in the dental pulp cell group showed no significant difference from those of the intact and autograft groups, and there was no significant difference in the latency of compound muscle action potentials between the groups at 13 weeks postoperatively. However, the latency in the dental pulp cell group was prolonged more than that of the intact group. Conclusion: Tubulation with dental pulp cells could recover facial nerve defects functionally and electrophysiologically, and the recovery became comparable to that of nerve autografting in rats.	Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Sch Med, Global Ctr Excellence Program, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Sch Med, Dept Plast Surg, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Tokyo Metropolitan Police Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan	Sasaki, R (reprint author), Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	sasaki@oms.twmu.ac.jp	Takeuchi, Yuichi/K-2873-2015	Takeuchi, Yuichi/0000-0001-7545-8401	Global COE program; Multidisciplinary Education and Research Center for Regenerative Medicine of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science [23792386]; Hiroto Yoshioka Memorial Fund for Medical Research	This study was partially supported by the Global COE program; the Multidisciplinary Education and Research Center for Regenerative Medicine of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research grant 23792386; and Hiroto Yoshioka Memorial Fund for Medical Research. The authors would like to thank Dr. Norio Ueno for editorial assistance in preparing this article.	Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; Sasaki R, 2008, TISSUE ENG PT A, V14, P1141, DOI 10.1089/ten.tea.2007.0157; Nosrat IV, 2004, EUR J NEUROSCI, V19, P2388, DOI 10.1111/j.1460-9568.2004.03314.x; Bae YC, 2006, PLAST RECONSTR SURG, V117, P2407, DOI 10.1097/01.prs.0000218798.95027.21; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Gioventu S, 2012, TRANSFUS APHER SCI, V47, P199, DOI 10.1016/j.transci.2012.06.005; Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036; Lee SY, 2010, J ENDODONT, V36, P1336, DOI 10.1016/j.joen.2010.04.015; Sakamoto T, 2003, J NEUROSCI RES, V72, P54, DOI 10.1002/jnr.10558; Shichinohe R, 2012, J PLAST RECONSTR AES, V65, P763, DOI 10.1016/j.bjps.2011.12.009; Harii K, 1998, PLAST RECONSTR SURG, V102, P941, DOI 10.1097/00006534-199809040-00001; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x; Watanabe Y, 2009, J PLAST RECONSTR AES, V62, P1589, DOI 10.1016/j.bjps.2008.07.025; Kumar PAV, 2002, PLAST RECONSTR SURG, V109, P451; Hadlock TA, 2005, ARCH FACIAL PLAST S, V7, P17, DOI 10.1001/archfaci.7.1.17; Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3; Sasaki R, 2008, EUR J NEUROSCI, V27, P538, DOI 10.1111/j.1460-9568.2008.06026.x; Berg T, 2004, OTOL NEUROTOL, V25, P1020, DOI 10.1097/00129492-200411000-00027; Bui CH, 2003, J ORAL MAXIL SURG, V61, P1379, DOI 10.1016/j.joms.2003.04.001; de Faria Simone Damasceno, 2006, Braz J Otorhinolaryngol, V72, P341; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Harii K, 2002, PLAST RECONSTR SURG, V109, P463, DOI 10.1097/00006534-200202000-00007; Huang AHC, 2009, J ENDODONT, V35, P673, DOI 10.1016/j.joen.2009.01.019; Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059; KIM DH, 1994, J NEUROSURG, V80, P254, DOI 10.3171/jns.1994.80.2.0254; Koshima I, 1997, PLAST RECONSTR SURG, V99, P234, DOI 10.1097/00006534-199701000-00036; LOMBARDI T, 1993, ACTA ANAT, V147, P35; Matsumine H, PLAST RECON IN PRESS; Matsumine H, 2014, J RECONSTR MICROSURG, V30, P127, DOI 10.1055/s-0033-1357500; Matsumine H, 2011, PLAST RECONSTR SURG, V128, P95; Matsumine H, 2014, J TISSUE ENG REGEN M, V8, P454, DOI 10.1002/term.1540; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mligiliche Nurru L., 2003, Anatomical Science International, V78, P156, DOI 10.1046/j.0022-7722.2003.00056.x; Nanci A, 2003, TENCATES ORAL HISTOL, P192; Sasaki R, 2013, J RECONSTR MICROSURG, V29, P209, DOI 10.1055/s-0032-1331147; SEMBA K, 1986, J COMP NEUROL, V247, P144, DOI 10.1002/cne.902470203; Shen ZL, 1999, MICROSURG, V19, P356, DOI 10.1002/(SICI)1098-2752(1999)19:8<356::AID-MICR2>3.0.CO;2-N; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610; Watanabe Y, J TISSUE EN IN PRESS	44	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	NOV	2014	134	5					970	978		10.1097/PRS.0000000000000602		9	Surgery	Surgery	AS9EN	WOS:000344546000047		
J	Herwan, J; Kondo, A; Morooka, S; Watanabe, N				Herwan, J.; Kondo, A.; Morooka, S.; Watanabe, N.			Effects of stitch density and stitch thread thickness on mode II delamination properties of Vectran stitched composites	PLASTICS RUBBER AND COMPOSITES			English	Article						CFRP; 3D reinforcement; Stitching; Delamination; Mode II; Interlaminar shear toughness	INTERLAMINAR FRACTURE-TOUGHNESS; POLYMER-MATRIX COMPOSITES; TEXTILE COMPOSITES; FAILURE; ORIENTATION; MECHANISMS; CFRPS	Mode II delamination properties of Vectran stitched composites were investigated, and tabbed end notch flexural specimen testing was used to prevent premature failure. The effects of stitch density and stitch thread thickness were explored, and fibre compaction due to the stitching process was also verified. The results show that, in moderately stitched laminates (low stitch density), the improvement in G(IIC) was negligible. Crack bridging by the stitch threads at the crack zone were mostly compensated for the effect of fibre compaction, which reduced the G(IIC) values. Conversely, in densely stitched laminates (high stitch density), G(IIC) values were improved significantly (2.4 times higher than those of unstitched laminates). The effects of stitch thread thickness appeared to be negligible in moderately stitched laminates. For densely stitched laminates, thicker stitch thread (500 denier) possessed G(IIC) values that were 45.7% higher than thinner stitch thread (200 denier).	[Herwan, J.; Kondo, A.; Morooka, S.; Watanabe, N.] Tokyo Metropolitan Univ, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan	Herwan, J (reprint author), Tokyo Metropolitan Univ, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	jonny-herwan@ed.tmu.ac.jp			Tokyo Metropolitan Government from the Asian Human Resources Fund; Tokyo Metropolitan Government from Asian Network of Major Cities 21 (ANMC-21) Project	The authors gratefully acknowledge Tokyo Metropolitan Government for its financial support from the Asian Human Resources Fund and Asian Network of Major Cities 21 (ANMC-21) Project. Special gratitude is extended to Professor L. A. Carlsson (Florida Atlantic University) for helpful discussion concerning the compliance calibration method, Dr A. Yudhanto (currently at King Abdullah University of Science and Technology) for guidance during our stay at Tokyo Metropolitan University, Dr H. Hoshi (Japan Aerospace Exploration Agency) for valuable input on this work and Mr P. Joshi for correcting the language of this manuscript.	Hojo M, 2001, ADV COMPOS MATER, V10, P237, DOI 10.1163/156855101753396717; [Anonymous], 1998, Hysol, Patent No. 5833802; Tan KT, 2010, J COMPOS MATER, V44, P3203, DOI 10.1177/0021998310369581; Blackman BRK, 2006, ENG FRACT MECH, V73, P2443, DOI 10.1016/j.engfracmech.2006.05.022; Mouritz AP, 1999, COMPOS PART A-APPL S, V30, P859, DOI 10.1016/S1359-835X(98)00197-3; Solaimurugan S, 2008, COMPOS SCI TECHNOL, V68, P1742, DOI 10.1016/j.compscitech.2008.02.008; Tan KT, 2013, COMPOS SCI TECHNOL, V74, P194, DOI 10.1016/j.compscitech.2012.11.001; Fu SY, 2000, COMPOS SCI TECHNOL, V60, P569, DOI 10.1016/S0266-3538(99)00157-8; Carlsson L. A., 1986, Journal of Reinforced Plastics and Composites, V5, DOI 10.1177/073168448600500302; Jain LK, 1998, COMPOS SCI TECHNOL, V58, P829, DOI 10.1016/S0266-3538(97)00186-3; Reeder JR, 2004, COMPOS PART A-APPL S, V35, P1337, DOI 10.1016/j.compositesa.2004.02.021; Wood MDK, 2007, COMPOS SCI TECHNOL, V67, P1058, DOI 10.1016/j.compscitech.2006.06.002; Feret V, 2013, APPL COMPOS MATER, V20, P415, DOI 10.1007/s10443-012-9276-5; Gill AF, 2009, COMPOS SCI TECHNOL, V69, P2368, DOI 10.1016/j.compscitech.2009.02.008; Dransfield KA, 1998, COMPOS SCI TECHNOL, V58, P815, DOI 10.1016/S0266-3538(97)00229-7; Ren J, 2011, TEXT RES J, V81, P335, DOI 10.1177/0040517510385172; Sankar BV, 1997, COMPOS SCI TECHNOL, V57, P729, DOI 10.1016/S0266-3538(97)00032-8; Tanzawa Y, 1999, COMPOS SCI TECHNOL, V59, P1261, DOI 10.1016/S0266-3538(98)00167-5; Mouritz AP, 2000, COMPOS PART A-APPL S, V31, P1, DOI 10.1016/S1359-835X(99)00056-1; Davies P, 1999, PLAST RUBBER COMPOS, V28, P432; Tan KT, 2011, J REINF PLAST COMP, V30, P99, DOI 10.1177/0731684410383065; [Anonymous], 1991, K7075 JIS JAP STAND; Fishpool DT, 2013, PLAST RUBBER COMPOS, V42, P108, DOI 10.1179/1743289812Y.0000000036; Mouritz AP, 2007, COMPOS PART A-APPL S, V38, P2383, DOI 10.1016/j.compositesa.2007.08.016; Brunner AJ, 2008, ENG FRACT MECH, V75, P2779, DOI 10.1016/j.engfracmech.2007.03.012; de Morais AB, 2004, COMPOS PART A-APPL S, V35, P51, DOI 10.1016/j.compositesa.2003.09.007; Wood MDK, 2007, J COMPOS MATER, V41, P1743, DOI 10.1177/0021998306069890; Carlsson L. A., 1989, MODE 2 INTERLAMINAR, P113; Chou I., 1995, 1230 ASTM STP, P132; de Moura MFSF, 2008, WOODHEAD PUBL MATER, P310, DOI 10.1533/9781845694821.3.310; Hufenbach W, 2013, MATER DESIGN, V50, P839, DOI 10.1016/j.matdes.2013.03.075; Japanese Standards Association, 1993, K7086 JIS JAP STAND, V7086; Lee SM, 1997, J MATER SCI, V32, P1287, DOI 10.1023/A:1018552506085; Mollon V, 2012, COMPOS STRUCT, V94, P1187, DOI 10.1016/j.compstruct.2011.10.025; Pereira AB, 2004, COMPOS SCI TECHNOL, V64, P1653, DOI 10.1016/j.compscitech.2003.12.001; Polaha JJ, 1996, J REINF PLAST COMP, V15, P141; Tong L, 2002, 3D FIBRE REINFORCED; Yudhanto A, 2013, COMPOS PART B-ENG, V46, P151, DOI 10.1016/j.compositesb.2012.10.003	38	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1465-8011	1743-2898		PLAST RUBBER COMPOS	Plast. Rubber Compos.	NOV	2014	43	9					300	308		10.1179/1743289814Y.0000000103		9	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	AT0OI	WOS:000344634800004		
J	Kinoshita-Kikuta, E; Kinoshita, E; Matsuda, A; Koike, T				Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Matsuda, Ayumi; Koike, Tohru			Tips on improving the efficiency of electrotransfer of target proteins from Phos-tag SDS-PAGE gel	PROTEOMICS			English	Article						Phosphoprotein; Phos-tag SDS-PAGE; Semidry blotting; Technology; Western blotting; Wet-tank blotting	ELECTROPHORESIS	The sensitivity of Western blotting analysis after Phos-tag SDS-PAGE is occasionally inferior to that after normal (Phos-tag-free) SDS-PAGE under similar experimental conditions, possibly as a result of inefficient electrotransfer from the Phos-tag gel to the blotting membrane. We therefore present tips on improving the efficiency of electrotransfer of proteins in semidry and wet-tank blotting. When model samples containing several standard phosphoproteins were subjected to semidry blotting, their electrotransfer efficiencies after Phos-tag SDS-PAGE were markedly inferior to those of their dephosphorylated counterparts in the same gel. This was ameliorated by immersing the electrophoresed Phos-tag gel in a transfer buffer containing 1 mM EDTA for 30 min before electroblotting. Similarly, phosphoproteomes in crude cell extracts were inefficiently transferred by semidry blotting, but the efficiencies of their electrotransfer were improved by pretreatment with EDTA. In contrast, the efficiencies of wet-tank blotting of the same samples were not dependent on the degree of phosphorylation, and the efficiencies of electrotransfer of all proteins from Phos-tag gels were similar to those from normal gels. In some cases involving the use of a Phos-tag gel, addition of 0.1% w/v of SDS to the transfer buffer significantly improved the electrotransfer.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Matsuda, Ayumi; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima 7348553, Japan	Kinoshita, E (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Kasumi 1-2-3, Hiroshima 7348553, Japan.	kinoeiji@hiroshima-u.ac.jp			KAKENHI [24590050, 25293005, 25560417, 25117718, 26460036]; Takeda Science Foundation	This work was supported in part by KAKENHI Grants (24590050, 25293005, 25560417, 25117718, and 26460036) and by a research grant from the Takeda Science Foundation.	Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kinoshita E, 2012, PROTEOMICS, V12, P932, DOI 10.1002/pmic.201100639; Kinoshita E, 2004, DALTON T, P1189, DOI 10.1039/b400269e; HIRANO H, 1990, ELECTROPHORESIS, V11, P573, DOI 10.1002/elps.1150110708; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; VANSEUNINGEN I, 1990, ANAL BIOCHEM, V186, P306, DOI 10.1016/0003-2697(90)90085-N	7	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	NOV	2014	14	21-22					2437	2442		10.1002/pmic.201400380		6	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT3AR	WOS:000344807600008		
J	Rahman, MA; Karl, K; Nonaka, M; Fujimura, H; Shinjo, R; Oomori, T; Worheide, G				Rahman, M. Azizur; Karl, Kristian; Nonaka, Masanori; Fujimura, Hiroyuki; Shinjo, Ryuichi; Oomori, Tamotsu; Woerheide, Gert			Characterization of the proteinaceous skeletal organic matrix from the precious coral Corallium konojoi	PROTEOMICS			English	Article						Animal proteomics; Biomineralization; Jewelry corals; Organic matrix proteins; Precious coral; Sclerites	RED CORAL; BIOMINERALIZATION PROCESSES; CLIMATE-CHANGE; SOFT CORAL; SCLERITES; RUBRUM; SHELL; SPICULES; CALCIFICATION; OCTOCORALLIA	The Japanese red and pink corals are known to be precious because of their commercial value resulting from their use in ornaments, jewelry, and medicine. Precious corals are very interesting models for biomineralization studies and possess two different skeletal structures: an axial skeleton and an endoskeleton (sclerites). Although it has long been known that the organic matrix proteins existing in coral skeletons are critical for the oriented precipitation of CaCO3 crystals, these proteins in moderate deep-sea Japanese precious corals remain uncharacterized. Therefore, in this study, we performed skeletal whole proteome analyses using 1D and 2D electrophoresis, nano-LC, and MALDI-TOF-TOF MS. We identified a total of 147 functional coral skeletal organic matrix proteins (120 from the sclerites and 36 from the axial skeleton), including two calcium-binding calmodulin. Among the organic matrix proteins identified, nine key proteins are highly typical and common in both skeletons. Strong glycosylation activity, which is essential for skeletal formation in calcifying organisms, was detected in both skeletons. This work demonstrates unique biomineralization-related proteins in precious corals and provides the first description of the major proteinaceous components of CaCO3 minerals in precious corals, enabling the comparative investigation of biocalcification in other octocorals.	[Rahman, M. Azizur] Univ Toronto, Dept Chem & Phys Sci, Toronto, ON M5S, Canada; [Rahman, M. Azizur; Karl, Kristian; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Rahman, M. Azizur; Fujimura, Hiroyuki; Oomori, Tamotsu] Univ Ryukyus, Fac Sci, Dept Chem, Okinawa, Japan; [Nonaka, Masanori] Okinawa Churaumi Aquarium, Motobu, Okinawa, Japan; [Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Okinawa, Japan; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBio Ctr, Munich, Germany	Rahman, MA (reprint author), Univ Toronto, Dept Chem & Phys Sci, Toronto, ON M5S, Canada.	mazizur.rahman@utoronto.ca	Worheide, Gert/C-1080-2008	Worheide, Gert/0000-0002-6380-7421	Japanese Society for the Promotion of Science (JSPS), Japan; Alexander von Humboldt Foundation, Germany	This work was supported by the Japanese Society for the Promotion of Science (JSPS), Japan, and the Alexander von Humboldt Foundation, Germany, through a research fellowship to MAR. The authors thank Dietrich Merkel and Christoph Kuntzsch (AB SCIEX, Germany) for assistance with the MALDI-TOF-TOF analysis.	Allemand D, 1996, J EXP ZOOL, V276, P270, DOI 10.1002/(SICI)1097-010X(19961101)276:4<270::AID-JEZ4>3.0.CO;2-L; Rahman MA, 2011, J BIOL CHEM, V286, P31638, DOI 10.1074/jbc.M109.070185; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; DEJONG EW, 1976, EUR J BIOCHEM, V70, P611; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Cvejic J, 2007, MAR BIOL, V152, P855, DOI 10.1007/s00227-007-0738-5; Dauphin Y, 2006, COMP BIOCHEM PHYS A, V145, P54, DOI 10.1016/j.cbpa.2006.04.029; Debreuil J, 2011, COMP BIOCHEM PHYS B, V159, P40, DOI 10.1016/j.cbpb.2011.01.007; Debreuil J, 2012, J BIOL CHEM, V287, P19367, DOI 10.1074/jbc.M112.352005; Floquet N, 2011, AM MINERAL, V96, P1228, DOI 10.2138/am.2011.3805; Grigg R. W., 1974, P 2 INT S COR REEFS, V2, P235; GRILLO MC, 1993, MAR BIOL, V117, P119, DOI 10.1007/BF00346433; KINGSLEY RJ, 1983, COMP BIOCHEM PHYS B, V76, P443, DOI 10.1016/0305-0491(83)90273-0; KOEHL MAR, 1982, J EXP BIOL, V98, P239; LEWIS JC, 1991, BIOL BULL, V181, P275, DOI 10.2307/1542099; Liverino B., 1989, RED CORAL JEWEL SEA, P9; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Nonaka M, 2009, MAR ECOL PROG SER, V397, P269, DOI 10.3354/meps08396; Rahman MA, 2005, J EXP MAR BIOL ECOL, V321, P71, DOI 10.1016/j.jembe.2005.01.012; Rahman MA, 2009, CONNECT TISSUE RES, V50, P285, DOI 10.3109/03008200802714933; Rahman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058781; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Ranson G, 1937, CR SOC BIOL, V126, P1149; TOMPA AS, 1977, COMP BIOCHEM PHYS B, V56, P279, DOI 10.1016/0305-0491(77)90016-5; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	NOV	2014	14	21-22					2600	2606		10.1002/pmic.201300519		7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT3AR	WOS:000344807600024		
J	Wardenaar, KJ; van Loo, HM; Cai, T; Fava, M; Gruber, MJ; Li, J; de Jonge, P; Nierenberg, AA; Petukhova, MV; Rose, S; Sampson, NA; Schoevers, RA; Wilcox, MA; Alonso, J; Bromet, EJ; Bunting, B; Florescu, SE; Fukao, A; Gureje, O; Hu, C; Huang, YQ; Karam, AN; Levinson, D; Mora, MEM; Posada-Villa, J; Scott, KM; Taib, NI; Viana, MC; Xavier, M; Zarkov, Z; Kessler, RC				Wardenaar, K. J.; van Loo, H. M.; Cai, T.; Fava, M.; Gruber, M. J.; Li, J.; de Jonge, P.; Nierenberg, A. A.; Petukhova, M. V.; Rose, S.; Sampson, N. A.; Schoevers, R. A.; Wilcox, M. A.; Alonso, J.; Bromet, E. J.; Bunting, B.; Florescu, S. E.; Fukao, A.; Gureje, O.; Hu, C.; Huang, Y. Q.; Karam, A. N.; Levinson, D.; Medina Mora, M. E.; Posada-Villa, J.; Scott, K. M.; Taib, N. I.; Viana, M. C.; Xavier, M.; Zarkov, Z.; Kessler, R. C.			The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity	PSYCHOLOGICAL MEDICINE			English	Article						Co-morbidity; data mining; depression subtypes; depression symptom profiles; elastic net; machine learning; predictive modeling; risk assessment	RECURSIVE PARTITIONING ANALYSIS; LARGE-SAMPLE; DISORDER; PREDICTORS; INPATIENTS; REMISSION; RISK; REGULARIZATION; SUICIDALITY; POPULATION	Background. Although variation in the long-term course of major depressive disorder (MDD) is not strongly predicted by existing symptom subtype distinctions, recent research suggests that prediction can be improved by using machine learning methods. However, it is not known whether these distinctions can be refined by added information about co-morbid conditions. The current report presents results on this question. Method. Data came from 8261 respondents with lifetime DSM-IV MDD in the World Health Organization (WHO) World Mental Health (WMH) Surveys. Outcomes included four retrospectively reported measures of persistence/severity of course (years in episode; years in chronic episodes; hospitalization for MDD; disability due to MDD). Machine learning methods (regression tree analysis; lasso, ridge and elastic net penalized regression) followed by k-means cluster analysis were used to augment previously detected subtypes with information about prior co-morbidity to predict these outcomes. Results. Predicted values were strongly correlated across outcomes. Cluster analysis of predicted values found three clusters with consistently high, intermediate or low values. The high-risk cluster (32.4% of cases) accounted for 56.6-72.9% of high persistence, high chronicity, hospitalization and disability. This high-risk cluster had both higher sensitivity and likelihood ratio positive (LR+; relative proportions of cases in the high-risk cluster versus other clusters having the adverse outcomes) than in a parallel analysis that excluded measures of co-morbidity as predictors. Conclusions. Although the results using the retrospective data reported here suggest that useful MDD subtyping distinctions can be made with machine learning and clustering across multiple indicators of illness persistence/severity, replication with prospective data is needed to confirm this preliminary conclusion.	[Wardenaar, K. J.; van Loo, H. M.; de Jonge, P.; Schoevers, R. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 AB Groningen, Netherlands; [Cai, T.; Li, J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fava, M.] Massachusetts Gen Hosp, Dept Psychiat, Depress Clin & Res Program, MGH Clin Trials Network & Inst, Boston, MA 02114 USA; [Gruber, M. J.; Petukhova, M. V.; Rose, S.; Sampson, N. A.; Kessler, R. C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Nierenberg, A. A.] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA 02114 USA; [Nierenberg, A. A.] Massachusetts Gen Hosp, Bipolar Clin, Boston, MA 02114 USA; [Nierenberg, A. A.] Massachusetts Gen Hosp, Res Program, Boston, MA 02114 USA; [Nierenberg, A. A.] Harvard Univ, Sch Med, Boston, MA USA; [Wilcox, M. A.] Johnson & Johnson Pharmaceut Res & Dev, Titusville, NJ USA; [Alonso, J.] Pompeu Fabra Univ UPF, IMIM, Hosp del Mar, Res Inst,Parc Salut Mar, Barcelona, Spain; [Alonso, J.] CIBERESP, Barcelona, Spain; [Bromet, E. J.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA; [Bunting, B.] Univ Ulster, Psychol Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Florescu, S. E.] Natl Sch Publ Hlth Management & Profess Dev, Bucharest, Romania; [Fukao, A.] Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata 990, Japan; [Gureje, O.] Univ Coll Hosp, Ibadan, Nigeria; [Hu, C.] Shenzhen Inst Mental Hlth, Shenzhen, Guangdong, Peoples R China; [Hu, C.] Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China; [Huang, Y. Q.] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Karam, A. N.] Balamand Univ, St George Hosp Univ Med Ctr, Dept Psychiat & Clin Psychol, Fac Med,Med Sch, Beirut, Lebanon; [Karam, A. N.] IDRAAC, Beirut, Lebanon; [Levinson, D.] Minist Hlth, Mental Hlth Serv, Jerusalem, Israel; [Medina Mora, M. E.] Calzada Mexico Xochimilco, Natl Inst Psychiat, Mexico City, DF, Mexico; [Posada-Villa, J.] Univ Colegio Mayor Cundinamarca, Bogota, Colombia; [Scott, K. M.] Univ Otago, Dept Psychol Med, Dunedin, New Zealand; [Taib, N. I.] Mental Hlth Ctr Duhok, Duhok, Kurdistan Regio, Iraq; [Viana, M. C.] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Brazil; [Xavier, M.] Univ Nova Lisboa, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Zarkov, Z.] Natl Ctr Publ Hlth & Anal, Dept Mental Hlth, Sofia, Bulgaria	Kessler, RC (reprint author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Alonso, Jordi/A-5514-2010; Wardenaar, Klaas/E-2985-2013	Alonso, Jordi/0000-0001-8627-9636; 			Alonso J, 2013, BURDENS OF MENTAL DISORDERS: GLOBAL PERSPECTIVES FROM THE WHO WORLD MENTAL HEALTH SURVEYS, P1; Altman D. G., 2000, STAT CONFIDENCE CONF; Andreescu C, 2008, AM J PSYCHIAT, V165, P855, DOI 10.1176/appi.ajp.2008.07081340; Vrieze E, 2014, J AFFECT DISORDERS, V155, P35, DOI 10.1016/j.jad.2013.10.020; Patten SB, 2010, CAN J PSYCHIAT, V55, P669; Clark LA, 2006, BRIT J PSYCHIAT, V189, P481, DOI 10.1192/bjp.bp.106.03825; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Jain FA, 2013, DEPRESS ANXIETY, V30, P624, DOI 10.1002/da.22045; COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Rhebergen D, 2012, PSYCHOL MED, V42, P1383, DOI 10.1017/S0033291711002509; Cooper C, 2007, PSYCHOL MED, V37, P1273, DOI 10.1017/S0033291707000116; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Uher R, 2011, J AFFECT DISORDERS, V132, P112, DOI 10.1016/j.jad.2011.02.014; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Friedman J, 2010, J STAT SOFTW, V33, P1; Rabinowitz JD, 2013, NATURE, V500, P283, DOI 10.1038/nature12544; Lamers F, 2012, BRIT J PSYCHIAT, V201, P143, DOI 10.1192/bjp.bp.111.098079; Musil R, 2013, EUR NEUROPSYCHOPHARM, V23, P663, DOI 10.1016/j.euroneuro.2012.08.009; Steinert C, 2014, J AFFECT DISORDERS, V152, P65, DOI 10.1016/j.jad.2013.10.017; Atkinson B, 2012, RPART RECURSIVE PART; Baumeister H, 2012, J AFFECT DISORDERS, V139, P126, DOI DOI 10.1016/J.JAD.2011.07.015; Berk RA, 2003, REGRESSION ANAL CONS, Vlist; Berk RA, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-77501-2_1; Bottomley C, 2010, BRIT J PSYCHIAT, V196, P13, DOI 10.1192/bjp.bp.109.067116; Candrian M, 2007, J NERV MENT DIS, V195, P729, DOI 10.1097/NMD.0b013e318142cbd5; Carragher N, 2009, J AFFECT DISORDERS, V113, P88, DOI 10.1016/j.jad.2008.05.015; Chan SS, 2013, J STEM CELL RES THER, V3, pe114; Chang YJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-2; Chao ST, 2012, INT J RADIAT ONCOL, V82, P1738, DOI 10.1016/j.ijrobp.2011.02.019; DRAPER N., 1981, APPL REGRESSION ANAL; Endicott J, 1978, FAMILY HIST RES DIAG; Fink M, 2007, J ECT, V23, P139, DOI 10.1097/yct.0b013e3180337344; First M. B., 2002, STRUCTURED CLIN INTE; van Loo HM, 2014, DEPRESS ANXIETY, V31, P765, DOI 10.1002/da.22233; Harkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91; Hastie T., 2009, ELEMENTS STAT LEARNI; Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14; Ilgen MA, 2009, J CLIN PSYCHIAT, V70, P1495, DOI 10.4088/JCP.08m04795; James G., 2013, INTRO STAT LEARNING; Kessler RC, 2008, WHO WORLD MENTAL HLT; Knauper B., 1999, INT J METH PSYCH RES, V8, P39, DOI DOI 10.1002/MPR.55; Lumley T., 2004, J STAT SOFTW, V9, P1; Nelson JC, 2012, CURR MED RES OPIN, V28, P325, DOI 10.1185/03007995.2011.654010; Nock MK, 2012, SUICIDE GLOBAL PERSP; Pennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33; R Core Team, 2013, R LANG ENV STAT COMP; Rabinoff M, 2011, Open Med Inform J, V5, P1, DOI 10.2174/1874431101105010001; Rayner BS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000023; Riedel M, 2011, J AFFECT DISORDERS, V133, P137, DOI 10.1016/j.jad.2011.04.007; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Scott KM, 2009, GLOBAL PERSPECTIVES; Seemuller F, 2009, INT J NEUROPSYCHOPH, V12, P181, DOI 10.1017/S1461145708009139; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156; Wolter KM, 1985, INTRO VARIANCE ESTIM; World Bank, 2009, DAT STAT COUNTR GROU; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	64	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	NOV	2014	44	15					3289	3302		10.1017/S0033291714000993		14	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	AS7YN	WOS:000344467900013		
J	Yamaguchi, T; Takeda, S; Nishimura, Y; Iida, Y; Tanaka, T				Yamaguchi, Tetsuji; Takeda, Seiji; Nishimura, Yuki; Iida, Yoshihisa; Tanaka, Tadao			An attempt to select thermodynamic data and to evaluate the solubility of radioelements with uncertainty under HLW disposal conditions	RADIOCHIMICA ACTA			English	Article						Solubility; Thermodynamic data; High-level radioactive waste; Uncertainty; Groundwater chemistry; Database	COMPLEXES; HYDROXIDE	An attempt was made to select thermodynamic data with uncertainties and to evaluate the solubility of radioelements with uncertainties considering the uncertainties of the thermodynamic data and variation in groundwater chemistry. The thermodynamic data were selected by reviewing the JAEA-TDB released in 2012 from the viewpoint of consistency of the data selection process, the conservativeness of the solubility evaluation and testing up-to-date data. A Monte Carlo-based probabilistic solubility calculation code, PA-SOL, was used for the uncertainty analysis of the solubility. The uncertainty analysis for the solubility of 13 elements showed large uncertainties for Nb, Tc and U. The variations in pH, pe and total carbonate concentration assumed in this study induce significant uncertainties to the evaluated solubility. The reactions whose log K-0 with uncertainties induce significant uncertainties to the evaluated solubilities were identified.	[Yamaguchi, Tetsuji; Takeda, Seiji; Nishimura, Yuki; Iida, Yoshihisa; Tanaka, Tadao] Japan Atom Energy Agcy, Nucl Safety Res Ctr, Tokai, Ibaraki 3191195, Japan	Yamaguchi, T (reprint author), Japan Atom Energy Agcy, Nucl Safety Res Ctr, Tokai, Ibaraki 3191195, Japan.	yamaguchi.tetsuji@jaea.go.jp					Neck V, 2003, RADIOCHIM ACTA, V91, P253, DOI 10.1524/ract.91.5.253.20306; [Anonymous], 2000, SKI REPORT 00 47; Fujiwara K, 2005, RADIOCHIM ACTA, V93, P347, DOI 10.1524/ract.93.6.347.65643; Duro L., 2006, SKB TR 06 32; Fellhauer D, 2010, RADIOCHIM ACTA, V98, P541, DOI 10.1524/ract.2010.1751; Iida Y., 2009, P MOB FISS ACT PROD, P135; Iida Y, 2010, J NUCL SCI TECHNOL, V47, P431, DOI 10.3327/jnst.47.431; Iman R. L., 1984, NUREG CR 3624; Japan Nuclear Cycle Development Institute, 2000, JNC TN1410 2000 004; Kitamura A., 2012, JAEA DATA CODE 2012; Lothenbach B., 1999, JNC TN8400 99 011; Oda C, 1996, MATER RES SOC SYMP P, V412, P881; Oda C., 1999, JNC TN8400 99 078; Parkhurst D.L., 1999, WATER RESOURCES INVE; Saltelli A., 1992, EUR 13924; Swedish Nuclear Fuel and Waste Management Co, 2000, SKB TR 10 52; van Middlesworth JM, 1999, GEOCHIM COSMOCHIM AC, V63, P1751, DOI 10.1016/S0016-7037(99)00058-7; Wolery T. J., 1992, UCRL MA 110662 PT I; WOOD SA, 1991, GEOCHIM COSMOCHIM AC, V55, P1759, DOI 10.1016/0016-7037(91)90021-V; Yajima T., 1994, YAYOI KENKYUKAI REPO, P127; Yamaguchi T., 2013, PRESENTED AT 14TH IN; Yamaguchi T, 2013, CLAY MINER, V48, P185, DOI 10.1180/claymin.2013.048.2.03	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-8230			RADIOCHIM ACTA	Radiochim. Acta	NOV	2014	102	11					999	1008		10.1515/ract-2014-2248		10	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AT0KM	WOS:000344625100005		
J	Itoh, Y; Oasa, Y; Kudo, T; Kusakabe, N; Hashimoto, J; Abe, L; Brandner, W; Brandt, TD; Carson, JC; Egner, S; Feldt, M; Grady, CA; Guyon, O; Hayano, Y; Hayashi, M; Hayashi, SS; Henning, T; Hodapp, KW; Ishii, M; Iye, M; Janson, M; Kandori, R; Knapp, GR; Kuzuhara, M; Kwon, J; Matsuo, T; McElwain, MW; Miyama, S; Morino, JI; Moro-Martin, A; Nishimura, T; Pyo, TS; Serabyn, E; Suenaga, T; Suto, H; Suzuki, R; Takahashi, YH; Takato, N; Terada, H; Thalmann, C; Tomono, D; Turner, EL; Watanabe, M; Wisniewski, J; Yamada, T; Mayama, S; Currie, T; Takami, H; Usuda, T; Tamura, M				Itoh, Yoichi; Oasa, Yumiko; Kudo, Tomoyuki; Kusakabe, Nobuhiko; Hashimoto, Jun; Abe, Lyu; Brandner, Wolfgang; Brandt, Timothy D.; Carson, Joseph C.; Egner, Sebastian; Feldt, Markus; Grady, Carol A.; Guyon, Olivier; Hayano, Yutaka; Hayashi, Masahiko; Hayashi, Saeko S.; Henning, Thomas; Hodapp, Klaus W.; Ishii, Miki; Iye, Masanori; Janson, Markus; Kandori, Ryo; Knapp, Gillian R.; Kuzuhara, Masayuki; Kwon, Jungmi; Matsuo, Taro; McElwain, Michael W.; Miyama, Shoken; Morino, Jun-Ichi; Moro-Martin, Amaya; Nishimura, Tetsuo; Pyo, Tae-Soo; Serabyn, Eugene; Suenaga, Takuya; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takato, Naruhisa; Terada, Hiroshi; Thalmann, Christian; Tomono, Daigo; Turner, Edwin L.; Watanabe, Makoto; Wisniewski, John; Yamada, Toru; Mayama, Satoshi; Currie, Thayne; Takami, Hideki; Usuda, Tomonori; Tamura, Motohide			Near-infrared polarimetry of the GG Tauri A binary system	RESEARCH IN ASTRONOMY AND ASTROPHYSICS			English	Article						stars: individual (GG Tauri); stars: pre-main sequence; techniques: high angular resolution	CIRCUMBINARY DISK; CIRCUMSTELLAR DISK; RING; ACCRETION; DYNAMICS; IMAGES	A high angular resolution near-infrared image that shows the intensity of polarization for the GG Tau A binary system was obtained with the Subaru Telescope. The image shows a circumbinary disk scattering the light from the central binary. The azimuthal profile of the intensity of polarization for the circumbinary disk is roughly reproduced by a simple disk model with the Henyey-Greenstein phase function and the Rayleigh function, indicating there are small dust grains at the surface of the disk. Combined with a previous observation of the circumbinary disk, our image indicates that the gap structure in the circumbinary disk orbits counterclockwise, but material in the disk orbits clockwise. We propose that there is a shadow caused by material located between the central binary and the circumbinary disk. The separations and position angles of the stellar components of the binary in the past 20 yr are consistent with the binary orbit with a = 33.4 AU and e = 0.34.	[Itoh, Yoichi] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Oasa, Yumiko] Saitama Univ, Fac Educ, Sakura, Saitama 3388570, Japan; [Kudo, Tomoyuki; Egner, Sebastian; Guyon, Olivier; Hayano, Yutaka; Hayashi, Saeko S.; Ishii, Miki; Nishimura, Tetsuo; Pyo, Tae-Soo; Takato, Naruhisa; Terada, Hiroshi; Tomono, Daigo] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Kusakabe, Nobuhiko; Hayashi, Masahiko; Iye, Masanori; Kandori, Ryo; Kwon, Jungmi; Morino, Jun-Ichi; Suto, Hiroshi; Suzuki, Ryuji; Takahashi, Yasuhiro H.; Takami, Hideki; Usuda, Tomonori; Tamura, Motohide] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Hashimoto, Jun; Wisniewski, John] Univ Oklahoma, HL Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Abe, Lyu] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Lagrange UMR 7293, F-06108 Nice 2, France; [Brandner, Wolfgang] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Brandt, Timothy D.; Janson, Markus; Knapp, Gillian R.; Turner, Edwin L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Carson, Joseph C.; Feldt, Markus] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Grady, Carol A.; McElwain, Michael W.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Grady, Carol A.] Eureka Sci, Oakland, CA 96002 USA; [Grady, Carol A.] Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; [Hodapp, Klaus W.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [Kuzuhara, Masayuki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Matsuo, Taro] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Miyama, Shoken] Hiroshima Univ, Higashihiroshima, Hiroshima 7398511, Japan; [Moro-Martin, Amaya] CAB CSIC INTA, Dept Astrophys, Madrid 28850, Spain; [Serabyn, Eugene] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Suenaga, Takuya] Grad Univ Adv Studies, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Takahashi, Yasuhiro H.; Tamura, Motohide] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Thalmann, Christian] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Turner, Edwin L.] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778568, Japan; [Watanabe, Makoto] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, Toru] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Mayama, Satoshi] Grad Univ Adv Studies SOKENDAI, Ctr Promot Integrated Sci, Hayama, Kanagawa 2400193, Japan; [Currie, Thayne] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada	Itoh, Y (reprint author), Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, 407-2 Nishigaichi, Sayo, Hyogo 6795313, Japan.	yitoh@nhao.jp	MIYAMA, Shoken/A-3598-2015		U.S. National Science Foundation [1009203];  [24540231]	We thank Dr. Michihiro Takami for a useful discussion. Y. I. is supported by a Grant-in-Aid for Scientific Research (No. 24540231). J. C. is supported by the U.S. National Science Foundation under Award (No. 1009203).	LEINERT C, 1993, ASTRON ASTROPHYS, V278, P129; Duchene G, 2004, ASTROPHYS J, V606, P969, DOI 10.1086/383126; GHEZ AM, 1993, ASTRON J, V106, P2005, DOI 10.1086/116782; Krist JE, 2002, ASTROPHYS J, V570, P785, DOI 10.1086/339777; Roddier C, 1996, ASTROPHYS J, V463, P326, DOI 10.1086/177245; Guilloteau S, 1999, ASTRON ASTROPHYS, V348, P570; Mayer L, 2004, ASTROPHYS J, V609, P1045, DOI 10.1086/421288; Artymowicz P, 1996, ASTROPHYS J, V467, pL77, DOI 10.1086/310200; Bate MR, 1997, MON NOT R ASTRON SOC, V285, P33; Beust H, 2005, ASTRON ASTROPHYS, V439, P585, DOI 10.1051/0004-6361:20042441; Beust H, 2006, ASTRON ASTROPHYS, V446, P137, DOI 10.1051/0004-6361:20053163; Fukagawa M, 2004, ASTROPHYS J, V605, pL53, DOI 10.1086/420699; Grinin V, 2008, ASTRON ASTROPHYS, V489, P1233, DOI 10.1051/0004-6361:200810349; Hanawa T, 2010, ASTROPHYS J, V708, P485, DOI 10.1088/0004-637X/708/1/485; Hioki T, 2007, ASTRON J, V134, P880, DOI 10.1086/519737; Hioki T, 2011, PUBL ASTRON SOC JPN, V63, P543; Itoh Y, 2002, PUBL ASTRON SOC JPN, V54, P963; KAWABE R, 1993, ASTROPHYS J, V404, pL63, DOI 10.1086/186744; Kusakabe N, 2005, ASTROPHYS J, V632, pL139, DOI 10.1086/497912; Pietu V, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015682; Potter D., 2001, BAAS, V33, P812; Shu FH, 2000, ASTROPHYS J, V535, P190, DOI 10.1086/308837; Silber J, 2000, ASTROPHYS J, V536, pL89, DOI 10.1086/312731; Tanii R, 2012, PUBL ASTRON SOC JPN, V64; WHITE RL, 1979, ASTROPHYS J, V229, P954, DOI 10.1086/157029; White RJ, 1999, ASTROPHYS J, V520, P811, DOI 10.1086/307494	26	0	0	NATL ASTRONOMICAL OBSERVATORIES, CHIN ACAD SCIENCES	BEIJING	20A DATUN RD, CHAOYANG, BEIJING, 100012, PEOPLES R CHINA	1674-4527			RES ASTRON ASTROPHYS	Res. Astron. Astrophys.	NOV	2014	14	11					1438	1446		10.1088/1674-4527/14/11/007		9	Astronomy & Astrophysics	Astronomy & Astrophysics	AT0BG	WOS:000344601200007		
J	Hojo, M; Iikura, M; Suzuki, M; Sugiyama, H				Hojo, M.; Iikura, M.; Suzuki, M.; Sugiyama, H.			ADD-ON EFFECT OF TIOTROPIUM BROMIDE TO ICS/LABA COMBINATION INHALER FOR PERIPHERAL AIRWAYS AMONG PATIENTS WITH SEVERE UNCONTROLLED ASTHMA	RESPIROLOGY			English	Meeting Abstract									[Hojo, M.; Iikura, M.; Suzuki, M.; Sugiyama, H.] Natl Ctr Global Hlth & Med, Div Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-A-010	4	4		10.1111/resp.12416_10		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300010		
J	Saji, J; Yamamoto, T; Arai, M; Mineshita, M; Miyazawa, T				Saji, J.; Yamamoto, T.; Arai, M.; Mineshita, M.; Miyazawa, T.			LONG-TERM EFFICACY OF OMALIZUMAB IN PATIENTS WITH SEVERE ASTHMA	RESPIROLOGY			English	Meeting Abstract									[Saji, J.; Yamamoto, T.] Kawasaki Municipal Tama Hosp, Dept Internal Med, Div Resp Dis, Kawasaki, Kanagawa, Japan; [Arai, M.] Tsurukawa Mem Hosp, Tokyo, Japan; [Mineshita, M.; Miyazawa, T.] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Miyazaki, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-A-019	7	7		10.1111/resp.12417_2		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300019		
J	Misawa, M; Nomori, H; Nakashima, K; Aoshima, M				Misawa, M.; Nomori, H.; Nakashima, K.; Aoshima, M.			BRONCHOSCOPIC LIPIODOL-MARKING UTILIZING DIAGNOSTIC GUIDED-BRONCHOSCOPY TO FACILITATE MINIMAL SURGERY FOR SMALL PULMONARY NODULE	RESPIROLOGY			English	Meeting Abstract									[Misawa, M.; Nakashima, K.; Aoshima, M.] Kameda Med Ctr, Dept Pulm, Kamogawa, Japan; [Nomori, H.] Kameda Med Ctr, Dept Thorac Surg, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-B-001	8	8		10.1111/resp.12417_3		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300020		
J	Nobuyama, S; Muraoka, H; Okamoto, M; Inoue, T; Furuya, N; Handa, H; Nishine, H; Ishida, A; Inoue, T; Mineshita, M; Miyazawa, T				Nobuyama, S.; Muraoka, H.; Okamoto, M.; Inoue, T.; Furuya, N.; Handa, H.; Nishine, H.; Ishida, A.; Inoue, T.; Mineshita, M.; Miyazawa, T.			FUNCTIONAL BRONCHOSCOPY IN THE MANAGEMENT OF AIRWAY STENOSIS DUE TO TRACHEOBRONCHIAL TUBERCULOSIS	RESPIROLOGY			English	Meeting Abstract									[Nobuyama, S.; Muraoka, H.; Okamoto, M.; Inoue, T.; Furuya, N.; Handa, H.; Nishine, H.; Ishida, A.; Inoue, T.; Mineshita, M.; Miyazawa, T.] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-B-003	8	8		10.1111/resp.12417_5		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300022		
J	Ise, Y; Oki, M; Saka, H; Kitagawa, C; Kogure, Y; Oka, S; Tsuboi, R; Nakahata, M; Hori, K; Murakami, Y				Ise, Y.; Oki, M.; Saka, H.; Kitagawa, C.; Kogure, Y.; Oka, S.; Tsuboi, R.; Nakahata, M.; Hori, K.; Murakami, Y.			TALC POUDRAGE USING CATHETER THROUGH FLEXI-RIGID THORACOSCOPE UNDER LOCAL ANESTHESIA FOR MALIGNANT PLEURAL EFFUSIONS	RESPIROLOGY			English	Meeting Abstract									[Ise, Y.; Oki, M.; Saka, H.; Kitagawa, C.; Kogure, Y.; Oka, S.; Tsuboi, R.; Nakahata, M.; Hori, K.; Murakami, Y.] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-B-006	9	9		10.1111/resp.12417_7		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300024		
J	Izumo, T; Sasada, S; Chavez, C; Matsumoto, Y; Hayama, M; Tsuchida, T				Izumo, T.; Sasada, S.; Chavez, C.; Matsumoto, Y.; Hayama, M.; Tsuchida, T.			ENDOBRONCHIAL ULTRASOUND ELASTOGRAPHY IN THE DIAGNOSIS OF MEDIASTINAL AND HILAR LYMPH NODES	RESPIROLOGY			English	Meeting Abstract									[Izumo, T.; Sasada, S.; Chavez, C.; Matsumoto, Y.; Hayama, M.; Tsuchida, T.] Natl Canc Ctr, Resp Endoscopy Div, Dept Endoscopy, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-B-005	9	9		10.1111/resp.12417_6		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300023		
J	He, M; Morimoto, K; Fujino, N; Suzuki, T; Takahasi, T; Yamada, M; Yamaya, M; Yamamoto, Y; Yamamoto, H; Qiu, Z; Kubo, H				He, M.; Morimoto, K.; Fujino, N.; Suzuki, T.; Takahasi, T.; Yamada, Mitsuhiro; Yamaya, M.; Yamamoto, Y.; Yamamoto, H.; Qiu, Z.; Kubo, Hiroshi			THE ROLE OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN LPS-INDUCED LUNG INJURY IN MICE	RESPIROLOGY			English	Meeting Abstract									[He, M.; Qiu, Z.] Tongji Univ, Sch Med, Tongji Hosp, Dept Resp Med, Shanghai 200092, Peoples R China; [He, M.; Fujino, N.; Yamaya, M.; Kubo, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Adv Prevent Med Infect Dis, Sendai, Miyagi 980, Japan; [Morimoto, K.] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Suzuki, T.] Tohoku Univ, Sch Med, Dept Thorac Surg, Sendai, Miyagi 980, Japan; [Takahasi, T.] Tohoku Univ, Sch Med, Dept Anesthesiol, Sendai, Miyagi 980, Japan; [Yamada, Mitsuhiro] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 980, Japan; [Yamamoto, Y.; Yamamoto, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-C-004	10	10		10.1111/resp.12417_11		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300028		
J	Matsushita, I; Hijikata, M; Ito, H; Keicho, N				Matsushita, I; Hijikata, M.; Ito, H.; Keicho, N.			AN IN VITRO MODEL OF SICK BUILDING SYNDROME USING HUMAN BRONCHIAL EPITHELIAL CELLS	RESPIROLOGY			English	Meeting Abstract									[Matsushita, I; Hijikata, M.; Keicho, N.] Res Inst TB JATA, Dept Pathophysiol & Host Def, Tokyo, Japan; [Hijikata, M.; Keicho, N.] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan; [Ito, H.] Natl Ctr Global Hlth & Med, Dept Thorac Surg, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-C-003	10	10		10.1111/resp.12417_10		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300027		
J	Takeuchi, M; Hirono, Y; Tanaka, Y; Inoue, S; Tanahashi, Y; Sakura, M				Takeuchi, M.; Hirono, Y.; Tanaka, Y.; Inoue, S.; Tanahashi, Y.; Sakura, M.			TOBACCO SMOKE EXPOSURE ALTERS IMMUNE FUNCTIONS MEDIATED WITH DNA DAMAGE IN ALVEOLAR MACROPHAGE (AM)	RESPIROLOGY			English	Meeting Abstract									[Takeuchi, M.; Hirono, Y.; Tanaka, Y.; Inoue, S.; Tanahashi, Y.; Sakura, M.] Kyoto Sangyo Univ, Dept Anim Med Sci, Kyoto 603, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-D-003	12	12		10.1111/resp.12417_15		1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300032		
J	Ando, K; Seyama, K; Kobayashi, E; Ebana, H; Hoshika, Y; Takahashi, K				Ando, K.; Seyama, K.; Kobayashi, E.; Ebana, H.; Hoshika, Y.; Takahashi, K.			PREGNANCY DOESN'T ALWAYS CAUSE DETERIORATION OF LYMPHANGIOLEIOMYOMATOSIS	RESPIROLOGY			English	Meeting Abstract									Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-E-005	16	16				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300040		
J	Baskoro, H; Sato, T; Mitsui, A; Suzuki, Y; Takahashi, F; Kato, M; Nurwidya, F; Seyama, K; Takahashi, K				Baskoro, H.; Sato, T.; Mitsui, A.; Suzuki, Y.; Takahashi, F.; Kato, M.; Nurwidya, F.; Seyama, K.; Takahashi, K.			MIR-146A PLAYS PATHOGENIC ROLE IN ABNORMAL INFLAMMATORY RESPONSE OF A MURINE COPD MODEL	RESPIROLOGY			English	Meeting Abstract									[Baskoro, H.; Sato, T.; Mitsui, A.; Suzuki, Y.; Takahashi, F.; Kato, M.; Nurwidya, F.; Seyama, K.; Takahashi, K.] Juntendo Univ, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-F-007	18	18				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300048		
J	Kobayashi, T				Kobayashi, T.			MILD TO MODERATE AIRFLOW OBSTRUCTION IS NOT DIRECTLY ASSOCIATED WITH CORONARY ARTERIOSCLEROSIS BUT IS ASSOCIATED WITH THE ELEVATION OF SERUM CREATININE LEVELS	RESPIROLOGY			English	Meeting Abstract									[Kobayashi, T.] Natl Hosp Org, Kinki Chuo Chest Hosp, Dept Resp Med, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-F-006	18	18				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300047		
J	Nakashima, K; Aoshima, M; Katsurada, N; Kaneko, N; Otsuka, Y; Ishifuji, T; Morimoto, K; Ariyoshi, K				Nakashima, K.; Aoshima, M.; Katsurada, N.; Kaneko, N.; Otsuka, Y.; Ishifuji, T.; Morimoto, K.; Ariyoshi, K.			CLINICAL IMPACT OF COMBINED VIRAL AND BACTERIAL INFECTION IN COPD PATIENTS WITH COMMUNITY-ONSET PNEUMONIA	RESPIROLOGY			English	Meeting Abstract									[Nakashima, K.; Aoshima, M.; Katsurada, N.; Kaneko, N.; Otsuka, Y.; Ishifuji, T.; Morimoto, K.; Ariyoshi, K.] APSG J, Tokyo, Japan; [Nakashima, K.; Aoshima, M.; Katsurada, N.; Kaneko, N.] Kameda Med Ctr, Dept Pulmonol, Tokyo, Japan; [Otsuka, Y.] Kameda Med Ctr, Dept Lab Med, Tokyo, Japan; [Ishifuji, T.; Morimoto, K.; Ariyoshi, K.] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaka, Yamanashi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-F-013	20	20				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300054		
J	Sato, T; Suzuki, Y; Baskoro, H; Nurwidya, F; Mori, T; Maeda, M; Abe, M; Hino, O; Takahashi, K				Sato, T.; Suzuki, Y.; Baskoro, H.; Nurwidya, F.; Mori, T.; Maeda, M.; Abe, M.; Hino, O.; Takahashi, K.			NEWLY ESTABLISHED ELISA FOR N-ERC/MESOTHELIN IMPROVES DIAGNOSTIC ACCURACY IN PATIENTS WITH SUSPECTED PLEURAL MESOTHELIOMA	RESPIROLOGY			English	Meeting Abstract									[Sato, T.; Suzuki, Y.; Baskoro, H.; Nurwidya, F.; Mori, T.; Maeda, M.; Abe, M.; Hino, O.; Takahashi, K.] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-H-003	26	26				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300075		
J	Umeda, A; Kato, T; Mochizuki, T; Watanabe, T; Yamane, T; Miyagawa, K; Takeda, H; Okada, Y				Umeda, A.; Kato, T.; Mochizuki, T.; Watanabe, T.; Yamane, T.; Miyagawa, K.; Takeda, H.; Okada, Y.			EFFECT OF INCOMPLETE SMOKING CESSATION WITH VARENICLINE OR NICOTINE PATCH ON VASCULAR ENDOTHELIAL FUNCTION AS ASSESSED BY FLOW-MEDIATED VASODILATION	RESPIROLOGY			English	Meeting Abstract									[Umeda, A.; Mochizuki, T.; Watanabe, T.; Yamane, T.] Int Univ Hlth & Welf, Dept Internal Med, Shioya Hosp, Otawara, Tochigi, Japan; [Kato, T.] Natl Hosp Org Tochigi Med Ctr, Dept Clin Res, Utsunomiya, Tochigi, Japan; [Miyagawa, K.; Takeda, H.] Int Univ Hlth & Welf, Sch Pharm, Dept Pharmacol, Otawara, Tochigi, Japan; [Okada, Y.] Murayama Med Ctr, Div Internal Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-H-002	26	26				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300074		
J	Ishii, H; Tazawa, R; Inoue, Y; Ishida, M; Koide, T; Saraya, T; Nakata, K				Ishii, H.; Tazawa, R.; Inoue, Y.; Ishida, M.; Koide, T.; Saraya, T.; Nakata, K.			CLINICAL CHARACTERISTICS OF SECONDARY PULMONARY ALVEOLAR PROTEINOSIS (SPAP): THE REASON FOR THE DIFFICULTY OF DIAGNOSIS AS SPAP (JSPS KAKENHI GRANT NUMBER 26305028)	RESPIROLOGY			English	Meeting Abstract									[Ishii, H.; Ishida, M.; Koide, T.; Saraya, T.] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan; [Tazawa, R.; Nakata, K.] Niigata Univ, Med & Dent Hosp, Biomed Sci Res Ctr, Niigata 95021, Japan; [Inoue, Y.] NHO Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-002	28	28				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300079		
J	Matsumuro, A; Hirose, M; Arai, T; Sugimoto, C; Kitaichi, M; Akira, M; Inoue, Y				Matsumuro, A.; Hirose, M.; Arai, T.; Sugimoto, C.; Kitaichi, M.; Akira, M.; Inoue, Y.			LONG TERM FOLLOW-UP OF SERUM AUTOANTIBODY AGAINST GM-CSF LEVELS IN PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	RESPIROLOGY			English	Meeting Abstract									[Matsumuro, A.; Hirose, M.; Arai, T.; Sugimoto, C.; Kitaichi, M.; Akira, M.; Inoue, Y.] Natl Hosp Org Kinki Chuo Chest Med Ctr, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-003	28	28				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300080		
J	Richeldi, L; Du Bois, RM; Raghu, G; Azuma, A; Brown, KK; Costabel, U; Cottin, V; Flaherty, KR; Inoue, Y; Kim, DS; Kolb, M; Noble, PW; Selman, M; Taniguchi, H; Brun, M; Girard, M; Schlenker-Herceg, R; Disse, B; Collard, HR				Richeldi, L.; Du Bois, R. M.; Raghu, G.; Azuma, A.; Brown, K. K.; Costabel, U.; Cottin, V; Flaherty, K. R.; Inoue, Y.; Kim, D. S.; Kolb, M.; Noble, P. W.; Selman, M.; Taniguchi, H.; Brun, M.; Girard, M.; Schlenker-Herceg, R.; Disse, B.; Collard, H. R.		INPULSIS Trial Investigators	EFFICACY AND SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: RESULTS OF TWO 52-WEEK, PHASE III, RANDOMIZED, PLACEBO-CONTROLLED TRIALS (INPULSIS (TM))	RESPIROLOGY			English	Meeting Abstract									[Richeldi, L.] Natl Inst Hlth Res, Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Richeldi, L.] Univ Southampton, Southampton, Hants, England; [Du Bois, R. M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Raghu, G.] Univ Washington, Seattle, WA 98195 USA; [Azuma, A.] Nippon Med Sch, Tokyo 113, Japan; [Brown, K. K.] Natl Jewish Hlth, Denver, CO USA; [Costabel, U.] Univ Duisburg Essen, Univ Hosp, Ruhrlandklin, Essen, Germany; [Cottin, V] Univ Lyon, Louis Pradel Hosp, Lyon, France; [Flaherty, K. R.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Inoue, Y.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Kim, D. S.] Univ Ulsan, Asan Med Ctr, Seoul, South Korea; [Kolb, M.] McMaster Univ, Hamilton, ON, Canada; [Noble, P. W.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Selman, M.] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Taniguchi, H.] Tosei Gen Hosp, Seto, Aichi, Japan; [Brun, M.; Girard, M.] Boehringer Ingelheim France SAS, Reims, France; [Schlenker-Herceg, R.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Disse, B.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Collard, H. R.] Univ Calif San Francisco, San Francisco, CA 94143 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-001	28	28				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300078		
J	Koba, T; Arai, T; Sugimoto, C; Hirose, M; Matsumuro, A; Homma, T; Akira, M; Kitaichi, M; Hayashi, S; Inoue, Y				Koba, T.; Arai, T.; Sugimoto, C.; Hirose, M.; Matsumuro, A.; Homma, T.; Akira, M.; Kitaichi, M.; Hayashi, S.; Inoue, Y.			TRANSBRONCHIAL LUNG BIOPSY FOR THE DIAGNOSIS OF LYMPHANGIOLEIOMYOMATOSIS	RESPIROLOGY			English	Meeting Abstract									[Koba, T.; Hayashi, S.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Internal Med, Gifu, Japan; [Arai, T.; Hirose, M.; Matsumuro, A.; Homma, T.; Inoue, Y.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Diffuse Lung Dis & Resp Failure, Sakai, Osaka, Japan; [Sugimoto, C.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Div Clin Trial, Sakai, Osaka, Japan; [Akira, M.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Radiol, Sakai, Osaka, Japan; [Kitaichi, M.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Pathol, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-006	29	29				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300082		
J	Tazawa, R; Nakagaki, K; Ito, Y; Hashimoto, A; Tanaka, T; Akasaka, KI; Nakata, K				Tazawa, R.; Nakagaki, K.; Ito, Y.; Hashimoto, A.; Tanaka, T.; Akasaka, K-, I; Nakata, K.			A PRE-CLINICAL STUDY FOR DEVELOPMENT OF A NEW GM-CSF INHALATION DRUG AS A TREATMENT OF PULMONARY ALVEOLAR PROTEINOSIS	RESPIROLOGY			English	Meeting Abstract									[Tazawa, R.; Ito, Y.; Hashimoto, A.; Tanaka, T.; Akasaka, K-, I; Nakata, K.] Niigata Univ, Med & Dent Hosp, Niigata 95021, Japan; [Nakagaki, K.] Nippon Vet & Life Sci Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-005	29	29				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300081		
J	Ichimura, Y; Tsushima, K; Matsumura, T; Yokota, A; Terada, J; Iesato, K; Sakao, S; Tada, Y; Tanabe, N; Tatsumi, K				Ichimura, Y.; Tsushima, K.; Matsumura, T.; Yokota, A.; Terada, J.; Iesato, K.; Sakao, S.; Tada, Y.; Tanabe, N.; Tatsumi, K.			PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS	RESPIROLOGY			English	Meeting Abstract									[Ichimura, Y.; Tsushima, K.; Matsumura, T.; Yokota, A.; Terada, J.; Iesato, K.; Sakao, S.; Tada, Y.; Tanabe, N.; Tatsumi, K.] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-009	30	30				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300085		
J	Taniguchi, H; Xu, Z; Azuma, A; Inoue, Y; Li, H; Fujimoto, T; Bailes, Z; Schlenker-Herceg, R; Kim, DS				Taniguchi, H.; Xu, Z.; Azuma, A.; Inoue, Y.; Li, H.; Fujimoto, T.; Bailes, Z.; Schlenker-Herceg, R.; Kim, D. S.			SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE INPULSIS (TM) TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS	RESPIROLOGY			English	Meeting Abstract									[Taniguchi, H.] Tosei Gen Hosp, Seto, Aichi, Japan; [Xu, Z.] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Azuma, A.] Nippon Med Sch, Tokyo 113, Japan; [Inoue, Y.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Li, H.] Shanghai Pulm Hosp, Shanghai, Peoples R China; [Fujimoto, T.] Nippon Boehringer Ingelheim Co Ltd, Tokyo, Japan; [Bailes, Z.] Boehringer Ingelheim Ltd, Bracknell, Berks, England; [Schlenker-Herceg, R.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Kim, D. S.] Univ Ulsan, Asan Med Ctr, Seoul, South Korea								0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-007	30	30				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300083		
J	Nakaoka, H; Baba, H; Okafuji, K; Kitamura, A; Tomishima, Y; Jinta, T; Nishimura, N; Chohnabayashi, N				Nakaoka, H.; Baba, H.; Okafuji, K.; Kitamura, A.; Tomishima, Y.; Jinta, T.; Nishimura, N.; Chohnabayashi, N.			CASE ANALYSIS OF INTERSTITIAL LUNG DISEASES INDUCED BY BREAST CANCER CHEMOTHERAPY	RESPIROLOGY			English	Meeting Abstract									[Nakaoka, H.; Baba, H.; Okafuji, K.; Kitamura, A.; Tomishima, Y.; Jinta, T.; Nishimura, N.; Chohnabayashi, N.] St Lukes Int Hosp, Div Pulm Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-011	31	31				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300087		
J	Kobayashi, T; Arai, T; Sugimoto, C; Homma, T; Hirose, M; Matsumuro, M; Akira, M; Kitaichi, M; Hayashi, S; Inoue, Y				Kobayashi, T.; Arai, T.; Sugimoto, C.; Homma, T.; Hirose, M.; Matsumuro, M.; Akira, M.; Kitaichi, M.; Hayashi, S.; Inoue, Y.			IMPROVEMENT OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS AFTER INFECTIOUS EPISODES	RESPIROLOGY			English	Meeting Abstract									[Kobayashi, T.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Resp Med, Sakai, Osaka, Japan; [Arai, T.; Homma, T.; Hirose, M.; Matsumuro, M.; Inoue, Y.] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Diffuse Lung Dis & Resp Failure, Sakai, Osaka, Japan; [Sugimoto, C.] Natl Hosp Org, Div Clin Trial, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan; [Akira, M.] Natl Hosp Org, Dept Radiol, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan; [Kitaichi, M.] Natl Hosp Org, Dept Pathol, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan; [Hayashi, S.] Natl Hosp Org, Dept Internal Med, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-I-014	32	32				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300090		
J	Nurwidya, F; Takahashi, F; Kobayashi, I; Shimada, N; Murakami, A; Baskoro, H; Suina, K; Kanemaru, R; Yagishita, S; Asao, T; Ohashi, R; Muraki, K; Yoshioka, Y; Takahashi, M; Sasaki, S; Takahashi, K				Nurwidya, F.; Takahashi, F.; Kobayashi, I; Shimada, N.; Murakami, A.; Baskoro, H.; Suina, K.; Kanemaru, R.; Yagishita, S.; Asao, T.; Ohashi, R.; Muraki, K.; Yoshioka, Y.; Takahashi, M.; Sasaki, S.; Takahashi, K.			TRANSLATIONAL EVIDENCE OF ZINC-FINGER E-BOX BINDING HOMEOBOX 1 INVOLVEMENT IN ACQUIRED RESISTANCE TO GEFITINIB IN NON-SMALL CELL LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Nurwidya, F.; Takahashi, F.; Kobayashi, I; Shimada, N.; Murakami, A.; Baskoro, H.; Suina, K.; Kanemaru, R.; Yagishita, S.; Asao, T.; Ohashi, R.; Muraki, K.; Yoshioka, Y.; Takahashi, M.; Sasaki, S.; Takahashi, K.] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-J-006	34	34				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300098		
J	Itakura, M; Terashima, Y; Singyoji, M; Matui, Y; Yoshida, Y; Ashinuma, H; Moriya, Y; Ishibashi, F; Tamura, H; Iizasa, T; Sekine, I				Itakura, M.; Terashima, Y.; Singyoji, M.; Matui, Y.; Yoshida, Y.; Ashinuma, H.; Moriya, Y.; Ishibashi, F.; Tamura, H.; Iizasa, T.; Sekine, I			KRUPPEL-LIKE FACTOR 2 IMPROVES POSTOPERATIVE PROGNOSIS OF LUNG ADENOCARCINOMA PATIENTS	RESPIROLOGY			English	Meeting Abstract									[Itakura, M.; Terashima, Y.; Singyoji, M.; Matui, Y.; Yoshida, Y.; Ashinuma, H.; Moriya, Y.; Ishibashi, F.; Tamura, H.; Iizasa, T.; Sekine, I] Chiba Canc Ctr, Dept Thorac Dis, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-J-010	35	35				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300102		
J	Marukawa, M				Marukawa, M.			ONCOLOGICAL EMERGENCIES ARISING AT DIAGNOSIS OF LUNG CANCER IN OUR HOSPITAL	RESPIROLOGY			English	Meeting Abstract									[Marukawa, M.] Fukuyama Med Ctr, Dept Resp Med, Fukuyama, Hiroshima, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-J-020	38	38				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300112		
J	Putra, AC; Eguchi, H; Lee, KL; Yamane, Y; Gustine, E; Nishiyama, M; Isobe, T; Keiko, H; Poellinger, L; Tanimoto, K				Putra, A. C.; Eguchi, H.; Lee, K. L.; Yamane, Y.; Gustine, E.; Nishiyama, M.; Isobe, T.; Keiko, Hiyama; Poellinger, L.; Tanimoto, K.			GENETIC ANALYSIS OF HYPOXIA INDUCIBLE FACTOR-2 ALPHA IN LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Putra, A. C.; Yamane, Y.; Gustine, E.; Keiko, Hiyama; Tanimoto, K.] Hiroshima Univ, Dept Radiat Med, RIRBM, Hiroshima 730, Japan; [Putra, A. C.] Univ Indonesia, Dept Pulmonol & Resp Med, Fac Med, Depok, Indonesia; [Eguchi, H.] Saitama Med Univ, Res Ctr Genom Med, Moroyama, Saitama, Japan; [Lee, K. L.; Poellinger, L.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Nishiyama, M.] Shimane Univ, Dept Internal Med, Div Med Oncol & Resp Med, Fac Med, Matsue, Shimane, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-J-019	38	38				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300111		
J	Nakano, K; Sugiyama, K; Satoh, H; Suka, S; Arifuku, H; Watanabe, H; Wakayama, T; Kohyama, K; Fueki, N; Fukushima, Y				Nakano, K.; Sugiyama, K.; Satoh, H.; Suka, S.; Arifuku, H.; Watanabe, H.; Wakayama, T.; Kohyama, K.; Fueki, N.; Fukushima, Y.			EFFECT OF THROMBOMODULIN ALPHA FOR DISSEMINATED INTRAVASCULAR COAGULATION TREATMENT IN PATIENTS WITH LUNG CANCER	RESPIROLOGY			English	Meeting Abstract									[Nakano, K.; Sugiyama, K.; Satoh, H.; Suka, S.; Arifuku, H.; Watanabe, H.; Wakayama, T.; Kohyama, K.; Fueki, N.; Fukushima, Y.] Dokkyo Med Univ, Koshigaya Hosp, Dept Resp Med, Koshigaya, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-M-003	44	44				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300127		
J	Seki, M; Yamamoto, N; Akeda, Y; Hamaguchi, S; Oishi, K; Tomono, K				Seki, M.; Yamamoto, N.; Akeda, Y.; Hamaguchi, S.; Oishi, K.; Tomono, K.			THE PATHOPHYSIOLOGICAL COMPARISON OF SECONDARY PNEUMOCOCCAL PNEUMONIA AFTER H1N1 PANDEMIC 2009 OR H1N1 NEW CALEDONIA INFLUENZA	RESPIROLOGY			English	Meeting Abstract									[Seki, M.; Yamamoto, N.; Hamaguchi, S.; Tomono, K.] Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Suita, Osaka 565, Japan; [Akeda, Y.; Oishi, K.] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-N-002	46	46				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300131		
J	Yoshikawa, H; Komiya, K; Umeki, K; Kushima, H; Toba, S; Nureki, SI; Ando, M; Tokimatsu, I; Hiramatsu, K; Kadota, JI				Yoshikawa, H.; Komiya, K.; Umeki, K.; Kushima, H.; Toba, S.; Nureki, S-, I; Ando, M.; Tokimatsu, I; Hiramatsu, K.; Kadota, J-, I			LONG-TERM MACROLIDE ANTIBIOTIC THERAPY MAY PREVENT THE DEVELOPMENT OF PNEUMONIA IN THE ELDERLY	RESPIROLOGY			English	Meeting Abstract									[Yoshikawa, H.; Komiya, K.; Umeki, K.; Kushima, H.; Toba, S.; Nureki, S-, I; Ando, M.; Tokimatsu, I; Hiramatsu, K.; Kadota, J-, I] Oita Univ, Fac Med, Oita, Japan; [Komiya, K.] Tenshindo Hetsugi Hosp, Clin Res Ctr Resp Med, Oita, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-N-004	46	46				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300133		
J	Nemoto, M; Nakashima, K; Matsue, Y; Ishifuji, T; Katsurada, N; Morimoto, K; Ariyoshi, K; Aoshima, M				Nemoto, M.; Nakashima, K.; Matsue, Y.; Ishifuji, T.; Katsurada, N.; Morimoto, K.; Ariyoshi, K.; Aoshima, M.			INCREMENTAL PROGNOSTIC PREDICT ABILITY OF CHEST COMPUTED TOMOGRAPHY IN PATIENTS WITH COMMUNITY ONSET PNEUMONIA	RESPIROLOGY			English	Meeting Abstract									[Nemoto, M.; Nakashima, K.; Matsue, Y.; Ishifuji, T.; Katsurada, N.; Morimoto, K.; Ariyoshi, K.; Aoshima, M.] APSG J, Tokyo, Japan; [Nemoto, M.; Nakashima, K.; Katsurada, N.; Aoshima, M.] Kameda Med Ctr, Dept Pulmonol, Kamogawa, Japan; [Matsue, Y.] Kameda Med Ctr, Dept Cardiol, Kamogawa, Japan; [Ishifuji, T.; Morimoto, K.; Ariyoshi, K.] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-N-009	47	47				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300138		
J	Kido, T; Kawanami, Y; Yatera, K; Mukae, H				Kido, T.; Kawanami, Y.; Yatera, K.; Mukae, H.			THE ROLE OF NITRIC OXIDE IN TRACHEOBRONCHIAL CILIARY MOTILITY	RESPIROLOGY			English	Meeting Abstract									[Kido, T.; Kawanami, Y.; Yatera, K.; Mukae, H.] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	NOV	2014	19			3	SI	O-P-001	53	53				1	Respiratory System	Respiratory System	AS8YQ	WOS:000344531300155		
